Citrus Sinensis ID: 017177

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370------
Protein Sequence
MGNCFGSLFVASNSSSNNINANASSSSAGAYNKYGHTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTTMLKYQILAWQSWGPLVESHMLQPGLWAHMVMQLQNMLQQVIFISSPLNLEML
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccccEEEEEccccccccccccccEEEEEEcccccccHHHHHHHHHHHHHcccccccccEEEEEcccccEEEEEEccccccHHHHccccccccccccHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccEEEEEEEEEEEEcHHHHHHHcccccccccccHHHHHHHHHHHHHccccccHHccccccccccHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHHHHHHcccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHHccccccccEEEEEEEcccccccccccccEEEEEEEcccccccccHHHHHHHHHHHHHccccHEEEEEEEEccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHccccEEEEcccHccEEEcccccccccEHcHccccccccccccEEEEEcccccccccHHccccccccccHHHHHHHHHHHcccccccccccccccHHHHHHHHHHccccccHHHHHHHHccHHHcccccHHHHHHHHHHHHHHHHHHHHHcccccccccc
Coil and Loop (DISEMBL)
MGNCFGSLFVasnsssnninanassssagaynkyghtmeisatsssagkSQFSQAISEagveeaspngqiletpdlkvfsfldlksatknfkpdsllgeggfgrvykgwvddktlapsktgLGMVVAIKKlnpesmqgFEEWQSEVNflgrlshpnLVKLLGYCWEDKELLLVYEYMQrgslenhlfrrnpsiqplswDIRLKIAIGAArglgflhtseKKVIYrdfkasnilldgvgflfdsHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTTMLKYQILAWqswgplveshmlqpgLWAHMVMQLQNMLQQVIFissplnleml
Flexible Loop (DISEMBL)
MGNCFGSLFVASNSSSNNINANASSSSAGAYNKYGHTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATknfkpdsllgeggFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTTMLKYQILAWQSWGPLVESHMLQPGLWAHMVMQLQNMLQQVIFISSPLNLEML
Low Complexity Region (SEG)
MGNCFGSLFVasnsssnninanassssagaYNKYGHTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHyiyiyihtyiiyiyiyvyiymyiyKCLRYAILYSVLLPRIYAWIKYLTLLKYsnsfafvfscvfsfYRTTMLKYQILAWQSWGPLVESHMLQPGLWAHmvmqlqnmlqqvIFISSPLNLEML
Disordered region (IsUnstruct)
************************************************************************TPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTTMLKYQILAWQSWGPLVESHMLQPGLWAHMVMQLQNMLQQVIFIS********
Disordered Region (DISOPRED)
MGNC***********************************************************************LKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRY*****VLL*RIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTTMLKYQILAWQSWGPLV********LWAHMVMQLQNMLQQVIFISSPLNLEM*
Disordered Region (DISEMBL)
MGNCFGSLFVASNSSSNNINANASSSSAGAYNKYGHTMEIS*************************NGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTTMLKYQILAWQSWGPLVESHMLQPGLWAHMVMQLQNMLQQVIFISSPLNLEML
Disordered Region (DISPRO)
*************************************************************************PDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTTMLKYQILAWQSWGPLVESHMLQPGLWAHMVMQLQNMLQQVIFI*********
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHoooooHHHHHHHHHHHHHHHHHHiiiiiiHHHHHHHHHHHHHHHHHHHoooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGNCFGSLFVASNSSSNNINANASSSSAGAYNKYGHTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTTMLKYQILAWQSWGPLVESHMLQPGLWAHMVMQLQNMLQQVIFISSPLNLEML
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	376	2.2.26 [Sep-21-2011]
P27450	419	Probable serine/threonine	yes	no	0.542	0.486	0.632	1e-73
P46573	412	Protein kinase APK1B, chl	no	no	0.446	0.407	0.660	9e-66
Q06548	410	Protein kinase APK1A, chl	no	no	0.529	0.485	0.570	3e-65
P43293	389	Probable serine/threonine	no	no	0.446	0.431	0.642	8e-64
O49840	426	Protein kinase 2B, chloro	no	no	0.441	0.389	0.660	2e-62
O49839	426	Protein kinase 2A, chloro	no	no	0.441	0.389	0.630	2e-60
O48814	395	Serine/threonine-protein	no	no	0.561	0.534	0.506	3e-60
Q9SRH7	490	Receptor-like serine/thre	no	no	0.420	0.322	0.660	2e-58
Q8H186	389	Probable receptor-like pr	no	no	0.446	0.431	0.597	6e-58
Q9LFP7	493	Probable receptor-like pr	no	no	0.561	0.427	0.531	2e-57

>sp|P27450|CX32_ARATH Probable serine/threonine-protein kinase Cx32, chloroplastic OS=Arabidopsis thaliana GN=At4g35600 PE=1 SV=2

 Score =  276 bits (707), Expect = 1e-73,   Method: Compositional matrix adjust.
 Identities = 141/223 (63%), Positives = 175/223 (78%), Gaps = 19/223 (8%)

Query: 14  SSSNNINANASSSSAGAYNKYGHTMEISATSSSAGK-SQFSQAISEAGVEEASPNGQILE 72
           +++N+ N    SS+ GA            T+SS G+ SQFS  IS   +   S +G++LE
Sbjct: 23  TTNNHSNGTEFSSTTGA-----------TTNSSVGQQSQFSD-ISTGII---SDSGKLLE 67

Query: 73  TPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN 132
           +P+LKV++FLDLK+ATKNFKPDS+LG+GGFG+VY+GWVD  TLAPS+ G GM+VAIK+LN
Sbjct: 68  SPNLKVYNFLDLKTATKNFKPDSMLGQGGFGKVYRGWVDATTLAPSRVGSGMIVAIKRLN 127

Query: 133 PESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS 192
            ES+QGF EW+SEVNFLG LSH NLVKLLGYC EDKELLLVYE+M +GSLE+HLFRRN  
Sbjct: 128 SESVQGFAEWRSEVNFLGMLSHRNLVKLLGYCREDKELLLVYEFMPKGSLESHLFRRN-- 185

Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
             P  WD+R+KI IGAARGL FLH+ +++VIYRDFKASNILLD
Sbjct: 186 -DPFPWDLRIKIVIGAARGLAFLHSLQREVIYRDFKASNILLD 227

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  251 bits (640), Expect = 9e-66,   Method: Compositional matrix adjust.
 Identities = 111/168 (66%), Positives = 141/168 (83%)

Query: 68  GQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVA 127
           G+IL++P+LK F+F +LK+AT+NF+PDS+LGEGGFG V+KGW+D++TL  SK G G+V+A
Sbjct: 46  GEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIA 105

Query: 128 IKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLF 187
           +KKLN +  QG +EW +EVN+LG+ SHPNLVKL+GYC ED+  LLVYE+M RGSLENHLF
Sbjct: 106 VKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLF 165

Query: 188 RRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           RR    QPLSW +RLK+A+GAA+GL FLH +E  VIYRDFK SNILLD
Sbjct: 166 RRGSYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLD 213

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1

 Score =  249 bits (635), Expect = 3e-65,   Method: Compositional matrix adjust.
 Identities = 118/207 (57%), Positives = 156/207 (75%), Gaps = 8/207 (3%)

Query: 37  TMEISATSSSAGKSQFSQAISEAGVEEAS--------PNGQILETPDLKVFSFLDLKSAT 88
           + ++ A SS A     ++ I   G + +S          G+IL++P+LK FSF +LKSAT
Sbjct: 6   SAQVKAESSGASTKYDAKDIGSLGSKASSVSVRPSPRTEGEILQSPNLKSFSFAELKSAT 65

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
           +NF+PDS+LGEGGFG V+KGW+D+K+L  S+ G G+V+A+KKLN +  QG +EW +EVN+
Sbjct: 66  RNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLNQDGWQGHQEWLAEVNY 125

Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           LG+ SH +LVKL+GYC ED+  LLVYE+M RGSLENHLFRR    QPLSW +RLK+A+GA
Sbjct: 126 LGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLYFQPLSWKLRLKVALGA 185

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLD 235
           A+GL FLH+SE +VIYRDFK SNILLD
Sbjct: 186 AKGLAFLHSSETRVIYRDFKTSNILLD 212

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  244 bits (623), Expect = 8e-64,   Method: Compositional matrix adjust.
 Identities = 108/168 (64%), Positives = 140/168 (83%)

Query: 68  GQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVA 127
           G+IL+  +LK FS  +LKSAT+NF+PDS++GEGGFG V+KGW+D+ +LAPSK G G+V+A
Sbjct: 45  GEILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIA 104

Query: 128 IKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLF 187
           +K+LN E  QG  EW +E+N+LG+L HPNLVKL+GYC E++  LLVYE+M RGSLENHLF
Sbjct: 105 VKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLF 164

Query: 188 RRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           RR    QPLSW+ R+++A+GAARGL FLH ++ +VIYRDFKASNILLD
Sbjct: 165 RRGTFYQPLSWNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLD 212

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1

 Score =  239 bits (611), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 111/168 (66%), Positives = 139/168 (82%), Gaps = 2/168 (1%)

Query: 68  GQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVA 127
           G+IL +P+LK F+F +LK+AT+NF+PDSLLGEGGFG V+KGW+D  TL  SK G G+VVA
Sbjct: 60  GEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVA 119

Query: 128 IKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLF 187
           +KKL  E  QG +EW +EVN+LG+LSHPNLVKL+GYC E +  LLVYE+M +GSLENHLF
Sbjct: 120 VKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLF 179

Query: 188 RRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           RR    QPL+W IR+K+AIGAA+GL FLH ++ +VIYRDFKA+NILLD
Sbjct: 180 RRG--AQPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLD 225

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1

 Score =  233 bits (593), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 106/168 (63%), Positives = 138/168 (82%), Gaps = 2/168 (1%)

Query: 68  GQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVA 127
           G+IL +P+LK F+F +LK+ATKNF+ D+LLGEGGFG V+KGW+D  +L  S+ G G+VVA
Sbjct: 63  GEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVA 122

Query: 128 IKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLF 187
           +K+L PE  QG +EW +EVN+LG+LSHPNLV L+GYC E +  LLVYE+M +GSLENHLF
Sbjct: 123 VKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLF 182

Query: 188 RRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           RR    QPL+W IR+K+A+GAA+GL FLH ++ +VIYRDFKA+NILLD
Sbjct: 183 RR--GAQPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLD 228

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1

 Score =  232 bits (592), Expect = 3e-60,   Method: Compositional matrix adjust.
 Identities = 119/235 (50%), Positives = 160/235 (68%), Gaps = 24/235 (10%)

Query: 1   MGNCFGSLFVASNSSSNNINANASSSSAGAYNKYGHTMEISATSSSAGKSQFSQAISEAG 60
           MG+CF S   A      +I  N  SS     + YG ++    +SS+   +Q ++      
Sbjct: 1   MGSCFSSRVKA------DIFHNGKSS-----DLYGLSLSSRKSSSTVAAAQKTE------ 43

Query: 61  VEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKT 120
                  G+IL +  +K F+F +LK AT+NF+PDS++GEGGFG V+KGW+D+ TL P+K 
Sbjct: 44  -------GEILSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKP 96

Query: 121 GLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRG 180
           G G+V+A+KKLN E  QG  EW +E+N+LG+LSHPNLVKL+GYC ED+  LLVYE+MQ+G
Sbjct: 97  GTGLVIAVKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKG 156

Query: 181 SLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           SLENHLFRR    +PL W +R+ +A+ AA+GL FLH+   KVIYRD KASNILLD
Sbjct: 157 SLENHLFRRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLD 211

Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1

 Score =  226 bits (577), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 107/162 (66%), Positives = 129/162 (79%), Gaps = 4/162 (2%)

Query: 76  LKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES 135
           LK FSF+DLK AT+NF+P+SLLGEGGFG V+KGWV++   AP K G G+ VA+K LNP+ 
Sbjct: 121 LKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDG 180

Query: 136 MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP 195
           +QG +EW +E+N+LG L HPNLVKL+GYC ED + LLVYE+M RGSLENHLFRR+    P
Sbjct: 181 LQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LP 237

Query: 196 LSWDIRLKIAIGAARGLGFLHTSE-KKVIYRDFKASNILLDG 236
           L W IR+KIA+GAA+GL FLH    K VIYRDFK SNILLDG
Sbjct: 238 LPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDG 279

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1

 Score =  224 bits (572), Expect = 6e-58,   Method: Compositional matrix adjust.
 Identities = 101/169 (59%), Positives = 136/169 (80%), Gaps = 1/169 (0%)

Query: 68  GQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVA 127
           G+IL +  +K FSF +LK AT+NF+ DS++GEGGFG V++GW+D+ TL P+K+  G+V+A
Sbjct: 38  GEILSSTTVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKSSSGLVIA 97

Query: 128 IKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLF 187
           +K+LNP+  QG  EW +E+N+LG+LSHPNLVKL+GYC ED++ LLVYE+M +GSLENHLF
Sbjct: 98  VKRLNPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLF 157

Query: 188 RR-NPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
              N   +PLSW +R+K+A+ AA+GL FLH+   KVIYRD KASNILLD
Sbjct: 158 ANGNKDFKPLSWILRIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLD 206

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  223 bits (568), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 118/222 (53%), Positives = 150/222 (67%), Gaps = 11/222 (4%)

Query: 22  NASSSSAGAYNKYGHTMEISATSSSAGK---SQFSQAISEAGVEEASPNGQILE----TP 74
           +ASSSS    N    TME  + +  +      Q S   + +  E +S    I E    + 
Sbjct: 66  DASSSSIYGSNCTVTTMESKSANEKSNDQPVGQVSSTTTTSNAESSSSTPVISEELNISS 125

Query: 75  DLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE 134
            L+ F+F DLK +T+NF+P+SLLGEGGFG V+KGW+++   AP K G G+ VA+K LNP+
Sbjct: 126 HLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPD 185

Query: 135 SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQ 194
            +QG +EW +E+NFLG L HPNLVKL+GYC ED + LLVYE+M RGSLENHLFRR+    
Sbjct: 186 GLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---L 242

Query: 195 PLSWDIRLKIAIGAARGLGFLHTSE-KKVIYRDFKASNILLD 235
           PL W IR+KIA+GAA+GL FLH    K VIYRDFK SNILLD
Sbjct: 243 PLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLD 284

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	376
255561407	420	serine/threonine-protein kinase cx32, pu	0.619	0.554	0.730	3e-97
296088660	315	unnamed protein product [Vitis vinifera]	0.627	0.749	0.685	7e-89
359477083	310	PREDICTED: probable serine/threonine-pro	0.627	0.761	0.685	7e-89
356529677	397	PREDICTED: probable serine/threonine-pro	0.595	0.564	0.680	4e-87
224114471	337	predicted protein [Populus trichocarpa]	0.454	0.507	0.853	2e-85
357517679	408	Serine/threonine protein kinase BIK1 [Me	0.531	0.490	0.734	3e-85
224084090	437	predicted protein [Populus trichocarpa]	0.625	0.537	0.686	2e-84
449456951	405	PREDICTED: probable serine/threonine-pro	0.611	0.567	0.663	5e-84
449495183	405	PREDICTED: LOW QUALITY PROTEIN: probable	0.611	0.567	0.668	1e-83
242060210	436	hypothetical protein SORBIDRAFT_04g00136	0.619	0.534	0.640	2e-82

>gi|255561407|ref|XP_002521714.1| serine/threonine-protein kinase cx32, putative [Ricinus communis] gi|223539105|gb|EEF40701.1| serine/threonine-protein kinase cx32, putative [Ricinus communis]

 Score =  361 bits (927), Expect = 3e-97,   Method: Compositional matrix adjust.
 Identities = 176/241 (73%), Positives = 208/241 (86%), Gaps = 8/241 (3%)

Query: 1   MGNCFGSL-FVASNSSSN---NINANASSSSAG-AYNKYGHTMEISATSSSAGKSQFSQA 55
           MGNCF S    A+N+S++    IN     SS+   +N    TM+ SATSSSAGKSQFS A
Sbjct: 1   MGNCFVSFSHDATNNSTSAFSTINPTTPGSSSNITFNTT--TMDFSATSSSAGKSQFSAA 58

Query: 56  ISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTL 115
           +SE   ++A+PNGQILE P++K F+F DLKSATKNF+ D+LLGEGGFG+V+KGW+D+KT 
Sbjct: 59  VSEMN-DDANPNGQILEVPNMKEFTFADLKSATKNFRADTLLGEGGFGKVFKGWIDEKTY 117

Query: 116 APSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYE 175
           APSKTG+GMVVAIKKLN ESMQGF+EWQSEVNFLGRLSHPNLVKL+GYCWEDKELLLVYE
Sbjct: 118 APSKTGIGMVVAIKKLNSESMQGFQEWQSEVNFLGRLSHPNLVKLIGYCWEDKELLLVYE 177

Query: 176 YMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           +MQ+GSLENHLFR+NP+++PLSW++RLKIAIGAARGL FLHTS+KKVIYRDFKASNILLD
Sbjct: 178 FMQKGSLENHLFRKNPAVEPLSWELRLKIAIGAARGLAFLHTSDKKVIYRDFKASNILLD 237

Query: 236 G 236
           G
Sbjct: 238 G 238

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296088660|emb|CBI37651.3| unnamed protein product [Vitis vinifera]

 Score =  333 bits (855), Expect = 7e-89,   Method: Compositional matrix adjust.
 Identities = 166/242 (68%), Positives = 191/242 (78%), Gaps = 6/242 (2%)

Query: 1   MGNCFGSLFVASNSS----SNNINANASS--SSAGAYNKYGHTMEISATSSSAGKSQFSQ 54
           MGNC GS       S    S  +N   SS  S +G  +   +   +S TSSSAG  + S 
Sbjct: 1   MGNCCGSPSTEPTPSFPGTSTQVNEVPSSKFSVSGTSDNTSNDGGLSITSSSAGNGRLSA 60

Query: 55  AISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKT 114
           A +    +EA P GQIL TP+LK+FSF DLK+AT+NFK D++LG GGFG V+KG VD+KT
Sbjct: 61  APASESHDEAFPEGQILPTPNLKIFSFADLKTATRNFKSDNVLGIGGFGTVFKGSVDEKT 120

Query: 115 LAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVY 174
           LAP K G GMVVAIKKLNPES+QGF+EWQSEVNFLGRLSHPNLVKLLGYCW+DKELLLVY
Sbjct: 121 LAPCKAGTGMVVAIKKLNPESLQGFQEWQSEVNFLGRLSHPNLVKLLGYCWDDKELLLVY 180

Query: 175 EYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           E+MQ+GSLENHLFRRNPSI+PLSW +RLKIAIGAARGL FLHTS+K+VIYRDFKASNILL
Sbjct: 181 EFMQKGSLENHLFRRNPSIEPLSWQLRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL 240

Query: 235 DG 236
           DG
Sbjct: 241 DG 242

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359477083|ref|XP_002280326.2| PREDICTED: probable serine/threonine-protein kinase Cx32, chloroplastic-like [Vitis vinifera]

 Score =  333 bits (854), Expect = 7e-89,   Method: Compositional matrix adjust.
 Identities = 166/242 (68%), Positives = 191/242 (78%), Gaps = 6/242 (2%)

Query: 1   MGNCFGSLFVASNSS----SNNINANASS--SSAGAYNKYGHTMEISATSSSAGKSQFSQ 54
           MGNC GS       S    S  +N   SS  S +G  +   +   +S TSSSAG  + S 
Sbjct: 1   MGNCCGSPSTEPTPSFPGTSTQVNEVPSSKFSVSGTSDNTSNDGGLSITSSSAGNGRLSA 60

Query: 55  AISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKT 114
           A +    +EA P GQIL TP+LK+FSF DLK+AT+NFK D++LG GGFG V+KG VD+KT
Sbjct: 61  APASESHDEAFPEGQILPTPNLKIFSFADLKTATRNFKSDNVLGIGGFGTVFKGSVDEKT 120

Query: 115 LAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVY 174
           LAP K G GMVVAIKKLNPES+QGF+EWQSEVNFLGRLSHPNLVKLLGYCW+DKELLLVY
Sbjct: 121 LAPCKAGTGMVVAIKKLNPESLQGFQEWQSEVNFLGRLSHPNLVKLLGYCWDDKELLLVY 180

Query: 175 EYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           E+MQ+GSLENHLFRRNPSI+PLSW +RLKIAIGAARGL FLHTS+K+VIYRDFKASNILL
Sbjct: 181 EFMQKGSLENHLFRRNPSIEPLSWQLRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL 240

Query: 235 DG 236
           DG
Sbjct: 241 DG 242

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356529677|ref|XP_003533415.1| PREDICTED: probable serine/threonine-protein kinase Cx32, chloroplastic-like [Glycine max]

 Score =  327 bits (839), Expect = 4e-87,   Method: Compositional matrix adjust.
 Identities = 164/241 (68%), Positives = 192/241 (79%), Gaps = 17/241 (7%)

Query: 1   MGNCFGSLFVASNSSSNNINANASSSSAGAYNKYGHTMEISATSSSAGKSQFSQAIS--- 57
           MG CF      S+SS N     + S+S  + N     +  SAT+SSAGKSQFS+  S   
Sbjct: 1   MGLCF------SSSSPNPPQQYSGSASTDSKN-----VGFSATTSSAGKSQFSEIASGSI 49

Query: 58  ---EAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKT 114
              +  +   SP+GQILE P+LKVFSF DLKSATK+FK D+LLGEGGFGRVYKGW+D+KT
Sbjct: 50  DSSQGSLPLPSPHGQILERPNLKVFSFGDLKSATKSFKSDTLLGEGGFGRVYKGWLDEKT 109

Query: 115 LAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVY 174
           L+P+K G GMVVAIKKLNP+S QGF+EWQSEVNFLGRLSHPNLVKLLGYCW+D ELLLVY
Sbjct: 110 LSPAKAGSGMVVAIKKLNPQSTQGFQEWQSEVNFLGRLSHPNLVKLLGYCWDDDELLLVY 169

Query: 175 EYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           E++ +GSLENHLFRRNP+I+PLSW+ R KIAIGAARGL FLH SEK++IYRDFKASNILL
Sbjct: 170 EFLPKGSLENHLFRRNPNIEPLSWNTRFKIAIGAARGLAFLHASEKQIIYRDFKASNILL 229

Query: 235 D 235
           D
Sbjct: 230 D 230

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224114471|ref|XP_002332362.1| predicted protein [Populus trichocarpa] gi|222874679|gb|EEF11810.1| predicted protein [Populus trichocarpa]

 Score =  322 bits (825), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 146/171 (85%), Positives = 164/171 (95%)

Query: 66  PNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMV 125
           PNGQILE+P+LK F+F DLKS TKNFK D+LLGEGGFG+VYKGW+D++T APSK+G GMV
Sbjct: 1   PNGQILESPNLKEFTFADLKSTTKNFKSDTLLGEGGFGKVYKGWIDERTYAPSKSGSGMV 60

Query: 126 VAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENH 185
           VAIKKLNPES+QGF+EWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYE+MQ+GSLENH
Sbjct: 61  VAIKKLNPESVQGFQEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEFMQKGSLENH 120

Query: 186 LFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
           LFR+NP+I+PLSWDIRLKIA+GAARGL FLHTS+KKVIYRDFKASNILLDG
Sbjct: 121 LFRKNPNIEPLSWDIRLKIAVGAARGLTFLHTSDKKVIYRDFKASNILLDG 171

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357517679|ref|XP_003629128.1| Serine/threonine protein kinase BIK1 [Medicago truncatula] gi|355523150|gb|AET03604.1| Serine/threonine protein kinase BIK1 [Medicago truncatula]

 Score =  321 bits (823), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 152/207 (73%), Positives = 178/207 (85%), Gaps = 7/207 (3%)

Query: 37  TMEISATSSSAGKSQFSQAIS-------EAGVEEASPNGQILETPDLKVFSFLDLKSATK 89
           T+  SAT+SSAG+SQFS+  S       +  +   SPNGQILE P+LKVFSF++LK+ATK
Sbjct: 31  TVGFSATTSSAGRSQFSEVASGSIDDTTDGSLPFPSPNGQILERPNLKVFSFIELKAATK 90

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFL 149
           +FK D+LLGEGGFG+VYKGW+D+KTL+P+K G GMVVAIKKLN ES QGF+EWQSEVNFL
Sbjct: 91  SFKSDTLLGEGGFGKVYKGWLDEKTLSPTKAGSGMVVAIKKLNSESTQGFQEWQSEVNFL 150

Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
           GRLSHPNLVKLLGYCW+D ELLLVYE+M +GSLENHLFRRNP+I+PLSW+ R+KIAIGAA
Sbjct: 151 GRLSHPNLVKLLGYCWDDDELLLVYEFMPKGSLENHLFRRNPNIEPLSWNTRIKIAIGAA 210

Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDG 236
           RGL FLH S  +VIYRDFKASNILLDG
Sbjct: 211 RGLAFLHDSADQVIYRDFKASNILLDG 237

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224084090|ref|XP_002307210.1| predicted protein [Populus trichocarpa] gi|222856659|gb|EEE94206.1| predicted protein [Populus trichocarpa]

 Score =  319 bits (817), Expect = 2e-84,   Method: Compositional matrix adjust.
 Identities = 164/239 (68%), Positives = 187/239 (78%), Gaps = 4/239 (1%)

Query: 1   MGNCFGSLFVASNSSSNNINANASSSSAGAYNKYGHTMEISATSSS-AGKSQFSQAISEA 59
           MGNC  S F    S S+  N N S+           T+++SATSSS   +SQFS+A S  
Sbjct: 1   MGNCLRSFFY-DPSPSSIANNNPSTPGTSNSTYSSTTIDVSATSSSIVCRSQFSEAASHD 59

Query: 60  GVEE--ASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAP 117
              E  ++ NGQILE+ +L+ F+F DLK ATKNFK D+LLGEGGFG+VYKGW+D KT AP
Sbjct: 60  EGNEVISNANGQILESSNLEEFTFSDLKRATKNFKSDTLLGEGGFGKVYKGWIDQKTYAP 119

Query: 118 SKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYM 177
           SK+G GMVVAIKKLN  SMQG EEWQSEVNFLGRLSHPNLVKLLG+CWEDKELLLVYE+M
Sbjct: 120 SKSGSGMVVAIKKLNSGSMQGLEEWQSEVNFLGRLSHPNLVKLLGFCWEDKELLLVYEFM 179

Query: 178 QRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
            +GSLENHLFR   +I+PLSWDIRLKIAIGAARGL FLH SEK+VIYRDFKASNILLDG
Sbjct: 180 PKGSLENHLFRSKRNIEPLSWDIRLKIAIGAARGLAFLHASEKQVIYRDFKASNILLDG 238

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449456951|ref|XP_004146212.1| PREDICTED: probable serine/threonine-protein kinase Cx32, chloroplastic-like [Cucumis sativus]

 Score =  317 bits (813), Expect = 5e-84,   Method: Compositional matrix adjust.
 Identities = 156/235 (66%), Positives = 187/235 (79%), Gaps = 5/235 (2%)

Query: 1   MGNCFGSLFVASNSSSNNINANASSSSAGAYNKYGHTMEISATSSSAGKSQFSQAISEAG 60
           MGNC      +S   SN +   A  S+ G    +   +E S T+S+AG SQFS A S   
Sbjct: 1   MGNCL----TSSAHHSNAVPCQAVFSTPGTSGNFSGIVESSGTNSTAGGSQFSAAGS-VD 55

Query: 61  VEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKT 120
           V E+ P+G+IL+ P+LK FSF +LK  TKNF+P+SL+G+GGFG+VYKGWVDDKTLAPSK+
Sbjct: 56  VSESCPSGKILDQPNLKEFSFTELKLITKNFRPESLIGQGGFGKVYKGWVDDKTLAPSKS 115

Query: 121 GLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRG 180
             GMVVAIKKLN ES+QGF++WQ+EVNFLGRL+HPN+VKLLG+CWED ELLLVYE+M RG
Sbjct: 116 NSGMVVAIKKLNAESVQGFQDWQAEVNFLGRLNHPNVVKLLGFCWEDDELLLVYEFMPRG 175

Query: 181 SLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           SLENHLF R  SI+PLSW+ RLKIAIGAARGL FLH+SEK+VIYRDFKASNILLD
Sbjct: 176 SLENHLFGRRSSIEPLSWERRLKIAIGAARGLAFLHSSEKEVIYRDFKASNILLD 230

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449495183|ref|XP_004159758.1| PREDICTED: LOW QUALITY PROTEIN: probable serine/threonine-protein kinase Cx32, chloroplastic-like [Cucumis sativus]

 Score =  316 bits (809), Expect = 1e-83,   Method: Compositional matrix adjust.
 Identities = 157/235 (66%), Positives = 185/235 (78%), Gaps = 5/235 (2%)

Query: 1   MGNCFGSLFVASNSSSNNINANASSSSAGAYNKYGHTMEISATSSSAGKSQFSQAISEAG 60
           MGNC      +S   SN +   A  S+ G    +   +E S T+S+AG SQFS A S   
Sbjct: 1   MGNCL----TSSAHHSNAVPCQAVFSTPGTSGNFSGIVESSGTNSTAGGSQFSAAGS-VD 55

Query: 61  VEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKT 120
           V E  P+G+IL+ P+LK FSF +LK  TKNF+P+SL+G+GGFG+VYKGWVDDKTLAPSK+
Sbjct: 56  VSEPYPSGKILDQPNLKEFSFTELKLITKNFRPESLIGQGGFGKVYKGWVDDKTLAPSKS 115

Query: 121 GLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRG 180
             GMVVAIKKLN ES+QGF+EWQ+EVNFLGRL+HPNLVKLLG+CWED E LLVYE+M RG
Sbjct: 116 NSGMVVAIKKLNAESVQGFQEWQAEVNFLGRLNHPNLVKLLGFCWEDDEFLLVYEFMPRG 175

Query: 181 SLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           SLENHLF R  SI+PLSW+ RLKIAIGAARGL FLH+SEK+VIYRDFKASNILLD
Sbjct: 176 SLENHLFGRRSSIEPLSWERRLKIAIGAARGLAFLHSSEKEVIYRDFKASNILLD 230

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|242060210|ref|XP_002451394.1| hypothetical protein SORBIDRAFT_04g001360 [Sorghum bicolor] gi|241931225|gb|EES04370.1| hypothetical protein SORBIDRAFT_04g001360 [Sorghum bicolor]

 Score =  311 bits (798), Expect = 2e-82,   Method: Compositional matrix adjust.
 Identities = 153/239 (64%), Positives = 189/239 (79%), Gaps = 6/239 (2%)

Query: 1   MGN-CFGSLFVASNSSSNNINANASSSSAGA-YNKYGHTMEISATSSSAGKSQFSQAISE 58
           MGN C G   VA +   ++     +S ++G+       T ++S+ SS    S  S++ S 
Sbjct: 1   MGNICGGKDRVAEDFRPSSPGTTMTSKTSGSLTTSQSTTGKLSSVSSGFMASAGSRSTSG 60

Query: 59  AGVEEAS--PNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLA 116
             V+E +  P+GQILE P+L+ F+F++LK+ATKNF+PDS+LGEGGFGRVYKGWVD+KT+A
Sbjct: 61  GFVDEGAKYPDGQILEAPNLRTFTFMELKTATKNFRPDSVLGEGGFGRVYKGWVDEKTMA 120

Query: 117 PSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEY 176
           P++ G GMVVA+KKLN ESMQG+EEWQSE+NFLGRLSHPNLVKLLGYCWEDKELLLVYE+
Sbjct: 121 PTRNGTGMVVAVKKLNSESMQGYEEWQSEINFLGRLSHPNLVKLLGYCWEDKELLLVYEF 180

Query: 177 MQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           M +GSLENHLFRR     PLSW++RLKI+IGAARGL FLH SEK+VIYRDFKASNILLD
Sbjct: 181 MAKGSLENHLFRRG--CAPLSWELRLKISIGAARGLAFLHASEKQVIYRDFKASNILLD 237

Source: Sorghum bicolor

Species: Sorghum bicolor

Genus: Sorghum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	376
TAIR|locus:2059642	414	Kin3 "kinase 3" [Arabidopsis t	0.515	0.468	0.659	5.6e-68
TAIR|locus:2053240	423	PK1B "protein kinase 1B" [Arab	0.510	0.453	0.609	6.2e-62
TAIR|locus:2014614	484	AT1G76360 [Arabidopsis thalian	0.460	0.357	0.653	4.3e-61
TAIR|locus:2180127	389	NAK [Arabidopsis thaliana (tax	0.537	0.519	0.557	2.7e-59
TAIR|locus:2058847	426	APK2B "protein kinase 2B" [Ara	0.510	0.450	0.611	1.9e-58
TAIR|locus:2039772	395	BIK1 "botrytis-induced kinase1	0.518	0.493	0.557	2.8e-57
TAIR|locus:2012492	426	APK2A "protein kinase 2A" [Ara	0.513	0.453	0.57	2e-56
TAIR|locus:2205714	412	AT1G26970 [Arabidopsis thalian	0.502	0.458	0.577	4.2e-56
TAIR|locus:2205050	387	AT1G69790 [Arabidopsis thalian	0.502	0.488	0.579	1.8e-55
TAIR|locus:2095517	453	AT3G28690 [Arabidopsis thalian	0.470	0.390	0.585	4.8e-55

TAIR|locus:2059642 Kin3 "kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 690 (248.0 bits), Expect = 5.6e-68, P = 5.6e-68
 Identities = 130/197 (65%), Positives = 163/197 (82%)

Query:    41 SATSSSAGKSQFSQA-ISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGE 99
             + T +S G +  S +  S A  E+A P+GQIL  P+L++FS  +L+++T+NF+ +++LGE
Sbjct:    36 TTTGTSRGSNISSNSGFSVASGEDAYPDGQILPIPNLRIFSLAELRASTRNFRSENVLGE 95

Query:   100 GGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVK 159
             GGFG+V+KGW++DKT  P K   G V+A+KKLN ES QGFEEWQ EVNFLGR+SHPNLVK
Sbjct:    96 GGFGKVFKGWLEDKT--PGKQSNGTVIAVKKLNAESFQGFEEWQCEVNFLGRVSHPNLVK 153

Query:   160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSE 219
             LLGYC E +ELLLVYEYMQ+GSLENHLFR+  ++QPLSW+IRLKIAIGAA+GL FLH SE
Sbjct:   154 LLGYCLEGEELLLVYEYMQKGSLENHLFRKGSAVQPLSWEIRLKIAIGAAKGLAFLHASE 213

Query:   220 KKVIYRDFKASNILLDG 236
             K+VIYRDFKASNILLDG
Sbjct:   214 KQVIYRDFKASNILLDG 230

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)]

 Score = 633 (227.9 bits), Expect = 6.2e-62, P = 6.2e-62
 Identities = 117/192 (60%), Positives = 150/192 (78%)

Query:    44 SSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFG 103
             SS A  S  S++ S +        G+IL++P+LK F+F +LK+AT+NF+PDS+LGEGGFG
Sbjct:    33 SSEANDSLGSKSSSVSIRTNPRTEGEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFG 92

Query:   104 RVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGY 163
              V+KGW+D++TL  SK G G+V+A+KKLN +  QG +EW +EVN+LG+ SHPNLVKL+GY
Sbjct:    93 SVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGY 152

Query:   164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVI 223
             C ED+  LLVYE+M RGSLENHLFRR    QPLSW +RLK+A+GAA+GL FLH +E  VI
Sbjct:   153 CLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHNAETSVI 212

Query:   224 YRDFKASNILLD 235
             YRDFK SNILLD
Sbjct:   213 YRDFKTSNILLD 224

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2014614 AT1G76360 [Arabidopsis thaliana (taxid:3702)]

 Score = 625 (225.1 bits), Expect = 4.3e-61, P = 4.3e-61
 Identities = 115/176 (65%), Positives = 144/176 (81%)

Query:    60 GVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSK 119
             G +   P+G+I+ TP+LK+F+ ++LK+ATKNF+P+S++GEGGFG+V+KGWVD+KTLAPS+
Sbjct:   133 GRKAVPPSGKIV-TPNLKMFTLVELKTATKNFRPESVIGEGGFGQVFKGWVDEKTLAPSR 191

Query:   120 TGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQR 179
              G+G+ VA+KK NP+S QG  EWQ EV FLG+  HPNLVKLLGYCWE+ + LLVYEY+ +
Sbjct:   192 AGVGIPVAVKKSNPDSEQGLHEWQCEVRFLGKFHHPNLVKLLGYCWEENQFLLVYEYLPK 251

Query:   180 GSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
             GSLENHLF +     P  WD RLKIAI AA+GL FLH SEK VIYRDFKASNILLD
Sbjct:   252 GSLENHLFSKGAEALP--WDTRLKIAIEAAQGLTFLHNSEKSVIYRDFKASNILLD 305

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)]

 Score = 608 (219.1 bits), Expect = 2.7e-59, P = 2.7e-59
 Identities = 116/208 (55%), Positives = 154/208 (74%)

Query:    34 YGHTMEISATSSSAGKSQFSQAISEAGVEEAS----PN--GQILETPDLKVFSFLDLKSA 87
             + + ++    SS+   S+F       G   AS    P   G+IL+  +LK FS  +LKSA
Sbjct:     5 FSNRIKTDIASSTWLSSKFLSRDGSKGSSTASFSYMPRTEGEILQNANLKNFSLSELKSA 64

Query:    88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
             T+NF+PDS++GEGGFG V+KGW+D+ +LAPSK G G+V+A+K+LN E  QG  EW +E+N
Sbjct:    65 TRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQGHREWLAEIN 124

Query:   148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
             +LG+L HPNLVKL+GYC E++  LLVYE+M RGSLENHLFRR    QPLSW+ R+++A+G
Sbjct:   125 YLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTRVRMALG 184

Query:   208 AARGLGFLHTSEKKVIYRDFKASNILLD 235
             AARGL FLH ++ +VIYRDFKASNILLD
Sbjct:   185 AARGLAFLHNAQPQVIYRDFKASNILLD 212

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009617 "response to bacterium" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)]

 Score = 600 (216.3 bits), Expect = 1.9e-58, P = 1.9e-58
 Identities = 121/198 (61%), Positives = 151/198 (76%)

Query:    41 SATSSSAGKSQFSQAISEAGVEEA-SPN--GQILETPDLKVFSFLDLKSATKNFKPDSLL 97
             S TS S   S  S   S + VE   +P   G+IL +P+LK F+F +LK+AT+NF+PDSLL
Sbjct:    31 SKTSRSTVPSSLS-INSYSSVESLPTPRTEGEILSSPNLKAFTFNELKNATRNFRPDSLL 89

Query:    98 GEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNL 157
             GEGGFG V+KGW+D  TL  SK G G+VVA+KKL  E  QG +EW +EVN+LG+LSHPNL
Sbjct:    90 GEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNL 149

Query:   158 VKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHT 217
             VKL+GYC E +  LLVYE+M +GSLENHLFRR    QPL+W IR+K+AIGAA+GL FLH 
Sbjct:   150 VKLVGYCVEGENRLLVYEFMPKGSLENHLFRRGA--QPLTWAIRMKVAIGAAKGLTFLHD 207

Query:   218 SEKKVIYRDFKASNILLD 235
             ++ +VIYRDFKA+NILLD
Sbjct:   208 AKSQVIYRDFKAANILLD 225

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)]

 Score = 589 (212.4 bits), Expect = 2.8e-57, P = 2.8e-57
 Identities = 112/201 (55%), Positives = 149/201 (74%)

Query:    35 GHTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPD 94
             G + ++   S S+ KS  S  ++ A   E    G+IL +  +K F+F +LK AT+NF+PD
Sbjct:    17 GKSSDLYGLSLSSRKS--SSTVAAAQKTE----GEILSSTPVKSFTFNELKLATRNFRPD 70

Query:    95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH 154
             S++GEGGFG V+KGW+D+ TL P+K G G+V+A+KKLN E  QG  EW +E+N+LG+LSH
Sbjct:    71 SVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQEGFQGHREWLTEINYLGQLSH 130

Query:   155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
             PNLVKL+GYC ED+  LLVYE+MQ+GSLENHLFRR    +PL W +R+ +A+ AA+GL F
Sbjct:   131 PNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAYFKPLPWFLRVNVALDAAKGLAF 190

Query:   215 LHTSEKKVIYRDFKASNILLD 235
             LH+   KVIYRD KASNILLD
Sbjct:   191 LHSDPVKVIYRDIKASNILLD 211

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005730 "nucleolus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009620 "response to fungus" evidence=IEP

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0050832 "defense response to fungus" evidence=RCA;IMP

GO:0052033 "pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response" evidence=IMP

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)]

 Score = 581 (209.6 bits), Expect = 2.0e-56, P = 2.0e-56
 Identities = 114/200 (57%), Positives = 148/200 (74%)

Query:    41 SATSSSAGKS-----QFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDS 95
             S TS S G S      +S   S   +      G+IL +P+LK F+F +LK+ATKNF+ D+
Sbjct:    31 SKTSRSTGPSGLSTTSYSTDSSFGPLPTLRTEGEILSSPNLKAFTFNELKNATKNFRQDN 90

Query:    96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
             LLGEGGFG V+KGW+D  +L  S+ G G+VVA+K+L PE  QG +EW +EVN+LG+LSHP
Sbjct:    91 LLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPEGFQGHKEWLTEVNYLGQLSHP 150

Query:   156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
             NLV L+GYC E +  LLVYE+M +GSLENHLFRR    QPL+W IR+K+A+GAA+GL FL
Sbjct:   151 NLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRRGA--QPLTWAIRMKVAVGAAKGLTFL 208

Query:   216 HTSEKKVIYRDFKASNILLD 235
             H ++ +VIYRDFKA+NILLD
Sbjct:   209 HEAKSQVIYRDFKAANILLD 228

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2205714 AT1G26970 [Arabidopsis thaliana (taxid:3702)]

 Score = 578 (208.5 bits), Expect = 4.2e-56, P = 4.2e-56
 Identities = 112/194 (57%), Positives = 145/194 (74%)

Query:    43 TSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGF 102
             +S +   S ++   S A ++     G++L +P LK F+F +LK+AT+NF+PDS++GEGGF
Sbjct:    35 SSLTIQSSSYNDDTSVASLQTPRSEGELLASPTLKAFTFNELKTATRNFRPDSVIGEGGF 94

Query:   103 GRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLG 162
             G VYKGW+D++TL+PSK G GMVVA+KKL  E  QG  +W +EV+ LGRL H NLVKL+G
Sbjct:    95 GYVYKGWIDERTLSPSKPGSGMVVAVKKLKEEGFQGHRQWLAEVDCLGRLHHMNLVKLIG 154

Query:   163 YCWEDKEL-LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK 221
             YC +   + LLVYEYM +GSLENHLFRR    +P+ W  R+K+AIGAARGL FLH  E +
Sbjct:   155 YCSKGDHIRLLVYEYMPKGSLENHLFRRGA--EPIPWRTRIKVAIGAARGLAFLH--EAQ 210

Query:   222 VIYRDFKASNILLD 235
             VIYRDFKASNILLD
Sbjct:   211 VIYRDFKASNILLD 224

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)]

 Score = 572 (206.4 bits), Expect = 1.8e-55, P = 1.8e-55
 Identities = 113/195 (57%), Positives = 146/195 (74%)

Query:    41 SATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEG 100
             S T  S   + F+ + S + +   S  G++L +P LK F+F +LK+AT+NFKP+S++GEG
Sbjct:    36 SLTIPSYSNNSFTTS-SWSNLTPRS-EGELLPSPTLKAFTFNELKTATRNFKPNSMIGEG 93

Query:   101 GFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKL 160
             GFG VYKGW+ +++L+PSK G GMVVA+KKL  E  QG +EW +EV++LGRL H NLVKL
Sbjct:    94 GFGCVYKGWIGERSLSPSKPGSGMVVAVKKLKSEGFQGHKEWLTEVHYLGRLHHMNLVKL 153

Query:   161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEK 220
             +GYC E ++ LLVYEYM +GSLENHLFRR    +P+ W  R+K+A  AARGL FLH  E 
Sbjct:   154 IGYCLEGEKRLLVYEYMPKGSLENHLFRRGA--EPIPWKTRMKVAFSAARGLSFLH--EA 209

Query:   221 KVIYRDFKASNILLD 235
             KVIYRDFKASNILLD
Sbjct:   210 KVIYRDFKASNILLD 224

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)]

 Score = 568 (205.0 bits), Expect = 4.8e-55, P = 4.8e-55
 Identities = 106/181 (58%), Positives = 138/181 (76%)

Query:    57 SEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLA 116
             +E+G      +G++  +  L++F F DLK AT+NF+P+SLLGEGGFG V+KGW+++   A
Sbjct:    69 AESGSSTPLMSGELKYSSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTA 128

Query:   117 PSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEY 176
             P K G G+ VA+K LNP+ +QG +EW +E+NFLG L HP+LVKL+GYC E+ + LLVYE+
Sbjct:   129 PVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEF 188

Query:   177 MQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHT-SEKKVIYRDFKASNILLD 235
             M RGSLENHLFRR     PL W +R+KIA+GAA+GL FLH  +EK VIYRDFK SNILLD
Sbjct:   189 MPRGSLENHLFRRT---LPLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD 245

Query:   236 G 236
             G
Sbjct:   246 G 246

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	376
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	8e-33
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-31
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-31
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-31
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-27
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-26
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-25
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-22
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-19
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-19
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-18
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-17
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-17
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-16
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-15
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-15
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-15
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-15
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-14
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	8e-14
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-14
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-13
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-13
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-13
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-13
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-13
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-13
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-13
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-13
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-13
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-13
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-12
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-12
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-12
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-12
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-12
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-12
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-12
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-12
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-12
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-11
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-11
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-11
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-11
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-11
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-11
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-11
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-11
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-11
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-11
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-11
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-11
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-11
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-11
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-11
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-10
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-10
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-10
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-10
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-10
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-10
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-10
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-10
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-09
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-09
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-09
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-09
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-09
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-09
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-09
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-09
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-09
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-09
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-09
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	9e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-08
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-08
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-08
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-08
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-08
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-08
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-08
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-08
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-08
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-08
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-08
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-08
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-07
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-07
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-07
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-07
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-07
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-07
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-07
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-07
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-07
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-07
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	9e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-06
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-06
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-06
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-06
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-06
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-06
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-06
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-06
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-06
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-06
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	9e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-05
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-05
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-05
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-05
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-05
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-05
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-05
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-05
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-05
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-05
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-05
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-05
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	8e-05
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-05
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-05
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-05
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-04
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-04
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-04
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-04
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-04
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-04
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-04
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-04
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-04
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-04
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-04
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-04
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-04
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-04
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-04
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-04
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-04
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-04
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-04
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-04
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-04
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-04
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-04
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-04
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	8e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	0.001
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	0.001
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	0.001
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.001
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	0.002
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	0.002
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	0.003
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	0.003
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	0.003
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.003
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	0.004

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  123 bits (310), Expect = 8e-33
 Identities = 56/143 (39%), Positives = 76/143 (53%), Gaps = 10/143 (6%)

Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRL 152
              LGEG FG VYKG     TL     G  + VA+K L  ++  Q  EE+  E   + +L
Sbjct: 4   GKKLGEGAFGEVYKG-----TLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58

Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
            HPN+VKLLG C E++ L++V EYM  G L ++L  R    + LS    L  A+  ARG+
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGM 116

Query: 213 GFLHTSEKKVIYRDFKASNILLD 235
            +L    K  I+RD  A N L+ 
Sbjct: 117 EYLE--SKNFIHRDLAARNCLVG 137

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  119 bits (302), Expect = 1e-31
 Identities = 51/140 (36%), Positives = 77/140 (55%), Gaps = 11/140 (7%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHP 155
           LGEG FG VYKG     TL     G    VA+K L   +  +  EE+  E + + +LSHP
Sbjct: 7   LGEGAFGEVYKG-----TLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           N+V+LLG C + + L +V EYM  G L + L R++   + L+    L++A+  A+G+ +L
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHG--EKLTLKDLLQMALQIAKGMEYL 118

Query: 216 HTSEKKVIYRDFKASNILLD 235
               K  ++RD  A N L+ 
Sbjct: 119 E--SKNFVHRDLAARNCLVT 136

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  119 bits (301), Expect = 1e-31
 Identities = 55/140 (39%), Positives = 75/140 (53%), Gaps = 11/140 (7%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHP 155
           LGEG FG VYKG      L        + VA+K L  ++  Q  EE+  E   + +L HP
Sbjct: 7   LGEGAFGEVYKG-----KLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           N+VKLLG C E++ L +V EYM+ G L ++L R+N     LS    L  A+  ARG+ +L
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRP--KLSLSDLLSFALQIARGMEYL 118

Query: 216 HTSEKKVIYRDFKASNILLD 235
               K  I+RD  A N L+ 
Sbjct: 119 E--SKNFIHRDLAARNCLVG 136

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  116 bits (294), Expect = 5e-31
 Identities = 54/140 (38%), Positives = 69/140 (49%), Gaps = 15/140 (10%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVNFLGRLSHP 155
           LGEGGFG VY                G  VAIK +  E      EE   E+  L +L+HP
Sbjct: 1   LGEGGFGTVYLAR---------DKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHP 51

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           N+VKL G   ++  L LV EY + GSL++ L         LS D  L+I +    GL +L
Sbjct: 52  NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYL 108

Query: 216 HTSEKKVIYRDFKASNILLD 235
           H     +I+RD K  NILLD
Sbjct: 109 H--SNGIIHRDLKPENILLD 126

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  108 bits (273), Expect = 2e-27
 Identities = 52/145 (35%), Positives = 75/145 (51%), Gaps = 14/145 (9%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHP 155
           LGEG FG VYKG          K G    VA+K L  ++  +  +++  E   + +L HP
Sbjct: 3   LGEGAFGEVYKG------KLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHP 56

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL-----FRRNPSIQPLSWDIRLKIAIGAAR 210
           N+V+LLG C E++ L LV EYM+ G L ++L        +P    LS    L  AI  A+
Sbjct: 57  NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 211 GLGFLHTSEKKVIYRDFKASNILLD 235
           G+ +L    KK ++RD  A N L+ 
Sbjct: 117 GMEYLA--SKKFVHRDLAARNCLVG 139

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  105 bits (263), Expect = 3e-26
 Identities = 55/153 (35%), Positives = 75/153 (49%), Gaps = 19/153 (12%)

Query: 91  FKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVN 147
           ++    LG G FG VYK                G +VA+K L   S   +  +  + E+ 
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGT----------GKIVAVKILKKRSEKSKKDQTARREIR 50

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
            L RLSHPN+V+L+    +   L LV EY + G L ++L R      PLS D   KIA+ 
Sbjct: 51  ILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQ 106

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
             RGL +LH     +I+RD K  NILLD  G +
Sbjct: 107 ILRGLEYLH--SNGIIHRDLKPENILLDENGVV 137

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  103 bits (259), Expect = 1e-25
 Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 16/151 (10%)

Query: 91  FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE-WQSEVNFL 149
           ++    LGEG FG+VY    D KT        G +VAIK +  + ++   E    E+  L
Sbjct: 1   YEILEKLGEGSFGKVYLA-RDKKT--------GKLVAIKVIKKKKIKKDRERILREIKIL 51

Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
            +L HPN+V+L     ++ +L LV EY + G L + L ++   +     + R        
Sbjct: 52  KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSE--DEAR-FYLRQIL 107

Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
             L +LH   K +++RD K  NILLD  G +
Sbjct: 108 SALEYLH--SKGIVHRDLKPENILLDEDGHV 136

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 93.0 bits (232), Expect = 7e-22
 Identities = 49/144 (34%), Positives = 73/144 (50%), Gaps = 14/144 (9%)

Query: 91  FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLG 150
           F+    +G+GGFG VYK     +T        G  VAIK +  ES +  E+  +E+  L 
Sbjct: 2   FEILEKIGKGGFGEVYKAR-HKRT--------GKEVAIKVIKLESKEKKEKIINEIQILK 52

Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           +  HPN+VK  G   +  EL +V E+   GSL++ L     + Q L+      +     +
Sbjct: 53  KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLK 109

Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
           GL +LH     +I+RD KA+NILL
Sbjct: 110 GLEYLH--SNGIIHRDIKAANILL 131

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 50/146 (34%), Positives = 77/146 (52%), Gaps = 19/146 (13%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLS 153
           L+G G FG VYKG ++ +T        G  VAIK+++ E +  +  +    E++ L  L 
Sbjct: 7   LIGRGAFGVVYKG-LNLET--------GDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK 57

Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           HPN+VK +G       L ++ EY + GSL   + +  P  + L      ++     +GL 
Sbjct: 58  HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV----LQGLA 113

Query: 214 FLHTSEKKVIYRDFKASNILL--DGV 237
           +LH  E+ VI+RD KA+NIL   DGV
Sbjct: 114 YLH--EQGVIHRDIKAANILTTKDGV 137

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 87.5 bits (217), Expect = 1e-19
 Identities = 44/142 (30%), Positives = 67/142 (47%), Gaps = 13/142 (9%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHP 155
           LGEG FG+V           P     G  VA+K LN     Q   +++ E+  L  L H 
Sbjct: 12  LGEGHFGKVELC-----RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66

Query: 156 NLVKLLGYCWED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           N+VK  G C +   + L L+ EY+  GSL ++L R    I   +    L  +    +G+ 
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQI---NLKRLLLFSSQICKGMD 123

Query: 214 FLHTSEKKVIYRDFKASNILLD 235
           +L    ++ I+RD  A NIL++
Sbjct: 124 YLG--SQRYIHRDLAARNILVE 143

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 81.8 bits (203), Expect = 7e-18
 Identities = 47/149 (31%), Positives = 71/149 (47%), Gaps = 19/149 (12%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQSEVNFLGRLS 153
           LLG G FG VY   +D  T        G ++A+K   L+ +S +  E  + E+  L  L 
Sbjct: 7   LLGRGSFGSVYLA-LDKDT--------GELMAVKSVELSGDSEEELEALEREIRILSSLQ 57

Query: 154 HPNLVKLLGYCW--EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           HPN+V+  G     E   L +  EY+  GSL + L ++   +      IR K       G
Sbjct: 58  HPNIVRYYGSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKLPEP--VIR-KYTRQILEG 113

Query: 212 LGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           L +LH     +++RD K +NIL+D  G +
Sbjct: 114 LAYLH--SNGIVHRDIKGANILVDSDGVV 140

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 80.9 bits (200), Expect = 2e-17
 Identities = 45/143 (31%), Positives = 71/143 (49%), Gaps = 20/143 (13%)

Query: 95  SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRL 152
           + +G+G FG V  G              G  VA+K L  +S   Q F    +E + +  L
Sbjct: 12  ATIGKGEFGDVMLG-----------DYRGQKVAVKCLKDDSTAAQAF---LAEASVMTTL 57

Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
            HPNLV+LLG   +   L +V EYM +GSL ++L  R  ++  ++   +L  A+    G+
Sbjct: 58  RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV--ITLAQQLGFALDVCEGM 115

Query: 213 GFLHTSEKKVIYRDFKASNILLD 235
            +L   EK  ++RD  A N+L+ 
Sbjct: 116 EYLE--EKNFVHRDLAARNVLVS 136

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 81.0 bits (200), Expect = 2e-17
 Identities = 51/166 (30%), Positives = 73/166 (43%), Gaps = 39/166 (23%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMV-------VAIKKLNPE-SMQGFEEWQSEVNF 148
           +G+G FGRV++               G++       VA+K L  E S     ++Q E   
Sbjct: 13  IGQGAFGRVFQA-----------RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61

Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQ-------------- 194
           +    HPN+VKLLG C   K + L++EYM  G L   L  R+P  Q              
Sbjct: 62  MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121

Query: 195 ----PLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
               PLS   +L IA   A G+ +L  SE+K ++RD    N L+  
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYL--SERKFVHRDLATRNCLVGE 165

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 80.2 bits (198), Expect = 4e-17
 Identities = 46/140 (32%), Positives = 69/140 (49%), Gaps = 16/140 (11%)

Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G FG V++G W   K            VAIK L  + +   +++Q EV  L RL H 
Sbjct: 14  LGSGYFGEVWEGLW---KNRVR--------VAIKILKSDDLLKQQDFQKEVQALKRLRHK 62

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           +L+ L   C   + + ++ E M++GSL    F R+P  Q L     + +A   A G+ +L
Sbjct: 63  HLISLFAVCSVGEPVYIITELMEKGSL--LAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120

Query: 216 HTSEKKVIYRDFKASNILLD 235
              E+  I+RD  A NIL+ 
Sbjct: 121 E--EQNSIHRDLAARNILVG 138

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 19/151 (12%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
           LGEG FG+VYKG    +   P++      VAIK L      +  +E++ E   +  L HP
Sbjct: 13  LGEGAFGKVYKG----ELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS------------IQPLSWDIRLK 203
           N+V LLG C +++   +++EY+  G L   L R +P                L     L 
Sbjct: 69  NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128

Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           IAI  A G+ +L  S    ++RD  A N L+
Sbjct: 129 IAIQIAAGMEYL--SSHHFVHRDLAARNCLV 157

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 76.9 bits (189), Expect = 6e-16
 Identities = 52/142 (36%), Positives = 72/142 (50%), Gaps = 15/142 (10%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE-WQSEVNFLGRLSHP 155
           LGEG FG+V     D     P+  G G +VA+K L  E  Q     W+ E+N L  L H 
Sbjct: 12  LGEGHFGKVSLYCYD-----PANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66

Query: 156 NLVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           N+VK  G C E   K L L+ EY+  GSL ++L +   ++  L     L  A     G+ 
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEGMA 121

Query: 214 FLHTSEKKVIYRDFKASNILLD 235
           +LH+  +  I+RD  A N+LLD
Sbjct: 122 YLHS--QHYIHRDLAARNVLLD 141

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 45/145 (31%), Positives = 76/145 (52%), Gaps = 24/145 (16%)

Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSH 154
           LG G FG VYKG W+      P    + + VAIK L  E+  +  +E   E   +  + H
Sbjct: 15  LGSGAFGTVYKGVWI------PEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-----SIQPLSWDIRLKIAIGAA 209
           P++V+LLG C    ++ L+ + M  G L +++  RN      S   L+W +++      A
Sbjct: 69  PHVVRLLGICL-SSQVQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWCVQI------A 119

Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
           +G+ +L   EK++++RD  A N+L+
Sbjct: 120 KGMSYL--EEKRLVHRDLAARNVLV 142

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 74.4 bits (184), Expect = 4e-15
 Identities = 51/155 (32%), Positives = 78/155 (50%), Gaps = 23/155 (14%)

Query: 91  FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----EV 146
           ++    LGEG +G VYK   D KT        G +VA+KK+  +     E   S    E+
Sbjct: 1   YEKLEKLGEGTYGVVYKAR-DKKT--------GEIVALKKIRLD--NEEEGIPSTALREI 49

Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK-IA 205
           + L  L HPN+VKLL     +++L LV+EY     L+ +L +R   + P      +K I 
Sbjct: 50  SLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSP----NLIKSIM 104

Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
               RGL + H+   ++++RD K  NIL++  G L
Sbjct: 105 YQLLRGLAYCHS--HRILHRDLKPQNILINRDGVL 137

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 74.2 bits (182), Expect = 5e-15
 Identities = 48/166 (28%), Positives = 75/166 (45%), Gaps = 27/166 (16%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNF 148
           N      LGEG FG+V K            T     VA+K L   +      +  SE N 
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYT----TVAVKMLKENASSSELRDLLSEFNL 56

Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL--------------------FR 188
           L +++HP+++KL G C +D  LLL+ EY + GSL + L                    + 
Sbjct: 57  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116

Query: 189 RNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
            NP  + L+    +  A   +RG+ +L  +E K+++RD  A N+L+
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLV 160

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 75.2 bits (183), Expect = 5e-15
 Identities = 51/153 (33%), Positives = 70/153 (45%), Gaps = 19/153 (12%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS---EV 146
           +++    LGEG FG VY                   VA+K L  +     +E +    E+
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKL------------VALKVLAKKLESKSKEVERFLREI 48

Query: 147 NFLGRLSHP-NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
             L  L+HP N+VKL  +  ++  L LV EY+  GSLE  L ++     PLS    L I 
Sbjct: 49  QILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLE-DLLKKIGRKGPLSESEALFIL 107

Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                 L +LH   K +I+RD K  NILLD  G
Sbjct: 108 AQILSALEYLH--SKGIIHRDIKPENILLDRDG 138

Length = 384

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 72.9 bits (179), Expect = 9e-15
 Identities = 45/144 (31%), Positives = 71/144 (49%), Gaps = 22/144 (15%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK----KLNPESMQGFEEWQSEVNFLGR 151
            +G+G FG VYKG +   T           VA+K     L P+  + F +   E   L +
Sbjct: 2   KIGKGNFGDVYKGVLKGNTE----------VAVKTCRSTLPPDLKRKFLQ---EAEILKQ 48

Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
             HPN+VKL+G C + + + +V E +  GSL   L  R    + L+    L++++ AA G
Sbjct: 49  YDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFL--RKKKNR-LTVKKLLQMSLDAAAG 105

Query: 212 LGFLHTSEKKVIYRDFKASNILLD 235
           + +L +  K  I+RD  A N L+ 
Sbjct: 106 MEYLES--KNCIHRDLAARNCLVG 127

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 55/162 (33%), Positives = 74/162 (45%), Gaps = 27/162 (16%)

Query: 84  LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP-ESMQGFEEW 142
           L   T  F+   ++GEG +G+VYK     KT        G +VAIK ++  E  +  EE 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKA-RHKKT--------GQLVAIKIMDIIEDEE--EEI 49

Query: 143 QSEVNFLGRLS-HPNLVKLLG------YCWEDKELLLVYEYMQRGS---LENHLFRRNPS 192
           + E N L + S HPN+    G          D +L LV E    GS   L   L ++   
Sbjct: 50  KEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG-- 107

Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
            + L  +    I     RGL +LH  E KVI+RD K  NILL
Sbjct: 108 -KRLKEEWIAYILRETLRGLAYLH--ENKVIHRDIKGQNILL 146

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 71.3 bits (175), Expect = 4e-14
 Identities = 49/151 (32%), Positives = 73/151 (48%), Gaps = 26/151 (17%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK--KLNPESMQGFE---EWQSEVNFLG 150
           LLG G FG VY+G   D          G   A+K   L  +   G E   + + E+  L 
Sbjct: 7   LLGSGSFGSVYEGLNLDD---------GDFFAVKEVSLADDGQTGQEAVKQLEQEIALLS 57

Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL---KIAIG 207
           +L HPN+V+ LG   E+  L +  E +  GSL   L +     +P+   IRL   +I + 
Sbjct: 58  KLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV---IRLYTRQILL- 113

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
              GL +LH  ++  ++RD K +NIL+D  G
Sbjct: 114 ---GLEYLH--DRNTVHRDIKGANILVDTNG 139

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 70.8 bits (174), Expect = 8e-14
 Identities = 49/154 (31%), Positives = 70/154 (45%), Gaps = 17/154 (11%)

Query: 97  LGEGGFGRVYKGWVD------DKTLAPSKTGLGMV-VAIKKLNP-ESMQGFEEWQSEVNF 148
           LGEG FG V+    D      +K  A +      V VA+K L P  S    E++  EV  
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-------SIQPLSWDIR 201
           L RLS PN+ +LLG C  D  L ++ EYM+ G L   L +          + + LS+   
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132

Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           L +A   A G+ +L       ++RD    N L+ 
Sbjct: 133 LYMATQIASGMRYL--ESLNFVHRDLATRNCLVG 164

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 70.5 bits (173), Expect = 9e-14
 Identities = 47/151 (31%), Positives = 69/151 (45%), Gaps = 20/151 (13%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFL------G 150
           LG G FG VY+G    +     +    + VA+K L PES       Q E +FL       
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVE----LQVAVKTL-PESCSE----QDESDFLMEALIMS 64

Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR-RNPSIQPLSWDIR--LKIAIG 207
           + +H N+V+L+G  +E     ++ E M  G L++ L   R    +P S  ++  L  A  
Sbjct: 65  KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            A+G  +L   E   I+RD  A N LL   G
Sbjct: 125 VAKGCKYLE--ENHFIHRDIAARNCLLTCKG 153

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 41/149 (27%), Positives = 66/149 (44%), Gaps = 19/149 (12%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVNFLGRLSHP 155
           LGEG FG+V+ G    +           +VA+K L    S    ++++ E   L    H 
Sbjct: 13  LGEGAFGKVFLG----ECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRN-----------PSIQPLSWDIRLKI 204
           N+VK  G C E    ++V+EYM+ G L N   R +             +  L+    L+I
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDL-NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNIL 233
           A+  A G+ +L  + +  ++RD    N L
Sbjct: 128 AVQIASGMVYL--ASQHFVHRDLATRNCL 154

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 42/143 (29%), Positives = 67/143 (46%), Gaps = 18/143 (12%)

Query: 96  LLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLS 153
            LG+G FG V +G W        +  G  + VA+K L  + +    +++  E   +  L 
Sbjct: 2   KLGDGSFGVVRRGEWS-------TSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD 54

Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLS--WDIRLKIAIGAARG 211
           H NL++L G       L++V E    GSL + L +       +S   D  ++I    A G
Sbjct: 55  HENLIRLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANG 109

Query: 212 LGFLHTSEKKVIYRDFKASNILL 234
           + +L +  K+ I+RD  A NILL
Sbjct: 110 MRYLES--KRFIHRDLAARNILL 130

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 42/144 (29%), Positives = 73/144 (50%), Gaps = 14/144 (9%)

Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ--SEVNFLGR 151
           + ++G G FG V +G    +   P K  +   VAIK L   S    +     +E + +G+
Sbjct: 9   EKVIGGGEFGEVCRG----RLKLPGKKEI--DVAIKTLKAGS-SDKQRLDFLTEASIMGQ 61

Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
             HPN+++L G   + + ++++ EYM+ GSL+  L R N      +    + +  G A G
Sbjct: 62  FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL-REND--GKFTVGQLVGMLRGIASG 118

Query: 212 LGFLHTSEKKVIYRDFKASNILLD 235
           + +L  SE   ++RD  A NIL++
Sbjct: 119 MKYL--SEMNYVHRDLAARNILVN 140

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 69.4 bits (171), Expect = 2e-13
 Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 15/154 (9%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE--EWQSEVN 147
            ++    +G+G FG+VY        L   K+  G +  +K+++  +M   E  +  +EV 
Sbjct: 1   KYEIIKQIGKGSFGKVY--------LVRRKSD-GKLYVLKEIDLSNMSEKEREDALNEVK 51

Query: 148 FLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
            L +L+HPN++K     +E+K  L +V EY   G L   + ++    +P   +  L   +
Sbjct: 52  ILKKLNHPNIIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV 110

Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                L +LH   +K+++RD K  NI L   G +
Sbjct: 111 QLCLALKYLH--SRKILHRDIKPQNIFLTSNGLV 142

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 43/145 (29%), Positives = 72/145 (49%), Gaps = 13/145 (8%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP-ESMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G          K      VAIK +N   SM+   E+ +E + +   +  
Sbjct: 14  LGQGSFGMVYEGLAKGV----VKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR------NPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG     +  L+V E M +G L+++L  R      NP + P +    +++A   A
Sbjct: 70  HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ +L    KK ++RD  A N ++
Sbjct: 130 DGMAYLA--AKKFVHRDLAARNCMV 152

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 43/139 (30%), Positives = 67/139 (48%), Gaps = 15/139 (10%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V+ G  +  T           VA+K L P +M   E +  E   + +L H  
Sbjct: 14  LGAGQFGEVWMGTWNGTT----------KVAVKTLKPGTMSP-EAFLQEAQIMKKLRHDK 62

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV+L   C E++ + +V EYM +GSL + L  ++   + L     + +A   A G+ +L 
Sbjct: 63  LVQLYAVCSEEEPIYIVTEYMSKGSLLDFL--KSGEGKKLRLPQLVDMAAQIAEGMAYLE 120

Query: 217 TSEKKVIYRDFKASNILLD 235
              +  I+RD  A NIL+ 
Sbjct: 121 --SRNYIHRDLAARNILVG 137

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 43/144 (29%), Positives = 64/144 (44%), Gaps = 13/144 (9%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           +G G FG+VY     D       TG  M V   ++     +  +E   E+  L  L HPN
Sbjct: 8   IGGGTFGKVYTAVNLD-------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LVK  G     +++ +  EY   G+LE  L   +  I      IR+   +    GL +LH
Sbjct: 61  LVKYYGVEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHV-IRV-YTLQLLEGLAYLH 116

Query: 217 TSEKKVIYRDFKASNILLDGVGFL 240
                +++RD K +NI LD  G +
Sbjct: 117 --SHGIVHRDIKPANIFLDHNGVI 138

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 3e-13
 Identities = 51/141 (36%), Positives = 67/141 (47%), Gaps = 20/141 (14%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           +G G +G VYK   D  T        G +VAIK +  E    FE  Q E++ L    HPN
Sbjct: 11  IGSGTYGDVYKA-RDIAT--------GELVAIKVIKLEPGDDFEIIQQEISMLKECRHPN 61

Query: 157 LVKLLG-YCWEDKELLLVYEYMQRGSLEN--HLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           +V   G Y   DK L +V EY   GSL++   + R      PLS      +     +GL 
Sbjct: 62  IVAYFGSYLRRDK-LWIVMEYCGGGSLQDIYQVTRG-----PLSELQIAYVCRETLKGLA 115

Query: 214 FLHTSEKKVIYRDFKASNILL 234
           +LH  E   I+RD K +NILL
Sbjct: 116 YLH--ETGKIHRDIKGANILL 134

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 46/154 (29%), Positives = 68/154 (44%), Gaps = 20/154 (12%)

Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRL 152
              LGEG FG+V K   +   L          VA+K L  ++  +   +  SE+  +  +
Sbjct: 17  GKPLGEGAFGQVVKA--EAVGLDNPNET--STVAVKMLKDDATEKDLSDLVSEMEMMKMI 72

Query: 153 -SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI------- 204
             H N++ LLG C ++  L +V EY   G+L + L  R P  +  S D            
Sbjct: 73  GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 205 -----AIGAARGLGFLHTSEKKVIYRDFKASNIL 233
                A   ARG+ FL  + KK I+RD  A N+L
Sbjct: 133 DLVSFAYQVARGMEFL--ASKKCIHRDLAARNVL 164

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 69.1 bits (169), Expect = 4e-13
 Identities = 55/145 (37%), Positives = 70/145 (48%), Gaps = 26/145 (17%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVNFLGRLS 153
           +G G FG VY    D +T          VVAIKK++    Q  E+WQ    EV FL +L 
Sbjct: 23  IGHGSFGAVYFAR-DVRT--------NEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73

Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGS----LENHLFRRNPSIQPLSWDIRLKIAIGAA 209
           HPN ++  G    +    LV EY   GS    LE H        +PL       I  GA 
Sbjct: 74  HPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHK-------KPLQEVEIAAICHGAL 125

Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
           +GL +LH+ E+  I+RD KA NILL
Sbjct: 126 QGLAYLHSHER--IHRDIKAGNILL 148

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 67.5 bits (165), Expect = 7e-13
 Identities = 45/142 (31%), Positives = 72/142 (50%), Gaps = 13/142 (9%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP-ESMQGFEEWQSEVNFLGRLSH 154
           ++G+G FG VY G + D      K       A+K LN    ++  E++  E   +   SH
Sbjct: 2   VIGKGHFGCVYHGTLIDS--DGQKIH----CAVKSLNRITDLEEVEQFLKEGIIMKDFSH 55

Query: 155 PNLVKLLGYCWEDKEL-LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           PN++ LLG C   +   L+V  YM+ G L N  F R+ +  P   D+ +   +  A+G+ 
Sbjct: 56  PNVLSLLGICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNPTVKDL-IGFGLQVAKGME 112

Query: 214 FLHTSEKKVIYRDFKASNILLD 235
           +L  + KK ++RD  A N +LD
Sbjct: 113 YL--ASKKFVHRDLAARNCMLD 132

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 67.6 bits (166), Expect = 8e-13
 Identities = 46/145 (31%), Positives = 66/145 (45%), Gaps = 17/145 (11%)

Query: 91  FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVNFL 149
           F     +G+G FG VYK  +D +T          VVAIK ++  E+    E+ Q E+ FL
Sbjct: 3   FTLLECIGKGSFGEVYKA-IDKRT--------NQVVAIKVIDLEEAEDEIEDIQQEIQFL 53

Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
            +   P + K  G   +  +L ++ EY   GS  + L         L       I     
Sbjct: 54  SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVL 108

Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            GL +LH  E+  I+RD KA+NILL
Sbjct: 109 LGLEYLH--EEGKIHRDIKAANILL 131

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 39/149 (26%), Positives = 61/149 (40%), Gaps = 29/149 (19%)

Query: 95  SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL--NPESMQGFEEWQSEVNFLGRL 152
            ++GEG +G V K               G +VAIKK   + +     +    EV  L +L
Sbjct: 7   GVVGEGAYGVVLKCRNKAT---------GEIVAIKKFKESEDDEDVKKTALREVKVLRQL 57

Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS------IQPLSWDIRLKIAI 206
            H N+V L         L LV+EY++R  LE  L   +P       ++   W +      
Sbjct: 58  RHENIVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQL------ 109

Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLD 235
              + + + H     +I+RD K  NIL+ 
Sbjct: 110 --LQAIAYCH--SHNIIHRDIKPENILVS 134

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 43/141 (30%), Positives = 62/141 (43%), Gaps = 22/141 (15%)

Query: 97  LGEGGFGRVYKG-W--VDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS 153
           LG G FG V+ G W    D             VAIK +   +M   +++  E   + +LS
Sbjct: 12  LGSGQFGVVHLGKWRGKID-------------VAIKMIREGAMSE-DDFIEEAKVMMKLS 57

Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           HPNLV+L G C + + + +V EYM  G L N+L R         W   L +       + 
Sbjct: 58  HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL-RERKGKLGTEW--LLDMCSDVCEAME 114

Query: 214 FLHTSEKKVIYRDFKASNILL 234
           +L       I+RD  A N L+
Sbjct: 115 YLE--SNGFIHRDLAARNCLV 133

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 43/139 (30%), Positives = 70/139 (50%), Gaps = 18/139 (12%)

Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           +G G FG V+ G W++ +            VAIK +   +M   E++  E   + +LSHP
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-----------VAIKTIREGAMSE-EDFIEEAQVMMKLSHP 59

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
            LV+L G C E   + LV+E+M+ G L ++L  +       S +  L + +    G+ +L
Sbjct: 60  KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYL 116

Query: 216 HTSEKKVIYRDFKASNILL 234
            +S   VI+RD  A N L+
Sbjct: 117 ESS--NVIHRDLAARNCLV 133

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 66.5 bits (162), Expect = 3e-12
 Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 25/163 (15%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPS-------KTGLGMVVAIKKLNPE-SMQGFEEWQSEVNF 148
           LGEG FG V+   V +    P+       + G  ++VA+K L P+ +     ++  EV  
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR---------NPSIQP---- 195
           L RL  PN+++LLG C ++  L ++ EYM+ G L   L            N ++ P    
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132

Query: 196 --LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
             +S+   L +A+  A G+ +L  S    ++RD    N L+  
Sbjct: 133 PAISYSSLLHVALQIASGMKYL--SSLNFVHRDLATRNCLVGE 173

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 65.6 bits (161), Expect = 3e-12
 Identities = 52/156 (33%), Positives = 72/156 (46%), Gaps = 27/156 (17%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLS 153
           LG+G FG+V    V        K   G + A+K L  + +   +  E   +E N L R++
Sbjct: 1   LGKGSFGKVLL--V-------RKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN 51

Query: 154 HPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA-IGAARG 211
           HP +VKL  Y ++ +E L LV EY   G L +HL  +           R   A I  A  
Sbjct: 52  HPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSE--ERARFYAAEIVLA-- 105

Query: 212 LGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI 247
           L +LH     +IYRD K  NILLD      D H+ +
Sbjct: 106 LEYLH--SLGIIYRDLKPENILLDA-----DGHIKL 134

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 53/168 (31%), Positives = 74/168 (44%), Gaps = 31/168 (18%)

Query: 86  SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK-LNPESMQGFE-EWQ 143
           S  ++++    LGEG FG VYK     KT        G VVA+KK L      GF     
Sbjct: 5   SKLRDYEILGKLGEGTFGEVYKA-RQIKT--------GRVVALKKILMHNEKDGFPITAL 55

Query: 144 SEVNFLGRLSHPNLVKLLGYCWED--------KELLLVYEYMQR---GSLENHLFRRNPS 192
            E+  L +L HPN+V L+    E           + +V  YM     G LEN   +   S
Sbjct: 56  REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES 115

Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                  I+    +    G+ +LH  E  +++RD KA+NIL+D  G L
Sbjct: 116 ------QIKC-YMLQLLEGINYLH--ENHILHRDIKAANILIDNQGIL 154

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 65.4 bits (159), Expect = 3e-12
 Identities = 44/139 (31%), Positives = 73/139 (52%), Gaps = 14/139 (10%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LLG+G FG V+KG + DKT    KT        K+  P+ ++   ++ SE   L +  HP
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKT-------CKEDLPQELK--IKFLSEARILKQYDHP 52

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           N+VKL+G C + + + +V E +  G   + L ++   ++       +K A+ AA G+ +L
Sbjct: 53  NIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQL---VKFALDAAAGMAYL 109

Query: 216 HTSEKKVIYRDFKASNILL 234
            +  K  I+RD  A N L+
Sbjct: 110 ES--KNCIHRDLAARNCLV 126

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 15/154 (9%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LGEG FG+V+    +   L+P+K    M+VA+K L   ++   +++Q E   L  L H +
Sbjct: 13  LGEGAFGKVF--LAECYNLSPTKDK--MLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI------QPLSWDIRLKIA----I 206
           +VK  G C +   L++V+EYM+ G L   L    P        QP      L ++    I
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
            +    G ++ + +  ++RD    N L+ G   L
Sbjct: 129 ASQIASGMVYLASQHFVHRDLATRNCLV-GANLL 161

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 65.6 bits (160), Expect = 4e-12
 Identities = 40/151 (26%), Positives = 68/151 (45%), Gaps = 12/151 (7%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEVNF 148
           N +  + LG G FG V+      K     + G   +V +K L     +  + E++ E++ 
Sbjct: 6   NLQEITTLGRGEFGEVFLA----KAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI-----QPLSWDIRLK 203
             +LSH N+V+LLG C E +   ++ EY   G L+  L             PLS   ++ 
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121

Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           +    A G+  L  +  + ++RD  A N L+
Sbjct: 122 LCTQIALGMDHLSNA--RFVHRDLAARNCLV 150

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 47/152 (30%), Positives = 76/152 (50%), Gaps = 20/152 (13%)

Query: 88  TKNFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSE 145
               +   LLG G FG V+KG W+      P    + + VAIK + +    Q F+E    
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWI------PEGDSIKIPVAIKTIQDRSGRQTFQEITDH 59

Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRL 202
           +  +G L H  +V+LLG C     L LV +    GSL +H+ +   S+ P   L+W +++
Sbjct: 60  MLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI 118

Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
                 A+G+ +L   E ++++R+  A NILL
Sbjct: 119 ------AKGMYYLE--EHRMVHRNLAARNILL 142

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 65.3 bits (160), Expect = 5e-12
 Identities = 43/160 (26%), Positives = 68/160 (42%), Gaps = 43/160 (26%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQS--EVNFLGRLS 153
           +GEG +G+VYK               G +VA+KK+  E+  +GF    +  E+  L +L 
Sbjct: 7   IGEGTYGQVYKA---------RNKKTGELVALKKIRMENEKEGFPI-TAIREIKLLQKLR 56

Query: 154 HPNLVKLLGYCWEDK--ELLLVYEYMQ---RGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           HPN+V+L           + +V+EYM     G L++                  K     
Sbjct: 57  HPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEV---------------KFTESQ 101

Query: 209 AR--------GLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
            +        GL +LH     +++RD K SNIL++  G L
Sbjct: 102 IKCYMKQLLEGLQYLH--SNGILHRDIKGSNILINNDGVL 139

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 65.2 bits (159), Expect = 5e-12
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 18/150 (12%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK--KLNPESMQGFEEWQSEVNFLGRLS 153
           +LGEG FG V +G +     +  K      VA+K  KL+  +    EE+ SE   +    
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLK------VAVKTMKLDIHTYSEIEEFLSEAACMKDFD 59

Query: 154 HPNLVKLLGYCWEDKEL------LLVYEYMQRGSLENHLFRRNPSIQPLSWDIR--LKIA 205
           HPN++KL+G C+E   L      +++  +M+ G L + L        P    ++  LK  
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119

Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           +  A G+ +L  S +  I+RD  A N +L 
Sbjct: 120 VDIALGMEYL--SNRNFIHRDLAARNCMLR 147

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 65.1 bits (159), Expect = 6e-12
 Identities = 46/140 (32%), Positives = 68/140 (48%), Gaps = 16/140 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHP 155
           LG G FG V KG          K+G  + VA+K L  E +  G +E+  E + + +L HP
Sbjct: 3   LGHGNFGSVVKGVYL------MKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP 56

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI-AIGAARGLGF 214
            +V+L+G C  +  L+LV E    G L  +L ++   I        LK  A   A G+ +
Sbjct: 57  CIVRLIGVCKGE-PLMLVMELAPLGPLLKYL-KKRREIP----VSDLKELAHQVAMGMAY 110

Query: 215 LHTSEKKVIYRDFKASNILL 234
           L    K  ++RD  A N+LL
Sbjct: 111 LE--SKHFVHRDLAARNVLL 128

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 64.9 bits (158), Expect = 8e-12
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 21/155 (13%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL----NPESMQG--FEEWQ 143
            +     LG G F   Y                G ++A+K++    N  S Q    E  +
Sbjct: 1   EWLKGQQLGTGAFSSCY---------QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALR 51

Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            E+  + RL+HP+++++LG   ED    L  E+M  GS+ + L +           + + 
Sbjct: 52  KEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG----AFKEAVIIN 107

Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                 RGL +LH  E ++I+RD K +N+L+D  G
Sbjct: 108 YTEQLLRGLSYLH--ENQIIHRDVKGANLLIDSTG 140

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 64.6 bits (158), Expect = 8e-12
 Identities = 47/149 (31%), Positives = 72/149 (48%), Gaps = 24/149 (16%)

Query: 91  FKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFL 149
           F     LGEG +G VYK    +           G VVAIK +  E     +E   E++ L
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKET----------GQVVAIKVVPVEE--DLQEIIKEISIL 52

Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI--- 206
            +   P +VK  G  +++ +L +V EY   GS+ + +   N   + L+ +   +IA    
Sbjct: 53  KQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN---KTLTEE---EIAAILY 106

Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLD 235
              +GL +LH+   K I+RD KA NILL+
Sbjct: 107 QTLKGLEYLHS--NKKIHRDIKAGNILLN 133

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 64.5 bits (158), Expect = 1e-11
 Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 20/156 (12%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----- 144
            ++    LGEG +  VYK   D +T        G +VAIKK+     +  ++  +     
Sbjct: 1   RYEKGKKLGEGTYAVVYKA-RDKET--------GRIVAIKKIKLGERKEAKDGINFTALR 51

Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E+  L  L HPN++ LL        + LV+E+M    LE  +  ++ SI     DI+   
Sbjct: 52  EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLE-KVI-KDKSIVLTPADIK-SY 107

Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
            +   RGL +LH     +++RD K +N+L+   G L
Sbjct: 108 MLMTLRGLEYLH--SNWILHRDLKPNNLLIASDGVL 141

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 64.1 bits (156), Expect = 1e-11
 Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 16/152 (10%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDD--KTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
           N++   LLG+G FGRVY  +  D  + LA  +      V     +PE+ +     + E+ 
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQ------VPFDPDSPETKKEVNALECEIQ 56

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVY-EYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
            L  L H  +V+  G C  D E L ++ EYM  GS+++ L     +   L+  +  K   
Sbjct: 57  LLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTR 111

Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
               G+ +LH++   +++RD K +NIL D  G
Sbjct: 112 QILEGVEYLHSNM--IVHRDIKGANILRDSAG 141

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 63.6 bits (155), Expect = 1e-11
 Identities = 44/147 (29%), Positives = 74/147 (50%), Gaps = 13/147 (8%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--EVN 147
           +FK    LG+G +G VYK     K L+ ++       A+K+++  SM   E   +  E+ 
Sbjct: 1   DFKVLKKLGKGSYGSVYKV----KRLSDNQF-----YALKEVDLGSMSQKEREDAVNEIR 51

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
            L  ++HPN++       +  +L +V EY   G L   + +R    + +      +I I 
Sbjct: 52  ILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQ 111

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILL 234
             RGL  LH  E+K+++RD K++NILL
Sbjct: 112 LLRGLQALH--EQKILHRDLKSANILL 136

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 44/143 (30%), Positives = 68/143 (47%), Gaps = 24/143 (16%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG+VYK        A  K   G+  A K +  ES +  E++  E++ L    HPN
Sbjct: 13  LGDGAFGKVYK--------AQHKE-TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFR-----RNPSIQPLSWDIRLKIAIGAARG 211
           +V L    + + +L ++ E+   G+L++ +         P I+ +   +           
Sbjct: 64  IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQM--------LEA 115

Query: 212 LGFLHTSEKKVIYRDFKASNILL 234
           L FLH    KVI+RD KA NILL
Sbjct: 116 LNFLH--SHKVIHRDLKAGNILL 136

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 45/149 (30%), Positives = 69/149 (46%), Gaps = 17/149 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LGEG FG+V+    +   L P +    M+VA+K L   S    +++Q E   L  L H +
Sbjct: 13  LGEGAFGKVF--LAECHNLLPEQDK--MLVAVKALKEASESARQDFQREAELLTVLQHQH 68

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQ-----------PLSWDIRLKIA 205
           +V+  G C E + LL+V+EYM+ G L   L    P  +            L+    L IA
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128

Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILL 234
              A G+ +L  +    ++RD    N L+
Sbjct: 129 SQIASGMVYL--ASLHFVHRDLATRNCLV 155

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 42/139 (30%), Positives = 67/139 (48%), Gaps = 8/139 (5%)

Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG+G F  +YKG       L     G  + V +K L     +    +    + + +LSH 
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS-DHRDSLAFFETASLMSQLSHK 61

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           +LVKL G C  D E ++V EY++ G L+  L  R  +   L W  +L +A   A  L +L
Sbjct: 62  HLVKLYGVCVRD-ENIMVEEYVKFGPLDVFL-HREKNNVSLHW--KLDVAKQLASALHYL 117

Query: 216 HTSEKKVIYRDFKASNILL 234
              +KK+++ +    NIL+
Sbjct: 118 E--DKKLVHGNVCGKNILV 134

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 46/142 (32%), Positives = 69/142 (48%), Gaps = 16/142 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V+ G          K    + VAIK +N  +M   E++  E   + +LSHP 
Sbjct: 12  LGSGQFGVVHLG----------KWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPK 60

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV+L G C + K L +V E+M+ G L N+L +R   +     D+ L +      G+ +L 
Sbjct: 61  LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK---DMLLSMCQDVCEGMEYLE 117

Query: 217 TSEKKVIYRDFKASNILLDGVG 238
            +    I+RD  A N L+   G
Sbjct: 118 RN--SFIHRDLAARNCLVSSTG 137

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 43/143 (30%), Positives = 71/143 (49%), Gaps = 19/143 (13%)

Query: 95  SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVNFLGRLS 153
            +LG+G  G VYK      T        G + A+KK++     +  ++   E+  L    
Sbjct: 7   KVLGQGSSGVVYKV-RHKPT--------GKIYALKKIHVDGDEEFRKQLLRELKTLRSCE 57

Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI--QPLSWDIRLKIAIGAARG 211
            P +VK  G  +++ E+ +V EYM  GSL + L ++   I    L+      IA    +G
Sbjct: 58  SPYVVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLA-----YIARQILKG 111

Query: 212 LGFLHTSEKKVIYRDFKASNILL 234
           L +LHT ++ +I+RD K SN+L+
Sbjct: 112 LDYLHT-KRHIIHRDIKPSNLLI 133

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 40/138 (28%), Positives = 67/138 (48%), Gaps = 15/138 (10%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V++G  ++ T           VA+K L P +M   +++ +E   + +L HP 
Sbjct: 14  LGAGQFGEVWEGLWNNTT----------PVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPK 62

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           L++L   C  ++ + +V E M+ GSL  +L         L   I   +A   A G+ +L 
Sbjct: 63  LIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DMAAQVASGMAYLE 120

Query: 217 TSEKKVIYRDFKASNILL 234
              +  I+RD  A N+L+
Sbjct: 121 --AQNYIHRDLAARNVLV 136

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 46/143 (32%), Positives = 70/143 (48%), Gaps = 9/143 (6%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSH 154
            LG G FG VY+G   D  L P    +   VA+K L   +  Q  +E+  E + +   +H
Sbjct: 2   FLGSGAFGEVYEGTATD-ILGPGSGPIR--VAVKTLRKGATDQEKKEFLKEAHLMSNFNH 58

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR-RNPSIQP--LSWDIRLKIAIGAARG 211
           PN+VKLLG C  ++   ++ E M+ G L ++L   R     P  L+    L I +  A+G
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 212 LGFLHTSEKKVIYRDFKASNILL 234
             +L   +   I+RD  A N L+
Sbjct: 119 CVYLE--QMHFIHRDLAARNCLV 139

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 63.0 bits (153), Expect = 2e-11
 Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 23/152 (15%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW--QSEVN 147
            ++   ++G G FG V+        L   K    +V+ IK++  E M   E    Q+E  
Sbjct: 1   KYEKIRVVGRGAFGIVH--------LCRRKADQKLVI-IKQIPVEQMTKDERLAAQNECQ 51

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP----LSWDIRLK 203
            L  LSHPN+++      EDK L++V EY   G+L  ++ +R  S+      L + +++ 
Sbjct: 52  VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111

Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           +A+         H   K +++RD K  NILLD
Sbjct: 112 LALH--------HVHTKLILHRDLKTQNILLD 135

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 49/140 (35%), Positives = 70/140 (50%), Gaps = 10/140 (7%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE-WQSEVNFLGRL-SH 154
           LG G FG+V    V+      SK+   M VA+K L P +     E   SE+  +  L +H
Sbjct: 43  LGAGAFGKV----VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
            N+V LLG C     +L++ EY   G L N L R+  S   L+ +  L  +   A+G+ F
Sbjct: 99  ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF--LTLEDLLSFSYQVAKGMAF 156

Query: 215 LHTSEKKVIYRDFKASNILL 234
           L  + K  I+RD  A N+LL
Sbjct: 157 L--ASKNCIHRDLAARNVLL 174

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 62.7 bits (152), Expect = 3e-11
 Identities = 44/155 (28%), Positives = 73/155 (47%), Gaps = 23/155 (14%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVN 147
            ++    +GEG FG++Y        LA +K+     V IK+++   M  +  E  + EV 
Sbjct: 1   RYEIIKKIGEGSFGKIY--------LAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVI 51

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI----QPLSWDIRLK 203
            L ++ HPN+V       E+  L +V EY   G L   + R+   +    Q LSW +++ 
Sbjct: 52  LLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQI- 110

Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                   LG  H  ++K+++RD K+ NI L   G
Sbjct: 111 -------SLGLKHIHDRKILHRDIKSQNIFLSKNG 138

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 22/148 (14%)

Query: 95  SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH 154
             LG+G FG V     D     P +   G VVA+KKL   + +   +++ E+  L  L H
Sbjct: 10  QQLGKGNFGSVELCRYD-----PLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQH 64

Query: 155 PNLVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRR-----NPSIQPLSWDIRLKIAIG 207
            N+VK  G C+    + L LV EY+  GSL ++L +      +  +   +  I       
Sbjct: 65  DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI------- 117

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLD 235
             +G+ +L    K+ ++RD    NIL++
Sbjct: 118 -CKGMEYL--GSKRYVHRDLATRNILVE 142

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 62.2 bits (151), Expect = 5e-11
 Identities = 47/139 (33%), Positives = 72/139 (51%), Gaps = 18/139 (12%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V+ G+ +  T           VAIK L   SM   E + +E N + +L HP 
Sbjct: 14  LGAGQFGEVWMGYYNGHT----------KVAIKSLKQGSMSP-EAFLAEANLMKQLQHPR 62

Query: 157 LVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           LV+L  Y    +E + ++ EYM+ GSL + L  + P    L+ +  + +A   A G+ F+
Sbjct: 63  LVRL--YAVVTQEPIYIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFI 118

Query: 216 HTSEKKVIYRDFKASNILL 234
               K  I+RD +A+NIL+
Sbjct: 119 E--RKNYIHRDLRAANILV 135

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 62.8 bits (152), Expect = 5e-11
 Identities = 56/167 (33%), Positives = 77/167 (46%), Gaps = 20/167 (11%)

Query: 71  LETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK 130
           L+ P++    F +     K F     +G G FG VY    D +T          VVAIKK
Sbjct: 9   LKDPEIAELFFKE--DPEKLFTDLREIGHGSFGAVYFAR-DVRT--------NEVVAIKK 57

Query: 131 LNPESMQGFEEWQ---SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLF 187
           ++    Q  E+WQ    EV FL R+ HPN ++  G    +    LV EY   GS  + L 
Sbjct: 58  MSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLE 116

Query: 188 RRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
                +Q +       I  GA +GL +LH+    +I+RD KA NILL
Sbjct: 117 VHKKPLQEVEI---AAITHGALQGLAYLHS--HNMIHRDIKAGNILL 158

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 62.4 bits (152), Expect = 5e-11
 Identities = 43/150 (28%), Positives = 66/150 (44%), Gaps = 20/150 (13%)

Query: 95  SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL----NPESMQGFEEWQSEVNFLG 150
           S LGEG  G V K     K         GM+ A+K +    NP+  +   +   E+    
Sbjct: 7   SRLGEGAGGSVTK--CRLK-------NTGMIFALKTITTDPNPDLQK---QILRELEINK 54

Query: 151 RLSHPNLVKLLGYCWEDKE--LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
               P +VK  G   ++    + +  EY + GSL++   +       +   +  KIA   
Sbjct: 55  SCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESV 114

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            +GL +LH   +K+I+RD K SNILL   G
Sbjct: 115 LKGLSYLH--SRKIIHRDIKPSNILLTRKG 142

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 16/153 (10%)

Query: 97  LGEGGFGRVYKGWVDD-----KTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLG 150
           LGEG FG V+    +         AP   G  ++VA+K L  +  +    ++  E+  + 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRN--------PSIQPLSWDIRL 202
           RL +PN+++LLG C  D  L ++ EYM+ G L   L +R          +I  +S    L
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
            +A+  A G+ +L  +    ++RD    N L+ 
Sbjct: 133 YMAVQIASGMKYL--ASLNFVHRDLATRNCLVG 163

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 62.4 bits (151), Expect = 6e-11
 Identities = 41/138 (29%), Positives = 72/138 (52%), Gaps = 14/138 (10%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG+VYK        A +K   G + A K +  +S +  E++  E+  L   +HP 
Sbjct: 20  LGDGAFGKVYK--------AKNKE-TGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           +VKLLG  + D +L ++ E+   G+++  +   +  +      +  +  + A   L +LH
Sbjct: 71  IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEA---LQYLH 127

Query: 217 TSEKKVIYRDFKASNILL 234
           +   K+I+RD KA N+LL
Sbjct: 128 S--MKIIHRDLKAGNVLL 143

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 62.2 bits (152), Expect = 6e-11
 Identities = 47/144 (32%), Positives = 65/144 (45%), Gaps = 27/144 (18%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           +GEG  G VYK   D  T        G  VAIKK+     Q  E   +E+  +    HPN
Sbjct: 27  IGEGASGEVYKA-TDRAT--------GKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA------R 210
           +V          EL +V EYM  GSL + +  +N         +R+     A       +
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTD-IITQNF--------VRMNEPQIAYVCREVLQ 127

Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
           GL +LH+  + VI+RD K+ NILL
Sbjct: 128 GLEYLHS--QNVIHRDIKSDNILL 149

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 47/143 (32%), Positives = 76/143 (53%), Gaps = 18/143 (12%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG+VYK        A +K   G++ A K ++ +S +  E++  E++ L    HPN
Sbjct: 13  LGDGAFGKVYK--------AQNKE-TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFR-RNPSIQPLSWDIRLKIAIGAARGLGFL 215
           +VKLL   + +  L ++ E+   G+++  +     P  +P    IR+ +       L +L
Sbjct: 64  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEP---QIRV-VCKQTLEALNYL 119

Query: 216 HTSEKKVIYRDFKASNIL--LDG 236
           H  E K+I+RD KA NIL  LDG
Sbjct: 120 H--ENKIIHRDLKAGNILFTLDG 140

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 62.4 bits (151), Expect = 7e-11
 Identities = 48/141 (34%), Positives = 67/141 (47%), Gaps = 18/141 (12%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVNFLGRLS 153
           +G G FG VY           + +    VVA+KK++    Q  E+WQ    EV FL +L 
Sbjct: 29  IGHGSFGAVYFA---------TNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79

Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           HPN ++  G   ++    LV EY   GS  + L      +Q +       I  GA +GL 
Sbjct: 80  HPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEI---AAITHGALQGLA 135

Query: 214 FLHTSEKKVIYRDFKASNILL 234
           +LH+     I+RD KA NILL
Sbjct: 136 YLHSHNM--IHRDIKAGNILL 154

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 62.0 bits (151), Expect = 7e-11
 Identities = 41/140 (29%), Positives = 62/140 (44%), Gaps = 13/140 (9%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHP 155
           +G G    VY                   VAIK+++ E  Q   +E + EV  + + +HP
Sbjct: 9   IGVGATAVVYAAICLPN---------NEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHP 59

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           N+VK         EL LV  Y+  GSL   + + +     L   I   +     +GL +L
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLL-DIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 216 HTSEKKVIYRDFKASNILLD 235
           H++ +  I+RD KA NILL 
Sbjct: 119 HSNGQ--IHRDIKAGNILLG 136

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 61.9 bits (150), Expect = 7e-11
 Identities = 45/155 (29%), Positives = 80/155 (51%), Gaps = 24/155 (15%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESM----QGFEEWQSEVNFL 149
           +LG+G +G VY G  +           G ++A+K+  L+  ++    + +E+ Q EV+ L
Sbjct: 7   VLGKGAYGTVYCGLTNQ----------GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLL 56

Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
             L H N+V+ LG C +D  + +  E++  GS+ + L R  P  +P+      +I  G A
Sbjct: 57  KSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA 116

Query: 210 RGLGFLHTSEKKVIYRDFKASNILL--DGVGFLFD 242
               +LH     V++RD K +N++L  +G+  L D
Sbjct: 117 ----YLH--NNCVVHRDIKGNNVMLMPNGIIKLID 145

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 61.5 bits (149), Expect = 9e-11
 Identities = 42/147 (28%), Positives = 73/147 (49%), Gaps = 24/147 (16%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-----SEVNFLG 150
           ++G G FG V++G +      P +    + VAIK L P    G+ E Q     SE + +G
Sbjct: 12  VIGAGEFGEVFRGILK----MPGRKE--VAVAIKTLKP----GYTEKQRQDFLSEASIMG 61

Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           + SH N+++L G   + K  +++ EYM+ G+L+ +L   +               +G  R
Sbjct: 62  QFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQ-------LVGMLR 114

Query: 211 GL--GFLHTSEKKVIYRDFKASNILLD 235
           G+  G  + S+   ++RD  A NIL++
Sbjct: 115 GIAAGMKYLSDMNYVHRDLAARNILVN 141

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 63.3 bits (154), Expect = 9e-11
 Identities = 54/170 (31%), Positives = 82/170 (48%), Gaps = 26/170 (15%)

Query: 69  QILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVA- 127
           Q  ++   K  +  D+ S+ K    ++++  G  G  YKG          K G+  VV  
Sbjct: 673 QFFDSKVSKSITINDILSSLKE---ENVISRGKKGASYKG-------KSIKNGMQFVVKE 722

Query: 128 IKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLF 187
           I  +N           SE+  +G+L HPN+VKL+G C  +K   L++EY++  +L   L 
Sbjct: 723 INDVNSIP-------SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL- 774

Query: 188 RRNPSIQPLSWDIRLKIAIGAARGLGFLHTS-EKKVIYRDFKASNILLDG 236
            RN     LSW+ R KIAIG A+ L FLH      V+  +     I++DG
Sbjct: 775 -RN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG 818

Length = 968

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 20/155 (12%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE---WQSEV 146
           N++   LLG+G FGRVY  +  D       TG  + V   + +PES +  +E    + E+
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDAD-------TGRELAVKQVQFDPESPETSKEVNALECEI 55

Query: 147 NFLGRLSHPNLVKLLGYCWED---KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
             L  L H  +V+  G C  D   + L +  E+M  GS+++ L     S   L+ ++  K
Sbjct: 56  QLLKNLLHERIVQYYG-CLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRK 110

Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                  G+ +LH++   +++RD K +NIL D VG
Sbjct: 111 YTRQILEGVSYLHSN--MIVHRDIKGANILRDSVG 143

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 46/152 (30%), Positives = 76/152 (50%), Gaps = 21/152 (13%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVNFLGRLSHP 155
           LGE  FG++YKG +    +  ++     +VAIK L +  + Q + E+Q E + +  L HP
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQ-----LVAIKTLKDINNPQQWGEFQQEASLMAELHHP 67

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI-------------QPLSWDIRL 202
           N+V LLG   +++ + +++EY+ +G L   L  R+P                 L     L
Sbjct: 68  NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
            IAI  A G+ +L  S    +++D  A NIL+
Sbjct: 128 HIAIQIAAGMEYL--SSHFFVHKDLAARNILI 157

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 16/139 (11%)

Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 14  LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 62

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L   N         + L +A   +  + +L
Sbjct: 63  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV--VLLYMATQISSAMEYL 120

Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+RD  A N L+
Sbjct: 121 E--KKNFIHRDLAARNCLV 137

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 38/141 (26%), Positives = 62/141 (43%), Gaps = 15/141 (10%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE--EWQSEVNFLGRLSH 154
           +G+G FG V+K                 V A+K+++   M   E  E   E   L +L  
Sbjct: 8   IGKGSFGVVFKVVRKAD---------KRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS 58

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
             +++      +  +L +V EY + G L  H   +    +PL  D   +  I    GL  
Sbjct: 59  SYIIRYYESFLDKGKLNIVMEYAENGDL--HKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116

Query: 215 LHTSEKKVIYRDFKASNILLD 235
           LH+  KK+++RD K+ N+ LD
Sbjct: 117 LHS--KKILHRDIKSLNLFLD 135

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 40/146 (27%), Positives = 63/146 (43%), Gaps = 17/146 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--EVNFLGRLSH 154
           +GEG +G VYK               G +VAIKK+            +  E+  L  L+H
Sbjct: 7   IGEGTYGVVYKARDKL---------TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNH 57

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           PN++KLL       +L LV+E+M        L +     + L   +         +GL F
Sbjct: 58  PNIIKLLDVFRHKGDLYLVFEFMDTDLY--KLIKDRQ--RGLPESLIKSYLYQLLQGLAF 113

Query: 215 LHTSEKKVIYRDFKASNILLDGVGFL 240
            H+    +++RD K  N+L++  G L
Sbjct: 114 CHSH--GILHRDLKPENLLINTEGVL 137

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 60.9 bits (147), Expect = 2e-10
 Identities = 45/144 (31%), Positives = 75/144 (52%), Gaps = 20/144 (13%)

Query: 96  LLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLS 153
           +LG G FG VYKG WV      P    + + VAIK LN  +  +   E+  E   +  + 
Sbjct: 14  VLGSGAFGTVYKGIWV------PEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67

Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKIAIGAAR 210
           HP+LV+LLG C     + LV + M  G L +++     +I     L+W +++      A+
Sbjct: 68  HPHLVRLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AK 120

Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
           G+ +L   E+++++RD  A N+L+
Sbjct: 121 GMMYLE--ERRLVHRDLAARNVLV 142

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 51/159 (32%), Positives = 74/159 (46%), Gaps = 23/159 (14%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP-ESMQGFEEWQSEVNF 148
           + K   ++GEG FG+V K  +        K GL M  AIK++    S     ++  E+  
Sbjct: 8   DIKFQDVIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60

Query: 149 LGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR------------NPSIQP 195
           L +L  HPN++ LLG C     L L  EY   G+L + L +             N +   
Sbjct: 61  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120

Query: 196 LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           LS    L  A   ARG+ +L  S+K+ I+RD  A NIL+
Sbjct: 121 LSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILV 157

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 59.7 bits (144), Expect = 3e-10
 Identities = 50/153 (32%), Positives = 71/153 (46%), Gaps = 23/153 (15%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP-ESMQGFEEWQSEVNFLGRLSH 154
           ++GEG FG+V K  +        K GL M  AIK++    S     ++  E+  L +L H
Sbjct: 2   VIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 54

Query: 155 -PNLVKLLGYCWEDKELLLVYEYMQRGSLENHL------------FRRNPSIQPLSWDIR 201
            PN++ LLG C     L L  EY   G+L + L               N +   LS    
Sbjct: 55  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114

Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           L  A   ARG+ +L  S+K+ I+RD  A NIL+
Sbjct: 115 LHFAADVARGMDYL--SQKQFIHRDLAARNILV 145

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 59.9 bits (145), Expect = 4e-10
 Identities = 46/142 (32%), Positives = 71/142 (50%), Gaps = 13/142 (9%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
           LGEG FG+V     D     P     G  VA+K L PES      + + E+  L  L H 
Sbjct: 12  LGEGHFGKVELCRYD-----PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66

Query: 156 NLVKLLGYCWED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           N+VK  G C ED    + L+ E++  GSL+ +L R    I   +   +LK A+   +G+ 
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKI---NLKQQLKYAVQICKGMD 123

Query: 214 FLHTSEKKVIYRDFKASNILLD 235
           +L    ++ ++RD  A N+L++
Sbjct: 124 YL--GSRQYVHRDLAARNVLVE 143

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 59.9 bits (146), Expect = 4e-10
 Identities = 47/163 (28%), Positives = 67/163 (41%), Gaps = 34/163 (20%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSE 145
            +F+    LG G FGRV         L   K   G   A+K L+      ++  E   +E
Sbjct: 1   DDFEFIKTLGTGSFGRV--------MLVRHKGS-GKYYALKILSKAKIVKLKQVEHVLNE 51

Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
              L  + HP LV L G   +D  L LV EY+  G L +HL +              +  
Sbjct: 52  KRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG------------RFP 99

Query: 206 IGAAR--------GLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
              AR         L +LH+    ++YRD K  N+LLD  G++
Sbjct: 100 EPVARFYAAQVVLALEYLHS--LDIVYRDLKPENLLLDSDGYI 140

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 47/160 (29%), Positives = 75/160 (46%), Gaps = 23/160 (14%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP-ESMQGFEEWQSEVN 147
           ++ K + ++GEG FG+V +  +        K GL M  AIK L    S     ++  E+ 
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMI-------KKDGLKMNAAIKMLKEFASENDHRDFAGELE 54

Query: 148 FLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL------------FRRNPSIQ 194
            L +L  HPN++ LLG C     L +  EY   G+L + L             + + +  
Sbjct: 55  VLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAS 114

Query: 195 PLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
            L+    L+ A   A G+ +L  SEK+ I+RD  A N+L+
Sbjct: 115 TLTSQQLLQFASDVATGMQYL--SEKQFIHRDLAARNVLV 152

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 59.1 bits (143), Expect = 7e-10
 Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 24/151 (15%)

Query: 92  KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-----SEV 146
           K + ++G G FG V +G    +   P K    + VAIK L      G+ E Q     SE 
Sbjct: 7   KIEEVIGAGEFGEVCRG----RLKLPGKRE--IFVAIKTLK----SGYTEKQRRDFLSEA 56

Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
           + +G+  HPN++ L G   + + ++++ E+M+ G+L++ L + +         I+L   +
Sbjct: 57  SIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV----IQL---V 109

Query: 207 GAARGL--GFLHTSEKKVIYRDFKASNILLD 235
           G  RG+  G  + SE   ++RD  A NIL++
Sbjct: 110 GMLRGIAAGMKYLSEMNYVHRDLAARNILVN 140

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 58.9 bits (142), Expect = 8e-10
 Identities = 43/147 (29%), Positives = 67/147 (45%), Gaps = 15/147 (10%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LGEG FG+V+    +   L P +  +  +VA+K L   S    +++  E   L  L H +
Sbjct: 13  LGEGAFGKVF--LAECYNLCPEQDKI--LVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI---------QPLSWDIRLKIAIG 207
           +VK  G C E   L++V+EYM+ G L   L    P             L+    L IA  
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILL 234
            A G+ +L  + +  ++RD    N L+
Sbjct: 129 IAAGMVYL--ASQHFVHRDLATRNCLV 153

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 59.0 bits (143), Expect = 8e-10
 Identities = 50/155 (32%), Positives = 79/155 (50%), Gaps = 24/155 (15%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQSEVN 147
           NF+    +GEG +G VYK        A +K   G VVA+KK  L+ E+         E++
Sbjct: 1   NFQKVEKIGEGTYGVVYK--------ARNKL-TGEVVALKKIRLDTETEGVPSTAIREIS 51

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPL----SWDIRLK 203
            L  L+HPN+VKLL     + +L LV+E++ +  L+  +     S  PL    S+  +L 
Sbjct: 52  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQL- 109

Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                 +GL F H+   +V++RD K  N+L++  G
Sbjct: 110 -----LQGLAFCHS--HRVLHRDLKPQNLLINTEG 137

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 58.9 bits (142), Expect = 8e-10
 Identities = 49/141 (34%), Positives = 69/141 (48%), Gaps = 18/141 (12%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVNFLGRLS 153
           +G G FG VY      + +  S+     VVAIKK++    Q  E+WQ    EV FL +L 
Sbjct: 23  IGHGSFGAVYFA----RDVRNSE-----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           HPN ++  G    +    LV EY   GS  + L      +Q +       +  GA +GL 
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEI---AAVTHGALQGLA 129

Query: 214 FLHTSEKKVIYRDFKASNILL 234
           +LH+    +I+RD KA NILL
Sbjct: 130 YLHS--HNMIHRDVKAGNILL 148

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 58.9 bits (142), Expect = 9e-10
 Identities = 42/151 (27%), Positives = 76/151 (50%), Gaps = 20/151 (13%)

Query: 91  FKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVNF 148
           FK   +LG G FG VYKG W+      P    + + VAIK+L    S +  +E   E   
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAYV 62

Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKIA 205
           +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++   
Sbjct: 63  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI--- 118

Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
              A+G+ +L   E+++++RD  A N+L+  
Sbjct: 119 ---AKGMNYLE--ERRLVHRDLAARNVLVKT 144

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 58.6 bits (141), Expect = 9e-10
 Identities = 50/143 (34%), Positives = 74/143 (51%), Gaps = 17/143 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
           +G+G FG V+KG +D++T          VVAIK ++ E  +   E+ Q E+  L +   P
Sbjct: 12  IGKGSFGEVFKG-IDNRTQK--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
            + K  G   +D +L ++ EY+  GS  + L    P   PL       I     +GL +L
Sbjct: 63  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPG--PLDETQIATILREILKGLDYL 117

Query: 216 HTSEKKVIYRDFKASNILLDGVG 238
           H SEKK I+RD KA+N+LL   G
Sbjct: 118 H-SEKK-IHRDIKAANVLLSEHG 138

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 44/142 (30%), Positives = 68/142 (47%), Gaps = 23/142 (16%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSH 154
           LG G FG V+ G+ ++ T           VA+K L P +M  Q F E   E N +  L H
Sbjct: 14  LGAGQFGEVWMGYYNNST----------KVAVKTLKPGTMSVQAFLE---EANLMKTLQH 60

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS--IQPLSWDIRLKIAIGAARGL 212
             LV+L     +++ + ++ EYM +GSL + L        + P   D   +IA G A   
Sbjct: 61  DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA--- 117

Query: 213 GFLHTSEKKVIYRDFKASNILL 234
              +   K  I+RD +A+N+L+
Sbjct: 118 ---YIERKNYIHRDLRAANVLV 136

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 40/146 (27%), Positives = 60/146 (41%), Gaps = 17/146 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGF-EEWQSEVNFLGRLSH 154
           +GEG  G V+K   D +T        G  VA+KK+       G   +   E+  L    H
Sbjct: 8   IGEGAHGIVFKA-KDRET--------GETVALKKVALRRLEGGIPNQALREIKALQACQH 58

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           P +VKLL         +LV EYM    L   L       +PL             +G+ +
Sbjct: 59  PYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAY 114

Query: 215 LHTSEKKVIYRDFKASNILLDGVGFL 240
           +H     +++RD K +N+L+   G L
Sbjct: 115 MH--ANGIMHRDLKPANLLISADGVL 138

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 39/153 (25%), Positives = 67/153 (43%), Gaps = 17/153 (11%)

Query: 97  LGEGGFGRVY-------KGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEVNF 148
           LGEG FG V+       + ++D            ++VA+K L  ++ +    ++  E+  
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------- 201
           + RL  PN+++LL  C     L ++ EYM+ G L   L R  P       D+        
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132

Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           + +A   A G+ +L  S    ++RD    N L+
Sbjct: 133 IFMATQIASGMKYL--SSLNFVHRDLATRNCLV 163

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 58.0 bits (141), Expect = 2e-09
 Identities = 45/157 (28%), Positives = 69/157 (43%), Gaps = 40/157 (25%)

Query: 95  SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQS---EVNFLG 150
           + +GEG +G VYK               G  VA+KK+  P S +G     S   E+  L 
Sbjct: 5   AEIGEGAYGTVYKA---------RDLNTGRFVALKKVRVPLSEEGIP--LSTLREIALLK 53

Query: 151 RL---SHPNLVKLLGYC--WEDKE---LLLVYEYMQRGSLENHLFRRNPS------IQPL 196
           +L    HPN+V+LL  C          L LV+E++ +  L  +L +          I+ L
Sbjct: 54  QLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDL 112

Query: 197 SWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL 233
              +         RG+ FLH+   ++++RD K  NIL
Sbjct: 113 MRQL--------LRGVDFLHSH--RIVHRDLKPQNIL 139

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 42/142 (29%), Positives = 66/142 (46%), Gaps = 12/142 (8%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G  G V K  V  +      TG  M V   +L        ++   E++ L + + P 
Sbjct: 9   LGAGNSGVVSK--VLHR-----PTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPY 60

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           +V   G  + + ++ +  EYM  GSL+  L         +   I  KIA+   +GL +LH
Sbjct: 61  IVGFYGAFYNNGDISICMEYMDGGSLDKILKE---VQGRIPERILGKIAVAVLKGLTYLH 117

Query: 217 TSEKKVIYRDFKASNILLDGVG 238
             + K+I+RD K SNIL++  G
Sbjct: 118 -EKHKIIHRDVKPSNILVNSRG 138

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 47/160 (29%), Positives = 72/160 (45%), Gaps = 18/160 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLS 153
           LG+GGFG V          A      G + A KKL+ + +   +G +   +E   L ++S
Sbjct: 1   LGKGGFGEVC---------ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS 51

Query: 154 HPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
              +V L  Y +E K +L LV   M  G L+ H++       P +  I     I      
Sbjct: 52  SRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQII----C 106

Query: 213 GFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFK 252
           G  H  +++++YRD K  N+LLD  G +  S L + V  K
Sbjct: 107 GLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELK 146

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 43/160 (26%), Positives = 71/160 (44%), Gaps = 22/160 (13%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---S 144
             NFK +  +G+G F  VYK               G VVA+KK+    M   +  Q    
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKA---------ICLLDGRVVALKKVQIFEMMDAKARQDCLK 51

Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLE---NHLFRRNPSI-QPLSWDI 200
           E++ L +L HPN++K L    E+ EL +V E    G L     H  ++   I +   W  
Sbjct: 52  EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111

Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
            +++       L  +H   K++++RD K +N+ +   G +
Sbjct: 112 FVQL----CSALEHMH--SKRIMHRDIKPANVFITATGVV 145

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 45/150 (30%), Positives = 66/150 (44%), Gaps = 24/150 (16%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLS 153
           LG+GGFG V          A      G + A KKLN + +   +G+E    E   L ++ 
Sbjct: 1   LGKGGFGEVS---------ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV- 50

Query: 154 HPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLF---RRNPSIQ-PLSWDIRLKIAIGA 208
           H   +  L Y ++ K +L LV   M  G L  H++     NP    P +     +I    
Sbjct: 51  HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQII--- 107

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
               G  H  ++++IYRD K  N+LLD  G
Sbjct: 108 ---SGLEHLHQRRIIYRDLKPENVLLDNDG 134

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 25/154 (16%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVNFLGRLSHP 155
           LGE  FG+VYKG +       +       VAIK L  ++     EE++ E     RL HP
Sbjct: 13  LGEDRFGKVYKGHL----FGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHP 68

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP---------------SIQPLSWDI 200
           N+V LLG   +++ L +++ Y     L   L  R+P               +++P  +  
Sbjct: 69  NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF-- 126

Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
            + I    A G+ FL  S   V+++D    N+L+
Sbjct: 127 -VHIVTQIAAGMEFL--SSHHVVHKDLATRNVLV 157

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 57.2 bits (138), Expect = 2e-09
 Identities = 47/153 (30%), Positives = 75/153 (49%), Gaps = 24/153 (15%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-----S 144
             K + ++G G FG V  G    +   P K  +   VAIK L      G+ E Q     S
Sbjct: 5   CIKIEKVIGAGEFGEVCSG----RLKLPGKREI--PVAIKTLK----AGYTEKQRRDFLS 54

Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E + +G+  HPN++ L G   + K +++V EYM+ GSL+  L + +         I+L  
Sbjct: 55  EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV----IQL-- 108

Query: 205 AIGAARGL--GFLHTSEKKVIYRDFKASNILLD 235
            +G  RG+  G  + S+   ++RD  A NIL++
Sbjct: 109 -VGMLRGIASGMKYLSDMGYVHRDLAARNILVN 140

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 18/152 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRL-SH 154
           LGEG FG+V     +   +   K    + VA+K L  ++  +   +  SE+  +  +  H
Sbjct: 20  LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDI------------RL 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R P     S+D              +
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
             A   ARG+ +L  + +K I+RD  A N+L+
Sbjct: 138 SCAYQVARGMEYL--ASQKCIHRDLAARNVLV 167

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 47/155 (30%), Positives = 67/155 (43%), Gaps = 30/155 (19%)

Query: 98  GEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS---EVNFLGRLSH 154
           G G +GRVYK     K     K       AIKK   +  Q     QS   E+  L  L H
Sbjct: 9   GRGTYGRVYKAK--RKNGKDGK-----EYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 155 PNLVKLLGYCWE--DKELLLVYEYMQRGSLE---NHLFRRNPSIQP-----LSWDIRLKI 204
            N+V L+    E  DK + L+++Y +    +    H   +  SI P     L W I    
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI---- 117

Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF 239
                 G+ +LH++   V++RD K +NIL+ G G 
Sbjct: 118 ----LNGVHYLHSNW--VLHRDLKPANILVMGEGP 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 57.0 bits (137), Expect = 3e-09
 Identities = 49/143 (34%), Positives = 74/143 (51%), Gaps = 17/143 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
           +G+G FG V+KG +D++T          VVAIK ++ E  +   E+ Q E+  L +   P
Sbjct: 12  IGKGSFGEVFKG-IDNRTQQ--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
            + K  G   +  +L ++ EY+  GS  + L R  P          LK  +   +GL +L
Sbjct: 63  YVTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGP-FDEFQIATMLKEIL---KGLDYL 117

Query: 216 HTSEKKVIYRDFKASNILLDGVG 238
           H SEKK I+RD KA+N+LL   G
Sbjct: 118 H-SEKK-IHRDIKAANVLLSEQG 138

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 48/148 (32%), Positives = 74/148 (50%), Gaps = 20/148 (13%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
           K  K    +G+G FG V  G  D +         G  VA+K + N  + Q F    +E +
Sbjct: 6   KELKLLQTIGKGEFGDVMLG--DYR---------GNKVAVKCIKNDATAQAF---LAEAS 51

Query: 148 FLGRLSHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
            + +L H NLV+LLG   E+K  L +V EYM +GSL ++L  R  S+  L  D  LK ++
Sbjct: 52  VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSL 109

Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILL 234
                + +L  +    ++RD  A N+L+
Sbjct: 110 DVCEAMEYLEAN--NFVHRDLAARNVLV 135

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 18/152 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLS-H 154
           LGEG FG+V +   +   +  S+    + VA+K L   +  +   +  SE+  +  +  H
Sbjct: 20  LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------L 202
            N++ LLG C ++  L ++ EY  +G+L   L  R P     ++DI             +
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
             A   ARG+ +L +  ++ I+RD  A N+L+
Sbjct: 138 SCAYQVARGMEYLES--RRCIHRDLAARNVLV 167

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 47/152 (30%), Positives = 74/152 (48%), Gaps = 18/152 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRL-SH 154
           LGEG FG+V     +   L   K      VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 26  LGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR---------NPSIQP---LSWDIRL 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R         NP+  P   LS+   +
Sbjct: 84  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
             A   ARG+ +L  + KK I+RD  A N+L+
Sbjct: 144 SCAYQVARGMEYL--ASKKCIHRDLAARNVLV 173

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 56.2 bits (135), Expect = 5e-09
 Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 20/155 (12%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE---WQSEV 146
           N++   LLG+G FGRVY  +  D       TG  +     + +PES +  +E    + E+
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVD-------TGRELAAKQVQFDPESPETSKEVSALECEI 55

Query: 147 NFLGRLSHPNLVKLLGYCWED---KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
             L  L H  +V+  G C  D   K L +  EYM  GS+++ L     +   L+  +  K
Sbjct: 56  QLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRK 110

Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                  G+ +LH++   +++RD K +NIL D  G
Sbjct: 111 YTRQILEGMSYLHSN--MIVHRDIKGANILRDSAG 143

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 56.1 bits (135), Expect = 5e-09
 Identities = 48/149 (32%), Positives = 75/149 (50%), Gaps = 22/149 (14%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
           +GEG FG V +G              G  VA+K +  + + Q F E   E   + +L H 
Sbjct: 14  IGEGEFGAVLQG-----------EYTGQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHK 59

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG    +  L +V E M +G+L N L  R  ++  +     L+ ++  A G+ +L
Sbjct: 60  NLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQ--LLQFSLDVAEGMEYL 116

Query: 216 HTSEKKVIYRDFKASNILL--DGVGFLFD 242
            +  KK+++RD  A NIL+  DGV  + D
Sbjct: 117 ES--KKLVHRDLAARNILVSEDGVAKVSD 143

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 56.4 bits (137), Expect = 5e-09
 Identities = 48/148 (32%), Positives = 68/148 (45%), Gaps = 28/148 (18%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS-----EVNFLGR 151
           LG+G FG VY     +          G +VAIKK+     + F  W+      EV  L +
Sbjct: 7   LGDGTFGSVYLARNKET---------GELVAIKKM----KKKFYSWEECMNLREVKSLRK 53

Query: 152 L-SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           L  HPN+VKL     E+ EL  V+EYM+ G+L   +  R    +P S  +   I     +
Sbjct: 54  LNEHPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKG--KPFSESVIRSIIYQILQ 110

Query: 211 GLGFLHTSEKKVIY--RDFKASNILLDG 236
           GL  +H    K  +  RD K  N+L+ G
Sbjct: 111 GLAHIH----KHGFFHRDLKPENLLVSG 134

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 56.2 bits (135), Expect = 8e-09
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 18/152 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLS-H 154
           LGEG FG+V     +   +   K    + VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 23  LGEGCFGQVVMA--EALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------L 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R P     S+DI             +
Sbjct: 81  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140

Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
                 ARG+ +L  + +K I+RD  A N+L+
Sbjct: 141 SCTYQVARGMEYL--ASQKCIHRDLAARNVLV 170

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 56.0 bits (135), Expect = 9e-09
 Identities = 49/150 (32%), Positives = 70/150 (46%), Gaps = 23/150 (15%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVN-FLGRL 152
           +G+G FG+V         LA  K   G   A+K L  +++   +E +   +E N  L  +
Sbjct: 3   IGKGSFGKVL--------LAKHKAD-GKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV 53

Query: 153 SHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI-AIGAAR 210
            HP LV L  Y ++  + L  V +Y+  G L  HL R     +P     R +  A   A 
Sbjct: 54  KHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-----RARFYAAEIAS 107

Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
            LG+LH     +IYRD K  NILLD  G +
Sbjct: 108 ALGYLH--SLNIIYRDLKPENILLDSQGHV 135

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 46/143 (32%), Positives = 71/143 (49%), Gaps = 17/143 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
           +G+G FG VYKG +D++T          VVAIK ++ E  +   E+ Q E+  L +   P
Sbjct: 12  IGKGSFGEVYKG-IDNRTKE--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
            + +  G   +  +L ++ EY+  GS  + L    P   PL       I     +GL +L
Sbjct: 63  YITRYYGSYLKGTKLWIIMEYLGGGSALDLL---KPG--PLEETYIATILREILKGLDYL 117

Query: 216 HTSEKKVIYRDFKASNILLDGVG 238
           H+  K  I+RD KA+N+LL   G
Sbjct: 118 HSERK--IHRDIKAANVLLSEQG 138

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 54.9 bits (132), Expect = 1e-08
 Identities = 45/148 (30%), Positives = 67/148 (45%), Gaps = 28/148 (18%)

Query: 97  LGEGGFGRV----YKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL 152
           LG G FG V    ++G  D              VAIK +   SM   +E+  E   + +L
Sbjct: 12  LGTGQFGVVKYGKWRGQYD--------------VAIKMIKEGSMSE-DEFIEEAKVMMKL 56

Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL--FRRNPSIQPLSWDIRLKIAIGAAR 210
           SH  LV+L G C + + + +V EYM  G L N+L    +      L     L++      
Sbjct: 57  SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCE 111

Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGVG 238
           G+ +L +  K+ I+RD  A N L+D  G
Sbjct: 112 GMAYLES--KQFIHRDLAARNCLVDDQG 137

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 22/153 (14%)

Query: 91  FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFL 149
           ++   L+G G +G VY+G     T        G VVA+K +N ++      + Q EV  L
Sbjct: 3   YQRLELIGRGAYGAVYRG-KHVPT--------GRVVALKIINLDTPDDDVSDIQREVALL 53

Query: 150 GRLSH---PNLVKLLGYCW-EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
            +L     PN+ K  G  + +   L ++ EY + GS+   L +  P  +     I  ++ 
Sbjct: 54  SQLRQSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVL 111

Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
           +     L ++H     VI+RD KA+NIL+   G
Sbjct: 112 VA----LKYIHKV--GVIHRDIKAANILVTNTG 138

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 22/156 (14%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-SEVNF 148
           NFK    LGEG +  VYKG         ++T  G +VA+K+++ ++ +G       E++ 
Sbjct: 1   NFKQLEKLGEGTYATVYKG--------RNRTT-GEIVALKEIHLDAEEGTPSTAIREISL 51

Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQ---RGSLENHLFRRN-PSIQPLSWDIRLKI 204
           +  L H N+V+L      + +L+LV+EYM    +  ++ H  R         S+  +L  
Sbjct: 52  MKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL-- 109

Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                +G+ F H  E +V++RD K  N+L++  G L
Sbjct: 110 ----LKGIAFCH--ENRVLHRDLKPQNLLINKRGEL 139

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 54.8 bits (132), Expect = 1e-08
 Identities = 42/151 (27%), Positives = 65/151 (43%), Gaps = 20/151 (13%)

Query: 95  SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-------FEEWQSEVN 147
           +L+G G FG VY G         + +G  M V   +L   S           +    E+ 
Sbjct: 6   ALIGSGSFGSVYLG-------MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIA 58

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
            L  L H N+V+ LG   +   L +  EY+  GS+   L       + L  +   +I   
Sbjct: 59  LLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI--- 115

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
             +GL +LH   + +I+RD K +NIL+D  G
Sbjct: 116 -LKGLNYLHN--RGIIHRDIKGANILVDNKG 143

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 25/153 (16%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQ--------SE 145
           L+G+G +GRVY        LA + T  G ++A+K+  L        +  Q        SE
Sbjct: 8   LIGKGTYGRVY--------LALNVTT-GEMMAVKQVELPATIAGRHDSRQKDMVKALRSE 58

Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
           +  L  L H N+V+ LG+   ++ L +  EY+  GS+ + L       + L      ++ 
Sbjct: 59  IETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV- 117

Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                GL +LH+  K +++RD KA N+L+D  G
Sbjct: 118 ---LEGLAYLHS--KGILHRDLKADNLLVDADG 145

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 24/150 (16%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----EVNFLGRL 152
           +GEG +G VYK        A  K   G +VA+KK+  E+    E   S    E++ L  L
Sbjct: 7   IGEGTYGVVYK--------ARDKLT-GEIVALKKIRLETED--EGVPSTAIREISLLKEL 55

Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL--KIAIGAAR 210
           +HPN+V+LL     + +L LV+E+     L+  L +   S      D  L         +
Sbjct: 56  NHPNIVRLLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ 110

Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           G+ + H+   +V++RD K  N+L+D  G L
Sbjct: 111 GIAYCHS--HRVLHRDLKPQNLLIDREGAL 138

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 41/141 (29%), Positives = 63/141 (44%), Gaps = 17/141 (12%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL--NPESMQGFEEWQSEVNFLGRLS 153
           L+GEG +G V K    +          G +VAIKK   + +     +    E+  L +L 
Sbjct: 8   LVGEGSYGMVMKCKHKET---------GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58

Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           H NLV L+      K L LV+E++    L++    + P+   L      K      RG+ 
Sbjct: 59  HENLVNLIEVFRRKKRLYLVFEFVDHTVLDD--LEKYPN--GLDESRVRKYLFQILRGIE 114

Query: 214 FLHTSEKKVIYRDFKASNILL 234
           F H+    +I+RD K  NIL+
Sbjct: 115 FCHSH--NIIHRDIKPENILV 133

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 54.9 bits (133), Expect = 2e-08
 Identities = 50/160 (31%), Positives = 75/160 (46%), Gaps = 54/160 (33%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS---------EVN 147
           LG+G +G V+K  +D +T          VVA+KK+       F+ +++         E+ 
Sbjct: 15  LGKGAYGIVWKA-IDRRT--------KEVVALKKI-------FDAFRNATDAQRTFREIM 58

Query: 148 FLGRLS-HPNLVKLLGY--CWEDKELLLVYEYM--------QRGSLEN-HLFRRNPSIQP 195
           FL  L  HPN+VKLL       DK++ LV+EYM        +   LE+ H  +R    Q 
Sbjct: 59  FLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH--KRYIMYQL 116

Query: 196 LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           L             + L ++H+    VI+RD K SNILL+
Sbjct: 117 L-------------KALKYIHSGN--VIHRDLKPSNILLN 141

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 42/145 (28%), Positives = 73/145 (50%), Gaps = 13/145 (8%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G          +T     VAIK +N   SM+   E+ +E + +   +  
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETR----VAIKTVNEAASMRERIEFLNEASVMKEFNCH 69

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG   + +  L++ E M RG L+++L         NP   P S    +++A   A
Sbjct: 70  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129

Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ +L+ +  K ++RD  A N ++
Sbjct: 130 DGMAYLNAN--KFVHRDLAARNCMV 152

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 18/154 (11%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PE--SMQGFEEWQSEV 146
           + +    +G G FGRV+        L   +       A+K +  PE   ++  +   +E 
Sbjct: 2   DLERIKTVGTGTFGRVH--------LVRDRIS-EHYYALKVMAIPEVIRLKQEQHVHNEK 52

Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
             L  +SHP +++L     + + L ++ EY+  G L ++L  RN      S    L  A 
Sbjct: 53  RVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL--RNSG--RFSNSTGLFYAS 108

Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                L +LH+  K+++YRD K  NILLD  G +
Sbjct: 109 EIVCALEYLHS--KEIVYRDLKPENILLDKEGHI 140

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 44/151 (29%), Positives = 68/151 (45%), Gaps = 24/151 (15%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           +GEG  G V         +A  K+  G  VA+KK++    Q  E   +EV  +    HPN
Sbjct: 27  IGEGSTGIV--------CIATDKST-GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLEN---HLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           +V++        EL +V E+++ G+L +   H       I          + +   + L 
Sbjct: 78  IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--------TVCLAVLKALS 129

Query: 214 FLHTSEKKVIYRDFKASNILL--DGVGFLFD 242
           FLH   + VI+RD K+ +ILL  DG   L D
Sbjct: 130 FLHA--QGVIHRDIKSDSILLTSDGRVKLSD 158

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 45/149 (30%), Positives = 71/149 (47%), Gaps = 32/149 (21%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----EVNFLGRL 152
           +GEG +G VYK   D  T           +A+KK+  E  Q  E   S    E++ L  +
Sbjct: 10  IGEGTYGVVYKA-RDRVT--------NETIALKKIRLE--QEDEGVPSTAIREISLLKEM 58

Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL-----FRRNPS-IQPLSWDIRLKIAI 206
            H N+V+L      +K L LV+EY+    L+ H+     F +NP  I+   + I      
Sbjct: 59  QHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQI------ 111

Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLD 235
              RG+ + H+   +V++RD K  N+L+D
Sbjct: 112 --LRGIAYCHS--HRVLHRDLKPQNLLID 136

Length = 294

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 53.7 bits (129), Expect = 3e-08
 Identities = 41/142 (28%), Positives = 73/142 (51%), Gaps = 15/142 (10%)

Query: 97  LGEGGFGRVYKG----WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL 152
           LG+G F +++KG      D   L  ++      V +K L+       E +    + + +L
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTE------VLLKVLDKSHRNYSESFFEAASMMSQL 56

Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
           SH +LV   G C    E ++V EY++ GSL+ +L ++N ++  +SW  +L++A   A  L
Sbjct: 57  SHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYL-KKNKNLINISW--KLEVAKQLAWAL 113

Query: 213 GFLHTSEKKVIYRDFKASNILL 234
            FL   +K + + +  A N+LL
Sbjct: 114 HFLE--DKGLTHGNVCAKNVLL 133

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 45/146 (30%), Positives = 75/146 (51%), Gaps = 19/146 (13%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----EVNFLGRL 152
           +GEG +G VYKG  + KT        G +VA+KK+  ES +  E   S    E++ L  L
Sbjct: 8   IGEGTYGVVYKG-RNKKT--------GQIVAMKKIRLESEE--EGVPSTAIREISLLKEL 56

Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
            HPN+V L     ++  L L++E++    L+ +L    P  Q +  ++         +G+
Sbjct: 57  QHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYL-DSLPKGQYMDAELVKSYLYQILQGI 114

Query: 213 GFLHTSEKKVIYRDFKASNILLDGVG 238
            F H+  ++V++RD K  N+L+D  G
Sbjct: 115 LFCHS--RRVLHRDLKPQNLLIDNKG 138

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 53.1 bits (127), Expect = 5e-08
 Identities = 40/139 (28%), Positives = 64/139 (46%), Gaps = 15/139 (10%)

Query: 97  LGEGGFGRVYKGWVD-DKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           +G G FG V+ G +  D T    K+        + L P+    F +   E   L + SHP
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKS------CRETLPPDLKAKFLQ---EARILKQYSHP 53

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           N+V+L+G C + + + +V E +Q G     L    P    L     +++   AA G+ +L
Sbjct: 54  NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR---LKVKELIQMVENAAAGMEYL 110

Query: 216 HTSEKKVIYRDFKASNILL 234
            +  K  I+RD  A N L+
Sbjct: 111 ES--KHCIHRDLAARNCLV 127

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 53.1 bits (127), Expect = 5e-08
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 20/155 (12%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE---WQSEV 146
           N++   LLG G FG VY  +  D       TG  + V     +P+S +  +E    + E+
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDAD-------TGRELAVKQVPFDPDSQETSKEVNALECEI 55

Query: 147 NFLGRLSHPNLVKLLGYCWED---KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
             L  L H  +V+  G C  D   K+L +  EYM  GS+++ L     +   L+ ++  +
Sbjct: 56  QLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRR 110

Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                 +G+ +LH++   +++RD K +NIL D  G
Sbjct: 111 YTRQILQGVSYLHSN--MIVHRDIKGANILRDSAG 143

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 53.1 bits (127), Expect = 5e-08
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 15/147 (10%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LGEG FG V +G      L    + L + V   K+   +    E++ SE   +    HPN
Sbjct: 7   LGEGEFGSVMEG-----QLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61

Query: 157 LVKLLGYCWEDKEL------LLVYEYMQRGSLENHLFRRNPSIQP--LSWDIRLKIAIGA 208
           +++L+G C +  E       +++  +M+ G L + L        P  L   + +K     
Sbjct: 62  VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLD 235
           A G+ +L  S K  I+RD  A N +L+
Sbjct: 122 ASGMEYL--SSKSFIHRDLAARNCMLN 146

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 42/154 (27%), Positives = 63/154 (40%), Gaps = 45/154 (29%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----------EV 146
           +GEG +G V+K    ++         G +VAIKK        F E +           E+
Sbjct: 9   IGEGSYGVVFK--CRNRET-------GQIVAIKK--------FVESEDDPVIKKIALREI 51

Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP------SIQPLSWDI 200
             L +L HPNLV L+      ++L LV+EY     L  +   +NP       I+ + W  
Sbjct: 52  RMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVL--NELEKNPRGVPEHLIKKIIWQT 109

Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
                    + + F H      I+RD K  NIL+
Sbjct: 110 --------LQAVNFCHKH--NCIHRDVKPENILI 133

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 38/150 (25%), Positives = 64/150 (42%), Gaps = 20/150 (13%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN----------PESMQGFEEWQSE 145
            LG G FG VYK           K     ++A+K++N           E  +   +  SE
Sbjct: 7   HLGSGAFGCVYK--------VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSE 58

Query: 146 VNFLG-RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           V  +  +L HPN+V+      E+  L +V + ++   L  H        Q  + +    I
Sbjct: 59  VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118

Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
            +     L +LH  EK++++RD   +NI+L
Sbjct: 119 FVQMVLALRYLH-KEKRIVHRDLTPNNIML 147

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 50/156 (32%), Positives = 70/156 (44%), Gaps = 30/156 (19%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SE 145
            +F+   ++G G FG V+   V DK         G V A+K L    M    +     +E
Sbjct: 1   DDFEVIKVIGRGAFGEVW--LVRDKDT-------GQVYAMKVLRKSDMIKRNQIAHVRAE 51

Query: 146 VNFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
            + L     P +VKL  Y ++D+E L LV EYM  G L N L R++  + P     R  I
Sbjct: 52  RDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKD--VFPEET-ARFYI 107

Query: 205 -----AIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                A+ +   LGF+H        RD K  NIL+D
Sbjct: 108 AELVLALDSVHKLGFIH--------RDIKPDNILID 135

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 52.2 bits (126), Expect = 1e-07
 Identities = 50/164 (30%), Positives = 73/164 (44%), Gaps = 26/164 (15%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSE 145
            +FK   ++GEG F  V      +K    +K       AIK L+       +  +  + E
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAK--EKE--TNKE-----YAIKILDKRQLIKEKKVKYVKIE 51

Query: 146 VNFLGRLS-HPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
              L RL+ HP ++KL  Y ++D+E L  V EY   G L  ++ R+  S   L       
Sbjct: 52  KEVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI-RKYGS---LDEKCTRF 106

Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI 247
            A      L +LH+  K +I+RD K  NILLD      D H+ I
Sbjct: 107 YAAEILLALEYLHS--KGIIHRDLKPENILLDK-----DMHIKI 143

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 42/149 (28%), Positives = 66/149 (44%), Gaps = 20/149 (13%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ--SEVNFLGRLSH 154
           +G+G FG V K  V  K+        G ++  K+++  +M   E+ Q  SEVN L  L H
Sbjct: 8   IGKGSFGTVRK--VRRKSD-------GKILVWKEIDYGNMTEKEKQQLVSEVNILRELKH 58

Query: 155 PNLVKLLGYCWE-DKE---LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           PN+V+   Y    D+    L +V EY + G L   + +     + +  +   +I      
Sbjct: 59  PNIVRY--YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116

Query: 211 GLGFLHT---SEKKVIYRDFKASNILLDG 236
            L   H        V++RD K +NI LD 
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDA 145

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 39/121 (32%), Positives = 56/121 (46%), Gaps = 12/121 (9%)

Query: 123 GMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRG 180
             +VA+KK+N +  S +  +  Q E+    +L HPN++  +     D EL +V   M  G
Sbjct: 25  NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84

Query: 181 SLENHLFRRNPSIQPLSWDIRLKIAI---GAARGLGFLHTSEKKVIYRDFKASNILLDGV 237
           S E+ L    P   P      L IA         L ++H   K  I+R  KAS+ILL G 
Sbjct: 85  SCEDLLKTHFPEGLP-----ELAIAFILKDVLNALDYIH--SKGFIHRSVKASHILLSGD 137

Query: 238 G 238
           G
Sbjct: 138 G 138

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 49/156 (31%), Positives = 65/156 (41%), Gaps = 22/156 (14%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-----EWQ 143
           K+FK   LLG+G  GRV+   V  K       G G + A+K L+ + M           +
Sbjct: 1   KHFKKIKLLGKGDVGRVF--LVRLK-------GTGKLFALKVLDKKEMIKRNKVKRVLTE 51

Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            E+  L  L HP L  L      +  L LV +Y   G L   L +R P         R  
Sbjct: 52  QEI--LATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQRQPGKCLSEEVARFY 108

Query: 204 IA-IGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            A +  A  L +LH     ++YRD K  NILL   G
Sbjct: 109 AAEVLLA--LEYLHL--LGIVYRDLKPENILLHESG 140

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 48/160 (30%), Positives = 70/160 (43%), Gaps = 30/160 (18%)

Query: 91  FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN--- 147
           F+  ++LG G FG+V         LA  K   G + AIK L    +   +E +S +    
Sbjct: 1   FRCLAVLGRGHFGKV--------LLAEYK-KTGELYAIKALKKGDIIARDEVESLMCEKR 51

Query: 148 -FL--GRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRR---NPSIQPLSWDI 200
            F       HP LV L   C++ ++ +  V EY   G L  H+       P     +  +
Sbjct: 52  IFETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACV 110

Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
            L        GL +LH  E K++YRD K  N+LLD  GF+
Sbjct: 111 VL--------GLQYLH--ENKIVYRDLKLDNLLLDTEGFV 140

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 52.1 bits (126), Expect = 2e-07
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 35/158 (22%)

Query: 91  FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS------ 144
           ++    +G G +G V    VD +T        G  VAIKK++      F++         
Sbjct: 2   YELLKPIGSGAYGVVCSA-VDKRT--------GRKVAIKKISNV----FDDLIDAKRILR 48

Query: 145 EVNFLGRLSHPNLVKLL-----GYCWEDKELLLVYEYMQRGSLENHLFR--RNPSIQPLS 197
           E+  L  L H N++ LL         +  ++ +V E M     E  L +  ++P  QPL+
Sbjct: 49  EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSP--QPLT 101

Query: 198 WDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
            D          RGL +LH++   VI+RD K SNIL++
Sbjct: 102 DDHIQYFLYQILRGLKYLHSA--NVIHRDLKPSNILVN 137

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 18/146 (12%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ---GFEEWQSEVNFLGRLS 153
           LG+GGFG V    V +          G + A KKL+ + ++   G +    E   L +++
Sbjct: 1   LGKGGFGEVCAVQVKNT---------GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN 51

Query: 154 HPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
            P +V L  Y +E K  L LV   M  G L+ H++    ++     ++   I   A    
Sbjct: 52  SPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIY----NVGERGLEMERVIHYSAQITC 106

Query: 213 GFLHTSEKKVIYRDFKASNILLDGVG 238
           G LH     ++YRD K  N+LLD  G
Sbjct: 107 GILHLHSMDIVYRDMKPENVLLDDQG 132

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 45/146 (30%), Positives = 71/146 (48%), Gaps = 16/146 (10%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
           ++ K +  LG G FG V+    +  T           VA+K + P SM   E + +E N 
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKHT----------KVAVKTMKPGSMS-VEAFLAEANV 54

Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           +  L H  LVKL     ++  + ++ E+M +GSL + L     S QPL   I     I  
Sbjct: 55  MKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI-- 111

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILL 234
           A G+ F+   ++  I+RD +A+NIL+
Sbjct: 112 AEGMAFIE--QRNYIHRDLRAANILV 135

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 44/143 (30%), Positives = 64/143 (44%), Gaps = 17/143 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL----NPESMQGFEEWQSEVNFLGRL 152
           +G G FG+V  G         SK      V +K+L     P+    F +   EV     L
Sbjct: 3   IGNGWFGKVLLGEAHRGM---SKAR----VVVKELRASATPDEQLLFLQ---EVQPYREL 52

Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR-RNPSIQPLSWDIRLKIAIGAARG 211
           +HPN+++ LG C E    LLV E+   G L+N+L   R    Q    D+  ++A   A G
Sbjct: 53  NHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG 112

Query: 212 LGFLHTSEKKVIYRDFKASNILL 234
           L +LH ++   I+ D    N  L
Sbjct: 113 LLWLHQAD--FIHSDLALRNCQL 133

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 35/142 (24%), Positives = 63/142 (44%), Gaps = 13/142 (9%)

Query: 93  PDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVNFLGR 151
               +GEG FG VY+G      +  S     + VA+K     +     E++  E   + +
Sbjct: 10  LGRCIGEGQFGDVYQG------VYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQ 63

Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
             HP++VKL+G    +  + +V E    G L ++L     S+   S    +  +   +  
Sbjct: 64  FDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASL---ILYSYQLSTA 119

Query: 212 LGFLHTSEKKVIYRDFKASNIL 233
           L +L +  K+ ++RD  A N+L
Sbjct: 120 LAYLES--KRFVHRDIAARNVL 139

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 51.0 bits (122), Expect = 2e-07
 Identities = 41/144 (28%), Positives = 66/144 (45%), Gaps = 23/144 (15%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE--EWQSEVNFLGRLSH 154
           +GEG FG+          L  SK   G    IK++N   M   E  E + EV  L  + H
Sbjct: 8   IGEGSFGKAI--------LVKSKED-GKQYVIKEINISKMSPKEREESRKEVAVLSNMKH 58

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRN----PSIQPLSWDIRLKIAIGAAR 210
           PN+V+      E+  L +V +Y + G L   +  +     P  Q L W +++ +A+    
Sbjct: 59  PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK--- 115

Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
                H  ++K+++RD K+ NI L
Sbjct: 116 -----HVHDRKILHRDIKSQNIFL 134

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 56/165 (33%), Positives = 78/165 (47%), Gaps = 24/165 (14%)

Query: 83  DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW 142
            L   T  ++    +G+G +G+VYK  V +K         G + A+K L+P S    EE 
Sbjct: 16  SLGDPTDTWEIIETIGKGTYGKVYK--VTNKKD-------GSLAAVKILDPISDVD-EEI 65

Query: 143 QSEVNFLGRLS-HPNLVKLLGYCWE-DK----ELLLVYEYMQRGS---LENHLFRRNPSI 193
           ++E N L  L  HPN+VK  G  ++ DK    +L LV E    GS   L   L       
Sbjct: 66  EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG--- 122

Query: 194 QPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
           Q L   +   I  GA  GL  LH +  ++I+RD K +NILL   G
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHNN--RIIHRDVKGNNILLTTEG 165

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 10/91 (10%)

Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E+  L  ++HPN+VK       + E+ ++ E+M  GSLE         +  ++  I    
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQI---- 177

Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                 G+ +LH   + +++RD K SN+L++
Sbjct: 178 ----LSGIAYLH--RRHIVHRDIKPSNLLIN 202

Length = 353

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 50/165 (30%), Positives = 82/165 (49%), Gaps = 33/165 (20%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ----- 143
           + ++  + +GEG +G+V+K     + L   K G G  VA+K++    +Q  EE       
Sbjct: 1   QQYECVAEIGEGAYGKVFKA----RDL---KNG-GRFVALKRVR---VQTGEEGMPLSTI 49

Query: 144 SEVNFLGRL---SHPNLVKLLGYCW---EDKE--LLLVYEYMQRGSLENHLFRR-NPSIQ 194
            EV  L  L    HPN+V+L   C     D+E  L LV+E++ +  L  +L +   P + 
Sbjct: 50  REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 108

Query: 195 PLSW-DIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
             +  D+  ++     RGL FLH+   +V++RD K  NIL+   G
Sbjct: 109 TETIKDMMFQL----LRGLDFLHS--HRVVHRDLKPQNILVTSSG 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 49.6 bits (119), Expect = 7e-07
 Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 22/154 (14%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS---EV 146
           +F+   ++G+G FG+V    +  K      T    + A+K +N +        ++   E 
Sbjct: 1   HFELLRVIGKGAFGKV---CIVQK----RDTKK--MFAMKYMNKQKCVEKGSVRNVLNER 51

Query: 147 NFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
             L  L+HP LV L  Y ++D+E + LV + +  G L  HL ++    +     ++  I 
Sbjct: 52  RILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQ---VKFWIC 107

Query: 206 -IGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            I  A  L +LH   K +I+RD K  NILLD  G
Sbjct: 108 EIVLA--LEYLH--SKGIIHRDIKPDNILLDEQG 137

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 49.7 bits (118), Expect = 7e-07
 Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 19/161 (11%)

Query: 82  LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE 141
           L  ++  ++F+    +G G +G VYK               G + AIK +  E  + F  
Sbjct: 2   LSRRNPQEDFELIQRIGSGTYGDVYKA---------RNVNTGELAAIKVIKLEPGEDFAV 52

Query: 142 WQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLEN--HLFRRNPSIQPLSWD 199
            Q E+  +    H N+V   G      +L +  E+   GSL++  H+        PLS  
Sbjct: 53  VQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV------TGPLSES 106

Query: 200 IRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
               ++    +GL +LH+  K  ++RD K +NILL   G +
Sbjct: 107 QIAYVSRETLQGLYYLHSKGK--MHRDIKGANILLTDNGHV 145

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 49.6 bits (118), Expect = 7e-07
 Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 22/156 (14%)

Query: 90  NFKPDSLLGEGGFGRVYKG--WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---S 144
           NF+ +  +G G F  VY+    +D K            VA+KK+    M   +  Q    
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKP-----------VALKKVQIFEMMDAKARQDCVK 51

Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL--FRRNPSIQPLSWDIRL 202
           E++ L +L+HPN++K L    ED EL +V E    G L   +  F++   + P     + 
Sbjct: 52  EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111

Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            + + +A      H   ++V++RD K +N+ +   G
Sbjct: 112 FVQLCSA----VEHMHSRRVMHRDIKPANVFITATG 143

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 49.6 bits (119), Expect = 8e-07
 Identities = 43/145 (29%), Positives = 63/145 (43%), Gaps = 20/145 (13%)

Query: 100 GGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG---FEEWQSEVNFLGRLSHPN 156
           G +GRV+        LA  K   G + AIK +    M      ++  +E + L +   P 
Sbjct: 4   GAYGRVF--------LA-KKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPY 54

Query: 157 LVKLLGYCWE-DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           +VKL  Y ++  K L LV EY+  G L   L     ++  L  D+           L +L
Sbjct: 55  VVKLY-YSFQGKKNLYLVMEYLPGGDLA-SLLE---NVGSLDEDVARIYIAEIVLALEYL 109

Query: 216 HTSEKKVIYRDFKASNILLDGVGFL 240
           H     +I+RD K  NIL+D  G L
Sbjct: 110 H--SNGIIHRDLKPDNILIDSNGHL 132

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 49.8 bits (119), Expect = 8e-07
 Identities = 43/144 (29%), Positives = 68/144 (47%), Gaps = 8/144 (5%)

Query: 95  SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH 154
            +LG+GG+G+V++  V   T A +     M V  K     + +     ++E N L  + H
Sbjct: 2   KVLGKGGYGKVFQ--VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKH 59

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           P +V L+       +L L+ EY+  G L  HL R    ++  +     +I++     L  
Sbjct: 60  PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA----LEH 115

Query: 215 LHTSEKKVIYRDFKASNILLDGVG 238
           LH   + +IYRD K  NILLD  G
Sbjct: 116 LHQ--QGIIYRDLKPENILLDAQG 137

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 50.0 bits (119), Expect = 9e-07
 Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 19/153 (12%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEVN 147
            +F+  S LG G  G V K  V  K   PS    G+++A K ++ E       +   E+ 
Sbjct: 5   DDFERISELGAGNGGVVTK--VQHK---PS----GLIMARKLIHLEIKPAIRNQIIRELQ 55

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL--FRRNPSIQPLSWDIRLKIA 205
            L   + P +V   G  + D E+ +  E+M  GSL+  L   +R P       +I  K++
Sbjct: 56  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE------EILGKVS 109

Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
           I   RGL +L   + ++++RD K SNIL++  G
Sbjct: 110 IAVLRGLAYLR-EKHQIMHRDVKPSNILVNSRG 141

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 49.7 bits (119), Expect = 9e-07
 Identities = 46/149 (30%), Positives = 71/149 (47%), Gaps = 21/149 (14%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-- 153
           +LG+G FG+V         LA  K G   + A+K L  + +   ++ +  +     L+  
Sbjct: 2   VLGKGSFGKVL--------LAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52

Query: 154 --HPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
             HP L +L   C++ K+ L  V EY+  G L  H+ R     +P +     +I +G   
Sbjct: 53  GKHPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG--- 108

Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGVGF 239
            L FLH  E+ +IYRD K  N+LLD  G 
Sbjct: 109 -LQFLH--ERGIIYRDLKLDNVLLDSEGH 134

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 45/147 (30%), Positives = 65/147 (44%), Gaps = 22/147 (14%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLS 153
           LG G FGRV         +A  K G G   AIK L       M+  +    E + L  LS
Sbjct: 26  LGTGSFGRV--------RIAKHK-GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76

Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR--RNPSIQPLSWDIRLKIAIGAARG 211
           HP +V ++    ++  +  + E++  G L  HL +  R P+     +   L +A      
Sbjct: 77  HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA------ 130

Query: 212 LGFLHTSEKKVIYRDFKASNILLDGVG 238
             +LH   K +IYRD K  N+LLD  G
Sbjct: 131 FEYLH--SKDIIYRDLKPENLLLDNKG 155

Length = 329

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 40/138 (28%), Positives = 66/138 (47%), Gaps = 16/138 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V+ G  +  T           VA+K L P +M   E +  E   + +L H  
Sbjct: 14  LGNGQFGEVWMGTWNGNT----------KVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDK 62

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV+L     E + + +V EYM +GSL +  F ++   + L     + +A   A G+ ++ 
Sbjct: 63  LVQLYAVVSE-EPIYIVTEYMSKGSLLD--FLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119

Query: 217 TSEKKVIYRDFKASNILL 234
                 I+RD +++NIL+
Sbjct: 120 --RMNYIHRDLRSANILV 135

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 20/145 (13%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP-ESMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY    D K +A  +  +   + + +LNP E++Q  +E Q     L +L HP
Sbjct: 8   LGKGSFGTVYL-VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQ----LLSKLDHP 62

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL--FRRN----PSIQPLSWDIRLKIAIGAA 209
            +VK      E     ++ EY +   L+  L   +         Q   W I+L +     
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL----- 117

Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ ++H  ++++++RD KA NI L
Sbjct: 118 -GVHYMH--QRRILHRDLKAKNIFL 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 48/153 (31%), Positives = 70/153 (45%), Gaps = 27/153 (17%)

Query: 96  LLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-----SEVNFL 149
           LL EG FGR++ G  +D+K   P K     V  +K           E Q      E   L
Sbjct: 13  LLQEGTFGRIFYGILIDEK---PGKEEEVFVKTVK-------DHASEIQVTLLLQESCLL 62

Query: 150 GRLSHPNLVKLLGYCWEDKELLLV-YEYMQRGSLENHLFRRNPSIQPLSWDIRLK----- 203
             LSH N++ +L  C ED E   V Y YM  G+L+  LF +   +   +    L      
Sbjct: 63  YGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLK--LFLQQCRLGEANNPQALSTQQLV 120

Query: 204 -IAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
            +AI  A G+ +LH  ++ VI++D  A N ++D
Sbjct: 121 HMAIQIACGMSYLH--KRGVIHKDIAARNCVID 151

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 40/150 (26%), Positives = 66/150 (44%), Gaps = 18/150 (12%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLS 153
           +LG+G FG V +  +       S+ G    VA+K L  +  S    EE+  E   +    
Sbjct: 6   MLGKGEFGSVREAQLK------SEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59

Query: 154 HPNLVKLLGYCWEDKEL------LLVYEYMQRGSLENHLFRRNPSIQP--LSWDIRLKIA 205
           HPN++KL+G     +        +++  +M+ G L   L       +P  L     ++  
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           I  A G+ +L  S K  I+RD  A N +L+
Sbjct: 120 IDIASGMEYL--SSKNFIHRDLAARNCMLN 147

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 41/158 (25%), Positives = 68/158 (43%), Gaps = 41/158 (25%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----EVNFLGRL 152
           +GEG +G V+K   + +T          +VA+K++  +     E   S    E+  L  L
Sbjct: 8   IGEGTYGTVFKA-KNRET--------HEIVALKRVRLDDDD--EGVPSSALREICLLKEL 56

Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQ----------RGSLENHLFRRNPSIQPLSWDIRL 202
            H N+V+L      DK+L LV+EY             G ++  + +        S+  +L
Sbjct: 57  KHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK--------SFMFQL 108

Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                  +GL F H     V++RD K  N+L++  G L
Sbjct: 109 ------LKGLAFCH--SHNVLHRDLKPQNLLINKNGEL 138

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 50/149 (33%), Positives = 72/149 (48%), Gaps = 23/149 (15%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVN-FLGR 151
           ++G+G FG+V         LA  K+  G   A+K L  +++   +E     +E N  L  
Sbjct: 2   VIGKGSFGKVL--------LAKRKSD-GSFYAVKVLQKKTILKKKEQNHIMAERNVLLKN 52

Query: 152 LSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI-AIGAA 209
           L HP LV L  Y ++  E L  V +Y+  G L  HL R    ++P     R +  A   A
Sbjct: 53  LKHPFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-----RARFYAAEVA 106

Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGVG 238
             +G+LH+    +IYRD K  NILLD  G
Sbjct: 107 SAIGYLHS--LNIIYRDLKPENILLDSQG 133

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 41/145 (28%), Positives = 74/145 (51%), Gaps = 13/145 (8%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G   D     ++T     VA+K +N   S++   E+ +E + +   +  
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETR----VAVKTVNESASLRERIEFLNEASVMKGFTCH 69

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG   + +  L+V E M  G L+++L         NP   P +    +++A   A
Sbjct: 70  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129

Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ +L+   KK ++RD  A N ++
Sbjct: 130 DGMAYLNA--KKFVHRDLAARNCMV 152

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 43/140 (30%), Positives = 64/140 (45%), Gaps = 20/140 (14%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V+ G  +  T           VAIK L P +M   E +  E   + +L H  
Sbjct: 14  LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 62

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQ--PLSWDIRLKIAIGAARGLGF 214
           LV+L     E+  + +V EYM +GSL + L          P   D+  +IA G A     
Sbjct: 63  LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA----- 116

Query: 215 LHTSEKKVIYRDFKASNILL 234
            +      ++RD +A+NIL+
Sbjct: 117 -YVERMNYVHRDLRAANILV 135

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 45/146 (30%), Positives = 68/146 (46%), Gaps = 18/146 (12%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK--KLNPESMQGFEEWQSEVNFLGRLSH 154
           LGEG +  VYKG         SK   G +VA+K  +L  E    F   + E + L  L H
Sbjct: 13  LGEGSYATVYKGR--------SKL-TGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKH 62

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
            N+V L       K L LV+EY+    L+ ++      +     ++RL       RGL +
Sbjct: 63  ANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMH--NVRL-FLFQLLRGLAY 118

Query: 215 LHTSEKKVIYRDFKASNILLDGVGFL 240
            H  +++V++RD K  N+L+   G L
Sbjct: 119 CH--QRRVLHRDLKPQNLLISERGEL 142

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 43/145 (29%), Positives = 70/145 (48%), Gaps = 22/145 (15%)

Query: 96  LLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLS 153
           +LG G FG VYKG W       P    + + VAIK L    S +  +E   E   +  + 
Sbjct: 14  VLGSGAFGTVYKGIW------IPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67

Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP----SIQPLSWDIRLKIAIGAA 209
            P + +LLG C     + LV + M  G L +++ R N     S   L+W +++      A
Sbjct: 68  SPYVCRLLGICLTST-VQLVTQLMPYGCLLDYV-RENKDRIGSQDLLNWCVQI------A 119

Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
           +G+ +L   E ++++RD  A N+L+
Sbjct: 120 KGMSYLE--EVRLVHRDLAARNVLV 142

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 46/151 (30%), Positives = 67/151 (44%), Gaps = 21/151 (13%)

Query: 91  FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLG 150
           F+   ++G G +G+VYKG              G + AIK ++    +  EE + E+N L 
Sbjct: 18  FELVEVVGNGTYGQVYKG---------RHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLK 67

Query: 151 RLSH-PNLVKLLGY------CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
           + SH  N+    G          D +L LV E+   GS+ + +  +N     L  D    
Sbjct: 68  KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV--KNTKGNALKEDWIAY 125

Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           I     RGL  LH    KVI+RD K  N+LL
Sbjct: 126 ICREILRGLAHLHA--HKVIHRDIKGQNVLL 154

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 49/151 (32%), Positives = 69/151 (45%), Gaps = 24/151 (15%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HP 155
           +G+G +G+V+K  V +K         G   A+K L+P      EE ++E N L  LS HP
Sbjct: 26  IGKGTYGKVFK--VLNKKN-------GSKAAVKILDPIHDID-EEIEAEYNILKALSDHP 75

Query: 156 NLVKLLG-YCWEDK----ELLLVYEYMQRGS---LENHLFRRNPSIQPLSWDIRLKIAIG 207
           N+VK  G Y  +D     +L LV E    GS   L     +R   ++       L  A+ 
Sbjct: 76  NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL- 134

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
               +G  H    K I+RD K +NILL   G
Sbjct: 135 ----MGLQHLHVNKTIHRDVKGNNILLTTEG 161

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 47.8 bits (113), Expect = 3e-06
 Identities = 40/158 (25%), Positives = 68/158 (43%), Gaps = 16/158 (10%)

Query: 77  KVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM 136
           K+ + + +    K +     +G+G  G V+                G  VAIK++N +  
Sbjct: 7   KLRTIVSIGDPKKKYTRYEKIGQGASGTVFTA---------IDVATGQEVAIKQINLQKQ 57

Query: 137 QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPL 196
              E   +E+  +  L +PN+V  L       EL +V EY+  GSL + +         +
Sbjct: 58  PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQI 117

Query: 197 SWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           +   R        + L FLH ++  VI+RD K+ N+LL
Sbjct: 118 AAVCR-----ECLQALEFLHANQ--VIHRDIKSDNVLL 148

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 47.6 bits (113), Expect = 3e-06
 Identities = 46/158 (29%), Positives = 72/158 (45%), Gaps = 24/158 (15%)

Query: 91  FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFE-EWQSEVNF 148
           ++P + +G G +G VYK               G  VA+K +    +  G       EV  
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHS---------GHFVALKSVRVQTNEDGLPLSTVREVAL 52

Query: 149 LGRLS---HPNLVKLLGYCWE---DKE--LLLVYEYMQRGSLENHLFRRNPSIQPLSWDI 200
           L RL    HPN+V+L+  C     D+E  + LV+E++ +  L  +L +  P   P    I
Sbjct: 53  LKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAE-TI 110

Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
           +  +     RGL FLH +   +++RD K  NIL+   G
Sbjct: 111 K-DLMRQFLRGLDFLHAN--CIVHRDLKPENILVTSGG 145

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 47.6 bits (114), Expect = 4e-06
 Identities = 47/162 (29%), Positives = 71/162 (43%), Gaps = 51/162 (31%)

Query: 99  EGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFE-EWQSEVNFLGRLSHPN 156
           EG +G VY+   D KT        G +VA+KKL  E   +GF      E+N L +L HPN
Sbjct: 15  EGTYGVVYRA-RDKKT--------GEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN 65

Query: 157 LVKLLGYCWEDKELL---------LVYEYMQ---RGSLENHLFRRNPS------IQPLSW 198
           +V +       KE++         +V EY++   +  +E        S      +Q LS 
Sbjct: 66  IVTV-------KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLS- 117

Query: 199 DIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                       G+  LH  +  +++RD K SN+LL+  G L
Sbjct: 118 ------------GVAHLH--DNWILHRDLKTSNLLLNNRGIL 145

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 18/159 (11%)

Query: 91  FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ---GFEEWQSEVN 147
           F+   +LG+GGFG V          A      G + A KKL  + ++   G     +E  
Sbjct: 2   FRHYRVLGKGGFGEV---------CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 52

Query: 148 FLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
            L +++   +V L  Y +E K+ L LV   M  G L+ H++    ++    +D    +  
Sbjct: 53  ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY----NMGNPGFDEERAVFY 107

Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL 245
            A    G      ++++YRD K  NILLD  G +  S L
Sbjct: 108 AAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDL 146

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 44/153 (28%), Positives = 67/153 (43%), Gaps = 19/153 (12%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEV 146
           +F    +LG+G FG+V         LA  K G   + AIK L  + +      E    E 
Sbjct: 1   DFNFLMVLGKGSFGKV--------MLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEK 51

Query: 147 NFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
             L     P  +  L  C++  + L  V EY+  G L  H+ +     +P +     +I+
Sbjct: 52  RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEIS 111

Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
           +G    L FLH   + +IYRD K  N++LD  G
Sbjct: 112 VG----LFFLH--RRGIIYRDLKLDNVMLDSEG 138

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 47.4 bits (112), Expect = 4e-06
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 16/146 (10%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
           ++ + D  LG+G FG V+ G  +  T           VAIK L P +M   E +  E   
Sbjct: 6   ESLRLDVKLGQGCFGEVWMGTWNGTT----------KVAIKTLKPGTMMP-EAFLQEAQI 54

Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           + +L H  LV L     E+  + +V E+M +GSL +  F +    + L     + +A   
Sbjct: 55  MKKLRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLD--FLKEGDGKYLKLPQLVDMAAQI 111

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILL 234
           A G+ ++       I+RD +A+NIL+
Sbjct: 112 ADGMAYIE--RMNYIHRDLRAANILV 135

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 38/155 (24%), Positives = 70/155 (45%), Gaps = 20/155 (12%)

Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SE 145
           NF+ +  +G G F  VY+   + D          G+ VA+KK+    +   +       E
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLD----------GVPVALKKVQIFDLMDAKARADCIKE 52

Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL--FRRNPSIQPLSWDIRLK 203
           ++ L +L+HPN++K      ED EL +V E    G L   +  F++   + P     +  
Sbjct: 53  IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYF 112

Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
           + + +A      H   ++V++RD K +N+ +   G
Sbjct: 113 VQLCSA----LEHMHSRRVMHRDIKPANVFITATG 143

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 47.4 bits (112), Expect = 5e-06
 Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 21/158 (13%)

Query: 84  LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ 143
           L+     F+   L+G G +G+VYKG              G + AIK ++    +  EE +
Sbjct: 1   LRDPAGIFELVELVGNGTYGQVYKG---------RHVKTGQLAAIKVMDVTGDEE-EEIK 50

Query: 144 SEVNFLGRLSH-PNLVKLLGYCWE------DKELLLVYEYMQRGSLENHLFRRNPSIQPL 196
            E+N L + SH  N+    G   +      D +L LV E+   GS+ + +  +N     L
Sbjct: 51  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTL 108

Query: 197 SWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
             +    I     RGL  LH  + KVI+RD K  N+LL
Sbjct: 109 KEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLL 144

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 46.9 bits (111), Expect = 6e-06
 Identities = 38/143 (26%), Positives = 58/143 (40%), Gaps = 20/143 (13%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           ++GEG FGR          L             +   P+S    E+ + E   L ++ HP
Sbjct: 7   VVGEGSFGRAL--------LVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHP 58

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP----LSWDIRLKIAIGAARG 211
           N+V        D  L +V EY   G L   +  +   + P    L W +++         
Sbjct: 59  NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQM--------C 110

Query: 212 LGFLHTSEKKVIYRDFKASNILL 234
           LG  H  EK+V++RD K+ NI L
Sbjct: 111 LGVQHIHEKRVLHRDIKSKNIFL 133

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 46.9 bits (111), Expect = 6e-06
 Identities = 43/147 (29%), Positives = 64/147 (43%), Gaps = 25/147 (17%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           +G G +G VYK               G + A+K +  E    F   Q E+  +    H N
Sbjct: 17  VGSGTYGDVYKA---------RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCN 67

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLEN--HLFRRNPSIQPLSWDIRLKIAI---GAARG 211
           +V   G     ++L +  EY   GSL++  H+        PLS    L+IA       +G
Sbjct: 68  IVAYFGSYLSREKLWICMEYCGGGSLQDIYHV------TGPLS---ELQIAYVCRETLQG 118

Query: 212 LGFLHTSEKKVIYRDFKASNILLDGVG 238
           L +LH+  K  ++RD K +NILL   G
Sbjct: 119 LAYLHSKGK--MHRDIKGANILLTDNG 143

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 47/170 (27%), Positives = 73/170 (42%), Gaps = 47/170 (27%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--EV 146
             F+  + +GEG +G VY+   D  +        G +VA+KK+  ++ +      S  E+
Sbjct: 7   TEFEKLNRIGEGTYGIVYRA-RDTTS--------GEIVALKKVRMDNERDGIPISSLREI 57

Query: 147 NFLGRLSHPNLVKLL---------------GYCWEDKELLLVYEYMQRGSLENHLFRRNP 191
             L  L HPN+V+L                 YC +D   LL  + M              
Sbjct: 58  TLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPT------------ 103

Query: 192 SIQPLSWDIRLK-IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
              P S + ++K + +   RGL +LH  E  +I+RD K SN+LL   G L
Sbjct: 104 ---PFS-ESQVKCLMLQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCL 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 46.8 bits (111), Expect = 8e-06
 Identities = 41/144 (28%), Positives = 62/144 (43%), Gaps = 28/144 (19%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           +G+G  G VY                G  VAIK++N +     E   +E+  +    HPN
Sbjct: 27  IGQGASGTVYTA---------IDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPN 77

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA------R 210
           +V  L       EL +V EY+  GSL +           +  +  +     AA      +
Sbjct: 78  IVNYLDSYLVGDELWVVMEYLAGGSLTD-----------VVTETCMDEGQIAAVCRECLQ 126

Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
            L FLH+++  VI+RD K+ NILL
Sbjct: 127 ALEFLHSNQ--VIHRDIKSDNILL 148

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 46.5 bits (110), Expect = 9e-06
 Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 18/151 (11%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL----NPESMQGFEEWQS 144
           K+ K + +LG G FG + +G +      PSK  L   VAI  L    + +  +GF    +
Sbjct: 5   KSIKIERILGTGRFGELCRGCLK----LPSKREL--PVAIHTLRAGCSDKQRRGF---LA 55

Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E   LG+  H N+V+L G       +++V EYM  G+L++ L +       L     + +
Sbjct: 56  EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ---LVAGQLMGM 112

Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
             G A G+ +L  SE   +++   A  +L++
Sbjct: 113 LPGLASGMKYL--SEMGYVHKGLAAHKVLVN 141

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 20/160 (12%)

Query: 91  FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ---GFEEWQSEVN 147
           F+   +LG+GGFG V          A      G + A KKL  + ++   G     +E  
Sbjct: 2   FRHYRVLGKGGFGEV---------CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKR 52

Query: 148 FLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRR-NPSIQPLSWDIRLKIA 205
            L +++   +V L  Y +E K+ L LV   M  G L+ H++   NP      +D +  I 
Sbjct: 53  ILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-----FDEQRAIF 106

Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL 245
             A    G      ++++YRD K  NILLD  G +  S L
Sbjct: 107 YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDL 146

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 47/149 (31%), Positives = 62/149 (41%), Gaps = 24/149 (16%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVNFLGRL 152
           LLG+G FG+V         L   K   G   A+K L  E +   +E     +E   L   
Sbjct: 2   LLGKGTFGKV--------ILVREKAT-GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT 52

Query: 153 SHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA--A 209
            HP L  L  Y ++  + L  V EY   G L  HL R     +      R +   GA   
Sbjct: 53  RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARF-YGAEIV 105

Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGVG 238
             LG+LH     V+YRD K  N++LD  G
Sbjct: 106 SALGYLH--SCDVVYRDLKLENLMLDKDG 132

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 18/164 (10%)

Query: 91  FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ---GFEEWQSEVN 147
           F+   +LG+GGFG V          A      G + A KKL  + ++   G     +E  
Sbjct: 2   FRQYRVLGKGGFGEV---------CACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQ 52

Query: 148 FLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
            L +++   +V L  Y +E K+ L LV   M  G L+ H++    +     ++    +  
Sbjct: 53  ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEA----GFEEGRAVFY 107

Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY 250
            A    G     +++++YRD K  NILLD  G +  S L + V+
Sbjct: 108 AAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVH 151

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 45/148 (30%), Positives = 67/148 (45%), Gaps = 21/148 (14%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVN-FLGR 151
           ++G+G FG+V         LA  K   G   A+K L  + +   +E +   +E N  L  
Sbjct: 2   VIGKGSFGKVL--------LAKRKLD-GKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKN 52

Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA-AR 210
           + HP LV L       ++L  V +++  G L  HL R     +P     R +      A 
Sbjct: 53  VKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-----RARFYAAEIAS 107

Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGVG 238
            LG+LH+    ++YRD K  NILLD  G
Sbjct: 108 ALGYLHSI--NIVYRDLKPENILLDSQG 133

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 35/160 (21%)

Query: 95  SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFE-EWQSEVNFLGRL 152
             +GEG +G+VYK   D  T        G +VA+KK+  ++  +GF      E+  L +L
Sbjct: 13  GQIGEGTYGQVYKA-RDKDT--------GELVALKKVRLDNEKEGFPITAIREIKILRQL 63

Query: 153 SHPNLVKLLGYCWEDKELL----------LVYEYMQR---GSLENHLFRRNPS-IQPLSW 198
           +H N+V L     + ++ L          LV+EYM     G LE+ L   +   I+    
Sbjct: 64  NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123

Query: 199 DIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            +          GL + H  +K  ++RD K SNILL+  G
Sbjct: 124 QL--------LEGLNYCH--KKNFLHRDIKCSNILLNNKG 153

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 25/153 (16%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVN 147
             ++  S +GEG +G V        T        G+ VAIKK++P   Q F +    E+ 
Sbjct: 5   PRYQNLSYIGEGAYGMVCSA-THKPT--------GVKVAIKKISPFEHQTFCQRTLREIK 55

Query: 148 FLGRLSHPNLVKLL------GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR 201
            L R  H N++ +L       +     ++ +V E M     E  L++   + Q LS D  
Sbjct: 56  ILRRFKHENIIGILDIIRPPSFE-SFNDVYIVQELM-----ETDLYKLIKT-QHLSNDHI 108

Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
                   RGL ++H++   V++RD K SN+LL
Sbjct: 109 QYFLYQILRGLKYIHSAN--VLHRDLKPSNLLL 139

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 47/145 (32%), Positives = 70/145 (48%), Gaps = 16/145 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEVNFLGRLSHP 155
           LGEG +  VYKG         SK    +V A+K++  E  +G       EV+ L  L H 
Sbjct: 14  LGEGTYATVYKG--------RSKLTDNLV-ALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           N+V L      +K L LV+EY+ +  L+ +L     SI   +  + L       RGL + 
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFL---FQLLRGLNYC 120

Query: 216 HTSEKKVIYRDFKASNILLDGVGFL 240
           H   +KV++RD K  N+L++  G L
Sbjct: 121 H--RRKVLHRDLKPQNLLINERGEL 143

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 9/96 (9%)

Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL--FRRNPSIQPLSWDIRL 202
           E+  L   + P +V   G  + D E+ +  E+M  GSL+  L    R P       +I  
Sbjct: 49  ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE------NILG 102

Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
           KI+I   RGL +L   + K+++RD K SNIL++  G
Sbjct: 103 KISIAVLRGLTYLR-EKHKIMHRDVKPSNILVNSRG 137

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 39/142 (27%), Positives = 70/142 (49%), Gaps = 10/142 (7%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G +G VYK       +    TG+ M +   +L  +  + F +   E++ L +   P 
Sbjct: 9   LGKGNYGSVYK-------VLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPY 60

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           +V   G  + +  + +  EYM  GSL+  L+    + + +  D+  +I     +GL FL 
Sbjct: 61  IVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFL- 118

Query: 217 TSEKKVIYRDFKASNILLDGVG 238
             E  +I+RD K +N+L++G G
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNG 140

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 46/161 (28%), Positives = 69/161 (42%), Gaps = 22/161 (13%)

Query: 91  FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ---GFEEWQSEVN 147
           F+   +LG+GGFG V          A      G + A K+L  + ++   G     +E  
Sbjct: 2   FRQYRVLGKGGFGEV---------CACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQ 52

Query: 148 FLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRR-NPSIQPLSWDIRLKIA 205
            L +++   +V L  Y +E K+ L LV   M  G L+ H++   NP  +        +  
Sbjct: 53  ILEKVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFE------EERAL 105

Query: 206 IGAARGL-GFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL 245
             AA  L G      +  +YRD K  NILLD  G +  S L
Sbjct: 106 FYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDL 146

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 44.4 bits (105), Expect = 4e-05
 Identities = 24/84 (28%), Positives = 46/84 (54%), Gaps = 5/84 (5%)

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           P +V   G    +  + +  E+M  GSL+  ++++     P+  +I  KIA+    GL +
Sbjct: 63  PYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKK---GGPIPVEILGKIAVAVVEGLTY 118

Query: 215 LHTSEKKVIYRDFKASNILLDGVG 238
           L+ +  ++++RD K SNIL++  G
Sbjct: 119 LY-NVHRIMHRDIKPSNILVNSRG 141

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 40/139 (28%), Positives = 63/139 (45%), Gaps = 14/139 (10%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVNFLGRLSHP 155
           LG G FG V KG    +          + VAIK L  E+ +   +E   E   + +L +P
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQ-------IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNP 55

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
            +V+++G C E + L+LV E    G L   L  +   I  +S  + L   +     +G  
Sbjct: 56  YIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEI-TVSNVVELMHQV----SMGMK 109

Query: 216 HTSEKKVIYRDFKASNILL 234
           +   K  ++RD  A N+LL
Sbjct: 110 YLEGKNFVHRDLAARNVLL 128

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 16/145 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEVNFLGRLSHP 155
           LGEG +  V+KG         SK    +V A+K++  E  +G       EV+ L  L H 
Sbjct: 14  LGEGTYATVFKG--------RSKLTENLV-ALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           N+V L      DK L LV+EY+ +  L+ ++      +   +  I L   +   RGL + 
Sbjct: 65  NIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQIL---RGLAYC 120

Query: 216 HTSEKKVIYRDFKASNILLDGVGFL 240
           H   +KV++RD K  N+L++  G L
Sbjct: 121 H--RRKVLHRDLKPQNLLINERGEL 143

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 41/145 (28%), Positives = 70/145 (48%), Gaps = 16/145 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEVNFLGRLSHP 155
           LGEG +  VYKG         S+   G +VA+K ++ ++ +G       E + L  L H 
Sbjct: 13  LGEGSYATVYKGI--------SRIN-GQLVALKVISMKTEEGVPFTAIREASLLKGLKHA 63

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           N+V L       + L  V+EYM    L  ++ +    + P  +++RL       RGL ++
Sbjct: 64  NIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHP--YNVRL-FMFQLLRGLAYI 119

Query: 216 HTSEKKVIYRDFKASNILLDGVGFL 240
           H   + +++RD K  N+L+  +G L
Sbjct: 120 H--GQHILHRDLKPQNLLISYLGEL 142

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 43.8 bits (103), Expect = 6e-05
 Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 26/146 (17%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE--WQSEVNFLGRLSH 154
           +G+G +G V        +L   +T  G    IKKLN  +    E    + E   L +L H
Sbjct: 8   VGKGSYGEV--------SLVRHRT-DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKH 58

Query: 155 PNLVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRN----PSIQPLSWDIRLKIAIGA 208
           PN+V      WE  D  L +V  + + G L + L  +     P  Q + W +++ +A   
Sbjct: 59  PNIV-AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA--- 114

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILL 234
              L +LH  EK +++RD K  N+ L
Sbjct: 115 ---LQYLH--EKHILHRDLKTQNVFL 135

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 43.9 bits (103), Expect = 7e-05
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 15/150 (10%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEVNF 148
           +F+  S LG G  G V+K  V  K   PS    G+++A K ++ E       +   E+  
Sbjct: 6   DFEKISELGAGNGGVVFK--VSHK---PS----GLIMARKLIHLEIKPAIRNQIIRELQV 56

Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           L   + P +V   G  + D E+ +  E+M  GSL+  L +       +   I  K++I  
Sbjct: 57  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAV 112

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            +GL +L   + K+++RD K SNIL++  G
Sbjct: 113 IKGLTYLR-EKHKIMHRDVKPSNILVNSRG 141

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 43.6 bits (103), Expect = 7e-05
 Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 23/157 (14%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTG--LGMVVAIKKLNPESM----QGFEEWQ 143
           NF+   +LG G +G+V+        L     G   G + A+K L   ++    +  E  +
Sbjct: 1   NFELLRVLGTGAYGKVF--------LVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTR 52

Query: 144 SEVNFLGRL-SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL 202
           +E   L  +   P LV L      D +L L+ +Y+  G L  HL++R    +    ++R+
Sbjct: 53  TERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRV 109

Query: 203 KIA-IGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            IA I  A  L  LH  +  +IYRD K  NILLD  G
Sbjct: 110 YIAEIVLA--LDHLH--QLGIIYRDIKLENILLDSEG 142

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.1 bits (104), Expect = 8e-05
 Identities = 35/98 (35%), Positives = 47/98 (47%), Gaps = 6/98 (6%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SH 154
           LG G FG+V    V+       K+   M VA+K L P + +   E   SE+  L  L +H
Sbjct: 43  LGAGAFGKV----VEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS 192
            N+V LLG C      L++ EY   G L N L R+  S
Sbjct: 99  INIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDS 136

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 43.6 bits (102), Expect = 8e-05
 Identities = 47/166 (28%), Positives = 75/166 (45%), Gaps = 20/166 (12%)

Query: 69  QILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAI 128
           +ILE    K+ S + +    K +     +G+G  G VY   +D  T        G  VAI
Sbjct: 3   EILE----KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTA-IDIAT--------GQEVAI 49

Query: 129 KKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR 188
           K++N +     E   +E+  +    +PN+V  L       EL +V EY+  GSL + +  
Sbjct: 50  KQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE 109

Query: 189 RNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
                  ++   R        + L FLH+++  VI+RD K+ NILL
Sbjct: 110 TCMDEGQIAAVCR-----ECLQALDFLHSNQ--VIHRDIKSDNILL 148

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 43.4 bits (103), Expect = 8e-05
 Identities = 44/147 (29%), Positives = 61/147 (41%), Gaps = 18/147 (12%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEW-QSEVNFLGRLS 153
           LG GGFGRV    V  K             A+K +    +   G +E   SE   L   +
Sbjct: 1   LGVGGFGRVEL--VKVK-------SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN 51

Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           HP +VKL     + K + ++ EY   G L   L  R        +  R  IA        
Sbjct: 52  HPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG---LFDEYTARFYIA-CVVLAFE 107

Query: 214 FLHTSEKKVIYRDFKASNILLDGVGFL 240
           +LH   + +IYRD K  N+LLD  G++
Sbjct: 108 YLH--NRGIIYRDLKPENLLLDSNGYV 132

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 46/149 (30%), Positives = 69/149 (46%), Gaps = 19/149 (12%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVN-FLGR 151
           ++G+G FG+V         LA  K       A+K L  +++   +E +   SE N  L  
Sbjct: 2   VIGKGSFGKVL--------LARHKAE-EKFYAVKVLQKKAILKKKEEKHIMSERNVLLKN 52

Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           + HP LV L        +L  V +Y+  G L  HL R    ++P +     +IA      
Sbjct: 53  VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIA----SA 108

Query: 212 LGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           LG+LH+    ++YRD K  NILLD  G +
Sbjct: 109 LGYLHSL--NIVYRDLKPENILLDSQGHI 135

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 43.3 bits (102), Expect = 9e-05
 Identities = 34/147 (23%), Positives = 61/147 (41%), Gaps = 26/147 (17%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           +LG+G +G VY      + L+         +AIK++     +  +    E+     L H 
Sbjct: 15  VLGKGTYGIVYAA----RDLSTQVR-----IAIKEIPERDSRYVQPLHEEIALHSYLKHR 65

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL-------FRRNPSIQPLSWDIRLKIAIGA 208
           N+V+ LG   E+    +  E +  GSL   L            +I   +  I        
Sbjct: 66  NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI-------- 117

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLD 235
             GL +LH  + ++++RD K  N+L++
Sbjct: 118 LEGLKYLH--DNQIVHRDIKGDNVLVN 142

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 40/142 (28%), Positives = 65/142 (45%), Gaps = 20/142 (14%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL----NPESMQGFEEWQSEVNFLGRL 152
           LG G FG V KG    K     KT     VA+K L    N  +++  +E   E N + +L
Sbjct: 3   LGSGNFGTVKKGMY--KMKKSEKT-----VAVKILKNDNNDPALK--DELLREANVMQQL 53

Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
            +P +V+++G C E +  +LV E  + G L N   ++N  +       +    +     +
Sbjct: 54  DNPYIVRMIGIC-EAESWMLVMELAELGPL-NKFLQKNKHVT-----EKNITELVHQVSM 106

Query: 213 GFLHTSEKKVIYRDFKASNILL 234
           G  +  E   ++RD  A N+LL
Sbjct: 107 GMKYLEETNFVHRDLAARNVLL 128

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 44/146 (30%), Positives = 71/146 (48%), Gaps = 18/146 (12%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEVNFLGRLSHP 155
           LGEG +  V+KG         SK     +VA+K++  E  +G       EV+ L  L H 
Sbjct: 13  LGEGTYATVFKG--------RSKL-TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI-GAARGLGF 214
           N+V L      ++ L LV+EY     L++ L +   +   L     +KI +    RGL +
Sbjct: 64  NIVTLHDIIHTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118

Query: 215 LHTSEKKVIYRDFKASNILLDGVGFL 240
            H  ++K+++RD K  N+L++  G L
Sbjct: 119 CH--KRKILHRDLKPQNLLINEKGEL 142

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 43/148 (29%), Positives = 65/148 (43%), Gaps = 19/148 (12%)

Query: 95  SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGR 151
            +LG+G FG+V         +   + G   + AIK L  + +      E    E   L  
Sbjct: 6   MVLGKGSFGKV---------MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLAL 56

Query: 152 LSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
              P  +  L  C++  + L  V EY+  G L  H+ +     +P +     +IAIG   
Sbjct: 57  PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG--- 113

Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGVG 238
            L FLH+  K +IYRD K  N++LD  G
Sbjct: 114 -LFFLHS--KGIIYRDLKLDNVMLDAEG 138

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 22/150 (14%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL----NPESMQGFEEWQSEVNFLGR 151
            +G G FG V K         PS T    ++A+K++    + +  +       +++ + R
Sbjct: 11  EIGRGAFGTVNKML-----HKPSGT----IMAVKRIRSTVDEKEQKRL---LMDLDVVMR 58

Query: 152 LSH-PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP--LSWDIRLKIAIGA 208
            S  P +VK  G  + + +  +  E M   SL+   ++    +    +  +I  KIA+  
Sbjct: 59  SSDCPYIVKFYGALFREGDCWICMELMDI-SLDK-FYKYVYEVLKSVIPEEILGKIAVAT 116

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            + L +L   E K+I+RD K SNILLD  G
Sbjct: 117 VKALNYLKE-ELKIIHRDVKPSNILLDRNG 145

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 18/147 (12%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTG--LGMVVAIKKLNPESMQGFEEWQS--EVNFLGR 151
           +LG+G FG+V+        L    TG   G + A+K L   +++  +  ++  E + L  
Sbjct: 3   VLGQGSFGKVF--------LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE 54

Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           ++HP +VKL      + +L L+ ++++ G L     R +  +     D++  +A   A  
Sbjct: 55  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLA-ELALA 110

Query: 212 LGFLHTSEKKVIYRDFKASNILLDGVG 238
           L  LH+    +IYRD K  NILLD  G
Sbjct: 111 LDHLHSL--GIIYRDLKPENILLDEEG 135

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 40/145 (27%), Positives = 68/145 (46%), Gaps = 16/145 (11%)

Query: 97  LGEGGFGRVYKG---WVDDKTLAPSKTGLGMVVAIKKLNPE----SMQGFEEWQSEVNFL 149
           LG G   ++Y G   + DD           + V +K L+P     S+  FE      + +
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFET----ASMM 58

Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
            ++SH ++V L G C  D E ++V E+++ G L+  LF    S   L+   + K+A   A
Sbjct: 59  RQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKS-DVLTTPWKFKVAKQLA 115

Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
             L +L   +K +++ +    NILL
Sbjct: 116 SALSYLE--DKDLVHGNVCTKNILL 138

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 35/121 (28%), Positives = 48/121 (39%), Gaps = 20/121 (16%)

Query: 123 GMVVAIKKL---NPESMQGFEEWQSEVNFLGRLSHPNLVKLL--GYCWEDKELLLVYEYM 177
           G  VAIK L    PE       ++ E     RL HPN+V LL  G       L  V+EY+
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61

Query: 178 QRGSLENHLFRRNPSIQPLSWDIRLKI----AIGAARGLGFLHTSEKKVIYRDFKASNIL 233
              +L   L        P     RL +    A+  A   G        +++RD K  NI+
Sbjct: 62  PGRTLREVL--AADGALPAGETGRLMLQVLDALACAHNQG--------IVHRDLKPQNIM 111

Query: 234 L 234
           +
Sbjct: 112 V 112

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 46/151 (30%), Positives = 62/151 (41%), Gaps = 25/151 (16%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLS 153
           LG G FGRV         LA  K      VAIK+     +   +  +   SE   L  ++
Sbjct: 38  LGTGSFGRV--------ILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG----AA 209
           HP  V L G   ++  L LV E++  G     L RRN          R    +G    A 
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-RRNK---------RFPNDVGCFYAAQ 139

Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
             L F +     ++YRD K  N+LLD  GF+
Sbjct: 140 IVLIFEYLQSLNIVYRDLKPENLLLDKDGFI 170

Length = 340

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 29/152 (19%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLG-R 151
           +LG+G FG+V         LA  K   G + A+K L  + +      E   +E   L   
Sbjct: 2   VLGKGSFGKV--------MLARLKES-GRLYAVKVLKKDVILQDDDVECTMTEKRILSLA 52

Query: 152 LSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHL--FRR--NPSIQPLSWDIRLKIAI 206
            +HP L +L   C++  + L  V E++  G L  H+   RR      +  + +I      
Sbjct: 53  RNHPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEI------ 105

Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                L FLH  +K +IYRD K  N+LLD  G
Sbjct: 106 --TSALMFLH--DKGIIYRDLKLDNVLLDHEG 133

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 35/155 (22%), Positives = 70/155 (45%), Gaps = 19/155 (12%)

Query: 90  NFKPDSLLGEGGFGR--VYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSE 145
           ++ P  +LG+G FG   +Y+           +T    +V  K++N   +  +   +  +E
Sbjct: 1   HYIPIRVLGKGAFGEATLYR-----------RTEDDSLVVWKEVNLTRLSEKERRDALNE 49

Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
           +  L  L HPN++    +  +D  LL+  EY   G+L + + R+   +      +     
Sbjct: 50  IVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ 109

Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           I +A  + ++H  +  +++RD K  NI L   G +
Sbjct: 110 IVSA--VSYIH--KAGILHRDIKTLNIFLTKAGLI 140

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 49/149 (32%), Positives = 69/149 (46%), Gaps = 23/149 (15%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-- 153
           +LG+G FG+V+        LA  K G     AIK L  + +   ++ +  +     LS  
Sbjct: 2   MLGKGSFGKVF--------LAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 52

Query: 154 --HPNLVKLLGYC-WEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
             HP L  L  YC ++ KE L  V EY+  G L  H+   +    P +     +I  G  
Sbjct: 53  WEHPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG-- 108

Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGVG 238
             L FLH+  K ++YRD K  NILLD  G
Sbjct: 109 --LQFLHS--KGIVYRDLKLDNILLDTDG 133

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 42.4 bits (99), Expect = 2e-04
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 20/166 (12%)

Query: 69  QILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAI 128
           +ILE    K+ S + +    K +     +G+G  G VY   +D  T        G  VAI
Sbjct: 4   EILE----KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTA-MDVAT--------GQEVAI 50

Query: 129 KKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR 188
           +++N +     E   +E+  +    +PN+V  L       EL +V EY+  GSL + +  
Sbjct: 51  RQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE 110

Query: 189 RNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
                  ++   R        + L FLH+++  VI+RD K+ NILL
Sbjct: 111 TCMDEGQIAAVCR-----ECLQALEFLHSNQ--VIHRDIKSDNILL 149

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 19/149 (12%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRL 152
           +LG+G FG+V         LA  K G   + AIK L  + +      E    E   L   
Sbjct: 7   VLGKGSFGKV--------MLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57

Query: 153 SHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
             P  +  L  C++  + L  V EY+  G L   + +     +P +     +IAIG    
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG---- 113

Query: 212 LGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           L FLH+  K +IYRD K  N++LD  G +
Sbjct: 114 LFFLHS--KGIIYRDLKLDNVMLDSEGHI 140

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 42.2 bits (99), Expect = 3e-04
 Identities = 44/148 (29%), Positives = 62/148 (41%), Gaps = 21/148 (14%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVNFLGRLS 153
           +G+G FG+VY+           K     + A+K L+ + +   +E      E N L R  
Sbjct: 1   IGKGTFGQVYQ---------VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL 51

Query: 154 H---PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
               P +V L      D +L LV +YM  G L  HL +     +      R K  I A  
Sbjct: 52  LDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED-----RAKFYI-AEL 105

Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGVG 238
            L   H  +  ++YRD K  NILLD  G
Sbjct: 106 VLALEHLHKYDIVYRDLKPENILLDATG 133

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 18/146 (12%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK--KLNPESMQGFEEWQSEVNFLGRLSH 154
           LGEG +  VYKG         SK   G +VA+K  +L  E    F   + E + L  L H
Sbjct: 13  LGEGSYATVYKG--------KSKVN-GKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKH 62

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
            N+V L       + L LV+EY+    L  ++ +    + P +  + L       RGL +
Sbjct: 63  ANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFL---FQLLRGLSY 118

Query: 215 LHTSEKKVIYRDFKASNILLDGVGFL 240
           +H  ++ +++RD K  N+L+   G L
Sbjct: 119 IH--QRYILHRDLKPQNLLISDTGEL 142

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 30/101 (29%), Positives = 49/101 (48%), Gaps = 6/101 (5%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE-WQSEVNFLGRL-S 153
           +LG G FG+V +G         S++   M VA+K L P +    ++   SE+  +  L  
Sbjct: 44  ILGSGAFGKVVEG----TAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGP 99

Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQ 194
           H N+V LLG C +   + ++ EY   G L N+L +   +  
Sbjct: 100 HLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFL 140

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 31/88 (35%), Positives = 42/88 (47%), Gaps = 6/88 (6%)

Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
           S+P LV L         L LV EY+  G L  H+ R+    +  +     +I I     L
Sbjct: 54  SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA----L 109

Query: 213 GFLHTSEKKVIYRDFKASNILLDGVGFL 240
            FLH  E+ +IYRD K  N+LLD  G +
Sbjct: 110 NFLH--ERGIIYRDLKLDNVLLDADGHI 135

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 33/104 (31%), Positives = 49/104 (47%), Gaps = 12/104 (11%)

Query: 141 EW-QSEVNFLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRN--PSIQPL 196
           +W Q+E +   + S HP LV L      +  L  V EY+  G L  H+ R+   P     
Sbjct: 40  DWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR 99

Query: 197 SWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
            +   + +A      L +LH  E+ +IYRD K  N+LLD  G +
Sbjct: 100 FYSAEISLA------LNYLH--ERGIIYRDLKLDNVLLDSEGHI 135

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 44/149 (29%), Positives = 64/149 (42%), Gaps = 20/149 (13%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVNFLGRL 152
           LLG+G FG+V         +   +   G   A+K L  E +   +E     +E   L   
Sbjct: 2   LLGKGTFGKV---------ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52

Query: 153 SHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
            HP L  L  Y ++ K+ L  V EY+  G L  HL R     +  S D            
Sbjct: 53  RHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRE----RVFSEDRTRFYGAEIVSA 107

Query: 212 LGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           L +LH+   K++YRD K  N++LD  G +
Sbjct: 108 LDYLHSG--KIVYRDLKLENLMLDKDGHI 134

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 38/148 (25%), Positives = 69/148 (46%), Gaps = 21/148 (14%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ--SEVNFLGRLSH 154
           LG G +G V      DK         G ++A+K++   ++   E+ +   +++   R   
Sbjct: 9   LGRGAYGVV------DKMRHVPT---GTIMAVKRI-RATVNSQEQKRLLMDLDISMRSVD 58

Query: 155 -PNLVKLLGYCWEDKELLLVYEYMQRGSLEN---HLFRRNPSIQPLSWDIRLKIAIGAAR 210
            P  V   G  + + ++ +  E M   SL+     ++ +  +I     DI  KIA+   +
Sbjct: 59  CPYTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPE---DILGKIAVSIVK 114

Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGVG 238
            L +LH S+  VI+RD K SN+L++  G
Sbjct: 115 ALEYLH-SKLSVIHRDVKPSNVLINRNG 141

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 40/139 (28%), Positives = 61/139 (43%), Gaps = 9/139 (6%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
           +G G FG+V  G V+     P++      V +K+L    S+Q   ++  E      L H 
Sbjct: 3   IGNGWFGKVILGEVNSG-YTPAQ------VVVKELRVSASVQEQMKFLEEAQPYRSLQHS 55

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NL++ LG C E    LLV E+   G L+ +L R     + ++ D      +     LG L
Sbjct: 56  NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLL 114

Query: 216 HTSEKKVIYRDFKASNILL 234
           H  +   I+ D    N LL
Sbjct: 115 HLHKNNFIHSDLALRNCLL 133

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 41.6 bits (97), Expect = 4e-04
 Identities = 31/116 (26%), Positives = 56/116 (48%), Gaps = 7/116 (6%)

Query: 123 GMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSL 182
           G  VA+KK++    Q  E   +EV  +    H N+V +        EL +V E+++ G+L
Sbjct: 47  GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106

Query: 183 ENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            + +     + + ++      + +   R L +LH   + VI+RD K+ +ILL   G
Sbjct: 107 TDIVTHTRMNEEQIA-----TVCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDG 155

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 40/151 (26%), Positives = 67/151 (44%), Gaps = 11/151 (7%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGL-GMVVAIKKLNPESMQGFEEWQSEVNF 148
           NF+   +LG G +G+V+   +  K        L  M V  K    +  +  E  ++E N 
Sbjct: 1   NFELLKVLGTGAYGKVF---LVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNV 57

Query: 149 LGRLSHPNLVKLLGYCWE-DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
           L  +     +  L Y ++ + +L L+ +Y+  G +  HL++R       S D  ++   G
Sbjct: 58  LEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR----DNFSED-EVRFYSG 112

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
               L   H  +  ++YRD K  NILLD  G
Sbjct: 113 EII-LALEHLHKLGIVYRDIKLENILLDSEG 142

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 44/160 (27%), Positives = 69/160 (43%), Gaps = 31/160 (19%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE---WQSE 145
           K+F   SL+G G FG V    V +K         G + A+K +    +   E    ++ E
Sbjct: 1   KDFDVKSLVGRGHFGEVQ--VVREKAT-------GDIYAMKVMKKSVLLAQETVSFFEEE 51

Query: 146 VNFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDI---- 200
            + L   + P + +L  Y ++DK+ L LV EY   G L + L R          D+    
Sbjct: 52  RDILSISNSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYE---DQFDEDMAQFY 107

Query: 201 --RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
              L +AI +   +G++H        RD K  N+L+D  G
Sbjct: 108 LAELVLAIHSVHQMGYVH--------RDIKPENVLIDRTG 139

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 33/158 (20%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFE-EWQSEVNFLGRLS 153
           +G+G FG V+K     KT          +VA+KK  +  E  +GF      E+  L  L 
Sbjct: 20  IGQGTFGEVFKA-RHKKT--------KQIVALKKVLMENEK-EGFPITALREIKILQLLK 69

Query: 154 HPNLVKLLGYCWEDK--------ELLLVYEYMQR---GSLENHLFRRNPSIQPLSWDIRL 202
           H N+V L+  C               LV+E+ +    G L N   +   S      +I+ 
Sbjct: 70  HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLS------EIK- 122

Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           K+      GL ++H +  K+++RD KA+NIL+   G L
Sbjct: 123 KVMKMLLNGLYYIHRN--KILHRDMKAANILITKDGIL 158

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 29/88 (32%), Positives = 41/88 (46%), Gaps = 10/88 (11%)

Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLF--RRNPSIQPLSWDIRLKIAIGAAR 210
           +HP LV L      +  L  V E++  G L  H+   R+ P      +   + +A     
Sbjct: 54  NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA----- 108

Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGVG 238
            L FLH  E+ +IYRD K  N+LLD  G
Sbjct: 109 -LNFLH--ERGIIYRDLKLDNVLLDAEG 133

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 30/89 (33%), Positives = 44/89 (49%), Gaps = 7/89 (7%)

Query: 152 LSH--PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
            SH  P +VK  GY   D ++ +  E M   +  + L +R     P+  DI  K+ +   
Sbjct: 69  KSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKR--IQGPIPEDILGKMTVAIV 124

Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGVG 238
           + L +L   +  VI+RD K SNILLD  G
Sbjct: 125 KALHYLKE-KHGVIHRDVKPSNILLDASG 152

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 41.2 bits (96), Expect = 5e-04
 Identities = 45/148 (30%), Positives = 59/148 (39%), Gaps = 17/148 (11%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVNFLGRL 152
           LLG+G FG+V         +   +   G   A+K L  E +   +E     +E   L   
Sbjct: 2   LLGKGTFGKV---------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52

Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
            HP L  L         L  V EY   G L  HL R     +  S D            L
Sbjct: 53  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSAL 108

Query: 213 GFLHTSEKKVIYRDFKASNILLDGVGFL 240
            +LH SEK V+YRD K  N++LD  G +
Sbjct: 109 DYLH-SEKNVVYRDLKLENLMLDKDGHI 135

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 42/168 (25%), Positives = 70/168 (41%), Gaps = 35/168 (20%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----- 144
            +KP   +G G +G V    +D ++        G  VAIKK+       F+         
Sbjct: 6   RYKPIENIGSGAYGVVCSA-IDTRS--------GKKVAIKKIP----HAFDVPTLAKRTL 52

Query: 145 -EVNFLGRLSHPNLVKLLGYCW----EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWD 199
            E+  L    H N++ +         + K++ +V + M     E+ L     S QPL+ +
Sbjct: 53  RELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-----ESDLHHIIHSDQPLTEE 107

Query: 200 IRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI 247
                     RGL ++H++   VI+RD K SN+L++      D  L I
Sbjct: 108 HIRYFLYQLLRGLKYIHSA--NVIHRDLKPSNLLVNE-----DCELRI 148

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 46/160 (28%), Positives = 70/160 (43%), Gaps = 32/160 (20%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SE 145
           K+F+  + +G+GG+G+V+        LA  K   G +VA+K++    +    E +   +E
Sbjct: 1   KDFQILTQVGQGGYGQVF--------LA-KKKDTGEIVALKRMKKSLLFKLNEVRHVLTE 51

Query: 146 VNFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWD----- 199
            + L       LVKLL Y ++D E L L  EY+  G     L         LS D     
Sbjct: 52  RDILTTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLG----VLSEDHARFY 106

Query: 200 -IRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
              +  A+ A   LG++H        RD K  N L+D  G
Sbjct: 107 MAEMFEAVDALHELGYIH--------RDLKPENFLIDASG 138

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 40.6 bits (95), Expect = 6e-04
 Identities = 35/142 (24%), Positives = 67/142 (47%), Gaps = 18/142 (12%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G  G VYK +        ++  L + V    +  E  +   +  SE+  L +   P 
Sbjct: 9   LGHGNGGTVYKAYH-----LLTRRILAVKVIPLDITVELQK---QIMSELEILYKCDSPY 60

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           ++   G  + +  + +  E+M  GSL+  ++R+ P        +  +IA+   +GL +L 
Sbjct: 61  IIGFYGAFFVENRISICTEFMDGGSLD--VYRKIPE------HVLGRIAVAVVKGLTYLW 112

Query: 217 TSEKKVIYRDFKASNILLDGVG 238
           +   K+++RD K SN+L++  G
Sbjct: 113 SL--KILHRDVKPSNMLVNTRG 132

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 34/172 (19%), Positives = 64/172 (37%), Gaps = 39/172 (22%)

Query: 86  SATKNFKP-DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS 144
           S ++ +    + LGEG +G+V K +          T  G +VAIKK+    +        
Sbjct: 5   SISERYIQKGAHLGEGTYGKVEKAY---------DTLTGKIVAIKKVKIIEISNDVTKDR 55

Query: 145 --------------EVNFLGRLSHPNLVKLLG-YCWEDKELLLVYEYMQ---RGSLENHL 186
                         E+  +  + H N++ L+  Y   D  + LV + M    +  ++  +
Sbjct: 56  QLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDF-INLVMDIMASDLKKVVDRKI 114

Query: 187 FRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                 ++ +   I          GL  LH      ++RD   +NI ++  G
Sbjct: 115 RLTESQVKCILLQI--------LNGLNVLHKW--YFMHRDLSPANIFINSKG 156

Length = 335

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 40.8 bits (95), Expect = 7e-04
 Identities = 36/138 (26%), Positives = 66/138 (47%), Gaps = 16/138 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           +GEG  G V         +A  K+  G +VA+KK++    Q  E   +EV  +    H N
Sbjct: 28  IGEGSTGIV--------CIATVKSS-GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           +V++        EL +V E+++ G+L + +     + + ++      + +   + L  LH
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLH 133

Query: 217 TSEKKVIYRDFKASNILL 234
              + VI+RD K+ +ILL
Sbjct: 134 A--QGVIHRDIKSDSILL 149

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 41.0 bits (96), Expect = 7e-04
 Identities = 24/93 (25%), Positives = 44/93 (47%), Gaps = 6/93 (6%)

Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E   L  ++HP+++++           +V  +     L  +L +R+   +PL  D  L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRS---RPLPIDQALII 162

Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGV 237
                 GL +LH   +++I+RD K  NI ++ V
Sbjct: 163 EKQILEGLRYLH--AQRIIHRDVKTENIFINDV 193

Length = 357

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 40.2 bits (94), Expect = 8e-04
 Identities = 25/86 (29%), Positives = 40/86 (46%), Gaps = 10/86 (11%)

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHL--FRRNPSIQPLSWDIRLKIAIGAARGL 212
           PN+V L  Y   +  + LV ++ + G L +H+  F   P      W   + +A+ A    
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100

Query: 213 GFLHTSEKKVIYRDFKASNILLDGVG 238
             LH   + ++ RD   +NILLD  G
Sbjct: 101 --LH--REGIVCRDLNPNNILLDDRG 122

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 41/147 (27%), Positives = 61/147 (41%), Gaps = 20/147 (13%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVNFLGRL 152
           LLG+G FG+V         +   +   G   A+K L  E +   +E     +E   L   
Sbjct: 2   LLGKGTFGKV---------ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 52

Query: 153 SHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
            HP L  L  Y ++  + L  V EY   G L  HL R     +  + +            
Sbjct: 53  RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSA 107

Query: 212 LGFLHTSEKKVIYRDFKASNILLDGVG 238
           L +LH+  + V+YRD K  N++LD  G
Sbjct: 108 LEYLHS--RDVVYRDIKLENLMLDKDG 132

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 40.0 bits (94), Expect = 0.001
 Identities = 45/162 (27%), Positives = 71/162 (43%), Gaps = 36/162 (22%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ----- 143
            +F+   ++G G FG V         L   K   G + A+KKL    M   E+ Q     
Sbjct: 1   DDFESIKVIGRGAFGEV--------RLVQKKDT-GHIYAMKKLRKSEM--LEKEQVAHVR 49

Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDI-R 201
           +E + L    +P +VKL  Y ++D+  L L+ EY+  G +   L +++      + +  R
Sbjct: 50  AERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDT----FTEEETR 104

Query: 202 LKI-----AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
             I     AI +   LG++H        RD K  N+LLD  G
Sbjct: 105 FYIAETILAIDSIHKLGYIH--------RDIKPDNLLLDAKG 138

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 39.8 bits (93), Expect = 0.001
 Identities = 47/148 (31%), Positives = 61/148 (41%), Gaps = 21/148 (14%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLG-R 151
           +LG+G FG+V         +     G   V AIK L  + +      +   +E   L   
Sbjct: 2   VLGKGSFGKV---------MLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALA 52

Query: 152 LSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
             HP L  L   C++ K+ L  V EY+  G L   + R     +P S   R   A     
Sbjct: 53  AKHPFLTALHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS---RF-YAAEVTL 107

Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGVG 238
            L FLH     VIYRD K  NILLD  G
Sbjct: 108 ALMFLHRHG--VIYRDLKLDNILLDAEG 133

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 39.8 bits (93), Expect = 0.001
 Identities = 33/107 (30%), Positives = 47/107 (43%), Gaps = 16/107 (14%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLG-----MVVAIKKLNPESMQGFEE-WQ 143
           N +    LG G FG+V +          +  GLG     + VA+K L   +     E   
Sbjct: 39  NLQFGKTLGAGAFGKVVEA---------TAFGLGKEDNVLRVAVKMLKASAHTDEREALM 89

Query: 144 SEVNFLGRL-SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR 189
           SE+  L  L  H N+V LLG C     +L++ EY   G L N L ++
Sbjct: 90  SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKK 136

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 31/130 (23%), Positives = 55/130 (42%), Gaps = 15/130 (11%)

Query: 113 KTLAPSKTGLGMV------VAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLL-GYCW 165
            +L P   G   V         KK+  +++ G +    E++ L  +SH  ++ L+  Y W
Sbjct: 98  SSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRW 157

Query: 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYR 225
           +    +++ +Y      +  LF       PL  +  + I       L +LH   + +I+R
Sbjct: 158 KSTVCMVMPKY------KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH--GRGIIHR 209

Query: 226 DFKASNILLD 235
           D K  NI LD
Sbjct: 210 DVKTENIFLD 219

Length = 392

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 39.0 bits (91), Expect = 0.002
 Identities = 50/156 (32%), Positives = 64/156 (41%), Gaps = 43/156 (27%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGR---- 151
           +LG+G FG+V         LA  K G     AIK L  + +   E+   E   + R    
Sbjct: 2   VLGKGSFGKVM--------LAELK-GTNEFFAIKALKKDVV--LEDDDVECTMVERRVLA 50

Query: 152 --LSHPNLVKLLGYC-WEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
               HP L  L  +C ++ KE L  V EY+  G L  H       IQ        +    
Sbjct: 51  LAWEHPFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFH-------IQS-----SGRFDEA 96

Query: 208 AAR--------GLGFLHTSEKKVIYRDFKASNILLD 235
            AR        GL FLH   K +IYRD K  N+LLD
Sbjct: 97  RARFYAAEIICGLQFLHK--KGIIYRDLKLDNVLLD 130

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 42/156 (26%), Positives = 69/156 (44%), Gaps = 21/156 (13%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTG--LGMVVAIKKLNPESM----QGFEEWQ 143
           NF+   +LG G +G+V+        L    +G   G + A+K L   ++    +  E  +
Sbjct: 1   NFELLKVLGTGAYGKVF--------LVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTR 52

Query: 144 SEVNFLGRLSHPNLVKLLGYCWE-DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL 202
           +E   L  +     +  L Y ++ D +L L+ +Y+  G L  HL +R    +       +
Sbjct: 53  TERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ-----EV 107

Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
           +I  G    L   H  +  +IYRD K  NILLD  G
Sbjct: 108 QIYSGEIV-LALEHLHKLGIIYRDIKLENILLDSNG 142

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 39.0 bits (91), Expect = 0.003
 Identities = 45/168 (26%), Positives = 69/168 (41%), Gaps = 36/168 (21%)

Query: 83  DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW 142
           DL S   + +P   LG G  G V+   VD              VA+KK+     Q  +  
Sbjct: 2   DLGSRYMDLRP---LGCGSNGLVFSA-VDSDC--------DKRVAVKKIVLTDPQSVKHA 49

Query: 143 QSEVNFLGRLSHPNLVKL--------------LGYCWEDKELLLVYEYMQRGSLENHLFR 188
             E+  + RL H N+VK+              +G   E   + +V EYM     E  L  
Sbjct: 50  LREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDL-A 103

Query: 189 RNPSIQPLSWD-IRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                 PLS +  RL       RGL ++H++   V++RD K +N+ ++
Sbjct: 104 NVLEQGPLSEEHARL-FMYQLLRGLKYIHSA--NVLHRDLKPANVFIN 148

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 38.6 bits (90), Expect = 0.003
 Identities = 23/81 (28%), Positives = 39/81 (48%), Gaps = 8/81 (9%)

Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELL----LVYEYMQRGSLENHLFRRNPSIQPLSWDI 200
           E+  L R+   N++K+ G+  +  + L    L+ EY  RG L   L +     + LS+  
Sbjct: 68  EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE----KDLSFKT 123

Query: 201 RLKIAIGAARGLGFLHTSEKK 221
           +L +AI   +GL  L+    K
Sbjct: 124 KLDMAIDCCKGLYNLYKYTNK 144

Length = 283

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 30/94 (31%), Positives = 46/94 (48%), Gaps = 6/94 (6%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE-WQSEVNFLGRLS-H 154
           LG G FGRV    V+      S +   M VA+K L   +    ++   SE+  +  L  H
Sbjct: 45  LGSGAFGRV----VEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPH 100

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR 188
            N+V LLG C +   + ++ EY + G L ++L R
Sbjct: 101 LNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHR 134

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 38.5 bits (89), Expect = 0.004
 Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 23/163 (14%)

Query: 83  DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE- 141
           DL+   ++++   ++G G FG V         L   K+    V A+K L+   M    + 
Sbjct: 37  DLRMKAEDYEVVKVIGRGAFGEV--------QLVRHKS-TRKVYAMKLLSKFEMIKRSDS 87

Query: 142 ---WQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRN-PSIQPLS 197
              W+ E + +   + P +V+L     +D+ L +V EYM  G L N +   + P      
Sbjct: 88  AFFWE-ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF 146

Query: 198 WDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           +   + +A+ A   +GF+H        RD K  N+LLD  G L
Sbjct: 147 YTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHL 181

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	376
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.98
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.98
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.98
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.98
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.98
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.98
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.98
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.98
PHA03211	461	serine/threonine kinase US3; Provisional	99.98
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.98
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.98
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.98
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.98
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.98
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.98
PHA03209	357	serine/threonine kinase US3; Provisional	99.98
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.98
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.98
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.98
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.98
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.98
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.98
KOG3653	534	consensus Transforming growth factor beta/activin	99.98
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.98
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.98
PHA03210	501	serine/threonine kinase US3; Provisional	99.98
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.98
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.98
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.98
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.98
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.98
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.98
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.98
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.97
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.97
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.97
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.97
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.97
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.97
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.97
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.97
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.97
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.97
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.97
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.97
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.97
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.97
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.97
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.97
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.97
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.97
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.97
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.97
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.97
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.97
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.97
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.97
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.97
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.97
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.97
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.97
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.97
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.97
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.97
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.97
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.97
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.97
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.97
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.97
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.97
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.97
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.97
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.97
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.97
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.97
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.97
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.97
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.97
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.97
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.97
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.97
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.97
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.97
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.97
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.97
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.97
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.97
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.97
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.97
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.97
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.97
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.97
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.97
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.97
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.97
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.97
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.97
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.97
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.97
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.97
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.97
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.97
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.97
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.97
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.97
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.97
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.97
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.97
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.97
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.97
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.97
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.97
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.97
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.97
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.97
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.97
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.97
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.97
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.97
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.97
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.97
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.97
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.97
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.97
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.97
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.97
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.97
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.97
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.97
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.97
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.97
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.97
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.97
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.97
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.97
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.97
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.96
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.96
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.96
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.96
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.96
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.96
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.96
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.96
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.96
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.96
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.96
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.96
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.96
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.96
PHA02882	294	putative serine/threonine kinase; Provisional	99.96
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.96
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.96
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.96
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.96
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.96
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.96
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.96
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.96
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.96
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.96
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.96
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.96
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.96
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.96
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.96
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.96
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.96
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.96
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.96
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.96
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.95
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.95
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.95
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.95
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.95
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.95
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.95
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.95
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.95
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.95
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.95
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.95
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.95
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.92
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.92
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
PRK10345	210	hypothetical protein; Provisional	99.88
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.86
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.86
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.85
smart00090	237	RIO RIO-like kinase.	99.84
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.82
PLN00181	793	protein SPA1-RELATED; Provisional	99.82
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.76
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.73
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.73
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.72
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.66
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.64
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.64
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.63
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.62
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.59
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.58
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.57
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.56
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.55
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.52
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.46
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.44
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.41
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.34
KOG3087	229	consensus Serine/threonine protein kinase [General	99.3
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.26
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.2
KOG1243	690	consensus Protein kinase [General function predict	99.16
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.11
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.04
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.01
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.9
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.86
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.85
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.81
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.75
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.69
PRK09902	216	hypothetical protein; Provisional	98.65
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.55
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.45
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.44
PF01636	239	APH: Phosphotransferase enzyme family This family	98.41
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.36
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.31
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.3
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.25
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.25
PLN02876	822	acyl-CoA dehydrogenase	98.25
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.05
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.95
PRK10593	297	hypothetical protein; Provisional	97.94
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.78
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.77
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.76
KOG2137	700	consensus Protein kinase [Signal transduction mech	97.73
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.72
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.68
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	97.67
PRK05231	319	homoserine kinase; Provisional	97.63
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.59
PLN02236	344	choline kinase	97.42
KOG2270	520	consensus Serine/threonine protein kinase involved	97.23
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.19
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.09
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.04
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.01
COG4248	637	Uncharacterized protein with protein kinase and he	96.91
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.83
KOG1290	590	consensus Serine/threonine protein kinase [Signal	96.79
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.77
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.64
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.57
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.51
PLN02756	418	S-methyl-5-thioribose kinase	96.48
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.14
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.14
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.03
PRK12396	409	5-methylribose kinase; Reviewed	95.98
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.84
PTZ00384	383	choline kinase; Provisional	95.6
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.41
PRK11768	325	serine/threonine protein kinase; Provisional	95.33
PRK06148	1013	hypothetical protein; Provisional	95.13
PTZ00296	442	choline kinase; Provisional	93.73

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=334.22  Aligned_cols=199  Identities=26%  Similarity=0.312  Sum_probs=173.8

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ...+|.+.+.||+|+||+||+|+++         .++..||||.+.+.  .....+.+..|+.+|+.++|||||++++++
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~---------~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~   78 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHK---------KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI   78 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEec---------cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE
Confidence            4567999999999999999999544         46899999999877  455667788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC------C
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV------G  238 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~------g  238 (376)
                      ++++.+|+|||||.||+|.++++++    ..+++..++.++.||+.||++||  +++||||||||+||||+..      -
T Consensus        79 ~~~~~i~lVMEyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~--~~~IiHRDLKPQNiLLs~~~~~~~~~  152 (429)
T KOG0595|consen   79 EDDDFIYLVMEYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLH--ENNIIHRDLKPQNILLSTTARNDTSP  152 (429)
T ss_pred             ecCCeEEEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCcceEEeccCCCCCCCc
Confidence            9999999999999999999999887    46999999999999999999999  6999999999999999764      4


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .+||+|||+|+.+.........        +|+|-||               |||++.... ++.|+|.||.|.|+++++
T Consensus       153 ~LKIADFGfAR~L~~~~~a~tl--------cGSplYM---------------APEV~~~~~-YdAKADLWSiG~Ilyq~l  208 (429)
T KOG0595|consen  153 VLKIADFGFARFLQPGSMAETL--------CGSPLYM---------------APEVIMSQQ-YDAKADLWSIGTILYQCL  208 (429)
T ss_pred             eEEecccchhhhCCchhHHHHh--------hCCcccc---------------CHHHHHhcc-ccchhhHHHHHHHHHHHH
Confidence            6999999999999865444333        7778888               899887655 488899999999999999


Q ss_pred             cccccc
Q 017177          319 SFYRTT  324 (376)
Q Consensus       319 ~~y~~~  324 (376)
                      +.+-+.
T Consensus       209 ~g~~Pf  214 (429)
T KOG0595|consen  209 TGKPPF  214 (429)
T ss_pred             hCCCCc
Confidence            665554

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-44  Score=321.78  Aligned_cols=200  Identities=26%  Similarity=0.328  Sum_probs=174.9

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ..++|+++++||+|+||+||.++         ++.+++.+|+|++++...   ...+...+|..||.+++||+||+++..
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vr---------k~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys   93 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVR---------KKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS   93 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEE---------EcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe
Confidence            45789999999999999999994         445799999999988633   345778899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      |++.+.+|+|+||+.||.|..+|.+.    ..+++..+..++.+|+.||.|||  +++||||||||+|||+|.+|+++|+
T Consensus        94 FQt~~kLylVld~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH--~~gIiyRDlKPENILLd~~GHi~Lt  167 (357)
T KOG0598|consen   94 FQTEEKLYLVLDYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLH--SKGIIYRDLKPENILLDEQGHIKLT  167 (357)
T ss_pred             cccCCeEEEEEeccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHH--hCCeeeccCCHHHeeecCCCcEEEe
Confidence            99999999999999999999999876    56999999999999999999999  6999999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||+++..-.....+   .|.    +||++||               |||++.+..| +..+|+||+|+++++|.+--.+
T Consensus       168 DFgL~k~~~~~~~~t---~tf----cGT~eYm---------------APEil~~~gy-~~~vDWWsLGillYeML~G~pP  224 (357)
T KOG0598|consen  168 DFGLCKEDLKDGDAT---RTF----CGTPEYM---------------APEILLGKGY-DKAVDWWSLGILLYEMLTGKPP  224 (357)
T ss_pred             ccccchhcccCCCcc---ccc----cCCcccc---------------ChHHHhcCCC-CcccchHhHHHHHHHHhhCCCC
Confidence            999999554332221   122    8999999               9999998864 8999999999999999955444


Q ss_pred             c
Q 017177          324 T  324 (376)
Q Consensus       324 ~  324 (376)
                      .
T Consensus       225 F  225 (357)
T KOG0598|consen  225 F  225 (357)
T ss_pred             C
Confidence            4

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-44  Score=324.03  Aligned_cols=203  Identities=24%  Similarity=0.273  Sum_probs=172.8

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh-------hHHHHHHHHHHHhcCCCCCc
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-------GFEEWQSEVNFLGRLSHPNL  157 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~il~~l~h~nI  157 (376)
                      +...+.|.+.+.||+|+||.|-+|         .++.+++.||||++.+....       ....+.+|++||++|+||||
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla---------~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~I  238 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLA---------YEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNI  238 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEE---------EEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCE
Confidence            345667899999999999999999         55568999999999875321       22346799999999999999


Q ss_pred             ceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC
Q 017177          158 VKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV  237 (376)
Q Consensus       158 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~  237 (376)
                      |+++++|..++..||||||++||+|.+.+..+    ..+.+...+.+++|++.|+.|||  ++||+||||||+|||+..+
T Consensus       239 V~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH--~~GI~HRDiKPeNILl~~~  312 (475)
T KOG0615|consen  239 VRIKDFFEVPDSSYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLH--SQGIIHRDIKPENILLSND  312 (475)
T ss_pred             EEEeeeeecCCceEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHH--HcCcccccCCcceEEeccC
Confidence            99999999999999999999999999999877    55888889999999999999999  5999999999999999655


Q ss_pred             ---CcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh--hhccccccccceee
Q 017177          238 ---GFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI--KYLTLLKYSNSFAF  312 (376)
Q Consensus       238 ---g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~--~~~~~~~dv~s~g~  312 (376)
                         ..+||+|||+|+...........        +|||.|.               |||++..+  .+.+.+.|+||+|+
T Consensus       313 ~e~~llKItDFGlAK~~g~~sfm~Tl--------CGTpsYv---------------APEVl~~kg~~~~~~kVDiWSlGc  369 (475)
T KOG0615|consen  313 AEDCLLKITDFGLAKVSGEGSFMKTL--------CGTPSYV---------------APEVLASKGVEYYPSKVDIWSLGC  369 (475)
T ss_pred             CcceEEEecccchhhccccceehhhh--------cCCcccc---------------ChhheecCCeecccchheeeeccc
Confidence               78999999999998754444333        6666666               69998865  55567899999999


Q ss_pred             eehhhccccccch
Q 017177          313 VFSCVFSFYRTTM  325 (376)
Q Consensus       313 v~~~~~~~y~~~~  325 (376)
                      |++-+++-|-+..
T Consensus       370 vLfvcLsG~pPFS  382 (475)
T KOG0615|consen  370 VLFVCLSGYPPFS  382 (475)
T ss_pred             eEEEEeccCCCcc
Confidence            9999997777763

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-44  Score=313.42  Aligned_cols=205  Identities=22%  Similarity=0.276  Sum_probs=176.2

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEe-EE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLG-YC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~-~~  164 (376)
                      ..+|+++++||+|+||.||++         ....++..+|.|.++-...  ...+.+..|+.+|++|+|||||++++ .|
T Consensus        18 l~~y~Il~~IG~GsFg~vykv---------~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f   88 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKV---------QCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF   88 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEe---------eeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh
Confidence            456999999999999999999         4555799999999986533  44567889999999999999999999 45


Q ss_pred             EeCCe-EEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhc--CCCCcEecCCCCCCEEEcCCCcEE
Q 017177          165 WEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHT--SEKKVIYRDFKASNILLDGVGFLF  241 (376)
Q Consensus       165 ~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs--~~~~iiHrDlKp~NILl~~~g~~k  241 (376)
                      .+++. ++||||+|++|+|.+.+++.+.....+++..+++++.|++.||..+|+  .+.-|+||||||.||+|+.+|.+|
T Consensus        89 ~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvK  168 (375)
T KOG0591|consen   89 IEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVK  168 (375)
T ss_pred             hccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCcee
Confidence            55555 899999999999999999877777889999999999999999999996  234499999999999999999999


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |+|||+++++.......   .+    .+|||.||               .||++...+| ..++||||+||+++||+..-
T Consensus       169 LGDfGL~r~l~s~~tfA---~S----~VGTPyYM---------------SPE~i~~~~Y-~~kSDiWslGCllyEMcaL~  225 (375)
T KOG0591|consen  169 LGDFGLGRFLSSKTTFA---HS----LVGTPYYM---------------SPERIHESGY-NFKSDIWSLGCLLYEMCALQ  225 (375)
T ss_pred             eccchhHhHhcchhHHH---Hh----hcCCCccc---------------CHHHHhcCCC-CcchhHHHHHHHHHHHHhcC
Confidence            99999999987654432   22    29999999               8999988775 89999999999999999554


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      .+.
T Consensus       226 ~PF  228 (375)
T KOG0591|consen  226 SPF  228 (375)
T ss_pred             CCc
Confidence            444

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=312.82  Aligned_cols=198  Identities=24%  Similarity=0.281  Sum_probs=173.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..+++.++.||+|..|+||+|         +++.+++.+|+|++..... ...+++.+|+++++.++||+||.+|++|..
T Consensus        78 ~~dle~~~~lG~G~gG~V~kv---------~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~  148 (364)
T KOG0581|consen   78 LSDLERLGVLGSGNGGTVYKV---------RHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS  148 (364)
T ss_pred             HHHhhhhhhcccCCCcEEEEE---------EEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence            446778899999999999999         5555899999999966533 445788999999999999999999999999


Q ss_pred             CC-eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          167 DK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       167 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      ++ .++|+||||++|+|.+++++.    +.+++.....++.+|++||.|||. +++||||||||+||||+.+|.+|||||
T Consensus       149 ~~~~isI~mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~-~~~IIHRDIKPsNlLvNskGeVKicDF  223 (364)
T KOG0581|consen  149 NGEEISICMEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHE-ERKIIHRDIKPSNLLVNSKGEVKICDF  223 (364)
T ss_pred             CCceEEeehhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhh-ccCeeeccCCHHHeeeccCCCEEeccc
Confidence            99 499999999999999999776    559999999999999999999995 599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      |.++.+.+.     .+.|.    +||..||               +||-+.|..| +.++||||||.+++|++.-.-+.
T Consensus       224 GVS~~lvnS-----~a~tf----vGT~~YM---------------sPERi~g~~Y-s~~sDIWSLGLsllE~a~GrfP~  277 (364)
T KOG0581|consen  224 GVSGILVNS-----IANTF----VGTSAYM---------------SPERISGESY-SVKSDIWSLGLSLLELAIGRFPY  277 (364)
T ss_pred             cccHHhhhh-----hcccc----ccccccc---------------ChhhhcCCcC-CcccceecccHHHHHHhhCCCCC
Confidence            999987665     22333    8888888               8999988765 88899999999999999654333

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.7e-42  Score=324.06  Aligned_cols=194  Identities=24%  Similarity=0.283  Sum_probs=170.8

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC---ChhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      .+|+..++||+|+|+.||+++.         ..+|..||+|++.+.   .....+.+.+||+|.+.|+|||||+++++|+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~---------~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE   88 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARD---------LDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE   88 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEE---------cCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence            5799999999999999999954         346999999999874   3345678899999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +.+++|||+|+|+.++|..+++++    .+++|.+++.+++||+.||.|||  .++|||||||..|+|++++-+|||+||
T Consensus        89 Ds~nVYivLELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH--~~~IiHRDLKLGNlfL~~~~~VKIgDF  162 (592)
T KOG0575|consen   89 DSNNVYIVLELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLH--SLGIIHRDLKLGNLFLNENMNVKIGDF  162 (592)
T ss_pred             cCCceEEEEEecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHH--hcCceecccchhheeecCcCcEEeccc
Confidence            999999999999999999999866    56999999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      |+|..+...+....   |+    +|||+|.               |||++... -....+||||+|||++-++.-
T Consensus       163 GLAt~le~~~Erk~---Tl----CGTPNYI---------------APEVl~k~-gHsfEvDiWSlGcvmYtLL~G  214 (592)
T KOG0575|consen  163 GLATQLEYDGERKK---TL----CGTPNYI---------------APEVLNKS-GHSFEVDIWSLGCVMYTLLVG  214 (592)
T ss_pred             ceeeeecCcccccc---ee----cCCCccc---------------ChhHhccC-CCCCchhhhhhhhHHHhhhhC
Confidence            99999986533221   22    7777777               79988844 468899999999999988853

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-42  Score=298.92  Aligned_cols=197  Identities=25%  Similarity=0.303  Sum_probs=176.3

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ..++|++++.||.|+||+|.++         +++.++..+|+|++++...   .+.+...+|..+|+.+.||+++++++.
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LV---------r~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t  112 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLV---------REKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT  112 (355)
T ss_pred             chhhhhheeeeccCccceEEEE---------EEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe
Confidence            3567999999999999999999         4445799999999988643   455677899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      |.+.+++||||||.+||.|..++++.    .++++..++.++.||+.||+|||  .++|++|||||||||+|.+|++||+
T Consensus       113 ~~d~~~lymvmeyv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleylH--~~~iiYRDLKPENiLlD~~G~iKit  186 (355)
T KOG0616|consen  113 FKDNSNLYMVMEYVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYLH--SLDIIYRDLKPENLLLDQNGHIKIT  186 (355)
T ss_pred             eccCCeEEEEEeccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHHH--hcCeeeccCChHHeeeccCCcEEEE
Confidence            99999999999999999999999887    56999999999999999999999  5999999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||+|+.....          +|+-+|||+|+               |||++..+.| ..++|+|+||+.++||+.-|-+
T Consensus       187 DFGFAK~v~~r----------T~TlCGTPeYL---------------APEii~sk~y-nkavDWWalGVLIYEMlaG~pP  240 (355)
T KOG0616|consen  187 DFGFAKRVSGR----------TWTLCGTPEYL---------------APEIIQSKGY-NKAVDWWALGVLIYEMLAGYPP  240 (355)
T ss_pred             eccceEEecCc----------EEEecCCcccc---------------ChHHhhcCCC-CcchhHHHHHHHHHHHHcCCCC
Confidence            99999986553          34449999999               9999998775 8899999999999999966666


Q ss_pred             c
Q 017177          324 T  324 (376)
Q Consensus       324 ~  324 (376)
                      .
T Consensus       241 F  241 (355)
T KOG0616|consen  241 F  241 (355)
T ss_pred             C
Confidence            5

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.5e-42  Score=319.94  Aligned_cols=219  Identities=20%  Similarity=0.229  Sum_probs=186.8

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEE
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLL  161 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~  161 (376)
                      +...++|+++++||+|+||.||+|         +++.+|..+|+|++++...   .+++.++.|-.+|...++|+||++|
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLa---------rKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLy  207 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLA---------RKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLY  207 (550)
T ss_pred             cCCcccchhheeeccccceeEEEE---------EEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEE
Confidence            445678999999999999999999         6666899999999998754   4567788999999999999999999


Q ss_pred             eEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEE
Q 017177          162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLF  241 (376)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~k  241 (376)
                      ..|++.+++||||||++||++..+|.+.    ..+++..+..++.+++.|+..||  +.|+|||||||+|+|||..|++|
T Consensus       208 YsFQD~~~LYLiMEylPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH--~~gyIHRDIKPdNlLiD~~GHiK  281 (550)
T KOG0605|consen  208 YSFQDKEYLYLIMEYLPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIH--QLGYIHRDIKPDNLLIDAKGHIK  281 (550)
T ss_pred             EEecCCCeeEEEEEecCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHH--HcCcccccCChhheeecCCCCEe
Confidence            9999999999999999999999999876    56999999999999999999999  79999999999999999999999


Q ss_pred             EcceeeeeeeccceeeEE----------------------------------------EeeeEEEEEeeeeehhhhhcch
Q 017177          242 DSHLLIYVYFKRHYIYIY----------------------------------------IHTYIIYIYIYVYIYMYIYKCL  281 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~----------------------------------------~~~~~~y~~~gt~~y~~~~~~~  281 (376)
                      |+||||+..+........                                        ......|--+|||.||      
T Consensus       282 LSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYi------  355 (550)
T KOG0605|consen  282 LSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYI------  355 (550)
T ss_pred             eccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCcccc------
Confidence            999999975533211000                                        0111244456777777      


Q ss_pred             hhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccchhhHHHHHHH
Q 017177          282 RYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTTMLKYQILAWQ  334 (376)
Q Consensus       282 e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~~~~~~~~~~~  334 (376)
                               |||++.+++ +...+|+||+|+|++|++.-|.+....-|...|+
T Consensus       356 ---------APEVll~kg-Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~r  398 (550)
T KOG0605|consen  356 ---------APEVLLGKG-YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYR  398 (550)
T ss_pred             ---------chHHHhcCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence                     999999998 5899999999999999999999987666666554

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=312.68  Aligned_cols=240  Identities=41%  Similarity=0.558  Sum_probs=197.7

Q ss_pred             CccccChhhhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCC
Q 017177           75 DLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH  154 (376)
Q Consensus        75 ~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h  154 (376)
                      ....+++.++...+++|.....||+|+||.||+|...+          +..||||++........++|.+|+.++.+++|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H  130 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD----------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRH  130 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC----------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCC
Confidence            45678899999999999999999999999999998775          57899998887654313559999999999999


Q ss_pred             CCcceEEeEEEeCC-eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCcEecCCCCCCE
Q 017177          155 PNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS-EKKVIYRDFKASNI  232 (376)
Q Consensus       155 ~nIv~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~-~~~iiHrDlKp~NI  232 (376)
                      ||+|+++|+|.+.+ +.+||+||+++|+|.++|......  .++|..+++|+.++|+||+|||.. ...||||||||+||
T Consensus       131 ~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNI  208 (361)
T KOG1187|consen  131 PNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNI  208 (361)
T ss_pred             cCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHe
Confidence            99999999999988 599999999999999999876432  789999999999999999999972 22699999999999


Q ss_pred             EEcCCCcEEEcceeeeeeecc-ceeeEEE-eeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccce
Q 017177          233 LLDGVGFLFDSHLLIYVYFKR-HYIYIYI-HTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSF  310 (376)
Q Consensus       233 Ll~~~g~~kl~Dfg~a~~~~~-~~~~~~~-~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~  310 (376)
                      |+|++...|++|||+|+.... ....... .||.+|        +               +||.+.. ...+.++|||||
T Consensus       209 LLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY--------~---------------~PEy~~~-g~lt~KsDVySF  264 (361)
T KOG1187|consen  209 LLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGY--------L---------------APEYAST-GKLTEKSDVYSF  264 (361)
T ss_pred             eECCCCCEEccCccCcccCCccccceeeecCCCCcc--------C---------------Chhhhcc-CCcCcccccccc
Confidence            999999999999999976544 2222112 444444        4               4885544 667999999999


Q ss_pred             eeeehhhccccccch-------hhHHHHHHHhhCCCccCcccCCChh
Q 017177          311 AFVFSCVFSFYRTTM-------LKYQILAWQSWGPLVESHMLQPGLW  350 (376)
Q Consensus       311 g~v~~~~~~~y~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~  350 (376)
                      |+|++|+++..+...       ..+....|..+......+++|+.|.
T Consensus       265 GVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~  311 (361)
T KOG1187|consen  265 GVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLK  311 (361)
T ss_pred             hHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCcc
Confidence            999999987665332       2355566788888888899998875

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-41  Score=312.37  Aligned_cols=195  Identities=24%  Similarity=0.282  Sum_probs=169.5

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..+.|+.++.||+|+||.||+|         ++..+|+.||+|+++.+..  ....-..|||.||++|+||||+++.+..
T Consensus       115 ~~~~feki~kIGeGTyg~VYkA---------r~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eiv  185 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKA---------RDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIV  185 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEe---------eecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEE
Confidence            3456889999999999999999         5666899999999987653  3345667999999999999999999998


Q ss_pred             EeC--CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          165 WED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       165 ~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                      .+.  +.+|||+|||+. +|.-++...   ...|++.++..+++||+.||.|||  .++|+|||||.+|||||.+|.+||
T Consensus       186 t~~~~~siYlVFeYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH--~~gvlHRDIK~SNiLidn~G~LKi  259 (560)
T KOG0600|consen  186 TSKLSGSIYLVFEYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCH--SRGVLHRDIKGSNILIDNNGVLKI  259 (560)
T ss_pred             EecCCceEEEEEecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHh--hcCeeeccccccceEEcCCCCEEe
Confidence            876  689999999987 898888654   356999999999999999999999  599999999999999999999999


Q ss_pred             cceeeeeeeccceee--EEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          243 SHLLIYVYFKRHYIY--IYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~--~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +|||+|+++......  +...-|..|.+                       ||++.|...++.+.|+||.|||+.|+..
T Consensus       260 aDFGLAr~y~~~~~~~~T~rVvTLWYRp-----------------------PELLLG~t~Yg~aVDlWS~GCIl~El~~  315 (560)
T KOG0600|consen  260 ADFGLARFYTPSGSAPYTSRVVTLWYRP-----------------------PELLLGATSYGTAVDLWSVGCILAELFL  315 (560)
T ss_pred             ccccceeeccCCCCcccccceEEeeccC-----------------------hHHhcCCcccccceeehhhhHHHHHHHc
Confidence            999999988776643  33444455555                       9999999999999999999999999983

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.9e-41  Score=295.22  Aligned_cols=194  Identities=22%  Similarity=0.248  Sum_probs=164.6

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-h-hHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-Q-GFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      +.|+.+.++|+|+||.||+|         +++.+|+.||||++..... . -.+-.+||+++|++|+|+|+|.++++|..
T Consensus         2 ekYE~LgkvGEGSYGvV~KC---------rnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr   72 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKC---------RNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR   72 (396)
T ss_pred             cHHhhhhccccCcceEEEEe---------ccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh
Confidence            46888899999999999999         6666899999999876543 2 23456799999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ...+++|+|||+. ++.+.|.+.-   ..++...+..++.|++.|+.|+|  .++||||||||+||||+.+|.+||||||
T Consensus        73 krklhLVFE~~dh-TvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cH--k~n~IHRDIKPENILit~~gvvKLCDFG  146 (396)
T KOG0593|consen   73 KRKLHLVFEYCDH-TVLHELERYP---NGVPSELVKKYLYQLLKAIHFCH--KNNCIHRDIKPENILITQNGVVKLCDFG  146 (396)
T ss_pred             cceeEEEeeecch-HHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhh--hcCeecccCChhheEEecCCcEEeccch
Confidence            9999999999987 6666666552   45899999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeecc-ceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          247 IYVYFKR-HYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       247 ~a~~~~~-~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      +|+.+.. .+.++....|..|.                       |||++.|..++....|||+.||||.|+++-
T Consensus       147 FAR~L~~pgd~YTDYVATRWYR-----------------------aPELLvGDtqYG~pVDiWAiGCv~aEl~~G  198 (396)
T KOG0593|consen  147 FARTLSAPGDNYTDYVATRWYR-----------------------APELLVGDTQYGKPVDIWAIGCVFAELLTG  198 (396)
T ss_pred             hhHhhcCCcchhhhhhhhhhcc-----------------------ChhhhcccCcCCCcccchhhhHHHHHHhcC
Confidence            9998873 33332222333333                       599999999999999999999999999954

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-40  Score=308.35  Aligned_cols=195  Identities=31%  Similarity=0.439  Sum_probs=166.5

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcE-EEEEEcCCCChh--hHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMV-VAIKKLNPESMQ--GFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~-vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      +....+.||+|+||+||+|.++           |.. ||+|++......  ..+.|.+|+.+|.+++|||||+++|++..
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~-----------g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~  110 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWR-----------GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS  110 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeC-----------CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            3455667999999999999887           444 999999875432  25689999999999999999999999998


Q ss_pred             CC-eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-cEecCCCCCCEEEcCCC-cEEEc
Q 017177          167 DK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK-VIYRDFKASNILLDGVG-FLFDS  243 (376)
Q Consensus       167 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~-iiHrDlKp~NILl~~~g-~~kl~  243 (376)
                      +. ...|||||+++|+|.+++.+.  ....+++..++.++.||++||.|||+  ++ ||||||||+|||++.++ ++||+
T Consensus       111 ~~~~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~--~~~iIHrDLK~~NiLv~~~~~~~KI~  186 (362)
T KOG0192|consen  111 PPGSLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS--EGPIIHRDLKSDNILVDLKGKTLKIA  186 (362)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc--CCCeeecccChhhEEEcCCCCEEEEC
Confidence            87 799999999999999999874  23679999999999999999999995  77 99999999999999998 99999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh-hhhccccccccceeeeehhhcccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW-IKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~-~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |||+++.........   +.    ..||+.||               |||++.+ ...++.++||||||+|+||+.+.-
T Consensus       187 DFGlsr~~~~~~~~~---~~----~~GT~~wM---------------APEv~~~~~~~~~~K~DvySFgIvlWEl~t~~  243 (362)
T KOG0192|consen  187 DFGLSREKVISKTSM---TS----VAGTYRWM---------------APEVLRGEKSPYTEKSDVYSFGIVLWELLTGE  243 (362)
T ss_pred             CCccceeeccccccc---cC----CCCCcccc---------------ChhhhcCCCCcCCccchhhhHHHHHHHHHHCC
Confidence            999999876543111   10    27888888               8999997 466799999999999999999653

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=8.2e-40  Score=281.44  Aligned_cols=192  Identities=24%  Similarity=0.291  Sum_probs=167.6

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhh--HHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .+|...+.||+|.||.||+|         ++..+|+.||||+++.....+  .....||++.|+.++|+||+.++++|..
T Consensus         2 ~rY~~~~~lGEG~~gvVyka---------~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~   72 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKA---------RDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH   72 (318)
T ss_pred             chhhhhhhhcCcceEEEEEE---------EecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence            46888899999999999999         455579999999998764432  2456899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      .+.+.||+||++. +|+..++..   ...++..++..++.++++||+|||  .+.|+||||||.|+|++.+|.+||+|||
T Consensus        73 ~~~l~lVfEfm~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H--~~~IlHRDlKPnNLLis~~g~lKiADFG  146 (318)
T KOG0659|consen   73 KSNLSLVFEFMPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCH--SKWILHRDLKPNNLLISSDGQLKIADFG  146 (318)
T ss_pred             CCceEEEEEeccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHH--hhhhhcccCCccceEEcCCCcEEeeccc
Confidence            9999999999976 999999766   367899999999999999999999  6999999999999999999999999999


Q ss_pred             eeeeeccceee-EEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          247 IYVYFKRHYIY-IYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       247 ~a~~~~~~~~~-~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      +|+.+...... ....-|..|.+                       ||++-|.+.+....|+||.||||+|++
T Consensus       147 LAr~f~~p~~~~~~~V~TRWYRA-----------------------PELLfGsr~Yg~~VDmWavGCI~AELl  196 (318)
T KOG0659|consen  147 LARFFGSPNRIQTHQVVTRWYRA-----------------------PELLFGSRQYGTGVDMWAVGCIFAELL  196 (318)
T ss_pred             chhccCCCCcccccceeeeeccC-----------------------hHHhccchhcCCcchhhhHHHHHHHHH
Confidence            99998765442 22233444444                       999999999999999999999999998

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-39  Score=303.66  Aligned_cols=200  Identities=23%  Similarity=0.259  Sum_probs=173.0

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC----Ch-hhHHHHHHHHHHHhcCC-CCCcceE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE----SM-QGFEEWQSEVNFLGRLS-HPNLVKL  160 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~il~~l~-h~nIv~l  160 (376)
                      ..++|.+.+.||+|+||+|+.|..         ..++..||+|+++..    .. ...+.+.+|+.+++.++ ||||+++
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~---------~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l   85 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKH---------RLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRL   85 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeee---------ccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEE
Confidence            456899999999999999999944         446899999987764    11 22356668999999999 9999999


Q ss_pred             EeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC-Cc
Q 017177          161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV-GF  239 (376)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~-g~  239 (376)
                      ++++.....+|+|||||.||+|.+++.+.    .++.+..+..+++|++.|++|||  .++|+||||||+|||++.+ ++
T Consensus        86 ~ev~~t~~~~~ivmEy~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H--~~gi~HRDLK~ENilld~~~~~  159 (370)
T KOG0583|consen   86 LEVFATPTKIYIVMEYCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCH--SRGIVHRDLKPENILLDGNEGN  159 (370)
T ss_pred             EEEEecCCeEEEEEEecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHH--hCCEeeCCCCHHHEEecCCCCC
Confidence            99999999999999999999999999884    56889999999999999999999  5999999999999999999 99


Q ss_pred             EEEcceeeeeeec-cceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhh-hccccccccceeeeehhh
Q 017177          240 LFDSHLLIYVYFK-RHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIK-YLTLLKYSNSFAFVFSCV  317 (376)
Q Consensus       240 ~kl~Dfg~a~~~~-~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~-~~~~~~dv~s~g~v~~~~  317 (376)
                      +||+|||++.... ........        +|||.|+               |||++.++. |...++||||+|+|++.+
T Consensus       160 ~Kl~DFG~s~~~~~~~~~l~t~--------cGsp~Y~---------------aPEvl~~~~~Y~g~~aDvWS~GViLy~m  216 (370)
T KOG0583|consen  160 LKLSDFGLSAISPGEDGLLKTF--------CGSPAYA---------------APEVLSGKGTYSGKAADVWSLGVILYVL  216 (370)
T ss_pred             EEEeccccccccCCCCCcccCC--------CCCcccC---------------CHHHhCCCCCcCCchhhhhhhHHHHHHH
Confidence            9999999999884 33333222        7778888               799999998 999999999999999999


Q ss_pred             ccccccc
Q 017177          318 FSFYRTT  324 (376)
Q Consensus       318 ~~~y~~~  324 (376)
                      +..+-+.
T Consensus       217 l~G~~PF  223 (370)
T KOG0583|consen  217 LCGRLPF  223 (370)
T ss_pred             HhCCCCC
Confidence            8655554

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=297.95  Aligned_cols=204  Identities=21%  Similarity=0.229  Sum_probs=171.6

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcC-CCCCcceE
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRL-SHPNLVKL  160 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~h~nIv~l  160 (376)
                      +....+|.+++.||+|+|++|++|         +++.+++.||||++.+.-.   ...+-+.+|-.+|.+| .||.|++|
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A---------~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkL  139 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLA---------REKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKL  139 (604)
T ss_pred             cCChhhcchhheeccccceeEEEe---------eecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEE
Confidence            455678999999999999999999         5555799999999987522   2234567899999999 59999999


Q ss_pred             EeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcE
Q 017177          161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL  240 (376)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~  240 (376)
                      +-.|+++..+|+|+||+++|+|.++|++.    ..+++..++.++.+|+.||+|||  .+|||||||||||||||.||++
T Consensus       140 y~TFQD~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH--~~GIIHRDlKPENILLd~dmhi  213 (604)
T KOG0592|consen  140 YFTFQDEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLH--SNGIIHRDLKPENILLDKDGHI  213 (604)
T ss_pred             EEEeecccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHH--hcCceeccCChhheeEcCCCcE
Confidence            99999999999999999999999999887    56999999999999999999999  5999999999999999999999


Q ss_pred             EEcceeeeeeeccceeeEE------EeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeee
Q 017177          241 FDSHLLIYVYFKRHYIYIY------IHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVF  314 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~------~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~  314 (376)
                      +|+|||.|+.+........      ......-..+||.+|.               .||++.. .+.+..+|+|+|||++
T Consensus       214 kITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYV---------------SPElL~~-~~~~~~sDiWAlGCil  277 (604)
T KOG0592|consen  214 KITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYV---------------SPELLND-SPAGPSSDLWALGCIL  277 (604)
T ss_pred             EEeeccccccCChhhccccCccCcccccCcccceeeeeccc---------------CHHHhcC-CCCCcccchHHHHHHH
Confidence            9999999998865433200      0011011238888888               7997765 4568999999999999


Q ss_pred             hhhcc
Q 017177          315 SCVFS  319 (376)
Q Consensus       315 ~~~~~  319 (376)
                      +.|+.
T Consensus       278 yQmla  282 (604)
T KOG0592|consen  278 YQMLA  282 (604)
T ss_pred             HHHhc
Confidence            99983

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-40  Score=296.51  Aligned_cols=194  Identities=20%  Similarity=0.297  Sum_probs=173.5

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ...+|++.+.||+|.||+|-+|+         +...|+.||||.++++..   +++-.+.+|++||..|+||||+.+|++
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~---------e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV  121 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAY---------EHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV  121 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehh---------hccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh
Confidence            45679999999999999999994         434699999999987643   455678899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      |+..+.+.|||||..+|.|++++.++    ..+++.++..+++||..|+.|+|  .++++|||||.+|||+|.++++||+
T Consensus       122 FENkdKIvivMEYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCH--knrVvHRDLKLENILLD~N~NiKIA  195 (668)
T KOG0611|consen  122 FENKDKIVIVMEYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCH--KNRVVHRDLKLENILLDQNNNIKIA  195 (668)
T ss_pred             hcCCceEEEEEEecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHh--hccceecccchhheeecCCCCeeee
Confidence            99999999999999999999999887    56999999999999999999999  7999999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      |||++..+......+..        +|+|-|.               .|||+.|..|..+..|.||+|++++.++
T Consensus       196 DFGLSNly~~~kfLqTF--------CGSPLYA---------------SPEIvNG~PY~GPEVDsWsLGvLLYtLV  247 (668)
T KOG0611|consen  196 DFGLSNLYADKKFLQTF--------CGSPLYA---------------SPEIVNGTPYKGPEVDSWSLGVLLYTLV  247 (668)
T ss_pred             ccchhhhhccccHHHHh--------cCCcccC---------------CccccCCCCCCCCccchhhHHHHHHHHh
Confidence            99999988776555444        5555555               4999999999999999999999999877

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=304.77  Aligned_cols=238  Identities=21%  Similarity=0.206  Sum_probs=188.4

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCC-CCCcceE
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLS-HPNLVKL  160 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~-h~nIv~l  160 (376)
                      +...++|.++++||+|+||+|+++...         .+++.+|||++++..   .++++....|.+|+...+ ||.++++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k---------~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L  434 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELK---------GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNL  434 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEc---------CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeec
Confidence            345678999999999999999999554         468899999999874   356788889999999887 9999999


Q ss_pred             EeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcE
Q 017177          161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL  240 (376)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~  240 (376)
                      +..|++.+++|+||||+.||++..+.+.     ..+++..+..++..|+.||+|||  +++||+||||.+|||+|.+|++
T Consensus       435 ~~~fQT~~~l~fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH--~~~IIYRDlKLdNiLLD~eGh~  507 (694)
T KOG0694|consen  435 FSCFQTKEHLFFVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLH--ENGIIYRDLKLDNLLLDTEGHV  507 (694)
T ss_pred             ccccccCCeEEEEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHH--hcCceeeecchhheEEcccCcE
Confidence            9999999999999999999995544322     45999999999999999999999  7999999999999999999999


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ||+|||+++..-..+..   .+|+    +|||+||               ||||+.+..| +.+.|+|+||+.++||+.-
T Consensus       508 kiADFGlcKe~m~~g~~---TsTf----CGTpey~---------------aPEil~e~~Y-t~aVDWW~lGVLlyeML~G  564 (694)
T KOG0694|consen  508 KIADFGLCKEGMGQGDR---TSTF----CGTPEFL---------------APEVLTEQSY-TRAVDWWGLGVLLYEMLVG  564 (694)
T ss_pred             EecccccccccCCCCCc---cccc----cCChhhc---------------ChhhhccCcc-cchhhHHHHHHHHHHHHcC
Confidence            99999999965433222   1333    9999999               9999998875 9999999999999999965


Q ss_pred             cccchhhHHHHHHHhhCCCccCcccCCChhHHHHHHHHHHhhh
Q 017177          321 YRTTMLKYQILAWQSWGPLVESHMLQPGLWAHMVMQLQNMLQQ  363 (376)
Q Consensus       321 y~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  363 (376)
                      --+..+.-.....++....  ...--..|..+.+.-++.||+.
T Consensus       565 q~PF~gddEee~FdsI~~d--~~~yP~~ls~ea~~il~~ll~k  605 (694)
T KOG0694|consen  565 ESPFPGDDEEEVFDSIVND--EVRYPRFLSKEAIAIMRRLLRK  605 (694)
T ss_pred             CCCCCCCCHHHHHHHHhcC--CCCCCCcccHHHHHHHHHHhcc
Confidence            5444444444444443332  1122223335555555555543

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.8e-39  Score=300.82  Aligned_cols=192  Identities=27%  Similarity=0.333  Sum_probs=171.5

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ++|.+.+.||+|+||.||+|         +++.+.+.||+|.+.+...  ++.+.+.+|++|++.++||||+.+++.|+.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKg---------rrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt   72 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKG---------RRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET   72 (808)
T ss_pred             cchhHHHHhcCCccceeeec---------ccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence            47889999999999999999         7777899999999987644  456789999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ..++|+|+|||.| +|..+|...    ..++++.+..++.+++.||.|||  .++|+|||+||.|||++..|.+|+||||
T Consensus        73 ~~~~~vVte~a~g-~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLh--s~rilhrd~kPqniLl~~~~~~KlcdFg  145 (808)
T KOG0597|consen   73 SAHLWVVTEYAVG-DLFTILEQD----GKLPEEQVRAIAYDLVSALYYLH--SNRILHRDMKPQNILLEKGGTLKLCDFG  145 (808)
T ss_pred             cceEEEEehhhhh-hHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH--hcCcccccCCcceeeecCCCceeechhh
Confidence            9999999999977 999999876    56999999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +|+.......   +...+    -|||-||               |||++.+.. +...+|.||+|||+||+.+
T Consensus       146 ~Ar~m~~~t~---vltsi----kGtPlYm---------------APElv~e~p-yd~~sDlWslGcilYE~~~  195 (808)
T KOG0597|consen  146 LARAMSTNTS---VLTSI----KGTPLYM---------------APELVEEQP-YDHTSDLWSLGCILYELYV  195 (808)
T ss_pred             hhhhcccCce---eeeec----cCccccc---------------CHHHHcCCC-ccchhhHHHHHHHHHHHhc
Confidence            9998766433   22333    7888888               899998655 5888999999999999984

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-40  Score=304.93  Aligned_cols=200  Identities=23%  Similarity=0.274  Sum_probs=175.1

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHH-HHHHHHHHHhcCC-CCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEVNFLGRLS-HPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~E~~il~~l~-h~nIv~l~~~~  164 (376)
                      ..++|.+++.||.|+||.||+|         ..+.++..||||.+++....-.+ .-+||+..|++|+ |||||++.+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la---------~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi   78 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLA---------KSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVI   78 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEe---------eecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHh
Confidence            4568999999999999999999         44446889999999876432211 2358999999999 99999999999


Q ss_pred             EeCC-eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          165 WEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       165 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      .+.+ .+|+|||||+. +|+++++++   ...+++..+..|+.||++||+|+|  ++|+.|||+||||||+..+..+||+
T Consensus        79 ~d~~~~L~fVfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiH--k~GfFHRDlKPENiLi~~~~~iKia  152 (538)
T KOG0661|consen   79 RDNDRILYFVFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIH--KHGFFHRDLKPENILISGNDVIKIA  152 (538)
T ss_pred             hccCceEeeeHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHH--hcCcccccCChhheEecccceeEec
Confidence            9888 89999999976 999999887   377999999999999999999999  7999999999999999988999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||+||.......++....|..|.|                       ||++....+++...|+|++|||++|+.++.-+
T Consensus       153 DFGLARev~SkpPYTeYVSTRWYRA-----------------------PEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPL  209 (538)
T KOG0661|consen  153 DFGLAREVRSKPPYTEYVSTRWYRA-----------------------PEVLLRSGYYSSPVDMWAVGCIMAELYSLRPL  209 (538)
T ss_pred             ccccccccccCCCcchhhhcccccc-----------------------hHHhhhccccCCchHHHHHHHHHHHHHHhccc
Confidence            9999999887777665556666666                       99999999999999999999999999987666


Q ss_pred             c
Q 017177          324 T  324 (376)
Q Consensus       324 ~  324 (376)
                      .
T Consensus       210 F  210 (538)
T KOG0661|consen  210 F  210 (538)
T ss_pred             C
Confidence            5

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-38  Score=289.56  Aligned_cols=200  Identities=23%  Similarity=0.288  Sum_probs=164.9

Q ss_pred             hhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--------------hhHHHHHHHHHHH
Q 017177           84 LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--------------QGFEEWQSEVNFL  149 (376)
Q Consensus        84 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~il  149 (376)
                      -+...+.|++++.||+|.||+|-+|         ++..+++.||||++.+...              ...+.+.+||.||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLa---------r~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIail  162 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLA---------RDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAIL  162 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEE---------eecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHH
Confidence            3445788999999999999999999         4445799999999976422              1235788999999


Q ss_pred             hcCCCCCcceEEeEEEeC--CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCC
Q 017177          150 GRLSHPNLVKLLGYCWED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDF  227 (376)
Q Consensus       150 ~~l~h~nIv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDl  227 (376)
                      ++|.|||||+|+++..++  +.+|||+|||..|.+...-..    ...+.+.+++.++++++.||.|||.  ++||||||
T Consensus       163 Kkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d----~~els~~~Ar~ylrDvv~GLEYLH~--QgiiHRDI  236 (576)
T KOG0585|consen  163 KKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD----KPELSEQQARKYLRDVVLGLEYLHY--QGIIHRDI  236 (576)
T ss_pred             HhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCC----cccccHHHHHHHHHHHHHHHHHHHh--cCeecccc
Confidence            999999999999998765  579999999998877543211    1238999999999999999999995  99999999


Q ss_pred             CCCCEEEcCCCcEEEcceeeeeeeccce---eeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh---hhhc
Q 017177          228 KASNILLDGVGFLFDSHLLIYVYFKRHY---IYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW---IKYL  301 (376)
Q Consensus       228 Kp~NILl~~~g~~kl~Dfg~a~~~~~~~---~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~---~~~~  301 (376)
                      ||+|+||+++|++||+|||.+..+....   ......++     +|||.||               |||+..+   ..+.
T Consensus       237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~t-----vGTPAF~---------------APE~c~~~~~~~~~  296 (576)
T KOG0585|consen  237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRT-----VGTPAFF---------------APELCSGGNSFSYS  296 (576)
T ss_pred             chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhc-----CCCcccc---------------chHhhcCCCCcccc
Confidence            9999999999999999999999773321   11122233     8999999               9998887   5677


Q ss_pred             cccccccceeeeehhhc
Q 017177          302 TLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       302 ~~~~dv~s~g~v~~~~~  318 (376)
                      ..+.|||++|+.++|++
T Consensus       297 g~a~DiWalGVTLYCll  313 (576)
T KOG0585|consen  297 GFALDIWALGVTLYCLL  313 (576)
T ss_pred             chhhhhhhhhhhHHHhh
Confidence            78999999999999987

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7e-39  Score=283.63  Aligned_cols=203  Identities=22%  Similarity=0.276  Sum_probs=174.1

Q ss_pred             hhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhh--HHHHHHHHHHHhcCCCCCcceEE
Q 017177           84 LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSEVNFLGRLSHPNLVKLL  161 (376)
Q Consensus        84 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~h~nIv~l~  161 (376)
                      -....++|+.+..|++|+||.||+|         +++.+++.||+|+++.+....  .-.-+|||.+|.+++|||||.+.
T Consensus        71 gCrsv~efe~lnrI~EGtyGiVYRa---------kdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vk  141 (419)
T KOG0663|consen   71 GCRSVEEFEKLNRIEEGTYGVVYRA---------KDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVK  141 (419)
T ss_pred             CcccHHHHHHHhhcccCcceeEEEe---------ccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeE
Confidence            3445667999999999999999999         677789999999998765322  12347899999999999999999


Q ss_pred             eEEEeC--CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc
Q 017177          162 GYCWED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF  239 (376)
Q Consensus       162 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~  239 (376)
                      .+....  +.+|||||||+. +|..++....   .++...++..++.|+++|++|||  ++.|+||||||+|+|+++.|.
T Consensus       142 EVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH--~~wilHRDLK~SNLLm~~~G~  215 (419)
T KOG0663|consen  142 EVVVGSNMDKIYIVMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLH--DNWILHRDLKTSNLLLSHKGI  215 (419)
T ss_pred             EEEeccccceeeeeHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHh--hceeEecccchhheeeccCCc
Confidence            987654  579999999987 9999997763   67999999999999999999999  699999999999999999999


Q ss_pred             EEEcceeeeeeecccee-eEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          240 LFDSHLLIYVYFKRHYI-YIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~-~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      +|++|||+|+.+..+.. .+...-|..|.+                       ||++.|.+.++...|+||+|||+.|+.
T Consensus       216 lKiaDFGLAR~ygsp~k~~T~lVVTLWYRa-----------------------PELLLG~~tyst~iDMWSvGCI~aE~l  272 (419)
T KOG0663|consen  216 LKIADFGLAREYGSPLKPYTPLVVTLWYRA-----------------------PELLLGAKTYSTAVDMWSVGCIFAELL  272 (419)
T ss_pred             EEecccchhhhhcCCcccCcceEEEeeecC-----------------------HHHhcCCcccCcchhhhhHHHHHHHHH
Confidence            99999999999987733 444556666766                       999999999999999999999999998


Q ss_pred             cccccc
Q 017177          319 SFYRTT  324 (376)
Q Consensus       319 ~~y~~~  324 (376)
                      ..--+.
T Consensus       273 ~~kPlf  278 (419)
T KOG0663|consen  273 TQKPLF  278 (419)
T ss_pred             hcCCCC
Confidence            554433

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=298.16  Aligned_cols=195  Identities=23%  Similarity=0.277  Sum_probs=173.4

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      .+....|...+.||+|+.|.||.|         .+..+++.||||.+........+-+.+|+.+|+..+|+|||++++.|
T Consensus       269 ~dP~~~y~~~~kigqgaSG~vy~A---------~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sy  339 (550)
T KOG0578|consen  269 GDPRSKYTDFKKIGQGATGGVYVA---------RKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSY  339 (550)
T ss_pred             CChhhhhcchhhhccccccceeee---------eeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHh
Confidence            344567888899999999999999         55557889999999887666667788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      ...+.+|+||||++||+|.+.+...     .+++.++..|+++++.||+|||  .++|||||||.+|||++.+|.+||+|
T Consensus       340 lv~deLWVVMEym~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH--~~gIiHrDIKSDnILL~~~g~vKltD  412 (550)
T KOG0578|consen  340 LVGDELWVVMEYMEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLH--ARGIIHRDIKSDNILLTMDGSVKLTD  412 (550)
T ss_pred             cccceeEEEEeecCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHH--hcceeeeccccceeEeccCCcEEEee
Confidence            9999999999999999999998654     4899999999999999999999  69999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      ||++..+......   ..|.    +|||.||               |||++..+. +..+.||||||+++.||+
T Consensus       413 FGFcaqi~~~~~K---R~Tm----VGTPYWM---------------APEVvtrk~-YG~KVDIWSLGIMaIEMv  463 (550)
T KOG0578|consen  413 FGFCAQISEEQSK---RSTM----VGTPYWM---------------APEVVTRKP-YGPKVDIWSLGIMAIEMV  463 (550)
T ss_pred             eeeeeccccccCc---cccc----cCCCCcc---------------chhhhhhcc-cCccccchhhhhHHHHHh
Confidence            9999988765432   2334    9999999               999887665 489999999999999999

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=283.38  Aligned_cols=203  Identities=24%  Similarity=0.269  Sum_probs=167.6

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ..+|...+.||+|+||.||++...+         ++...|||.+........+.+.+|+.+|++++|||||+++|.....
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~---------~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~   86 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKK---------TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSR   86 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecC---------CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccc
Confidence            3468889999999999999995543         4889999999876443467789999999999999999999975444


Q ss_pred             C--eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC-CCcEEEcc
Q 017177          168 K--ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-VGFLFDSH  244 (376)
Q Consensus       168 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~-~g~~kl~D  244 (376)
                      .  .++|.|||+++|+|.+++.+..   ..+++..++.+.+||++||.|||  .++||||||||+|||++. +|.+||+|
T Consensus        87 ~~~~~~i~mEy~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylH--s~g~vH~DiK~~NiLl~~~~~~~KlaD  161 (313)
T KOG0198|consen   87 ENDEYNIFMEYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLH--SKGIVHCDIKPANILLDPSNGDVKLAD  161 (313)
T ss_pred             cCeeeEeeeeccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCEeccCcccceEEEeCCCCeEEecc
Confidence            4  6999999999999999998774   25999999999999999999999  599999999999999999 79999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ||+++...............    .|||.||               |||++.........+||||+||++.||++-..+
T Consensus       162 FG~a~~~~~~~~~~~~~~~~----~Gtp~~m---------------aPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~P  221 (313)
T KOG0198|consen  162 FGLAKKLESKGTKSDSELSV----QGTPNYM---------------APEVIRNGEVARRESDIWSLGCTVVEMLTGKPP  221 (313)
T ss_pred             Cccccccccccccccccccc----cCCcccc---------------CchhhcCCCcCCccchhhhcCCEEEeccCCCCc
Confidence            99999876411110111112    7889999               899888533334699999999999999986444

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-38  Score=296.65  Aligned_cols=201  Identities=27%  Similarity=0.326  Sum_probs=167.2

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..+.+++++.||+|.||.||.|.+++          ...||+|.++..... .+.|.+|+.+|++|+|+|||++++++..
T Consensus       204 ~r~~l~l~~~LG~G~FG~V~~g~~~~----------~~~vavk~ik~~~m~-~~~f~~Ea~iMk~L~H~~lV~l~gV~~~  272 (468)
T KOG0197|consen  204 PREELKLIRELGSGQFGEVWLGKWNG----------STKVAVKTIKEGSMS-PEAFLREAQIMKKLRHEKLVKLYGVCTK  272 (468)
T ss_pred             cHHHHHHHHHhcCCccceEEEEEEcC----------CCcccceEEeccccC-hhHHHHHHHHHHhCcccCeEEEEEEEec
Confidence            34456788999999999999999986          447999999876433 3678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++.+|||||||+.|+|.++|+...  ...+...+.+.++.|||+||+||+  .+++|||||.++||||++++.+||+|||
T Consensus       273 ~~piyIVtE~m~~GsLl~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLe--s~~~IHRDLAARNiLV~~~~~vKIsDFG  348 (468)
T KOG0197|consen  273 QEPIYIVTEYMPKGSLLDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLE--SKNYIHRDLAARNILVDEDLVVKISDFG  348 (468)
T ss_pred             CCceEEEEEecccCcHHHHhhhcC--CCccchHHHHHHHHHHHHHHHHHH--hCCccchhhhhhheeeccCceEEEcccc
Confidence            889999999999999999998733  366889999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      +|+...+........+.+ -+.                    |.|||.+.... ++.++||||||++++|++++-+..
T Consensus       349 LAr~~~d~~Y~~~~~~kf-PIk--------------------WtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~p  404 (468)
T KOG0197|consen  349 LARLIGDDEYTASEGGKF-PIK--------------------WTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVP  404 (468)
T ss_pred             cccccCCCceeecCCCCC-Cce--------------------ecCHHHHhhCC-cccccceeehhhhHHHHhccCCCC
Confidence            999655544432222221 111                    23699777554 699999999999999999774443

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.4e-38  Score=282.70  Aligned_cols=197  Identities=26%  Similarity=0.333  Sum_probs=166.4

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh--hHHHHHHHHHHHhcCCCCC-cceEEeEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFEEWQSEVNFLGRLSHPN-LVKLLGYC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~n-Iv~l~~~~  164 (376)
                      ...|+.++.||+|+||+||+|         +.+.+|+.||+|++..+...  ......+|+.+++.|+|+| |+++++++
T Consensus        10 ~~~~~~~eklGeGtyg~Vyka---------r~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~   80 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKA---------RSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVI   80 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEE---------EEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeee
Confidence            345777888999999999999         44557899999999876442  2345689999999999999 99999999


Q ss_pred             EeCC------eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          165 WEDK------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       165 ~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      ...+      .+++|+||++. +|.+++.........++...++.+++||+.||+|||  .++|+||||||+||||+++|
T Consensus        81 ~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H--~~~IlHRDLKPQNlLi~~~G  157 (323)
T KOG0594|consen   81 HTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH--SHGILHRDLKPQNLLISSSG  157 (323)
T ss_pred             eecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH--hCCeecccCCcceEEECCCC
Confidence            8877      79999999976 999999876532245777899999999999999999  59999999999999999999


Q ss_pred             cEEEcceeeeeeeccc-eeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhh
Q 017177          239 FLFDSHLLIYVYFKRH-YIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCV  317 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~-~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~  317 (376)
                      .+||+|||+|+.+.-+ ..++....|..|.+                       ||++.|...+....|+||+||+|+||
T Consensus       158 ~lKlaDFGlAra~~ip~~~yt~evvTlWYRa-----------------------PEvLlGs~~Ys~~vDiWs~GcIfaEm  214 (323)
T KOG0594|consen  158 VLKLADFGLARAFSIPMRTYTPEVVTLWYRA-----------------------PEVLLGSTSYSTSVDIWSLGCIFAEM  214 (323)
T ss_pred             cEeeeccchHHHhcCCcccccccEEEeeccC-----------------------HHHhcCCCcCCCCcchHhHHHHHHHH
Confidence            9999999999977633 33444445554544                       99999998999999999999999999


Q ss_pred             cc
Q 017177          318 FS  319 (376)
Q Consensus       318 ~~  319 (376)
                      ++
T Consensus       215 ~~  216 (323)
T KOG0594|consen  215 FT  216 (323)
T ss_pred             Hh
Confidence            94

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-37  Score=280.57  Aligned_cols=206  Identities=22%  Similarity=0.224  Sum_probs=177.2

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ..+.|++.++||.|.-+.||+|+..         .++..||||++..+.- .+.+.+++|+..|+.++||||++++..|.
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~---------p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv   94 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCI---------PTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV   94 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeec---------ccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence            4568999999999999999999554         3589999999987644 34688999999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      .+..+|+||.||.+|++.++++...+  ..+++..+..|.+++++||.|||  ++|.||||||+.||||+.+|.|||+||
T Consensus        95 v~~~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH--~~G~IHRdvKAgnILi~~dG~VkLadF  170 (516)
T KOG0582|consen   95 VDSELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLH--QNGHIHRDVKAGNILIDSDGTVKLADF  170 (516)
T ss_pred             ecceeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHH--hcCceecccccccEEEcCCCcEEEcCc
Confidence            99999999999999999999988765  44899999999999999999999  799999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEe-eeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHH-hhhhhccccccccceeeeehhhcccccc
Q 017177          246 LIYVYFKRHYIYIYIH-TYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIY-AWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~-~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~-~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |.+..+-......... .++    +|||.||               |||++ ....-++.|+||||||+...|++.---+
T Consensus       171 gvsa~l~~~G~R~~~rf~tf----vgtp~wm---------------APEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aP  231 (516)
T KOG0582|consen  171 GVSASLFDSGDRQVTRFNTF----VGTPCWM---------------APEVLMQQLHGYDFKADIWSFGITACELAHGHAP  231 (516)
T ss_pred             eeeeeecccCceeeEeeccc----cCccccc---------------ChHHhhhcccCccchhhhhhhhHHHHHHhcCCCC
Confidence            9998876655332222 333    9999999               99984 3445568999999999999999955444


Q ss_pred             c
Q 017177          324 T  324 (376)
Q Consensus       324 ~  324 (376)
                      .
T Consensus       232 f  232 (516)
T KOG0582|consen  232 F  232 (516)
T ss_pred             c
Confidence            3

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-37  Score=296.49  Aligned_cols=195  Identities=21%  Similarity=0.207  Sum_probs=173.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..-|++++.||.|+-|.|-+|         ++..||+.+|||++.+...   .....+.+|+.||+-+.||||+++|++|
T Consensus        11 iGpwkLgkTLG~Gstg~vrla---------kh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw   81 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLA---------KHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW   81 (786)
T ss_pred             ccceeccccccCCCCceehhh---------hcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee
Confidence            345899999999999999999         6666899999999987622   2345778999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      ++..++|+|.||++||.|++++.++    +++++.++.++++||+.|+.|+|  ..+|+||||||+|+|||.++++||+|
T Consensus        82 e~~~~lylvlEyv~gGELFdylv~k----G~l~e~eaa~ff~QIi~gv~yCH--~~~icHRDLKpENlLLd~~~nIKIAD  155 (786)
T KOG0588|consen   82 ENKQHLYLVLEYVPGGELFDYLVRK----GPLPEREAAHFFRQILDGVSYCH--AFNICHRDLKPENLLLDVKNNIKIAD  155 (786)
T ss_pred             ccCceEEEEEEecCCchhHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHh--hhcceeccCCchhhhhhcccCEeeec
Confidence            9999999999999999999999887    56999999999999999999999  69999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ||+|..-.........        +|+|.|.               +|||+.|..|...++||||-|+|++.+++-
T Consensus       156 FGMAsLe~~gklLeTS--------CGSPHYA---------------~PEIV~G~pYdG~~sDVWSCGVILfALLtG  208 (786)
T KOG0588|consen  156 FGMASLEVPGKLLETS--------CGSPHYA---------------APEIVSGRPYDGRPSDVWSCGVILFALLTG  208 (786)
T ss_pred             cceeecccCCcccccc--------CCCcccC---------------CchhhcCCCCCCCccccchhHHHHHHHHhC
Confidence            9999976655554444        5666666               699999999999999999999998877754

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.6e-36  Score=289.62  Aligned_cols=206  Identities=18%  Similarity=0.227  Sum_probs=169.1

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ++|++.+.||+|+||.||+|...         .+++.||+|+++...   ......+.+|+.++..++|+||+++++.+.
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~   71 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKK---------DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ   71 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            46899999999999999999543         468899999997542   223456788999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +...+|+||||+++|+|.+++.+.    ..+++..+..++.|++.||.|||  +++|+||||||+|||++.+|.+||+||
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH--~~givHrDlKp~NILi~~~~~vkL~DF  145 (363)
T cd05628          72 DKLNLYLIMEFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIH--QLGFIHRDIKPDNLLLDSKGHVKLSDF  145 (363)
T ss_pred             cCCeEEEEEcCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecCCCHHHeEECCCCCEEEeec
Confidence            999999999999999999999765    45899999999999999999999  699999999999999999999999999


Q ss_pred             eeeeeeccceeeEEE----------------------------eeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh
Q 017177          246 LIYVYFKRHYIYIYI----------------------------HTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW  297 (376)
Q Consensus       246 g~a~~~~~~~~~~~~----------------------------~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~  297 (376)
                      |+++...........                            .....+..+||+.|+               |||++.+
T Consensus       146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~---------------aPE~~~~  210 (363)
T cd05628         146 GLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYI---------------APEVFMQ  210 (363)
T ss_pred             cCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCcccc---------------CHHHHcC
Confidence            999865432110000                            000112236888888               8998877


Q ss_pred             hhhccccccccceeeeehhhccccccch
Q 017177          298 IKYLTLLKYSNSFAFVFSCVFSFYRTTM  325 (376)
Q Consensus       298 ~~~~~~~~dv~s~g~v~~~~~~~y~~~~  325 (376)
                      .. ++.++|+||+|++++++++-..+..
T Consensus       211 ~~-~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         211 TG-YNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             CC-CCCchhhhhhHHHHHHHHhCCCCCC
Confidence            65 4789999999999999997666553

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-37  Score=291.03  Aligned_cols=200  Identities=21%  Similarity=0.327  Sum_probs=166.2

Q ss_pred             hhhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcce
Q 017177           82 LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVK  159 (376)
Q Consensus        82 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~  159 (376)
                      .++.+..+...+++.||+|.||+||+|+|.+            .||||+++...  ....+.|++|+.++++-+|.||+-
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG------------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlL  452 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG------------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILL  452 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc------------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhhee
Confidence            4455566677889999999999999998876            39999998763  456789999999999999999999


Q ss_pred             EEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc
Q 017177          160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF  239 (376)
Q Consensus       160 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~  239 (376)
                      +.|++..++. .||+-+|+|-+|+.+|+...   .+|+....+.|++||++|+.|||  .++|||||||..|||+.+++.
T Consensus       453 FMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLH--AK~IIHrDLKSnNIFl~~~~k  526 (678)
T KOG0193|consen  453 FMGACMNPPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLH--AKNIIHRDLKSNNIFLHEDLK  526 (678)
T ss_pred             eehhhcCCce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhh--hhhhhhhhccccceEEccCCc
Confidence            9999988776 99999999999999997653   67899999999999999999999  699999999999999999999


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh--hhccccccccceeeeehhh
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI--KYLTLLKYSNSFAFVFSCV  317 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~--~~~~~~~dv~s~g~v~~~~  317 (376)
                      |||+|||++..-+.-...... ...    .|.-.||               |||++...  ..++..+|||+||+|+||+
T Consensus       527 VkIgDFGLatvk~~w~g~~q~-~qp----~gsilwm---------------APEvIRmqd~nPfS~qSDVYaFGiV~YEL  586 (678)
T KOG0193|consen  527 VKIGDFGLATVKTRWSGEQQL-EQP----HGSLLWM---------------APEVIRMQDDNPFSFQSDVYAFGIVWYEL  586 (678)
T ss_pred             EEEecccceeeeeeecccccc-CCC----ccchhhh---------------cHHHHhhcccCCCCcccchhhhhHHHHHH
Confidence            999999999865443111111 111    2333344               79998865  5567999999999999999


Q ss_pred             cc
Q 017177          318 FS  319 (376)
Q Consensus       318 ~~  319 (376)
                      .+
T Consensus       587 lt  588 (678)
T KOG0193|consen  587 LT  588 (678)
T ss_pred             Hh
Confidence            84

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.4e-37  Score=288.04  Aligned_cols=196  Identities=22%  Similarity=0.287  Sum_probs=168.3

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      .++|++.+.||+|+||.||+|...         .+++.||+|+++...   ....+.+.+|+.+++.++||||+++++++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   87 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHK---------GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF   87 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            467999999999999999999554         358899999987542   23346788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .+++..|+||||+++|+|.+++.+.    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.+|.+||+|
T Consensus        88 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~~~kl~D  161 (329)
T PTZ00263         88 QDENRVYFLLEFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLH--SKDIIYRDLKPENLLLDNKGHVKVTD  161 (329)
T ss_pred             EcCCEEEEEEcCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHEEECCCCCEEEee
Confidence            9999999999999999999999765    45889999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ||+++.......          ...||+.|+               |||++.+.. .+.++|+||+|++++++++-+.+.
T Consensus       162 fg~~~~~~~~~~----------~~~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf  215 (329)
T PTZ00263        162 FGFAKKVPDRTF----------TLCGTPEYL---------------APEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPF  215 (329)
T ss_pred             ccCceEcCCCcc----------eecCChhhc---------------CHHHHcCCC-CCCcceeechHHHHHHHHcCCCCC
Confidence            999987644221          126778888               899887765 478999999999999999765554

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-37  Score=287.73  Aligned_cols=200  Identities=22%  Similarity=0.255  Sum_probs=175.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      .++|..++++|+|+||.++++         +++..+..+++|.+.....  ...+...+|+.+++++.|||||.+.+.|.
T Consensus         3 m~~Ye~~~~iG~GafG~a~lv---------rhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~   73 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLV---------RHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE   73 (426)
T ss_pred             cchhhhhhhcCccccchhhhh---------hhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh
Confidence            357999999999999999998         5556688999999987643  34456789999999999999999999999


Q ss_pred             eCCe-EEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          166 EDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       166 ~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .++. ++|||+||+||+|.+.+.+.+  ...+++..+..++.|++.|+.|||  +++|+|||||+.|||++.++.++|+|
T Consensus        74 ~~~~~l~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH--~~~iLHRDlK~~Nifltk~~~VkLgD  149 (426)
T KOG0589|consen   74 EDGQLLCIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLH--ENRVLHRDLKCANIFLTKDKKVKLGD  149 (426)
T ss_pred             cCCceEEEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHH--hhhhhcccchhhhhhccccCceeecc
Confidence            9888 999999999999999998876  366999999999999999999999  69999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ||+|+.+.........   .    +|||.||               -||++.+..| ..++|+||+||+++|+++.-..
T Consensus       150 fGlaK~l~~~~~~a~t---v----vGTp~Ym---------------cPEil~d~pY-n~KSDiWsLGC~~yEm~~lk~a  205 (426)
T KOG0589|consen  150 FGLAKILNPEDSLAST---V----VGTPYYM---------------CPEILSDIPY-NEKSDIWSLGCCLYEMCTLKPA  205 (426)
T ss_pred             hhhhhhcCCchhhhhe---e----cCCCccc---------------CHHHhCCCCC-CccCcchhhcchHHHHHhcccc
Confidence            9999998776532222   2    8899999               6999998875 8999999999999999955333

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-36  Score=288.85  Aligned_cols=205  Identities=20%  Similarity=0.254  Sum_probs=168.3

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ++|++.+.||+|+||.||+|...         .+++.||||++....   ......+.+|+.+++.++||||+++++.+.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~   71 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKK---------DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ   71 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence            47899999999999999999544         358899999997542   233456788999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +++.+|+||||+++|+|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.+|.++|+||
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl~Df  145 (364)
T cd05599          72 DENYLYLIMEYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIH--KLGYIHRDIKPDNLLLDAKGHIKLSDF  145 (364)
T ss_pred             cCCeEEEEECCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEeec
Confidence            999999999999999999999765    45899999999999999999999  699999999999999999999999999


Q ss_pred             eeeeeeccceeeEEE-------------------------------eeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHH
Q 017177          246 LIYVYFKRHYIYIYI-------------------------------HTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRI  294 (376)
Q Consensus       246 g~a~~~~~~~~~~~~-------------------------------~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi  294 (376)
                      |++..+.........                               .....+..+||+.|+               |||+
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~---------------aPE~  210 (364)
T cd05599         146 GLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYI---------------APEV  210 (364)
T ss_pred             ccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCcccc---------------CHHH
Confidence            999865432111000                               000112236788888               8998


Q ss_pred             Hhhhhhccccccccceeeeehhhccccccc
Q 017177          295 YAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       295 ~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      +.+.. ++.++|+||+|++++++++.+.+.
T Consensus       211 ~~~~~-~~~~~DiwSlG~il~el~~G~~Pf  239 (364)
T cd05599         211 FLQTG-YNKECDWWSLGVIMYEMLVGYPPF  239 (364)
T ss_pred             HcCCC-CCCeeeeecchhHHHHhhcCCCCC
Confidence            76654 588999999999999999765554

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-37  Score=263.46  Aligned_cols=209  Identities=22%  Similarity=0.252  Sum_probs=175.4

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh---hHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ---GFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ..++|++++.||+|.||.||+|+         .+.++..||+|++.+....   ....+.+|++|...|+||||+++|++
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlar---------ekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~   90 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAR---------EKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY   90 (281)
T ss_pred             chhhccccccccCCccccEeEee---------eccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh
Confidence            45789999999999999999994         4446889999999876432   23578899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      |.+...+|+++||..+|+|+..|....  ...+++.....++.|++.||.|+|  .++||||||||+|+|++.+|.+|++
T Consensus        91 fhd~~riyLilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h--~k~VIhRdiKpenlLlg~~~~lkiA  166 (281)
T KOG0580|consen   91 FHDSKRIYLILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCH--LKRVIHRDIKPENLLLGSAGELKIA  166 (281)
T ss_pred             eeccceeEEEEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhc--cCCcccCCCCHHHhccCCCCCeecc
Confidence            999999999999999999999998543  256899999999999999999999  6999999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||.+.... .......+||..|.+                       ||++.+..+ +...|+|++|+..+|++.-+.+
T Consensus       167 dfGwsV~~p-~~kR~tlcgt~dyl~-----------------------pEmv~~~~h-d~~Vd~w~lgvl~yeflvg~pp  221 (281)
T KOG0580|consen  167 DFGWSVHAP-SNKRKTLCGTLDYLP-----------------------PEMVEGRGH-DKFVDLWSLGVLCYEFLVGLPP  221 (281)
T ss_pred             CCCceeecC-CCCceeeecccccCC-----------------------HhhcCCCCc-cchhhHHHHHHHHHHHHhcCCc
Confidence            999999765 344444555555555                       999998764 8899999999999998866666


Q ss_pred             chhhHHHHHH
Q 017177          324 TMLKYQILAW  333 (376)
Q Consensus       324 ~~~~~~~~~~  333 (376)
                      ..........
T Consensus       222 Fes~~~~etY  231 (281)
T KOG0580|consen  222 FESQSHSETY  231 (281)
T ss_pred             hhhhhhHHHH
Confidence            5433333333

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2e-37  Score=278.30  Aligned_cols=190  Identities=25%  Similarity=0.260  Sum_probs=160.0

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC-
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK-  168 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~-  168 (376)
                      .|.-.+++|.|+||.||+|....         ++..||||+.-.+..    --.+|+.+|+.++|||||++.-+|.... 
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e---------~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~   91 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRE---------TEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTE   91 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcC---------CCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence            46778999999999999997664         478899999876543    2246999999999999999998886532 


Q ss_pred             ----eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC-CcEEEc
Q 017177          169 ----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV-GFLFDS  243 (376)
Q Consensus       169 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~-g~~kl~  243 (376)
                          ...+||||++. +|.++++.....+..++...++-++.||++||.|||  ..+|+||||||.|+|+|.+ |.+|||
T Consensus        92 ~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh--~~~IcHRDIKPqNlLvD~~tg~LKic  168 (364)
T KOG0658|consen   92 SDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH--SHGICHRDIKPQNLLVDPDTGVLKIC  168 (364)
T ss_pred             CchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH--hcCcccCCCChheEEEcCCCCeEEec
Confidence                35689999977 999999865444467888999999999999999999  5999999999999999977 999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      |||.|+.+...........+..|.|                       ||++-|...++.+.||||.|||++|++
T Consensus       169 DFGSAK~L~~~epniSYicSRyYRa-----------------------PELifga~~Yt~~IDiWSaGCV~aELl  220 (364)
T KOG0658|consen  169 DFGSAKVLVKGEPNISYICSRYYRA-----------------------PELIFGATEYTTSIDIWSAGCVMAELL  220 (364)
T ss_pred             cCCcceeeccCCCceeEEEeccccC-----------------------HHHHcCccccCceeEEhhhhHHHHHHh
Confidence            9999999877655433333444555                       999999999999999999999999999

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-36  Score=286.76  Aligned_cols=205  Identities=20%  Similarity=0.228  Sum_probs=165.9

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ++|++.+.||+|+||.||+|...         .+++.||||++....   ....+.+.+|+.+++.++||||+++++++.
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~   71 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKK---------DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ   71 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEEC---------CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence            46899999999999999999543         468899999986542   233467788999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +++.+|+||||+++|+|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.+|.+||+||
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH--~~givHrDlkp~NIll~~~~~~kl~Df  145 (377)
T cd05629          72 DAQYLYLIMEFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVH--KLGFIHRDIKPDNILIDRGGHIKLSDF  145 (377)
T ss_pred             cCCeeEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEECCCCCEEEeec
Confidence            999999999999999999999765    45889999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEE----------------------------------------eeeEEEEEeeeeehhhhhcchhhHH
Q 017177          246 LIYVYFKRHYIYIYI----------------------------------------HTYIIYIYIYVYIYMYIYKCLRYAI  285 (376)
Q Consensus       246 g~a~~~~~~~~~~~~----------------------------------------~~~~~y~~~gt~~y~~~~~~~e~~d  285 (376)
                      |+++.+.........                                        .....+..+||+.|+          
T Consensus       146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~----------  215 (377)
T cd05629         146 GLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYI----------  215 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCcccc----------
Confidence            999743221100000                                        000001125777777          


Q ss_pred             HHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          286 LYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       286 ~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                           |||++.+.. ++.++|+||+|++++++++.+.+.
T Consensus       216 -----aPE~~~~~~-~~~~~DiwSlGvil~elltG~~Pf  248 (377)
T cd05629         216 -----APEIFLQQG-YGQECDWWSLGAIMFECLIGWPPF  248 (377)
T ss_pred             -----CHHHHccCC-CCCceeeEecchhhhhhhcCCCCC
Confidence                 899887655 578999999999999999765554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=8.9e-36  Score=284.88  Aligned_cols=202  Identities=19%  Similarity=0.148  Sum_probs=168.7

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEe
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLG  162 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~  162 (376)
                      ...++|++.+.||+|+||.||++...         .+++.||+|++.+..   ......+.+|+.+++.++||||+++++
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~  110 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHK---------SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC  110 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            34568999999999999999999544         358899999986532   223356778999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                      ++.+++.+|+||||+++|+|.+++...     .+++..+..++.||+.||.|||  .++|+||||||+|||++.+|.+||
T Consensus       111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH--~~~IvHrDLKp~NILl~~~~~~kL  183 (370)
T cd05621         111 AFQDDKYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIH--SMGLIHRDVKPDNMLLDKHGHLKL  183 (370)
T ss_pred             EEEcCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEECCCCCEEE
Confidence            999999999999999999999998643     3788999999999999999999  599999999999999999999999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhh---hccccccccceeeeehhhcc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIK---YLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~---~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +|||++.........  ...+    ..||+.||               |||++.+..   +.+.++|+||+|++++++++
T Consensus       184 ~DFG~a~~~~~~~~~--~~~~----~~gt~~Y~---------------aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~  242 (370)
T cd05621         184 ADFGTCMKMDETGMV--RCDT----AVGTPDYI---------------SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV  242 (370)
T ss_pred             EecccceecccCCce--eccc----CCCCcccC---------------CHHHHhccCCCCCCCcccCEEeehHHHHHHHh
Confidence            999999876543221  1111    26888888               899887653   46789999999999999996


Q ss_pred             ccccc
Q 017177          320 FYRTT  324 (376)
Q Consensus       320 ~y~~~  324 (376)
                      ...+.
T Consensus       243 G~~Pf  247 (370)
T cd05621         243 GDTPF  247 (370)
T ss_pred             CCCCC
Confidence            65554

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=9.2e-36  Score=286.14  Aligned_cols=204  Identities=19%  Similarity=0.164  Sum_probs=166.5

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .|++++.||+|+||+||+|...         .+++.||+|++....   ......+.+|+.+++.++||||+++++++.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~   72 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKV---------DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD   72 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence            5888999999999999999543         468899999997642   2345678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++.+|+||||+++|+|.+++.+.    ..+++..+..++.||+.||.|||  ..+|+||||||+|||++.+|.+||+|||
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH--~~givHrDlKp~Nili~~~~~~kL~DFG  146 (381)
T cd05626          73 KDNLYFVMDYIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVH--KMGFIHRDIKPDNILIDLDGHIKLTDFG  146 (381)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCcHHHEEECCCCCEEEeeCc
Confidence            99999999999999999999765    45889999999999999999999  6999999999999999999999999999


Q ss_pred             eeeeeccceeeEE----------------------------------------EeeeEEEEEeeeeehhhhhcchhhHHH
Q 017177          247 IYVYFKRHYIYIY----------------------------------------IHTYIIYIYIYVYIYMYIYKCLRYAIL  286 (376)
Q Consensus       247 ~a~~~~~~~~~~~----------------------------------------~~~~~~y~~~gt~~y~~~~~~~e~~d~  286 (376)
                      ++..+........                                        .........+||+.|+           
T Consensus       147 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~-----------  215 (381)
T cd05626         147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYI-----------  215 (381)
T ss_pred             CCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCcccc-----------
Confidence            9865421110000                                        0000111236788888           


Q ss_pred             HHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          287 YSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       287 ~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                          |||++.+.. ++.++||||+|++++++++-..+.
T Consensus       216 ----aPE~~~~~~-~~~~~DiwSlG~il~elltG~~Pf  248 (381)
T cd05626         216 ----APEVLLRKG-YTQLCDWWSVGVILFEMLVGQPPF  248 (381)
T ss_pred             ----CHHHHcCCC-CCCccceeehhhHHHHHHhCCCCC
Confidence                899887655 478999999999999999765554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.8e-35  Score=277.85  Aligned_cols=191  Identities=24%  Similarity=0.213  Sum_probs=160.0

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELL  171 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~  171 (376)
                      +.||+|+||.||+|...         .+++.||+|+++...   ......+.+|+.+++.++||||+++++++..++.+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   71 (323)
T cd05571           1 KLLGKGTFGKVILVREK---------ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC   71 (323)
T ss_pred             CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence            47999999999999543         358899999987542   233456788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeee
Q 017177          172 LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYF  251 (376)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~  251 (376)
                      +||||+++|+|.+++...    ..+++..+..++.||+.||+|||  .++|+||||||+|||++.+|.+||+|||+++..
T Consensus        72 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH--~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~  145 (323)
T cd05571          72 FVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALGYLH--SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             EEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence            999999999999998765    45899999999999999999999  599999999999999999999999999998754


Q ss_pred             ccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          252 KRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       252 ~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ......   ..    ...||+.|+               |||++.+.. ++.++|+||+|++++++++...+
T Consensus       146 ~~~~~~---~~----~~~gt~~y~---------------aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P  194 (323)
T cd05571         146 ISDGAT---MK----TFCGTPEYL---------------APEVLEDND-YGRAVDWWGLGVVMYEMMCGRLP  194 (323)
T ss_pred             ccCCCc---cc----ceecCcccc---------------ChhhhcCCC-CCccccCcccchhhhhhhcCCCC
Confidence            322111   01    126888888               899887654 47899999999999999965443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.7e-35  Score=283.86  Aligned_cols=205  Identities=19%  Similarity=0.170  Sum_probs=164.9

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ++|++++.||+|+||.||+|...         .+++.||+|++.....   .....+.+|+.+++.++||||+++++.+.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~   71 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKV---------DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ   71 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEEC---------CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence            36899999999999999999543         3588999999875422   23456789999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +++.+|+|||||++|+|.+++.+.    ..+++..+..++.||+.||+|||  .++|+||||||+|||++.++.+||+||
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nill~~~~~ikL~DF  145 (376)
T cd05598          72 DKDNLYFVMDYIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILIDRDGHIKLTDF  145 (376)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHEEECCCCCEEEEeC
Confidence            999999999999999999999765    45889999999999999999999  699999999999999999999999999


Q ss_pred             eeeeeeccceeeEE------------------------------------EeeeEEEEEeeeeehhhhhcchhhHHHHHH
Q 017177          246 LIYVYFKRHYIYIY------------------------------------IHTYIIYIYIYVYIYMYIYKCLRYAILYSV  289 (376)
Q Consensus       246 g~a~~~~~~~~~~~------------------------------------~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~  289 (376)
                      |++..+........                                    .........+||+.||              
T Consensus       146 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~--------------  211 (376)
T cd05598         146 GLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYI--------------  211 (376)
T ss_pred             CCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCcccc--------------
Confidence            99864321100000                                    0000001126777777              


Q ss_pred             HHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          290 LLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       290 ~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                       |||++.+.. .+.++||||+|++++++++-..+.
T Consensus       212 -aPE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf  244 (376)
T cd05598         212 -APEVLLRTG-YTQLCDWWSVGVILYEMLVGQPPF  244 (376)
T ss_pred             -CHHHHcCCC-CCcceeeeeccceeeehhhCCCCC
Confidence             899887655 478999999999999998655443

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=279.20  Aligned_cols=195  Identities=22%  Similarity=0.221  Sum_probs=166.9

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ++|++.+.||+|+||.||+|...         .+++.||+|+++....   ...+.+.+|+.++..++||||+++++++.
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~   71 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKK---------DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ   71 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence            36899999999999999999554         3588999999875422   33467789999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      .++..|+||||+++|+|.+++...    ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+||
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kL~Df  145 (333)
T cd05600          72 DDEYLYLAMEYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALH--ELGYIHRDLKPENFLIDASGHIKLTDF  145 (333)
T ss_pred             cCCEEEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCCEEEEeC
Confidence            999999999999999999999765    45889999999999999999999  699999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      |++.......      .+    ..||+.|+               +||++.+. ..+.++||||+|++++++++-..+.
T Consensus       146 g~a~~~~~~~------~~----~~gt~~y~---------------aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf  198 (333)
T cd05600         146 GLSKGIVTYA------NS----VVGSPDYM---------------APEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPF  198 (333)
T ss_pred             cCCccccccc------CC----cccCcccc---------------ChhHhcCC-CCCCccceecchHHHhhhhhCCCCC
Confidence            9998764411      11    16777888               79988876 4578999999999999998765554

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2e-35  Score=279.38  Aligned_cols=198  Identities=22%  Similarity=0.252  Sum_probs=167.2

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ..++|++.+.||+|+||.||+|.+...        .+..||+|.+....   ....+.+.+|+.+++.++||||++++++
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~   99 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNE--------DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGS   99 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECC--------CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEE
Confidence            346799999999999999999965431        24689999986432   2334677899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +.+.+.+|+||||+++|+|.+++.+.    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.+|.+||+
T Consensus       100 ~~~~~~~~lv~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~ikL~  173 (340)
T PTZ00426        100 FKDESYLYLVLEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQ--SLNIVYRDLKPENLLLDKDGFIKMT  173 (340)
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEccCCCHHHEEECCCCCEEEe
Confidence            99999999999999999999999765    45899999999999999999999  5999999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||++.......          +...||+.||               |||++.+.. .+.++|+||+|++++++++-..+
T Consensus       174 DFG~a~~~~~~~----------~~~~gt~~y~---------------aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~P  227 (340)
T PTZ00426        174 DFGFAKVVDTRT----------YTLCGTPEYI---------------APEILLNVG-HGKAADWWTLGIFIYEILVGCPP  227 (340)
T ss_pred             cCCCCeecCCCc----------ceecCChhhc---------------CHHHHhCCC-CCccccccchhhHHHHHhcCCCC
Confidence            999998764321          1126788888               899887654 47899999999999999865544


Q ss_pred             c
Q 017177          324 T  324 (376)
Q Consensus       324 ~  324 (376)
                      .
T Consensus       228 f  228 (340)
T PTZ00426        228 F  228 (340)
T ss_pred             C
Confidence            4

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-35  Score=268.99  Aligned_cols=217  Identities=20%  Similarity=0.171  Sum_probs=169.3

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh---hHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ---GFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ..+.|++++.||.|.-|.||+|+..+         ++..+|+|++.++...   ...+.+.|-+||+.++||.++.+|..
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~---------t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~  145 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRG---------TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS  145 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecC---------CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe
Confidence            34568899999999999999996554         5789999999987543   34577789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      |+.++..|++||||+||+|..+++++.  ...+++..++.++.+++.||+|||  -.|||.||||||||||.++|++-|+
T Consensus       146 fet~~~~cl~meyCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLH--mlGivYRDLKPENILvredGHIMLs  221 (459)
T KOG0610|consen  146 FETDKYSCLVMEYCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLH--MLGIVYRDLKPENILVREDGHIMLS  221 (459)
T ss_pred             eeccceeEEEEecCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHH--hhceeeccCCcceeEEecCCcEEee
Confidence            999999999999999999999887764  477999999999999999999999  5999999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEE-----------eeeEEEEEeeeeehhhh--------------------hcchhhHHHH----H
Q 017177          244 HLLIYVYFKRHYIYIYI-----------HTYIIYIYIYVYIYMYI--------------------YKCLRYAILY----S  288 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~-----------~~~~~y~~~gt~~y~~~--------------------~~~~e~~d~~----s  288 (376)
                      ||.++............           +.+. -..+-+|.....                    ....+++..|    .
T Consensus       222 DFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~-~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE  300 (459)
T KOG0610|consen  222 DFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSR-QPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE  300 (459)
T ss_pred             eccccccCCCCCeeeccCCCCCCCCCcccccc-cccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence            99998866332111000           0000 000011111101                    0111223333    2


Q ss_pred             HHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          289 VLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       289 ~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      |+||||+.|.+ .+.+.|+|+||++++||+
T Consensus       301 YlAPEvI~G~G-HgsAVDWWtfGIflYEmL  329 (459)
T KOG0610|consen  301 YLAPEVIRGEG-HGSAVDWWTFGIFLYEML  329 (459)
T ss_pred             cccceeeecCC-CCchhhHHHHHHHHHHHH
Confidence            77999999887 589999999999999998

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.7e-35  Score=282.26  Aligned_cols=206  Identities=19%  Similarity=0.243  Sum_probs=169.0

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ++|++.+.||+|+||.||+|...         .+++.||+|+++...   ......+.+|+.++..++||||+++++.+.
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   71 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKK---------DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ   71 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            36889999999999999999544         358899999987532   233467788999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +++.+|+||||+++|+|.+++.+.    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.+|.++|+||
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH--~~givHrDLkp~NIli~~~~~vkL~Df  145 (360)
T cd05627          72 DKRNLYLIMEFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIH--QLGFIHRDIKPDNLLLDAKGHVKLSDF  145 (360)
T ss_pred             cCCEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEccCCCHHHEEECCCCCEEEeec
Confidence            999999999999999999999765    45899999999999999999999  699999999999999999999999999


Q ss_pred             eeeeeeccceeeEE----------------------------EeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh
Q 017177          246 LIYVYFKRHYIYIY----------------------------IHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW  297 (376)
Q Consensus       246 g~a~~~~~~~~~~~----------------------------~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~  297 (376)
                      |++...........                            ......+..+||+.|+               |||++.+
T Consensus       146 G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~---------------APE~~~~  210 (360)
T cd05627         146 GLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYI---------------APEVFMQ  210 (360)
T ss_pred             cCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCcccc---------------CHHHHcC
Confidence            99886533211000                            0001112336888888               8998877


Q ss_pred             hhhccccccccceeeeehhhccccccch
Q 017177          298 IKYLTLLKYSNSFAFVFSCVFSFYRTTM  325 (376)
Q Consensus       298 ~~~~~~~~dv~s~g~v~~~~~~~y~~~~  325 (376)
                      .. ++.++|+||+|++++++++-+.+..
T Consensus       211 ~~-~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         211 TG-YNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             CC-CCCcceeccccceeeecccCCCCCC
Confidence            65 4789999999999999997766653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-36  Score=270.38  Aligned_cols=205  Identities=22%  Similarity=0.252  Sum_probs=166.5

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCC--CChhhHHHHHHHHHHHhcCCCCCcceEEe
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP--ESMQGFEEWQSEVNFLGRLSHPNLVKLLG  162 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~l~~  162 (376)
                      -.....|...+.||+|+||.|..+.         ++.++..||||++..  ......++..||+++|+.++|+||+.+.+
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~---------~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~d   88 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAK---------DKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLD   88 (359)
T ss_pred             EeccceecccccccCcceeeEEEEE---------EcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEe
Confidence            3455677778999999999999994         444789999999983  34455678899999999999999999999


Q ss_pred             EEEe-----CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC
Q 017177          163 YCWE-----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV  237 (376)
Q Consensus       163 ~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~  237 (376)
                      ++..     -+.+|+|+|+|+ -+|.+.++..    ..++...+..++.|+++||+|+||  .+|+||||||.|+|++.+
T Consensus        89 i~~p~~~~~f~DvYiV~elMe-tDL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHS--AnViHRDLKPsNll~n~~  161 (359)
T KOG0660|consen   89 IFRPPSRDKFNDVYLVFELME-TDLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHS--ANVIHRDLKPSNLLLNAD  161 (359)
T ss_pred             ecccccccccceeEEehhHHh-hHHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhc--ccccccccchhheeeccC
Confidence            9876     246999999994 4999999776    448999999999999999999995  999999999999999999


Q ss_pred             CcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhh
Q 017177          238 GFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCV  317 (376)
Q Consensus       238 g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~  317 (376)
                      +.+||+|||+|+............+   |  +-|-.|-               ||||+.....++.+.||||.||+|+|+
T Consensus       162 c~lKI~DFGLAR~~~~~~~~~~mTe---Y--VaTRWYR---------------APElll~~~~Yt~aiDiWSvGCI~AEm  221 (359)
T KOG0660|consen  162 CDLKICDFGLARYLDKFFEDGFMTE---Y--VATRWYR---------------APELLLNSSEYTKAIDIWSVGCILAEM  221 (359)
T ss_pred             CCEEeccccceeeccccCcccchhc---c--eeeeeec---------------CHHHHhccccccchhhhhhhhHHHHHH
Confidence            9999999999998864311111111   1  2233333               599887777779999999999999999


Q ss_pred             ccccccch
Q 017177          318 FSFYRTTM  325 (376)
Q Consensus       318 ~~~y~~~~  325 (376)
                      ++---+..
T Consensus       222 L~gkplFp  229 (359)
T KOG0660|consen  222 LTGKPLFP  229 (359)
T ss_pred             HcCCCCCC
Confidence            96555543

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.6e-35  Score=284.53  Aligned_cols=204  Identities=19%  Similarity=0.175  Sum_probs=165.6

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .|+.++.||+|+||.||+|...         .+++.||+|++....   ......+.+|+.+++.++||||+++++.+.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~   72 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKV---------DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD   72 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEEC---------CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence            5888999999999999999543         468899999987542   2334678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++.+|+|||||++|+|.+++.+.    ..+++..+..++.||+.||+|||  .++|+||||||+|||++.+|.+||+|||
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH--~~~ivHrDlKp~NILl~~~g~~kL~DFG  146 (382)
T cd05625          73 KDNLYFVMDYIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFG  146 (382)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEEeECC
Confidence            99999999999999999999765    45889999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEE----------------------------------------EeeeEEEEEeeeeehhhhhcchhhHHH
Q 017177          247 IYVYFKRHYIYIY----------------------------------------IHTYIIYIYIYVYIYMYIYKCLRYAIL  286 (376)
Q Consensus       247 ~a~~~~~~~~~~~----------------------------------------~~~~~~y~~~gt~~y~~~~~~~e~~d~  286 (376)
                      ++..+........                                        .........+||+.|+           
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~-----------  215 (382)
T cd05625         147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYI-----------  215 (382)
T ss_pred             CCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccC-----------
Confidence            9864321100000                                        0000011226777787           


Q ss_pred             HHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          287 YSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       287 ~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                          |||++.+.. ++.++|+||+|++++++++-..+.
T Consensus       216 ----aPE~~~~~~-~~~~~DiwSlGvil~elltG~~Pf  248 (382)
T cd05625         216 ----APEVLLRTG-YTQLCDWWSVGVILYEMLVGQPPF  248 (382)
T ss_pred             ----CHHHhcCCC-CCCeeeEEechHHHHHHHhCCCCC
Confidence                899887765 478999999999999999765554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.9e-35  Score=274.17  Aligned_cols=193  Identities=24%  Similarity=0.217  Sum_probs=160.1

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELL  171 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~  171 (376)
                      +.||+|+||.||++...         .++..||+|+++...   ......+.+|+.+++.++||||+++++++..++.+|
T Consensus         1 ~~lG~G~~g~V~~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~   71 (325)
T cd05594           1 KLLGKGTFGKVILVKEK---------ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC   71 (325)
T ss_pred             CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence            46999999999999543         368899999997642   233456778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeee
Q 017177          172 LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYF  251 (376)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~  251 (376)
                      +||||+++|+|..++.+.    ..+++..+..++.||+.||.|||+ .++|+||||||+|||++.+|.+||+|||+++..
T Consensus        72 lv~E~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~-~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~  146 (325)
T cd05594          72 FVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG  146 (325)
T ss_pred             EEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh-cCCEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence            999999999999988665    458999999999999999999994 379999999999999999999999999998864


Q ss_pred             ccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          252 KRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       252 ~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      .......   .+    ..||+.|+               |||++.+.. .+.++|+||+|++++++++-..+.
T Consensus       147 ~~~~~~~---~~----~~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf  196 (325)
T cd05594         147 IKDGATM---KT----FCGTPEYL---------------APEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPF  196 (325)
T ss_pred             CCCCccc---cc----ccCCcccC---------------CHHHHccCC-CCCccccccccceeeeeccCCCCC
Confidence            3222111   11    15778888               899887654 478999999999999999755443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.7e-35  Score=275.80  Aligned_cols=201  Identities=18%  Similarity=0.173  Sum_probs=168.4

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ++|++.+.||+|+||.||+|...         .+++.||+|+++....   ...+.+.+|+.+++.++|+||+++++++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~   71 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREK---------ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ   71 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence            46899999999999999999543         3588999999986432   23456788999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +.+..|+||||+++|+|.+++.+..   ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.+|.+||+||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH--~~~i~H~Dlkp~NIll~~~~~~kL~Df  146 (330)
T cd05601          72 DKDNLYLVMEYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVH--QMGYVHRDIKPENVLIDRTGHIKLADF  146 (330)
T ss_pred             cCCeEEEEECCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeEcccCchHheEECCCCCEEeccC
Confidence            9999999999999999999997652   45899999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh-----hhhccccccccceeeeehhhccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW-----IKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~-----~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      |++..........      .....||+.|+               |||++..     ....+.++||||+|++++++++-
T Consensus       147 g~a~~~~~~~~~~------~~~~~gt~~y~---------------aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g  205 (330)
T cd05601         147 GSAARLTANKMVN------SKLPVGTPDYI---------------APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYG  205 (330)
T ss_pred             CCCeECCCCCcee------eecccCCcccc---------------CHHHhccccccccCCCCCcceeecccceeeeeccC
Confidence            9998765433221      11126778888               7998874     34567899999999999999876


Q ss_pred             cccc
Q 017177          321 YRTT  324 (376)
Q Consensus       321 y~~~  324 (376)
                      ..+.
T Consensus       206 ~~Pf  209 (330)
T cd05601         206 RSPF  209 (330)
T ss_pred             CCCC
Confidence            5544

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-35  Score=276.28  Aligned_cols=201  Identities=18%  Similarity=0.121  Sum_probs=167.4

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ++|++.+.||+|+||.||++...         .+++.||+|++.+..   ....+.+.+|+.++..++|+||+++++++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMK---------NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ   71 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence            46899999999999999999544         358899999987532   223456788999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +++.+|+||||+++|+|.+++.+..   ..+++..+..++.||+.||+|||  +++|+||||||+|||++.+|.+||+||
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Df  146 (331)
T cd05597          72 DENNLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVH--QLGYVHRDIKPDNVLLDKNGHIRLADF  146 (331)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCeEECCCCHHHEEECCCCCEEEEEC
Confidence            9999999999999999999997642   45899999999999999999999  699999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh----hhhccccccccceeeeehhhcccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW----IKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~----~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |++...........      ....||+.||               +||++..    ....+.++|+||+|++++++++-.
T Consensus       147 g~~~~~~~~~~~~~------~~~~gt~~y~---------------aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~  205 (331)
T cd05597         147 GSCLRLLADGTVQS------NVAVGTPDYI---------------SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE  205 (331)
T ss_pred             CceeecCCCCCccc------cceecccccc---------------CHHHHhhccccccCCCCcceeehhhhHHHHHhhCC
Confidence            99987654322111      1126788888               8998874    345678999999999999999765


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      .+.
T Consensus       206 ~Pf  208 (331)
T cd05597         206 TPF  208 (331)
T ss_pred             CCC
Confidence            554

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3e-35  Score=277.40  Aligned_cols=201  Identities=24%  Similarity=0.259  Sum_probs=167.2

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC----hhhHHHHHHHHHHHhcCC-CCCcceEEeEE
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES----MQGFEEWQSEVNFLGRLS-HPNLVKLLGYC  164 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~-h~nIv~l~~~~  164 (376)
                      +|++.+.||+|+||.||+++...      ...++..||+|++....    ....+.+.+|+.+++.++ |+||+++++++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~   74 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVT------GHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF   74 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcc------cCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence            48889999999999999986542      23358899999987532    123456788999999995 99999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      ..++.+++||||+++|+|.+++.+.    ..+++..+..++.||+.||.|||  +++|+||||||+|||++.+|.+||+|
T Consensus        75 ~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~ivHrDlkp~Nili~~~~~~kl~D  148 (332)
T cd05614          75 QTEAKLHLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLH--KLGIVYRDIKLENILLDSEGHVVLTD  148 (332)
T ss_pred             ecCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCHHHeEECCCCCEEEee
Confidence            9999999999999999999999765    45899999999999999999999  69999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ||+++.........      .+...||+.||               |||++.+....+.++||||+|++++++++...+
T Consensus       149 fG~~~~~~~~~~~~------~~~~~gt~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~elltg~~p  206 (332)
T cd05614         149 FGLSKEFLSEEKER------TYSFCGTIEYM---------------APEIIRGKGGHGKAVDWWSLGILIFELLTGASP  206 (332)
T ss_pred             CcCCccccccCCCc------cccccCCcccc---------------CHHHhcCCCCCCCccccccchhhhhhhhcCCCC
Confidence            99998654322211      11126778888               899988777678899999999999999875544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=275.32  Aligned_cols=195  Identities=21%  Similarity=0.215  Sum_probs=166.4

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ++|++.+.||+|+||.||+|...         .+++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   71 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDR---------ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH   71 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEc---------CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence            46899999999999999999544         3588999999875422   33456789999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +++.+|+||||+++|+|.+++...    ..+++..+..++.|++.||+|||  .++|+||||||+|||++.+|.+||+||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~NIli~~~~~~kl~Df  145 (291)
T cd05612          72 DQRFLYMLMEYVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLH--SKEIVYRDLKPENILLDKEGHIKLTDF  145 (291)
T ss_pred             cCCeEEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEEEec
Confidence            999999999999999999999765    45889999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      |+++.......          ...||+.|+               |||++.+.. .+.++||||+|++++++++...+.
T Consensus       146 g~~~~~~~~~~----------~~~gt~~y~---------------aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf  198 (291)
T cd05612         146 GFAKKLRDRTW----------TLCGTPEYL---------------APEVIQSKG-HNKAVDWWALGILIYEMLVGYPPF  198 (291)
T ss_pred             CcchhccCCcc----------cccCChhhc---------------CHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            99987643211          115777777               899887665 478999999999999999765554

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.1e-35  Score=282.52  Aligned_cols=201  Identities=19%  Similarity=0.142  Sum_probs=167.0

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ..++|++.+.||+|+||.||+|...         .++..||+|++....   ......+.+|+.+++.++||||++++++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~  111 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHK---------SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYA  111 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            3567999999999999999999544         368899999986532   1233457789999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +.+++.+|+||||+++|+|.+++...     .+++..+..++.|++.||.|||  .++|+||||||+|||++.+|.+||+
T Consensus       112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~~kL~  184 (370)
T cd05596         112 FQDDKYLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKLA  184 (370)
T ss_pred             EecCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEcCCCCEEEE
Confidence            99999999999999999999988643     3788999999999999999999  5999999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh---hhccccccccceeeeehhhccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI---KYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~---~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      |||++..........  ..    ...||+.||               |||++.+.   .+.+.++|+||+|++++++++.
T Consensus       185 DfG~~~~~~~~~~~~--~~----~~~gt~~y~---------------aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG  243 (370)
T cd05596         185 DFGTCMKMDANGMVR--CD----TAVGTPDYI---------------SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG  243 (370)
T ss_pred             eccceeeccCCCccc--CC----CCCCCcCeE---------------CHHHhccCCCCCCCCCceeeeehhHHHHHHHhC
Confidence            999998765432211  01    126788888               89988754   3468899999999999999976


Q ss_pred             cccc
Q 017177          321 YRTT  324 (376)
Q Consensus       321 y~~~  324 (376)
                      ..+.
T Consensus       244 ~~Pf  247 (370)
T cd05596         244 DTPF  247 (370)
T ss_pred             CCCc
Confidence            5554

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=8.5e-35  Score=274.22  Aligned_cols=201  Identities=18%  Similarity=0.116  Sum_probs=167.2

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ++|++.+.||+|+||.||+++..         .+++.||+|.+....   ......+.+|+.++..++|+||+++++++.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~   71 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMK---------HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ   71 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            47899999999999999999544         358899999987532   223355778999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +++..|+||||+++|+|.+++.+..   ..+++..+..++.|++.||+|||  .++|+||||||+|||++.+|.+||+||
T Consensus        72 ~~~~~~lv~Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH--~~~iiHrDlkp~Nill~~~~~~kl~Df  146 (331)
T cd05624          72 DENYLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIH--QLHYVHRDIKPDNVLLDMNGHIRLADF  146 (331)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCchHHEEEcCCCCEEEEec
Confidence            9999999999999999999997642   45889999999999999999999  699999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh----hhccccccccceeeeehhhcccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI----KYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~----~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |++...........  .    ...||+.|+               |||++.+.    ...+.++|+||+|++++++++-.
T Consensus       147 G~a~~~~~~~~~~~--~----~~~gt~~y~---------------aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~  205 (331)
T cd05624         147 GSCLKMNQDGTVQS--S----VAVGTPDYI---------------SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE  205 (331)
T ss_pred             cceeeccCCCceee--c----cccCCcccC---------------CHHHHhccccCCCCCCCcccEEeeehhhhhhhhCC
Confidence            99987654332211  1    126788888               89988753    34578899999999999999765


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      .+.
T Consensus       206 ~Pf  208 (331)
T cd05624         206 TPF  208 (331)
T ss_pred             CCc
Confidence            544

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=278.26  Aligned_cols=190  Identities=21%  Similarity=0.200  Sum_probs=159.4

Q ss_pred             EeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC---ChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEE
Q 017177           97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        97 lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv  173 (376)
                      ||+|+||.||+|...         .+++.||+|+++..   .......+.+|+.+++.++||||+++++++..++..|+|
T Consensus         1 lg~G~~g~Vy~~~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   71 (312)
T cd05585           1 IGKGSFGKVMQVRKR---------DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV   71 (312)
T ss_pred             CCcCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence            699999999999554         35889999998753   223446778899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      |||+++|+|.+++.+.    ..+++..+..++.|++.||.|||  +++|+||||||+|||++.+|.+||+|||+++....
T Consensus        72 ~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~  145 (312)
T cd05585          72 LAFINGGELFHHLQRE----GRFDLSRARFYTAELLCALENLH--KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK  145 (312)
T ss_pred             EcCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence            9999999999999765    45899999999999999999999  69999999999999999999999999999986432


Q ss_pred             ceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          254 HYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       254 ~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ....   ..+    ..||+.|+               |||++.+.. ++.++||||+|++++++++-..+.
T Consensus       146 ~~~~---~~~----~~gt~~y~---------------aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf  193 (312)
T cd05585         146 DDDK---TNT----FCGTPEYL---------------APELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPF  193 (312)
T ss_pred             CCCc---ccc----ccCCcccC---------------CHHHHcCCC-CCCccceechhHHHHHHHhCCCCc
Confidence            2211   111    16778888               899887755 588899999999999999665553

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.5e-35  Score=280.22  Aligned_cols=204  Identities=19%  Similarity=0.161  Sum_probs=169.1

Q ss_pred             hhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceE
Q 017177           84 LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKL  160 (376)
Q Consensus        84 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l  160 (376)
                      .....++|++.+.||+|+||.||+|...         .+++.||+|++....   ......+.+|+.+++.++||||+++
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~  108 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHK---------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL  108 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEEC---------CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            3445578999999999999999999544         468899999986432   2233567789999999999999999


Q ss_pred             EeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcE
Q 017177          161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL  240 (376)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~  240 (376)
                      ++.+.+++.+|+||||+++|+|.+++...     .+++..+..++.||+.||.|||  .++|+||||||+|||++.+|.+
T Consensus       109 ~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NIll~~~~~i  181 (371)
T cd05622         109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHL  181 (371)
T ss_pred             EEEEEcCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHEEECCCCCE
Confidence            99999999999999999999999998643     3788999999999999999999  5999999999999999999999


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhh---hccccccccceeeeehhh
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIK---YLTLLKYSNSFAFVFSCV  317 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~---~~~~~~dv~s~g~v~~~~  317 (376)
                      ||+|||+++.........  ..+    ..||+.||               |||++.+..   .++.++|+||+|++++++
T Consensus       182 kL~DfG~a~~~~~~~~~~--~~~----~~gt~~y~---------------aPE~l~~~~~~~~~~~~~DiwSlGvilyel  240 (371)
T cd05622         182 KLADFGTCMKMNKEGMVR--CDT----AVGTPDYI---------------SPEVLKSQGGDGYYGRECDWWSVGVFLYEM  240 (371)
T ss_pred             EEEeCCceeEcCcCCccc--ccC----cccCcccc---------------CHHHHhccCCCccCCCccceeehhHHHHHH
Confidence            999999998765432211  111    26888888               899887643   467899999999999999


Q ss_pred             ccccccc
Q 017177          318 FSFYRTT  324 (376)
Q Consensus       318 ~~~y~~~  324 (376)
                      ++...+.
T Consensus       241 l~G~~Pf  247 (371)
T cd05622         241 LVGDTPF  247 (371)
T ss_pred             HhCCCCC
Confidence            9655444

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.8e-35  Score=275.03  Aligned_cols=192  Identities=23%  Similarity=0.212  Sum_probs=160.5

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELL  171 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~  171 (376)
                      +.||+|+||.||++...         .+++.||+|++....   ......+.+|+.+++.++||||+++++.+..++.+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   71 (328)
T cd05593           1 KLLGKGTFGKVILVREK---------ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC   71 (328)
T ss_pred             CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence            46999999999999543         358899999997642   234467789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeee
Q 017177          172 LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYF  251 (376)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~  251 (376)
                      +||||+++|+|.+++...    ..+++..+..++.||+.||+|||  .++|+||||||+|||++.+|.+||+|||+++..
T Consensus        72 lv~Ey~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~  145 (328)
T cd05593          72 FVMEYVNGGELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLH--SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (328)
T ss_pred             EEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecccCHHHeEECCCCcEEEecCcCCccC
Confidence            999999999999988665    45899999999999999999999  599999999999999999999999999998864


Q ss_pred             ccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          252 KRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       252 ~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ......   ..    ...||+.|+               |||++.+.. .+.++|+||+|++++++++...+.
T Consensus       146 ~~~~~~---~~----~~~gt~~y~---------------aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf  195 (328)
T cd05593         146 ITDAAT---MK----TFCGTPEYL---------------APEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPF  195 (328)
T ss_pred             CCcccc---cc----cccCCcCcc---------------ChhhhcCCC-CCccCCccccchHHHHHhhCCCCC
Confidence            322111   01    126778888               899887654 488999999999999999755443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.5e-35  Score=275.94  Aligned_cols=192  Identities=22%  Similarity=0.195  Sum_probs=159.9

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELL  171 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~  171 (376)
                      +.||+|+||.||++...         .++..||+|+++...   ......+.+|+.+++.++||||+++++++...+.+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~   71 (323)
T cd05595           1 KLLGKGTFGKVILVREK---------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   71 (323)
T ss_pred             CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence            47999999999999543         358899999987642   233456778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeee
Q 017177          172 LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYF  251 (376)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~  251 (376)
                      +||||+++|+|..++.+.    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.++.+||+|||++...
T Consensus        72 lv~E~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  145 (323)
T cd05595          72 FVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             EEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence            999999999999888765    45899999999999999999999  599999999999999999999999999998754


Q ss_pred             ccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          252 KRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       252 ~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ......   ...    ..||+.|+               |||++.+.. .+.++|+||+|++++++++-..+.
T Consensus       146 ~~~~~~---~~~----~~gt~~y~---------------aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf  195 (323)
T cd05595         146 ISDGAT---MKT----FCGTPEYL---------------APEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPF  195 (323)
T ss_pred             cCCCCc---ccc----ccCCcCcC---------------CcccccCCC-CCchhchhhhHHHHHHHHhCCCCC
Confidence            222111   011    16778888               899887654 478999999999999999655443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3e-35  Score=278.02  Aligned_cols=206  Identities=25%  Similarity=0.307  Sum_probs=162.3

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcC-CCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|.....    .+..++..||+|+++... ....+.+.+|+.+++.+ +||||+++++++
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGI----DKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGAC   80 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEecc----CCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence            346799999999999999999975321    122346789999997643 23446788999999999 799999999988


Q ss_pred             EeC-CeEEEEEeccCCCCHHHHHhhcCCC---------------------------------------------------
Q 017177          165 WED-KELLLVYEYMQRGSLENHLFRRNPS---------------------------------------------------  192 (376)
Q Consensus       165 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~---------------------------------------------------  192 (376)
                      ... +.++++|||+++|+|.+++......                                                   
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            764 4689999999999999999753210                                                   


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEE
Q 017177          193 -------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYII  265 (376)
Q Consensus       193 -------~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~  265 (376)
                             ...+++..+..++.||+.||.|||  .++|+||||||+|||++.++.+||+|||+++......... ..++. 
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~-  236 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-RKGSA-  236 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHH--HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchh-cccCC-
Confidence                   134778889999999999999999  5999999999999999999999999999998654322211 11111 


Q ss_pred             EEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          266 YIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       266 y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                         .+++.||               |||++.+.. ++.++||||+|++++|+++
T Consensus       237 ---~~~~~y~---------------aPE~~~~~~-~~~~sDiwslG~il~el~~  271 (338)
T cd05102         237 ---RLPLKWM---------------APESIFDKV-YTTQSDVWSFGVLLWEIFS  271 (338)
T ss_pred             ---CCCcccc---------------CcHHhhcCC-CCcccCHHHHHHHHHHHHh
Confidence               3445666               799876654 5889999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-36  Score=289.32  Aligned_cols=240  Identities=20%  Similarity=0.283  Sum_probs=187.9

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCC----CChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP----ESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .+...+||+|+|-+||+|.+         ..+|..||--.++.    ......++|..|+++|+.|+||||+++|+.|.+
T Consensus        42 ~k~~evLGrGafKtVYka~D---------e~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d  112 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFD---------EEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD  112 (632)
T ss_pred             eehhhhcccccceeeeeccc---------cccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec
Confidence            35668999999999999944         44677777433332    133556899999999999999999999999988


Q ss_pred             CCe--EEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC-CCcEEEc
Q 017177          167 DKE--LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-VGFLFDS  243 (376)
Q Consensus       167 ~~~--~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~-~g~~kl~  243 (376)
                      ...  +.+|+|++..|+|..++++.    ..+....++.|++||++||.|||++..+|||||||.+||+|+. -|.|||+
T Consensus       113 ~~n~~in~iTEL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIG  188 (632)
T KOG0584|consen  113 TDNKTINFITELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIG  188 (632)
T ss_pred             CCCceeeeeeecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeec
Confidence            755  88999999999999999987    4588899999999999999999998899999999999999975 4999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |+|+|..........     .    +|||+||               |||++.  ..+....||||||+.++||+++=-+
T Consensus       189 DLGLAtl~r~s~aks-----v----IGTPEFM---------------APEmYE--E~YnE~VDVYaFGMCmLEMvT~eYP  242 (632)
T KOG0584|consen  189 DLGLATLLRKSHAKS-----V----IGTPEFM---------------APEMYE--ENYNELVDVYAFGMCMLEMVTSEYP  242 (632)
T ss_pred             chhHHHHhhccccce-----e----ccCcccc---------------ChHHHh--hhcchhhhhhhhhHHHHHHHhccCC
Confidence            999999877654442     2    8999999               999887  5568999999999999999977322


Q ss_pred             c---hhh--HHH--------HHHHhhCCCccCcccCCChh-HHHHHHHHHHhhheeeecC
Q 017177          324 T---MLK--YQI--------LAWQSWGPLVESHMLQPGLW-AHMVMQLQNMLQQVIFISS  369 (376)
Q Consensus       324 ~---~~~--~~~--------~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~  369 (376)
                      .   ++.  +..        .++..-.+.-..++|..||. +...+...++|+...|=..
T Consensus       243 YsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  243 YSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLATKSERLSAKELLKDPFFDED  302 (632)
T ss_pred             hhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcCchhccCHHHHhhChhhccc
Confidence            2   211  111        12222233334555666666 6666677778877766554

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-35  Score=276.62  Aligned_cols=205  Identities=21%  Similarity=0.221  Sum_probs=169.2

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ++|++.+.||+|+||.||+|...         .+++.||+|+++....   .....+.+|+.++..++||||+++++++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDK---------DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ   71 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEEC---------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence            46899999999999999999544         3588999999875422   33467889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +++..|+||||+++++|.+++.+.    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH--~~giiH~Dlkp~NIll~~~~~~kL~Df  145 (350)
T cd05573          72 DEEHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVH--KLGFIHRDIKPDNILIDADGHIKLADF  145 (350)
T ss_pred             cCCeEEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEeecC
Confidence            999999999999999999999765    45899999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeE----------------------EEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccc
Q 017177          246 LIYVYFKRHYIYI----------------------YIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTL  303 (376)
Q Consensus       246 g~a~~~~~~~~~~----------------------~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~  303 (376)
                      |++..........                      ...........||+.|+               |||++.+. ..+.
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~---------------aPE~~~~~-~~~~  209 (350)
T cd05573         146 GLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYI---------------APEVLRGT-PYGL  209 (350)
T ss_pred             CCCccCcccCcccccccccccccccccccccccccccccccccccccCcccc---------------CHHHHcCC-CCCC
Confidence            9998765443000                      00000111226777777               89988876 4588


Q ss_pred             cccccceeeeehhhccccccc
Q 017177          304 LKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       304 ~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ++||||+|++++++++...+.
T Consensus       210 ~~DiwSlG~il~ell~g~~Pf  230 (350)
T cd05573         210 ECDWWSLGVILYEMLYGFPPF  230 (350)
T ss_pred             ceeeEecchhhhhhccCCCCC
Confidence            999999999999999765554

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.1e-35  Score=269.41  Aligned_cols=196  Identities=24%  Similarity=0.262  Sum_probs=163.4

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      |+..+.||+|+||.||+|...         .+++.||+|.+.....   .....+.+|+.+++.++|+||+++++++.++
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~   72 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK   72 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEe---------cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC
Confidence            778899999999999999544         3588999999875432   2234577899999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++||||+++|+|.+++....  ...+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.++|+|||+
T Consensus        73 ~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH--~~~iiH~dikp~Nill~~~~~~kl~Dfg~  148 (285)
T cd05631          73 DALCLVLTIMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQ--RERIVYRDLKPENILLDDRGHIRISDLGL  148 (285)
T ss_pred             CeEEEEEEecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHEEECCCCCEEEeeCCC
Confidence            99999999999999998886542  245899999999999999999999  59999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      +..........   .     ..||+.||               +||++.+.. ++.++||||+|++++++++...+
T Consensus       149 ~~~~~~~~~~~---~-----~~g~~~y~---------------aPE~~~~~~-~~~~~DvwslGvil~el~~g~~p  200 (285)
T cd05631         149 AVQIPEGETVR---G-----RVGTVGYM---------------APEVINNEK-YTFSPDWWGLGCLIYEMIQGQSP  200 (285)
T ss_pred             cEEcCCCCeec---C-----CCCCCCcc---------------CHhhhcCCC-CCcccCchhHHHHHHHHHhCCCC
Confidence            98764432221   1     15677777               799887654 57889999999999999965444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.8e-35  Score=286.61  Aligned_cols=205  Identities=17%  Similarity=0.163  Sum_probs=170.2

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      ..|.+.+.||+|+||.||+|.....        .+..||+|.+..........+.+|+.+++.++||||+++++++..++
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~--------~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~  138 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSD--------PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD  138 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCC--------CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC
Confidence            3489999999999999999954331        16778999887666555567788999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeee
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a  248 (376)
                      ..||||||+++|+|.+++.........+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||++
T Consensus       139 ~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivHrDlkp~NIll~~~~~~kL~DFgla  216 (478)
T PTZ00267        139 KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH--SRKMMHRDLKSANIFLMPTGIIKLGDFGFS  216 (478)
T ss_pred             EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--hCCEEECCcCHHhEEECCCCcEEEEeCcCc
Confidence            999999999999999988654333456899999999999999999999  599999999999999999999999999999


Q ss_pred             eeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          249 VYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      +.+....... ...+    .+||+.|+               +||++.+.. ++.++||||+|++++++++...+.
T Consensus       217 ~~~~~~~~~~-~~~~----~~gt~~y~---------------aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~Pf  271 (478)
T PTZ00267        217 KQYSDSVSLD-VASS----FCGTPYYL---------------APELWERKR-YSKKADMWSLGVILYELLTLHRPF  271 (478)
T ss_pred             eecCCccccc-cccc----cCCCcccc---------------CHhHhCCCC-CCcHHhHHHHHHHHHHHHhCCCCC
Confidence            9765432211 1111    26888888               899877654 588999999999999999765553

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2e-34  Score=271.87  Aligned_cols=201  Identities=18%  Similarity=0.117  Sum_probs=166.4

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ++|++.+.||+|+||.||++....         +++.+|+|++.+..   ......+.+|+.++..++|+||+++++.+.
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ   71 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence            468999999999999999996543         57889999986532   122345778999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +++.+|+||||+++|+|.+++.+..   ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+||
T Consensus        72 ~~~~~~lv~ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH--~~~iiHrDlkp~Nili~~~~~~kL~Df  146 (332)
T cd05623          72 DENNLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVH--QLHYVHRDIKPDNILMDMNGHIRLADF  146 (332)
T ss_pred             cCCEEEEEEeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEECCCCCEEEeec
Confidence            9999999999999999999997642   45899999999999999999999  699999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh----hhhccccccccceeeeehhhcccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW----IKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~----~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |++..........      .....||+.|+               +||++..    ....+.++|+||+|++++++++..
T Consensus       147 G~a~~~~~~~~~~------~~~~~gt~~y~---------------aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~  205 (332)
T cd05623         147 GSCLKLMEDGTVQ------SSVAVGTPDYI---------------SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE  205 (332)
T ss_pred             chheecccCCcce------ecccccCcccc---------------CHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCC
Confidence            9997654322211      11126788888               8998863    345688999999999999999655


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      .+.
T Consensus       206 ~Pf  208 (332)
T cd05623         206 TPF  208 (332)
T ss_pred             CCC
Confidence            554

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.4e-34  Score=271.82  Aligned_cols=196  Identities=23%  Similarity=0.253  Sum_probs=160.8

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC----hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCe
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES----MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE  169 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~  169 (376)
                      ++.||+|+||.||+++...      ...+++.||+|+++...    ......+.+|+.+++.++||||+++++.+..++.
T Consensus         1 ~~~lg~G~~g~V~~~~~~~------~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~   74 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVT------GADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGK   74 (323)
T ss_pred             CceeeecCCeEEEEEEEcc------cCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCe
Confidence            3689999999999997542      22358899999987532    1233566789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeee
Q 017177          170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYV  249 (376)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~  249 (376)
                      +|+||||+++|+|.+++.+.    ..+.+..+..++.|++.||.|||  .++|+||||||+|||++.+|.+||+|||+++
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  148 (323)
T cd05584          75 LYLILEYLSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLH--QQGIIYRDLKPENILLDAQGHVKLTDFGLCK  148 (323)
T ss_pred             EEEEEeCCCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEEeeCcCCe
Confidence            99999999999999999765    45788899999999999999999  6999999999999999999999999999987


Q ss_pred             eeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          250 YFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      .........       ....||+.|+               |||++.+.. .+.++||||+|++++++++-..+.
T Consensus       149 ~~~~~~~~~-------~~~~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf  200 (323)
T cd05584         149 ESIHEGTVT-------HTFCGTIEYM---------------APEILMRSG-HGKAVDWWSLGALMYDMLTGAPPF  200 (323)
T ss_pred             ecccCCCcc-------cccCCCcccc---------------ChhhccCCC-CCCcceecccHHHHHHHhcCCCCC
Confidence            543322211       1115777777               799887654 478999999999999998765543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.6e-34  Score=271.53  Aligned_cols=197  Identities=23%  Similarity=0.238  Sum_probs=163.0

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCC-CCCcceEEeEEE
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLS-HPNLVKLLGYCW  165 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~-h~nIv~l~~~~~  165 (376)
                      +|++.+.||+|+||.||+|...         .++..||+|++.+...   ...+.+..|..++..+. |++|+++++++.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERK---------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ   71 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence            4788999999999999999544         3588999999876422   23345677888888875 899999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +.+.+|+||||+++|+|.+.+...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+||
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~kL~Df  145 (323)
T cd05616          72 TMDRLYFVMEYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADF  145 (323)
T ss_pred             cCCEEEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCEEecCCCHHHeEECCCCcEEEccC
Confidence            999999999999999999998765    45889999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      |+++.........   .+    ..||+.|+               |||++.+.. ++.++|+||+|++++++++...+.
T Consensus       146 G~~~~~~~~~~~~---~~----~~gt~~y~---------------aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf  201 (323)
T cd05616         146 GMCKENMWDGVTT---KT----FCGTPDYI---------------APEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPF  201 (323)
T ss_pred             CCceecCCCCCcc---cc----CCCChhhc---------------CHHHhcCCC-CCCccchhchhHHHHHHHhCCCCC
Confidence            9998643222111   11    16778888               899887655 588999999999999999765554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.2e-34  Score=268.82  Aligned_cols=195  Identities=23%  Similarity=0.255  Sum_probs=161.5

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLL  172 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l  172 (376)
                      +.||+|+||.||+++..      ....++..||+|+++....  .....+.+|+.++++++||||+++++++.+++.+|+
T Consensus         2 ~~lg~G~~g~Vy~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   75 (318)
T cd05582           2 KVLGQGSFGKVFLVRKI------TGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL   75 (318)
T ss_pred             ceeeeCCCEEEEEEEEe------ccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence            67999999999998653      1223588999999976432  233566789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeec
Q 017177          173 VYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFK  252 (376)
Q Consensus       173 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~  252 (376)
                      ||||+++|+|.+++.+.    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.++.+||+|||++....
T Consensus        76 v~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  149 (318)
T cd05582          76 ILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  149 (318)
T ss_pred             EEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence            99999999999999664    45899999999999999999999  5999999999999999999999999999998654


Q ss_pred             cceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          253 RHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       253 ~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ......       +...||+.|+               +||++.+.. .+.++|+||+|++++++++-..+.
T Consensus       150 ~~~~~~-------~~~~g~~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~  198 (318)
T cd05582         150 DHEKKA-------YSFCGTVEYM---------------APEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPF  198 (318)
T ss_pred             CCCCce-------ecccCChhhc---------------CHHHHcCCC-CCCccceeccceEeeeeccCCCCC
Confidence            432211       1126777787               899887654 478999999999999998654443

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.2e-34  Score=270.66  Aligned_cols=197  Identities=24%  Similarity=0.227  Sum_probs=162.8

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCC-CCcceEEeEEE
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSH-PNLVKLLGYCW  165 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h-~nIv~l~~~~~  165 (376)
                      +|++.+.||+|+||.||+|...         .+++.||+|++....   ....+.+..|+.++..++| ++|+++++++.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERK---------GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ   71 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence            4888999999999999999544         357899999987642   2345677889999999985 56888999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      ..+.+|+||||+++|+|.+++...    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.+|.+||+||
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~~~~kL~Df  145 (324)
T cd05587          72 TMDRLYFVMEYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDAEGHIKIADF  145 (324)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEEcCCCCEEEeec
Confidence            999999999999999999998765    45889999999999999999999  699999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      |++..........   .    ...||+.|+               +||++.+.. .+.++|+||+|++++++++-..+.
T Consensus       146 g~~~~~~~~~~~~---~----~~~gt~~y~---------------aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf  201 (324)
T cd05587         146 GMCKENIFGGKTT---R----TFCGTPDYI---------------APEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPF  201 (324)
T ss_pred             CcceecCCCCCce---e----eecCCcccc---------------ChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCC
Confidence            9987542221111   1    116778888               799887765 478899999999999999755443

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.5e-34  Score=265.36  Aligned_cols=209  Identities=23%  Similarity=0.325  Sum_probs=166.6

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCC-------cccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcce
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLA-------PSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVK  159 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~  159 (376)
                      .++|++.+.||+|+||.||+|.+......       ..+...+..||+|.+.... ......+.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            46799999999999999999986542100       0123346689999998753 334567889999999999999999


Q ss_pred             EEeEEEeCCeEEEEEeccCCCCHHHHHhhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEe
Q 017177          160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNP---------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIY  224 (376)
Q Consensus       160 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiH  224 (376)
                      +++++.+.+..++||||+++|+|.+++.....               ....+++..+..++.||+.||.|||  +.+|+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~ivH  161 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS--SLNFVH  161 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH--HCCccc
Confidence            99999999999999999999999999865321               1134678889999999999999999  599999


Q ss_pred             cCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcccc
Q 017177          225 RDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLL  304 (376)
Q Consensus       225 rDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~  304 (376)
                      |||||+|||++.++.+||+|||+++......... ..+..    .+++.||               +||++.+.. .+.+
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~-~~~~~----~~~~~y~---------------aPE~~~~~~-~~~~  220 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR-IQGRA----VLPIRWM---------------AWECILMGK-FTTA  220 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeE-ecCcC----CCCcccc---------------CHHHHhcCC-CCch
Confidence            9999999999999999999999998765443321 11221    4456666               799776544 6889


Q ss_pred             ccccceeeeehhhcc
Q 017177          305 KYSNSFAFVFSCVFS  319 (376)
Q Consensus       305 ~dv~s~g~v~~~~~~  319 (376)
                      +||||+|++++++++
T Consensus       221 ~Dv~slG~~l~el~~  235 (304)
T cd05096         221 SDVWAFGVTLWEILM  235 (304)
T ss_pred             hhhHHHHHHHHHHHH
Confidence            999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-36  Score=301.73  Aligned_cols=207  Identities=20%  Similarity=0.180  Sum_probs=180.5

Q ss_pred             hhhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcc
Q 017177           82 LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLV  158 (376)
Q Consensus        82 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv  158 (376)
                      .+++...++|+++++||+|+||.|.++         +++.+++.||+|++.+...   .+...|..|-.+|..-+.+.|+
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lV---------r~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv  138 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALV---------RHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIV  138 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEE---------EeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHH
Confidence            355666789999999999999999999         5556899999999988532   3446788899999999999999


Q ss_pred             eEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          159 KLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       159 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      +++-+|+++.++|+||||++||+|..++.+.    .++++..++.++..|..||.-||  ..|+|||||||+|||||..|
T Consensus       139 ~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH--~mgyVHRDiKPDNvLld~~G  212 (1317)
T KOG0612|consen  139 QLHYAFQDERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLH--SMGYVHRDIKPDNVLLDKSG  212 (1317)
T ss_pred             HHHHHhcCccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHH--hccceeccCCcceeEecccC
Confidence            9999999999999999999999999999776    36999999999999999999999  69999999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh----hhccccccccceeeee
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI----KYLTLLKYSNSFAFVF  314 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~----~~~~~~~dv~s~g~v~  314 (376)
                      ++||+|||.+..+...+...      .-+++|||.|.               .|||+...    ..+.+.+|+||+|++.
T Consensus       213 HikLADFGsClkm~~dG~V~------s~~aVGTPDYI---------------SPEvLqs~~~~~g~yG~ecDwWSlGV~~  271 (1317)
T KOG0612|consen  213 HIKLADFGSCLKMDADGTVR------SSVAVGTPDYI---------------SPEVLQSQGDGKGEYGRECDWWSLGVFM  271 (1317)
T ss_pred             cEeeccchhHHhcCCCCcEE------eccccCCCCcc---------------CHHHHHhhcCCccccCCccchhhhHHHH
Confidence            99999999999887654432      22349999999               89988743    5678999999999999


Q ss_pred             hhhc----cccccc
Q 017177          315 SCVF----SFYRTT  324 (376)
Q Consensus       315 ~~~~----~~y~~~  324 (376)
                      |||+    .||.-.
T Consensus       272 YEMlyG~TPFYads  285 (1317)
T KOG0612|consen  272 YEMLYGETPFYADS  285 (1317)
T ss_pred             HHHHcCCCcchHHH
Confidence            9998    677665

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.3e-35  Score=281.32  Aligned_cols=193  Identities=18%  Similarity=0.124  Sum_probs=160.8

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ...+|++.+.||+|+||.||+|...+       ...+..||+|.+....     ...+|+.+++.++||||+++++++..
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~-------~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~  157 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHG-------DEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRW  157 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcC-------CccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEee
Confidence            34579999999999999999996543       1246789999887542     34679999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      .+..+++||++. ++|.+++...    ..+++..++.++.||+.||.|||  .++|+||||||+|||++.++.++|+|||
T Consensus       158 ~~~~~lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH--~~givHrDlkp~Nill~~~~~~~l~DfG  230 (392)
T PHA03207        158 KSTVCMVMPKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLH--GRGIIHRDVKTENIFLDEPENAVLGDFG  230 (392)
T ss_pred             CCEEEEEehhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEcCCCCEEEccCc
Confidence            999999999995 5898888443    55899999999999999999999  6999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ++............     +...||+.|+               |||++.+.. ++.++||||+|++++++++
T Consensus       231 ~a~~~~~~~~~~~~-----~~~~gt~~y~---------------aPE~~~~~~-~~~~~DvwslGvil~el~~  282 (392)
T PHA03207        231 AACKLDAHPDTPQC-----YGWSGTLETN---------------SPELLALDP-YCAKTDIWSAGLVLFEMSV  282 (392)
T ss_pred             cccccCcccccccc-----cccccccCcc---------------CHhHhcCCC-CCchhhHHHHHHHHHHHHH
Confidence            99876543322111     1226888888               899887655 4788999999999999985

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.3e-34  Score=269.27  Aligned_cols=192  Identities=24%  Similarity=0.273  Sum_probs=155.9

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHH-HHhcCCCCCcceEEeEEEeCCeE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVN-FLGRLSHPNLVKLLGYCWEDKEL  170 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-il~~l~h~nIv~l~~~~~~~~~~  170 (376)
                      +.||+|+||+||+|...         .+++.||+|++.....   .....+.+|.. +++.++||||+++++.+..++..
T Consensus         1 ~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~   71 (323)
T cd05575           1 KVIGKGSFGKVLLAKHK---------ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL   71 (323)
T ss_pred             CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence            47999999999999554         3588999999875422   22334455554 56789999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      |+||||+++|+|..++.+.    ..+++..+..++.||+.||.|||  +++|+||||||+|||++.+|.+||+|||++..
T Consensus        72 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~givH~dikp~NIll~~~~~~kl~Dfg~~~~  145 (323)
T cd05575          72 YFVLDYVNGGELFFHLQRE----RSFPEPRARFYAAEIASALGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKE  145 (323)
T ss_pred             EEEEcCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence            9999999999999998765    45889999999999999999999  69999999999999999999999999999875


Q ss_pred             eccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          251 FKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ........   ..    ..||+.|+               +||++.+.. .+.++||||+|++++++++...+.
T Consensus       146 ~~~~~~~~---~~----~~gt~~y~---------------aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf  196 (323)
T cd05575         146 GIEHSKTT---ST----FCGTPEYL---------------APEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPF  196 (323)
T ss_pred             cccCCCcc---cc----ccCChhhc---------------ChhhhcCCC-CCccccccccchhhhhhhcCCCCC
Confidence            43222110   11    15777787               899887654 578999999999999999765553

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=284.39  Aligned_cols=200  Identities=27%  Similarity=0.335  Sum_probs=172.1

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-ChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      .|...+.||+|+||.||++         +++.+|+.||||.++.. .....+++.+|+++|++++|+|||++++.-++..
T Consensus        14 ~W~~~e~LG~Ga~g~V~rg---------rnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~   84 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRG---------RNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKF   84 (732)
T ss_pred             ceeehhhhcCCccceeeee---------cccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccc
Confidence            4667789999999999999         66668999999999875 3455688899999999999999999999765543


Q ss_pred             ------eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE--cCCCc-
Q 017177          169 ------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL--DGVGF-  239 (376)
Q Consensus       169 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl--~~~g~-  239 (376)
                            ...+|||||.||+|...|.+... ...+++.+.+.+..+++.||.|||  +++|+||||||.||++  ..+|. 
T Consensus        85 ~~~~~~~~vlvmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~Lr--En~IvHRDlKP~NIvl~~Gedgq~  161 (732)
T KOG4250|consen   85 LGLVTRLPVLVMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLR--ENGIVHRDLKPGNIVLQIGEDGQS  161 (732)
T ss_pred             cCcccccceEEEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHH--HcCceeccCCCCcEEEeecCCCce
Confidence                  47899999999999999986543 345999999999999999999999  7999999999999998  34454 


Q ss_pred             -EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          240 -LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       240 -~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                       .||+|||.|+-+.++......        +||++|.               +||++...++++.-+|.||||+++++.+
T Consensus       162 IyKLtDfG~Arel~d~s~~~S~--------vGT~~YL---------------hPel~E~q~~y~~tVDLWS~GvtlY~ca  218 (732)
T KOG4250|consen  162 IYKLTDFGAARELDDNSLFTSL--------VGTEEYL---------------HPELYERQKKYTATVDLWSFGVTLYECA  218 (732)
T ss_pred             EEeeecccccccCCCCCeeeee--------cCchhhc---------------ChHHHhhccCcCceeehhhhhhHHHHHh
Confidence             799999999998887654333        7778877               7999988788899999999999999999


Q ss_pred             cccccc
Q 017177          319 SFYRTT  324 (376)
Q Consensus       319 ~~y~~~  324 (376)
                      +-+.+.
T Consensus       219 TG~lPF  224 (732)
T KOG4250|consen  219 TGELPF  224 (732)
T ss_pred             ccCCCC
Confidence            888776

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.9e-34  Score=269.48  Aligned_cols=192  Identities=24%  Similarity=0.235  Sum_probs=158.8

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcC-CCCCcceEEeEEEeCCeE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWEDKEL  170 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~  170 (376)
                      +.||+|+||.||+|...         .+++.||+|+++...   ....+.+..|.+++..+ +||||+++++++..++.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~   71 (321)
T cd05591           1 KVLGKGSFGKVMLAELK---------GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL   71 (321)
T ss_pred             CccccCCCeEEEEEEEC---------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence            46999999999999544         358899999987642   23345677899999876 699999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      |+||||+++|+|...+.+.    ..+++..+..++.|++.||.|||  +++|+||||||+|||++.+|.+||+|||++..
T Consensus        72 ~lv~E~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~  145 (321)
T cd05591          72 FFVMEYVNGGDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKE  145 (321)
T ss_pred             EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEeeccccee
Confidence            9999999999999988765    45889999999999999999999  69999999999999999999999999999986


Q ss_pred             eccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          251 FKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ........   .+    ..||+.|+               |||++.+.. ++.++|+||+|++++++++-..+.
T Consensus       146 ~~~~~~~~---~~----~~gt~~y~---------------aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf  196 (321)
T cd05591         146 GILNGVTT---TT----FCGTPDYI---------------APEILQELE-YGPSVDWWALGVLMYEMMAGQPPF  196 (321)
T ss_pred             cccCCccc---cc----cccCcccc---------------CHHHHcCCC-CCCccceechhHHHHHHhcCCCCC
Confidence            43322211   11    15777787               799887654 578899999999999999765554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-35  Score=272.58  Aligned_cols=195  Identities=19%  Similarity=0.240  Sum_probs=176.4

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhH--HHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF--EEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .-|.+.+.||+|.|+.|-+|         ++..+|..||||++++...+..  ..+.+|++.|+-++|||||++|++...
T Consensus        18 GLYDLekTlG~GHFAVVKLA---------rHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT   88 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLA---------RHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT   88 (864)
T ss_pred             eeehhhhhhcCCceehhhhh---------hhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc
Confidence            45888999999999999998         7888999999999998766543  567899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE-cCCCcEEEcce
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL-DGVGFLFDSHL  245 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl-~~~g~~kl~Df  245 (376)
                      +..+|+|+|+=++|+|++++-++.   ..+.+..+.+++.||+.|+.|+|  +..+|||||||+|+.+ ..-|.|||.||
T Consensus        89 QTKlyLiLELGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCH--qLHVVHRDLKPENVVFFEKlGlVKLTDF  163 (864)
T KOG4717|consen   89 QTKLYLILELGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCH--QLHVVHRDLKPENVVFFEKLGLVKLTDF  163 (864)
T ss_pred             cceEEEEEEecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHh--hhhhhcccCCcceeEEeeecCceEeeec
Confidence            999999999999999999998774   56899999999999999999999  7999999999999987 55699999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      |++..+.........+|+..|-+                       |||+.|..|..++.||||+|+|++-++.-
T Consensus       164 GFSNkf~PG~kL~TsCGSLAYSA-----------------------PEILLGDsYDAPAVDiWSLGVILyMLVCG  215 (864)
T KOG4717|consen  164 GFSNKFQPGKKLTTSCGSLAYSA-----------------------PEILLGDSYDAPAVDIWSLGVILYMLVCG  215 (864)
T ss_pred             cccccCCCcchhhcccchhhccC-----------------------chhhhcCccCCcchhhhHHHHHHHHHHhC
Confidence            99999988877777777777776                       99999999999999999999999887744

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.2e-34  Score=268.80  Aligned_cols=192  Identities=23%  Similarity=0.234  Sum_probs=155.6

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHH-HHhcCCCCCcceEEeEEEeCCeE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVN-FLGRLSHPNLVKLLGYCWEDKEL  170 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-il~~l~h~nIv~l~~~~~~~~~~  170 (376)
                      +.||+|+||+||+|...         .+++.||+|++....   ......+.+|.. +++.++||||+++++.+..++..
T Consensus         1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~   71 (325)
T cd05604           1 KVIGKGSFGKVLLAKRK---------LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL   71 (325)
T ss_pred             CceeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence            46999999999999543         358899999987542   122344555554 56778999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      |+||||+++|+|..++.+.    ..+++..+..++.||+.||.|||  +++|+||||||+|||++.+|.+||+|||+++.
T Consensus        72 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH--~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~  145 (325)
T cd05604          72 YFVLDFVNGGELFFHLQRE----RSFPEPRARFYAAEIASALGYLH--SINIVYRDLKPENILLDSQGHVVLTDFGLCKE  145 (325)
T ss_pred             EEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEEeecCCccc
Confidence            9999999999999888654    45899999999999999999999  69999999999999999999999999999875


Q ss_pred             eccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          251 FKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ........   ..    ..||+.||               +||++.+.. .+.++||||+|++++++++-..+.
T Consensus       146 ~~~~~~~~---~~----~~gt~~y~---------------aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf  196 (325)
T cd05604         146 GIAQSDTT---TT----FCGTPEYL---------------APEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPF  196 (325)
T ss_pred             CCCCCCCc---cc----ccCChhhC---------------CHHHHcCCC-CCCcCccccccceehhhhcCCCCC
Confidence            43221111   11    16778888               899887655 478999999999999998655443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.1e-34  Score=268.00  Aligned_cols=199  Identities=21%  Similarity=0.208  Sum_probs=165.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|...         .++..||+|.++.... .....+.+|+.+++.++||||+++++++.+
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   74 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSK---------LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT   74 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEEC---------CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            357999999999999999999544         3588999999875432 223567789999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++..++||||+++ +|.+++....   ..+++..+..++.||+.||+|||  .++|+||||||+|||++.++.+||+|||
T Consensus        75 ~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~DfG  148 (288)
T cd07871          75 ERCLTLVFEYLDS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCH--KRKILHRDLKPQNLLINEKGELKLADFG  148 (288)
T ss_pred             CCeEEEEEeCCCc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEECcCc
Confidence            9999999999975 9999886542   34788999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      +++........  ...     ..||+.|+               |||++.+....+.++|+||+|++++++++...+
T Consensus       149 ~~~~~~~~~~~--~~~-----~~~~~~y~---------------aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p  203 (288)
T cd07871         149 LARAKSVPTKT--YSN-----EVVTLWYR---------------PPDVLLGSTEYSTPIDMWGVGCILYEMATGRPM  203 (288)
T ss_pred             ceeeccCCCcc--ccC-----ceeccccc---------------ChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence            99865432221  111     15667777               799887766678899999999999999865544

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.1e-34  Score=270.71  Aligned_cols=195  Identities=23%  Similarity=0.262  Sum_probs=159.2

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHH---hcCCCCCcceEEeEE
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFL---GRLSHPNLVKLLGYC  164 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il---~~l~h~nIv~l~~~~  164 (376)
                      |++.+.||+|+||.||+|...         .+++.||||+++...   ....+.+.+|+.++   +.++||||+++++++
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~   71 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYK---------KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF   71 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence            677899999999999999554         358899999997542   22345666676655   566799999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      ...+..|+||||+++|+|...+.+     ..+++..+..++.||+.||.|||  +.+|+||||||+|||++.+|.+||+|
T Consensus        72 ~~~~~~~lv~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH--~~~ivHrdlkp~Nill~~~~~~kL~D  144 (324)
T cd05589          72 QTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLH--ENKIVYRDLKLDNLLLDTEGFVKIAD  144 (324)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecCCCHHHeEECCCCcEEeCc
Confidence            999999999999999999988753     34899999999999999999999  69999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ||+++........   ..+    ..||+.||               |||++.+.. .+.++|+||+|++++++++...+.
T Consensus       145 fg~~~~~~~~~~~---~~~----~~g~~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~el~~G~~pf  201 (324)
T cd05589         145 FGLCKEGMGFGDR---TST----FCGTPEFL---------------APEVLTETS-YTRAVDWWGLGVLIYEMLVGESPF  201 (324)
T ss_pred             ccCCccCCCCCCc---ccc----cccCcccc---------------CHhHhcCCC-CCcccchhhHHHHHHHHHhCCCCC
Confidence            9998754322211   111    16778888               899887654 578899999999999998665543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-35  Score=275.44  Aligned_cols=199  Identities=23%  Similarity=0.251  Sum_probs=171.8

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh---hHHHHHHHHHHHhcCC-CCCcceEE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ---GFEEWQSEVNFLGRLS-HPNLVKLL  161 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~-h~nIv~l~  161 (376)
                      .....|++.+.||+|.||.||+|         .++.+|..+|+|.+.+....   ..+.+.+|+.+|+++. ||||+.++
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~---------~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~  102 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLC---------REKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLK  102 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEE---------EecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEE
Confidence            34567999999999999999999         45557999999999876543   3468899999999999 99999999


Q ss_pred             eEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC----C
Q 017177          162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG----V  237 (376)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~----~  237 (376)
                      ++|++...+++|||+|.||.|.+.+.+.     .+++..+..++.|++.++.|||  ..+|+||||||+|+|+..    +
T Consensus       103 ~~~e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH--~~gvvHrDlKpEN~L~~~~~~~~  175 (382)
T KOG0032|consen  103 DAFEDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLH--SLGVVHRDLKPENLLLASKDEGS  175 (382)
T ss_pred             EEEEcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCHHHeeeccccCCC
Confidence            9999999999999999999999999776     2899999999999999999999  599999999999999953    3


Q ss_pred             CcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhh
Q 017177          238 GFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCV  317 (376)
Q Consensus       238 g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~  317 (376)
                      +.+|++|||++............        +|||+|+               |||++.... ++..+|+||+|++.+.+
T Consensus       176 ~~ik~~DFGla~~~~~~~~~~~~--------~Gtp~y~---------------APEvl~~~~-y~~~~DiWS~Gvi~yiL  231 (382)
T KOG0032|consen  176 GRIKLIDFGLAKFIKPGERLHTI--------VGTPEYV---------------APEVLGGRP-YGDEVDVWSIGVILYIL  231 (382)
T ss_pred             CcEEEeeCCCceEccCCceEeee--------cCCcccc---------------CchhhcCCC-CCcccchhHHHHHHHHH
Confidence            57999999999998874444333        7778888               799776654 58999999999999999


Q ss_pred             ccccccc
Q 017177          318 FSFYRTT  324 (376)
Q Consensus       318 ~~~y~~~  324 (376)
                      ++-+.+.
T Consensus       232 L~G~~PF  238 (382)
T KOG0032|consen  232 LSGVPPF  238 (382)
T ss_pred             hhCCCCC
Confidence            8665555

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.6e-34  Score=269.25  Aligned_cols=192  Identities=23%  Similarity=0.248  Sum_probs=154.8

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHH-HHHhcCCCCCcceEEeEEEeCCeE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEV-NFLGRLSHPNLVKLLGYCWEDKEL  170 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~-~il~~l~h~nIv~l~~~~~~~~~~  170 (376)
                      +.||+|+||.||+|+...         +++.||+|++.....   .....+..|. .+++.++||||+++++.+..++..
T Consensus         1 ~~lg~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~   71 (325)
T cd05602           1 KVIGKGSFGKVLLARHKA---------EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL   71 (325)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence            479999999999995543         578899999875421   2223444444 456788999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      |+||||+++|+|.+++...    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.+|.+||+|||+++.
T Consensus        72 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH--~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~  145 (325)
T cd05602          72 YFVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLCKE  145 (325)
T ss_pred             EEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence            9999999999999999765    45788899999999999999999  59999999999999999999999999999975


Q ss_pred             eccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          251 FKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ........   .    ...||+.|+               |||++.+.. .+.++||||+|++++++++-..+.
T Consensus       146 ~~~~~~~~---~----~~~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf  196 (325)
T cd05602         146 NIEHNGTT---S----TFCGTPEYL---------------APEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPF  196 (325)
T ss_pred             cccCCCCc---c----cccCCcccc---------------CHHHHcCCC-CCCccccccccHHHHHHhcCCCCC
Confidence            43221110   1    116778888               899887654 578999999999999999655543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-36  Score=275.50  Aligned_cols=193  Identities=24%  Similarity=0.269  Sum_probs=170.1

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ..|...++||+|+||.||+|.+.         .+++.||+|++..+.. ...+.+++|+.+|..++++||.++|+.+..+
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~---------~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g   83 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDN---------KTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG   83 (467)
T ss_pred             cccccchhccccccceeeeeeec---------cccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence            45777899999999999999544         4799999999998754 4568899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      ..+|++||||.||++.++|+..    ..+++..+..++++++.||.|||  ..+.+|||||+.|||+..+|.+|++|||.
T Consensus        84 ~~LwiiMey~~gGsv~~lL~~~----~~~~E~~i~~ilre~l~~l~ylH--~~~kiHrDIKaanil~s~~g~vkl~DfgV  157 (467)
T KOG0201|consen   84 TKLWIIMEYCGGGSVLDLLKSG----NILDEFEIAVILREVLKGLDYLH--SEKKIHRDIKAANILLSESGDVKLADFGV  157 (467)
T ss_pred             ccHHHHHHHhcCcchhhhhccC----CCCccceeeeehHHHHHHhhhhh--hcceecccccccceeEeccCcEEEEecce
Confidence            9999999999999999999765    33588888999999999999999  59999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +..+.......   .|+    +|||.||               |||++.+.. +..++|+||+|+...|+++
T Consensus       158 a~ql~~~~~rr---~tf----vGTPfwM---------------APEVI~~~~-Y~~KADIWSLGITaiEla~  206 (467)
T KOG0201|consen  158 AGQLTNTVKRR---KTF----VGTPFWM---------------APEVIKQSG-YDTKADIWSLGITAIELAK  206 (467)
T ss_pred             eeeeechhhcc---ccc----ccccccc---------------chhhhcccc-ccchhhhhhhhHHHHHHhc
Confidence            99887755442   233    9999999               999999554 5889999999999999993

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-34  Score=274.31  Aligned_cols=194  Identities=23%  Similarity=0.251  Sum_probs=172.7

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ....|.+.+.||+|.|++|.++++.         .++..||||.+++...  ..++.+.+|+++|+.|+|||||+++.+.
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~---------~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~  124 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHI---------LTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI  124 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEec---------CCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence            4567999999999999999999544         4799999999998744  3345688999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      ..+..+|+||||+.+|.+++++.++    ....+..+..++.|+..|++|||  .++|+|||||++||||+.+-++||+|
T Consensus       125 ~t~~~lylV~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH--~k~ivHrdLk~eNilL~~~mnikIaD  198 (596)
T KOG0586|consen  125 ETEATLYLVMEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCH--SKNIVHRDLKAENILLDENMNIKIAD  198 (596)
T ss_pred             eecceeEEEEEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHh--hcceeccccchhhcccccccceeeec
Confidence            9999999999999999999999887    34667889999999999999999  69999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      ||++.++.........        +|+|.|.               |||++.|..|..+.+|+||+|+|++.++
T Consensus       199 fgfS~~~~~~~~lqt~--------cgsppyA---------------aPEl~~g~~y~gpe~D~Wslgvvly~LV  249 (596)
T KOG0586|consen  199 FGFSTFFDYGLMLQTF--------CGSPPYA---------------APELFNGKKYDGPEVDIWSLGVVLYALV  249 (596)
T ss_pred             cccceeeccccccccc--------CCCCCcc---------------ChHhhcCcccCCcceehhhhhhhheeee
Confidence            9999998865554333        6777777               7999999999999999999999999877

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-34  Score=270.12  Aligned_cols=199  Identities=20%  Similarity=0.213  Sum_probs=164.5

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|...         .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   74 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSK---------VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT   74 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEEC---------CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence            467999999999999999999544         3588999999876432 223456789999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++..++||||++ ++|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.+|.+||+|||
T Consensus        75 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg  148 (303)
T cd07869          75 KETLTLVFEYVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIH--QRYILHRDLKPQNLLISDTGELKLADFG  148 (303)
T ss_pred             CCeEEEEEECCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECCCC
Confidence            999999999995 58888886542   45888999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ++.........  ...     ..||+.|+               |||++.+....+.++|+||+|++++++++-..+
T Consensus       149 ~~~~~~~~~~~--~~~-----~~~~~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  203 (303)
T cd07869         149 LARAKSVPSHT--YSN-----EVVTLWYR---------------PPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA  203 (303)
T ss_pred             cceeccCCCcc--CCC-----CcccCCCC---------------ChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            99865432211  111     15677777               899888776678899999999999999865433

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-36  Score=284.40  Aligned_cols=251  Identities=20%  Similarity=0.280  Sum_probs=201.4

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .+.|.++..||.|+||+||+|.         .+.++...|.|++.......++.+.-||+||..++||+|+++++.|..+
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~---------nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e  101 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAV---------NKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE  101 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhh---------cccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc
Confidence            4568888999999999999994         4446888899999988888889999999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +.+||+.|||.||-...++.+-   ...+.+.++..+++|++.||.|||  .++|||||||+.|||++-+|.++|+|||.
T Consensus       102 nkLwiliEFC~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LH--s~~iIHRDLKAGNiL~TldGdirLADFGV  176 (1187)
T KOG0579|consen  102 NKLWILIEFCGGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLH--SQNIIHRDLKAGNILLTLDGDIRLADFGV  176 (1187)
T ss_pred             CceEEEEeecCCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHh--hcchhhhhccccceEEEecCcEeeecccc
Confidence            9999999999999998888665   366999999999999999999999  59999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh----hhccccccccceeeeehhhcccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI----KYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~----~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      +.........   ..++    +|||.||               |||++.-.    ..+..++||||||+.+.||+-.--+
T Consensus       177 SAKn~~t~qk---RDsF----IGTPYWM---------------APEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPP  234 (1187)
T KOG0579|consen  177 SAKNKSTRQK---RDSF----IGTPYWM---------------APEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPP  234 (1187)
T ss_pred             cccchhHHhh---hccc----cCCcccc---------------cchheeeccccCCCchhhhhHHhhhhHHHHHhccCCC
Confidence            9876554322   1222    8999999               88866532    4457889999999999999966544


Q ss_pred             chhhHHHHHHHhhCCCccCcccCCChh----HHHHHHHH-----------HHhhheeeecCCccccC
Q 017177          324 TMLKYQILAWQSWGPLVESHMLQPGLW----AHMVMQLQ-----------NMLQQVIFISSPLNLEM  375 (376)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~l~----~~~~~~~~-----------~~~~~~~~~~~~~~~~~  375 (376)
                      ...--|....--......+-+++|.-|    .|.+.+|.           .+|+++.|-+.|-| +|
T Consensus       235 HhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn-K~  300 (1187)
T KOG0579|consen  235 HHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN-KM  300 (1187)
T ss_pred             ccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc-hH
Confidence            433333333333444455667888877    56666553           46777777666665 44

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.6e-34  Score=268.22  Aligned_cols=192  Identities=24%  Similarity=0.237  Sum_probs=157.3

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcC-CCCCcceEEeEEEeCCeE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWEDKEL  170 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~  170 (376)
                      +.||+|+||.||+|....         +++.||+|+++...   ....+.+..|..++..+ +||||+++++++..++.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~   71 (316)
T cd05592           1 KVLGKGSFGKVMLAELKG---------TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL   71 (316)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence            469999999999996543         58899999987642   22334556677777755 699999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      |+||||+++|+|.+++...    ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+++.
T Consensus        72 ~lv~e~~~gg~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH--~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~  145 (316)
T cd05592          72 FFVMEYLNGGDLMFHIQSS----GRFDEARARFYAAEIICGLQFLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKE  145 (316)
T ss_pred             EEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence            9999999999999998765    45899999999999999999999  59999999999999999999999999999986


Q ss_pred             eccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          251 FKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      .......   ...    ..||+.|+               +||++.+.. .+.++|+||+|++++++++...+.
T Consensus       146 ~~~~~~~---~~~----~~gt~~y~---------------aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf  196 (316)
T cd05592         146 NMNGEGK---AST----FCGTPDYI---------------APEILKGQK-YNESVDWWSFGVLLYEMLIGQSPF  196 (316)
T ss_pred             CCCCCCc---ccc----ccCCcccc---------------CHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCC
Confidence            5332211   111    16778888               899887665 578899999999999998655443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.7e-34  Score=268.60  Aligned_cols=192  Identities=22%  Similarity=0.226  Sum_probs=158.9

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcC-CCCCcceEEeEEEeCCeE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWEDKEL  170 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~  170 (376)
                      +.||+|+||.||+|...         .+++.||+|+++...   ....+.+.+|..++..+ +||||+++++++...+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   71 (320)
T cd05590           1 RVLGKGSFGKVMLARLK---------ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL   71 (320)
T ss_pred             CeeeeCCCeEEEEEEEc---------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence            46999999999999544         358899999987542   23345677888888877 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      |+||||+++|+|.+++.+.    ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+++.
T Consensus        72 ~iv~Ey~~~g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH--~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~  145 (320)
T cd05590          72 FFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEITSALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE  145 (320)
T ss_pred             EEEEcCCCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence            9999999999999988765    45899999999999999999999  69999999999999999999999999999876


Q ss_pred             eccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          251 FKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ........   .    ...||+.|+               |||++.+.. .+.++|+||+|++++++++...+.
T Consensus       146 ~~~~~~~~---~----~~~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf  196 (320)
T cd05590         146 GIFNGKTT---S----TFCGTPDYI---------------APEILQEML-YGPSVDWWAMGVLLYEMLCGHAPF  196 (320)
T ss_pred             cCcCCCcc---c----ccccCcccc---------------CHHHHcCCC-CCCccchhhhHHHHHHHhhCCCCC
Confidence            43221111   1    116777887               799887654 578899999999999999766554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=274.62  Aligned_cols=199  Identities=26%  Similarity=0.359  Sum_probs=162.1

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC---ChhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      .++..+.+.||+|+||.||+|.+....     ......||+|..+..   ......++.+|+++|++++|||||++||+.
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~-----~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa  230 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKN-----GFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA  230 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecC-----CceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            345567799999999999999876421     111223899999853   356678999999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .....++||||+|+||+|.++|++..   ..++..+...++.+++.||+|||  .+++|||||.++|+|++.++.+||+|
T Consensus       231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh--~k~~IHRDIAARNcL~~~~~~vKISD  305 (474)
T KOG0194|consen  231 VLEEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLH--SKNCIHRDIAARNCLYSKKGVVKISD  305 (474)
T ss_pred             cCCCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHH--HCCCcchhHhHHHheecCCCeEEeCc
Confidence            99999999999999999999998873   35899999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ||+++....-........                      -.-.|+|||.+... .++.++||||||++.+|+.+
T Consensus       306 FGLs~~~~~~~~~~~~~k----------------------lPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~  357 (474)
T KOG0194|consen  306 FGLSRAGSQYVMKKFLKK----------------------LPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFE  357 (474)
T ss_pred             cccccCCcceeecccccc----------------------CcceecChhhhccC-ccccccchhheeeeEEeeec
Confidence            999886541111100110                      00124579977765 67899999999999999985

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.2e-34  Score=277.81  Aligned_cols=196  Identities=25%  Similarity=0.301  Sum_probs=165.0

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-C-----CCcceEEeE
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-H-----PNLVKLLGY  163 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h-----~nIv~l~~~  163 (376)
                      +|++.+.||+|+||+|.+|++..         +++.||||+++.... .......|+.+|..|+ |     -|+|+++++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~---------T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~  256 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHK---------TGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDY  256 (586)
T ss_pred             EEEEEEEecccccceeEEEEecC---------CCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence            68899999999999999996554         799999999987643 3355578999999997 4     489999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC--CcEE
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV--GFLF  241 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~--g~~k  241 (376)
                      |...+++|||+|.+.. +|+++|+.++.  ..++...++.++.||+.||.+||  +.+|||+|||||||||.+.  ..+|
T Consensus       257 F~fr~HlciVfELL~~-NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~--~l~IIHcDLKPENILL~~~~r~~vK  331 (586)
T KOG0667|consen  257 FYFRNHLCIVFELLST-NLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLH--ELGIIHCDLKPENILLKDPKRSRIK  331 (586)
T ss_pred             cccccceeeeehhhhh-hHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCChhheeeccCCcCcee
Confidence            9999999999999955 99999998865  55899999999999999999999  7999999999999999654  4699


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      ++|||.+.+...... .++ .+..|.                       |||++.|..| ..+.|+||||||++|+.+-+
T Consensus       332 VIDFGSSc~~~q~vy-tYi-QSRfYR-----------------------APEVILGlpY-~~~IDmWSLGCIlAEL~tG~  385 (586)
T KOG0667|consen  332 VIDFGSSCFESQRVY-TYI-QSRFYR-----------------------APEVILGLPY-DTAIDMWSLGCILAELFTGE  385 (586)
T ss_pred             EEecccccccCCcce-eee-eccccc-----------------------cchhhccCCC-CCccceeehhhhHHhHhcCc
Confidence            999999998766433 222 333444                       4999999876 88899999999999999776


Q ss_pred             ccchh
Q 017177          322 RTTML  326 (376)
Q Consensus       322 ~~~~~  326 (376)
                      -+..+
T Consensus       386 PLfpG  390 (586)
T KOG0667|consen  386 PLFPG  390 (586)
T ss_pred             cccCC
Confidence            66533

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.8e-34  Score=268.90  Aligned_cols=197  Identities=22%  Similarity=0.238  Sum_probs=162.6

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCC-CCCcceEEeEEE
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLS-HPNLVKLLGYCW  165 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~  165 (376)
                      +|+..+.||+|+||.||+|...         .+++.||+|++....   ....+.+..|..++..+. |++|+++++++.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERK---------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ   71 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence            3678899999999999999543         368899999987542   233456778999998887 678889999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +.+.+|+||||+++|+|.+++.+.    ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+||
T Consensus        72 ~~~~~~lv~Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH--~~~ivHrDikp~Nill~~~~~ikL~Df  145 (323)
T cd05615          72 TVDRLYFVMEYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADF  145 (323)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEecc
Confidence            999999999999999999998765    45899999999999999999999  699999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      |+++.........   .+    ..||+.|+               |||++.+.. .+.++|+||+|++++++++...+.
T Consensus       146 g~~~~~~~~~~~~---~~----~~gt~~y~---------------aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf  201 (323)
T cd05615         146 GMCKEHMVDGVTT---RT----FCGTPDYI---------------APEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPF  201 (323)
T ss_pred             ccccccCCCCccc---cC----ccCCcccc---------------CHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCC
Confidence            9998643322111   11    15778888               899887654 578999999999999999755554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=8.1e-34  Score=266.40  Aligned_cols=192  Identities=23%  Similarity=0.252  Sum_probs=155.1

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHH-HHhcCCCCCcceEEeEEEeCCeE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVN-FLGRLSHPNLVKLLGYCWEDKEL  170 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-il~~l~h~nIv~l~~~~~~~~~~  170 (376)
                      ++||+|+||.||+|+..         .+++.||+|++.....   .....+.+|.. +++.++||||+++++.+.+.+..
T Consensus         1 ~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~   71 (321)
T cd05603           1 KVIGKGSFGKVLLAKRK---------SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL   71 (321)
T ss_pred             CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence            47999999999999554         3588999999875422   22344555554 67889999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      |+||||+++|+|...+.+.    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.+|.+||+|||+++.
T Consensus        72 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  145 (321)
T cd05603          72 YFVLDYVNGGELFFHLQRE----RCFLEPRARFYAAEVASAIGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKE  145 (321)
T ss_pred             EEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence            9999999999999888654    45888999999999999999999  59999999999999999999999999999875


Q ss_pred             eccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          251 FKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ........   ..    ..||+.|+               |||++.+.. .+.++|+||+|++++++++-..+.
T Consensus       146 ~~~~~~~~---~~----~~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf  196 (321)
T cd05603         146 GVEPEETT---ST----FCGTPEYL---------------APEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPF  196 (321)
T ss_pred             CCCCCCcc---cc----ccCCcccC---------------CHHHhcCCC-CCCcCcccccchhhhhhhcCCCCC
Confidence            42221110   11    15777777               799877654 578999999999999998655443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=7.8e-35  Score=286.24  Aligned_cols=208  Identities=27%  Similarity=0.362  Sum_probs=171.6

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh-hHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..+.+.+..+.||+|+||+||+|+..+.    ........||||.++..... ...+|+||++++..|+|||||+++|+|
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l----~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC  558 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGL----LPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC  558 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCC----CCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence            3456677889999999999999976542    22335778999999987665 678999999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCC----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPS----------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL  234 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl  234 (376)
                      ..++.++||+|||..|||.++|+.+.+.          ..+++..+.+.|+.||+.||.||-  .+.+|||||..+|+||
T Consensus       559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs--~~~FVHRDLATRNCLV  636 (774)
T KOG1026|consen  559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS--SHHFVHRDLATRNCLV  636 (774)
T ss_pred             ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCcccccchhhhhcee
Confidence            9999999999999999999999865431          234889999999999999999999  5999999999999999


Q ss_pred             cCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeee
Q 017177          235 DGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVF  314 (376)
Q Consensus       235 ~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~  314 (376)
                      .++-.|||+|||+++..=..+.+.....+.--     -.               ||+||-+...+ ++.++||||+|+|+
T Consensus       637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lP-----IR---------------WMppEsIly~k-FTteSDVWs~GVvL  695 (774)
T KOG1026|consen  637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLP-----IR---------------WMPPESILYGK-FTTESDVWSFGVVL  695 (774)
T ss_pred             ccceEEEecccccchhhhhhhhhcccCCceee-----ee---------------cCCHHHhhcCc-ccchhhhhhhhhhh
Confidence            99999999999999976554444322223211     22               44799666544 59999999999999


Q ss_pred             hhhccc
Q 017177          315 SCVFSF  320 (376)
Q Consensus       315 ~~~~~~  320 (376)
                      ||+++|
T Consensus       696 WEIFsy  701 (774)
T KOG1026|consen  696 WEIFSY  701 (774)
T ss_pred             hhhhcc
Confidence            999965

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-35  Score=275.85  Aligned_cols=190  Identities=28%  Similarity=0.327  Sum_probs=166.5

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhh---HHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG---FEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ...|.-++.||.|+||.||-|         ++..+...||||++.-.....   ..+++.|+..|++++|||+|.+.|+|
T Consensus        25 Eklf~dLrEIGHGSFGAVYfA---------rd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCy   95 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCY   95 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEe---------eccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCccccccee
Confidence            345777899999999999999         444578999999998665433   45778999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      ..+...|+|||||- |+-.|++.-.+   .++.+.++..|+.+.+.||.||||  .+.||||||+.|||+++.|.|||+|
T Consensus        96 Lre~TaWLVMEYCl-GSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS--~~~IHRDiKAGNILLse~g~VKLaD  169 (948)
T KOG0577|consen   96 LREHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS--HNRIHRDIKAGNILLSEPGLVKLAD  169 (948)
T ss_pred             eccchHHHHHHHHh-ccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHH--hhHHhhhccccceEecCCCeeeecc
Confidence            99999999999995 58888886653   678999999999999999999996  8999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh--hhhccccccccceeeeehhhc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW--IKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~--~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      ||.|........+           +|||.||               |||++..  .++++.++||||+|+...|++
T Consensus       170 FGSAsi~~PAnsF-----------vGTPywM---------------APEVILAMDEGqYdgkvDvWSLGITCIELA  219 (948)
T KOG0577|consen  170 FGSASIMAPANSF-----------VGTPYWM---------------APEVILAMDEGQYDGKVDVWSLGITCIELA  219 (948)
T ss_pred             ccchhhcCchhcc-----------cCCcccc---------------chhHheeccccccCCccceeeccchhhhhh
Confidence            9999877655444           9999999               9998774  378899999999999999988

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8.3e-34  Score=267.28  Aligned_cols=191  Identities=21%  Similarity=0.239  Sum_probs=158.5

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcC-CCCCcceEEeEEEeCCeE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWEDKEL  170 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~  170 (376)
                      ++||+|+||.||+|...         .+++.||+|+++...   ....+.+.+|..++..+ +||||+++++++.+++.+
T Consensus         1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~   71 (329)
T cd05588           1 RVIGRGSYAKVLLVELK---------KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL   71 (329)
T ss_pred             CeEeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence            47999999999999554         358899999997642   23345678899999998 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      |+||||+++|+|.+++.+.    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++.
T Consensus        72 ~lv~e~~~~g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  145 (329)
T cd05588          72 FFVIEFVSGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE  145 (329)
T ss_pred             EEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEECcCccccc
Confidence            9999999999999988665    45899999999999999999999  69999999999999999999999999999875


Q ss_pred             eccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          251 FKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      .......   ..    ...||+.|+               |||++.+.. .+.++|+||+|++++++++...+
T Consensus       146 ~~~~~~~---~~----~~~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~P  195 (329)
T cd05588         146 GIRPGDT---TS----TFCGTPNYI---------------APEILRGED-YGFSVDWWALGVLMFEMMAGRSP  195 (329)
T ss_pred             cccCCCc---cc----cccCCcccc---------------CHHHHcCCC-CCCccceechHHHHHHHHHCCCC
Confidence            3221111   01    126777787               799887754 47889999999999999865443

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1e-33  Score=266.59  Aligned_cols=191  Identities=21%  Similarity=0.245  Sum_probs=158.2

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcC-CCCCcceEEeEEEeCCeE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWEDKEL  170 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~  170 (376)
                      +.||+|+||.||+|...         .+++.||+|+++...   ......+.+|+.++..+ +||||+++++++..++.+
T Consensus         1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   71 (329)
T cd05618           1 RVIGRGSYAKVLLVRLK---------KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   71 (329)
T ss_pred             CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence            47999999999999554         358899999997642   23345677899988877 699999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      |+||||+++|+|..++.+.    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++.
T Consensus        72 ~lv~E~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~  145 (329)
T cd05618          72 FFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  145 (329)
T ss_pred             EEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence            9999999999999888665    45899999999999999999999  59999999999999999999999999999975


Q ss_pred             eccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          251 FKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ........   .+    ..||+.|+               |||++.+.. .+.++|+||+|++++++++-..+
T Consensus       146 ~~~~~~~~---~~----~~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~el~~g~~P  195 (329)
T cd05618         146 GLRPGDTT---ST----FCGTPNYI---------------APEILRGED-YGFSVDWWALGVLMFEMMAGRSP  195 (329)
T ss_pred             ccCCCCcc---cc----ccCCcccc---------------CHHHHcCCC-CCCccceecccHHHHHHhhCCCC
Confidence            43221111   11    16777777               799887654 47889999999999999865444

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.6e-35  Score=259.94  Aligned_cols=202  Identities=22%  Similarity=0.280  Sum_probs=166.6

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhh--HHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ...|+....||+|.||.||+|...+..     ......+|+|+++.+....  .....||+.+++.++||||+.+..+|.
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n-----~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl   97 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTN-----DKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL   97 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCC-----cccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence            457999999999999999999543311     1113479999998763321  245679999999999999999999988


Q ss_pred             e-CCeEEEEEeccCCCCHHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC----Cc
Q 017177          166 E-DKELLLVYEYMQRGSLENHLFRRNP-SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV----GF  239 (376)
Q Consensus       166 ~-~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~----g~  239 (376)
                      . +..+|+++||.+. +|.++++.++. ....++...+..|+.||+.|+.|||  .+.|+||||||.||||..+    |.
T Consensus        98 ~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH--~NWvlHRDLKPaNIlvmgdgperG~  174 (438)
T KOG0666|consen   98 SHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH--SNWVLHRDLKPANILVMGDGPERGR  174 (438)
T ss_pred             ccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh--hhheeeccCCcceEEEeccCCccCe
Confidence            7 7889999999987 89998875432 2356899999999999999999999  5999999999999999766    99


Q ss_pred             EEEcceeeeeeecccee----eEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeeh
Q 017177          240 LFDSHLLIYVYFKRHYI----YIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFS  315 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~----~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~  315 (376)
                      |||+|||+++.+...-.    ...+.-|+.|.|                       ||++.|.+.+|.+.|+|+.||||+
T Consensus       175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRA-----------------------PELLLGa~hYT~AiDvWAiGCIfa  231 (438)
T KOG0666|consen  175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRA-----------------------PELLLGARHYTKAIDVWAIGCIFA  231 (438)
T ss_pred             eEeecccHHHHhhccccccccCCceEEEEEecC-----------------------hHHhcccccccchhhhHHHHHHHH
Confidence            99999999998876533    334555566666                       999999999999999999999999


Q ss_pred             hhccc
Q 017177          316 CVFSF  320 (376)
Q Consensus       316 ~~~~~  320 (376)
                      |+++.
T Consensus       232 ElLtl  236 (438)
T KOG0666|consen  232 ELLTL  236 (438)
T ss_pred             HHHcc
Confidence            99854

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-34  Score=268.14  Aligned_cols=191  Identities=24%  Similarity=0.224  Sum_probs=156.1

Q ss_pred             EeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcC---CCCCcceEEeEEEeCCeE
Q 017177           97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRL---SHPNLVKLLGYCWEDKEL  170 (376)
Q Consensus        97 lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l---~h~nIv~l~~~~~~~~~~  170 (376)
                      ||+|+||.||+|...         .+++.||+|++.....   .....+..|..++..+   .||||+++++.+.+++.+
T Consensus         1 lG~G~~g~Vy~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~   71 (330)
T cd05586           1 IGKGTFGQVYQVRKK---------DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL   71 (330)
T ss_pred             CCCCCceEEEEEEEC---------CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence            699999999999543         4688999999865322   2233455677777665   699999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      |+||||+++|+|.+++.+.    ..+++..+..++.||+.||+|||  .++|+||||||+|||++.++.++|+|||++..
T Consensus        72 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH--~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~  145 (330)
T cd05586          72 YLVTDYMSGGELFWHLQKE----GRFSEDRAKFYIAELVLALEHLH--KYDIVYRDLKPENILLDATGHIALCDFGLSKA  145 (330)
T ss_pred             EEEEcCCCCChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence            9999999999999988765    45899999999999999999999  59999999999999999999999999999876


Q ss_pred             eccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          251 FKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ........   .+.    .||+.||               +||++.+...++.++||||+|++++++++-..+.
T Consensus       146 ~~~~~~~~---~~~----~gt~~y~---------------aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf  197 (330)
T cd05586         146 NLTDNKTT---NTF----CGTTEYL---------------APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF  197 (330)
T ss_pred             CCCCCCCc---cCc----cCCcccc---------------CHHHHcCCCCCCCccceeccccEEEEeccCCCCC
Confidence            43222111   111    5777777               7998887766789999999999999998765553

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.3e-34  Score=266.58  Aligned_cols=192  Identities=24%  Similarity=0.264  Sum_probs=157.3

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcC-CCCCcceEEeEEEeCCeE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWEDKEL  170 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~  170 (376)
                      +.||+|+||.||+|...         .++..||+|.++...   ....+.+..|..++..+ +||||+++++++.+++.+
T Consensus         1 ~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~   71 (316)
T cd05620           1 KVLGKGSFGKVLLAELK---------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL   71 (316)
T ss_pred             CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence            47999999999999544         368899999997642   12345567788888765 799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      |+||||+++|+|..++...    ..+++..+..++.|++.||+|||  .++|+||||||+|||++.+|.++|+|||+++.
T Consensus        72 ~lv~E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05620          72 FFVMEFLNGGDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLH--SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKE  145 (316)
T ss_pred             EEEECCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence            9999999999999998765    45889999999999999999999  69999999999999999999999999999875


Q ss_pred             eccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          251 FKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      .......   ..    ...||+.|+               |||++.+.. ++.++|+||+|++++++++...+.
T Consensus       146 ~~~~~~~---~~----~~~gt~~y~---------------aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf  196 (316)
T cd05620         146 NVFGDNR---AS----TFCGTPDYI---------------APEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPF  196 (316)
T ss_pred             cccCCCc---ee----ccCCCcCcc---------------CHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCC
Confidence            3221111   11    126777787               899887665 578899999999999998655443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=9.3e-34  Score=269.52  Aligned_cols=193  Identities=20%  Similarity=0.209  Sum_probs=157.3

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..+|+..+.||+|+||.||+|...         .+++.||||++..... .....+.+|+++++.++|+||+++++++..
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  143 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHR---------PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH  143 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEEC---------CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc
Confidence            346788899999999999999554         3588999999875533 334678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++.+++||||+++|+|.+.        ....+..+..++.||+.||.|||  +++|+||||||+|||++.++.+||+|||
T Consensus       144 ~~~~~lv~e~~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~kL~DfG  213 (353)
T PLN00034        144 NGEIQVLLEFMDGGSLEGT--------HIADEQFLADVARQILSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFG  213 (353)
T ss_pred             CCeEEEEEecCCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCEEEcccc
Confidence            9999999999999998642        22567788899999999999999  6999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh----hhhccccccccceeeeehhhcccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW----IKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~----~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      +++.+.......   ..    ..||+.|+               +||++..    ..+...++||||||++++++++..
T Consensus       214 ~~~~~~~~~~~~---~~----~~gt~~y~---------------aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~  270 (353)
T PLN00034        214 VSRILAQTMDPC---NS----SVGTIAYM---------------SPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR  270 (353)
T ss_pred             cceecccccccc---cc----cccCcccc---------------CccccccccccCcCCCcchhHHHHHHHHHHHHhCC
Confidence            998765432211   11    16777777               7897643    234456899999999999988543

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.1e-33  Score=264.89  Aligned_cols=192  Identities=25%  Similarity=0.267  Sum_probs=157.5

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcC-CCCCcceEEeEEEeCCeE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWEDKEL  170 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~  170 (376)
                      +.||+|+||.||+|...         .+++.||+|+++...   .........|..++..+ +||||+++++++.+++.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~   71 (316)
T cd05619           1 KMLGKGSFGKVFLAELK---------GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL   71 (316)
T ss_pred             CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence            46999999999999554         358899999987642   12335566788888764 799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      |+||||+++|+|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||++..
T Consensus        72 ~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH--~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05619          72 FFVMEYLNGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKE  145 (316)
T ss_pred             EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence            9999999999999999765    35889999999999999999999  59999999999999999999999999999986


Q ss_pred             eccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          251 FKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ........   .    ...||+.|+               |||++.+.. .+.++|+||+|++++++++...+.
T Consensus       146 ~~~~~~~~---~----~~~gt~~y~---------------aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf  196 (316)
T cd05619         146 NMLGDAKT---C----TFCGTPDYI---------------APEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPF  196 (316)
T ss_pred             CCCCCCce---e----eecCCcccc---------------CHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCC
Confidence            43222111   1    116777788               799887655 578999999999999999755443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.4e-34  Score=281.35  Aligned_cols=207  Identities=19%  Similarity=0.166  Sum_probs=169.3

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ...++|++.+.||+|+||.||+|...         .+++.||||++....  ......+.+|+.++..++|+||+++++.
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~---------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~   99 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRV---------SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED   99 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEc---------CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecc
Confidence            34578999999999999999999543         358899999987653  3445678899999999999999999887


Q ss_pred             EEeCC--------eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc
Q 017177          164 CWEDK--------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD  235 (376)
Q Consensus       164 ~~~~~--------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~  235 (376)
                      +...+        .+++||||+++|+|.+++.........+++..+..++.|++.||.|||  .++|+||||||+|||++
T Consensus       100 ~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH--~~~IiHrDLKP~NILl~  177 (496)
T PTZ00283        100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH--SKHMIHRDIKSANILLC  177 (496)
T ss_pred             eecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEe
Confidence            75432        378999999999999999765444467899999999999999999999  59999999999999999


Q ss_pred             CCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeeh
Q 017177          236 GVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFS  315 (376)
Q Consensus       236 ~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~  315 (376)
                      .++.+||+|||+++.+....... ...+    ..||+.|+               +||++.+.. ++.++||||+|++++
T Consensus       178 ~~~~vkL~DFGls~~~~~~~~~~-~~~~----~~Gt~~Y~---------------aPE~~~~~~-~s~k~DVwSlGvily  236 (496)
T PTZ00283        178 SNGLVKLGDFGFSKMYAATVSDD-VGRT----FCGTPYYV---------------APEIWRRKP-YSKKADMFSLGVLLY  236 (496)
T ss_pred             CCCCEEEEecccCeecccccccc-cccc----ccCCccee---------------CHHHhCCCC-CCcHHHHHHHHHHHH
Confidence            99999999999998765432211 1111    26778888               799887654 578999999999999


Q ss_pred             hhccccccc
Q 017177          316 CVFSFYRTT  324 (376)
Q Consensus       316 ~~~~~y~~~  324 (376)
                      ++++...+.
T Consensus       237 eLltG~~Pf  245 (496)
T PTZ00283        237 ELLTLKRPF  245 (496)
T ss_pred             HHHHCCCCC
Confidence            999765554

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.7e-33  Score=264.99  Aligned_cols=191  Identities=22%  Similarity=0.239  Sum_probs=159.2

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCC-CCCcceEEeEEEeCCeE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKEL  170 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~  170 (376)
                      +.||+|+||.||+|....         +++.||+|+++....   ...+.+.+|+.++.++. ||||+++++++.+.+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   71 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKK---------NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL   71 (327)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence            479999999999995543         588999999986532   33456788999999884 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      |+||||+++|+|..++...    ..+++..+..++.||+.||+|||  .++|+||||||+|||++.++.+||+|||++..
T Consensus        72 ~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~  145 (327)
T cd05617          72 FLVIEYVNGGDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKE  145 (327)
T ss_pred             EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEeCCCCEEEecccccee
Confidence            9999999999999988765    45899999999999999999999  59999999999999999999999999999985


Q ss_pred             eccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          251 FKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ........       ....||+.|+               |||++.+.. .+.++|+||+|++++++++...+
T Consensus       146 ~~~~~~~~-------~~~~gt~~y~---------------aPE~~~~~~-~~~~~DiwslGvil~ell~g~~p  195 (327)
T cd05617         146 GLGPGDTT-------STFCGTPNYI---------------APEILRGEE-YGFSVDWWALGVLMFEMMAGRSP  195 (327)
T ss_pred             ccCCCCce-------ecccCCcccC---------------CHHHHCCCC-CCchheeehhHHHHHHHHhCCCC
Confidence            33221111       1126788888               899887655 47899999999999999865444

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.9e-34  Score=272.45  Aligned_cols=206  Identities=27%  Similarity=0.322  Sum_probs=164.8

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcC-CCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|.+...    .+..++..||+|+++... ....+.+.+|+.+++.+ +||||+++++++
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~  108 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGL----FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC  108 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEecc----ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence            456799999999999999999975321    223357789999997543 23446788999999999 799999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCC-----------------------------------------------------
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNP-----------------------------------------------------  191 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------  191 (376)
                      .+.+..++|||||++|+|.+++.+...                                                     
T Consensus       109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            999999999999999999999975321                                                     


Q ss_pred             ------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          192 ------------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       192 ------------------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                                        ....+++..+..++.||+.||.|||  .++|+||||||+|||++.++.+||+|||+++....
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                              0124788889999999999999999  59999999999999999999999999999987654


Q ss_pred             ceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          254 HYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       254 ~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ..... ..++.    .+++.|+               +||.+.+.. .+.++|+||||++++++++
T Consensus       267 ~~~~~-~~~~~----~~~~~y~---------------aPE~~~~~~-~~~~sDi~slG~~l~ellt  311 (375)
T cd05104         267 DSNYV-VKGNA----RLPVKWM---------------APESIFNCV-YTFESDVWSYGILLWEIFS  311 (375)
T ss_pred             ccccc-ccCCC----CCCccee---------------ChhHhcCCC-CCCCCCHHHHHHHHHHHHh
Confidence            33221 11111    2334455               699876654 5889999999999999886

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.1e-33  Score=270.93  Aligned_cols=207  Identities=26%  Similarity=0.314  Sum_probs=164.5

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcC-CCCCcceEEeE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGY  163 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~l~~~  163 (376)
                      ...++|++.+.||+|+||.||+|.....    .+..++..||+|.++... ....+.+.+|+.+++.+ +|+||++++++
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~  110 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGL----GKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGA  110 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecC----CcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence            3456799999999999999999975431    112245689999997653 33456788999999999 79999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCC----------------------------------------------------
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNP----------------------------------------------------  191 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------  191 (376)
                      +...+..++|||||++|+|.+++.+...                                                    
T Consensus       111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (374)
T cd05106         111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS  190 (374)
T ss_pred             ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence            9999999999999999999999865321                                                    


Q ss_pred             --------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeeccceee
Q 017177          192 --------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIY  257 (376)
Q Consensus       192 --------------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~  257 (376)
                                    ....+++..+..++.||+.||.|||  .++|+||||||+|||+++++.+||+|||+++........
T Consensus       191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH--~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA--SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                          0124788889999999999999999  599999999999999999999999999999876543322


Q ss_pred             EEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          258 IYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       258 ~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      . ..++.    .+++.||               |||++... .++.++||||+|++++++++
T Consensus       269 ~-~~~~~----~~~~~y~---------------aPE~~~~~-~~~~~~DvwSlGvil~ellt  309 (374)
T cd05106         269 V-VKGNA----RLPVKWM---------------APESIFDC-VYTVQSDVWSYGILLWEIFS  309 (374)
T ss_pred             e-eccCC----CCcccee---------------CHHHhcCC-CCCccccHHHHHHHHHHHHh
Confidence            1 11211    3344566               79977544 46889999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=259.93  Aligned_cols=189  Identities=26%  Similarity=0.339  Sum_probs=168.2

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeE
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKEL  170 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~  170 (376)
                      |.++..||+|+||.||+|         .++.+|+.+|||.+..+.  +++++..|+.||++++.|++|++||.+.....+
T Consensus        35 FDi~~KLGEGSYGSV~KA---------IH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDL  103 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKA---------IHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDL  103 (502)
T ss_pred             HHHHHHhcCCcchHHHHH---------HHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCce
Confidence            667789999999999999         455579999999988764  567889999999999999999999999988999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      |||||||..|+..++++.++   .++.+.++..+++..+.||+|||  ...-||||||+.|||++.+|..||+|||.|..
T Consensus       104 WIVMEYCGAGSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH--~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQ  178 (502)
T KOG0574|consen  104 WIVMEYCGAGSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLH--DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQ  178 (502)
T ss_pred             EeehhhcCCCcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHH--HHHHHHhhcccccEEEcccchhhhhhccccch
Confidence            99999999999999998763   67999999999999999999999  69999999999999999999999999999998


Q ss_pred             eccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          251 FKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      +++.-...   .|.    +|||-||               |||++...+| ..++|+||+|+...||+
T Consensus       179 LTDTMAKR---NTV----IGTPFWM---------------APEVI~EIGY-~~~ADIWSLGITaIEMA  223 (502)
T KOG0574|consen  179 LTDTMAKR---NTV----IGTPFWM---------------APEVIEEIGY-DTKADIWSLGITAIEMA  223 (502)
T ss_pred             hhhhHHhh---Ccc----ccCcccc---------------cHHHHHHhcc-chhhhHhhhcchhhhhh
Confidence            87653321   222    8999999               9999988886 56779999999999998

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.2e-34  Score=269.88  Aligned_cols=198  Identities=22%  Similarity=0.251  Sum_probs=160.3

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      +|++.+.||+|+||.||+|...         .++..||+|.+...  .......+.+|+.+++.++||||+++++++...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   71 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDT---------HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP   71 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEEC---------CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence            4888999999999999999543         35889999998753  223345688999999999999999999988643


Q ss_pred             -----CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          168 -----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       168 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                           ..+|+|||||. ++|.+++.+.    ..+++..+..++.||+.||.|||  +++|+||||||+|||++.+|.+||
T Consensus        72 ~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~~~kL  144 (338)
T cd07859          72 SRREFKDIYVVFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIH--TANVFHRDLKPKNILANADCKLKI  144 (338)
T ss_pred             CCCCCceEEEEEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCcEEE
Confidence                 25899999995 6899988765    45899999999999999999999  599999999999999999999999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh-hhccccccccceeeeehhhcccc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI-KYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~-~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      +|||+++..............    ..||+.|+               |||++.+. ...+.++||||+|++++++++..
T Consensus       145 ~Dfg~~~~~~~~~~~~~~~~~----~~~t~~y~---------------aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~  205 (338)
T cd07859         145 CDFGLARVAFNDTPTAIFWTD----YVATRWYR---------------APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK  205 (338)
T ss_pred             ccCccccccccccCccccccC----CCCCCCcC---------------CHHHHhccccccCchhHHHHHHHHHHHHHcCC
Confidence            999999865332221111111    16778888               89987652 45688999999999999999754


Q ss_pred             c
Q 017177          322 R  322 (376)
Q Consensus       322 ~  322 (376)
                      .
T Consensus       206 ~  206 (338)
T cd07859         206 P  206 (338)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.4e-34  Score=261.16  Aligned_cols=193  Identities=24%  Similarity=0.296  Sum_probs=159.7

Q ss_pred             EeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEE
Q 017177           97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        97 lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv  173 (376)
                      ||+|+||+||+|...         .+++.||+|.+.....   ...+.+..|+.+++.++|+||+++.+++..++..++|
T Consensus         1 lg~G~~g~Vy~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   71 (280)
T cd05608           1 LGKGGFGEVSACQMR---------ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV   71 (280)
T ss_pred             CCCCCceeEEEEEEc---------cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence            699999999999544         3588999999875432   2335677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      |||+++|+|.+++.........+++..+..++.||+.||.|||  +++|+||||||+||+++.++.++|+|||++.....
T Consensus        72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  149 (280)
T cd05608          72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD  149 (280)
T ss_pred             EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence            9999999999888654333456899999999999999999999  59999999999999999999999999999987654


Q ss_pred             ceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          254 HYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       254 ~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      .....  .+     ..||+.|+               +||++.+.. .+.++|+||+|++++++++-..+
T Consensus       150 ~~~~~--~~-----~~g~~~y~---------------aPE~~~~~~-~~~~~DvwslG~il~el~~g~~p  196 (280)
T cd05608         150 GQSKT--KG-----YAGTPGFM---------------APELLQGEE-YDFSVDYFALGVTLYEMIAARGP  196 (280)
T ss_pred             CCccc--cc-----cCCCcCcc---------------CHHHhcCCC-CCccccHHHHHHHHHHHHhCCCC
Confidence            32211  11     15777777               799887764 47899999999999999865444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.7e-34  Score=274.71  Aligned_cols=191  Identities=18%  Similarity=0.127  Sum_probs=159.9

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ...+|++.+.||+|+||.||+|...         .+++.||+|....      ..+.+|+.+++.++||||+++++++..
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~---------~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~  154 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDN---------KTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTY  154 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEEC---------CCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence            3467999999999999999999544         4688999997542      346789999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      +...++|||++. ++|..++...    ..+++..++.++.||+.||.|||  .++|+||||||+|||++.+|.+||+|||
T Consensus       155 ~~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH--~~~IvHrDiKP~NIll~~~~~vkL~DFG  227 (391)
T PHA03212        155 NKFTCLILPRYK-TDLYCYLAAK----RNIAICDILAIERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFG  227 (391)
T ss_pred             CCeeEEEEecCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHhEEEcCCCCEEEEeCC
Confidence            999999999995 6898888665    35889999999999999999999  5899999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      ++.........      ..+...||+.|+               +||++.+.. ++.++|+||+|++++++++..
T Consensus       228 ~a~~~~~~~~~------~~~~~~gt~~y~---------------aPE~~~~~~-~~~~~DiwSlGvil~elltg~  280 (391)
T PHA03212        228 AACFPVDINAN------KYYGWAGTIATN---------------APELLARDP-YGPAVDIWSAGIVLFEMATCH  280 (391)
T ss_pred             ccccccccccc------ccccccCccCCC---------------ChhhhcCCC-CCcHHHHHHHHHHHHHHHHCC
Confidence            99754332111      111226788888               899887654 588999999999999998644

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.1e-33  Score=266.61  Aligned_cols=198  Identities=22%  Similarity=0.240  Sum_probs=167.4

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||++...         .++..+|+|.+..... ...+.+.+|+++++.++||||+++++++..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHK---------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS   74 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEEC---------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            468999999999999999999544         3588999999986532 334678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++.+++||||+++|+|.+++...    ..+++..+..++.|++.||.|||+ ..+|+||||||+|||++.+|.+||+|||
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg  149 (331)
T cd06649          75 DGEISICMEHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFG  149 (331)
T ss_pred             CCEEEEEeecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhh-cCCEEcCCCChhhEEEcCCCcEEEccCc
Confidence            99999999999999999999765    348899999999999999999995 3469999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ++.........     .    ..||+.|+               +||++.+.. .+.++|+||+|++++++++...+.
T Consensus       150 ~~~~~~~~~~~-----~----~~g~~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~  202 (331)
T cd06649         150 VSGQLIDSMAN-----S----FVGTRSYM---------------SPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPI  202 (331)
T ss_pred             ccccccccccc-----c----CCCCcCcC---------------CHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCC
Confidence            99866432111     1    15677777               799887654 578999999999999998655443

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2e-33  Score=276.87  Aligned_cols=197  Identities=20%  Similarity=0.230  Sum_probs=155.3

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCC------CCcce
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH------PNLVK  159 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h------~nIv~  159 (376)
                      ...++|++.+.||+|+||.||+|...         .+++.||||+++.... ..+.+..|+.+++.++|      .+|++
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~---------~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~  195 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDR---------KRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMK  195 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEc---------CCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceee
Confidence            34578999999999999999999554         3588999999975322 22445667777777654      45888


Q ss_pred             EEeEEEeC-CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          160 LLGYCWED-KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       160 l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      +++++..+ +++++|||++ +++|.+++.+.    ..+++..+..++.||+.||.|||+ +.+||||||||+|||++.++
T Consensus       196 i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~-~~gIiHrDlKP~NILl~~~~  269 (467)
T PTZ00284        196 IQRYFQNETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHT-ELHLMHTDLKPENILMETSD  269 (467)
T ss_pred             eEEEEEcCCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCHHHEEEecCC
Confidence            99988765 5789999998 77899988765    458999999999999999999994 36999999999999998765


Q ss_pred             ----------------cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcc
Q 017177          239 ----------------FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLT  302 (376)
Q Consensus       239 ----------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~  302 (376)
                                      .+||+|||.+.......      .+    .+||+.|+               |||++.+.. ++
T Consensus       270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~~------~~----~~gt~~Y~---------------APE~~~~~~-~~  323 (467)
T PTZ00284        270 TVVDPVTNRALPPDPCRVRICDLGGCCDERHSR------TA----IVSTRHYR---------------SPEVVLGLG-WM  323 (467)
T ss_pred             cccccccccccCCCCceEEECCCCccccCcccc------cc----ccCCcccc---------------CcHHhhcCC-CC
Confidence                            49999999876432211      11    27788888               899888765 47


Q ss_pred             ccccccceeeeehhhccccccc
Q 017177          303 LLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       303 ~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      .++||||+|++++|+++-..+.
T Consensus       324 ~~~DiwSlGvil~elltG~~pf  345 (467)
T PTZ00284        324 YSTDMWSMGCIIYELYTGKLLY  345 (467)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCC
Confidence            8899999999999999655443

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.1e-33  Score=256.40  Aligned_cols=199  Identities=23%  Similarity=0.308  Sum_probs=162.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|.+...      ...+..||+|.++.... .....+.+|+.++++++||||+++++++..
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~------~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   77 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLP------SKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR   77 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecC------CCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence            35689999999999999999976531      22467899999987533 334678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++..++||||+++|+|.+++....   ..+++..++.++.|++.||+|||  +++++||||||+|||++.++.++++|||
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH--~~~iiH~dikp~nili~~~~~~~l~dfg  152 (266)
T cd05064          78 GNTMMIVTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLS--EMGYVHKGLAAHKVLVNSDLVCKISGFR  152 (266)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--HCCEeeccccHhhEEEcCCCcEEECCCc
Confidence            999999999999999999997642   45889999999999999999999  6999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      .+.............+      .+++.|+               +||.+.+.. .+.++|+||+|++++++++
T Consensus       153 ~~~~~~~~~~~~~~~~------~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~~l~ell~  203 (266)
T cd05064         153 RLQEDKSEAIYTTMSG------KSPVLWA---------------APEAIQYHH-FSSASDVWSFGIVMWEVMS  203 (266)
T ss_pred             ccccccccchhcccCC------CCceeec---------------CHHHHhhCC-ccchhHHHHHHHHHHHHhc
Confidence            8775432221111111      2334455               799877654 5789999999999999664

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.6e-33  Score=262.66  Aligned_cols=192  Identities=23%  Similarity=0.274  Sum_probs=158.8

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcC-CCCCcceEEeEEEeCCeE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWEDKEL  170 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~  170 (376)
                      +.||+|+||.||+|...         .++..||+|+++...   ......+.+|..+++.+ +||||+++++++...+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~   71 (318)
T cd05570           1 KVLGKGSFGKVLLAELK---------GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL   71 (318)
T ss_pred             CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence            46999999999999554         358899999987542   23345677899999888 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      |+||||+++|+|..++.+.    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+++.
T Consensus        72 ~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  145 (318)
T cd05570          72 FFVMEYVNGGDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKE  145 (318)
T ss_pred             EEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeEccCCCHHHeEECCCCcEEecccCCCee
Confidence            9999999999999988765    45899999999999999999999  69999999999999999999999999999875


Q ss_pred             eccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          251 FKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ........   .    ...||+.|+               +||++.+.. .+.++|+||+|++++++++-..+.
T Consensus       146 ~~~~~~~~---~----~~~g~~~y~---------------aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf  196 (318)
T cd05570         146 GILGGVTT---S----TFCGTPDYI---------------APEILSYQP-YGPAVDWWALGVLLYEMLAGQSPF  196 (318)
T ss_pred             cCcCCCcc---c----ceecCcccc---------------CHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCC
Confidence            32222111   1    115777777               899887765 478999999999999998655443

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.6e-33  Score=269.93  Aligned_cols=208  Identities=25%  Similarity=0.306  Sum_probs=165.4

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCC-CCCcceEEe
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLS-HPNLVKLLG  162 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-h~nIv~l~~  162 (376)
                      ....++|++++.||+|+||.||+|.....    .+...+..||||+++.... ...+.+.+|+.++++++ ||||+++++
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~  108 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGL----SRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLG  108 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEccc----CCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence            33467899999999999999999976431    1223356799999976533 33467889999999997 999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcCC---------------------------------------------------
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRNP---------------------------------------------------  191 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------  191 (376)
                      ++.+.+.+|||||||++|+|.+++.+...                                                   
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (400)
T cd05105         109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY  188 (400)
T ss_pred             EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence            99999999999999999999999865321                                                   


Q ss_pred             -----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCC
Q 017177          192 -----------------------------------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKAS  230 (376)
Q Consensus       192 -----------------------------------------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~  230 (376)
                                                               ....+++..+..++.|++.||.|||  ..+|+||||||+
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivH~dikp~  266 (400)
T cd05105         189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA--SKNCVHRDLAAR  266 (400)
T ss_pred             chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChH
Confidence                                                     0124778888999999999999999  599999999999


Q ss_pred             CEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccce
Q 017177          231 NILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSF  310 (376)
Q Consensus       231 NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~  310 (376)
                      |||++.++.+||+|||+++.............+     .+++.|+               +||.+.+.. .+.++||||+
T Consensus       267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~-----~~~~~y~---------------aPE~~~~~~-~~~~~DiwSl  325 (400)
T cd05105         267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGST-----FLPVKWM---------------APESIFDNL-YTTLSDVWSY  325 (400)
T ss_pred             hEEEeCCCEEEEEeCCcceeccccccccccCCc-----CCCcceE---------------ChhhhcCCC-CCchhhHHHH
Confidence            999999999999999999876443222111111     4455666               799776644 5789999999


Q ss_pred             eeeehhhcc
Q 017177          311 AFVFSCVFS  319 (376)
Q Consensus       311 g~v~~~~~~  319 (376)
                      |++++++++
T Consensus       326 Gvil~ellt  334 (400)
T cd05105         326 GILLWEIFS  334 (400)
T ss_pred             HHHHHHHHH
Confidence            999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.3e-34  Score=277.90  Aligned_cols=199  Identities=21%  Similarity=0.243  Sum_probs=160.3

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||||++....    ....+|+.+++.++||||+++++++..
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~---------~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~  130 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICI---------DTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYT  130 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEEC---------CCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEee
Confidence            3467999999999999999999554         358899999886543    233579999999999999999988754


Q ss_pred             C--------CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          167 D--------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       167 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      .        ..+++||||+++ +|.+++.........+++..+..++.||+.||.|||  .++|+||||||+|||++.++
T Consensus       131 ~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH--~~~IiHrDLKp~NILl~~~~  207 (440)
T PTZ00036        131 ECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNT  207 (440)
T ss_pred             cccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCcCHHHEEEcCCC
Confidence            2        247799999975 788777653333466899999999999999999999  59999999999999998665


Q ss_pred             -cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhh
Q 017177          239 -FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCV  317 (376)
Q Consensus       239 -~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~  317 (376)
                       .+||+|||+++.+........        ..||+.|+               |||++.+...++.++|+||+|++++++
T Consensus       208 ~~vkL~DFGla~~~~~~~~~~~--------~~~t~~y~---------------aPE~~~~~~~~~~~~DiwSlGvil~el  264 (440)
T PTZ00036        208 HTLKLCDFGSAKNLLAGQRSVS--------YICSRFYR---------------APELMLGATNYTTHIDLWSLGCIIAEM  264 (440)
T ss_pred             CceeeeccccchhccCCCCccc--------CCCCcCcc---------------CHHHhcCCCCCCcHHHHHHHHHHHHHH
Confidence             699999999987654322211        15677777               899888777778999999999999999


Q ss_pred             ccccccc
Q 017177          318 FSFYRTT  324 (376)
Q Consensus       318 ~~~y~~~  324 (376)
                      ++-+.+.
T Consensus       265 ltG~~pf  271 (440)
T PTZ00036        265 ILGYPIF  271 (440)
T ss_pred             HhCCCCC
Confidence            9765544

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.9e-33  Score=261.20  Aligned_cols=201  Identities=20%  Similarity=0.282  Sum_probs=161.5

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..+|++.+.||+|+||.||+|.+...     .......||+|.++... ....+++.+|+.+++.++||||+++++++..
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~   80 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT   80 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecC-----CCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence            35699999999999999999976431     12224569999997653 3445678899999999999999999999876


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      . ..++++||+++|+|.+++.+..   ..+++..+..++.||+.||+|||  +++|+||||||+|||++.++.+||+|||
T Consensus        81 ~-~~~~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH--~~~iiH~dlkp~Nill~~~~~~kl~DfG  154 (316)
T cd05108          81 S-TVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFG  154 (316)
T ss_pred             C-CceeeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHH--hcCeeccccchhheEecCCCcEEEcccc
Confidence            4 5789999999999999997652   45788999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      +++............+.     .+++.|+               +||.+... ..+.++|+||||+++++++++
T Consensus       155 ~a~~~~~~~~~~~~~~~-----~~~~~y~---------------apE~~~~~-~~~~~~Di~slGv~l~el~t~  207 (316)
T cd05108         155 LAKLLGADEKEYHAEGG-----KVPIKWM---------------ALESILHR-IYTHQSDVWSYGVTVWELMTF  207 (316)
T ss_pred             ccccccCCCcceeccCC-----ccceeec---------------ChHHhccC-CCCchhhhHHHHHHHHHHHcC
Confidence            99987554332111111     2344555               79977654 458899999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=255.74  Aligned_cols=201  Identities=21%  Similarity=0.230  Sum_probs=167.0

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEEeEEEeCCeEEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lv  173 (376)
                      +.||+|+|+.|-.|         ....++..||||++.+.....+.++.+|++++..++ |+||++++++|+++..+|+|
T Consensus        84 e~LGeGAyasVqtc---------v~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV  154 (463)
T KOG0607|consen   84 ELLGEGAYASVQTC---------VSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV  154 (463)
T ss_pred             HHhcCccceeeeee---------eeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence            68999999999988         445579999999999987777889999999999998 99999999999999999999


Q ss_pred             EeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC---cEEEcceeeeee
Q 017177          174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG---FLFDSHLLIYVY  250 (376)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g---~~kl~Dfg~a~~  250 (376)
                      ||.+.||.|...+.++    ..+++.++.++.++|+.||.|||  .++|.||||||+|||-....   -+|||||.+..-
T Consensus       155 fEKm~GGplLshI~~~----~~F~E~EAs~vvkdia~aLdFlH--~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg  228 (463)
T KOG0607|consen  155 FEKMRGGPLLSHIQKR----KHFNEREASRVVKDIASALDFLH--TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG  228 (463)
T ss_pred             EecccCchHHHHHHHh----hhccHHHHHHHHHHHHHHHHHHh--hcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence            9999999999999887    56999999999999999999999  79999999999999985443   489999987765


Q ss_pred             eccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHh---h-hhhccccccccceeeeehhhccccccch
Q 017177          251 FKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYA---W-IKYLTLLKYSNSFAFVFSCVFSFYRTTM  325 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~---~-~~~~~~~~dv~s~g~v~~~~~~~y~~~~  325 (376)
                      .+.....+.....--..++|+.+||               |||++.   + ..++..++|.||+|+|++.|++-|-+..
T Consensus       229 ~k~~~~~spastP~L~tPvGSAEfM---------------APEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFv  292 (463)
T KOG0607|consen  229 IKLNNDCSPASTPELLTPVGSAEFM---------------APEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFV  292 (463)
T ss_pred             cccCCCCCCCCCccccCcccchhhc---------------chhHHhhhccccccccccccHHHHHHHHHHHHhCCCCcc
Confidence            5443322211111122348999999               666543   2 2566789999999999999998887763

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=252.09  Aligned_cols=199  Identities=19%  Similarity=0.237  Sum_probs=168.0

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..+.|++.++||+|.|+.|++|         .+..+|+.+|+|++.....  .+.+.+.+|+.|.+.|+||||+++.+.+
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc---------~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti   79 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI   79 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHH---------HhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh
Confidence            3567899999999999999998         5555799999999876532  4568889999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC---CCcEE
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG---VGFLF  241 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~---~g~~k  241 (376)
                      ...+..|||+|++.|++|..-+..+    ..+++..+-.+++||+++|.|+|  .++|||||+||+|+|+..   ..-+|
T Consensus        80 ~~~~~~ylvFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH--~n~IvHRDvkP~nllLASK~~~A~vK  153 (355)
T KOG0033|consen   80 QEESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCH--SNGIVHRDLKPENLLLASKAKGAAVK  153 (355)
T ss_pred             cccceeEEEEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHH--hcCceeccCChhheeeeeccCCCcee
Confidence            9999999999999999998777665    45889999999999999999999  599999999999999953   34599


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |+|||+|..+.....   .+|.     +|||.||               +||++... .+....|+|+-|+|++.++.-|
T Consensus       154 L~~FGvAi~l~~g~~---~~G~-----~GtP~fm---------------aPEvvrkd-py~kpvDiW~cGViLfiLL~G~  209 (355)
T KOG0033|consen  154 LADFGLAIEVNDGEA---WHGF-----AGTPGYL---------------SPEVLKKD-PYSKPVDIWACGVILYILLVGY  209 (355)
T ss_pred             ecccceEEEeCCccc---cccc-----cCCCccc---------------CHHHhhcC-CCCCcchhhhhhHHHHHHHhCC
Confidence            999999998873221   2232     8999999               99977654 4588899999999999888555


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      -+.
T Consensus       210 ~PF  212 (355)
T KOG0033|consen  210 PPF  212 (355)
T ss_pred             CCC
Confidence            444

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-33  Score=262.05  Aligned_cols=202  Identities=24%  Similarity=0.335  Sum_probs=167.6

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ..+...+.+.||+|.||.|.+|....          +..||+|.++.... ...++|.+|+++|.+|+||||++++++|.
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg----------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~  605 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEG----------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCV  605 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecC----------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeee
Confidence            34567888999999999999997764          68999999998754 44589999999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      .++.+++++||+++|+|.+++.++...  .+......+|+.||+.||+||.+  .++|||||.++|+|+|.++++||+||
T Consensus       606 ~DePicmI~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes--~nfVHrd~a~rNcLv~~e~~iKiadf  681 (807)
T KOG1094|consen  606 QDDPLCMITEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLES--LNFVHRDLATRNCLVDGEFTIKIADF  681 (807)
T ss_pred             cCCchHHHHHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHh--hchhhccccccceeecCcccEEecCc
Confidence            999999999999999999999887432  24566778899999999999995  99999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |+++.+-..+.+... |..    +-.-.||               |||-+... .++.++|||.||..+||++.+.+.
T Consensus       682 gmsR~lysg~yy~vq-gr~----vlpiRwm---------------awEsillg-kFttaSDvWafgvTlwE~~~~C~e  738 (807)
T KOG1094|consen  682 GMSRNLYSGDYYRVQ-GRA----VLPIRWM---------------AWESILLG-KFTTASDVWAFGVTLWEVFMLCRE  738 (807)
T ss_pred             ccccccccCCceeee-cce----eeeeeeh---------------hHHHHHhc-cccchhhhhhhHHHHHHHHHHHhh
Confidence            999976555444222 221    2223444               79955543 358999999999999999966544

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=9e-34  Score=261.54  Aligned_cols=196  Identities=20%  Similarity=0.191  Sum_probs=161.3

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ++|++.+.||+|+||.||+|+..         .+++.||+|++.....  ...+.+.+|+.+++.++||||+++++++..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHK---------ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR   71 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEEC---------CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence            46899999999999999999554         3588999999875422  234677899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++..|+||||++++.+..+....    ..+++..+..++.|++.||.|||  ..+|+||||||+||+++.++.+||+|||
T Consensus        72 ~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dlkp~Nill~~~~~~kl~Dfg  145 (287)
T cd07848          72 RGKLYLVFEYVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCH--KNDIVHRDIKPENLLISHNDVLKLCDFG  145 (287)
T ss_pred             CCEEEEEEecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEEeecc
Confidence            99999999999987665544322    45899999999999999999999  6999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      ++...........  ..    ..||+.|+               +||++.+.. .+.++|+||+|++++++++..
T Consensus       146 ~~~~~~~~~~~~~--~~----~~~~~~y~---------------aPE~~~~~~-~~~~~DiwslGvil~el~~g~  198 (287)
T cd07848         146 FARNLSEGSNANY--TE----YVATRWYR---------------SPELLLGAP-YGKAVDMWSVGCILGELSDGQ  198 (287)
T ss_pred             Ccccccccccccc--cc----cccccccC---------------CcHHHcCCC-CCCchhHHhHHHHHHHHHhCC
Confidence            9987644322111  11    15677777               799887665 578999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=255.72  Aligned_cols=206  Identities=24%  Similarity=0.256  Sum_probs=176.3

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEe
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLG  162 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~  162 (376)
                      ...++|..+++||+|.||+|.+|         +.+.+++.+|+|+++++..   ..+..-+.|-++|+..+||.+..+--
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~---------rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKY  235 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILC---------REKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKY  235 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEE---------eecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhh
Confidence            34578999999999999999999         7777899999999998743   33455678999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                      .|+..+++++||||..||.|.-+|.+.    ..+++...+.+...|+.||.|||+  ++||.||||.+|+|+|.+|++||
T Consensus       236 sFQt~drlCFVMeyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs--~~ivYRDlKLENLlLDkDGHIKi  309 (516)
T KOG0690|consen  236 SFQTQDRLCFVMEYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHS--RNIVYRDLKLENLLLDKDGHIKI  309 (516)
T ss_pred             hhccCceEEEEEEEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhh--CCeeeeechhhhheeccCCceEe
Confidence            999999999999999999999999776    558999999999999999999995  99999999999999999999999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc----
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF----  318 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~----  318 (376)
                      +|||+++---....   ...|+    +|||+|.               |||++.... +..+.|+|-+|+|.+||+    
T Consensus       310 tDFGLCKE~I~~g~---t~kTF----CGTPEYL---------------APEVleDnD-YgraVDWWG~GVVMYEMmCGRL  366 (516)
T KOG0690|consen  310 TDFGLCKEEIKYGD---TTKTF----CGTPEYL---------------APEVLEDND-YGRAVDWWGVGVVMYEMMCGRL  366 (516)
T ss_pred             eecccchhcccccc---eeccc----cCChhhc---------------Cchhhcccc-ccceeehhhhhHHHHHHHhccC
Confidence            99999985322211   12233    8999999               899777665 489999999999999998    


Q ss_pred             cccccchhhHH
Q 017177          319 SFYRTTMLKYQ  329 (376)
Q Consensus       319 ~~y~~~~~~~~  329 (376)
                      .||.-+..++.
T Consensus       367 PFyn~dh~kLF  377 (516)
T KOG0690|consen  367 PFYNKDHEKLF  377 (516)
T ss_pred             cccccchhHHH
Confidence            67777665544

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=8.6e-33  Score=254.90  Aligned_cols=189  Identities=20%  Similarity=0.234  Sum_probs=157.7

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhh---HHHHHHHHHHHhcCCCCCcceEEeEEEe----C
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG---FEEWQSEVNFLGRLSHPNLVKLLGYCWE----D  167 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~----~  167 (376)
                      ..||+|++|.||+|.+.           ++.||||.++......   .+.+.+|+.+|++++||||+++++++.+    .
T Consensus        26 ~~i~~g~~~~v~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~   94 (283)
T PHA02988         26 VLIKENDQNSIYKGIFN-----------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL   94 (283)
T ss_pred             eEEeeCCceEEEEEEEC-----------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence            67999999999999764           7789999998653322   4677899999999999999999999877    3


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      ..+++||||+++|+|.+++.+.    ..+++.....++.|++.||.|||. ..+++||||||+|||++.++.+|++|||+
T Consensus        95 ~~~~lv~Ey~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~Hrdlkp~nill~~~~~~kl~dfg~  169 (283)
T PHA02988         95 PRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYK-YTNKPYKNLTSVSFLVTENYKLKIICHGL  169 (283)
T ss_pred             CceEEEEEeCCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHh-cCCCCCCcCChhhEEECCCCcEEEcccch
Confidence            5789999999999999999765    458889999999999999999994 35899999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh-hhccccccccceeeeehhhccccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI-KYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~-~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ++........  .        .||+.|+               |||++.+. ..++.++||||||++++|+++...+.
T Consensus       170 ~~~~~~~~~~--~--------~~~~~y~---------------aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf  222 (283)
T PHA02988        170 EKILSSPPFK--N--------VNFMVYF---------------SYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF  222 (283)
T ss_pred             Hhhhcccccc--c--------cCccccc---------------CHHHhhhccccccchhhhhHHHHHHHHHHHCCCCC
Confidence            9865432211  1        5566666               79988763 45689999999999999998755443

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-33  Score=257.26  Aligned_cols=198  Identities=24%  Similarity=0.261  Sum_probs=164.0

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      +|++.+.||+|+||.||++...         .+++.||+|++.....   .....+.+|+.+++.++||||+++++.+..
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET   71 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEc---------CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence            4788899999999999999543         3588999999875432   223456789999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++.+++||||+++|+|.+++....  ...+++..+..++.|++.||.|||  ..+|+||||||+||++++++.++|+|||
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~l~Dfg  147 (285)
T cd05605          72 KDALCLVLTLMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLH--RERIVYRDLKPENILLDDYGHIRISDLG  147 (285)
T ss_pred             CCeEEEEEeccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCHHHEEECCCCCEEEeeCC
Confidence            999999999999999998886542  245899999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ++............        .|++.|+               +||++.+.. .+.++|+||+|++++++++...+.
T Consensus       148 ~~~~~~~~~~~~~~--------~~~~~y~---------------aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf  201 (285)
T cd05605         148 LAVEIPEGETIRGR--------VGTVGYM---------------APEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPF  201 (285)
T ss_pred             CceecCCCCccccc--------cCCCCcc---------------CcHHhcCCC-CCccccchhHHHHHHHHHHCCCCC
Confidence            99876433222111        5667777               799887654 578899999999999999765554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.1e-33  Score=267.84  Aligned_cols=196  Identities=23%  Similarity=0.243  Sum_probs=162.2

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      +|++.+.||+|+||.||+|...         .+++.||+|++...  .....+++.+|+.+++.++||||+++++++..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   71 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDP---------RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP   71 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEEC---------CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence            4788999999999999999543         35889999998754  223446788999999999999999999999877


Q ss_pred             C-----eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          168 K-----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       168 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                      +     ..|+||||+. ++|.+.+...    ..+++..+..++.||+.||.|||  ..+|+||||||+|||++.++.+||
T Consensus        72 ~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~Nili~~~~~~kL  144 (372)
T cd07853          72 HIDPFEEIYVVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLH--SAGILHRDIKPGNLLVNSNCVLKI  144 (372)
T ss_pred             CccccceEEEEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChHHEEECCCCCEEe
Confidence            6     7999999996 5888887554    45899999999999999999999  599999999999999999999999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      +|||+++......... . ..    ..+|+.|+               |||++.+...++.++|+||+|++++++++-..
T Consensus       145 ~Dfg~a~~~~~~~~~~-~-~~----~~~~~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~el~~g~~  203 (372)
T cd07853         145 CDFGLARVEEPDESKH-M-TQ----EVVTQYYR---------------APEILMGSRHYTSAVDIWSVGCIFAELLGRRI  203 (372)
T ss_pred             ccccceeecccCcccc-C-CC----CCcCCCcC---------------CHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCC
Confidence            9999998754332211 1 11    15667777               89998887777899999999999999986443

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-34  Score=232.92  Aligned_cols=191  Identities=24%  Similarity=0.300  Sum_probs=164.4

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh--hHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      +|...+.||+|.||+||+|         ++..+++.||+|.++.+...  ......+|+-+++.++|.|||+++++...+
T Consensus         3 ~ydkmekigegtygtvfka---------rn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd   73 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKA---------RNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD   73 (292)
T ss_pred             chHHHHhhcCCcceeeEec---------ccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence            4667789999999999999         55557999999998765432  235678999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +.+-+|+|||+. +|..+....   +..++...+..++.|+++||.|+|+  ++++||||||.|+||+.+|.+|++|||+
T Consensus        74 kkltlvfe~cdq-dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchs--hnvlhrdlkpqnllin~ngelkladfgl  147 (292)
T KOG0662|consen   74 KKLTLVFEFCDQ-DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHS--HNVLHRDLKPQNLLINRNGELKLADFGL  147 (292)
T ss_pred             ceeEEeHHHhhH-HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhh--hhhhhccCCcceEEeccCCcEEecccch
Confidence            999999999965 888888665   3668999999999999999999995  9999999999999999999999999999


Q ss_pred             eeeecccee-eEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          248 YVYFKRHYI-YIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       248 a~~~~~~~~-~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      ++.++-+.. +....-|..|.+                       |.++-|.+.++...|+||.||+|+|++
T Consensus       148 arafgipvrcysaevvtlwyrp-----------------------pdvlfgakly~tsidmwsagcifaela  196 (292)
T KOG0662|consen  148 ARAFGIPVRCYSAEVVTLWYRP-----------------------PDVLFGAKLYSTSIDMWSAGCIFAELA  196 (292)
T ss_pred             hhhcCCceEeeeceeeeeeccC-----------------------cceeeeeehhccchHhhhcchHHHHHh
Confidence            998876542 333444555555                       888889888899999999999999998

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-32  Score=256.59  Aligned_cols=187  Identities=22%  Similarity=0.254  Sum_probs=157.4

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEE
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELL  171 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~  171 (376)
                      .++||.|.||+||-|         .++.+|+.||||++++...  .....+++|+.||++++||.||.+...|+..+.++
T Consensus       569 devLGSGQFG~VYgg---------~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF  639 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGG---------KHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF  639 (888)
T ss_pred             HhhccCCcceeeecc---------eecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence            479999999999999         4555799999999987633  33467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC---CcEEEcceeee
Q 017177          172 LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV---GFLFDSHLLIY  248 (376)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~---g~~kl~Dfg~a  248 (376)
                      +|||.+.|.-|.-+|...   ...+++.....++.||+.||.|||  .++|+|+||||+|||+.+.   -.+||||||.|
T Consensus       640 VVMEKl~GDMLEMILSsE---kgRL~er~TkFlvtQIL~ALr~LH--~knIvHCDLKPENVLLas~~~FPQvKlCDFGfA  714 (888)
T KOG4236|consen  640 VVMEKLHGDMLEMILSSE---KGRLPERITKFLVTQILVALRYLH--FKNIVHCDLKPENVLLASASPFPQVKLCDFGFA  714 (888)
T ss_pred             EEehhhcchHHHHHHHhh---cccchHHHHHHHHHHHHHHHHHhh--hcceeeccCCchheeeccCCCCCceeeccccce
Confidence            999999664455555444   367999999999999999999999  7999999999999999643   46999999999


Q ss_pred             eeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          249 VYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      +.+.+......+        +|||.|.               |||++..++| .+.-|+||.|++++--+
T Consensus       715 RiIgEksFRrsV--------VGTPAYL---------------aPEVLrnkGy-NrSLDMWSVGVIiYVsL  760 (888)
T KOG4236|consen  715 RIIGEKSFRRSV--------VGTPAYL---------------APEVLRNKGY-NRSLDMWSVGVIIYVSL  760 (888)
T ss_pred             eecchhhhhhhh--------cCCcccc---------------CHHHHhhccc-cccccceeeeEEEEEEe
Confidence            999876554333        7777777               7999888875 77789999999988644

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1e-32  Score=253.27  Aligned_cols=207  Identities=23%  Similarity=0.258  Sum_probs=164.9

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ..++|++.+.||+|+||.||+|.....    .....+..||+|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccC----CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            456799999999999999999976532    122346789999986543 234457889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCC------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPS------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF  239 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~  239 (376)
                      .....++||||+++|+|.+++.+....      ...+++..+..++.|++.||.|||  +.+++||||||+|||+++++.
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~~vH~dlkp~Nil~~~~~~  157 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFT  157 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCcchheEEEcCCCC
Confidence            889999999999999999999754321      133577888999999999999999  599999999999999999999


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ++++|||+++........... ..    ..+++.||               +||.+.+.. .+.++|+||+|++++++++
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~-~~----~~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~~l~el~~  216 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKG-GK----GLLPVRWM---------------SPESLKDGV-FTTYSDVWSFGVVLWEIAT  216 (277)
T ss_pred             EEECCCCCccccCCcceeecC-CC----CccCHhhc---------------ChhHhhcCC-cCchhHHHHHHHHHHHHHc
Confidence            999999999865443222111 11    13345566               899877644 5889999999999999987


Q ss_pred             c
Q 017177          320 F  320 (376)
Q Consensus       320 ~  320 (376)
                      +
T Consensus       217 ~  217 (277)
T cd05062         217 L  217 (277)
T ss_pred             C
Confidence            4

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.4e-32  Score=251.09  Aligned_cols=190  Identities=25%  Similarity=0.263  Sum_probs=157.6

Q ss_pred             EeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEE
Q 017177           97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        97 lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv  173 (376)
                      ||+|+||.||++...         .+++.||+|.+.....   .....+..|++++++++||||+++++.+..+...++|
T Consensus         1 lg~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv   71 (277)
T cd05607           1 LGKGGFGEVCAVQVK---------NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV   71 (277)
T ss_pred             CCCCCceEEEEEEEc---------cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence            699999999999544         3588999999875322   1223456799999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      |||+++++|.+++....  ...+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.++|+|||++.....
T Consensus        72 ~e~~~g~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~  147 (277)
T cd05607          72 MSLMNGGDLKYHIYNVG--ERGLEMERVIHYSAQITCGILHLH--SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD  147 (277)
T ss_pred             EecCCCCCHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHH--HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence            99999999998886543  245888999999999999999999  69999999999999999999999999999987755


Q ss_pred             ceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          254 HYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       254 ~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      .......        .||+.|+               +||++.+.. .+.++|+||+|++++++++-..+
T Consensus       148 ~~~~~~~--------~~~~~y~---------------aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p  193 (277)
T cd05607         148 GKTITQR--------AGTNGYM---------------APEILKEEP-YSYPVDWFAMGCSIYEMVAGRTP  193 (277)
T ss_pred             Cceeecc--------CCCCCcc---------------CHHHHccCC-CCCchhHHHHHHHHHHHHhCCCC
Confidence            3322111        5667777               799887665 68899999999999999865444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.8e-33  Score=262.49  Aligned_cols=197  Identities=22%  Similarity=0.247  Sum_probs=165.5

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||++...         .++..+|+|.+..... .....+.+|+++++.++||||+++++++.+
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHK---------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS   74 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEEC---------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence            468999999999999999999544         3588899999876532 334678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++.+++||||+++|+|.+++.+.    ..+++..+..++.|++.||.|||+ ..+|+||||||+|||++.+|.+||+|||
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~-~~~ivH~dlkp~Nili~~~~~~kL~Dfg  149 (333)
T cd06650          75 DGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFG  149 (333)
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChhhEEEcCCCCEEEeeCC
Confidence            99999999999999999999765    458899999999999999999994 3579999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ++.........     .    ..||+.|+               +||++.+.. .+.++|+||+|++++++++...+
T Consensus       150 ~~~~~~~~~~~-----~----~~~~~~y~---------------aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p  201 (333)
T cd06650         150 VSGQLIDSMAN-----S----FVGTRSYM---------------SPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYP  201 (333)
T ss_pred             cchhhhhhccc-----c----CCCCcccc---------------CHHHhcCCC-CCcHHHHHHHHHHHHHHHHCCCC
Confidence            99765332111     1    15667777               799877654 57889999999999999865544

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9.5e-33  Score=253.59  Aligned_cols=205  Identities=24%  Similarity=0.338  Sum_probs=166.3

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh-hHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|.+.+.||+|+||.||+|.....    ....++..||+|.++..... ..+.+.+|+++++.++|+||+++++++..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   79 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHL----EPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE   79 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccc----cCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence            35688999999999999999976432    11234678999999865443 45788999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNP----------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG  236 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~  236 (376)
                      ....++||||+++++|.+++.....          ....+++..+..++.|++.||.|||  .++++||||||+||+++.
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--~~~i~h~dlkp~nili~~  157 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA--SQHFVHRDLATRNCLVGY  157 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh--hCCeeccccccceEEEcC
Confidence            9999999999999999999976421          2245788999999999999999999  699999999999999999


Q ss_pred             CCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehh
Q 017177          237 VGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSC  316 (376)
Q Consensus       237 ~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~  316 (376)
                      ++.++|+|||++...............     .+++.|+               |||++.+.. .+.++|+||+|+++++
T Consensus       158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~-----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~e  216 (280)
T cd05049         158 DLVVKIGDFGMSRDVYTTDYYRVGGHT-----MLPIRWM---------------PPESIMYRK-FTTESDVWSFGVVLWE  216 (280)
T ss_pred             CCeEEECCcccceecccCcceecCCCC-----cccceec---------------ChhhhccCC-cchhhhHHHHHHHHHH
Confidence            999999999999865433221111111     3445566               799887665 5788999999999999


Q ss_pred             hcc
Q 017177          317 VFS  319 (376)
Q Consensus       317 ~~~  319 (376)
                      +++
T Consensus       217 ~~~  219 (280)
T cd05049         217 IFT  219 (280)
T ss_pred             HHh
Confidence            986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.2e-32  Score=251.34  Aligned_cols=199  Identities=23%  Similarity=0.263  Sum_probs=167.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|++.+.||+|+||.||+|...         .+++.||+|.++.........+.+|+.+++.++||||+++++.+..+
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~   78 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNV---------NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR   78 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEc---------CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Confidence            357899999999999999999543         35889999998876555556788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..|+||||+++++|.+++...    ..+++..+..++.|++.||.|||  ..+|+||||||+||+++.++.++|+|||+
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nili~~~~~~~l~dfg~  152 (267)
T cd06645          79 DKLWICMEFCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLH--SKGKMHRDIKGANILLTDNGHVKLADFGV  152 (267)
T ss_pred             CEEEEEEeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECccee
Confidence            9999999999999999998765    45899999999999999999999  58999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHh--hhhhccccccccceeeeehhhcccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYA--WIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~--~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      +...........       ...|++.|+               |||.+.  .....+.++|+||+|++++++++...+
T Consensus       153 ~~~~~~~~~~~~-------~~~~~~~y~---------------aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p  208 (267)
T cd06645         153 SAQITATIAKRK-------SFIGTPYWM---------------APEVAAVERKGGYNQLCDIWAVGITAIELAELQPP  208 (267)
T ss_pred             eeEccCcccccc-------cccCccccc---------------ChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCC
Confidence            987643221110       115667777               799764  234467899999999999999876544

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2e-32  Score=249.83  Aligned_cols=199  Identities=22%  Similarity=0.239  Sum_probs=165.8

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|++.+.||+|+||.||+|...         .+++.||+|++..........+.+|+.+++.++||||+++++.+..+
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~   78 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNL---------HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR   78 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEEC---------CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence            457999999999999999999543         35889999999766545556778999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++||||+++++|.+++.+.    ..+++..+..++.|++.||.|||  ..+|+||||||+||+++.++.++++|||+
T Consensus        79 ~~~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nill~~~~~~~l~dfg~  152 (267)
T cd06646          79 EKLWICMEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLH--SKGKMHRDIKGANILLTDNGDVKLADFGV  152 (267)
T ss_pred             CEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCCEEECcCcc
Confidence            9999999999999999998654    45889999999999999999999  59999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh--hhhccccccccceeeeehhhcccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW--IKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~--~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      +..........   .    ...|++.|+               +||.+.+  ....+.++|+||+|++++++++...+
T Consensus       153 ~~~~~~~~~~~---~----~~~~~~~y~---------------~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p  208 (267)
T cd06646         153 AAKITATIAKR---K----SFIGTPYWM---------------APEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP  208 (267)
T ss_pred             ceeeccccccc---C----ccccCcccc---------------CHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence            98764322110   0    114566666               7997753  23356789999999999999876544

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.6e-32  Score=251.25  Aligned_cols=205  Identities=24%  Similarity=0.333  Sum_probs=167.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|.+.+.||+|+||.||++.....    ....++..+|+|.+..........+.+|+.++++++||||+++++++...
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccC----CCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            45789999999999999999965331    12234667999999876666667889999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCC---------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNP---------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      +..++||||+++++|.+++.....         ....+++..+..++.|++.||.|||  .++++||||||+|||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH--~~~i~H~dlkp~Nili~~~~  157 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA--SQHFVHRDLATRNCLVGENL  157 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEEEccCC
Confidence            999999999999999999975431         1235899999999999999999999  69999999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .++++|||+++......... ..+..    .+++.|+               +||.+.+. ..+.++|+||+|+++++++
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~-~~~~~----~~~~~y~---------------aPE~~~~~-~~~~~sDiwslG~il~~l~  216 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYR-VGGHT----MLPIRWM---------------PPESIMYR-KFTTESDVWSLGVVLWEIF  216 (288)
T ss_pred             cEEeccCCccccccCCceee-cCCCC----Ccccccc---------------CHHHhccC-CCCchhhHHHHHHHHHHHH
Confidence            99999999998664432211 11111    3345566               79977664 4688999999999999998


Q ss_pred             c
Q 017177          319 S  319 (376)
Q Consensus       319 ~  319 (376)
                      +
T Consensus       217 t  217 (288)
T cd05093         217 T  217 (288)
T ss_pred             h
Confidence            6

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-33  Score=274.94  Aligned_cols=207  Identities=20%  Similarity=0.199  Sum_probs=161.1

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEEeE-EE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGY-CW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~-~~  165 (376)
                      ..++++.+.|.+|||+.||+|....         .+..||+|++-.......+.+.+|+.+|+.|+ |+|||.+++. ..
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~---------~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~  106 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVK---------GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI  106 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecC---------CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence            4567888999999999999997664         34889999998888888899999999999998 9999999993 22


Q ss_pred             e---C---CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc
Q 017177          166 E---D---KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF  239 (376)
Q Consensus       166 ~---~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~  239 (376)
                      .   .   -+++|.||||.||.|-+++..+..  ..|++.++++|+.|+++|+.+||....+|||||||-|||||+.+|.
T Consensus       107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~  184 (738)
T KOG1989|consen  107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN  184 (738)
T ss_pred             cccCCCceeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC
Confidence            1   1   258899999999999999987654  4499999999999999999999986677999999999999999999


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh--hhccccccccceeeeehhh
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI--KYLTLLKYSNSFAFVFSCV  317 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~--~~~~~~~dv~s~g~v~~~~  317 (376)
                      .||||||.+.-.-......             .+......--++.-.+.|.+||++.-.  ..++.|+|||++||++|-+
T Consensus       185 ~KLCDFGSatt~~~~~~~~-------------~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkL  251 (738)
T KOG1989|consen  185 YKLCDFGSATTKILSPTSA-------------QEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKL  251 (738)
T ss_pred             EEeCcccccccccCCCccH-------------HHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHH
Confidence            9999999987432211100             000000000111112234568876633  5568999999999999987


Q ss_pred             c
Q 017177          318 F  318 (376)
Q Consensus       318 ~  318 (376)
                      +
T Consensus       252 C  252 (738)
T KOG1989|consen  252 C  252 (738)
T ss_pred             H
Confidence            7

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.6e-32  Score=280.34  Aligned_cols=208  Identities=19%  Similarity=0.209  Sum_probs=166.2

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ++|++.+.||+|+||.||+|...         .+++.||+|+++...   ....+++.+|+.+++.++||||+++++++.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~---------~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~   72 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDP---------VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS   72 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEEC---------CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence            57999999999999999999544         358899999997542   233467889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNP-------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      +++..|++|||++||+|.+++.....       .....+...++.++.||+.||+|||  .++|+||||||+|||++.+|
T Consensus        73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH--s~GIIHRDLKPeNILLd~dg  150 (932)
T PRK13184         73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH--SKGVLHRDLKPDNILLGLFG  150 (932)
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH--HCCccccCCchheEEEcCCC
Confidence            99999999999999999999864211       1123566778899999999999999  59999999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeE-----------EEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccc
Q 017177          239 FLFDSHLLIYVYFKRHYIYI-----------YIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYS  307 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~-----------~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv  307 (376)
                      .++|+|||+++.........           ....+.....+||+.||               |||++.+.. .+.++|+
T Consensus       151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~Ym---------------APE~l~g~~-~S~kSDI  214 (932)
T PRK13184        151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYM---------------APERLLGVP-ASESTDI  214 (932)
T ss_pred             CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCC---------------CHHHhcCCC-CCcHhHH
Confidence            99999999998763211100           00000011126888888               899877665 4889999


Q ss_pred             cceeeeehhhcccccc
Q 017177          308 NSFAFVFSCVFSFYRT  323 (376)
Q Consensus       308 ~s~g~v~~~~~~~y~~  323 (376)
                      ||+|++++++++...+
T Consensus       215 WSLGVILyELLTG~~P  230 (932)
T PRK13184        215 YALGVILYQMLTLSFP  230 (932)
T ss_pred             HHHHHHHHHHHHCCCC
Confidence            9999999999975444

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-33  Score=282.94  Aligned_cols=206  Identities=27%  Similarity=0.369  Sum_probs=167.6

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-ChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..+.++.+.||+|.||.||.|.+.+..   ... ....||+|.++.. ..+...+|.+|..+|++++||||++++|++.+
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~---~~~-~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVP---GSV-SPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCC---CCc-cceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            445678899999999999999887632   111 1456999999876 44567899999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPS---IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      ....+|++|||+||+|..+|++.+..   ...+...+.+.++.||++|+.||+  ++++|||||.++|+||+.+..|||+
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe--~~~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE--SKHFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH--hCCCcCcchhhhheeecccCcEEEc
Confidence            99999999999999999999876321   345788999999999999999999  6999999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      |||+|+.+-+...+.......-     .-.               ||+||.+.. ..++.++||||||+++||++++
T Consensus       845 DFGlArDiy~~~yyr~~~~a~l-----Pvk---------------Wm~PEsl~d-~iFtskSDvWsFGVllWEifsl  900 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAML-----PVK---------------WMPPESLKD-GIFTSKSDVWSFGVLLWEIFSL  900 (1025)
T ss_pred             ccchhHhhhhchheeccCcccc-----cee---------------cCCHHHHhh-cccccccchhhhHHHHHHHHhC
Confidence            9999995433333321111110     122               448997775 5679999999999999999954

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.4e-33  Score=259.34  Aligned_cols=198  Identities=23%  Similarity=0.223  Sum_probs=163.4

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ++|++.+.||+|+||.||+|+..         .++..||+|.++.... .....+.+|+.+++.++||||+++++++..+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   76 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSK---------LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD   76 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEec---------CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence            57999999999999999999543         3578899999875532 2234567899999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++||||+++ +|.+++....   ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+
T Consensus        77 ~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  150 (309)
T cd07872          77 KSLTLVFEYLDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCH--RRKVLHRDLKPQNLLINERGELKLADFGL  150 (309)
T ss_pred             CeEEEEEeCCCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECcccc
Confidence            999999999975 8888886542   45788999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      +...........  .     ..+|+.|+               +||++.+....+.++|+||+|++++++++-..+
T Consensus       151 ~~~~~~~~~~~~--~-----~~~~~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~el~tg~~p  204 (309)
T cd07872         151 ARAKSVPTKTYS--N-----EVVTLWYR---------------PPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPL  204 (309)
T ss_pred             ceecCCCccccc--c-----cccccccc---------------CCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            986543322110  1     14566677               799887766678899999999999999865443

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-32  Score=251.49  Aligned_cols=201  Identities=24%  Similarity=0.300  Sum_probs=168.7

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|++.+.||.|+||.||++....         ++..+|+|.+........+.+.+|+.++++++||||+++++.+..+
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKE---------TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE   74 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcC---------CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC
Confidence            4579999999999999999996543         4788999999877666677889999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      ...|+||||+++++|.+++.+..   ..+++..+..++.|++.||.|||  +.+|+||||||+||+++.++.++|+|||+
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~nili~~~~~~~l~d~g~  149 (280)
T cd06611          75 NKLWILIEFCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLH--SHKVIHRDLKAGNILLTLDGDVKLADFGV  149 (280)
T ss_pred             CeEEEEeeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEECCCCCEEEccCcc
Confidence            99999999999999999987642   45899999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh----hhccccccccceeeeehhhcccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI----KYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~----~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      +...........   .    ..||+.|+               +||++...    ...+.++|+||+|++++++++...+
T Consensus       150 ~~~~~~~~~~~~---~----~~~~~~y~---------------~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p  207 (280)
T cd06611         150 SAKNKSTLQKRD---T----FIGTPYWM---------------APEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP  207 (280)
T ss_pred             chhhcccccccc---e----eecchhhc---------------CHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCC
Confidence            876543322111   1    15666666               79977532    3356789999999999999876555


Q ss_pred             c
Q 017177          324 T  324 (376)
Q Consensus       324 ~  324 (376)
                      .
T Consensus       208 ~  208 (280)
T cd06611         208 H  208 (280)
T ss_pred             c
Confidence            4

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.6e-32  Score=281.52  Aligned_cols=207  Identities=15%  Similarity=0.167  Sum_probs=166.5

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEe
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLG  162 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~  162 (376)
                      ....++|++++.||+|+||.||+|...         .++..||+|.+....  ......+.+|+.+++.|+||||+++++
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk---------~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d   79 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHK---------RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYID   79 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEEC---------CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEE
Confidence            345678999999999999999999544         358899999987542  234567889999999999999999999


Q ss_pred             EEEeC--CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCcEecCCCCCCEEEc
Q 017177          163 YCWED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSE-----KKVIYRDFKASNILLD  235 (376)
Q Consensus       163 ~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~-----~~iiHrDlKp~NILl~  235 (376)
                      +|.+.  ..+||||||+++|+|.++|.........+++..++.|+.||+.||.|||+..     .+||||||||+||||+
T Consensus        80 ~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~  159 (1021)
T PTZ00266         80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS  159 (1021)
T ss_pred             EEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence            88653  5699999999999999999764333356899999999999999999999521     4599999999999996


Q ss_pred             C-----------------CCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh
Q 017177          236 G-----------------VGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI  298 (376)
Q Consensus       236 ~-----------------~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~  298 (376)
                      .                 .+.+||+|||++..........    .    ..||+.|+               +||++.+.
T Consensus       160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~----s----~vGTp~Ym---------------APEvL~ge  216 (1021)
T PTZ00266        160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH----S----CVGTPYYW---------------SPELLLHE  216 (1021)
T ss_pred             cCccccccccccccccCCCCceEEccCCcccccccccccc----c----cCCCcccc---------------CHHHHhcc
Confidence            4                 3458999999998764432221    1    16777787               79988654


Q ss_pred             -hhccccccccceeeeehhhcccccc
Q 017177          299 -KYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       299 -~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                       ..++.++||||||+|++++++...+
T Consensus       217 ~~~~s~KSDVWSLG~ILYELLTGk~P  242 (1021)
T PTZ00266        217 TKSYDDKSDMWALGCIIYELCSGKTP  242 (1021)
T ss_pred             CCCCCchhHHHHHHHHHHHHHHCCCC
Confidence             4568899999999999999975544

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.4e-32  Score=250.39  Aligned_cols=205  Identities=24%  Similarity=0.350  Sum_probs=167.1

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|.+.+.||+|+||.||+|.....    ....++..+++|.+........+.+.+|+.++++++|+||+++++++...
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNL----SPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeecc----CCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            34688899999999999999975431    12234667999999877666667889999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNP------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD  235 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~  235 (376)
                      +..++||||+++++|.+++.....            ....+++..++.++.||+.||.|||  +++|+||||||+|||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~Nil~~  157 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA--SQHFVHRDLATRNCLVG  157 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEEEc
Confidence            999999999999999999976431            1234789999999999999999999  69999999999999999


Q ss_pred             CCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeeh
Q 017177          236 GVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFS  315 (376)
Q Consensus       236 ~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~  315 (376)
                      .++.++++|||++..............+     .+++.|+               +||.+.+. ..+.++|+||+|++++
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~-----~~~~~y~---------------aPE~~~~~-~~~~~~Di~slG~il~  216 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHT-----MLPIRWM---------------PPESIMYR-KFTTESDVWSFGVILW  216 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCC-----Ccceeec---------------ChHHhccC-CCCchhhHHHHHHHHH
Confidence            9999999999999866443322111111     4455666               79977664 4578899999999999


Q ss_pred             hhcc
Q 017177          316 CVFS  319 (376)
Q Consensus       316 ~~~~  319 (376)
                      ++++
T Consensus       217 el~t  220 (291)
T cd05094         217 EIFT  220 (291)
T ss_pred             HHHh
Confidence            9886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-32  Score=248.03  Aligned_cols=201  Identities=21%  Similarity=0.253  Sum_probs=164.4

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-----hhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-----QGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ++|++.+.||+|+||.||+|...         .+++.+|+|.+.....     .....+.+|+.++++++||||++++++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~---------~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   72 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDV---------DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC   72 (263)
T ss_pred             CcccccceecCCCceEEEEEEEc---------CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence            46899999999999999999543         3588999999865421     234567899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +.+++.+++|+||+++++|.+++...    ..+++..+..++.|++.||.|||  +.+|+||||||+||+++.++.++|+
T Consensus        73 ~~~~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nilv~~~~~~~l~  146 (263)
T cd06625          73 LRDDETLSIFMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLH--SNMIVHRDIKGANILRDSAGNVKLG  146 (263)
T ss_pred             EccCCeEEEEEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEe
Confidence            99999999999999999999998765    44888999999999999999999  6999999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||+++............    ....|++.|+               +||++.+.. .+.++|+||+|++++++++...+
T Consensus       147 dfg~~~~~~~~~~~~~~~----~~~~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p  206 (263)
T cd06625         147 DFGASKRLQTICSSGTGM----KSVTGTPYWM---------------SPEVISGEG-YGRKADVWSVGCTVVEMLTEKPP  206 (263)
T ss_pred             ecccceeccccccccccc----cCCCcCcccc---------------CcceeccCC-CCchhhhHHHHHHHHHHHhCCCC
Confidence            999998654322111000    0113455555               799777654 68899999999999999976554


Q ss_pred             c
Q 017177          324 T  324 (376)
Q Consensus       324 ~  324 (376)
                      .
T Consensus       207 ~  207 (263)
T cd06625         207 W  207 (263)
T ss_pred             c
Confidence            3

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.4e-32  Score=250.79  Aligned_cols=210  Identities=24%  Similarity=0.220  Sum_probs=167.1

Q ss_pred             hhhhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcC-CCCCcce
Q 017177           81 FLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVK  159 (376)
Q Consensus        81 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~  159 (376)
                      +.......++|++.+.||+|+||.||+|...         .++..+|+|++..... ....+.+|+.+++.+ +||||++
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~---------~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~   79 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNK---------KNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVK   79 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEEC---------CCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeee
Confidence            3445566789999999999999999999554         3578899998875432 235677899999999 5999999


Q ss_pred             EEeEEE-----eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE
Q 017177          160 LLGYCW-----EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL  234 (376)
Q Consensus       160 l~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl  234 (376)
                      +++++.     .++.+++||||+++++|.+++.........+++..+..++.|++.||.|||  ..+|+||||||+||++
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nili  157 (286)
T cd06638          80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH--VNKTIHRDVKGNNILL  157 (286)
T ss_pred             eeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH--hCCccccCCCHHhEEE
Confidence            999874     345799999999999999988654333356889999999999999999999  5999999999999999


Q ss_pred             cCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh----hhccccccccce
Q 017177          235 DGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI----KYLTLLKYSNSF  310 (376)
Q Consensus       235 ~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~----~~~~~~~dv~s~  310 (376)
                      +.++.++++|||++..........       ....|++.|+               +||++...    ...+.++|+||+
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~~~~~-------~~~~~~~~y~---------------aPE~~~~~~~~~~~~~~~~Dv~sl  215 (286)
T cd06638         158 TTEGGVKLVDFGVSAQLTSTRLRR-------NTSVGTPFWM---------------APEVIACEQQLDSTYDARCDVWSL  215 (286)
T ss_pred             CCCCCEEEccCCceeecccCCCcc-------ccccCCCccc---------------ChhhhchhhhccccccchhhhhhH
Confidence            999999999999998764432111       1115667777               79977542    235789999999


Q ss_pred             eeeehhhccccccc
Q 017177          311 AFVFSCVFSFYRTT  324 (376)
Q Consensus       311 g~v~~~~~~~y~~~  324 (376)
                      |++++++++...+.
T Consensus       216 Gvi~~el~~g~~p~  229 (286)
T cd06638         216 GITAIELGDGDPPL  229 (286)
T ss_pred             HHHHHHHhcCCCCC
Confidence            99999998765543

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.3e-33  Score=283.08  Aligned_cols=213  Identities=23%  Similarity=0.264  Sum_probs=166.1

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      +...+|+.+++||+|+||.||++         +++-+|+.||||++.... ......+.+|+.+|.+|+|||||++|..|
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkV---------RNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAW  546 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKV---------RNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAW  546 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEE---------eecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhh
Confidence            34567889999999999999999         666689999999998764 23346788999999999999999999887


Q ss_pred             E-------------------------------------------------------------------------------
Q 017177          165 W-------------------------------------------------------------------------------  165 (376)
Q Consensus       165 ~-------------------------------------------------------------------------------  165 (376)
                      .                                                                               
T Consensus       547 VEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~ded  626 (1351)
T KOG1035|consen  547 VESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDED  626 (1351)
T ss_pred             hccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccc
Confidence            5                                                                               


Q ss_pred             --------------------------------eC--------CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHH
Q 017177          166 --------------------------------ED--------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA  205 (376)
Q Consensus       166 --------------------------------~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~  205 (376)
                                                      .+        -.+||-||||+..+|.+++.+++..   -.....++++
T Consensus       627 g~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLF  703 (1351)
T KOG1035|consen  627 GRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLF  703 (1351)
T ss_pred             ccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHH
Confidence                                            00        2379999999997788877766421   1467889999


Q ss_pred             HHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeecc----cee----eEEEe--ee-EEEEEeeeeeh
Q 017177          206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKR----HYI----YIYIH--TY-IIYIYIYVYIY  274 (376)
Q Consensus       206 ~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~----~~~----~~~~~--~~-~~y~~~gt~~y  274 (376)
                      ++|+.||.|+|  +.+||||||||.||++|+++.|||+|||+|.....    ...    .....  .+ -..-.+||.-|
T Consensus       704 reIlEGLaYIH--~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalY  781 (1351)
T KOG1035|consen  704 REILEGLAYIH--DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALY  781 (1351)
T ss_pred             HHHHHHHHHHH--hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeee
Confidence            99999999999  69999999999999999999999999999998320    000    00000  00 11122677777


Q ss_pred             hhhhcchhhHHHHHHHHHHHHhhhh--hccccccccceeeeehhhccccccchhh
Q 017177          275 MYIYKCLRYAILYSVLLPRIYAWIK--YLTLLKYSNSFAFVFSCVFSFYRTTMLK  327 (376)
Q Consensus       275 ~~~~~~~e~~d~~s~~apEi~~~~~--~~~~~~dv~s~g~v~~~~~~~y~~~~~~  327 (376)
                      +               |||++.+..  .++.|.|+||+|+||+||+--|...+..
T Consensus       782 v---------------APEll~~~~~~~Yn~KiDmYSLGIVlFEM~yPF~TsMER  821 (1351)
T KOG1035|consen  782 V---------------APELLSDTSSNKYNSKIDMYSLGIVLFEMLYPFGTSMER  821 (1351)
T ss_pred             e---------------cHHHhcccccccccchhhhHHHHHHHHHHhccCCchHHH
Confidence            7               799998876  6899999999999999998545554443

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8.8e-34  Score=245.06  Aligned_cols=200  Identities=20%  Similarity=0.208  Sum_probs=169.1

Q ss_pred             hhhhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--------hhHHHHHHHHHHHhcC
Q 017177           81 FLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--------QGFEEWQSEVNFLGRL  152 (376)
Q Consensus        81 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l  152 (376)
                      ....+...++|...+.||+|..+.|-+|         -++.++..+|+|++.....        .-.+.-.+|+.||+++
T Consensus         9 ~~aa~~fy~~y~pkeilgrgvss~vrRc---------i~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv   79 (411)
T KOG0599|consen    9 KDAAKGFYAKYEPKEILGRGVSSVVRRC---------IHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQV   79 (411)
T ss_pred             hhhHhhHHhhcChHHHhcccchhhhhhh---------hhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHh
Confidence            3445566778999999999999999888         4455788999999864311        2235667899999999


Q ss_pred             C-CCCcceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCC
Q 017177          153 S-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASN  231 (376)
Q Consensus       153 ~-h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~N  231 (376)
                      . ||+|+++.++|+.+..+++|+|.|+.|.|.++|...    ..++++....|++|+.+|+.|||  .++||||||||+|
T Consensus        80 ~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylH--a~~IVHRDLKpEN  153 (411)
T KOG0599|consen   80 MGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLH--ARNIVHRDLKPEN  153 (411)
T ss_pred             cCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHH--HhhhhhcccChhh
Confidence            7 999999999999999999999999999999999776    56899999999999999999999  6999999999999


Q ss_pred             EEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHh-----hhhhcccccc
Q 017177          232 ILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYA-----WIKYLTLLKY  306 (376)
Q Consensus       232 ILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~-----~~~~~~~~~d  306 (376)
                      ||+|++-++||+|||++..+.........+        |||+|.               |||++.     +..-++...|
T Consensus       154 ILlddn~~i~isDFGFa~~l~~GekLrelC--------GTPgYL---------------APEtikC~m~e~~pGYs~EVD  210 (411)
T KOG0599|consen  154 ILLDDNMNIKISDFGFACQLEPGEKLRELC--------GTPGYL---------------APETIKCSMYENHPGYSKEVD  210 (411)
T ss_pred             eeeccccceEEeccceeeccCCchhHHHhc--------CCCccc---------------ChhheeeecccCCCCccchhh
Confidence            999999999999999999998887765554        455555               599765     3345578889


Q ss_pred             ccceeeeehhhc
Q 017177          307 SNSFAFVFSCVF  318 (376)
Q Consensus       307 v~s~g~v~~~~~  318 (376)
                      .|+.|++.+-+.
T Consensus       211 ~Wa~GVImyTLL  222 (411)
T KOG0599|consen  211 EWACGVIMYTLL  222 (411)
T ss_pred             HHHHHHHHHHHH
Confidence            999999987765

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.3e-32  Score=250.47  Aligned_cols=204  Identities=28%  Similarity=0.377  Sum_probs=164.9

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ++|++.+.||+|+||.||+|......    .......||+|.++.... .....+.+|+.+++.++||||+++++++...
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPN----ERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCC----CCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            46889999999999999999765421    122457899999876543 3346788999999999999999999999998


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPS------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD  235 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~  235 (376)
                      +..+++|||+++|+|.+++.+....            ...+++..+..++.|++.||.|||  +++|+||||||+||+++
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH--~~~i~H~dlkp~Nil~~  158 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS--SHHFVHRDLAARNCLVG  158 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccccceEEEc
Confidence            9999999999999999999764221            145788999999999999999999  69999999999999999


Q ss_pred             CCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeeh
Q 017177          236 GVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFS  315 (376)
Q Consensus       236 ~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~  315 (376)
                      +++.++|+|||+++..............     .+++.|+               |||.+.+.. .+.++|+||+|++++
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~-----~~~~~y~---------------aPE~~~~~~-~~~~sDv~slG~il~  217 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKS-----LLPVRWM---------------PPEAILYGK-FTTESDIWSFGVVLW  217 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCC-----ccccccc---------------CHHHhccCc-CchhhhHHHHHHHHH
Confidence            9999999999999865443222111111     4556666               799776544 588999999999999


Q ss_pred             hhcc
Q 017177          316 CVFS  319 (376)
Q Consensus       316 ~~~~  319 (376)
                      |+++
T Consensus       218 el~~  221 (283)
T cd05048         218 EIFS  221 (283)
T ss_pred             HHHc
Confidence            9986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.5e-31  Score=242.32  Aligned_cols=199  Identities=22%  Similarity=0.269  Sum_probs=166.0

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-ChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      +|++.+.||+|+||.||++...         .++..+|+|.++.. .....+.+.+|+.+++.++|+||+++++.+.+++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   71 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHV---------NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG   71 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEc---------CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence            4788999999999999999543         35888999998653 3344567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeee
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a  248 (376)
                      .+|++|||+++++|.+++....  ...+++..+..++.|++.||.|||  +++|+|+||||+||++++++.++++|||++
T Consensus        72 ~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dl~p~nili~~~~~~~l~dfg~~  147 (255)
T cd08219          72 HLYIVMEYCDGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIH--EKRVLHRDIKSKNIFLTQNGKVKLGDFGSA  147 (255)
T ss_pred             EEEEEEeeCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCcceEEECCCCcEEEcccCcc
Confidence            9999999999999999886543  245789999999999999999999  699999999999999999999999999999


Q ss_pred             eeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          249 VYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ...........       ...|++.|+               +||++.+.. .+.++|+||+|++++++++...+.
T Consensus       148 ~~~~~~~~~~~-------~~~~~~~~~---------------aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~  200 (255)
T cd08219         148 RLLTSPGAYAC-------TYVGTPYYV---------------PPEIWENMP-YNNKSDIWSLGCILYELCTLKHPF  200 (255)
T ss_pred             eeecccccccc-------cccCCcccc---------------CHHHHccCC-cCchhhhhhhchhheehhhccCCC
Confidence            87654322211       115666777               799776654 688999999999999998665554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.1e-32  Score=258.08  Aligned_cols=198  Identities=19%  Similarity=0.247  Sum_probs=156.5

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe--CCeEE
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE--DKELL  171 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~~~  171 (376)
                      .+.||+|+||.||+|....       ..+++.||+|.+.....  ...+.+|+.+++.++||||+++++++..  +..+|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~-------~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   76 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKD-------GKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW   76 (317)
T ss_pred             ccccccCCCeEEEEEEEcc-------CCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence            4689999999999996542       12467899999876532  2456789999999999999999998864  45689


Q ss_pred             EEEeccCCCCHHHHHhhcCC-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE----cCCCcEEE
Q 017177          172 LVYEYMQRGSLENHLFRRNP-----SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL----DGVGFLFD  242 (376)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl----~~~g~~kl  242 (376)
                      ++|||+. ++|.+++.....     ....+++..+..++.||+.||.|||  +++|+||||||+|||+    +.++.+||
T Consensus        77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivHrDlkp~Nil~~~~~~~~~~~kl  153 (317)
T cd07868          77 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKI  153 (317)
T ss_pred             EEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH--hCCEEcCCCCHHHEEEecCCCCcCcEEE
Confidence            9999995 488888754321     1235889999999999999999999  5999999999999999    45688999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      +|||+++...............    .||+.|+               |||++.+...++.++|+||+|++++++++...
T Consensus       154 ~DfG~a~~~~~~~~~~~~~~~~----~~t~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~el~~g~~  214 (317)
T cd07868         154 ADMGFARLFNSPLKPLADLDPV----VVTFWYR---------------APELLLGARHYTKAIDIWAIGCIFAELLTSEP  214 (317)
T ss_pred             eecCceeccCCCCccccccCCc----ccccccc---------------CCHHHcCCCCcCchhhHHHHHHHHHHHHhCCC
Confidence            9999998765432211111111    6778888               89998887777899999999999999986543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.1e-32  Score=252.81  Aligned_cols=197  Identities=23%  Similarity=0.308  Sum_probs=156.3

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcC---CCCCcceEEeE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRL---SHPNLVKLLGY  163 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l---~h~nIv~l~~~  163 (376)
                      ++|++.+.||+|+||.||+|.....        .+..||+|.++....  .....+.+|+.+++.+   +||||++++++
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~   72 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV   72 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCC--------CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence            4689999999999999999965321        367899999875432  2234556777777766   69999999998


Q ss_pred             EEe-----CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          164 CWE-----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       164 ~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      +..     ...+++||||++ ++|.+++.....  ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH--~~~iiH~dlkp~Nil~~~~~  147 (290)
T cd07862          73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSG  147 (290)
T ss_pred             EecccCCCCCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEEcCCC
Confidence            853     356899999996 599999875432  45889999999999999999999  69999999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .+||+|||+++..........        ..||+.|+               |||++.+.. .+.++|+||+|+++++++
T Consensus       148 ~~kl~Dfg~~~~~~~~~~~~~--------~~~~~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~el~  203 (290)
T cd07862         148 QIKLADFGLARIYSFQMALTS--------VVVTLWYR---------------APEVLLQSS-YATPVDLWSVGCIFAEMF  203 (290)
T ss_pred             CEEEccccceEeccCCccccc--------cccccccc---------------ChHHHhCCC-CCCccchHHHHHHHHHHH
Confidence            999999999987654322111        15677777               799876654 578899999999999998


Q ss_pred             cccc
Q 017177          319 SFYR  322 (376)
Q Consensus       319 ~~y~  322 (376)
                      +...
T Consensus       204 ~g~~  207 (290)
T cd07862         204 RRKP  207 (290)
T ss_pred             cCCC
Confidence            6443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.5e-32  Score=247.82  Aligned_cols=204  Identities=24%  Similarity=0.353  Sum_probs=165.1

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      +.|++.+.||+|+||.||+|.+..     ....++..||+|.++... ......+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDP-----EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED   78 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEcc-----CCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            347889999999999999997643     234468899999987653 33456788999999999999999999998775


Q ss_pred             --CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          168 --KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       168 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                        ...++||||+++++|.+++.+..   ..+++..+..++.|++.||+|||  +++|+||||||+||+++.++.++|+||
T Consensus        79 ~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH--~~gi~H~dlkp~Nil~~~~~~~~l~df  153 (284)
T cd05079          79 GGNGIKLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLG--SRQYVHRDLAARNVLVESEHQVKIGDF  153 (284)
T ss_pred             CCCceEEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccchheEEEcCCCCEEECCC
Confidence              56899999999999999986542   35799999999999999999999  699999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      |+++.+.............    .++..|+               +||.+.+. ..+.++|+||+|+++++++++..
T Consensus       154 g~~~~~~~~~~~~~~~~~~----~~~~~y~---------------apE~~~~~-~~~~~~Di~slG~il~ellt~~~  210 (284)
T cd05079         154 GLTKAIETDKEYYTVKDDL----DSPVFWY---------------APECLIQS-KFYIASDVWSFGVTLYELLTYCD  210 (284)
T ss_pred             ccccccccCccceeecCCC----CCCcccc---------------CHHHhccC-CCCccccchhhhhhhhhhhcCCC
Confidence            9998765433221111111    3444555               79977654 46789999999999999987543

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6.7e-32  Score=249.82  Aligned_cols=202  Identities=22%  Similarity=0.295  Sum_probs=166.9

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..+.|++.+.||.|+||.||+|....         ++..+++|.+........+.+.+|+.+++.++||||+++++.+..
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   80 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW   80 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECC---------CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe
Confidence            34679999999999999999995543         578999999987776667888999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++.+++||||+++++|..++.+..   ..+++..+..++.|++.||.|||  +.+|+||||||+||+++.++.++|+|||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~kl~dfg  155 (292)
T cd06644          81 DGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLH--SMKIIHRDLKAGNVLLTLDGDIKLADFG  155 (292)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh--cCCeeecCCCcceEEEcCCCCEEEccCc
Confidence            999999999999999988876542   45899999999999999999999  6999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh----hhccccccccceeeeehhhccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI----KYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~----~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      ++..........   .    ...+++.|+               +||++.+.    ...+.++|+||+|++++++++...
T Consensus       156 ~~~~~~~~~~~~---~----~~~~~~~y~---------------aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~  213 (292)
T cd06644         156 VSAKNVKTLQRR---D----SFIGTPYWM---------------APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP  213 (292)
T ss_pred             cceecccccccc---c----eecCCcccc---------------CceeeccccccCCCCCchhhhHhHHHHHHHHhcCCC
Confidence            987643321110   0    114556666               68876532    334678999999999999996655


Q ss_pred             cc
Q 017177          323 TT  324 (376)
Q Consensus       323 ~~  324 (376)
                      +.
T Consensus       214 p~  215 (292)
T cd06644         214 PH  215 (292)
T ss_pred             CC
Confidence            43

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.3e-32  Score=246.08  Aligned_cols=196  Identities=23%  Similarity=0.228  Sum_probs=153.8

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv  173 (376)
                      +.||+|+||.||+|.....       .....+|+|.+..... .....+.+|+.+++.++||||+++++.+.+....++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv   73 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRG-------MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLV   73 (269)
T ss_pred             CcCCccCCceEEEEEEecC-------CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEE
Confidence            3689999999999965431       1356789998765432 3345678999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeec
Q 017177          174 YEYMQRGSLENHLFRRNPS-IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFK  252 (376)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~  252 (376)
                      |||+++|+|.+++...... ....++..+..++.|++.||+|||  +++|+||||||+|||++.++.+|++|||++....
T Consensus        74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  151 (269)
T cd05042          74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--QADFIHSDLALRNCQLTADLSVKIGDYGLALEQY  151 (269)
T ss_pred             EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH--hcCEecccccHhheEecCCCcEEEeccccccccc
Confidence            9999999999999765321 123467788999999999999999  6999999999999999999999999999987543


Q ss_pred             cceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh------hhccccccccceeeeehhhcc
Q 017177          253 RHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI------KYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       253 ~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~------~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      .........+.     .+++.|+               +||++...      ...+.++|+||+|++++++++
T Consensus       152 ~~~~~~~~~~~-----~~~~~y~---------------aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~  204 (269)
T cd05042         152 PEDYYITKDCH-----AVPLRWL---------------APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT  204 (269)
T ss_pred             cchheeccCCC-----CCccccc---------------CHHHHhhccccccccccchhhHHHHHHHHHHHHHh
Confidence            32211111111     3445566               79987542      345789999999999999886

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.6e-32  Score=249.82  Aligned_cols=207  Identities=25%  Similarity=0.314  Sum_probs=165.5

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcC-CCCCcceEEeE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGY  163 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~l~~~  163 (376)
                      ...++|++.+.||+|+||.||++......    .......+|+|.+.... ......+.+|+.+++++ +|+||++++++
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~----~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   84 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLD----NPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGV   84 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCC----CCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            34567999999999999999999765321    11235789999988643 33446788999999999 79999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCC
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRN------------PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASN  231 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~N  231 (376)
                      +..++.++++|||+++|+|.+++.+..            .....+++..++.++.|++.||.|||  +++|+||||||+|
T Consensus        85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivH~dlkp~N  162 (293)
T cd05053          85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA--SKKCIHRDLAARN  162 (293)
T ss_pred             EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--HCCccccccceee
Confidence            999999999999999999999997532            12356889999999999999999999  6999999999999


Q ss_pred             EEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcccccccccee
Q 017177          232 ILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFA  311 (376)
Q Consensus       232 ILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g  311 (376)
                      ||++.++.+||+|||+++..............     .+++.|+               +||.+.+. ..+.++|+||+|
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~-----~~~~~y~---------------aPE~~~~~-~~~~~~Di~slG  221 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNG-----RLPVKWM---------------APEALFDR-VYTHQSDVWSFG  221 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCC-----CCCcccc---------------CHHHhccC-CcCcccceeehh
Confidence            99999999999999999976554322111111     2334455               79976554 457889999999


Q ss_pred             eeehhhcc
Q 017177          312 FVFSCVFS  319 (376)
Q Consensus       312 ~v~~~~~~  319 (376)
                      ++++++++
T Consensus       222 ~il~el~~  229 (293)
T cd05053         222 VLLWEIFT  229 (293)
T ss_pred             hHHHHHhc
Confidence            99999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=8.2e-32  Score=247.91  Aligned_cols=198  Identities=23%  Similarity=0.343  Sum_probs=164.6

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeE
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKEL  170 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~  170 (376)
                      |++.+.||+|+||.||+|....         ++..+++|.+........+.+.+|+.+++.++||||+++++.+..++..
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~   77 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL   77 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECC---------CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEE
Confidence            6788999999999999995543         5788999999877666677889999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      ++||||+++++|..++.+..   ..+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.++++|||++..
T Consensus        78 ~~v~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH--~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  152 (282)
T cd06643          78 WILIEFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLH--ENKIIHRDLKAGNILFTLDGDIKLADFGVSAK  152 (282)
T ss_pred             EEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCcccEEEccCCCEEEcccccccc
Confidence            99999999999998876532   45899999999999999999999  59999999999999999999999999999976


Q ss_pred             eccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh----hhhccccccccceeeeehhhccccccc
Q 017177          251 FKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW----IKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~----~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ........   ..    ..||+.|+               +||++..    ....+.++|+||+|++++++++...+.
T Consensus       153 ~~~~~~~~---~~----~~~~~~y~---------------aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~  208 (282)
T cd06643         153 NTRTIQRR---DS----FIGTPYWM---------------APEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPH  208 (282)
T ss_pred             cccccccc---cc----cccccccc---------------CHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCc
Confidence            54322110   00    14566666               7997742    234567899999999999999765443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-32  Score=245.77  Aligned_cols=200  Identities=24%  Similarity=0.324  Sum_probs=163.1

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|.+...      ......||+|.++.... .....+.+|+.+++.++||||+++++.+..
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~------~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   76 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLP------GKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK   76 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccC------CCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence            35789999999999999999977531      12356799999876533 334678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      .+..+++|||+++++|.+++....   ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.++++|||
T Consensus        77 ~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh--~~~i~H~di~p~nili~~~~~~~l~dfg  151 (266)
T cd05033          77 SRPVMIITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFG  151 (266)
T ss_pred             CCceEEEEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCCCCEEECccc
Confidence            999999999999999999997653   36899999999999999999999  6999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ++...............     .+++.|+               +||.+.+.. .+.++|+||+|++++++++
T Consensus       152 ~~~~~~~~~~~~~~~~~-----~~~~~y~---------------~Pe~~~~~~-~~~~~Dv~slG~~l~~l~~  203 (266)
T cd05033         152 LSRRLEDSEATYTTKGG-----KIPIRWT---------------APEAIAYRK-FTSASDVWSFGIVMWEVMS  203 (266)
T ss_pred             hhhcccccccceeccCC-----CCCcccc---------------ChhhhccCC-CccccchHHHHHHHHHHHc
Confidence            99987522211111111     2334455               799776544 5789999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.98  E-value=3.7e-33  Score=241.29  Aligned_cols=198  Identities=20%  Similarity=0.220  Sum_probs=163.4

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-ChhhHHHHHHHHHHHhcCC-CCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~  165 (376)
                      .++.+.+..||.|+.|.|++++++         .++...|||.+... +..+.++++..+.++.+.. .|.||+.+|+|.
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~r---------s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi  161 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFR---------STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI  161 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEc---------ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence            455677889999999999999655         46899999999875 4455678888888888776 999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      .+..++|.||.|. -.+..++++-.   .++++..+-++...++.||.||.. .++|||||+||+|||+|+.|++|+|||
T Consensus       162 ~n~dV~IcMelMs-~C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILlDe~GniKlCDF  236 (391)
T KOG0983|consen  162 TNTDVFICMELMS-TCAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGNIKLCDF  236 (391)
T ss_pred             eCchHHHHHHHHH-HHHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEEccCCCEEeecc
Confidence            9999999999984 36666666553   569999999999999999999997 889999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      |++.++.+....+..        .|-|.||    +||+.|      |+   .+..+...+||||||+.+.|+++-
T Consensus       237 GIsGrlvdSkAhtrs--------AGC~~YM----aPERid------p~---~~~kYDiRaDVWSlGITlveLaTg  290 (391)
T KOG0983|consen  237 GISGRLVDSKAHTRS--------AGCAAYM----APERID------PP---DKPKYDIRADVWSLGITLVELATG  290 (391)
T ss_pred             cccceeecccccccc--------cCCcccc----CccccC------CC---CCCccchhhhhhhhccchhhhhcc
Confidence            999998776555444        4557777    555555      33   134557889999999999999954

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.98  E-value=6.2e-32  Score=248.84  Aligned_cols=203  Identities=28%  Similarity=0.367  Sum_probs=162.5

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ++|++.+.||+|+||.||+|....     .....+..+|+|.+.... ......+.+|+.+++.++||||+++++++..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~-----~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYL-----PGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEec-----CCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence            568889999999999999997532     222347889999997543 33446788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNP-------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL  234 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl  234 (376)
                      +..|+||||+++++|.+++.....             ....+++..+..++.|++.||.|||  +++|+||||||+|||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~nili  157 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS--SHFFVHKDLAARNILI  157 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hcCeehhccccceEEE
Confidence            999999999999999999864321             1234788899999999999999999  6999999999999999


Q ss_pred             cCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeee
Q 017177          235 DGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVF  314 (376)
Q Consensus       235 ~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~  314 (376)
                      ++++.+|++|||+++..............     .++..|+               +||.+.+.. .+.++|+||+|+++
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~-----~~~~~y~---------------aPE~~~~~~-~~~~~Dv~slG~il  216 (283)
T cd05090         158 GEQLHVKISDLGLSREIYSADYYRVQPKS-----LLPIRWM---------------PPEAIMYGK-FSSDSDIWSFGVVL  216 (283)
T ss_pred             cCCCcEEeccccccccccCCcceecccCC-----Cccceec---------------ChHHhccCC-CCchhhhHHHHHHH
Confidence            99999999999999876443221111111     2334444               699776554 58899999999999


Q ss_pred             hhhcc
Q 017177          315 SCVFS  319 (376)
Q Consensus       315 ~~~~~  319 (376)
                      +++++
T Consensus       217 ~el~~  221 (283)
T cd05090         217 WEIFS  221 (283)
T ss_pred             HHHHc
Confidence            99886

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.98  E-value=6.9e-32  Score=246.09  Aligned_cols=201  Identities=21%  Similarity=0.253  Sum_probs=161.6

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-----hhhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-----MQGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      .+|++.+.||+|+||.||+|...         .++..||+|.+....     ....+.+.+|+.+++.++||||++++++
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~---------~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   72 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDA---------DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC   72 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEc---------CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence            57899999999999999999544         358899999886431     2335678899999999999999999998


Q ss_pred             EEeC--CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEE
Q 017177          164 CWED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLF  241 (376)
Q Consensus       164 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~k  241 (376)
                      +.+.  ..++++|||+++++|.+++.+.    ..+++..+..++.|++.||.|||  +.+|+|+||||+||+++.++.++
T Consensus        73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~  146 (265)
T cd06652          73 LRDPMERTLSIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLH--SNMIVHRDIKGANILRDSVGNVK  146 (265)
T ss_pred             eccCCCceEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEecCCCCEE
Confidence            8764  4688999999999999998765    34788899999999999999999  59999999999999999999999


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |+|||++.............    ....|+..|+               +||.+.+.. .+.++|+||+|++++++++..
T Consensus       147 l~Dfg~~~~~~~~~~~~~~~----~~~~~~~~y~---------------aPE~~~~~~-~~~~~Dv~slG~il~el~~g~  206 (265)
T cd06652         147 LGDFGASKRLQTICLSGTGM----KSVTGTPYWM---------------SPEVISGEG-YGRKADIWSVGCTVVEMLTEK  206 (265)
T ss_pred             ECcCcccccccccccccccc----ccCCCCcccc---------------ChhhhcCCC-CCcchhHHHHHHHHHHHhhCC
Confidence            99999998664321110000    0113555566               799877644 588999999999999999655


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      .+.
T Consensus       207 ~p~  209 (265)
T cd06652         207 PPW  209 (265)
T ss_pred             CCC
Confidence            443

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.98  E-value=6.2e-32  Score=249.37  Aligned_cols=197  Identities=25%  Similarity=0.262  Sum_probs=163.2

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      |+..+.||+|+||+||+|....         +++.||+|.+.....   .....+.+|+.+++.++|+||+.+++.+..+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~   72 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRA---------TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK   72 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECC---------CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC
Confidence            6677899999999999995543         588999999876432   2234567899999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..+++|||+++++|.+++....  ...+++..+..++.|++.||.|||  ..+|+||||||+||++++++.++|+|||+
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH--~~~iiH~dikp~Nili~~~~~~kl~Dfg~  148 (285)
T cd05632          73 DALCLVLTIMNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLH--RENTVYRDLKPENILLDDYGHIRISDLGL  148 (285)
T ss_pred             CEEEEEEEeccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCHHHEEECCCCCEEEecCCc
Confidence            99999999999999998886542  245899999999999999999999  59999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      +............        .|++.|+               +||++.+.. .+.++|+||+|++++++++-..+.
T Consensus       149 ~~~~~~~~~~~~~--------~g~~~~~---------------aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~  201 (285)
T cd05632         149 AVKIPEGESIRGR--------VGTVGYM---------------APEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPF  201 (285)
T ss_pred             ceecCCCCcccCC--------CCCcCcc---------------ChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCC
Confidence            9765432221111        5667777               799887654 578899999999999998765554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-33  Score=265.19  Aligned_cols=178  Identities=22%  Similarity=0.352  Sum_probs=141.3

Q ss_pred             CccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEE
Q 017177           92 KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELL  171 (376)
Q Consensus        92 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~  171 (376)
                      .-++-||.|+.|.||+|+.+           ++.||||+++...       ..+|+-|++|+||||+.|.|+|.....++
T Consensus       127 sELeWlGSGaQGAVF~Grl~-----------netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyC  188 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH-----------NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYC  188 (904)
T ss_pred             hhhhhhccCcccceeeeecc-----------CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeE
Confidence            34577999999999999877           5679999876432       34788899999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeee
Q 017177          172 LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYF  251 (376)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~  251 (376)
                      ||||||..|-|+.+|+..    ..+.......|..+|+.|+.|||  .+.|||||||.-||||..+..|||+|||.++..
T Consensus       189 IiMEfCa~GqL~~VLka~----~~itp~llv~Wsk~IA~GM~YLH--~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~  262 (904)
T KOG4721|consen  189 IIMEFCAQGQLYEVLKAG----RPITPSLLVDWSKGIAGGMNYLH--LHKIIHRDLKSPNILISYDDVVKISDFGTSKEL  262 (904)
T ss_pred             EeeeccccccHHHHHhcc----CccCHHHHHHHHHHhhhhhHHHH--HhhHhhhccCCCceEeeccceEEeccccchHhh
Confidence            999999999999999876    45888899999999999999999  599999999999999999999999999999988


Q ss_pred             ccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHH--HHHHHHHh
Q 017177          252 KRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYS--VLLPRIYA  296 (376)
Q Consensus       252 ~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s--~~apEi~~  296 (376)
                      .+.......+||..+||   |+.+....|.|+.||||  |++.|+++
T Consensus       263 ~~~STkMSFaGTVaWMA---PEvIrnePcsEKVDIwSfGVVLWEmLT  306 (904)
T KOG4721|consen  263 SDKSTKMSFAGTVAWMA---PEVIRNEPCSEKVDIWSFGVVLWEMLT  306 (904)
T ss_pred             hhhhhhhhhhhhHhhhC---HHHhhcCCcccccceehhHHHHHHHHh
Confidence            77644444444444444   33333334444444332  44444433

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.98  E-value=6.9e-32  Score=246.16  Aligned_cols=202  Identities=20%  Similarity=0.256  Sum_probs=166.2

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC---ChhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ++|++.+.||+|+||.||+|+..         .++..||+|.++..   .......+.+|+.+++.++||||+++++++.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   72 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCL---------LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI   72 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEe---------CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence            57999999999999999999544         35889999987643   2233457889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +.+..+++|||+++|+|.+++.........+++..+..++.|++.||.|||  +++++||||||+||+++.++.++++||
T Consensus        73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~nil~~~~~~~~l~d~  150 (267)
T cd08228          73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH--SRRVMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCCHHHEEEcCCCCEEECcc
Confidence            999999999999999999988654333355889999999999999999999  699999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      |++..........   ...    .|++.|+               +||.+.+.. .+.++|+||+|++++++++...+.
T Consensus       151 g~~~~~~~~~~~~---~~~----~~~~~~~---------------aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~  206 (267)
T cd08228         151 GLGRFFSSKTTAA---HSL----VGTPYYM---------------SPERIHENG-YNFKSDIWSLGCLLYEMAALQSPF  206 (267)
T ss_pred             ccceeccchhHHH---hcC----CCCcccc---------------ChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCC
Confidence            9998765432210   011    4556666               799777654 578899999999999999765553

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.98  E-value=2.8e-32  Score=257.63  Aligned_cols=206  Identities=25%  Similarity=0.321  Sum_probs=161.8

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcC-CCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|...+.    .+..+++.||+|+++... ....+.+.+|+.++.++ +|+||+++++++
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~----~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~   80 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGI----EKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGAC   80 (337)
T ss_pred             CHHHhhhhcccccCcCceEEecccccc----ccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence            345799999999999999999965321    233357899999987543 23346678899999999 799999999988


Q ss_pred             EeC-CeEEEEEeccCCCCHHHHHhhcCCC---------------------------------------------------
Q 017177          165 WED-KELLLVYEYMQRGSLENHLFRRNPS---------------------------------------------------  192 (376)
Q Consensus       165 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~---------------------------------------------------  192 (376)
                      ... ..++++|||+++++|.+++......                                                   
T Consensus        81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (337)
T cd05054          81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE  160 (337)
T ss_pred             ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence            654 5689999999999999998643210                                                   


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEE
Q 017177          193 ------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIY  266 (376)
Q Consensus       193 ------~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y  266 (376)
                            ...+++..+..++.|++.||.|||  .++|+||||||+|||++.++.++|+|||++..+....... ..++.  
T Consensus       161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~-~~~~~--  235 (337)
T cd05054         161 EGDELYKEPLTLEDLISYSFQVARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-RKGDA--  235 (337)
T ss_pred             hhhHHhhcCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh-hccCC--
Confidence                  125789999999999999999999  6999999999999999999999999999998764332211 11111  


Q ss_pred             EEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          267 IYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       267 ~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                        .++..|+               +||.+.+.. .+.++|+||+|++++++++
T Consensus       236 --~~~~~y~---------------aPE~~~~~~-~~~~~Di~SlGv~l~el~t  270 (337)
T cd05054         236 --RLPLKWM---------------APESIFDKV-YTTQSDVWSFGVLLWEIFS  270 (337)
T ss_pred             --CCCcccc---------------CcHHhcCCC-CCccccHHHHHHHHHHHHH
Confidence              3345566               799776654 5888999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.98  E-value=6.5e-32  Score=251.43  Aligned_cols=209  Identities=22%  Similarity=0.302  Sum_probs=165.0

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcC-CCCCcceEEeE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGY  163 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~l~~~  163 (376)
                      ...++|++.+.||+|+||.||+|......  ......+..||+|.+.... ....+.+.+|+.+++.+ +||||++++++
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccC--CCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            34567899999999999999999753210  0112235689999987543 34457788999999999 79999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCC
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPS------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASN  231 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~N  231 (376)
                      +...+..|++|||+++|+|.+++.+....            ...+++..+..++.|++.||.|||  +++|+||||||+|
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~givH~dlkp~N  167 (304)
T cd05101          90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA--SQKCIHRDLAARN  167 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH--HCCeeecccccce
Confidence            99999999999999999999999765321            235788889999999999999999  6999999999999


Q ss_pred             EEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcccccccccee
Q 017177          232 ILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFA  311 (376)
Q Consensus       232 ILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g  311 (376)
                      ||++.++.+||+|||+++..............     .+++.|+               +||++.+.. .+.++|+||+|
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~-----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG  226 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNG-----RLPVKWM---------------APEALFDRV-YTHQSDVWSFG  226 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCC-----CCCceee---------------CchhhccCC-CCchhhHHHHH
Confidence            99999999999999999877543322111111     2334455               699776644 57889999999


Q ss_pred             eeehhhcc
Q 017177          312 FVFSCVFS  319 (376)
Q Consensus       312 ~v~~~~~~  319 (376)
                      ++++++++
T Consensus       227 ~~l~el~~  234 (304)
T cd05101         227 VLMWEIFT  234 (304)
T ss_pred             HHHHHHHc
Confidence            99999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=2.6e-32  Score=266.44  Aligned_cols=190  Identities=21%  Similarity=0.139  Sum_probs=158.6

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ..+|.+.+.||+|+||.||+|....         +++.||||....      ..+.+|+.++++++|+||+++++++..+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~---------~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~  232 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPD---------YPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVG  232 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECC---------CCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence            4579999999999999999995543         578899996432      3456899999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++|||++. ++|.+++....   ..+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+
T Consensus       233 ~~~~lv~e~~~-~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH--~~gIvHrDLKP~NILl~~~~~vkL~DFGl  306 (461)
T PHA03211        233 GLTCLVLPKYR-SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIH--GEGIIHRDIKTENVLVNGPEDICLGDFGA  306 (461)
T ss_pred             CEEEEEEEccC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCEEECcCCHHHEEECCCCCEEEcccCC
Confidence            99999999995 68988886542   45899999999999999999999  59999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ++...........     +...||+.||               +||++.+.. ++.++||||||++++|+++
T Consensus       307 a~~~~~~~~~~~~-----~~~~GT~~Y~---------------APE~~~~~~-~~~~sDvwSlGviL~El~~  357 (461)
T PHA03211        307 ACFARGSWSTPFH-----YGIAGTVDTN---------------APEVLAGDP-YTPSVDIWSAGLVIFEAAV  357 (461)
T ss_pred             ceecccccccccc-----cccCCCcCCc---------------CHHHHcCCC-CCchHHHHHHHHHHHHHHH
Confidence            9876443221111     1126788888               899887765 5789999999999999874

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.98  E-value=1.4e-32  Score=262.00  Aligned_cols=194  Identities=21%  Similarity=0.211  Sum_probs=158.3

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|...         .++..||+|++...  .......+.+|+.+++.++||||+++++++
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   89 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDT---------VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVF   89 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEc---------CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence            4578999999999999999999543         35889999998754  223346778999999999999999999998


Q ss_pred             EeCC------eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          165 WEDK------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       165 ~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      ...+      .+|+||||+++ +|.+.+..      .+++..+..++.|++.||.|||  .++|+||||||+|||++.+|
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH--~~~ivHrDlkp~NIl~~~~~  160 (359)
T cd07876          90 TPQKSLEEFQDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDC  160 (359)
T ss_pred             ccCCCccccceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCC
Confidence            6543      57999999975 67666632      3788899999999999999999  69999999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .+||+|||+++..........        ..||+.|+               |||++.+.. .+.++|+||+|+++++++
T Consensus       161 ~~kl~Dfg~a~~~~~~~~~~~--------~~~t~~y~---------------aPE~~~~~~-~~~~~DiwSlG~il~el~  216 (359)
T cd07876         161 TLKILDFGLARTACTNFMMTP--------YVVTRYYR---------------APEVILGMG-YKENVDIWSVGCIMGELV  216 (359)
T ss_pred             CEEEecCCCccccccCccCCC--------CcccCCCC---------------CchhccCCC-CCcchhhHHHHHHHHHHH
Confidence            999999999986543222111        16677777               799887755 478899999999999998


Q ss_pred             cccc
Q 017177          319 SFYR  322 (376)
Q Consensus       319 ~~y~  322 (376)
                      +...
T Consensus       217 tg~~  220 (359)
T cd07876         217 KGSV  220 (359)
T ss_pred             hCCC
Confidence            6443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.98  E-value=2.1e-31  Score=246.77  Aligned_cols=210  Identities=23%  Similarity=0.292  Sum_probs=168.5

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCC-------cccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcce
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLA-------PSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVK  159 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~  159 (376)
                      .++|++.+.||+|+||.||+|........       ..+...+..||+|.+.... ....+.+.+|+.+++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            46799999999999999999976542100       1233345779999988654 344577889999999999999999


Q ss_pred             EEeEEEeCCeEEEEEeccCCCCHHHHHhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCE
Q 017177          160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI  232 (376)
Q Consensus       160 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NI  232 (376)
                      +++++..++..+++|||+++++|.+++.+...       ....+++..+..++.|++.||.|||  +.+|+||||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH--~~~i~H~dlkp~Ni  161 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE--SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH--HcCccccccchhce
Confidence            99999999999999999999999999976531       1125899999999999999999999  59999999999999


Q ss_pred             EEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceee
Q 017177          233 LLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAF  312 (376)
Q Consensus       233 Ll~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~  312 (376)
                      +++.++.++++|||+++......... ..+..    .+++.||               +||.+.+. ..+.++||||+|+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~----~~~~~y~---------------aPE~~~~~-~~~~~~Dv~slG~  220 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYR-VQGRA----PLPIRWM---------------AWESVLLG-KFTTKSDVWAFGV  220 (296)
T ss_pred             eecCCCceEEccccceeecccCccee-ecCcC----CCCceec---------------CHHHhhcC-CCCccchhhhhHH
Confidence            99999999999999998765433221 11111    4456666               79977654 4689999999999


Q ss_pred             eehhhccc
Q 017177          313 VFSCVFSF  320 (376)
Q Consensus       313 v~~~~~~~  320 (376)
                      +++++++.
T Consensus       221 ~l~el~~~  228 (296)
T cd05051         221 TLWEILTL  228 (296)
T ss_pred             HHHHHHhc
Confidence            99998864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.98  E-value=5.4e-32  Score=249.78  Aligned_cols=197  Identities=24%  Similarity=0.269  Sum_probs=163.1

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      |+..+.||+|+||.||++...         .+++.||+|.+.....   .....+.+|+.+++.++|+||+.+++.+.++
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~   72 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK   72 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEc---------CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC
Confidence            677899999999999999554         3688999999875422   2234567899999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++||||+++++|.+++.....  ..+++..+..++.|++.||.|||  ..+|+||||||+||+++.++.++|+|||+
T Consensus        73 ~~~~lv~e~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH--~~~iiH~dikp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05630          73 DALCLVLTLMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLH--QERIVYRDLKPENILLDDHGHIRISDLGL  148 (285)
T ss_pred             CEEEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHEEECCCCCEEEeeccc
Confidence            999999999999999998865432  45899999999999999999999  59999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      +............        .||+.|+               |||++.+.. .+.++|+||+|++++++++...+.
T Consensus       149 ~~~~~~~~~~~~~--------~g~~~y~---------------aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf  201 (285)
T cd05630         149 AVHVPEGQTIKGR--------VGTVGYM---------------APEVVKNER-YTFSPDWWALGCLLYEMIAGQSPF  201 (285)
T ss_pred             eeecCCCccccCC--------CCCcccc---------------ChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCC
Confidence            9865433222111        5667777               799887654 578899999999999998654443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.98  E-value=1.5e-32  Score=261.30  Aligned_cols=195  Identities=19%  Similarity=0.182  Sum_probs=159.8

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|.+....  ......+.+|+.+++.++||||+++++++
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   85 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDA---------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF   85 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEec---------CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeee
Confidence            4678999999999999999999543         358889999987542  23346778999999999999999999988


Q ss_pred             EeC------CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          165 WED------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       165 ~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      ...      ...|+||||+++ +|.+.+..      .+++..+..++.|++.||.|||  +++|+||||||+|||++.++
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH--~~givHrDikp~Nill~~~~  156 (355)
T cd07874          86 TPQKSLEEFQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDC  156 (355)
T ss_pred             eccccccccceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHHEEECCCC
Confidence            654      357999999965 67777643      3788899999999999999999  69999999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .+||+|||+++..........        ..||+.|+               |||++.+.. .+.++|+||+|+++++++
T Consensus       157 ~~kl~Dfg~~~~~~~~~~~~~--------~~~t~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~el~  212 (355)
T cd07874         157 TLKILDFGLARTAGTSFMMTP--------YVVTRYYR---------------APEVILGMG-YKENVDIWSVGCIMGEMV  212 (355)
T ss_pred             CEEEeeCcccccCCCccccCC--------ccccCCcc---------------CHHHHcCCC-CCchhhHHHHHHHHHHHH
Confidence            999999999987544322211        15677777               799887765 578899999999999998


Q ss_pred             ccccc
Q 017177          319 SFYRT  323 (376)
Q Consensus       319 ~~y~~  323 (376)
                      +...+
T Consensus       213 ~g~~p  217 (355)
T cd07874         213 RHKIL  217 (355)
T ss_pred             hCCCC
Confidence            65443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.98  E-value=1e-31  Score=247.12  Aligned_cols=206  Identities=25%  Similarity=0.339  Sum_probs=167.3

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|+..+.||+|+||.||++.....    ....++..+|+|.+..........+.+|+++++.++|+||+++++++.+.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecC----CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            45788899999999999999965321    12334678999998877766677899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPS-----------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG  236 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~  236 (376)
                      +..+++|||+++++|.+++......           ...+++..++.++.|++.||.|||  +.+++||||||+|||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~~i~H~dlkp~nil~~~  157 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA--SLHFVHRDLATRNCLVGQ  157 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH--HCCeecccccHhhEEEcC
Confidence            9999999999999999999764321           134788999999999999999999  699999999999999999


Q ss_pred             CCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehh
Q 017177          237 VGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSC  316 (376)
Q Consensus       237 ~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~  316 (376)
                      ++.+||+|||++..............+     .+++.|+               +||.+.+.. .+.++|+||||+++++
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~-----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~e  216 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRT-----MLPIRWM---------------PPESILYRK-FTTESDIWSFGVVLWE  216 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCc-----ccccccc---------------CHHHhccCC-cCchhhHHHHHHHHHH
Confidence            999999999999865443222111111     3445666               799776654 5888999999999999


Q ss_pred             hccc
Q 017177          317 VFSF  320 (376)
Q Consensus       317 ~~~~  320 (376)
                      ++++
T Consensus       217 l~~~  220 (280)
T cd05092         217 IFTY  220 (280)
T ss_pred             HHcC
Confidence            9873

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.98  E-value=5.1e-33  Score=231.43  Aligned_cols=206  Identities=21%  Similarity=0.217  Sum_probs=164.9

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcC-CCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~l~~~~  164 (376)
                      ..++...+..||+|+||.|-+.         ++..+|...|+|.+...- .+..+++++|+.+..+. ..|.+|++||.+
T Consensus        44 ~ad~L~~i~elGrGayG~vekm---------rh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~  114 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKM---------RHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL  114 (282)
T ss_pred             chhhhhhhhhhcCCccchhhhe---------eeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhh
Confidence            3455667788999999999877         555579999999998653 34456778899887776 499999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .+.+.+||.||.|+- +|..+.++-......+++..+-+|+..+..||.|||+ +..+||||+||+||||+.+|.+|+||
T Consensus       115 ~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~-kL~vIHRDvKPsNiLIn~~GqVKiCD  192 (282)
T KOG0984|consen  115 FREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS-KLSVIHRDVKPSNILINYDGQVKICD  192 (282)
T ss_pred             hccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH-HhhhhhccCCcceEEEccCCcEEEcc
Confidence            999999999999965 8887776654455779999999999999999999998 89999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ||++..+.+.-..+..        .|--.||    +||+.+      || +.. ..++-++||||+|+...|+++..-+
T Consensus       193 FGIsG~L~dSiAkt~d--------aGCkpYm----aPEri~------~e-~n~-~gY~vksDvWSLGItmiElA~lr~P  251 (282)
T KOG0984|consen  193 FGISGYLVDSIAKTMD--------AGCKPYM----APERIN------PE-LNQ-KGYSVKSDVWSLGITMIEMAILRFP  251 (282)
T ss_pred             cccceeehhhhHHHHh--------cCCCccC----ChhhcC------cc-cCc-ccceeehhhhhhhhhhhhhhhcccc
Confidence            9999998776544323        3445556    344444      44 122 3568999999999999999876444

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=1.6e-32  Score=261.45  Aligned_cols=188  Identities=20%  Similarity=0.187  Sum_probs=157.1

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ..+|++.+.||+|+||.||+|....         ++..||+|+.....      ...|+.++++++||||+++++++...
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~  129 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPG---------QPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVSG  129 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECC---------CCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEeC
Confidence            4579999999999999999996543         57889999865432      34699999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++|||++. ++|.+++....   ..+++..+..++.||+.||.|||  .++|+||||||+|||++.++.+||+|||+
T Consensus       130 ~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DfG~  203 (357)
T PHA03209        130 AITCMVLPHYS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLH--AQRIIHRDVKTENIFINDVDQVCIGDLGA  203 (357)
T ss_pred             CeeEEEEEccC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEecCcc
Confidence            99999999995 58888886542   56899999999999999999999  59999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ++..........        ..||+.|+               +||++.+.. ++.++|+||+|+++++++++
T Consensus       204 a~~~~~~~~~~~--------~~gt~~y~---------------aPE~~~~~~-~~~~~DiwSlGvvl~ell~~  252 (357)
T PHA03209        204 AQFPVVAPAFLG--------LAGTVETN---------------APEVLARDK-YNSKADIWSAGIVLFEMLAY  252 (357)
T ss_pred             ccccccCccccc--------cccccccc---------------CCeecCCCC-CCchhhHHHHHHHHHHHHHc
Confidence            985433222111        15677777               799877654 57899999999999999863

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.98  E-value=7.2e-32  Score=246.70  Aligned_cols=202  Identities=24%  Similarity=0.271  Sum_probs=163.1

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcC-CCCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~  165 (376)
                      ..+.|++.+.||+|+||.||+|...         .+++.||+|.+.... .....+.+|+.+++++ +|+||+++++++.
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   73 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHV---------KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI   73 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEc---------CCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence            4567889999999999999999554         358899999987653 2335678899999998 5999999999987


Q ss_pred             eC------CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc
Q 017177          166 ED------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF  239 (376)
Q Consensus       166 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~  239 (376)
                      ..      ..+|++|||+++++|.+++....  ...+++..+..++.|++.||.|||  .++|+||||||+||+++.++.
T Consensus        74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH--~~~ivh~dl~~~nili~~~~~  149 (272)
T cd06637          74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAE  149 (272)
T ss_pred             ecCCCCCCcEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHEEECCCCC
Confidence            53      46899999999999999997643  245889999999999999999999  589999999999999999999


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh----hhccccccccceeeeeh
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI----KYLTLLKYSNSFAFVFS  315 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~----~~~~~~~dv~s~g~v~~  315 (376)
                      ++|+|||++.........   ..+    ..|++.|+               +||++.+.    ..++.++|+||+|++++
T Consensus       150 ~~l~Dfg~~~~~~~~~~~---~~~----~~g~~~y~---------------aPE~~~~~~~~~~~~~~~~Dv~slGv~l~  207 (272)
T cd06637         150 VKLVDFGVSAQLDRTVGR---RNT----FIGTPYWM---------------APEVIACDENPDATYDFKSDLWSLGITAI  207 (272)
T ss_pred             EEEccCCCceeccccccc---CCc----cccccccc---------------CHhHhccccCcCCCCCchhhHHHHHHHHH
Confidence            999999999865432211   011    15666666               79987632    34577899999999999


Q ss_pred             hhccccccc
Q 017177          316 CVFSFYRTT  324 (376)
Q Consensus       316 ~~~~~y~~~  324 (376)
                      ++++...+.
T Consensus       208 el~~g~~p~  216 (272)
T cd06637         208 EMAEGAPPL  216 (272)
T ss_pred             HHHhCCCCc
Confidence            999765543

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=9.3e-34  Score=287.19  Aligned_cols=204  Identities=24%  Similarity=0.297  Sum_probs=172.8

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEe
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLG  162 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~  162 (376)
                      ....-+|+....||.|.||.||.|.         +..+|...|+|.++....  .....+.+|..++..++|||+|++||
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtav---------N~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyG 1301 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAV---------NLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYG 1301 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEee---------cCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCc
Confidence            3345578888999999999999994         444799999999876432  33456789999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                      +-.+.+.++|.||||++|+|.+++...    ...++.....+..|++.|+.|||  +.+||||||||+|||++.+|.+|+
T Consensus      1302 VEvHRekv~IFMEyC~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH--~~gIVHRDIK~aNI~Ld~~g~iK~ 1375 (1509)
T KOG4645|consen 1302 VEVHREKVYIFMEYCEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLH--EHGIVHRDIKPANILLDFNGLIKY 1375 (1509)
T ss_pred             eeecHHHHHHHHHHhccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHH--hcCceecCCCccceeeecCCcEEe
Confidence            999999999999999999999999765    34677888889999999999999  699999999999999999999999


Q ss_pred             cceeeeeeeccceee--EEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhh--hccccccccceeeeehhhc
Q 017177          243 SHLLIYVYFKRHYIY--IYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIK--YLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~--~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~--~~~~~~dv~s~g~v~~~~~  318 (376)
                      +|||.|..+..+...  ....+.     .|||-||               |||+++|.+  -...++||||+|||..||+
T Consensus      1376 ~DFGsa~ki~~~~~~~~~el~~~-----~GT~~YM---------------APEvit~t~~kG~~~A~DiWslGCVVlEM~ 1435 (1509)
T KOG4645|consen 1376 GDFGSAVKIKNNAQTMPGELQSM-----MGTPMYM---------------APEVITGTKGKGHGGAADIWSLGCVVLEMA 1435 (1509)
T ss_pred             ecccceeEecCchhcCCHHHHhh-----cCCchhc---------------CchhhcccccCCCCcchhhhcccceEEEee
Confidence            999999998776421  112222     7999999               999999863  4568999999999999999


Q ss_pred             ccccc
Q 017177          319 SFYRT  323 (376)
Q Consensus       319 ~~y~~  323 (376)
                      +--++
T Consensus      1436 tGkrP 1440 (1509)
T KOG4645|consen 1436 TGKRP 1440 (1509)
T ss_pred             cCCCc
Confidence            76555

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.98  E-value=1.2e-31  Score=245.78  Aligned_cols=206  Identities=23%  Similarity=0.263  Sum_probs=165.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|......    ...++..||+|.+.... ......+.+|+.+++.++||||+++++++..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVV----KGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccC----CCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            467899999999999999999765421    12346789999987653 3444678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCC------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcE
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPS------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL  240 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~  240 (376)
                      ....++||||+++|+|.+++......      ...+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~di~p~nill~~~~~~  158 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA--AKKFVHRDLAARNCMVAEDLTV  158 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccChheEEEcCCCCE
Confidence            99999999999999999999764321      124688899999999999999999  6999999999999999999999


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ||+|||+++........... +..    .++..|+               +||.+.... .+.++|+||+|+++++++++
T Consensus       159 kl~dfg~~~~~~~~~~~~~~-~~~----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~el~t~  217 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKG-GKG----LLPVRWM---------------APESLKDGV-FTTKSDVWSFGVVLWEMATL  217 (277)
T ss_pred             EECCcccchhhccCcccccC-CCC----Ccccccc---------------CHHHHhcCC-CCcccchHHHHHHHHHhhcc
Confidence            99999999866443321111 111    3344555               799776544 68899999999999999873

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.98  E-value=6.5e-32  Score=248.78  Aligned_cols=204  Identities=25%  Similarity=0.361  Sum_probs=163.7

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe--
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE--  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--  166 (376)
                      ++|++.+.||+|+||.||+|....     .+..++..||+|.+........+.+.+|+.+++.++||||+++++++..  
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDP-----LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   78 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecC-----CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence            478899999999999999996542     2334588999999987776667788999999999999999999998754  


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ...+++||||+++|+|.+++.+..   ..+++..+..++.|++.||.|||  +++|+||||||+||+++.++.+||+|||
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH--~~~i~H~dlkp~nili~~~~~~~l~dfg  153 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLG--SKRYVHRDLATRNILVESENRVKIGDFG  153 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCHhhEEECCCCeEEECCCc
Confidence            346899999999999999996542   35889999999999999999999  6999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      +++........... ...+   .++..|+               +||.+.+.. .+.++|+||+|++++|++++..
T Consensus       154 ~~~~~~~~~~~~~~-~~~~---~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~  209 (284)
T cd05081         154 LTKVLPQDKEYYKV-REPG---ESPIFWY---------------APESLTESK-FSVASDVWSFGVVLYELFTYSD  209 (284)
T ss_pred             ccccccCCCcceee-cCCC---CCceEee---------------CHHHhccCC-cChHHHHHHHHHHHHHHhhcCC
Confidence            99976543221111 0000   1112233               599876654 5788999999999999987544

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.98  E-value=8.6e-32  Score=249.80  Aligned_cols=200  Identities=21%  Similarity=0.209  Sum_probs=167.7

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ....+|++.+.||+|+||.||+|...         .++..||+|.+........+.+.+|+.+++.++|+||+++++.+.
T Consensus        17 ~~~~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~   87 (296)
T cd06654          17 DPKKKYTRFEKIGQGASGTVYTAMDV---------ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL   87 (296)
T ss_pred             CcccceeeEEEecCCCCeEEEEEEEC---------CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            34568999999999999999999543         357899999998765555677889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      .+...|+||||+++++|.+++...     .+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.++|+||
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH--~~gi~H~dLkp~Nill~~~~~~kl~df  160 (296)
T cd06654          88 VGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDF  160 (296)
T ss_pred             eCCEEEEeecccCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEcCCCCEEECcc
Confidence            999999999999999999998542     3788999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      |++..........   ..    ..|++.|+               +||.+.+.. .+.++|+|++|++++++++.+.+.
T Consensus       161 g~~~~~~~~~~~~---~~----~~~~~~y~---------------aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf  216 (296)
T cd06654         161 GFCAQITPEQSKR---ST----MVGTPYWM---------------APEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPY  216 (296)
T ss_pred             ccchhcccccccc---Cc----ccCCcccc---------------CHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCC
Confidence            9988654322110   01    14566666               799777544 578999999999999999776664

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.98  E-value=1.7e-31  Score=241.87  Aligned_cols=199  Identities=21%  Similarity=0.240  Sum_probs=166.5

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      +|++.+.||+|+||.||+|....         ++..|++|.+...  .......+.+|+.+++.++||||+++++++.++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKA---------DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK   71 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcC---------CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence            47788999999999999996543         5888999998754  334557788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++||||+++++|.+++....  ...+++..+..++.|++.||.|||  +.+++||||||+||+++.++.++++|||+
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH--~~~i~h~dl~~~nili~~~~~~~l~df~~  147 (256)
T cd08529          72 GKLNIVMEYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGV  147 (256)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEEeCCCCEEEccccc
Confidence            99999999999999999997642  246889999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      +...........   +    ..|++.|+               +||++.+.. .+.++|+||+|++++++++...+.
T Consensus       148 ~~~~~~~~~~~~---~----~~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~  201 (256)
T cd08529         148 AKLLSDNTNFAN---T----IVGTPYYL---------------SPELCEDKP-YNEKSDVWALGVVLYECCTGKHPF  201 (256)
T ss_pred             ceeccCccchhh---c----cccCcccc---------------CHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCC
Confidence            987755432211   1    14556666               799776654 578999999999999999765553

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=6.4e-33  Score=255.83  Aligned_cols=193  Identities=24%  Similarity=0.298  Sum_probs=163.7

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcC--CCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL--SHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l--~h~nIv~l~~~~~  165 (376)
                      ....++.++||+|.||.||+|...           ++.||||++....   .+.|+.|-+|.+..  +|+||++++++-.
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~-----------~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ek  274 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD-----------NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEK  274 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc-----------CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhc
Confidence            445778899999999999999765           5789999997643   46677787777765  6999999999876


Q ss_pred             eCC----eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhc-------CCCCcEecCCCCCCEEE
Q 017177          166 EDK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHT-------SEKKVIYRDFKASNILL  234 (376)
Q Consensus       166 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs-------~~~~iiHrDlKp~NILl  234 (376)
                      ...    .++||+||.+.|+|.++|+.+     .++|....+++.-+++||+|||+       ++..|+|||||..||||
T Consensus       275 r~t~~~~eywLVt~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv  349 (534)
T KOG3653|consen  275 RGTADRMEYWLVTEFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV  349 (534)
T ss_pred             cCCccccceeEEeeeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE
Confidence            554    799999999999999999875     48999999999999999999997       35689999999999999


Q ss_pred             cCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcc-----ccccccc
Q 017177          235 DGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLT-----LLKYSNS  309 (376)
Q Consensus       235 ~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~-----~~~dv~s  309 (376)
                      ..|++..|+|||+|..+..........+.     +||-.||               |||++.|.-.+.     ...||||
T Consensus       350 K~DlTccIaDFGLAl~~~p~~~~~d~~~q-----VGT~RYM---------------APEvLEgainl~d~~Afkr~DvYa  409 (534)
T KOG3653|consen  350 KNDLTCCIADFGLALRLEPGKPQGDTHGQ-----VGTRRYM---------------APEVLEGAINLQDRDAFKRIDVYA  409 (534)
T ss_pred             ccCCcEEeeccceeEEecCCCCCcchhhh-----hhhhhhc---------------CHHHHhhhcccccHHHHHHHHHHH
Confidence            99999999999999998765544444443     8899999               899999874433     6789999


Q ss_pred             eeeeehhhcc
Q 017177          310 FAFVFSCVFS  319 (376)
Q Consensus       310 ~g~v~~~~~~  319 (376)
                      +|.|+||+++
T Consensus       410 mgLVLWEi~S  419 (534)
T KOG3653|consen  410 MGLVLWEIAS  419 (534)
T ss_pred             HHHHHHHHHh
Confidence            9999999993

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.98  E-value=1.3e-31  Score=246.22  Aligned_cols=201  Identities=20%  Similarity=0.270  Sum_probs=160.1

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|.+...     .......||+|.++.... ...+.+.+|+.+++.++||||+++++++..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPD-----GENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT   80 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecC-----CCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence            45788999999999999999976431     111234689999876533 345678899999999999999999998875


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                       ...++++||+++|+|.+++....   ..+++..++.++.|++.||.|||  +++|+||||||+|||+++++.+||+|||
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH--~~~iiH~dlkp~Nil~~~~~~~kL~dfG  154 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLE--EVRLVHRDLAARNVLVKSPNHVKITDFG  154 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccccceEEEcCCCcEEECCCC
Confidence             45789999999999999997642   45899999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      +++............+.     .+++.|+               +||.+.+.. .+.++|+||+|++++|++++
T Consensus       155 ~~~~~~~~~~~~~~~~~-----~~~~~y~---------------~PE~~~~~~-~~~~~Di~slG~~l~el~t~  207 (279)
T cd05109         155 LARLLDIDETEYHADGG-----KVPIKWM---------------ALESILHRR-FTHQSDVWSYGVTVWELMTF  207 (279)
T ss_pred             ceeecccccceeecCCC-----ccchhhC---------------CHHHhccCC-CCchhHHHHHHHHHHHHHcC
Confidence            99877543222111111     2345566               799776554 57899999999999998763

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.98  E-value=1.5e-31  Score=243.13  Aligned_cols=195  Identities=21%  Similarity=0.337  Sum_probs=162.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|++.+.||+|+||.||+|...+          +..||+|.+..... ..+.+.+|+.+++.++|+||+++++.+...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   73 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNN----------STKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKE   73 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecC----------CceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            4678999999999999999997543          56799999876443 346788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..+++|||+++++|.+++.+..  ...+++..+..++.|++.||+|||  ..+++||||||+||+++.++.++|+|||+
T Consensus        74 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~dfg~  149 (261)
T cd05072          74 EPIYIITEYMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIE--RKNYIHRDLRAANVLVSESLMCKIADFGL  149 (261)
T ss_pred             CCcEEEEecCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhhEEecCCCcEEECCCcc
Confidence            99999999999999999997643  245788899999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +.......... ..+.     .++..|+               +||.+.+.. .+.++|+||+|++++++++
T Consensus       150 ~~~~~~~~~~~-~~~~-----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~~l~~l~t  199 (261)
T cd05072         150 ARVIEDNEYTA-REGA-----KFPIKWT---------------APEAINFGS-FTIKSDVWSFGILLYEIVT  199 (261)
T ss_pred             ceecCCCceec-cCCC-----ccceecC---------------CHHHhccCC-CChhhhhhhhHHHHHHHHc
Confidence            98765432221 1111     2344555               799776544 5788999999999999987

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=2.6e-32  Score=270.53  Aligned_cols=208  Identities=18%  Similarity=0.189  Sum_probs=153.9

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcc------cCCCCcE----EEEEEcCCCChhhHHHHHHHHHHHhcCCCC
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPS------KTGLGMV----VAIKKLNPESMQGFEEWQSEVNFLGRLSHP  155 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~------~~~~~~~----vavK~~~~~~~~~~~~~~~E~~il~~l~h~  155 (376)
                      ...++|++++.||+|+||+||+|..+.......      ....+..    ++.|.+.. .......+.+|+.+|+.++||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCC
Confidence            345789999999999999999987543210000      0000011    11222221 112345678999999999999


Q ss_pred             CcceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE
Q 017177          156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL  234 (376)
Q Consensus       156 nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl  234 (376)
                      ||+++++++...+..|+|+|++. ++|..++..... .........+..++.||+.||.|||  .++||||||||+|||+
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH--~~gIiHrDLKP~NILl  300 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH--DKKLIHRDIKLENIFL  300 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEE
Confidence            99999999999999999999995 578777754321 1122346677889999999999999  5999999999999999


Q ss_pred             cCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeee
Q 017177          235 DGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVF  314 (376)
Q Consensus       235 ~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~  314 (376)
                      +.+|.+||+|||+++.+....... .     +...||+.|+               +||++.+.. ++.++||||+|+++
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~-~-----~~~~gt~~y~---------------aPE~~~~~~-~~~~~DiwSlGvil  358 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAF-D-----YGWVGTVATN---------------SPEILAGDG-YCEITDIWSCGLIL  358 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccc-c-----ccccCCcCCC---------------CchhhcCCC-CCcHHHHHHHHHHH
Confidence            999999999999998775432211 1     1126788888               899887765 57889999999999


Q ss_pred             hhhcc
Q 017177          315 SCVFS  319 (376)
Q Consensus       315 ~~~~~  319 (376)
                      +|+++
T Consensus       359 ~ell~  363 (501)
T PHA03210        359 LDMLS  363 (501)
T ss_pred             HHHHH
Confidence            99985

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.98  E-value=1.3e-31  Score=243.35  Aligned_cols=193  Identities=26%  Similarity=0.342  Sum_probs=159.5

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      ++|++.+.||+|+||.||++.+.+          +..+|+|.+..... ..+.+.+|+.++++++||||+++++++...+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR   72 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC----------CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            468889999999999999996543          44599999876543 2367889999999999999999999999888


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeee
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a  248 (376)
                      ..+++|||+.+|+|.+++....   ..+++..++.++.|++.||.|||  +.+++||||||+|||++.++.+||+|||++
T Consensus        73 ~~~lv~e~~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~nili~~~~~~kl~d~g~~  147 (256)
T cd05113          73 PIYIVTEYMSNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLE--SKQFIHRDLAARNCLVDDQGCVKVSDFGLS  147 (256)
T ss_pred             CcEEEEEcCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEEcCCCCEEECCCccc
Confidence            9999999999999999997642   35899999999999999999999  699999999999999999999999999999


Q ss_pred             eeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          249 VYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +......... ..++     .++..|+               +||.+.+.. .+.++|+||+|++++++++
T Consensus       148 ~~~~~~~~~~-~~~~-----~~~~~y~---------------~pe~~~~~~-~~~~~Di~slG~~l~~l~~  196 (256)
T cd05113         148 RYVLDDEYTS-SVGS-----KFPVRWS---------------PPEVLLYSK-FSSKSDVWAFGVLMWEVYS  196 (256)
T ss_pred             eecCCCceee-cCCC-----ccChhhC---------------CHHHHhcCc-ccchhHHHHHHHHHHHHhc
Confidence            8764432211 1111     2333444               799776654 5788999999999999986

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.98  E-value=8.4e-32  Score=243.58  Aligned_cols=190  Identities=23%  Similarity=0.285  Sum_probs=154.2

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv  173 (376)
                      +.||+|+||.||+|....         ++..+|+|.+..... .....+.+|+++++.++||||+++++++...+..++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   71 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRA---------DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV   71 (252)
T ss_pred             CccCcccCccEEEEEEec---------CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence            468999999999995543         588899998875432 3346788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      |||+++++|.+++.+..   ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+|++|||++.....
T Consensus        72 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  146 (252)
T cd05084          72 MELVQGGDFLTFLRTEG---PRLKVKELIQMVENAAAGMEYLE--SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEED  146 (252)
T ss_pred             EeeccCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--hCCccccccchheEEEcCCCcEEECccccCccccc
Confidence            99999999999996542   45789999999999999999999  69999999999999999999999999999986543


Q ss_pred             ceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          254 HYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       254 ~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ..... ..+..    ..+..|+               +||.+.+.. .+.++|+||+|++++++++
T Consensus       147 ~~~~~-~~~~~----~~~~~y~---------------aPE~~~~~~-~~~~~Dv~slG~il~e~~~  191 (252)
T cd05084         147 GVYAS-TGGMK----QIPVKWT---------------APEALNYGR-YSSESDVWSFGILLWEAFS  191 (252)
T ss_pred             ccccc-cCCCC----CCceeec---------------CchhhcCCC-CChHHHHHHHHHHHHHHHh
Confidence            21110 00100    1123344               699776654 5788999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.98  E-value=2.9e-32  Score=258.15  Aligned_cols=196  Identities=21%  Similarity=0.199  Sum_probs=162.6

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ...++|++.+.||+|+||.||+|...         .++..||+|++.....  ...+.+.+|+.+++.++||||++++++
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   82 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDT---------RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV   82 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEEC---------CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhh
Confidence            34578999999999999999999543         3588999999876432  234567789999999999999999998


Q ss_pred             EEeC------CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC
Q 017177          164 CWED------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV  237 (376)
Q Consensus       164 ~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~  237 (376)
                      +...      ...|++||++ +++|.+++..     ..+++..+..++.|++.||.|||  .++|+||||||+|||++.+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrdikp~Nil~~~~  154 (343)
T cd07878          83 FTPATSIENFNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIH--SAGIIHRDLKPSNVAVNED  154 (343)
T ss_pred             hcccccccccCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--HCCeecccCChhhEEECCC
Confidence            7543      3579999998 7799887753     34899999999999999999999  5999999999999999999


Q ss_pred             CcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhh
Q 017177          238 GFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCV  317 (376)
Q Consensus       238 g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~  317 (376)
                      +.+||+|||+++.......     +     ..||+.|+               |||++.+...++.++|+||+|++++++
T Consensus       155 ~~~kl~Dfg~~~~~~~~~~-----~-----~~~t~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~el  209 (343)
T cd07878         155 CELRILDFGLARQADDEMT-----G-----YVATRWYR---------------APEIMLNWMHYNQTVDIWSVGCIMAEL  209 (343)
T ss_pred             CCEEEcCCccceecCCCcC-----C-----cccccccc---------------CchHhcCCccCCchhhhHhHHHHHHHH
Confidence            9999999999987644211     1     15677777               799888766778999999999999999


Q ss_pred             cccccc
Q 017177          318 FSFYRT  323 (376)
Q Consensus       318 ~~~y~~  323 (376)
                      ++.+.+
T Consensus       210 ~~g~~p  215 (343)
T cd07878         210 LKGKAL  215 (343)
T ss_pred             HHCCCC
Confidence            875544

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.98  E-value=1.3e-31  Score=247.48  Aligned_cols=207  Identities=23%  Similarity=0.242  Sum_probs=162.1

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ..++|++.+.||+|+||.||+|...+.    .....+..||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDI----IKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEecc----CCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            356799999999999999999975431    1112356899999875532 33456788999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCC------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNP------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF  239 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~  239 (376)
                      +.+..++||||+++|+|.+++.+...      .....+...+..++.|++.||.|||  +++|+||||||+|||++.++.
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dikp~nili~~~~~  157 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFT  157 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCcCCCCChheEEEcCCCc
Confidence            99999999999999999999975421      1233567788999999999999999  699999999999999999999


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ++++|||+++.......... .+..    .++..|+               +||.+.+.. .+.++|+||+|++++++++
T Consensus       158 ~~L~Dfg~~~~~~~~~~~~~-~~~~----~~~~~y~---------------~pE~~~~~~-~~~~~DvwslG~~l~el~~  216 (288)
T cd05061         158 VKIGDFGMTRDIYETDYYRK-GGKG----LLPVRWM---------------APESLKDGV-FTTSSDMWSFGVVLWEITS  216 (288)
T ss_pred             EEECcCCccccccccccccc-cCCC----ccccccc---------------CHHHhccCC-CChHhHHHHHHHHHHHHHh
Confidence            99999999986543322111 1110    2334455               799776544 5789999999999999886


Q ss_pred             c
Q 017177          320 F  320 (376)
Q Consensus       320 ~  320 (376)
                      .
T Consensus       217 ~  217 (288)
T cd05061         217 L  217 (288)
T ss_pred             C
Confidence            3

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.98  E-value=1.3e-31  Score=244.18  Aligned_cols=196  Identities=22%  Similarity=0.349  Sum_probs=162.6

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ..+|.+.+.||+|+||.||+|....         ++..||+|.+.... .....+.+|+.+++.++|+||+++++++..+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE   74 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEec---------CCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCC
Confidence            3458888999999999999996543         47889999987653 3356788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +.++++|||+++++|.+++.....  ..+++..++.++.|++.||.|||  .++++||||||+|||+++++.+||+|||+
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~df~~  150 (263)
T cd05052          75 PPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGL  150 (263)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEEcCCCcEEeCCCcc
Confidence            999999999999999999976432  45889999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +............ ..     .+++.|+               +||.+.+.. .+.++|+||+|++++++++
T Consensus       151 ~~~~~~~~~~~~~-~~-----~~~~~y~---------------aPE~~~~~~-~~~~~Dv~slG~il~el~t  200 (263)
T cd05052         151 SRLMTGDTYTAHA-GA-----KFPIKWT---------------APESLAYNK-FSIKSDVWAFGVLLWEIAT  200 (263)
T ss_pred             ccccccceeeccC-CC-----CCccccC---------------CHHHhccCC-CCchhHHHHHHHHHHHHHc
Confidence            9876543222111 10     2234455               799776654 5788999999999999987

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.98  E-value=1.1e-31  Score=243.54  Aligned_cols=193  Identities=28%  Similarity=0.390  Sum_probs=159.1

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      ++|++.+.||+|+||.||++.+..          +..+|+|.+..... ....+.+|+.+++.++||||+++++++..++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA----------QIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK   72 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc----------CceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence            458888999999999999996653          45799998875432 2357888999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeee
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a  248 (376)
                      ..++||||+++|+|.+++....   ..+++..+..++.|++.||.|||  +++|+||||||+||+++.++.+|++|||++
T Consensus        73 ~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~  147 (256)
T cd05114          73 PLYIVTEFMENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLE--RNSFIHRDLAARNCLVSSTGVVKVSDFGMT  147 (256)
T ss_pred             CEEEEEEcCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcceEEEcCCCeEEECCCCCc
Confidence            9999999999999999987542   35789999999999999999999  699999999999999999999999999999


Q ss_pred             eeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          249 VYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +........... +.     .++..|+               +||.+.+.. .+.++|+||+|++++++++
T Consensus       148 ~~~~~~~~~~~~-~~-----~~~~~y~---------------aPE~~~~~~-~~~~~Di~s~G~~l~el~~  196 (256)
T cd05114         148 RYVLDDEYTSSS-GA-----KFPVKWS---------------PPEVFNFSK-YSSKSDVWSFGVLMWEVFT  196 (256)
T ss_pred             cccCCCceeccC-CC-----CCchhhC---------------ChhhcccCc-cchhhhhHHHHHHHHHHHc
Confidence            876443222111 11     2233455               799876554 5789999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.98  E-value=1.5e-31  Score=248.82  Aligned_cols=204  Identities=27%  Similarity=0.327  Sum_probs=165.3

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcC-CCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~l~~~~  164 (376)
                      ..++|.+.+.||+|+||.||++.....    .+..++..||+|.++... ....+.+.+|+.+++++ +||||+++++++
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  108 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGL----SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC  108 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecC----CCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            445799999999999999999975321    223346789999987653 23346788999999999 799999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      ...+..|++|||+.+|+|.+++.+...  ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.++++|
T Consensus       109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~l~d  184 (302)
T cd05055         109 TIGGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNVLLTHGKIVKICD  184 (302)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeehhhhccceEEEcCCCeEEECC
Confidence            999999999999999999999976432  34899999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ||+++........... +..    .+++.|+               +||.+.+.. .+.++|+||+|++++++++
T Consensus       185 fg~~~~~~~~~~~~~~-~~~----~~~~~y~---------------aPE~~~~~~-~~~~~DiwslGvil~el~t  238 (302)
T cd05055         185 FGLARDIMNDSNYVVK-GNA----RLPVKWM---------------APESIFNCV-YTFESDVWSYGILLWEIFS  238 (302)
T ss_pred             CcccccccCCCceeec-CCC----CcccccC---------------CHhhhccCC-CCcHhHHHHHHHHHHHHHh
Confidence            9999876543322111 111    3455666               799776654 5789999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.97  E-value=1.1e-31  Score=252.65  Aligned_cols=204  Identities=19%  Similarity=0.157  Sum_probs=159.5

Q ss_pred             ccceEeec--CcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           93 PDSLLGEG--GFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        93 ~~~~lG~G--~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      ++++||+|  +|++||++..         +.+++.||+|.++...  ....+.+.+|+.+++.++||||+++++++..++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~   72 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARY---------KPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN   72 (327)
T ss_pred             hhhhccccccceEEEEEEee---------cccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence            56889999  7889999944         3468999999997653  233456778999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeee
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a  248 (376)
                      ..++||||+++|+|.+++.....  ..+++..++.++.|++.||.|||  .++|+||||||+|||++.++.++++||+..
T Consensus        73 ~~~lv~e~~~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH--~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~  148 (327)
T cd08227          73 ELWVVTSFMAYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLSGLRSN  148 (327)
T ss_pred             EEEEEEeccCCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCChhhEEEecCCcEEEcccchh
Confidence            99999999999999999976432  34889999999999999999999  599999999999999999999999999876


Q ss_pred             eeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh-hhccccccccceeeeehhhccccccc
Q 017177          249 VYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI-KYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~-~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      .....................++..|+               +||.+.+. ..++.++|+||+|++++++++-..+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~---------------aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf  210 (327)
T cd08227         149 LSMINHGQRLRVVHDFPKYSVKVLPWL---------------SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF  210 (327)
T ss_pred             hccccccccccccccccccccceeccc---------------ChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            544322111101000001113444555               79988764 34678999999999999998655543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.97  E-value=6.8e-32  Score=245.65  Aligned_cols=198  Identities=32%  Similarity=0.465  Sum_probs=159.3

Q ss_pred             ccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEE
Q 017177           93 PDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELL  171 (376)
Q Consensus        93 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~  171 (376)
                      +.+.||.|.||.||+|.+..     .....+..|+||.++... ....+.+.+|++.+++++||||+++++++...+..+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~-----~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQ-----KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEES-----TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred             EeeEEccCCCcEEEEEEEEc-----ccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccc
Confidence            46789999999999998873     233347889999997643 344688999999999999999999999999888899


Q ss_pred             EEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeee
Q 017177          172 LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYF  251 (376)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~  251 (376)
                      +||||+++|+|.++|....  ...+++..+..++.||+.||.|||  .++++|+||+++|||++.++.+||+|||++...
T Consensus        78 lv~e~~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh--~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~  153 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLH--SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPI  153 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHH--HTTEEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred             ccccccccccccccccccc--cccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccc
Confidence            9999999999999998762  255899999999999999999999  589999999999999999999999999999887


Q ss_pred             ccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          252 KRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       252 ~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ............     .+...|+               +||.+.... .+.++||||||++++|+++.
T Consensus       154 ~~~~~~~~~~~~-----~~~~~~~---------------aPE~~~~~~-~~~ksDVysfG~~l~ei~~~  201 (259)
T PF07714_consen  154 SEKSKYKNDSSQ-----QLPLRYL---------------APEVLKDGE-YTKKSDVYSFGMLLYEILTL  201 (259)
T ss_dssp             TTSSSEEESTTS-----ESGGGGS----------------HHHHHHSE-ESHHHHHHHHHHHHHHHHTT
T ss_pred             cccccccccccc-----ccccccc---------------ccccccccc-cccccccccccccccccccc
Confidence            332222111111     3334444               799877665 69999999999999999984

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.97  E-value=1.3e-31  Score=249.86  Aligned_cols=207  Identities=25%  Similarity=0.307  Sum_probs=163.1

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcC-CCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~  165 (376)
                      .++|.+.+.||+|+||.||++......  .........+|+|.++... ......+.+|+.+++.+ +||||+++++++.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~--~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLD--KEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccC--CcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            467999999999999999999764311  0111234679999998653 34456788899999999 6999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEE
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPS------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL  233 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NIL  233 (376)
                      ..+..|+||||+++|+|.+++......            ...+++..++.++.|++.||+|||  +++++||||||+|||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~Nil  172 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVL  172 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHHheE
Confidence            999999999999999999999765321            135788999999999999999999  699999999999999


Q ss_pred             EcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeee
Q 017177          234 LDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFV  313 (376)
Q Consensus       234 l~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v  313 (376)
                      ++.++.++|+|||+++..............     .+++.|+               +||.+.+.. .+.++|+||+|++
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~-----~~~~~y~---------------aPE~~~~~~-~~~~~DvwslG~~  231 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNG-----RLPVKWM---------------APEALFDRI-YTHQSDVWSFGVL  231 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccC-----CCcccee---------------ChHHhccCC-CCcHHHHHHHHHH
Confidence            999999999999999866432221111110     2223455               699776644 5789999999999


Q ss_pred             ehhhcc
Q 017177          314 FSCVFS  319 (376)
Q Consensus       314 ~~~~~~  319 (376)
                      ++++++
T Consensus       232 l~el~~  237 (307)
T cd05098         232 LWEIFT  237 (307)
T ss_pred             HHHHHc
Confidence            999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.97  E-value=1.3e-31  Score=246.60  Aligned_cols=204  Identities=26%  Similarity=0.325  Sum_probs=163.0

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh-hHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .+|++.+.||+|+||.||+|.....    .....+..||+|+++..... ..+.+.+|+.++..++||||+++++++...
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGT----APGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecC----CCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            3578889999999999999976532    11224678999999865432 346788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNP------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD  235 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~  235 (376)
                      +..++++||+.+++|.+++.....            ....+++..+..++.|++.||.|||  +++|+||||||+|||++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH--~~gi~H~dlkp~Nil~~  158 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS--SHHVVHKDLATRNVLVF  158 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--HcCccccccchhheEec
Confidence            999999999999999999853211            1234788889999999999999999  59999999999999999


Q ss_pred             CCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeeh
Q 017177          236 GVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFS  315 (376)
Q Consensus       236 ~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~  315 (376)
                      +++.+||+|||+++........... +..    .+++.|+               +||.+.+.. .+.++|+||+|++++
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~-~~~----~~~~~y~---------------aPE~~~~~~-~~~~~Dv~slG~~l~  217 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLM-GNS----LLPIRWM---------------SPEAIMYGK-FSIDSDIWSYGVVLW  217 (283)
T ss_pred             CCCceEecccccccccccchheeec-cCc----cCCcccc---------------CHHHHhcCC-CCcchhHHHHHHHHH
Confidence            9999999999999876543322111 111    4455666               799776544 588999999999999


Q ss_pred             hhcc
Q 017177          316 CVFS  319 (376)
Q Consensus       316 ~~~~  319 (376)
                      |+++
T Consensus       218 el~~  221 (283)
T cd05091         218 EVFS  221 (283)
T ss_pred             HHHc
Confidence            9886

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.97  E-value=5.6e-33  Score=237.12  Aligned_cols=204  Identities=25%  Similarity=0.228  Sum_probs=169.5

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ....++|.+.+.||+|+|+.||++         ....++..||+|++.....++.+..++|++..++++|||+++++++.
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV---------~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~   87 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLV---------KGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQ   87 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeee---------cccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHH
Confidence            345678999999999999999999         55667999999999988878888999999999999999999999876


Q ss_pred             EeC-----CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc
Q 017177          165 WED-----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF  239 (376)
Q Consensus       165 ~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~  239 (376)
                      ..+     ...||+++|...|+|.+.+.+.+.....+++.+++.|+.+|++||++||.....++||||||.|||+.+.+.
T Consensus        88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~  167 (302)
T KOG2345|consen   88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL  167 (302)
T ss_pred             HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc
Confidence            443     359999999999999999998777667899999999999999999999953334999999999999999999


Q ss_pred             EEEcceeeeeeeccceeeEE----------EeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh--hhccccccc
Q 017177          240 LFDSHLLIYVYFKRHYIYIY----------IHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI--KYLTLLKYS  307 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~----------~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~--~~~~~~~dv  307 (376)
                      +++.|||.+....-......          ...|..                       |.|||++.-+  ...+.+.||
T Consensus       168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~p-----------------------yRAPELf~vk~~~ti~ertDI  224 (302)
T KOG2345|consen  168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIP-----------------------YRAPELFNVKSHCTITERTDI  224 (302)
T ss_pred             eEEEeccCccccceEeechHHHHHHHHHHHHhCCCc-----------------------ccCchheecccCcccccccch
Confidence            99999999986533211100          011112                       5579998865  456799999


Q ss_pred             cceeeeehhhccc
Q 017177          308 NSFAFVFSCVFSF  320 (376)
Q Consensus       308 ~s~g~v~~~~~~~  320 (376)
                      ||+||+++.++-+
T Consensus       225 WSLGCtLYa~mf~  237 (302)
T KOG2345|consen  225 WSLGCTLYAMMFG  237 (302)
T ss_pred             hhhhHHHHHHHHc
Confidence            9999999988733

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-32  Score=252.60  Aligned_cols=200  Identities=25%  Similarity=0.275  Sum_probs=171.5

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh---hHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ---GFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      .+.|..-++||+|+||.|+-|..+         .+|+.+|.|.+.+....   .....++|-.||.+++.+.||.+--+|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvr---------aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf  254 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVR---------ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF  254 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEe---------cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence            456788899999999999999554         47999999998765332   224567899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      ++++.+++||..|.||+|.-+|.....  ..+++..++.++.+|+.||.+||  +.+||.|||||+|||+|+.|+++|+|
T Consensus       255 eTkd~LClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH--~~~iVYRDLKPeNILLDd~GhvRISD  330 (591)
T KOG0986|consen  255 ETKDALCLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLH--RRRIVYRDLKPENILLDDHGHVRISD  330 (591)
T ss_pred             cCCCceEEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHH--hcceeeccCChhheeeccCCCeEeec
Confidence            999999999999999999988876643  57999999999999999999999  69999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      +|+|..+.........        +||.+||               |||++.... ++...|+|++||.++||+.-..+.
T Consensus       331 LGLAvei~~g~~~~~r--------vGT~GYM---------------APEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPF  386 (591)
T KOG0986|consen  331 LGLAVEIPEGKPIRGR--------VGTVGYM---------------APEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPF  386 (591)
T ss_pred             cceEEecCCCCccccc--------cCccccc---------------CHHHHcCCc-ccCCccHHHHHhHHHHHHcccCch
Confidence            9999988776554222        6777777               799998887 688899999999999999544443

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.97  E-value=5.8e-32  Score=260.49  Aligned_cols=208  Identities=25%  Similarity=0.317  Sum_probs=165.0

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCC-CCCcceEEeE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLS-HPNLVKLLGY  163 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-h~nIv~l~~~  163 (376)
                      ...++|.+.+.||+|+||.||+|++++.    .....+..||+|+++.... ...+.+.+|+.+|..+. ||||++++++
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGL----SHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCC----CCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            3445788999999999999999987642    1223467899999986533 33457889999999998 9999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCC----------------------------------------------------
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNP----------------------------------------------------  191 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------  191 (376)
                      +...+..++||||+++|+|.+++.+...                                                    
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            9999999999999999999999975421                                                    


Q ss_pred             ------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCC
Q 017177          192 ------------------------------------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKA  229 (376)
Q Consensus       192 ------------------------------------------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp  229 (376)
                                                                ....+++..+..++.|++.||.|||  ..+|+||||||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrdlkp  267 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA--SKNCVHRDLAA  267 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh--cCCcCcccCCc
Confidence                                                      0123677788999999999999999  69999999999


Q ss_pred             CCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccc
Q 017177          230 SNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNS  309 (376)
Q Consensus       230 ~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s  309 (376)
                      +|||+++++.+|++|||+++.............+     .+++.||               +||.+.+.. .+.++|+||
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~-----~~~~~y~---------------aPE~~~~~~-~~~~~Dvws  326 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGST-----FLPLKWM---------------APESIFNNL-YTTLSDVWS  326 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCc-----CCCCcee---------------ChHHhcCCC-CCcHhHHHH
Confidence            9999999999999999999875432221111111     4456666               799776544 578899999


Q ss_pred             eeeeehhhccc
Q 017177          310 FAFVFSCVFSF  320 (376)
Q Consensus       310 ~g~v~~~~~~~  320 (376)
                      +|++++|+++.
T Consensus       327 lGvil~e~l~~  337 (401)
T cd05107         327 FGILLWEIFTL  337 (401)
T ss_pred             HHHHHHHHHHc
Confidence            99999998863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.97  E-value=4.7e-31  Score=241.21  Aligned_cols=196  Identities=22%  Similarity=0.201  Sum_probs=154.6

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv  173 (376)
                      +.||+|+||.||+|.....       .++..+|+|.++.... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   73 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSG-------YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV   73 (269)
T ss_pred             CcccccCCceEEEEEEcCC-------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence            3689999999999976431       2356799999876543 3345788899999999999999999999998999999


Q ss_pred             EeccCCCCHHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeec
Q 017177          174 YEYMQRGSLENHLFRRNP-SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFK  252 (376)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~  252 (376)
                      |||+++|+|.+++..... .....++..+..++.|++.||.|||  ..+++||||||+||+++.++.++++|||++....
T Consensus        74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~  151 (269)
T cd05087          74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKY  151 (269)
T ss_pred             EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--HCCEeccccCcceEEEcCCCcEEECCcccccccc
Confidence            999999999999975432 1234567788899999999999999  5999999999999999999999999999997543


Q ss_pred             cceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhh------hccccccccceeeeehhhcc
Q 017177          253 RHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIK------YLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       253 ~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~------~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ..........     ..|++.|+               +||++.+..      ..+.++|+||+|++++++++
T Consensus       152 ~~~~~~~~~~-----~~~~~~y~---------------aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~  204 (269)
T cd05087         152 KEDYYVTPDQ-----LWVPLRWI---------------APELVDEVHGNLLVVDQTKESNVWSLGVTIWELFE  204 (269)
T ss_pred             CcceeecCCC-----cCCccccc---------------CHhHhccccccccccCCCccchhHHHHHHHHHHHh
Confidence            3322111111     14455666               799876432      24789999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=5.3e-34  Score=245.56  Aligned_cols=207  Identities=22%  Similarity=0.254  Sum_probs=162.0

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcC-CCCCcceEEeEEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRL-SHPNLVKLLGYCWE  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~  166 (376)
                      ++.+-+..||.|+||.|++-         .++.+|+..|||.++.... .+..+++.|.+...+- +.||||++||+...
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM---------~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~  134 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKM---------LHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS  134 (361)
T ss_pred             chHHHHHHhcCCcchhhhhh---------hcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence            34555678999999999998         5555799999999987654 5557888888876665 59999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRN-PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      ++..||.||+|+- +|..+.+.-. .....+++..+-.|....+.||.||-. +..|||||+||+|||++..|.+|||||
T Consensus       135 EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~-~lkiIHRDvKPSNILldr~G~vKLCDF  212 (361)
T KOG1006|consen  135 EGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE-ELKIIHRDVKPSNILLDRHGDVKLCDF  212 (361)
T ss_pred             CCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH-HhhhhhccCChhheEEecCCCEeeecc
Confidence            9999999999964 6655543211 112458999999999999999999987 789999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhh-ccccccccceeeeehhhccccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKY-LTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~-~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      |++..+.+....+...|.        -.||               |||-+..... +..++||||+|+.++|+++     
T Consensus       213 GIcGqLv~SiAkT~daGC--------rpYm---------------APERi~p~~~gyDiRSDvWSLGITL~EvAt-----  264 (361)
T KOG1006|consen  213 GICGQLVDSIAKTVDAGC--------RPYM---------------APERIDPSDKGYDIRSDVWSLGITLYEVAT-----  264 (361)
T ss_pred             cchHhHHHHHHhhhccCC--------cccc---------------ChhccCCccCCcchhhhhhhhcceEeeeec-----
Confidence            999988776555444444        4555               3775554333 5788999999988777664     


Q ss_pred             hhhHHHHHHHh
Q 017177          325 MLKYQILAWQS  335 (376)
Q Consensus       325 ~~~~~~~~~~~  335 (376)
                       +++|...|.+
T Consensus       265 -G~fPyr~w~s  274 (361)
T KOG1006|consen  265 -GNFPYRKWDS  274 (361)
T ss_pred             -CCCCcchHHH
Confidence             6677666765

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.97  E-value=6.9e-32  Score=250.91  Aligned_cols=199  Identities=23%  Similarity=0.224  Sum_probs=164.2

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|...         .++..||+|.++.... .....+.+|+.+++.++||||+++++++..
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~   75 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSK---------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT   75 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEc---------CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec
Confidence            457999999999999999999544         3588999999875432 223467789999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++..++||||++ ++|.+++.+..   ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.++|+|||
T Consensus        76 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~dfg  149 (301)
T cd07873          76 EKSLTLVFEYLD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCH--RRKVLHRDLKPQNLLINERGELKLADFG  149 (301)
T ss_pred             CCeEEEEEeccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHHHEEECCCCcEEECcCc
Confidence            999999999997 58998886642   45789999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ++..........  ...     .+++.|+               +||++.+....+.++||||+|++++++++...+
T Consensus       150 ~~~~~~~~~~~~--~~~-----~~~~~y~---------------~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~  204 (301)
T cd07873         150 LARAKSIPTKTY--SNE-----VVTLWYR---------------PPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPL  204 (301)
T ss_pred             chhccCCCCCcc--ccc-----ceeeccc---------------CcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCC
Confidence            998654322110  011     4556666               799887776778899999999999999876443

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.8e-31  Score=242.01  Aligned_cols=201  Identities=21%  Similarity=0.260  Sum_probs=162.2

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-----ChhhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-----SMQGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      .+|++.+.||+|+||.||+|...         .++..||+|.+...     .......+.+|+.+++.++|+||++++++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~   72 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDA---------DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC   72 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEc---------CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence            47899999999999999999543         35889999987532     12344678899999999999999999999


Q ss_pred             EEeC--CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEE
Q 017177          164 CWED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLF  241 (376)
Q Consensus       164 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~k  241 (376)
                      +.+.  +.++++|||+++++|.+++...    ..+++..+..++.|++.||.|||  ..+++||||||+||+++.++.++
T Consensus        73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH--~~~i~H~dl~p~ni~i~~~~~~~  146 (264)
T cd06653          73 LRDPEEKKLSIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLH--SNMIVHRDIKGANILRDSAGNVK  146 (264)
T ss_pred             EEcCCCCEEEEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEE
Confidence            8764  4689999999999999998764    34788999999999999999999  59999999999999999999999


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      ++|||+++.............    ...|++.|+               +||.+.+.. .+.++|+||+|++++++++..
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~----~~~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~l~~g~  206 (264)
T cd06653         147 LGDFGASKRIQTICMSGTGIK----SVTGTPYWM---------------SPEVISGEG-YGRKADVWSVACTVVEMLTEK  206 (264)
T ss_pred             ECccccccccccccccCcccc----ccCCccccc---------------CHhhhcCCC-CCccccHHHHHHHHHHHHhCC
Confidence            999999987643211100000    114566666               799887654 578999999999999999755


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      .+.
T Consensus       207 ~p~  209 (264)
T cd06653         207 PPW  209 (264)
T ss_pred             CCC
Confidence            443

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.97  E-value=2.3e-31  Score=246.05  Aligned_cols=204  Identities=25%  Similarity=0.281  Sum_probs=161.1

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      +|++.+.||+|+||.||+|.....    ........+++|.+..... .....+.+|+.+++.++||||+++++.+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRL----KGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG   76 (290)
T ss_pred             CccccccccCcCCcceEEEEEecC----CCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            478889999999999999976431    1112346789998876543 34567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCC
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNP--------------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFK  228 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlK  228 (376)
                      ..+++|||+.+|+|.+++.....                    ....+++..+..++.|++.||.|||  +.+|+|||||
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~ivH~dik  154 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA--EMKLVHRDLA  154 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH--HCCeehhhhh
Confidence            99999999999999999865321                    1134788999999999999999999  6999999999


Q ss_pred             CCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcccccccc
Q 017177          229 ASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSN  308 (376)
Q Consensus       229 p~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~  308 (376)
                      |+|||+++++.+||+|||+++..............     .++..|+               +||.+.+. ..+.++|+|
T Consensus       155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~-----~~~~~y~---------------apE~~~~~-~~~~~~Di~  213 (290)
T cd05045         155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKG-----RIPVKWM---------------AIESLFDH-IYTTQSDVW  213 (290)
T ss_pred             hheEEEcCCCcEEeccccccccccCccchhcccCC-----CCCcccc---------------CHHHHccC-CcchHhHHH
Confidence            99999999999999999999865433221111110     2334455               79976554 468899999


Q ss_pred             ceeeeehhhccc
Q 017177          309 SFAFVFSCVFSF  320 (376)
Q Consensus       309 s~g~v~~~~~~~  320 (376)
                      |+|+++++++++
T Consensus       214 slG~~l~el~t~  225 (290)
T cd05045         214 SFGVLLWEIVTL  225 (290)
T ss_pred             HHHHHHHHHHhc
Confidence            999999999873

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=1.5e-31  Score=245.38  Aligned_cols=192  Identities=20%  Similarity=0.264  Sum_probs=153.5

Q ss_pred             eEeecCcEEEEEEEEcCCC---------------CCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceE
Q 017177           96 LLGEGGFGRVYKGWVDDKT---------------LAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKL  160 (376)
Q Consensus        96 ~lG~G~fg~V~~~~~~~~~---------------~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l  160 (376)
                      .||+|+||.||+|......               ....+......|++|.+..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            6999999999999753211               0112233346789999977655555678889999999999999999


Q ss_pred             EeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC--
Q 017177          161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG--  238 (376)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g--  238 (376)
                      ++++..++..++||||+++|+|..++.+..   ..+++..+..++.|++.||+|||  +++|+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLE--DKNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--cCCccCCCCCcccEEEeccCcc
Confidence            999999999999999999999999886542   45889999999999999999999  69999999999999997654  


Q ss_pred             -----cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeee
Q 017177          239 -----FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFV  313 (376)
Q Consensus       239 -----~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v  313 (376)
                           .+|++|||++........   .        .+++.|+               +||.+.+....+.++|+||||++
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~~~---~--------~~~~~~~---------------aPe~~~~~~~~~~~~Dv~slG~~  210 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSREE---R--------VERIPWI---------------APECVPGGNSLSTAADKWSFGTT  210 (274)
T ss_pred             cCccceeeecCCccccccccccc---c--------ccCCccc---------------CchhhcCCCCCCcHHHHHHHHHH
Confidence                 489999998865432211   1        3445555               69988766667899999999999


Q ss_pred             ehhhc
Q 017177          314 FSCVF  318 (376)
Q Consensus       314 ~~~~~  318 (376)
                      +++++
T Consensus       211 l~el~  215 (274)
T cd05076         211 LLEIC  215 (274)
T ss_pred             HHHHH
Confidence            99974

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.97  E-value=5.4e-32  Score=258.44  Aligned_cols=193  Identities=19%  Similarity=0.173  Sum_probs=158.4

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||||++....  ......+.+|+.+++.++||||+++++++
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~   92 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDA---------ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF   92 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEEC---------CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceee
Confidence            3578999999999999999999543         358889999987542  23346778999999999999999999987


Q ss_pred             EeC------CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          165 WED------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       165 ~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      ...      ..+|+||||+++ +|.+.+..      .+++..+..++.|++.||.|||  .++|+||||||+|||++.++
T Consensus        93 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~  163 (364)
T cd07875          93 TPQKSLEEFQDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDC  163 (364)
T ss_pred             cccccccccCeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHh--hCCeecCCCCHHHEEECCCC
Confidence            543      357999999965 78777743      3788899999999999999999  59999999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .+||+|||+++..........        ..||+.|+               |||++.+.. .+.++|+||+|+++++++
T Consensus       164 ~~kL~DfG~a~~~~~~~~~~~--------~~~t~~y~---------------aPE~~~~~~-~~~~~DiwSlG~il~ell  219 (364)
T cd07875         164 TLKILDFGLARTAGTSFMMTP--------YVVTRYYR---------------APEVILGMG-YKENVDIWSVGCIMGEMI  219 (364)
T ss_pred             cEEEEeCCCccccCCCCcccC--------CcccCCcC---------------CHHHHhCCC-CCchhhHHhHHHHHHHHH
Confidence            999999999987644322211        15677777               799887754 578999999999999998


Q ss_pred             ccc
Q 017177          319 SFY  321 (376)
Q Consensus       319 ~~y  321 (376)
                      +..
T Consensus       220 ~g~  222 (364)
T cd07875         220 KGG  222 (364)
T ss_pred             hCC
Confidence            643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.97  E-value=1.6e-31  Score=249.47  Aligned_cols=196  Identities=23%  Similarity=0.248  Sum_probs=164.2

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ++|++.+.||+|+||.||++...         .++..+|+|.++.... .....+.+|+++++.++||||+++++.+.++
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   71 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHR---------PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD   71 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEc---------CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            36899999999999999999543         3578899999876533 3345688999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +.+++||||+++++|.+++.+.    ..+++..+..++.|++.||.|||+ ..+++||||||+|||++.++.+|++|||+
T Consensus        72 ~~~~lv~ey~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dl~p~nil~~~~~~~~l~dfg~  146 (308)
T cd06615          72 GEISICMEHMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGV  146 (308)
T ss_pred             CEEEEEeeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh-hCCEEECCCChHHEEEecCCcEEEccCCC
Confidence            9999999999999999999765    458899999999999999999995 36899999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      +........     .+    ..|++.|+               +||.+.+.. .+.++|+||+|++++++++...+
T Consensus       147 ~~~~~~~~~-----~~----~~~~~~~~---------------aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p  197 (308)
T cd06615         147 SGQLIDSMA-----NS----FVGTRSYM---------------SPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYP  197 (308)
T ss_pred             ccccccccc-----cc----CCCCcCcc---------------ChhHhcCCC-CCccchHHHHHHHHHHHHhCCCC
Confidence            876533211     11    15566666               799876654 67899999999999999975444

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.97  E-value=3.2e-31  Score=242.00  Aligned_cols=200  Identities=25%  Similarity=0.320  Sum_probs=161.1

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ++|++.+.||+|+||.||+|.....      ...+..+|+|.++... ....+.+.+|+.+++.++||||+++++++..+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~------~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLP------GKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS   77 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecC------CCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            5688999999999999999965421      1124579999987643 23456788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++||||+++++|.+++.+..   ..+++..+..++.|++.||.|||  +++++||||||+|||++.++.++++|||+
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH--~~~i~h~dlkp~nili~~~~~~~l~dfg~  152 (267)
T cd05066          78 KPVMIVTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILVNSNLVCKVSDFGL  152 (267)
T ss_pred             CccEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCEeehhhchhcEEECCCCeEEeCCCCc
Confidence            99999999999999999997652   45789999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +................    .+++.|+               +||.+.+.. .+.++|+|++|++++++++
T Consensus       153 ~~~~~~~~~~~~~~~~~----~~~~~y~---------------~pe~~~~~~-~~~~~Dv~slG~~l~ell~  204 (267)
T cd05066         153 SRVLEDDPEAAYTTRGG----KIPIRWT---------------APEAIAYRK-FTSASDVWSYGIVMWEVMS  204 (267)
T ss_pred             ccccccccceeeecCCC----ccceeec---------------CHhHhccCc-cCchhhhHHHHHHHHHHhc
Confidence            98775433211110000    1233455               699877644 5889999999999999664

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-32  Score=265.34  Aligned_cols=199  Identities=25%  Similarity=0.361  Sum_probs=167.7

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-ChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ...++.++||.|.||+|++|+.+...      .....||||.++.. ..++..+|+.|+.||-+++||||++|.|+....
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pg------kre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks  702 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPG------KREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS  702 (996)
T ss_pred             hheEEEEEEecccccceecccccCCC------CcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence            34577899999999999999876432      23678999999986 346678999999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      ..+.||+|||++|+|..+|+.+.   ..+..-+...+.+.|+.||+||-  +.++|||||.++||||+.+-.+|++|||+
T Consensus       703 ~PvMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLs--dm~YVHRDLAARNILVNsnLvCKVsDFGL  777 (996)
T KOG0196|consen  703 KPVMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLS--DMNYVHRDLAARNILVNSNLVCKVSDFGL  777 (996)
T ss_pred             ceeEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHh--hcCchhhhhhhhheeeccceEEEeccccc
Confidence            99999999999999999998875   45888899999999999999999  79999999999999999999999999999


Q ss_pred             eeeecccee--eEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          248 YVYFKRHYI--YIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       248 a~~~~~~~~--~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ++.+.+...  ++...|.+ -+     .               |-|||.+...+ +|.++||||+|+|.||+++|
T Consensus       778 SRvledd~~~~ytt~GGKI-Pi-----R---------------WTAPEAIa~RK-FTsASDVWSyGIVmWEVmSy  830 (996)
T KOG0196|consen  778 SRVLEDDPEAAYTTLGGKI-PI-----R---------------WTAPEAIAYRK-FTSASDVWSYGIVMWEVMSY  830 (996)
T ss_pred             eeecccCCCccccccCCcc-ce-----e---------------ecChhHhhhcc-cCchhhccccceEEEEeccc
Confidence            998865442  22222222 11     1               23699877654 69999999999999999966

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.97  E-value=1.8e-31  Score=246.82  Aligned_cols=194  Identities=25%  Similarity=0.306  Sum_probs=165.2

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ++|++.+.||+|+||.||++....         +++.||+|.+....   ....+.+.+|+++++.++||||+++++.+.
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKG---------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ   71 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence            468999999999999999996543         58899999987542   233467889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +.+.+|+||||+++++|.+++.+.    ..+++..+..++.|++.||.|||  +.+|+||||||+|||++.+|.+||+||
T Consensus        72 ~~~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH--~~~i~H~dl~p~nili~~~~~~kl~df  145 (290)
T cd05580          72 DDSNLYLVMEYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLH--SLDIVYRDLKPENLLLDSDGYIKITDF  145 (290)
T ss_pred             cCCeEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEECCCCCEEEeeC
Confidence            999999999999999999999765    45899999999999999999999  699999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |++........          ...|++.|+               +||.+.+. ..+.++|+||+|++++++++...+
T Consensus       146 g~~~~~~~~~~----------~~~~~~~y~---------------aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  197 (290)
T cd05580         146 GFAKRVKGRTY----------TLCGTPEYL---------------APEIILSK-GYGKAVDWWALGILIYEMLAGYPP  197 (290)
T ss_pred             CCccccCCCCC----------CCCCCcccc---------------ChhhhcCC-CCCccccHHHHHHHHHHHHhCCCC
Confidence            99987654411          115666676               79987665 457889999999999999965544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.97  E-value=9.8e-32  Score=251.50  Aligned_cols=197  Identities=19%  Similarity=0.253  Sum_probs=155.4

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe--CCeEE
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE--DKELL  171 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~~~  171 (376)
                      ...||+|+||.||+|...+.       .++..||+|.+.....  ...+.+|+.+++.++||||+++++++..  +..++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~-------~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   76 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDG-------KDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVW   76 (317)
T ss_pred             ceEeccCCCeeEEEEEecCC-------CccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEE
Confidence            36899999999999975431       2467899999876532  2456789999999999999999998854  46789


Q ss_pred             EEEeccCCCCHHHHHhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE----cCCCcEEE
Q 017177          172 LVYEYMQRGSLENHLFRRN-----PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL----DGVGFLFD  242 (376)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl----~~~g~~kl  242 (376)
                      +||||+.+ +|.+++....     .....+++..+..++.|++.||.|||  ..+|+||||||+|||+    +.++.+||
T Consensus        77 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~~kl  153 (317)
T cd07867          77 LLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKI  153 (317)
T ss_pred             EEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH--hCCEEcCCCCHHHEEEccCCCCCCcEEE
Confidence            99999965 8888775321     11235789999999999999999999  5999999999999999    56789999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      +|||+++...............    .||+.|+               |||++.+....+.++|+||+|++++++++..
T Consensus       154 ~DfG~a~~~~~~~~~~~~~~~~----~~t~~y~---------------aPE~~~~~~~~~~~~DiwSlG~il~el~tg~  213 (317)
T cd07867         154 ADMGFARLFNSPLKPLADLDPV----VVTFWYR---------------APELLLGARHYTKAIDIWAIGCIFAELLTSE  213 (317)
T ss_pred             eeccceeccCCCcccccccCcc----eeccccc---------------CcHHhcCCCccCcHHHHHhHHHHHHHHHhCC
Confidence            9999998765433211111111    6677777               8998887777789999999999999999653

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.97  E-value=9.6e-32  Score=244.37  Aligned_cols=195  Identities=25%  Similarity=0.338  Sum_probs=164.3

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ..+|++.+.||.|+||.||+|....          +..+|+|.+..........+.+|+.+++.++|+||+++++++.+.
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~----------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   74 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN----------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG   74 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC----------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence            4569999999999999999996553          678999999877665667888999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++||||+++++|.+++.+..  ...+++..+..++.|++.||.|||  +++|+||||||+||+++.++.+||+|||+
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH--~~~i~h~dl~~~nilv~~~~~~kl~d~g~  150 (261)
T cd05148          75 EPVYIITELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLE--EQNSIHRDLAARNILVGEDLVCKVADFGL  150 (261)
T ss_pred             CCeEEEEeecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccCcceEEEcCCceEEEccccc
Confidence            99999999999999999997643  245789999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +...........  +.     .+++.|+               +||.+... ..+.++|+||+|++++++++
T Consensus       151 ~~~~~~~~~~~~--~~-----~~~~~~~---------------~PE~~~~~-~~~~~~DiwslG~~l~~l~~  199 (261)
T cd05148         151 ARLIKEDVYLSS--DK-----KIPYKWT---------------APEAASHG-TFSTKSDVWSFGILLYEMFT  199 (261)
T ss_pred             hhhcCCcccccc--CC-----CCceEec---------------CHHHHccC-CCCchhhHHHHHHHHHHHHc
Confidence            987644322111  11     2334455               69977654 46788999999999999986

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.97  E-value=4e-31  Score=241.66  Aligned_cols=200  Identities=23%  Similarity=0.333  Sum_probs=158.1

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      |++.+.||+|+||.||+|....      +...+..||+|.++...  ......+.+|+.+++.++||||+++++++....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   74 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQ------DDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS   74 (273)
T ss_pred             CccccccCcCCCceEEEEEEec------CCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence            5778999999999999997643      12235789999988643  344567899999999999999999999886654


Q ss_pred             e------EEEEEeccCCCCHHHHHhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcE
Q 017177          169 E------LLLVYEYMQRGSLENHLFRRNP--SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL  240 (376)
Q Consensus       169 ~------~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~  240 (376)
                      .      .+++|||+++|+|..++.....  ....+++..+..++.|++.||.|||  +.+|+||||||+||++++++.+
T Consensus        75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH--~~~i~H~dlkp~Nil~~~~~~~  152 (273)
T cd05035          75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS--NRNFIHRDLAARNCMLREDMTV  152 (273)
T ss_pred             ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH--hCCeeccccchheEEECCCCeE
Confidence            4      7999999999999999865321  1246899999999999999999999  6999999999999999999999


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ||+|||+++............     ...+++.|+               +||.+.+ ...+.++||||+|++++|+++
T Consensus       153 kl~dfg~~~~~~~~~~~~~~~-----~~~~~~~~~---------------~pe~~~~-~~~~~~~Dv~SlG~il~el~~  210 (273)
T cd05035         153 CVADFGLSKKIYSGDYYRQGR-----IAKMPVKWI---------------AIESLAD-RVYTSKSDVWAFGVTMWEIAT  210 (273)
T ss_pred             EECCccceeeccccccccccc-----cccCCcccc---------------CHhhccc-CCCCcccchHHHHHHHHHHHh
Confidence            999999998764432211000     112234455               7997654 446889999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.97  E-value=4.2e-31  Score=241.09  Aligned_cols=201  Identities=21%  Similarity=0.255  Sum_probs=161.3

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-----hhhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-----MQGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      .+|+..+.||+|+||.||+|...         .++..||+|.+....     ......+.+|+.+++.++||||+++++.
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   72 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDV---------DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC   72 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEc---------CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence            47899999999999999999543         358899999886432     2334578899999999999999999998


Q ss_pred             EEeC--CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEE
Q 017177          164 CWED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLF  241 (376)
Q Consensus       164 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~k  241 (376)
                      +.+.  +.++++|||+++++|.+++...    ..+++.....++.|++.||.|||  ..+|+||||||+||+++.++.++
T Consensus        73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH--~~~i~H~~l~p~nil~~~~~~~~  146 (266)
T cd06651          73 LRDRAEKTLTIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLH--SNMIVHRDIKGANILRDSAGNVK  146 (266)
T ss_pred             EEcCCCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEE
Confidence            8753  6789999999999999999764    34788999999999999999999  69999999999999999999999


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |+|||+++.............    ...++..|+               +||.+.+. ..+.++|+||+|++++++++..
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~----~~~~~~~y~---------------aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~  206 (266)
T cd06651         147 LGDFGASKRLQTICMSGTGIR----SVTGTPYWM---------------SPEVISGE-GYGRKADVWSLGCTVVEMLTEK  206 (266)
T ss_pred             EccCCCccccccccccCCccc----cCCcccccc---------------CHHHhCCC-CCCchhhhHHHHHHHHHHHHCC
Confidence            999999986543211100000    013445555               79987764 4578999999999999999765


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      .+.
T Consensus       207 ~pf  209 (266)
T cd06651         207 PPW  209 (266)
T ss_pred             CCc
Confidence            554

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.97  E-value=1.4e-31  Score=248.43  Aligned_cols=200  Identities=22%  Similarity=0.207  Sum_probs=167.1

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ....+|++.+.||+|+||.||+|...         .++..||+|.+........+.+.+|+.+++.++|+||+++++++.
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   86 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDI---------ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL   86 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEEC---------CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            34578999999999999999999543         358899999998765555577889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      .++..|+||||+++++|.+++.+.     .+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.++++||
T Consensus        87 ~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH--~~~i~H~dL~p~Nili~~~~~~~l~Df  159 (297)
T cd06656          87 VGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLH--SNQVIHRDIKSDNILLGMDGSVKLTDF  159 (297)
T ss_pred             cCCEEEEeecccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEECcC
Confidence            999999999999999999998543     4788999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      |++..........   ..    ..|++.|+               +||.+.+.. .+.++|+||+|++++++++-+.+.
T Consensus       160 g~~~~~~~~~~~~---~~----~~~~~~y~---------------aPE~~~~~~-~~~~~Di~slGvil~~l~tg~~pf  215 (297)
T cd06656         160 GFCAQITPEQSKR---ST----MVGTPYWM---------------APEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPY  215 (297)
T ss_pred             ccceEccCCccCc---Cc----ccCCcccc---------------CHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCC
Confidence            9998654332211   11    14556666               799777644 578999999999999998765543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.97  E-value=4.9e-31  Score=239.03  Aligned_cols=199  Identities=22%  Similarity=0.305  Sum_probs=166.2

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      +|+..+.||+|+||.||.+...         .++..+++|.+...  .......+.+|+.++++++|+||+++++++.+.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   71 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRT---------EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD   71 (256)
T ss_pred             CceEeeEecccCCceEEEEEEc---------CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence            5888999999999999998543         35888999987654  234456788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..+++|||+++++|.+++.+..  ...+++..+..++.|++.||.|||  +.+++||||||+||+++.++.+|++|||+
T Consensus        72 ~~~~~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~ni~~~~~~~~kl~d~~~  147 (256)
T cd08221          72 NTLLIEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIH--KAGILHRDIKTLNIFLTKAGLIKLGDFGI  147 (256)
T ss_pred             CeEEEEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCChHhEEEeCCCCEEECcCcc
Confidence            99999999999999999997653  245889999999999999999999  59999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      +.........   ...    ..|++.|+               +||++.+.. .+.++|+||+|++++++++...+.
T Consensus       148 ~~~~~~~~~~---~~~----~~~~~~y~---------------ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~  201 (256)
T cd08221         148 SKILGSEYSM---AET----VVGTPYYM---------------SPELCQGVK-YNFKSDIWALGCVLYELLTLKRTF  201 (256)
T ss_pred             eEEccccccc---ccc----cCCCcccc---------------CHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCC
Confidence            9876443321   111    15666666               799777654 578899999999999998765553

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.97  E-value=1.1e-31  Score=247.25  Aligned_cols=197  Identities=23%  Similarity=0.283  Sum_probs=162.5

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      +|++.+.||+|+||.||+|...         .++..||+|.++....  .....+.+|+.+++.++||||+++++++.++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNK---------KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE   71 (285)
T ss_pred             CceEeeEecccCceEEEEEEEC---------CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence            4788899999999999999654         3588999999875432  2235678899999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..|+||||++ ++|.+++..... ...+++..+..++.|++.||.|||  +.+|+||||||+|||++.+|.++|+|||+
T Consensus        72 ~~~~~v~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~  147 (285)
T cd07861          72 SRLYLIFEFLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCH--SRRVLHRDLKPQNLLIDNKGVIKLADFGL  147 (285)
T ss_pred             CeEEEEEecCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCHHHEEEcCCCcEEECcccc
Confidence            99999999997 589888865432 246899999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      +.........  ...     ..+++.|+               +||++.+....+.++|+||+|++++++++..
T Consensus       148 ~~~~~~~~~~--~~~-----~~~~~~y~---------------aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~  199 (285)
T cd07861         148 ARAFGIPVRV--YTH-----EVVTLWYR---------------APEVLLGSPRYSTPVDIWSIGTIFAEMATKK  199 (285)
T ss_pred             eeecCCCccc--ccC-----Cccccccc---------------ChHHhcCCCCcCcHHHHHHHHHHHHHHHHCC
Confidence            9865433211  001     14456666               7998877766788999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.97  E-value=3.6e-32  Score=246.63  Aligned_cols=195  Identities=31%  Similarity=0.392  Sum_probs=164.0

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhH--HHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF--EEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      |++++.||+|+||.||++...         .+++.||+|.+........  ....+|+.+++.++||||+++++++.+..
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~---------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~   71 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNK---------KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN   71 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEET---------TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred             CEEeEEEEeCCCEEEEEEEEC---------CCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc
Confidence            678899999999999999544         4688999999988765432  23456999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeee
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a  248 (376)
                      ..++|||++++++|.+++...    ..+++..+..++.|++.||.+||  ..+|+||||||+||+++.++.++|+|||.+
T Consensus        72 ~~~~v~~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh--~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~  145 (260)
T PF00069_consen   72 YLYIVMEYCPGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLH--SKGIVHRDIKPENILLDENGEVKLIDFGSS  145 (260)
T ss_dssp             EEEEEEEEETTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHH--HTTEEESSBSGGGEEESTTSEEEESSGTTT
T ss_pred             ccccccccccccccccccccc----ccccccccccccccccccccccc--cccccccccccccccccccccccccccccc
Confidence            999999999999999999844    45899999999999999999999  599999999999999999999999999999


Q ss_pred             eeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          249 VYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      .........  ....     .+|+.|+               +||++......+.++|+||+|++++++++...
T Consensus       146 ~~~~~~~~~--~~~~-----~~~~~y~---------------aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~  197 (260)
T PF00069_consen  146 VKLSENNEN--FNPF-----VGTPEYM---------------APEVLQQGKKYTRKSDIWSLGIILYELLTGKL  197 (260)
T ss_dssp             EESTSTTSE--BSSS-----SSSGGGS---------------CHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSS
T ss_pred             ccccccccc--cccc-----ccccccc---------------cccccccccccccccccccccccccccccccc
Confidence            864221111  1111     6677777               79987756677999999999999999986543

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=1.4e-31  Score=243.91  Aligned_cols=193  Identities=22%  Similarity=0.274  Sum_probs=155.6

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCc---ccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAP---SKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELL  171 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~---~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~  171 (376)
                      +.||+|+||.||+|.........   ........+++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            46899999999999764322110   011234568999987765555567888999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc-------EEEcc
Q 017177          172 LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF-------LFDSH  244 (376)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~-------~kl~D  244 (376)
                      +||||+++|+|..++.+..   ..+++..+..++.||+.||+|||  +++|+||||||+|||++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhh--hCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            9999999999998886542   45899999999999999999999  699999999999999987664       89999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      ||++.........           .|+..|+               +||.+......+.++||||+|+++++++
T Consensus       156 ~g~~~~~~~~~~~-----------~~~~~y~---------------aPE~~~~~~~~~~~~DiwslG~~l~el~  203 (262)
T cd05077         156 PGIPITVLSRQEC-----------VERIPWI---------------APECVEDSKNLSIAADKWSFGTTLWEIC  203 (262)
T ss_pred             CCCCccccCcccc-----------ccccccc---------------ChhhhcCCCCCCchhHHHHHHHHHHHHH
Confidence            9998765332111           4555566               7998775566788999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.97  E-value=5.7e-31  Score=239.85  Aligned_cols=201  Identities=22%  Similarity=0.279  Sum_probs=166.6

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC---ChhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ++|++.+.||+|+||.||+|...         .+++.||+|.++..   .....+.+.+|++++++++|+||+++++.+.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~   72 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICL---------LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI   72 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEc---------CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence            57999999999999999999654         35889999988643   2233567889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +++..++||||+++++|.+++.........+++..+..++.|++.||.|||  +.+|+||||||+||+++.++.++++||
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~nil~~~~~~~~l~d~  150 (267)
T cd08224          73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH--SKRIMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH--hCCEecCCcChhhEEECCCCcEEEecc
Confidence            999999999999999999998764333456899999999999999999999  699999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |++..........       ....|++.|+               +||.+.+.. .+.++|+||+|++++++++...+
T Consensus       151 ~~~~~~~~~~~~~-------~~~~~~~~y~---------------apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p  205 (267)
T cd08224         151 GLGRFFSSKTTAA-------HSLVGTPYYM---------------SPERIHENG-YNFKSDIWSLGCLLYEMAALQSP  205 (267)
T ss_pred             ceeeeccCCCccc-------ceecCCcccc---------------CHHHhccCC-CCchhcHHHHHHHHHHHHHCCCC
Confidence            9998765432211       1114555566               699776554 57889999999999999876554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.97  E-value=2.1e-31  Score=247.10  Aligned_cols=211  Identities=20%  Similarity=0.290  Sum_probs=164.2

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCC-------cccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcce
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLA-------PSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVK  159 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~  159 (376)
                      .++|++.+.||+|+||.||++........       .....+...+|+|.+.... ......+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            35699999999999999999864321100       0112235679999998653 334567889999999999999999


Q ss_pred             EEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCE
Q 017177          160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS-------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI  232 (376)
Q Consensus       160 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NI  232 (376)
                      +++++..++..+++|||+++|+|.+++......       ...+++..+..++.|++.||+|||  +++|+||||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dlkp~Ni  161 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS--SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH--HCCeecccCChheE
Confidence            999999999999999999999999999764321       124678889999999999999999  59999999999999


Q ss_pred             EEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceee
Q 017177          233 LLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAF  312 (376)
Q Consensus       233 Ll~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~  312 (376)
                      |++.++.++++|||+++.+....... ..+..    .+++.|+               +||...+. ..+.++|+||+|+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~----~~~~~~~---------------~pe~~~~~-~~~~~~DiwSlG~  220 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYR-IQGRA----VLPIRWM---------------SWESILLG-KFTTASDVWAFGV  220 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCccee-ccCcC----cCccccC---------------CHHHHhcC-CccchhhhhHHHH
Confidence            99999999999999998664432221 11111    3345566               69966554 4688999999999


Q ss_pred             eehhhcccc
Q 017177          313 VFSCVFSFY  321 (376)
Q Consensus       313 v~~~~~~~y  321 (376)
                      +++|+++.+
T Consensus       221 ~l~el~~~~  229 (296)
T cd05095         221 TLWEILTLC  229 (296)
T ss_pred             HHHHHHHhC
Confidence            999998643

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.97  E-value=2.7e-31  Score=244.27  Aligned_cols=201  Identities=20%  Similarity=0.206  Sum_probs=159.1

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHH-HhcCCCCCcceEEeEEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNF-LGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~i-l~~l~h~nIv~l~~~~~~  166 (376)
                      ++|++.+.||+|+||.||++...         .++..||+|.++.... .....+..|+.+ ++.++||||+++++++..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~   71 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHV---------PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR   71 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEc---------CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence            46889999999999999999544         4689999999876532 223445556665 566789999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++..|++|||++ |+|.+++.........+++..+..++.|++.||.|||+ ..+++||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~~~~~~kl~dfg  149 (283)
T cd06617          72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFG  149 (283)
T ss_pred             CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCCCEEEeecc
Confidence            999999999996 58988887643334568999999999999999999994 2399999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh---hhccccccccceeeeehhhcccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI---KYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~---~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ++............        .|++.|+               +||.+.+.   ...+.++|+|++|++++++++...+
T Consensus       150 ~~~~~~~~~~~~~~--------~~~~~y~---------------aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  206 (283)
T cd06617         150 ISGYLVDSVAKTID--------AGCKPYM---------------APERINPELNQKGYDVKSDVWSLGITMIELATGRFP  206 (283)
T ss_pred             cccccccccccccc--------cCCcccc---------------ChhhcCCcccccccCccccchhhHHHHHHHHhCCCC
Confidence            99876432221111        4555666               79987652   3357889999999999999965444

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.6e-31  Score=240.48  Aligned_cols=201  Identities=25%  Similarity=0.274  Sum_probs=168.1

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|++.+.||.|+||.||+|....         ++..+++|.+........+.+.+|+.+++.++||||+++++.+...
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   72 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIA---------TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR   72 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecC---------CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeC
Confidence            3579999999999999999995543         4778999999876655667889999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +.+|++|||+++++|.+++....   ..+++..+..++.|++.||.|||  +++|+|+||||+||+++.++.++++|||+
T Consensus        73 ~~~~l~~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~  147 (262)
T cd06613          73 DKLWIVMEYCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLH--ETGKIHRDIKGANILLTEDGDVKLADFGV  147 (262)
T ss_pred             CEEEEEEeCCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCChhhEEECCCCCEEECcccc
Confidence            99999999999999999887642   45889999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh--hhccccccccceeeeehhhccccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI--KYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~--~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      +..........   ..    ..+++.|+               +||++.+.  ...+.++|+||+|++++++++...+.
T Consensus       148 ~~~~~~~~~~~---~~----~~~~~~y~---------------~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~  204 (262)
T cd06613         148 SAQLTATIAKR---KS----FIGTPYWM---------------APEVAAVERKGGYDGKCDIWALGITAIELAELQPPM  204 (262)
T ss_pred             chhhhhhhhcc---cc----ccCCcccc---------------CchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCC
Confidence            98765432111   01    14555566               79987655  24578899999999999999765543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=6.1e-31  Score=241.75  Aligned_cols=199  Identities=21%  Similarity=0.288  Sum_probs=160.6

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .+|++.+.||+|+||.||+|.....     .......+|+|.+..... .....+.+|+.+++.++||||+++++++.. 
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~-----~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPE-----GEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecC-----CCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence            5688999999999999999976431     112245799999876643 345678899999999999999999999887 


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      ...++||||+++|+|.+++.+..   ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH--~~~i~H~di~p~nil~~~~~~~kL~dfg~  155 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFGL  155 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--hCCEEecccCcceEEEcCCCeEEECCCcc
Confidence            78999999999999999997653   34899999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ++............+.     .+++.|+               +||.+.. ...+.++|+||+|++++++++
T Consensus       156 ~~~~~~~~~~~~~~~~-----~~~~~y~---------------~PE~~~~-~~~~~~~Di~slG~~l~el~~  206 (279)
T cd05057         156 AKLLDVDEKEYHAEGG-----KVPIKWM---------------ALESILH-RIYTHKSDVWSYGVTVWELMT  206 (279)
T ss_pred             cccccCcccceecCCC-----ccccccc---------------CHHHhhc-CCcCchhhHHHHHHHHHHHhc
Confidence            9876543222111110     2234555               7997654 345789999999999999886

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.8e-31  Score=247.37  Aligned_cols=210  Identities=24%  Similarity=0.339  Sum_probs=163.9

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCC-----CcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTL-----APSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLL  161 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~  161 (376)
                      .++|++.+.||+|+||.||+|+..+...     ..........||+|.++... ......+.+|++++++++|+||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4579999999999999999986543110     00112234568999998653 33446788999999999999999999


Q ss_pred             eEEEeCCeEEEEEeccCCCCHHHHHhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEE
Q 017177          162 GYCWEDKELLLVYEYMQRGSLENHLFRRNP--------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL  233 (376)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NIL  233 (376)
                      +++...+..++||||+++++|.+++.....        ....+++..++.++.|++.||.|||  +++++||||||+|||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~Nil  161 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA--SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH--hcCeeccccChhhEE
Confidence            999999999999999999999999865321        0123688899999999999999999  699999999999999


Q ss_pred             EcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeee
Q 017177          234 LDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFV  313 (376)
Q Consensus       234 l~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v  313 (376)
                      +++++.+|++|||++.......... ..+..    .+++.|+               +||.+.+.. .+.++|+||||++
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~----~~~~~y~---------------aPE~~~~~~-~~~~~DvwSlG~~  220 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYR-IQGRA----VLPIRWM---------------AWESILLGK-FTTASDVWAFGVT  220 (295)
T ss_pred             EcCCCcEEecccccccccccCccee-ccCcC----cCceeec---------------ChhhhccCC-cCchhhHHHHHHH
Confidence            9999999999999998764432221 11111    3445666               799776544 6899999999999


Q ss_pred             ehhhccc
Q 017177          314 FSCVFSF  320 (376)
Q Consensus       314 ~~~~~~~  320 (376)
                      ++++++.
T Consensus       221 l~el~~~  227 (295)
T cd05097         221 LWEMFTL  227 (295)
T ss_pred             HHHHHHc
Confidence            9999763

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.5e-31  Score=247.76  Aligned_cols=207  Identities=23%  Similarity=0.239  Sum_probs=166.0

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh---hHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ---GFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ++|++.+.||+|+||.||+|....         +++.||+|.+......   ..+.+.+|+++++.++|+||+++++.+.
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   71 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKG---------TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ   71 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcC---------CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence            368899999999999999995543         5889999999865432   4467889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +.+..|+||||+.+++|.+++.+..  ...+++..+..++.|++.||.|||  ..+++||||||+||+++.+|.++|+||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~df  147 (316)
T cd05574          72 TETYLCLVMDYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLH--LLGIVYRDLKPENILLHESGHIMLSDF  147 (316)
T ss_pred             cCCEEEEEEEecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHH--HCCeeccCCChHHeEEcCCCCEEEeec
Confidence            9999999999999999999987542  256899999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEe---e-------------------eEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccc
Q 017177          246 LIYVYFKRHYIYIYIH---T-------------------YIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTL  303 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~---~-------------------~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~  303 (376)
                      |++.............   .                   .......||+.|+               +||++.+.. .+.
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~---------------aPE~~~~~~-~~~  211 (316)
T cd05574         148 DLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYI---------------APEVISGDG-HGS  211 (316)
T ss_pred             chhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCc---------------CHHHHcCCC-CCc
Confidence            9988654322110000   0                   0000114555666               899887654 588


Q ss_pred             cccccceeeeehhhccccccc
Q 017177          304 LKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       304 ~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ++|+||+|++++++++-..+.
T Consensus       212 ~~Di~slG~ll~~l~~g~~pf  232 (316)
T cd05574         212 AVDWWTLGILLYEMLYGTTPF  232 (316)
T ss_pred             hHHHHHHHHHHHHHhhCCCCC
Confidence            999999999999998655443

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.9e-32  Score=258.78  Aligned_cols=189  Identities=22%  Similarity=0.235  Sum_probs=162.6

Q ss_pred             eEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEEEe
Q 017177           96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYE  175 (376)
Q Consensus        96 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e  175 (376)
                      +||+|.||+||.|         ++..+....|||.+........+-+..|+.+.+.|+|.|||+++|.+..++++-|.||
T Consensus       582 VLGKGTYG~VYA~---------RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME  652 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAA---------RDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME  652 (1226)
T ss_pred             EeecCceeEEEee---------ccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence            6999999999999         5555788999999998877777888999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc-CCCcEEEcceeeeeeeccc
Q 017177          176 YMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD-GVGFLFDSHLLIYVYFKRH  254 (376)
Q Consensus       176 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~-~~g~~kl~Dfg~a~~~~~~  254 (376)
                      -++||+|.++|+..-+ ..+=.+...-.+.+||++||.|||  ++.|||||||-+|+||+ -.|.+||+|||.++.+..-
T Consensus       653 qVPGGSLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLH--en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi  729 (1226)
T KOG4279|consen  653 QVPGGSLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLH--ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI  729 (1226)
T ss_pred             cCCCCcHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhh--hcceeeccccCCcEEEeeccceEEecccccchhhccC
Confidence            9999999999976542 122378888999999999999999  79999999999999996 5799999999999987654


Q ss_pred             eeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHh-hhhhccccccccceeeeehhhc
Q 017177          255 YIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYA-WIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       255 ~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~-~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      ...+   .|+    .||-.||               |||++. |.+-+..++|||||||..-||+
T Consensus       730 nP~T---ETF----TGTLQYM---------------APEvIDqG~RGYG~aADIWS~GCT~vEMA  772 (1226)
T KOG4279|consen  730 NPCT---ETF----TGTLQYM---------------APEVIDQGPRGYGKAADIWSFGCTMVEMA  772 (1226)
T ss_pred             Cccc---ccc----ccchhhh---------------ChHhhccCCcCCCchhhhhhccceeEeec
Confidence            3322   222    6677777               799776 5566789999999999999999

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.8e-31  Score=242.34  Aligned_cols=197  Identities=24%  Similarity=0.245  Sum_probs=166.5

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ++|++.+.||.|+||.||+|....         ++..||+|.+.... ......+.+|+.+++.++|+||+++++.+.++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKR---------TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG   71 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECC---------CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC
Confidence            368889999999999999995543         58899999987653 34456788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      ..+|+|+||+++++|.+++...     .+++..+..++.|++.||.|||  ..+++||||+|+||++++++.++++|||+
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~  144 (274)
T cd06609          72 SKLWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLH--EEGKIHRDIKAANILLSEEGDVKLADFGV  144 (274)
T ss_pred             CeEEEEEEeeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEEccccc
Confidence            9999999999999999998653     5899999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ++.........       ....|++.|+               +||.+.+.. .+.++|+|++|++++++++...+.
T Consensus       145 ~~~~~~~~~~~-------~~~~~~~~y~---------------~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~  198 (274)
T cd06609         145 SGQLTSTMSKR-------NTFVGTPFWM---------------APEVIKQSG-YDEKADIWSLGITAIELAKGEPPL  198 (274)
T ss_pred             ceeeccccccc-------ccccCCcccc---------------ChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCc
Confidence            98876542110       1115566666               799877665 789999999999999998755543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.97  E-value=4e-31  Score=243.07  Aligned_cols=189  Identities=20%  Similarity=0.273  Sum_probs=158.4

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ++|++.++||+|+||.||+|...         .+++.||+|.+.... ....+.+.+|+.++++++||||+++++.+..+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   71 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHL---------LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE   71 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEc---------CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence            36888999999999999999543         358899999987652 33446788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++||||+++++|..+.        .+++..+..++.|++.||.|||  +.+|+|+||||+|||++.++.++|+|||+
T Consensus        72 ~~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nill~~~~~~~l~dfg~  141 (279)
T cd06619          72 NRISICTEFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLW--SLKILHRDVKPSNMLVNTRGQVKLCDFGV  141 (279)
T ss_pred             CEEEEEEecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHH--HCCEeeCCCCHHHEEECCCCCEEEeeCCc
Confidence            9999999999999986542        3678889999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      +.........     .    ..||+.|+               +||.+.+.. .+.++|+||+|++++++++-.
T Consensus       142 ~~~~~~~~~~-----~----~~~~~~y~---------------aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~  190 (279)
T cd06619         142 STQLVNSIAK-----T----YVGTNAYM---------------APERISGEQ-YGIHSDVWSLGISFMELALGR  190 (279)
T ss_pred             ceeccccccc-----C----CCCChhhc---------------CceeecCCC-CCCcchHHHHHHHHHHHHhCC
Confidence            9866432211     1    15666777               799777654 578999999999999998543

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.97  E-value=5.5e-31  Score=243.50  Aligned_cols=208  Identities=26%  Similarity=0.249  Sum_probs=165.9

Q ss_pred             hhhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcC-CCCCcceE
Q 017177           82 LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKL  160 (376)
Q Consensus        82 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l  160 (376)
                      .++....++|++.+.||+|+||.||++...         .+++.+|+|.+..... ....+.+|+.+++++ +||||+++
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~---------~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~   84 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNK---------KDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKF   84 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEEC---------CCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEE
Confidence            344456788999999999999999999554         3588999999875432 235677899999999 69999999


Q ss_pred             EeEEEeC-----CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc
Q 017177          161 LGYCWED-----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD  235 (376)
Q Consensus       161 ~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~  235 (376)
                      ++++...     +..++||||+++++|.+++.........+++..+..++.|++.||.|||  +.+|+||||||+||+++
T Consensus        85 ~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~nili~  162 (291)
T cd06639          85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH--NNRIIHRDVKGNNILLT  162 (291)
T ss_pred             EEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEEc
Confidence            9998754     3589999999999999988653333356899999999999999999999  69999999999999999


Q ss_pred             CCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhh----hcccccccccee
Q 017177          236 GVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIK----YLTLLKYSNSFA  311 (376)
Q Consensus       236 ~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~----~~~~~~dv~s~g  311 (376)
                      .++.+|++|||++..........   ..    ..|++.|+               +||.+....    ..+.++|+||+|
T Consensus       163 ~~~~~kl~dfg~~~~~~~~~~~~---~~----~~~~~~y~---------------aPE~~~~~~~~~~~~~~~~Di~slG  220 (291)
T cd06639         163 TEGGVKLVDFGVSAQLTSTRLRR---NT----SVGTPFWM---------------APEVIACEQQYDYSYDARCDVWSLG  220 (291)
T ss_pred             CCCCEEEeecccchhcccccccc---cC----ccCCcccc---------------ChhhhcCCCCcccccCCccchHHHH
Confidence            99999999999998765432211   01    14556666               799776433    257899999999


Q ss_pred             eeehhhcccccc
Q 017177          312 FVFSCVFSFYRT  323 (376)
Q Consensus       312 ~v~~~~~~~y~~  323 (376)
                      ++++++++...+
T Consensus       221 vi~~el~~g~~p  232 (291)
T cd06639         221 ITAIELGDGDPP  232 (291)
T ss_pred             HHHHHHhhCCCC
Confidence            999999865444

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.97  E-value=4e-31  Score=239.92  Aligned_cols=193  Identities=25%  Similarity=0.351  Sum_probs=158.3

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      .+|++.+.||+|+||.||+|.+..          +..+|+|.+..... ....+.+|+.+++.++||||+++++++...+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~----------~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRG----------KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR   72 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecC----------CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            358889999999999999996542          55799999875432 2356788999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeee
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a  248 (376)
                      ..++||||+++++|.+++....   ..+++..+..++.|++.||.|||  +.+|+||||||+||+++.+|.+|++|||++
T Consensus        73 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~  147 (256)
T cd05059          73 PIFIVTEYMANGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLE--SNGFIHRDLAARNCLVGEDNVVKVSDFGLA  147 (256)
T ss_pred             ceEEEEecCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHhhEEECCCCcEEECCcccc
Confidence            9999999999999999997642   35889999999999999999999  699999999999999999999999999999


Q ss_pred             eeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          249 VYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +......... ..++     .++..|+               +||++.+.. .+.++|+||+|++++++++
T Consensus       148 ~~~~~~~~~~-~~~~-----~~~~~y~---------------~Pe~~~~~~-~~~~~Di~slG~il~~l~~  196 (256)
T cd05059         148 RYVLDDQYTS-SQGT-----KFPVKWA---------------PPEVFDYSR-FSSKSDVWSFGVLMWEVFS  196 (256)
T ss_pred             eecccccccc-cCCC-----CCCcccc---------------CHHHhccCC-CCchhhHHHHHHHHHHHhc
Confidence            8764332211 1111     1222344               699887654 5788999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=8.1e-32  Score=244.82  Aligned_cols=195  Identities=24%  Similarity=0.236  Sum_probs=157.9

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVY  174 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~  174 (376)
                      +.||+|+||.||+|.......  ........+|+|.+........+.+.+|+.+++.++||||+++++++..++..++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGD--YGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeeccccc--ccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            468999999999997643210  011234568999887665555678889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc--------EEEccee
Q 017177          175 EYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF--------LFDSHLL  246 (376)
Q Consensus       175 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~--------~kl~Dfg  246 (376)
                      ||+++|+|.+++....   ..+++..++.++.||+.||.|||  +++|+||||||+|||++.++.        ++++|||
T Consensus        79 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          79 EYVKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLE--DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             ecCCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence            9999999999997653   35789999999999999999999  699999999999999987765        6899999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      ++........   .        .+++.|+               +||.+.+....+.++|+||+|++++++++...
T Consensus       154 ~~~~~~~~~~---~--------~~~~~y~---------------aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~  203 (258)
T cd05078         154 ISITVLPKEI---L--------LERIPWV---------------PPECIENPQNLSLAADKWSFGTTLWEIFSGGD  203 (258)
T ss_pred             cccccCCchh---c--------cccCCcc---------------CchhccCCCCCCchhhHHHHHHHHHHHHcCCC
Confidence            8875433211   1        4555666               79988776667899999999999999987643

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.97  E-value=6.3e-31  Score=240.38  Aligned_cols=195  Identities=18%  Similarity=0.181  Sum_probs=151.7

Q ss_pred             eEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEEE
Q 017177           96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVY  174 (376)
Q Consensus        96 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~  174 (376)
                      .||+|+||.||++.....       .....+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....|+||
T Consensus         2 ~lg~G~~g~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~   74 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTD-------TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVF   74 (268)
T ss_pred             cCCCCcCceEEEEEEEcC-------CCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEE
Confidence            589999999999865331       124457788776543 334578899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeeccc
Q 017177          175 EYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRH  254 (376)
Q Consensus       175 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~  254 (376)
                      ||+++|+|.+++.+........++..+..++.|++.||.|||  +.+|+||||||+|||++.++.++++|||++......
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~  152 (268)
T cd05086          75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH--KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE  152 (268)
T ss_pred             ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--HCCeeccCCccceEEEcCCccEEecccccccccCcc
Confidence            999999999999765433345677788899999999999999  699999999999999999999999999998643221


Q ss_pred             eeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh------hhccccccccceeeeehhhcc
Q 017177          255 YIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI------KYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       255 ~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~------~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      .......+     ..|++.|+               +||++...      ...+.++|+||+|++++++++
T Consensus       153 ~~~~~~~~-----~~~~~~y~---------------aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~  203 (268)
T cd05086         153 DYIETEDD-----KCVPLRWL---------------APELVGEFHGGLITAEQTKPSNVWALGVTLWELFE  203 (268)
T ss_pred             hhhhcccC-----CcCccccc---------------CchhcccccCccccCCCCCcchhHHHHHHHHHHHh
Confidence            11100001     14555666               69976432      124678999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.97  E-value=2.8e-31  Score=242.08  Aligned_cols=201  Identities=21%  Similarity=0.291  Sum_probs=165.8

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ++|++.+.||+|+||.||+|...         .++..+|+|.+....   ......+.+|+.+++.++||||+++++++.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~---------~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   72 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCL---------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI   72 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeec---------CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence            46889999999999999999543         358899999876532   234467889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      .++..+++|||+++++|.+++.........+++..+..++.|++.||.|||  +++++|+||||+||+++.++.++++||
T Consensus        73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~df  150 (267)
T cd08229          73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEECcc
Confidence            999999999999999999998754333456899999999999999999999  699999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |++..........  ..     ..|++.|+               +||.+.+.. .+.++|+||+|++++++++...+
T Consensus       151 g~~~~~~~~~~~~--~~-----~~~~~~~~---------------ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p  205 (267)
T cd08229         151 GLGRFFSSKTTAA--HS-----LVGTPYYM---------------SPERIHENG-YNFKSDIWSLGCLLYEMAALQSP  205 (267)
T ss_pred             hhhhccccCCccc--cc-----ccCCcCcc---------------CHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCC
Confidence            9988765432211  01     14566666               799776544 57889999999999999876544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.8e-32  Score=259.99  Aligned_cols=213  Identities=20%  Similarity=0.191  Sum_probs=162.8

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      -|..++.||-|+||+|.++         ++..+...||+|.+++...   .+...+..|-.||...+++.||+||-.|++
T Consensus       630 mFvkik~iGvGAFGeV~Lv---------~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD  700 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLV---------RKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD  700 (1034)
T ss_pred             ceEEEeeecccccceeEEE---------eecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence            3677889999999999999         4444688999999987643   344567789999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++.+|+||||++||++..+|.+.    .-|++..++.++.++..|+++.|  ..|+|||||||+|||||.+|++||.|||
T Consensus       701 kdnLYFVMdYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVH--kmGFIHRDiKPDNILIDrdGHIKLTDFG  774 (1034)
T KOG0608|consen  701 KDNLYFVMDYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFG  774 (1034)
T ss_pred             CCceEEEEeccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHH--hccceecccCccceEEccCCceeeeecc
Confidence            99999999999999999999886    56899999999999999999999  7999999999999999999999999999


Q ss_pred             eeeeeccceeeEE-EeeeEEE--EEeeeeehhhhhcchhhHHH--------------H---HHHHHHHHhhhhhcccccc
Q 017177          247 IYVYFKRHYIYIY-IHTYIIY--IYIYVYIYMYIYKCLRYAIL--------------Y---SVLLPRIYAWIKYLTLLKY  306 (376)
Q Consensus       247 ~a~~~~~~~~~~~-~~~~~~y--~~~gt~~y~~~~~~~e~~d~--------------~---s~~apEi~~~~~~~~~~~d  306 (376)
                      |+.-+.=.....+ ..|...-  ..--.++|....+|+.....              .   .|+|||++...+ ++..+|
T Consensus       775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cd  853 (1034)
T KOG0608|consen  775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCD  853 (1034)
T ss_pred             ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccch
Confidence            9985422111100 0010000  00111222222222211110              0   155999877666 489999


Q ss_pred             ccceeeeehhhc
Q 017177          307 SNSFAFVFSCVF  318 (376)
Q Consensus       307 v~s~g~v~~~~~  318 (376)
                      +||.|+|++||+
T Consensus       854 wws~gvil~em~  865 (1034)
T KOG0608|consen  854 WWSVGVILYEML  865 (1034)
T ss_pred             hhHhhHHHHHHh
Confidence            999999999998

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=7.5e-31  Score=240.46  Aligned_cols=203  Identities=23%  Similarity=0.320  Sum_probs=163.6

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh-hHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ++|++.+.||+|+||.||+|+....    ........+++|.+...... ..+.+.+|++++++++|+||+++++++.+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   80 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGI----EEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA   80 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccC----CcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence            5788999999999999999976542    12334678999998765443 456789999999999999999999999988


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPS-----IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                      +..++||||+++|+|.+++......     ...+++..+..++.|++.||+|||  +.+|+||||||+|||++.++.+++
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH--~~~i~H~dlkp~Nili~~~~~~~l  158 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS--NARFVHRDLAARNCLVSSQREVKV  158 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh--hcCcccCcCccceEEEeCCCcEEE
Confidence            9999999999999999999765321     125899999999999999999999  699999999999999999999999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +|||++............ ..     .+++.|+               +||.+.+.. .+.++|+||+|++++++++
T Consensus       159 ~~~~~~~~~~~~~~~~~~-~~-----~~~~~y~---------------~PE~~~~~~-~~~~~Di~slG~~l~~l~~  213 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLR-NA-----LIPLRWL---------------APEAVQEDD-FSTKSDVWSFGVLMWEVFT  213 (275)
T ss_pred             cccccccccCcccccccC-Cc-----eeEEeec---------------ChhhhccCC-CCchhhHHHHHHHHHHHHh
Confidence            999998755332221111 11     3445555               699766554 4688999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=2.7e-31  Score=244.63  Aligned_cols=201  Identities=28%  Similarity=0.356  Sum_probs=159.3

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC--
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED--  167 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--  167 (376)
                      |++.+.||+|+||+||++.+..     ....++..||+|.++.... .....+.+|+.++++++||||+++++++...  
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDP-----ANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             ceeceecccCCCcEEEEeeEcc-----ccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            4889999999999999876542     2334578899999976532 3456788999999999999999999987653  


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      ..++++|||+++++|.+++...     .+++..+..++.|++.||.|||  +++|+||||||+|||++.++.++|+|||+
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~  153 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLH--SQHYIHRDLAARNVLLDNDRLVKIGDFGL  153 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHH--HCCeeccccChheEEEcCCCcEEEeeccc
Confidence            4689999999999999998653     3899999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ++...............    .++..|+               +||.+.+.. .+.++|+||+|++++++++...+
T Consensus       154 ~~~~~~~~~~~~~~~~~----~~~~~~~---------------~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~p  209 (283)
T cd05080         154 AKAVPEGHEYYRVREDG----DSPVFWY---------------AVECLKENK-FSYASDVWSFGVTLYELLTHCDS  209 (283)
T ss_pred             ccccCCcchhhccCCCC----CCCceee---------------CHhHhcccC-CCcccccHHHHHHHHHHHhCCCC
Confidence            98765432211000000    1222333               699776543 57899999999999999976544

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.97  E-value=4.7e-31  Score=245.68  Aligned_cols=199  Identities=26%  Similarity=0.332  Sum_probs=157.6

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcC-CCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~  165 (376)
                      .++|++.+.||+|+||.||+|.+...       .....+|+|.++... ......+.+|+.++.++ +||||+++++++.
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~   78 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKD-------GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE   78 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccC-------CceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC
Confidence            45789999999999999999975431       112456888776532 33446788999999999 7999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEE
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNP------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL  233 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NIL  233 (376)
                      .++.+|+||||+++++|.+++.+...            ....+++..++.++.|++.||+|||  +++|+||||||+|||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~gi~H~dlkp~Nil  156 (303)
T cd05088          79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNIL  156 (303)
T ss_pred             CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH--hCCccccccchheEE
Confidence            99999999999999999999976431            1235789999999999999999999  699999999999999


Q ss_pred             EcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeee
Q 017177          234 LDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFV  313 (376)
Q Consensus       234 l~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v  313 (376)
                      ++.++.+||+|||++.........  ..+      .+++.|+               +||.+.+. ..+.++|+||+|++
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~--~~~------~~~~~y~---------------aPE~~~~~-~~~~~~Di~slG~i  212 (303)
T cd05088         157 VGENYVAKIADFGLSRGQEVYVKK--TMG------RLPVRWM---------------AIESLNYS-VYTTNSDVWSYGVL  212 (303)
T ss_pred             ecCCCcEEeCccccCcccchhhhc--ccC------CCccccc---------------CHHHHhcc-CCcccccchhhhhH
Confidence            999999999999998643211111  001      1233455               79977654 46789999999999


Q ss_pred             ehhhcc
Q 017177          314 FSCVFS  319 (376)
Q Consensus       314 ~~~~~~  319 (376)
                      ++++++
T Consensus       213 l~ellt  218 (303)
T cd05088         213 LWEIVS  218 (303)
T ss_pred             HHHHHh
Confidence            999986

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.97  E-value=4.5e-31  Score=243.74  Aligned_cols=205  Identities=27%  Similarity=0.363  Sum_probs=162.6

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|.....    .+..++..||+|.+..... .....+.+|+.+++.++||||+++++++.+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~   79 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV   79 (288)
T ss_pred             hHhceecccccccccccEEEEEEccc----CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence            46799999999999999999975421    1123467899999886543 334678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCC------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCC
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNP------------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFK  228 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~------------------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlK  228 (376)
                      ++..+++|||+++|+|.+++.....                  ....+++..++.++.|++.||.|||  .++++|||||
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH--~~~i~H~dl~  157 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS--ERKFVHRDLA  157 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hCCeeccccc
Confidence            9999999999999999999975321                  1134788899999999999999999  6999999999


Q ss_pred             CCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcccccccc
Q 017177          229 ASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSN  308 (376)
Q Consensus       229 p~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~  308 (376)
                      |+|||++.++.++++|||++...............     .+++.|+               +||.+.+.. .+.++|+|
T Consensus       158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~-----~~~~~y~---------------aPE~~~~~~-~~~~~Dv~  216 (288)
T cd05050         158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASEND-----AIPIRWM---------------PPESIFYNR-YTTESDVW  216 (288)
T ss_pred             HhheEecCCCceEECccccceecccCccccccCCC-----ccChhhc---------------CHHHHhcCC-CCchhHHH
Confidence            99999999999999999998865433221111111     1223344               799777654 57899999


Q ss_pred             ceeeeehhhcc
Q 017177          309 SFAFVFSCVFS  319 (376)
Q Consensus       309 s~g~v~~~~~~  319 (376)
                      |+|++++++++
T Consensus       217 slG~il~el~~  227 (288)
T cd05050         217 AYGVVLWEIFS  227 (288)
T ss_pred             HHHHHHHHHHh
Confidence            99999999985

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.97  E-value=8.1e-31  Score=237.62  Aligned_cols=199  Identities=21%  Similarity=0.233  Sum_probs=162.7

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe-
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE-  166 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-  166 (376)
                      +|++.+.||+|++|.||++...         .+++.||+|.+....  ....+.+.+|+.++++++|+||+++++.+.. 
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHR---------TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE   71 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEc---------CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence            4889999999999999999543         357889999987543  2345678899999999999999999998764 


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      +..+|++|||+++++|.+++....  ...+++..+..++.|++.||.|||  +.+|+||||||+||+++.++.++|+|||
T Consensus        72 ~~~~~lv~e~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH--~~~i~H~di~p~nil~~~~~~~~l~df~  147 (257)
T cd08223          72 DGLLYIVMGFCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLG  147 (257)
T ss_pred             CCEEEEEecccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCchhEEEecCCcEEEeccc
Confidence            446899999999999999997643  245899999999999999999999  6999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ++..........   .+    ..|++.|+               +||++.+.. .+.++|+||+|++++++++...+.
T Consensus       148 ~~~~~~~~~~~~---~~----~~~~~~y~---------------aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~  202 (257)
T cd08223         148 IARVLENQCDMA---ST----LIGTPYYM---------------SPELFSNKP-YNYKSDVWALGCCVYEMATLKHAF  202 (257)
T ss_pred             ceEEecccCCcc---cc----ccCCcCcc---------------ChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCC
Confidence            998775432211   11    15666677               799776654 578899999999999999765443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.97  E-value=6.3e-31  Score=238.75  Aligned_cols=190  Identities=23%  Similarity=0.291  Sum_probs=153.4

Q ss_pred             eEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEE
Q 017177           96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        96 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv  173 (376)
                      .||+|+||.||+|.+..       ..++..+|+|+++....  ...+.+.+|+.+++.++||||+++++++. .+..++|
T Consensus         2 ~lg~G~~g~v~~~~~~~-------~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv   73 (257)
T cd05116           2 ELGSGNFGTVKKGMYKM-------KKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLV   73 (257)
T ss_pred             cCCCcCCcceEEeEEec-------CCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEE
Confidence            58999999999996542       12477899999875532  34567889999999999999999999875 4567999


Q ss_pred             EeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      |||+++|+|.+++...    ..+++..+..++.|++.||.|||  +++|+||||||.|||++.++.+|++|||++.....
T Consensus        74 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~  147 (257)
T cd05116          74 MELAELGPLNKFLQKN----KHVTEKNITELVHQVSMGMKYLE--ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGA  147 (257)
T ss_pred             EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccchhhEEEcCCCeEEECCCccccccCC
Confidence            9999999999999754    35889999999999999999999  69999999999999999999999999999987655


Q ss_pred             ceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          254 HYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       254 ~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ..........    ..+++.|+               +||.+... ..+.++|+||+|++++|+++
T Consensus       148 ~~~~~~~~~~----~~~~~~y~---------------aPE~~~~~-~~~~~~Di~slG~~l~el~t  193 (257)
T cd05116         148 DENYYKAKTH----GKWPVKWY---------------APECMNYY-KFSSKSDVWSFGVLMWEAFS  193 (257)
T ss_pred             CCCeeeecCC----CCCCcccc---------------CHhHhccC-CcCchhHHHHHHHHHHHHHh
Confidence            4332111111    02335566               79977543 45789999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=7.5e-31  Score=238.68  Aligned_cols=195  Identities=22%  Similarity=0.336  Sum_probs=161.2

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|++.+.||+|+||.||+|....          +..||+|.++.... ..+.+.+|+.++++++||||+++++++...
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   73 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN----------TTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE   73 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC----------CeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence            4568999999999999999996543          56799999876543 346788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..+++|||+++++|.+++....  ...+++..+..++.|++.||.|||  +.+|+||||||+||++++++.++|+|||+
T Consensus        74 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~dfg~  149 (261)
T cd05068          74 EPIYIVTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLE--AQNYIHRDLAARNVLVGENNICKVADFGL  149 (261)
T ss_pred             CCeeeeeecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCcceEEEcCCCCEEECCcce
Confidence            99999999999999999997653  245899999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +.......... ..+.     .++..|+               +||.+.+. ..+.++|+||+|++++++++
T Consensus       150 ~~~~~~~~~~~-~~~~-----~~~~~y~---------------aPE~~~~~-~~~~~~Di~slG~~l~el~t  199 (261)
T cd05068         150 ARVIKEDIYEA-REGA-----KFPIKWT---------------APEAALYN-RFSIKSDVWSFGILLTEIVT  199 (261)
T ss_pred             EEEccCCcccc-cCCC-----cCceecc---------------CccccccC-CCCchhhHHHHHHHHHHHHh
Confidence            99876332211 1111     1123444               69966654 46889999999999999987

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.97  E-value=7.9e-31  Score=237.80  Aligned_cols=195  Identities=22%  Similarity=0.289  Sum_probs=158.8

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv  173 (376)
                      +.||+|++|.||+|.+...      ......||+|.+..... ...+.+.+|+.++++++||||+++++.+.. ...++|
T Consensus         1 ~~ig~g~~~~v~~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v   73 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTS------GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMV   73 (257)
T ss_pred             CcCCccCcccEEeeeEecC------CCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEE
Confidence            4689999999999976531      12244799999988766 566788999999999999999999999988 889999


Q ss_pred             EeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      |||+++++|.+++.+...  ..+++..+..++.|++.||+|||  .++++||||||+||+++.++.+||+|||++.....
T Consensus        74 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~  149 (257)
T cd05040          74 TELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLE--SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQ  149 (257)
T ss_pred             EEecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHH--hCCccccccCcccEEEecCCEEEeccccccccccc
Confidence            999999999999977532  45899999999999999999999  69999999999999999999999999999998754


Q ss_pred             ceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          254 HYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       254 ~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      .........    ...++..|+               +||.+.+.. .+.++|+||+|+++++++++
T Consensus       150 ~~~~~~~~~----~~~~~~~y~---------------~pE~~~~~~-~~~~~Di~slG~~l~el~t~  196 (257)
T cd05040         150 NEDHYVMEE----HLKVPFAWC---------------APESLRTRT-FSHASDVWMFGVTLWEMFTY  196 (257)
T ss_pred             cccceeccc----CCCCCceec---------------CHHHhcccC-cCchhhhHHHHHHHHHHHhC
Confidence            322110100    013344455               699776554 57889999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.97  E-value=8.1e-31  Score=243.30  Aligned_cols=198  Identities=25%  Similarity=0.317  Sum_probs=156.6

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-ChhhHHHHHHHHHHHhcC-CCCCcceEEeEEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWE  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~  166 (376)
                      ++|++.+.||+|+||.||+|.....       .....+++|.++.. .....+.+.+|+.++.++ +||||+++++++..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~   74 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKD-------GLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN   74 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCC-------CCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence            5789999999999999999966432       11345788888753 334456788999999999 69999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNP------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL  234 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl  234 (376)
                      .+.+|++|||+++++|.+++.+...            ....+++..+..++.|++.||+|||  +++|+||||||+|||+
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH--~~~ivH~dlkp~Nill  152 (297)
T cd05089          75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS--EKQFIHRDLAARNVLV  152 (297)
T ss_pred             CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCcCCcceEEE
Confidence            9999999999999999999975431            1134788999999999999999999  6999999999999999


Q ss_pred             cCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeee
Q 017177          235 DGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVF  314 (376)
Q Consensus       235 ~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~  314 (376)
                      +.++.+||+|||++.........  ..+      ..+..|+               +||.+.+.. .+.++||||+|+++
T Consensus       153 ~~~~~~kl~dfg~~~~~~~~~~~--~~~------~~~~~y~---------------aPE~~~~~~-~~~~~DvwSlG~il  208 (297)
T cd05089         153 GENLASKIADFGLSRGEEVYVKK--TMG------RLPVRWM---------------AIESLNYSV-YTTKSDVWSFGVLL  208 (297)
T ss_pred             CCCCeEEECCcCCCccccceecc--CCC------CcCcccc---------------CchhhccCC-CCchhhHHHHHHHH
Confidence            99999999999998743221111  001      1123344               699776544 57899999999999


Q ss_pred             hhhcc
Q 017177          315 SCVFS  319 (376)
Q Consensus       315 ~~~~~  319 (376)
                      +++++
T Consensus       209 ~el~t  213 (297)
T cd05089         209 WEIVS  213 (297)
T ss_pred             HHHHc
Confidence            99985

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.97  E-value=1e-30  Score=236.87  Aligned_cols=197  Identities=23%  Similarity=0.295  Sum_probs=163.9

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-----hhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-----MQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      +|+..+.||+|+||.||+|....         ++..|++|.+....     ....+.+.+|+.+++.++|+||+++++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   71 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLD---------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE   71 (258)
T ss_pred             CccccceeeecCCceEEEEEEcC---------CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence            47788999999999999996542         47889999886543     23456788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      ..+..+++++||+++++|.+++.+.    ..+++..+..++.|++.||.|||  ..+|+|+||||+||+++.++.+||+|
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~~~ni~~~~~~~~kl~d  145 (258)
T cd06632          72 REEDNLYIFLELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLH--DRNTVHRDIKGANILVDTNGVVKLAD  145 (258)
T ss_pred             ecCCeEEEEEEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEcc
Confidence            9999999999999999999999765    34789999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ||++............        .|++.|+               +||.+......+.++|+|++|++++++++...+.
T Consensus       146 ~~~~~~~~~~~~~~~~--------~~~~~y~---------------~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf  202 (258)
T cd06632         146 FGMAKQVVEFSFAKSF--------KGSPYWM---------------APEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW  202 (258)
T ss_pred             Cccceecccccccccc--------CCCccee---------------CHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCc
Confidence            9999876544321111        4555566               6997765544678899999999999999755543

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.97  E-value=1.8e-31  Score=246.19  Aligned_cols=195  Identities=24%  Similarity=0.345  Sum_probs=155.3

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh--hHHHHHHHHHHHhcC---CCCCcceEEeEE
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFEEWQSEVNFLGRL---SHPNLVKLLGYC  164 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l---~h~nIv~l~~~~  164 (376)
                      +|++.+.||+|+||.||+|...         .+++.||+|.++.....  ....+.+|+.+++.+   +||||+++++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~   71 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDP---------HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC   71 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEEC---------CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence            4888999999999999999544         36889999998754221  123455677777665   699999999988


Q ss_pred             Ee-----CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc
Q 017177          165 WE-----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF  239 (376)
Q Consensus       165 ~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~  239 (376)
                      ..     ...++++|||+.+ +|.+++.+...  ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.
T Consensus        72 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dikp~Nili~~~~~  146 (288)
T cd07863          72 ATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENILVTSGGQ  146 (288)
T ss_pred             ccccCCCCceEEEEEccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCC
Confidence            64     2458999999975 89888866432  45899999999999999999999  599999999999999999999


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +||+|||++............        .||+.|+               +||++.+.. .+.++|+||+|++++++++
T Consensus       147 ~kl~dfg~~~~~~~~~~~~~~--------~~~~~y~---------------aPE~~~~~~-~~~~~DiwslG~~l~~l~~  202 (288)
T cd07863         147 VKLADFGLARIYSCQMALTPV--------VVTLWYR---------------APEVLLQST-YATPVDMWSVGCIFAEMFR  202 (288)
T ss_pred             EEECccCccccccCcccCCCc--------ccccccc---------------CchHhhCCC-CCCcchhhhHHHHHHHHHh
Confidence            999999999876543222111        4566677               799876654 6889999999999999985


Q ss_pred             ccc
Q 017177          320 FYR  322 (376)
Q Consensus       320 ~y~  322 (376)
                      ...
T Consensus       203 g~~  205 (288)
T cd07863         203 RKP  205 (288)
T ss_pred             CCc
Confidence            543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.97  E-value=6.9e-31  Score=245.72  Aligned_cols=208  Identities=23%  Similarity=0.319  Sum_probs=163.1

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcC-CCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~l~~~~  164 (376)
                      ..++|.+.+.||+|+||.||+|......  .........+|+|.++... ......+.+|+.+++.+ +||||+++++++
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~--~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGID--KSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccC--CccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            3457889999999999999999753211  0111235679999988643 34456788999999999 599999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCE
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNP------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI  232 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NI  232 (376)
                      ...+..|++|||+++|+|.+++.....            ....+++..+..++.|++.||.|||  +++|+||||||+||
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~Ni  165 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE--SRRCIHRDLAARNV  165 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH--HCCeeeccccceeE
Confidence            999999999999999999999976431            1245888999999999999999999  69999999999999


Q ss_pred             EEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceee
Q 017177          233 LLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAF  312 (376)
Q Consensus       233 Ll~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~  312 (376)
                      |++.++.+||+|||+++..............     .+++.||               +||.+.+. ..+.++|+||+|+
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~-----~~~~~y~---------------aPE~~~~~-~~~~~~DiwslG~  224 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNG-----RLPVKWM---------------APEALFDR-VYTHQSDVWSFGI  224 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccC-----CCCcccc---------------CHHHHccC-CcCccchhhHHHH
Confidence            9999999999999999876543221111000     2223455               79977654 4688999999999


Q ss_pred             eehhhcc
Q 017177          313 VFSCVFS  319 (376)
Q Consensus       313 v~~~~~~  319 (376)
                      +++++++
T Consensus       225 ~l~el~~  231 (314)
T cd05099         225 LMWEIFT  231 (314)
T ss_pred             HHHHHHh
Confidence            9999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.97  E-value=8.1e-31  Score=241.10  Aligned_cols=199  Identities=24%  Similarity=0.278  Sum_probs=156.8

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ++|++.+.||+|+||.||+|.+...     .......+++|.+..... ....++..|+.+++.++||||+++++++. .
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPE-----GDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCC-----CCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence            4688899999999999999976431     111233688888865432 33467788899999999999999999875 4


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      ...++++||+++|+|.+++....   ..+++..+..++.|++.||.|||  +++++||||||+|||++.++.+|++|||+
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp~nili~~~~~~kl~Dfg~  155 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLE--EHRMVHRNLAARNILLKSDSIVQIADFGV  155 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH--HCCEeccccCcceEEEcCCCcEEEcCCcc
Confidence            56789999999999999997642   45899999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ++......... .....    .++..|+               +||.+.+.. .+.++|+||||++++|+++
T Consensus       156 ~~~~~~~~~~~-~~~~~----~~~~~y~---------------~pE~~~~~~-~~~~~Dv~slG~il~el~t  206 (279)
T cd05111         156 ADLLYPDDKKY-FYSEH----KTPIKWM---------------ALESILFGR-YTHQSDVWSYGVTVWEMMS  206 (279)
T ss_pred             ceeccCCCccc-ccCCC----CCccccc---------------CHHHhccCC-cCchhhHHHHHHHHHHHHc
Confidence            98764332111 11111    3444555               699776554 5889999999999999986

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.97  E-value=3.4e-31  Score=245.81  Aligned_cols=199  Identities=21%  Similarity=0.222  Sum_probs=166.6

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ...+|++.+.||.|+||.||+|...         .+++.|++|.+........+.+.+|+.+++.++||||+++++.+..
T Consensus        17 ~~~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   87 (296)
T cd06655          17 PKKKYTRYEKIGQGASGTVFTAIDV---------ATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV   87 (296)
T ss_pred             CcceEEEEEEEecCCCeEEEEEEEc---------CCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec
Confidence            4457999999999999999999543         3588999999876655556778899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      .+..|+|+||+++++|..++...     .+++..+..++.|++.||.|||  ..+++||||||+||+++.++.++|+|||
T Consensus        88 ~~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH--~~~i~H~dL~p~Nili~~~~~~kl~dfg  160 (296)
T cd06655          88 GDELFVVMEYLAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLH--ANQVIHRDIKSDNVLLGMDGSVKLTDFG  160 (296)
T ss_pred             CceEEEEEEecCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEccCc
Confidence            99999999999999999988543     4789999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ++..........   ..    ..|++.|+               +||.+.+.. .+.++|+||+|++++++++.+.+.
T Consensus       161 ~~~~~~~~~~~~---~~----~~~~~~y~---------------aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf  215 (296)
T cd06655         161 FCAQITPEQSKR---ST----MVGTPYWM---------------APEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPY  215 (296)
T ss_pred             cchhcccccccC---CC----cCCCcccc---------------CcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            988654432211   01    14556666               699776544 578999999999999999776654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.97  E-value=8.2e-31  Score=237.33  Aligned_cols=198  Identities=26%  Similarity=0.294  Sum_probs=167.5

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|++.+.||+|+||.||+|....         ++..+++|.+.....  .+.+.+|+++++.++||||+++++.+..+
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~   70 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKE---------TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKN   70 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcC---------CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecC
Confidence            3679999999999999999996543         478899999876533  57889999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      ...|+++||+++++|.+++....   ..+++..+..++.|++.||.|||  ..+|+||||+|+||+++.++.++|+|||+
T Consensus        71 ~~~~l~~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh--~~~i~H~dl~~~ni~~~~~~~~~l~dfg~  145 (256)
T cd06612          71 TDLWIVMEYCGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLH--SNKKIHRDIKAGNILLNEEGQAKLADFGV  145 (256)
T ss_pred             CcEEEEEecCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEECCCCcEEEccccc
Confidence            99999999999999999986542   45899999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      +...........       ...|++.|+               +||++.+.. .+.++|+||+|++++++++...+.
T Consensus       146 ~~~~~~~~~~~~-------~~~~~~~y~---------------~PE~~~~~~-~~~~~Di~s~G~il~~l~~g~~p~  199 (256)
T cd06612         146 SGQLTDTMAKRN-------TVIGTPFWM---------------APEVIQEIG-YNNKADIWSLGITAIEMAEGKPPY  199 (256)
T ss_pred             chhcccCccccc-------cccCCcccc---------------CHHHHhcCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            997755432111       114555666               799887664 578999999999999999776554

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8.7e-31  Score=239.41  Aligned_cols=203  Identities=26%  Similarity=0.262  Sum_probs=165.2

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcC-CCCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~  165 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++.
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   73 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHK---------KTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFI   73 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEEC---------CCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence            4578999999999999999999554         3478899999876653 336788999999999 5999999999997


Q ss_pred             eCC------eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc
Q 017177          166 EDK------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF  239 (376)
Q Consensus       166 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~  239 (376)
                      ...      .+|+||||+++++|.+++.........+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH--~~~i~H~~l~p~ni~~~~~~~  151 (275)
T cd06608          74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH--ENKVIHRDIKGQNILLTKNAE  151 (275)
T ss_pred             ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHHHEEEccCCe
Confidence            644      489999999999999998764322356899999999999999999999  599999999999999999999


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh----hhccccccccceeeeeh
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI----KYLTLLKYSNSFAFVFS  315 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~----~~~~~~~dv~s~g~v~~  315 (376)
                      ++++|||++..........   .    ...|++.|+               |||++...    ...+.++|+||+|++++
T Consensus       152 ~~l~d~~~~~~~~~~~~~~---~----~~~~~~~y~---------------aPE~~~~~~~~~~~~~~~~Dv~slG~il~  209 (275)
T cd06608         152 VKLVDFGVSAQLDSTLGRR---N----TFIGTPYWM---------------APEVIACDEQPDASYDARSDVWSLGITAI  209 (275)
T ss_pred             EEECCCccceecccchhhh---c----Ccccccccc---------------CHhHhcccccccCCccccccHHHhHHHHH
Confidence            9999999998764432211   1    115666777               79987543    33467899999999999


Q ss_pred             hhcccccc
Q 017177          316 CVFSFYRT  323 (376)
Q Consensus       316 ~~~~~y~~  323 (376)
                      ++++-..+
T Consensus       210 ~l~~g~~p  217 (275)
T cd06608         210 ELADGKPP  217 (275)
T ss_pred             HHHhCCCC
Confidence            99975444

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.97  E-value=6.8e-31  Score=247.94  Aligned_cols=207  Identities=24%  Similarity=0.309  Sum_probs=162.1

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcC-CCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~  165 (376)
                      ..+|++.+.||+|+||.||+|......  .........||+|.++... ....+.+.+|+.+++++ +||||+++++++.
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~--~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGID--KDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccC--CccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            356899999999999999999754311  0111224578999987643 33456788999999999 6999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEE
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNP------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL  233 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NIL  233 (376)
                      .++.++++|||+++|+|.+++.+...            ....+++..+..++.|++.||.|||  +++|+||||||+|||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~givH~dlkp~Nil  166 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA--SQKCIHRDLAARNVL  166 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCeeccccccceEE
Confidence            99999999999999999999976431            1235788889999999999999999  699999999999999


Q ss_pred             EcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeee
Q 017177          234 LDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFV  313 (376)
Q Consensus       234 l~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v  313 (376)
                      ++.++.+||+|||+++..............     .+++.|+               +||++.+.. .+.++|+||+|++
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~-----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~i  225 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHNIDYYKKTTNG-----RLPVKWM---------------APEALFDRV-YTHQSDVWSFGVL  225 (334)
T ss_pred             EcCCCcEEECCcccceecccccccccccCC-----CcCceEc---------------CHHHhccCC-cCchhhhHHHHHH
Confidence            999999999999999876543221111110     2233455               699776544 5778999999999


Q ss_pred             ehhhcc
Q 017177          314 FSCVFS  319 (376)
Q Consensus       314 ~~~~~~  319 (376)
                      ++++++
T Consensus       226 l~el~~  231 (334)
T cd05100         226 LWEIFT  231 (334)
T ss_pred             HHHHHh
Confidence            999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=6.8e-31  Score=240.99  Aligned_cols=197  Identities=23%  Similarity=0.308  Sum_probs=164.8

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCC---CCCcceEEeEEE
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLS---HPNLVKLLGYCW  165 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~---h~nIv~l~~~~~  165 (376)
                      .|+..+.||+|+||.||+|...         .++..||+|.++... ......+.+|+.+++.++   ||||+++++++.
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~   72 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHV---------PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL   72 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEc---------CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee
Confidence            4788899999999999999653         358899999987653 344567889999999996   999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      .+...++||||+++++|.+++...     .+++..+..++.|++.||.|||  +.+|+||||+|+||+++.++.++++||
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~p~ni~i~~~~~~~l~df  145 (277)
T cd06917          73 KGPRLWIIMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIH--KVGVIHRDIKAANILVTNTGNVKLCDF  145 (277)
T ss_pred             eCCEEEEEEecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHHEEEcCCCCEEEccC
Confidence            999999999999999999988542     4889999999999999999999  699999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      |++..........   ..    ..|++.|+               +||.+.+....+.++|+||+|++++++++...+.
T Consensus       146 g~~~~~~~~~~~~---~~----~~~~~~y~---------------aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~  202 (277)
T cd06917         146 GVAALLNQNSSKR---ST----FVGTPYWM---------------APEVITEGKYYDTKADIWSLGITIYEMATGNPPY  202 (277)
T ss_pred             CceeecCCCcccc---cc----ccCCccee---------------CHHHhccCCccccchhHHHHHHHHHHHHhCCCCC
Confidence            9998775543211   11    14555565               6998876666788999999999999999765554

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.97  E-value=3.7e-31  Score=250.67  Aligned_cols=205  Identities=25%  Similarity=0.290  Sum_probs=159.8

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcC-CCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRL-SHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~l~~~~~  165 (376)
                      .++|++.+.||+|+||.||+|.+...    .+..+++.||||.++.... .....+.+|+.++.++ +||||+++++++.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccC----CccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            46799999999999999999975431    2334578999999976532 3346788999999999 5899999999876


Q ss_pred             eC-CeEEEEEeccCCCCHHHHHhhcCCC----------------------------------------------------
Q 017177          166 ED-KELLLVYEYMQRGSLENHLFRRNPS----------------------------------------------------  192 (376)
Q Consensus       166 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------  192 (376)
                      .. ..++++||||++|+|.+++......                                                    
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            54 5689999999999999998653210                                                    


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEe
Q 017177          193 -----------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIH  261 (376)
Q Consensus       193 -----------~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~  261 (376)
                                 ...+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+|++|||++.......... ..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~  238 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-RK  238 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh-hc
Confidence                       123678888999999999999999  6999999999999999999999999999998753322211 11


Q ss_pred             eeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          262 TYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       262 ~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ++.    .+++.|+               +||.+.+.. .+.++|+||+|++++++++
T Consensus       239 ~~~----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~~l~el~~  276 (343)
T cd05103         239 GDA----RLPLKWM---------------APETIFDRV-YTIQSDVWSFGVLLWEIFS  276 (343)
T ss_pred             CCC----CCCcceE---------------CcHHhcCCC-CCchhhHHHHHHHHHHHHH
Confidence            111    2334455               699776544 5788999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=1e-30  Score=238.77  Aligned_cols=200  Identities=20%  Similarity=0.199  Sum_probs=163.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .+++.....||+|+||.||+|....         ++..||+|.+........+.+.+|+.+++.++|+||+++++++..+
T Consensus         7 ~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   77 (268)
T cd06624           7 YDENGERVVLGKGTYGIVYAARDLS---------TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN   77 (268)
T ss_pred             cccCCceEEEecCCceEEEEeEecC---------CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC
Confidence            3445555789999999999995443         5788999998877666677889999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC-CCcEEEcc
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPL--SWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-VGFLFDSH  244 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~--~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~-~g~~kl~D  244 (376)
                      +..++++||+++++|.+++....   ..+  ++..+..++.|++.||.|||  .++|+||||||+||+++. ++.++|+|
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~h~dl~p~nil~~~~~~~~~l~d  152 (268)
T cd06624          78 GFFKIFMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLH--DNQIVHRDIKGDNVLVNTYSGVVKISD  152 (268)
T ss_pred             CEEEEEEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCeEEEec
Confidence            99999999999999999997542   224  78888999999999999999  599999999999999976 67999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh-hhccccccccceeeeehhhcccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI-KYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~-~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ||++...........       ...|++.|+               +||.+.+. ...+.++|+||+|++++++++-+.+
T Consensus       153 fg~~~~~~~~~~~~~-------~~~~~~~~~---------------aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p  210 (268)
T cd06624         153 FGTSKRLAGINPCTE-------TFTGTLQYM---------------APEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP  210 (268)
T ss_pred             chhheecccCCCccc-------cCCCCcccc---------------ChhhhccccccCCchhhhHHHHHHHHHHHhCCCC
Confidence            999986643222110       114556666               79987554 3467899999999999999875544

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.97  E-value=1.1e-30  Score=238.45  Aligned_cols=201  Identities=24%  Similarity=0.314  Sum_probs=161.6

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|+..+.||+|+||.||+|.....      ......+|+|.++... ....+.+.+|+.+++.++||||+++++++..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~------~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMP------GRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK   77 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecC------CCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc
Confidence            34688889999999999999976431      1123579999987653 3445678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      .+..++||||+++++|.+++....   ..+++..+..++.|++.||.|||  +.+++||||||+||+++.++.+|++|||
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dlkp~Nili~~~~~~kl~dfg  152 (268)
T cd05063          78 FKPAMIITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLS--DMNYVHRDLAARNILVNSNLECKVSDFG  152 (268)
T ss_pred             CCCcEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhhEEEcCCCcEEECCCc
Confidence            999999999999999999997642   45889999999999999999999  6999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ++............. ..   ...++.|+               +||.+.+.. .+.++|+||+|++++++++
T Consensus       153 ~~~~~~~~~~~~~~~-~~---~~~~~~y~---------------~PE~~~~~~-~~~~~Dv~slG~il~ell~  205 (268)
T cd05063         153 LSRVLEDDPEGTYTT-SG---GKIPIRWT---------------APEAIAYRK-FTSASDVWSFGIVMWEVMS  205 (268)
T ss_pred             cceecccccccceec-cC---CCcCceec---------------CHHHhhcCC-cChHhHHHHHHHHHHHHHh
Confidence            998765432221110 00   01123455               799877654 5889999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.97  E-value=1.2e-30  Score=236.77  Aligned_cols=188  Identities=25%  Similarity=0.300  Sum_probs=155.1

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEE-eC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW-ED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~-~~  167 (376)
                      ++|++.+.||+|+||.||++...           +..+|+|.++...  ..+.+.+|+.+++.++|+||+++++++. .+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-----------~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK   72 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-----------CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence            47899999999999999998543           6679999987543  2357889999999999999999999764 45


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..+++|||+++++|.+++.+...  ..+++..+..++.|++.||+|||  .++|+||||||+||++++++.+|++|||+
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~dfg~  148 (256)
T cd05082          73 GGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLE--ANNFVHRDLAARNVLVSEDNVAKVSDFGL  148 (256)
T ss_pred             CceEEEEECCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCEeccccchheEEEcCCCcEEecCCcc
Confidence            679999999999999999976532  34789999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +.........  .        .++..|+               +||++.+. ..+.++|+||+|++++++++
T Consensus       149 ~~~~~~~~~~--~--------~~~~~y~---------------aPE~~~~~-~~~~~~Dv~slG~i~~~l~~  194 (256)
T cd05082         149 TKEASSTQDT--G--------KLPVKWT---------------APEALREK-KFSTKSDVWSFGILLWEIYS  194 (256)
T ss_pred             ceeccccCCC--C--------ccceeec---------------CHHHHccC-CCCchhhhHHHHHHHHHHHh
Confidence            8865432211  1        1223344               69977654 45788999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.97  E-value=7.5e-31  Score=239.05  Aligned_cols=194  Identities=22%  Similarity=0.313  Sum_probs=157.5

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|++.+.||+|+||.||+|...+          ...||+|.++.... ..+.+.+|+.+++.++||||+++++.+. .
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~----------~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~   72 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-E   72 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecC----------CceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-C
Confidence            4569999999999999999996543          34599999986433 2357889999999999999999999874 4


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++||||+++|+|.+++.+..  ...+++..+..++.|++.||.|||  +.+|+||||||+||++++++.++|+|||.
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~Nill~~~~~~~L~dfg~  148 (262)
T cd05071          73 EPIYIVTEYMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGL  148 (262)
T ss_pred             CCcEEEEEcCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcccEEEcCCCcEEeccCCc
Confidence            56899999999999999997642  245788999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ++......... ..+.     .++..|+               +||...+.. .+.++|+||+|++++++++
T Consensus       149 ~~~~~~~~~~~-~~~~-----~~~~~y~---------------~PE~~~~~~-~~~~~DvwslG~~l~ellt  198 (262)
T cd05071         149 ARLIEDNEYTA-RQGA-----KFPIKWT---------------APEAALYGR-FTIKSDVWSFGILLTELTT  198 (262)
T ss_pred             eeecccccccc-ccCC-----cccceec---------------CHhHhccCC-CCchhhHHHHHHHHHHHHc
Confidence            98765433221 1111     3344455               699665444 5889999999999999986

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.97  E-value=2.1e-31  Score=246.21  Aligned_cols=199  Identities=23%  Similarity=0.237  Sum_probs=162.3

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh-hHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|...         .+++.||+|.+...... ....+.+|+.+++.++|+||+++++++.+
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   74 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSK---------LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT   74 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEc---------CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec
Confidence            367999999999999999999543         35788999998754322 22456789999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++..++||||+++ +|.+++.+..   ..+++..+..++.|++.||.|||  +.+|+||||||+|||++.+|.+||+|||
T Consensus        75 ~~~~~lv~e~~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg  148 (291)
T cd07844          75 KKTLTLVFEYLDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCH--QRRVLHRDLKPQNLLISERGELKLADFG  148 (291)
T ss_pred             CCeEEEEEecCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeecccCCHHHEEEcCCCCEEECccc
Confidence            9999999999975 9999887652   35789999999999999999999  6999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      +++.........  ...     .+++.|+               +||++.+....+.++|+||+|++++++++-+.+
T Consensus       149 ~~~~~~~~~~~~--~~~-----~~~~~~~---------------aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~  203 (291)
T cd07844         149 LARAKSVPSKTY--SNE-----VVTLWYR---------------PPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPL  203 (291)
T ss_pred             cccccCCCCccc--ccc-----ccccccC---------------CcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence            987643321110  000     3345555               799887766678899999999999999865444

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=3.1e-31  Score=244.53  Aligned_cols=200  Identities=22%  Similarity=0.282  Sum_probs=163.8

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-ChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ++|++.+.||+|+||.||++....         ++..||+|.+... .......+.+|+.++++++||||+++++.+..+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRP---------TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE   71 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence            368899999999999999995543         5889999988764 333456788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..|+||||+++++|..++..... ...+++..+..++.|++.||.|||+ ..+|+||||||+||+++.++.++++|||+
T Consensus        72 ~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~dfg~  149 (286)
T cd06622          72 GAVYMCMEYMDAGSLDKLYAGGVA-TEGIPEDVLRRITYAVVKGLKFLKE-EHNIIHRDVKPTNVLVNGNGQVKLCDFGV  149 (286)
T ss_pred             CeEEEEEeecCCCCHHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHh-cCCEeeCCCCHHHEEECCCCCEEEeecCC
Confidence            999999999999999998865321 2358999999999999999999995 46999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhh-----hccccccccceeeeehhhccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIK-----YLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~-----~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      +.........     +    ..|++.|+               +||.+.+..     ..+.++|+||+|++++++++-..
T Consensus       150 ~~~~~~~~~~-----~----~~~~~~y~---------------aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~  205 (286)
T cd06622         150 SGNLVASLAK-----T----NIGCQSYM---------------APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRY  205 (286)
T ss_pred             cccccCCccc-----c----CCCccCcc---------------CcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCC
Confidence            9865432211     1    14555666               799775432     34789999999999999986544


Q ss_pred             c
Q 017177          323 T  323 (376)
Q Consensus       323 ~  323 (376)
                      +
T Consensus       206 p  206 (286)
T cd06622         206 P  206 (286)
T ss_pred             C
Confidence            3

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=5e-31  Score=241.20  Aligned_cols=200  Identities=24%  Similarity=0.266  Sum_probs=162.2

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh----------hhHHHHHHHHHHHhcCCCCCcce
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM----------QGFEEWQSEVNFLGRLSHPNLVK  159 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~il~~l~h~nIv~  159 (376)
                      +|.+.+.||.|+||.||+|...         .+++.+|+|.++....          ...+.+.+|+.+++.++||||++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~   72 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNV---------TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ   72 (272)
T ss_pred             ceeecceecccCceEEEEEeec---------CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcce
Confidence            4788899999999999999543         3588999998764211          12346778999999999999999


Q ss_pred             EEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc
Q 017177          160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF  239 (376)
Q Consensus       160 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~  239 (376)
                      +++++...+..++||||+++++|.+++.+.    ..+++..+..++.|++.||.|||  +.+++||||||+||+++.++.
T Consensus        73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~~~nil~~~~~~  146 (272)
T cd06629          73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLH--SKGILHRDLKADNLLVDADGI  146 (272)
T ss_pred             EEEEeccCCceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh--hCCeeecCCChhhEEEcCCCe
Confidence            999999999999999999999999999765    45888999999999999999999  699999999999999999999


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhh-hccccccccceeeeehhhc
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIK-YLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~-~~~~~~dv~s~g~v~~~~~  318 (376)
                      ++++|||++............ ..    ..|+..|+               +||.+.... ..+.++|+||+|+++++++
T Consensus       147 ~~l~d~~~~~~~~~~~~~~~~-~~----~~~~~~y~---------------~PE~~~~~~~~~~~~~Dv~slG~~l~~l~  206 (272)
T cd06629         147 CKISDFGISKKSDDIYDNDQN-MS----MQGSVFWM---------------APEVIHSYSQGYSAKVDIWSLGCVVLEMF  206 (272)
T ss_pred             EEEeecccccccccccccccc-cc----ccCCcccc---------------CHHHhccccCCCCccchhHHHHHHHHHHH
Confidence            999999999865432211100 00    13455555               699877654 4688999999999999999


Q ss_pred             cccccc
Q 017177          319 SFYRTT  324 (376)
Q Consensus       319 ~~y~~~  324 (376)
                      +-..+.
T Consensus       207 ~g~~p~  212 (272)
T cd06629         207 AGRRPW  212 (272)
T ss_pred             hCCCCC
Confidence            765553

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.97  E-value=1.2e-30  Score=238.38  Aligned_cols=202  Identities=22%  Similarity=0.322  Sum_probs=160.6

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-ChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .+|++.+.||+|+||.||+|.....      ...+..||+|.++.. .......+.+|+.+++.++||||+++++++.++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   77 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLP------GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS   77 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecC------CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence            4578899999999999999976531      112457999999865 334457889999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++||||+++++|.+++....   ..+++..+..++.|++.||.|||  +++++||||||+||+++.++.++++|||+
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH--~~g~~H~dl~p~nili~~~~~~kl~dfg~  152 (269)
T cd05065          78 RPVMIITEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFGL  152 (269)
T ss_pred             CceEEEEecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccChheEEEcCCCcEEECCCcc
Confidence            99999999999999999987642   45889999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +................+.  ..+..|+               +||.+.+.. .+.++||||+|++++|+++
T Consensus       153 ~~~~~~~~~~~~~~~~~~~--~~~~~y~---------------~PE~~~~~~-~~~~~DvwslG~~l~e~l~  206 (269)
T cd05065         153 SRFLEDDTSDPTYTSSLGG--KIPIRWT---------------APEAIAYRK-FTSASDVWSYGIVMWEVMS  206 (269)
T ss_pred             ccccccCccccccccccCC--Ccceeec---------------CHhHhccCc-ccchhhhhhhHHHHHHHhc
Confidence            9876443221111111000  0122344               699776554 5889999999999999765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.5e-32  Score=247.10  Aligned_cols=197  Identities=24%  Similarity=0.309  Sum_probs=161.5

Q ss_pred             hhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhc--CCCCCcceEE
Q 017177           84 LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGR--LSHPNLVKLL  161 (376)
Q Consensus        84 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~h~nIv~l~  161 (376)
                      .+...+...+.+.||+|.||+||+|.++           |..||||++.....   +.+.+|.+|.+.  |+|+||+.++
T Consensus       206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-----------Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFI  271 (513)
T KOG2052|consen  206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-----------GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFI  271 (513)
T ss_pred             HHhhhheeEEEEEecCccccceeecccc-----------CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhh
Confidence            3455667889999999999999999888           77799999976543   567889888886  4899999999


Q ss_pred             eEEEeCC----eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCcEecCCCCCC
Q 017177          162 GYCWEDK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS------EKKVIYRDFKASN  231 (376)
Q Consensus       162 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~------~~~iiHrDlKp~N  231 (376)
                      +.-..+.    .+|||++|.+.|+|+|+|.+.     .++....++++.-++.||++||.+      +..|.|||||..|
T Consensus       272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKN  346 (513)
T KOG2052|consen  272 AADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKN  346 (513)
T ss_pred             hccccCCCceEEEEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccccc
Confidence            8765443    599999999999999999774     488999999999999999999962      4579999999999


Q ss_pred             EEEcCCCcEEEcceeeeeeecccee-eEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh-----hhccccc
Q 017177          232 ILLDGVGFLFDSHLLIYVYFKRHYI-YIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI-----KYLTLLK  305 (376)
Q Consensus       232 ILl~~~g~~kl~Dfg~a~~~~~~~~-~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~-----~~~~~~~  305 (376)
                      |||..+|.+.|+|||+|........ ........    +||-.||               |||++...     ..-...+
T Consensus       347 ILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~r----VGTKRYM---------------APEvLdetin~~~Fesyk~A  407 (513)
T KOG2052|consen  347 ILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPR----VGTKRYM---------------APEVLDETINMKHFESYKRA  407 (513)
T ss_pred             EEEccCCcEEEeeceeeEEecccCCcccCCCCCc----cceeecc---------------ChHHhhhhcChhhhhhhhHH
Confidence            9999999999999999998765422 11111122    7888888               78876643     3345789


Q ss_pred             cccceeeeehhhc
Q 017177          306 YSNSFAFVFSCVF  318 (376)
Q Consensus       306 dv~s~g~v~~~~~  318 (376)
                      ||||||.|+||++
T Consensus       408 DIYafgLVlWEia  420 (513)
T KOG2052|consen  408 DIYAFGLVLWEIA  420 (513)
T ss_pred             HHHHHHHHHHHHH
Confidence            9999999999998

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-30  Score=256.01  Aligned_cols=201  Identities=25%  Similarity=0.299  Sum_probs=170.5

Q ss_pred             hhhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceE
Q 017177           82 LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKL  160 (376)
Q Consensus        82 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l  160 (376)
                      ..+....+.|++.++||.|.+|+||++         +++.+++.+|+|++......+ +++..|.++++.+. |||++.+
T Consensus        12 ~~lpdp~d~~ei~evig~Gtygkv~k~---------k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~f   81 (953)
T KOG0587|consen   12 SSLPDPADIFEIIEVIGNGTYGKVYKG---------RHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATF   81 (953)
T ss_pred             hhCCCCCCccEEEEEEeeccceeEEEE---------eeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceE
Confidence            334455677999999999999999999         555578899999988765443 56677899999986 9999999


Q ss_pred             EeEEEe-----CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc
Q 017177          161 LGYCWE-----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD  235 (376)
Q Consensus       161 ~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~  235 (376)
                      |++|.-     ++.+|||||||.+|+..|+++...  ...+.|..+..|++.++.||.+||  .+.+||||||-.|||++
T Consensus        82 yg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH--~nkviHRDikG~NiLLT  157 (953)
T KOG0587|consen   82 YGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLH--NNKVIHRDIKGQNVLLT  157 (953)
T ss_pred             EEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHh--hcceeeecccCceEEEe
Confidence            999864     467999999999999999998776  467999999999999999999999  69999999999999999


Q ss_pred             CCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh----hhcccccccccee
Q 017177          236 GVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI----KYLTLLKYSNSFA  311 (376)
Q Consensus       236 ~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~----~~~~~~~dv~s~g  311 (376)
                      .+|.|||+|||.+..++......   +|.    +|||.||               |||++.-.    ..++..+|+||+|
T Consensus       158 ~e~~VKLvDFGvSaQldsT~grR---nT~----iGtP~WM---------------APEViac~e~~d~tyd~R~D~WsLG  215 (953)
T KOG0587|consen  158 ENAEVKLVDFGVSAQLDSTVGRR---NTF----IGTPYWM---------------APEVIACDESPDATYDYRSDLWSLG  215 (953)
T ss_pred             ccCcEEEeeeeeeeeeecccccc---cCc----CCCcccc---------------cceeeecccCCCCCcccccchhhcc
Confidence            99999999999999887654432   222    9999999               89987754    3345778999999


Q ss_pred             eeehhhc
Q 017177          312 FVFSCVF  318 (376)
Q Consensus       312 ~v~~~~~  318 (376)
                      ++..|++
T Consensus       216 ITaIEla  222 (953)
T KOG0587|consen  216 ITAIEMA  222 (953)
T ss_pred             ceeehhc
Confidence            9999998

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.97  E-value=5.3e-32  Score=256.49  Aligned_cols=203  Identities=22%  Similarity=0.349  Sum_probs=165.5

Q ss_pred             hhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-ChhhHHHHHHHHHHHhcCCCCCcceEE
Q 017177           83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLL  161 (376)
Q Consensus        83 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~l~  161 (376)
                      +....+....+.++||+|.||.||+|.+.+.     +++....||||..+.+ ..++.+.|+.|+.+|++++||||++++
T Consensus       383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~-----~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLI  457 (974)
T KOG4257|consen  383 NYELRRELITLKRLIGEGQFGDVYKGVYTDP-----EKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLI  457 (974)
T ss_pred             cceeehhhccHHHhhcCCcccceeeeEeccc-----ccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhhee
Confidence            3334445567778999999999999988762     2445677999999884 556678999999999999999999999


Q ss_pred             eEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEE
Q 017177          162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLF  241 (376)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~k  241 (376)
                      |++.+ ...|||||+++.|.|..+|+.++   ..++......++.||+.||.||||  +++|||||..+|||+.....||
T Consensus       458 Gv~~e-~P~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeS--krfVHRDIAaRNiLVsSp~CVK  531 (974)
T KOG4257|consen  458 GVCVE-QPMWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLES--KRFVHRDIAARNILVSSPQCVK  531 (974)
T ss_pred             eeeec-cceeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHh--hchhhhhhhhhheeecCcceee
Confidence            99875 56999999999999999998875   458888999999999999999996  9999999999999999999999


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      |+|||+++.+.....+....+. -.+.                    ||+||-+... .++.++|||=||+..||++
T Consensus       532 LaDFGLSR~~ed~~yYkaS~~k-LPIK--------------------WmaPESINfR-rFTtASDVWMFgVCmWEIl  586 (974)
T KOG4257|consen  532 LADFGLSRYLEDDAYYKASRGK-LPIK--------------------WMAPESINFR-RFTTASDVWMFGVCMWEIL  586 (974)
T ss_pred             ecccchhhhccccchhhccccc-ccee--------------------ecCccccchh-cccchhhHHHHHHHHHHHH
Confidence            9999999998876665433222 1122                    3367755543 4677788888888887776

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.97  E-value=3.4e-31  Score=245.64  Aligned_cols=195  Identities=23%  Similarity=0.288  Sum_probs=161.9

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh-----hHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-----GFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      +|++.+.||+|+||.||+|....         +++.||+|.++.....     ....+.+|+.+++.++|+||+++++++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   71 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKE---------TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF   71 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECC---------CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence            47888999999999999995443         4889999999765432     234567899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .+.+..++||||+ +|+|.+++....   ..+++..+..++.||+.||.|||  .++|+||||||+|||++.+|.++|+|
T Consensus        72 ~~~~~~~lv~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dl~p~nill~~~~~~~l~d  145 (298)
T cd07841          72 GHKSNINLVFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLH--SNWILHRDLKPNNLLIASDGVLKLAD  145 (298)
T ss_pred             ecCCEEEEEEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCChhhEEEcCCCCEEEcc
Confidence            9999999999999 889999997642   35899999999999999999999  69999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      ||++..........  ..     ..+++.|+               +||++.+....+.++|+||+|++++++++.+
T Consensus       146 fg~~~~~~~~~~~~--~~-----~~~~~~y~---------------aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~  200 (298)
T cd07841         146 FGLARSFGSPNRKM--TH-----QVVTRWYR---------------APELLFGARHYGVGVDMWSVGCIFAELLLRV  200 (298)
T ss_pred             ceeeeeccCCCccc--cc-----cccceeee---------------CHHHHhCCCCCCcHHHHHHHHHHHHHHHcCC
Confidence            99998775532210  00     02344455               6998877666789999999999999988653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.97  E-value=2.4e-31  Score=241.45  Aligned_cols=195  Identities=23%  Similarity=0.241  Sum_probs=164.4

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      +|++.+.||.|+||.||+|...         .++..||+|.+.....   ...+.+.+|+.++++++||||+++++.+..
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   71 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKR---------DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD   71 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEc---------cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence            4888999999999999999543         3588899999976432   345788899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++..++|+||+.+++|.+++...    ..+++..+..++.|++.||.|||  +++++|+||||+||++++++.++|+|||
T Consensus        72 ~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~nil~~~~~~~~l~d~~  145 (258)
T cd05578          72 EENMYLVVDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLH--SKGIIHRDIKPDNILLDEQGHVHITDFN  145 (258)
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeEEcCCCCEEEeecc
Confidence            99999999999999999999765    45889999999999999999999  6999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ++............        .|+..|+               +||++.+.. .+.++|+||+|++++++++-..+
T Consensus       146 ~~~~~~~~~~~~~~--------~~~~~y~---------------~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p  198 (258)
T cd05578         146 IATKVTPDTLTTST--------SGTPGYM---------------APEVLCRQG-YSVAVDWWSLGVTAYECLRGKRP  198 (258)
T ss_pred             cccccCCCcccccc--------CCChhhc---------------CHHHHcccC-CCCcccchhhHHHHHHHHhCCCC
Confidence            99876543322111        3445555               699877655 68899999999999999865544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.97  E-value=3.7e-31  Score=243.68  Aligned_cols=197  Identities=23%  Similarity=0.248  Sum_probs=163.2

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ++|++.+.||+|+||.||+|...         .+++.||+|++.....  ...+.+.+|+.+++.++|+||+++++++..
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   71 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNR---------ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR   71 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEEC---------CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence            46889999999999999999554         3588999998865422  223567899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      +...++||||++++.|..++...    ..+++..+..++.|++.||.|||  ..+|+||||||+||+++.++.++|+|||
T Consensus        72 ~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH--~~~i~H~dl~p~nil~~~~~~~~l~dfg  145 (286)
T cd07847          72 KRKLHLVFEYCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCH--KHNCIHRDVKPENILITKQGQIKLCDFG  145 (286)
T ss_pred             CCEEEEEEeccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCChhhEEEcCCCcEEECccc
Confidence            99999999999998887776543    35899999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      ++..........   ..    ..++..|+               +||.+.+....+.++|+||+|++++++++-..
T Consensus       146 ~~~~~~~~~~~~---~~----~~~~~~~~---------------aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~  199 (286)
T cd07847         146 FARILTGPGDDY---TD----YVATRWYR---------------APELLVGDTQYGPPVDVWAIGCVFAELLTGQP  199 (286)
T ss_pred             cceecCCCcccc---cC----cccccccC---------------CHHHHhCCCCcCchhhhHHHHHHHHHHHhCCC
Confidence            999775543210   00    13445555               79988776667889999999999999997544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.97  E-value=6.2e-31  Score=241.50  Aligned_cols=205  Identities=24%  Similarity=0.310  Sum_probs=161.8

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|.+...    .....+..||+|.+..... .....+.+|+.+++.++|+||+++++++.+
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGR----DGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE   80 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecC----CCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            45789999999999999999976531    1112467899999875543 334568899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC---cE
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPS---IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG---FL  240 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g---~~  240 (376)
                      .+..++||||+++++|.+++.+....   ...+++..++.++.||+.||.|||  .++++||||||+|||++.++   .+
T Consensus        81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE--ENHFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccchheEEEeccCCCcce
Confidence            99999999999999999999765321   135889999999999999999999  58999999999999998765   59


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ||+|||+++........... +..    ..++.|+               +||.+.+.. .+.++|+||+|++++++++
T Consensus       159 kl~dfg~~~~~~~~~~~~~~-~~~----~~~~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~el~~  216 (277)
T cd05036         159 KIADFGMARDIYRASYYRKG-GRA----MLPIKWM---------------PPEAFLDGI-FTSKTDVWSFGVLLWEIFS  216 (277)
T ss_pred             EeccCccccccCCccceecC-CCC----CccHhhC---------------CHHHHhcCC-cCchhHHHHHHHHHHHHHc
Confidence            99999999876432221111 000    1223444               799876554 6899999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.97  E-value=5.9e-31  Score=244.95  Aligned_cols=202  Identities=23%  Similarity=0.329  Sum_probs=159.3

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|+..+.||+|+||.||+|.+...     .......+|+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~   80 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPE-----GETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS   80 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecC-----CCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence            35688889999999999999976431     111134689998876543 233467899999999999999999998865


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      . ..++++||+++|+|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||
T Consensus        81 ~-~~~~v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~dikp~Nill~~~~~~kL~Dfg  154 (303)
T cd05110          81 P-TIQLVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFG  154 (303)
T ss_pred             C-CceeeehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHh--hcCeeccccccceeeecCCCceEEcccc
Confidence            4 5779999999999999987652   35789999999999999999999  6999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      +++............+.     .+++.|+               +||.+.+.. .+.++|+||+|+++++++++-
T Consensus       155 ~~~~~~~~~~~~~~~~~-----~~~~~y~---------------~PE~~~~~~-~~~~~DiwslG~~l~el~t~g  208 (303)
T cd05110         155 LARLLEGDEKEYNADGG-----KMPIKWM---------------ALECIHYRK-FTHQSDVWSYGVTIWELMTFG  208 (303)
T ss_pred             ccccccCcccccccCCC-----ccccccC---------------CHHHhccCC-CChHHHHHHHHHHHHHHHhCC
Confidence            99876543222111111     3445566               799776544 588899999999999988743

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.97  E-value=1.4e-30  Score=236.73  Aligned_cols=194  Identities=22%  Similarity=0.310  Sum_probs=158.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|++.+.||+|+||.||+|....          +..+|+|.+..... ..+.+.+|+.++++++|+||+++++++. .
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~   72 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNG----------NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-E   72 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecC----------CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-C
Confidence            4579999999999999999996543          56699999876543 3357889999999999999999999875 4


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      ...+++|||+++++|.+++....  ...+++..+..++.|++.||.|||  +.+|+||||||+||++++++.++|+|||+
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~di~p~Nili~~~~~~~l~dfg~  148 (260)
T cd05070          73 EPIYIVTEYMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIE--RMNYIHRDLRSANILVGDGLVCKIADFGL  148 (260)
T ss_pred             CCcEEEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCccceEEEeCCceEEeCCcee
Confidence            56899999999999999997542  245789999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +.......... ..+.     .++..|+               +||.+.+. ..+.++|+||+|++++++++
T Consensus       149 ~~~~~~~~~~~-~~~~-----~~~~~y~---------------aPE~~~~~-~~~~~~Di~slG~~l~~l~~  198 (260)
T cd05070         149 ARLIEDNEYTA-RQGA-----KFPIKWT---------------APEAALYG-RFTIKSDVWSFGILLTELVT  198 (260)
T ss_pred             eeeccCccccc-ccCC-----CCCcccc---------------ChHHHhcC-CCcchhhhHHHHHHHHHHHh
Confidence            98765433221 1111     2233455               69976554 46789999999999999986

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.97  E-value=8.8e-31  Score=243.99  Aligned_cols=204  Identities=16%  Similarity=0.171  Sum_probs=161.4

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ++|++.+.||+|+||.||++...         .+++.|++|.+.....   .....+.+|+.+++.++||||+++++.+.
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~---------~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHK---------ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE   71 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEEC---------CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence            36889999999999999999544         3588999999876532   33457789999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      .++.+++||||++|++|.+++...    ..+++..+..++.|++.||.|||  +.+++||||||+||+++.+|.++++||
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~NIll~~~~~~~l~df  145 (305)
T cd05609          72 TKRHLCMVMEYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLH--NYGIVHRDLKPDNLLITSMGHIKLTDF  145 (305)
T ss_pred             cCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCchHHEEECCCCCEEEeeC
Confidence            999999999999999999999765    45899999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEee--------eEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhh
Q 017177          246 LIYVYFKRHYIYIYIHT--------YIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCV  317 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~--------~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~  317 (376)
                      |+++............+        ...-...|++.|+               +||.+... ..+.++|+||+|++++++
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~---------------aPE~~~~~-~~~~~~Di~slG~vl~el  209 (305)
T cd05609         146 GLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYI---------------APEVILRQ-GYGKPVDWWAMGIILYEF  209 (305)
T ss_pred             CCccccCcCccccccccccccchhhccccCCccCcccc---------------CchhccCC-CCCchhhHHHHHHHHHHH
Confidence            99874221111000000        0000013444455               79976654 458899999999999999


Q ss_pred             cccccc
Q 017177          318 FSFYRT  323 (376)
Q Consensus       318 ~~~y~~  323 (376)
                      ++-..+
T Consensus       210 ~~g~~p  215 (305)
T cd05609         210 LVGCVP  215 (305)
T ss_pred             HhCCCC
Confidence            865444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.97  E-value=4e-31  Score=245.48  Aligned_cols=196  Identities=20%  Similarity=0.179  Sum_probs=161.9

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCe
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE  169 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~  169 (376)
                      .|.....||+|+||.||++...         .++..||+|.+........+.+.+|+.+++.++||||+++++.+..++.
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~   92 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREK---------HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE   92 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEc---------CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCe
Confidence            3445568999999999999543         3478999999876544445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeee
Q 017177          170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYV  249 (376)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~  249 (376)
                      .|++|||+++++|..++..     ..+++..+..++.|++.||.|||  +.+|+||||||+||+++.++.++|+|||++.
T Consensus        93 ~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~  165 (297)
T cd06659          93 LWVLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLH--SQGVIHRDIKSDSILLTLDGRVKLSDFGFCA  165 (297)
T ss_pred             EEEEEecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHeEEccCCcEEEeechhHh
Confidence            9999999999999987754     34789999999999999999999  6999999999999999999999999999987


Q ss_pred             eeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          250 YFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      .........   .    ...|++.|+               +||++.+.. .+.++|+||+|++++++++-+.+.
T Consensus       166 ~~~~~~~~~---~----~~~~~~~y~---------------aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~  217 (297)
T cd06659         166 QISKDVPKR---K----SLVGTPYWM---------------APEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPY  217 (297)
T ss_pred             hcccccccc---c----ceecCcccc---------------CHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            654322111   0    115666777               799887654 578999999999999999665543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.97  E-value=1.8e-30  Score=237.47  Aligned_cols=199  Identities=22%  Similarity=0.292  Sum_probs=155.7

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC-
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED-  167 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~-  167 (376)
                      |.+.+.||+|+||.||+|......       ....+|+|.++..  .....+.+.+|+.+++.++|+||+++++++... 
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   73 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDD-------SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV   73 (272)
T ss_pred             CccccccCcccCceEEEeEEccCC-------CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence            346789999999999999765421       1236899998764  334457788999999999999999999986432 


Q ss_pred             -----CeEEEEEeccCCCCHHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcE
Q 017177          168 -----KELLLVYEYMQRGSLENHLFRRN--PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL  240 (376)
Q Consensus       168 -----~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~  240 (376)
                           ...+++|||+++|+|.+++....  .....+++..+..++.|++.||+|||  +++|+||||||+|||++.++.+
T Consensus        74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~  151 (272)
T cd05075          74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS--SKSFIHRDLAARNCMLNENMNV  151 (272)
T ss_pred             cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhheEEcCCCCE
Confidence                 24789999999999999875332  12245789999999999999999999  6999999999999999999999


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ||+|||+++........  ..+   ....+++.|+               +||.+.+. ..+.++|+||+|++++++++
T Consensus       152 kl~Dfg~~~~~~~~~~~--~~~---~~~~~~~~~~---------------~pe~~~~~-~~~~~~Di~slG~il~el~~  209 (272)
T cd05075         152 CVADFGLSKKIYNGDYY--RQG---RIAKMPVKWI---------------AIESLADR-VYTTKSDVWSFGVTMWEIAT  209 (272)
T ss_pred             EECCCCcccccCcccce--ecC---CcccCCcccC---------------CHHHccCC-CcChHHHHHHHHHHHHHHHc
Confidence            99999999876543321  111   1113445666               79966554 46889999999999999876

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.97  E-value=1.5e-30  Score=236.61  Aligned_cols=195  Identities=25%  Similarity=0.357  Sum_probs=159.4

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..++|++.+.||+|+||.||+|...+          +..||+|.+..... ....+.+|+.+++.++|+||+++++++. 
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~----------~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   71 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNG----------HTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-   71 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCC----------CceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-
Confidence            35679999999999999999996442          67899999886543 3467889999999999999999999864 


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      .+..+++|||+++++|.+++....  ...+++..+..++.|++.||.|||  +.+++||||||+||+++.++.++++|||
T Consensus        72 ~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH--~~~i~H~dl~p~ni~i~~~~~~~l~dfg  147 (260)
T cd05067          72 QEPIYIITEYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIE--RKNYIHRDLRAANILVSETLCCKIADFG  147 (260)
T ss_pred             cCCcEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHh--cCCeecccccHHhEEEcCCCCEEEccCc
Confidence            567999999999999999986543  246889999999999999999999  6999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ++.......... ..+.     .++..|+               +||.+.+.. .+.++|+||+|++++++++
T Consensus       148 ~~~~~~~~~~~~-~~~~-----~~~~~y~---------------~pe~~~~~~-~~~~~Di~slG~~l~el~~  198 (260)
T cd05067         148 LARLIEDNEYTA-REGA-----KFPIKWT---------------APEAINYGT-FTIKSDVWSFGILLTEIVT  198 (260)
T ss_pred             ceeecCCCCccc-ccCC-----ccccccc---------------CHHHhccCC-cCcccchHHHHHHHHHHHh
Confidence            998776332211 1111     2334455               699776544 5789999999999999986

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.97  E-value=2.3e-30  Score=235.23  Aligned_cols=191  Identities=23%  Similarity=0.304  Sum_probs=152.6

Q ss_pred             eEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEEE
Q 017177           96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVY  174 (376)
Q Consensus        96 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~  174 (376)
                      .||+|+||.||+|.+...       ..+..||+|++..... ...+.+.+|+.++++++||||+++++++. .+..++||
T Consensus         2 ~ig~G~~g~v~~~~~~~~-------~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~   73 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMR-------KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVM   73 (257)
T ss_pred             ccCCCCcccEEEEEEecC-------CCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEE
Confidence            389999999999976431       1356799999976643 33467889999999999999999999875 45789999


Q ss_pred             eccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeeccc
Q 017177          175 EYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRH  254 (376)
Q Consensus       175 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~  254 (376)
                      ||+++++|.+++....   ..+++..++.++.|++.||.|||  .++++||||||+|||++.++.+|++|||++......
T Consensus        74 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  148 (257)
T cd05115          74 EMASGGPLNKFLSGKK---DEITVSNVVELMHQVSMGMKYLE--GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             EeCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--hcCeeecccchheEEEcCCCcEEeccCCccccccCC
Confidence            9999999999987542   45899999999999999999999  699999999999999999999999999999866443


Q ss_pred             eeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          255 YIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       255 ~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ...... .+.   ..+++.|+               +||.+.+.. .+.++|+||||++++++++
T Consensus       149 ~~~~~~-~~~---~~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~~l~el~~  193 (257)
T cd05115         149 DSYYKA-RSA---GKWPLKWY---------------APECINFRK-FSSRSDVWSYGITMWEAFS  193 (257)
T ss_pred             ccceec-cCC---CCCCcccC---------------CHHHHccCC-CCchhhHHHHHHHHHHHhc
Confidence            322111 100   02234566               799776544 5789999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.97  E-value=1.5e-30  Score=236.58  Aligned_cols=196  Identities=23%  Similarity=0.309  Sum_probs=153.0

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-ChhhHHHHHHHHHHHhcCCCCCcceEEeEEE-eCCeEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW-EDKELLL  172 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~-~~~~~~l  172 (376)
                      +.||+|+||.||+|.....      ......+|+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l   74 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDS------DGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV   74 (262)
T ss_pred             CcccccCCceEEEEEEecC------CCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence            4689999999999976431      123568999998653 3345578889999999999999999999775 4556899


Q ss_pred             EEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeec
Q 017177          173 VYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFK  252 (376)
Q Consensus       173 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~  252 (376)
                      +|||+.+|+|.+++.+..   ...++..+..++.|++.||.|||  +.+++||||||+|||+++++.+||+|||+++...
T Consensus        75 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~  149 (262)
T cd05058          75 VLPYMKHGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLA--SKKFVHRDLAARNCMLDESFTVKVADFGLARDIY  149 (262)
T ss_pred             EEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEEcCCCcEEECCcccccccc
Confidence            999999999999997542   34577788899999999999999  6999999999999999999999999999998654


Q ss_pred             cceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          253 RHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       253 ~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ..........   ....+++.|+               +||.+.+. ..+.++||||+|++++++++.
T Consensus       150 ~~~~~~~~~~---~~~~~~~~y~---------------aPE~~~~~-~~~~~~Di~slG~~l~el~~~  198 (262)
T cd05058         150 DKEYYSVHNH---TGAKLPVKWM---------------ALESLQTQ-KFTTKSDVWSFGVLLWELMTR  198 (262)
T ss_pred             CCcceeeccc---ccCcCCcccc---------------ChhHhccC-ccchHHHHHHHHHHHHHHHcC
Confidence            3221111100   0013345566               79977654 457899999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.97  E-value=9.7e-31  Score=238.58  Aligned_cols=199  Identities=22%  Similarity=0.308  Sum_probs=162.4

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC------hhhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES------MQGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      +|+..+.||+|+||.||++..         ..++..||+|.+....      ....+.+.+|+.+++.++|+||++++++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~---------~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   71 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARD---------VKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA   71 (268)
T ss_pred             CccccceecCcCceEEEEEEE---------cCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence            478889999999999999954         3358899999987543      1234678899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC-cEEE
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG-FLFD  242 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g-~~kl  242 (376)
                      +.+.+..++||||+++++|.+++.+.    ..+++..+..++.|++.||.|||  +++++||||||+||+++.++ .++|
T Consensus        72 ~~~~~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH--~~~i~H~~i~~~nil~~~~~~~~~l  145 (268)
T cd06630          72 TCEDSHFNLFVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLH--ENQIIHRDVKGANLLIDSTGQRLRI  145 (268)
T ss_pred             eccCCeEEEEEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEE
Confidence            99999999999999999999999765    45889999999999999999999  69999999999999998776 5999


Q ss_pred             cceeeeeeeccceeeE-EEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          243 SHLLIYVYFKRHYIYI-YIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~-~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      +|||++.......... ...+..    .||+.|+               +||++.+.. .+.++|+|++|++++++++..
T Consensus       146 ~dfg~~~~~~~~~~~~~~~~~~~----~~~~~~~---------------~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~  205 (268)
T cd06630         146 ADFGAAARLAAKGTGAGEFQGQL----LGTIAFM---------------APEVLRGEQ-YGRSCDVWSVGCVIIEMATAK  205 (268)
T ss_pred             cccccccccccccccCCcccccc----cccccee---------------CHhHhccCC-CCcccchHHHHHHHHHHHhCC
Confidence            9999998775432110 001111    4555555               699876654 578899999999999999765


Q ss_pred             cc
Q 017177          322 RT  323 (376)
Q Consensus       322 ~~  323 (376)
                      .+
T Consensus       206 ~p  207 (268)
T cd06630         206 PP  207 (268)
T ss_pred             CC
Confidence            44

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.97  E-value=3.4e-31  Score=245.37  Aligned_cols=197  Identities=20%  Similarity=0.220  Sum_probs=163.5

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      +.|.....||+|+||.||++...         .++..||||.+........+.+.+|+.+++.++|+||+++++.+..++
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~   92 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEK---------HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD   92 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEEC---------CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC
Confidence            44555678999999999999543         358899999987765555677889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeee
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a  248 (376)
                      ..++||||+++++|.+++..     ..+++..+..++.||+.||.|||  .++|+||||||+||+++.++.++|+|||++
T Consensus        93 ~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nill~~~~~~kL~dfg~~  165 (292)
T cd06658          93 ELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLH--NQGVIHRDIKSDSILLTSDGRIKLSDFGFC  165 (292)
T ss_pred             eEEEEEeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCEEEccCcch
Confidence            99999999999999998743     34788999999999999999999  589999999999999999999999999998


Q ss_pred             eeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          249 VYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ..........   .    ...|++.|+               +||++.+.. .+.++|+||+|++++++++.+.+.
T Consensus       166 ~~~~~~~~~~---~----~~~~~~~y~---------------aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~  218 (292)
T cd06658         166 AQVSKEVPKR---K----SLVGTPYWM---------------APEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPY  218 (292)
T ss_pred             hhcccccccC---c----eeecCcccc---------------CHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            7654322111   1    125667777               799776544 578999999999999999766554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.97  E-value=9.3e-31  Score=240.80  Aligned_cols=206  Identities=25%  Similarity=0.276  Sum_probs=164.5

Q ss_pred             hhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcC-CCCCcceEE
Q 017177           83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLL  161 (376)
Q Consensus        83 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~  161 (376)
                      ++....+.|++.+.||.|+||.||+|....         +++.+|+|.+..... ....+..|+.+++++ +|+||++++
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~   79 (282)
T cd06636          10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYY   79 (282)
T ss_pred             hhcChhhhhhhheeeccCCCeEEEEEEEcC---------CCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEe
Confidence            444456789999999999999999996543         578999999866532 335678899999999 599999999


Q ss_pred             eEEEe------CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc
Q 017177          162 GYCWE------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD  235 (376)
Q Consensus       162 ~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~  235 (376)
                      +++..      ...+|++|||+++|+|.+++.....  ..+++..+..++.|++.||.|||  ..+|+||||||+||+++
T Consensus        80 ~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH--~~~ivH~dl~~~nili~  155 (282)
T cd06636          80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLH--AHKVIHRDIKGQNVLLT  155 (282)
T ss_pred             eehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEC
Confidence            99853      4578999999999999999976432  45788889999999999999999  59999999999999999


Q ss_pred             CCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh----hhhcccccccccee
Q 017177          236 GVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW----IKYLTLLKYSNSFA  311 (376)
Q Consensus       236 ~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~----~~~~~~~~dv~s~g  311 (376)
                      .++.++|+|||++.........   ..    ...|++.|+               +||.+..    ....+.++|+||+|
T Consensus       156 ~~~~~~l~dfg~~~~~~~~~~~---~~----~~~~~~~y~---------------aPE~l~~~~~~~~~~~~~~DvwslG  213 (282)
T cd06636         156 ENAEVKLVDFGVSAQLDRTVGR---RN----TFIGTPYWM---------------APEVIACDENPDATYDYRSDIWSLG  213 (282)
T ss_pred             CCCCEEEeeCcchhhhhccccC---CC----ccccccccc---------------CHhhcCcccCcCcCCCcccchhHHH
Confidence            9999999999998865432111   01    115666777               7997753    23356789999999


Q ss_pred             eeehhhccccccc
Q 017177          312 FVFSCVFSFYRTT  324 (376)
Q Consensus       312 ~v~~~~~~~y~~~  324 (376)
                      ++++++++...+.
T Consensus       214 ~~l~el~~g~~p~  226 (282)
T cd06636         214 ITAIEMAEGAPPL  226 (282)
T ss_pred             HHHHHHHhCCCCc
Confidence            9999999765543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.97  E-value=1.7e-30  Score=235.47  Aligned_cols=197  Identities=30%  Similarity=0.399  Sum_probs=162.2

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhh-HHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv  173 (376)
                      +.||+|+||.||+|......      ..+..|++|.+....... .+.+.+|+.+++.++|+||+++++++......++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   74 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD------GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV   74 (262)
T ss_pred             CccccCCceEEEEEEEecCC------CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEE
Confidence            46899999999999765421      237789999998764433 67888999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeee
Q 017177          174 YEYMQRGSLENHLFRRNPS-----IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a  248 (376)
                      |||+++++|.+++......     ...+++..+..++.|++.||.|||  +++++||||||+||+++.++.++|+|||.+
T Consensus        75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~di~p~nili~~~~~~~l~dfg~~  152 (262)
T cd00192          75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLS  152 (262)
T ss_pred             EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH--cCCcccCccCcceEEECCCCcEEEcccccc
Confidence            9999999999999775211     256899999999999999999999  699999999999999999999999999999


Q ss_pred             eeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          249 VYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ...............     .+++.|+               +||.+... ..+.++|+||+|++++++++.
T Consensus       153 ~~~~~~~~~~~~~~~-----~~~~~y~---------------aPE~~~~~-~~~~~~Di~slG~il~~l~~~  203 (262)
T cd00192         153 RDVYDDDYYRKKTGG-----KLPIRWM---------------APESLKDG-IFTSKSDVWSFGVLLWEIFTL  203 (262)
T ss_pred             cccccccccccccCC-----CcCcccc---------------CHHHhccC-CcchhhccHHHHHHHHHHHhc
Confidence            987654321111111     4455566               79977665 468899999999999998864

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.97  E-value=1.2e-31  Score=246.92  Aligned_cols=195  Identities=23%  Similarity=0.262  Sum_probs=161.1

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      +|++.+.||+|+||.||+|...         .++..||+|.++....  .....+.+|+.+++.++||||+++++++.+.
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~---------~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   71 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNR---------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD   71 (284)
T ss_pred             CceeEEEecccCCeEEEEEEEC---------CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence            4888899999999999999554         3588999999875422  2234677899999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++++||++ ++|.+++....   ..+++..+..++.||+.||.|||  .++|+||||||+||+++.++.++|+|||+
T Consensus        72 ~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH--~~~i~H~dl~~~nil~~~~~~~~l~dfg~  145 (284)
T cd07839          72 KKLTLVFEYCD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADFGL  145 (284)
T ss_pred             CceEEEEecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEEcCCCcEEECccch
Confidence            99999999997 48888876542   45899999999999999999999  59999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      ++........  . ..    ..+++.|+               +||.+.+....+.++|+||+|++++++++..
T Consensus       146 ~~~~~~~~~~--~-~~----~~~~~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~~l~tg~  197 (284)
T cd07839         146 ARAFGIPVRC--Y-SA----EVVTLWYR---------------PPDVLFGAKLYSTSIDMWSAGCIFAELANAG  197 (284)
T ss_pred             hhccCCCCCC--c-CC----CccccCCc---------------ChHHHhCCcccCcHHHHHHHHHHHHHHHhcC
Confidence            9865432211  0 11    14556666               7998888776788999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.97  E-value=3.9e-31  Score=247.10  Aligned_cols=205  Identities=20%  Similarity=0.270  Sum_probs=164.3

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      +|++.+.||+|+||.||+|.....       .++..||+|.+....   ....+.+.+|+.+++.++||||+++++++.+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~-------~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG-------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE   73 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC-------CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC
Confidence            478889999999999999965431       148899999998743   2334667889999999999999999999998


Q ss_pred             C--CeEEEEEeccCCCCHHHHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC----CCc
Q 017177          167 D--KELLLVYEYMQRGSLENHLFRRNPS-IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG----VGF  239 (376)
Q Consensus       167 ~--~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~----~g~  239 (376)
                      .  ..+++||||+++ +|.+++...... ...+++..+..++.|++.||.|||  ..+|+||||||+|||++.    +|.
T Consensus        74 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~h~dlkp~Nil~~~~~~~~~~  150 (316)
T cd07842          74 HADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH--SNWVLHRDLKPANILVMGEGPERGV  150 (316)
T ss_pred             CCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH--hCCEeeCCCCHHHEEEcCCCCccce
Confidence            8  789999999975 777777543322 236899999999999999999999  599999999999999999    999


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +|++|||++................    .+|+.|+               |||.+.+....+.++|+||+|++++++++
T Consensus       151 ~kl~Dfg~~~~~~~~~~~~~~~~~~----~~~~~y~---------------aPE~~~~~~~~~~~~Dv~slG~~l~~l~~  211 (316)
T cd07842         151 VKIGDLGLARLFNAPLKPLADLDPV----VVTIWYR---------------APELLLGARHYTKAIDIWAIGCIFAELLT  211 (316)
T ss_pred             EEECCCccccccCCCcccccccCCc----ccccccc---------------CHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence            9999999998765443211111111    4566666               79988877777899999999999999987


Q ss_pred             cccc
Q 017177          320 FYRT  323 (376)
Q Consensus       320 ~y~~  323 (376)
                      .+.+
T Consensus       212 ~~~~  215 (316)
T cd07842         212 LEPI  215 (316)
T ss_pred             cCCC
Confidence            6544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=1.6e-30  Score=237.19  Aligned_cols=203  Identities=22%  Similarity=0.296  Sum_probs=162.6

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---------hhHHHHHHHHHHHhcCCCCCcceE
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---------QGFEEWQSEVNFLGRLSHPNLVKL  160 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~il~~l~h~nIv~l  160 (376)
                      +|.+.+.||+|+||.||+|....         ++..+|+|.+.....         ...+.+.+|+.++++++||||+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~   71 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNAS---------SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY   71 (267)
T ss_pred             CccccceeecCCCeEEEEEEecC---------CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence            47788999999999999995442         478899998865422         123567899999999999999999


Q ss_pred             EeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcE
Q 017177          161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL  240 (376)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~  240 (376)
                      ++++...+..+++|||+++++|.+++...    ..+++..+..++.|++.||.|||  +++++||||||+||++++++.+
T Consensus        72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH--~~~ivH~di~p~nil~~~~~~~  145 (267)
T cd06628          72 LGSSLDADHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLH--NRGIIHRDIKGANILVDNKGGI  145 (267)
T ss_pred             EEEEEeCCccEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHH--hcCcccccCCHHHEEEcCCCCE
Confidence            99999999999999999999999999765    45788999999999999999999  6999999999999999999999


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      +|+|||+++............+ ......|++.|+               +||.+.+.. .+.++|+|++|++++++++-
T Consensus       146 ~l~dfg~~~~~~~~~~~~~~~~-~~~~~~~~~~y~---------------~pe~~~~~~-~~~~~Dv~slG~il~~l~~g  208 (267)
T cd06628         146 KISDFGISKKLEANSLSTKTNG-ARPSLQGSVFWM---------------APEVVKQTS-YTRKADIWSLGCLVVEMLTG  208 (267)
T ss_pred             EecccCCCcccccccccCCccc-cccccCCCcCcc---------------ChhHhccCC-CCchhhhHHHHHHHHHHhhC
Confidence            9999999987753221100000 000113555565               799776654 57889999999999999976


Q ss_pred             cccc
Q 017177          321 YRTT  324 (376)
Q Consensus       321 y~~~  324 (376)
                      ..+.
T Consensus       209 ~~p~  212 (267)
T cd06628         209 KHPF  212 (267)
T ss_pred             CCCC
Confidence            5553

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.97  E-value=2.1e-30  Score=236.22  Aligned_cols=201  Identities=22%  Similarity=0.300  Sum_probs=161.4

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC------hhhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES------MQGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      +|+..+.||+|+||.||+|...          ++..+|+|.++...      ......+.+|+.+++.++|+||++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~----------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   70 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN----------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT   70 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc----------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence            4788999999999999999643          37789999887542      1233568899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +.+.+..+++|||+++++|.+++.+.    ..+++..+..++.|++.||.|||  +.+|+|+||||+||+++.++.++|+
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~l~  144 (265)
T cd06631          71 CLDDNTISIFMEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLH--NNCVVHRDIKGNNVMLMPNGIIKLI  144 (265)
T ss_pred             eecCCeEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHhEEECCCCeEEec
Confidence            99999999999999999999999765    34789999999999999999999  6899999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||++............. .......|++.|+               +||.+.+.. .+.++|+||+|++++++++-..+
T Consensus       145 dfg~~~~~~~~~~~~~~~-~~~~~~~~~~~~~---------------~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p  207 (265)
T cd06631         145 DFGCARRLAWVGLHGTHS-NMLKSMHGTPYWM---------------APEVINESG-YGRKSDIWSIGCTVFEMATGKPP  207 (265)
T ss_pred             cchhhHhhhhcccccccc-ccccccCCCcccc---------------ChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCc
Confidence            999998653211110000 0001114556666               799776654 57889999999999999975544

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.97  E-value=2.6e-31  Score=247.97  Aligned_cols=200  Identities=24%  Similarity=0.286  Sum_probs=162.3

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh--hHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|...         .++..||+|.++.....  ....+.+|+.++++++|+||+++++++
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   75 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDT---------TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVV   75 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEEC---------CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEE
Confidence            4568999999999999999999554         35889999998754321  123456899999999999999999998


Q ss_pred             EeC--CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          165 WED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       165 ~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                      ...  +.+++||||+++ +|.+++....   ..+++..+..++.|++.||.|||  ..+++||||||+||+++.++.+||
T Consensus        76 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~kL  149 (309)
T cd07845          76 VGKHLDSIFLVMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKI  149 (309)
T ss_pred             ecCCCCeEEEEEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEE
Confidence            765  568999999965 8988886542   45899999999999999999999  599999999999999999999999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      +|||++.........  ....     .+++.|+               +||++.+....+.++|+||+|++++++++...
T Consensus       150 ~dfg~~~~~~~~~~~--~~~~-----~~~~~y~---------------aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  207 (309)
T cd07845         150 ADFGLARTYGLPAKP--MTPK-----VVTLWYR---------------APELLLGCTTYTTAIDMWAVGCILAELLAHKP  207 (309)
T ss_pred             CccceeeecCCccCC--CCcc-----ccccccc---------------ChhhhcCCCCcCchHHHHHHHHHHHHHHhCCC
Confidence            999999877543211  0000     3345555               79988776677899999999999999986544


Q ss_pred             c
Q 017177          323 T  323 (376)
Q Consensus       323 ~  323 (376)
                      +
T Consensus       208 ~  208 (309)
T cd07845         208 L  208 (309)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.9e-30  Score=235.83  Aligned_cols=196  Identities=24%  Similarity=0.346  Sum_probs=161.4

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..++|++.+.||+|+||.||+|...+          ++.+|+|.+..... ..+.+.+|+.+++.++|+||+++++++..
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~----------~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNG----------TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSE   72 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcC----------CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeec
Confidence            35689999999999999999996543          56799999886543 34678899999999999999999999998


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ....++||||+++++|.+++....  ...+++..+..++.|++.||.|||  +++++|+||||+||++++++.++++|||
T Consensus        73 ~~~~~~v~e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh--~~~i~h~di~p~nili~~~~~~~l~d~g  148 (261)
T cd05034          73 EEPIYIVTEYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLE--SRNYIHRDLAARNILVGENLVCKIADFG  148 (261)
T ss_pred             CCceEEEEeccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcchheEEEcCCCCEEECccc
Confidence            899999999999999999997643  245889999999999999999999  6999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ++.......... ..+.     .++..|+               +||.+.+. ..+.++|+||+|++++++++
T Consensus       149 ~~~~~~~~~~~~-~~~~-----~~~~~y~---------------~PE~~~~~-~~~~~~Di~slG~il~~l~t  199 (261)
T cd05034         149 LARLIEDDEYTA-REGA-----KFPIKWT---------------APEAANYG-RFTIKSDVWSFGILLTEIVT  199 (261)
T ss_pred             cceeccchhhhh-hhcc-----CCCcccc---------------CHHHhccC-CcCchhHHHHHHHHHHHHHh
Confidence            998765421110 1111     1223344               69977654 46889999999999999987

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.97  E-value=1.7e-30  Score=235.98  Aligned_cols=203  Identities=20%  Similarity=0.250  Sum_probs=165.4

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe-
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE-  166 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-  166 (376)
                      +|++.+.||.|+||.||++...         .++..+|+|.+....  ....+.+.+|+.+++.++||||+++++.+.. 
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRK---------SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR   71 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeec---------CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence            4788899999999999999544         357889999987543  3445678899999999999999999998764 


Q ss_pred             -CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcC---CCCcEecCCCCCCEEEcCCCcEEE
Q 017177          167 -DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS---EKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       167 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~---~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                       ....+++|||+++++|.+++.........+++..++.++.|++.||.|||..   ..+++|+||||+||+++.++.+|+
T Consensus        72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl  151 (265)
T cd08217          72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKL  151 (265)
T ss_pred             CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEE
Confidence             3568999999999999999976543346789999999999999999999931   388999999999999999999999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      +|||++..........   .+    ..|++.|+               +||.+.+.. .+.++|+|++|++++++++...
T Consensus       152 ~d~g~~~~~~~~~~~~---~~----~~~~~~~~---------------~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~  208 (265)
T cd08217         152 GDFGLAKILGHDSSFA---KT----YVGTPYYM---------------SPEQLNHMS-YDEKSDIWSLGCLIYELCALSP  208 (265)
T ss_pred             ecccccccccCCcccc---cc----cccCCCcc---------------ChhhhcCCC-CCchhHHHHHHHHHHHHHHCCC
Confidence            9999999875543211   11    15667777               799876654 6788999999999999987554


Q ss_pred             cc
Q 017177          323 TT  324 (376)
Q Consensus       323 ~~  324 (376)
                      +.
T Consensus       209 p~  210 (265)
T cd08217         209 PF  210 (265)
T ss_pred             cc
Confidence            43

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=250.49  Aligned_cols=192  Identities=21%  Similarity=0.260  Sum_probs=162.3

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh--------hHHHHHHHHHHHhcCC---CCC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--------GFEEWQSEVNFLGRLS---HPN  156 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~---h~n  156 (376)
                      ..+|..++.+|+|+||+|++|.++.         ....|+||.+.++..-        .+-.+-.|+.||..|+   |+|
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~---------n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~N  630 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKE---------NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHEN  630 (772)
T ss_pred             cccceeeeeccccccceEEEeeecc---------cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccc
Confidence            3468999999999999999996654         4778999999876321        1122346999999997   999


Q ss_pred             cceEEeEEEeCCeEEEEEecc-CCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc
Q 017177          157 LVKLLGYCWEDKELLLVYEYM-QRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD  235 (376)
Q Consensus       157 Iv~l~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~  235 (376)
                      |++++++|++++++||+||-- +|-+|++++..+    ..+++.++..|++|++.|+++||  +.+|||||||-+|++++
T Consensus       631 IlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh--~~~ivhrdikdenvivd  704 (772)
T KOG1152|consen  631 ILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLH--DQGIVHRDIKDENVIVD  704 (772)
T ss_pred             hhhhhheeecCCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhcccccc--ccCceecccccccEEEe
Confidence            999999999999999999965 456899999765    66999999999999999999999  69999999999999999


Q ss_pred             CCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeeh
Q 017177          236 GVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFS  315 (376)
Q Consensus       236 ~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~  315 (376)
                      .+|.+||+|||.+...+..... ...||.+|.|                       ||++.|..|....-|+|++|+.++
T Consensus       705 ~~g~~klidfgsaa~~ksgpfd-~f~gtv~~aa-----------------------pevl~g~~y~gk~qdiwalgilly  760 (772)
T KOG1152|consen  705 SNGFVKLIDFGSAAYTKSGPFD-VFVGTVDYAA-----------------------PEVLGGEKYLGKPQDIWALGILLY  760 (772)
T ss_pred             cCCeEEEeeccchhhhcCCCcc-eeeeeccccc-----------------------hhhhCCCccCCCcchhhhhhheee
Confidence            9999999999999876654333 3434555544                       999999999999999999999998


Q ss_pred             hhc
Q 017177          316 CVF  318 (376)
Q Consensus       316 ~~~  318 (376)
                      -++
T Consensus       761 tiv  763 (772)
T KOG1152|consen  761 TIV  763 (772)
T ss_pred             EEE
Confidence            765

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.97  E-value=4.5e-31  Score=243.08  Aligned_cols=195  Identities=23%  Similarity=0.270  Sum_probs=164.4

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      +|++.+.||+|+||.||+|....         ++..||+|++....  ......+.+|+.+++.++||||+++++++..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG   71 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECC---------CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence            48889999999999999995543         58899999987654  23346788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      ...++||||+ +++|.+++....   ..+++..+..++.|++.||.|||  ..+++|+||||+||+++.++.++++|||+
T Consensus        72 ~~~~~v~e~~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~~~~~~~~~l~dfg~  145 (286)
T cd07832          72 SGFVLVMEYM-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMH--ANGIMHRDLKPANLLISADGVLKIADFGL  145 (286)
T ss_pred             CeeEEEeccc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCcCHHHEEEcCCCcEEEeeeee
Confidence            9999999999 999999987643   45899999999999999999999  59999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      +.............      ..|++.|+               +||++.+....+.++|+||+|++++++++-
T Consensus       146 ~~~~~~~~~~~~~~------~~~~~~y~---------------aPE~~~~~~~~~~~~Di~slG~~l~~l~tg  197 (286)
T cd07832         146 ARLFSEEEPRLYSH------QVATRWYR---------------APELLYGARKYDPGVDLWAVGCIFAELLNG  197 (286)
T ss_pred             cccccCCCCCcccc------ccCccccc---------------CceeeeccccCCchhHHHHHHHHHHHHHcC
Confidence            98775543211111      14566666               699877766678999999999999999865

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-32  Score=247.88  Aligned_cols=194  Identities=25%  Similarity=0.300  Sum_probs=166.2

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCC-CCCcceEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLS-HPNLVKLLG  162 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~-h~nIv~l~~  162 (376)
                      ...+|..+.+||+|+||+|.++         .++++.+.+|||+++++..   .+.+--..|-++|.... -|.+++++.
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLa---------erkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHS  417 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLA---------ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHS  417 (683)
T ss_pred             eecccceEEEeccCccceeeee---------cccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHH
Confidence            3457889999999999999999         6667899999999998733   34455567888888775 889999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                      +|+.-+.+|+||||+.||+|.-.+++.    ..+.+..+..++..|+-||-|||  .++||.||||.+|||+|.+|++||
T Consensus       418 cFQTmDRLyFVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh--~kgIiYRDLKLDNvmLd~eGHiKi  491 (683)
T KOG0696|consen  418 CFQTMDRLYFVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKI  491 (683)
T ss_pred             HhhhhhheeeEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhh--cCCeeeeeccccceEeccCCceEe
Confidence            999999999999999999999999876    45888899999999999999999  599999999999999999999999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      +|||+++-.--....   ..|.    +|||.|+               ||||+..+.| ...+|+|++|++++|++
T Consensus       492 ~DFGmcKEni~~~~T---TkTF----CGTPdYi---------------APEIi~YqPY-gksvDWWa~GVLLyEml  544 (683)
T KOG0696|consen  492 ADFGMCKENIFDGVT---TKTF----CGTPDYI---------------APEIIAYQPY-GKSVDWWAFGVLLYEML  544 (683)
T ss_pred             eecccccccccCCcc---eeee----cCCCccc---------------ccceEEeccc-ccchhHHHHHHHHHHHH
Confidence            999999854332222   2233    8999999               8998887654 88999999999999998

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=1.4e-30  Score=236.19  Aligned_cols=193  Identities=25%  Similarity=0.320  Sum_probs=154.2

Q ss_pred             ceEeecCcEEEEEEEEcCCCCC-cccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLA-PSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv  173 (376)
                      +.||+|+||.||+|........ .........+++|.+...... ...+.+|+.+++.++||||+++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            4689999999999977642100 001122346888887665433 5778899999999999999999999888 778999


Q ss_pred             EeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC-------cEEEccee
Q 017177          174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG-------FLFDSHLL  246 (376)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g-------~~kl~Dfg  246 (376)
                      |||+++|+|.+++.+..   ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++       .+|++|||
T Consensus        79 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHh--hCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            99999999999997653   25889999999999999999999  69999999999999999888       79999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh-hhccccccccceeeeehhhccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI-KYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~-~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ++........   .        .++..|+               +||.+.+. ...+.++|+||+|++++++++.
T Consensus       154 ~a~~~~~~~~---~--------~~~~~y~---------------aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~  202 (259)
T cd05037         154 IPITVLSREE---R--------VERIPWI---------------APECIRNGQASLTIAADKWSFGTTLLEICSN  202 (259)
T ss_pred             cccccccccc---c--------ccCCCcc---------------ChhhhcCCCCCcchhhHHHHHHHHHHHHHhC
Confidence            9987644111   1        3334455               69987766 4678899999999999998753

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.97  E-value=2.7e-30  Score=234.16  Aligned_cols=199  Identities=22%  Similarity=0.239  Sum_probs=164.6

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      +|++.+.||+|+||.||++....         +++.||+|.+...  .....+.+.+|+.+++.++||||+++++++...
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKE---------DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN   71 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcC---------CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence            48889999999999999995443         5889999998653  233446788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++||||+++++|.+++.....  ..+++..+..++.|++.||.|||  +++++|+||+|+|||++.++.++++|||+
T Consensus        72 ~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~~l~~~nil~~~~~~~~l~d~~~  147 (256)
T cd08218          72 GNLYIVMDYCEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVH--DRKILHRDIKSQNIFLTKDGTIKLGDFGI  147 (256)
T ss_pred             CeEEEEEecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEEEeeccc
Confidence            999999999999999999876432  35789999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      +...........   .    ..|++.|+               +||.+.+.. .+.++|+||+|++++++++...+.
T Consensus       148 ~~~~~~~~~~~~---~----~~~~~~~~---------------~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~  201 (256)
T cd08218         148 ARVLNSTVELAR---T----CIGTPYYL---------------SPEICENRP-YNNKSDIWALGCVLYEMCTLKHAF  201 (256)
T ss_pred             eeecCcchhhhh---h----ccCCcccc---------------CHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCc
Confidence            987654322110   0    14555566               799776544 678999999999999999776554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=2e-30  Score=235.19  Aligned_cols=190  Identities=26%  Similarity=0.340  Sum_probs=159.7

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|++.+.||.|+||.||+|...           ++.||+|.++.... ..+++.+|+.+++.++|+||+++++++.+.
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   72 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG   72 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-----------CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence            457899999999999999999543           67799999987654 457888999999999999999999999988


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++||||+++++|.+++.....  ..+++..+..++.|++.||.|||  .++++||||||+||+++.++.++|+|||.
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~p~Nili~~~~~~~l~d~g~  148 (256)
T cd05039          73 NPLYIVTEYMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLE--EKNFVHRDLAARNVLVSEDLVAKVSDFGL  148 (256)
T ss_pred             CCeEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCccchhcccceEEEeCCCCEEEccccc
Confidence            999999999999999999976532  35899999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ++.......  ..        .++..|+               +||.+... ..+.++|+||+|++++++++
T Consensus       149 ~~~~~~~~~--~~--------~~~~~~~---------------ape~~~~~-~~~~~~Di~slG~il~~l~~  194 (256)
T cd05039         149 AKEASQGQD--SG--------KLPVKWT---------------APEALREK-KFSTKSDVWSFGILLWEIYS  194 (256)
T ss_pred             ccccccccc--cC--------CCccccc---------------CchhhcCC-cCCcHHHHHHHHHHHHHHHh
Confidence            987633211  11        1222333               59966543 45788999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.97  E-value=2.8e-30  Score=235.21  Aligned_cols=206  Identities=22%  Similarity=0.230  Sum_probs=169.9

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ++|++.+.||.|+||.||+|....         ++..+|+|++..... .....+.+|+.+++.++|+||+++++.+..+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLP---------NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG   71 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcC---------CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC
Confidence            468999999999999999996443         478899999876432 3457788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..|+|||++++++|.+++..... ...+++..+..++.|++.||.|||  +.+|+||||||+||++++++.++|+|||+
T Consensus        72 ~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh--~~~i~h~~l~p~ni~~~~~~~~~l~df~~  148 (267)
T cd06610          72 DELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLH--SNGQIHRDIKAGNILLGEDGSVKIADFGV  148 (267)
T ss_pred             CEEEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHhEEEcCCCCEEEcccch
Confidence            999999999999999999976432 245899999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      +...........   ...+...|++.|+               +||.+......+.++|+||+|++++++++-..+.
T Consensus       149 ~~~~~~~~~~~~---~~~~~~~~~~~y~---------------~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~  207 (267)
T cd06610         149 SASLADGGDRTR---KVRKTFVGTPCWM---------------APEVMEQVHGYDFKADIWSFGITAIELATGAAPY  207 (267)
T ss_pred             HHHhccCccccc---cccccccCChhhc---------------ChHHHccccCcCcccchHhHhHHHHHHHhCCCCc
Confidence            987654332210   1112225666666               7998876657789999999999999999765543

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.97  E-value=2.3e-30  Score=236.64  Aligned_cols=198  Identities=20%  Similarity=0.274  Sum_probs=160.1

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|.+.+.||+|+||.||+|.....      ......||+|...... ....+.+.+|+.+++.++||||+++++++.+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~------~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   78 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSP------ENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE   78 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecC------CCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence            45688999999999999999976431      1224579999987765 4455788999999999999999999998865


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                       +..|+||||+++|+|.+++.+..   ..+++..+..++.|++.||.|||  +.+++||||||+|||++.++.++++|||
T Consensus        79 -~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH--~~~~~H~dl~p~nili~~~~~~~l~d~g  152 (270)
T cd05056          79 -NPVWIVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLE--SKRFVHRDIAARNVLVSSPDCVKLGDFG  152 (270)
T ss_pred             -CCcEEEEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccChheEEEecCCCeEEccCc
Confidence             56789999999999999997642   35899999999999999999999  6999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ++.............+      .+++.|+               +||.+.+. ..+.++|+||+|++++++++
T Consensus       153 ~~~~~~~~~~~~~~~~------~~~~~y~---------------aPE~~~~~-~~~~~~Di~slG~il~el~~  203 (270)
T cd05056         153 LSRYLEDESYYKASKG------KLPIKWM---------------APESINFR-RFTSASDVWMFGVCMWEILM  203 (270)
T ss_pred             eeeecccccceecCCC------Ccccccc---------------ChhhhccC-CCCchhhhHHHHHHHHHHHH
Confidence            9987655422211111      2234455               79977655 45789999999999999774

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=3.9e-30  Score=233.48  Aligned_cols=192  Identities=27%  Similarity=0.337  Sum_probs=153.8

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv  173 (376)
                      +.||+|+||.||+|.+...      ...+..+|+|.+..... ...+.+.+|+.+++.++|+||+++++++. .+..++|
T Consensus         1 ~~ig~G~~g~v~~~~~~~~------~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v   73 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMK------SGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLV   73 (257)
T ss_pred             CccCccCceeEEEeEeecc------CCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEE
Confidence            4699999999999976431      11347899999987654 34467889999999999999999999875 4568999


Q ss_pred             EeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      |||+++|+|.+++...    ..+++..+..++.|++.||.|||  ..+++||||||+|||++.++.+||+|||+++....
T Consensus        74 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~  147 (257)
T cd05060          74 MELAPLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLE--SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGA  147 (257)
T ss_pred             EEeCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHh--hcCeeccCcccceEEEcCCCcEEeccccccceeec
Confidence            9999999999999765    35899999999999999999999  69999999999999999999999999999987654


Q ss_pred             ceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          254 HYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       254 ~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ...........    .++..|+               +||.+.+.. .+.++|+||+|++++++++
T Consensus       148 ~~~~~~~~~~~----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~~l~~~~~  193 (257)
T cd05060         148 GSDYYRATTAG----RWPLKWY---------------APECINYGK-FSSKSDVWSYGVTLWEAFS  193 (257)
T ss_pred             CCcccccccCc----ccccccc---------------CHHHhcCCC-CCccchHHHHHHHHHHHHc
Confidence            33221110000    1123344               799776544 6889999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.97  E-value=3.9e-30  Score=232.88  Aligned_cols=198  Identities=30%  Similarity=0.407  Sum_probs=162.5

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh-hHHHHHHHHHHHhcCCCCCcceEEeEEEeCCe
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE  169 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~  169 (376)
                      +++.+.||.|+||.||+|.....     ....+..||+|.+...... ..+.+.+|+.+++.++|+||+++++.+.+.+.
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGL-----SGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCC-----CCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence            35678999999999999976542     1123588999999876543 56788899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeee
Q 017177          170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYV  249 (376)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~  249 (376)
                      .+++|||+++++|.+++.....  ..+++..+..++.|++.||.|||  +.+++||||||+||+++.++.++++|||++.
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh--~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~  151 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLE--SKNFIHRDLAARNCLVGENLVVKISDFGLSR  151 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHh--cCCeeecccccceEEEccCCeEEEcccCCce
Confidence            9999999999999999976532  22899999999999999999999  6999999999999999999999999999998


Q ss_pred             eeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          250 YFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ........... ..     .+++.|+               +||.+.+ ...+.++|+|++|++++++++
T Consensus       152 ~~~~~~~~~~~-~~-----~~~~~y~---------------~Pe~~~~-~~~~~~~Di~slG~i~~~l~~  199 (258)
T smart00219      152 DLYDDDYYKKK-GG-----KLPIRWM---------------APESLKD-GKFTSKSDVWSFGVLLWEIFT  199 (258)
T ss_pred             ecccccccccc-cC-----CCccccc---------------ChHHhcc-CCCCcchhHHHHHHHHHHHHh
Confidence            77654222111 01     2445566               7997744 456889999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.2e-30  Score=244.82  Aligned_cols=197  Identities=19%  Similarity=0.182  Sum_probs=161.1

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCC-CCCcceEE
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLS-HPNLVKLL  161 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~-h~nIv~l~  161 (376)
                      +...+.|++++.||.||.++||++...+          ...||+|++...  ..+....+.+|+..|.+|+ |.+||+++
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~----------~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~  426 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSD----------KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLY  426 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCC----------CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEe
Confidence            3345679999999999999999996553          566787776543  3345678999999999998 99999999


Q ss_pred             eEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEE
Q 017177          162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLF  241 (376)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~k  241 (376)
                      +|-..++.+|||||+= ..+|..+|++...   ..+...++.+..|++.|+.++|  +.+|||.||||.|+|+- +|.+|
T Consensus       427 DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~---~~~~~~lk~ywkqML~aV~~IH--~~gIVHSDLKPANFLlV-kG~LK  499 (677)
T KOG0596|consen  427 DYEVTDGYLYMVMECG-DIDLNKILKKKKS---IDPDWFLKFYWKQMLLAVKTIH--QHGIVHSDLKPANFLLV-KGRLK  499 (677)
T ss_pred             eeeccCceEEEEeecc-cccHHHHHHhccC---CCchHHHHHHHHHHHHHHHHHH--HhceeecCCCcccEEEE-eeeEE
Confidence            9999999999999975 4599999987642   2343488899999999999999  79999999999999986 68999


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhh----------cccccccccee
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKY----------LTLLKYSNSFA  311 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~----------~~~~~dv~s~g  311 (376)
                      |+|||+|..+........... .    +||+.||               +||-+.-..+          ..+++||||+|
T Consensus       500 LIDFGIA~aI~~DTTsI~kds-Q----vGT~NYM---------------sPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLG  559 (677)
T KOG0596|consen  500 LIDFGIANAIQPDTTSIVKDS-Q----VGTVNYM---------------SPEALTDMSSSRENGKSKIKISRKSDVWSLG  559 (677)
T ss_pred             eeeechhcccCccccceeecc-c----cCccccc---------------CHHHHhhccccccCCCcceeecCccchhhhh
Confidence            999999998866544432222 2    8999999               7887764432          35889999999


Q ss_pred             eeehhhc
Q 017177          312 FVFSCVF  318 (376)
Q Consensus       312 ~v~~~~~  318 (376)
                      ||+|+|+
T Consensus       560 CILYqMv  566 (677)
T KOG0596|consen  560 CILYQMV  566 (677)
T ss_pred             hHHHHHH
Confidence            9999988

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.97  E-value=3.8e-30  Score=236.47  Aligned_cols=205  Identities=23%  Similarity=0.243  Sum_probs=162.1

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-ChhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ..++|++.+.||+|+||.||+|.....     ....+..|++|.+... .....+.+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~-----~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~   78 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDE-----KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI   78 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecC-----CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            356799999999999999999976541     1123678999998754 3344577889999999999999999999876


Q ss_pred             e-CCeEEEEEeccCCCCHHHHHhhcCCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcE
Q 017177          166 E-DKELLLVYEYMQRGSLENHLFRRNPS----IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL  240 (376)
Q Consensus       166 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~  240 (376)
                      . +...++++||+++++|.+++......    ...+++..+..++.|++.||.|||  +.+++||||||+||+++.++.+
T Consensus        79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~i~H~di~p~nil~~~~~~~  156 (280)
T cd05043          79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH--KRGVIHKDIAARNCVIDEELQV  156 (280)
T ss_pred             cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccCHhhEEEcCCCcE
Confidence            6 46789999999999999999764321    145889999999999999999999  6999999999999999999999


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      |++|||+++.+....... .....    .++..|+               +||.+.+.. .+.++|+||+|++++++++
T Consensus       157 kl~d~g~~~~~~~~~~~~-~~~~~----~~~~~y~---------------apE~~~~~~-~~~~~Di~slG~~l~el~~  214 (280)
T cd05043         157 KITDNALSRDLFPMDYHC-LGDNE----NRPVKWM---------------ALESLVNKE-YSSASDVWSFGVLLWELMT  214 (280)
T ss_pred             EECCCCCcccccCCceEE-eCCCC----Ccchhcc---------------CHHHHhcCC-CCchhhHHHhHHHHHHHhc
Confidence            999999998654322110 00000    2233344               799776544 5889999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.97  E-value=5.4e-30  Score=231.37  Aligned_cols=188  Identities=25%  Similarity=0.323  Sum_probs=153.4

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv  173 (376)
                      ++||+|+||.||+|...          .+..+|+|.+..... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus         1 ~~ig~g~~g~vy~~~~~----------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   70 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK----------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV   70 (250)
T ss_pred             CccCCCCCceEEEEEec----------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence            46899999999999643          267899999876643 2335688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      |||+++++|.+++....   ..+++..+..++.|++.||.|||  .++++||||||+||+++.++.+|++|||++.....
T Consensus        71 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  145 (250)
T cd05085          71 MELVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDD  145 (250)
T ss_pred             EECCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccChheEEEcCCCeEEECCCccceeccc
Confidence            99999999999986542   35789999999999999999999  69999999999999999999999999999976543


Q ss_pred             ceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          254 HYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       254 ~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      .....  .+..    .+++.|+               +||.+.+. ..+.++|+||+|++++++++
T Consensus       146 ~~~~~--~~~~----~~~~~y~---------------aPE~~~~~-~~~~~~Di~slG~ll~~~~~  189 (250)
T cd05085         146 GIYSS--SGLK----QIPIKWT---------------APEALNYG-RYSSESDVWSYGILLWETFS  189 (250)
T ss_pred             ccccc--CCCC----CCccccc---------------CHHHhccC-CCCchhHHHHHHHHHHHHhc
Confidence            22211  0110    2234455               79977654 45788999999999999876

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=4.5e-31  Score=244.10  Aligned_cols=199  Identities=21%  Similarity=0.223  Sum_probs=160.4

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhh-HHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|....         ++..||+|.+....... ...+.+|+.+++.++|+||+++++++..
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   74 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRI---------NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT   74 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcC---------CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence            3679999999999999999995543         57889999987653322 2456789999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++..|+||||+. ++|.+++....   ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.++|+|||
T Consensus        75 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~Dfg  148 (291)
T cd07870          75 KETLTFVFEYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIH--GQHILHRDLKPQNLLISYLGELKLADFG  148 (291)
T ss_pred             CCeEEEEEeccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHHEEEcCCCcEEEeccc
Confidence            999999999996 68877775432   34678888999999999999999  5899999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      +++.........  ..     ..+++.|+               +||.+.+....+.++|+||+|++++++++-..+
T Consensus       149 ~~~~~~~~~~~~--~~-----~~~~~~y~---------------aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~  203 (291)
T cd07870         149 LARAKSIPSQTY--SS-----EVVTLWYR---------------PPDVLLGATDYSSALDIWGAGCIFIEMLQGQPA  203 (291)
T ss_pred             cccccCCCCCCC--CC-----cccccccc---------------CCceeecCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            998643322110  00     14556666               799877665567889999999999999965443

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.97  E-value=3.6e-30  Score=235.20  Aligned_cols=202  Identities=20%  Similarity=0.263  Sum_probs=163.3

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC----------ChhhHHHHHHHHHHHhc-CCCCCcc
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE----------SMQGFEEWQSEVNFLGR-LSHPNLV  158 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~E~~il~~-l~h~nIv  158 (376)
                      +|++.+.||+|+||.||+|.....        .+..+|+|.+...          .......+.+|+.++.+ ++||||+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~--------~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~   72 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNN--------GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV   72 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCC--------CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCee
Confidence            478889999999999999976531        3678999987542          22234567789888875 7899999


Q ss_pred             eEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          159 KLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       159 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      ++++++..++..+++|||+++++|.+++.........+++..++.++.|++.||.|||+ ..+++||||||+|||++.++
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~i~H~dl~~~nil~~~~~  151 (269)
T cd08528          73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK-EKRIVHRDLTPNNIMLGEDD  151 (269)
T ss_pred             eEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc-CCceeecCCCHHHEEECCCC
Confidence            99999999999999999999999999886533333568999999999999999999994 46899999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .++|+|||++............        .|+..|+               +||.+.+.. .+.++|+||+|+++++++
T Consensus       152 ~~~l~dfg~~~~~~~~~~~~~~--------~~~~~~~---------------~Pe~~~~~~-~~~~~Dv~slG~ll~~l~  207 (269)
T cd08528         152 KVTITDFGLAKQKQPESKLTSV--------VGTILYS---------------CPEIVKNEP-YGEKADVWAFGCILYQMC  207 (269)
T ss_pred             cEEEecccceeecccccccccc--------cCcccCc---------------ChhhhcCCC-CchHHHHHHHHHHHHHHH
Confidence            9999999999876554322112        4555566               699887644 588999999999999999


Q ss_pred             cccccc
Q 017177          319 SFYRTT  324 (376)
Q Consensus       319 ~~y~~~  324 (376)
                      +...+.
T Consensus       208 ~g~~p~  213 (269)
T cd08528         208 TLQPPF  213 (269)
T ss_pred             hCCCcc
Confidence            765553

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.97  E-value=2e-30  Score=234.75  Aligned_cols=198  Identities=24%  Similarity=0.242  Sum_probs=164.1

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      +|++.+.||+|+||.||+|....         ++..+|+|.+....  ....+.+.+|+.+++.++||||+++++.+..+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKA---------DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED   71 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcC---------CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence            58889999999999999995543         58899999987653  23456788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC-CcEEEccee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV-GFLFDSHLL  246 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~-g~~kl~Dfg  246 (376)
                      +..++||||+++++|.+++....  ...+++..+..++.|++.||.|||  +++|+||||||+||+++.+ +.++++|||
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~nil~~~~~~~~~l~d~~  147 (256)
T cd08220          72 KALMIVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVH--TKLILHRDLKTQNILLDKHKMVVKIGDFG  147 (256)
T ss_pred             CEEEEEEecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEEccCC
Confidence            99999999999999999997653  245889999999999999999999  6999999999999999865 468999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ++...........        ..|++.|+               +||.+.+.. .+.++|+||+|++++++++...+.
T Consensus       148 ~~~~~~~~~~~~~--------~~~~~~y~---------------aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~  201 (256)
T cd08220         148 ISKILSSKSKAYT--------VVGTPCYI---------------SPELCEGKP-YNQKSDIWALGCVLYELASLKRAF  201 (256)
T ss_pred             CceecCCCccccc--------cccCCccc---------------CchhccCCC-CCcccchHHHHHHHHHHHhCCCCc
Confidence            9997754322211        15566666               799776543 578999999999999999765544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=2e-30  Score=238.62  Aligned_cols=189  Identities=24%  Similarity=0.246  Sum_probs=151.2

Q ss_pred             eEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHh---cCCCCCcceEEeEEEeCCe
Q 017177           96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLG---RLSHPNLVKLLGYCWEDKE  169 (376)
Q Consensus        96 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~---~l~h~nIv~l~~~~~~~~~  169 (376)
                      .||+|+||.||++...         .++..+|+|.+.....   .....+.+|..+++   ..+||||+.+++.+..++.
T Consensus         1 ~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~   71 (279)
T cd05633           1 IIGRGGFGEVYGCRKA---------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK   71 (279)
T ss_pred             CcccCCCeEEEEEEEC---------CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence            4899999999999544         3588999998865422   11223344544433   3469999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeee
Q 017177          170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYV  249 (376)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~  249 (376)
                      .++||||+++|+|.+++...    ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.++++|||++.
T Consensus        72 ~~lv~e~~~~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH--~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~  145 (279)
T cd05633          72 LCFILDLMNGGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLAC  145 (279)
T ss_pred             EEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcCCCCCCHHHEEECCCCCEEEccCCcce
Confidence            99999999999999988765    45899999999999999999999  5999999999999999999999999999997


Q ss_pred             eeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          250 YFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ........         ...||+.|+               +||.+......+.++|+||+|++++++++...+
T Consensus       146 ~~~~~~~~---------~~~~~~~y~---------------aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  195 (279)
T cd05633         146 DFSKKKPH---------ASVGTHGYM---------------APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP  195 (279)
T ss_pred             eccccCcc---------CcCCCcCcc---------------CHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCC
Confidence            65432211         115677777               799876555567899999999999999875444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.97  E-value=4.1e-31  Score=243.45  Aligned_cols=196  Identities=23%  Similarity=0.241  Sum_probs=162.4

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ++|++.+.||+|+||.||+|....         +++.||+|.+.....  ...+.+.+|+++++.++||||+++++++..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   71 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR   71 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECC---------CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence            368899999999999999996543         478899999865432  234567889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++..++||||++++.|..+....    ..+++..+..++.|++.||.|||  +.+|+||||+|+||++++++.++++|||
T Consensus        72 ~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH--~~~i~h~~l~p~ni~~~~~~~~~l~dfg  145 (286)
T cd07846          72 KKRLYLVFEFVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCH--SHNIIHRDIKPENILVSQSGVVKLCDFG  145 (286)
T ss_pred             CCeEEEEEecCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCcEEEEeee
Confidence            99999999999998888776543    34899999999999999999999  5899999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      ++..........   ..    ..+++.|+               +||++.+....+.++|+||+|++++++++-.
T Consensus       146 ~~~~~~~~~~~~---~~----~~~~~~y~---------------aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~  198 (286)
T cd07846         146 FARTLAAPGEVY---TD----YVATRWYR---------------APELLVGDTKYGRAVDIWAVGCLVTEMLTGE  198 (286)
T ss_pred             eeeeccCCcccc---Cc----ccceeecc---------------CcHHhccccccCchHhHHHHHHHHHHHHcCC
Confidence            998764432210   11    14556666               6998877666778999999999999998753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7e-33  Score=239.59  Aligned_cols=199  Identities=22%  Similarity=0.254  Sum_probs=161.0

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .+.+..+.||.|+||.||.+.+.         .+|+.||+|++..-.  ...-+++.+|+++|..++|.|++..++..+.
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDP---------RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQP  123 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDP---------RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQP  123 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCC---------CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCC
Confidence            34566789999999999998543         358999999987542  2334788999999999999999999998765


Q ss_pred             CC-----eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEE
Q 017177          167 DK-----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLF  241 (376)
Q Consensus       167 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~k  241 (376)
                      ..     .+|+++|++.. +|..++...    ..++.+.++-+..||++||+|||+  .+|+||||||.|+|++.+..+|
T Consensus       124 ph~dfFqEiYV~TELmQS-DLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLHs--A~ILHRDIKPGNLLVNSNCvLK  196 (449)
T KOG0664|consen  124 ANPSFFQELYVLTELMQS-DLHKIIVSP----QALTPDHVKVFVYQILRGLKYLHT--ANILHRDIKPGNLLVNSNCILK  196 (449)
T ss_pred             CCchHHHHHHHHHHHHHh-hhhheeccC----CCCCcchhhhhHHHHHhhhHHHhh--cchhhccCCCccEEeccCceEE
Confidence            53     47899999965 888887654    668899999999999999999995  9999999999999999999999


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |||||+++..+.......+..      +-|..               |.||||+.|.+.++.+.||||.||+|.|+..-.
T Consensus       197 ICDFGLARvee~d~~~hMTqE------VVTQY---------------YRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRr  255 (449)
T KOG0664|consen  197 ICDFGLARTWDQRDRLNMTHE------VVTQY---------------YRAPELLMGARRYTGAVDIWSVGCIFAELLQRK  255 (449)
T ss_pred             ecccccccccchhhhhhhHHH------HHHHH---------------hccHHHhhcchhhcCccceehhhHHHHHHHhhh
Confidence            999999998755443321111      11112               347999999999999999999999999999554


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      -+.
T Consensus       256 ILF  258 (449)
T KOG0664|consen  256 ILF  258 (449)
T ss_pred             hhh
Confidence            444

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.97  E-value=6e-30  Score=232.56  Aligned_cols=197  Identities=23%  Similarity=0.267  Sum_probs=166.7

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ++|++.+.||+|++|.||+|....         +++.|++|++..... .....+.+|+.++..++|+||+++++++..+
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKP---------TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE   71 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcC---------CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC
Confidence            368889999999999999995543         588999999887654 3457788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSE-KKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~-~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      +..++||||+++++|.+++...    ..+++..+..++.|++.||.|||  . .+++||||+|+||+++.++.++|+|||
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh--~~~~~~H~~l~~~ni~~~~~~~~~l~df~  145 (264)
T cd06623          72 GEISIVLEYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFG  145 (264)
T ss_pred             CeEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHh--ccCCCccCCCCHHHEEECCCCCEEEccCc
Confidence            9999999999999999999765    45899999999999999999999  7 999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      .+..........       ....++..|+               +||.+... ..+.++|+|++|++++++++-..+
T Consensus       146 ~~~~~~~~~~~~-------~~~~~~~~y~---------------~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p  199 (264)
T cd06623         146 ISKVLENTLDQC-------NTFVGTVTYM---------------SPERIQGE-SYSYAADIWSLGLTLLECALGKFP  199 (264)
T ss_pred             cceecccCCCcc-------cceeeccccc---------------CHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            998775433321       0114555566               69976655 567899999999999999875444

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.97  E-value=3.7e-30  Score=240.04  Aligned_cols=197  Identities=26%  Similarity=0.281  Sum_probs=161.5

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEe
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLG  162 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~  162 (376)
                      ...+.|+..+.||+|+||.||+|....         +++.||+|.+....   ....+.+.+|+.+++.++||||+++++
T Consensus        12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~   82 (307)
T cd06607          12 DPEKLFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG   82 (307)
T ss_pred             CcchhhhhheeecCCCCeEEEEEEEcC---------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            344669999999999999999995543         47899999986432   233457889999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                      ++.+++..|+||||++ |++.+++....   ..+++..+..++.|++.||.|||  ..+|+||||+|+||+++.++.++|
T Consensus        83 ~~~~~~~~~lv~e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH--~~~i~H~dl~p~nIl~~~~~~~kL  156 (307)
T cd06607          83 CYLREHTAWLVMEYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLH--SHERIHRDIKAGNILLTEPGTVKL  156 (307)
T ss_pred             EEEeCCeEEEEHHhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcccEEECCCCCEEE
Confidence            9999999999999997 57877775432   45899999999999999999999  599999999999999999999999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh--hhhccccccccceeeeehhhccc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW--IKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~--~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      +|||++.........           .|++.|+               +||++..  ....+.++||||+|++++++++.
T Consensus       157 ~dfg~~~~~~~~~~~-----------~~~~~y~---------------aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg  210 (307)
T cd06607         157 ADFGSASLVSPANSF-----------VGTPYWM---------------APEVILAMDEGQYDGKVDVWSLGITCIELAER  210 (307)
T ss_pred             eecCcceecCCCCCc-----------cCCcccc---------------CceeeeccCCCCCCcccchHHHHHHHHHHHcC
Confidence            999999765432211           4556666               7997642  34567899999999999999876


Q ss_pred             ccc
Q 017177          321 YRT  323 (376)
Q Consensus       321 y~~  323 (376)
                      ..+
T Consensus       211 ~~p  213 (307)
T cd06607         211 KPP  213 (307)
T ss_pred             CCC
Confidence            554

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.97  E-value=4.9e-30  Score=233.26  Aligned_cols=193  Identities=23%  Similarity=0.318  Sum_probs=156.3

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      ++|.+.+.||+|+||.||+|....          +..+|+|.+..... ..+.+.+|+.+++.++|+||+++++++. .+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~   73 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNG----------TTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EE   73 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcC----------CceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CC
Confidence            468899999999999999996543          34689998876432 3367889999999999999999998875 45


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeee
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a  248 (376)
                      ..+++|||+++++|.+++.+..  ...+++..+..++.|++.||.|||  +.+|+||||||+||++++++.++|+|||++
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dl~~~Nill~~~~~~~l~dfg~~  149 (260)
T cd05069          74 PIYIVTEFMGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIE--RMNYIHRDLRAANILVGDNLVCKIADFGLA  149 (260)
T ss_pred             CcEEEEEcCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEEcCCCeEEECCCccc
Confidence            6899999999999999997643  245789999999999999999999  699999999999999999999999999999


Q ss_pred             eeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          249 VYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      .......... ..+.     .++..|+               +||...+.. .+.++|+||+|++++++++
T Consensus       150 ~~~~~~~~~~-~~~~-----~~~~~y~---------------~Pe~~~~~~-~~~~~Di~slG~~l~el~t  198 (260)
T cd05069         150 RLIEDNEYTA-RQGA-----KFPIKWT---------------APEAALYGR-FTIKSDVWSFGILLTELVT  198 (260)
T ss_pred             eEccCCcccc-cCCC-----ccchhhC---------------CHHHhccCC-cChHHHHHHHHHHHHHHHh
Confidence            8765432211 1111     2334455               699666544 6889999999999999986

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=3.4e-30  Score=236.87  Aligned_cols=205  Identities=24%  Similarity=0.342  Sum_probs=164.7

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh-hHHHHHHHHHHHhcCCCCCcceEEeEEEe-
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHPNLVKLLGYCWE-  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~-  166 (376)
                      ++|++.+.||+|+||.||+|.+..     .+..++..+|+|.++..... ..+.+.+|+.+++.++|+||+++++++.. 
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~-----~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~   78 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDP-----LGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP   78 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecC-----CCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence            468888999999999999997653     22335789999999876543 45788999999999999999999999877 


Q ss_pred             -CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          167 -DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       167 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                       ....+++|||+++++|.+++....   ..+++..+..++.|++.||.|||  .++++||||||+||+++.++.++++||
T Consensus        79 ~~~~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~nil~~~~~~~~l~df  153 (284)
T cd05038          79 GGRSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLG--SQRYIHRDLAARNILVESEDLVKISDF  153 (284)
T ss_pred             CCCceEEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHhEEEcCCCCEEEccc
Confidence             557999999999999999997653   35899999999999999999999  699999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |++................    .++..|+               +||.+.+. ..+.++|+||+|++++++++...+
T Consensus       154 g~~~~~~~~~~~~~~~~~~----~~~~~~~---------------~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p  211 (284)
T cd05038         154 GLAKVLPEDKDYYYVKEPG----ESPIFWY---------------APECLRTS-KFSSASDVWSFGVTLYELFTYGDP  211 (284)
T ss_pred             ccccccccCCcceeccCCC----CCccccc---------------CcHHHccC-CCCcccchHHHhhhhheeeccCCC
Confidence            9999876332221111000    1122233               69976654 467889999999999999976544

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=9.2e-30  Score=231.48  Aligned_cols=195  Identities=21%  Similarity=0.303  Sum_probs=158.9

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..++|++.+.||+|+||.||++....          +..+|+|.+.... ...+.+.+|+.+++.++|+||+++++.+..
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~----------~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   72 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK   72 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecC----------CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC
Confidence            45679999999999999999996543          4569999887643 234678899999999999999999999877


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                       ...+++|||+++++|.+++.+..  ...+++..+..++.|++.||.|||  +.+++||||||+||+++.++.+|++|||
T Consensus        73 -~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~ni~i~~~~~~~l~d~~  147 (260)
T cd05073          73 -EPIYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFG  147 (260)
T ss_pred             -CCeEEEEEeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEEcCCCcEEECCCc
Confidence             77899999999999999997643  245788899999999999999999  6999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ++.......... ..+.     .++..|+               +||.+... ..+.++|+||+|++++++++
T Consensus       148 ~~~~~~~~~~~~-~~~~-----~~~~~y~---------------~PE~~~~~-~~~~~~Di~slG~~l~~l~t  198 (260)
T cd05073         148 LARVIEDNEYTA-REGA-----KFPIKWT---------------APEAINFG-SFTIKSDVWSFGILLMEIVT  198 (260)
T ss_pred             ceeeccCCCccc-ccCC-----ccccccc---------------CHhHhccC-CcCccccchHHHHHHHHHHh
Confidence            998764432211 1111     2233444               79977654 46888999999999999887

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.97  E-value=4e-30  Score=233.89  Aligned_cols=202  Identities=24%  Similarity=0.280  Sum_probs=166.8

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      +|++.+.||+|+||.||+|....         +++.|++|.++....  ...+.+.+|+.+++.++|+||+++++.+...
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~   71 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLD---------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR   71 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECC---------CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence            48889999999999999995543         478899999876644  3567889999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +.+++|+||+++++|.+++.+.    ..+++..+..++.|++.||.|||  +.+|+|+||||+||+++.++.+||+|||+
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~~~nil~~~~~~~kl~d~g~  145 (264)
T cd06626          72 EKVYIFMEYCSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLH--SHGIVHRDIKPANIFLDHNGVIKLGDFGC  145 (264)
T ss_pred             CEEEEEEecCCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEccccc
Confidence            9999999999999999999764    34788999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhh--hccccccccceeeeehhhccccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIK--YLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~--~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      +............   ......+++.|+               +||.+.+..  ..+.++|+|++|++++++++-+.+.
T Consensus       146 ~~~~~~~~~~~~~---~~~~~~~~~~~~---------------~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf  206 (264)
T cd06626         146 AVKLKNNTTTMGE---EVQSLAGTPAYM---------------APEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW  206 (264)
T ss_pred             ccccCCCCCcccc---cccCCcCCcCcc---------------ChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCc
Confidence            9887554332110   001114556666               799877653  3678999999999999999665553

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.97  E-value=6.8e-30  Score=234.60  Aligned_cols=196  Identities=23%  Similarity=0.275  Sum_probs=162.9

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ..|+..+.||.|+||.||+|....         ++..||+|.+.... ......+.+|+.+++.++||||+++++.+.++
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNR---------TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG   74 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEcc---------CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            357888999999999999995543         57889999987553 34457788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++||||+++|+|.+++..     ..+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.++++|||+
T Consensus        75 ~~~~lv~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh--~~~ivH~dl~p~Nil~~~~~~~~l~dfg~  147 (277)
T cd06640          75 TKLWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLH--SEKKIHRDIKAANVLLSEQGDVKLADFGV  147 (277)
T ss_pred             CEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--hCCccCcCCChhhEEEcCCCCEEEccccc
Confidence            999999999999999998854     34788999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      +...........       ...++..|+               +||++.+.. .+.++|+||+|++++++++...+
T Consensus       148 ~~~~~~~~~~~~-------~~~~~~~y~---------------apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p  200 (277)
T cd06640         148 AGQLTDTQIKRN-------TFVGTPFWM---------------APEVIQQSA-YDSKADIWSLGITAIELAKGEPP  200 (277)
T ss_pred             ceeccCCccccc-------cccCccccc---------------CHhHhccCC-CccHHHHHHHHHHHHHHHHCCCC
Confidence            987654322110       114455555               699876554 58899999999999999865544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=232.95  Aligned_cols=193  Identities=20%  Similarity=0.182  Sum_probs=158.1

Q ss_pred             hcCCCCcc-ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEEeEE
Q 017177           87 ATKNFKPD-SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~  164 (376)
                      ..++|.+. ++||-|-.|+|..|         .++.+++.+|+|++...     ...++|++..-..+ |||||+++++|
T Consensus        59 itedY~is~qvLG~GinGkV~~C---------~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVy  124 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQC---------VHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVY  124 (400)
T ss_pred             chhhheehhhhhccccCCceEEE---------EeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhh
Confidence            45667654 68999999999999         55558999999998754     34567888888776 99999999998


Q ss_pred             Ee----CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc---CC
Q 017177          165 WE----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD---GV  237 (376)
Q Consensus       165 ~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~---~~  237 (376)
                      ..    ...+.+|||.++||.|+..+..+..  ..+++.++..|++||+.|+.|||  ..+|.||||||+|+|..   .+
T Consensus       125 eNs~~~rkcLLiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH--~~nIAHRDlKpENLLyt~t~~n  200 (400)
T KOG0604|consen  125 ENSYQGRKCLLIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLH--SMNIAHRDLKPENLLYTTTSPN  200 (400)
T ss_pred             hhhccCceeeEeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHH--hcchhhccCChhheeeecCCCC
Confidence            64    3568999999999999999988754  67999999999999999999999  59999999999999995   45


Q ss_pred             CcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhh
Q 017177          238 GFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCV  317 (376)
Q Consensus       238 g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~  317 (376)
                      ..+||+|||+|+.-......    .|+    +.||.|.               |||+ .|.+.+...+|+||+|++.+.+
T Consensus       201 a~lKLtDfGFAK~t~~~~~L----~TP----c~TPyYv---------------aPev-lg~eKydkscdmwSlgVimYIl  256 (400)
T KOG0604|consen  201 APLKLTDFGFAKETQEPGDL----MTP----CFTPYYV---------------APEV-LGPEKYDKSCDMWSLGVIMYIL  256 (400)
T ss_pred             cceEecccccccccCCCccc----cCC----ccccccc---------------CHHH-hCchhcCCCCCccchhHHHHHh
Confidence            67999999999976654333    222    6677777               7994 4555578999999999999888


Q ss_pred             cccc
Q 017177          318 FSFY  321 (376)
Q Consensus       318 ~~~y  321 (376)
                      +.-|
T Consensus       257 LCGy  260 (400)
T KOG0604|consen  257 LCGY  260 (400)
T ss_pred             hcCC
Confidence            7433

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=1.8e-29  Score=228.14  Aligned_cols=201  Identities=21%  Similarity=0.307  Sum_probs=169.1

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      +|++.+.||.|+||.||++....         ++..+++|++.....  .....+.+|+++++.++|||++++++.+...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~   71 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKS---------DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK   71 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcC---------CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence            47888999999999999996543         578899999986543  4556788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++|+||+++++|.+++.+.......+++..+..++.+++.||.|||  +.+++|+||+|+||+++.++.++++|||.
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--~~~~~H~dl~~~nil~~~~~~~~l~d~~~  149 (258)
T cd08215          72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH--SRKILHRDIKPQNIFLTSNGLVKLGDFGI  149 (258)
T ss_pred             CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH--hCCEecccCChHHeEEcCCCcEEECCccc
Confidence            9999999999999999999875433366899999999999999999999  58999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      +.........   ..    ...|++.|+               +||.+.... .+.++|+|++|++++++++...+.
T Consensus       150 ~~~~~~~~~~---~~----~~~~~~~y~---------------~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~  203 (258)
T cd08215         150 SKVLSSTVDL---AK----TVVGTPYYL---------------SPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPF  203 (258)
T ss_pred             eeecccCcce---ec----ceeeeeccc---------------ChhHhccCC-CCccccHHHHHHHHHHHHcCCCCC
Confidence            9877554311   11    126677777               799766554 678899999999999998765553

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=9e-30  Score=238.55  Aligned_cols=194  Identities=26%  Similarity=0.275  Sum_probs=159.3

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ..|+..+.||+|+||.||++....         ++..+|+|.+....   ......+.+|+.+++.++|||++++++++.
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   95 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL   95 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcC---------CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            347888999999999999995543         57899999987532   233457889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +++..++||||+.+ +|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+||+++.++.++++||
T Consensus        96 ~~~~~~lv~e~~~g-~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH--~~~i~H~dL~p~Nil~~~~~~~kl~df  169 (317)
T cd06635          96 REHTAWLVMEYCLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADF  169 (317)
T ss_pred             eCCeEEEEEeCCCC-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcccEEECCCCCEEEecC
Confidence            99999999999975 8888775542   45899999999999999999999  699999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh--hhhccccccccceeeeehhhcccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW--IKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~--~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |++.........           .|++.|+               +||.+..  ....+.++|+||+|++++++++-..+
T Consensus       170 g~~~~~~~~~~~-----------~~~~~y~---------------aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p  223 (317)
T cd06635         170 GSASIASPANSF-----------VGTPYWM---------------APEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  223 (317)
T ss_pred             CCccccCCcccc-----------cCCcccc---------------ChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCC
Confidence            998764432111           4556666               7997642  24568899999999999999865544

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.97  E-value=2.4e-30  Score=239.51  Aligned_cols=201  Identities=23%  Similarity=0.263  Sum_probs=161.7

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCC-CCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLS-HPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~-h~nIv~l~~~~~  165 (376)
                      ++|++.+.||+|+||.||+|....         +++.||+|.++....  .....+.+|+.+++.+. ||||+++++++.
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~   71 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKN---------TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEH   71 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECC---------CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence            468899999999999999996543         588999999875432  22356788999999996 699999999988


Q ss_pred             eCCe-----EEEEEeccCCCCHHHHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC-CC
Q 017177          166 EDKE-----LLLVYEYMQRGSLENHLFRRNPS-IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-VG  238 (376)
Q Consensus       166 ~~~~-----~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~-~g  238 (376)
                      ..+.     .|+||||+++ +|.+++...... ...+++..+..++.||+.||.|||  .++|+||||||+||+++. ++
T Consensus        72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH--~~~i~H~dl~~~nil~~~~~~  148 (295)
T cd07837          72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH--KHGVMHRDLKPQNLLVDKQKG  148 (295)
T ss_pred             ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChHHEEEecCCC
Confidence            7665     8999999986 898888654322 346899999999999999999999  699999999999999998 89


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .+||+|||++..+....... ..      ..+++.|+               +||++.+....+.++|+||+|+++++++
T Consensus       149 ~~kl~dfg~~~~~~~~~~~~-~~------~~~~~~~~---------------aPE~~~~~~~~~~~~Di~slG~~l~~l~  206 (295)
T cd07837         149 LLKIADLGLGRAFSIPVKSY-TH------EIVTLWYR---------------APEVLLGSTHYSTPVDIWSVGCIFAEMS  206 (295)
T ss_pred             eEEEeecccceecCCCcccc-CC------cccccCCC---------------ChHHhhCCCCCCchHHHHHHHHHHHHHH
Confidence            99999999998664322110 00      14455666               7998877666789999999999999998


Q ss_pred             ccccc
Q 017177          319 SFYRT  323 (376)
Q Consensus       319 ~~y~~  323 (376)
                      +...+
T Consensus       207 ~g~~~  211 (295)
T cd07837         207 RKQPL  211 (295)
T ss_pred             cCCCC
Confidence            76543

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.97  E-value=1.1e-29  Score=234.37  Aligned_cols=196  Identities=21%  Similarity=0.232  Sum_probs=162.3

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCe
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE  169 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~  169 (376)
                      .|...+.||+|++|.||++...         .++..+++|.++.......+.+.+|+.+++.++||||+++++++...+.
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~   90 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDK---------STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE   90 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEEC---------CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence            4555689999999999999543         3478899999876554555678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeee
Q 017177          170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYV  249 (376)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~  249 (376)
                      .++++||+++++|.+++..     ..+++..+..++.|++.||.|||  +++|+||||||+||+++.++.++++|||++.
T Consensus        91 ~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~  163 (285)
T cd06648          91 LWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLH--AQGVIHRDIKSDSILLTSDGRVKLSDFGFCA  163 (285)
T ss_pred             EEEEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCChhhEEEcCCCcEEEcccccch
Confidence            9999999999999999865     23788999999999999999999  5999999999999999999999999999887


Q ss_pred             eeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          250 YFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      .........   ..    ..|++.|+               +||.+.+.. .+.++|+||+|++++++++...+.
T Consensus       164 ~~~~~~~~~---~~----~~~~~~y~---------------aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~  215 (285)
T cd06648         164 QVSKEVPRR---KS----LVGTPYWM---------------APEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPY  215 (285)
T ss_pred             hhccCCccc---cc----ccCCcccc---------------CHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCC
Confidence            654322111   11    14666666               799876654 578899999999999999765543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.97  E-value=9e-30  Score=232.95  Aligned_cols=200  Identities=21%  Similarity=0.276  Sum_probs=155.7

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      |++.+.||+|+||.||+|....      ...+++.||+|.+....  ....+.+.+|+.+++.++||||+++++++....
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   74 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKS------EDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR   74 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeec------cCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            5678899999999999997642      23357899999987652  334567889999999999999999999886532


Q ss_pred             ------eEEEEEeccCCCCHHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcE
Q 017177          169 ------ELLLVYEYMQRGSLENHLFRRN--PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL  240 (376)
Q Consensus       169 ------~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~  240 (376)
                            ..++++||+.+|+|.+++....  .....+++..+..++.|++.||+|||  .++|+||||||+||+++.++.+
T Consensus        75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~nili~~~~~~  152 (273)
T cd05074          75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS--SKNFIHRDLAARNCMLNENMTV  152 (273)
T ss_pred             CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccchhhEEEcCCCCE
Confidence                  2478999999999998875432  11234788999999999999999999  5999999999999999999999


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      |++|||+++.............     ..+++.|+               +||.+... ..+.++|+||+|++++++++
T Consensus       153 kl~dfg~~~~~~~~~~~~~~~~-----~~~~~~~~---------------~pe~~~~~-~~~~~sDi~slG~il~el~~  210 (273)
T cd05074         153 CVADFGLSKKIYSGDYYRQGCA-----SKLPVKWL---------------ALESLADN-VYTTHSDVWAFGVTMWEIMT  210 (273)
T ss_pred             EECcccccccccCCcceecCCC-----ccCchhhc---------------CHhHHhcC-ccchhhhhHHHHHHHHHHhh
Confidence            9999999987644322111100     02334455               69966544 45789999999999999886

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=3.6e-30  Score=237.31  Aligned_cols=198  Identities=21%  Similarity=0.202  Sum_probs=164.6

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||++....         ++..||+|++.... ....+.+.+|+++++.++||||+++++.+..
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   74 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIP---------TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN   74 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcC---------CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec
Confidence            3578899999999999999995543         57889999887543 2345678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      .+.+++||||+++++|.+++.+.    ..+++..+..++.+++.||.|||+ ..+++||||||+||+++.++.++|+|||
T Consensus        75 ~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~d~g  149 (284)
T cd06620          75 ENNICMCMEFMDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYN-VHRIMHRDIKPSNILVNSRGQIKLCDFG  149 (284)
T ss_pred             CCEEEEEEecCCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH-hcCeeccCCCHHHEEECCCCcEEEccCC
Confidence            99999999999999999988764    458999999999999999999994 3689999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ++.........     .    ..|+..|+               +||.+.+. ..+.++|+||+|++++++++...+.
T Consensus       150 l~~~~~~~~~~-----~----~~~~~~~~---------------aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~  202 (284)
T cd06620         150 VSGELINSIAD-----T----FVGTSTYM---------------SPERIQGG-KYTVKSDVWSLGISIIELALGKFPF  202 (284)
T ss_pred             cccchhhhccC-----c----cccCcccC---------------CHHHHccC-CCCccchHHHHHHHHHHHHhCCCCC
Confidence            98765332111     1    15666676               79977654 5678999999999999998655443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.97  E-value=1e-29  Score=229.61  Aligned_cols=189  Identities=25%  Similarity=0.343  Sum_probs=155.0

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh-hHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv  173 (376)
                      +.||+|+||.||+|....          ++.||+|.+...... ....+.+|+.++++++|+||+++++++.+....++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~----------~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   70 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG----------NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV   70 (251)
T ss_pred             CccccCCCceEEEEEEeC----------CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence            468999999999995442          778999998876443 456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      |||+++++|.+++.+..   ..+++..+..++.+++.||.|||  +++++||||||+|||++.++.++|+|||++.....
T Consensus        71 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH--~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  145 (251)
T cd05041          71 MELVPGGSLLTFLRKKK---NRLTVKKLLQMSLDAAAGMEYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEG  145 (251)
T ss_pred             EEcCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCEehhhcCcceEEEcCCCcEEEeeccccccccC
Confidence            99999999999996642   35788999999999999999999  69999999999999999999999999999986543


Q ss_pred             ceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          254 HYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       254 ~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ..... ..+.    ..++..|+               +||.+.+.. .+.++|+||+|++++++++
T Consensus       146 ~~~~~-~~~~----~~~~~~y~---------------~PE~~~~~~-~~~~~Di~slG~i~~~l~t  190 (251)
T cd05041         146 GIYTV-SDGL----KQIPIKWT---------------APEALNYGR-YTSESDVWSYGILLWETFS  190 (251)
T ss_pred             Cccee-cccc----CcceeccC---------------ChHhhccCC-CCcchhHHHHHHHHHHHHh
Confidence            21110 0000    01233444               699877654 6889999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.97  E-value=1e-29  Score=232.52  Aligned_cols=192  Identities=26%  Similarity=0.346  Sum_probs=151.0

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcC-CCCCcceEEeEEEeCCeEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWEDKELLL  172 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~l  172 (376)
                      +.||+|+||.||+|...+.       .....+++|.++... ....+.+.+|+.++.++ +||||+++++++...+..++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l   73 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKD-------GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   73 (270)
T ss_pred             CcCCCCCCceEEEEEEcCC-------CCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence            3689999999999966431       112357889887543 34456788999999999 69999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcE
Q 017177          173 VYEYMQRGSLENHLFRRNP------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL  240 (376)
Q Consensus       173 v~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~  240 (376)
                      ||||+++|+|.+++.....            ....+++..+..++.|++.||+|||  +++++||||||+|||++.++.+
T Consensus        74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH--~~~i~H~dikp~nili~~~~~~  151 (270)
T cd05047          74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVA  151 (270)
T ss_pred             EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccccceEEEcCCCeE
Confidence            9999999999999976431            1134789999999999999999999  6999999999999999999999


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      |++|||++.........  ..+      ..++.|+               +||.+.. ...+.++|+||+|++++++++
T Consensus       152 kl~dfgl~~~~~~~~~~--~~~------~~~~~y~---------------apE~~~~-~~~~~~~Di~slG~il~el~~  206 (270)
T cd05047         152 KIADFGLSRGQEVYVKK--TMG------RLPVRWM---------------AIESLNY-SVYTTNSDVWSYGVLLWEIVS  206 (270)
T ss_pred             EECCCCCccccchhhhc--cCC------CCccccC---------------ChHHHcc-CCCCchhhHHHHHHHHHHHHc
Confidence            99999998632211111  000      1223344               6997654 446889999999999999985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.97  E-value=3.7e-30  Score=238.46  Aligned_cols=199  Identities=22%  Similarity=0.215  Sum_probs=165.9

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..++|++.+.||+|+||.||++...         .++..||+|.+........+.+.+|+.+++.++||||+++++.+..
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~   87 (293)
T cd06647          17 PKKKYTRFEKIGQGASGTVYTAIDV---------ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV   87 (293)
T ss_pred             chhhceeeeEecCCCCeEEEEEEEc---------CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee
Confidence            3468999999999999999999543         2477899999876555555778899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      .+..|+|+||+++++|.+++.+.     .+++..+..++.|++.||.|||  +++++||||||+||+++.++.++|+|||
T Consensus        88 ~~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH--~~gi~H~dL~p~Nili~~~~~~kL~dfg  160 (293)
T cd06647          88 GDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFG  160 (293)
T ss_pred             CCcEEEEEecCCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH--hCCEeeccCCHHHEEEcCCCCEEEccCc
Confidence            99999999999999999998653     3788899999999999999999  6999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ++..........   ..    ..|++.|+               +||.+.+.. .+.++|+||+|++++++++.+.+.
T Consensus       161 ~~~~~~~~~~~~---~~----~~~~~~y~---------------~PE~~~~~~-~~~~~Dv~slG~ll~~ll~g~~pf  215 (293)
T cd06647         161 FCAQITPEQSKR---ST----MVGTPYWM---------------APEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPY  215 (293)
T ss_pred             ceeccccccccc---cc----ccCChhhc---------------CchhhccCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            988654432211   11    14556666               799776644 578999999999999999766553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.97  E-value=1.2e-29  Score=229.88  Aligned_cols=193  Identities=25%  Similarity=0.377  Sum_probs=158.0

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      .+|++.+.||+|+||.||++.+..          +..+|+|.+..... ....+.+|+++++.++||||+++++++....
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE----------KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS   72 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC----------CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence            468888999999999999996542          56799999875533 2356888999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeee
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a  248 (376)
                      ..++||||+++++|.+++....   ..+++..+..++.|++.||.|||  +.+++||||||+||+++.++.++|+|||++
T Consensus        73 ~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~  147 (256)
T cd05112          73 PICLVFEFMEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLE--SSNVIHRDLAARNCLVGENQVVKVSDFGMT  147 (256)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHH--HCCccccccccceEEEcCCCeEEECCCcce
Confidence            9999999999999999986542   35788999999999999999999  699999999999999999999999999999


Q ss_pred             eeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          249 VYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      .......... ..+.     .++..|+               +||.+.+. ..+.++|+||+|++++++++
T Consensus       148 ~~~~~~~~~~-~~~~-----~~~~~~~---------------aPe~~~~~-~~~~~~Dv~slG~~l~el~~  196 (256)
T cd05112         148 RFVLDDQYTS-STGT-----KFPVKWS---------------SPEVFSFS-KYSSKSDVWSFGVLMWEVFS  196 (256)
T ss_pred             eecccCcccc-cCCC-----ccchhhc---------------CHhHhccC-CcChHHHHHHHHHHHHHHHc
Confidence            8664322110 1111     2223444               79977654 46788999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.97  E-value=2e-30  Score=244.93  Aligned_cols=200  Identities=25%  Similarity=0.234  Sum_probs=161.4

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|...         .++..||+|.+.... ......+.+|+.+++.++|+||+++++++..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   74 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHK---------PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRP   74 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEc---------CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeec
Confidence            468999999999999999999543         358899999987532 2334567889999999999999999998765


Q ss_pred             C-----CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEE
Q 017177          167 D-----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLF  241 (376)
Q Consensus       167 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~k  241 (376)
                      .     ...|+++||+.+ +|.+++..     ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+|
T Consensus        75 ~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH--~~~ivH~dlkp~Nill~~~~~~k  146 (336)
T cd07849          75 PSFESFNDVYIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTNCDLK  146 (336)
T ss_pred             ccccccceEEEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEECCCCCEE
Confidence            4     358999999964 88887743     34899999999999999999999  59999999999999999999999


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |+|||++..............    ...||+.|+               |||.+.+....+.++|+||+|++++++++..
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~----~~~~~~~y~---------------aPE~~~~~~~~~~~~DvwslGvil~el~~G~  207 (336)
T cd07849         147 ICDFGLARIADPEHDHTGFLT----EYVATRWYR---------------APEIMLNSKGYTKAIDIWSVGCILAEMLSNR  207 (336)
T ss_pred             ECcccceeeccccccccCCcC----CcCcCCCcc---------------ChHHhhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            999999987654322111111    115677777               8998776666789999999999999998754


Q ss_pred             cc
Q 017177          322 RT  323 (376)
Q Consensus       322 ~~  323 (376)
                      .+
T Consensus       208 ~~  209 (336)
T cd07849         208 PL  209 (336)
T ss_pred             CC
Confidence            43

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.97  E-value=1.6e-30  Score=240.66  Aligned_cols=198  Identities=22%  Similarity=0.283  Sum_probs=163.5

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh--hHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      .++|++.+.||+|+||.||+|....         ++..+|+|.++.....  ....+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~   74 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKK---------TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVV   74 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECC---------CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEE
Confidence            3579999999999999999996543         5788999999754322  2235678999999999999999999988


Q ss_pred             eC--CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          166 ED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       166 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      .+  +..|+||||+++ +|.+++....   ..+++..+..++.|++.||+|||  .++++||||||+|||++.+|.++++
T Consensus        75 ~~~~~~~~lv~e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH--~~~i~H~dl~p~nili~~~~~~~l~  148 (293)
T cd07843          75 GSNLDKIYMVMEYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLH--DNWILHRDLKTSNLLLNNRGILKIC  148 (293)
T ss_pred             ecCCCcEEEEehhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHHHEEECCCCcEEEe
Confidence            77  889999999975 9999887643   35899999999999999999999  5999999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      |||++..........  ..     ..+++.|+               +||++.+....+.++|+||+|++++++++...
T Consensus       149 d~g~~~~~~~~~~~~--~~-----~~~~~~~~---------------aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~  205 (293)
T cd07843         149 DFGLAREYGSPLKPY--TQ-----LVVTLWYR---------------APELLLGAKEYSTAIDMWSVGCIFAELLTKKP  205 (293)
T ss_pred             ecCceeeccCCcccc--cc-----cccccccc---------------CchhhcCCccccchhhHHHHHHHHHHHHhCCC
Confidence            999999776542211  01     14556666               79988776667889999999999999986543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=5.9e-30  Score=235.31  Aligned_cols=190  Identities=23%  Similarity=0.235  Sum_probs=152.0

Q ss_pred             eEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh---hHHHHHHHH---HHHhcCCCCCcceEEeEEEeCCe
Q 017177           96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ---GFEEWQSEV---NFLGRLSHPNLVKLLGYCWEDKE  169 (376)
Q Consensus        96 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~---~il~~l~h~nIv~l~~~~~~~~~  169 (376)
                      +||+|+||.||+|...         .+++.||+|.+......   ....+..|.   ..++...||||+++++++...+.
T Consensus         1 ~ig~g~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~   71 (278)
T cd05606           1 IIGRGGFGEVYGCRKA---------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   71 (278)
T ss_pred             CcccCCCeEEEEEEEe---------cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence            4899999999999543         35889999998764221   112233343   34445679999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeee
Q 017177          170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYV  249 (376)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~  249 (376)
                      .++||||++||+|.+++...    ..+++..+..++.|++.||.|||  +.+|+||||||+||+++.++.++|+|||++.
T Consensus        72 ~~~v~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~di~p~nili~~~~~~kl~dfg~~~  145 (278)
T cd05606          72 LSFILDLMNGGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLAC  145 (278)
T ss_pred             EEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCEEcCCCCHHHEEECCCCCEEEccCcCcc
Confidence            99999999999999988654    45899999999999999999999  5999999999999999999999999999987


Q ss_pred             eeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          250 YFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ........         ...|++.|+               +||.+.+....+.++|+||+|++++++++...+.
T Consensus       146 ~~~~~~~~---------~~~~~~~y~---------------aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~  196 (278)
T cd05606         146 DFSKKKPH---------ASVGTHGYM---------------APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF  196 (278)
T ss_pred             ccCccCCc---------CcCCCcCCc---------------CcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCC
Confidence            65432211         115677777               7998876555688999999999999999665543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.97  E-value=7.1e-30  Score=231.34  Aligned_cols=187  Identities=26%  Similarity=0.333  Sum_probs=153.4

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      ++|++.+.||+|+||.||++..           +++.||+|.++...  ..+.+.+|+.+++.++||||+++++++..+ 
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-----------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-   71 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-----------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-   71 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-----------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-
Confidence            4689999999999999998843           26779999987643  235788999999999999999999988654 


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeee
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a  248 (376)
                      ..+++|||+++++|.+++....  ...+++..+..++.|++.||.|||  +.+++||||||+||+++.++.++|+|||++
T Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH--~~~~~H~dl~p~nili~~~~~~kl~Dfg~~  147 (254)
T cd05083          72 GLYIVMELMSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLE--SKKLVHRDLAARNILVSEDGVAKVSDFGLA  147 (254)
T ss_pred             CcEEEEECCCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEEcCCCcEEECCCccc
Confidence            4799999999999999997653  245789999999999999999999  699999999999999999999999999999


Q ss_pred             eeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          249 VYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      .........  .        ..++.|+               +||.+.+. ..+.+.|+||+|++++++++
T Consensus       148 ~~~~~~~~~--~--------~~~~~y~---------------~pe~~~~~-~~~~~~Dv~slG~~l~el~~  192 (254)
T cd05083         148 RVGSMGVDN--S--------KLPVKWT---------------APEALKHK-KFSSKSDVWSYGVLLWEVFS  192 (254)
T ss_pred             eeccccCCC--C--------CCCceec---------------CHHHhccC-CcCchhhHHHHHHHHHHHHh
Confidence            865332111  1        1123343               69977654 45788999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8.8e-30  Score=231.45  Aligned_cols=188  Identities=21%  Similarity=0.193  Sum_probs=152.6

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHh-cCCCCCcceEEeEEEeCCeE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLG-RLSHPNLVKLLGYCWEDKEL  170 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~-~l~h~nIv~l~~~~~~~~~~  170 (376)
                      +.||+|+||.||+|...         .+++.||+|.+.....   .....+..|..++. ..+|+||+++++++..++.+
T Consensus         2 ~~l~~g~~~~v~~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   72 (260)
T cd05611           2 KPISKGAFGSVYLAKKR---------STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL   72 (260)
T ss_pred             ccCCcCCCeeEEEEEec---------CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence            57899999999999543         3578999999876432   22234455555444 45799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      |+||||+++++|.+++...    ..+++..+..++.|++.||.|||  ..+++||||+|+||+++.++.++|+|||++..
T Consensus        73 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  146 (260)
T cd05611          73 YLVMEYLNGGDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLH--QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN  146 (260)
T ss_pred             EEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCcEEEeeccccee
Confidence            9999999999999999765    45889999999999999999999  59999999999999999999999999999886


Q ss_pred             eccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          251 FKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ......       .    .|++.|+               +||.+.+.. .+.++|+|++|++++++++...+.
T Consensus       147 ~~~~~~-------~----~~~~~y~---------------~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~  193 (260)
T cd05611         147 GLENKK-------F----VGTPDYL---------------APETILGVG-DDKMSDWWSLGCVIFEFLFGYPPF  193 (260)
T ss_pred             cccccc-------C----CCCcCcc---------------ChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCC
Confidence            543111       1    4556666               799887765 688999999999999998654443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.97  E-value=3e-30  Score=236.93  Aligned_cols=195  Identities=24%  Similarity=0.297  Sum_probs=161.1

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      .|+..+.||+|+||.||+|....         ++..||+|.++... ....+.+.+|+.+++.++||||+++++.+..++
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNR---------TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT   75 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcC---------CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence            46777899999999999995543         47889999987553 334567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeee
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a  248 (376)
                      ..|+||||+++++|.+++..     ..+++..+..++.|++.||.|||  .++++|+||+|+||+++.++.++++|||++
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH--~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~  148 (277)
T cd06642          76 KLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLH--SERKIHRDIKAANVLLSEQGDVKLADFGVA  148 (277)
T ss_pred             ceEEEEEccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHh--cCCeeccCCChheEEEeCCCCEEEcccccc
Confidence            99999999999999998853     34788999999999999999999  699999999999999999999999999999


Q ss_pred             eeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          249 VYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ............       ..|+..|+               +||.+.+.. .+.++|+||+|++++++++...+
T Consensus       149 ~~~~~~~~~~~~-------~~~~~~y~---------------aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p  200 (277)
T cd06642         149 GQLTDTQIKRNT-------FVGTPFWM---------------APEVIKQSA-YDFKADIWSLGITAIELAKGEPP  200 (277)
T ss_pred             ccccCcchhhhc-------ccCccccc---------------CHHHhCcCC-CchhhhHHHHHHHHHHHHhCCCC
Confidence            876543221100       13455555               699877654 57889999999999999865444

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-31  Score=253.56  Aligned_cols=202  Identities=22%  Similarity=0.333  Sum_probs=170.8

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh-hHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ++..+.++||+|.||.|++|.|....      +.-..||||.++..... ....|++|+.+|.+|+|+|+++|||+..+ 
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~ps------gk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-  182 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPS------GKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-  182 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCC------CcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-
Confidence            34567789999999999999887532      23567999999987654 56899999999999999999999999887 


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      ....||||+++.|+|.+.|++..  ...|.......++.||+.||.||.+  +++|||||..+|+|+.....|||+|||+
T Consensus       183 qp~mMV~ELaplGSLldrLrka~--~~~llv~~Lcdya~QiA~aM~YLes--krlvHRDLAARNlllasprtVKI~DFGL  258 (1039)
T KOG0199|consen  183 QPAMMVFELAPLGSLLDRLRKAK--KAILLVSRLCDYAMQIAKAMQYLES--KRLVHRDLAARNLLLASPRTVKICDFGL  258 (1039)
T ss_pred             chhhHHhhhcccchHHHHHhhcc--ccceeHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhhhheecccceeeeecccc
Confidence            67899999999999999998732  3568888999999999999999995  9999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      .+.++..+..        |.       |    .+.+---|.|+|||-+.. ..++-++|||.+|+.+|||++|=
T Consensus       259 mRaLg~ned~--------Yv-------m----~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyG  312 (1039)
T KOG0199|consen  259 MRALGENEDM--------YV-------M----APQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYG  312 (1039)
T ss_pred             eeccCCCCcc--------eE-------e----cCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccC
Confidence            9998775443        11       1    455555667889996654 45799999999999999999773

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.97  E-value=3.8e-30  Score=236.81  Aligned_cols=199  Identities=23%  Similarity=0.302  Sum_probs=163.0

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      +|+..+.||.|++|.||+|...         .++..||+|.++.... .....+.+|+.+++.++|+||+++++++.+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   71 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNR---------TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN   71 (284)
T ss_pred             CceEeeeeccCCceEEEEEEEC---------CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC
Confidence            5888999999999999999554         3588999999876533 23456778999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeee
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a  248 (376)
                      ..++||||+++ +|.+++..... ...+++..+..++.|++.||.|||  ..+++||||||+||++++++.++++|||++
T Consensus        72 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~  147 (284)
T cd07836          72 KLMLVFEYMDK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLA  147 (284)
T ss_pred             cEEEEEecCCc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEECCCCcEEEeecchh
Confidence            99999999975 89888865432 245899999999999999999999  589999999999999999999999999999


Q ss_pred             eeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          249 VYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ..........   ..    ..+++.|+               +||.+.+....+.++|+|++|++++++++-..+
T Consensus       148 ~~~~~~~~~~---~~----~~~~~~y~---------------~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~  200 (284)
T cd07836         148 RAFGIPVNTF---SN----EVVTLWYR---------------APDVLLGSRTYSTSIDIWSVGCIMAEMITGRPL  200 (284)
T ss_pred             hhhcCCcccc---cc----cccccccc---------------ChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            8654322110   00    14455566               699887766678899999999999999865543

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.97  E-value=2e-29  Score=231.44  Aligned_cols=196  Identities=25%  Similarity=0.288  Sum_probs=161.3

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      -|+..+.||.|+||.||+|....         ++..||+|.+.... ......+.+|+.+++.++||||+++++.+..++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   75 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNR---------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT   75 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECC---------CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC
Confidence            47788999999999999995543         47899999987543 233467889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeee
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a  248 (376)
                      ..|+||||+++++|.+++..     ..+++..+..++.|++.||.|||  +.+++|+||||+||+++.++.++++|||++
T Consensus        76 ~~~lv~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~  148 (277)
T cd06641          76 KLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFGVA  148 (277)
T ss_pred             eEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHc--cCCeecCCCCHHhEEECCCCCEEEeecccc
Confidence            99999999999999998853     34789999999999999999999  699999999999999999999999999998


Q ss_pred             eeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          249 VYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ..........   ..    ..|+..|+               +||.+.+. ..+.++|+||+|++++++++...+.
T Consensus       149 ~~~~~~~~~~---~~----~~~~~~y~---------------~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~  201 (277)
T cd06641         149 GQLTDTQIKR---NT----FVGTPFWM---------------APEVIKQS-AYDSKADIWSLGITAIELAKGEPPH  201 (277)
T ss_pred             eecccchhhh---cc----ccCCcccc---------------ChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCC
Confidence            8764432110   11    14555565               69977654 4578899999999999998765543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=4.9e-30  Score=237.06  Aligned_cols=200  Identities=24%  Similarity=0.260  Sum_probs=162.2

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh----hhHHHHHHHHHHHhcCC-CCCcceEEeEE
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM----QGFEEWQSEVNFLGRLS-HPNLVKLLGYC  164 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~-h~nIv~l~~~~  164 (376)
                      +|++.+.||+|+||.||+|....      ...++..||+|.+.....    ...+.+.+|+.+++.+. |+||+++++.+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~------~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~   74 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVS------GHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF   74 (290)
T ss_pred             CceeeeeeccCCcceEEEEEecc------CCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence            47888999999999999996542      122478899999875422    22356788999999995 99999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      ..+...|+||||+++++|.+++...    ..+++..+..++.|++.||.|||  +.+++||||||+|||++.++.+||+|
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl~d  148 (290)
T cd05613          75 QTDTKLHLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTD  148 (290)
T ss_pred             ecCCeEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeEECCCCCEEEee
Confidence            9999999999999999999999765    45788999999999999999999  69999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh-hhccccccccceeeeehhhccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI-KYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~-~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      ||++..........      .+...|++.|+               +||.+... ...+.+.|+||+|++++++++-..
T Consensus       149 fg~~~~~~~~~~~~------~~~~~~~~~y~---------------aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~  206 (290)
T cd05613         149 FGLSKEFHEDEVER------AYSFCGTIEYM---------------APDIVRGGDGGHDKAVDWWSMGVLMYELLTGAS  206 (290)
T ss_pred             Cccceecccccccc------cccccCCcccC---------------ChhhccCCCCCCCccccHHHHHHHHHHHhcCCC
Confidence            99998764432211      01124666666               79977643 345788999999999999986543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.97  E-value=1.6e-29  Score=233.21  Aligned_cols=201  Identities=23%  Similarity=0.224  Sum_probs=167.6

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ....+.|+..+.||+|+||.||+|....         ++..+++|++..... ..+.+.+|+.+++.++|+||+++++.+
T Consensus        15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~   84 (286)
T cd06614          15 GDPRELYKNLEKIGEGASGEVYKATDRA---------TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSY   84 (286)
T ss_pred             CCccccchHhHhccCCCCeEEEEEEEcc---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEE
Confidence            3456779999999999999999996543         478899999987654 456788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      ...+..|+++||+++++|.+++....   ..+++..+..++.|++.||.|||  ..+|+|+||||+||+++.++.++|+|
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH--~~gi~H~dl~p~ni~i~~~~~~~l~d  159 (286)
T cd06614          85 LVGDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLH--SQNVIHRDIKSDNILLSKDGSVKLAD  159 (286)
T ss_pred             EECCEEEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCChhhEEEcCCCCEEECc
Confidence            99999999999999999999998753   36899999999999999999999  69999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ||++..........   .+    ..+++.|+               +||++.+.. .+.++|+||+|++++++++-..+
T Consensus       160 ~~~~~~~~~~~~~~---~~----~~~~~~y~---------------~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p  215 (286)
T cd06614         160 FGFAAQLTKEKSKR---NS----VVGTPYWM---------------APEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPP  215 (286)
T ss_pred             cchhhhhccchhhh---cc----ccCCcccC---------------CHhHhcCCC-CCCccccHHHHHHHHHHHhCCCC
Confidence            99987654332110   00    13455566               699776654 57899999999999999875443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=251.96  Aligned_cols=197  Identities=22%  Similarity=0.329  Sum_probs=164.9

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ..+.....+||-|.||.||.|.|..         ....||||.++.+.. .+++|+.|+.+|+.++|||+|+++|+|..+
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKk---------yslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~E  335 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHE  335 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeec---------cceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence            3455666789999999999997764         467899999987664 458999999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      ..+|||+|||..|+|.++|++...  ..++....+.++.||..|+.||.  .+++|||||.++|+|+.++..||++|||+
T Consensus       336 pPFYIiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLE--kknFIHRDLAARNCLVgEnhiVKvADFGL  411 (1157)
T KOG4278|consen  336 PPFYIITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHIVKVADFGL  411 (1157)
T ss_pred             CCeEEEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHH--HhhhhhhhhhhhhccccccceEEeeccch
Confidence            999999999999999999998764  45777888999999999999999  79999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ++.++..... ...|...-+.                    |.|||-+... .++.++|||.||+++||+++|
T Consensus       412 sRlMtgDTYT-AHAGAKFPIK--------------------WTAPEsLAyN-tFSiKSDVWAFGVLLWEIATY  462 (1157)
T KOG4278|consen  412 SRLMTGDTYT-AHAGAKFPIK--------------------WTAPESLAYN-TFSIKSDVWAFGVLLWEIATY  462 (1157)
T ss_pred             hhhhcCCcee-cccCccCccc--------------------ccCccccccc-ccccchhhHHHHHHHHHHHhc
Confidence            9988764332 2223221122                    3368866554 468999999999999999955

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.97  E-value=5.3e-30  Score=235.33  Aligned_cols=190  Identities=25%  Similarity=0.263  Sum_probs=156.6

Q ss_pred             EeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEE
Q 017177           97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        97 lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv  173 (376)
                      ||+|+||.||+|....         +++.||+|.+.....   .....+.+|+.+++.++||||+++++.+...+..|+|
T Consensus         1 lg~g~~g~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   71 (277)
T cd05577           1 LGKGGFGEVCACQVKA---------TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV   71 (277)
T ss_pred             CCCCCceeEEEEEEcC---------CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence            6899999999995443         588999999875422   2234667899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      |||+++++|.+++.+...  ..+++..+..++.|++.||.|||  ..+++||||||+||+++.++.++|+|||++.....
T Consensus        72 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH--~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~  147 (277)
T cd05577          72 MTLMNGGDLKYHIYNVGE--PGFPEARAIFYAAQIICGLEHLH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG  147 (277)
T ss_pred             EecCCCCcHHHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence            999999999999976532  35899999999999999999999  69999999999999999999999999999986543


Q ss_pred             ceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          254 HYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       254 ~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      .......        .+++.|+               +||.+.+.. .+.++|+||+|++++++++-..+
T Consensus       148 ~~~~~~~--------~~~~~y~---------------~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p  193 (277)
T cd05577         148 GKKIKGR--------AGTPGYM---------------APEVLQGEV-YDFSVDWFALGCTLYEMIAGRSP  193 (277)
T ss_pred             CCccccc--------cCCCCcC---------------CHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCC
Confidence            2221111        4555666               799877655 67889999999999999865443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=6.9e-30  Score=236.53  Aligned_cols=199  Identities=21%  Similarity=0.255  Sum_probs=160.4

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ++|++.+.||+|++|.||+|...         .+++.||+|.+.....  ...+.+.+|+.+++.++||||+++++++.+
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDR---------VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS   72 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEec---------CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence            56899999999999999999543         3588999999875432  223567889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC-CCcEEEcce
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-VGFLFDSHL  245 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~-~g~~kl~Df  245 (376)
                      ++..|+||||++ ++|.+++.....  ..+++..+..++.||+.||+|||  +++++||||||+||+++. ++.+|++||
T Consensus        73 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~i~H~dl~p~nill~~~~~~~kl~df  147 (294)
T PLN00009         73 EKRLYLVFEYLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCH--SHRVLHRDLKPQNLLIDRRTNALKLADF  147 (294)
T ss_pred             CCeEEEEEeccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCcceEEEECCCCEEEEccc
Confidence            999999999996 588888765432  34678888999999999999999  699999999999999985 457999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |++..........  ..     ..+++.|+               +||.+.+....+.++|+||+|++++++++...+
T Consensus       148 g~~~~~~~~~~~~--~~-----~~~~~~y~---------------~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~p  203 (294)
T PLN00009        148 GLARAFGIPVRTF--TH-----EVVTLWYR---------------APEILLGSRHYSTPVDIWSVGCIFAEMVNQKPL  203 (294)
T ss_pred             ccccccCCCcccc--cc-----Cceeeccc---------------CHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            9998654321110  00     14456666               699887766678899999999999999876443

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.97  E-value=7.8e-30  Score=232.86  Aligned_cols=199  Identities=25%  Similarity=0.320  Sum_probs=156.4

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv  173 (376)
                      +.||+|+||.||+|...+..   .....+..+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~---~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDIL---GPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII   77 (269)
T ss_pred             CccccccceeEEeeeecccc---cCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence            36899999999999765321   112234689999886543 23456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC-----cEEEcce
Q 017177          174 YEYMQRGSLENHLFRRNP---SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG-----FLFDSHL  245 (376)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g-----~~kl~Df  245 (376)
                      |||+++++|.+++.+...   ....+++..++.++.|++.||.|||  +.+++|+||||+||+++.++     .++++||
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~~~~~~l~df  155 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDF  155 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH--hCCcccCCCChheEEEecCCCCCCcceEECCc
Confidence            999999999999975422   1234788999999999999999999  59999999999999999887     8999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      |++............ +..    .++..|+               +||.+.+.. .+.++|+||||++++++++
T Consensus       156 g~~~~~~~~~~~~~~-~~~----~~~~~y~---------------aPE~~~~~~-~~~~~Dv~slG~il~ellt  208 (269)
T cd05044         156 GLARDIYKSDYYRKE-GEG----LLPVRWM---------------APESLLDGK-FTTQSDVWSFGVLMWEILT  208 (269)
T ss_pred             ccccccccccccccC-ccc----CCCcccc---------------CHHHHccCC-cccchhHHHHHHHHHHHHH
Confidence            999866443221111 111    3344555               799776544 5899999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.8e-32  Score=251.02  Aligned_cols=198  Identities=21%  Similarity=0.186  Sum_probs=170.4

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..+++.+..||-|+||.|-++..+..         ...+|+|++++..   ..+.+.+..|-.||..++.|.||++|..|
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~---------~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf  489 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQ---------KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF  489 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEeccc---------chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence            45677888999999999999876642         2358888887653   34457788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .+..++|++||-|-||.|...|+.+    ..++...+..++..+++|++|||  .++||.|||||+|+|+|.+|.+||.|
T Consensus       490 rd~kyvYmLmEaClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH--~k~iIYRDLKPENllLd~~Gy~KLVD  563 (732)
T KOG0614|consen  490 RDSKYVYMLMEACLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLH--RKGIIYRDLKPENLLLDNRGYLKLVD  563 (732)
T ss_pred             ccchhhhhhHHhhcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHH--hcCceeccCChhheeeccCCceEEee
Confidence            9999999999999999999999877    56899999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ||+|+.++.....        ++.+|||+|.               ||||+..++ ...++|.|++|+..+|+++---+.
T Consensus       564 FGFAKki~~g~KT--------wTFcGTpEYV---------------APEIILnKG-HD~avDyWaLGIli~ELL~G~pPF  619 (732)
T KOG0614|consen  564 FGFAKKIGSGRKT--------WTFCGTPEYV---------------APEIILNKG-HDRAVDYWALGILIYELLTGSPPF  619 (732)
T ss_pred             hhhHHHhccCCce--------eeecCCcccc---------------cchhhhccC-cchhhHHHHHHHHHHHHHcCCCCC
Confidence            9999998775443        3348888888               899888766 578899999999999999544333

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=1.9e-29  Score=230.61  Aligned_cols=194  Identities=19%  Similarity=0.127  Sum_probs=155.2

Q ss_pred             hhhhcCCCCccceE--eecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcC-CCCCcceE
Q 017177           84 LKSATKNFKPDSLL--GEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKL  160 (376)
Q Consensus        84 ~~~~~~~y~~~~~l--G~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l  160 (376)
                      .....++|++.+.+  |+|+||.||++...         .++..+|+|.+........     |+.+...+ +||||+++
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~   74 (267)
T PHA03390          9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHK---------PTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKL   74 (267)
T ss_pred             HHHHHHhhccccceeecCCCceEEEEEEEc---------CCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEE
Confidence            33445677777776  99999999999543         3588899999875432211     22223223 69999999


Q ss_pred             EeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC-c
Q 017177          161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG-F  239 (376)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g-~  239 (376)
                      ++.+..++..|+||||+++++|.+++...    ..+++..+..++.|++.||.|||  +.+++||||||+||+++.++ .
T Consensus        75 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~  148 (267)
T PHA03390         75 YYSVTTLKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLH--KHNIIHNDIKLENVLYDRAKDR  148 (267)
T ss_pred             EEEEecCCeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEEeCCCCe
Confidence            99999999999999999999999999765    36899999999999999999999  58999999999999999998 9


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ++++|||++.........           .|++.|+               +||.+.+.. .+.++|+||+|++++++++
T Consensus       149 ~~l~dfg~~~~~~~~~~~-----------~~~~~y~---------------aPE~~~~~~-~~~~~DvwslG~il~~l~~  201 (267)
T PHA03390        149 IYLCDYGLCKIIGTPSCY-----------DGTLDYF---------------SPEKIKGHN-YDVSFDWWAVGVLTYELLT  201 (267)
T ss_pred             EEEecCccceecCCCccC-----------CCCCccc---------------ChhhhcCCC-CCchhhHHHHHHHHHHHHH
Confidence            999999999876543211           4556666               799887655 4788999999999999997


Q ss_pred             ccccc
Q 017177          320 FYRTT  324 (376)
Q Consensus       320 ~y~~~  324 (376)
                      ...+.
T Consensus       202 g~~p~  206 (267)
T PHA03390        202 GKHPF  206 (267)
T ss_pred             CCCCC
Confidence            65443

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.97  E-value=1.4e-29  Score=234.56  Aligned_cols=194  Identities=21%  Similarity=0.221  Sum_probs=160.1

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeE
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKEL  170 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~  170 (376)
                      |.....||+|+||.||++....         ++..||+|++..........+.+|+.+++.++|+||+++++.+...+..
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   92 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL   92 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcC---------CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEE
Confidence            3445789999999999995543         5889999998765555556788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      ++||||+++++|.+++..     ..+++..+..++.|++.||.|||  +.+++||||||+||+++.++.++++|||++..
T Consensus        93 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH--~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~  165 (292)
T cd06657          93 WVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ  165 (292)
T ss_pred             EEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEccccccee
Confidence            999999999999998743     24788999999999999999999  58999999999999999999999999999876


Q ss_pred             eccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          251 FKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ........   .    ...|++.|+               +||.+.... .+.++|+||+|++++++++...+
T Consensus       166 ~~~~~~~~---~----~~~~~~~y~---------------~pE~~~~~~-~~~~~Dv~slGvil~el~tg~~p  215 (292)
T cd06657         166 VSKEVPRR---K----SLVGTPYWM---------------APELISRLP-YGPEVDIWSLGIMVIEMVDGEPP  215 (292)
T ss_pred             cccccccc---c----ccccCcccc---------------CHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCC
Confidence            54322111   1    114666666               799776544 47899999999999999975554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.96  E-value=1.2e-30  Score=240.22  Aligned_cols=197  Identities=25%  Similarity=0.342  Sum_probs=161.1

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      +|+..+.||.|+||.||+|...         .++..||+|.++....  .....+.+|++++++++||||+++++++.++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   71 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNK---------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE   71 (284)
T ss_pred             CceeeeeecCCCceEEEEEEEC---------CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence            4888999999999999999543         3588999999875432  2235678999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++||||+. ++|..++....  ...+++..+..++.|++.||+|||  +.+++||||||+||+++.++.+|++|||+
T Consensus        72 ~~~~~v~e~~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh--~~~i~H~~l~p~nill~~~~~~~l~dfg~  146 (284)
T cd07860          72 NKLYLVFEFLH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGL  146 (284)
T ss_pred             CcEEEEeeccc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999999996 58988886543  245899999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      +............       ..+++.|+               +||++.+....+.++|+||+|++++++++-..
T Consensus       147 ~~~~~~~~~~~~~-------~~~~~~y~---------------aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~  199 (284)
T cd07860         147 ARAFGVPVRTYTH-------EVVTLWYR---------------APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA  199 (284)
T ss_pred             hhhcccCcccccc-------cccccccc---------------CCeEEecCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence            8865432211000       03445555               69977776667888999999999999986543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.96  E-value=8.5e-30  Score=231.97  Aligned_cols=197  Identities=22%  Similarity=0.250  Sum_probs=164.8

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ++|+..+.||+|+||.||++...         .+++.+|+|.+..... .....+.+|+.+++.++||||+++++.+..+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHR---------PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN   71 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEc---------CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC
Confidence            36888899999999999999554         3588899999877633 3446788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +.+++++||+++++|.+++....   ..+++..+..++.|++.||.|||+ ..+++||||||+||+++.++.++|+|||.
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~-~~~i~H~dl~~~ni~~~~~~~~~l~d~g~  147 (265)
T cd06605          72 GDISICMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFGV  147 (265)
T ss_pred             CEEEEEEEecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcC-CCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999999999999999997652   458899999999999999999993 28999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      +.......... .        .|++.|+               +||.+.+. ..+.++|+||+|++++++++...+
T Consensus       148 ~~~~~~~~~~~-~--------~~~~~y~---------------~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p  198 (265)
T cd06605         148 SGQLVNSLAKT-F--------VGTSSYM---------------APERIQGN-DYSVKSDIWSLGLSLIELATGRFP  198 (265)
T ss_pred             chhhHHHHhhc-c--------cCChhcc---------------CHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            88664332221 1        4555566               79988765 467889999999999999974433

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.96  E-value=1.9e-29  Score=229.54  Aligned_cols=189  Identities=23%  Similarity=0.238  Sum_probs=158.6

Q ss_pred             EeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEE
Q 017177           97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        97 lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv  173 (376)
                      ||.|+||.||+|....         ++..+|+|++.....   ...+.+.+|+.+++.++||||+++++.+.++...+++
T Consensus         1 lg~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   71 (262)
T cd05572           1 LGVGGFGRVELVKVKS---------KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML   71 (262)
T ss_pred             CCCCCceEEEEEEECC---------CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence            6899999999996543         588999999875432   2346788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      |||+++++|.+++.+.    ..+++..+..++.|++.||.|||  +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        72 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH--~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~  145 (262)
T cd05572          72 MEYCLGGELWTILRDR----GLFDEYTARFYIACVVLAFEYLH--NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS  145 (262)
T ss_pred             EecCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence            9999999999999765    34889999999999999999999  69999999999999999999999999999987755


Q ss_pred             ceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          254 HYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       254 ~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ....        +...|++.|+               +||.+.+.. .+.++|+|++|++++++++...+.
T Consensus       146 ~~~~--------~~~~~~~~~~---------------~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~  192 (262)
T cd05572         146 GQKT--------WTFCGTPEYV---------------APEIILNKG-YDFSVDYWSLGILLYELLTGRPPF  192 (262)
T ss_pred             cccc--------ccccCCcCcc---------------ChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCc
Confidence            3211        2225667777               799776544 578899999999999998654443

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=4.7e-29  Score=225.27  Aligned_cols=196  Identities=26%  Similarity=0.353  Sum_probs=165.5

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      +|++.+.||+|++|.||++....         .++.|++|.+.....  .....+.+|++++++++|+|++++++++..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLE---------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS   71 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcC---------CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence            47888999999999999995543         478899999987654  4567889999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..+++|||+++++|.+++...    ..+++..+..++.|++.||.|||  ..+|+||||||+||+++.++.++|+|||+
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~~l~d~~~  145 (254)
T cd06627          72 DSLYIILEYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLH--EQGVIHRDIKAANILTTKDGVVKLADFGV  145 (254)
T ss_pred             CEEEEEEecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCHHHEEECCCCCEEEecccc
Confidence            9999999999999999999765    45899999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      +..........       ....+++.|+               +||.+.+.. .+.++|+|++|++++++++...+
T Consensus       146 ~~~~~~~~~~~-------~~~~~~~~y~---------------~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p  198 (254)
T cd06627         146 ATKLNDVSKDD-------ASVVGTPYWM---------------APEVIEMSG-ASTASDIWSLGCTVIELLTGNPP  198 (254)
T ss_pred             ceecCCCcccc-------cccccchhhc---------------CHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCC
Confidence            99876543310       1114455555               799776655 67899999999999999865433

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.96  E-value=5.3e-29  Score=224.14  Aligned_cols=196  Identities=27%  Similarity=0.305  Sum_probs=166.5

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCe
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE  169 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~  169 (376)
                      +|+..+.||+|++|.||++....         ++..+++|++..........+.+|+.+++.++|+||+++++.+..+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   71 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE   71 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECC---------CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            47788999999999999996543         478899999987765566788999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeee
Q 017177          170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYV  249 (376)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~  249 (376)
                      .++++||+++++|.+++....   ..+++..+..++.|++.||.|||  ..+++||||+|+||++++++.++|+|||.+.
T Consensus        72 ~~l~~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~  146 (253)
T cd05122          72 LWIVMEFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSA  146 (253)
T ss_pred             EEEEEecCCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhh--cCCEecCCCCHHHEEEccCCeEEEeeccccc
Confidence            999999999999999987652   45899999999999999999999  6999999999999999999999999999998


Q ss_pred             eeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          250 YFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ...........        .|++.|+               +||.+.+.. .+.+.|+|++|++++++++-..+
T Consensus       147 ~~~~~~~~~~~--------~~~~~~~---------------~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p  196 (253)
T cd05122         147 QLSDTKARNTM--------VGTPYWM---------------APEVINGKP-YDYKADIWSLGITAIELAEGKPP  196 (253)
T ss_pred             cccccccccce--------ecCCccc---------------CHHHHcCCC-CCccccHHHHHHHHHHHHhCCCC
Confidence            77654321112        4555565               699877654 68899999999999999865433

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.96  E-value=3.9e-29  Score=233.30  Aligned_cols=195  Identities=27%  Similarity=0.296  Sum_probs=159.5

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC---ChhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      .+.|+..+.||+|+||.||+|....         ++..+|+|.+...   ......++.+|+.+++.++|+|++++++++
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   84 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY   84 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcC---------CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence            3457788999999999999996543         5788999998643   223345778899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      ...+..++||||+. |+|.+++....   ..+++..+..++.|++.||.|||  ..+++||||||+|||++.++.++++|
T Consensus        85 ~~~~~~~lv~e~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH--~~~i~H~dl~p~nil~~~~~~~kl~d  158 (308)
T cd06634          85 LREHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGD  158 (308)
T ss_pred             EcCCeeEEEEEccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHhEEECCCCcEEECC
Confidence            99999999999996 58888775442   45889999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh--hhhccccccccceeeeehhhccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW--IKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~--~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      ||++........           ..|++.|+               +||.+.+  ....+.++|+||+|++++++++...
T Consensus       159 fg~~~~~~~~~~-----------~~~~~~y~---------------aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~  212 (308)
T cd06634         159 FGSASIMAPANX-----------FVGTPYWM---------------APEVILAMDEGQYDGKVDVWSLGITCIELAERKP  212 (308)
T ss_pred             cccceeecCccc-----------ccCCcccc---------------CHHHHhhcccCCCCcccchHHHHHHHHHHHcCCC
Confidence            999886543211           14556666               7997753  2446789999999999999986655


Q ss_pred             c
Q 017177          323 T  323 (376)
Q Consensus       323 ~  323 (376)
                      +
T Consensus       213 p  213 (308)
T cd06634         213 P  213 (308)
T ss_pred             C
Confidence            4

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.96  E-value=3.6e-30  Score=237.34  Aligned_cols=198  Identities=22%  Similarity=0.226  Sum_probs=163.5

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ++|++.+.||+|+||.||+|....         +++.||+|.++...  ....+.+.+|+++++.++|+||+++++++..
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   71 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKA---------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR   71 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCC---------CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE
Confidence            368899999999999999995543         57899999987542  2334678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++..+++|||++++.+..+..+.    ..+++..+..++.|++.||.|||  +.+++||||||+||++++++.+||+|||
T Consensus        72 ~~~~~iv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~ni~~~~~~~~kl~d~g  145 (288)
T cd07833          72 KGRLYLVFEYVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCH--SHNIIHRDIKPENILVSESGVLKLCDFG  145 (288)
T ss_pred             CCEEEEEEecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEEEeee
Confidence            99999999999986666555433    44889999999999999999999  6999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      ++...........  ..    ..+++.|+               +||++.+....+.++|+||+|++++++++...
T Consensus       146 ~~~~~~~~~~~~~--~~----~~~~~~~~---------------~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~  200 (288)
T cd07833         146 FARALRARPASPL--TD----YVATRWYR---------------APELLVGDTNYGKPVDVWAIGCIMAELLDGEP  200 (288)
T ss_pred             cccccCCCccccc--cC----cccccCCc---------------CCchhcCCCCcCchhhHHHHHHHHHHHHhCCC
Confidence            9988765432100  11    15566666               79988877567899999999999999987543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.96  E-value=1.9e-29  Score=228.53  Aligned_cols=199  Identities=23%  Similarity=0.309  Sum_probs=163.5

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      +|++.+.||+|+||.||++....         ++..+|+|.+.....  ...+.+.+|+.+++.++|+||+++++.+..+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~   71 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKS---------DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN   71 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcC---------CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence            47888999999999999996543         578899999876422  3345778999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc-EEEccee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF-LFDSHLL  246 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~-~kl~Dfg  246 (376)
                      +..++|+||+++++|.+++.+...  ..+++..+..++.|++.||.|||  ..+++|+||||+||++++++. ++++|||
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh--~~~i~H~dl~~~nil~~~~~~~~~l~d~~  147 (257)
T cd08225          72 GRLFIVMEYCDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIH--DRKILHRDIKSQNIFLSKNGMVAKLGDFG  147 (257)
T ss_pred             CeEEEEEecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEEcCCCCeEEecccc
Confidence            999999999999999999976532  35789999999999999999999  599999999999999998864 6999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      .+..........       ....|++.|+               +||.+... ..+.++|+||+|++++++++...+.
T Consensus       148 ~~~~~~~~~~~~-------~~~~~~~~~~---------------ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~  202 (257)
T cd08225         148 IARQLNDSMELA-------YTCVGTPYYL---------------SPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPF  202 (257)
T ss_pred             cchhccCCcccc-------cccCCCcccc---------------CHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            998765432211       1115666677               79976654 3578999999999999998765554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.96  E-value=1.4e-29  Score=233.66  Aligned_cols=201  Identities=22%  Similarity=0.205  Sum_probs=158.9

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCC-CCCcceEEeEEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLS-HPNLVKLLGYCWE  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~  166 (376)
                      ++|+..+.||+|+||.||++...         .++..+|+|.+..... .....+.+|+.++.++. |+||+++++++..
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~   74 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHK---------PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR   74 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEEC---------CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec
Confidence            35677789999999999999544         3588999999876432 34467889999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRN-PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      ++..+++|||+.. ++.++..... .....+++..+..++.|++.||+|||+ ..+|+||||||+||+++.++.++|+||
T Consensus        75 ~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~~~kl~df  152 (288)
T cd06616          75 EGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDF  152 (288)
T ss_pred             CCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-cCCeeccCCCHHHEEEccCCcEEEeec
Confidence            9999999999864 6655442210 112568999999999999999999995 469999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh--hhccccccccceeeeehhhcccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI--KYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~--~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |+++...........        .|++.|+               +||.+.+.  ...+.++|+||+|++++++++-..+
T Consensus       153 g~~~~~~~~~~~~~~--------~~~~~y~---------------aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p  209 (288)
T cd06616         153 GISGQLVDSIAKTRD--------AGCRPYM---------------APERIDPSARDGYDVRSDVWSLGITLYEVATGKFP  209 (288)
T ss_pred             chhHHhccCCccccc--------cCccCcc---------------CHHHhccccccCCcchhhhhHHHHHHHHHHhCCCC
Confidence            999866443222112        4555566               69988766  4678899999999999999865444

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=1.7e-29  Score=233.17  Aligned_cols=199  Identities=23%  Similarity=0.237  Sum_probs=161.5

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ++|+..+.||.|++|.||+|....         +++.+|+|.+..... .....+.+|+++++.++||||+++++++.+.
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   71 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKN---------TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE   71 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECC---------CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc
Confidence            367888999999999999996543         588899999876533 3456788999999999999999999988653


Q ss_pred             --CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          168 --KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       168 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                        +.+++||||+++++|.+++.........+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.++|+||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH--~~~i~H~dl~~~nil~~~~~~~~l~df  149 (287)
T cd06621          72 SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDF  149 (287)
T ss_pred             CCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEecCCeEEEeec
Confidence              4689999999999999987654333456889999999999999999999  699999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |++......... ..        .++..|+               +||.+.+.. .+.++|+|++|++++++++...+
T Consensus       150 g~~~~~~~~~~~-~~--------~~~~~y~---------------~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p  202 (287)
T cd06621         150 GVSGELVNSLAG-TF--------TGTSFYM---------------APERIQGKP-YSITSDVWSLGLTLLEVAQNRFP  202 (287)
T ss_pred             cccccccccccc-cc--------cCCcccc---------------CHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCC
Confidence            998765432211 11        3344455               699776554 57889999999999999865443

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.96  E-value=1.3e-29  Score=240.96  Aligned_cols=193  Identities=20%  Similarity=0.196  Sum_probs=157.7

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|+..+.||+|+||.||+|...         .++..||+|.+...  .......+.+|+.+++.++||||+++++++
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   84 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDT---------VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVF   84 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEEC---------CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence            4578999999999999999999543         35889999998753  223345677899999999999999999988


Q ss_pred             EeC------CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          165 WED------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       165 ~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      ...      ...|+||||+.+ +|.+.+...      +++..+..++.|++.||.|||  ..+|+||||||+|||++.++
T Consensus        85 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH--~~gi~H~dlkp~Nil~~~~~  155 (353)
T cd07850          85 TPQKSLEEFQDVYLVMELMDA-NLCQVIQMD------LDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDC  155 (353)
T ss_pred             ccCCCccccCcEEEEEeccCC-CHHHHHhhc------CCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCC
Confidence            644      357999999964 888887532      788899999999999999999  59999999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .+||+|||+++..........        ..||+.|+               +||++.+.. .+.++|+||+|+++++++
T Consensus       156 ~~kL~Dfg~~~~~~~~~~~~~--------~~~~~~y~---------------aPE~~~~~~-~~~~~DvwslG~~l~~l~  211 (353)
T cd07850         156 TLKILDFGLARTAGTSFMMTP--------YVVTRYYR---------------APEVILGMG-YKENVDIWSVGCIMGEMI  211 (353)
T ss_pred             CEEEccCccceeCCCCCCCCC--------Cccccccc---------------CHHHHhCCC-CCCchhhHhHHHHHHHHH
Confidence            999999999987654322111        14556666               799887755 578999999999999998


Q ss_pred             ccc
Q 017177          319 SFY  321 (376)
Q Consensus       319 ~~y  321 (376)
                      +-.
T Consensus       212 ~g~  214 (353)
T cd07850         212 RGT  214 (353)
T ss_pred             HCC
Confidence            543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.96  E-value=9.4e-30  Score=237.01  Aligned_cols=204  Identities=21%  Similarity=0.224  Sum_probs=161.2

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|...         .++..||+|.+.....  .....+.+|+.++++++||||+++++++
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   80 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHK---------KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEIC   80 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEEC---------CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEE
Confidence            4567999999999999999999544         3588999998865422  2224556899999999999999999988


Q ss_pred             EeCC--------eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC
Q 017177          165 WEDK--------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG  236 (376)
Q Consensus       165 ~~~~--------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~  236 (376)
                      ...+        ..++||||+.+ +|.+++....   ..+++..+..++.|++.||.|||  +++++||||||+||+++.
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dl~p~nil~~~  154 (310)
T cd07865          81 RTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIH--RNKILHRDMKAANILITK  154 (310)
T ss_pred             ecccccccCCCceEEEEEcCCCc-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEECC
Confidence            7653        45999999964 8888876542   35899999999999999999999  589999999999999999


Q ss_pred             CCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehh
Q 017177          237 VGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSC  316 (376)
Q Consensus       237 ~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~  316 (376)
                      ++.+||+|||++............   ......++..|+               +||++.+....+.++|+||+|+++++
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~---~~~~~~~~~~y~---------------aPE~~~~~~~~~~~~Di~slG~~l~e  216 (310)
T cd07865         155 DGILKLADFGLARAFSLSKNSKPN---RYTNRVVTLWYR---------------PPELLLGERDYGPPIDMWGAGCIMAE  216 (310)
T ss_pred             CCcEEECcCCCcccccCCcccCCC---CccCcccCcccc---------------CcHHhcCCcccCchhhhHHHHHHHHH
Confidence            999999999999876543321100   000114555666               79988776666889999999999999


Q ss_pred             hcccccc
Q 017177          317 VFSFYRT  323 (376)
Q Consensus       317 ~~~~y~~  323 (376)
                      +++.+.+
T Consensus       217 l~t~~~~  223 (310)
T cd07865         217 MWTRSPI  223 (310)
T ss_pred             HHhCCCC
Confidence            9875544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.96  E-value=2e-29  Score=228.93  Aligned_cols=196  Identities=21%  Similarity=0.198  Sum_probs=156.9

Q ss_pred             EeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEE
Q 017177           97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        97 lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv  173 (376)
                      ||.|+||.||++....         +++.+++|.+.....   ...+.+.+|+.+++.++||||+++++.+..+...|++
T Consensus         1 lg~g~~~~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   71 (265)
T cd05579           1 ISKGAYGRVFLAKKKS---------TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV   71 (265)
T ss_pred             CCCCCceEEEEEEECC---------CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence            6899999999996543         588999999976543   3456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      |||+++++|.+++.+.    ..+++..+..++.|++.||.|||  +.+++||||+|+||+++.++.++|+|||++.....
T Consensus        72 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH--~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~  145 (265)
T cd05579          72 MEYLPGGDLASLLENV----GSLDEDVARIYIAEIVLALEYLH--SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV  145 (265)
T ss_pred             EecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HcCeecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence            9999999999999765    35899999999999999999999  69999999999999999999999999999886543


Q ss_pred             ceeeEEEeee-EEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          254 HYIYIYIHTY-IIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       254 ~~~~~~~~~~-~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ........+. ......+++.|+               +||.+.... .+.++|+|++|++++++++-..+
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~---------------~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p  200 (265)
T cd05579         146 RRQINLNDDEKEDKRIVGTPDYI---------------APEVILGQG-HSKTVDWWSLGCILYEFLVGIPP  200 (265)
T ss_pred             CcccccccccccccCcccCcccc---------------CHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCC
Confidence            2111000000 000013445555               799776554 68899999999999999865444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.96  E-value=2e-29  Score=237.27  Aligned_cols=201  Identities=22%  Similarity=0.208  Sum_probs=154.6

Q ss_pred             ceEeec--CcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeE
Q 017177           95 SLLGEG--GFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKEL  170 (376)
Q Consensus        95 ~~lG~G--~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~  170 (376)
                      ..||+|  +||+||++.+         ..+++.||+|++....  ....+.+.+|+.+++.++||||++++++|..++..
T Consensus         4 ~~ig~g~~~~~~v~~a~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~   74 (328)
T cd08226           4 VEIGRGFCNLTSVYLARH---------TPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL   74 (328)
T ss_pred             HHhCCcccCceeEEEEEE---------cCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce
Confidence            456666  9999999954         3468999999987543  23356788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      ++||||+.+++|.+++.+...  ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.++++||+.+..
T Consensus        75 ~~v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH--~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~  150 (328)
T cd08226          75 WVISPFMAYGSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLH--QNGYIHRNIKASHILISGDGLVSLSGLSHLYS  150 (328)
T ss_pred             EEEEecccCCCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence            999999999999999876532  35889999999999999999999  59999999999999999999999999986654


Q ss_pred             eccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh-hhccccccccceeeeehhhcccccc
Q 017177          251 FKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI-KYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~-~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ...................++..||               +||++.+. ...+.++|+||+|++++++++...+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~y~---------------aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p  209 (328)
T cd08226         151 LVRNGQKAKVVYDFPQFSTSVLPWL---------------SPELLRQDLYGYNVKSDIYSVGITACELATGRVP  209 (328)
T ss_pred             hhccCccccccccccccccCccCcc---------------ChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            3222111000000000011223344               79988764 3357899999999999999864443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=8.5e-32  Score=230.38  Aligned_cols=196  Identities=22%  Similarity=0.288  Sum_probs=159.7

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ...|+...+||+|.||.||+|         +.+.+++.||+|++-.+..  .......+|+.+|..|+|+|++.+++.|.
T Consensus        16 ~~~yek~~kigqGtfgeVFkA---------r~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~   86 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKA---------RSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR   86 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHH---------hhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence            356778889999999999999         4555788899987654322  22245678999999999999999988875


Q ss_pred             eC--------CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC
Q 017177          166 ED--------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV  237 (376)
Q Consensus       166 ~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~  237 (376)
                      ..        ..+|+|+++|+. +|.-+|...   ...++..++..++.+++.||.|+|  +..|+|||+||+|+||+.+
T Consensus        87 tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iH--r~kilHRDmKaaNvLIt~d  160 (376)
T KOG0669|consen   87 TKATPTNRDRATFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIH--RNKILHRDMKAANVLITKD  160 (376)
T ss_pred             hccCCcccccceeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHH--HhhHHhhcccHhhEEEcCC
Confidence            32        349999999987 899888654   356899999999999999999999  6999999999999999999


Q ss_pred             CcEEEcceeeeeeecccee-----eEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceee
Q 017177          238 GFLFDSHLLIYVYFKRHYI-----YIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAF  312 (376)
Q Consensus       238 g~~kl~Dfg~a~~~~~~~~-----~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~  312 (376)
                      |.+||+|||+++.+.....     ++...-|..|..                       ||++.|.+.+++..|+|..||
T Consensus       161 gilklADFGlar~fs~~~n~~kprytnrvvTLwYrp-----------------------pEllLG~r~yg~~iDiWgAgC  217 (376)
T KOG0669|consen  161 GILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRP-----------------------PELLLGDREYGPPIDIWGAGC  217 (376)
T ss_pred             ceEEeeccccccceecccccCCCCcccceeeeecCC-----------------------HHHhhcccccCCcchhHhHHH
Confidence            9999999999987754432     111222444444                       999999999999999999999


Q ss_pred             eehhhcccc
Q 017177          313 VFSCVFSFY  321 (376)
Q Consensus       313 v~~~~~~~y  321 (376)
                      |..||.+--
T Consensus       218 imaeMwtrs  226 (376)
T KOG0669|consen  218 IMAEMWTRS  226 (376)
T ss_pred             HHHHHHccC
Confidence            999998543

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.96  E-value=1.5e-29  Score=232.43  Aligned_cols=194  Identities=24%  Similarity=0.251  Sum_probs=157.3

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCC-CCCcceEEeEEEeC-
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLS-HPNLVKLLGYCWED-  167 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~-  167 (376)
                      |++.+.||+|+||.||+|...         .++..||+|.++.... .......+|+.+++++. |+||+++++++.++ 
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~---------~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   71 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSR---------KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK   71 (282)
T ss_pred             CceEeeccccccceEEEEEEc---------CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence            677889999999999999544         3578899999876422 22234457999999996 99999999999987 


Q ss_pred             -CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          168 -KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       168 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                       +.+++||||++ ++|.+.+....   ..+++..+..++.|++.||.|||  ..+|+||||||+||+++. +.+||+|||
T Consensus        72 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH--~~~i~H~dl~p~ni~l~~-~~~kl~dfg  144 (282)
T cd07831          72 TGRLALVFELMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMH--RNGIFHRDIKPENILIKD-DILKLADFG  144 (282)
T ss_pred             CCcEEEEEecCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCceecccCHHHEEEcC-CCeEEEecc
Confidence             88999999997 48888886542   45899999999999999999999  699999999999999999 999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ++............        .+++.|+               +||.+......+.++|+||+|++++++++...+
T Consensus       145 ~~~~~~~~~~~~~~--------~~~~~y~---------------aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p  198 (282)
T cd07831         145 SCRGIYSKPPYTEY--------ISTRWYR---------------APECLLTDGYYGPKMDIWAVGCVFFEILSLFPL  198 (282)
T ss_pred             cccccccCCCcCCC--------CCCcccC---------------ChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcC
Confidence            99876543322111        3555666               799776666678899999999999999875443

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.96  E-value=1.3e-29  Score=235.05  Aligned_cols=208  Identities=17%  Similarity=0.086  Sum_probs=149.7

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhH-----------HHHHHHHHHHhcCCCC
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-----------EEWQSEVNFLGRLSHP  155 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~il~~l~h~  155 (376)
                      ..++|++.+.||+|+||.||+|......      ..+..+|+|+.........           .....+...+..+.|+
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~------~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~   83 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDH------CINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHL   83 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCc------ccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCC
Confidence            3468999999999999999999765421      1145567776543322110           1122344556677899


Q ss_pred             CcceEEeEEEeCC----eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCC
Q 017177          156 NLVKLLGYCWEDK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASN  231 (376)
Q Consensus       156 nIv~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~N  231 (376)
                      ||+++++.+....    ..++++|++. .++.+.+...    ...++..+..++.|++.||.|||  +++|+||||||+|
T Consensus        84 ~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH--~~~iiHrDiKp~N  156 (294)
T PHA02882         84 GIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIH--EHGISHGDIKPEN  156 (294)
T ss_pred             CCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHH
Confidence            9999999765543    4578888874 4777776543    23578889999999999999999  6999999999999


Q ss_pred             EEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcccccccccee
Q 017177          232 ILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFA  311 (376)
Q Consensus       232 ILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g  311 (376)
                      ||++.++.++|+|||+++.+..................||+.|+               +||+..+.. .+.++||||+|
T Consensus       157 ill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~---------------ape~~~~~~-~~~~~DiwSlG  220 (294)
T PHA02882        157 IMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYA---------------GLDAHNGAC-VTRRGDLESLG  220 (294)
T ss_pred             EEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCcccc---------------CHHHhCCCC-CCcHHHHHHHH
Confidence            99999999999999999877433221111111111226888888               799877655 58999999999


Q ss_pred             eeehhhcccccc
Q 017177          312 FVFSCVFSFYRT  323 (376)
Q Consensus       312 ~v~~~~~~~y~~  323 (376)
                      ++++++++...+
T Consensus       221 ~~l~el~~g~~P  232 (294)
T PHA02882        221 YCMLKWAGIKLP  232 (294)
T ss_pred             HHHHHHHhCCCC
Confidence            999999865444

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.96  E-value=8.8e-29  Score=231.46  Aligned_cols=194  Identities=26%  Similarity=0.266  Sum_probs=158.2

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .|...+.||+|+||.||+|...         .++..|++|.+.....   .....+.+|+.+++.++|||++++++++.+
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~---------~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   92 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNS---------HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK   92 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEEC---------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence            3777788999999999999543         3588999999875422   334567889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ....|+||||+. |+|.+++....   ..+++..+..++.|++.||.|||  ..+|+||||||+||+++.++.++|+|||
T Consensus        93 ~~~~~lv~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH--~~gi~H~dl~p~nili~~~~~~kL~dfg  166 (313)
T cd06633          93 EHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFG  166 (313)
T ss_pred             CCEEEEEEecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCChhhEEECCCCCEEEeecC
Confidence            999999999996 58888776542   45889999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh--hhhccccccccceeeeehhhccccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW--IKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~--~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ++........   .        .|++.|+               +||.+..  ....+.++|+||+|++++++++.+.+.
T Consensus       167 ~~~~~~~~~~---~--------~~~~~y~---------------aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~  220 (313)
T cd06633         167 SASKSSPANS---F--------VGTPYWM---------------APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL  220 (313)
T ss_pred             CCcccCCCCC---c--------ccccccc---------------ChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            9864322111   1        4555566               6997753  345678899999999999998766543

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.96  E-value=1.8e-29  Score=231.49  Aligned_cols=205  Identities=20%  Similarity=0.185  Sum_probs=165.9

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCC-CCCcceEEeEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLS-HPNLVKLLGYC  164 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~-h~nIv~l~~~~  164 (376)
                      ++|++.+.||+|+||.||+|....         ++..||+|++....   ....+.+.+|+.++++++ ||||+++++.+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~   71 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKE---------TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF   71 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcC---------CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence            468999999999999999996543         58899999987632   233467788999999999 99999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      ..++..++|||++++++|.+++.+.    ..+++..+..++.|++.||.|||  +.+++|+||||+||+++.+|.++++|
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh--~~~~~H~dl~~~ni~i~~~~~~~l~d  145 (280)
T cd05581          72 QDEENLYFVLEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLH--SKGIIHRDLKPENILLDKDMHIKITD  145 (280)
T ss_pred             cCCceEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEecC
Confidence            9999999999999999999999765    35899999999999999999999  69999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEe-------------eeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcccccccccee
Q 017177          245 LLIYVYFKRHYIYIYIH-------------TYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFA  311 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~-------------~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g  311 (376)
                      ||++.............             ........|++.|+               +||.+.+. ..+.++|+|++|
T Consensus       146 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~Pe~~~~~-~~~~~~Di~slG  209 (280)
T cd05581         146 FGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYV---------------SPELLNEK-PAGKSSDLWALG  209 (280)
T ss_pred             CccccccCCccccccCCCCCccccccccccccccccccCCcccc---------------CHHHhCCC-CCChhhhHHHHH
Confidence            99998775533210000             00011114455555               79976654 468899999999


Q ss_pred             eeehhhccccccc
Q 017177          312 FVFSCVFSFYRTT  324 (376)
Q Consensus       312 ~v~~~~~~~y~~~  324 (376)
                      ++++++++...+.
T Consensus       210 ~~l~~l~~g~~p~  222 (280)
T cd05581         210 CIIYQMLTGKPPF  222 (280)
T ss_pred             HHHHHHHhCCCCC
Confidence            9999998765554

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.96  E-value=1.5e-29  Score=239.60  Aligned_cols=200  Identities=22%  Similarity=0.219  Sum_probs=159.1

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ..+|++.+.||.|+||.||+|...         .++..||+|.+........+.+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~---------~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~   74 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDS---------DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPS   74 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEEC---------CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence            468999999999999999999543         46889999998776655667788999999999999999999876543


Q ss_pred             --------------CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEE
Q 017177          168 --------------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL  233 (376)
Q Consensus       168 --------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NIL  233 (376)
                                    ...|+||||++ ++|.+++..     ..+++..+..++.||+.||.|||  +.+|+||||||+||+
T Consensus        75 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH--~~givH~dikp~Nil  146 (342)
T cd07854          75 GSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIH--SANVLHRDLKPANVF  146 (342)
T ss_pred             ccccccccccccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEE
Confidence                          35899999997 589888753     24889999999999999999999  699999999999999


Q ss_pred             EcC-CCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceee
Q 017177          234 LDG-VGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAF  312 (376)
Q Consensus       234 l~~-~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~  312 (376)
                      ++. ++.++++|||++..............    ...++..|+               |||++......+.++|+||+|+
T Consensus       147 i~~~~~~~kl~dfg~~~~~~~~~~~~~~~~----~~~~~~~y~---------------aPE~~~~~~~~~~~~DiwSlGv  207 (342)
T cd07854         147 INTEDLVLKIGDFGLARIVDPHYSHKGYLS----EGLVTKWYR---------------SPRLLLSPNNYTKAIDMWAAGC  207 (342)
T ss_pred             EcCCCceEEECCcccceecCCccccccccc----ccccccccc---------------CHHHHhCccccCchhhHHHHHH
Confidence            974 56789999999987643222110000    013455555               7998766566788999999999


Q ss_pred             eehhhcccccc
Q 017177          313 VFSCVFSFYRT  323 (376)
Q Consensus       313 v~~~~~~~y~~  323 (376)
                      +++++++...+
T Consensus       208 il~el~~g~~p  218 (342)
T cd07854         208 IFAEMLTGKPL  218 (342)
T ss_pred             HHHHHHhCCCC
Confidence            99999865443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.96  E-value=8.1e-30  Score=240.58  Aligned_cols=201  Identities=21%  Similarity=0.243  Sum_probs=161.3

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      .++|++.+.||+|+||.||+|...         .++..||+|++.....  .....+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~---------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   74 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDT---------RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILR   74 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEc---------CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcc
Confidence            367999999999999999999543         3588999999876422  33467788999999999999999999876


Q ss_pred             e----CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEE
Q 017177          166 E----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLF  241 (376)
Q Consensus       166 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~k  241 (376)
                      .    ....++||||+. ++|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+||+++.+|.+|
T Consensus        75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~Nil~~~~~~~k  147 (334)
T cd07855          75 PPGADFKDVYVVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIH--SANVIHRDLKPSNLLVNEDCELR  147 (334)
T ss_pred             ccCCCCceEEEEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEE
Confidence            3    356899999995 5898888654    44899999999999999999999  69999999999999999999999


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |+|||++..........   ........|++.|+               +||++......+.++|+||+|++++++++-.
T Consensus       148 l~dfg~~~~~~~~~~~~---~~~~~~~~~~~~y~---------------~PE~~~~~~~~~~~~Di~slG~~l~el~~g~  209 (334)
T cd07855         148 IGDFGMARGLSSSPTEH---KYFMTEYVATRWYR---------------APELLLSLPEYTTAIDMWSVGCIFAEMLGRR  209 (334)
T ss_pred             ecccccceeecccCcCC---Cccccccccccccc---------------ChHHhcCCcccccccchHHHHHHHHHHHcCC
Confidence            99999998764432210   00000115566666               7998876666789999999999999988544


Q ss_pred             c
Q 017177          322 R  322 (376)
Q Consensus       322 ~  322 (376)
                      .
T Consensus       210 ~  210 (334)
T cd07855         210 Q  210 (334)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.96  E-value=1.6e-29  Score=234.89  Aligned_cols=199  Identities=24%  Similarity=0.293  Sum_probs=161.0

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|....         +++.||+|.++....  .....+.+|+.+++.++||||+++++++
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~   75 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKD---------TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIV   75 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECC---------CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeehee
Confidence            45679999999999999999996543         478899999875432  2235667899999999999999999998


Q ss_pred             EeCC----------eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE
Q 017177          165 WEDK----------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL  234 (376)
Q Consensus       165 ~~~~----------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl  234 (376)
                      .+..          .+++|+||+++ ++.+.+...   ...+++..+..++.|++.||.|||  +.+|+||||||+||++
T Consensus        76 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH--~~~i~H~dl~p~nili  149 (302)
T cd07864          76 TDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCH--KKNFLHRDIKCSNILL  149 (302)
T ss_pred             cCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEE
Confidence            7654          79999999976 777777554   245899999999999999999999  6999999999999999


Q ss_pred             cCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeee
Q 017177          235 DGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVF  314 (376)
Q Consensus       235 ~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~  314 (376)
                      ++++.+||+|||++.............      ..+++.|+               +||.+.+....+.++|+|++|+++
T Consensus       150 ~~~~~~kl~dfg~~~~~~~~~~~~~~~------~~~~~~y~---------------~PE~~~~~~~~~~~~Di~slG~~~  208 (302)
T cd07864         150 NNKGQIKLADFGLARLYNSEESRPYTN------KVITLWYR---------------PPELLLGEERYGPAIDVWSCGCIL  208 (302)
T ss_pred             CCCCcEEeCcccccccccCCccccccc------ceeccCcc---------------ChHHhcCCCCCCchhHHHHHHHHH
Confidence            999999999999998765433211110      13345555               799887666678899999999999


Q ss_pred             hhhcccc
Q 017177          315 SCVFSFY  321 (376)
Q Consensus       315 ~~~~~~y  321 (376)
                      +++++-+
T Consensus       209 ~el~~g~  215 (302)
T cd07864         209 GELFTKK  215 (302)
T ss_pred             HHHHhCC
Confidence            9998654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.3e-30  Score=227.44  Aligned_cols=196  Identities=21%  Similarity=0.256  Sum_probs=166.8

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCC-CCCcceEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLS-HPNLVKLLG  162 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~-h~nIv~l~~  162 (376)
                      ..++|.++++||+|+|++|.++         +.+.+.+.+|+|+++++-.   .++.=++.|-.+..... ||.+|.++.
T Consensus       248 ~l~df~ll~vigrgsyakvl~~---------~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhs  318 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLV---------RLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHS  318 (593)
T ss_pred             ccccceeeeeecCcchhhhhhe---------ehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhh
Confidence            4578999999999999999998         5566899999999987632   33444567878887775 999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                      +|+.+..+++|.||++||+|.-++++.    .++++..+..+...|+.||.|||  +++||.||||.+|+|+|..|++|+
T Consensus       319 cfqtesrlffvieyv~ggdlmfhmqrq----rklpeeharfys~ei~lal~flh--~rgiiyrdlkldnvlldaeghikl  392 (593)
T KOG0695|consen  319 CFQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEICLALNFLH--ERGIIYRDLKLDNVLLDAEGHIKL  392 (593)
T ss_pred             hhcccceEEEEEEEecCcceeeehhhh----hcCcHHHhhhhhHHHHHHHHHHh--hcCeeeeeccccceEEccCCceee
Confidence            999999999999999999999888776    45999999999999999999999  699999999999999999999999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      .|+|+++..-.....+   .|    .+|||.|.               ||||+.|..| ....|+|++|++..||+.-
T Consensus       393 tdygmcke~l~~gd~t---st----fcgtpnyi---------------apeilrgeey-gfsvdwwalgvlmfemmag  447 (593)
T KOG0695|consen  393 TDYGMCKEGLGPGDTT---ST----FCGTPNYI---------------APEILRGEEY-GFSVDWWALGVLMFEMMAG  447 (593)
T ss_pred             cccchhhcCCCCCccc---cc----ccCCCccc---------------chhhhccccc-CceehHHHHHHHHHHHHcC
Confidence            9999998643332221   12    27888888               8999999876 7888999999999998843

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.96  E-value=3.8e-29  Score=226.25  Aligned_cols=199  Identities=25%  Similarity=0.304  Sum_probs=165.1

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      +|++.+.||+|+||.||++...         .++..+|+|.+....  ......+.+|+.+++.++|+||+++++.+.+.
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRL---------SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG   71 (256)
T ss_pred             CceEeeeecCCCceeEEEEEEC---------CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence            4788899999999999999543         357889999987643  23446778899999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      ...++||||+++++|.+++.+.......+++..+..++.|++.||.|||  ..+++|+||+|+||+++.++.+|++|||+
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh--~~~i~h~~l~~~ni~~~~~~~~kl~d~g~  149 (256)
T cd08530          72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGI  149 (256)
T ss_pred             CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCcceEEEecCCcEEEeeccc
Confidence            9999999999999999998774433456899999999999999999999  69999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      +......... ..        .|++.|+               +||.+.+.. .+.++|+|++|++++++++.+.+.
T Consensus       150 ~~~~~~~~~~-~~--------~~~~~~~---------------~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~  201 (256)
T cd08530         150 SKVLKKNMAK-TQ--------IGTPHYM---------------APEVWKGRP-YSYKSDIWSLGCLLYEMATFAPPF  201 (256)
T ss_pred             hhhhccCCcc-cc--------cCCcccc---------------CHHHHCCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            9876554111 11        4455555               699876654 477899999999999998765543

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.96  E-value=1.7e-29  Score=238.64  Aligned_cols=198  Identities=22%  Similarity=0.244  Sum_probs=161.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      .++|++.+.||+|+||.||+|...         .++..||+|.+...  .......+.+|+.+++.++|+||+++++++.
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~   74 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNS---------ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMP   74 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEec---------CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence            457999999999999999999543         36889999998754  2233456778999999999999999999876


Q ss_pred             eC-----CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcE
Q 017177          166 ED-----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL  240 (376)
Q Consensus       166 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~  240 (376)
                      ..     ...|+|+||+. ++|.+++...    ..+++..+..++.|++.||.|||  .++++||||||+||+++.++.+
T Consensus        75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH--~~~i~H~dlkp~Nil~~~~~~~  147 (337)
T cd07858          75 PPHREAFNDVYIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIH--SANVLHRDLKPSNLLLNANCDL  147 (337)
T ss_pred             cccccccCcEEEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCE
Confidence            54     35899999995 6898888654    45899999999999999999999  5999999999999999999999


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ||+|||++.........  . .    ...++..|+               +||.+......+.++|+||+|++++++++.
T Consensus       148 kL~Dfg~~~~~~~~~~~--~-~----~~~~~~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~~l~~g  205 (337)
T cd07858         148 KICDFGLARTTSEKGDF--M-T----EYVVTRWYR---------------APELLLNCSEYTTAIDVWSVGCIFAELLGR  205 (337)
T ss_pred             EECcCccccccCCCccc--c-c----ccccccCcc---------------ChHHHhcCCCCCCcccHHHHHHHHHHHHcC
Confidence            99999999876543211  0 0    114556666               799877655578899999999999999866


Q ss_pred             ccc
Q 017177          321 YRT  323 (376)
Q Consensus       321 y~~  323 (376)
                      +.+
T Consensus       206 ~~p  208 (337)
T cd07858         206 KPL  208 (337)
T ss_pred             CCC
Confidence            544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.96  E-value=1.5e-28  Score=222.03  Aligned_cols=195  Identities=23%  Similarity=0.288  Sum_probs=165.2

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      +|+..+.||+|++|.||+|....         ++..|++|++.....  ...+.+.+|+.++++++||||+++++.+...
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKD---------TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE   71 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECC---------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence            47788999999999999996543         588899999876643  4467888999999999999999999999988


Q ss_pred             --CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          168 --KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       168 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                        ...++++||+++++|.+++...    ..+++..+..++.|++.||.|||  +.+++|+||+|+||+++.++.++|+||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh--~~~~~h~dl~p~ni~i~~~~~~~l~d~  145 (260)
T cd06606          72 EKNTLNIFLEYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLH--SNGIVHRDIKGANILVDSDGVVKLADF  145 (260)
T ss_pred             CCCeEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEcCCCCEEEccc
Confidence              8899999999999999999765    36899999999999999999999  699999999999999999999999999


Q ss_pred             eeeeeecccee---eEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          246 LIYVYFKRHYI---YIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       246 g~a~~~~~~~~---~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      |.+........   ....        .+++.|+               +||.+.+.. .+.++|+|++|++++++++-..
T Consensus       146 ~~~~~~~~~~~~~~~~~~--------~~~~~y~---------------~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~  201 (260)
T cd06606         146 GCAKRLGDIETGEGTGSV--------RGTPYWM---------------APEVIRGEE-YGRAADIWSLGCTVIEMATGKP  201 (260)
T ss_pred             ccEEecccccccccccCC--------CCCcccc---------------CHhhhcCCC-CCchhhHHHHHHHHHHHHhCCC
Confidence            99998766543   1111        4445555               699776654 6889999999999999987444


Q ss_pred             c
Q 017177          323 T  323 (376)
Q Consensus       323 ~  323 (376)
                      +
T Consensus       202 p  202 (260)
T cd06606         202 P  202 (260)
T ss_pred             C
Confidence            4

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.96  E-value=1.6e-29  Score=232.54  Aligned_cols=197  Identities=23%  Similarity=0.281  Sum_probs=162.0

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC-
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED-  167 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~-  167 (376)
                      |++.+.||+|+||.||+|....         ++..+|+|.+....  ......+.+|+.+++.++|+|++++++++... 
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   71 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKK---------TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG   71 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECC---------CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence            6778999999999999996543         47889999998763  23345678899999999999999999999888 


Q ss_pred             -CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          168 -KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       168 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                       +..++||||+++ +|.+++....   ..+++..+..++.|++.||.|||  +.+++|+||||+||++++++.++++|||
T Consensus        72 ~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH--~~~~~h~dl~p~nil~~~~~~~~l~d~g  145 (287)
T cd07840          72 KGSIYMVFEYMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLH--SNGILHRDIKGSNILINNDGVLKLADFG  145 (287)
T ss_pred             CCcEEEEeccccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCcHHHeEEcCCCCEEEcccc
Confidence             889999999975 8988886542   46899999999999999999999  6999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ++............. .     .+++.|+               +||.+.+....+.++|+|++|++++++++...+
T Consensus       146 ~~~~~~~~~~~~~~~-~-----~~~~~y~---------------~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p  201 (287)
T cd07840         146 LARPYTKRNSADYTN-R-----VITLWYR---------------PPELLLGATRYGPEVDMWSVGCILAELFLGKPI  201 (287)
T ss_pred             ceeeccCCCcccccc-c-----ccccccC---------------CceeeEccccCChHHHHHHHHHHHHHHHhCCCC
Confidence            999776543211111 0     3344555               699777666678899999999999999866544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.96  E-value=3e-29  Score=231.58  Aligned_cols=201  Identities=23%  Similarity=0.252  Sum_probs=162.8

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh----hhHHHHHHHHHHHhcCC-CCCcceEEeEE
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM----QGFEEWQSEVNFLGRLS-HPNLVKLLGYC  164 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~-h~nIv~l~~~~  164 (376)
                      +|++.+.||+|+||.||++....      ...++..||+|.++....    ...+.+.+|+.++..+. ||||+++++.+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~------~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~   74 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVG------GHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF   74 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEec------cccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence            47888999999999999986542      223478899999875422    23356788999999995 99999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      ..+...++||||+++|+|.+++...    ..+++..+..++.|++.||.|||  ..+++||||||+||+++.++.++++|
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH--~~~~~H~dl~p~nil~~~~~~~~l~d  148 (288)
T cd05583          75 QTDTKLHLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLH--QLGIIYRDIKLENILLDSEGHVVLTD  148 (288)
T ss_pred             ecCCEEEEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEEE
Confidence            9999999999999999999998754    35889999999999999999999  69999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhh-hccccccccceeeeehhhcccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIK-YLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~-~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ||+++.........      .+...|++.|+               +||.+.+.. ..+.++|+|++|++++++++...+
T Consensus       149 fg~~~~~~~~~~~~------~~~~~~~~~y~---------------aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p  207 (288)
T cd05583         149 FGLSKEFLAEEEER------AYSFCGTIEYM---------------APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP  207 (288)
T ss_pred             Cccccccccccccc------cccccCCcccc---------------CHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCC
Confidence            99988754432211      11124566666               799876543 467899999999999999975444

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.96  E-value=2.9e-29  Score=234.57  Aligned_cols=202  Identities=22%  Similarity=0.133  Sum_probs=155.5

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      +.+++.+|.|+++.|+++.           .+++.||+|++...  .....+.+.+|+.+++.++|+||+++++++..++
T Consensus         4 ~~i~~~~~~~~~v~~~~~~-----------~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~   72 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHK-----------PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS   72 (314)
T ss_pred             hhhhHhhcCCceEEEEEec-----------CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC
Confidence            3445555566555555542           25889999998765  3345678899999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeee
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a  248 (376)
                      ..+++|||+++|+|.+++.+...  ..+++..+..++.|++.||.|||  +++|+||||||+||+++.+|.+|++|||.+
T Consensus        73 ~~~~~~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH--~~~ivH~dlk~~Nili~~~~~~kl~d~~~~  148 (314)
T cd08216          73 ELYVVSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIH--SKGFIHRSVKASHILLSGDGKVVLSGLRYS  148 (314)
T ss_pred             eEEEEEeccCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCcceEEEecCCceEEecCccc
Confidence            99999999999999999976532  45889999999999999999999  699999999999999999999999999998


Q ss_pred             eeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh-hhccccccccceeeeehhhccccc
Q 017177          249 VYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI-KYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~-~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      .....................++..|+               +||++... ..++.++|+||+|++++++++-..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~---------------aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~  208 (314)
T cd08216         149 VSMIKHGKRQRVVHDFPKSSVKNLPWL---------------SPEVLQQNLQGYNEKSDIYSVGITACELANGHV  208 (314)
T ss_pred             eeecccccccccccccccccccccccc---------------CHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCC
Confidence            866432221101110001113444555               79988654 345788999999999999986433

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.96  E-value=1.4e-29  Score=233.07  Aligned_cols=197  Identities=23%  Similarity=0.289  Sum_probs=161.3

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      |++.+.||.|++|.||+|....         ++..||+|++.....  ...+.+.+|+.+++.++||||+++++++.+++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~   71 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKL---------TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN   71 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcC---------CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence            6778999999999999995543         588999999876532  22356788999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeee
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a  248 (376)
                      ..|++|||++ ++|.+++.....  ..+++..+..++.|++.||.|||  .++++||||+|+||+++.++.++|+|||++
T Consensus        72 ~~~iv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH--~~~~~H~dl~p~nil~~~~~~~~l~df~~~  146 (283)
T cd07835          72 KLYLVFEFLD-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCH--SHRVLHRDLKPQNLLIDREGALKLADFGLA  146 (283)
T ss_pred             eEEEEEeccC-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCHHHEEEcCCCcEEEeecccc
Confidence            9999999995 689998876532  35899999999999999999999  589999999999999999999999999999


Q ss_pred             eeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          249 VYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      .......... . .     ..+++.|+               +||.+.+....+.++|+||+|++++++++...+
T Consensus       147 ~~~~~~~~~~-~-~-----~~~~~~~~---------------aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  199 (283)
T cd07835         147 RAFGVPVRTY-T-H-----EVVTLWYR---------------APEILLGSRQYSTPVDIWSIGCIFAEMVNRRPL  199 (283)
T ss_pred             cccCCCcccc-C-c-----cccccCCC---------------CCceeecCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence            7654321110 0 0     03456666               799777666668889999999999999876543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.96  E-value=2.2e-29  Score=237.68  Aligned_cols=205  Identities=19%  Similarity=0.208  Sum_probs=160.4

Q ss_pred             cCCCC-ccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhh--------------HHHHHHHHHHHhcC
Q 017177           88 TKNFK-PDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG--------------FEEWQSEVNFLGRL  152 (376)
Q Consensus        88 ~~~y~-~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~il~~l  152 (376)
                      .++|. +.+.||+|+||.||+|...         .+++.||+|++.......              ...+.+|+.+++.+
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   77 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDT---------LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI   77 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEEC---------CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC
Confidence            34565 5578999999999999543         358899999986543211              12467899999999


Q ss_pred             CCCCcceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCE
Q 017177          153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI  232 (376)
Q Consensus       153 ~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NI  232 (376)
                      +|+||+++++++...+..++||||+. |+|.+++...    ..+++..+..++.|++.||.|||  ..+|+||||||+||
T Consensus        78 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH--~~~i~H~dl~~~ni  150 (335)
T PTZ00024         78 KHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLH--KWYFMHRDLSPANI  150 (335)
T ss_pred             CCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecccccHHHe
Confidence            99999999999999999999999996 5999988654    45899999999999999999999  69999999999999


Q ss_pred             EEcCCCcEEEcceeeeeeeccceeeEEEe-------eeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccc
Q 017177          233 LLDGVGFLFDSHLLIYVYFKRHYIYIYIH-------TYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLK  305 (376)
Q Consensus       233 Ll~~~g~~kl~Dfg~a~~~~~~~~~~~~~-------~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~  305 (376)
                      +++.++.++++|||++.............       ........+++.|+               +||.+.+....+.++
T Consensus       151 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~---------------aPE~~~~~~~~~~~~  215 (335)
T PTZ00024        151 FINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYR---------------APELLMGAEKYHFAV  215 (335)
T ss_pred             EECCCCCEEECCccceeecccccccccccccccccccccccccccccCCC---------------CChhcccCCCCCcHH
Confidence            99999999999999998765221100000       00000013455565               799887776678999


Q ss_pred             cccceeeeehhhcccccc
Q 017177          306 YSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       306 dv~s~g~v~~~~~~~y~~  323 (376)
                      |+||+|++++++++...+
T Consensus       216 Dv~slG~~l~el~tg~~p  233 (335)
T PTZ00024        216 DMWSVGCIFAELLTGKPL  233 (335)
T ss_pred             HHHHHHHHHHHHHhCCCC
Confidence            999999999999875443

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.96  E-value=4.7e-29  Score=236.50  Aligned_cols=199  Identities=20%  Similarity=0.215  Sum_probs=161.7

Q ss_pred             hhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceE
Q 017177           83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKL  160 (376)
Q Consensus        83 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l  160 (376)
                      .+....++|++.+.||+|+||.||+|...         .++..||+|++....  ....+.+.+|+.++++++||||+++
T Consensus        11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~   81 (345)
T cd07877          11 TIWEVPERYQNLSPVGSGAYGSVCAAFDT---------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL   81 (345)
T ss_pred             HHhhccCceEEEEEeeecCCeEEEEEEEc---------CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccce
Confidence            44556789999999999999999999543         358899999987642  2234567889999999999999999


Q ss_pred             EeEEEeC------CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE
Q 017177          161 LGYCWED------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL  234 (376)
Q Consensus       161 ~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl  234 (376)
                      ++++...      ...|++++++ +++|.+++...     .+++..+..++.|++.||+|||  +.+|+||||||+||++
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIll  153 (345)
T cd07877          82 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAV  153 (345)
T ss_pred             eeeeeecccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChHHEEE
Confidence            9988643      3478898887 77998887542     4889999999999999999999  6999999999999999


Q ss_pred             cCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeee
Q 017177          235 DGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVF  314 (376)
Q Consensus       235 ~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~  314 (376)
                      +.+|.+||+|||++........     .     ..||+.|+               +||++.+....+.++|+||+|+++
T Consensus       154 ~~~~~~kl~dfg~~~~~~~~~~-----~-----~~~~~~y~---------------aPE~~~~~~~~~~~~DvwslG~il  208 (345)
T cd07877         154 NEDCELKILDFGLARHTDDEMT-----G-----YVATRWYR---------------APEIMLNWMHYNQTVDIWSVGCIM  208 (345)
T ss_pred             cCCCCEEEeccccccccccccc-----c-----cccCCCcc---------------CHHHHhCccCCCchhhHHHHHHHH
Confidence            9999999999999886533211     1     15566666               799887766678899999999999


Q ss_pred             hhhcccccc
Q 017177          315 SCVFSFYRT  323 (376)
Q Consensus       315 ~~~~~~y~~  323 (376)
                      +++++...+
T Consensus       209 ~el~~g~~p  217 (345)
T cd07877         209 AELLTGRTL  217 (345)
T ss_pred             HHHHhCCCC
Confidence            999865443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.96  E-value=1.8e-29  Score=238.46  Aligned_cols=203  Identities=24%  Similarity=0.235  Sum_probs=162.0

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcC-CCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRL-SHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l-~h~nIv~l~~~  163 (376)
                      ..++|++.+.||+|+||.||+|....         ++..+|+|++...  .......+.+|+.+++++ +||||++++++
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~   75 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRR---------TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNV   75 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcC---------CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeee
Confidence            45789999999999999999996542         4788999988643  223345677899999999 89999999998


Q ss_pred             EEeC--CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEE
Q 017177          164 CWED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLF  241 (376)
Q Consensus       164 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~k  241 (376)
                      +...  ...|+||||++ ++|..++...     .+++..+..++.|++.||.|||  +++|+||||||+|||++.+|.+|
T Consensus        76 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH--~~~i~H~dl~p~nill~~~~~~k  147 (337)
T cd07852          76 IKAENDKDIYLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIH--SGNVIHRDLKPSNILLNSDCRVK  147 (337)
T ss_pred             eccCCCceEEEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEE
Confidence            8654  36899999997 5998888543     4788889999999999999999  69999999999999999999999


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |+|||++............  .......||+.|+               +||++.+....+.++|+||+|++++++++..
T Consensus       148 l~d~g~~~~~~~~~~~~~~--~~~~~~~~~~~y~---------------aPE~~~~~~~~~~~sDi~slG~~l~el~tg~  210 (337)
T cd07852         148 LADFGLARSLSELEENPEN--PVLTDYVATRWYR---------------APEILLGSTRYTKGVDMWSVGCILGEMLLGK  210 (337)
T ss_pred             EeeccchhccccccccccC--cchhccccccccc---------------CceeeeccccccccchHHHHHHHHHHHHhCC
Confidence            9999999876543321000  0001125667777               7997776666788999999999999999765


Q ss_pred             cc
Q 017177          322 RT  323 (376)
Q Consensus       322 ~~  323 (376)
                      .+
T Consensus       211 ~p  212 (337)
T cd07852         211 PL  212 (337)
T ss_pred             CC
Confidence            43

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-29  Score=231.14  Aligned_cols=212  Identities=20%  Similarity=0.183  Sum_probs=163.5

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--h-----hhHHHHHHHHHHHhcCCCCCc
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--M-----QGFEEWQSEVNFLGRLSHPNL  157 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~-----~~~~~~~~E~~il~~l~h~nI  157 (376)
                      ....++|-++.+||+|+|+.||+|.+         ....+.||+|+-....  .     ...+...+|.+|.+.|+||.|
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFD---------l~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRI  529 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFD---------LTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRI  529 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcc---------cchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCccee
Confidence            34456788999999999999999943         3357889999865432  1     123456789999999999999


Q ss_pred             ceEEeEEEe-CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE--
Q 017177          158 VKLLGYCWE-DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL--  234 (376)
Q Consensus       158 v~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl--  234 (376)
                      |++|++|.- .+.++-|+|||+|.+|.-+|+.+    ..+++.++..|+.||+.||.||..-..+|||-||||.|||+  
T Consensus       530 VKlYDyfslDtdsFCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~  605 (775)
T KOG1151|consen  530 VKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVN  605 (775)
T ss_pred             eeeeeeeeeccccceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEec
Confidence            999999865 46799999999999999999877    45899999999999999999999656799999999999999  


Q ss_pred             -cCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHh-h--hhhccccccccce
Q 017177          235 -DGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYA-W--IKYLTLLKYSNSF  310 (376)
Q Consensus       235 -~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~-~--~~~~~~~~dv~s~  310 (376)
                       +..|.+||.|||+++.+++........-.++.-..||+.|.               .||-|. +  ...++.+.||||.
T Consensus       606 GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYL---------------PPEcFvVgkePPKIsnKVDVWSv  670 (775)
T KOG1151|consen  606 GTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYL---------------PPECFVVGKEPPKISNKVDVWSV  670 (775)
T ss_pred             CcccceeEeeecchhhhccCCccCcccceeeecccCceeeec---------------CcceeecCCCCCccccceeeEee
Confidence             45688999999999988664332111111111125555555               477544 3  2456899999999


Q ss_pred             eeeehhhccccccc
Q 017177          311 AFVFSCVFSFYRTT  324 (376)
Q Consensus       311 g~v~~~~~~~y~~~  324 (376)
                      |+||+..+--.++.
T Consensus       671 GVIFyQClYGrKPF  684 (775)
T KOG1151|consen  671 GVIFYQCLYGRKPF  684 (775)
T ss_pred             ehhhhhhhccCCCC
Confidence            99999877444444

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.96  E-value=6e-29  Score=235.55  Aligned_cols=194  Identities=20%  Similarity=0.195  Sum_probs=159.3

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|...         .++..||+|.+....  ......+.+|+.+++.++||||+++++++
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDR---------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVF   83 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEEC---------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeee
Confidence            4678999999999999999999543         358899999986532  22335678999999999999999999998


Q ss_pred             EeCC------eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          165 WEDK------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       165 ~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      ..+.      ..++||||+ +++|.+++..     ..+++..+..++.|++.||.|||  +.+|+||||||+||+++.++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH--~~gi~H~dlkp~Nill~~~~  155 (343)
T cd07880          84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIH--AAGIIHRDLKPGNLAVNEDC  155 (343)
T ss_pred             cCCccccccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCC
Confidence            7653      468999999 7799888753     34889999999999999999999  69999999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .++++|||++.........          ..+++.|+               +||.+.+....+.++|+||+|+++++++
T Consensus       156 ~~kl~dfg~~~~~~~~~~~----------~~~~~~y~---------------aPE~~~~~~~~~~~~Di~slG~ll~~l~  210 (343)
T cd07880         156 ELKILDFGLARQTDSEMTG----------YVVTRWYR---------------APEVILNWMHYTQTVDIWSVGCIMAEML  210 (343)
T ss_pred             CEEEeecccccccccCccc----------cccCCccc---------------CHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence            9999999999865432111          14556666               7998876556788999999999999988


Q ss_pred             cccc
Q 017177          319 SFYR  322 (376)
Q Consensus       319 ~~y~  322 (376)
                      +...
T Consensus       211 ~g~~  214 (343)
T cd07880         211 TGKP  214 (343)
T ss_pred             hCCC
Confidence            6543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.96  E-value=2.9e-29  Score=233.87  Aligned_cols=206  Identities=24%  Similarity=0.251  Sum_probs=161.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh--hHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      .++|++.+.||+|+||.||+|...         .++..+|+|.+......  ....+.+|+++++.++||||+++++++.
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   77 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQI---------KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAV   77 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEEC---------CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence            578999999999999999999544         35788999988654322  2245678999999999999999999875


Q ss_pred             eC--------CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC
Q 017177          166 ED--------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV  237 (376)
Q Consensus       166 ~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~  237 (376)
                      +.        ..+++||||+.+ +|...+...   ...+++..+..++.|++.||.|||  ..+|+||||||+|||++++
T Consensus        78 ~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH--~~~i~H~dl~p~nil~~~~  151 (311)
T cd07866          78 ERPDKSKRKRGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLH--ENHILHRDIKAANILIDNQ  151 (311)
T ss_pred             cccccccccCceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCC
Confidence            43        347999999965 777777543   246899999999999999999999  5999999999999999999


Q ss_pred             CcEEEcceeeeeeeccceeeEEEe---e-eEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeee
Q 017177          238 GFLFDSHLLIYVYFKRHYIYIYIH---T-YIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFV  313 (376)
Q Consensus       238 g~~kl~Dfg~a~~~~~~~~~~~~~---~-~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v  313 (376)
                      +.++|+|||+++............   . .......|++.|+               +||++.+....+.++|+||+|++
T Consensus       152 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~---------------aPE~~~~~~~~~~~~Dv~slG~i  216 (311)
T cd07866         152 GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYR---------------PPELLLGERRYTTAVDIWGIGCV  216 (311)
T ss_pred             CCEEECcCccchhccCCCcccccCCcccccccccceeccCcC---------------ChHHhhCCCccCchhHhHHHHHH
Confidence            999999999998765432211100   0 0001125566677               89988776667889999999999


Q ss_pred             ehhhcccccc
Q 017177          314 FSCVFSFYRT  323 (376)
Q Consensus       314 ~~~~~~~y~~  323 (376)
                      ++++++-..+
T Consensus       217 l~el~~g~~~  226 (311)
T cd07866         217 FAEMFTRRPI  226 (311)
T ss_pred             HHHHHhCCCC
Confidence            9999865433

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.96  E-value=2.3e-29  Score=236.94  Aligned_cols=198  Identities=24%  Similarity=0.233  Sum_probs=162.9

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      +|++.+.||+|+||.||+|....         ++..||+|.+....  ....+.+.+|+.+++.++|+||+++++++...
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKR---------TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPP   71 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCC---------CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence            58889999999999999996443         48889999987653  33446788999999999999999999998877


Q ss_pred             C-----eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          168 K-----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       168 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                      +     .+|++|||++ ++|.+++.+.    ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.++|
T Consensus        72 ~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH--~~gi~H~dlkp~nili~~~~~~~L  144 (330)
T cd07834          72 SPEDFNDVYIVTELME-TDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLH--SANVIHRDLKPSNILVNSNCDLKI  144 (330)
T ss_pred             CcccccceEEEecchh-hhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEE
Confidence            5     7999999997 4898888654    36899999999999999999999  599999999999999999999999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      +|||++...............    ..+|+.|+               +||++.+....+.++|+||+|++++++++-..
T Consensus       145 ~dfg~~~~~~~~~~~~~~~~~----~~~~~~y~---------------aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~  205 (330)
T cd07834         145 CDFGLARGVDPDEDEKGFLTE----YVVTRWYR---------------APELLLSSSRYTKAIDIWSVGCIFAELLTRKP  205 (330)
T ss_pred             cccCceEeecccccccccccc----cccccCcC---------------CceeeecccCCCcchhHHHHHHHHHHHHcCCC
Confidence            999999987654321000011    14566666               79988877577899999999999999886533

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=3e-30  Score=218.06  Aligned_cols=188  Identities=16%  Similarity=0.227  Sum_probs=156.3

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~  165 (376)
                      ..++|++.+.+|+|.|++||.|         .+..+++.++||++++-..   +.+.+|+.||+.|+ ||||+++++...
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg---------~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~  103 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEG---------INITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVK  103 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcc---------cccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhc
Confidence            4578999999999999999999         4444688899999987543   56789999999998 999999999988


Q ss_pred             eCC--eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC-CcEEE
Q 017177          166 EDK--ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV-GFLFD  242 (376)
Q Consensus       166 ~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~-g~~kl  242 (376)
                      ++.  ...+++||+.+.+...+.       ..++...+..++.+++.||.|+||  .||+|||+||.|++||.. ..++|
T Consensus       104 Dp~SktpaLiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS--~GImHRDVKPhNvmIdh~~rkLrl  174 (338)
T KOG0668|consen  104 DPESKTPSLIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHS--MGIMHRDVKPHNVMIDHELRKLRL  174 (338)
T ss_pred             CccccCchhHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHh--cCcccccCCcceeeechhhceeee
Confidence            764  578999999987777665       457888899999999999999995  999999999999999865 56999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      +|+|+|.++.....+.-...        +-.|-               -||++-...++...-|+||+||+++.++
T Consensus       175 IDWGLAEFYHp~~eYnVRVA--------SRyfK---------------GPELLVdy~~YDYSLD~WS~GcmlA~mi  227 (338)
T KOG0668|consen  175 IDWGLAEFYHPGKEYNVRVA--------SRYFK---------------GPELLVDYQMYDYSLDMWSLGCMLASMI  227 (338)
T ss_pred             eecchHhhcCCCceeeeeee--------hhhcC---------------CchheeechhccccHHHHHHHHHHHHHH
Confidence            99999999876555432221        11121               4998888888888889999999999987

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.96  E-value=1e-28  Score=232.97  Aligned_cols=201  Identities=20%  Similarity=0.159  Sum_probs=157.4

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCC-CCCcceEEeEEEe
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLS-HPNLVKLLGYCWE  166 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~  166 (376)
                      +|++.+.||+|+||.||++.....       ..+..||+|.+.....  ...+.+.+|+.+++++. ||||+++++.+..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   73 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAET-------SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIV   73 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCC-------CcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence            478889999999999999965431       0167899999875321  22456788999999995 9999999987543


Q ss_pred             C----CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          167 D----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       167 ~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                      .    ..+|+++||+. ++|.+++...    ..+++..++.++.||+.||.|||  ..+|+||||||+|||++.++.++|
T Consensus        74 ~~~~~~~~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~givH~dlkp~Nili~~~~~~kl  146 (332)
T cd07857          74 FPGNFNELYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIH--SANVLHRDLKPGNLLVNADCELKI  146 (332)
T ss_pred             ccccCCcEEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHeEEcCCCCEEe
Confidence            2    45889999986 5899988654    45899999999999999999999  699999999999999999999999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      +|||++............   ......||+.|+               +||.+.+....+.++|+||+|++++++++...
T Consensus       147 ~Dfg~a~~~~~~~~~~~~---~~~~~~g~~~y~---------------aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~  208 (332)
T cd07857         147 CDFGLARGFSENPGENAG---FMTEYVATRWYR---------------APEIMLSFQSYTKAIDVWSVGCILAELLGRKP  208 (332)
T ss_pred             CcCCCceecccccccccc---cccCcccCcccc---------------CcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCc
Confidence            999999876543221000   000115667777               79987766667889999999999999885543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.96  E-value=3.8e-28  Score=225.23  Aligned_cols=201  Identities=22%  Similarity=0.238  Sum_probs=160.2

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCC-CCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLS-HPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|....         +++.||||.++.... .....+.+|+.++.++. ||||+++++++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~   83 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKK---------TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF   83 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECC---------CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee
Confidence            45679999999999999999996543         578899999976432 23455667887777775 99999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .++...|++|||+. ++|.+++....   ..+++..+..++.|++.||.|||+ ..+|+||||||+||+++.++.+||+|
T Consensus        84 ~~~~~~~~v~e~~~-~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~-~~~i~H~dl~p~nill~~~~~~kL~d  158 (296)
T cd06618          84 ITDSDVFICMELMS-TCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKE-KHGVIHRDVKPSNILLDASGNVKLCD  158 (296)
T ss_pred             ecCCeEEEEeeccC-cCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-hCCEecCCCcHHHEEEcCCCCEEECc
Confidence            99999999999985 47877776532   468899999999999999999995 36999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh---hhccccccccceeeeehhhcccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI---KYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~---~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      ||++..+.........        .+++.|+               +||.+.+.   ...+.++|+||+|++++++++-.
T Consensus       159 fg~~~~~~~~~~~~~~--------~~~~~y~---------------aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~  215 (296)
T cd06618         159 FGISGRLVDSKAKTRS--------AGCAAYM---------------APERIDPPDPNPKYDIRADVWSLGISLVELATGQ  215 (296)
T ss_pred             cccchhccCCCcccCC--------CCCcccc---------------CHhhcCCCCCccccccchhHHHHHHHHHHHHhCC
Confidence            9999876543222111        3445555               69987654   33578899999999999999755


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      .+.
T Consensus       216 ~p~  218 (296)
T cd06618         216 FPY  218 (296)
T ss_pred             CCC
Confidence            543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.96  E-value=9.4e-29  Score=232.77  Aligned_cols=198  Identities=21%  Similarity=0.173  Sum_probs=160.5

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEe
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLG  162 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~  162 (376)
                      -...++|++.+.||+|+||.||+|...         .++..||+|++....  ....+.+.+|+.+++.++||||+++++
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~   76 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQ---------LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSD   76 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEEC---------CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEee
Confidence            345678999999999999999999543         368899999886532  223466788999999999999999999


Q ss_pred             EEEe-CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEE
Q 017177          163 YCWE-DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLF  241 (376)
Q Consensus       163 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~k  241 (376)
                      ++.. ....+++|||+ +++|.+++..     ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.++
T Consensus        77 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH--~~~iiH~dl~p~Nili~~~~~~~  148 (328)
T cd07856          77 IFISPLEDIYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVH--SAGVVHRDLKPSNILINENCDLK  148 (328)
T ss_pred             eEecCCCcEEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEeECCCCCEE
Confidence            9876 45789999999 5689888753     24788888999999999999999  69999999999999999999999


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |+|||++.........  .        .+++.|+               +||.+.+....+.++|+|++|++++++++..
T Consensus       149 l~dfg~~~~~~~~~~~--~--------~~~~~y~---------------aPE~~~~~~~~~~~~Dv~slG~il~el~tg~  203 (328)
T cd07856         149 ICDFGLARIQDPQMTG--Y--------VSTRYYR---------------APEIMLTWQKYDVEVDIWSAGCIFAEMLEGK  203 (328)
T ss_pred             eCccccccccCCCcCC--C--------ccccccc---------------CceeeeccCCcCcHHHHHHHHHHHHHHHhCC
Confidence            9999999864332111  1        3455565               6997766556788999999999999999765


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      .+.
T Consensus       204 ~~f  206 (328)
T cd07856         204 PLF  206 (328)
T ss_pred             CCC
Confidence            443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=6.2e-29  Score=228.61  Aligned_cols=195  Identities=26%  Similarity=0.337  Sum_probs=160.8

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCC-CCCcceEEeEEEeCC
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDK  168 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~  168 (376)
                      |++.+.||+|+||.||+|....         +++.|++|.+..... .......+|+..+++++ |+||+++++++.+++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   71 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKE---------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND   71 (283)
T ss_pred             CeeheeeccCCceEEEEEEECC---------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence            6778999999999999996543         478899999875432 22234457999999999 999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeee
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a  248 (376)
                      ..++||||+ +|+|.+++....  ...+++..+..++.|++.+|.|||  +++++|+||||+||++++++.++|+|||++
T Consensus        72 ~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh--~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~  146 (283)
T cd07830          72 ELYFVFEYM-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIH--KHGFFHRDLKPENLLVSGPEVVKIADFGLA  146 (283)
T ss_pred             cEEEEEecC-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEEcCCCCEEEeecccc
Confidence            999999999 779999887653  245899999999999999999999  699999999999999999999999999999


Q ss_pred             eeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          249 VYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      ............        .++..|+               +||++......+.++|+||+|++++++++...
T Consensus       147 ~~~~~~~~~~~~--------~~~~~~~---------------aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~  197 (283)
T cd07830         147 REIRSRPPYTDY--------VSTRWYR---------------APEILLRSTSYSSPVDIWALGCIMAELYTLRP  197 (283)
T ss_pred             eeccCCCCcCCC--------CCccccc---------------CceeeecCcCcCCccchhhHHHHHHHHHhCCC
Confidence            876543322111        4455565               69987666667899999999999999987643

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.96  E-value=1.3e-28  Score=226.27  Aligned_cols=196  Identities=25%  Similarity=0.311  Sum_probs=162.8

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh--hHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      |++.+.||+|++|.||+|...         .++..+++|.++.....  ....+.+|+.+++.++|+||+++++++..++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   71 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDK---------LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG   71 (283)
T ss_pred             CccceeeecCCCceEEEEEcC---------CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence            567789999999999999543         35888999998765332  3467788999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeee
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a  248 (376)
                      ..++|+||+++ +|.+++....   ..+++..+..++.|++.||.|||  +.+|+|+||||+||+++.++.++++|||.+
T Consensus        72 ~~~~v~e~~~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~df~~~  145 (283)
T cd05118          72 DLYLVFEFMDT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCH--SHGILHRDLKPENLLINTEGVLKLADFGLA  145 (283)
T ss_pred             CEEEEEeccCC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHH--HCCeeecCcCHHHEEECCCCcEEEeeeeee
Confidence            99999999975 8888886642   46899999999999999999999  699999999999999999999999999999


Q ss_pred             eeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          249 VYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      .........  ...     ..+++.|+               +||++.+....+.++|+||+|++++++++...+
T Consensus       146 ~~~~~~~~~--~~~-----~~~~~~~~---------------~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~  198 (283)
T cd05118         146 RSFGSPVRP--YTH-----YVVTRWYR---------------APELLLGDKGYSTPVDIWSVGCIFAELLSRRPL  198 (283)
T ss_pred             EecCCCccc--ccC-----ccCccccc---------------CcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCC
Confidence            877654311  000     13455555               799887765678999999999999999976543

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.95  E-value=2.4e-28  Score=221.96  Aligned_cols=200  Identities=20%  Similarity=0.218  Sum_probs=156.1

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCC---C--ChhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP---E--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~---~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      +|.+.+.||+|+||.||++....         .+..+++|.++.   .  .......+.+|+.+++.++||||+++++++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   71 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKK---------AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF   71 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecC---------CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence            48889999999999999996543         234455555443   1  112334567899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .+....++||||+++++|.+++.+.......+++..++.++.|++.||.|||  +.+++|+||||+||+++. +.++++|
T Consensus        72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~~l~~~nili~~-~~~~l~d  148 (260)
T cd08222          72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH--QRRILHRDLKAKNIFLKN-NLLKIGD  148 (260)
T ss_pred             hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH--HcCccccCCChhheEeec-CCEeecc
Confidence            9999999999999999999998764433456899999999999999999999  699999999999999975 6799999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ||++..........   ...    .|++.|+               +||.+.+.. .+.++|+||+|++++++++...+.
T Consensus       149 ~g~~~~~~~~~~~~---~~~----~~~~~~~---------------~pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~  205 (260)
T cd08222         149 FGVSRLLMGSCDLA---TTF----TGTPYYM---------------SPEALKHQG-YDSKSDIWSLGCILYEMCCLAHAF  205 (260)
T ss_pred             cCceeecCCCcccc---cCC----CCCcCcc---------------CHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            99998764432211   111    4556666               699776544 467899999999999988655443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.95  E-value=6.8e-28  Score=217.38  Aligned_cols=188  Identities=26%  Similarity=0.282  Sum_probs=156.4

Q ss_pred             EeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEE
Q 017177           97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        97 lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv  173 (376)
                      ||+|+||.||++....         ++..+|+|.+.....   .....+.+|+.+++.++||||+++++.+..++..+++
T Consensus         1 lg~G~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   71 (250)
T cd05123           1 LGKGSFGKVLLVRKKD---------TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV   71 (250)
T ss_pred             CCCCCceEEEEEEECC---------CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence            6899999999996543         478999999876533   2446788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      |||+++++|.+++...    ..+++..+..++.|++.||.|||  +.+++|+||||+||+++.++.++++|||++.....
T Consensus        72 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh--~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~  145 (250)
T cd05123          72 LEYAPGGELFSHLSKE----GRFSEERARFYAAEIVLALEYLH--SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSS  145 (250)
T ss_pred             EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence            9999999999999765    35899999999999999999999  69999999999999999999999999999987655


Q ss_pred             ce-eeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          254 HY-IYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       254 ~~-~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      .. .....        .++..|+               +||.+.+.. .+.++|+|++|++++++.+-..+
T Consensus       146 ~~~~~~~~--------~~~~~~~---------------~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p  192 (250)
T cd05123         146 EGSRTNTF--------CGTPEYL---------------APEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPP  192 (250)
T ss_pred             CCCcccCC--------cCCcccc---------------ChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCC
Confidence            32 11111        3445555               699776544 57889999999999998865443

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.95  E-value=7.4e-28  Score=221.67  Aligned_cols=195  Identities=24%  Similarity=0.321  Sum_probs=156.3

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcC---CCCCcceEEeEEE
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRL---SHPNLVKLLGYCW  165 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l---~h~nIv~l~~~~~  165 (376)
                      |++.+.||+|+||.||+|....         ++..||+|.++....  .....+.+|+.+++++   +|+||+++++++.
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~   71 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLN---------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH   71 (287)
T ss_pred             CeEEEEecccCceEEEEEEECC---------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence            6778999999999999996543         478999999975432  1234566788777766   5999999999998


Q ss_pred             eCCe-----EEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcE
Q 017177          166 EDKE-----LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL  240 (376)
Q Consensus       166 ~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~  240 (376)
                      ..+.     .+++|||+.+ +|.+++.+...  ..+++..+..++.|++.||.|||  +.+++|+||||+||+++.++.+
T Consensus        72 ~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH--~~~i~h~~l~~~nili~~~~~~  146 (287)
T cd07838          72 GPRTDRELKLTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLH--SHRIVHRDLKPQNILVTSDGQV  146 (287)
T ss_pred             eccCCCCceeEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCChhhEEEccCCCE
Confidence            8776     9999999975 89998876432  35899999999999999999999  6999999999999999999999


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      +|+|||++............        .+++.|+               +||.+.+.. .+.++|+||+|++++++++.
T Consensus       147 ~l~dfg~~~~~~~~~~~~~~--------~~~~~~~---------------~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~  202 (287)
T cd07838         147 KIADFGLARIYSFEMALTSV--------VVTLWYR---------------APEVLLQSS-YATPVDMWSVGCIFAELFRR  202 (287)
T ss_pred             EEeccCcceeccCCcccccc--------ccccccc---------------ChHHhccCC-CCCcchhhhHHHHHHHHHhC
Confidence            99999999876544322111        3445555               699877654 57889999999999999865


Q ss_pred             ccc
Q 017177          321 YRT  323 (376)
Q Consensus       321 y~~  323 (376)
                      ..+
T Consensus       203 ~~~  205 (287)
T cd07838         203 RPL  205 (287)
T ss_pred             CCc
Confidence            433

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.95  E-value=3.8e-28  Score=248.14  Aligned_cols=188  Identities=20%  Similarity=0.243  Sum_probs=152.7

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      .++|++.+.||+|+||.||+|....         +++.||||+++...   ......+.+|+.+++.++||||+++++.+
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~   73 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKN---------NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL   73 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE
Confidence            3679999999999999999996543         58899999987543   23346788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      ...+.+||||||+.+++|.+++...    ..+++..++.++.||+.||.|||  .++|+||||||+||||+.+|.+||+|
T Consensus        74 ~~~~~~~lVmEy~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH--~~gIiHrDLKP~NILl~~~g~vkL~D  147 (669)
T cd05610          74 QSANNVYLVMEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLH--RHGIIHRDLKPDNMLISNEGHIKLTD  147 (669)
T ss_pred             EECCEEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCccHHHEEEcCCCCEEEEe
Confidence            9999999999999999999999765    34788999999999999999999  58999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceee
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAF  312 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~  312 (376)
                      ||+++..........  . .    .+|+.|+               +||.......-....++|++|.
T Consensus       148 FGls~~~~~~~~~~~--~-~----~~t~~~~---------------~pe~~~~~~~~~~~s~~~s~g~  193 (669)
T cd05610         148 FGLSKVTLNRELNMM--D-I----LTTPSMA---------------KPKNDYSRTPGQVLSLISSLGF  193 (669)
T ss_pred             CCCCccccCCccccc--c-c----ccCcccc---------------CccccccCCCCceeeeeeecCc
Confidence            999997654432211  1 1    6677777               5774444444444556666663

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=2.5e-28  Score=231.22  Aligned_cols=193  Identities=21%  Similarity=0.210  Sum_probs=156.5

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      .++|.+.+.||+|+||.||+|...         .++..||+|++.....  .....+.+|+.+++.++||||+++++++.
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~   84 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDK---------RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFT   84 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeC---------CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence            468999999999999999999543         3588999999875422  22356789999999999999999999987


Q ss_pred             eCC------eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc
Q 017177          166 EDK------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF  239 (376)
Q Consensus       166 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~  239 (376)
                      ...      ..++|+||+.. +|..++.      ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH--~~~i~H~dlkp~NIll~~~~~  155 (342)
T cd07879          85 SAVSGDEFQDFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIH--SAGIIHRDLKPGNLAVNEDCE  155 (342)
T ss_pred             ccccCCCCceEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCC
Confidence            542      46999999964 7776652      24889999999999999999999  699999999999999999999


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ++|+|||+++.......     +     ..+|+.|+               +||++.+....+.++|+||+|++++++++
T Consensus       156 ~kL~dfg~~~~~~~~~~-----~-----~~~~~~y~---------------aPE~~~~~~~~~~~~Dv~slGvil~el~~  210 (342)
T cd07879         156 LKILDFGLARHADAEMT-----G-----YVVTRWYR---------------APEVILNWMHYNQTVDIWSVGCIMAEMLT  210 (342)
T ss_pred             EEEeeCCCCcCCCCCCC-----C-----ceeeeccc---------------ChhhhcCccccCchHHHHHHHHHHHHHHh
Confidence            99999999886533211     1     14556666               79988765567889999999999999986


Q ss_pred             cccc
Q 017177          320 FYRT  323 (376)
Q Consensus       320 ~y~~  323 (376)
                      -..+
T Consensus       211 g~~p  214 (342)
T cd07879         211 GKTL  214 (342)
T ss_pred             CCCC
Confidence            5444

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-28  Score=220.32  Aligned_cols=196  Identities=20%  Similarity=0.219  Sum_probs=161.2

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-C-C----Ccce
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-H-P----NLVK  159 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h-~----nIv~  159 (376)
                      ...++|++.+.+|+|.||+|..|+++.         ++..||||+++.-. ...+..+-|+++|+++. + |    -++.
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~---------~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~  155 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRE---------TKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQ  155 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecC---------CCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence            347889999999999999999997664         37889999997543 33456677999999995 2 2    3778


Q ss_pred             EEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC---
Q 017177          160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG---  236 (376)
Q Consensus       160 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~---  236 (376)
                      +.++|.-.++.+||+|.+ |-++.++|..++.  .+++...+..++.|++.++.|||  +.+++|-||||||||+-+   
T Consensus       156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh--~~kl~HTDLKPENILfvss~~  230 (415)
T KOG0671|consen  156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLH--DLKLTHTDLKPENILFVSSEY  230 (415)
T ss_pred             eehhhhccCceEEEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHH--hcceeecCCChheEEEeccce
Confidence            888899999999999998 6699999987653  67899999999999999999999  699999999999999831   


Q ss_pred             -----------------CCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhh
Q 017177          237 -----------------VGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIK  299 (376)
Q Consensus       237 -----------------~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~  299 (376)
                                       +-.++++|||.|++-.....  .+..|..|.|                       ||++.|-+
T Consensus       231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs--~iVsTRHYRA-----------------------PEViLgLG  285 (415)
T KOG0671|consen  231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHS--TIVSTRHYRA-----------------------PEVILGLG  285 (415)
T ss_pred             EEEeccCCccceeccCCCcceEEEecCCcceeccCcc--eeeeccccCC-----------------------chheeccC
Confidence                             22489999999998766553  3555666666                       99999887


Q ss_pred             hccccccccceeeeehhhccccc
Q 017177          300 YLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       300 ~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      . +..+||||+|||+.|+.+-..
T Consensus       286 w-S~pCDvWSiGCIL~ElytG~~  307 (415)
T KOG0671|consen  286 W-SQPCDVWSIGCILVELYTGET  307 (415)
T ss_pred             c-CCccCceeeeeEEEEeeccce
Confidence            5 788999999999999884433

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.95  E-value=1.1e-27  Score=234.18  Aligned_cols=220  Identities=15%  Similarity=0.120  Sum_probs=148.7

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCC-------CcccCCCCcEEEEEEcCCCChhhHHH--------------HHH
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTL-------APSKTGLGMVVAIKKLNPESMQGFEE--------------WQS  144 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~-------~~~~~~~~~~vavK~~~~~~~~~~~~--------------~~~  144 (376)
                      ...++|++.++||+|+||.||+|.......       .......++.||||.+........+.              ...
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            456789999999999999999996522110       00122346789999987654322222              234


Q ss_pred             HHHHHhcCCCCCc-----ceEEeEEEe--------CCeEEEEEeccCCCCHHHHHhhcCCC-------------------
Q 017177          145 EVNFLGRLSHPNL-----VKLLGYCWE--------DKELLLVYEYMQRGSLENHLFRRNPS-------------------  192 (376)
Q Consensus       145 E~~il~~l~h~nI-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------  192 (376)
                      |+.++.+++|.++     ++++++|..        .+..|+||||+++++|.+++......                   
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6777777766544     667776643        35689999999999999998643210                   


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeee
Q 017177          193 -IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYV  271 (376)
Q Consensus       193 -~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt  271 (376)
                       ...+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++.............+      .+|
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH--~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g------~~t  373 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLH--RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYG------MLD  373 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCcccc------CCC
Confidence             123467788999999999999999  58999999999999999999999999999976543322211111      345


Q ss_pred             eehhhhhcchhhHH------------HHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          272 YIYMYIYKCLRYAI------------LYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       272 ~~y~~~~~~~e~~d------------~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      |.|+    +||...            +...+.|.. .. .....+.|+||+|+|+++++.
T Consensus       374 p~Y~----aPE~l~~~~~~~~~~~~~~~~~l~~~~-~~-yg~~~~~DvwSlGvil~em~~  427 (507)
T PLN03224        374 PRYS----PPEELVMPQSCPRAPAPAMAALLSPFA-WL-YGRPDLFDSYTAGVLLMQMCV  427 (507)
T ss_pred             ccee----ChhhhcCCCCCCccchhhhhhhhhhhH-Hh-cCCCCccchhhHHHHHHHHHh
Confidence            6666    333211            111222221 11 112346799999999999974

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=5.2e-29  Score=242.58  Aligned_cols=198  Identities=24%  Similarity=0.269  Sum_probs=163.6

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCe
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE  169 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~  169 (376)
                      .+..++||.|+||+||+|.+-.     +....+.+||+|++..... +...++++|+.+|.+++|||++++++++.... 
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~P-----ege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIP-----EGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEec-----CCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence            4556899999999999997754     3333478899999876543 44578999999999999999999999997765 


Q ss_pred             EEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeee
Q 017177          170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYV  249 (376)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~  249 (376)
                      +-||++|+++|+|.++++.++   ..+.....+.|..||++||.|||  +++++||||..+||||.....+|+.|||+++
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe--~qrlVHrdLaaRNVLVksP~hvkitdfgla~  846 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLE--EQRLVHRDLAARNVLVKSPNHVKITDFGLAK  846 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHH--hcchhhhhhhhhheeecCCCeEEEEecchhh
Confidence            889999999999999998874   56888999999999999999999  7999999999999999999999999999999


Q ss_pred             eeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          250 YFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      .+......-...+..     -.+.               |||-|.+.... ++..+|||+||+..||+++|
T Consensus       847 ll~~d~~ey~~~~gK-----~pik---------------wmale~i~~~~-~thqSDVWsfGVtiWElmTF  896 (1177)
T KOG1025|consen  847 LLAPDEKEYSAPGGK-----VPIK---------------WMALESIRIRK-YTHQSDVWSFGVTIWELMTF  896 (1177)
T ss_pred             ccCcccccccccccc-----cCcH---------------HHHHHHhhccC-CCchhhhhhhhhhHHHHHhc
Confidence            886654432121110     1122               44788776554 59999999999999999988

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.95  E-value=3.7e-29  Score=224.56  Aligned_cols=178  Identities=19%  Similarity=0.142  Sum_probs=144.4

Q ss_pred             cCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEEEeccCC
Q 017177          100 GGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQR  179 (376)
Q Consensus       100 G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  179 (376)
                      |.||.||+++.         +.+++.||+|.+.....     ..+|...+....||||+++++++.+.+..+++|||+++
T Consensus         4 g~~~~v~~~~~---------~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   69 (237)
T cd05576           4 GVIDKVLLVMD---------TRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG   69 (237)
T ss_pred             cccceEEEEEE---------ccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence            89999999954         44688999999976532     23455555566799999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEE
Q 017177          180 GSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIY  259 (376)
Q Consensus       180 g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~  259 (376)
                      |+|.+++.+.    ..+++..+..++.|++.||.|||  +++|+||||||+||+++.++.++++|||.+........   
T Consensus        70 ~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~---  140 (237)
T cd05576          70 GKLWSHISKF----LNIPEECVKRWAAEMVVALDALH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD---  140 (237)
T ss_pred             CCHHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEEcCCCCEEEecccchhccccccc---
Confidence            9999998765    34899999999999999999999  69999999999999999999999999998876543211   


Q ss_pred             EeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          260 IHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       260 ~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                        +.     .+++.|+               +||.+.+.. .+.++|+||+|++++++++-+.+
T Consensus       141 --~~-----~~~~~y~---------------aPE~~~~~~-~~~~~DvwslG~il~el~~g~~~  181 (237)
T cd05576         141 --GE-----AVENMYC---------------APEVGGISE-ETEACDWWSLGAILFELLTGKTL  181 (237)
T ss_pred             --cC-----CcCcccc---------------CCcccCCCC-CCchhhHHHHHHHHHHHHHCcch
Confidence              11     3344455               699665443 47889999999999999876543

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.95  E-value=6e-28  Score=258.00  Aligned_cols=189  Identities=27%  Similarity=0.396  Sum_probs=152.4

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ....+...++||+|+||.||+|....         ++..||+|.++.....    ...|++++++++||||+++++++.+
T Consensus       688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~  754 (968)
T PLN00113        688 ILSSLKEENVISRGKKGASYKGKSIK---------NGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS  754 (968)
T ss_pred             HHhhCCcccEEccCCCeeEEEEEECC---------CCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc
Confidence            34567778899999999999996532         4889999998754322    1346889999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS-EKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~-~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      ++..|+||||+++|+|.++++       .+++..+..++.|++.||+|||.. ..+|+||||||+||+++.++..++. |
T Consensus       755 ~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~  826 (968)
T PLN00113        755 EKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-L  826 (968)
T ss_pred             CCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-e
Confidence            999999999999999999994       278899999999999999999952 4699999999999999998887765 6


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |.........       +    ..||+.||               |||++.+.. ++.++||||+|++++|+++...+
T Consensus       827 ~~~~~~~~~~-------~----~~~t~~y~---------------aPE~~~~~~-~~~~sDv~S~Gvvl~el~tg~~p  877 (968)
T PLN00113        827 SLPGLLCTDT-------K----CFISSAYV---------------APETRETKD-ITEKSDIYGFGLILIELLTGKSP  877 (968)
T ss_pred             ccccccccCC-------C----cccccccc---------------CcccccCCC-CCcccchhhHHHHHHHHHhCCCC
Confidence            5554322111       1    15566677               799776554 58899999999999999976655

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=2.1e-28  Score=224.78  Aligned_cols=194  Identities=28%  Similarity=0.356  Sum_probs=160.6

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      |+..+.||+|.||.||+|...         .+++.+|+|.+....  ....+.+.+|+.+++.++|+||+++++++.+.+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   71 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDK---------KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER   71 (282)
T ss_pred             CeeehcccccCcceEEEeeec---------CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence            566789999999999999543         358899999998753  233456788999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeee
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a  248 (376)
                      ..++||||++ ++|.+++.+..   ..+++..+..++.|++.||.|||  +.+|+||||+|+||++++++.++|+|||++
T Consensus        72 ~~~~v~e~~~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~  145 (282)
T cd07829          72 KLYLVFEYCD-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCH--SHRILHRDLKPQNILINRDGVLKLADFGLA  145 (282)
T ss_pred             ceEEEecCcC-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChheEEEcCCCCEEEecCCcc
Confidence            9999999997 59999997652   35899999999999999999999  699999999999999999999999999999


Q ss_pred             eeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          249 VYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      .......... . ..     .++..|+               +||.+.+....+.++|+|++|++++++++-.
T Consensus       146 ~~~~~~~~~~-~-~~-----~~~~~~~---------------aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~  196 (282)
T cd07829         146 RAFGIPLRTY-T-HE-----VVTLWYR---------------APEILLGSKHYSTAVDIWSVGCIFAEMITGK  196 (282)
T ss_pred             cccCCCcccc-C-cc-----ccCcCcC---------------ChHHhcCCcCCCccccHHHHHHHHHHHHhCC
Confidence            8765432210 0 00     3344455               7998877656788999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.95  E-value=2.6e-28  Score=231.24  Aligned_cols=196  Identities=22%  Similarity=0.203  Sum_probs=162.0

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|....         ++..||+|++....  ......+.+|+.+++.++||||+++++++
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTK---------TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF   83 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECC---------CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence            46789999999999999999996543         58889999987542  23345677899999999999999999988


Q ss_pred             EeCCe------EEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          165 WEDKE------LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       165 ~~~~~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      ...+.      .++|+||+ +++|.+++..     ..+++..+..++.|++.||.|||  ..+|+||||||+||+++.++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH--~~gi~H~dlkp~Nill~~~~  155 (343)
T cd07851          84 TPASSLEDFQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIH--SAGIIHRDLKPSNIAVNEDC  155 (343)
T ss_pred             hccccccccccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCC
Confidence            76554      89999999 6699998864     34899999999999999999999  59999999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .++|+|||++.........          ..+++.|+               +||++.+....+.++||||+|+++++++
T Consensus       156 ~~kL~dfg~~~~~~~~~~~----------~~~~~~y~---------------aPE~~~~~~~~~~~~DvwslGv~l~ell  210 (343)
T cd07851         156 ELKILDFGLARHTDDEMTG----------YVATRWYR---------------APEIMLNWMHYNQTVDIWSVGCIMAELL  210 (343)
T ss_pred             CEEEccccccccccccccC----------Cccccccc---------------CHHHHhCCCCCCchHhHHHHHHHHHHHH
Confidence            9999999999876443111          14556666               7998876556788999999999999999


Q ss_pred             cccccc
Q 017177          319 SFYRTT  324 (376)
Q Consensus       319 ~~y~~~  324 (376)
                      +.+.+.
T Consensus       211 tg~~pf  216 (343)
T cd07851         211 TGKTLF  216 (343)
T ss_pred             hCCCCC
Confidence            765543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.95  E-value=2.8e-29  Score=245.41  Aligned_cols=246  Identities=21%  Similarity=0.168  Sum_probs=176.3

Q ss_pred             CCccceEeecCcEE-EEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEEeEEEeCC
Q 017177           91 FKPDSLLGEGGFGR-VYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDK  168 (376)
Q Consensus        91 y~~~~~lG~G~fg~-V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~  168 (376)
                      |...+++|.|+.|+ ||+|.+.           ++.||||.+-.+..   ....+|+..|+.-+ |||||++|+.-.++.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-----------~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~q  576 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-----------GREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQ  576 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-----------CceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCc
Confidence            44457899999977 7899776           77899998865432   45578999999997 999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC---C--CcEEEc
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG---V--GFLFDS  243 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~---~--g~~kl~  243 (376)
                      ..||..|.|.. +|.+++...............+.+..|++.||++||+  .+||||||||.||||+.   +  .+++|+
T Consensus       577 F~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs--l~iVHRDLkPQNILI~~~~~~~~~ra~iS  653 (903)
T KOG1027|consen  577 FLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS--LKIVHRDLKPQNILISVPSADGTLRAKIS  653 (903)
T ss_pred             eEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh--cccccccCCCceEEEEccCCCcceeEEec
Confidence            99999999965 9999997641111111114457888999999999995  99999999999999965   3  468999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc-cc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF-YR  322 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~-y~  322 (376)
                      |||+++.+......-....+.    .||.+|+               |||++..... +.+.|++|+||||+.+++- -.
T Consensus       654 DfglsKkl~~~~sS~~r~s~~----sGt~GW~---------------APE~L~~~~~-~~avDiFslGCvfyYvltgG~H  713 (903)
T KOG1027|consen  654 DFGLSKKLAGGKSSFSRLSGG----SGTSGWQ---------------APEQLREDRK-TQAVDIFSLGCVFYYVLTGGSH  713 (903)
T ss_pred             ccccccccCCCcchhhcccCC----CCccccc---------------CHHHHhcccc-CcccchhhcCceEEEEecCCcc
Confidence            999999986654421112222    6777777               8998887654 6799999999999987743 22


Q ss_pred             cchhhHHHHHH--------HhhCCC---ccCcccCCChh--HHHHHHHHHHhhheeeecCCccc
Q 017177          323 TTMLKYQILAW--------QSWGPL---VESHMLQPGLW--AHMVMQLQNMLQQVIFISSPLNL  373 (376)
Q Consensus       323 ~~~~~~~~~~~--------~~~~~~---~~~~~~~~~l~--~~~~~~~~~~~~~~~~~~~~~~~  373 (376)
                      +..-.+...+-        ..+.+.   ...++|..|+.  -+..+..+..|.+++||+++--|
T Consensus       714 pFGd~~~R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL  777 (903)
T KOG1027|consen  714 PFGDSLERQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRL  777 (903)
T ss_pred             CCCchHHhhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHH
Confidence            22212211111        111111   23445555555  44455678899999999986443

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-27  Score=240.27  Aligned_cols=210  Identities=25%  Similarity=0.318  Sum_probs=167.3

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCC-CCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLS-HPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-h~nIv~l~~~~  164 (376)
                      ..++.++.+.||+|.||.|++|.........  ......||||.++.... .+.+.+..|+++|+.+. |+||+.+++++
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~--~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKAL--LSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             chhhccccceeecccccceEeEEEeeccccc--ccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            3445567789999999999999866422110  12367899999986533 55678899999999996 99999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcC---C-------CC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCE
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRN---P-------SI--QPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI  232 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~---~-------~~--~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NI  232 (376)
                      ...+.+++|+||+..|+|.++|++.+   .       ..  ..++..+.+.++.||+.|++||+  ..++|||||.++||
T Consensus       372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~--~~~~vHRDLAaRNV  449 (609)
T KOG0200|consen  372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA--SVPCVHRDLAARNV  449 (609)
T ss_pred             ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh--hCCccchhhhhhhE
Confidence            99999999999999999999998875   0       01  13889999999999999999999  59999999999999


Q ss_pred             EEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceee
Q 017177          233 LLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAF  312 (376)
Q Consensus       233 Ll~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~  312 (376)
                      |+..+..+||+|||+++.......+....+      .|+-+             ..|||||-+.. ..++.++||||||+
T Consensus       450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~------~~~LP-------------~kWmApEsl~~-~~ft~kSDVWSfGI  509 (609)
T KOG0200|consen  450 LITKNKVIKIADFGLARDHYNKDYYRTKSS------AGTLP-------------VKWMAPESLFD-RVFTSKSDVWSFGI  509 (609)
T ss_pred             EecCCCEEEEccccceeccCCCCceEecCC------CCccc-------------eeecCHHHhcc-CcccccchhhHHHH
Confidence            999999999999999997655544422211      11111             11348998887 56789999999999


Q ss_pred             eehhhccc
Q 017177          313 VFSCVFSF  320 (376)
Q Consensus       313 v~~~~~~~  320 (376)
                      +++|++++
T Consensus       510 ~L~EifsL  517 (609)
T KOG0200|consen  510 LLWEIFTL  517 (609)
T ss_pred             HHHHHhhC
Confidence            99999854

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=3.9e-29  Score=238.89  Aligned_cols=197  Identities=23%  Similarity=0.275  Sum_probs=172.8

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      +..++|+++..+|.|+||.||++         +++.++...|+|+++.+...+..-+++|+-+++.++||||+.+++.+.
T Consensus        12 nP~ddyellqrvgsgTygdvyKa---------Rd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsyl   82 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKA---------RDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYL   82 (829)
T ss_pred             CCccchhheeeecCCcccchhhh---------cccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhh
Confidence            45678999999999999999999         666679999999999987778888899999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      ..+.+|++||||.+|+|.+..+-.    .++++.++..+++..++||+|||+  .+-+|||||-.|||+++.|.+|++||
T Consensus        83 r~dklwicMEycgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs--~gk~hRdiKGanilltd~gDvklaDf  156 (829)
T KOG0576|consen   83 RRDKLWICMEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHS--QGKIHRDIKGANILLTDEGDVKLADF  156 (829)
T ss_pred             hhcCcEEEEEecCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhc--CCcccccccccceeecccCceeeccc
Confidence            999999999999999999987655    669999999999999999999995  99999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHh--hhhhccccccccceeeeehhhcc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYA--WIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~--~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      |.+..++..-....   ++    .|||.||               |||+-.  .+.-+...+|+|+.|+...|+.-
T Consensus       157 gvsaqitati~Krk---sf----iGtpywm---------------apEvaaverkggynqlcdiwa~gitAiel~e  210 (829)
T KOG0576|consen  157 GVSAQITATIAKRK---SF----IGTPYWM---------------APEVAAVERKGGYNQLCDIWALGITAIELGE  210 (829)
T ss_pred             Cchhhhhhhhhhhh---cc----cCCcccc---------------chhHHHHHhcccccccccccccccchhhhhh
Confidence            99998766433221   12    8999999               788544  23455789999999999998883

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6.6e-28  Score=230.70  Aligned_cols=192  Identities=23%  Similarity=0.253  Sum_probs=156.9

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~  165 (376)
                      +.+.|++...+|.|+|+.|-.|         .+..+++..++|++....    ....+|+.++.... ||||+++.+.+.
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~---------~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~  386 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYC---------ESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYE  386 (612)
T ss_pred             cchhhccccccCCCCccceeee---------eccccccchhheeccccc----cccccccchhhhhcCCCcceeecceec
Confidence            4678999999999999999998         455578899999998763    22345777777665 999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE-cCCCcEEEcc
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL-DGVGFLFDSH  244 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl-~~~g~~kl~D  244 (376)
                      ++.+.|+|||++.|+-|.+.+....     .....+..|+.+|+.|+.|||  +++||||||||+|||+ +..|+++|+|
T Consensus       387 ~~~~~~~v~e~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH--~~gvvhRDLkp~NIL~~~~~g~lrlty  459 (612)
T KOG0603|consen  387 DGKEIYLVMELLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLH--EQGVVHRDLKPGNILLDGSAGHLRLTY  459 (612)
T ss_pred             CCceeeeeehhccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHH--hcCeeecCCChhheeecCCCCcEEEEE
Confidence            9999999999999998888775542     233777889999999999999  6999999999999999 6999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ||.++.....      +-+.    +-|-.|.               |||++. ..-++.++|+||+|.++++|.+-+.+.
T Consensus       460 FG~a~~~~~~------~~tp----~~t~~y~---------------APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~  513 (612)
T KOG0603|consen  460 FGFWSELERS------CDTP----ALTLQYV---------------APEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLF  513 (612)
T ss_pred             echhhhCchh------hccc----chhhccc---------------Chhhhc-cCCCCcchhhHHHHHHHHHHHhCCCcc
Confidence            9999977665      1111    2233333               699777 445699999999999999999777665

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.94  E-value=1.7e-27  Score=237.95  Aligned_cols=210  Identities=20%  Similarity=0.183  Sum_probs=136.5

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeE---
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGY---  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~---  163 (376)
                      ..++|++.+.||+|+||.||+|......     ...+..||+|++......  +.+..|  .++...+.++..+...   
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~-----~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQ-----SKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLE  200 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCc-----cccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence            5678999999999999999999765411     122788999988654321  111111  1222223333322222   


Q ss_pred             ---EEeCCeEEEEEeccCCCCHHHHHhhcCCC----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEe
Q 017177          164 ---CWEDKELLLVYEYMQRGSLENHLFRRNPS----------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIY  224 (376)
Q Consensus       164 ---~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiH  224 (376)
                         ...+...++||||+.+++|.+++......                ........+..++.|++.||.|||  .++|+|
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH--~~gIiH  278 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH--STGIVH  278 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH--HCCEEe
Confidence               23456799999999999999998654210                011123446689999999999999  589999


Q ss_pred             cCCCCCCEEEcC-CCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHH------------HHHHHH
Q 017177          225 RDFKASNILLDG-VGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAI------------LYSVLL  291 (376)
Q Consensus       225 rDlKp~NILl~~-~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d------------~~s~~a  291 (376)
                      |||||+|||++. ++.+||+|||+++.+......  ...+    ..|||.||    +||...            +...+.
T Consensus       279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~--~~~~----~~~t~~Y~----APE~~~~~~~~~~~~~~~~~~~~s  348 (566)
T PLN03225        279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY--IPKE----FLLDPRYA----APEQYIMSTQTPSAPSAPVATALS  348 (566)
T ss_pred             CcCCHHHEEEeCCCCcEEEEeCCCcccccccccc--CCcc----cccCCCcc----ChHHhhccCCCCCCcccccccccc
Confidence            999999999985 689999999999866433221  1111    26778888    333111            000112


Q ss_pred             HHHHhhhhhccccccccceeeeehhhcc
Q 017177          292 PRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       292 pEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      |++.  ...++.++||||+|+|++|++.
T Consensus       349 p~l~--~~~~~~k~DVwSlGviL~el~~  374 (566)
T PLN03225        349 PVLW--QLNLPDRFDIYSAGLIFLQMAF  374 (566)
T ss_pred             chhc--cccCCCCcccHHHHHHHHHHHh
Confidence            2211  1224567799999999999883

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.9e-26  Score=216.58  Aligned_cols=144  Identities=19%  Similarity=0.165  Sum_probs=115.4

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-----ChhhHHHHHHHHHHHhcCCCCCcce-
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-----SMQGFEEWQSEVNFLGRLSHPNLVK-  159 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~h~nIv~-  159 (376)
                      ...++|.+.+.||+|+||+||+|.+...        +++.+|||++...     .....+.+.+|+++|+.++|+||+. 
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~--------~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~   86 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGD--------PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQ   86 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCC--------CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcE
Confidence            3457899999999999999999965421        3677899987543     1223467889999999999999985 


Q ss_pred             EEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCC-CCCCEEEcCCC
Q 017177          160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDF-KASNILLDGVG  238 (376)
Q Consensus       160 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDl-Kp~NILl~~~g  238 (376)
                      +++    .+..|+||||++|++|.. +. .      ..   ...++.|++.||.|||  .++|+|||| ||+|||++.++
T Consensus        87 l~~----~~~~~LVmE~~~G~~L~~-~~-~------~~---~~~~~~~i~~aL~~lH--~~gIiHrDL~KP~NILv~~~~  149 (365)
T PRK09188         87 LLA----TGKDGLVRGWTEGVPLHL-AR-P------HG---DPAWFRSAHRALRDLH--RAGITHNDLAKPQNWLMGPDG  149 (365)
T ss_pred             EEE----cCCcEEEEEccCCCCHHH-hC-c------cc---hHHHHHHHHHHHHHHH--HCCCeeCCCCCcceEEEcCCC
Confidence            443    246899999999999963 21 1      11   1467889999999999  599999999 99999999999


Q ss_pred             cEEEcceeeeeeeccc
Q 017177          239 FLFDSHLLIYVYFKRH  254 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~  254 (376)
                      .+||+|||+++.+...
T Consensus       150 ~ikLiDFGlA~~~~~~  165 (365)
T PRK09188        150 EAAVIDFQLASVFRRR  165 (365)
T ss_pred             CEEEEECccceecccC
Confidence            9999999999987654

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=6.3e-27  Score=202.52  Aligned_cols=217  Identities=16%  Similarity=0.218  Sum_probs=158.2

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEEeE-E
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGY-C  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~-~  164 (376)
                      ..+.|.+.+.||+|-||++-+|         +++.++..+++|.+..... ..++|.+|...--.|. |.||+.-|+. |
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~---------eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaF   91 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLA---------EHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAF   91 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEee---------eccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHh
Confidence            3456899999999999999999         4555788999999886543 3478899998877787 9999998775 7


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc--CCCcEEE
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD--GVGFLFD  242 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~--~~g~~kl  242 (376)
                      +..+.+++++||++.|+|..-+..     ..+-+.....++.|++.|+.|+|+  +++||||||.+||||-  +.-++|+
T Consensus        92 qt~d~YvF~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHs--knlVHRdlK~eNiLif~~df~rvKl  164 (378)
T KOG1345|consen   92 QTSDAYVFVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHS--KNLVHRDLKAENILIFDADFYRVKL  164 (378)
T ss_pred             hcCceEEEeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhc--cchhhcccccceEEEecCCccEEEe
Confidence            778889999999999999887744     337888899999999999999995  9999999999999993  3457999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      ||||..+..+.....  ..        .+..|.    +||..+       ++..+.-...+..|+|.||+||+.+++---
T Consensus       165 cDFG~t~k~g~tV~~--~~--------~~~~y~----~pe~~~-------~~~ne~~~~~ps~D~WqfGIi~f~cltG~~  223 (378)
T KOG1345|consen  165 CDFGLTRKVGTTVKY--LE--------YVNNYH----APELCD-------TVVNEKLVVNPSTDIWQFGIIFFYCLTGKF  223 (378)
T ss_pred             eecccccccCceehh--hh--------hhcccC----CcHHHh-------hccccceEecccccchheeeeeeeeecCCC
Confidence            999999875543222  11        222333    222221       222344455688899999999876664311


Q ss_pred             c---c-hhhHHHHHHHhhCCCcc
Q 017177          323 T---T-MLKYQILAWQSWGPLVE  341 (376)
Q Consensus       323 ~---~-~~~~~~~~~~~~~~~~~  341 (376)
                      +   + ...-+...|..|...+.
T Consensus       224 PWQka~~~d~~Y~~~~~w~~rk~  246 (378)
T KOG1345|consen  224 PWQKASIMDKPYWEWEQWLKRKN  246 (378)
T ss_pred             cchhhhccCchHHHHHHHhcccC
Confidence            1   1 12223345556655544

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=9.6e-26  Score=199.54  Aligned_cols=197  Identities=26%  Similarity=0.324  Sum_probs=163.2

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh-hHHHHHHHHHHHhcCCCCCcceEEeEEEeCCe
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE  169 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~  169 (376)
                      |.+.+.||.|++|.||++...+         ++..+|+|.+...... ..+.+.+|+..++.++|+|++++++++.....
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~   71 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKG---------TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP   71 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcC---------CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence            5677899999999999996553         4788999999876554 56788899999999999999999999998899


Q ss_pred             EEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeee
Q 017177          170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYV  249 (376)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~  249 (376)
                      .++++|++++++|.+++.....   .+++..+..++.+++.+|.+||  +.+++|+||+|.||+++.++.++|+|||.+.
T Consensus        72 ~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~  146 (225)
T smart00221       72 LYLVMEYCEGGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLH--SLGIVHRDLKPENILLGMDGLVKLADFGLAR  146 (225)
T ss_pred             eEEEEeccCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeeCceee
Confidence            9999999999999999976521   1788999999999999999999  5899999999999999999999999999999


Q ss_pred             eeccce--eeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          250 YFKRHY--IYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       250 ~~~~~~--~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ......  .....        .++..|+               +||++......+.++|+|++|++++++++-..+.
T Consensus       147 ~~~~~~~~~~~~~--------~~~~~~~---------------~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf  200 (225)
T smart00221      147 FIHRDLAALLKTV--------KGTPFYL---------------APEVLLGGKGYGEAVDIWSLGVILYELLWGPEPF  200 (225)
T ss_pred             EecCcccccccce--------eccCCcC---------------CHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCc
Confidence            876543  11111        3444555               6997744445566999999999999998754443

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=8.3e-27  Score=206.12  Aligned_cols=205  Identities=21%  Similarity=0.168  Sum_probs=163.0

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ...+|.-++.+|.|.- .|..+         .+...+++||+|++.....  ...++..+|..++..++|+||++++.+|
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a---------~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~f   84 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAA---------FDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVF   84 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEec---------chhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeecc
Confidence            3457888888999987 55555         4555688999998865421  2236678999999999999999999998


Q ss_pred             EeCC------eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          165 WEDK------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       165 ~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      ....      .+|+|||++.. +|.+.+.-.      ++-..+..+..|++.|++|||  ..+|+||||||+||++..++
T Consensus        85 tP~~~l~~~~e~y~v~e~m~~-nl~~vi~~e------lDH~tis~i~yq~~~~ik~lh--s~~IihRdLkPsnivv~~~~  155 (369)
T KOG0665|consen   85 TPQKTLEEFQEVYLVMELMDA-NLCQVILME------LDHETISYILYQMLCGIKHLH--SAGIIHRDLKPSNIVVNSDC  155 (369)
T ss_pred             CccccHHHHHhHHHHHHhhhh-HHHHHHHHh------cchHHHHHHHHHHHHHHHHHH--hcceeecccCcccceecchh
Confidence            7543      58999999965 999888633      778889999999999999999  59999999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .+|+.|||+|+........+....+.-|.                       |||++.|.. +...+|+||.||++.|++
T Consensus       156 ~lKi~dfg~ar~e~~~~~mtpyVvtRyyr-----------------------apevil~~~-~ke~vdiwSvGci~gEli  211 (369)
T KOG0665|consen  156 TLKILDFGLARTEDTDFMMTPYVVTRYYR-----------------------APEVILGMG-YKENVDIWSVGCIMGELI  211 (369)
T ss_pred             heeeccchhhcccCcccccCchhheeecc-----------------------CchheeccC-CcccchhhhhhhHHHHHh
Confidence            99999999999766653322222333333                       599999988 688999999999999999


Q ss_pred             cccccchhhHHHHHHH
Q 017177          319 SFYRTTMLKYQILAWQ  334 (376)
Q Consensus       319 ~~y~~~~~~~~~~~~~  334 (376)
                      .---+..++...-.|.
T Consensus       212 ~~~Vlf~g~d~idQ~~  227 (369)
T KOG0665|consen  212 LGTVLFPGKDHIDQWN  227 (369)
T ss_pred             hceEEecCchHHHHHH
Confidence            6655555666655554

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.92  E-value=9.7e-25  Score=194.89  Aligned_cols=184  Identities=27%  Similarity=0.314  Sum_probs=153.7

Q ss_pred             CcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhh-HHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEEEeccCC
Q 017177          101 GFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQR  179 (376)
Q Consensus       101 ~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  179 (376)
                      +||.||+|....         +++.+|+|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++
T Consensus         1 ~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   71 (244)
T smart00220        1 SFGKVYLARDKK---------TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG   71 (244)
T ss_pred             CceEEEEEEECC---------CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence            589999996543         47899999998765544 67889999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEE
Q 017177          180 GSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIY  259 (376)
Q Consensus       180 g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~  259 (376)
                      ++|.+++....    .+++..+..++.+++.++.|||  +.+++|+||+|+||+++.++.++++|||.+...........
T Consensus        72 ~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~  145 (244)
T smart00220       72 GDLFDLLKKRG----RLSEDEARFYARQILSALEYLH--SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTT  145 (244)
T ss_pred             CCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHH--HcCeecCCcCHHHeEECCCCcEEEccccceeeecccccccc
Confidence            99999987652    2788999999999999999999  68999999999999999999999999999998765432211


Q ss_pred             EeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          260 IHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       260 ~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      .        .+++.|+               +||.+.+.. .+.++|+|++|++++++++-..+
T Consensus       146 ~--------~~~~~~~---------------~pE~~~~~~-~~~~~Di~slG~~l~~l~~~~~p  185 (244)
T smart00220      146 F--------VGTPEYM---------------APEVLLGKG-YGKAVDVWSLGVILYELLTGKPP  185 (244)
T ss_pred             c--------cCCcCCC---------------CHHHHccCC-CCchhhHHHHHHHHHHHHhCCCC
Confidence            2        3445555               699776444 47799999999999998865433

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.92  E-value=8.7e-26  Score=210.61  Aligned_cols=197  Identities=18%  Similarity=0.157  Sum_probs=159.9

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC------CCCcceEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS------HPNLVKLLG  162 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~------h~nIv~l~~  162 (376)
                      .+|.+....|+|-|+.|..|.+.         .-+..||||+|..+..-. +.=++|++||++|+      --|+++|+.
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~---------~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hclrl~r  501 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQ---------ARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCLRLFR  501 (752)
T ss_pred             ceeEEEeccccceeeeeeecccc---------CCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence            46777888999999999999544         347799999998765322 34467999999995      348999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC-CcEE
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV-GFLF  241 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~-g~~k  241 (376)
                      .|...+++|||+|-+. -+|.++|++... +..+....+..++.|+..||..|-  .++|+|.||||+||||++. ..+|
T Consensus       502 ~F~hknHLClVFE~Ls-lNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK--~c~vlHaDIKPDNiLVNE~k~iLK  577 (752)
T KOG0670|consen  502 HFKHKNHLCLVFEPLS-LNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLK--KCGVLHADIKPDNILVNESKNILK  577 (752)
T ss_pred             HhhhcceeEEEehhhh-chHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHH--hcCeeecccCccceEeccCcceee
Confidence            9999999999999885 499999988654 456888999999999999999999  7999999999999999865 5689


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |||||.|.+...+....+... ..                       |.||||+.|..| ....|+||.||.+||+-+--
T Consensus       578 LCDfGSA~~~~eneitPYLVS-RF-----------------------YRaPEIiLG~~y-d~~iD~WSvgctLYElYtGk  632 (752)
T KOG0670|consen  578 LCDFGSASFASENEITPYLVS-RF-----------------------YRAPEIILGLPY-DYPIDTWSVGCTLYELYTGK  632 (752)
T ss_pred             eccCccccccccccccHHHHH-Hh-----------------------ccCcceeecCcc-cCCccceeeceeeEEeeccc
Confidence            999999998877665533321 12                       345999999887 55569999999999988544


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      -+.
T Consensus       633 IlF  635 (752)
T KOG0670|consen  633 ILF  635 (752)
T ss_pred             eec
Confidence            443

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.91  E-value=1.6e-23  Score=182.40  Aligned_cols=185  Identities=32%  Similarity=0.439  Sum_probs=153.8

Q ss_pred             EeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh-hHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEEEe
Q 017177           97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYE  175 (376)
Q Consensus        97 lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e  175 (376)
                      ||+|++|.||++....         +++.+++|++...... ..+.+.+|+..++.++|++|+++++++......++++|
T Consensus         1 l~~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e   71 (215)
T cd00180           1 LGEGGFGTVYLARDKK---------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME   71 (215)
T ss_pred             CCcCCceEEEEEEecC---------CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEe
Confidence            6899999999996543         4788999999876543 34678899999999999999999999999899999999


Q ss_pred             ccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC-CCcEEEcceeeeeeeccc
Q 017177          176 YMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-VGFLFDSHLLIYVYFKRH  254 (376)
Q Consensus       176 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~-~g~~kl~Dfg~a~~~~~~  254 (376)
                      ++++++|.+++....   ..++...+..++.+++.+|.+||  ..+++|+||+|.||+++. ++.++++|||.+......
T Consensus        72 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh--~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~  146 (215)
T cd00180          72 YCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLH--SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD  146 (215)
T ss_pred             cCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence            999999999987642   35789999999999999999999  589999999999999999 899999999999877554


Q ss_pred             eeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhh
Q 017177          255 YIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCV  317 (376)
Q Consensus       255 ~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~  317 (376)
                      ....       ....+.+.|+               +||.+......+.+.|+|++|++++++
T Consensus       147 ~~~~-------~~~~~~~~~~---------------~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         147 KSLL-------KTIVGTPAYM---------------APEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             cchh-------hcccCCCCcc---------------ChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            3100       0013444555               589776654668889999999999998

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=6.2e-25  Score=200.89  Aligned_cols=203  Identities=18%  Similarity=0.137  Sum_probs=161.1

Q ss_pred             hhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEEe
Q 017177           84 LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLG  162 (376)
Q Consensus        84 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~  162 (376)
                      .....+.|..+++||+|.|+.||++.....      ....+.||+|.+......  .++.+|+++|..+. +.||+++.+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~------~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~  102 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQ------DTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNG  102 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhh------ccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchh
Confidence            344567799999999999999999976541      224788999999876543  56889999999997 999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC-CcEE
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV-GFLF  241 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~-g~~k  241 (376)
                      ++..++...+||||++.....+++.       .++..++..+++.++.||.++|  .+|||||||||.|+|.+.. +.-.
T Consensus       103 ~~rnnd~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h--~~GIvHRDiKpsNFL~n~~t~rg~  173 (418)
T KOG1167|consen  103 CFRNNDQVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLH--KNGIVHRDIKPSNFLYNRRTQRGV  173 (418)
T ss_pred             hhccCCeeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhh--ccCccccCCCccccccccccCCce
Confidence            9999999999999999988888873       3678999999999999999999  6999999999999999754 6678


Q ss_pred             Ecceeeeeeeccceee---------------------EEEee---eEE-------------EEEeeeeehhhhhcchhhH
Q 017177          242 DSHLLIYVYFKRHYIY---------------------IYIHT---YII-------------YIYIYVYIYMYIYKCLRYA  284 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~---------------------~~~~~---~~~-------------y~~~gt~~y~~~~~~~e~~  284 (376)
                      |.|||+|.........                     ....+   ..+             +-..|||+           
T Consensus       174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~G-----------  242 (418)
T KOG1167|consen  174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPG-----------  242 (418)
T ss_pred             EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCC-----------
Confidence            9999999832111100                     00000   001             11234444           


Q ss_pred             HHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          285 ILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       285 d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                          +.|||++.....-+.+.|+||.|+|++.++
T Consensus       243 ----fRaPEvL~k~~~QttaiDiws~GVI~Lsll  272 (418)
T KOG1167|consen  243 ----FRAPEVLFRCPRQTTAIDIWSAGVILLSLL  272 (418)
T ss_pred             ----CCchHHHhhccCcCCccceeeccceeehhh
Confidence                449999998888899999999999999887

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=3.6e-24  Score=185.17  Aligned_cols=141  Identities=18%  Similarity=0.166  Sum_probs=108.3

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh--h-------H-----------------HHHHHHHH
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--G-------F-----------------EEWQSEVN  147 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~  147 (376)
                      ...||+|+||.||+|...          +|+.||+|+++.....  .       .                 ....+|+.
T Consensus         2 ~~~ig~G~~~~Vy~a~~~----------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   71 (190)
T cd05147           2 NGCISTGKEANVYHATTA----------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR   71 (190)
T ss_pred             CCccccccceEEEEEECC----------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence            468999999999999543          4899999999764211  0       0                 12235999


Q ss_pred             HHhcCCCCCcceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCcEecC
Q 017177          148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL-HTSEKKVIYRD  226 (376)
Q Consensus       148 il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yL-Hs~~~~iiHrD  226 (376)
                      ++.++.++++........  ...+|||||++|+++.......    ..++...+..++.|++.+|.++ |  ..+|+|||
T Consensus        72 ~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrD  143 (190)
T cd05147          72 NLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQ--DCRLVHAD  143 (190)
T ss_pred             HHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCC
Confidence            999998887754433322  2238999999988776543322    3578899999999999999999 6  58999999


Q ss_pred             CCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          227 FKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       227 lKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      |||+|||++ ++.++|+|||++.....
T Consensus       144 lkP~NIli~-~~~v~LiDFG~a~~~~~  169 (190)
T cd05147         144 LSEYNLLYH-DGKLYIIDVSQSVEHDH  169 (190)
T ss_pred             CCHHHEEEE-CCcEEEEEccccccCCC
Confidence            999999998 57899999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=5.2e-23  Score=180.48  Aligned_cols=172  Identities=13%  Similarity=0.076  Sum_probs=131.3

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhh---HHH------HHHHHHHHhcCCCCC
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG---FEE------WQSEVNFLGRLSHPN  156 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~------~~~E~~il~~l~h~n  156 (376)
                      ...++|+..++||.|+||.||++...           +..+|+|++.......   ...      +.+|+..+.++.|++
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~~-----------~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~G   96 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDTD-----------YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEG   96 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEecC-----------CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCC
Confidence            35678999999999999999986331           4569999997653322   122      578999999999999


Q ss_pred             cceEEeEEEeC--------CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCC
Q 017177          157 LVKLLGYCWED--------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFK  228 (376)
Q Consensus       157 Iv~l~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlK  228 (376)
                      |..+.+++...        +..+|+|||++|.+|.++..        +++    ....+++.+|..+|  +.+++|||+|
T Consensus        97 I~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH--~~gi~H~Dik  162 (232)
T PRK10359         97 LASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLH--QHGMVSGDPH  162 (232)
T ss_pred             CCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHH--HcCCccCCCC
Confidence            99999886643        35899999999999988631        222    24568999999999  6999999999


Q ss_pred             CCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcccccccc
Q 017177          229 ASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSN  308 (376)
Q Consensus       229 p~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~  308 (376)
                      |+||+++.+| ++++|||...........                                  ..++....+. .++|+|
T Consensus       163 p~Nili~~~g-i~liDfg~~~~~~e~~a~----------------------------------d~~vler~y~-~~~di~  206 (232)
T PRK10359        163 KGNFIVSKNG-LRIIDLSGKRCTAQRKAK----------------------------------DRIDLERHYG-IKNEIK  206 (232)
T ss_pred             hHHEEEeCCC-EEEEECCCcccccchhhH----------------------------------HHHHHHhHhc-cccccc
Confidence            9999999999 999999988754221100                                  1123333444 789999


Q ss_pred             ceeeeehhhc
Q 017177          309 SFAFVFSCVF  318 (376)
Q Consensus       309 s~g~v~~~~~  318 (376)
                      ++|..+....
T Consensus       207 ~lg~~~~~~~  216 (232)
T PRK10359        207 DLGYYLLIYK  216 (232)
T ss_pred             ceeEeehHHH
Confidence            9999987543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=6.7e-23  Score=177.63  Aligned_cols=142  Identities=17%  Similarity=0.160  Sum_probs=110.7

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh---------------------h-----HHHHHHHHH
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ---------------------G-----FEEWQSEVN  147 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~  147 (376)
                      .+.||+|+||.||+|...          +|+.||||+++.....                     .     ...+.+|..
T Consensus         2 ~~~ig~G~~~~Vy~a~~~----------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   71 (190)
T cd05145           2 NGCISTGKEANVYHARTG----------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFR   71 (190)
T ss_pred             CceeecCCCcEEEEEEcC----------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHH
Confidence            578999999999999533          4899999998765210                     0     122357999


Q ss_pred             HHhcCCCCCcceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCC
Q 017177          148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDF  227 (376)
Q Consensus       148 il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDl  227 (376)
                      .+.++.|++|.....+....  .+|||||++|+++.......    ..++......++.|++.+|.++|+ ..+|+||||
T Consensus        72 ~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~-~~givHrDl  144 (190)
T cd05145          72 NLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQ-EAGLVHGDL  144 (190)
T ss_pred             HHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCC
Confidence            99999999886555443332  48999999987554432222    346788899999999999999993 389999999


Q ss_pred             CCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          228 KASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       228 Kp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      ||+|||++ ++.++++|||++.....
T Consensus       145 kP~NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         145 SEYNILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             ChhhEEEE-CCCEEEEEcccceecCC
Confidence            99999999 89999999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10345 hypothetical protein; Provisional

Probab=99.88  E-value=6e-22  Score=173.06  Aligned_cols=137  Identities=15%  Similarity=0.167  Sum_probs=106.3

Q ss_pred             CccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcC-----CCCCcceEEeEEEe
Q 017177           92 KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-----SHPNLVKLLGYCWE  166 (376)
Q Consensus        92 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-----~h~nIv~l~~~~~~  166 (376)
                      .-.+.||+|+||.||.  +..         ++.. +||++........+.+.+|+.+++.+     +||||+++++++++
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~---------~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et   72 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPE---------DAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVET   72 (210)
T ss_pred             CCcceecCCCceEEEE--CCC---------CcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEe
Confidence            3457899999999995  221         2334 69988776444557789999999999     57999999999988


Q ss_pred             CC---eEE-EEEec--cCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCcEecCCCCCCEEEcC---
Q 017177          167 DK---ELL-LVYEY--MQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL-GFLHTSEKKVIYRDFKASNILLDG---  236 (376)
Q Consensus       167 ~~---~~~-lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L-~yLHs~~~~iiHrDlKp~NILl~~---  236 (376)
                      +.   .++ +||||  +.+|+|.+++.+.     .+++.  ..++.|++.++ +|||  +++|+||||||+|||++.   
T Consensus        73 ~~g~g~v~~~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh--~~~IvhrDlKp~NILl~~~~~  143 (210)
T PRK10345         73 DCGTGYVYDVIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLL--DNRIVTMELKPQNILCQRISE  143 (210)
T ss_pred             CCCCeEEEEEEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEeccCC
Confidence            73   434 78999  5579999999653     24544  35678888888 9999  699999999999999974   


Q ss_pred             -CCcEEEcceeeee
Q 017177          237 -VGFLFDSHLLIYV  249 (376)
Q Consensus       237 -~g~~kl~Dfg~a~  249 (376)
                       ++.++|+||+-+.
T Consensus       144 ~~~~~~LiDg~G~~  157 (210)
T PRK10345        144 SEVIPVVCDNIGES  157 (210)
T ss_pred             CCCcEEEEECCCCc
Confidence             3479999944443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=1.5e-22  Score=180.16  Aligned_cols=193  Identities=20%  Similarity=0.194  Sum_probs=150.6

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~  167 (376)
                      -.|+++++||+|+||..+.|         .+..++++||||.-...+..  -.+..|.+..+.|. .++|..+|-+..++
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G---------~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG   96 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLG---------KNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEG   96 (449)
T ss_pred             ccceeccccccCcceeeecc---------cccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeecccc
Confidence            46999999999999999999         55667999999986544322  45667888888887 89999999988888


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC-----cEEE
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG-----FLFD  242 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g-----~~kl  242 (376)
                      .+-.||||++ |.+|+|++.-+   ...|+.+.++.++.|++.-++|+|  ++.+|.|||||+|+||...|     .+-+
T Consensus        97 ~~NiLVidLL-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH--~k~LIYRDIKPdNFLIGrp~~k~~n~Ihi  170 (449)
T KOG1165|consen   97 KYNILVIDLL-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVH--EKDLIYRDIKPDNFLIGRPGTKDANVIHI  170 (449)
T ss_pred             chhhhhhhhh-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHH--hcceeecccCccceeecCCCCCCCceEEE
Confidence            8899999998 78999988655   356999999999999999999999  69999999999999996543     5899


Q ss_pred             cceeeeeeeccceeeEE----EeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          243 SHLLIYVYFKRHYIYIY----IHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~----~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      +|||+|+.+.+..+...    ...++    .||..||+               -.--.|++ -++..|.-++|-||...+
T Consensus       171 iDFGmAK~YrDp~TkqHIPYrE~KSL----sGTARYMS---------------INTHlGrE-QSRRDDLEaLGHvFmYFL  230 (449)
T KOG1165|consen  171 IDFGMAKEYRDPKTKQHIPYREHKSL----SGTARYMS---------------INTHLGRE-QSRRDDLEALGHVFMYFL  230 (449)
T ss_pred             EeccchhhhcCccccccCcccccccc----ccceeeeE---------------eeccccch-hhhhhhHHHhhhhhhhhc
Confidence            99999998877644221    11222    56666661               11111333 378889999999986544

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=2.8e-22  Score=171.14  Aligned_cols=153  Identities=20%  Similarity=0.245  Sum_probs=128.7

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~  165 (376)
                      ...+|.+++.||.|+||.+|+|.         ....|..||||+-......  ..+..|..+.+.|+ ...|..+..++.
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~---------~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~   81 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGI---------SITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGT   81 (341)
T ss_pred             eccceEEEEeecCCchhheeeee---------eccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhcc
Confidence            45789999999999999999994         4446999999986654322  35677999999998 678888888888


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc---CCCcEEE
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD---GVGFLFD  242 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~---~~g~~kl  242 (376)
                      +..+-.+|||++ |.+|.+++.-..   ..++...++.++-|++.-++|+|  .+++|||||||+|+|..   ....+.+
T Consensus        82 e~~ynvlVMdLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH--~r~fiHRDIKPdNFLMGlgrh~~kl~L  155 (341)
T KOG1163|consen   82 EKDYNVLVMDLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVH--LRNFIHRDIKPDNFLMGLGRHCNKLYL  155 (341)
T ss_pred             ccccceeeeecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHH--hhccccccCCccceeeccccccceEEE
Confidence            889999999998 789999886552   45889999999999999999999  69999999999999985   3456899


Q ss_pred             cceeeeeeecccee
Q 017177          243 SHLLIYVYFKRHYI  256 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~  256 (376)
                      +|||+|+.+.+...
T Consensus       156 IDFGLaKky~d~~t  169 (341)
T KOG1163|consen  156 IDFGLAKKYRDIRT  169 (341)
T ss_pred             Eeccchhhhccccc
Confidence            99999998865433

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=4.2e-21  Score=178.41  Aligned_cols=133  Identities=24%  Similarity=0.324  Sum_probs=114.9

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-C-------CCcceE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-H-------PNLVKL  160 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h-------~nIv~l  160 (376)
                      .+|.+.++||-|.|++||+|++..         ..+.||+|+.+... ...+....||++|++++ +       .+||+|
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq---------~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L  147 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQ---------NKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQL  147 (590)
T ss_pred             ceEEEEEeccccccceeEEEeecc---------CCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence            689999999999999999996654         57899999988654 23466788999999984 2       379999


Q ss_pred             EeEEEeC----CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc
Q 017177          161 LGYCWED----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD  235 (376)
Q Consensus       161 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~  235 (376)
                      ++.|...    .+++||+|++ |.+|..+|.....  ..++...++.|++||+.||.|||. +++|||-||||+|||+.
T Consensus       148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~-ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHR-ECGIIHTDLKPENVLLC  222 (590)
T ss_pred             eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHH-hcCccccCCCcceeeee
Confidence            9999764    4799999999 7799999987654  568999999999999999999998 89999999999999994

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.86  E-value=3.8e-22  Score=180.81  Aligned_cols=212  Identities=19%  Similarity=0.149  Sum_probs=162.8

Q ss_pred             hhhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-ChhhHHHHHHHHHHHhcCCCCCcceE
Q 017177           82 LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKL  160 (376)
Q Consensus        82 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~l  160 (376)
                      .++.....++++..++-+|.||.||.|.+++..    .-.+.+.|-+|.++.. +.-+...++.|.-.+..+.|||+..+
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEd----t~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V  352 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREED----TYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSV  352 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccC----CcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccce
Confidence            345555667888999999999999999887531    2223456677877654 44556788999999999999999999


Q ss_pred             EeEEEeC-CeEEEEEeccCCCCHHHHHhhcCC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc
Q 017177          161 LGYCWED-KELLLVYEYMQRGSLENHLFRRNP----SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD  235 (376)
Q Consensus       161 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~  235 (376)
                      .++..++ ...++++.++.-|+|..+|...+.    ....++..+...++.|++.|++|||  .++|||.||.++|++||
T Consensus       353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh--~~~ViHkDiAaRNCvId  430 (563)
T KOG1024|consen  353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH--NHGVIHKDIAARNCVID  430 (563)
T ss_pred             eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH--hcCcccchhhhhcceeh
Confidence            9987654 568888999999999999984332    2345677888899999999999999  69999999999999999


Q ss_pred             CCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeeh
Q 017177          236 GVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFS  315 (376)
Q Consensus       236 ~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~  315 (376)
                      +.-.+||+|=.+++.+-..+...          .|.-++-          .--||+||-+.... ++.++||||||+.+|
T Consensus       431 d~LqVkltDsaLSRDLFP~DYhc----------LGDnEnR----------PvkWMslEal~n~~-yssasDvWsfGVllW  489 (563)
T KOG1024|consen  431 DQLQVKLTDSALSRDLFPGDYHC----------LGDNENR----------PVKWMSLEALQNSH-YSSASDVWSFGVLLW  489 (563)
T ss_pred             hheeEEeccchhccccCcccccc----------cCCCCCC----------cccccCHHHHhhhh-hcchhhhHHHHHHHH
Confidence            99999999999999764433221          1111110          01134799776654 589999999999999


Q ss_pred             hhccc
Q 017177          316 CVFSF  320 (376)
Q Consensus       316 ~~~~~  320 (376)
                      |+++.
T Consensus       490 ELmtl  494 (563)
T KOG1024|consen  490 ELMTL  494 (563)
T ss_pred             HHHhc
Confidence            99844

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=3.7e-21  Score=180.47  Aligned_cols=148  Identities=26%  Similarity=0.243  Sum_probs=123.1

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCC----CCcceEEeEE-
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH----PNLVKLLGYC-  164 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h----~nIv~l~~~~-  164 (376)
                      +|++.+.||+|+||.||+|......        ...+|+|............+..|..++..+..    +++..+++.+ 
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~--------~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~   90 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK--------NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR   90 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC--------CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence            7999999999999999999654310        45788988776533322367789999998873    6999999998 


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC-----Cc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV-----GF  239 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~-----g~  239 (376)
                      ..+...||||+.+ |.+|.++.....  ...++...+..++.|++.+|.+||  +.+++||||||+|+++...     -.
T Consensus        91 ~~~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH--~~G~iHRDiKp~N~~~g~~~~~~~~~  165 (322)
T KOG1164|consen   91 STEDFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLH--SKGFIHRDIKPENFVVGQSSRSEVRT  165 (322)
T ss_pred             CCCceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHH--hcCcccCCcCHHHeeecCCCCcccce
Confidence            4778899999988 789999876553  467999999999999999999999  6999999999999999765     35


Q ss_pred             EEEcceeeeee
Q 017177          240 LFDSHLLIYVY  250 (376)
Q Consensus       240 ~kl~Dfg~a~~  250 (376)
                      +.+.|||+++.
T Consensus       166 ~~llDfGlar~  176 (322)
T KOG1164|consen  166 LYLLDFGLARR  176 (322)
T ss_pred             EEEEecCCCcc
Confidence            99999999993

>smart00090 RIO RIO-like kinase

Probab=99.84  E-value=9.8e-21  Score=169.22  Aligned_cols=146  Identities=16%  Similarity=0.121  Sum_probs=111.8

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh------------------------hHHHHHH
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ------------------------GFEEWQS  144 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~  144 (376)
                      ..|.+.+.||+|+||.||+|.+        +..+++.||+|+++.....                        ....+.+
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~--------~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   99 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALD--------FDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEK   99 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEe--------cCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHH
Confidence            3588999999999999999952        2224889999998754210                        0123568


Q ss_pred             HHHHHhcCCCC--CcceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-
Q 017177          145 EVNFLGRLSHP--NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK-  221 (376)
Q Consensus       145 E~~il~~l~h~--nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~-  221 (376)
                      |+.++.++.+.  .++++++.    ...++||||++|++|.......    ..+....+..++.|++.+|.+||  ..+ 
T Consensus       100 E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH--~~g~  169 (237)
T smart00090      100 EFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLY--KEGE  169 (237)
T ss_pred             HHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHH--hcCC
Confidence            99999999753  34444442    2358999999998887654322    23556667899999999999999  588 


Q ss_pred             cEecCCCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          222 VIYRDFKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       222 iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      |+||||||+||+++ ++.++++|||.+.....
T Consensus       170 iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      170 LVHGDLSEYNILVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             EEeCCCChhhEEEE-CCCEEEEEChhhhccCC
Confidence            99999999999999 88999999999986554

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=2.8e-20  Score=172.45  Aligned_cols=201  Identities=28%  Similarity=0.338  Sum_probs=159.4

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh---hHHHHHHHHHHHhcCCCC-CcceEEeEEEe
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ---GFEEWQSEVNFLGRLSHP-NLVKLLGYCWE  166 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h~-nIv~l~~~~~~  166 (376)
                      |.+.+.||.|+||.||++...            ..+++|.+......   ....+.+|+.+++.+.|+ +|+++++.+..
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~   69 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD   69 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence            677889999999999999543            56899998776432   357888999999999987 79999999987


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC-cEEEcce
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG-FLFDSHL  245 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g-~~kl~Df  245 (376)
                      ....+++++++.++++.+++...... ..+.......++.|++.++.|+|  ..+++|||+||+||+++..+ .++++||
T Consensus        70 ~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H--~~~~~hrd~kp~nil~~~~~~~~~l~df  146 (384)
T COG0515          70 EGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDF  146 (384)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeeecCCCCeEEEecc
Confidence            78889999999999999777654211 25889999999999999999999  58999999999999999988 7999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh--hhccccccccceeeeehhhccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI--KYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~--~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      |++............. .......||+.|+               +||.+.+.  .+.....|+|++|++++++..-..
T Consensus       147 g~~~~~~~~~~~~~~~-~~~~~~~~t~~~~---------------~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~  209 (384)
T COG0515         147 GLAKLLPDPGSTSSIP-ALPSTSVGTPGYM---------------APEVLLGLSLAYASSSSDIWSLGITLYELLTGLP  209 (384)
T ss_pred             CcceecCCCCcccccc-ccccccccccccC---------------CHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCC
Confidence            9998665543221100 0011116777777               79988875  578899999999988777554433

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=9.5e-20  Score=160.50  Aligned_cols=135  Identities=20%  Similarity=0.289  Sum_probs=113.1

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--h------hHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--Q------GFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~------~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      +.||+|++|.||+|...           +..+++|+......  .      ....+.+|+.++..+.|++|.....++.+
T Consensus         2 ~~l~~G~~~~vy~~~~~-----------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~   70 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFL-----------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD   70 (211)
T ss_pred             cccccCceEEEEEEeeC-----------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence            57999999999999653           56789998654321  1      12457789999999999999887777777


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      .+..+++|||++|++|.+++...       .. ....++.+++.+|.++|  ..+++|||++|+|||++ ++.++++|||
T Consensus        71 ~~~~~lv~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH--~~~i~H~Dl~p~Nil~~-~~~~~liDf~  139 (211)
T PRK14879         71 PENFIIVMEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLH--SAGIIHGDLTTSNMILS-GGKIYLIDFG  139 (211)
T ss_pred             CCCCEEEEEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHH--hCCcccCCCCcccEEEE-CCCEEEEECC
Confidence            78899999999999999998543       12 77889999999999999  69999999999999999 7899999999


Q ss_pred             eeeee
Q 017177          247 IYVYF  251 (376)
Q Consensus       247 ~a~~~  251 (376)
                      ++...
T Consensus       140 ~a~~~  144 (211)
T PRK14879        140 LAEFS  144 (211)
T ss_pred             cccCC
Confidence            98863

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.9e-19  Score=154.95  Aligned_cols=132  Identities=20%  Similarity=0.122  Sum_probs=104.8

Q ss_pred             ccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh----hHHHHHHHHHHHhcCC-CCCcceEEeEEEeC
Q 017177           93 PDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ----GFEEWQSEVNFLGRLS-HPNLVKLLGYCWED  167 (376)
Q Consensus        93 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~  167 (376)
                      ....|++|+||+|+.+..           .+.+++.+.+......    ....+.+|+++|++|. |++|++++++    
T Consensus         6 ~~~~l~~~~f~~v~~~~~-----------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----   70 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-----------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----   70 (218)
T ss_pred             cceeecCCCcceEEEeec-----------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----
Confidence            457899999999997633           2667787777654331    1235789999999996 6889999885    


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCC-CCCCEEEcCCCcEEEccee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDF-KASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDl-Kp~NILl~~~g~~kl~Dfg  246 (376)
                      +..+++|||+.|.+|.+.+..          . ...++.|++.+|.++|  +.+|+|||| ||+|||++.+|.++|+|||
T Consensus        71 ~~~~lvmeyI~G~~L~~~~~~----------~-~~~~~~qi~~~L~~lH--~~GIvHrDL~kp~NILv~~~g~i~LIDFG  137 (218)
T PRK12274         71 DGRHLDRSYLAGAAMYQRPPR----------G-DLAYFRAARRLLQQLH--RCGVAHNDLAKEANWLVQEDGSPAVIDFQ  137 (218)
T ss_pred             cCEEEEEeeecCccHHhhhhh----------h-hHHHHHHHHHHHHHHH--HCcCccCCCCCcceEEEcCCCCEEEEECC
Confidence            447999999999888754311          1 1357789999999999  699999999 7999999999999999999


Q ss_pred             eeeeec
Q 017177          247 IYVYFK  252 (376)
Q Consensus       247 ~a~~~~  252 (376)
                      ++....
T Consensus       138 ~A~~~~  143 (218)
T PRK12274        138 LAVRGN  143 (218)
T ss_pred             CceecC
Confidence            998544

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.82  E-value=2.7e-21  Score=202.21  Aligned_cols=150  Identities=11%  Similarity=0.007  Sum_probs=107.1

Q ss_pred             CCC-CCcceEEeEE-------EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcE
Q 017177          152 LSH-PNLVKLLGYC-------WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVI  223 (376)
Q Consensus       152 l~h-~nIv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~ii  223 (376)
                      ++| +||.++++.|       .....++.++|++ +++|.++|...   ...+++..++.++.||+.||.|||  .++|+
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH--~~gIv  102 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAH--SQGIV  102 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            344 5777777776       2334678889987 56999999653   245899999999999999999999  59999


Q ss_pred             ecCCCCCCEEEcCC-------------------CcEEEcceeeeeeeccceee-----EEEee----eEEEEEeeeeehh
Q 017177          224 YRDFKASNILLDGV-------------------GFLFDSHLLIYVYFKRHYIY-----IYIHT----YIIYIYIYVYIYM  275 (376)
Q Consensus       224 HrDlKp~NILl~~~-------------------g~~kl~Dfg~a~~~~~~~~~-----~~~~~----~~~y~~~gt~~y~  275 (376)
                      ||||||+||||+..                   +.+|++|||+++........     ....+    .......||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            99999999999654                   45566666666543211000     00000    0111236777788


Q ss_pred             hhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          276 YIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       276 ~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                                     |||++.+..+ +.++||||+|++++|+++-+..
T Consensus       183 ---------------APE~~~~~~~-~~~sDVwSlGviL~ELl~~~~~  214 (793)
T PLN00181        183 ---------------SPEEDNGSSS-NCASDVYRLGVLLFELFCPVSS  214 (793)
T ss_pred             ---------------ChhhhccCCC-CchhhhhhHHHHHHHHhhCCCc
Confidence                           8998877665 8899999999999999864443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=7.6e-21  Score=190.04  Aligned_cols=198  Identities=21%  Similarity=0.195  Sum_probs=150.4

Q ss_pred             CccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhH-HHHHHHHHHHhcCCCCCcceEEeEEEeCCeE
Q 017177           92 KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVNFLGRLSHPNLVKLLGYCWEDKEL  170 (376)
Q Consensus        92 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~  170 (376)
                      ....++|.|++|.|+.+.....    ........+++|.......... ..+..|..+-..+.|+|++.....+.+....
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~----~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~  396 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSD----LKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI  396 (601)
T ss_pred             CccceeeecccCceEEEEecCC----CccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence            5678899999997777643321    1111112223320011222221 2266788888889999998888877776666


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      +-.||||++ +|..++.+.    ..+...++..++.|++.|++|+|  ..+|.||||||+|++++.+|.+||+|||.+..
T Consensus       397 ~~~mE~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h--~~GiahrdlK~enll~~~~g~lki~Dfg~~~v  469 (601)
T KOG0590|consen  397 LQSMEYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLH--SMGLAHRDLKLENLLVTENGILKIIDFGAASV  469 (601)
T ss_pred             hhhhhcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHH--hcCceeccCccccEEEecCCceEEeecCccee
Confidence            666999999 999999765    34788889999999999999999  59999999999999999999999999999998


Q ss_pred             eccceee--EEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          251 FKRHYIY--IYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       251 ~~~~~~~--~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      +......  ....|.     +|+..|+               |||++.+..|.....||||.|+|+.+|..-
T Consensus       470 f~~~~e~~~~~~~g~-----~gS~pY~---------------apE~~~~~~ydpr~vDiwS~~ii~~~m~~~  521 (601)
T KOG0590|consen  470 FRYPWEKNIHESSGI-----VGSDPYL---------------APEVLTGKEYDPRAVDVWSCGIIYICMILG  521 (601)
T ss_pred             eccCcchhhhhhcCc-----ccCCcCc---------------CcccccccccCcchhhhhhccceEEEEecC
Confidence            7665443  223333     7777777               799999999999999999999999999854

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.81  E-value=1.9e-19  Score=180.00  Aligned_cols=141  Identities=19%  Similarity=0.208  Sum_probs=112.4

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--C------hhhHHHHHHHHHHHhcCCCCC
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--S------MQGFEEWQSEVNFLGRLSHPN  156 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~------~~~~~~~~~E~~il~~l~h~n  156 (376)
                      ......|...+.||+|+||.||++.+..           ..+++|+....  .      ....+++.+|+++++.++|++
T Consensus       329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-----------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~  397 (535)
T PRK09605        329 EEVKRRKIPDHLIGKGAEADIKKGEYLG-----------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAG  397 (535)
T ss_pred             cccccccCccceeccCCcEEEEEEeecC-----------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccC
Confidence            3334556778999999999999987653           22333322111  1      112356789999999999999


Q ss_pred             cceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC
Q 017177          157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG  236 (376)
Q Consensus       157 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~  236 (376)
                      |+....++.+....++||||++|++|.+++.            ....++.+++.+|.+||  +.+|+||||||+|||+ .
T Consensus       398 i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH--~~giiHrDlkp~NILl-~  462 (535)
T PRK09605        398 VPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLH--KAGIVHGDLTTSNFIV-R  462 (535)
T ss_pred             CCeeEEEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHH--hCCCccCCCChHHEEE-E
Confidence            9988887777778899999999999999884            34678999999999999  6999999999999999 5


Q ss_pred             CCcEEEcceeeeeee
Q 017177          237 VGFLFDSHLLIYVYF  251 (376)
Q Consensus       237 ~g~~kl~Dfg~a~~~  251 (376)
                      ++.++++|||+++..
T Consensus       463 ~~~~~liDFGla~~~  477 (535)
T PRK09605        463 DDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCcEEEEeCcccccC
Confidence            789999999999874

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=1.8e-19  Score=157.25  Aligned_cols=131  Identities=23%  Similarity=0.299  Sum_probs=106.4

Q ss_pred             eEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--------hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--------QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        96 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .||+|+||.||+|.+.           +..+++|.......        ....++.+|++++..+.|+++.....++...
T Consensus         1 ~ig~G~~~~vy~~~~~-----------~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~   69 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-----------GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP   69 (199)
T ss_pred             CCCCCceEEEEEeecC-----------CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence            4899999999999643           56789998654321        1135677899999999988766655556667


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++||||++|++|.+++....        .   .++.+++.+|.+||  ..+++|||+||+||+++ ++.+++.|||+
T Consensus        70 ~~~~lv~e~~~g~~l~~~~~~~~--------~---~~~~~i~~~l~~lH--~~gi~H~Dl~~~Nil~~-~~~~~liDfg~  135 (199)
T TIGR03724        70 DNKTIVMEYIEGKPLKDVIEEGN--------D---ELLREIGRLVGKLH--KAGIVHGDLTTSNIIVR-DDKLYLIDFGL  135 (199)
T ss_pred             CCCEEEEEEECCccHHHHHhhcH--------H---HHHHHHHHHHHHHH--HCCeecCCCCcceEEEE-CCcEEEEECCC
Confidence            77899999999999998874421        0   78899999999999  69999999999999999 89999999999


Q ss_pred             eeee
Q 017177          248 YVYF  251 (376)
Q Consensus       248 a~~~  251 (376)
                      +...
T Consensus       136 a~~~  139 (199)
T TIGR03724       136 GKYS  139 (199)
T ss_pred             CcCC
Confidence            8864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=5.4e-19  Score=154.24  Aligned_cols=138  Identities=17%  Similarity=0.039  Sum_probs=107.5

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh----------------------hHHHHHHHHH
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ----------------------GFEEWQSEVN  147 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~  147 (376)
                      .|.+.+.||+|+||.||++...          +++.||||+++.....                      ......+|+.
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   85 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP----------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFA   85 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC----------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHH
Confidence            3788899999999999999543          4889999987653210                      0123567899


Q ss_pred             HHhcCCCC--CcceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEec
Q 017177          148 FLGRLSHP--NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYR  225 (376)
Q Consensus       148 il~~l~h~--nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHr  225 (376)
                      ++..+.|+  .++..++    ....++||||++|++|......          .....++.+++.++.++|  ..+|+||
T Consensus        86 ~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh--~~gi~H~  149 (198)
T cd05144          86 ALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAY--KHGIIHG  149 (198)
T ss_pred             HHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHH--HCCCCcC
Confidence            99999877  4444443    2456899999999998765421          234578889999999999  6999999


Q ss_pred             CCCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          226 DFKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       226 DlKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      ||||+||+++.++.++++|||++.....
T Consensus       150 Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         150 DLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCCcccEEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999999999976544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.76  E-value=4e-20  Score=177.54  Aligned_cols=185  Identities=22%  Similarity=0.201  Sum_probs=153.0

Q ss_pred             eEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhh--HHHHHHHHHHHhcCC-CCCcceEEeEEEeCCeEEE
Q 017177           96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLL  172 (376)
Q Consensus        96 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~l  172 (376)
                      ++|+|+||.|++++--.      ....+..+|+|++++.....  ......|..++..++ ||.++++...++.+...++
T Consensus         1 vlg~g~~gkvfLvrk~~------g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l   74 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAG------GADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL   74 (612)
T ss_pred             CCCcCCCcchHHHHHhc------cccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence            37899999999875332      22247789999988764322  124456888999998 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeec
Q 017177          173 VYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFK  252 (376)
Q Consensus       173 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~  252 (376)
                      +++|..||+|...+.+.    ..+.+.....+...++.+++++|  +.+|+|||+|++||+++.+|++++.|||+++..-
T Consensus        75 ~ld~~rgg~lft~l~~~----~~f~~~~~~~~~aelaLald~lh--~l~iiyrd~k~enilld~~Ghi~~tdfglske~v  148 (612)
T KOG0603|consen   75 ILDFLRGGDLFTRLSKE----VMFDELDVAFYLAELALALDHLH--KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAV  148 (612)
T ss_pred             hhhhcccchhhhccccC----CchHHHHHHHHHHHHHHHHhhcc--hhHHHHhcccccceeecccCccccCCchhhhHhH
Confidence            99999999999888665    45778888888899999999999  7999999999999999999999999999999876


Q ss_pred             cceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          253 RHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       253 ~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      .....           +||.+||               ||||+.|   ....+|+||+|....++++--
T Consensus       149 ~~~~~-----------cgt~eym---------------ApEI~~g---h~~a~D~ws~gvl~felltg~  188 (612)
T KOG0603|consen  149 KEKIA-----------CGTYEYR---------------APEIING---HLSAADWWSFGVLAFELLTGT  188 (612)
T ss_pred             hhhhc-----------ccchhhh---------------hhHhhhc---cCCcccchhhhhhHHHHhhCC
Confidence            54443           6778888               8999883   457889999999999988543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=4.8e-18  Score=173.82  Aligned_cols=192  Identities=18%  Similarity=0.168  Sum_probs=137.0

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC---CCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS---HPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~l~~~  163 (376)
                      ....|.+.+.||+|+||+||+|...+          ++.||+|+-++....+.   .-=.+++.+|+   -+.|..+..+
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~----------~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a  762 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSN----------GKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSA  762 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCC----------CcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHH
Confidence            34568888999999999999996543          89999999887654321   00112223332   3456666677


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc-------C
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD-------G  236 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~-------~  236 (376)
                      +...+.-++|+||.+.|+|.+++...    ..+++..+..+..|++..+..||  +.+|||+||||+|+||.       +
T Consensus       763 ~~~~~~S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH--~~~IIHgDiKPDNfll~~~~~~~~~  836 (974)
T KOG1166|consen  763 HVFQNASVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLH--AMGIIHGDIKPDNFLLRREICADSD  836 (974)
T ss_pred             HccCCcceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHH--hcceecccCCcceeEeecccCCCCc
Confidence            77778899999999999999999743    66899999999999999999999  79999999999999993       2


Q ss_pred             CCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehh
Q 017177          237 VGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSC  316 (376)
Q Consensus       237 ~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~  316 (376)
                      ...++|+|||.+..+.-........+.     ++|-.+-               =+|+..|+.. +...|-+-++.+++.
T Consensus       837 ~~~l~lIDfG~siDm~lfp~~~~F~~~-----~~td~f~---------------C~EM~~grpW-tYq~DyfGlAa~~h~  895 (974)
T KOG1166|consen  837 SKGLYLIDFGRSIDMKLFPDGTKFKAV-----WHTDLFD---------------CIEMREGRPW-TYQIDYFGLAATVHV  895 (974)
T ss_pred             ccceEEEecccceeeeEcCCCcEEeee-----eccccch---------------hHHHhcCCCC-chhhhhHHHHHHHHH
Confidence            345999999999866443221111111     4444444               2788877753 455555655555555


Q ss_pred             hc
Q 017177          317 VF  318 (376)
Q Consensus       317 ~~  318 (376)
                      |+
T Consensus       896 mL  897 (974)
T KOG1166|consen  896 ML  897 (974)
T ss_pred             HH
Confidence            44

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.73  E-value=2.2e-17  Score=142.62  Aligned_cols=138  Identities=20%  Similarity=0.166  Sum_probs=98.8

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh--hHHH----------------------HHHHHHHH
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFEE----------------------WQSEVNFL  149 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~il  149 (376)
                      .+.||+|+||.||+|...          +++.||||+++.....  ....                      ...|...+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~----------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l   71 (187)
T cd05119           2 GGPIGTGKEADVYLALDG----------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNL   71 (187)
T ss_pred             CcccccccceeEEEEECC----------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHH
Confidence            468999999999999543          3788999998754221  1111                      13566666


Q ss_pred             hcCCCC--CcceEEeEEEeCCeEEEEEeccCCCCHHH-HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecC
Q 017177          150 GRLSHP--NLVKLLGYCWEDKELLLVYEYMQRGSLEN-HLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRD  226 (376)
Q Consensus       150 ~~l~h~--nIv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrD  226 (376)
                      ..+.+.  .+.++++.    ...++||||++++.+.. .+....     .. ..+..++.+++.++.++|. ..+|+|||
T Consensus        72 ~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~-~~~ivH~D  140 (187)
T cd05119          72 KRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYR-EAGLVHGD  140 (187)
T ss_pred             HHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhh-ccCcCcCC
Confidence            666543  34455443    24689999999855432 121110     11 5678899999999999993 39999999


Q ss_pred             CCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          227 FKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       227 lKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      |||+||+++ ++.++++|||.+.....
T Consensus       141 l~p~Nili~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         141 LSEYNILVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CChhhEEEE-CCcEEEEECcccccccC
Confidence            999999999 89999999999987655

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.72  E-value=6.5e-17  Score=144.83  Aligned_cols=136  Identities=18%  Similarity=0.129  Sum_probs=102.6

Q ss_pred             ceEe-ecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-------------hhhHHHHHHHHHHHhcCCCCCc--c
Q 017177           95 SLLG-EGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-------------MQGFEEWQSEVNFLGRLSHPNL--V  158 (376)
Q Consensus        95 ~~lG-~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~il~~l~h~nI--v  158 (376)
                      ..|| .|+.|.||.+...           +..++||......             .....++.+|+.++..|.|++|  +
T Consensus        37 ~~lg~~~g~gtv~~v~~~-----------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP  105 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-----------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVP  105 (239)
T ss_pred             ceeecCCCCccEEEEEeC-----------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCc
Confidence            4676 7888888887543           5668888775321             0123467889999999998775  6


Q ss_pred             eEEeEEEeCC----eEEEEEeccCC-CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEE
Q 017177          159 KLLGYCWEDK----ELLLVYEYMQR-GSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL  233 (376)
Q Consensus       159 ~l~~~~~~~~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NIL  233 (376)
                      ..+++.....    ..++|||+++| .+|.+++...     .++..    .+.+++.+|.+||  +.+|+||||||+|||
T Consensus       106 ~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH--~~GI~HrDlkp~NIL  174 (239)
T PRK01723        106 RPIAARVVRHGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFH--DAGVYHADLNAHNIL  174 (239)
T ss_pred             eeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHH--HCCCCCCCCCchhEE
Confidence            7777644332    23599999997 6898887542     24443    3568999999999  699999999999999


Q ss_pred             EcCCCcEEEcceeeeeeec
Q 017177          234 LDGVGFLFDSHLLIYVYFK  252 (376)
Q Consensus       234 l~~~g~~kl~Dfg~a~~~~  252 (376)
                      ++.++.++++|||.+....
T Consensus       175 v~~~~~v~LIDfg~~~~~~  193 (239)
T PRK01723        175 LDPDGKFWLIDFDRGELRT  193 (239)
T ss_pred             EcCCCCEEEEECCCcccCC
Confidence            9999999999999998643

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=7.2e-17  Score=133.49  Aligned_cols=134  Identities=23%  Similarity=0.116  Sum_probs=110.7

Q ss_pred             ccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCC--CCcceEEeEEEeCCeE
Q 017177           93 PDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH--PNLVKLLGYCWEDKEL  170 (376)
Q Consensus        93 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h--~nIv~l~~~~~~~~~~  170 (376)
                      +.+.||+|.++.||++...           +..+++|.......  ...+.+|+.+++.+.|  .++++++.++...+..
T Consensus         2 ~~~~i~~g~~~~v~~~~~~-----------~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~   68 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK-----------DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWS   68 (155)
T ss_pred             cceecccccccceEEEEec-----------CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence            3578999999999999653           35689999876543  4567889999999986  5999999988877889


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCcEecCCCCCCEEEcCCCcEEEcceeeee
Q 017177          171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS-EKKVIYRDFKASNILLDGVGFLFDSHLLIYV  249 (376)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~-~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~  249 (376)
                      +++|||++++.+..+           +......++.+++.+|.++|.. ..+++|+|+||+||+++..+.+++.|||.++
T Consensus        69 ~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          69 YLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             EEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            999999988766543           3455667889999999999941 1479999999999999998999999999987


Q ss_pred             e
Q 017177          250 Y  250 (376)
Q Consensus       250 ~  250 (376)
                      .
T Consensus       138 ~  138 (155)
T cd05120         138 Y  138 (155)
T ss_pred             C
Confidence            5

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.66  E-value=1.3e-17  Score=157.61  Aligned_cols=129  Identities=18%  Similarity=0.170  Sum_probs=105.1

Q ss_pred             eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeee
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a  248 (376)
                      ++||.|++|.-.+|.++|.++.. ....+....+.++.|++.|+.|     ++.+|||+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhhe
Confidence            48999999999999999976543 3456788899999999999998     78999999999999999999999999999


Q ss_pred             eeecccee----eEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          249 VYFKRHYI----YIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       249 ~~~~~~~~----~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ........    ...... .    +||..||               .||-+.|.. +..+.|+|++|.+++|+...+...
T Consensus       404 ts~~~~~~~~~~~a~~t~-~----~gt~~Ym---------------sPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~  462 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQ-Q----VGTLLYM---------------SPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQ  462 (516)
T ss_pred             eecccCCcccchhhhhhh-c----ccccccC---------------CHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccH
Confidence            98766551    101111 1    6777777               799888875 499999999999999998755443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.64  E-value=2.1e-16  Score=144.21  Aligned_cols=141  Identities=22%  Similarity=0.218  Sum_probs=104.5

Q ss_pred             CCCCcceEEeEEEe---------------------------CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHH
Q 017177          153 SHPNLVKLLGYCWE---------------------------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA  205 (376)
Q Consensus       153 ~h~nIv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~  205 (376)
                      +|||||++.++|.+                           +..+|+||.-++. +|..++..+.     .+......++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHH
Confidence            59999999988863                           2358999998865 9999997653     5667778899


Q ss_pred             HHHHHHHHHhhcCCCCcEecCCCCCCEEE--cCCC--cEEEcceeeeeeeccceee-----EEEeeeEEEEEeeeeehhh
Q 017177          206 IGAARGLGFLHTSEKKVIYRDFKASNILL--DGVG--FLFDSHLLIYVYFKRHYIY-----IYIHTYIIYIYIYVYIYMY  276 (376)
Q Consensus       206 ~qi~~~L~yLHs~~~~iiHrDlKp~NILl--~~~g--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~~y~~~gt~~y~~  276 (376)
                      .|+++|+.|||  +++|.|||+|.+|||+  |+|+  .+.++|||++---+.....     .++..      .|.-.   
T Consensus       348 aQlLEav~hL~--~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~------GGNa~---  416 (598)
T KOG4158|consen  348 AQLLEAVTHLH--KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDL------GGNAK---  416 (598)
T ss_pred             HHHHHHHHHHH--HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccC------CCcce---
Confidence            99999999999  7999999999999998  4444  5899999998754332111     01100      22222   


Q ss_pred             hhcchhhHHHHHHHHHHHHhhh-----hhccccccccceeeeehhhc----cccc
Q 017177          277 IYKCLRYAILYSVLLPRIYAWI-----KYLTLLKYSNSFAFVFSCVF----SFYR  322 (376)
Q Consensus       277 ~~~~~e~~d~~s~~apEi~~~~-----~~~~~~~dv~s~g~v~~~~~----~~y~  322 (376)
                                  .|||||.+..     .....++|.|..|-+.+|++    .||.
T Consensus       417 ------------lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~  459 (598)
T KOG4158|consen  417 ------------LMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK  459 (598)
T ss_pred             ------------ecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence                        3489987743     23357889999999999998    5565

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.64  E-value=3e-17  Score=142.86  Aligned_cols=188  Identities=21%  Similarity=0.247  Sum_probs=144.5

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      ..+.-+|.+...|+.|+|++.+           ..+++|++....  ....+.|..|.-.|+-+.||||+.++++|..+.
T Consensus       192 lnl~tkl~e~hsgelwrgrwqg-----------ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp  260 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQG-----------NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP  260 (448)
T ss_pred             hhhhhhhccCCCcccccccccC-----------cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC
Confidence            3455678889999999998874           446677765442  233367889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc--cee
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS--HLL  246 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~--Dfg  246 (376)
                      ++.++..||+.|+|+.+|++..  ....+..++.+++.++++|++|||+.+.-|.---|....++||++-+.+|.  |--
T Consensus       261 nlv~isq~mp~gslynvlhe~t--~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~k  338 (448)
T KOG0195|consen  261 NLVIISQYMPFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTK  338 (448)
T ss_pred             CceEeeeeccchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccce
Confidence            9999999999999999998764  355788899999999999999999855545556788999999999876663  221


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcc--ccccccceeeeehhhccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLT--LLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~--~~~dv~s~g~v~~~~~~~  320 (376)
                      ++        ++.. |.     ...|.||               +||-+..+....  .++|+|||+++++|+.+-
T Consensus       339 fs--------fqe~-gr-----~y~pawm---------------spealqrkped~n~raadmwsfaillwel~tr  385 (448)
T KOG0195|consen  339 FS--------FQEV-GR-----AYSPAWM---------------SPEALQRKPEDLNIRAADMWSFAILLWELNTR  385 (448)
T ss_pred             ee--------eecc-cc-----ccCcccC---------------CHHHHhcCchhcchhhhhHHHHHHHHHHhhcc
Confidence            11        1111 21     4456677               788777654333  678999999999998853

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.63  E-value=3.3e-16  Score=133.69  Aligned_cols=104  Identities=21%  Similarity=0.140  Sum_probs=85.8

Q ss_pred             CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEE
Q 017177          180 GSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIY  259 (376)
Q Consensus       180 g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~  259 (376)
                      |+|.+++..+.   ..+++..+..++.|++.||.|||+  .+      ||+|||++.++.+|+  ||++........   
T Consensus         1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~--~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~---   64 (176)
T smart00750        1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHR--QA------KSGNILLTWDGLLKL--DGSVAFKTPEQS---   64 (176)
T ss_pred             CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh--cC------CcccEeEcCccceee--ccceEeeccccC---
Confidence            68999997642   459999999999999999999994  54      999999999999999  999987644211   


Q ss_pred             EeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          260 IHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       260 ~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                               .||+.||               |||++.+..+ +.++||||+|++++|+++...+.
T Consensus        65 ---------~g~~~y~---------------aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~  104 (176)
T smart00750       65 ---------RVDPYFM---------------APEVIQGQSY-TEKADIYSLGITLYEALDYELPY  104 (176)
T ss_pred             ---------CCccccc---------------ChHHhcCCCC-cchhhHHHHHHHHHHHHhCCCCc
Confidence                     4667777               7998877654 78999999999999999765543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.62  E-value=6.4e-17  Score=163.42  Aligned_cols=197  Identities=19%  Similarity=0.192  Sum_probs=141.4

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-h---hhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-M---QGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ++...+.||.+.|=+|.+|.+++          |. |+||++-+.. .   ....+.+.|++ ...++|||++.+..+..
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e----------G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~   91 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE----------GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV   91 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC----------ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH
Confidence            57788999999999999997664          54 8889876543 2   22333344555 55567999999988877


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      .+...|||=+|... +|+|.|..+    .-+...+.+-|+.|++.||.-+|  +.+|+|+|||.|||||+.=.-+.|+||
T Consensus        92 t~kAAylvRqyvkh-nLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH--~~gVcHGDIKsENILiTSWNW~~LtDF  164 (1431)
T KOG1240|consen   92 TDKAAYLVRQYVKH-NLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCH--KLGVCHGDIKSENILITSWNWLYLTDF  164 (1431)
T ss_pred             hhHHHHHHHHHHhh-hhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHH--HcCccccccccceEEEeeechhhhhcc
Confidence            77888999999865 999988655    44677888899999999999999  799999999999999999889999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh----------hhccccccccceeeeeh
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI----------KYLTLLKYSNSFAFVFS  315 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~----------~~~~~~~dv~s~g~v~~  315 (376)
                      .-.+..-   ......+.++|.. +|-.        ++.   =|+|||-|-..          ..++++.|++|+|||++
T Consensus       165 AsFKPtY---LPeDNPadf~fFF-DTSr--------RRt---CYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCVia  229 (1431)
T KOG1240|consen  165 ASFKPTY---LPEDNPADFTFFF-DTSR--------RRT---CYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIA  229 (1431)
T ss_pred             cccCCcc---CCCCCcccceEEE-ecCC--------cee---eecChHhhhccccccccCCcccccChhhhhhhhhHHHH
Confidence            8876431   1101111111111 0000        000   03458766542          12678999999999999


Q ss_pred             hhccc
Q 017177          316 CVFSF  320 (376)
Q Consensus       316 ~~~~~  320 (376)
                      |++.-
T Consensus       230 ELf~E  234 (1431)
T KOG1240|consen  230 ELFLE  234 (1431)
T ss_pred             HHHhc
Confidence            98844

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.59  E-value=6.7e-15  Score=142.98  Aligned_cols=141  Identities=20%  Similarity=0.198  Sum_probs=98.4

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhH-----------------------------------
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-----------------------------------  139 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------------------------------  139 (376)
                      +.||.|++|+||+|+..+          |+.||||+.++......                                   
T Consensus       123 ~plasaSigQVh~A~l~~----------G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~  192 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVD----------GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEK  192 (437)
T ss_pred             cceeeeehhheEEEEecC----------CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHH
Confidence            679999999999997653          88999999876532110                                   


Q ss_pred             -----HHHHHHHHHHhcCC----CCCcceEEeEEE-eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 017177          140 -----EEWQSEVNFLGRLS----HPNLVKLLGYCW-EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA  209 (376)
Q Consensus       140 -----~~~~~E~~il~~l~----h~nIv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~  209 (376)
                           -++.+|+..+.++.    |.+-+.+-..+. .....+|||||++|++|.++.....   ...+   ...++.+++
T Consensus       193 ~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~  266 (437)
T TIGR01982       193 TLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLA  266 (437)
T ss_pred             HHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHH
Confidence                 02345666555552    222233322222 2345799999999999988765321   1122   234555555


Q ss_pred             H-HHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          210 R-GLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       210 ~-~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      . .+..+|  ..+++|+|+||.||+++.+|.++++|||++..+..
T Consensus       267 ~~~l~ql~--~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       267 RSFLNQVL--RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHHHHH--hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            5 467788  69999999999999999999999999999988754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.58  E-value=6.7e-16  Score=139.69  Aligned_cols=196  Identities=18%  Similarity=0.223  Sum_probs=120.7

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCC----------CC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSH----------PN  156 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h----------~n  156 (376)
                      .+...+.||.|+++.||.+.+         ..+++.+|+|+......   ...+.+.+|.-....+.+          -.
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d---------~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r   83 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTD---------VETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLR   83 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEE---------TTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-
T ss_pred             EEEEccccccCCceEEEEEEE---------ccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhce
Confidence            456778999999999999954         44799999998754332   345677777655554322          12


Q ss_pred             cceEEeEEE---------eCC--------eEEEEEeccCCCCHHHHHh---hcCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 017177          157 LVKLLGYCW---------EDK--------ELLLVYEYMQRGSLENHLF---RRNPSIQPLSWDIRLKIAIGAARGLGFLH  216 (376)
Q Consensus       157 Iv~l~~~~~---------~~~--------~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~~i~~qi~~~L~yLH  216 (376)
                      ++-.++...         ...        +.+++|+-+. ++|.+++.   ........+.....+.+..|+++.+++||
T Consensus        84 ~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh  162 (288)
T PF14531_consen   84 FLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH  162 (288)
T ss_dssp             B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeeeEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh
Confidence            222222222         111        2467888774 48888764   22211122334445667789999999999


Q ss_pred             cCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHh
Q 017177          217 TSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYA  296 (376)
Q Consensus       217 s~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~  296 (376)
                        ..+++|+||||+|+|++.+|.++|+||+.....+.....  .        ..+..|.               .||+..
T Consensus       163 --~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~--------~~~~~~~---------------PPe~~~  215 (288)
T PF14531_consen  163 --SYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--S--------EFPVAFT---------------PPELES  215 (288)
T ss_dssp             --HTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--G--------GS-TTTS----------------HHHHH
T ss_pred             --hcceEecccceeeEEEcCCCCEEEcChHHHeecCceeec--c--------CCCcccC---------------Chhhhh
Confidence              599999999999999999999999999888765442221  0        2223344               377544


Q ss_pred             hh-------hhccccccccceeeeehhhccccc
Q 017177          297 WI-------KYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       297 ~~-------~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      -.       ...+.+.|.|.+|++++.+....-
T Consensus       216 ~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  216 CAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             HHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             hhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            32       245788899999999988775533

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.57  E-value=1.1e-15  Score=154.21  Aligned_cols=168  Identities=17%  Similarity=0.204  Sum_probs=116.1

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ...+|..+++|-.|+||.||.+         +++.+.+.+|+| +++...-     .+-  ++....+|.+|        
T Consensus        81 ~e~df~~IklisngAygavylv---------rh~~trqrfa~k-iNkq~li-----lRn--ilt~a~npfvv--------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLV---------RHKETRQRFAMK-INKQNLI-----LRN--ILTFAGNPFVV--------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeee---------eccccccchhhc-ccccchh-----hhc--cccccCCccee--------
Confidence            4568999999999999999999         555578889994 4433211     110  33333344433        


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                                   |+....++.-    ..++...        +.+++|||  ..+|+|||+||+|.||+.-|++|+.|||
T Consensus       136 -------------gDc~tllk~~----g~lPvdm--------vla~Eylh--~ygivhrdlkpdnllIT~mGhiKlTDfg  188 (1205)
T KOG0606|consen  136 -------------GDCATLLKNI----GPLPVDM--------VLAVEYLH--SYGIVHRDLKPDNLLITSMGHIKLTDFG  188 (1205)
T ss_pred             -------------chhhhhcccC----CCCcchh--------hHHhHhhc--cCCeecCCCCCCcceeeecccccccchh
Confidence                         5666666443    2333222        67899999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeE------------EEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeee
Q 017177          247 IYVYFKRHYIYI------------YIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVF  314 (376)
Q Consensus       247 ~a~~~~~~~~~~------------~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~  314 (376)
                      +++..-......            ......    +|||+|.               |||++..++| ..-.|+|++|+|.
T Consensus       189 Lsk~GLms~atnl~eg~I~k~t~Ef~dKqv----cgTPeyi---------------aPeVilrqgy-gkpvdwwamGiIl  248 (1205)
T KOG0606|consen  189 LSKKGLMSLATNLKEGHIEKDTHEFQDKQV----CGTPEYI---------------APEVILRQGY-GKPVDWWAMGIIL  248 (1205)
T ss_pred             hhhhhhhhccchhhhcchHHHHHHhhhccc----cCCcccc---------------Chhhhhhhcc-CCCccHHHHHHHH
Confidence            998653321110            011111    6778887               8998877765 7889999999999


Q ss_pred             hhhccccccchh
Q 017177          315 SCVFSFYRTTML  326 (376)
Q Consensus       315 ~~~~~~y~~~~~  326 (376)
                      ++......+..+
T Consensus       249 yeFLVgcvpffG  260 (1205)
T KOG0606|consen  249 YEFLVGCVPFFG  260 (1205)
T ss_pred             HHHheeeeeccC
Confidence            997744444433

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.56  E-value=4.5e-15  Score=145.99  Aligned_cols=148  Identities=14%  Similarity=0.130  Sum_probs=96.6

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhh-----------------------------
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-----------------------------  138 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------------------  138 (376)
                      ...|+. +.||.|++|+||+|+.++         +|+.||||++++.-...                             
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~---------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~  188 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKD---------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPRE  188 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECC---------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHH
Confidence            345776 789999999999997653         48899999998652110                             


Q ss_pred             -----HH------HHHHHHHHHhcCC----CCCcceEEeEEEe-CCeEEEEEeccCCCCHHHHH--hhcCCCCCCCCHHH
Q 017177          139 -----FE------EWQSEVNFLGRLS----HPNLVKLLGYCWE-DKELLLVYEYMQRGSLENHL--FRRNPSIQPLSWDI  200 (376)
Q Consensus       139 -----~~------~~~~E~~il~~l~----h~nIv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~~  200 (376)
                           .+      ++.+|+..+.++.    +.+.+.+-.++.+ ....+|||||++|+.+.++-  .........+.+..
T Consensus       189 ~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~  268 (537)
T PRK04750        189 VVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERG  268 (537)
T ss_pred             HHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHH
Confidence                 01      1334444444442    3333333333322 34567999999999998743  22210001233333


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC----cEEEcceeeeeeeccc
Q 017177          201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG----FLFDSHLLIYVYFKRH  254 (376)
Q Consensus       201 ~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g----~~kl~Dfg~a~~~~~~  254 (376)
                      +..++.|+       +  ..|++|+|+||.||+++.+|    .+++.|||++..+...
T Consensus       269 v~~~~~Qi-------f--~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        269 VEVFFTQV-------F--RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             HHHHHHHH-------H--hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence            44444444       3  47999999999999999888    9999999999988654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=4.8e-16  Score=155.68  Aligned_cols=199  Identities=21%  Similarity=0.195  Sum_probs=158.8

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCC-CCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLS-HPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~  165 (376)
                      ..|.+.+.||+|+|+.|-.+....        .....+|+|.+....  .........|..+-+.+. |+|++++++...
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~--------~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~   91 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSR--------DPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS   91 (601)
T ss_pred             ccccccccccccccchhhhhhhcC--------CCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccC
Confidence            347777889999999998764332        235567777776553  223345556888888888 999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC-cEEEcc
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG-FLFDSH  244 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g-~~kl~D  244 (376)
                      .....++++++.+|+++.+.+....  ....+...+..++.|+..++.|+|. ..++.||||||+|.+++..+ .++++|
T Consensus        92 ~~~~~~~~~~~s~g~~~f~~i~~~~--~~~~~~~~~~~~~~ql~s~l~~~H~-~~~~~h~~ikP~n~~l~~s~~~l~~~d  168 (601)
T KOG0590|consen   92 SPRSYLLSLSYSDGGSLFSKISHPD--STGTSSSSASRYLPQLNSGLSYLHP-ENGVTHRDIKPSNSLLDESGSALKIAD  168 (601)
T ss_pred             CCcccccccCcccccccccccccCC--ccCCCCcchhhhhhhhccCccccCc-ccccccCCCCCccchhccCCCcccCCC
Confidence            9999999999999999998884221  1246677788899999999999995 59999999999999999999 999999


Q ss_pred             eeeeeeecc-ceeeEEEeeeEEEEEee-eeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          245 LLIYVYFKR-HYIYIYIHTYIIYIYIY-VYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       245 fg~a~~~~~-~~~~~~~~~~~~y~~~g-t~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      ||+|..+.. ..........     +| +++|+               |||...+..+..+..|+||.|+++.-+.
T Consensus       169 f~~At~~~~~~g~~~~~~~~-----~g~s~~y~---------------a~E~~~~~~~~~~~~d~~S~g~~l~~~~  224 (601)
T KOG0590|consen  169 FGLATAYRNKNGAERSLKDR-----CGSSPPYG---------------APEHLSGKAYRGPSVDVWSLGIVLSAML  224 (601)
T ss_pred             chhhccccccCCcceeeecc-----cCCCCCCC---------------CcccccchhhcCCCcccccccccccccc
Confidence            999998876 3333222222     66 88888               8999999889999999999999988766

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.52  E-value=1.4e-14  Score=139.36  Aligned_cols=146  Identities=23%  Similarity=0.242  Sum_probs=118.1

Q ss_pred             HhcCCCCCcceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCC
Q 017177          149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFK  228 (376)
Q Consensus       149 l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlK  228 (376)
                      |+.+.|.|+.+++|.+.+++..++|.+||..|+|.+.+...   ...+++.....++++|+.||.|||+.... .|+-++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~-~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNSPIG-YHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcCcce-eeeeec
Confidence            46788999999999999999999999999999999999764   36789999999999999999999963333 999999


Q ss_pred             CCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh---hh---cc
Q 017177          229 ASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI---KY---LT  302 (376)
Q Consensus       229 p~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~---~~---~~  302 (376)
                      ..|+++|....+|++|||+.......         ..+.+           .+...--+=|.|||++.+.   ..   .+
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~---------~~~~~-----------~~~~~~~~lw~aPellr~~~~~~~~~~~~  136 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEET---------AEPEA-----------HHPIRKALLWTAPELLRGALSQSLESALT  136 (484)
T ss_pred             cccceeeeeEEEEechhhhccccccc---------ccccc-----------cchhHHHHhccCHHHhccccccccccccc
Confidence            99999999999999999999876541         00000           1111112226689998874   22   47


Q ss_pred             ccccccceeeeehhhc
Q 017177          303 LLKYSNSFAFVFSCVF  318 (376)
Q Consensus       303 ~~~dv~s~g~v~~~~~  318 (376)
                      .+.|+||+|++++|++
T Consensus       137 ~~gdiYs~~ii~~ei~  152 (484)
T KOG1023|consen  137 QKGDIYSFGIIMYEIL  152 (484)
T ss_pred             ccCCeehHHHHHHHHH
Confidence            8899999999999998

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.46  E-value=2.6e-13  Score=115.06  Aligned_cols=128  Identities=17%  Similarity=0.082  Sum_probs=94.5

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCc-ceEEeEEEeCCeEEE
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNL-VKLLGYCWEDKELLL  172 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nI-v~l~~~~~~~~~~~l  172 (376)
                      .+.|+.|.++.||++...           +..|++|........ ...+.+|+.+++.+.+.++ .+++...  ....++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-----------~~~~~lK~~~~~~~~-~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~l   68 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-----------NKKYVVRIPGNGTEL-LINRENEAENSKLAAEAGIGPKLYYFD--PETGVL   68 (170)
T ss_pred             eeecCCcccCceEEEEEC-----------CeEEEEEeCCCCccc-ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeE
Confidence            357889999999998643           567999997655321 2345789999999875444 4555543  334589


Q ss_pred             EEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-----cEecCCCCCCEEEcCCCcEEEcceee
Q 017177          173 VYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK-----VIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       173 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~-----iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      ||||++|.++....         .   ....+..+++++|..||.  .+     ++|+|++|.||+++ ++.++++||+.
T Consensus        69 v~e~i~G~~l~~~~---------~---~~~~~~~~l~~~l~~LH~--~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~  133 (170)
T cd05151          69 ITEFIEGSELLTED---------F---SDPENLEKIAKLLKKLHS--SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY  133 (170)
T ss_pred             EEEecCCCcccccc---------c---cCHHHHHHHHHHHHHHhC--CCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence            99999998775420         1   112456789999999994  65     59999999999999 67899999999


Q ss_pred             eee
Q 017177          248 YVY  250 (376)
Q Consensus       248 a~~  250 (376)
                      +..
T Consensus       134 a~~  136 (170)
T cd05151         134 AGM  136 (170)
T ss_pred             ccC
Confidence            885

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.44  E-value=3.5e-13  Score=129.89  Aligned_cols=203  Identities=15%  Similarity=0.027  Sum_probs=152.9

Q ss_pred             CCCCccceEee--cCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCC-CCCcceEEeE
Q 017177           89 KNFKPDSLLGE--GGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLS-HPNLVKLLGY  163 (376)
Q Consensus        89 ~~y~~~~~lG~--G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~-h~nIv~l~~~  163 (376)
                      ..+.+.+.+|.  |.+|.||.+....       ..++..+|+|.-+..  ......+-.+|+...++++ |+|.++.+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~-------~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~  186 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTN-------SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA  186 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCc-------ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence            45677789999  9999999985421       335788999984433  2233344467888888887 9999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCCcEecCCCCCCEEEcCC-C
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR----GLGFLHTSEKKVIYRDFKASNILLDGV-G  238 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~----~L~yLHs~~~~iiHrDlKp~NILl~~~-g  238 (376)
                      +...+..|+-+|+|. .+|..+.....   ..++...+.....+...    ||.++|+  .+++|-|+||+||++..+ .
T Consensus       187 ~e~~~~lfiqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs--~~~~~~~~kp~~i~~~~~~~  260 (524)
T KOG0601|consen  187 WEGSGILFIQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHS--NNIVHDDLKPANIFTTSDWT  260 (524)
T ss_pred             cccCCcceeeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCC--Ccccccccchhheecccccc
Confidence            999999999999995 68888776542   33677888888888888    9999995  999999999999999999 8


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      ..+++|||+...+............  +-+.|..-|+               +||+..+.  .+...|++++|.|+.+.+
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~--~r~~~~~~Y~---------------~ke~~~~l--~~~~~di~sl~ev~l~~~  321 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVS--KRPEGDCIYA---------------AKELLNGL--ATFASDIFSLGEVILEAI  321 (524)
T ss_pred             eeecCCcceeEEccCCccccceeee--ecCCCCceEe---------------Chhhhccc--cchHhhhcchhhhhHhhH
Confidence            8999999999988776532111100  1112333333               59977654  478999999999999988


Q ss_pred             ccccc
Q 017177          319 SFYRT  323 (376)
Q Consensus       319 ~~y~~  323 (376)
                      .....
T Consensus       322 l~~~~  326 (524)
T KOG0601|consen  322 LGSHL  326 (524)
T ss_pred             hhccc
Confidence            44333

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.41  E-value=2.9e-12  Score=110.28  Aligned_cols=145  Identities=14%  Similarity=0.075  Sum_probs=101.7

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh----------------------hhHHHH----HHHHH
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM----------------------QGFEEW----QSEVN  147 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~----~~E~~  147 (376)
                      ...||.|.-+.||.|...+..   .....+..+|||+.+....                      .....+    .+|++
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~---~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r   78 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNE---TEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMH   78 (197)
T ss_pred             CCccccCcceEEEEEecCccc---ccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHH
Confidence            357899999999999643210   0111357899998643110                      001222    38999


Q ss_pred             HHhcCC--CCCcceEEeEEEeCCeEEEEEeccCCCCHHH-HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCcE
Q 017177          148 FLGRLS--HPNLVKLLGYCWEDKELLLVYEYMQRGSLEN-HLFRRNPSIQPLSWDIRLKIAIGAARGLGFL-HTSEKKVI  223 (376)
Q Consensus       148 il~~l~--h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yL-Hs~~~~ii  223 (376)
                      .|+++.  .-++++++++    ..-+|||||+.++.+.. .++.     ..++......+..+++.+|..| |  +.+||
T Consensus        79 ~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H--~~glV  147 (197)
T cd05146          79 NLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYK--ECNLV  147 (197)
T ss_pred             HHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            999996  4577777764    45789999997654422 2221     2245556677889999999998 7  68999


Q ss_pred             ecCCCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          224 YRDFKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       224 HrDlKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      |+||++.|||++ +|.+.++|||.+.....
T Consensus       148 HGDLs~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         148 HADLSEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             cCCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence            999999999997 47899999999887643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.34  E-value=1.1e-11  Score=103.31  Aligned_cols=134  Identities=20%  Similarity=0.271  Sum_probs=100.9

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-----h---hHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-----Q---GFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~---~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..+++|+-+.++.+.+.           +..+++|.-.+...     +   ..++..+|+.++.++.--.|...+=++.+
T Consensus         2 ~~i~~GAEa~i~~~~~~-----------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD   70 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-----------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD   70 (204)
T ss_pred             chhhCCcceeEEeeecc-----------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence            45788999999998554           44566776433211     1   12466789999999986566655556677


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++...|+|||++|..|.+.+...           ...++..+-.-+.-||  ..+|+|+||.++||++...+ +.++|||
T Consensus        71 ~~~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH--~~givHGDLTtsNiIl~~~~-i~~IDfG  136 (204)
T COG3642          71 PDNGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLH--KAGIVHGDLTTSNIILSGGR-IYFIDFG  136 (204)
T ss_pred             CCCCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHH--hcCeecCCCccceEEEeCCc-EEEEECC
Confidence            88889999999998888888543           1345666667778899  79999999999999998665 8999999


Q ss_pred             eeeeecc
Q 017177          247 IYVYFKR  253 (376)
Q Consensus       247 ~a~~~~~  253 (376)
                      ++.+-..
T Consensus       137 Lg~~s~~  143 (204)
T COG3642         137 LGEFSDE  143 (204)
T ss_pred             ccccccc
Confidence            9986443

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.30  E-value=4.3e-11  Score=99.48  Aligned_cols=145  Identities=16%  Similarity=0.141  Sum_probs=108.6

Q ss_pred             ccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--------hhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           93 PDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--------QGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        93 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      .+.+|-+|+-+.|+++.+.           |+...||.-.....        -...+..+|++.|.++.--.|.-..=++
T Consensus        11 ~l~likQGAEArv~~~~~~-----------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~   79 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-----------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF   79 (229)
T ss_pred             cceeeeccceeeEeeeccC-----------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence            4578889999999999665           66777776433211        1235778999999999755665555567


Q ss_pred             EeCCeEEEEEeccCC-CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc---E
Q 017177          165 WEDKELLLVYEYMQR-GSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF---L  240 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~---~  240 (376)
                      .+...-.|+|||++| .++.+++.....  ..........++.+|-+.+.-||  ..+|||+||..+||++.++|.   +
T Consensus        80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH--~ndiiHGDLTTSNill~~~~~~~~~  155 (229)
T KOG3087|consen   80 IDTYGGQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLH--DNDIIHGDLTTSNILLRSDGNQITP  155 (229)
T ss_pred             EecCCCeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhh--hCCeecccccccceEEecCCCcCce
Confidence            777778899999977 478888876532  22222333688888999999999  699999999999999976653   5


Q ss_pred             EEcceeeeeeec
Q 017177          241 FDSHLLIYVYFK  252 (376)
Q Consensus       241 kl~Dfg~a~~~~  252 (376)
                      .++|||++....
T Consensus       156 ~lIdfgls~~s~  167 (229)
T KOG3087|consen  156 ILIDFGLSSVSR  167 (229)
T ss_pred             EEEeecchhccc
Confidence            899999997653

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.26  E-value=3.4e-11  Score=106.41  Aligned_cols=141  Identities=19%  Similarity=0.231  Sum_probs=105.5

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCC--CCcceEEeEEEeC---C
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSH--PNLVKLLGYCWED---K  168 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h--~nIv~l~~~~~~~---~  168 (376)
                      +.|+.|.++.||++...+          +..+++|....... .....+.+|+.+++.+.+  .++.+++.+....   +
T Consensus         4 ~~l~~G~~n~~~~v~~~~----------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~   73 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG----------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG   73 (223)
T ss_pred             eecCCCccceEEEEEecC----------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence            578999999999986542          56799999876432 134567889999999975  4567777766553   2


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS------------------------------  218 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~------------------------------  218 (376)
                      ..++||||++|.++.+.+..     ..++......++.+++++|..||+.                              
T Consensus        74 ~~~~v~e~i~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (223)
T cd05154          74 TPFYVMERVDGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDA  148 (223)
T ss_pred             CceEEEEEeCCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHh
Confidence            67899999999888765421     2356666677777777777777741                              


Q ss_pred             ------------------------CCCcEecCCCCCCEEEcC--CCcEEEcceeeeee
Q 017177          219 ------------------------EKKVIYRDFKASNILLDG--VGFLFDSHLLIYVY  250 (376)
Q Consensus       219 ------------------------~~~iiHrDlKp~NILl~~--~g~~kl~Dfg~a~~  250 (376)
                                              ...++|+|++|.|||++.  ++.+.++||+.+..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         149 SRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             hcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                    245699999999999998  67789999998874

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.20  E-value=1.2e-11  Score=119.27  Aligned_cols=200  Identities=18%  Similarity=0.055  Sum_probs=148.0

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhH--HHHHHHHHHHhcCC-CCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF--EEWQSEVNFLGRLS-HPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~il~~l~-h~nIv~l~~~  163 (376)
                      ...+|..+..||.|.|+.|+.+..+.        ..+..|++|.+.+......  ..-..|+.+...+. |.+++.++..
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~--------~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~  334 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRP--------EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS  334 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecC--------CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC
Confidence            34578889999999999999875432        2477899998876533222  22346777777776 9999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC-CcEEE
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV-GFLFD  242 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~-g~~kl  242 (376)
                      |....+.|+-.|||+++++...+.-.    ..+++...+++..|++.++.++|  .+.++|+|+||+||++..+ +..++
T Consensus       335 W~~~r~~~ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~--s~~~~~~d~~psni~i~~~~~~~~~  408 (524)
T KOG0601|consen  335 WSQLRQGYIPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIH--SKLFVHLDVKPSNILISNDGFFSKL  408 (524)
T ss_pred             ccccccccCchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhcccccc--chhhhcccccccceeeccchhhhhc
Confidence            98888889999999999877655222    45788889999999999999999  5999999999999999876 78899


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      .|||+...+.-.... .....        ..|      |         +.|++.....+..+.|++++|.-+.+.++.+-
T Consensus       409 ~~~~~~t~~~~~~~~-~~~~~--------r~~------p---------~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~  464 (524)
T KOG0601|consen  409 GDFGCWTRLAFSSGV-FHHID--------RLY------P---------IAEILLEDYPHLSKADIFSLGLSVDEAITGSP  464 (524)
T ss_pred             cccccccccceeccc-ccccc--------ccc------c---------cchhhccccccccccccccccccccccccCcc
Confidence            999998752221111 01111        111      0         14556656667888999999988888876655


Q ss_pred             cc
Q 017177          323 TT  324 (376)
Q Consensus       323 ~~  324 (376)
                      +.
T Consensus       465 ls  466 (524)
T KOG0601|consen  465 LS  466 (524)
T ss_pred             cC
Confidence            53

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.16  E-value=8.5e-11  Score=114.80  Aligned_cols=126  Identities=18%  Similarity=0.129  Sum_probs=105.4

Q ss_pred             cCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCH
Q 017177          119 KTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSW  198 (376)
Q Consensus       119 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~  198 (376)
                      .+.++.+|.|...+...........+-++.|+.++||||+++++.++.++.+|||+|-+.  .|..++++.       ..
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~  103 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GK  103 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HH
Confidence            344578888888876655333456678889999999999999999999999999999985  688888654       35


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeeccc
Q 017177          199 DIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRH  254 (376)
Q Consensus       199 ~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~  254 (376)
                      ..+..-+.||+.||.|||. +++++|++|.-.-|+|+..|..||++|-++......
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~-d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~  158 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLND-DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGF  158 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhc-cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccC
Confidence            6677788999999999986 899999999999999999999999999888765443

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.11  E-value=2.7e-09  Score=96.89  Aligned_cols=124  Identities=15%  Similarity=0.033  Sum_probs=91.0

Q ss_pred             CcEEEEEEcCCCChhh-H----------HHHHHHHHHHhcCCCCC--cceEEeEEEe-----CCeEEEEEeccCCC-CHH
Q 017177          123 GMVVAIKKLNPESMQG-F----------EEWQSEVNFLGRLSHPN--LVKLLGYCWE-----DKELLLVYEYMQRG-SLE  183 (376)
Q Consensus       123 ~~~vavK~~~~~~~~~-~----------~~~~~E~~il~~l~h~n--Iv~l~~~~~~-----~~~~~lv~e~~~~g-~L~  183 (376)
                      |+.|.||......... .          ..+.+|...+..|...+  .+.+++++..     ...-++|||++++. +|.
T Consensus        45 g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~  124 (268)
T PRK15123         45 GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLE  124 (268)
T ss_pred             CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHH
Confidence            6678899764433111 1          14678999998885333  3445555543     23578999999875 799


Q ss_pred             HHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC-------CCcEEEcceeeeee
Q 017177          184 NHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-------VGFLFDSHLLIYVY  250 (376)
Q Consensus       184 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~-------~g~~kl~Dfg~a~~  250 (376)
                      +++.....  ...+......++.+++..+.-||  +.||+|+|+++.|||++.       ++.+.++||+.+..
T Consensus       125 ~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH--~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        125 DYCADWAT--NPPDPRLKRMLIKRVATMVRDMH--AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHH--HCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            88854211  23456777889999999999999  699999999999999975       46799999998864

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.04  E-value=2.1e-09  Score=92.11  Aligned_cols=100  Identities=20%  Similarity=0.107  Sum_probs=66.5

Q ss_pred             HHHHHHHHHhcCCCC--CcceEEeEEEeCCeEEEEEeccC--CCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHH-h
Q 017177          141 EWQSEVNFLGRLSHP--NLVKLLGYCWEDKELLLVYEYMQ--RGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF-L  215 (376)
Q Consensus       141 ~~~~E~~il~~l~h~--nIv~l~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~y-L  215 (376)
                      ...+|.+.|.++..-  ++++++++.    .-.|||||++  |..+..+....      ++......++.+++..+.. +
T Consensus        54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~  123 (188)
T PF01163_consen   54 WAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKML  123 (188)
T ss_dssp             HHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHH
Confidence            456899999999854  677777542    3479999998  55555433222      1233445667777775554 5


Q ss_pred             hcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          216 HTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       216 Hs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      |  ..+|+|+||.+.|||++++ .+.++|||.+.....
T Consensus       124 ~--~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~~  158 (188)
T PF01163_consen  124 H--KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSSH  158 (188)
T ss_dssp             H--CTTEEESS-STTSEEEETT-CEEE--GTTEEETTS
T ss_pred             H--hcCceecCCChhhEEeecc-eEEEEecCcceecCC
Confidence            7  6999999999999999977 899999999886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.01  E-value=7.3e-11  Score=106.01  Aligned_cols=97  Identities=26%  Similarity=0.392  Sum_probs=85.3

Q ss_pred             HHHhcCCCCCcceEEeEEEeCC-----eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 017177          147 NFLGRLSHPNLVKLLGYCWEDK-----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK  221 (376)
Q Consensus       147 ~il~~l~h~nIv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~  221 (376)
                      .-|-.+.|.||++++.+|.+.+     ...+++||+..|+|..+|++.+.....+......+|+-||+.||.|||+++..
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            3445566999999999987643     47899999999999999998766667788899999999999999999999999


Q ss_pred             cEecCCCCCCEEEcCCCcEEEc
Q 017177          222 VIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       222 iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      |+|+.+..+-|++..+|.+|+.
T Consensus       199 iihgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             cccCCcchhheeecCCceEEec
Confidence            9999999999999999988875

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.90  E-value=9e-09  Score=91.14  Aligned_cols=136  Identities=18%  Similarity=0.094  Sum_probs=95.4

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh----------------------hhHHHHHHHHHH
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM----------------------QGFEEWQSEVNF  148 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~i  148 (376)
                      +.++..||.|.-+.||.|....          +.++|||.=+....                      -.+....+|.++
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~----------g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~  162 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPK----------GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA  162 (304)
T ss_pred             HhhccccccCccceEEEEECCC----------CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence            4567899999999999996653          88899997432110                      012345789999


Q ss_pred             HhcCCCC--CcceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecC
Q 017177          149 LGRLSHP--NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRD  226 (376)
Q Consensus       149 l~~l~h~--nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrD  226 (376)
                      |.+|...  .+++.+++    +.-.+||||++|-.|...-         ++......++..|++-+.-+-  ..||||+|
T Consensus       163 L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~--~~GiVHGD  227 (304)
T COG0478         163 LQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAY--RRGIVHGD  227 (304)
T ss_pred             HHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHH--HcCccccC
Confidence            9999744  77777663    5678999999986665432         112222233333333333333  38999999


Q ss_pred             CCCCCEEEcCCCcEEEcceeeeeee
Q 017177          227 FKASNILLDGVGFLFDSHLLIYVYF  251 (376)
Q Consensus       227 lKp~NILl~~~g~~kl~Dfg~a~~~  251 (376)
                      +.+=|||++++|.+.++||=-+...
T Consensus       228 lSefNIlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         228 LSEFNILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             CchheEEEecCCCEEEEeCcccccC
Confidence            9999999999999999999776654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.86  E-value=6.1e-09  Score=102.27  Aligned_cols=143  Identities=15%  Similarity=0.152  Sum_probs=94.2

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhh------------------------------HH----
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG------------------------------FE----  140 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~------------------------------~~----  140 (376)
                      ..|+.++-|+||+|....          |+.||||+.++.-...                              .+    
T Consensus       131 ~PiAsASIaQVH~A~L~s----------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~  200 (517)
T COG0661         131 EPIASASIAQVHRAVLKS----------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK  200 (517)
T ss_pred             CchhhhhHhhheeEEecC----------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence            579999999999998874          8999999987642210                              00    


Q ss_pred             ------HHHHHHHHHhcCC-----CCCcceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 017177          141 ------EWQSEVNFLGRLS-----HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA  209 (376)
Q Consensus       141 ------~~~~E~~il~~l~-----h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~  209 (376)
                            ++.+|+..+.++.     .+++.-..=++.-.+.-.|+|||++|-.+.+......   ..++.+.+.....++.
T Consensus       201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f  277 (517)
T COG0661         201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAF  277 (517)
T ss_pred             HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHH
Confidence                  2345666666552     3333222222333466789999999988888743221   2244333332222222


Q ss_pred             HHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeeccc
Q 017177          210 RGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRH  254 (376)
Q Consensus       210 ~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~  254 (376)
                        +.-+-  ..++.|.|..|.||+++.+|.+.+.|||+...+...
T Consensus       278 --~~q~~--~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         278 --LRQLL--RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             --HHHHH--hcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence              11111  378999999999999999999999999999987654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.85  E-value=5.4e-08  Score=85.30  Aligned_cols=107  Identities=21%  Similarity=0.166  Sum_probs=84.8

Q ss_pred             HHHHHHHHHHhcCC--CCCcceEEeEEEeCC----eEEEEEeccCCC-CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 017177          140 EEWQSEVNFLGRLS--HPNLVKLLGYCWEDK----ELLLVYEYMQRG-SLENHLFRRNPSIQPLSWDIRLKIAIGAARGL  212 (376)
Q Consensus       140 ~~~~~E~~il~~l~--h~nIv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L  212 (376)
                      .+..+|...+..|.  .-.+++.+++.....    ..++|+|++++. +|.+++....    ..+......++.+++..+
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI  131 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence            46678888888886  344566666665532    468999999874 7999887642    155667788999999999


Q ss_pred             HHhhcCCCCcEecCCCCCCEEEcCCC---cEEEcceeeeeeec
Q 017177          213 GFLHTSEKKVIYRDFKASNILLDGVG---FLFDSHLLIYVYFK  252 (376)
Q Consensus       213 ~yLHs~~~~iiHrDlKp~NILl~~~g---~~kl~Dfg~a~~~~  252 (376)
                      .-||  +.+|+|+|+++.|||++.++   .+.++||+-++...
T Consensus       132 ~~lH--~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  132 AKLH--DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHH--HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            9999  69999999999999999887   79999999887643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.81  E-value=5e-10  Score=114.14  Aligned_cols=232  Identities=15%  Similarity=0.022  Sum_probs=153.7

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ..+.+.+.+-+-+|.++.++.+         ....++...++|+......   .+.+...++-.++-...||.+++...-
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~---------~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s  872 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPA---------SPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS  872 (1205)
T ss_pred             CCccceecccccCCCCcccccC---------CccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC
Confidence            4556777788889999999877         4444565556555443321   222333344444444456777766655


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +......+++++|+.+++|...|+..    ...+.......+..+..+++|||+  ..++|||+||.|+|+..+|..+++
T Consensus       873 ~~~rsP~~L~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s--~~r~h~~~~p~~~l~~~~gh~~l~  946 (1205)
T KOG0606|consen  873 FPCRSPLPLVGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHS--SLRKHRDLKPDSLLIAYDGHRPLT  946 (1205)
T ss_pred             CCCCCCcchhhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhcccc--chhhcccccccchhhcccCCcccC
Confidence            55667899999999999999998765    345555666777788899999994  669999999999999999999999


Q ss_pred             ceeeeeeeccceeeE----------------------EEe--eeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhh
Q 017177          244 HLLIYVYFKRHYIYI----------------------YIH--TYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIK  299 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~----------------------~~~--~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~  299 (376)
                      |||............                      ...  ....+...||+.|.               +||+..+..
T Consensus       947 ~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~l---------------aPe~~lg~~ 1011 (1205)
T KOG0606|consen  947 DFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYL---------------APEILLGRR 1011 (1205)
T ss_pred             ccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCccc---------------CCccccccc
Confidence            998444321110000                      000  01123335555555               999777765


Q ss_pred             hccccccccceeeeehhhccccccchhhHHHHHHHhhCCCccCcccCCCh
Q 017177          300 YLTLLKYSNSFAFVFSCVFSFYRTTMLKYQILAWQSWGPLVESHMLQPGL  349 (376)
Q Consensus       300 ~~~~~~dv~s~g~v~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~l  349 (376)
                       ....+|+|++|.++++..+-....+...+....+........-..-+.+
T Consensus      1012 -hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~ 1060 (1205)
T KOG0606|consen 1012 -HGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEE 1060 (1205)
T ss_pred             -CCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccc
Confidence             5788899999999999887766665555555555555444433333333

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.75  E-value=7.3e-08  Score=91.99  Aligned_cols=141  Identities=20%  Similarity=0.188  Sum_probs=109.4

Q ss_pred             EEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe----CCeEEEEEeccC
Q 017177          103 GRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE----DKELLLVYEYMQ  178 (376)
Q Consensus       103 g~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~----~~~~~lv~e~~~  178 (376)
                      .+.|+|+..         .+|..|++|+++............-++.++++.|+|||++.++|..    +..+++|++|.+
T Consensus       290 ~Ttyk~~s~---------~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP  360 (655)
T KOG3741|consen  290 ITTYKATSN---------VDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYP  360 (655)
T ss_pred             ceeEeeeec---------cCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCC
Confidence            456777543         3688999999954433222223345778999999999999999873    456999999998


Q ss_pred             C-CCHHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          179 R-GSLENHLFRRNP-----------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       179 ~-g~L~~~l~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      + ++|.++......           .+...++..++.++.|+..||.++|+  .|+.-+-|-|.+||++.+.+++|...|
T Consensus       361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs--sGLAck~L~~~kIlv~G~~RIriS~C~  438 (655)
T KOG3741|consen  361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS--SGLACKTLDLKKILVTGKMRIRISGCG  438 (655)
T ss_pred             CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh--cCceeecccHhHeEeeCcceEEEeccc
Confidence            6 578887643322           12457889999999999999999995  888889999999999999899999888


Q ss_pred             eeeeeccc
Q 017177          247 IYVYFKRH  254 (376)
Q Consensus       247 ~a~~~~~~  254 (376)
                      +...+...
T Consensus       439 i~Dvl~~d  446 (655)
T KOG3741|consen  439 IMDVLQED  446 (655)
T ss_pred             ceeeecCC
Confidence            88776544

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.69  E-value=3.2e-07  Score=81.52  Aligned_cols=140  Identities=18%  Similarity=0.201  Sum_probs=85.9

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCC--CcceEEeEEEeCCeEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP--NLVKLLGYCWEDKELLL  172 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~--nIv~l~~~~~~~~~~~l  172 (376)
                      ..||+|..+.||+.             .+..+++|......  ......+|.++++.+..-  .+.+.+++....+...+
T Consensus         7 ~~i~~G~t~~~y~~-------------~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl   71 (226)
T TIGR02172         7 TQTGEGGNGESYTH-------------KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL   71 (226)
T ss_pred             eeecCCCCcceeEe-------------cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence            57899999999984             13457888877543  224568899999998633  35777888777788899


Q ss_pred             EEeccCCCC-HHHHH--------------hh----cCCC-CCCCCHHHH-HHHHHH----------HHH-HHHHhh--cC
Q 017177          173 VYEYMQRGS-LENHL--------------FR----RNPS-IQPLSWDIR-LKIAIG----------AAR-GLGFLH--TS  218 (376)
Q Consensus       173 v~e~~~~g~-L~~~l--------------~~----~~~~-~~~~~~~~~-~~i~~q----------i~~-~L~yLH--s~  218 (376)
                      |||+++|.+ +...+              .+    -+.. ......... ..+-.+          +.. ...+|.  ..
T Consensus        72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~  151 (226)
T TIGR02172        72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD  151 (226)
T ss_pred             eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence            999999863 21111              11    1100 000111100 000000          000 111221  12


Q ss_pred             CCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          219 EKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       219 ~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      ...++|+|+.|.||++++++ +.++||+.+..
T Consensus       152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            34678999999999999888 99999998874

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PRK09902 hypothetical protein; Provisional

Probab=98.65  E-value=6e-07  Score=77.73  Aligned_cols=138  Identities=17%  Similarity=0.066  Sum_probs=99.5

Q ss_pred             EeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC------hhhHHHHHHHHHHHhcCC--CCCcceEEeEEE-eC
Q 017177           97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES------MQGFEEWQSEVNFLGRLS--HPNLVKLLGYCW-ED  167 (376)
Q Consensus        97 lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~il~~l~--h~nIv~l~~~~~-~~  167 (376)
                      -|+|+.+-|+.....           |..+=+|....-.      +.....|.+|+..+..|.  .-.++++. ++. ..
T Consensus        26 ~~rgG~SgV~r~~~~-----------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k   93 (216)
T PRK09902         26 YRRNGMSGVQCVERN-----------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVK   93 (216)
T ss_pred             cCCCCcceEEEEEeC-----------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeec
Confidence            356888888886544           3356677654211      223467889999999986  33355555 332 11


Q ss_pred             ----CeEEEEEeccCC-CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc--E
Q 017177          168 ----KELLLVYEYMQR-GSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF--L  240 (376)
Q Consensus       168 ----~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~--~  240 (376)
                          -.-+||+|-++| -+|.+++....  ..+.+......+..+++..+.-||  +.++.|+|+-+.|||++.+|.  +
T Consensus        94 ~~~~~rA~LVTe~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH--~~Gv~Hgdly~khIll~~~g~~~v  169 (216)
T PRK09902         94 IEGEWRALLVTEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMH--SVNRQHGCCYVRHIYVKTEGKAEA  169 (216)
T ss_pred             cCCceEEEEEEEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHhheeecCCCCeeE
Confidence                237899997753 58888885532  134577777899999999999999  799999999999999987777  8


Q ss_pred             EEcceeeeee
Q 017177          241 FDSHLLIYVY  250 (376)
Q Consensus       241 kl~Dfg~a~~  250 (376)
                      +++||--++.
T Consensus       170 ~lIDlEk~r~  179 (216)
T PRK09902        170 GFLDLEKSRR  179 (216)
T ss_pred             EEEEhhccch
Confidence            9999977664

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.55  E-value=8.5e-07  Score=77.09  Aligned_cols=139  Identities=14%  Similarity=0.075  Sum_probs=92.3

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHH---------HHHHHHHHhcCCCCC
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE---------WQSEVNFLGRLSHPN  156 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~il~~l~h~n  156 (376)
                      ....+|...+++-......|.+-...           +..+++|..+.......+.         ..+++..+..+...+
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei~-----------~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g   96 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEID-----------GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEG   96 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEEC-----------CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcC
Confidence            34567888888888888878776544           6789999987754322221         234444444443322


Q ss_pred             c---ceEEeEEEe-----CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCC
Q 017177          157 L---VKLLGYCWE-----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFK  228 (376)
Q Consensus       157 I---v~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlK  228 (376)
                      +   ..++-+..-     ....+++|||++|..|.++..        +++    .+...+.+++.-||  +.|+.|+|..
T Consensus        97 ~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH--~~G~~HGD~h  162 (229)
T PF06176_consen   97 FTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLH--KHGFYHGDPH  162 (229)
T ss_pred             ccccccceeeeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHH--HcCCccCCCC
Confidence            2   222222221     234678999999988766541        222    24455677889999  6999999999


Q ss_pred             CCCEEEcCCCcEEEcceeeeee
Q 017177          229 ASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       229 p~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      |.|+++++++ ++++||+..+.
T Consensus       163 pgNFlv~~~~-i~iID~~~k~~  183 (229)
T PF06176_consen  163 PGNFLVSNNG-IRIIDTQGKRM  183 (229)
T ss_pred             cCcEEEECCc-EEEEECccccc
Confidence            9999999655 89999987764

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.45  E-value=1.1e-06  Score=86.43  Aligned_cols=141  Identities=15%  Similarity=0.102  Sum_probs=91.9

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhh------------------------------H-----
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG------------------------------F-----  139 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~------------------------------~-----  139 (376)
                      +.||.-+.|+||+|+.++          |+.||||+.++.-...                              .     
T Consensus       167 ~piaaASlaQVhrA~L~~----------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~  236 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN----------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP  236 (538)
T ss_pred             chhhhcchhheEEEEecC----------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence            679999999999998765          8999999987642210                              0     


Q ss_pred             --HHHHHHHHHHhcC----CCCC------cceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 017177          140 --EEWQSEVNFLGRL----SHPN------LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG  207 (376)
Q Consensus       140 --~~~~~E~~il~~l----~h~n------Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~q  207 (376)
                        -+|.+|++...++    .|-+      |+++|-.+  ...-.|+||||+|..+.+.-.-..   ..++...+..-+.+
T Consensus       237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~---~gi~~~~i~~~l~~  311 (538)
T KOG1235|consen  237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDK---RGISPHDILNKLVE  311 (538)
T ss_pred             hhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHH---cCCCHHHHHHHHHH
Confidence              0234555544443    3444      44444322  345789999999986665432221   22454544444443


Q ss_pred             HHHHHHHhhcCCCCcEecCCCCCCEEEcC----CCcEEEcceeeeeeeccc
Q 017177          208 AARGLGFLHTSEKKVIYRDFKASNILLDG----VGFLFDSHLLIYVYFKRH  254 (376)
Q Consensus       208 i~~~L~yLHs~~~~iiHrDlKp~NILl~~----~g~~kl~Dfg~a~~~~~~  254 (376)
                      ...-+-+ +   .|++|+|-.|.||++..    ++.+.+-|||+...+...
T Consensus       312 ~~~~qIf-~---~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  312 AYLEQIF-K---TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             HHHHHHH-h---cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            3322222 3   67999999999999983    678999999999987654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.44  E-value=2.6e-06  Score=76.60  Aligned_cols=141  Identities=18%  Similarity=0.032  Sum_probs=84.9

Q ss_pred             eEeecCc-EEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEEeEEEeCCeEEEE
Q 017177           96 LLGEGGF-GRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        96 ~lG~G~f-g~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lv  173 (376)
                      .|-.|.. ..||+....           +..+.+|......   ...+.+|+++++.+. +--+.+++++....+..++|
T Consensus         5 ~~~~g~~~~~v~~~~~~-----------~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   70 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-----------NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLL   70 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-----------CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEE
Confidence            3445555 778987322           3468888876543   234567999988885 55567888877766778999


Q ss_pred             EeccCCCCHHHHH----------------hhcCC---CCCCCCHH--HHHHH-----------------------HHHHH
Q 017177          174 YEYMQRGSLENHL----------------FRRNP---SIQPLSWD--IRLKI-----------------------AIGAA  209 (376)
Q Consensus       174 ~e~~~~g~L~~~l----------------~~~~~---~~~~~~~~--~~~~i-----------------------~~qi~  209 (376)
                      ||+++|.+|....                .+-+.   ....+...  .....                       ..++.
T Consensus        71 ~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (244)
T cd05150          71 TSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELY  150 (244)
T ss_pred             EEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHH
Confidence            9999987766432                11010   00011100  00000                       11111


Q ss_pred             HHHHHhh--cCCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          210 RGLGFLH--TSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       210 ~~L~yLH--s~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      ..|.-..  .....++|+|+.|.|||++.++.+.|+||+.+..
T Consensus       151 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         151 AELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            1111100  0134589999999999999987788999998874

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.41  E-value=2.4e-06  Score=75.77  Aligned_cols=144  Identities=20%  Similarity=0.155  Sum_probs=83.7

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCC--CcceEEeEEEe---CC
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP--NLVKLLGYCWE---DK  168 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~--nIv~l~~~~~~---~~  168 (376)
                      ++.|+.|..+.||++...           +..+++|.....  .....+.+|..+++.+...  .+.+++.....   ..
T Consensus         2 i~~l~~G~~n~~~~v~~~-----------~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~   68 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTD-----------DGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNG   68 (239)
T ss_dssp             EEEEEESSSSEEEEEEET-----------TSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETS
T ss_pred             CccCCCCCeeeEEEEEEC-----------CcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccc
Confidence            367899999999998554           247999997665  3446777899999888632  35677764433   34


Q ss_pred             eEEEEEeccCCCCHHH----------------HHhh---cCCCCCCCCHHH---------HHHH------------HHHH
Q 017177          169 ELLLVYEYMQRGSLEN----------------HLFR---RNPSIQPLSWDI---------RLKI------------AIGA  208 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~----------------~l~~---~~~~~~~~~~~~---------~~~i------------~~qi  208 (376)
                      ..+++|++++|..+..                .+.+   ............         ....            ...+
T Consensus        69 ~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (239)
T PF01636_consen   69 FPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEEL  148 (239)
T ss_dssp             EEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHH
T ss_pred             cceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHH
Confidence            5799999999987777                1111   100001111000         0000            0011


Q ss_pred             HH-HHHHhhc-----CCCCcEecCCCCCCEEEc-CCCcEEEcceeeeee
Q 017177          209 AR-GLGFLHT-----SEKKVIYRDFKASNILLD-GVGFLFDSHLLIYVY  250 (376)
Q Consensus       209 ~~-~L~yLHs-----~~~~iiHrDlKp~NILl~-~~g~~kl~Dfg~a~~  250 (376)
                      .. .+..++.     ....++|+|+.|.|||++ .++.+.++||+.+..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  149 EERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            11 2222221     256799999999999999 667677999988874

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.36  E-value=3.1e-06  Score=70.55  Aligned_cols=134  Identities=16%  Similarity=0.122  Sum_probs=91.3

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcc-eEEeEEEeCCe
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLV-KLLGYCWEDKE  169 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv-~l~~~~~~~~~  169 (376)
                      ....+.|++|.+|.||+|.+.           +..+|+|+-+.+..  ...+..|+++|..+.-.++. ++|.+.    .
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~-----------~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg----~   86 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR-----------GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYG----E   86 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc-----------CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEec----h
Confidence            345678999999999999876           55799999877654  36788999999999866554 455443    2


Q ss_pred             EEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCC-CCCEEEcCCCcEEEcceeee
Q 017177          170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFK-ASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlK-p~NILl~~~g~~kl~Dfg~a  248 (376)
                      .++.|||+.|..|.+.-...       +...+..+    ++.---|-  ..+|-|..|. |..++|-.++.+.|+||--|
T Consensus        87 ~~i~me~i~G~~L~~~~~~~-------~rk~l~~v----lE~a~~LD--~~GI~H~El~~~~k~vlv~~~~~~iIDFd~A  153 (201)
T COG2112          87 DFIRMEYIDGRPLGKLEIGG-------DRKHLLRV----LEKAYKLD--RLGIEHGELSRPWKNVLVNDRDVYIIDFDSA  153 (201)
T ss_pred             hhhhhhhhcCcchhhhhhcc-------cHHHHHHH----HHHHHHHH--HhccchhhhcCCceeEEecCCcEEEEEccch
Confidence            44569999998887765321       22333333    33322233  4677777774 55555555668999999999


Q ss_pred             eeeccc
Q 017177          249 VYFKRH  254 (376)
Q Consensus       249 ~~~~~~  254 (376)
                      +....+
T Consensus       154 t~k~~p  159 (201)
T COG2112         154 TFKKKP  159 (201)
T ss_pred             hhccCC
Confidence            865444

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.31  E-value=4.6e-06  Score=73.45  Aligned_cols=149  Identities=17%  Similarity=0.118  Sum_probs=97.7

Q ss_pred             hhhhcCCCCccc---eEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh-------------------hHH-
Q 017177           84 LKSATKNFKPDS---LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-------------------GFE-  140 (376)
Q Consensus        84 ~~~~~~~y~~~~---~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------------~~~-  140 (376)
                      +....++..+..   .|..|.-+.||+|...          .+..+|+|+.+.....                   ..+ 
T Consensus        40 l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~----------~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~  109 (268)
T COG1718          40 LRRLLSRGVITELVGCISTGKEANVYLAETG----------DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRK  109 (268)
T ss_pred             HHHHhcCCceeeeEeeecCCcceEEEeeccC----------CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHH
Confidence            334444444444   4566777789998543          3788999998653211                   011 


Q ss_pred             ---H-HHHHHHHHhcCC--CCCcceEEeEEEeCCeEEEEEeccCCC-CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 017177          141 ---E-WQSEVNFLGRLS--HPNLVKLLGYCWEDKELLLVYEYMQRG-SLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG  213 (376)
Q Consensus       141 ---~-~~~E~~il~~l~--h~nIv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~  213 (376)
                         . ..+|...|+++.  +-.+++.+.+.    .-.|||||+... .-.-.|+.     ..+...+...+..++++.+.
T Consensus       110 lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~  180 (268)
T COG1718         110 LVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMR  180 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHH
Confidence               1 136888888875  55566666654    357999999542 11111111     12233356777778888887


Q ss_pred             HhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          214 FLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       214 yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      -|-. ..++||+||..=|||+. +|.+.++|||-|.....
T Consensus       181 ~l~~-~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h  218 (268)
T COG1718         181 RLYK-EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             HHHH-hcCcccccchhhheEEE-CCeEEEEECccccccCC
Confidence            7763 58999999999999999 88999999999987654

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.30  E-value=1.1e-05  Score=69.27  Aligned_cols=125  Identities=25%  Similarity=0.321  Sum_probs=88.1

Q ss_pred             CCCCccceEeecCc-EEEEEEEEcCCCCCcccCCCCcEEEEEEcCC---CCh------------------hhHHHHHHHH
Q 017177           89 KNFKPDSLLGEGGF-GRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP---ESM------------------QGFEEWQSEV  146 (376)
Q Consensus        89 ~~y~~~~~lG~G~f-g~V~~~~~~~~~~~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~  146 (376)
                      .+++.++.||.|.. |.||++...           |+.+|+|++..   ...                  .....|..|.
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-----------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC  105 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-----------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC  105 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-----------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence            67899999999999 999999776           67899999321   100                  1123567788


Q ss_pred             HHHhcCC---CCCc--ceEEeEEEeC------------------CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 017177          147 NFLGRLS---HPNL--VKLLGYCWED------------------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK  203 (376)
Q Consensus       147 ~il~~l~---h~nI--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~  203 (376)
                      +...+|+   +.++  ++++|+..-.                  ....||.||.+...             .+.    ..
T Consensus       106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~  168 (207)
T PF13095_consen  106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IR  168 (207)
T ss_pred             HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hh
Confidence            8887775   4455  8999986322                  11356777765532             122    23


Q ss_pred             HHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeee
Q 017177          204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       204 i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a  248 (376)
                      -+.+|.+-|..+|  ..+|+=+|+|+.|..   +|  ||+|||.+
T Consensus       169 ~~~~~~~dl~~~~--k~gI~~~Dv~~~ny~---~G--~lvDfs~~  206 (207)
T PF13095_consen  169 DIPQMLRDLKILH--KLGIVPRDVKPRNYR---GG--KLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHHHHH--HCCeeeccCcccccc---CC--EEEecccC
Confidence            3456677788899  699999999999987   33  89999864

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.25  E-value=2.9e-05  Score=67.18  Aligned_cols=132  Identities=21%  Similarity=0.298  Sum_probs=90.3

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC----------------hhhHHHHHHHHHHHhcCC----
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES----------------MQGFEEWQSEVNFLGRLS----  153 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~il~~l~----  153 (376)
                      ...||+|+.=.||.-  ..          ....+||+.....                ....+...+|+.....+.    
T Consensus         6 ~~~i~~G~~R~cy~H--P~----------dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~   73 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--PD----------DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRG   73 (199)
T ss_pred             CcccccCCCceEEEC--CC----------CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccC
Confidence            467999999999863  11          3346888887765                112345566766666555    


Q ss_pred             --CCCcceEEeEEEeCCeEEEEEeccCC------CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEec
Q 017177          154 --HPNLVKLLGYCWEDKELLLVYEYMQR------GSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYR  225 (376)
Q Consensus       154 --h~nIv~l~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHr  225 (376)
                        +.+|.+++|+.+++....+|+|.+..      .+|.+++.+.     .++. .....+.++   ..||-  +.+|+.+
T Consensus        74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~~~~~L~~f---~~~l~--~~~Iv~~  142 (199)
T PF10707_consen   74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-ELRQALDEF---KRYLL--DHHIVIR  142 (199)
T ss_pred             CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-HHHHHHHHH---HHHHH--HcCCeec
Confidence              88999999999999999999998742      3788888543     2444 444444444   34555  5889999


Q ss_pred             CCCCCCEEEcCC--C--cEEEcc-eeee
Q 017177          226 DFKASNILLDGV--G--FLFDSH-LLIY  248 (376)
Q Consensus       226 DlKp~NILl~~~--g--~~kl~D-fg~a  248 (376)
                      |++|.||++...  |  .+.++| ||..
T Consensus       143 dl~~~NIv~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  143 DLNPHNIVVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             CCCcccEEEEecCCCceEEEEEeCCCCc
Confidence            999999999533  2  466666 4443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.25  E-value=7.4e-06  Score=73.28  Aligned_cols=73  Identities=15%  Similarity=0.177  Sum_probs=46.4

Q ss_pred             ceEeecCcE-EEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCC---CcceEEeEEEeC---
Q 017177           95 SLLGEGGFG-RVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP---NLVKLLGYCWED---  167 (376)
Q Consensus        95 ~~lG~G~fg-~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~---nIv~l~~~~~~~---  167 (376)
                      +.|+.|+.. .||+.              +..+++|..+...  ....+.+|.+++..+...   .+.++++.....   
T Consensus         3 ~~~~~gG~~n~vy~~--------------~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~   66 (235)
T cd05155           3 EPVDSGGTDNATFRL--------------GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGY   66 (235)
T ss_pred             eeccCCCcccceEEc--------------CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCC
Confidence            567766666 48875              3347788765432  234678899999888632   345555443322   


Q ss_pred             CeEEEEEeccCCCCHH
Q 017177          168 KELLLVYEYMQRGSLE  183 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~  183 (376)
                      +..+++|++++|.++.
T Consensus        67 ~~~~~l~~~i~G~~l~   82 (235)
T cd05155          67 PWPWSVYRWLEGETAT   82 (235)
T ss_pred             CcceEEEEeecCCCCC
Confidence            2458999999986653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=98.25  E-value=1.3e-05  Score=84.68  Aligned_cols=81  Identities=19%  Similarity=0.244  Sum_probs=56.4

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCC-CCCc--ceEEeEEEeC--
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLS-HPNL--VKLLGYCWED--  167 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~nI--v~l~~~~~~~--  167 (376)
                      .+.++.|.++.+|+.......       ....+++|+..... ......+.+|+++|+.+. |.+|  ++++.++.+.  
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~-------~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v  115 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGG-------SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV  115 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCC-------cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence            467899999999987554310       11357777765432 122356789999999996 6665  7778777654  


Q ss_pred             -CeEEEEEeccCCCC
Q 017177          168 -KELLLVYEYMQRGS  181 (376)
Q Consensus       168 -~~~~lv~e~~~~g~  181 (376)
                       +..|+||||++|..
T Consensus       116 ~G~~flVME~v~G~~  130 (822)
T PLN02876        116 IGTAFYIMEYLEGRI  130 (822)
T ss_pred             CCCceEEEEecCCcc
Confidence             46899999998864

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.05  E-value=1.9e-05  Score=67.97  Aligned_cols=103  Identities=26%  Similarity=0.221  Sum_probs=79.4

Q ss_pred             HHHHHHHhcCCC-CCcceEEeEEEeCCeEEEEEeccCCCCHHHH---HhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 017177          143 QSEVNFLGRLSH-PNLVKLLGYCWEDKELLLVYEYMQRGSLENH---LFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS  218 (376)
Q Consensus       143 ~~E~~il~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~  218 (376)
                      ..|.-+++.+.+ +++++++|+|   + -++|.||...+++...   +.+.    ...+|..+.+|+.++++.+.+++..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C---G-~~~v~E~~~~~~~~~~~~~l~~~----~~~~w~~R~~iA~~lL~~l~~l~~~   78 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC---G-RFYVVEYVGAGSLYGIYRPLSQF----LQSPWEQRAKIALQLLELLEELDHG   78 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC---C-CEEEEEeecCccccccccccccc----cccCHHHHHHHHHHHHHHHHHHhcC
Confidence            358888999985 6999999998   2 3568899987665421   1111    2368999999999999999999842


Q ss_pred             C-CCcEecCCCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          219 E-KKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       219 ~-~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      . ..+.-.|++|+|+-++++|.+|+.|...+.....
T Consensus        79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~~  114 (188)
T PF12260_consen   79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVEDK  114 (188)
T ss_pred             CCCcEEEeecchHHeEEeCCCcEEEEechhcchhHH
Confidence            2 3456699999999999999999999987775543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.95  E-value=1e-06  Score=86.32  Aligned_cols=184  Identities=17%  Similarity=0.039  Sum_probs=124.1

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCC-cceEEeE
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN-LVKLLGY  163 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n-Iv~l~~~  163 (376)
                      ++....+.....+++|+++++++.         +...+...+ .+.+...     ....-++++|.+++||| .+..++-
T Consensus       238 kDk~kws~~fh~fvK~altknpKk---------RptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d  302 (829)
T KOG0576|consen  238 KDKTKWSEFFHNFVKGALTKNPKK---------RPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLED  302 (829)
T ss_pred             cCCccchHHHHHHHHHHhcCCCcc---------CCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCccccccc
Confidence            334445566667889999999987         333333333 4444433     23345888999999999 7777777


Q ss_pred             EEeCCeEEEEEeccCCC-CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          164 CWEDKELLLVYEYMQRG-SLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                      +..++..+++|+++.++ +-....   ......+.+.+...+.+.-.++|+++|+  ..-+|||    ||+..+ +..+.
T Consensus       303 ~~~E~~~~i~~~i~s~~rs~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~--~~~~~~d----~~l~s~-~~~~~  372 (829)
T KOG0576|consen  303 YDGEDYLWIPMRICSTGRSSALEM---TVSEIALEQYQFAYPLRKETRPLAELHS--SYKVHRD----NILGSE-EEVKL  372 (829)
T ss_pred             CCcccccchhhhhhcCCccccccC---ChhhHhhhhhhhhhhhhhhccccccccc--ccccCcc----cccccc-ccccc
Confidence            77778899999999876 221111   1111234445556677777889999995  4468999    887765 67799


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhh
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCV  317 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~  317 (376)
                      .||+....+.....    ..+.    .+|++.+               +||+..... +...-|+|+.+.-..++
T Consensus       373 ~~~~v~~~L~~~~~----~~t~----~~~~~~~---------------~pev~~~~~-~~~~p~~~~~~~~~~~~  423 (829)
T KOG0576|consen  373 LDFAVPPQLTRTMK----PRTA----IGTPEPL---------------APEVIQENT-IDGCPDSGSLAVSAIQM  423 (829)
T ss_pred             ccccCCcccCcccc----cccC----CCCCCCC---------------Cchhhcccc-cccCCCccCCCcchhhc
Confidence            99999988776542    2222    8889988               899555443 46777899998743333

>PRK10593 hypothetical protein; Provisional

Probab=97.94  E-value=0.00014  Score=67.41  Aligned_cols=78  Identities=14%  Similarity=0.035  Sum_probs=55.5

Q ss_pred             CccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-C--CCcceEEeEEEe--
Q 017177           92 KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-H--PNLVKLLGYCWE--  166 (376)
Q Consensus        92 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h--~nIv~l~~~~~~--  166 (376)
                      .-.+.||.|..+.||.....+          + .+.+|..+...  ....+.+|...|+.|. +  ..++++++++..  
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~----------~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~   83 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQ----------G-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ   83 (297)
T ss_pred             heeeecCCccceeEEEEEcCC----------C-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC
Confidence            345689999999999874332          3 46667744311  2257788999999886 2  468888887754  


Q ss_pred             -CCeEEEEEeccCCCCH
Q 017177          167 -DKELLLVYEYMQRGSL  182 (376)
Q Consensus       167 -~~~~~lv~e~~~~g~L  182 (376)
                       .+..++|||+++|+++
T Consensus        84 ~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         84 SPGPDVLLLERLRGVSV  100 (297)
T ss_pred             cCCCeEEEEeccCCEec
Confidence             3668999999998754

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.78  E-value=0.00035  Score=62.25  Aligned_cols=75  Identities=17%  Similarity=0.124  Sum_probs=47.0

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEEeEEEeCCeEEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lv  173 (376)
                      +.|..|-...+|++...+.        .+..|++|+........ -...+|+.+++.+. +.-.++++..+.  +  .++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~--------~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l   70 (235)
T cd05157           4 KRFTGGITNKLVKVSNKED--------NQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ--N--GLI   70 (235)
T ss_pred             EEcCCcccceEEEEEcCCC--------CCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEE
Confidence            5677788889998843310        14578899776543221 22347888999885 333455554332  2  479


Q ss_pred             EeccCCCCH
Q 017177          174 YEYMQRGSL  182 (376)
Q Consensus       174 ~e~~~~g~L  182 (376)
                      |||++|.++
T Consensus        71 ~e~i~G~~l   79 (235)
T cd05157          71 YEFIPGRTL   79 (235)
T ss_pred             EEeeCCCcC
Confidence            999998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.77  E-value=0.00013  Score=66.10  Aligned_cols=138  Identities=17%  Similarity=0.058  Sum_probs=76.6

Q ss_pred             EeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCc-ceEEeEEEeCCeEEEEEe
Q 017177           97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNL-VKLLGYCWEDKELLLVYE  175 (376)
Q Consensus        97 lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nI-v~l~~~~~~~~~~~lv~e  175 (376)
                      +..|-.+.+|+...           .+..+++|..........-...+|..+++.+....+ .+++...  .  -++|||
T Consensus         4 ~~~G~tn~~y~~~~-----------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e   68 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-----------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVE   68 (256)
T ss_pred             CCCcCcCCeEEEEe-----------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEE
Confidence            45677788898742           255688887654322210134679999998863333 4444433  2  368999


Q ss_pred             ccCCCCHHH--------------HHhhcCC---CCCCCCHH-HHHHHHHHH---------HHHHHHhhc------CCCCc
Q 017177          176 YMQRGSLEN--------------HLFRRNP---SIQPLSWD-IRLKIAIGA---------ARGLGFLHT------SEKKV  222 (376)
Q Consensus       176 ~~~~g~L~~--------------~l~~~~~---~~~~~~~~-~~~~i~~qi---------~~~L~yLHs------~~~~i  222 (376)
                      |++|..+..              .+.+-+.   ...+++.. .+..+..++         ...+..+-.      ....+
T Consensus        69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  148 (256)
T TIGR02721        69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP  148 (256)
T ss_pred             eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence            999865432              1111111   11112211 111111111         111111111      02368


Q ss_pred             EecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          223 IYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       223 iHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      +|+|+.|.||++++++ +.++||..+..
T Consensus       149 ~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       149 LHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             ecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            9999999999999887 78999998874

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.76  E-value=0.00041  Score=66.53  Aligned_cols=75  Identities=19%  Similarity=0.231  Sum_probs=53.6

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCC-cEEEEEEcCCC------C-hhhHHHHHHHHHHHhcCC---CCCcceEEeE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLG-MVVAIKKLNPE------S-MQGFEEWQSEVNFLGRLS---HPNLVKLLGY  163 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~E~~il~~l~---h~nIv~l~~~  163 (376)
                      +.||.|.+..||++...+          + +.++||.-...      . ....++...|.+.|+.+.   ..++++++.+
T Consensus        32 ~elggGn~N~VyrV~~~~----------g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~  101 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTE----------GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY  101 (401)
T ss_pred             eEcCCCceEEEEEEEeCC----------CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE
Confidence            679999999999986543          3 47999985421      1 123467778888888864   3567778766


Q ss_pred             EEeCCeEEEEEeccCCCC
Q 017177          164 CWEDKELLLVYEYMQRGS  181 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~  181 (376)
                        +++..++|||++++..
T Consensus       102 --D~~~~~lVME~L~~~~  117 (401)
T PRK09550        102 --DEELAVTVMEDLSDHK  117 (401)
T ss_pred             --CCCCCEEEEecCCCcc
Confidence              4466889999998643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=97.73  E-value=2.8e-05  Score=77.20  Aligned_cols=136  Identities=15%  Similarity=0.082  Sum_probs=87.6

Q ss_pred             HHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHH-
Q 017177          207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAI-  285 (376)
Q Consensus       207 qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d-  285 (376)
                      +++.||.|+|. ..++||+.|.|++|.++..|..||+.|+.+........+                 -    ++++.. 
T Consensus       107 ~v~dgl~flh~-sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~-----------------p----~~~yd~~  164 (700)
T KOG2137|consen  107 NVADGLAFLHR-SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEY-----------------P----FSEYDPP  164 (700)
T ss_pred             cccchhhhhcc-CcceeecccchhheeeccCcceeeccchhhhccCCCCcc-----------------c----cccCCCC
Confidence            44599999997 789999999999999999999999999998866543221                 0    111111 


Q ss_pred             ---HH----HHHHHHHHhhhhhccccccccceeeeehhhc-cccccc--hhhHHHHHHHhhCCCccCcccCCChhHHHHH
Q 017177          286 ---LY----SVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF-SFYRTT--MLKYQILAWQSWGPLVESHMLQPGLWAHMVM  355 (376)
Q Consensus       286 ---~~----s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~-~~y~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  355 (376)
                         .-    .++|||.+.+ .-.+.++|++|+|+..+.+. .--.+.  .+............+....-....+..+...
T Consensus       165 lp~~~~~~~~f~apE~~~~-~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~  243 (700)
T KOG2137|consen  165 LPLLLQPHLNFLAPEYLLG-TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRE  243 (700)
T ss_pred             CChhhccCcccccchhhcc-ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHH
Confidence               11    1778997776 56789999999999988665 111111  1122233333333333333444555566666


Q ss_pred             HHHHHhhhee
Q 017177          356 QLQNMLQQVI  365 (376)
Q Consensus       356 ~~~~~~~~~~  365 (376)
                      -+++++.-..
T Consensus       244 ~l~k~l~~~~  253 (700)
T KOG2137|consen  244 SLKKLLNGDS  253 (700)
T ss_pred             HHHHHhcCCc
Confidence            6666655443

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.72  E-value=0.0003  Score=65.09  Aligned_cols=143  Identities=15%  Similarity=0.061  Sum_probs=82.7

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCC--CcceEEeE------EE
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP--NLVKLLGY------CW  165 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~--nIv~l~~~------~~  165 (376)
                      .+.|..|....+|+....           +..+++|+....   ....+..|+.++..+.+.  .+++++..      ..
T Consensus        19 i~~i~~G~~n~~y~v~~~-----------~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~   84 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-----------SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE   84 (296)
T ss_pred             eecccCccccceEEEEeC-----------CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence            456777877889987433           335888987652   234566788888887532  24454432      23


Q ss_pred             eCCeEEEEEeccCCCCHHH-----------HHhhcC----C--CC----CCCCHHHH----------HHHHHHHHHHHHH
Q 017177          166 EDKELLLVYEYMQRGSLEN-----------HLFRRN----P--SI----QPLSWDIR----------LKIAIGAARGLGF  214 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~-----------~l~~~~----~--~~----~~~~~~~~----------~~i~~qi~~~L~y  214 (376)
                      .++..+++++|++|..+..           .+.+-+    .  ..    ....+...          ......+..++.+
T Consensus        85 ~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  164 (296)
T cd05153          85 LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELAR  164 (296)
T ss_pred             eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHH
Confidence            3456789999998866421           111100    0  00    00011000          0011112233333


Q ss_pred             hhc-----CCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          215 LHT-----SEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       215 LHs-----~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      +..     ...+++|+|+.|.|||+++++.+.++||..+..
T Consensus       165 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         165 QDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             HHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            331     135799999999999999887788999988874

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.68  E-value=0.00033  Score=65.32  Aligned_cols=144  Identities=17%  Similarity=0.086  Sum_probs=80.9

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCC--CCcceEEeE------EE
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH--PNLVKLLGY------CW  165 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h--~nIv~l~~~------~~  165 (376)
                      .+.++.|....+|++...           +..+++|+......  ...+..|.+++..|..  -.+++++..      ..
T Consensus        27 i~~~~~G~~n~~y~v~t~-----------~~~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~   93 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD-----------VGRYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLST   93 (307)
T ss_pred             ccccCCccccceEEEEeC-----------CCcEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehh
Confidence            456777777889987432           23577888755321  2344567777777742  224444432      12


Q ss_pred             eCCeEEEEEeccCCCCHH-----------HHHhhcC---CC---C--C--CCC-HHHHH------------HHHHHHHHH
Q 017177          166 EDKELLLVYEYMQRGSLE-----------NHLFRRN---PS---I--Q--PLS-WDIRL------------KIAIGAARG  211 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~-----------~~l~~~~---~~---~--~--~~~-~~~~~------------~i~~qi~~~  211 (376)
                      ..+..++++||++|..+.           ..+.+-+   ..   .  .  ..+ |....            .....+...
T Consensus        94 ~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~  173 (307)
T TIGR00938        94 LAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKE  173 (307)
T ss_pred             cCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHH
Confidence            245688999999885431           1111100   00   0  0  000 00000            001112334


Q ss_pred             HHHhhc-----CCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          212 LGFLHT-----SEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       212 L~yLHs-----~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      ++++..     ...+++|+|+.+.||+++.++.+.++||+.+..
T Consensus       174 ~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       174 LDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            444431     147899999999999999988778999998864

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=97.67  E-value=2.2e-05  Score=81.13  Aligned_cols=81  Identities=6%  Similarity=-0.141  Sum_probs=59.3

Q ss_pred             EecCCCCC-CEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhc
Q 017177          223 IYRDFKAS-NILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYL  301 (376)
Q Consensus       223 iHrDlKp~-NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~  301 (376)
                      .|++.+|. |++++..+.+++.|||.++........ ...++.    +||+.||               +||++.+.. +
T Consensus       499 ~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~-~~~~~~----vGT~~Y~---------------APE~l~~~~-~  557 (669)
T cd05610         499 PTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAP-VEGERI----LGTPDYL---------------APELLLGKP-H  557 (669)
T ss_pred             CCCCCCCCCceeECCccccccccCCCchhhhccccc-ccCCce----eeCcccc---------------CHHHcCCCC-C
Confidence            45666666 666777778899999998876543321 122222    7889998               899888766 5


Q ss_pred             cccccccceeeeehhhccccccc
Q 017177          302 TLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       302 ~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      +.++||||+|++++|+++-..+.
T Consensus       558 ~~~~DiwSlG~il~ElltG~~pf  580 (669)
T cd05610         558 GPAVDWWALGVCLFEFLTGIPPF  580 (669)
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCC
Confidence            78999999999999998755544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PRK05231 homoserine kinase; Provisional

Probab=97.63  E-value=0.0013  Score=61.63  Aligned_cols=32  Identities=19%  Similarity=0.163  Sum_probs=27.6

Q ss_pred             CCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          219 EKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       219 ~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      ..++||+|+.|.|||++.+...-++||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            36899999999999999776668999998874

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.59  E-value=0.00053  Score=63.68  Aligned_cols=149  Identities=20%  Similarity=0.174  Sum_probs=84.1

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCC-cceEEeEEEeCCeEEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN-LVKLLGYCWEDKELLLV  173 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n-Iv~l~~~~~~~~~~~lv  173 (376)
                      +.|..|-...+|++......   ..+..+..+++|+...... ......+|.+++..+...+ ..+++..+. +   .+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~---~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v   75 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDED---ALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRI   75 (302)
T ss_pred             EEecCcccceeEEEEcCCcc---cccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence            45566777789988644311   1223467899999765432 2234567888888886322 345555543 2   368


Q ss_pred             EeccCCCCHHHH--------------HhhcCCCCC--------CCC--HHHHHH--------------------------
Q 017177          174 YEYMQRGSLENH--------------LFRRNPSIQ--------PLS--WDIRLK--------------------------  203 (376)
Q Consensus       174 ~e~~~~g~L~~~--------------l~~~~~~~~--------~~~--~~~~~~--------------------------  203 (376)
                      +||++|..+...              +.+-+....        ..+  +.....                          
T Consensus        76 ~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (302)
T cd05156          76 EEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSL  155 (302)
T ss_pred             hheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHH
Confidence            999988765431              111010000        011  001100                          


Q ss_pred             HHHHHHHHHHHhhc-------CCCCcEecCCCCCCEEEcCC----CcEEEcceeeeeee
Q 017177          204 IAIGAARGLGFLHT-------SEKKVIYRDFKASNILLDGV----GFLFDSHLLIYVYF  251 (376)
Q Consensus       204 i~~qi~~~L~yLHs-------~~~~iiHrDlKp~NILl~~~----g~~kl~Dfg~a~~~  251 (376)
                      +...+..-+.++-.       ....++|+|+.|.|||++.+    +.+.++||..+...
T Consensus       156 ~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~  214 (302)
T cd05156         156 FLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN  214 (302)
T ss_pred             HHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence            11112222333321       24678999999999999975    88999999988753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PLN02236 choline kinase

Probab=97.42  E-value=0.0017  Score=61.60  Aligned_cols=147  Identities=18%  Similarity=0.138  Sum_probs=82.9

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCc-ceEEeEEEeCCeEEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNL-VKLLGYCWEDKELLLV  173 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nI-v~l~~~~~~~~~~~lv  173 (376)
                      +.|-.|-...+|++.....     ....+..|++|+..........+ .+|..+++.+...++ .++++.+.. +   .|
T Consensus        42 ~~l~gGlTN~~y~v~~~~~-----~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v  111 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTK-----EGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPN-G---RV  111 (344)
T ss_pred             EEcCCcccceeEEEEeCCC-----CCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECC-c---eE
Confidence            4455577788999865321     11124678999887654332233 679999988864333 456665532 2   57


Q ss_pred             EeccCCCCHHHH--------------HhhcCCCC---C--CCCHHHHHHHHHHH-----------------HHHHHH---
Q 017177          174 YEYMQRGSLENH--------------LFRRNPSI---Q--PLSWDIRLKIAIGA-----------------ARGLGF---  214 (376)
Q Consensus       174 ~e~~~~g~L~~~--------------l~~~~~~~---~--~~~~~~~~~i~~qi-----------------~~~L~y---  214 (376)
                      .||+++.+|...              +.+-+...   .  ...+..+..+..++                 ...+..   
T Consensus       112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~  191 (344)
T PLN02236        112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK  191 (344)
T ss_pred             EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence            999987665321              11111100   0  11122222222111                 111111   


Q ss_pred             -hhc--CCCCcEecCCCCCCEEEcC-CCcEEEcceeeeeee
Q 017177          215 -LHT--SEKKVIYRDFKASNILLDG-VGFLFDSHLLIYVYF  251 (376)
Q Consensus       215 -LHs--~~~~iiHrDlKp~NILl~~-~g~~kl~Dfg~a~~~  251 (376)
                       +..  ....++|+|+++.|||+++ ++.+.++||..+...
T Consensus       192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~  232 (344)
T PLN02236        192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN  232 (344)
T ss_pred             HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence             111  1457899999999999986 478999999888754

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.23  E-value=0.0026  Score=59.43  Aligned_cols=144  Identities=19%  Similarity=0.165  Sum_probs=95.8

Q ss_pred             CccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC------------------------h-hhHHH-HHHH
Q 017177           92 KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES------------------------M-QGFEE-WQSE  145 (376)
Q Consensus        92 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~------------------------~-~~~~~-~~~E  145 (376)
                      .+..+|..|.-+.||.|.-.+          |..+|||+.+..-                        + ..++- ...|
T Consensus       147 ~inGCiSTGKEANVYHat~~d----------G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE  216 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEED----------GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKE  216 (520)
T ss_pred             ecccccccCccceeEeeecCC----------CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHH
Confidence            344678889999999985543          7779999875320                        0 01111 1368


Q ss_pred             HHHHhcCCCCCcceEEeEEEeCCeEEEEEeccCCCCH-HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEe
Q 017177          146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSL-ENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIY  224 (376)
Q Consensus       146 ~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiH  224 (376)
                      ++-|++++...|.-.--...  ..-.|||+|+..... .-.|+     ...++...+..+-.|++.-+.-|.. .+++||
T Consensus       217 ~RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~-~c~LVH  288 (520)
T KOG2270|consen  217 MRNLKRLNNAGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQ-KCRLVH  288 (520)
T ss_pred             HHHHHHHHhcCCCCCCceee--ecceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHH-Hhceec
Confidence            88888887666544332222  235789999953222 11221     1346666777777777777777764 789999


Q ss_pred             cCCCCCCEEEcCCCcEEEcceeeeeeeccc
Q 017177          225 RDFKASNILLDGVGFLFDSHLLIYVYFKRH  254 (376)
Q Consensus       225 rDlKp~NILl~~~g~~kl~Dfg~a~~~~~~  254 (376)
                      .||.-=|+|+. +|.+.++|.+-+.-...+
T Consensus       289 ADLSEfN~Lyh-dG~lyiIDVSQSVE~DHP  317 (520)
T KOG2270|consen  289 ADLSEFNLLYH-DGKLYIIDVSQSVEHDHP  317 (520)
T ss_pred             cchhhhhheEE-CCEEEEEEccccccCCCh
Confidence            99999999997 578899999887755443

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.19  E-value=0.00051  Score=63.01  Aligned_cols=135  Identities=15%  Similarity=0.064  Sum_probs=89.4

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--------h--------------hHHHHHHHHHH
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--------Q--------------GFEEWQSEVNF  148 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~--------------~~~~~~~E~~i  148 (376)
                      +.+++.||-|.-+.||.+-..+          |.+.++|.-+....        .              .+-...+|...
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~----------G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfaf  163 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEE----------GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAF  163 (465)
T ss_pred             hhhccccccccccceEEEecCC----------CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHH
Confidence            5678899999999999986554          67778876432110        0              01134578888


Q ss_pred             HhcCC-CC-CcceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecC
Q 017177          149 LGRLS-HP-NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRD  226 (376)
Q Consensus       149 l~~l~-h~-nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrD  226 (376)
                      |+.|. |. -+++.++    .+..++|||++.|-.|.+.-+-       .+...+..-+..++   --|-  .+|+||+|
T Consensus       164 mkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly~~lm~~I---v~la--~~GlIHgD  227 (465)
T KOG2268|consen  164 MKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRHV-------EDPPTLYDDLMGLI---VRLA--NHGLIHGD  227 (465)
T ss_pred             HHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeeec-------CChHHHHHHHHHHH---HHHH--HcCceecc
Confidence            88886 32 2444444    3567899999999887664422       22233332222222   2233  58999999


Q ss_pred             CCCCCEEEcCCCcEEEcceeeeeee
Q 017177          227 FKASNILLDGVGFLFDSHLLIYVYF  251 (376)
Q Consensus       227 lKp~NILl~~~g~~kl~Dfg~a~~~  251 (376)
                      ..-=||++++++.++++||=-....
T Consensus       228 FNEFNimv~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  228 FNEFNIMVKDDDKIVVIDFPQMVST  252 (465)
T ss_pred             cchheeEEecCCCEEEeechHhhcc
Confidence            9999999999999999999554433

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.09  E-value=0.0045  Score=57.48  Aligned_cols=34  Identities=9%  Similarity=0.004  Sum_probs=29.6

Q ss_pred             CCcEecCCCCCCEEEcCCCcEEEcceeeeeeecc
Q 017177          220 KKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKR  253 (376)
Q Consensus       220 ~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~  253 (376)
                      ..++|+|+++.||+++..+-+-+.||+++..-+.
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            4689999999999999988899999999986443

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.04  E-value=0.0084  Score=56.55  Aligned_cols=73  Identities=15%  Similarity=0.225  Sum_probs=48.1

Q ss_pred             eEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCC-------CChhhHHHHHHHHHHHhcCC--CC-CcceEEeEEE
Q 017177           96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP-------ESMQGFEEWQSEVNFLGRLS--HP-NLVKLLGYCW  165 (376)
Q Consensus        96 ~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~E~~il~~l~--h~-nIv~l~~~~~  165 (376)
                      .||.|....||++...+         .+..|+||.-..       ...-..++..-|...|+...  -| .++++|.  .
T Consensus         2 EigdGnlN~VfrV~~~~---------g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~   70 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQE---------GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--F   70 (370)
T ss_pred             cCCCCceEEEEEEEcCC---------CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--E
Confidence            57999999999996432         135789987432       11233456667888887764  33 4666654  3


Q ss_pred             eCCeEEEEEeccCC
Q 017177          166 EDKELLLVYEYMQR  179 (376)
Q Consensus       166 ~~~~~~lv~e~~~~  179 (376)
                      +++...+|||+++.
T Consensus        71 D~e~~~~vMEdL~~   84 (370)
T TIGR01767        71 DTEMAVTVMEDLSH   84 (370)
T ss_pred             ccccceehHhhCcc
Confidence            55667799999854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.01  E-value=0.0064  Score=55.71  Aligned_cols=31  Identities=13%  Similarity=-0.032  Sum_probs=26.3

Q ss_pred             CCcEecCCCCCCEEEcCCCc-EEEcceeeeee
Q 017177          220 KKVIYRDFKASNILLDGVGF-LFDSHLLIYVY  250 (376)
Q Consensus       220 ~~iiHrDlKp~NILl~~~g~-~kl~Dfg~a~~  250 (376)
                      ..++|+|+.|.|||+++++. .-+.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997565 56999999875

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=96.91  E-value=0.0068  Score=57.52  Aligned_cols=159  Identities=16%  Similarity=0.124  Sum_probs=97.0

Q ss_pred             CccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcC-CCCCcceEEeEE------
Q 017177           92 KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGYC------  164 (376)
Q Consensus        92 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~------  164 (376)
                      .+.+.||+|+.+.+|..-.-            ...+.|+...........   -+..|... .||-+-.=+.+=      
T Consensus        14 ~~gr~LgqGgea~ly~l~e~------------~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G   78 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV------------RDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHG   78 (637)
T ss_pred             CCCccccCCccceeeecchh------------hchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhC
Confidence            45688999999999964111            113456666544322222   12233333 366443311110      


Q ss_pred             -EeCCeEEEEEeccCCCC-HHHHHhh--cCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcE
Q 017177          165 -WEDKELLLVYEYMQRGS-LENHLFR--RNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL  240 (376)
Q Consensus       165 -~~~~~~~lv~e~~~~g~-L~~~l~~--~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~  240 (376)
                       .....+.++|..+.+.. ...++.-  ++.....+.|...+++++.++.+.+-||  +.|-+-+|+.++|+|+.+++.|
T Consensus        79 ~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH--~~Gh~vGDVn~~~~lVsd~~~V  156 (637)
T COG4248          79 GRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH--EHGHVVGDVNQNSFLVSDDSKV  156 (637)
T ss_pred             CCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH--hcCCcccccCccceeeecCceE
Confidence             11223778888887642 3333321  1222355789999999999999999999  6888899999999999999999


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehh
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYM  275 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~  275 (376)
                      .|.|-.......+....        --.+|.++|.
T Consensus       157 ~LVdsDsfqi~~ng~~~--------~cpVg~~eft  183 (637)
T COG4248         157 VLVDSDSFQINANGTLH--------LCPVGVSEFT  183 (637)
T ss_pred             EEEcccceeeccCCceE--------ecccCccccC
Confidence            99875444333222111        1227777777

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.83  E-value=0.0028  Score=59.08  Aligned_cols=76  Identities=14%  Similarity=0.073  Sum_probs=57.1

Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      .+.|++|++- |+++.. +       ..-.+.++..++.+.+..+.-+.. +...-|||+.-.||||+ +|.+.|+||-+
T Consensus       299 ~y~yl~~kdh-gt~is~-i-------k~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfkl  367 (488)
T COG5072         299 LYLYLHFKDH-GTPISI-I-------KADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKL  367 (488)
T ss_pred             eEEEEEEecC-Cceeee-e-------ecccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeee
Confidence            4577888865 555532 2       123567788888887776666654 67889999999999999 99999999999


Q ss_pred             eeeeccc
Q 017177          248 YVYFKRH  254 (376)
Q Consensus       248 a~~~~~~  254 (376)
                      ++.-..+
T Consensus       368 sRl~~~q  374 (488)
T COG5072         368 SRLSYSQ  374 (488)
T ss_pred             eecccCC
Confidence            9954443

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=96.79  E-value=0.00013  Score=69.59  Aligned_cols=57  Identities=12%  Similarity=-0.097  Sum_probs=44.0

Q ss_pred             CCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehh
Q 017177          237 VGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSC  316 (376)
Q Consensus       237 ~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~  316 (376)
                      +-.+||+|||.|.......+.  ...|..|.+                       ||++.|.+| ...+|+||++|+.+|
T Consensus       390 di~vKIaDlGNACW~~khFT~--DIQTRQYRa-----------------------pEVllGsgY-~~~ADiWS~AC~~FE  443 (590)
T KOG1290|consen  390 DIRVKIADLGNACWVHKHFTE--DIQTRQYRA-----------------------PEVLLGSGY-STSADIWSTACMAFE  443 (590)
T ss_pred             ceeEEEeeccchhhhhhhhch--hhhhhhccC-----------------------cceeecCCC-CCchhHHHHHHHHHH
Confidence            446999999999987665444  233444544                       999999886 677799999999999


Q ss_pred             hcc
Q 017177          317 VFS  319 (376)
Q Consensus       317 ~~~  319 (376)
                      ++|
T Consensus       444 LaT  446 (590)
T KOG1290|consen  444 LAT  446 (590)
T ss_pred             hhc
Confidence            994

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.77  E-value=0.026  Score=52.48  Aligned_cols=31  Identities=16%  Similarity=0.172  Sum_probs=26.6

Q ss_pred             CCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          219 EKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       219 ~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      ..+++|+|+.+.||+++. +.+.++||+.+..
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            368899999999999987 6788999987763

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.64  E-value=0.022  Score=53.69  Aligned_cols=147  Identities=18%  Similarity=0.212  Sum_probs=80.4

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCc-ceEEeEEEeCCeEEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNL-VKLLGYCWEDKELLLV  173 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nI-v~l~~~~~~~~~~~lv  173 (376)
                      +.|..|-...+|++...+..      ..+..|++|+........+ .-.+|..+++.+..-++ +++++++. .+   +|
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~------~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i   88 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEEN------GNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFG-NG---MI   88 (330)
T ss_pred             EEeCCcccceEEEEEecCCC------CCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeC-Cc---Ee
Confidence            44545777788988654311      1134788998766543222 22578889988874444 45665552 22   58


Q ss_pred             EeccCCCCHHH--------------HHhhcCCCC----CCC-CHHHHHHHHHHH-------------------------H
Q 017177          174 YEYMQRGSLEN--------------HLFRRNPSI----QPL-SWDIRLKIAIGA-------------------------A  209 (376)
Q Consensus       174 ~e~~~~g~L~~--------------~l~~~~~~~----~~~-~~~~~~~i~~qi-------------------------~  209 (376)
                      .+|+++.+|..              .+++-+...    ... .+..+..+..++                         +
T Consensus        89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  168 (330)
T PLN02421         89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI  168 (330)
T ss_pred             ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence            89987765421              111111100    001 122222222111                         1


Q ss_pred             HHHH-Hhhc--CCCCcEecCCCCCCEEEcC-CCcEEEcceeeeeeec
Q 017177          210 RGLG-FLHT--SEKKVIYRDFKASNILLDG-VGFLFDSHLLIYVYFK  252 (376)
Q Consensus       210 ~~L~-yLHs--~~~~iiHrDlKp~NILl~~-~g~~kl~Dfg~a~~~~  252 (376)
                      ..+. ++.+  ...-++|.|+-+.|||+++ ++.++++||..|....
T Consensus       169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd  215 (330)
T PLN02421        169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSY  215 (330)
T ss_pred             HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCCc
Confidence            1111 1211  1234789999999999975 5789999999888643

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.57  E-value=0.0058  Score=57.90  Aligned_cols=60  Identities=18%  Similarity=0.160  Sum_probs=42.0

Q ss_pred             EEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc
Q 017177          170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD  235 (376)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~  235 (376)
                      ..|+-+|..|-.+..+++...     .++.....++.--.+|+.-+-- -.+++|.|+.|.||++-
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~-----~pe~l~kkva~lg~~AllkMl~-vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS-----QPEALVKKVAKLGVNALLKMLI-VDNFVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhhccc-----ChHHHHHHHHHHHHHHHHHHHH-hhcceecccCCCcEEEE
Confidence            556677888888988886542     4555566666555555443332 36899999999999994

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.51  E-value=0.008  Score=52.40  Aligned_cols=88  Identities=13%  Similarity=0.185  Sum_probs=60.8

Q ss_pred             HHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 017177          140 EEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSE  219 (376)
Q Consensus       140 ~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~  219 (376)
                      .-+..+.+++.++.  .|+++..-  ....+.++.|.|-....             ..    ..++..=+.+|.-.|++.
T Consensus       103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------------~~----~N~i~agi~~L~~fH~~~  161 (308)
T PF07387_consen  103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------------NF----SNFITAGIKDLMDFHSEN  161 (308)
T ss_pred             hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------------ch----hHHHHHhHHHHHHhhccC
Confidence            45567888888774  56776632  23347799999843110             11    112222246678889778


Q ss_pred             CCcEecCCCCCCEEEcCCCcEEEcceeee
Q 017177          220 KKVIYRDFKASNILLDGVGFLFDSHLLIY  248 (376)
Q Consensus       220 ~~iiHrDlKp~NILl~~~g~~kl~Dfg~a  248 (376)
                      .+.+|+|..|+||+-|..|.+||.|=+..
T Consensus       162 ~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  162 QHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             CCeecCCCChhheeecCCCCEEecChhhh
Confidence            89999999999999999999999996654

The function of this family is unknown.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.48  E-value=0.043  Score=52.76  Aligned_cols=73  Identities=16%  Similarity=0.104  Sum_probs=49.5

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-------hhhHHHHHHHHHHHhcCC---CCCcceEEeE
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-------MQGFEEWQSEVNFLGRLS---HPNLVKLLGY  163 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~il~~l~---h~nIv~l~~~  163 (376)
                      .+.||.|....||+....           +..++||.-....       .....+-..|...|+.+.   ..++++++.+
T Consensus        37 ~~eiggGn~N~VyrV~~~-----------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~  105 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-----------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHF  105 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-----------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence            467899999999997542           3458888765211       113344455677777664   3578888877


Q ss_pred             EEeCCeEEEEEeccCC
Q 017177          164 CWEDKELLLVYEYMQR  179 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~  179 (376)
                      +.  +..+++||++++
T Consensus       106 de--d~~vlvME~L~~  119 (418)
T PLN02756        106 DR--TMALIGMRYLEP  119 (418)
T ss_pred             CC--CCCEEEEeecCC
Confidence            65  456788999976

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.14  E-value=0.0019  Score=69.90  Aligned_cols=156  Identities=12%  Similarity=-0.110  Sum_probs=107.2

Q ss_pred             HHHHHHHHHHhcCCCCCcceEEeEEEe--CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 017177          140 EEWQSEVNFLGRLSHPNLVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHT  217 (376)
Q Consensus       140 ~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs  217 (376)
                      +....|...++...|+++...+.-...  ....|.+++|+.+|.+.+.+-+.......+....+.....+...+..-+|+
T Consensus      1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            444556666677789988876654433  345799999999999999998765555566666666666665666667665


Q ss_pred             C---CCCcEecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHH
Q 017177          218 S---EKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRI  294 (376)
Q Consensus       218 ~---~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi  294 (376)
                      .   ..-.+|+++|+-|.+|..+-.++++++|+.+..... ..  ..|..    .++|.|+               +|++
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~s--f~Gl~----l~sp~~v---------------~qli 1411 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LS--FFGLE----LCSPIYV---------------LQLI 1411 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCch-Hh--hhhhh----hCCHHHH---------------HHHH
Confidence            2   234689999999999999999999999999932221 11  22333    6777777               6775


Q ss_pred             Hhhhhhccccccccceeeeehhhc
Q 017177          295 YAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       295 ~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      ....+ .+.+.|+|..++-.++..
T Consensus      1412 ~N~ik-~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1412 KNEIK-FTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             HHHHh-hhhHHHHHHHHHHHHHHh
Confidence            55444 355588887555555444

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.14  E-value=0.06  Score=47.35  Aligned_cols=58  Identities=19%  Similarity=0.217  Sum_probs=41.5

Q ss_pred             CcEEEEEEcCCCChhhHHHHHHHHHHHhcCC---CCCcceEEeEEEeCCeEEEEEeccCCCCHH
Q 017177          123 GMVVAIKKLNPESMQGFEEWQSEVNFLGRLS---HPNLVKLLGYCWEDKELLLVYEYMQRGSLE  183 (376)
Q Consensus       123 ~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~  183 (376)
                      ..++-+|+-..   .....|..|+.-|..+.   --.+.+++.+....++.|+||||++-|.+.
T Consensus        39 ~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          39 TDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             CcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            34577776433   33456777877666664   466888888888899999999999875543

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.03  E-value=0.013  Score=53.86  Aligned_cols=75  Identities=17%  Similarity=0.231  Sum_probs=46.9

Q ss_pred             CccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC---CCCcceEEeEEEeCC
Q 017177           92 KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS---HPNLVKLLGYCWEDK  168 (376)
Q Consensus        92 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~l~~~~~~~~  168 (376)
                      +-.+.|+-|....+|+...           .+..+-||+-..   .....|..|.+-|+.|.   --.+++++++...++
T Consensus        20 ~~~~~v~GG~i~~a~~~~~-----------~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~   85 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLDT-----------DGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD   85 (288)
T ss_dssp             -EEEEE--SSSSEEEEEET-----------TS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS
T ss_pred             eeeEecCCCChhheEEEEC-----------CCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC
Confidence            3446788899999998741           367788998762   22246777888888873   456788999888777


Q ss_pred             eEEEEEeccCCC
Q 017177          169 ELLLVYEYMQRG  180 (376)
Q Consensus       169 ~~~lv~e~~~~g  180 (376)
                      ..|+||||++.+
T Consensus        86 ~~fLlle~l~~~   97 (288)
T PF03881_consen   86 DAFLLLEFLEMG   97 (288)
T ss_dssp             CCEEEEE-----
T ss_pred             CceEEEEeecCC
Confidence            789999999765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.98  E-value=0.044  Score=52.43  Aligned_cols=75  Identities=17%  Similarity=0.232  Sum_probs=50.5

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCC------CChhhHHHHHHHHHHHhcCC--CC-CcceEEeEE
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP------ESMQGFEEWQSEVNFLGRLS--HP-NLVKLLGYC  164 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~------~~~~~~~~~~~E~~il~~l~--h~-nIv~l~~~~  164 (376)
                      .+.||.|.-..||++....         .+..|+||.-..      ...-..++..-|.++|+...  -| .++++|.  
T Consensus        34 ~~eigdGnlN~VfrV~~~~---------~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--  102 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQ---------KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--  102 (409)
T ss_pred             eeEcCCCceEEEEEEeeCC---------CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--
Confidence            4678999999999996421         135688887432      11234567777888888774  33 5666664  


Q ss_pred             EeCCeEEEEEeccCC
Q 017177          165 WEDKELLLVYEYMQR  179 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~  179 (376)
                      .++....+|||+++.
T Consensus       103 ~D~e~~~~vMEdL~~  117 (409)
T PRK12396        103 FDSVMNCCVMEDLSD  117 (409)
T ss_pred             ECcHHhhHHHHhCcc
Confidence            355667899999854

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.84  E-value=0.12  Score=48.08  Aligned_cols=32  Identities=9%  Similarity=0.029  Sum_probs=28.4

Q ss_pred             CCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          219 EKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       219 ~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      ..+++|+|+.+.|||++.++.+.++||-.+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45899999999999999999999999987774

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PTZ00384 choline kinase; Provisional

Probab=95.60  E-value=0.15  Score=49.05  Aligned_cols=81  Identities=16%  Similarity=0.099  Sum_probs=46.1

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCC-CCcceEEeEEEeCCeEEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH-PNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~l~~~~~~~~~~~lv  173 (376)
                      +.|..|-...+|++...+..   ......+.|.++.......... .-.+|+.+++.+.. .--.++++.+.    -+++
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~---~~~~~~k~Vl~R~~g~~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l  127 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGD---KDRYPIKSVCIKKSSTYNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFG----DFTI  127 (383)
T ss_pred             EEeCCcccceEEEEEecCCC---CCccccceEEEEeccCCCceEe-ccHHHHHHHHHHHhCCCCCeEEEecC----CEEE
Confidence            45656888899998654321   0000112345544322221111 22568999999974 44456666653    3699


Q ss_pred             EeccCCCCHH
Q 017177          174 YEYMQRGSLE  183 (376)
Q Consensus       174 ~e~~~~g~L~  183 (376)
                      .||++|.+|.
T Consensus       128 ~efIeGr~l~  137 (383)
T PTZ00384        128 QEWVEGNTMG  137 (383)
T ss_pred             EEEeccccCC
Confidence            9999987653

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.41  E-value=0.14  Score=47.11  Aligned_cols=79  Identities=14%  Similarity=0.127  Sum_probs=46.5

Q ss_pred             eecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-----hhHHHHHHHHHHHhcCC-------------CCCcce
Q 017177           98 GEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-----QGFEEWQSEVNFLGRLS-------------HPNLVK  159 (376)
Q Consensus        98 G~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~-------------h~nIv~  159 (376)
                      |.|-.|.+|++...... ..........++||.......     .....+.+|+...+.+-             .....+
T Consensus         2 Gd~y~s~~~rv~v~~~~-~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~   80 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYEL-KGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPK   80 (294)
T ss_pred             CCcceeEEEEEEEEEEE-ccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeece
Confidence            66777889987664300 001222356789999873211     12345678887776551             123456


Q ss_pred             EEeEEEeCCeEEEEEecc
Q 017177          160 LLGYCWEDKELLLVYEYM  177 (376)
Q Consensus       160 l~~~~~~~~~~~lv~e~~  177 (376)
                      ++....+++..+||||-+
T Consensus        81 ~~~~~~~~~~~~lvlEDL   98 (294)
T PF02958_consen   81 CYYADEDPGDEVLVLEDL   98 (294)
T ss_pred             EEEeccCCCceeeehhhh
Confidence            666555555688999866

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.33  E-value=0.41  Score=44.98  Aligned_cols=30  Identities=17%  Similarity=-0.153  Sum_probs=25.1

Q ss_pred             CCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          219 EKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       219 ~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      ..++||+|+.+.|||++ + .+.++||+.+..
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            45789999999999995 4 467899998874

>PRK06148 hypothetical protein; Provisional

Probab=95.13  E-value=0.3  Score=53.04  Aligned_cols=32  Identities=25%  Similarity=0.078  Sum_probs=27.2

Q ss_pred             CCCcEecCCCCCCEEEcCCC--cEE-Ecceeeeee
Q 017177          219 EKKVIYRDFKASNILLDGVG--FLF-DSHLLIYVY  250 (376)
Q Consensus       219 ~~~iiHrDlKp~NILl~~~g--~~k-l~Dfg~a~~  250 (376)
                      ...+||.|+.+.|||++.++  .+. |+|||.+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            46899999999999999875  454 999998875

>PTZ00296 choline kinase; Provisional

Probab=93.73  E-value=0.81  Score=44.90  Aligned_cols=84  Identities=12%  Similarity=0.072  Sum_probs=49.2

Q ss_pred             ccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcc-eEEeEEEeCCeEE
Q 017177           93 PDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLV-KLLGYCWEDKELL  171 (376)
Q Consensus        93 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv-~l~~~~~~~~~~~  171 (376)
                      -.+.|..|-.-.+|++...+.... .....++.|.+++.......-. .-.+|..+++.+...+|. ++++.+.    -+
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~-~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg  182 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETAN-NYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GG  182 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCc-cccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CC
Confidence            345666677788898865532100 1112256788988766543322 235688888887644443 4555442    24


Q ss_pred             EEEeccCCCCH
Q 017177          172 LVYEYMQRGSL  182 (376)
Q Consensus       172 lv~e~~~~g~L  182 (376)
                      .|.||++|.+|
T Consensus       183 ~I~efi~g~~l  193 (442)
T PTZ00296        183 RIEEWLYGDPL  193 (442)
T ss_pred             EEEEeeCCccC
Confidence            57899987644

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	376
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		9e-31
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-30
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-29
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-29
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-26
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-26
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-26
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-24
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-13
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-12
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-11
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-11
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-11
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-11
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-11
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		6e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-11
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		9e-11
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		9e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		9e-11
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		9e-11
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		9e-11
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		9e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		9e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-11
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-11
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-10
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		7e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		7e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		7e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		9e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-09
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-09
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-09
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-09
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-09
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-09
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-09
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-09
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-09
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-09
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-09
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-09
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-09
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-09
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-09
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-09
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-09
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-09
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-09
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-09
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		6e-09
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-09
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		8e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-09
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-08
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-08
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-08
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-08
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-08
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-08
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-08
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-08
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-08
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-08
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-08
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-08
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-08
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-08
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-08
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-08
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-08
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-08
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-08
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-08
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		7e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-08
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-08
3a4o_X	286	Lyn Kinase Domain Length = 286		8e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		8e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		9e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		9e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		9e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		9e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-08
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		9e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		9e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		9e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-07
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-07
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-07
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-07
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-07
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-07
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-07
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-07
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-07
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-07
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-07
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-07
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-07
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-07
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		9e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-07
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		9e-07
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-06
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-06
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-06
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-06
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-06
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-06
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-06
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-06
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-06
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-06
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-06
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-06
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-06
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-06
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-06
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-06
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-06
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-06
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-06
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-06
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-06
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-06
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-06
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-06
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-06
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-06
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-06
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-06
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-06
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-06
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-06
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-06
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-06
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-06
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-06
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-06
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-06
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-06
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-06
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-06
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-06
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-06
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-06
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-06
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-06
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-06
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-06
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-06
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-05
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-05
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-05
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-05
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-05
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-05
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-05
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-05
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-05
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-05
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-05
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-05
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-05
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-05
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-05
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-05
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-05
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-05
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-05
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-05
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-05
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-05
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-05
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-05
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-05
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-05
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-05
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-05
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-05
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-05
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-05
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-05
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-05
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-05
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-05
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-05
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-05
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-05
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-05
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-05
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-05
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-05
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-05
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-05
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-05
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-05
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-05
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-05
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-05
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-05
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-05
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-05
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-05
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-05
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-05
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-05
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-05
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-05
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-05
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-05
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-05
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		7e-05
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-05
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-05
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-05
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-05
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-05
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-05
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-05
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-05
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-05
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-05
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-05
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		8e-05
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-05
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-04
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-04
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-04
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-04
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-04
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-04
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-04
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-04
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-04
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-04
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-04
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-04
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-04
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-04
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-04
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-04
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-04
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-04
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-04
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-04
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-04
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-04
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-04
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-04
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-04
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-04
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-04
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-04
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-04
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-04
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-04
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-04
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-04
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-04
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-04
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-04
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-04
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-04
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-04
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-04
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-04
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-04
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-04
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-04
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-04
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-04
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-04
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-04
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-04
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-04
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-04
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-04
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-04
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-04
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		8e-04
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		9e-04
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		9e-04
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 74/162 (45%), Positives = 100/162 (61%), Gaps = 12/162 (7%)
Query: 76  LKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES 135
           LK FS  +L+ A+ NF   ++LG GGFG+VYKG + D TL          VA+K+L  E 
Sbjct: 25  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTL----------VAVKRLKEER 74
Query: 136 MQGFE-EWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQ 194
            QG E ++Q+EV  +    H NL++L G+C    E LLVY YM  GS+ + L  R  S  
Sbjct: 75  XQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 134
Query: 195 PLSWDIRLKIAIGAARGLGFLHT-SEKKVIYRDFKASNILLD 235
           PL W  R +IA+G+ARGL +LH   + K+I+RD KA+NILLD
Sbjct: 135 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 176

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 73/162 (45%), Positives = 100/162 (61%), Gaps = 12/162 (7%)
Query: 76  LKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES 135
           LK FS  +L+ A+ NF   ++LG GGFG+VYKG + D          G +VA+K+L  E 
Sbjct: 17  LKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLAD----------GXLVAVKRLKEER 66
Query: 136 MQGFE-EWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQ 194
            QG E ++Q+EV  +    H NL++L G+C    E LLVY YM  GS+ + L  R  S  
Sbjct: 67  TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 195 PLSWDIRLKIAIGAARGLGFLHT-SEKKVIYRDFKASNILLD 235
           PL W  R +IA+G+ARGL +LH   + K+I+RD KA+NILLD
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 168

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 70/155 (45%), Positives = 101/155 (65%), Gaps = 12/155 (7%)
Query: 81  FLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE 140
            +DL+ AT NF    L+G G FG+VYKG + D          G  VA+K+  PES QG E
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD----------GAKVALKRRTPESSQGIE 80
Query: 141 EWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDI 200
           E+++E+  L    HP+LV L+G+C E  E++L+Y+YM+ G+L+ HL+  +     +SW+ 
Sbjct: 81  EFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           RL+I IGAARGL +LHT  + +I+RD K+ NILLD
Sbjct: 141 RLEICIGAARGLHYLHT--RAIIHRDVKSINILLD 173

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 70/155 (45%), Positives = 101/155 (65%), Gaps = 12/155 (7%)
Query: 81  FLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE 140
            +DL+ AT NF    L+G G FG+VYKG + D          G  VA+K+  PES QG E
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD----------GAKVALKRRTPESSQGIE 80
Query: 141 EWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDI 200
           E+++E+  L    HP+LV L+G+C E  E++L+Y+YM+ G+L+ HL+  +     +SW+ 
Sbjct: 81  EFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           RL+I IGAARGL +LHT  + +I+RD K+ NILLD
Sbjct: 141 RLEICIGAARGLHYLHT--RAIIHRDVKSINILLD 173

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 72/173 (41%), Positives = 105/173 (60%), Gaps = 18/173 (10%)
Query: 71  LETPDLKV--FSFLDLKSATKNF--KPDSL----LGEGGFGRVYKGWVDDKTLAPSKTGL 122
           LE  D +   FSF +LK+ T NF  +P S+    +GEGGFG VYKG+V++ T+A  K   
Sbjct: 5   LEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKK--- 61
Query: 123 GMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSL 182
             + A+  +  E ++  +++  E+  + +  H NLV+LLG+  +  +L LVY YM  GSL
Sbjct: 62  --LAAMVDITTEELK--QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
Query: 183 ENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
            + L   + +  PLSW +R KIA GAA G+ FLH  E   I+RD K++NILLD
Sbjct: 118 LDRLSCLDGT-PPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLD 167

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 72/173 (41%), Positives = 105/173 (60%), Gaps = 18/173 (10%)
Query: 71  LETPDLKV--FSFLDLKSATKNF--KPDSL----LGEGGFGRVYKGWVDDKTLAPSKTGL 122
           LE  D +   FSF +LK+ T NF  +P S+    +GEGGFG VYKG+V++ T+A  K   
Sbjct: 5   LEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKK--- 61
Query: 123 GMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSL 182
             + A+  +  E ++  +++  E+  + +  H NLV+LLG+  +  +L LVY YM  GSL
Sbjct: 62  --LAAMVDITTEELK--QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
Query: 183 ENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
            + L   + +  PLSW +R KIA GAA G+ FLH  E   I+RD K++NILLD
Sbjct: 118 LDRLSCLDGT-PPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLD 167

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/163 (42%), Positives = 101/163 (61%), Gaps = 16/163 (9%)
Query: 79  FSFLDLKSATKNF--KPDSL----LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN 132
           FSF +LK+ T NF  +P S+    +GEGGFG VYKG+V++ T+A  K     + A+  + 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKK-----LAAMVDIT 63
Query: 133 PESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS 192
            E ++  +++  E+  + +  H NLV+LLG+  +  +L LVY YM  GSL + L   + +
Sbjct: 64  TEELK--QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 121
Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
             PLSW +R KIA GAA G+ FLH  E   I+RD K++NILLD
Sbjct: 122 -PPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLD 161

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 68/163 (41%), Positives = 97/163 (59%), Gaps = 16/163 (9%)
Query: 79  FSFLDLKSATKNF--KPDSL----LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN 132
           FSF +LK+ T NF  +P S+     GEGGFG VYKG+V++ T+A  K     + A+  + 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKK-----LAAMVDIT 60
Query: 133 PESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS 192
            E ++  +++  E+    +  H NLV+LLG+  +  +L LVY Y   GSL + L   + +
Sbjct: 61  TEELK--QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGT 118
Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
             PLSW  R KIA GAA G+ FLH  E   I+RD K++NILLD
Sbjct: 119 -PPLSWHXRCKIAQGAANGINFLH--ENHHIHRDIKSANILLD 158

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 77/139 (55%), Gaps = 9/139 (6%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           +G+GGFG V+KG  V DK++   K+   +++   +   E ++ F+E+Q EV  +  L+HP
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKS---LILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           N+VKL G       +  V E++  G L + L  +     P+ W ++L++ +  A G+ ++
Sbjct: 84  NIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYM 138
Query: 216 HTSEKKVIYRDFKASNILL 234
                 +++RD ++ NI L
Sbjct: 139 QNQNPPIVHRDLRSPNIFL 157

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 77/139 (55%), Gaps = 9/139 (6%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           +G+GGFG V+KG  V DK++   K+   +++   +   E ++ F+E+Q EV  +  L+HP
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKS---LILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           N+VKL G       +  V E++  G L + L  +     P+ W ++L++ +  A G+ ++
Sbjct: 84  NIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYM 138
Query: 216 HTSEKKVIYRDFKASNILL 234
                 +++RD ++ NI L
Sbjct: 139 QNQNPPIVHRDLRSPNIFL 157

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 77/139 (55%), Gaps = 9/139 (6%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           +G+GGFG V+KG  V DK++   K+   +++   +   E ++ F+E+Q EV  +  L+HP
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKS---LILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           N+VKL G       +  V E++  G L + L  +     P+ W ++L++ +  A G+ ++
Sbjct: 84  NIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYM 138
Query: 216 HTSEKKVIYRDFKASNILL 234
                 +++RD ++ NI L
Sbjct: 139 QNQNPPIVHRDLRSPNIFL 157

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 73/145 (50%), Gaps = 19/145 (13%)
Query: 94  DSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLG 150
           + ++G GGFG+VY+  W+ D+          + V   + +P+    Q  E  + E     
Sbjct: 12  EEIIGIGGFGKVYRAFWIGDE----------VAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
            L HPN++ L G C ++  L LV E+ + G L   L  +   I P   DI +  A+  AR
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPP---DILVNWAVQIAR 116
Query: 211 GLGFLHTSE-KKVIYRDFKASNILL 234
           G+ +LH      +I+RD K+SNIL+
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILI 141

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 83/182 (45%), Gaps = 27/182 (14%)
Query: 67  NGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVV 126
           N ++   PD  ++  LD      + K   ++GEG FG+V K  +        K GL M  
Sbjct: 4   NRKVKNNPDPTIYPVLDWN----DIKFQDVIGEGNFGQVLKARI-------KKDGLRMDA 52
Query: 127 AIKKLNP-ESMQGFEEWQSEVNFLGRLSH-PNLVKLLGYCWEDKELLLVYEYMQRGSLEN 184
           AIK++    S     ++  E+  L +L H PN++ LLG C     L L  EY   G+L +
Sbjct: 53  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 112
Query: 185 HLFRR------------NPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI 232
            L +             N +   LS    L  A   ARG+ +L  S+K+ I+R+  A NI
Sbjct: 113 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--SQKQFIHRNLAARNI 170
Query: 233 LL 234
           L+
Sbjct: 171 LV 172

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 80/176 (45%), Gaps = 27/176 (15%)
Query: 73  TPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN 132
            PD  ++  LD      + K   ++GEG FG+V K  +        K GL M  AIK++ 
Sbjct: 3   NPDPTIYPVLDWN----DIKFQDVIGEGNFGQVLKARI-------KKDGLRMDAAIKRMK 51
Query: 133 P-ESMQGFEEWQSEVNFLGRLSH-PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR- 189
              S     ++  E+  L +L H PN++ LLG C     L L  EY   G+L + L +  
Sbjct: 52  EYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR 111
Query: 190 -----------NPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
                      N +   LS    L  A   ARG+ +L  S+K+ I+RD  A NIL+
Sbjct: 112 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILV 165

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 80/176 (45%), Gaps = 27/176 (15%)
Query: 73  TPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN 132
            PD  ++  LD      + K   ++GEG FG+V K  +        K GL M  AIK++ 
Sbjct: 13  NPDPTIYPVLDWN----DIKFQDVIGEGNFGQVLKARI-------KKDGLRMDAAIKRMK 61
Query: 133 P-ESMQGFEEWQSEVNFLGRLSH-PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR- 189
              S     ++  E+  L +L H PN++ LLG C     L L  EY   G+L + L +  
Sbjct: 62  EYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR 121
Query: 190 -----------NPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
                      N +   LS    L  A   ARG+ +L  S+K+ I+RD  A NIL+
Sbjct: 122 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILV 175

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 16/142 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSEVNFLGRLS 153
           +G G FG V++  W             G  VA+K L  +        E+  EV  + RL 
Sbjct: 45  IGAGSFGTVHRAEW------------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR 92
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           HPN+V  +G   +   L +V EY+ RGSL   L  ++ + + L    RL +A   A+G+ 
Sbjct: 93  HPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 214 FLHTSEKKVIYRDFKASNILLD 235
           +LH     +++RD K+ N+L+D
Sbjct: 152 YLHNRNPPIVHRDLKSPNLLVD 173

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 74/160 (46%), Gaps = 29/160 (18%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEVNFLGRLSHP 155
           +GEG FGRV++       L P +     +VA+K L  E+    + ++Q E   +    +P
Sbjct: 55  IGEGAFGRVFQARA--PGLLPYEPF--TMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR---------------------RNPSIQ 194
           N+VKLLG C   K + L++EYM  G L N   R                      +P   
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDL-NEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 195 PLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           PLS   +L IA   A G+ +L  SE+K ++RD    N L+
Sbjct: 170 PLSCAEQLCIARQVAAGMAYL--SERKFVHRDLATRNCLV 207

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 70/142 (49%), Gaps = 16/142 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSEVNFLGRLS 153
           +G G FG V++  W             G  VA+K L  +        E+  EV  + RL 
Sbjct: 45  IGAGSFGTVHRAEW------------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR 92
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           HPN+V  +G   +   L +V EY+ RGSL   L  ++ + + L    RL +A   A+G+ 
Sbjct: 93  HPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 214 FLHTSEKKVIYRDFKASNILLD 235
           +LH     +++R+ K+ N+L+D
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVD 173

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 25/172 (14%)
Query: 71  LETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK 130
            E P   V  F     AT N   D ++G G FG V  G    +   PSK  +   VAIK 
Sbjct: 28  FEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSG----RLKLPSKKEIS--VAIKT 80
Query: 131 LNPESMQGFEEWQ-----SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENH 185
           L      G+ E Q      E + +G+  HPN+++L G   + K +++V EYM+ GSL++ 
Sbjct: 81  LK----VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 186 LFRRNPSIQPLSWDIRLKIAIGAARGL--GFLHTSEKKVIYRDFKASNILLD 235
           L + +     +         +G  RG+  G  + S+   ++RD  A NIL++
Sbjct: 137 LRKHDAQFTVIQL-------VGMLRGIASGMKYLSDMGFVHRDLAARNILIN 181

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 81/171 (47%), Gaps = 25/171 (14%)
Query: 72  ETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL 131
           E P   V  F     AT N   D ++G G FG V  G    +   PSK  +   VAIK L
Sbjct: 27  EDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSG----RLKLPSKKEIS--VAIKTL 79
Query: 132 NPESMQGFEEWQ-----SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL 186
                 G+ E Q      E + +G+  HPN+++L G   + K +++V EYM+ GSL++ L
Sbjct: 80  K----VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 135
Query: 187 FRRNPSIQPLSWDIRLKIAIGAARGL--GFLHTSEKKVIYRDFKASNILLD 235
            + +     +         +G  RG+  G  + S+   ++RD  A NIL++
Sbjct: 136 RKHDAQFTVIQL-------VGMLRGIASGMKYLSDMGYVHRDLAARNILIN 179

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 25/172 (14%)
Query: 71  LETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK 130
            E P   V  F     AT N   D ++G G FG V  G    +   PSK  +   VAIK 
Sbjct: 28  FEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSG----RLKLPSKKEIS--VAIKT 80
Query: 131 LNPESMQGFEEWQ-----SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENH 185
           L      G+ E Q      E + +G+  HPN+++L G   + K +++V EYM+ GSL++ 
Sbjct: 81  LK----VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 186 LFRRNPSIQPLSWDIRLKIAIGAARGL--GFLHTSEKKVIYRDFKASNILLD 235
           L + +     +         +G  RG+  G  + S+   ++RD  A NIL++
Sbjct: 137 LRKHDAQFTVIQL-------VGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 25/172 (14%)
Query: 71  LETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK 130
            E P   V  F     AT N   D ++G G FG V  G    +   PSK  +   VAIK 
Sbjct: 28  FEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSG----RLKLPSKKEIS--VAIKT 80
Query: 131 LNPESMQGFEEWQ-----SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENH 185
           L      G+ E Q      E + +G+  HPN+++L G   + K +++V EYM+ GSL++ 
Sbjct: 81  LK----VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 186 LFRRNPSIQPLSWDIRLKIAIGAARGL--GFLHTSEKKVIYRDFKASNILLD 235
           L + +     +         +G  RG+  G  + S+   ++RD  A NIL++
Sbjct: 137 LRKHDAQFTVIQL-------VGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 18/150 (12%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LGEG FG+V+    +   L+P+K    M+VA+K L   ++   +++Q E   L  L H +
Sbjct: 23  LGEGAFGKVF--LAECYNLSPTKDK--MLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI------QP------LSWDIRLKI 204
           +VK  G C +   L++V+EYM+ G L   L    P        QP      L     L I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           A   A G+ +L  + +  ++RD    N L+
Sbjct: 139 ASQIASGMVYL--ASQHFVHRDLATRNCLV 166

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 25/172 (14%)
Query: 71  LETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK 130
            E P   V  F     AT N   D ++G G FG V  G    +   PSK  +   VAIK 
Sbjct: 28  FEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSG----RLKLPSKKEIS--VAIKT 80
Query: 131 LNPESMQGFEEWQ-----SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENH 185
           L      G+ E Q      E + +G+  HPN+++L G   + K +++V EYM+ GSL++ 
Sbjct: 81  LK----VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 186 LFRRNPSIQPLSWDIRLKIAIGAARGL--GFLHTSEKKVIYRDFKASNILLD 235
           L + +     +         +G  RG+  G  + S+   ++RD  A NIL++
Sbjct: 137 LRKHDAQFTVIQL-------VGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 81/171 (47%), Gaps = 25/171 (14%)
Query: 72  ETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL 131
           E P   V  F     AT N   D ++G G FG V  G    +   PSK  +   VAIK L
Sbjct: 29  EDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSG----RLKLPSKKEIS--VAIKTL 81
Query: 132 NPESMQGFEEWQ-----SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL 186
                 G+ E Q      E + +G+  HPN+++L G   + K +++V EYM+ GSL++ L
Sbjct: 82  K----VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Query: 187 FRRNPSIQPLSWDIRLKIAIGAARGL--GFLHTSEKKVIYRDFKASNILLD 235
            + +     +         +G  RG+  G  + S+   ++RD  A NIL++
Sbjct: 138 RKHDAQFTVIQL-------VGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 81/171 (47%), Gaps = 25/171 (14%)
Query: 72  ETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL 131
           E P   V  F     AT N   D ++G G FG V  G    +   PSK  +   VAIK L
Sbjct: 29  EDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSG----RLKLPSKKEIS--VAIKTL 81
Query: 132 NPESMQGFEEWQ-----SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL 186
                 G+ E Q      E + +G+  HPN+++L G   + K +++V EYM+ GSL++ L
Sbjct: 82  K----VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Query: 187 FRRNPSIQPLSWDIRLKIAIGAARGL--GFLHTSEKKVIYRDFKASNILLD 235
            + +     +         +G  RG+  G  + S+   ++RD  A NIL++
Sbjct: 138 RKHDAQFTVIQL-------VGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 68/147 (46%), Gaps = 13/147 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LGEG FG+V+    +   L P +    M+VA+K L   S    +++Q E   L  L H +
Sbjct: 49  LGEGAFGKVF--LAECHNLLPEQDK--MLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP---------SIQPLSWDIRLKIAIG 207
           +V+  G C E + LL+V+EYM+ G L   L    P          + P    +   +A+ 
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILL 234
           +    G ++ +    ++RD    N L+
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLV 191

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 25/172 (14%)
Query: 71  LETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK 130
            E P   V  F     AT N   D ++G G FG V  G    +   PSK  +   VAIK 
Sbjct: 28  FEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSG----RLKLPSKKEIS--VAIKT 80
Query: 131 LNPESMQGFEEWQ-----SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENH 185
           L      G+ E Q      E + +G+  HPN+++L G   + K +++V EYM+ GSL++ 
Sbjct: 81  LK----VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 186 LFRRNPSIQPLSWDIRLKIAIGAARGL--GFLHTSEKKVIYRDFKASNILLD 235
           L + +     +         +G  RG+  G  + S+   ++RD  A NIL++
Sbjct: 137 LRKHDAQFTVIQL-------VGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 68/147 (46%), Gaps = 13/147 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LGEG FG+V+    +   L P +    M+VA+K L   S    +++Q E   L  L H +
Sbjct: 26  LGEGAFGKVF--LAECHNLLPEQDK--MLVAVKALKEASESARQDFQREAELLTMLQHQH 81
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP---------SIQPLSWDIRLKIAIG 207
           +V+  G C E + LL+V+EYM+ G L   L    P          + P    +   +A+ 
Sbjct: 82  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILL 234
           +    G ++ +    ++RD    N L+
Sbjct: 142 SQVAAGMVYLAGLHFVHRDLATRNCLV 168

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 68/147 (46%), Gaps = 13/147 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LGEG FG+V+    +   L P +    M+VA+K L   S    +++Q E   L  L H +
Sbjct: 20  LGEGAFGKVF--LAECHNLLPEQDK--MLVAVKALKEASESARQDFQREAELLTMLQHQH 75
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP---------SIQPLSWDIRLKIAIG 207
           +V+  G C E + LL+V+EYM+ G L   L    P          + P    +   +A+ 
Sbjct: 76  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILL 234
           +    G ++ +    ++RD    N L+
Sbjct: 136 SQVAAGMVYLAGLHFVHRDLATRNCLV 162

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 73/142 (51%), Gaps = 15/142 (10%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHP 155
           LGEG FG+V     D     P+  G G +VA+K L  +   Q    W+ E++ L  L H 
Sbjct: 22  LGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHE 76
Query: 156 NLVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           +++K  G C +  +K L LV EY+  GSL ++L R +  +  L     L  A     G+ 
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMA 131
Query: 214 FLHTSEKKVIYRDFKASNILLD 235
           +LH+  +  I+R+  A N+LLD
Sbjct: 132 YLHS--QHYIHRNLAARNVLLD 151

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 73/144 (50%), Gaps = 13/144 (9%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL 152
           + ++G G FG VY G + D        G  +  A+K LN  +  G   ++ +E   +   
Sbjct: 40  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 93
Query: 153 SHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           SHPN++ LLG C   +   L+V  YM+ G L N  F RN +  P   D+ +   +  A+G
Sbjct: 94  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDL-IGFGLQVAKG 150
Query: 212 LGFLHTSEKKVIYRDFKASNILLD 235
           + FL  + KK ++RD  A N +LD
Sbjct: 151 MKFL--ASKKFVHRDLAARNCMLD 172

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 73/144 (50%), Gaps = 13/144 (9%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL 152
           + ++G G FG VY G + D        G  +  A+K LN  +  G   ++ +E   +   
Sbjct: 33  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 86
Query: 153 SHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           SHPN++ LLG C   +   L+V  YM+ G L N  F RN +  P   D+ +   +  A+G
Sbjct: 87  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDL-IGFGLQVAKG 143
Query: 212 LGFLHTSEKKVIYRDFKASNILLD 235
           + FL  + KK ++RD  A N +LD
Sbjct: 144 MKFL--ASKKFVHRDLAARNCMLD 165

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/174 (32%), Positives = 87/174 (50%), Gaps = 24/174 (13%)
Query: 71  LETPDLKVFSFLDLKSATKNFKPDSL------LGEGGFGRVYKGWVDDKTLAPSKTGLGM 124
           L  P  +    LD  S TK  +P+ +      LGEG +G VYK  +  +T        G 
Sbjct: 7   LRNPPRRQLKKLDEDSLTK--QPEEVFDVLEKLGEGSYGSVYKA-IHKET--------GQ 55
Query: 125 VVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLEN 184
           +VAIK++  ES    +E   E++ + +   P++VK  G  +++ +L +V EY   GS+ +
Sbjct: 56  IVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD 113
Query: 185 HLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            +  RN +   L+ D    I     +GL +LH   K  I+RD KA NILL+  G
Sbjct: 114 IIRLRNKT---LTEDEIATILQSTLKGLEYLHFMRK--IHRDIKAGNILLNTEG 162

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 73/144 (50%), Gaps = 13/144 (9%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL 152
           + ++G G FG VY G + D        G  +  A+K LN  +  G   ++ +E   +   
Sbjct: 35  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 88
Query: 153 SHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           SHPN++ LLG C   +   L+V  YM+ G L N  F RN +  P   D+ +   +  A+G
Sbjct: 89  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDL-IGFGLQVAKG 145
Query: 212 LGFLHTSEKKVIYRDFKASNILLD 235
           + FL  + KK ++RD  A N +LD
Sbjct: 146 MKFL--ASKKFVHRDLAARNCMLD 167

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 73/144 (50%), Gaps = 13/144 (9%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL 152
           + ++G G FG VY G + D        G  +  A+K LN  +  G   ++ +E   +   
Sbjct: 36  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 89
Query: 153 SHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           SHPN++ LLG C   +   L+V  YM+ G L N  F RN +  P   D+ +   +  A+G
Sbjct: 90  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDL-IGFGLQVAKG 146
Query: 212 LGFLHTSEKKVIYRDFKASNILLD 235
           + FL  + KK ++RD  A N +LD
Sbjct: 147 MKFL--ASKKFVHRDLAARNCMLD 168

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 73/144 (50%), Gaps = 13/144 (9%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL 152
           + ++G G FG VY G + D        G  +  A+K LN  +  G   ++ +E   +   
Sbjct: 94  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 147
Query: 153 SHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           SHPN++ LLG C   +   L+V  YM+ G L N  F RN +  P   D+ +   +  A+G
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDL-IGFGLQVAKG 204
Query: 212 LGFLHTSEKKVIYRDFKASNILLD 235
           + FL  + KK ++RD  A N +LD
Sbjct: 205 MKFL--ASKKFVHRDLAARNCMLD 226

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 73/144 (50%), Gaps = 13/144 (9%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL 152
           + ++G G FG VY G + D        G  +  A+K LN  +  G   ++ +E   +   
Sbjct: 36  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 89
Query: 153 SHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           SHPN++ LLG C   +   L+V  YM+ G L N  F RN +  P   D+ +   +  A+G
Sbjct: 90  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDL-IGFGLQVAKG 146
Query: 212 LGFLHTSEKKVIYRDFKASNILLD 235
           + FL  + KK ++RD  A N +LD
Sbjct: 147 MKFL--ASKKFVHRDLAARNCMLD 168

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 73/144 (50%), Gaps = 13/144 (9%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL 152
           + ++G G FG VY G + D        G  +  A+K LN  +  G   ++ +E   +   
Sbjct: 35  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 88
Query: 153 SHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           SHPN++ LLG C   +   L+V  YM+ G L N  F RN +  P   D+ +   +  A+G
Sbjct: 89  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDL-IGFGLQVAKG 145
Query: 212 LGFLHTSEKKVIYRDFKASNILLD 235
           + FL  + KK ++RD  A N +LD
Sbjct: 146 MKFL--ASKKFVHRDLAARNCMLD 167

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 72/142 (50%), Gaps = 15/142 (10%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHP 155
           LGEG FG+V     D     P+  G G +VA+K L  +   Q    W+ E++ L  L H 
Sbjct: 22  LGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHE 76
Query: 156 NLVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           +++K  G C +  +K L LV EY+  GSL ++L R +  +  L     L  A     G+ 
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMA 131
Query: 214 FLHTSEKKVIYRDFKASNILLD 235
           +LH   +  I+R+  A N+LLD
Sbjct: 132 YLHA--QHYIHRNLAARNVLLD 151

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 12/142 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V     D     P +   G VVA+KKL   + +   +++ E+  L  L H N
Sbjct: 49  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103
Query: 157 LVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           +VK  G C+    + L L+ EY+  GSL ++L +    I  +     L+      +G+ +
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEY 160
Query: 215 LHTSEKKVIYRDFKASNILLDG 236
           L T  K+ I+RD    NIL++ 
Sbjct: 161 LGT--KRYIHRDLATRNILVEN 180

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 12/142 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V     D     P +   G VVA+KKL   + +   +++ E+  L  L H N
Sbjct: 24  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 78
Query: 157 LVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           +VK  G C+    + L L+ EY+  GSL ++L +    I  +     L+      +G+ +
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEY 135
Query: 215 LHTSEKKVIYRDFKASNILLDG 236
           L T  K+ I+RD    NIL++ 
Sbjct: 136 LGT--KRYIHRDLATRNILVEN 155

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 22/178 (12%)
Query: 67  NGQILETPDLKVFSFLDLKSATKNFKPDSL------LGEGGFGRVYKGWVDDKTLAPSKT 120
           +G  L T +L   S    +  T++  P+        LG+G FG+VYK             
Sbjct: 9   SGVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKA---------QNK 59
Query: 121 GLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRG 180
              ++ A K ++ +S +  E++  E++ L    HPN+VKLL   + +  L ++ E+   G
Sbjct: 60  ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 119
Query: 181 SLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL--LDG 236
           +++  +       +PL+      +       L +LH  + K+I+RD KA NIL  LDG
Sbjct: 120 AVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDG 172

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 12/142 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V     D     P +   G VVA+KKL   + +   +++ E+  L  L H N
Sbjct: 17  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 71
Query: 157 LVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           +VK  G C+    + L L+ EY+  GSL ++L +    I  +     L+      +G+ +
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEY 128
Query: 215 LHTSEKKVIYRDFKASNILLDG 236
           L T  K+ I+RD    NIL++ 
Sbjct: 129 LGT--KRYIHRDLATRNILVEN 148

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 12/142 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V     D     P +   G VVA+KKL   + +   +++ E+  L  L H N
Sbjct: 16  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 70
Query: 157 LVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           +VK  G C+    + L L+ EY+  GSL ++L +    I  +     L+      +G+ +
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEY 127
Query: 215 LHTSEKKVIYRDFKASNILLDG 236
           L T  K+ I+RD    NIL++ 
Sbjct: 128 LGT--KRYIHRDLATRNILVEN 147

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 12/142 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V     D     P +   G VVA+KKL   + +   +++ E+  L  L H N
Sbjct: 18  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 157 LVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           +VK  G C+    + L L+ EY+  GSL ++L +    I  +     L+      +G+ +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEY 129
Query: 215 LHTSEKKVIYRDFKASNILLDG 236
           L T  K+ I+RD    NIL++ 
Sbjct: 130 LGT--KRYIHRDLATRNILVEN 149

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 22/178 (12%)
Query: 67  NGQILETPDLKVFSFLDLKSATKNFKPDSL------LGEGGFGRVYKGWVDDKTLAPSKT 120
           +G  L T +L   S    +  T++  P+        LG+G FG+VYK             
Sbjct: 9   SGVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKA---------QNK 59
Query: 121 GLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRG 180
              ++ A K ++ +S +  E++  E++ L    HPN+VKLL   + +  L ++ E+   G
Sbjct: 60  ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 119
Query: 181 SLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL--LDG 236
           +++  +       +PL+      +       L +LH  + K+I+RD KA NIL  LDG
Sbjct: 120 AVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDG 172

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 22/178 (12%)
Query: 67  NGQILETPDLKVFSFLDLKSATKNFKPDSL------LGEGGFGRVYKGWVDDKTLAPSKT 120
           +G  L T +L   S    +  T++  P+        LG+G FG+VYK             
Sbjct: 9   SGVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKA---------QNK 59
Query: 121 GLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRG 180
              ++ A K ++ +S +  E++  E++ L    HPN+VKLL   + +  L ++ E+   G
Sbjct: 60  ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 119
Query: 181 SLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL--LDG 236
           +++  +       +PL+      +       L +LH  + K+I+RD KA NIL  LDG
Sbjct: 120 AVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDG 172

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 12/142 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V     D     P +   G VVA+KKL   + +   +++ E+  L  L H N
Sbjct: 23  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 77
Query: 157 LVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           +VK  G C+    + L L+ EY+  GSL ++L +    I  +     L+      +G+ +
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEY 134
Query: 215 LHTSEKKVIYRDFKASNILLDG 236
           L T  K+ I+RD    NIL++ 
Sbjct: 135 LGT--KRYIHRDLATRNILVEN 154

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 27/179 (15%)
Query: 61  VEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKG-WVDDKTLAPSK 119
           VE  +P+G       L++    +LK          +LG G FG VYKG WV      P  
Sbjct: 17  VEPLTPSGTAPNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWV------PEG 63
Query: 120 TGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQ 178
             + + VAIK LN  +  +   E+  E   +  + HP+LV+LLG C     + LV + M 
Sbjct: 64  ETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCL-SPTIQLVTQLMP 122
Query: 179 RGSLENHLFRRNPSIQP---LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
            G L  ++     +I     L+W +++      A+G+ +L   E+++++RD  A N+L+
Sbjct: 123 HGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYL--EERRLVHRDLAARNVLV 173

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 12/142 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V     D     P +   G VVA+KKL   + +   +++ E+  L  L H N
Sbjct: 18  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 157 LVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           +VK  G C+    + L L+ EY+  GSL ++L +    I  +     L+      +G+ +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEY 129
Query: 215 LHTSEKKVIYRDFKASNILLDG 236
           L T  K+ I+RD    NIL++ 
Sbjct: 130 LGT--KRYIHRDLATRNILVEN 149

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 12/142 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V     D     P +   G VVA+KKL   + +   +++ E+  L  L H N
Sbjct: 22  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 76
Query: 157 LVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           +VK  G C+    + L L+ EY+  GSL ++L +    I  +     L+      +G+ +
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEY 133
Query: 215 LHTSEKKVIYRDFKASNILLDG 236
           L T  K+ I+RD    NIL++ 
Sbjct: 134 LGT--KRYIHRDLATRNILVEN 153

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 12/142 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V     D     P +   G VVA+KKL   + +   +++ E+  L  L H N
Sbjct: 36  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 157 LVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           +VK  G C+    + L L+ EY+  GSL ++L +    I  +     L+      +G+ +
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEY 147
Query: 215 LHTSEKKVIYRDFKASNILLDG 236
           L T  K+ I+RD    NIL++ 
Sbjct: 148 LGT--KRYIHRDLATRNILVEN 167

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 12/142 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V     D     P +   G VVA+KKL   + +   +++ E+  L  L H N
Sbjct: 21  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 157 LVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           +VK  G C+    + L L+ EY+  GSL ++L +    I  +     L+      +G+ +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEY 132
Query: 215 LHTSEKKVIYRDFKASNILLDG 236
           L T  K+ I+RD    NIL++ 
Sbjct: 133 LGT--KRYIHRDLATRNILVEN 152

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 12/142 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V     D     P +   G VVA+KKL   + +   +++ E+  L  L H N
Sbjct: 18  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 157 LVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           +VK  G C+    + L L+ EY+  GSL ++L +    I  +     L+      +G+ +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEY 129
Query: 215 LHTSEKKVIYRDFKASNILLDG 236
           L T  K+ I+RD    NIL++ 
Sbjct: 130 LGT--KRYIHRDLATRNILVEN 149

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 12/142 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V     D     P +   G VVA+KKL   + +   +++ E+  L  L H N
Sbjct: 25  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 79
Query: 157 LVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           +VK  G C+    + L L+ EY+  GSL ++L +    I  +     L+      +G+ +
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEY 136
Query: 215 LHTSEKKVIYRDFKASNILLDG 236
           L T  K+ I+RD    NIL++ 
Sbjct: 137 LGT--KRYIHRDLATRNILVEN 156

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 12/142 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V     D     P +   G VVA+KKL   + +   +++ E+  L  L H N
Sbjct: 36  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 157 LVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           +VK  G C+    + L L+ EY+  GSL ++L +    I  +     L+      +G+ +
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEY 147
Query: 215 LHTSEKKVIYRDFKASNILLDG 236
           L T  K+ I+RD    NIL++ 
Sbjct: 148 LGT--KRYIHRDLATRNILVEN 167

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/143 (34%), Positives = 72/143 (50%), Gaps = 17/143 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHP 155
           LGEG FG+V     D     P+  G G +VA+K L  ++  Q    W+ E++ L  L H 
Sbjct: 39  LGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93
Query: 156 NLVKLLGYCWED---KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
           +++K  G C ED     L LV EY+  GSL ++L R +  +  L     L  A     G+
Sbjct: 94  HIIKYKG-CCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGM 147
Query: 213 GFLHTSEKKVIYRDFKASNILLD 235
            +LH   +  I+RD  A N+LLD
Sbjct: 148 AYLHA--QHYIHRDLAARNVLLD 168

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 80/172 (46%), Gaps = 25/172 (14%)
Query: 71  LETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK 130
            E P   V  F     AT N   D ++G G FG V  G    +   PSK  +   VAIK 
Sbjct: 28  FEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSG----RLKLPSKKEIS--VAIKT 80
Query: 131 LNPESMQGFEEWQ-----SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENH 185
           L      G+ E Q      E + +G+  HPN+++L G   + K +++V E M+ GSL++ 
Sbjct: 81  LK----VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSF 136
Query: 186 LFRRNPSIQPLSWDIRLKIAIGAARGL--GFLHTSEKKVIYRDFKASNILLD 235
           L + +     +         +G  RG+  G  + S+   ++RD  A NIL++
Sbjct: 137 LRKHDAQFTVIQL-------VGMLRGIASGMKYLSDMGAVHRDLAARNILIN 181

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 73/144 (50%), Gaps = 13/144 (9%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL 152
           + ++G G FG VY G + D        G  +  A+K LN  +  G   ++ +E   +   
Sbjct: 54  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 107
Query: 153 SHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           SHPN++ LLG C   +   L+V  YM+ G L N  F RN +  P   D+ +   +  A+G
Sbjct: 108 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDL-IGFGLQVAKG 164
Query: 212 LGFLHTSEKKVIYRDFKASNILLD 235
           + +L  + KK ++RD  A N +LD
Sbjct: 165 MKYL--ASKKFVHRDLAARNCMLD 186

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 73/144 (50%), Gaps = 13/144 (9%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL 152
           + ++G G FG VY G + D        G  +  A+K LN  +  G   ++ +E   +   
Sbjct: 35  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 88
Query: 153 SHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           SHPN++ LLG C   +   L+V  YM+ G L N  F RN +  P   D+ +   +  A+G
Sbjct: 89  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDL-IGFGLQVAKG 145
Query: 212 LGFLHTSEKKVIYRDFKASNILLD 235
           + +L  + KK ++RD  A N +LD
Sbjct: 146 MKYL--ASKKFVHRDLAARNCMLD 167

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 73/144 (50%), Gaps = 13/144 (9%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL 152
           + ++G G FG VY G + D        G  +  A+K LN  +  G   ++ +E   +   
Sbjct: 34  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 87
Query: 153 SHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           SHPN++ LLG C   +   L+V  YM+ G L N  F RN +  P   D+ +   +  A+G
Sbjct: 88  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDL-IGFGLQVAKG 144
Query: 212 LGFLHTSEKKVIYRDFKASNILLD 235
           + +L  + KK ++RD  A N +LD
Sbjct: 145 MKYL--ASKKFVHRDLAARNCMLD 166

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 24/153 (15%)
Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-----S 144
           N   D ++G G FG V  G    +   PSK  +   VAIK L      G+ E Q      
Sbjct: 34  NISIDKVVGAGEFGEVCSG----RLKLPSKKEIS--VAIKTLK----VGYTEKQRRDFLG 83
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E + +G+  HPN+++L G   + K +++V EYM+ GSL++ L + +     +        
Sbjct: 84  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL------ 137
Query: 205 AIGAARGL--GFLHTSEKKVIYRDFKASNILLD 235
            +G  RG+  G  + S+   ++RD  A NIL++
Sbjct: 138 -VGMLRGIASGMKYLSDMGYVHRDLAARNILIN 169

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 24/153 (15%)
Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-----S 144
           N   D ++G G FG V  G    +   PSK  +   VAIK L      G+ E Q      
Sbjct: 17  NISIDKVVGAGEFGEVCSG----RLKLPSKKEIS--VAIKTLK----VGYTEKQRRDFLG 66
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E + +G+  HPN+++L G   + K +++V EYM+ GSL++ L + +     +        
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL------ 120
Query: 205 AIGAARGL--GFLHTSEKKVIYRDFKASNILLD 235
            +G  RG+  G  + S+   ++RD  A NIL++
Sbjct: 121 -VGMLRGIASGMKYLSDMGYVHRDLAARNILIN 152

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 73/144 (50%), Gaps = 13/144 (9%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL 152
           + ++G G FG VY G + D        G  +  A+K LN  +  G   ++ +E   +   
Sbjct: 30  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 83
Query: 153 SHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           SHPN++ LLG C   +   L+V  YM+ G L N  F RN +  P   D+ +   +  A+G
Sbjct: 84  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDL-IGFGLQVAKG 140
Query: 212 LGFLHTSEKKVIYRDFKASNILLD 235
           + +L  + KK ++RD  A N +LD
Sbjct: 141 MKYL--ASKKFVHRDLAARNCMLD 162

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 73/144 (50%), Gaps = 13/144 (9%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL 152
           + ++G G FG VY G + D        G  +  A+K LN  +  G   ++ +E   +   
Sbjct: 35  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 88
Query: 153 SHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           SHPN++ LLG C   +   L+V  YM+ G L N  F RN +  P   D+ +   +  A+G
Sbjct: 89  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDL-IGFGLQVAKG 145
Query: 212 LGFLHTSEKKVIYRDFKASNILLD 235
           + +L  + KK ++RD  A N +LD
Sbjct: 146 MKYL--ASKKFVHRDLAARNCMLD 167

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 73/144 (50%), Gaps = 13/144 (9%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL 152
           + ++G G FG VY G + D        G  +  A+K LN  +  G   ++ +E   +   
Sbjct: 34  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 87
Query: 153 SHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           SHPN++ LLG C   +   L+V  YM+ G L N  F RN +  P   D+ +   +  A+G
Sbjct: 88  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDL-IGFGLQVAKG 144
Query: 212 LGFLHTSEKKVIYRDFKASNILLD 235
           + +L  + KK ++RD  A N +LD
Sbjct: 145 MKYL--ASKKFVHRDLAARNCMLD 166

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 73/144 (50%), Gaps = 13/144 (9%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL 152
           + ++G G FG VY G + D        G  +  A+K LN  +  G   ++ +E   +   
Sbjct: 53  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 106
Query: 153 SHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           SHPN++ LLG C   +   L+V  YM+ G L N  F RN +  P   D+ +   +  A+G
Sbjct: 107 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDL-IGFGLQVAKG 163
Query: 212 LGFLHTSEKKVIYRDFKASNILLD 235
           + +L  + KK ++RD  A N +LD
Sbjct: 164 MKYL--ASKKFVHRDLAARNCMLD 185

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 73/144 (50%), Gaps = 13/144 (9%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL 152
           + ++G G FG VY G + D        G  +  A+K LN  +  G   ++ +E   +   
Sbjct: 32  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 85
Query: 153 SHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           SHPN++ LLG C   +   L+V  YM+ G L N  F RN +  P   D+ +   +  A+G
Sbjct: 86  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDL-IGFGLQVAKG 142
Query: 212 LGFLHTSEKKVIYRDFKASNILLD 235
           + +L  + KK ++RD  A N +LD
Sbjct: 143 MKYL--ASKKFVHRDLAARNCMLD 164

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 73/144 (50%), Gaps = 13/144 (9%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL 152
           + ++G G FG VY G + D        G  +  A+K LN  +  G   ++ +E   +   
Sbjct: 33  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 86
Query: 153 SHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           SHPN++ LLG C   +   L+V  YM+ G L N  F RN +  P   D+ +   +  A+G
Sbjct: 87  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDL-IGFGLQVAKG 143
Query: 212 LGFLHTSEKKVIYRDFKASNILLD 235
           + +L  + KK ++RD  A N +LD
Sbjct: 144 MKYL--ASKKFVHRDLAARNCMLD 165

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 73/144 (50%), Gaps = 13/144 (9%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL 152
           + ++G G FG VY G + D        G  +  A+K LN  +  G   ++ +E   +   
Sbjct: 27  NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 80
Query: 153 SHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           SHPN++ LLG C   +   L+V  YM+ G L N  F RN +  P   D+ +   +  A+G
Sbjct: 81  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDL-IGFGLQVAKG 137
Query: 212 LGFLHTSEKKVIYRDFKASNILLD 235
           + +L  + KK ++RD  A N +LD
Sbjct: 138 MKYL--ASKKFVHRDLAARNCMLD 159

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 69/138 (50%), Gaps = 14/138 (10%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG+VYK               G + A K +  +S +  E++  E+  L    HP 
Sbjct: 19  LGDGAFGKVYKA---------KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 69
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           +VKLLG  + D +L ++ E+   G+++  +   +  +      +  +  + A   L FLH
Sbjct: 70  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA---LNFLH 126
Query: 217 TSEKKVIYRDFKASNILL 234
           +  K++I+RD KA N+L+
Sbjct: 127 S--KRIIHRDLKAGNVLM 142

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 69/138 (50%), Gaps = 14/138 (10%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG+VYK               G + A K +  +S +  E++  E+  L    HP 
Sbjct: 27  LGDGAFGKVYKA---------KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           +VKLLG  + D +L ++ E+   G+++  +   +  +      +  +  + A   L FLH
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA---LNFLH 134
Query: 217 TSEKKVIYRDFKASNILL 234
           +  K++I+RD KA N+L+
Sbjct: 135 S--KRIIHRDLKAGNVLM 150

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 80/171 (46%), Gaps = 25/171 (14%)
Query: 72  ETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL 131
           E P   V  F     AT N   D ++G G FG V  G    +   PSK  +   VAIK L
Sbjct: 29  EDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSG----RLKLPSKKEIS--VAIKTL 81
Query: 132 NPESMQGFEEWQ-----SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL 186
                 G+ E Q      E + +G+  HPN+++L G   + K +++V E M+ GSL++ L
Sbjct: 82  K----VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL 137
Query: 187 FRRNPSIQPLSWDIRLKIAIGAARGL--GFLHTSEKKVIYRDFKASNILLD 235
            + +     +         +G  RG+  G  + S+   ++RD  A NIL++
Sbjct: 138 RKHDAQFTVIQL-------VGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 72/142 (50%), Gaps = 13/142 (9%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHP 155
           LGEG FG+V     D     P     G  VA+K L PES      + + E+  L  L H 
Sbjct: 29  LGEGHFGKVELCRYD-----PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83
Query: 156 NLVKLLGYCWED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           N+VK  G C ED    + L+ E++  GSL+ +L +    I   +   +LK A+   +G+ 
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI---NLKQQLKYAVQICKGMD 140
Query: 214 FLHTSEKKVIYRDFKASNILLD 235
           +L +  ++ ++RD  A N+L++
Sbjct: 141 YLGS--RQYVHRDLAARNVLVE 160

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 72/142 (50%), Gaps = 13/142 (9%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHP 155
           LGEG FG+V     D     P     G  VA+K L PES      + + E+  L  L H 
Sbjct: 17  LGEGHFGKVELCRYD-----PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 71
Query: 156 NLVKLLGYCWED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           N+VK  G C ED    + L+ E++  GSL+ +L +    I   +   +LK A+   +G+ 
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI---NLKQQLKYAVQICKGMD 128
Query: 214 FLHTSEKKVIYRDFKASNILLD 235
           +L +  ++ ++RD  A N+L++
Sbjct: 129 YLGS--RQYVHRDLAARNVLVE 148

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G FG VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 19  LGGGQFGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 67
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q +S  + L +A   +  + +L
Sbjct: 68  NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+RD  A N L+
Sbjct: 126 E--KKNFIHRDLAARNCLV 142

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 69/142 (48%), Gaps = 12/142 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V     D     P +   G VVA+KKL   + +   +++ E+  L  L H N
Sbjct: 21  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 157 LVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           +VK  G C+    + L L+ EY+  GSL ++L      I  +     L+      +G+ +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKL---LQYTSQICKGMEY 132
Query: 215 LHTSEKKVIYRDFKASNILLDG 236
           L T  K+ I+RD    NIL++ 
Sbjct: 133 LGT--KRYIHRDLATRNILVEN 152

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/173 (32%), Positives = 80/173 (46%), Gaps = 20/173 (11%)
Query: 71  LETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK 130
           L+ PD+    F D     K F     +G G FG VY      + +  S+     VVAIKK
Sbjct: 38  LKDPDVAELFFKD--DPEKLFSDLREIGHGSFGAVYFA----RDVRNSE-----VVAIKK 86
Query: 131 LNPESMQGFEEWQS---EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLF 187
           ++    Q  E+WQ    EV FL +L HPN ++  G    +    LV EY   GS  + L 
Sbjct: 87  MSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLE 145
Query: 188 RRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                +Q +       +  GA +GL +LH+    +I+RD KA NILL   G +
Sbjct: 146 VHKKPLQEVEI---AAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLV 193

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 70/142 (49%), Gaps = 12/142 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V     D     P +   G VVA+KKL   + +   +++ E+  L  L H N
Sbjct: 19  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 73
Query: 157 LVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           +VK  G C+    + L L+ EY+  GSL ++L +    I  +     L+      +G+ +
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEY 130
Query: 215 LHTSEKKVIYRDFKASNILLDG 236
           L T  K+ I+R+    NIL++ 
Sbjct: 131 LGT--KRYIHRNLATRNILVEN 150

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 69/142 (48%), Gaps = 12/142 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V     D     P +   G VVA+KKL   + +   +++ E+  L  L H N
Sbjct: 21  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 157 LVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           +VK  G C+    + L L+ E++  GSL  +L +    I  +     L+      +G+ +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKL---LQYTSQICKGMEY 132
Query: 215 LHTSEKKVIYRDFKASNILLDG 236
           L T  K+ I+RD    NIL++ 
Sbjct: 133 LGT--KRYIHRDLATRNILVEN 152

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 70/145 (48%), Gaps = 21/145 (14%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN----PESMQGFEEWQSEVNFLGRL 152
           LGEG FG+V     D     P+  G G +VA+K L     P+   G   WQ E+  L  L
Sbjct: 17  LGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKEGCGPQLRSG---WQREIEILRTL 68
Query: 153 SHPNLVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
            H ++VK  G C +  +K + LV EY+  GSL ++L R    +  L     L  A     
Sbjct: 69  YHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICE 123
Query: 211 GLGFLHTSEKKVIYRDFKASNILLD 235
           G+ +LH   +  I+R   A N+LLD
Sbjct: 124 GMAYLHA--QHYIHRALAARNVLLD 146

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 70/145 (48%), Gaps = 21/145 (14%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN----PESMQGFEEWQSEVNFLGRL 152
           LGEG FG+V     D     P+  G G +VA+K L     P+   G   WQ E+  L  L
Sbjct: 16  LGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKEGCGPQLRSG---WQREIEILRTL 67
Query: 153 SHPNLVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
            H ++VK  G C +  +K + LV EY+  GSL ++L R    +  L     L  A     
Sbjct: 68  YHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICE 122
Query: 211 GLGFLHTSEKKVIYRDFKASNILLD 235
           G+ +LH   +  I+R   A N+LLD
Sbjct: 123 GMAYLHA--QHYIHRALAARNVLLD 145

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 68/149 (45%), Gaps = 15/149 (10%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVNFLGRLSHP 155
           LGE  FG+VYKG +      P+       VAIK L  ++     EE++ E     RL HP
Sbjct: 34  LGEDRFGKVYKGHL----FGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 89
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP--SIQPLSWDIRLKIAIG------ 207
           N+V LLG   +D+ L +++ Y   G L   L  R+P   +     D  +K A+       
Sbjct: 90  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 149
Query: 208 --AARGLGFLHTSEKKVIYRDFKASNILL 234
             A    G  + S   V+++D    N+L+
Sbjct: 150 LVAQIAAGMEYLSSHHVVHKDLATRNVLV 178

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LGEG FG+V+    +   L P +  +  +VA+K L   S    +++  E   L  L H +
Sbjct: 21  LGEGAFGKVF--LAECYNLCPEQDKI--LVAVKTLKDASDNARKDFHREAELLTNLQHEH 76
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI---------QPLSWDIRLKIAIG 207
           +VK  G C E   L++V+EYM+ G L   L    P             L+    L IA  
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILL 234
            A G+ +L  + +  ++RD    N L+
Sbjct: 137 IAAGMVYL--ASQHFVHRDLATRNCLV 161

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 21  LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 69
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q +S  + L +A   +  + +L
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+RD  A N L+
Sbjct: 128 E--KKNFIHRDLAARNCLV 144

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 21  LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 69
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q +S  + L +A   +  + +L
Sbjct: 70  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+RD  A N L+
Sbjct: 128 E--KKNFIHRDLAARNCLV 144

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 68/149 (45%), Gaps = 15/149 (10%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVNFLGRLSHP 155
           LGE  FG+VYKG +      P+       VAIK L  ++     EE++ E     RL HP
Sbjct: 17  LGEDRFGKVYKGHL----FGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP--SIQPLSWDIRLKIAIG------ 207
           N+V LLG   +D+ L +++ Y   G L   L  R+P   +     D  +K A+       
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 208 --AARGLGFLHTSEKKVIYRDFKASNILL 234
             A    G  + S   V+++D    N+L+
Sbjct: 133 LVAQIAAGMEYLSSHHVVHKDLATRNVLV 161

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 21  LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 69
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q +S  + L +A   +  + +L
Sbjct: 70  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+RD  A N L+
Sbjct: 128 E--KKNFIHRDLAARNCLV 144

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 26  LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 74
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q +S  + L +A   +  + +L
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYL 132
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+RD  A N L+
Sbjct: 133 E--KKNFIHRDLAARNCLV 149

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 19  LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 67
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q +S  + L +A   +  + +L
Sbjct: 68  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+RD  A N L+
Sbjct: 126 E--KKNFIHRDLAARNCLV 142

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 19  LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 67
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q +S  + L +A   +  + +L
Sbjct: 68  NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+RD  A N L+
Sbjct: 126 E--KKNFIHRDLAARNCLV 142

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 21  LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 69
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q +S  + L +A   +  + +L
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+RD  A N L+
Sbjct: 128 E--KKNFIHRDLAARNCLV 144

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 83/175 (47%), Gaps = 37/175 (21%)
Query: 79  FSFLDLKSATKNF---------KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK 129
           F+F D   A + F         K + ++G G FG V  G    +   P K  +   VAIK
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSG----RLKVPGKREI--CVAIK 63
Query: 130 KLNPESMQGFEEWQ-----SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLEN 184
            L      G+ + Q     SE + +G+  HPN++ L G   + K ++++ EYM+ GSL+ 
Sbjct: 64  TLK----AGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 119
Query: 185 HLFRRNPSIQPLSWDIRLKIA--IGAARGL--GFLHTSEKKVIYRDFKASNILLD 235
            L R+N        D R  +   +G  RG+  G  + S+   ++RD  A NIL++
Sbjct: 120 FL-RKN--------DGRFTVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVN 165

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 74  PDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP 133
           PD+    F D     K F     +G G FG VY      + +  S+     VVAIKK++ 
Sbjct: 2   PDVAELFFKD--DPEKLFSDLREIGHGSFGAVYFA----RDVRNSE-----VVAIKKMSY 50
Query: 134 ESMQGFEEWQS---EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRN 190
              Q  E+WQ    EV FL +L HPN ++  G    +    LV EY   GS  + L    
Sbjct: 51  SGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHK 109
Query: 191 PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
             +Q +       +  GA +GL +LH+    +I+RD KA NILL   G +
Sbjct: 110 KPLQEVEI---AAVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEPGLV 154

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 20/140 (14%)
Query: 97  LGEGGFGRVYKG-WVD-DKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH 154
           +G G FG V+ G W++ DK            VAIK +   +M   E++  E   + +LSH
Sbjct: 15  IGSGQFGLVHLGYWLNKDK------------VAIKTIREGAMSE-EDFIEEAEVMMKLSH 61
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           P LV+L G C E   + LV+E+M+ G L ++L R    +   + +  L + +    G+ +
Sbjct: 62  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGL--FAAETLLGMCLDVCEGMAY 118
Query: 215 LHTSEKKVIYRDFKASNILL 234
           L   E  VI+RD  A N L+
Sbjct: 119 LE--EASVIHRDLAARNCLV 136

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 26  LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 74
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q ++  + L +A   +  + +L
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+RD  A N L+
Sbjct: 133 E--KKNFIHRDLAARNCLV 149

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 26  LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 74
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q ++  + L +A   +  + +L
Sbjct: 75  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+RD  A N L+
Sbjct: 133 E--KKNFIHRDLAARNCLV 149

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 21  LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 69
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q ++  + L +A   +  + +L
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL 127
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+RD  A N L+
Sbjct: 128 E--KKNFIHRDLAARNCLV 144

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 21  LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 69
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q ++  + L +A   +  + +L
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL 127
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+RD  A N L+
Sbjct: 128 E--KKNFIHRDLAARNCLV 144

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 84/184 (45%), Gaps = 24/184 (13%)
Query: 71  LETPDLKVFSFLDLKSATK-NFKPDSL-----LGEGGFGRVYKGWVDDKTLAPSKTGLGM 124
           ++TP L   S  +L    K  F  D L     LGEG FG+V     +   +   K    +
Sbjct: 3   MDTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVV--MAEAVGIDKDKPKEAV 60
Query: 125 VVAIKKLNPESMQ-GFEEWQSEVNFLGRL-SHPNLVKLLGYCWEDKELLLVYEYMQRGSL 182
            VA+K L  ++ +    +  SE+  +  +  H N++ LLG C +D  L ++ EY  +G+L
Sbjct: 61  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 120
Query: 183 ENHLFRRNPSIQPLSWDIR------------LKIAIGAARGLGFLHTSEKKVIYRDFKAS 230
             +L  R P     S+DI             +      ARG+ +L  + +K I+RD  A 
Sbjct: 121 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDLAAR 178
Query: 231 NILL 234
           N+L+
Sbjct: 179 NVLV 182

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 20/140 (14%)
Query: 97  LGEGGFGRVYKG-WVD-DKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH 154
           +G G FG V+ G W++ DK            VAIK +   +M   E++  E   + +LSH
Sbjct: 13  IGSGQFGLVHLGYWLNKDK------------VAIKTIREGAMSE-EDFIEEAEVMMKLSH 59
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           P LV+L G C E   + LV+E+M+ G L ++L R    +   + +  L + +    G+ +
Sbjct: 60  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGL--FAAETLLGMCLDVCEGMAY 116
Query: 215 LHTSEKKVIYRDFKASNILL 234
           L   E  VI+RD  A N L+
Sbjct: 117 LE--EACVIHRDLAARNCLV 134

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 26  LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 74
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q ++  + L +A   +  + +L
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+RD  A N L+
Sbjct: 133 E--KKNFIHRDLAARNCLV 149

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 34  LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 82
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q ++  + L +A   +  + +L
Sbjct: 83  NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL 140
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+RD  A N L+
Sbjct: 141 E--KKNFIHRDLAARNCLV 157

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 23  LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 71
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q ++  + L +A   +  + +L
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+RD  A N L+
Sbjct: 130 E--KKNFIHRDLAARNCLV 146

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 25  LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 73
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q ++  + L +A   +  + +L
Sbjct: 74  NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL 131
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+RD  A N L+
Sbjct: 132 E--KKNFIHRDLAARNCLV 148

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 77/159 (48%), Gaps = 27/159 (16%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
           K  + + ++G G FG V K     K            VAIK++  ES +  + +  E+  
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKWRAKD-----------VAIKQIESESER--KAFIVELRQ 55
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-----SIQPLSWDIRLK 203
           L R++HPN+VKL G C     + LV EY + GSL N L    P     +   +SW     
Sbjct: 56  LSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW----- 108
Query: 204 IAIGAARGLGFLHTSEKK-VIYRDFKASNILLDGVGFLF 241
             +  ++G+ +LH+ + K +I+RD K  N+LL   G + 
Sbjct: 109 -CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVL 146

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 23  LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 71
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q ++  + L +A   +  + +L
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+RD  A N L+
Sbjct: 130 E--KKNFIHRDLAARNCLV 146

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 24/153 (15%)
Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-----S 144
           N   D ++G G FG V  G    +   PSK  +   VAIK L      G+ E Q      
Sbjct: 17  NISIDKVVGAGEFGEVCSG----RLKLPSKKEIS--VAIKTLK----VGYTEKQRRDFLG 66
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E + +G+  HPN+++L G   + K +++V E M+ GSL++ L + +     +        
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL------ 120
Query: 205 AIGAARGL--GFLHTSEKKVIYRDFKASNILLD 235
            +G  RG+  G  + S+   ++RD  A NIL++
Sbjct: 121 -VGMLRGIASGMKYLSDMGYVHRDLAARNILIN 152

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 22  LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 70
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q ++  + L +A   +  + +L
Sbjct: 71  NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL 128
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+RD  A N L+
Sbjct: 129 E--KKNFIHRDLAARNCLV 145

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 26  LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 74
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q ++  + L +A   +  + +L
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+RD  A N L+
Sbjct: 133 E--KKNFIHRDLAARNCLV 149

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 23  LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 71
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q ++  + L +A   +  + +L
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+RD  A N L+
Sbjct: 130 E--KKNFIHRDLAARNCLV 146

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 13/146 (8%)
Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           +LGEG FG V +G +  +      T L + V   KL+  S +  EE+ SE   +   SHP
Sbjct: 41  ILGEGEFGSVMEGNLKQE----DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 156 NLVKLLGYCWEDK-----ELLLVYEYMQRGSLENHLFRRNPSIQP--LSWDIRLKIAIGA 208
           N+++LLG C E       + +++  +M+ G L  +L        P  +     LK  +  
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILL 234
           A G+ +L  S +  ++RD  A N +L
Sbjct: 157 ALGMEYL--SNRNFLHRDLAARNCML 180

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 20/140 (14%)
Query: 97  LGEGGFGRVYKG-WVD-DKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH 154
           +G G FG V+ G W++ DK            VAIK +   +M   E++  E   + +LSH
Sbjct: 15  IGSGQFGLVHLGYWLNKDK------------VAIKTIREGAMSE-EDFIEEAEVMMKLSH 61
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           P LV+L G C E   + LV+E+M+ G L ++L R    +   + +  L + +    G+ +
Sbjct: 62  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGL--FAAETLLGMCLDVCEGMAY 118
Query: 215 LHTSEKKVIYRDFKASNILL 234
           L   E  VI+RD  A N L+
Sbjct: 119 LE--EACVIHRDLAARNCLV 136

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 77/159 (48%), Gaps = 27/159 (16%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
           K  + + ++G G FG V K     K            VAIK++  ES +  + +  E+  
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRAKD-----------VAIKQIESESER--KAFIVELRQ 54
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-----SIQPLSWDIRLK 203
           L R++HPN+VKL G C     + LV EY + GSL N L    P     +   +SW     
Sbjct: 55  LSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW----- 107
Query: 204 IAIGAARGLGFLHTSEKK-VIYRDFKASNILLDGVGFLF 241
             +  ++G+ +LH+ + K +I+RD K  N+LL   G + 
Sbjct: 108 -CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVL 145

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 22  LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 70
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q ++  + L +A   +  + +L
Sbjct: 71  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL 128
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+RD  A N L+
Sbjct: 129 E--KKNFIHRDLAARNCLV 145

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 69/139 (49%), Gaps = 18/139 (12%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           +G G FG V+ G W++              VAIK +   SM   +++  E   + +LSHP
Sbjct: 35  IGSGQFGLVHLGYWLNKDK-----------VAIKTIKEGSMSE-DDFIEEAEVMMKLSHP 82
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
            LV+L G C E   + LV+E+M+ G L ++L R    +   + +  L + +    G+ +L
Sbjct: 83  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGL--FAAETLLGMCLDVCEGMAYL 139
Query: 216 HTSEKKVIYRDFKASNILL 234
              E  VI+RD  A N L+
Sbjct: 140 E--EACVIHRDLAARNCLV 156

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 18/152 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRL-SH 154
           LGEG FG+V     +   +   K    + VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 43  LGEGAFGQVV--MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------L 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R P     S+DI             +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
                 ARG+ +L  + +K I+RD  A N+L+
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLV 190

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 18/152 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRL-SH 154
           LGEG FG+V     +   +   K    + VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 43  LGEGAFGQVV--MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------L 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R P     S+DI             +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
                 ARG+ +L  + +K I+RD  A N+L+
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLV 190

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 18/152 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRL-SH 154
           LGEG FG+V     +   +   K    + VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 43  LGEGAFGQVV--MAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------L 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R P     S+DI             +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
                 ARG+ +L  + +K I+RD  A N+L+
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLV 190

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 18/152 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRL-SH 154
           LGEG FG+V     +   +   K    + VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 43  LGEGAFGQVV--MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------L 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R P     S+DI             +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
                 ARG+ +L  + +K I+RD  A N+L+
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLV 190

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 18/152 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRL-SH 154
           LGEG FG+V     +   +   K    + VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 43  LGEGAFGQVV--MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------L 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R P     S+DI             +
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
                 ARG+ +L  + +K I+RD  A N+L+
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLV 190

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 18/152 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRL-SH 154
           LGEG FG+V     +   +   K    + VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 43  LGEGAFGQVV--MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------L 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R P     S+DI             +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
                 ARG+ +L  + +K I+RD  A N+L+
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLV 190

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 70/148 (47%), Gaps = 19/148 (12%)
Query: 97  LGEGGFGRV--YKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH 154
           LGEGGF  V   +G  D           G   A+K++     Q  EE Q E +     +H
Sbjct: 37  LGEGGFSYVDLVEGLHD-----------GHFYALKRILCHEQQDREEAQREADMHRLFNH 85
Query: 155 PNLVKLLGYCWEDK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           PN+++L+ YC  ++    E  L+  + +RG+L N + R       L+ D  L + +G  R
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGVG 238
           GL  +H   K   +RD K +NILL   G
Sbjct: 146 GLEAIHA--KGYAHRDLKPTNILLGDEG 171

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 69/139 (49%), Gaps = 18/139 (12%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           +G G FG V+ G W++              VAIK +   +M   E++  E   + +LSHP
Sbjct: 18  IGSGQFGLVHLGYWLNKDK-----------VAIKTIREGAMSE-EDFIEEAEVMMKLSHP 65
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
            LV+L G C E   + LV+E+M+ G L ++L R    +   + +  L + +    G+ +L
Sbjct: 66  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGL--FAAETLLGMCLDVCEGMAYL 122
Query: 216 HTSEKKVIYRDFKASNILL 234
              E  VI+RD  A N L+
Sbjct: 123 E--EACVIHRDLAARNCLV 139

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 20/144 (13%)
Query: 96  LLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLS 153
           +LG G FG VYKG WV      P    + + VAIK LN  +  +   E+  E   +  + 
Sbjct: 22  VLGSGAFGTVYKGIWV------PEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 75
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKIAIGAAR 210
           HP+LV+LLG C     + LV + M  G L  ++     +I     L+W +++      A+
Sbjct: 76  HPHLVRLLGVCLS-PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AK 128
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
           G+ +L   E+++++RD  A N+L+
Sbjct: 129 GMMYL--EERRLVHRDLAARNVLV 150

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 18/152 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRL-SH 154
           LGEG FG+V     +   L   K      VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 29  LGEGAFGQVV--LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 86
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR---------NPSIQP---LSWDIRL 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R         NPS  P   LS    +
Sbjct: 87  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
             A   ARG+ +L  + KK I+RD  A N+L+
Sbjct: 147 SCAYQVARGMEYL--ASKKCIHRDLAARNVLV 176

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 83/183 (45%), Gaps = 24/183 (13%)
Query: 72  ETPDLKVFSFLDLKSATK-NFKPDSL-----LGEGGFGRVYKGWVDDKTLAPSKTGLGMV 125
           +TP L   S  +L    K  F  D L     LGEG FG+V     +   +   K    + 
Sbjct: 58  DTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVV--MAEAVGIDKDKPKEAVT 115
Query: 126 VAIKKLNPESMQ-GFEEWQSEVNFLGRL-SHPNLVKLLGYCWEDKELLLVYEYMQRGSLE 183
           VA+K L  ++ +    +  SE+  +  +  H N++ LLG C +D  L ++ EY  +G+L 
Sbjct: 116 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 175
Query: 184 NHLFRRNPSIQPLSWDIR------------LKIAIGAARGLGFLHTSEKKVIYRDFKASN 231
            +L  R P     S+DI             +      ARG+ +L  + +K I+RD  A N
Sbjct: 176 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDLAARN 233
Query: 232 ILL 234
           +L+
Sbjct: 234 VLV 236

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 18/152 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRL-SH 154
           LGEG FG+V     +   L   K      VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 36  LGEGAFGQVV--LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR---------NPSIQP---LSWDIRL 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R         NPS  P   LS    +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
             A   ARG+ +L  + KK I+RD  A N+L+
Sbjct: 154 SCAYQVARGMEYL--ASKKCIHRDLAARNVLV 183

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 18/152 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRL-SH 154
           LGEG FG+V     +   L   K      VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 77  LGEGAFGQVV--LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR---------NPSIQP---LSWDIRL 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R         NPS  P   LS    +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
             A   ARG+ +L  + KK I+RD  A N+L+
Sbjct: 195 SCAYQVARGMEYL--ASKKCIHRDLAARNVLV 224

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 18/152 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRL-SH 154
           LGEG FG+V     +   +   K    + VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 43  LGEGAFGQVV--MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------L 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R P     S+DI             +
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
                 ARG+ +L  + +K I+RD  A N+L+
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLV 190

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 18/152 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRL-SH 154
           LGEG FG+V     +   L   K      VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 21  LGEGAFGQVV--LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR---------NPSIQP---LSWDIRL 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R         NPS  P   LS    +
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
             A   ARG+ +L  + KK I+RD  A N+L+
Sbjct: 139 SCAYQVARGMEYL--ASKKCIHRDLAARNVLV 168

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 18/152 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRL-SH 154
           LGEG FG+V     +   L   K      VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 36  LGEGAFGQVV--LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR---------NPSIQP---LSWDIRL 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R         NPS  P   LS    +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
             A   ARG+ +L  + KK I+RD  A N+L+
Sbjct: 154 SCAYQVARGMEYL--ASKKCIHRDLAARNVLV 183

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 18/152 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRL-SH 154
           LGEG FG+V     +   L   K      VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 36  LGEGAFGQVV--LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR---------NPSIQP---LSWDIRL 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R         NPS  P   LS    +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
             A   ARG+ +L  + KK I+RD  A N+L+
Sbjct: 154 SCAYQVARGMEYL--ASKKCIHRDLAARNVLV 183

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 18/152 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRL-SH 154
           LGEG FG+V     +   L   K      VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 28  LGEGAFGQVV--LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 85
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR---------NPSIQP---LSWDIRL 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R         NPS  P   LS    +
Sbjct: 86  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
             A   ARG+ +L  + KK I+RD  A N+L+
Sbjct: 146 SCAYQVARGMEYL--ASKKCIHRDLAARNVLV 175

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 18/152 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRL-SH 154
           LGEG FG+V     +   L   K      VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 25  LGEGAFGQVV--LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 82
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR---------NPSIQP---LSWDIRL 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R         NPS  P   LS    +
Sbjct: 83  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
             A   ARG+ +L  + KK I+RD  A N+L+
Sbjct: 143 SCAYQVARGMEYL--ASKKCIHRDLAARNVLV 172

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 18/152 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRL-SH 154
           LGEG FG+V     +   L   K      VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 36  LGEGAFGQVV--LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR---------NPSIQP---LSWDIRL 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R         NPS  P   LS    +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
             A   ARG+ +L  + KK I+RD  A N+L+
Sbjct: 154 SCAYQVARGMEYL--ASKKCIHRDLAARNVLV 183

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 18/152 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRL-SH 154
           LGEG FG+V     +   +   K    + VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 30  LGEGCFGQVV--MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------L 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R P     S+DI             +
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
                 ARG+ +L  + +K I+RD  A N+L+
Sbjct: 148 SCTYQLARGMEYL--ASQKCIHRDLTARNVLV 177

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 70/139 (50%), Gaps = 18/139 (12%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           +G G FG VYKG W  D           + V I K+   + + F+ +++EV  L +  H 
Sbjct: 44  IGSGSFGTVYKGKWHGD-----------VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHV 92
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           N++  +GY  +D  L +V ++ +  SL  HL  +    Q       + IA   A+G+ +L
Sbjct: 93  NILLFMGYMTKD-NLAIVTQWCEGSSLYKHLHVQETKFQMFQL---IDIARQTAQGMDYL 148
Query: 216 HTSEKKVIYRDFKASNILL 234
           H   K +I+RD K++NI L
Sbjct: 149 HA--KNIIHRDMKSNNIFL 165

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 18/152 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRL-SH 154
           LGEG FG+V     +   +   K    + VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 32  LGEGCFGQVV--MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------L 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R P     S+DI             +
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
                 ARG+ +L  + +K I+RD  A N+L+
Sbjct: 150 SCTYQLARGMEYL--ASQKCIHRDLAARNVLV 179

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 70/139 (50%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 40  LGGGQYGEVYVGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 88
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    +V EYM  G+L ++L  R  + + ++  + L +A   +  + +L
Sbjct: 89  NLVQLLGVCTLEPPFYIVTEYMPYGNLLDYL--RECNREEVTAVVLLYMATQISSAMEYL 146
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+RD  A N L+
Sbjct: 147 E--KKNFIHRDLAARNCLV 163

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 228 LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 276
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q +S  + L +A   +  + +L
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+R+  A N L+
Sbjct: 335 E--KKNFIHRNLAARNCLV 351

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 72/138 (52%), Gaps = 16/138 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V+ G+ +  T           VA+K L   SM   + + +E N + +L H  
Sbjct: 16  LGAGQFGEVWMGYYNGHT----------KVAVKSLKQGSMSP-DAFLAEANLMKQLQHQR 64
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV+L     ++  + ++ EYM+ GSL +  F + PS   L+ +  L +A   A G+ F+ 
Sbjct: 65  LVRLYAVVTQEP-IYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 121
Query: 217 TSEKKVIYRDFKASNILL 234
             E+  I+RD +A+NIL+
Sbjct: 122 --ERNYIHRDLRAANILV 137

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 85/183 (46%), Gaps = 37/183 (20%)
Query: 73  TPDLKVF----SFLDLKSATKNF---------KPDSLLGEGGFGRVYKGWVDDKTLAPSK 119
           TP +K+F    +F D   A + F         K + ++G G FG V  G +      P K
Sbjct: 4   TPGMKIFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLK----LPGK 59
Query: 120 TGLGMVVAIKKLNPESMQGFEEWQ-----SEVNFLGRLSHPNLVKLLGYCWEDKELLLVY 174
             +   VAIK L      G+ E Q     SE + +G+  HPN++ L G   +   ++++ 
Sbjct: 60  REI--FVAIKTLK----SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 113
Query: 175 EYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL--GFLHTSEKKVIYRDFKASNI 232
           E+M+ GSL++ L + +     +         +G  RG+  G  + ++   ++RD  A NI
Sbjct: 114 EFMENGSLDSFLRQNDGQFTVIQL-------VGMLRGIAAGMKYLADMNYVHRDLAARNI 166
Query: 233 LLD 235
           L++
Sbjct: 167 LVN 169

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 72/144 (50%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLN-----PESMQGFEEWQSEVNFLG 150
           +G G FG VYKG W  D             VA+K LN     P+ +Q F   ++EV  L 
Sbjct: 20  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAF---KNEVGVLR 63
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           +  H N++  +GY  +  +L +V ++ +  SL +HL   + S         + IA   AR
Sbjct: 64  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTAR 119
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
           G+ +LH   K +I+RD K++NI L
Sbjct: 120 GMDYLHA--KSIIHRDLKSNNIFL 141

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 72/144 (50%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLN-----PESMQGFEEWQSEVNFLG 150
           +G G FG VYKG W  D             VA+K LN     P+ +Q F   ++EV  L 
Sbjct: 32  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAF---KNEVGVLR 75
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           +  H N++  +GY  +  +L +V ++ +  SL +HL   + S         + IA   AR
Sbjct: 76  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTAR 131
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
           G+ +LH   K +I+RD K++NI L
Sbjct: 132 GMDYLHA--KSIIHRDLKSNNIFL 153

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 72/138 (52%), Gaps = 16/138 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V+ G+ +  T           VA+K L   SM   + + +E N + +L H  
Sbjct: 21  LGAGQFGEVWMGYYNGHT----------KVAVKSLKQGSMSP-DAFLAEANLMKQLQHQR 69
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV+L     ++  + ++ EYM+ GSL +  F + PS   L+ +  L +A   A G+ F+ 
Sbjct: 70  LVRLYAVVTQEP-IYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 217 TSEKKVIYRDFKASNILL 234
             E+  I+RD +A+NIL+
Sbjct: 127 --ERNYIHRDLRAANILV 142

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 72/138 (52%), Gaps = 16/138 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V+ G+ +  T           VA+K L   SM   + + +E N + +L H  
Sbjct: 21  LGAGQFGEVWMGYYNGHT----------KVAVKSLKQGSMSP-DAFLAEANLMKQLQHQR 69
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV+L     ++  + ++ EYM+ GSL +  F + PS   L+ +  L +A   A G+ F+ 
Sbjct: 70  LVRLYAVVTQEP-IYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 217 TSEKKVIYRDFKASNILL 234
             E+  I+RD +A+NIL+
Sbjct: 127 --ERNYIHRDLRAANILV 142

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 72/138 (52%), Gaps = 16/138 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V+ G+ +  T           VA+K L   SM   + + +E N + +L H  
Sbjct: 22  LGAGQFGEVWMGYYNGHT----------KVAVKSLKQGSMSP-DAFLAEANLMKQLQHQR 70
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV+L     ++  + ++ EYM+ GSL +  F + PS   L+ +  L +A   A G+ F+ 
Sbjct: 71  LVRLYAVVTQEP-IYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 127
Query: 217 TSEKKVIYRDFKASNILL 234
             E+  I+RD +A+NIL+
Sbjct: 128 --ERNYIHRDLRAANILV 143

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 72/138 (52%), Gaps = 16/138 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V+ G+ +  T           VA+K L   SM   + + +E N + +L H  
Sbjct: 27  LGAGQFGEVWMGYYNGHT----------KVAVKSLKQGSMSP-DAFLAEANLMKQLQHQR 75
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV+L     ++  + ++ EYM+ GSL +  F + PS   L+ +  L +A   A G+ F+ 
Sbjct: 76  LVRLYAVVTQEP-IYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 132
Query: 217 TSEKKVIYRDFKASNILL 234
             E+  I+RD +A+NIL+
Sbjct: 133 --ERNYIHRDLRAANILV 148

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 72/138 (52%), Gaps = 16/138 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V+ G+ +  T           VA+K L   SM   + + +E N + +L H  
Sbjct: 23  LGAGQFGEVWMGYYNGHT----------KVAVKSLKQGSMSP-DAFLAEANLMKQLQHQR 71
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV+L     ++  + ++ EYM+ GSL +  F + PS   L+ +  L +A   A G+ F+ 
Sbjct: 72  LVRLYAVVTQEP-IYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 128
Query: 217 TSEKKVIYRDFKASNILL 234
             E+  I+RD +A+NIL+
Sbjct: 129 --ERNYIHRDLRAANILV 144

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 72/138 (52%), Gaps = 16/138 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V+ G+ +  T           VA+K L   SM   + + +E N + +L H  
Sbjct: 26  LGAGQFGEVWMGYYNGHT----------KVAVKSLKQGSMSP-DAFLAEANLMKQLQHQR 74
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV+L     ++  + ++ EYM+ GSL +  F + PS   L+ +  L +A   A G+ F+ 
Sbjct: 75  LVRLYAVVTQEP-IYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 131
Query: 217 TSEKKVIYRDFKASNILL 234
             E+  I+RD +A+NIL+
Sbjct: 132 --ERNYIHRDLRAANILV 147

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 72/138 (52%), Gaps = 16/138 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V+ G+ +  T           VA+K L   SM   + + +E N + +L H  
Sbjct: 31  LGAGQFGEVWMGYYNGHT----------KVAVKSLKQGSMSP-DAFLAEANLMKQLQHQR 79
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV+L     ++  + ++ EYM+ GSL +  F + PS   L+ +  L +A   A G+ F+ 
Sbjct: 80  LVRLYAVVTQEP-IYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 136
Query: 217 TSEKKVIYRDFKASNILL 234
             E+  I+RD +A+NIL+
Sbjct: 137 --ERNYIHRDLRAANILV 152

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 72/138 (52%), Gaps = 16/138 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V+ G+ +  T           VA+K L   SM   + + +E N + +L H  
Sbjct: 30  LGAGQFGEVWMGYYNGHT----------KVAVKSLKQGSMSP-DAFLAEANLMKQLQHQR 78
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV+L     ++  + ++ EYM+ GSL +  F + PS   L+ +  L +A   A G+ F+ 
Sbjct: 79  LVRLYAVVTQEP-IYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 135
Query: 217 TSEKKVIYRDFKASNILL 234
             E+  I+RD +A+NIL+
Sbjct: 136 --ERNYIHRDLRAANILV 151

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 70/140 (50%), Gaps = 20/140 (14%)
Query: 97  LGEGGFGRVYKG-WVD-DKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH 154
           +G G FG V+ G W++ DK            VAIK +   +M   E++  E   + +LSH
Sbjct: 16  IGSGQFGLVHLGYWLNKDK------------VAIKTIREGAMSE-EDFIEEAEVMMKLSH 62
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           P LV+L G C E   + LV E+M+ G L ++L R    +   + +  L + +    G+ +
Sbjct: 63  PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGL--FAAETLLGMCLDVCEGMAY 119
Query: 215 LHTSEKKVIYRDFKASNILL 234
           L   E  VI+RD  A N L+
Sbjct: 120 LE--EACVIHRDLAARNCLV 137

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 72/138 (52%), Gaps = 16/138 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V+ G+ +  T           VA+K L   SM   + + +E N + +L H  
Sbjct: 27  LGAGQFGEVWMGYYNGHT----------KVAVKSLKQGSMSP-DAFLAEANLMKQLQHQR 75
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV+L     ++  + ++ EYM+ GSL +  F + PS   L+ +  L +A   A G+ F+ 
Sbjct: 76  LVRLYAVVTQEP-IYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 132
Query: 217 TSEKKVIYRDFKASNILL 234
             E+  I+RD +A+NIL+
Sbjct: 133 --ERNYIHRDLRAANILV 148

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 72/138 (52%), Gaps = 16/138 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V+ G+ +  T           VA+K L   SM   + + +E N + +L H  
Sbjct: 21  LGAGQFGEVWMGYYNGHT----------KVAVKSLKQGSMSP-DAFLAEANLMKQLQHQR 69
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV+L     ++  + ++ EYM+ GSL +  F + PS   L+ +  L +A   A G+ F+ 
Sbjct: 70  LVRLYAVVTQEP-IYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 217 TSEKKVIYRDFKASNILL 234
             E+  I+RD +A+NIL+
Sbjct: 127 --ERNYIHRDLRAANILV 142

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 72/138 (52%), Gaps = 16/138 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V+ G+ +  T           VA+K L   SM   + + +E N + +L H  
Sbjct: 29  LGAGQFGEVWMGYYNGHT----------KVAVKSLKQGSMSP-DAFLAEANLMKQLQHQR 77
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV+L     ++  + ++ EYM+ GSL +  F + PS   L+ +  L +A   A G+ F+ 
Sbjct: 78  LVRLYAVVTQEP-IYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 134
Query: 217 TSEKKVIYRDFKASNILL 234
             E+  I+RD +A+NIL+
Sbjct: 135 --ERNYIHRDLRAANILV 150

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 66/143 (46%), Gaps = 24/143 (16%)
Query: 97  LGEGGFGRV----YKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL 152
           LG G FG V    +KG  D              VA+K +   SM   E +Q E   + +L
Sbjct: 16  LGSGQFGVVKLGKWKGQYD--------------VAVKMIKEGSMSEDEFFQ-EAQTMMKL 60
Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
           SHP LVK  G C ++  + +V EY+  G L N+L      ++P      L++      G+
Sbjct: 61  SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL---LEMCYDVCEGM 117
Query: 213 GFLHTSEKKVIYRDFKASNILLD 235
            FL + +   I+RD  A N L+D
Sbjct: 118 AFLESHQ--FIHRDLAARNCLVD 138

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 71/144 (49%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLN-----PESMQGFEEWQSEVNFLG 150
           +G G FG VYKG W  D             VA+K LN     P+ +Q F   ++EV  L 
Sbjct: 32  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAF---KNEVGVLR 75
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           +  H N++  +GY     +L +V ++ +  SL +HL   + S         + IA   AR
Sbjct: 76  KTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTAR 131
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
           G+ +LH   K +I+RD K++NI L
Sbjct: 132 GMDYLHA--KSIIHRDLKSNNIFL 153

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 85/164 (51%), Gaps = 23/164 (14%)
Query: 76  LKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPE 134
           +KV + +  ++  +  K   +LG G FG V+KG W+      P    + + V IK +  +
Sbjct: 3   MKVLARIFKETELRKLK---VLGSGVFGTVHKGVWI------PEGESIKIPVCIKVIEDK 53
Query: 135 S-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI 193
           S  Q F+     +  +G L H ++V+LLG C     L LV +Y+  GSL +H+ +   ++
Sbjct: 54  SGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGAL 112
Query: 194 QP---LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
            P   L+W +++      A+G+ +L   E  +++R+  A N+LL
Sbjct: 113 GPQLLLNWGVQI------AKGMYYL--EEHGMVHRNLAARNVLL 148

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 18/152 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRL-SH 154
           LGEG FG+V     +   +   K    + VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 43  LGEGAFGQVV--MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------L 202
            N++ LLG C +D  L ++  Y  +G+L  +L  R P     S+DI             +
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
                 ARG+ +L  + +K I+RD  A N+L+
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLV 190

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 267 LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 315
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q ++  + L +A   +  + +L
Sbjct: 316 NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL 373
Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+R+  A N L+
Sbjct: 374 --EKKNFIHRNLAARNCLV 390

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 76/154 (49%), Gaps = 28/154 (18%)
Query: 91  FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-----SE 145
            K + ++G G FG V  G    +   P K  +   VAIK L      G+ + Q     SE
Sbjct: 10  IKIEKVIGVGEFGEVCSG----RLKVPGKREI--CVAIKTLK----AGYTDKQRRDFLSE 59
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
            + +G+  HPN++ L G   + K ++++ EYM+ GSL+  L R+N        D R  + 
Sbjct: 60  ASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL-RKN--------DGRFTVI 110
Query: 206 --IGAARGL--GFLHTSEKKVIYRDFKASNILLD 235
             +G  RG+  G  + S+   ++RD  A NIL++
Sbjct: 111 QLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVN 144

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 76/154 (49%), Gaps = 28/154 (18%)
Query: 91  FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-----SE 145
            K + ++G G FG V  G    +   P K  +   VAIK L      G+ + Q     SE
Sbjct: 16  IKIEKVIGVGEFGEVCSG----RLKVPGKREI--CVAIKTLK----AGYTDKQRRDFLSE 65
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
            + +G+  HPN++ L G   + K ++++ EYM+ GSL+  L R+N        D R  + 
Sbjct: 66  ASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL-RKN--------DGRFTVI 116
Query: 206 --IGAARGL--GFLHTSEKKVIYRDFKASNILLD 235
             +G  RG+  G  + S+   ++RD  A NIL++
Sbjct: 117 QLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVN 150

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 76/144 (52%), Gaps = 20/144 (13%)
Query: 96  LLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLS 153
           +LG G FG V+KG W+      P    + + V IK +  +S  Q F+     +  +G L 
Sbjct: 38  VLGSGVFGTVHKGVWI------PEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 91
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKIAIGAAR 210
           H ++V+LLG C     L LV +Y+  GSL +H+ +   ++ P   L+W +++      A+
Sbjct: 92  HAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AK 144
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
           G+ +L   E  +++R+  A N+LL
Sbjct: 145 GMYYL--EEHGMVHRNLAARNVLL 166

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 73/147 (49%), Gaps = 23/147 (15%)
Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-----SEVNFLG 150
           ++G G FG VYKG +  KT +  K    + VAIK L      G+ E Q      E   +G
Sbjct: 51  VIGAGEFGEVYKGML--KTSSGKKE---VPVAIKTLK----AGYTEKQRVDFLGEAGIMG 101
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           + SH N+++L G   + K ++++ EYM+ G+L+  L  ++     L         +G  R
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL-------VGMLR 154
Query: 211 GL--GFLHTSEKKVIYRDFKASNILLD 235
           G+  G  + +    ++RD  A NIL++
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILVN 181

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 76/167 (45%), Gaps = 27/167 (16%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE-WQSEVN 147
           +N +   +LG G FG+V    ++      SKTG+ + VA+K L  ++     E   SE+ 
Sbjct: 45  ENLEFGKVLGSGAFGKV----MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 148 FLGRL-SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL-------------------F 187
            + +L SH N+V LLG C     + L++EY   G L N+L                    
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 188 RRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
                +  L+++  L  A   A+G+ FL    K  ++RD  A N+L+
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLV 205

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 72/138 (52%), Gaps = 16/138 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V+ G+ +  T           VA+K L   SM   + + +E N + +L H  
Sbjct: 17  LGAGQFGEVWMGYYNGHT----------KVAVKSLKQGSMSP-DAFLAEANLMKQLQHQR 65
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV+L     ++  + ++ EYM+ GSL +  F + PS   L+ +  L +A   A G+ F+ 
Sbjct: 66  LVRLYAVVTQEP-IYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 122
Query: 217 TSEKKVIYRDFKASNILL 234
             E+  I+R+ +A+NIL+
Sbjct: 123 --ERNYIHRNLRAANILV 138

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 18/152 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRL-SH 154
           LGEG FG+V     +   +   K    + VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 43  LGEGAFGQVV--MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------L 202
            N++ LLG C +D  L ++  Y  +G+L  +L  R P     S+DI             +
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
                 ARG+ +L  + +K I+RD  A N+L+
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLV 190

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G          +T     VAIK +N   SM+   E+ +E + +   +  
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETR----VAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG   + +  L++ E M RG L+++L         NP + P S    +++A   A
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ +L+ +  K ++RD  A N ++
Sbjct: 142 DGMAYLNAN--KFVHRDLAARNCMV 164

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G          +T     VAIK +N   SM+   E+ +E + +   +  
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETR----VAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG   + +  L++ E M RG L+++L         NP + P S    +++A   A
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ +L+ +  K ++RD  A N ++
Sbjct: 142 DGMAYLNAN--KFVHRDLAARNCMV 164

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G          +T     VAIK +N   SM+   E+ +E + +   +  
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETR----VAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG   + +  L++ E M RG L+++L         NP + P S    +++A   A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 148
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ +L+ +  K ++RD  A N ++
Sbjct: 149 DGMAYLNAN--KFVHRDLAARNCMV 171

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G          +T     VAIK +N   SM+   E+ +E + +   +  
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETR----VAIKTVNEAASMRERIEFLNEASVMKEFNCH 110
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG   + +  L++ E M RG L+++L         NP + P S    +++A   A
Sbjct: 111 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 170
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ +L+ +  K ++RD  A N ++
Sbjct: 171 DGMAYLNAN--KFVHRDLAARNCMV 193

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G          +T     VAIK +N   SM+   E+ +E + +   +  
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETR----VAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG   + +  L++ E M RG L+++L         NP + P S    +++A   A
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ +L+ +  K ++RD  A N ++
Sbjct: 143 DGMAYLNAN--KFVHRDLAARNCMV 165

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G          +T     VAIK +N   SM+   E+ +E + +   +  
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETR----VAIKTVNEAASMRERIEFLNEASVMKEFNCH 79
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG   + +  L++ E M RG L+++L         NP + P S    +++A   A
Sbjct: 80  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 139
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ +L+ +  K ++RD  A N ++
Sbjct: 140 DGMAYLNAN--KFVHRDLAARNCMV 162

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G          +T     VAIK +N   SM+   E+ +E + +   +  
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETR----VAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG   + +  L++ E M RG L+++L         NP + P S    +++A   A
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ +L+ +  K ++RD  A N ++
Sbjct: 136 DGMAYLNAN--KFVHRDLAARNCMV 158

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G          +T     VAIK +N   SM+   E+ +E + +   +  
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETR----VAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG   + +  L++ E M RG L+++L         NP + P S    +++A   A
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ +L+ +  K ++RD  A N ++
Sbjct: 143 DGMAYLNAN--KFVHRDLAARNCMV 165

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 25/171 (14%)
Query: 72  ETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL 131
           E P+  V  F     A+     + ++G G FG V  G    +   P K  L   VAIK L
Sbjct: 6   EDPNQAVHEFAKEIEAS-CITIERVIGAGEFGEVCSG----RLKLPGKRELP--VAIKTL 58
Query: 132 NPESMQGFEEWQ-----SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL 186
                 G+ E Q      E + +G+  HPN++ L G   + K +++V EYM+ GSL+  L
Sbjct: 59  K----VGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFL 114
Query: 187 FRRNPSIQPLSWDIRLKIAIGAARGL--GFLHTSEKKVIYRDFKASNILLD 235
            + +     +         +G  RG+  G  + S+   ++RD  A NIL++
Sbjct: 115 KKNDGQFTVIQL-------VGMLRGISAGMKYLSDMGYVHRDLAARNILIN 158

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 21/150 (14%)
Query: 91  FKPDSL-----LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVA-IKKLNPESMQGFEEWQS 144
           F+P  L     LG+G FG+  K       +   +TG  MV+  + + + E+ + F     
Sbjct: 7   FRPSDLIHGEVLGKGCFGQAIK-------VTHRETGEVMVMKELIRFDEETQRTF---LK 56
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           EV  +  L HPN++K +G  ++DK L  + EY++ G+L   + +   S  P  W  R+  
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRG-IIKSMDSQYP--WSQRVSF 113
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           A   A G+ +LH+    +I+RD  + N L+
Sbjct: 114 AKDIASGMAYLHSM--NIIHRDLNSHNCLV 141

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G          +T     VAIK +N   SM+   E+ +E + +   +  
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETR----VAIKTVNEAASMRERIEFLNEASVMKEFNCH 73
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG   + +  L++ E M RG L+++L         NP + P S    +++A   A
Sbjct: 74  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 133
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ +L+ +  K ++RD  A N ++
Sbjct: 134 DGMAYLNAN--KFVHRDLAARNCMV 156

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 72/144 (50%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLN-----PESMQGFEEWQSEVNFLG 150
           +G G FG VYKG W  D             VA+K LN     P+ +Q F   ++EV  L 
Sbjct: 21  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAF---KNEVGVLR 64
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           +  H N++  +GY  +  +L +V ++ +  SL +HL       + +     + IA   A+
Sbjct: 65  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQ 120
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
           G+ +LH   K +I+RD K++NI L
Sbjct: 121 GMDYLHA--KSIIHRDLKSNNIFL 142

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 72/144 (50%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLN-----PESMQGFEEWQSEVNFLG 150
           +G G FG VYKG W  D             VA+K LN     P+ +Q F   ++EV  L 
Sbjct: 18  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAF---KNEVGVLR 61
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           +  H N++  +GY  +  +L +V ++ +  SL +HL       + +     + IA   A+
Sbjct: 62  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQ 117
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
           G+ +LH   K +I+RD K++NI L
Sbjct: 118 GMDYLHA--KSIIHRDLKSNNIFL 139

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G          +T     VAIK +N   SM+   E+ +E + +   +  
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETR----VAIKTVNEAASMRERIEFLNEASVMKEFNCH 78
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG   + +  L++ E M RG L+++L         NP + P S    +++A   A
Sbjct: 79  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 138
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ +L+ +  K ++RD  A N ++
Sbjct: 139 DGMAYLNAN--KFVHRDLAARNCMV 161

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 72/144 (50%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLN-----PESMQGFEEWQSEVNFLG 150
           +G G FG VYKG W  D             VA+K LN     P+ +Q F   ++EV  L 
Sbjct: 16  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAF---KNEVGVLR 59
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           +  H N++  +GY  +  +L +V ++ +  SL +HL       + +     + IA   A+
Sbjct: 60  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQ 115
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
           G+ +LH   K +I+RD K++NI L
Sbjct: 116 GMDYLHA--KSIIHRDLKSNNIFL 137

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 82/189 (43%), Gaps = 29/189 (15%)
Query: 69  QILETPDLKVFSFLDLKS---------ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSK 119
           +I+E+ +   ++F+D               N +    LG G FG+V    V+       K
Sbjct: 17  KIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKV----VEATAFGLGK 72
Query: 120 TGLGMVVAIKKLNPESMQGFEE-WQSEVNFLGRL-SHPNLVKLLGYCWEDKELLLVYEYM 177
               + VA+K L   +    +E   SE+  +  L  H N+V LLG C     +L++ EY 
Sbjct: 73  EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYC 132
Query: 178 QRGSLENHLFRR---------NPSIQP---LSWDIRLKIAIGAARGLGFLHTSEKKVIYR 225
             G L N L R+         NPS  P   LS    L  +   A+G+ FL  + K  I+R
Sbjct: 133 CYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL--ASKNCIHR 190
Query: 226 DFKASNILL 234
           D  A N+LL
Sbjct: 191 DVAARNVLL 199

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G          +T     VAIK +N   SM+   E+ +E + +   +  
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETR----VAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG   + +  L++ E M RG L+++L         NP + P S    +++A   A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ +L+ +  K ++RD  A N ++
Sbjct: 149 DGMAYLNAN--KFVHRDLAARNCMV 171

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 72/144 (50%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLN-----PESMQGFEEWQSEVNFLG 150
           +G G FG VYKG W  D             VA+K LN     P+ +Q F   ++EV  L 
Sbjct: 21  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAF---KNEVGVLR 64
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           +  H N++  +GY  +  +L +V ++ +  SL +HL       + +     + IA   A+
Sbjct: 65  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQ 120
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
           G+ +LH   K +I+RD K++NI L
Sbjct: 121 GMDYLHA--KSIIHRDLKSNNIFL 142

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 20/164 (12%)
Query: 82  LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN----PESMQ 137
           LD+KS  K ++    LGEG F  VYK   D  T          +VAIKK+      E+  
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKAR-DKNT--------NQIVAIKKIKLGHRSEAKD 53
Query: 138 GFEEWQ-SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPL 196
           G       E+  L  LSHPN++ LL        + LV+++M+   LE  +   +  + P 
Sbjct: 54  GINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPS 112
Query: 197 SWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                + + +   +GL +LH  +  +++RD K +N+LLD  G L
Sbjct: 113 HIKAYMLMTL---QGLEYLH--QHWILHRDLKPNNLLLDENGVL 151

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 72/144 (50%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLN-----PESMQGFEEWQSEVNFLG 150
           +G G FG VYKG W  D             VA+K LN     P+ +Q F   ++EV  L 
Sbjct: 16  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAF---KNEVGVLR 59
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           +  H N++  +GY  +  +L +V ++ +  SL +HL       + +     + IA   A+
Sbjct: 60  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQ 115
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
           G+ +LH   K +I+RD K++NI L
Sbjct: 116 GMDYLHA--KSIIHRDLKSNNIFL 137

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 72/144 (50%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLN-----PESMQGFEEWQSEVNFLG 150
           +G G FG VYKG W  D             VA+K LN     P+ +Q F   ++EV  L 
Sbjct: 36  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAF---KNEVGVLR 79
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           +  H N++  +GY  +  +L +V ++ +  SL +HL       + +     + IA   A+
Sbjct: 80  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQ 135
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
           G+ +LH   K +I+RD K++NI L
Sbjct: 136 GMDYLHA--KSIIHRDLKSNNIFL 157

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 16/154 (10%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQS 144
           + +NF+    +GEG +G VYK               G VVA+KK  L+ E+         
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIR 52
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E++ L  L+HPN+VKLL     + +L LV+E++   S++   F    ++  +   +    
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSY 109
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +GL F H+   +V++RD K  N+L++  G
Sbjct: 110 LFQLLQGLAFCHSH--RVLHRDLKPENLLINTEG 141

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 15/158 (9%)
Query: 86  SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-S 144
           S++  FK    LG G +  VYKG   +KT        G+ VA+K++  +S +G       
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGL--NKTT-------GVYVALKEVKLDSEEGTPSTAIR 52
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK- 203
           E++ +  L H N+V+L      + +L LV+E+M    L+ ++  R     P   ++ L  
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVK 111
Query: 204 -IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                  +GL F H  E K+++RD K  N+L++  G L
Sbjct: 112 YFQWQLLQGLAFCH--ENKILHRDLKPQNLLINKRGQL 147

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 72/144 (50%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLN-----PESMQGFEEWQSEVNFLG 150
           +G G FG VYKG W  D             VA+K LN     P+ +Q F   ++EV  L 
Sbjct: 43  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAF---KNEVGVLR 86
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           +  H N++  +GY  +  +L +V ++ +  SL +HL       + +     + IA   A+
Sbjct: 87  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQ 142
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
           G+ +LH   K +I+RD K++NI L
Sbjct: 143 GMDYLHA--KSIIHRDLKSNNIFL 164

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 16/154 (10%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQS 144
           + +NF+    +GEG +G VYK               G VVA+KK  L+ E+         
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIR 54
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E++ L  L+HPN+VKLL     + +L LV+E++   S++   F    ++  +   +    
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSY 111
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +GL F H+   +V++RD K  N+L++  G
Sbjct: 112 LFQLLQGLAFCHSH--RVLHRDLKPENLLINTEG 143

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 16/154 (10%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQS 144
           + +NF+    +GEG +G VYK               G VVA+KK  L+ E+         
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIR 54
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E++ L  L+HPN+VKLL     + +L LV+E++   S++   F    ++  +   +    
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSY 111
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +GL F H+   +V++RD K  N+L++  G
Sbjct: 112 LFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEG 143

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 72/144 (50%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLN-----PESMQGFEEWQSEVNFLG 150
           +G G FG VYKG W  D             VA+K LN     P+ +Q F   ++EV  L 
Sbjct: 44  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAF---KNEVGVLR 87
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           +  H N++  +GY  +  +L +V ++ +  SL +HL       + +     + IA   A+
Sbjct: 88  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQ 143
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
           G+ +LH   K +I+RD K++NI L
Sbjct: 144 GMDYLHA--KSIIHRDLKSNNIFL 165

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 71/144 (49%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLN-----PESMQGFEEWQSEVNFLG 150
           +G G FG VYKG W  D             VA+K LN     P+ +Q F   ++EV  L 
Sbjct: 16  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAF---KNEVGVLR 59
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           +  H N++  +GY     +L +V ++ +  SL +HL       + +     + IA   A+
Sbjct: 60  KTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQ 115
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
           G+ +LH   K +I+RD K++NI L
Sbjct: 116 GMDYLHA--KSIIHRDLKSNNIFL 137

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 72/144 (50%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLN-----PESMQGFEEWQSEVNFLG 150
           +G G FG VYKG W  D             VA+K LN     P+ +Q F   ++EV  L 
Sbjct: 44  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAF---KNEVGVLR 87
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           +  H N++  +GY  +  +L +V ++ +  SL +HL       + +     + IA   A+
Sbjct: 88  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQ 143
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
           G+ +LH   K +I+RD K++NI L
Sbjct: 144 GMDYLHA--KSIIHRDLKSNNIFL 165

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 16/154 (10%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQS 144
           + +NF+    +GEG +G VYK               G VVA+KK  L+ E+         
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIR 53
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E++ L  L+HPN+VKLL     + +L LV+E++   S++   F    ++  +   +    
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSY 110
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +GL F H+   +V++RD K  N+L++  G
Sbjct: 111 LFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEG 142

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 16/148 (10%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
           ++ K +  LG G FG V+    +  T           VA+K + P SM   E + +E N 
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHT----------KVAVKTMKPGSM-SVEAFLAEANV 230
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           +  L H  LVKL     ++  + ++ E+M +GSL + L     S QPL   I     I  
Sbjct: 231 MKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI-- 287
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDG 236
           A G+ F+   ++  I+RD +A+NIL+  
Sbjct: 288 AEGMAFIE--QRNYIHRDLRAANILVSA 313

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 16/148 (10%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
           ++ K +  LG G FG V+    +  T           VA+K + P SM   E + +E N 
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHT----------KVAVKTMKPGSM-SVEAFLAEANV 63
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           +  L H  LVKL     ++  + ++ E+M +GSL + L     S QPL   I     I  
Sbjct: 64  MKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI-- 120
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDG 236
           A G+ F+   ++  I+RD +A+NIL+  
Sbjct: 121 AEGMAFIE--QRNYIHRDLRAANILVSA 146

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 76/168 (45%), Gaps = 29/168 (17%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLG-MVVAIKKLNPE-SMQGFEEWQSEV 146
           KN      LGEG FG+V K      T    K   G   VA+K L    S     +  SE 
Sbjct: 23  KNLVLGKTLGEGEFGKVVKA-----TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEF 77
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR----------------- 189
           N L +++HP+++KL G C +D  LLL+ EY + GSL   L                    
Sbjct: 78  NVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 190 ---NPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
              +P  + L+    +  A   ++G+ +L  +E K+++RD  A NIL+
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILV 183

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 73/145 (50%), Gaps = 13/145 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G          +T     VAIK +N   SM+   E+ +E + +   +  
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETR----VAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG   + +  L++ E M RG L+++L         NP + P S    +++A   A
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ +L+ +  K ++RD  A N  +
Sbjct: 136 DGMAYLNAN--KFVHRDLAARNCXV 158

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 76/168 (45%), Gaps = 29/168 (17%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLG-MVVAIKKLNPE-SMQGFEEWQSEV 146
           KN      LGEG FG+V K      T    K   G   VA+K L    S     +  SE 
Sbjct: 23  KNLVLGKTLGEGEFGKVVKA-----TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEF 77
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR----------------- 189
           N L +++HP+++KL G C +D  LLL+ EY + GSL   L                    
Sbjct: 78  NVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 190 ---NPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
              +P  + L+    +  A   ++G+ +L  +E K+++RD  A NIL+
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILV 183

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 71/146 (48%), Gaps = 16/146 (10%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
           ++ K +  LG G FG V+    +  T           VA+K + P SM   E + +E N 
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHT----------KVAVKTMKPGSM-SVEAFLAEANV 236
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           +  L H  LVKL     ++  + ++ E+M +GSL + L     S QPL   I     I  
Sbjct: 237 MKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI-- 293
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILL 234
           A G+ F+   ++  I+RD +A+NIL+
Sbjct: 294 AEGMAFIE--QRNYIHRDLRAANILV 317

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 71/138 (51%), Gaps = 16/138 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G  G V+ G+ +  T           VA+K L   SM   + + +E N + +L H  
Sbjct: 21  LGAGQAGEVWMGYYNGHT----------KVAVKSLKQGSMSP-DAFLAEANLMKQLQHQR 69
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV+L     ++  + ++ EYM+ GSL +  F + PS   L+ +  L +A   A G+ F+ 
Sbjct: 70  LVRLYAVVTQEP-IYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 217 TSEKKVIYRDFKASNILL 234
             E+  I+RD +A+NIL+
Sbjct: 127 --ERNYIHRDLRAANILV 142

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQS 144
           + +NF+    +GEG +G VYK               G VVA+KK  L+ E+         
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIR 51
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E++ L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKD---FMDASALTGIPLPLIKSY 108
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +GL F H+   +V++RD K  N+L++  G
Sbjct: 109 LFQLLQGLAFCHSH--RVLHRDLKPENLLINTEG 140

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 25/176 (14%)
Query: 67  NGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVV 126
           + +  E P+  V  F     A+   K + ++G G FG V  G    +   P K  +   V
Sbjct: 22  DPETYEDPNRAVHQFAKELDAS-CIKIERVIGAGEFGEVCSG----RLKLPGKRDVA--V 74
Query: 127 AIKKLNPESMQGFEEWQ-----SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGS 181
           AIK L      G+ E Q      E + +G+  HPN+V L G     K +++V E+M+ G+
Sbjct: 75  AIKTLK----VGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGA 130
Query: 182 LENHLFRRNPSIQPLSWDIRLKIAIGAARGL--GFLHTSEKKVIYRDFKASNILLD 235
           L+  L + +     +         +G  RG+  G  + ++   ++RD  A NIL++
Sbjct: 131 LDAFLRKHDGQFTVIQL-------VGMLRGIAAGMRYLADMGYVHRDLAARNILVN 179

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 72/166 (43%), Gaps = 9/166 (5%)
Query: 77  KVFSFLDLKSAT-KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE- 134
           K  S  DLK    KN      LG G FG VY+G V      PS     + VA+K L PE 
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP----LQVAVKTL-PEV 86
Query: 135 -SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-S 192
            S Q   ++  E   + +L+H N+V+ +G   +     ++ E M  G L++ L    P  
Sbjct: 87  CSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 146
Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            QP S  +   + +      G  +  E   I+RD  A N LL   G
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 192

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 85/176 (48%), Gaps = 27/176 (15%)
Query: 64  ASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGL 122
            SP+G   E P+  +   L        FK   +LG G FG VYKG W+      P    +
Sbjct: 1   GSPSG---EAPNQALLRIL----KETEFKKIKVLGSGAFGTVYKGLWI------PEGEKV 47
Query: 123 GMVVAIKKL-NPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGS 181
            + VAIK+L    S +  +E   E   +  + +P++ +LLG C     + L+ + M  G 
Sbjct: 48  KIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIMQLMPFGC 106
Query: 182 LENHLFRRNPSIQP---LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           L +++     +I     L+W +++      A+G+ +L   ++++++RD  A N+L+
Sbjct: 107 LLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLE--DRRLVHRDLAARNVLV 154

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQS 144
           + +NF+    +GEG +G VYK               G VVA+KK  L+ E+         
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIR 54
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E++ L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +    
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ---DLKTFMDASALTGIPLPLIKSY 111
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +GL F H+   +V++RD K  N+L++  G
Sbjct: 112 LFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 143

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 72/166 (43%), Gaps = 9/166 (5%)
Query: 77  KVFSFLDLKSAT-KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE- 134
           K  S  DLK    KN      LG G FG VY+G V      PS     + VA+K L PE 
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP----LQVAVKTL-PEV 72
Query: 135 -SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-S 192
            S Q   ++  E   + +L+H N+V+ +G   +     ++ E M  G L++ L    P  
Sbjct: 73  CSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 132
Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            QP S  +   + +      G  +  E   I+RD  A N LL   G
Sbjct: 133 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 178

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 67/142 (47%), Gaps = 23/142 (16%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSH 154
           LG G FG V+ G+ ++ T           VA+K L P +M  Q F E   E N +  L H
Sbjct: 21  LGAGQFGEVWMGYYNNST----------KVAVKTLKPGTMSVQAFLE---EANLMKTLQH 67
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRN--PSIQPLSWDIRLKIAIGAARGL 212
             LV+L      ++ + ++ EYM +GSL + L        + P   D   +IA G A   
Sbjct: 68  DKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA--- 124
Query: 213 GFLHTSEKKVIYRDFKASNILL 234
              +   K  I+RD +A+N+L+
Sbjct: 125 ---YIERKNYIHRDLRAANVLV 143

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQS 144
           + +NF+    +GEG +G VYK               G VVA+KK  L+ E+         
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIR 51
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E++ L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSY 108
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +GL F H+   +V++RD K  N+L++  G
Sbjct: 109 LFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 140

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQSEV 146
           +NF+    +GEG +G VYK               G VVA+KK  L+ E+         E+
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREI 52
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
           + L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +      
Sbjct: 53  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLF 109
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
              +GL F H+   +V++RD K  N+L++  G
Sbjct: 110 QLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 139

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 80/183 (43%), Gaps = 23/183 (12%)
Query: 69  QILETPDLKVFSFLDLKS---------ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSK 119
           +I+E+ +   ++F+D               N +    LG G FG+V    V+       K
Sbjct: 9   KIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKV----VEATAFGLGK 64
Query: 120 TGLGMVVAIKKLNPESMQGFEE-WQSEVNFLGRL-SHPNLVKLLGYCWEDKELLLVYEYM 177
               + VA+K L   +    +E   SE+  +  L  H N+V LLG C     +L++ EY 
Sbjct: 65  EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYC 124
Query: 178 QRGSLENHLFRRNPSI------QPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASN 231
             G L N L R+  +       +PL     L  +   A+G+ FL  + K  I+RD  A N
Sbjct: 125 CYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARN 182
Query: 232 ILL 234
           +LL
Sbjct: 183 VLL 185

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQS 144
           + +NF+    +GEG +G VYK               G VVA+KK  L+ E+         
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIR 51
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E++ L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSY 108
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +GL F H+   +V++RD K  N+L++  G
Sbjct: 109 LFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 140

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQS 144
           + +NF+    +GEG +G VYK               G VVA+KK  L+ E+         
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIR 51
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E++ L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSY 108
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +GL F H+   +V++RD K  N+L++  G
Sbjct: 109 LFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 140

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 74/147 (50%), Gaps = 20/147 (13%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQSEVNFLGRLSH 154
           +GEG +G VYK          +K   G +VA+K+  L+ E          E++ L  L H
Sbjct: 29  VGEGTYGVVYK----------AKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH 78
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI-GAARGLG 213
           PN+V L+     ++ L LV+E+M++  L+  L      +Q    D ++KI +    RG+ 
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQ----DSQIKIYLYQLLRGVA 133
Query: 214 FLHTSEKKVIYRDFKASNILLDGVGFL 240
             H  + ++++RD K  N+L++  G L
Sbjct: 134 --HCHQHRILHRDLKPQNLLINSDGAL 158

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQS 144
           + +NF+    +GEG +G VYK               G VVA+KK  L+ E+         
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIR 52
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E++ L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +    
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSY 109
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +GL F H+   +V++RD K  N+L++  G
Sbjct: 110 LFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 141

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQS 144
           + +NF+    +GEG +G VYK               G VVA+KK  L+ E+         
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIR 54
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E++ L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +    
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSY 111
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +GL F H+   +V++RD K  N+L++  G
Sbjct: 112 LFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 143

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQS 144
           + +NF+    +GEG +G VYK               G VVA+KK  L+ E+         
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIR 53
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E++ L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +    
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSY 110
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +GL F H+   +V++RD K  N+L++  G
Sbjct: 111 LFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 142

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQSEV 146
           +NF+    +GEG +G VYK               G VVA+KK  L+ E+         E+
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREI 52
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
           + L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +      
Sbjct: 53  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLF 109
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
              +GL F H+   +V++RD K  N+L++  G
Sbjct: 110 QLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 139

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQS 144
           + +NF+    +GEG +G VYK               G VVA+KK  L+ E+         
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIR 51
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E++ L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSY 108
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +GL F H+   +V++RD K  N+L++  G
Sbjct: 109 LFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 140

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 74/147 (50%), Gaps = 20/147 (13%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQSEVNFLGRLSH 154
           +GEG +G VYK          +K   G +VA+K+  L+ E          E++ L  L H
Sbjct: 29  VGEGTYGVVYK----------AKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH 78
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI-GAARGLG 213
           PN+V L+     ++ L LV+E+M++  L+  L      +Q    D ++KI +    RG+ 
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQ----DSQIKIYLYQLLRGVA 133
Query: 214 FLHTSEKKVIYRDFKASNILLDGVGFL 240
             H  + ++++RD K  N+L++  G L
Sbjct: 134 --HCHQHRILHRDLKPQNLLINSDGAL 158

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQSEV 146
           +NF+    +GEG +G VYK               G VVA+KK  L+ E+         E+
Sbjct: 4   ENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREI 54
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
           + L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +      
Sbjct: 55  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLF 111
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
              +GL F H+   +V++RD K  N+L++  G
Sbjct: 112 QLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 141

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQSEV 146
           +NF+    +GEG +G VYK               G VVA+KK  L+ E+         E+
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREI 53
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
           + L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +      
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLF 110
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
              +GL F H+   +V++RD K  N+L++  G
Sbjct: 111 QLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 140

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQSEV 146
           +NF+    +GEG +G VYK               G VVA+KK  L+ E+         E+
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREI 52
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
           + L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +      
Sbjct: 53  SLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQ---DLKTFMDASALTGIPLPLIKSYLF 109
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
              +GL F H+   +V++RD K  N+L++  G
Sbjct: 110 QLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 139

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQSEV 146
           +NF+    +GEG +G VYK               G VVA+KK  L+ E+         E+
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREI 52
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
           + L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +      
Sbjct: 53  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLF 109
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
              +GL F H+   +V++RD K  N+L++  G
Sbjct: 110 QLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 139

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQSEV 146
           +NF+    +GEG +G VYK               G VVA+KK  L+ E+         E+
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREI 52
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
           + L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +      
Sbjct: 53  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLF 109
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
              +GL F H+   +V++RD K  N+L++  G
Sbjct: 110 QLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 139

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 24/151 (15%)
Query: 92  KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-----SEV 146
           K + ++G G FG V +G    +  AP K      VAIK L      G+ E Q     SE 
Sbjct: 17  KIEEVIGAGEFGEVCRG----RLKAPGKKE--SCVAIKTLK----GGYTERQRREFLSEA 66
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
           + +G+  HPN+++L G       ++++ E+M+ G+L++ L   +     +         +
Sbjct: 67  SIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL-------V 119
Query: 207 GAARGL--GFLHTSEKKVIYRDFKASNILLD 235
           G  RG+  G  + +E   ++RD  A NIL++
Sbjct: 120 GMLRGIASGMRYLAEMSYVHRDLAARNILVN 150

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 70/143 (48%), Gaps = 11/143 (7%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS 153
           D ++G+G FG VY G   D+     +  +  +  I +     MQ  E +  E   +  L+
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE-----MQQVEAFLREGLLMRGLN 80
Query: 154 HPNLVKLLGYCWEDKELL-LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
           HPN++ L+G     + L  ++  YM  G L    F R+P   P   D+ +   +  ARG+
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQ--FIRSPQRNPTVKDL-ISFGLQVARGM 137
Query: 213 GFLHTSEKKVIYRDFKASNILLD 235
            +L  +E+K ++RD  A N +LD
Sbjct: 138 EYL--AEQKFVHRDLAARNCMLD 158

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQS 144
           + +NF+    +GEG +G VYK               G VVA+KK  L+ E+         
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIR 52
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E++ L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +    
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSY 109
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +GL F H+   +V++RD K  N+L++  G
Sbjct: 110 LFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 141

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQSEV 146
           +NF+    +GEG +G VYK               G VVA+KK  L+ E+         E+
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREI 53
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
           + L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +      
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLF 110
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
              +GL F H+   +V++RD K  N+L++  G
Sbjct: 111 QLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 140

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQS 144
           + +NF+    +GEG +G VYK               G VVA+KK  L+ E+         
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIR 52
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E++ L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +    
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSY 109
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +GL F H+   +V++RD K  N+L++  G
Sbjct: 110 LFQLLQGLAFCHSH--RVLHRDLKPENLLINTEG 141

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQSEV 146
           +NF+    +GEG +G VYK               G VVA+KK  L+ E+         E+
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREI 53
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
           + L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +      
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLF 110
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
              +GL F H+   +V++RD K  N+L++  G
Sbjct: 111 QLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 140

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G   D     ++T     VA+K +N   S++   E+ +E + +   +  
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETR----VAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG   + +  L+V E M  G L+++L         NP   P +    +++A   A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ +L+   KK ++RD  A N ++
Sbjct: 141 DGMAYLNA--KKFVHRDLAARNCMV 163

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 80/183 (43%), Gaps = 23/183 (12%)
Query: 69  QILETPDLKVFSFLDLKS---------ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSK 119
           +I+E+ +   ++F+D               N +    LG G FG+V    V+       K
Sbjct: 17  KIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKV----VEATAFGLGK 72
Query: 120 TGLGMVVAIKKLNPESMQGFEE-WQSEVNFLGRL-SHPNLVKLLGYCWEDKELLLVYEYM 177
               + VA+K L   +    +E   SE+  +  L  H N+V LLG C     +L++ EY 
Sbjct: 73  EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYC 132
Query: 178 QRGSLENHLFRRNPSI------QPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASN 231
             G L N L R+  +       +PL     L  +   A+G+ FL  + K  I+RD  A N
Sbjct: 133 CYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARN 190
Query: 232 ILL 234
           +LL
Sbjct: 191 VLL 193

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 24/151 (15%)
Query: 92  KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-----SEV 146
           K + ++G G FG V +G    +  AP K      VAIK L      G+ E Q     SE 
Sbjct: 19  KIEEVIGAGEFGEVCRG----RLKAPGKKE--SCVAIKTLK----GGYTERQRREFLSEA 68
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
           + +G+  HPN+++L G       ++++ E+M+ G+L++ L   +     +         +
Sbjct: 69  SIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL-------V 121
Query: 207 GAARGL--GFLHTSEKKVIYRDFKASNILLD 235
           G  RG+  G  + +E   ++RD  A NIL++
Sbjct: 122 GMLRGIASGMRYLAEMSYVHRDLAARNILVN 152

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G   D     ++T     VA+K +N   S++   E+ +E + +   +  
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETR----VAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG   + +  L+V E M  G L+++L         NP   P +    +++A   A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ +L+   KK ++RD  A N ++
Sbjct: 141 DGMAYLNA--KKFVHRDLAARNCMV 163

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQS 144
           + +NF+    +GEG +G VYK               G VVA+KK  L+ E+         
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIR 53
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E++ L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +    
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSY 110
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +GL F H+   +V++RD K  N+L++  G
Sbjct: 111 LFQLLQGLAFCHSH--RVLHRDLKPENLLINTEG 142

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQS 144
           + +NF+    +GEG +G VYK               G VVA+KK  L+ E+         
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIR 53
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E++ L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +    
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSY 110
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +GL F H+   +V++RD K  N+L++  G
Sbjct: 111 LFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 142

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 71/154 (46%), Gaps = 22/154 (14%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SH 154
           LG G FG+V    V+       K+   M VA+K L P + +   E   SE+  L  L +H
Sbjct: 31  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR---------NPSIQ-----PLSWDI 200
            N+V LLG C      L++ EY   G L N L R+         +P+I       L  + 
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
            L  +   A+G+ FL  + K  I+RD  A NILL
Sbjct: 147 LLSFSYQVAKGMAFL--ASKNCIHRDLAARNILL 178

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 83/172 (48%), Gaps = 24/172 (13%)
Query: 68  GQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVV 126
           G + E P+  +   L        FK   +LG G FG VYKG W+      P    + + V
Sbjct: 1   GSMGEAPNQALLRIL----KETEFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPV 50
Query: 127 AIKKL-NPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENH 185
           AIK+L    S +  +E   E   +  + +P++ +LLG C     + L+ + M  G L ++
Sbjct: 51  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDY 109
Query: 186 LFRRNPSIQP---LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           +     +I     L+W +++      A+G+ +L   ++++++RD  A N+L+
Sbjct: 110 VREHKDNIGSQYLLNWCVQI------AKGMNYLE--DRRLVHRDLAARNVLV 153

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 83/172 (48%), Gaps = 24/172 (13%)
Query: 68  GQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVV 126
           G + E P+  +   L        FK   +LG G FG VYKG W+      P    + + V
Sbjct: 1   GSMGEAPNQALLRIL----KETEFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPV 50
Query: 127 AIKKL-NPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENH 185
           AIK+L    S +  +E   E   +  + +P++ +LLG C     + L+ + M  G L ++
Sbjct: 51  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDY 109
Query: 186 LFRRNPSIQP---LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           +     +I     L+W +++      A+G+ +L   ++++++RD  A N+L+
Sbjct: 110 VREHKDNIGSQYLLNWCVQI------AKGMNYLE--DRRLVHRDLAARNVLV 153

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQS 144
           + +NF+    +GEG +G VYK               G VVA+KK  L+ E+         
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIR 55
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E++ L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +    
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSY 112
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +GL F H+   +V++RD K  N+L++  G
Sbjct: 113 LFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 144

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G   D     ++T     VA+K +N   S++   E+ +E + +   +  
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAET----RVAVKTVNESASLRERIEFLNEASVMKGFTCH 79
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG   + +  L+V E M  G L+++L         NP   P +    +++A   A
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 139
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ +L+   KK ++RD  A N ++
Sbjct: 140 DGMAYLNA--KKFVHRDLAARNCMV 162

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G   D     ++T     VA+K +N   S++   E+ +E + +   +  
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETR----VAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG   + +  L+V E M  G L+++L         NP   P +    +++A   A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ +L+   KK ++RD  A N ++
Sbjct: 141 DGMAYLNA--KKFVHRDLAARNCMV 163

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQSEV 146
           +NF+    +GEG +G VYK               G VVA+KK  L+ E+         E+
Sbjct: 7   ENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREI 57
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
           + L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +      
Sbjct: 58  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLF 114
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
              +GL F H+   +V++RD K  N+L++  G
Sbjct: 115 QLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 144

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQSEV 146
           +NF+    +GEG +G VYK               G VVA+KK  L+ E+         E+
Sbjct: 10  ENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
           + L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +      
Sbjct: 61  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLF 117
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
              +GL F H+   +V++RD K  N+L++  G
Sbjct: 118 QLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 147

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQSEV 146
           +NF+    +GEG +G VYK               G VVA+KK  L+ E+         E+
Sbjct: 10  ENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
           + L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +      
Sbjct: 61  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLF 117
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
              +GL F H+   +V++RD K  N+L++  G
Sbjct: 118 QLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 147

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G   D     ++T     VA+K +N   S++   E+ +E + +   +  
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETR----VAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG   + +  L+V E M  G L+++L         NP   P +    +++A   A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ +L+   KK ++RD  A N ++
Sbjct: 141 DGMAYLNA--KKFVHRDLAARNCMV 163

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQSEV 146
           +NF+    +GEG +G VYK               G VVA+KK  L+ E+         E+
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREI 53
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
           + L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +      
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLF 110
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
              +GL F H+   +V++RD K  N+L++  G
Sbjct: 111 QLLQGLSFCHSH--RVLHRDLKPQNLLINTEG 140

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQS 144
           + +NF+    +GEG +G VYK               G VVA+KK  L+ E+         
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIR 54
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E++ L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +    
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSY 111
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +GL F H+   +V++RD K  N+L++  G
Sbjct: 112 LFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 143

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G   D     ++T     VA+K +N   S++   E+ +E + +   +  
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETR----VAVKTVNESASLRERIEFLNEASVMKGFTCH 77
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG   + +  L+V E M  G L+++L         NP   P +    +++A   A
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 137
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ +L+   KK ++RD  A N ++
Sbjct: 138 DGMAYLNA--KKFVHRDLAARNCMV 160

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 83/172 (48%), Gaps = 24/172 (13%)
Query: 68  GQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVV 126
           G + E P+  +   L        FK   +LG G FG VYKG W+      P    + + V
Sbjct: 1   GAMGEAPNQALLRIL----KETEFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPV 50
Query: 127 AIKKL-NPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENH 185
           AIK+L    S +  +E   E   +  + +P++ +LLG C     + L+ + M  G L ++
Sbjct: 51  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDY 109
Query: 186 LFRRNPSIQP---LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           +     +I     L+W +++      A+G+ +L   ++++++RD  A N+L+
Sbjct: 110 VREHKDNIGSQYLLNWCVQI------AKGMNYLE--DRRLVHRDLAARNVLV 153

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 83/172 (48%), Gaps = 24/172 (13%)
Query: 68  GQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVV 126
           G + E P+  +   L        FK   +LG G FG VYKG W+      P    + + V
Sbjct: 1   GAMGEAPNQALLRIL----KETEFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPV 50
Query: 127 AIKKL-NPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENH 185
           AIK+L    S +  +E   E   +  + +P++ +LLG C     + L+ + M  G L ++
Sbjct: 51  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDY 109
Query: 186 LFRRNPSIQP---LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           +     +I     L+W +++      A+G+ +L   ++++++RD  A N+L+
Sbjct: 110 VREHKDNIGSQYLLNWCVQI------AKGMNYLE--DRRLVHRDLAARNVLV 153

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 22/158 (13%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
           K  K    +G+G FG V  G              G  VA+K + N  + Q F    +E +
Sbjct: 193 KELKLLQTIGKGEFGDVMLG-----------DYRGNKVAVKCIKNDATAQAF---LAEAS 238
Query: 148 FLGRLSHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
            + +L H NLV+LLG   E+K  L +V EYM +GSL ++L  R  S+  L  D  LK ++
Sbjct: 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSL 296
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILL--DGVGFLFD 242
                + +L  +    ++RD  A N+L+  D V  + D
Sbjct: 297 DVCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSD 332

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 23/142 (16%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSH 154
           LG G FG V+ G+ ++ T           VA+K L P +M  Q F E   E N +  L H
Sbjct: 20  LGAGQFGEVWMGYYNNST----------KVAVKTLKPGTMSVQAFLE---EANLMKTLQH 66
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRN--PSIQPLSWDIRLKIAIGAARGL 212
             LV+L     +++ + ++ E+M +GSL + L        + P   D   +IA G A   
Sbjct: 67  DKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA--- 123
Query: 213 GFLHTSEKKVIYRDFKASNILL 234
              +   K  I+RD +A+N+L+
Sbjct: 124 ---YIERKNYIHRDLRAANVLV 142

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 71/154 (46%), Gaps = 22/154 (14%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SH 154
           LG G FG+V    V+       K+   M VA+K L P + +   E   SE+  L  L +H
Sbjct: 54  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 109
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR---------NPSIQ-----PLSWDI 200
            N+V LLG C      L++ EY   G L N L R+         +P+I       L  + 
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 169
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
            L  +   A+G+ FL  + K  I+RD  A NILL
Sbjct: 170 LLSFSYQVAKGMAFL--ASKNCIHRDLAARNILL 201

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 71/154 (46%), Gaps = 22/154 (14%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SH 154
           LG G FG+V    V+       K+   M VA+K L P + +   E   SE+  L  L +H
Sbjct: 49  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 104
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR---------NPSIQ-----PLSWDI 200
            N+V LLG C      L++ EY   G L N L R+         +P+I       L  + 
Sbjct: 105 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 164
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
            L  +   A+G+ FL  + K  I+RD  A NILL
Sbjct: 165 LLSFSYQVAKGMAFL--ASKNCIHRDLAARNILL 196

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 86/179 (48%), Gaps = 27/179 (15%)
Query: 61  VEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKG-WVDDKTLAPSK 119
           VE  +P+G   E P+  +   L        FK   +LG G FG VYKG W+      P  
Sbjct: 28  VEPLTPSG---EAPNQALLRIL----KETEFKKIKVLGSGAFGTVYKGLWI------PEG 74
Query: 120 TGLGMVVAIKKL-NPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQ 178
             + + VAI +L    S +  +E   E   +  + +P++ +LLG C     + L+ + M 
Sbjct: 75  EKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMP 133
Query: 179 RGSLENHLFRRNPSIQP---LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
            G L +++     +I     L+W +++      A+G+ +L   ++++++RD  A N+L+
Sbjct: 134 FGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLE--DRRLVHRDLAARNVLV 184

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 71/154 (46%), Gaps = 22/154 (14%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SH 154
           LG G FG+V    V+       K+   M VA+K L P + +   E   SE+  L  L +H
Sbjct: 54  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 109
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR---------NPSIQ-----PLSWDI 200
            N+V LLG C      L++ EY   G L N L R+         +P+I       L  + 
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 169
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
            L  +   A+G+ FL  + K  I+RD  A NILL
Sbjct: 170 LLSFSYQVAKGMAFL--ASKNCIHRDLAARNILL 201

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 20/150 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
            FK   +LG G FG VYKG W+      P    + + VAIK+L    S +  +E   E  
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKI 204
            +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++  
Sbjct: 64  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 120
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
               A+G+ +L   ++++++RD  A N+L+
Sbjct: 121 ----AKGMNYL--EDRRLVHRDLAARNVLV 144

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 71/154 (46%), Gaps = 22/154 (14%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SH 154
           LG G FG+V    V+       K+   M VA+K L P + +   E   SE+  L  L +H
Sbjct: 47  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 102
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR---------NPSIQ-----PLSWDI 200
            N+V LLG C      L++ EY   G L N L R+         +P+I       L  + 
Sbjct: 103 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 162
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
            L  +   A+G+ FL  + K  I+RD  A NILL
Sbjct: 163 LLSFSYQVAKGMAFL--ASKNCIHRDLAARNILL 194

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 20/150 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
            FK   +LG G FG VYKG W+      P    + + VAIK+L    S +  +E   E  
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKI 204
            +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++  
Sbjct: 71  VMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 127
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
               A+G+ +L   ++++++RD  A N+L+
Sbjct: 128 ----AKGMNYLE--DRRLVHRDLAARNVLV 151

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 71/153 (46%), Gaps = 21/153 (13%)
Query: 91  FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLG 150
            K D  +G G F  VYKG   + T+  +   L      +KL     Q F+E   E   L 
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL----QDRKLTKSERQRFKE---EAEXLK 80
Query: 151 RLSHPNLVKLLGYCWED-----KELLLVYEYMQRGSLENHLFR-RNPSIQPL-SWDIRLK 203
            L HPN+V+     WE      K ++LV E    G+L+ +L R +   I+ L SW  ++ 
Sbjct: 81  GLQHPNIVRFYD-SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI- 138
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
                 +GL FLHT    +I+RD K  NI + G
Sbjct: 139 -----LKGLQFLHTRTPPIIHRDLKCDNIFITG 166

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 22/158 (13%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
           K  K    +G+G FG V  G              G  VA+K + N  + Q F    +E +
Sbjct: 6   KELKLLQTIGKGEFGDVMLG-----------DYRGNKVAVKCIKNDATAQAF---LAEAS 51
Query: 148 FLGRLSHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
            + +L H NLV+LLG   E+K  L +V EYM +GSL ++L  R  S+  L  D  LK ++
Sbjct: 52  VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSL 109
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILL--DGVGFLFD 242
                + +L  +    ++RD  A N+L+  D V  + D
Sbjct: 110 DVCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSD 145

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 20/150 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
            FK   +LG G FG VYKG W+      P    + + VAIK+L    S +  +E   E  
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAY 75
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKI 204
            +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++  
Sbjct: 76  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 132
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
               A+G+ +L   ++++++RD  A N+L+
Sbjct: 133 ----AKGMNYL--EDRRLVHRDLAARNVLV 156

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 22/158 (13%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
           K  K    +G+G FG V  G              G  VA+K + N  + Q F    +E +
Sbjct: 21  KELKLLQTIGKGEFGDVMLG-----------DYRGNKVAVKCIKNDATAQAF---LAEAS 66
Query: 148 FLGRLSHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
            + +L H NLV+LLG   E+K  L +V EYM +GSL ++L  R  S+  L  D  LK ++
Sbjct: 67  VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSL 124
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILL--DGVGFLFD 242
                + +L  +    ++RD  A N+L+  D V  + D
Sbjct: 125 DVCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSD 160

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 20/150 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
            FK   +LG G FG VYKG W+      P    + + VAIK+L    S +  +E   E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKI 204
            +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++  
Sbjct: 72  VMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
               A+G+ +L   ++++++RD  A N+L+
Sbjct: 129 ----AKGMNYLE--DRRLVHRDLAARNVLV 152

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 20/150 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
            FK   +LG G FG VYKG W+      P    + + VAIK+L    S +  +E   E  
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKI 204
            +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++  
Sbjct: 74  VMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 130
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
               A+G+ +L   ++++++RD  A N+L+
Sbjct: 131 ----AKGMNYLE--DRRLVHRDLAARNVLV 154

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 20/150 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
            FK   +LG G FG VYKG W+      P    + + VAIK+L    S +  +E   E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKI 204
            +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++  
Sbjct: 70  VMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
               A+G+ +L   ++++++RD  A N+L+
Sbjct: 127 ----AKGMNYLE--DRRLVHRDLAARNVLV 150

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 20/150 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
            FK   +LG G FG VYKG W+      P    + + VAIK+L    S +  +E   E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKI 204
            +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++  
Sbjct: 70  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
               A+G+ +L   ++++++RD  A N+L+
Sbjct: 127 ----AKGMNYLE--DRRLVHRDLAARNVLV 150

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 20/150 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
            FK   +LG G FG VYKG W+      P    + + VAIK+L    S +  +E   E  
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAY 94
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKI 204
            +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++  
Sbjct: 95  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 151
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
               A+G+ +L   ++++++RD  A N+L+
Sbjct: 152 ----AKGMNYLE--DRRLVHRDLAARNVLV 175

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 71/166 (42%), Gaps = 9/166 (5%)
Query: 77  KVFSFLDLKSAT-KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE- 134
           K  S  DLK    KN      LG G FG VY+G V      PS     + VA+K L PE 
Sbjct: 58  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP----LQVAVKTL-PEV 112
Query: 135 -SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-S 192
            S Q   ++  E   + + +H N+V+ +G   +     ++ E M  G L++ L    P  
Sbjct: 113 CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 172
Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            QP S  +   + +      G  +  E   I+RD  A N LL   G
Sbjct: 173 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 218

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 20/150 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
            FK   +LG G FG VYKG W+      P    + + VAIK+L    S +  +E   E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKI 204
            +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++  
Sbjct: 70  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
               A+G+ +L   ++++++RD  A N+L+
Sbjct: 127 ----AKGMNYLE--DRRLVHRDLAARNVLV 150

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 20/150 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
            FK   +LG G FG VYKG W+      P    + + VAIK+L    S +  +E   E  
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKI 204
            +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++  
Sbjct: 77  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
               A+G+ +L   ++++++RD  A N+L+
Sbjct: 134 ----AKGMNYLE--DRRLVHRDLAARNVLV 157

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 75/168 (44%), Gaps = 29/168 (17%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLG-MVVAIKKLNPE-SMQGFEEWQSEV 146
           KN      LGEG FG+V K      T    K   G   VA+K L    S     +  SE 
Sbjct: 23  KNLVLGKTLGEGEFGKVVKA-----TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEF 77
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR----------------- 189
           N L +++HP+++KL G C +D  LLL+ EY + GSL   L                    
Sbjct: 78  NVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 190 ---NPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
              +P  + L+    +  A   ++G+ +L  +E  +++RD  A NIL+
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYL--AEMSLVHRDLAARNILV 183

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 20/150 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
            FK   +LG G FG VYKG W+      P    + + VAIK+L    S +  +E   E  
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAY 79
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKI 204
            +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++  
Sbjct: 80  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 136
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
               A+G+ +L   ++++++RD  A N+L+
Sbjct: 137 ----AKGMNYLE--DRRLVHRDLAARNVLV 160

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 20/150 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
            FK   +LG G FG VYKG W+      P    + + VAIK+L    S +  +E   E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKI 204
            +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++  
Sbjct: 72  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
               A+G+ +L   ++++++RD  A N+L+
Sbjct: 129 ----AKGMNYLE--DRRLVHRDLAARNVLV 152

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 71/166 (42%), Gaps = 9/166 (5%)
Query: 77  KVFSFLDLKSAT-KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE- 134
           K  S  DLK    KN      LG G FG VY+G V      PS     + VA+K L PE 
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP----LQVAVKTL-PEV 86
Query: 135 -SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-S 192
            S Q   ++  E   + + +H N+V+ +G   +     ++ E M  G L++ L    P  
Sbjct: 87  YSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 146
Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            QP S  +   + +      G  +  E   I+RD  A N LL   G
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 192

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 20/150 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
            FK   +LG G FG VYKG W+      P    + + VAIK+L    S +  +E   E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKI 204
            +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++  
Sbjct: 72  VMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
               A+G+ +L   ++++++RD  A N+L+
Sbjct: 129 ----AKGMNYLE--DRRLVHRDLAARNVLV 152

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 71/166 (42%), Gaps = 9/166 (5%)
Query: 77  KVFSFLDLKSAT-KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE- 134
           K  S  DLK    KN      LG G FG VY+G V      PS     + VA+K L PE 
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP----LQVAVKTL-PEV 72
Query: 135 -SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-S 192
            S Q   ++  E   + + +H N+V+ +G   +     ++ E M  G L++ L    P  
Sbjct: 73  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 132
Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            QP S  +   + +      G  +  E   I+RD  A N LL   G
Sbjct: 133 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 178

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 71/166 (42%), Gaps = 9/166 (5%)
Query: 77  KVFSFLDLKSAT-KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE- 134
           K  S  DLK    KN      LG G FG VY+G V      PS     + VA+K L PE 
Sbjct: 34  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP----LQVAVKTL-PEV 88
Query: 135 -SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-S 192
            S Q   ++  E   + + +H N+V+ +G   +     ++ E M  G L++ L    P  
Sbjct: 89  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 148
Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            QP S  +   + +      G  +  E   I+RD  A N LL   G
Sbjct: 149 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 194

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 20/150 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
            FK   +LG G FG VYKG W+      P    + + VAIK+L    S +  +E   E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKI 204
            +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++  
Sbjct: 70  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
               A+G+ +L   ++++++RD  A N+L+
Sbjct: 127 ----AKGMNYLE--DRRLVHRDLAARNVLV 150

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 71/166 (42%), Gaps = 9/166 (5%)
Query: 77  KVFSFLDLKSAT-KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE- 134
           K  S  DLK    KN      LG G FG VY+G V      PS     + VA+K L PE 
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP----LQVAVKTL-PEV 86
Query: 135 -SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-S 192
            S Q   ++  E   + + +H N+V+ +G   +     ++ E M  G L++ L    P  
Sbjct: 87  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP 146
Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            QP S  +   + +      G  +  E   I+RD  A N LL   G
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 192

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 20/150 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
            FK   +LG G FG VYKG W+      P    + + VAIK+L    S +  +E   E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKI 204
            +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++  
Sbjct: 72  VMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
               A+G+ +L   ++++++RD  A N+L+
Sbjct: 129 ----AKGMNYLE--DRRLVHRDLAARNVLV 152

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 73/143 (51%), Gaps = 19/143 (13%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLS 153
           LG+G FG V +G  D    APS  G  + VA+K L P+ +   +  +++  EVN +  L 
Sbjct: 16  LGDGSFGVVRRGEWD----APS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS--IQPLSWDIRLKIAIGAARG 211
           H NL++L G       + +V E    GSL + L +      +  LS     + A+  A G
Sbjct: 70  HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEG 123
Query: 212 LGFLHTSEKKVIYRDFKASNILL 234
           +G+L +  K+ I+RD  A N+LL
Sbjct: 124 MGYLES--KRFIHRDLAARNLLL 144

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 20/150 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
            FK   +LG G FG VYKG W+      P    + + VAIK+L    S +  +E   E  
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKI 204
            +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++  
Sbjct: 77  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
               A+G+ +L   ++++++RD  A N+L+
Sbjct: 134 ----AKGMNYLE--DRRLVHRDLAARNVLV 157

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 71/166 (42%), Gaps = 9/166 (5%)
Query: 77  KVFSFLDLKSAT-KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE- 134
           K  S  DLK    KN      LG G FG VY+G V      PS     + VA+K L PE 
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP----LQVAVKTL-PEV 72
Query: 135 -SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-S 192
            S Q   ++  E   + + +H N+V+ +G   +     ++ E M  G L++ L    P  
Sbjct: 73  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 132
Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            QP S  +   + +      G  +  E   I+RD  A N LL   G
Sbjct: 133 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 178

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 71/166 (42%), Gaps = 9/166 (5%)
Query: 77  KVFSFLDLKSAT-KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE- 134
           K  S  DLK    KN      LG G FG VY+G V      PS     + VA+K L PE 
Sbjct: 44  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP----LQVAVKTL-PEV 98
Query: 135 -SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-S 192
            S Q   ++  E   + + +H N+V+ +G   +     ++ E M  G L++ L    P  
Sbjct: 99  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 158
Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            QP S  +   + +      G  +  E   I+RD  A N LL   G
Sbjct: 159 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 204

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 71/166 (42%), Gaps = 9/166 (5%)
Query: 77  KVFSFLDLKSAT-KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE- 134
           K  S  DLK    KN      LG G FG VY+G V      PS     + VA+K L PE 
Sbjct: 9   KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP----LQVAVKTL-PEV 63
Query: 135 -SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-S 192
            S Q   ++  E   + + +H N+V+ +G   +     ++ E M  G L++ L    P  
Sbjct: 64  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 123
Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            QP S  +   + +      G  +  E   I+RD  A N LL   G
Sbjct: 124 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 169

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 71/166 (42%), Gaps = 9/166 (5%)
Query: 77  KVFSFLDLKSAT-KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE- 134
           K  S  DLK    KN      LG G FG VY+G V      PS     + VA+K L PE 
Sbjct: 17  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP----LQVAVKTL-PEV 71
Query: 135 -SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-S 192
            S Q   ++  E   + + +H N+V+ +G   +     ++ E M  G L++ L    P  
Sbjct: 72  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP 131
Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            QP S  +   + +      G  +  E   I+RD  A N LL   G
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 177

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 71/166 (42%), Gaps = 9/166 (5%)
Query: 77  KVFSFLDLKSAT-KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE- 134
           K  S  DLK    KN      LG G FG VY+G V      PS     + VA+K L PE 
Sbjct: 35  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP----LQVAVKTL-PEV 89
Query: 135 -SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-S 192
            S Q   ++  E   + + +H N+V+ +G   +     ++ E M  G L++ L    P  
Sbjct: 90  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 149
Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            QP S  +   + +      G  +  E   I+RD  A N LL   G
Sbjct: 150 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 195

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 20/150 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
            FK   +LG G FG VYKG W+      P    + + VAIK+L    S +  +E   E  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKI 204
            +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++  
Sbjct: 72  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
               A+G+ +L   ++++++RD  A N+L+
Sbjct: 129 ----AKGMNYLE--DRRLVHRDLAARNVLV 152

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 73/143 (51%), Gaps = 19/143 (13%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLS 153
           LG+G FG V +G  D    APS  G  + VA+K L P+ +   +  +++  EVN +  L 
Sbjct: 16  LGDGSFGVVRRGEWD----APS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS--IQPLSWDIRLKIAIGAARG 211
           H NL++L G       + +V E    GSL + L +      +  LS     + A+  A G
Sbjct: 70  HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEG 123
Query: 212 LGFLHTSEKKVIYRDFKASNILL 234
           +G+L +  K+ I+RD  A N+LL
Sbjct: 124 MGYLES--KRFIHRDLAARNLLL 144

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 20/150 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
            FK   +LG G FG VYKG W+      P    + + VAIK+L    S +  +E   E  
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKI 204
            +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++  
Sbjct: 71  VMASVDNPHVCRLLGICLTST-VQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI-- 127
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
               A+G+ +L   ++++++RD  A N+L+
Sbjct: 128 ----AKGMNYLE--DRRLVHRDLAARNVLV 151

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 22/158 (13%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
           K  K    +G+G FG V  G              G  VA+K + N  + Q F    +E +
Sbjct: 12  KELKLLQTIGKGEFGDVMLG-----------DYRGNKVAVKCIKNDATAQAF---LAEAS 57
Query: 148 FLGRLSHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
            + +L H NLV+LLG   E+K  L +V EYM +GSL ++L  R  S+  L  D  LK ++
Sbjct: 58  VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSL 115
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILL--DGVGFLFD 242
                + +L  +    ++RD  A N+L+  D V  + D
Sbjct: 116 DVCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSD 151

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQS 144
           + +NF+    +GEG +G VYK               G VVA+KK  L+ E+         
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIR 54
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E++ L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +    
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQ---DLKKFMDASALTGIPLPLIKSY 111
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +GL F H+   +V++RD K  N+L++  G
Sbjct: 112 LFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 143

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 73/143 (51%), Gaps = 19/143 (13%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLS 153
           LG+G FG V +G  D    APS  G  + VA+K L P+ +   +  +++  EVN +  L 
Sbjct: 16  LGDGSFGVVRRGEWD----APS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS--IQPLSWDIRLKIAIGAARG 211
           H NL++L G       + +V E    GSL + L +      +  LS     + A+  A G
Sbjct: 70  HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEG 123
Query: 212 LGFLHTSEKKVIYRDFKASNILL 234
           +G+L +  K+ I+RD  A N+LL
Sbjct: 124 MGYLES--KRFIHRDLAARNLLL 144

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 74/160 (46%), Gaps = 24/160 (15%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 61
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY  RG +   L       Q LS     +
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL-------QKLSKFDEQR 114
Query: 204 IA---IGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
            A      A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 115 TATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 152

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 73/143 (51%), Gaps = 19/143 (13%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLS 153
           LG+G FG V +G  D    APS  G  + VA+K L P+ +   +  +++  EVN +  L 
Sbjct: 20  LGDGSFGVVRRGEWD----APS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 73
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS--IQPLSWDIRLKIAIGAARG 211
           H NL++L G       + +V E    GSL + L +      +  LS     + A+  A G
Sbjct: 74  HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEG 127
Query: 212 LGFLHTSEKKVIYRDFKASNILL 234
           +G+L +  K+ I+RD  A N+LL
Sbjct: 128 MGYLES--KRFIHRDLAARNLLL 148

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 71/166 (42%), Gaps = 9/166 (5%)
Query: 77  KVFSFLDLKSAT-KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE- 134
           K  S  DLK    KN      LG G FG VY+G V      PS     + VA+K L PE 
Sbjct: 24  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP----LQVAVKTL-PEV 78
Query: 135 -SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-S 192
            S Q   ++  E   + + +H N+V+ +G   +     ++ E M  G L++ L    P  
Sbjct: 79  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 138
Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            QP S  +   + +      G  +  E   I+RD  A N LL   G
Sbjct: 139 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 184

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 67/148 (45%), Gaps = 19/148 (12%)
Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL--NPESMQGFEEWQSEVNFLGRLS 153
           L+GEG +G V K    D          G +VAIKK   + +     +    E+  L +L 
Sbjct: 32  LVGEGSYGMVMKCRNKDT---------GRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLEN-HLFRRNPSIQPLSWDIRLKIAIGAARGL 212
           H NLV LL  C + K   LV+E++    L++  LF        L + +  K       G+
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG-----LDYQVVQKYLFQIINGI 137
Query: 213 GFLHTSEKKVIYRDFKASNILLDGVGFL 240
           GF H+    +I+RD K  NIL+   G +
Sbjct: 138 GFCHSH--NIIHRDIKPENILVSQSGVV 163

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 71/166 (42%), Gaps = 9/166 (5%)
Query: 77  KVFSFLDLKSAT-KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE- 134
           K  S  DLK    KN      LG G FG VY+G V      PS     + VA+K L PE 
Sbjct: 17  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP----LQVAVKTL-PEV 71
Query: 135 -SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-S 192
            S Q   ++  E   + + +H N+V+ +G   +     ++ E M  G L++ L    P  
Sbjct: 72  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 131
Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            QP S  +   + +      G  +  E   I+RD  A N LL   G
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 177

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 19/162 (11%)
Query: 78  VFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAI---KKLNPE 134
           + S  D +    N++    +G+G F +V       K      TG  + V I    +LNP 
Sbjct: 4   ITSATDEQPHIGNYRLQKTIGKGNFAKV-------KLARHVLTGREVAVKIIDKTQLNPT 56
Query: 135 SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQ 194
           S+Q   +   EV  +  L+HPN+VKL      +K L LV EY   G + ++L      ++
Sbjct: 57  SLQ---KLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMK 112
Query: 195 PLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
                 + +  + A +     +  +K +++RD KA N+LLDG
Sbjct: 113 EKEARAKFRQIVSAVQ-----YCHQKYIVHRDLKAENLLLDG 149

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 73/143 (51%), Gaps = 19/143 (13%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLS 153
           LG+G FG V +G  D    APS  G  + VA+K L P+ +   +  +++  EVN +  L 
Sbjct: 20  LGDGSFGVVRRGEWD----APS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 73
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS--IQPLSWDIRLKIAIGAARG 211
           H NL++L G       + +V E    GSL + L +      +  LS     + A+  A G
Sbjct: 74  HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEG 127
Query: 212 LGFLHTSEKKVIYRDFKASNILL 234
           +G+L +  K+ I+RD  A N+LL
Sbjct: 128 MGYLES--KRFIHRDLAARNLLL 148

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 17/149 (11%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG---FEEWQSE 145
           ++FK  +LLG+G F  VY+               G+ VAIK ++ ++M      +  Q+E
Sbjct: 11  EDFKVGNLLGKGSFAGVYRA---------ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNE 61
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
           V    +L HP++++L  Y  +   + LV E    G +  +L  R   ++P S +      
Sbjct: 62  VKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR---VKPFSENEARHFM 118
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILL 234
                G+ +LH+    +++RD   SN+LL
Sbjct: 119 HQIITGMLYLHS--HGILHRDLTLSNLLL 145

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 20/150 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
            FK   +LG G FG VYKG W+      P    + + VAIK+L    S +  +E   E  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKI 204
            +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++  
Sbjct: 70  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
               A+G+ +L   ++++++RD  A N+L+
Sbjct: 127 ----AKGMNYLE--DRRLVHRDLAARNVLV 150

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 73/143 (51%), Gaps = 19/143 (13%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLS 153
           LG+G FG V +G  D    APS  G  + VA+K L P+ +   +  +++  EVN +  L 
Sbjct: 26  LGDGSFGVVRRGEWD----APS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS--IQPLSWDIRLKIAIGAARG 211
           H NL++L G       + +V E    GSL + L +      +  LS     + A+  A G
Sbjct: 80  HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEG 133
Query: 212 LGFLHTSEKKVIYRDFKASNILL 234
           +G+L +  K+ I+RD  A N+LL
Sbjct: 134 MGYLES--KRFIHRDLAARNLLL 154

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 73/143 (51%), Gaps = 19/143 (13%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLS 153
           LG+G FG V +G  D    APS  G  + VA+K L P+ +   +  +++  EVN +  L 
Sbjct: 26  LGDGSFGVVRRGEWD----APS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS--IQPLSWDIRLKIAIGAARG 211
           H NL++L G       + +V E    GSL + L +      +  LS     + A+  A G
Sbjct: 80  HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEG 133
Query: 212 LGFLHTSEKKVIYRDFKASNILL 234
           +G+L +  K+ I+RD  A N+LL
Sbjct: 134 MGYLES--KRFIHRDLAARNLLL 154

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 74/160 (46%), Gaps = 24/160 (15%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 61
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY  RG +   L       Q LS     +
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL-------QKLSKFDEQR 114
Query: 204 IA---IGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
            A      A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 115 TATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 152

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 75/150 (50%), Gaps = 20/150 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
            FK   +LG G FG VYKG W+      P    + + VAIK+L    S +  +E   E  
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAY 66
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKI 204
            +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++  
Sbjct: 67  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 123
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
               A G+ +L   ++++++RD  A N+L+
Sbjct: 124 ----AEGMNYLE--DRRLVHRDLAARNVLV 147

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 68/154 (44%), Gaps = 20/154 (12%)
Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-H 154
           +L EGGF  VY+             G G   A+K+L     +       EV F+ +LS H
Sbjct: 35  VLAEGGFAFVYEA---------QDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGH 85
Query: 155 PNLVKLLGYCWEDKE--------LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
           PN+V+        KE         LL+ E + +G L   L ++  S  PLS D  LKI  
Sbjct: 86  PNIVQFCSAASIGKEESDTGQAEFLLLTE-LCKGQLVEFL-KKMESRGPLSCDTVLKIFY 143
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
              R +  +H  +  +I+RD K  N+LL   G +
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 81/187 (43%), Gaps = 27/187 (14%)
Query: 69  QILETPDLKVFSFLDLKS---------ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSK 119
           +I+E+ +   ++F+D               N +    LG G FG+V    V+       K
Sbjct: 17  KIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKV----VEATAFGLGK 72
Query: 120 TGLGMVVAIKKLNPESMQGFEE-WQSEVNFLGRL-SHPNLVKLLGYCWEDKELLLVYEYM 177
               + VA+K L   +    +E   SE+  +  L  H N+V LLG C     +L++ EY 
Sbjct: 73  EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYC 132
Query: 178 QRGSLENHLFRRNPSIQ----------PLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDF 227
             G L N L R++  ++           LS    L  +   A+G+ FL  + K  I+RD 
Sbjct: 133 CYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL--ASKNCIHRDV 190
Query: 228 KASNILL 234
            A N+LL
Sbjct: 191 AARNVLL 197

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 16/152 (10%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQSEV 146
           +NF+    +GEG +G VYK               G VVA+ K  L+ E+         E+
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALXKIRLDTETEGVPSTAIREI 53
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
           + L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +      
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLF 110
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
              +GL F H+   +V++RD K  N+L++  G
Sbjct: 111 QLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 140

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 16/152 (10%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQSEV 146
           +NF+    +GEG +G VYK               G VVA+ K  L+ E+         E+
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALXKIRLDTETEGVPSTAIREI 52
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
           + L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +      
Sbjct: 53  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLF 109
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
              +GL F H+   +V++RD K  N+L++  G
Sbjct: 110 QLLQGLAFCHSH--RVLHRDLKPQNLLINTEG 139

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G   D     ++T     VA+K +N   S++   E+ +E + +   +  
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETR----VAVKTVNESASLRERIEFLNEASVMKGFTCH 81
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG   + +  L+V E M  G L+++L         NP   P +    +++A   A
Sbjct: 82  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 141
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ +L+   KK ++R+  A N ++
Sbjct: 142 DGMAYLNA--KKFVHRNLAARNCMV 164

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G   D     ++T     VA+K +N   S++   E+ +E + +   +  
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETR----VAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG   + +  L+V E M  G L+++L         NP   P +    +++A   A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
            G+ +L+   KK ++R+  A N ++
Sbjct: 141 DGMAYLNA--KKFVHRNLAARNCMV 163

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 71/162 (43%), Gaps = 23/162 (14%)
Query: 73  TPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN 132
           TPD+    F        +F+    LG+G FG VY        LA  K     +VA+K L 
Sbjct: 12  TPDILTRHF-----TIDDFEIGRPLGKGKFGNVY--------LAREKKS-HFIVALKVLF 57
Query: 133 PESMQ--GFE-EWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR 189
              ++  G E + + E+     L HPN+++L  Y ++ + + L+ EY  RG L   L + 
Sbjct: 58  KSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKS 117
Query: 190 NPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASN 231
                  ++D +    I        ++   KKVI+RD K  N
Sbjct: 118 ------CTFDEQRTATIMEELADALMYCHGKKVIHRDIKPEN 153

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--------LAREKNS-KFILALKVLFKAQLEKAGVEHQLR 56
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 112
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  KKVI+RD K  N+LL   G L
Sbjct: 113 YITELANALSYCHS--KKVIHRDIKPENLLLGSAGEL 147

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 24/149 (16%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-----SEVNF 148
           + ++G G  G V  G    +   P +  +   VAIK L      G+ E Q     SE + 
Sbjct: 54  EKIIGSGDSGEVCYG----RLRVPGQRDV--PVAIKALK----AGYTERQRRDFLSEASI 103
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           +G+  HPN+++L G     +  ++V EYM+ GSL+  L   +     +         +G 
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL-------VGM 156
Query: 209 ARGL--GFLHTSEKKVIYRDFKASNILLD 235
            RG+  G  + S+   ++RD  A N+L+D
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVD 185

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 24/149 (16%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-----SEVNF 148
           + ++G G  G V  G    +   P +  +   VAIK L      G+ E Q     SE + 
Sbjct: 54  EKIIGSGDSGEVCYG----RLRVPGQRDV--PVAIKALK----AGYTERQRRDFLSEASI 103
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           +G+  HPN+++L G     +  ++V EYM+ GSL+  L   +     +         +G 
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL-------VGM 156
Query: 209 ARGL--GFLHTSEKKVIYRDFKASNILLD 235
            RG+  G  + S+   ++RD  A N+L+D
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVD 185

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 67/143 (46%), Gaps = 18/143 (12%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL---NPESMQGFEEWQSEVNFLGRLS 153
           LG GG   VY        LA   T L + VAIK +     E  +  + ++ EV+   +LS
Sbjct: 19  LGGGGMSTVY--------LA-EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           H N+V ++    ED    LV EY++  +L  ++     S  PLS D  +        G+ 
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIK 125
Query: 214 FLHTSEKKVIYRDFKASNILLDG 236
             H  + ++++RD K  NIL+D 
Sbjct: 126 --HAHDMRIVHRDIKPQNILIDS 146

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 82/196 (41%), Gaps = 36/196 (18%)
Query: 69  QILETPDLKVFSFLDLKS---------ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSK 119
           +I+E+ +   ++F+D               N +    LG G FG+V    V+       K
Sbjct: 2   KIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKV----VEATAFGLGK 57
Query: 120 TGLGMVVAIKKLNPESMQGFEE-WQSEVNFLGRL-SHPNLVKLLGYCWEDKELLLVYEYM 177
               + VA+K L   +    +E   SE+  +  L  H N+V LLG C     +L++ EY 
Sbjct: 58  EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYC 117
Query: 178 QRGSLENHLFRR-----NPSI--------------QPLSWDIRLKIAIGAARGLGFLHTS 218
             G L N L R+      PS+              +PL     L  +   A+G+ FL  +
Sbjct: 118 CYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL--A 175
Query: 219 EKKVIYRDFKASNILL 234
            K  I+RD  A N+LL
Sbjct: 176 SKNCIHRDVAARNVLL 191

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 77/188 (40%), Gaps = 29/188 (15%)
Query: 69  QILETPDLKVFSFLDLKS---------ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSK 119
           +I+E+ +   ++F+D               N +    LG G FG+V    V+       K
Sbjct: 17  KIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKV----VEATAFGLGK 72
Query: 120 TGLGMVVAIKKLNPESMQGFEE-WQSEVNFLGRL-SHPNLVKLLGYCWEDKELLLVYEYM 177
               + VA+K L   +    +E   SE+  +  L  H N+V LLG C     +L++ EY 
Sbjct: 73  EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYC 132
Query: 178 QRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS-----------EKKVIYRD 226
             G L N L R++   + L  D    IA   A     LH S            K  I+RD
Sbjct: 133 CYGDLLNFLRRKS---RVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRD 189
Query: 227 FKASNILL 234
             A N+LL
Sbjct: 190 VAARNVLL 197

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 75/150 (50%), Gaps = 20/150 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
            FK   +L  G FG VYKG W+      P    + + VAIK+L    S +  +E   E  
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKI 204
            +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++  
Sbjct: 77  VMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
               A+G+ +L   ++++++RD  A N+L+
Sbjct: 134 ----AKGMNYLE--DRRLVHRDLAARNVLV 157

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 75/150 (50%), Gaps = 20/150 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
            FK   +L  G FG VYKG W+      P    + + VAIK+L    S +  +E   E  
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKI 204
            +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++  
Sbjct: 70  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
               A+G+ +L   ++++++RD  A N+L+
Sbjct: 127 ----AKGMNYLE--DRRLVHRDLAARNVLV 150

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 75/150 (50%), Gaps = 20/150 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
            FK   +L  G FG VYKG W+      P    + + VAIK+L    S +  +E   E  
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKI 204
            +  + +P++ +LLG C     + L+ + M  G L +++     +I     L+W +++  
Sbjct: 77  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
               A+G+ +L   ++++++RD  A N+L+
Sbjct: 134 ----AKGMNYLE--DRRLVHRDLAARNVLV 157

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 74/164 (45%), Gaps = 39/164 (23%)
Query: 90  NFKPDSLLGEGGFGRVYKG--WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
           +FK   L+G GGFG+V+K    +D KT          V+   K N E        + EV 
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKT---------YVIKRVKYNNEKA------EREVK 56
Query: 148 FLGRLSHPNLVKLLGYCWE-----------------DKELLLVYEYMQRGSLENHLFRRN 190
            L +L H N+V   G CW+                  K L +  E+  +G+LE  + +R 
Sbjct: 57  ALAKLDHVNIVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 115
Query: 191 PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
              + L   + L++     +G+ ++H+  KK+I RD K SNI L
Sbjct: 116 G--EKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFL 155

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/143 (34%), Positives = 74/143 (51%), Gaps = 17/143 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVNFLGRLSHP 155
           +G+G FG V+KG +D++T          VVAIK ++  E+    E+ Q E+  L +   P
Sbjct: 35  IGKGSFGEVFKG-IDNRTQK--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 85
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
            + K  G   +D +L ++ EY+  GS  + L    P   PL       I     +GL +L
Sbjct: 86  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPG--PLDETQIATILREILKGLDYL 140
Query: 216 HTSEKKVIYRDFKASNILLDGVG 238
           H SEKK I+RD KA+N+LL   G
Sbjct: 141 H-SEKK-IHRDIKAANVLLSEHG 161

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 31/157 (19%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSEVNFLGRLSH 154
           +GEG FG         K +    T  G    IK++N   M     EE + EV  L  + H
Sbjct: 32  IGEGSFG---------KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSL-------ENHLFRRNPSIQPLSWDIRLKIAIG 207
           PN+V+      E+  L +V +Y + G L       +  LF+ +   Q L W +++ +A+ 
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQED---QILDWFVQICLALK 139
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILL--DGVGFLFD 242
                   H  ++K+++RD K+ NI L  DG   L D
Sbjct: 140 --------HVHDRKILHRDIKSQNIFLTKDGTVQLGD 168

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/143 (34%), Positives = 74/143 (51%), Gaps = 17/143 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVNFLGRLSHP 155
           +G+G FG V+KG +D++T          VVAIK ++  E+    E+ Q E+  L +   P
Sbjct: 15  IGKGSFGEVFKG-IDNRTQK--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 65
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
            + K  G   +D +L ++ EY+  GS  + L    P   PL       I     +GL +L
Sbjct: 66  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPG--PLDETQIATILREILKGLDYL 120
Query: 216 HTSEKKVIYRDFKASNILLDGVG 238
           H SEKK I+RD KA+N+LL   G
Sbjct: 121 H-SEKK-IHRDIKAANVLLSEHG 141

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/143 (34%), Positives = 74/143 (51%), Gaps = 17/143 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVNFLGRLSHP 155
           +G+G FG V+KG +D++T          VVAIK ++  E+    E+ Q E+  L +   P
Sbjct: 15  IGKGSFGEVFKG-IDNRTQK--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 65
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
            + K  G   +D +L ++ EY+  GS  + L    P   PL       I     +GL +L
Sbjct: 66  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPG--PLDETQIATILREILKGLDYL 120
Query: 216 HTSEKKVIYRDFKASNILLDGVG 238
           H SEKK I+RD KA+N+LL   G
Sbjct: 121 H-SEKK-IHRDIKAANVLLSEHG 141

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/143 (34%), Positives = 74/143 (51%), Gaps = 17/143 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVNFLGRLSHP 155
           +G+G FG V+KG +D++T          VVAIK ++  E+    E+ Q E+  L +   P
Sbjct: 30  IGKGSFGEVFKG-IDNRTQK--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
            + K  G   +D +L ++ EY+  GS  + L    P   PL       I     +GL +L
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPG--PLDETQIATILREILKGLDYL 135
Query: 216 HTSEKKVIYRDFKASNILLDGVG 238
           H SEKK I+RD KA+N+LL   G
Sbjct: 136 H-SEKK-IHRDIKAANVLLSEHG 156

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 59
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 115
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 116 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 150

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 59
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 115
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 116 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 150

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 55
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 56  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 111
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 112 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 146

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 56
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 112
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 113 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 147

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 59
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 115
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 116 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 150

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 58
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 59  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 114
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 115 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 149

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 56
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 112
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 113 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 147

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 61
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 117
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 118 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 152

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 56
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 112
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 113 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 147

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 59
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 115
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 116 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 150

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 61
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 117
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 118 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 152

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 58
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 59  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 114
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 115 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 149

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 57
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 113
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 114 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 148

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 57
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 113
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 114 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 148

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 57
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 113
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 114 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 148

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 56
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 112
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 113 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 147

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 15/139 (10%)
Query: 97  LGEGGFGRVYKGWVD-DKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           +G G FG V+ G +  D TL   K+        + L P+    F +   E   L + SHP
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKS------CRETLPPDLKAKFLQ---EARILKQYSHP 172
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           N+V+L+G C + + + +V E +Q G      F R    + L     L++   AA G+ +L
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLT--FLRTEGAR-LRVKTLLQMVGDAAAGMEYL 229
Query: 216 HTSEKKVIYRDFKASNILL 234
            +  K  I+RD  A N L+
Sbjct: 230 ES--KCCIHRDLAARNCLV 246

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 60
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 61  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 116
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 117 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 151

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 72/151 (47%), Gaps = 24/151 (15%)
Query: 92  KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-----SEV 146
           K + ++G G FG V  G +      P K  +   VAIK L      G+ E Q     SE 
Sbjct: 10  KIEQVIGAGEFGEVCSGHLK----LPGKREI--FVAIKTLK----SGYTEKQRRDFLSEA 59
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
           + +G+  HPN++ L G   +   ++++ E+M+ GSL++ L + +     +         +
Sbjct: 60  SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL-------V 112
Query: 207 GAARGL--GFLHTSEKKVIYRDFKASNILLD 235
           G  RG+  G  + ++   ++R   A NIL++
Sbjct: 113 GMLRGIAAGMKYLADMNYVHRALAARNILVN 143

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 56
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 112
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 113 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 147

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 15/139 (10%)
Query: 97  LGEGGFGRVYKGWVD-DKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           +G G FG V+ G +  D TL   K+        + L P+    F +   E   L + SHP
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKS------CRETLPPDLKAKFLQ---EARILKQYSHP 172
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           N+V+L+G C + + + +V E +Q G      F R    + L     L++   AA G+ +L
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLT--FLRTEGAR-LRVKTLLQMVGDAAAGMEYL 229
Query: 216 HTSEKKVIYRDFKASNILL 234
            +  K  I+RD  A N L+
Sbjct: 230 ES--KCCIHRDLAARNCLV 246

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 56
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 112
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 113 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 147

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 56
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 112
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 113 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 147

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 61
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 117
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 118 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 152

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 73
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 74  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 129
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 130 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 164

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 59
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 115
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 116 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 150

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 66/138 (47%), Gaps = 14/138 (10%)
Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           +LG G FG+V+K           +T  G+ +A K +    M+  EE ++E++ + +L H 
Sbjct: 96  ILGGGRFGQVHKC---------EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHA 146
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NL++L        +++LV EY+  G L + +   + ++  L   + +K         G  
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE-----GIR 201
Query: 216 HTSEKKVIYRDFKASNIL 233
           H  +  +++ D K  NIL
Sbjct: 202 HMHQMYILHLDLKPENIL 219

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           +LG+GG+G+V++  V   T A +     M V  K +   + +     ++E N L  + HP
Sbjct: 24  VLGKGGYGKVFQ--VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
            +V L+       +L L+ EY+  G L   L R    ++  +     +I++     LG L
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA----LGHL 137
Query: 216 HTSEKKVIYRDFKASNILLDGVGFL 240
           H  +K +IYRD K  NI+L+  G +
Sbjct: 138 H--QKGIIYRDLKPENIMLNHQGHV 160

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 59
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 115
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 116 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 150

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           +LG+GG+G+V++  V   T A +     M V  K +   + +     ++E N L  + HP
Sbjct: 24  VLGKGGYGKVFQ--VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
            +V L+       +L L+ EY+  G L   L R    ++  +     +I++     LG L
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA----LGHL 137
Query: 216 HTSEKKVIYRDFKASNILLDGVGFL 240
           H  +K +IYRD K  NI+L+  G +
Sbjct: 138 H--QKGIIYRDLKPENIMLNHQGHV 160

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVY--------LAREKQR-KFILALKVLFKAQLEKAGVEHQLR 53
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 54  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 109
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 110 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 144

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 72/158 (45%), Gaps = 22/158 (13%)
Query: 90  NFKPDSLLGEGGFGRVYKG--WVDDKTLAPSKTGLGMVVAIKKL---NPESMQGFEEWQS 144
           NF+ +  +G G F  VY+    +D           G+ VA+KK+   +    +   +   
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLD-----------GVPVALKKVQIFDLMDAKARADCIK 81
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL--FRRNPSIQPLSWDIRL 202
           E++ L +L+HPN++K      ED EL +V E    G L   +  F++   + P     + 
Sbjct: 82  EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
            + + +A      H   ++V++RD K +N+ +   G +
Sbjct: 142 FVQLCSA----LEHMHSRRVMHRDIKPANVFITATGVV 175

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 67/150 (44%), Gaps = 28/150 (18%)
Query: 97  LGEGGFGRV----YKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL 152
           LG G FG V    ++G  D              VAIK +   SM   +E+  E   +  L
Sbjct: 12  LGTGQFGVVKYGKWRGQYD--------------VAIKMIKEGSMSE-DEFIEEAKVMMNL 56
Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL--FRRNPSIQPLSWDIRLKIAIGAAR 210
           SH  LV+L G C + + + ++ EYM  G L N+L   R     Q L     L++      
Sbjct: 57  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCE 111
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
            + +L +  K+ ++RD  A N L++  G +
Sbjct: 112 AMEYLES--KQFLHRDLAARNCLVNDQGVV 139

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 73/162 (45%), Gaps = 24/162 (14%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFE-EWQS 144
           AT  ++P + +G G +G VYK               G  VA+K +  P   +G       
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVPNGEEGLPISTVR 52
Query: 145 EVNFLGRL---SHPNLVKLLGYCW---EDKEL--LLVYEYMQRGSLENHLFRRNPSIQPL 196
           EV  L RL    HPN+V+L+  C     D+E+   LV+E++ +  L  +L +  P   P 
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 111
Query: 197 SWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                L       RGL FLH +   +++RD K  NIL+   G
Sbjct: 112 ETIKDLMRQF--LRGLDFLHAN--CIVHRDLKPENILVTSGG 149

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 82
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G+    ++R    +          
Sbjct: 83  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTAT 138
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 139 YITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 173

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 73/162 (45%), Gaps = 24/162 (14%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFE-EWQS 144
           AT  ++P + +G G +G VYK               G  VA+K +  P   +G       
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVPNGEEGLPISTVR 52
Query: 145 EVNFLGRL---SHPNLVKLLGYCW---EDKEL--LLVYEYMQRGSLENHLFRRNPSIQPL 196
           EV  L RL    HPN+V+L+  C     D+E+   LV+E++ +  L  +L +  P   P 
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 111
Query: 197 SWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                L       RGL FLH +   +++RD K  NIL+   G
Sbjct: 112 ETIKDLMRQF--LRGLDFLHAN--CIVHRDLKPENILVTSGG 149

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 75/162 (46%), Gaps = 19/162 (11%)
Query: 78  VFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAI---KKLNPE 134
           + S  D +    N++    +G+G F +V       K      TG  + + I    +LNP 
Sbjct: 4   IASCADEQPHIGNYRLLKTIGKGNFAKV-------KLARHILTGREVAIKIIDKTQLNPT 56
Query: 135 SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQ 194
           S+Q   +   EV  +  L+HPN+VKL      +K L L+ EY   G + ++L      ++
Sbjct: 57  SLQ---KLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMK 112
Query: 195 PLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
                 + +  + A +     +  +K++++RD KA N+LLD 
Sbjct: 113 EKEARSKFRQIVSAVQ-----YCHQKRIVHRDLKAENLLLDA 149

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 57/117 (48%), Gaps = 10/117 (8%)
Query: 126 VAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENH 185
           VAIK +   SM   +E+  E   +  LSH  LV+L G C + + + ++ EYM  G L N+
Sbjct: 35  VAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 93
Query: 186 L--FRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           L   R     Q L     L++       + +L +  K+ ++RD  A N L++  G +
Sbjct: 94  LREMRHRFQTQQL-----LEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVV 143

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 73/162 (45%), Gaps = 24/162 (14%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFE-EWQS 144
           AT  ++P + +G G +G VYK               G  VA+K +  P   +G       
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVPNGEEGLPISTVR 52
Query: 145 EVNFLGRL---SHPNLVKLLGYCW---EDKEL--LLVYEYMQRGSLENHLFRRNPSIQPL 196
           EV  L RL    HPN+V+L+  C     D+E+   LV+E++ +  L  +L +  P   P 
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 111
Query: 197 SWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                L       RGL FLH +   +++RD K  NIL+   G
Sbjct: 112 ETIKDLMRQF--LRGLDFLHAN--CIVHRDLKPENILVTSGG 149

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 57/117 (48%), Gaps = 10/117 (8%)
Query: 126 VAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENH 185
           VAIK +   SM   +E+  E   +  LSH  LV+L G C + + + ++ EYM  G L N+
Sbjct: 36  VAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 94
Query: 186 L--FRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           L   R     Q L     L++       + +L +  K+ ++RD  A N L++  G +
Sbjct: 95  LREMRHRFQTQQL-----LEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVV 144

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 24/160 (15%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQ 143
           A ++F+    LG+G FG VY        LA  K     ++A+K L    ++  G E + +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLR 82
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            EV     L HPN+++L GY  +   + L+ EY   G++   L       Q LS     +
Sbjct: 83  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-------QKLSKFDEQR 135
Query: 204 IA---IGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
            A      A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 136 TATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGEL 173

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 57/117 (48%), Gaps = 10/117 (8%)
Query: 126 VAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENH 185
           VAIK +   SM   +E+  E   +  LSH  LV+L G C + + + ++ EYM  G L N+
Sbjct: 36  VAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 94
Query: 186 L--FRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           L   R     Q L     L++       + +L +  K+ ++RD  A N L++  G +
Sbjct: 95  LREMRHRFQTQQL-----LEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVV 144

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 57/117 (48%), Gaps = 10/117 (8%)
Query: 126 VAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENH 185
           VAIK +   SM   +E+  E   +  LSH  LV+L G C + + + ++ EYM  G L N+
Sbjct: 42  VAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 100
Query: 186 L--FRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           L   R     Q L     L++       + +L +  K+ ++RD  A N L++  G +
Sbjct: 101 LREMRHRFQTQQL-----LEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVV 150

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 57/117 (48%), Gaps = 10/117 (8%)
Query: 126 VAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENH 185
           VAIK +   SM   +E+  E   +  LSH  LV+L G C + + + ++ EYM  G L N+
Sbjct: 51  VAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 109
Query: 186 L--FRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           L   R     Q L     L++       + +L +  K+ ++RD  A N L++  G +
Sbjct: 110 LREMRHRFQTQQL-----LEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVV 159

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 57/117 (48%), Gaps = 10/117 (8%)
Query: 126 VAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENH 185
           VAIK +   SM   +E+  E   +  LSH  LV+L G C + + + ++ EYM  G L N+
Sbjct: 51  VAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 109
Query: 186 L--FRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           L   R     Q L     L++       + +L +  K+ ++RD  A N L++  G +
Sbjct: 110 LREMRHRFQTQQL-----LEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVV 159

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 60/119 (50%), Gaps = 14/119 (11%)
Query: 123 GMVVAIK-----KLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYM 177
           G  VAIK     +LNP S+Q   +   EV  +  L+HPN+VKL      +K L L+ EY 
Sbjct: 37  GREVAIKIIDKTQLNPTSLQ---KLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA 93
Query: 178 QRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
             G + ++L      ++      + +  + A +     +  +K++++RD KA N+LLD 
Sbjct: 94  SGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQ-----YCHQKRIVHRDLKAENLLLDA 146

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 75/149 (50%), Gaps = 13/149 (8%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSE 145
           A ++   + +LGEG FG VY+G      +  +  G  + VA+K    + ++   E++ SE
Sbjct: 6   AREDVVLNRILGEGFFGEVYEG------VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 59
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
              +  L HP++VKL+G   E++   ++ E    G L ++L R   S++ L+    +  +
Sbjct: 60  AVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTL---VLYS 115
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILL 234
           +   + + +L +     ++RD    NIL+
Sbjct: 116 LQICKAMAYLESI--NCVHRDIAVRNILV 142

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 66/145 (45%), Gaps = 19/145 (13%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
           LG GGFG V + W+   T        G  VAIK+   E S +  E W  E+  + +L+HP
Sbjct: 22  LGTGGFGYVLR-WIHQDT--------GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 156 NLVKL------LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
           N+V        L     +   LL  EY + G L  +L +           IR  ++   +
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DIS 131
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
             L +LH  E ++I+RD K  NI+L
Sbjct: 132 SALRYLH--ENRIIHRDLKPENIVL 154

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 77/159 (48%), Gaps = 18/159 (11%)
Query: 85  KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEE 141
           K + ++F+    LG G FGRV+        L  S+   G   A+K L  E    ++  E 
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVH--------LIRSRHN-GRYYAMKVLKKEIVVRLKQVEH 52
Query: 142 WQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR 201
              E   L  ++HP ++++ G   + +++ ++ +Y++ G L + L +      P++    
Sbjct: 53  TNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA 112
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
            ++ +     L +LH+  K +IYRD K  NILLD  G +
Sbjct: 113 AEVCLA----LEYLHS--KDIIYRDLKPENILLDKNGHI 145

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 66/145 (45%), Gaps = 19/145 (13%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
           LG GGFG V + W+   T        G  VAIK+   E S +  E W  E+  + +L+HP
Sbjct: 23  LGTGGFGYVLR-WIHQDT--------GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 73
Query: 156 NLVKL------LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
           N+V        L     +   LL  EY + G L  +L +           IR  ++   +
Sbjct: 74  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DIS 132
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL 234
             L +LH  E ++I+RD K  NI+L
Sbjct: 133 SALRYLH--ENRIIHRDLKPENIVL 155

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 75/149 (50%), Gaps = 13/149 (8%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSE 145
           A ++   + +LGEG FG VY+G      +  +  G  + VA+K    + ++   E++ SE
Sbjct: 22  AREDVVLNRILGEGFFGEVYEG------VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 75
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
              +  L HP++VKL+G   E++   ++ E    G L ++L R   S++ L+    +  +
Sbjct: 76  AVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTL---VLYS 131
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILL 234
           +   + + +L +     ++RD    NIL+
Sbjct: 132 LQICKAMAYLESI--NCVHRDIAVRNILV 158

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 75/149 (50%), Gaps = 13/149 (8%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSE 145
           A ++   + +LGEG FG VY+G      +  +  G  + VA+K    + ++   E++ SE
Sbjct: 10  AREDVVLNRILGEGFFGEVYEG------VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 63
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
              +  L HP++VKL+G   E++   ++ E    G L ++L R   S++ L+    +  +
Sbjct: 64  AVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTL---VLYS 119
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILL 234
           +   + + +L +     ++RD    NIL+
Sbjct: 120 LQICKAMAYLESI--NCVHRDIAVRNILV 146

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 70/143 (48%), Gaps = 17/143 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVNFLGRLSHP 155
           +G+G FG VYKG +D+ T          VVAIK ++  E+    E+ Q E+  L +   P
Sbjct: 27  IGKGSFGEVYKG-IDNHT--------KEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 77
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
            + +  G   +  +L ++ EY+  GS  + L    P   PL       I     +GL +L
Sbjct: 78  YITRYFGSYLKSTKLWIIMEYLGGGSALDLL---KPG--PLEETYIATILREILKGLDYL 132
Query: 216 HTSEKKVIYRDFKASNILLDGVG 238
           H+  K  I+RD KA+N+LL   G
Sbjct: 133 HSERK--IHRDIKAANVLLSEQG 153

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 68/146 (46%), Gaps = 17/146 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQ-SEVNFLGRLSH 154
           +GEG +G V+K                 +VA+K++   +  +G       E+  L  L H
Sbjct: 10  IGEGTYGTVFKA---------KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
            N+V+L      DK+L LV+E+  +  L+ +    N  + P   +I         +GLGF
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDP---EIVKSFLFQLLKGLGF 116
Query: 215 LHTSEKKVIYRDFKASNILLDGVGFL 240
            H+  + V++RD K  N+L++  G L
Sbjct: 117 CHS--RNVLHRDLKPQNLLINRNGEL 140

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 68/146 (46%), Gaps = 17/146 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQ-SEVNFLGRLSH 154
           +GEG +G V+K                 +VA+K++   +  +G       E+  L  L H
Sbjct: 10  IGEGTYGTVFKA---------KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
            N+V+L      DK+L LV+E+  +  L+ +    N  + P   +I         +GLGF
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDP---EIVKSFLFQLLKGLGF 116
Query: 215 LHTSEKKVIYRDFKASNILLDGVGFL 240
            H+  + V++RD K  N+L++  G L
Sbjct: 117 CHS--RNVLHRDLKPQNLLINRNGEL 140

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 66/144 (45%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V+ G  +  T           VAIK L P +M   E +  E   + +L H  
Sbjct: 16  LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 64
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSL------ENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           LV+L     E+  + +V EYM +GSL      E   + R P +     D+  +IA G A 
Sbjct: 65  LVQLYAVVSEEP-IXIVTEYMSKGSLLDFLKGETGKYLRLPQLV----DMAAQIASGMA- 118
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
                +      ++RD +A+NIL+
Sbjct: 119 -----YVERMNYVHRDLRAANILV 137

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 68/163 (41%), Gaps = 27/163 (16%)
Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-----SMQGFEEWQS 144
           N++    LGEG FG+V   +          T  G  VA+K +N +      MQG    + 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAY---------HTTTGQKVALKIINKKVLAKSDMQG--RIER 53
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEY---------MQRGSLENHLFRR--NPSI 193
           E+++L  L HP+++KL        E+++V EY         +QR  +     RR     I
Sbjct: 54  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQII 113
Query: 194 QPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
             + +  R KI     +    L      V   DF  SNI+ DG
Sbjct: 114 SAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 156

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 68/163 (41%), Gaps = 27/163 (16%)
Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-----SMQGFEEWQS 144
           N++    LGEG FG+V   +          T  G  VA+K +N +      MQG    + 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAY---------HTTTGQKVALKIINKKVLAKSDMQG--RIER 63
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEY---------MQRGSLENHLFRR--NPSI 193
           E+++L  L HP+++KL        E+++V EY         +QR  +     RR     I
Sbjct: 64  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQII 123
Query: 194 QPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
             + +  R KI     +    L      V   DF  SNI+ DG
Sbjct: 124 SAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 166

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 66/144 (45%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V+ G  +  T           VAIK L P +M   E +  E   + +L H  
Sbjct: 23  LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 71
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSL------ENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           LV+L     E+  + +V EYM +GSL      E   + R P +     D+  +IA G A 
Sbjct: 72  LVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLV----DMSAQIASGMA- 125
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
                +      ++RD +A+NIL+
Sbjct: 126 -----YVERMNYVHRDLRAANILV 144

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 68/163 (41%), Gaps = 27/163 (16%)
Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-----SMQGFEEWQS 144
           N++    LGEG FG+V   +          T  G  VA+K +N +      MQG    + 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAY---------HTTTGQKVALKIINKKVLAKSDMQG--RIER 62
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEY---------MQRGSLENHLFRR--NPSI 193
           E+++L  L HP+++KL        E+++V EY         +QR  +     RR     I
Sbjct: 63  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQII 122
Query: 194 QPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
             + +  R KI     +    L      V   DF  SNI+ DG
Sbjct: 123 SAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 66/144 (45%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V+ G  +  T           VAIK L P +M   E +  E   + +L H  
Sbjct: 23  LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 71
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSL------ENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           LV+L     E+  + +V EYM +GSL      E   + R P +     D+  +IA G A 
Sbjct: 72  LVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLV----DMSAQIASGMA- 125
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
                +      ++RD +A+NIL+
Sbjct: 126 -----YVERMNYVHRDLRAANILV 144

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 66/144 (45%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V+ G  +  T           VAIK L P +M   E +  E   + +L H  
Sbjct: 192 LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 240
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSL------ENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           LV+L     E+  + +V EYM +GSL      E   + R P +     D+  +IA G A 
Sbjct: 241 LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLV----DMAAQIASGMA- 294
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
                +      ++RD +A+NIL+
Sbjct: 295 -----YVERMNYVHRDLRAANILV 313

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 66/138 (47%), Gaps = 16/138 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V+ G  +  T           VAIK L P +M   E +  E   + +L H  
Sbjct: 17  LGNGQFGEVWMGTWNGNT----------KVAIKTLKPGTMSP-ESFLEEAQIMKKLKHDK 65
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV+L     E+  + +V EYM +GSL +  F ++   + L     + +A   A G+ ++ 
Sbjct: 66  LVQLYAVVSEEP-IYIVTEYMNKGSLLD--FLKDGEGRALKLPNLVDMAAQVAAGMAYIE 122
Query: 217 TSEKKVIYRDFKASNILL 234
                 I+RD +++NIL+
Sbjct: 123 --RMNYIHRDLRSANILV 138

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 67/138 (48%), Gaps = 16/138 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V+ G  +  T           VAIK L P +M   E +  E   + +L H  
Sbjct: 192 LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 240
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV+L     E+  + +V EYM +GSL +  F +  + + L     + +A   A G+ ++ 
Sbjct: 241 LVQLYAVVSEEP-IYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 217 TSEKKVIYRDFKASNILL 234
                 ++RD +A+NIL+
Sbjct: 298 --RMNYVHRDLRAANILV 313

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 66/144 (45%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V+ G  +  T           VAIK L P +M   E +  E   + +L H  
Sbjct: 19  LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 67
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSL------ENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           LV+L     E+  + +V EYM +GSL      E   + R P +     D+  +IA G A 
Sbjct: 68  LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLV----DMAAQIASGMA- 121
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
                +      ++RD +A+NIL+
Sbjct: 122 -----YVERMNYVHRDLRAANILV 140

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 68/163 (41%), Gaps = 27/163 (16%)
Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-----SMQGFEEWQS 144
           N++    LGEG FG+V   +          T  G  VA+K +N +      MQG    + 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAY---------HTTTGQKVALKIINKKVLAKSDMQG--RIER 57
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEY---------MQRGSLENHLFRR--NPSI 193
           E+++L  L HP+++KL        E+++V EY         +QR  +     RR     I
Sbjct: 58  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQII 117
Query: 194 QPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
             + +  R KI     +    L      V   DF  SNI+ DG
Sbjct: 118 SAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 160

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 75/177 (42%), Gaps = 52/177 (29%)
Query: 90  NFKPDSLLGEGGFGRVYKG--WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
           +FK   L+G GGFG+V+K    +D KT          V+   K N E        + EV 
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKT---------YVIRRVKYNNEKA------EREVK 57
Query: 148 FLGRLSHPNLVKLLGYCWE------------------------------DKELLLVYEYM 177
            L +L H N+V   G CW+                               K L +  E+ 
Sbjct: 58  ALAKLDHVNIVHYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFC 116
Query: 178 QRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
            +G+LE  + +R    + L   + L++     +G+ ++H+  KK+I+RD K SNI L
Sbjct: 117 DKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHS--KKLIHRDLKPSNIFL 169

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V+ G  +  T           VAIK L P +M   E +  E   + +L H  
Sbjct: 15  LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 63
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAAR 210
           LV+L     E+  + +V EYM +GSL + L      + R P +     D+  +IA G A 
Sbjct: 64  LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV----DMAAQIASGMA- 117
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
                +      ++RD +A+NIL+
Sbjct: 118 -----YVERMNYVHRDLRAANILV 136

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 139 FEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE--LLLVYEYMQRGSLENHLFRRNPSIQPL 196
            E+   E+  L +L HPN+VKL+    +  E  L +V+E + +G +        P+++PL
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-----MEVPTLKPL 134
Query: 197 SWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           S D          +G+ +LH   +K+I+RD K SN+L+   G +
Sbjct: 135 SEDQARFYFQDLIKGIEYLHY--QKIIHRDIKPSNLLVGEDGHI 176

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 77/158 (48%), Gaps = 14/158 (8%)
Query: 85  KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS 144
           K+   +F+   +LG+G FG+V+   +  K   P     G + A+K L   +++  +  ++
Sbjct: 24  KADPSHFELLKVLGQGSFGKVF---LVRKVTRPDS---GHLYAMKVLKKATLKVRDRVRT 77
Query: 145 --EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL 202
             E + L  ++HP +VKL      + +L L+ ++++ G L     R +  +     D++ 
Sbjct: 78  KMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKF 134
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
            +A  A   LG  H     +IYRD K  NILLD  G +
Sbjct: 135 YLAELA---LGLDHLHSLGIIYRDLKPENILLDEEGHI 169

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V+ G  +  T           VAIK L P +M   E +  E   + +L H  
Sbjct: 17  LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 65
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAAR 210
           LV+L     E+  + +V EYM +GSL + L      + R P +     D+  +IA G A 
Sbjct: 66  LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV----DMAAQIASGMA- 119
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
                +      ++RD +A+NIL+
Sbjct: 120 -----YVERMNYVHRDLRAANILV 138

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V+ G  +  T           VAIK L P +M   E +  E   + +L H  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 74
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAAR 210
           LV+L     E+  + +V EYM +GSL + L      + R P +     D+  +IA G A 
Sbjct: 75  LVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV----DMAAQIASGMA- 128
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
                +      ++RD +A+NIL+
Sbjct: 129 -----YVERMNYVHRDLRAANILV 147

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 24/158 (15%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQSE 145
           ++F     LG+G FG VY        LA  +     ++A+K L    ++  G E + + E
Sbjct: 12  EDFDIGRPLGKGKFGNVY--------LARERQS-KFILALKVLFKTQLEKAGVEHQLRRE 62
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
           V     L HPN+++L GY  +   + L+ EY   G++   L       Q LS     + A
Sbjct: 63  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-------QKLSRFDEQRTA 115
Query: 206 ---IGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                 A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 116 TYITELANALSYCHS--KRVIHRDIKPENLLLGSNGEL 151

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V+ G  +  T           VAIK L P +M   E +  E   + +L H  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 74
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAAR 210
           LV+L     E+  + +V EYM +GSL + L      + R P +     D+  +IA G A 
Sbjct: 75  LVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV----DMAAQIASGMA- 128
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
                +      ++RD +A+NIL+
Sbjct: 129 -----YVERMNYVHRDLRAANILV 147

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V+ G  +  T           VAIK L P +M   E +  E   + +L H  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 74
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAAR 210
           LV+L     E+  + +V EYM +GSL + L      + R P +     D+  +IA G A 
Sbjct: 75  LVQLYAVVSEEP-IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLV----DMAAQIASGMA- 128
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
                +      ++RD +A+NIL+
Sbjct: 129 -----YVERMNYVHRDLRAANILV 147

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V+ G  +  T           VAIK L P +M   E +  E   + +L H  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 74
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAAR 210
           LV+L     E+  + +V EYM +GSL + L      + R P +     D+  +IA G A 
Sbjct: 75  LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV----DMAAQIASGMA- 128
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
                +      ++RD +A+NIL+
Sbjct: 129 -----YVERMNYVHRDLRAANILV 147

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 71/146 (48%), Gaps = 18/146 (12%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGL-GMVVAIKKLNPESMQGFEEWQ-SEVNFLGRLSH 154
           LGEG +  VYKG          K+ L   +VA+K++  E  +G       EV+ L  L H
Sbjct: 10  LGEGTYATVYKG----------KSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH 59
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
            N+V L      +K L LV+EY+ +  L+ +L      I     +++L       RGL +
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIIN--MHNVKL-FLFQLLRGLAY 115
Query: 215 LHTSEKKVIYRDFKASNILLDGVGFL 240
            H   +KV++RD K  N+L++  G L
Sbjct: 116 CH--RQKVLHRDLKPQNLLINERGEL 139

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 24/158 (15%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQSE 145
           ++F     LG+G FG VY        LA  +     ++A+K L    ++  G E + + E
Sbjct: 12  EDFDIGRPLGKGKFGNVY--------LARERQS-KFILALKVLFKTQLEKAGVEHQLRRE 62
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
           V     L HPN+++L GY  +   + L+ EY   G++   L       Q LS     + A
Sbjct: 63  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-------QKLSRFDEQRTA 115
Query: 206 ---IGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                 A  L + H+  K+VI+RD K  N+LL   G L
Sbjct: 116 TYITELANALSYCHS--KRVIHRDIKPENLLLGSNGEL 151

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 66/144 (45%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V+ G  +  T           VAIK L P +M   E +  E   + +L H  
Sbjct: 275 LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 323
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSL------ENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           LV+L     E+  + +V EYM +GSL      E   + R P +     D+  +IA G A 
Sbjct: 324 LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQL----VDMAAQIASGMA- 377
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
                +      ++RD +A+NIL+
Sbjct: 378 -----YVERMNYVHRDLRAANILV 396

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 64/147 (43%), Gaps = 16/147 (10%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ--SEVNFLGRLSH 154
           +G G +GR  K           +   G ++  K+L+  SM   E+    SEVN L  L H
Sbjct: 14  IGTGSYGRCQK---------IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 155 PNLVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
           PN+V+      +  +  L +V EY + G L + + +     Q L  +  L++       L
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 213 GFLHTSEK---KVIYRDFKASNILLDG 236
              H        V++RD K +N+ LDG
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDG 151

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 64/147 (43%), Gaps = 16/147 (10%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ--SEVNFLGRLSH 154
           +G G +GR  K           +   G ++  K+L+  SM   E+    SEVN L  L H
Sbjct: 14  IGTGSYGRCQK---------IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 155 PNLVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
           PN+V+      +  +  L +V EY + G L + + +     Q L  +  L++       L
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 213 GFLHTSEK---KVIYRDFKASNILLDG 236
              H        V++RD K +N+ LDG
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDG 151

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 65/155 (41%), Gaps = 23/155 (14%)
Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEV 146
           + +F+  SLLGEG +G V        T  P+    G +VAIKK+ P     F      E+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSA-----THKPT----GEIVAIKKIEPFDKPLFALRTLREI 60
Query: 147 NFLGRLSHPNLVKLLGYCWED-----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR 201
             L    H N++ +      D      E+ ++ E MQ          R  S Q LS D  
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD------LHRVISTQMLSDDHI 114
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
                   R +  LH S   VI+RD K SN+L++ 
Sbjct: 115 QYFIYQTLRAVKVLHGS--NVIHRDLKPSNLLINS 147

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 65/155 (41%), Gaps = 23/155 (14%)
Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEV 146
           + +F+  SLLGEG +G V        T  P+    G +VAIKK+ P     F      E+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSA-----THKPT----GEIVAIKKIEPFDKPLFALRTLREI 60
Query: 147 NFLGRLSHPNLVKLLGYCWED-----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR 201
             L    H N++ +      D      E+ ++ E MQ          R  S Q LS D  
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD------LHRVISTQMLSDDHI 114
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
                   R +  LH S   VI+RD K SN+L++ 
Sbjct: 115 QYFIYQTLRAVKVLHGS--NVIHRDLKPSNLLINS 147

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 70/144 (48%), Gaps = 20/144 (13%)
Query: 96  LLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLS 153
           +LG G FG VYKG W+      P    + + VAIK L    S +  +E   E   +  + 
Sbjct: 24  VLGSGAFGTVYKGIWI------PDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 77
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR---RNPSIQPLSWDIRLKIAIGAAR 210
            P + +LLG C     + LV + M  G L +H+     R  S   L+W +++      A+
Sbjct: 78  SPYVSRLLGICLT-STVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQI------AK 130
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
           G+ +L   + ++++RD  A N+L+
Sbjct: 131 GMSYLE--DVRLVHRDLAARNVLV 152

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 69/147 (46%), Gaps = 18/147 (12%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQSEVNFLGRLS 153
           LG+G FG VY        LA  K     ++A+K L    ++  G E + + E+     L 
Sbjct: 22  LGKGKFGNVY--------LAREKQN-KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           HPN++++  Y  + K + L+ E+  RG L   L +     +  S     ++    A  L 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL----ADALH 128
Query: 214 FLHTSEKKVIYRDFKASNILLDGVGFL 240
           + H  E+KVI+RD K  N+L+   G L
Sbjct: 129 YCH--ERKVIHRDIKPENLLMGYKGEL 153

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 66/144 (45%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V+ G  +  T           VAIK L P +M   E +  E   + +L H  
Sbjct: 192 LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 240
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSL------ENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           LV+L     E+  + +V EYM +GSL      E   + R P +     D+  +IA G A 
Sbjct: 241 LVQLYAVVSEEP-IYIVGEYMSKGSLLDFLKGETGKYLRLPQLV----DMAAQIASGMA- 294
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
                +      ++RD +A+NIL+
Sbjct: 295 -----YVERMNYVHRDLRAANILV 313

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 65/155 (41%), Gaps = 23/155 (14%)
Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEV 146
           + +F+  SLLGEG +G V        T  P+    G +VAIKK+ P     F      E+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSA-----THKPT----GEIVAIKKIEPFDKPLFALRTLREI 60
Query: 147 NFLGRLSHPNLVKLLGYCWED-----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR 201
             L    H N++ +      D      E+ ++ E MQ          R  S Q LS D  
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD------LHRVISTQMLSDDHI 114
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
                   R +  LH S   VI+RD K SN+L++ 
Sbjct: 115 QYFIYQTLRAVKVLHGS--NVIHRDLKPSNLLINS 147

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 16/160 (10%)
Query: 84  LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ 143
           + S  ++++    +G G +GR  K           +   G ++  K+L+  SM   E+  
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQK---------IRRKSDGKILVWKELDYGSMTEAEKQM 51
Query: 144 --SEVNFLGRLSHPNLVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWD 199
             SEVN L  L HPN+V+      +  +  L +V EY + G L + + +     Q L  +
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 200 IRLKIAIGAARGLGFLHTSEK---KVIYRDFKASNILLDG 236
             L++       L   H        V++RD K +N+ LDG
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG 151

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 74/169 (43%), Gaps = 35/169 (20%)
Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFL 149
           N K   L+G G +G VYKG +D++            VA+K  +  + Q F   +  +  +
Sbjct: 14  NLKLLELIGRGRYGAVYKGSLDERP-----------VAVKVFSFANRQNFIN-EKNIYRV 61
Query: 150 GRLSHPNLVKLLGYCWEDK-------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL 202
             + H N+ + +    +++       E LLV EY   GSL  +L     S+    W    
Sbjct: 62  PLMEHDNIARFI--VGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSC 114
Query: 203 KIAIGAARGLGFLHTS-------EKKVIYRDFKASNILL--DGVGFLFD 242
           ++A    RGL +LHT        +  + +RD  + N+L+  DG   + D
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 69/147 (46%), Gaps = 18/147 (12%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFE-EWQSEVNFLGRLS 153
           LG+G FG VY        LA  K     ++A+K L    ++  G E + + E+     L 
Sbjct: 23  LGKGKFGNVY--------LAREKQN-KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 73
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           HPN++++  Y  + K + L+ E+  RG L   L +     +  S     ++    A  L 
Sbjct: 74  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL----ADALH 129
Query: 214 FLHTSEKKVIYRDFKASNILLDGVGFL 240
           + H  E+KVI+RD K  N+L+   G L
Sbjct: 130 YCH--ERKVIHRDIKPENLLMGYKGEL 154

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V+ G  +  T           VAIK L P +M   E +  E   + +L H  
Sbjct: 193 LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGNMSP-EAFLQEAQVMKKLRHEK 241
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAAR 210
           LV+L     E+  + +V EYM +GSL + L      + R P +     D+  +IA G A 
Sbjct: 242 LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV----DMAAQIASGMA- 295
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
                +      ++RD +A+NIL+
Sbjct: 296 -----YVERMNYVHRDLRAANILV 314

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 67/144 (46%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V+ G  +  T           VAIK L P +M   E +  E   + ++ H  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKIRHEK 74
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAAR 210
           LV+L     E+  + +V EYM +GSL + L      + R P +     D+  +IA G A 
Sbjct: 75  LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV----DMAAQIASGMA- 128
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
                +      ++RD +A+NIL+
Sbjct: 129 -----YVERMNYVHRDLRAANILV 147

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 66/144 (45%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V+ G  +  T           VAIK L P +M   E +  E   + +L H  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 74
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAAR 210
           LV+L     E+  + +V EYM +GSL + L      + R P +     D+  +IA G A 
Sbjct: 75  LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV----DMAAQIASGMA- 128
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
                +      ++RD  A+NIL+
Sbjct: 129 -----YVERMNYVHRDLAAANILV 147

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 68/149 (45%), Gaps = 17/149 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
           LG G FG+V    ++       KT     VA+K L   +         SE+  L  + H 
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 156 -NLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQP--------LSWDIRLKIA 205
            N+V LLG C +    L+++ E+ + G+L  +L  +     P        L+ +  +  +
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYS 150
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILL 234
              A+G+ FL  + +K I+RD  A NILL
Sbjct: 151 FQVAKGMEFL--ASRKXIHRDLAARNILL 177

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/139 (25%), Positives = 65/139 (46%), Gaps = 12/139 (8%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHP 155
           LG G FG V+   V++++     +GL  V  IK +N +  Q   E+ ++E+  L  L HP
Sbjct: 30  LGSGAFGDVH--LVEERS-----SGLERV--IKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           N++K+     +   + +V E  + G L   +       + LS     ++       L + 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 216 HTSEKKVIYRDFKASNILL 234
           H+  + V+++D K  NIL 
Sbjct: 141 HS--QHVVHKDLKPENILF 157

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 66/144 (45%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V+ G  +  T           VAIK L P +M   E +  E   + +L H  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 74
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAAR 210
           LV+L     E+  + +V EYM +G L + L      + R P +     D+  +IA G A 
Sbjct: 75  LVQLYAVVSEEP-IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLV----DMAAQIASGMA- 128
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
                +      ++RD +A+NIL+
Sbjct: 129 -----YVERMNYVHRDLRAANILV 147

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 70/160 (43%), Gaps = 29/160 (18%)
Query: 90  NFKPDSLLGEGGFGRVY--KGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
           +F+P   LG GGFG V+  K  VDD   A  +  L          P      E+   EV 
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRL----------PNRELAREKVMREVK 55
Query: 148 FLGRLSHPNLVKLLGYCWEDKELL--------LVYEYMQ-----RGSLENHLFRRNPSIQ 194
            L +L HP +V+     W +K            VY Y+Q     + +L++ +  R  +I+
Sbjct: 56  ALAKLEHPGIVRYFN-AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC-TIE 113
Query: 195 PLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
                + L I +  A  + FLH+  K +++RD K SNI  
Sbjct: 114 ERERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFF 151

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 68/149 (45%), Gaps = 17/149 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
           LG G FG+V    ++       KT     VA+K L   +         SE+  L  + H 
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 156 -NLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQP--------LSWDIRLKIA 205
            N+V LLG C +    L+++ E+ + G+L  +L  +     P        L+ +  +  +
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYS 150
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILL 234
              A+G+ FL  + +K I+RD  A NILL
Sbjct: 151 FQVAKGMEFL--ASRKXIHRDLAARNILL 177

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 66/144 (45%), Gaps = 28/144 (19%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V+ G  +  T           VAIK L P +M   E +  E   + +L H  
Sbjct: 26  LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 74
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAAR 210
           LV+L     E+  + +V EYM +G L + L      + R P +     D+  +IA G A 
Sbjct: 75  LVQLYAVVSEEP-IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLV----DMAAQIASGMA- 128
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
                +      ++RD +A+NIL+
Sbjct: 129 -----YVERMNYVHRDLRAANILV 147

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 29/168 (17%)
Query: 84  LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ 143
           L  A + ++  + +GEG +G+V+K     + L   K G G  VA+K++    +Q  EE  
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKA----RDL---KNG-GRFVALKRVR---VQTGEEGM 54
Query: 144 -----SEVNFLGRLS---HPNLVKLLGYCW---EDKE--LLLVYEYMQRGSLENHLFRRN 190
                 EV  L  L    HPN+V+L   C     D+E  L LV+E++ +  L  +L  + 
Sbjct: 55  PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKV 112
Query: 191 PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
           P     +  I+  +     RGL FLH+   +V++RD K  NIL+   G
Sbjct: 113 PEPGVPTETIK-DMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSG 157

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 80  SFLDLKSATKNFKPD-----SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE 134
           +FL  K      K D     S LG G  G V+K  V  K   PS    G+V+A K ++ E
Sbjct: 11  AFLTQKQKVGELKDDDFEKISELGAGNGGVVFK--VSHK---PS----GLVMARKLIHLE 61
Query: 135 SMQGFE-EWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI 193
                  +   E+  L   + P +V   G  + D E+ +  E+M  GSL+  L +     
Sbjct: 62  IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--- 118
Query: 194 QPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
             +   I  K++I   +GL +L   + K+++RD K SNIL++  G
Sbjct: 119 -RIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRG 161

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 67/147 (45%), Gaps = 21/147 (14%)
Query: 95  SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH 154
            L+G G +G+VYKG              G + AIK ++    +  EE + E+N L + SH
Sbjct: 30  ELVGNGTYGQVYKG---------RHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSH 79
Query: 155 -PNLVKLLGYCWE------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
             N+    G   +      D +L LV E+   GS+ + +  +N     L  +    I   
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICRE 137
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILL 234
             RGL  LH  + KVI+RD K  N+LL
Sbjct: 138 ILRGLSHLH--QHKVIHRDIKGQNVLL 162

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 73/143 (51%), Gaps = 17/143 (11%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVNFLGRLSHP 155
           +G+G FG V+KG +D++T          VVAIK ++  E+    E+ Q E+  L +    
Sbjct: 31  IGKGSFGEVFKG-IDNRT--------QQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSS 81
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
            + K  G   +  +L ++ EY+  GS  + L R  P          LK  +   +GL +L
Sbjct: 82  YVTKYYGSYLKGSKLWIIMEYLGGGSALD-LLRAGP-FDEFQIATMLKEIL---KGLDYL 136
Query: 216 HTSEKKVIYRDFKASNILLDGVG 238
           H SEKK I+RD KA+N+LL   G
Sbjct: 137 H-SEKK-IHRDIKAANVLLSEQG 157

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 76/176 (43%), Gaps = 22/176 (12%)
Query: 69  QILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAI 128
           +ILE    K+ S + +    K +     +G+G  G VY                G  VAI
Sbjct: 4   EILE----KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAM---------DVATGQEVAI 50
Query: 129 KKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR 188
           +++N +     E   +E+  +    +PN+V  L       EL +V EY+  GSL + +  
Sbjct: 51  RQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE 110
Query: 189 RNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL--DGVGFLFD 242
                  ++   R        + L FLH+++  VI+RD K+ NILL  DG   L D
Sbjct: 111 TCMDEGQIAAVCR-----ECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTD 159

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 63/144 (43%), Gaps = 25/144 (17%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK-LNPESMQGFEEWQ-SEVNFLGRLSH 154
           +GEG +G V+K    D          G +VAIKK L  E     ++    E+  L +L H
Sbjct: 11  IGEGSYGVVFKCRNRDT---------GQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLE--NHLFRRNPS--IQPLSWDIRLKIAIGAAR 210
           PNLV LL      + L LV+EY     L   +   R  P   ++ ++W           +
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ--------TLQ 113
Query: 211 GLGFLHTSEKKVIYRDFKASNILL 234
            + F H  +   I+RD K  NIL+
Sbjct: 114 AVNFCH--KHNCIHRDVKPENILI 135

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 76/176 (43%), Gaps = 22/176 (12%)
Query: 69  QILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAI 128
           +ILE    K+ S + +    K +     +G+G  G VY                G  VAI
Sbjct: 4   EILE----KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAM---------DVATGQEVAI 50
Query: 129 KKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR 188
           +++N +     E   +E+  +    +PN+V  L       EL +V EY+  GSL + +  
Sbjct: 51  RQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE 110
Query: 189 RNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL--DGVGFLFD 242
                  ++   R        + L FLH+++  VI+RD K+ NILL  DG   L D
Sbjct: 111 TCMDEGQIAAVCR-----ECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTD 159

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 72/168 (42%), Gaps = 18/168 (10%)
Query: 77  KVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM 136
           K+ S + +    K +     +G+G  G VY                G  VAI+++N +  
Sbjct: 9   KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAM---------DVATGQEVAIRQMNLQQQ 59
Query: 137 QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPL 196
              E   +E+  +    +PN+V  L       EL +V EY+  GSL + +         +
Sbjct: 60  PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 119
Query: 197 SWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL--DGVGFLFD 242
           +   R        + L FLH+++  VI+RD K+ NILL  DG   L D
Sbjct: 120 AAVCR-----ECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTD 160

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 76/176 (43%), Gaps = 22/176 (12%)
Query: 69  QILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAI 128
           +ILE    K+ S + +    K +     +G+G  G VY                G  VAI
Sbjct: 4   EILE----KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAM---------DVATGQEVAI 50
Query: 129 KKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR 188
           +++N +     E   +E+  +    +PN+V  L       EL +V EY+  GSL + +  
Sbjct: 51  RQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE 110
Query: 189 RNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL--DGVGFLFD 242
                  ++   R        + L FLH+++  VI+RD K+ NILL  DG   L D
Sbjct: 111 TCMDEGQIAAVCR-----ECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTD 159

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 29/168 (17%)
Query: 84  LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ 143
           L  A + ++  + +GEG +G+V+K     + L   K G G  VA+K++    +Q  EE  
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKA----RDL---KNG-GRFVALKRVR---VQTGEEGM 54
Query: 144 -----SEVNFLGRLS---HPNLVKLLGYCW---EDKE--LLLVYEYMQRGSLENHLFRRN 190
                 EV  L  L    HPN+V+L   C     D+E  L LV+E++ +  L  +L  + 
Sbjct: 55  PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKV 112
Query: 191 PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
           P     +  I+  +     RGL FLH+   +V++RD K  NIL+   G
Sbjct: 113 PEPGVPTETIK-DMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSG 157

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 15/150 (10%)
Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEVNF 148
           +F+  S LG G  G V+K      +  PS    G+V+A K ++ E       +   E+  
Sbjct: 7   DFEKISELGAGNGGVVFK-----VSHKPS----GLVMARKLIHLEIKPAIRNQIIRELQV 57
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           L   + P +V   G  + D E+ +  E+M  GSL+  L +       +   I  K++I  
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAV 113
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            +GL +L   + K+++RD K SNIL++  G
Sbjct: 114 IKGLTYLR-EKHKIMHRDVKPSNILVNSRG 142

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 68/147 (46%), Gaps = 13/147 (8%)
Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFL 149
           N++    +G+G F +V       + +   K     ++   +LN  S+Q   +   EV  +
Sbjct: 15  NYRLLKTIGKGNFAKVKLA----RHILTGKEVAVRIIDKTQLNSSSLQ---KLFREVRIM 67
Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
             L+HPN+VKL      +K L LV EY   G + ++L      ++      + +  + A 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMKEKEARAKFRQIVSAV 126
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDG 236
           +     +  +K +++RD KA N+LLD 
Sbjct: 127 Q-----YCHQKFIVHRDLKAENLLLDA 148

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 29/168 (17%)
Query: 84  LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ 143
           L  A + ++  + +GEG +G+V+K     + L   K G G  VA+K++    +Q  EE  
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKA----RDL---KNG-GRFVALKRVR---VQTGEEGM 54
Query: 144 -----SEVNFLGRLS---HPNLVKLLGYCW---EDKE--LLLVYEYMQRGSLENHLFRRN 190
                 EV  L  L    HPN+V+L   C     D+E  L LV+E++ +  L  +L  + 
Sbjct: 55  PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKV 112
Query: 191 PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
           P     +  I+  +     RGL FLH+   +V++RD K  NIL+   G
Sbjct: 113 PEPGVPTETIK-DMMFQLLRGLDFLHSH--RVVHRDLKPQNILVTSSG 157

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 19/150 (12%)
Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAI---KKLNPESMQGFEEWQSEV 146
           N++    +G+G F +V       K      TG  + V I    +LN  S+Q   +   EV
Sbjct: 15  NYRLLKTIGKGNFAKV-------KLARHILTGKEVAVKIIDKTQLNSSSLQ---KLFREV 64
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
             +  L+HPN+VKL      +K L LV EY   G + ++L      ++      + +  +
Sbjct: 65  RIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMKEKEARAKFRQIV 123
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDG 236
            A +     +  +K +++RD KA N+LLD 
Sbjct: 124 SAVQ-----YCHQKFIVHRDLKAENLLLDA 148

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 19/150 (12%)
Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAI---KKLNPESMQGFEEWQSEV 146
           N++    +G+G F +V       K      TG  + V I    +LN  S+Q   +   EV
Sbjct: 15  NYRLLKTIGKGNFAKV-------KLARHILTGKEVAVKIIDKTQLNSSSLQ---KLFREV 64
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
             +  L+HPN+VKL      +K L LV EY   G + ++L      ++      + +  +
Sbjct: 65  RIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMKEKEARAKFRQIV 123
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDG 236
            A +     +  +K +++RD KA N+LLD 
Sbjct: 124 SAVQ-----YCHQKFIVHRDLKAENLLLDA 148

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 68/147 (46%), Gaps = 13/147 (8%)
Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFL 149
           N++    +G+G F +V       + +   K     ++   +LN  S+Q   +   EV  +
Sbjct: 15  NYRLLKTIGKGNFAKVKLA----RHILTGKEVAVRIIDKTQLNSSSLQ---KLFREVRIM 67
Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
             L+HPN+VKL      +K L LV EY   G + ++L      ++      + +  + A 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMKEKEARAKFRQIVSAV 126
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDG 236
           +     +  +K +++RD KA N+LLD 
Sbjct: 127 Q-----YCHQKFIVHRDLKAENLLLDA 148

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 15/150 (10%)
Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEVNF 148
           +F+  S LG G  G V+K      +  PS    G+V+A K ++ E       +   E+  
Sbjct: 7   DFEKISELGAGNGGVVFK-----VSHKPS----GLVMARKLIHLEIKPAIRNQIIRELQV 57
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           L   + P +V   G  + D E+ +  E+M  GSL+  L +       +   I  K++I  
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAV 113
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            +GL +L   + K+++RD K SNIL++  G
Sbjct: 114 IKGLTYLR-EKHKIMHRDVKPSNILVNSRG 142

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 15/150 (10%)
Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEVNF 148
           +F+  S LG G  G V+K      +  PS    G+V+A K ++ E       +   E+  
Sbjct: 7   DFEKISELGAGNGGVVFK-----VSHKPS----GLVMARKLIHLEIKPAIRNQIIRELQV 57
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           L   + P +V   G  + D E+ +  E+M  GSL+  L +       +   I  K++I  
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAV 113
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            +GL +L   + K+++RD K SNIL++  G
Sbjct: 114 IKGLTYLR-EKHKIMHRDVKPSNILVNSRG 142

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 15/150 (10%)
Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEVNF 148
           +F+  S LG G  G V+K      +  PS    G+V+A K ++ E       +   E+  
Sbjct: 7   DFEKISELGAGNGGVVFK-----VSHKPS----GLVMARKLIHLEIKPAIRNQIIRELQV 57
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           L   + P +V   G  + D E+ +  E+M  GSL+  L +       +   I  K++I  
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAV 113
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            +GL +L   + K+++RD K SNIL++  G
Sbjct: 114 IKGLTYLR-EKHKIMHRDVKPSNILVNSRG 142

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 15/150 (10%)
Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEVNF 148
           +F+  S LG G  G V+K  V  K   PS    G+V+A K ++ E       +   E+  
Sbjct: 10  DFEKISELGAGNGGVVFK--VSHK---PS----GLVMARKLIHLEIKPAIRNQIIRELQV 60
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           L   + P +V   G  + D E+ +  E+M  GSL+  L +       +   I  K++I  
Sbjct: 61  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAV 116
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            +GL +L   + K+++RD K SNIL++  G
Sbjct: 117 IKGLTYLR-EKHKIMHRDVKPSNILVNSRG 145

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 68/151 (45%), Gaps = 19/151 (12%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
           LG G FG+V    ++       KT     VA+K L   +         SE+  L  + H 
Sbjct: 37  LGRGAFGQV----IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 156 -NLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQP----------LSWDIRLK 203
            N+V LLG C +    L+++ E+ + G+L  +L  +     P          L+ +  + 
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIX 152
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
            +   A+G+ FL  + +K I+RD  A NILL
Sbjct: 153 YSFQVAKGMEFL--ASRKXIHRDLAARNILL 181

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 68/147 (46%), Gaps = 13/147 (8%)
Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFL 149
           N++    +G+G F +V       + +   K     ++   +LN  S+Q   +   EV  +
Sbjct: 15  NYRLLKTIGKGNFAKVKLA----RHILTGKEVAVKIIDKTQLNSSSLQ---KLFREVRIM 67
Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
             L+HPN+VKL      +K L LV EY   G + ++L      ++      + +  + A 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMKEKEARAKFRQIVSAV 126
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDG 236
           +     +  +K +++RD KA N+LLD 
Sbjct: 127 Q-----YCHQKFIVHRDLKAENLLLDA 148

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 20/152 (13%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
           LG G FG+V    ++       KT     VA+K L   +         SE+  L  + H 
Sbjct: 36  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 91
Query: 156 -NLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQP-----------LSWDIRL 202
            N+V LLG C +    L+++ E+ + G+L  +L  +     P           L+ +  +
Sbjct: 92  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLI 151
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
             +   A+G+ FL  + +K I+RD  A NILL
Sbjct: 152 CYSFQVAKGMEFL--ASRKCIHRDLAARNILL 181

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/109 (27%), Positives = 54/109 (49%), Gaps = 6/109 (5%)
Query: 140 EEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWD 199
           EE  +E++ L  L HPN++KL     + K   LV E+ + G L   +  R+   +  + +
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN 150
Query: 200 IRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIY 248
           I  +I      G+ +LH     +++RD K  NILL+    L +  ++ +
Sbjct: 151 IMKQI----LSGICYLHKH--NIVHRDIKPENILLENKNSLLNIKIVDF 193

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 15/150 (10%)
Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEVNF 148
           +F+  S LG G  G V+K      +  PS    G+V+A K ++ E       +   E+  
Sbjct: 7   DFEKISELGAGNGGVVFK-----VSHKPS----GLVMARKLIHLEIKPAIRNQIIRELQV 57
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           L   + P +V   G  + D E+ +  E+M  GSL+  L +       +   I  K++I  
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAV 113
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            +GL +L   + K+++RD K SNIL++  G
Sbjct: 114 IKGLTYLR-EKHKIMHRDVKPSNILVNSRG 142

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 20/168 (11%)
Query: 77  KVFSFLDLKSATKNFKPD-----SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL 131
           ++ +FL  K      K D     S LG G  G V+K  V  K   PS    G+V+A K +
Sbjct: 51  RLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFK--VSHK---PS----GLVMARKLI 101
Query: 132 NPESMQGFE-EWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRN 190
           + E       +   E+  L   + P +V   G  + D E+ +  E+M  GSL+  L +  
Sbjct: 102 HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG 161
Query: 191 PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +   I  K++I   +GL +L   + K+++RD K SNIL++  G
Sbjct: 162 ----RIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRG 204

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 62/142 (43%), Gaps = 15/142 (10%)
Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           L E   G ++KG W           G  +VV + K+   S +   ++  E   L   SHP
Sbjct: 18  LNENHSGELWKGRW----------QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 156 NLVKLLGYCWEDK--ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           N++ +LG C         L+  +M  GSL N L      +   S  +  K A+  ARG+ 
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAV--KFALDMARGMA 125
Query: 214 FLHTSEKKVIYRDFKASNILLD 235
           FLHT E  +      + ++++D
Sbjct: 126 FLHTLEPLIPRHALNSRSVMID 147

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 21/153 (13%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
           LG G FG+V    ++       KT     VA+K L   +         SE+  L  + H 
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 156 -NLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQP------------LSWDIR 201
            N+V LLG C +    L+++ E+ + G+L  +L  +     P            L+ +  
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           +  +   A+G+ FL  + +K I+RD  A NILL
Sbjct: 142 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILL 172

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 62/141 (43%), Gaps = 12/141 (8%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS 153
           D  LG G FG V +G          K  + + + + K   E     EE   E   + +L 
Sbjct: 15  DIELGCGNFGSVRQG-----VYRMRKKQIDVAIKVLKQGTEKADT-EEMMREAQIMHQLD 68
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           +P +V+L+G C + + L+LV E    G L   L  +   I P+S    L   +     +G
Sbjct: 69  NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEI-PVSNVAELLHQVS----MG 122
Query: 214 FLHTSEKKVIYRDFKASNILL 234
             +  EK  ++RD  A N+LL
Sbjct: 123 MKYLEEKNFVHRDLAARNVLL 143

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 21/153 (13%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
           LG G FG+V    ++       KT     VA+K L   +         SE+  L  + H 
Sbjct: 72  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 127
Query: 156 -NLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQP------------LSWDIR 201
            N+V LLG C +    L+++ E+ + G+L  +L  +     P            L+ +  
Sbjct: 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 187
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           +  +   A+G+ FL  + +K I+RD  A NILL
Sbjct: 188 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILL 218

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 72/162 (44%), Gaps = 14/162 (8%)
Query: 80  SFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF 139
           +FL  K+     K D        G    G V      PS    G+++A K ++ E     
Sbjct: 2   AFLTQKAKVGELKDDDFERISELGAGNGGVVTKVQHRPS----GLIMARKLIHLEIKPAI 57
Query: 140 E-EWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL--FRRNPSIQPL 196
             +   E+  L   + P +V   G  + D E+ +  E+M  GSL+  L   +R P     
Sbjct: 58  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE---- 113
Query: 197 SWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
             +I  K++I   RGL +L   + ++++RD K SNIL++  G
Sbjct: 114 --EILGKVSIAVLRGLAYLR-EKHQIMHRDVKPSNILVNSRG 152

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 64/162 (39%), Gaps = 17/162 (10%)
Query: 82  LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE 141
           +D +     F+   LLG+G FG+V         +   +   G   A+K L  E +   +E
Sbjct: 3   MDPRVTMNEFEYLKLLGKGTFGKV---------ILVKEKATGRYYAMKILKKEVIVAKDE 53
Query: 142 WQ---SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSW 198
                +E   L    HP L  L         L  V EY   G L  HL R     +  S 
Sbjct: 54  VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE----RVFSE 109
Query: 199 DIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           D            L +LH SEK V+YRD K  N++LD  G +
Sbjct: 110 DRARFYGAEIVSALDYLH-SEKNVVYRDLKLENLMLDKDGHI 150

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 21/153 (13%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
           LG G FG+V    ++       KT     VA+K L   +         SE+  L  + H 
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 156 -NLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQP------------LSWDIR 201
            N+V LLG C +    L+++ E+ + G+L  +L  +     P            L+ +  
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           +  +   A+G+ FL  + +K I+RD  A NILL
Sbjct: 142 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILL 172

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 21/153 (13%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
           LG G FG+V    ++       KT     VA+K L   +         SE+  L  + H 
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 156 -NLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQP------------LSWDIR 201
            N+V LLG C +    L+++ E+ + G+L  +L  +     P            L+ +  
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           +  +   A+G+ FL  + +K I+RD  A NILL
Sbjct: 142 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILL 172

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 21/153 (13%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
           LG G FG+V    ++       KT     VA+K L   +         SE+  L  + H 
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 156 -NLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQP------------LSWDIR 201
            N+V LLG C +    L+++ E+ + G+L  +L  +     P            L+ +  
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           +  +   A+G+ FL  + +K I+RD  A NILL
Sbjct: 151 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILL 181

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 72/165 (43%), Gaps = 27/165 (16%)
Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQ-- 143
           AT  ++P + +G G +G VYK               G  VA+K +  P    G       
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVPNGGGGGGGLPIS 57
Query: 144 --SEVNFLGRL---SHPNLVKLLGYCW---EDKEL--LLVYEYMQRGSLENHLFRRNPSI 193
              EV  L RL    HPN+V+L+  C     D+E+   LV+E++ +  L  +L +  P  
Sbjct: 58  TVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG 116
Query: 194 QPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            P      L       RGL FLH +   +++RD K  NIL+   G
Sbjct: 117 LPAETIKDLMRQF--LRGLDFLHAN--CIVHRDLKPENILVTSGG 157

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 20/168 (11%)
Query: 77  KVFSFLDLKSATKNFKPD-----SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL 131
           ++ +FL  K      K D     S LG G  G V+K      +  PS    G+V+A K +
Sbjct: 16  RLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFK-----VSHKPS----GLVMARKLI 66
Query: 132 NPESMQGFE-EWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRN 190
           + E       +   E+  L   + P +V   G  + D E+ +  E+M  GSL+  L +  
Sbjct: 67  HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG 126
Query: 191 PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +   I  K++I   +GL +L   + K+++RD K SNIL++  G
Sbjct: 127 ----RIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRG 169

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 21/153 (13%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
           LG G FG+V    ++       KT     VA+K L   +         SE+  L  + H 
Sbjct: 37  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 156 -NLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQP------------LSWDIR 201
            N+V LLG C +    L+++ E+ + G+L  +L  +     P            L+ +  
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHL 152
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           +  +   A+G+ FL  + +K I+RD  A NILL
Sbjct: 153 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILL 183

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 21/153 (13%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
           LG G FG+V    ++       KT     VA+K L   +         SE+  L  + H 
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 156 -NLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQP------------LSWDIR 201
            N+V LLG C +    L+++ E+ + G+L  +L  +     P            L+ +  
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           +  +   A+G+ FL  + +K I+RD  A NILL
Sbjct: 142 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILL 172

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 21/153 (13%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
           LG G FG+V    ++       KT     VA+K L   +         SE+  L  + H 
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 156 -NLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQP------------LSWDIR 201
            N+V LLG C +    L+++ E+ + G+L  +L  +     P            L+ +  
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           +  +   A+G+ FL  + +K I+RD  A NILL
Sbjct: 151 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILL 181

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 19/149 (12%)
Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVN-FLGR 151
           ++G+G FG+V         L        +  A+K L  +++   +E +   SE N  L  
Sbjct: 45  VIGKGSFGKV---------LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN 95
Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           + HP LV L        +L  V +Y+  G L  HL R    ++P +     +IA      
Sbjct: 96  VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIA----SA 151
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           LG+LH+    ++YRD K  NILLD  G +
Sbjct: 152 LGYLHSL--NIVYRDLKPENILLDSQGHI 178

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 68/149 (45%), Gaps = 17/149 (11%)
Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFL 149
           N++    +G+G F +V       + +   K     ++   +LN  S+Q   +   EV  +
Sbjct: 8   NYRLLKTIGKGNFAKVKLA----RHILTGKEVAVKIIDKTQLNSSSLQ---KLFREVRIM 60
Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
             L+HPN+VKL      +K L LV EY   G + ++L           W ++ K A    
Sbjct: 61  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-------GW-MKEKEARAKF 112
Query: 210 RGL--GFLHTSEKKVIYRDFKASNILLDG 236
           R +     +  +K +++RD KA N+LLD 
Sbjct: 113 RQIVSAVQYCHQKFIVHRDLKAENLLLDA 141

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 21/153 (13%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
           LG G FG+V    ++       KT     VA+K L   +         SE+  L  + H 
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 156 -NLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQP------------LSWDIR 201
            N+V LLG C +    L+++ E+ + G+L  +L  +     P            L+ +  
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           +  +   A+G+ FL  + +K I+RD  A NILL
Sbjct: 151 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILL 181

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 63/143 (44%), Gaps = 12/143 (8%)
Query: 95  SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH 154
           S LG+G FG V     D     P     G +VA+K+L         ++Q E+  L  L  
Sbjct: 13  SQLGKGNFGSVELCRYD-----PLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS 67
Query: 155 PNLVKLLG--YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
             +VK  G  Y     EL LV EY+  G L + L R       L     L  +    +G+
Sbjct: 68  DFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGM 124
Query: 213 GFLHTSEKKVIYRDFKASNILLD 235
            +L +  ++ ++RD  A NIL++
Sbjct: 125 EYLGS--RRCVHRDLAARNILVE 145

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 18/140 (12%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--EVNFLGRLSH 154
           LGEG +G VYK  +D  T           VAIK++  E  +      +  EV+ L  L H
Sbjct: 42  LGEGTYGEVYKA-IDTVT--------NETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH 92
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
            N+++L      +  L L++EY +   L+ ++  +NP +   S  +          G+ F
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAE-NDLKKYM-DKNPDV---SMRVIKSFLYQLINGVNF 147
Query: 215 LHTSEKKVIYRDFKASNILL 234
            H+  ++ ++RD K  N+LL
Sbjct: 148 CHS--RRCLHRDLKPQNLLL 165

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 74/181 (40%), Gaps = 14/181 (7%)
Query: 59  AGVEEASPNGQILETPDLKVF-SFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAP 117
             V E     +I++  D     S  D +   +  +    +GEG FG V++G      +  
Sbjct: 359 VSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQG------IYM 412
Query: 118 SKTGLGMVVAIKKL-NPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEY 176
           S     M VAIK   N  S    E++  E   + +  HP++VKL+G   E+  + ++ E 
Sbjct: 413 SPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMEL 471
Query: 177 MQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
              G L + L      ++  S D+   I           +   K+ ++RD  A N+L+  
Sbjct: 472 CTLGELRSFL-----QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSA 526
Query: 237 V 237
Sbjct: 527 T 527

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 68/151 (45%), Gaps = 18/151 (11%)
Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--- 144
           +  +K   +LG+G FG V         L   K   G   A+K ++   ++   + +S   
Sbjct: 31  SDRYKGQRVLGKGSFGEV--------ILCKDKI-TGQECAVKVISKRQVKQKTDKESLLR 81
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           EV  L +L HPN++KL  +  +     LV E    G L + +  R    +  S     +I
Sbjct: 82  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR----KRFSEVDAARI 137
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                 G+ ++H +  K+++RD K  N+LL+
Sbjct: 138 IRQVLSGITYMHKN--KIVHRDLKPENLLLE 166

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 71/170 (41%), Gaps = 25/170 (14%)
Query: 85  KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS 144
           +     F+ + + G+G FG V  G          +   GM VAIKK+  +      E Q 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLG---------KEKSTGMSVAIKKVIQDPRFRNRELQI 69
Query: 145 EVNFLGRLSHPNLVKLLGYCW-------EDKELLLVYEYMQRG--SLENHLFRRNPSIQP 195
            +  L  L HPN+V+L  Y +        D  L +V EY+         + +RR  +  P
Sbjct: 70  -MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPP 128
Query: 196 LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL---DGVGFLFD 242
           +   + L   I   R +G LH     V +RD K  N+L+   DG   L D
Sbjct: 129 ILIKVFLFQLI---RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 62/142 (43%), Gaps = 13/142 (9%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVNFLGRLSHP 155
           +GEG FG V++G      +  S     M VAIK   N  S    E++  E   + +  HP
Sbjct: 18  IGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           ++VKL+G   E+  + ++ E    G L + L      ++  S D+   I           
Sbjct: 72  HIVKLIGVITENP-VWIIMELCTLGELRSFL-----QVRKFSLDLASLILYAYQLSTALA 125
Query: 216 HTSEKKVIYRDFKASNILLDGV 237
           +   K+ ++RD  A N+L+   
Sbjct: 126 YLESKRFVHRDIAARNVLVSAT 147

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 70/138 (50%), Gaps = 7/138 (5%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G F +++KG    + +          V +K L+       E +    + + +LSH +
Sbjct: 16  LGQGTFTKIFKGV--RREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV   G C+   E +LV E+++ GSL+ +L ++N +   + W  +L++A   A  + FL 
Sbjct: 74  LVLNYGVCFCGDENILVQEFVKFGSLDTYL-KKNKNCINILW--KLEVAKQLAWAMHFL- 129
Query: 217 TSEKKVIYRDFKASNILL 234
             E  +I+ +  A NILL
Sbjct: 130 -EENTLIHGNVCAKNILL 146

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 74/178 (41%), Gaps = 14/178 (7%)
Query: 59  AGVEEASPNGQILETPDLKVF-SFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAP 117
             V E     +I++  D     S  D +   +  +    +GEG FG V++G      +  
Sbjct: 359 VSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQG------IYM 412
Query: 118 SKTGLGMVVAIKKL-NPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEY 176
           S     M VAIK   N  S    E++  E   + +  HP++VKL+G   E+  + ++ E 
Sbjct: 413 SPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMEL 471
Query: 177 MQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
              G L + L      ++  S D+   I           +   K+ ++RD  A N+L+
Sbjct: 472 CTLGELRSFL-----QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV 524

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 66/149 (44%), Gaps = 19/149 (12%)
Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRL 152
           +LG+G FG+V         +   + G   + AIK L  + +      E    E   L  L
Sbjct: 26  VLGKGSFGKV---------MLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALL 76
Query: 153 SHPNLVKLLGYCWED-KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
             P  +  L  C++    L  V EY+  G L  H+ +     +P +     +I+IG    
Sbjct: 77  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIG---- 132
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           L FLH  ++ +IYRD K  N++LD  G +
Sbjct: 133 LFFLH--KRGIIYRDLKLDNVMLDSEGHI 159

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 69/138 (50%), Gaps = 7/138 (5%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G F +++KG    + +          V +K L+       E +    + + +LSH +
Sbjct: 16  LGQGTFTKIFKGV--RREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV   G C    E +LV E+++ GSL+ +L ++N +   + W  +L++A   A  + FL 
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILW--KLEVAKQLAAAMHFL- 129
Query: 217 TSEKKVIYRDFKASNILL 234
             E  +I+ +  A NILL
Sbjct: 130 -EENTLIHGNVCAKNILL 146

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/164 (23%), Positives = 67/164 (40%), Gaps = 22/164 (13%)
Query: 83  DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFE 140
           D+    + F    +LG+G FG V +  +        + G  + VA+K L  +  +    E
Sbjct: 17  DVLIPEQQFTLGRMLGKGEFGSVREAQLK------QEDGSFVKVAVKMLKADIIASSDIE 70
Query: 141 EWQSEVNFLGRLSHPNLVKLLGYCWEDKEL------LLVYEYMQRGSLENHLFR----RN 190
           E+  E   +    HP++ KL+G     +        +++  +M+ G L   L       N
Sbjct: 71  EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130
Query: 191 PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           P   PL   +R  + I      G  + S +  I+RD  A N +L
Sbjct: 131 PFNLPLQTLVRFMVDIAC----GMEYLSSRNFIHRDLAARNCML 170

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 59/148 (39%), Gaps = 17/148 (11%)
Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVNFLGRL 152
           LLG+G FG+V         +   +   G   A+K L  E +   +E     +E   L   
Sbjct: 16  LLGKGTFGKV---------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 66
Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
            HP L  L         L  V EY   G L  HL R     +  S D            L
Sbjct: 67  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSAL 122
Query: 213 GFLHTSEKKVIYRDFKASNILLDGVGFL 240
            +LH SEK V+YRD K  N++LD  G +
Sbjct: 123 DYLH-SEKNVVYRDLKLENLMLDKDGHI 149

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 66/149 (44%), Gaps = 12/149 (8%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
           ++ K  S LG+G FG V     D     P     G +VA+K+L         ++Q E+  
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYD-----PLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77
Query: 149 LGRLSHPNLVKLLG--YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
           L  L    +VK  G  Y    + L LV EY+  G L + L R       L     L  + 
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSS 134
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLD 235
              +G+ +L +  ++ ++RD  A NIL++
Sbjct: 135 QICKGMEYLGS--RRCVHRDLAARNILVE 161

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 59/148 (39%), Gaps = 17/148 (11%)
Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVNFLGRL 152
           LLG+G FG+V         +   +   G   A+K L  E +   +E     +E   L   
Sbjct: 15  LLGKGTFGKV---------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 65
Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
            HP L  L         L  V EY   G L  HL R     +  S D            L
Sbjct: 66  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSAL 121
Query: 213 GFLHTSEKKVIYRDFKASNILLDGVGFL 240
            +LH SEK V+YRD K  N++LD  G +
Sbjct: 122 DYLH-SEKNVVYRDLKLENLMLDKDGHI 148

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 68/151 (45%), Gaps = 18/151 (11%)
Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--- 144
           +  +K   +LG+G FG V         L   K   G   A+K ++   ++   + +S   
Sbjct: 25  SDRYKGQRVLGKGSFGEV--------ILCKDKI-TGQECAVKVISKRQVKQKTDKESLLR 75
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           EV  L +L HPN++KL  +  +     LV E    G L + +  R    +  S     +I
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR----KRFSEVDAARI 131
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                 G+ ++H +  K+++RD K  N+LL+
Sbjct: 132 IRQVLSGITYMHKN--KIVHRDLKPENLLLE 160

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 66/149 (44%), Gaps = 12/149 (8%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
           ++ K  S LG+G FG V     D     P     G +VA+K+L         ++Q E+  
Sbjct: 10  RHLKYISQLGKGNFGSVELCRYD-----PLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 64
Query: 149 LGRLSHPNLVKLLG--YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
           L  L    +VK  G  Y    + L LV EY+  G L + L R       L     L  + 
Sbjct: 65  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSS 121
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLD 235
              +G+ +L +  ++ ++RD  A NIL++
Sbjct: 122 QICKGMEYLGS--RRCVHRDLAARNILVE 148

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 62/139 (44%), Gaps = 13/139 (9%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVNFLGRLSHP 155
           +GEG FG V++G      +  S     M VAIK   N  S    E++  E   + +  HP
Sbjct: 18  IGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           ++VKL+G   E+  + ++ E    G L + L      ++  S D+   I           
Sbjct: 72  HIVKLIGVITENP-VWIIMELCTLGELRSFL-----QVRKFSLDLASLILYAYQLSTALA 125
Query: 216 HTSEKKVIYRDFKASNILL 234
           +   K+ ++RD  A N+L+
Sbjct: 126 YLESKRFVHRDIAARNVLV 144

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 63/143 (44%), Gaps = 12/143 (8%)
Query: 95  SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH 154
           S LG+G FG V     D     P     G +VA+K+L         ++Q E+  L  L  
Sbjct: 17  SQLGKGNFGSVELCRYD-----PLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS 71
Query: 155 PNLVKLLG--YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
             +VK  G  Y    + L LV EY+  G L + L R       L     L  +    +G+
Sbjct: 72  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGM 128
Query: 213 GFLHTSEKKVIYRDFKASNILLD 235
            +L +  ++ ++RD  A NIL++
Sbjct: 129 EYLGS--RRCVHRDLAARNILVE 149

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 62/143 (43%), Gaps = 17/143 (11%)
Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ--SEVNFLGRLS 153
           +LG+G FG V K    D+             A+K +N  S +  +      EV  L +L 
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQE-------YAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           HPN++KL     +     +V E    G L + + +R    +  S     +I      G+ 
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGIT 135
Query: 214 FLHTSEKKVIYRDFKASNILLDG 236
           ++H  +  +++RD K  NILL+ 
Sbjct: 136 YMH--KHNIVHRDLKPENILLES 156

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 62/143 (43%), Gaps = 17/143 (11%)
Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ--SEVNFLGRLS 153
           +LG+G FG V K    D+             A+K +N  S +  +      EV  L +L 
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQE-------YAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           HPN++KL     +     +V E    G L + + +R    +  S     +I      G+ 
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGIT 135
Query: 214 FLHTSEKKVIYRDFKASNILLDG 236
           ++H  +  +++RD K  NILL+ 
Sbjct: 136 YMH--KHNIVHRDLKPENILLES 156

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 62/130 (47%), Gaps = 14/130 (10%)
Query: 124 MVVAIKKLNPESMQGFEE-WQSEVNFLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGS 181
           M V  ++L+PE ++   E  + E + L +++ HP+++ L+        + LV++ M++G 
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE 186
Query: 182 LENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG----- 236
           L ++L  +      LS      I       + FLH +   +++RD K  NILLD      
Sbjct: 187 LFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN--NIVHRDLKPENILLDDNMQIR 240
Query: 237 -VGFLFDSHL 245
              F F  HL
Sbjct: 241 LSDFGFSCHL 250

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 68/151 (45%), Gaps = 18/151 (11%)
Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--- 144
           +  +K   +LG+G FG V         L   K   G   A+K ++   ++   + +S   
Sbjct: 48  SDRYKGQRVLGKGSFGEV--------ILCKDKI-TGQECAVKVISKRQVKQKTDKESLLR 98
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           EV  L +L HPN++KL  +  +     LV E    G L + +  R    +  S     +I
Sbjct: 99  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR----KRFSEVDAARI 154
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                 G+ ++H +  K+++RD K  N+LL+
Sbjct: 155 IRQVLSGITYMHKN--KIVHRDLKPENLLLE 183

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 38/156 (24%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQ-SEVNFLGRLSH 154
           +GEG +G VYK          ++   G   A+KK+  E   +G       E++ L  L H
Sbjct: 10  IGEGTYGVVYK----------AQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQR----------GSLENHLFRRNPSIQPLSWDIRLKI 204
            N+VKL       K L+LV+E++ +          G LE        S+   S+ ++L  
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLE--------SVTAKSFLLQL-- 109
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                 G+ + H  +++V++RD K  N+L++  G L
Sbjct: 110 ----LNGIAYCH--DRRVLHRDLKPQNLLINREGEL 139

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 38/156 (24%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQ-SEVNFLGRLSH 154
           +GEG +G VYK          ++   G   A+KK+  E   +G       E++ L  L H
Sbjct: 10  IGEGTYGVVYK----------AQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQR----------GSLENHLFRRNPSIQPLSWDIRLKI 204
            N+VKL       K L+LV+E++ +          G LE        S+   S+ ++L  
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLE--------SVTAKSFLLQL-- 109
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                 G+ + H  +++V++RD K  N+L++  G L
Sbjct: 110 ----LNGIAYCH--DRRVLHRDLKPQNLLINREGEL 139

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 38/156 (24%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQ-SEVNFLGRLSH 154
           +GEG +G VYK          ++   G   A+KK+  E   +G       E++ L  L H
Sbjct: 10  IGEGTYGVVYK----------AQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQR----------GSLENHLFRRNPSIQPLSWDIRLKI 204
            N+VKL       K L+LV+E++ +          G LE        S+   S+ ++L  
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLE--------SVTAKSFLLQL-- 109
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                 G+ + H  +++V++RD K  N+L++  G L
Sbjct: 110 ----LNGIAYCH--DRRVLHRDLKPQNLLINREGEL 139

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 68/151 (45%), Gaps = 18/151 (11%)
Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--- 144
           +  +K   +LG+G FG V         L   K   G   A+K ++   ++   + +S   
Sbjct: 49  SDRYKGQRVLGKGSFGEV--------ILCKDKI-TGQECAVKVISKRQVKQKTDKESLLR 99
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           EV  L +L HPN++KL  +  +     LV E    G L + +  R    +  S     +I
Sbjct: 100 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR----KRFSEVDAARI 155
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                 G+ ++H +  K+++RD K  N+LL+
Sbjct: 156 IRQVLSGITYMHKN--KIVHRDLKPENLLLE 184

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 62/139 (44%), Gaps = 13/139 (9%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVNFLGRLSHP 155
           +GEG FG V++G      +  S     M VAIK   N  S    E++  E   + +  HP
Sbjct: 18  IGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           ++VKL+G   E+  + ++ E    G L + L      ++  S D+   I           
Sbjct: 72  HIVKLIGVITENP-VWIIMELCTLGELRSFL-----QVRKYSLDLASLILYAYQLSTALA 125
Query: 216 HTSEKKVIYRDFKASNILL 234
           +   K+ ++RD  A N+L+
Sbjct: 126 YLESKRFVHRDIAARNVLV 144

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 59/148 (39%), Gaps = 17/148 (11%)
Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVNFLGRL 152
           LLG+G FG+V         +   +   G   A+K L  E +   +E     +E   L   
Sbjct: 155 LLGKGTFGKV---------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
            HP L  L         L  V EY   G L  HL R     +  S D            L
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSAL 261
Query: 213 GFLHTSEKKVIYRDFKASNILLDGVGFL 240
            +LH SEK V+YRD K  N++LD  G +
Sbjct: 262 DYLH-SEKNVVYRDLKLENLMLDKDGHI 288

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 67/141 (47%), Gaps = 12/141 (8%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS 153
           D  LG G FG V KG+     +      + + +   + N  +++  +E  +E N + +L 
Sbjct: 12  DKELGSGNFGTVKKGYY---QMKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLD 66
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           +P +V+++G C E +  +LV E  + G L N   ++N  ++      +  I +     +G
Sbjct: 67  NPYIVRMIGIC-EAESWMLVMEMAELGPL-NKYLQQNRHVKD-----KNIIELVHQVSMG 119
Query: 214 FLHTSEKKVIYRDFKASNILL 234
             +  E   ++RD  A N+LL
Sbjct: 120 MKYLEESNFVHRDLAARNVLL 140

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 67/141 (47%), Gaps = 12/141 (8%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS 153
           D  LG G FG V KG+     +      + + +   + N  +++  +E  +E N + +L 
Sbjct: 32  DKELGSGNFGTVKKGYY---QMKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLD 86
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           +P +V+++G C E +  +LV E  + G L N   ++N  ++      +  I +     +G
Sbjct: 87  NPYIVRMIGIC-EAESWMLVMEMAELGPL-NKYLQQNRHVKD-----KNIIELVHQVSMG 139
Query: 214 FLHTSEKKVIYRDFKASNILL 234
             +  E   ++RD  A N+LL
Sbjct: 140 MKYLEESNFVHRDLAARNVLL 160

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 67/141 (47%), Gaps = 12/141 (8%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS 153
           D  LG G FG V KG+     +      + + +   + N  +++  +E  +E N + +L 
Sbjct: 32  DKELGSGNFGTVKKGYY---QMKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLD 86
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           +P +V+++G C E +  +LV E  + G L N   ++N  ++      +  I +     +G
Sbjct: 87  NPYIVRMIGIC-EAESWMLVMEMAELGPL-NKYLQQNRHVKD-----KNIIELVHQVSMG 139
Query: 214 FLHTSEKKVIYRDFKASNILL 234
             +  E   ++RD  A N+LL
Sbjct: 140 MKYLEESNFVHRDLAARNVLL 160

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 62/143 (43%), Gaps = 17/143 (11%)
Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ--SEVNFLGRLS 153
           +LG+G FG V K    D+             A+K +N  S +  +      EV  L +L 
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQE-------YAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           HPN++KL     +     +V E    G L + + +R    +  S     +I      G+ 
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGIT 135
Query: 214 FLHTSEKKVIYRDFKASNILLDG 236
           ++H  +  +++RD K  NILL+ 
Sbjct: 136 YMH--KHNIVHRDLKPENILLES 156

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 67/141 (47%), Gaps = 12/141 (8%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS 153
           D  LG G FG V KG+     +      + + +   + N  +++  +E  +E N + +L 
Sbjct: 10  DKELGSGNFGTVKKGYY---QMKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLD 64
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           +P +V+++G C E +  +LV E  + G L N   ++N  ++      +  I +     +G
Sbjct: 65  NPYIVRMIGIC-EAESWMLVMEMAELGPL-NKYLQQNRHVKD-----KNIIELVHQVSMG 117
Query: 214 FLHTSEKKVIYRDFKASNILL 234
             +  E   ++RD  A N+LL
Sbjct: 118 MKYLEESNFVHRDLAARNVLL 138

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 67/149 (44%), Gaps = 9/149 (6%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-SEVN 147
           +N++P  +LG G    V +  +   T       +  V      + E +Q   E    EV+
Sbjct: 17  ENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 148 FLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
            L ++S HPN+++L      +    LV++ M++G L ++L  +      LS     KI  
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMR 131
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLD 235
                +  LH  +  +++RD K  NILLD
Sbjct: 132 ALLEVICALH--KLNIVHRDLKPENILLD 158

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 70/163 (42%), Gaps = 20/163 (12%)
Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTG-LGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH 154
           +LG GGFG V+   +         TG L     + K   +  +G++    E   L ++ H
Sbjct: 192 VLGRGGFGEVFACQM-------KATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-H 243
Query: 155 PNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLF---RRNPSIQ-PLSWDIRLKIAIGAA 209
              +  L Y +E K +L LV   M  G +  H++     NP  Q P +     +I  G  
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG-- 301
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFK 252
                 H  ++ +IYRD K  N+LLD  G +  S L + V  K
Sbjct: 302 ----LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 59/148 (39%), Gaps = 17/148 (11%)
Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVNFLGRL 152
           LLG+G FG+V         +   +   G   A+K L  E +   +E     +E   L   
Sbjct: 158 LLGKGTFGKV---------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 208
Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
            HP L  L         L  V EY   G L  HL R     +  S D            L
Sbjct: 209 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSAL 264
Query: 213 GFLHTSEKKVIYRDFKASNILLDGVGFL 240
            +LH SEK V+YRD K  N++LD  G +
Sbjct: 265 DYLH-SEKNVVYRDLKLENLMLDKDGHI 291

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 75/146 (51%), Gaps = 24/146 (16%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS---EVNFLGRLS 153
           LG+G +G V+K  +D +T        G VVA+KK+  ++ Q   + Q    E+  L  LS
Sbjct: 17  LGKGAYGIVWKS-IDRRT--------GEVVAVKKI-FDAFQNSTDAQRTFREIMILTELS 66
Query: 154 -HPNLVKLLGY--CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
            H N+V LL       D+++ LV++YM+    + H   R   ++P+    +  +     +
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYME---TDLHAVIRANILEPVH---KQYVVYQLIK 120
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDG 236
            + +LH+    +++RD K SNILL+ 
Sbjct: 121 VIKYLHSG--GLLHRDMKPSNILLNA 144

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 67/149 (44%), Gaps = 9/149 (6%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-SEVN 147
           +N++P  +LG G    V +  +   T       +  V      + E +Q   E    EV+
Sbjct: 17  ENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 148 FLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
            L ++S HPN+++L      +    LV++ M++G L ++L  +      LS     KI  
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMR 131
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLD 235
                +  LH  +  +++RD K  NILLD
Sbjct: 132 ALLEVICALH--KLNIVHRDLKPENILLD 158

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 67/141 (47%), Gaps = 12/141 (8%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS 153
           D  LG G FG V KG+     +      + + +   + N  +++  +E  +E N + +L 
Sbjct: 22  DKELGSGNFGTVKKGYY---QMKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLD 76
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           +P +V+++G C E +  +LV E  + G L N   ++N  ++      +  I +     +G
Sbjct: 77  NPYIVRMIGIC-EAESWMLVMEMAELGPL-NKYLQQNRHVKD-----KNIIELVHQVSMG 129
Query: 214 FLHTSEKKVIYRDFKASNILL 234
             +  E   ++RD  A N+LL
Sbjct: 130 MKYLEESNFVHRDLAARNVLL 150

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 70/163 (42%), Gaps = 20/163 (12%)
Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTG-LGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH 154
           +LG GGFG V+   +         TG L     + K   +  +G++    E   L ++ H
Sbjct: 192 VLGRGGFGEVFACQM-------KATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-H 243
Query: 155 PNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLF---RRNPSIQ-PLSWDIRLKIAIGAA 209
              +  L Y +E K +L LV   M  G +  H++     NP  Q P +     +I  G  
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG-- 301
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFK 252
                 H  ++ +IYRD K  N+LLD  G +  S L + V  K
Sbjct: 302 ----LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 67/141 (47%), Gaps = 12/141 (8%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS 153
           D  LG G FG V KG+     +      + + +   + N  +++  +E  +E N + +L 
Sbjct: 16  DKELGSGNFGTVKKGYY---QMKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLD 70
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           +P +V+++G C E +  +LV E  + G L N   ++N  ++      +  I +     +G
Sbjct: 71  NPYIVRMIGIC-EAESWMLVMEMAELGPL-NKYLQQNRHVKD-----KNIIELVHQVSMG 123
Query: 214 FLHTSEKKVIYRDFKASNILL 234
             +  E   ++RD  A N+LL
Sbjct: 124 MKYLEESNFVHRDLAARNVLL 144

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 70/163 (42%), Gaps = 20/163 (12%)
Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTG-LGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH 154
           +LG GGFG V+   +         TG L     + K   +  +G++    E   L ++ H
Sbjct: 192 VLGRGGFGEVFACQM-------KATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-H 243
Query: 155 PNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLF---RRNPSIQ-PLSWDIRLKIAIGAA 209
              +  L Y +E K +L LV   M  G +  H++     NP  Q P +     +I  G  
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG-- 301
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFK 252
                 H  ++ +IYRD K  N+LLD  G +  S L + V  K
Sbjct: 302 ----LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 67/141 (47%), Gaps = 12/141 (8%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS 153
           D  LG G FG V KG+     +      + + +   + N  +++  +E  +E N + +L 
Sbjct: 16  DKELGSGNFGTVKKGYY---QMKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLD 70
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           +P +V+++G C E +  +LV E  + G L N   ++N  ++      +  I +     +G
Sbjct: 71  NPYIVRMIGIC-EAESWMLVMEMAELGPL-NKYLQQNRHVKD-----KNIIELVHQVSMG 123
Query: 214 FLHTSEKKVIYRDFKASNILL 234
             +  E   ++RD  A N+LL
Sbjct: 124 MKYLEESNFVHRDLAARNVLL 144

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 70/163 (42%), Gaps = 20/163 (12%)
Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTG-LGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH 154
           +LG GGFG V+   +         TG L     + K   +  +G++    E   L ++ H
Sbjct: 192 VLGRGGFGEVFACQM-------KATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-H 243
Query: 155 PNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLF---RRNPSIQ-PLSWDIRLKIAIGAA 209
              +  L Y +E K +L LV   M  G +  H++     NP  Q P +     +I  G  
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG-- 301
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFK 252
                 H  ++ +IYRD K  N+LLD  G +  S L + V  K
Sbjct: 302 ----LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 67/161 (41%), Gaps = 19/161 (11%)
Query: 82  LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE 141
           L +K   ++F+   +LG+G FG+V+        LA  K       AIK L  + +   ++
Sbjct: 11  LQIKLKIEDFELHKMLGKGSFGKVF--------LAEFKKT-NQFFAIKALKKDVVLMDDD 61
Query: 142 WQSEVNFLGRLS----HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLS 197
            +  +     LS    HP L  +       + L  V EY+  G L  H+     S     
Sbjct: 62  VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFD 117
Query: 198 WDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                  A     GL FLH+  K ++YRD K  NILLD  G
Sbjct: 118 LSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDG 156

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 67/141 (47%), Gaps = 12/141 (8%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS 153
           D  LG G FG V KG+     +      + + +   + N  +++  +E  +E N + +L 
Sbjct: 30  DKELGSGNFGTVKKGYY---QMKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLD 84
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           +P +V+++G C E +  +LV E  + G L N   ++N  ++      +  I +     +G
Sbjct: 85  NPYIVRMIGIC-EAESWMLVMEMAELGPL-NKYLQQNRHVKD-----KNIIELVHQVSMG 137
Query: 214 FLHTSEKKVIYRDFKASNILL 234
             +  E   ++RD  A N+LL
Sbjct: 138 MKYLEESNFVHRDLAARNVLL 158

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 67/149 (44%), Gaps = 9/149 (6%)
Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-SEVN 147
           +N++P  +LG G    V +  +   T       +  V      + E +Q   E    EV+
Sbjct: 4   ENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 62
Query: 148 FLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
            L ++S HPN+++L      +    LV++ M++G L ++L  +      LS     KI  
Sbjct: 63  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMR 118
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLD 235
                +  LH  +  +++RD K  NILLD
Sbjct: 119 ALLEVICALH--KLNIVHRDLKPENILLD 145

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 67/150 (44%), Gaps = 19/150 (12%)
Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAI---KKLNPESMQGFEEWQSEV 146
           N++    +G+G F +V       K      TG  + V I    +LN  S+Q   +   EV
Sbjct: 15  NYRLLKTIGKGNFAKV-------KLARHILTGKEVAVKIIDKTQLNSSSLQ---KLFREV 64
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
                L+HPN+VKL      +K L LV EY   G + ++L       +      + +  +
Sbjct: 65  RIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHG-RXKEKEARAKFRQIV 123
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDG 236
            A +     +  +K +++RD KA N+LLD 
Sbjct: 124 SAVQ-----YCHQKFIVHRDLKAENLLLDA 148

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/138 (24%), Positives = 62/138 (44%), Gaps = 11/138 (7%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           +GEG FG V++G      ++P    L + +   K N  S    E++  E   + +  HP+
Sbjct: 18  IGEGQFGDVHQGIY----MSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPH 72
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           +VKL+G   E+  + ++ E    G L + L      ++  S D+   I           +
Sbjct: 73  IVKLIGVITENP-VWIIMELCTLGELRSFL-----QVRKYSLDLASLILYAYQLSTALAY 126
Query: 217 TSEKKVIYRDFKASNILL 234
              K+ ++RD  A N+L+
Sbjct: 127 LESKRFVHRDIAARNVLV 144

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 65/148 (43%), Gaps = 18/148 (12%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           +G+G  G VY                G  VAI+++N +     E   +E+  +    +PN
Sbjct: 29  IGQGASGTVYTAM---------DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 79
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           +V  L       EL +V EY+  GSL + +         ++   R        + L FLH
Sbjct: 80  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLH 134
Query: 217 TSEKKVIYRDFKASNILL--DGVGFLFD 242
           +++  VI+R+ K+ NILL  DG   L D
Sbjct: 135 SNQ--VIHRNIKSDNILLGMDGSVKLTD 160

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 81/185 (43%), Gaps = 38/185 (20%)
Query: 71  LETPDLKVFSFLDLKSATKNFKPDSL--------------LGEGGFGRVYK-GWVDDKTL 115
           +  P  K  + +D KSA     PD L              LG+GGF + Y+   +D K  
Sbjct: 10  IAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKE- 68
Query: 116 APSKTGLGMVVAIKKLNPESM----QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELL 171
                     V   K+ P+SM       E+  +E+     L +P++V   G+  +D  + 
Sbjct: 69  ----------VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVY 118
Query: 172 LVYEYMQRGSLENHLFRRNPSIQPLS-WDIRLKIAIGAARGLGFLHTSEKKVIYRDFKAS 230
           +V E  +R SL     RR    +P + + +R  I     +G+ +LH +  +VI+RD K  
Sbjct: 119 VVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYLHNN--RVIHRDLKLG 171
Query: 231 NILLD 235
           N+ L+
Sbjct: 172 NLFLN 176

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/138 (24%), Positives = 62/138 (44%), Gaps = 11/138 (7%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           +GEG FG V++G      ++P    L + +   K N  S    E++  E   + +  HP+
Sbjct: 46  IGEGQFGDVHQGIY----MSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPH 100
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           +VKL+G   E+  + ++ E    G L + L      ++  S D+   I           +
Sbjct: 101 IVKLIGVITENP-VWIIMELCTLGELRSFL-----QVRKYSLDLASLILYAYQLSTALAY 154
Query: 217 TSEKKVIYRDFKASNILL 234
              K+ ++RD  A N+L+
Sbjct: 155 LESKRFVHRDIAARNVLV 172

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/138 (24%), Positives = 62/138 (44%), Gaps = 11/138 (7%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           +GEG FG V++G      ++P    L + +   K N  S    E++  E   + +  HP+
Sbjct: 15  IGEGQFGDVHQGIY----MSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPH 69
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           +VKL+G   E+  + ++ E    G L + L      ++  S D+   I           +
Sbjct: 70  IVKLIGVITENP-VWIIMELCTLGELRSFL-----QVRKYSLDLASLILYAYQLSTALAY 123
Query: 217 TSEKKVIYRDFKASNILL 234
              K+ ++RD  A N+L+
Sbjct: 124 LESKRFVHRDIAARNVLV 141

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 81/185 (43%), Gaps = 38/185 (20%)
Query: 71  LETPDLKVFSFLDLKSATKNFKPDSL--------------LGEGGFGRVYK-GWVDDKTL 115
           +  P  K  + +D KSA     PD L              LG+GGF + Y+   +D K  
Sbjct: 10  IAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKE- 68
Query: 116 APSKTGLGMVVAIKKLNPESM----QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELL 171
                     V   K+ P+SM       E+  +E+     L +P++V   G+  +D  + 
Sbjct: 69  ----------VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVY 118
Query: 172 LVYEYMQRGSLENHLFRRNPSIQPLS-WDIRLKIAIGAARGLGFLHTSEKKVIYRDFKAS 230
           +V E  +R SL     RR    +P + + +R  I     +G+ +LH +  +VI+RD K  
Sbjct: 119 VVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYLHNN--RVIHRDLKLG 171
Query: 231 NILLD 235
           N+ L+
Sbjct: 172 NLFLN 176

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/138 (24%), Positives = 62/138 (44%), Gaps = 11/138 (7%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           +GEG FG V++G      ++P    L + +   K N  S    E++  E   + +  HP+
Sbjct: 20  IGEGQFGDVHQGIY----MSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPH 74
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           +VKL+G   E+  + ++ E    G L + L      ++  S D+   I           +
Sbjct: 75  IVKLIGVITENP-VWIIMELCTLGELRSFL-----QVRKYSLDLASLILYAYQLSTALAY 128
Query: 217 TSEKKVIYRDFKASNILL 234
              K+ ++RD  A N+L+
Sbjct: 129 LESKRFVHRDIAARNVLV 146

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 69/142 (48%), Gaps = 17/142 (11%)
Query: 95  SLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS 153
            L+G+G FG+VY G W  +  +         ++ I++ N + ++ F   + EV    +  
Sbjct: 39  ELIGKGRFGQVYHGRWHGEVAIR--------LIDIERDNEDQLKAF---KREVMAYRQTR 87
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           H N+V  +G C     L ++    +  +L + +  R+  I  L  +   +IA    +G+G
Sbjct: 88  HENVVLFMGACMSPPHLAIITSLCKGRTLYSVV--RDAKI-VLDVNKTRQIAQEIVKGMG 144
Query: 214 FLHTSEKKVIYRDFKASNILLD 235
           +LH   K ++++D K+ N+  D
Sbjct: 145 YLHA--KGILHKDLKSKNVFYD 164

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 81/185 (43%), Gaps = 38/185 (20%)
Query: 71  LETPDLKVFSFLDLKSATKNFKPDSL--------------LGEGGFGRVYK-GWVDDKTL 115
           +  P  K  + +D KSA     PD L              LG+GGF + Y+   +D K  
Sbjct: 10  IAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKE- 68
Query: 116 APSKTGLGMVVAIKKLNPESM----QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELL 171
                     V   K+ P+SM       E+  +E+     L +P++V   G+  +D  + 
Sbjct: 69  ----------VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVY 118
Query: 172 LVYEYMQRGSLENHLFRRNPSIQPLS-WDIRLKIAIGAARGLGFLHTSEKKVIYRDFKAS 230
           +V E  +R SL     RR    +P + + +R  I     +G+ +LH +  +VI+RD K  
Sbjct: 119 VVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYLHNN--RVIHRDLKLG 171
Query: 231 NILLD 235
           N+ L+
Sbjct: 172 NLFLN 176

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 64/143 (44%), Gaps = 18/143 (12%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE---EWQSEVNFLGRLS 153
           LG G FG+V  G              G  VA+K LN + ++  +   + + E+  L    
Sbjct: 24  LGVGTFGKVKVG---------KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           HP+++KL        ++ +V EY+  G L +++ +     +  S  +  +I      G+ 
Sbjct: 75  HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI----LSGVD 130
Query: 214 FLHTSEKKVIYRDFKASNILLDG 236
           + H     V++RD K  N+LLD 
Sbjct: 131 YCH--RHMVVHRDLKPENVLLDA 151

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 68/141 (48%), Gaps = 12/141 (8%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS 153
           D  LG G FG V KG+     +      + + +   + N  +++  +E  +E N + +L 
Sbjct: 374 DKELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLD 428
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           +P +V+++G C E +  +LV E  + G L N   ++N  ++    D  + I +     +G
Sbjct: 429 NPYIVRMIGIC-EAESWMLVMEMAELGPL-NKYLQQNRHVK----DKNI-IELVHQVSMG 481
Query: 214 FLHTSEKKVIYRDFKASNILL 234
             +  E   ++RD  A N+LL
Sbjct: 482 MKYLEESNFVHRDLAARNVLL 502

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/138 (24%), Positives = 62/138 (44%), Gaps = 11/138 (7%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           +GEG FG V++G      ++P    L + +   K N  S    E++  E   + +  HP+
Sbjct: 23  IGEGQFGDVHQGIY----MSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPH 77
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           +VKL+G   E+  + ++ E    G L + L      ++  S D+   I           +
Sbjct: 78  IVKLIGVITENP-VWIIMELCTLGELRSFL-----QVRKYSLDLASLILYAYQLSTALAY 131
Query: 217 TSEKKVIYRDFKASNILL 234
              K+ ++RD  A N+L+
Sbjct: 132 LESKRFVHRDIAARNVLV 149

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 68/141 (48%), Gaps = 12/141 (8%)
Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS 153
           D  LG G FG V KG+     +      + + +   + N  +++  +E  +E N + +L 
Sbjct: 375 DKELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLD 429
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           +P +V+++G C E +  +LV E  + G L N   ++N  ++    D  + I +     +G
Sbjct: 430 NPYIVRMIGIC-EAESWMLVMEMAELGPL-NKYLQQNRHVK----DKNI-IELVHQVSMG 482
Query: 214 FLHTSEKKVIYRDFKASNILL 234
             +  E   ++RD  A N+LL
Sbjct: 483 MKYLEESNFVHRDLAARNVLL 503

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 58/138 (42%), Gaps = 14/138 (10%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V++       +    TG            ES +  E  + E+  +  L HP 
Sbjct: 59  LGTGAFGVVHR-------VTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVLRHPT 109
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV L     +D E++++YE+M  G L   +   +     +S D  ++      +GL  +H
Sbjct: 110 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMH 166
Query: 217 TSEKKVIYRDFKASNILL 234
             E   ++ D K  NI+ 
Sbjct: 167 --ENNYVHLDLKPENIMF 182

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/138 (24%), Positives = 62/138 (44%), Gaps = 11/138 (7%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           +GEG FG V++G      ++P    L + +   K N  S    E++  E   + +  HP+
Sbjct: 21  IGEGQFGDVHQGIY----MSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPH 75
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           +VKL+G   E+  + ++ E    G L + L      ++  S D+   I           +
Sbjct: 76  IVKLIGVITENP-VWIIMELCTLGELRSFL-----QVRKYSLDLASLILYAYQLSTALAY 129
Query: 217 TSEKKVIYRDFKASNILL 234
              K+ ++RD  A N+L+
Sbjct: 130 LESKRFVHRDIAARNVLV 147

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 58/138 (42%), Gaps = 14/138 (10%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V++       +    TG            ES +  E  + E+  +  L HP 
Sbjct: 165 LGTGAFGVVHR-------VTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVLRHPT 215
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV L     +D E++++YE+M  G L   +   +     +S D  ++      +GL  +H
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMH 272
Query: 217 TSEKKVIYRDFKASNILL 234
             E   ++ D K  NI+ 
Sbjct: 273 --ENNYVHLDLKPENIMF 288

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 66/161 (40%), Gaps = 19/161 (11%)
Query: 82  LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE 141
           L +K   ++F    +LG+G FG+V+        LA  K       AIK L  + +   ++
Sbjct: 10  LQIKLKIEDFILHKMLGKGSFGKVF--------LAEFKKT-NQFFAIKALKKDVVLMDDD 60
Query: 142 WQSEVNFLGRLS----HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLS 197
            +  +     LS    HP L  +       + L  V EY+  G L  H+     S     
Sbjct: 61  VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFD 116
Query: 198 WDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                  A     GL FLH+  K ++YRD K  NILLD  G
Sbjct: 117 LSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDG 155

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 20/152 (13%)
Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--- 144
           +  +K   +LG+G FG V         L   K   G   A+K ++   ++   + +S   
Sbjct: 25  SDRYKGQRVLGKGSFGEV--------ILCKDKI-TGQECAVKVISKRQVKQKTDKESLLR 75
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
           EV  L +L HPN+ KL  + +EDK    LV E    G L + +  R    +  S     +
Sbjct: 76  EVQLLKQLDHPNIXKLYEF-FEDKGYFYLVGEVYTGGELFDEIISR----KRFSEVDAAR 130
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           I      G+ + H +  K+++RD K  N+LL+
Sbjct: 131 IIRQVLSGITYXHKN--KIVHRDLKPENLLLE 160

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 67/147 (45%), Gaps = 18/147 (12%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLS 153
           +G G FGRV         +       G   A+K L+ +    ++  E   +E   L  ++
Sbjct: 49  IGTGSFGRV---------MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
            P LVKL     ++  L +V EYM  G + +HL R     +P +     +I +       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVL----TFE 155
Query: 214 FLHTSEKKVIYRDFKASNILLDGVGFL 240
           +LH+ +  +IYRD K  N+L+D  G++
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQGYI 180

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 68/147 (46%), Gaps = 18/147 (12%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLS 153
           LG G FGRV         L   K   G   A+K L+ +    ++  E   +E   L  ++
Sbjct: 49  LGTGSFGRV--------MLVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
            P LVKL     ++  L +V EY+  G + +HL R     +P +     +I +       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVL----TFE 155
Query: 214 FLHTSEKKVIYRDFKASNILLDGVGFL 240
           +LH+ +  +IYRD K  N+L+D  G++
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQGYI 180

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 68/147 (46%), Gaps = 18/147 (12%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLS 153
           LG G FGRV         L   K   G   A+K L+ +    ++  E   +E   L  ++
Sbjct: 49  LGTGSFGRV--------MLVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
            P LVKL     ++  L +V EY+  G + +HL R     +P +     +I +       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL----TFE 155
Query: 214 FLHTSEKKVIYRDFKASNILLDGVGFL 240
           +LH+ +  +IYRD K  N+L+D  G++
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQGYI 180

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 68/147 (46%), Gaps = 18/147 (12%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLS 153
           LG G FGRV         L   K   G   A+K L+ +    ++  E   +E   L  ++
Sbjct: 44  LGTGSFGRV--------MLVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 94
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
            P LVKL     ++  L +V EY+  G + +HL R     +P +     +I +       
Sbjct: 95  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL----TFE 150
Query: 214 FLHTSEKKVIYRDFKASNILLDGVGFL 240
           +LH+ +  +IYRD K  N+L+D  G++
Sbjct: 151 YLHSLD--LIYRDLKPENLLIDQQGYI 175

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 67/147 (45%), Gaps = 18/147 (12%)
Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLS 153
           +G G FGRV         +       G   A+K L+ +    ++  E   +E   L  ++
Sbjct: 49  IGTGSFGRV---------MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
            P LVKL     ++  L +V EYM  G + +HL R     +P +     +I +       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVL----TFE 155
Query: 214 FLHTSEKKVIYRDFKASNILLDGVGFL 240
           +LH+ +  +IYRD K  N+L+D  G++
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQGYI 180

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	376
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-89
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	8e-88
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-75
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-42
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-38
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-37
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-37
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-35
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-35
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-35
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-34
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-34
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-32
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-32
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-29
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-29
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-28
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-28
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-28
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-27
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-27
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-27
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-27
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-26
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	8e-26
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-25
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-25
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-25
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-25
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-25
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-25
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-25
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-25
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-25
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-24
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-24
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-24
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-24
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-24
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-24
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	9e-24
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-23
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-23
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-23
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-23
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-23
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-23
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-23
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-23
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-23
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	8e-23
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	9e-23
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-23
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-22
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-22
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-22
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-22
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-22
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-22
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-22
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-22
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-22
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-22
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-22
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-21
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-21
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-21
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-21
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-21
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-21
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-21
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-21
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-21
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-21
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-21
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-20
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-20
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-20
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-20
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-20
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-20
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	9e-20
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-19
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-19
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-19
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-19
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-19
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-19
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-19
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-19
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-18
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-18
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-18
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-18
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-18
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-18
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	8e-18
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	8e-18
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-17
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-17
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-17
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-17
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-17
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-17
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-17
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-17
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-17
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-17
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-16
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-16
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-16
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-16
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-15
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-15
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-15
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-14
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-14
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-14
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	8e-14
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	9e-14
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-13
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-13
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-13
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-13
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-13
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-13
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-13
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-12
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-12
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-12
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-12
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-12
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-12
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-12
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-12
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-12
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-12
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-12
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-12
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-12
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	9e-12
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-11
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-11
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-11
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-11
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-11
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-11
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-11
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-11
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-11
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-11
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-11
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-11
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-11
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	8e-11
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-10
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-10
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-10
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-10
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-10
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-10
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-10
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-10
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-10
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-10
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-10
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-10
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-10
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-10
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-10
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-10
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-10
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-10
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	8e-10
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-10
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-09
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-09
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-09
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-09
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-09
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-09
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-09
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-09
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-09
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-09
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-09
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-09
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-09
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-09
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	9e-09
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-08
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-08
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-08
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-08
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-08
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-08
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-08
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-08
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-08
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-08
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-08
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-06
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-08
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-08
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-08
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-08
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-08
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-08
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-07
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-07
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-07
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-07
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-07
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-06
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-04
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  270 bits (692), Expect = 6e-89
 Identities = 71/183 (38%), Positives = 106/183 (57%), Gaps = 12/183 (6%)

Query: 53  SQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDD 112
           S+          + +   L   +      +DL+ AT NF    L+G G FG+VYKG + D
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 113 KTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLL 172
                     G  VA+K+  PES QG EE+++E+  L    HP+LV L+G+C E  E++L
Sbjct: 63  ----------GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112

Query: 173 VYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI 232
           +Y+YM+ G+L+ HL+  +     +SW+ RL+I IGAARGL +LH   + +I+RD K+ NI
Sbjct: 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINI 170

Query: 233 LLD 235
           LLD
Sbjct: 171 LLD 173

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  266 bits (683), Expect = 8e-88
 Identities = 67/175 (38%), Positives = 97/175 (55%), Gaps = 24/175 (13%)

Query: 71  LETPDLKVFSFLDLKSATKNFKP------DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGM 124
           +       FSF +LK+ T NF         + +GEGGFG VYKG+V++            
Sbjct: 7   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT----------- 55

Query: 125 VVAIKKL----NPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRG 180
            VA+KKL    +  + +  +++  E+  + +  H NLV+LLG+  +  +L LVY YM  G
Sbjct: 56  TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG 115

Query: 181 SLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           SL + L   + +  PLSW +R KIA GAA G+ FLH  E   I+RD K++NILLD
Sbjct: 116 SLLDRLSCLDGT-PPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLD 167

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  234 bits (600), Expect = 4e-75
 Identities = 73/162 (45%), Positives = 100/162 (61%), Gaps = 12/162 (7%)

Query: 76  LKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES 135
           LK FS  +L+ A+ NF   ++LG GGFG+VYKG + D          G +VA+K+L  E 
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD----------GTLVAVKRLKEER 66

Query: 136 MQGFE-EWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQ 194
            QG E ++Q+EV  +    H NL++L G+C    E LLVY YM  GS+ + L  R  S  
Sbjct: 67  TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126

Query: 195 PLSWDIRLKIAIGAARGLGFLH-TSEKKVIYRDFKASNILLD 235
           PL W  R +IA+G+ARGL +LH   + K+I+RD KA+NILLD
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 168

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  150 bits (381), Expect = 1e-42
 Identities = 38/169 (22%), Positives = 70/169 (41%), Gaps = 29/169 (17%)

Query: 79  FSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG 138
               +L   +   +   +   G FG V+K  + ++            VA+K    +  Q 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-----------VAVKIFPIQDKQS 62

Query: 139 FEEWQSEVNFLGRLSHPNLVKLLGYCWED----KELLLVYEYMQRGSLENHLFRRNPSIQ 194
           ++  + EV  L  + H N+++ +G          +L L+  + ++GSL + L        
Sbjct: 63  WQN-EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----N 116

Query: 195 PLSWDIRLKIAIGAARGLGFLHT--------SEKKVIYRDFKASNILLD 235
            +SW+    IA   ARGL +LH          +  + +RD K+ N+LL 
Sbjct: 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK 165

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  137 bits (347), Expect = 6e-38
 Identities = 43/142 (30%), Positives = 70/142 (49%), Gaps = 16/142 (11%)

Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSEVNFLGRLS 153
           +G G FG V++  W             G  VA+K L  +        E+  EV  + RL 
Sbjct: 45  IGAGSFGTVHRAEW------------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR 92

Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           HPN+V  +G   +   L +V EY+ RGSL   L  ++ + + L    RL +A   A+G+ 
Sbjct: 93  HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMN 151

Query: 214 FLHTSEKKVIYRDFKASNILLD 235
           +LH     +++R+ K+ N+L+D
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVD 173

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  135 bits (343), Expect = 2e-37
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 23/157 (14%)

Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQG-------FEEWQSEVNF 148
           +G+GGFG V+KG  V D            VVAIK L     +G       F+E+Q EV  
Sbjct: 27  IGKGGFGLVHKGRLVKD----------KSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76

Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           +  L+HPN+VKL G         +V E++  G L + L  +     P+ W ++L++ +  
Sbjct: 77  MSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDI 131

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL 245
           A G+ ++      +++RD ++ NI L  +        
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA 168

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  136 bits (343), Expect = 4e-37
 Identities = 40/169 (23%), Positives = 67/169 (39%), Gaps = 29/169 (17%)

Query: 79  FSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG 138
            +  +      N K   L+G G +G VYKG +D++            VA+K  +  + Q 
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP-----------VAVKVFSFANRQN 51

Query: 139 FEEWQSEVNFLGRLSHPNLVKLLGYCWED-----KELLLVYEYMQRGSLENHLFRRNPSI 193
           F   +  +  +  + H N+ + +            E LLV EY   GSL  +L       
Sbjct: 52  FIN-EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL----- 105

Query: 194 QPLSWDIRLKIAIGAARGLGFLHT-------SEKKVIYRDFKASNILLD 235
               W    ++A    RGL +LHT        +  + +RD  + N+L+ 
Sbjct: 106 HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK 154

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  129 bits (327), Expect = 2e-35
 Identities = 36/144 (25%), Positives = 58/144 (40%), Gaps = 19/144 (13%)

Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSEVNFLGRLS 153
           L E   G ++KG W             G  + +K L           ++  E   L   S
Sbjct: 18  LNENHSGELWKGRW------------QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65

Query: 154 HPNLVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           HPN++ +LG C         L+  +M  GSL N L     +   +     +K A+  ARG
Sbjct: 66  HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARG 123

Query: 212 LGFLHTSEKKVIYRDFKASNILLD 235
           + FLHT E  +      + ++++D
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMID 147

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  130 bits (329), Expect = 3e-35
 Identities = 37/140 (26%), Positives = 63/140 (45%), Gaps = 16/140 (11%)

Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG+G FG+  K                G V+ +K+L     +    +  EV  +  L HP
Sbjct: 18  LGKGCFGQAIKVTH----------RETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHP 67

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           N++K +G  ++DK L  + EY++ G+L   +   +       W  R+  A   A G+ +L
Sbjct: 68  NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYL 124

Query: 216 HTSEKKVIYRDFKASNILLD 235
           H     +I+RD  + N L+ 
Sbjct: 125 H--SMNIIHRDLNSHNCLVR 142

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  129 bits (326), Expect = 6e-35
 Identities = 45/140 (32%), Positives = 69/140 (49%), Gaps = 17/140 (12%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           +G G FG V K     K            VAIK++  ES +  + +  E+  L R++HPN
Sbjct: 16  VGRGAFGVVCKAKWRAKD-----------VAIKQIESESER--KAFIVELRQLSRVNHPN 62

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           +VKL G C     + LV EY + GSL N L    P     +    +   +  ++G+ +LH
Sbjct: 63  IVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLH 119

Query: 217 TSE-KKVIYRDFKASNILLD 235
           + + K +I+RD K  N+LL 
Sbjct: 120 SMQPKALIHRDLKPPNLLLV 139

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  126 bits (320), Expect = 3e-34
 Identities = 44/145 (30%), Positives = 68/145 (46%), Gaps = 23/145 (15%)

Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQ----GFEEWQSEVNFLGR 151
           +G GGFG+VY+  W            +G  VA+K    +  +      E  + E      
Sbjct: 15  IGIGGFGKVYRAFW------------IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62

Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           L HPN++ L G C ++  L LV E+ + G L   L  +      +  DI +  A+  ARG
Sbjct: 63  LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARG 117

Query: 212 LGFLHTS-EKKVIYRDFKASNILLD 235
           + +LH      +I+RD K+SNIL+ 
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILIL 142

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  127 bits (321), Expect = 4e-34
 Identities = 33/142 (23%), Positives = 63/142 (44%), Gaps = 21/142 (14%)

Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSEVNFLGRLS 153
           +G+G FG+VY G W  +             VAI+ ++ E       + ++ EV    +  
Sbjct: 41  IGKGRFGQVYHGRWHGE-------------VAIRLIDIERDNEDQLKAFKREVMAYRQTR 87

Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           H N+V  +G C     L ++    +  +L + +         L  +   +IA    +G+G
Sbjct: 88  HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEIVKGMG 144

Query: 214 FLHTSEKKVIYRDFKASNILLD 235
           +LH   K ++++D K+ N+  D
Sbjct: 145 YLHA--KGILHKDLKSKNVFYD 164

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  122 bits (307), Expect = 3e-32
 Identities = 43/142 (30%), Positives = 67/142 (47%), Gaps = 22/142 (15%)

Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSEVNFLGRLS 153
           +G G FG VYKG W  D             VA+K LN  +      + +++EV  L +  
Sbjct: 32  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78

Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           H N++  +GY    + L +V ++ +  SL +HL               + IA   ARG+ 
Sbjct: 79  HVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMD 134

Query: 214 FLHTSEKKVIYRDFKASNILLD 235
           +LH   K +I+RD K++NI L 
Sbjct: 135 YLHA--KSIIHRDLKSNNIFLH 154

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  113 bits (284), Expect = 6e-29
 Identities = 33/150 (22%), Positives = 61/150 (40%), Gaps = 27/150 (18%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
            +G+G +G V++G    +            VA+K  +    + +   ++E+     L H 
Sbjct: 15  CVGKGRYGEVWRGSWQGEN-----------VAVKIFSSRDEKSWFR-ETELYNTVMLRHE 62

Query: 156 NLVKLLGYCWEDK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           N++  +      +    +L L+  Y + GSL ++L         L     L+I +  A G
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASG 117

Query: 212 LGFLHTSEK------KVIYRDFKASNILLD 235
           L  LH           + +RD K+ NIL+ 
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVK 147

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  113 bits (284), Expect = 1e-28
 Identities = 36/153 (23%), Positives = 59/153 (38%), Gaps = 33/153 (21%)

Query: 96  LLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSE--VNFLGRL 152
            +G+G +G V+ G W             G  VA+K            W  E  +     +
Sbjct: 44  QIGKGRYGEVWMGKW------------RGEKVAVKVFFT---TEEASWFRETEIYQTVLM 88

Query: 153 SHPNLVKLLGYCWEDK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
            H N++  +    +      +L L+ +Y + GSL ++L         L     LK+A  +
Sbjct: 89  RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSS 143

Query: 209 ARGLGFLHTSEK------KVIYRDFKASNILLD 235
             GL  LHT          + +RD K+ NIL+ 
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  113 bits (284), Expect = 1e-28
 Identities = 36/150 (24%), Positives = 67/150 (44%), Gaps = 27/150 (18%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
            +G+G FG V++G    +            VA+K  +    + +   ++E+     L H 
Sbjct: 49  SIGKGRFGEVWRGKWRGEE-----------VAVKIFSSREERSWFR-EAEIYQTVMLRHE 96

Query: 156 NLVKLLGYCWEDK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           N++  +    +D     +L LV +Y + GSL ++L R       ++ +  +K+A+  A G
Sbjct: 97  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASG 151

Query: 212 LGFLHTSEK------KVIYRDFKASNILLD 235
           L  LH           + +RD K+ NIL+ 
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVK 181

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  110 bits (278), Expect = 6e-28
 Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 20/181 (11%)

Query: 65  SPNGQILETPDLKVFSFLDLKSATKN---FKPDSL-----LGEGGFGRVYKGWVDDKTLA 116
             +  I  T +L     +      ++   F+   L     LG+G FG V           
Sbjct: 9   HHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMC-----RYD 63

Query: 117 PSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE--LLLVY 174
           P +   G VVA+KKL   + +   +++ E+  L  L H N+VK  G C+      L L+ 
Sbjct: 64  PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM 123

Query: 175 EYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           EY+  GSL ++L +    I  +     L+      +G+ +L    K+ I+RD    NIL+
Sbjct: 124 EYLPYGSLRDYLQKHKERIDHIK---LLQYTSQICKGMEYL--GTKRYIHRDLATRNILV 178

Query: 235 D 235
           +
Sbjct: 179 E 179

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  108 bits (272), Expect = 2e-27
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 17/152 (11%)

Query: 91  FKPDSL-----LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSE 145
           F+   L     LG+G FG V           P +   G VVA+KKL   + +   +++ E
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMC-----RYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 61

Query: 146 VNFLGRLSHPNLVKLLGYCWEDKE--LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
           +  L  L H N+VK  G C+      L L+ EY+  GSL ++L +    I  +     L+
Sbjct: 62  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK---LLQ 118

Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                 +G+ +L    K+ I+RD    NIL++
Sbjct: 119 YTSQICKGMEYL--GTKRYIHRDLATRNILVE 148

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  107 bits (269), Expect = 7e-27
 Identities = 39/151 (25%), Positives = 70/151 (46%), Gaps = 7/151 (4%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G F +++KG    + +          V +K L+       E +    + + +LSH +
Sbjct: 16  LGQGTFTKIFKGVR--REVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV   G C    E +LV E+++ GSL+ +L ++N +   + W  +L++A   A  + FL 
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILW--KLEVAKQLAAAMHFL- 129

Query: 217 TSEKKVIYRDFKASNILLDGVGFLFDSHLLI 247
             E  +I+ +  A NILL         +   
Sbjct: 130 -EENTLIHGNVCAKNILLIREEDRKTGNPPF 159

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  107 bits (270), Expect = 8e-27
 Identities = 48/184 (26%), Positives = 76/184 (41%), Gaps = 28/184 (15%)

Query: 67  NGQILETPDLKVFSFLDLKSATKNFKPDSL-----LGEGGFGRVYKGWVDDKTLAPSKTG 121
            G I+E P     + +       + K   +     LGEG FG+V+     +      K  
Sbjct: 20  QGHIIENPQYFSDACV------HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKM- 72

Query: 122 LGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGS 181
              +VA+K L   S    +++Q E   L  L H ++V+  G C E + LL+V+EYM+ G 
Sbjct: 73  ---LVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGD 129

Query: 182 LENHLFRRNP-----------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKAS 230
           L   L    P           +  PL     L +A   A G+ +L  +    ++RD    
Sbjct: 130 LNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL--AGLHFVHRDLATR 187

Query: 231 NILL 234
           N L+
Sbjct: 188 NCLV 191

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  106 bits (268), Expect = 9e-27
 Identities = 41/150 (27%), Positives = 66/150 (44%), Gaps = 18/150 (12%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LGEG FG+V+     + +    K     +VA+K L   ++   +++Q E   L  L H +
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKM----LVAVKALKDPTLAARKDFQREAELLTNLQHEH 78

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI------------QPLSWDIRLKI 204
           +VK  G C +   L++V+EYM+ G L   L    P                L     L I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           A   A G+ +L  + +  ++RD    N L+
Sbjct: 139 ASQIASGMVYL--ASQHFVHRDLATRNCLV 166

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  107 bits (268), Expect = 2e-26
 Identities = 42/172 (24%), Positives = 68/172 (39%), Gaps = 19/172 (11%)

Query: 65  SPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGM 124
             + Q+    D  +F    LK  ++       LG+G FG V           P     G 
Sbjct: 6   HHHAQLYACQDPTIFEERHLKYISQ-------LGKGNFGSVELC-----RYDPLGDNTGA 53

Query: 125 VVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE--LLLVYEYMQRGSL 182
           +VA+K+L         ++Q E+  L  L    +VK  G  +      L LV EY+  G L
Sbjct: 54  LVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL 113

Query: 183 ENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
            + L R    +        L  +    +G+ +L    ++ ++RD  A NIL+
Sbjct: 114 RDFLQRHRARLDASRL---LLYSSQICKGMEYL--GSRRCVHRDLAARNILV 160

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  105 bits (263), Expect = 8e-26
 Identities = 42/146 (28%), Positives = 61/146 (41%), Gaps = 10/146 (6%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHP 155
           LG G FG VY+G V      PS       VA+K L      Q   ++  E   + + +H 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPL----QVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI---QPLSWDIRLKIAIGAARGL 212
           N+V+ +G   +     ++ E M  G L++ L    P       L+    L +A   A G 
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153

Query: 213 GFLHTSEKKVIYRDFKASNILLDGVG 238
            +L   E   I+RD  A N LL   G
Sbjct: 154 QYL--EENHFIHRDIAARNCLLTCPG 177

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  105 bits (265), Expect = 1e-25
 Identities = 41/141 (29%), Positives = 61/141 (43%), Gaps = 17/141 (12%)

Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSH 154
           +G G FG V+ G    D TL          VA+K            ++  E   L + SH
Sbjct: 122 IGRGNFGEVFSGRLRADNTL----------VAVKSCRETLPPDLKAKFLQEARILKQYSH 171

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           PN+V+L+G C + + + +V E +Q G     L R       L     L++   AA G+ +
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEG--ARLRVKTLLQMVGDAAAGMEY 228

Query: 215 LHTSEKKVIYRDFKASNILLD 235
           L    K  I+RD  A N L+ 
Sbjct: 229 LE--SKCCIHRDLAARNCLVT 247

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  104 bits (261), Expect = 1e-25
 Identities = 47/142 (33%), Positives = 70/142 (49%), Gaps = 15/142 (10%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHP 155
           LGEG FG+V           P+  G G +VA+K L  ++  Q    W+ E++ L  L H 
Sbjct: 39  LGEGHFGKVSLY-----CYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93

Query: 156 NLVKLLGYCWEDKE--LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           +++K  G C +     L LV EY+  GSL ++L R +  +  L     L  A     G+ 
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMA 148

Query: 214 FLHTSEKKVIYRDFKASNILLD 235
           +LH   +  I+RD  A N+LLD
Sbjct: 149 YLH--AQHYIHRDLAARNVLLD 168

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  103 bits (260), Expect = 1e-25
 Identities = 43/140 (30%), Positives = 71/140 (50%), Gaps = 16/140 (11%)

Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 21  LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHP 69

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q +S  + L +A   +  + +L
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYL 127

Query: 216 HTSEKKVIYRDFKASNILLD 235
              +K  I+RD  A N L+ 
Sbjct: 128 --EKKNFIHRDLAARNCLVG 145

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  104 bits (261), Expect = 1e-25
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 13/146 (8%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
           LG+G FG VY+G          +T     VAIK +N  +      E+ +E + +   +  
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPET----RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
           ++V+LLG   + +  L++ E M RG L+++L         NP + P S    +++A   A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 210 RGLGFLHTSEKKVIYRDFKASNILLD 235
            G+ +L  +  K ++RD  A N ++ 
Sbjct: 149 DGMAYL--NANKFVHRDLAARNCMVA 172

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  104 bits (262), Expect = 2e-25
 Identities = 43/146 (29%), Positives = 62/146 (42%), Gaps = 10/146 (6%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
           LG G FG VY+G V      PS       VA+K L    S Q   ++  E   + + +H 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPL----QVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI---QPLSWDIRLKIAIGAARGL 212
           N+V+ +G   +     ++ E M  G L++ L    P       L+    L +A   A G 
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194

Query: 213 GFLHTSEKKVIYRDFKASNILLDGVG 238
            +L   E   I+RD  A N LL   G
Sbjct: 195 QYL--EENHFIHRDIAARNCLLTCPG 218

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  103 bits (259), Expect = 3e-25
 Identities = 40/165 (24%), Positives = 73/165 (44%), Gaps = 16/165 (9%)

Query: 72  ETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL 131
           E P+  +   L      K      +LG G FG VYKG        P    + + VAIK+L
Sbjct: 2   EAPNQALLRILKETEFKK----IKVLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKEL 52

Query: 132 NPESMQG-FEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRN 190
              +     +E   E   +  + +P++ +LLG C     + L+ + M  G L +++    
Sbjct: 53  REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK 111

Query: 191 PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
            +I        L   +  A+G+ +L   ++++++RD  A N+L+ 
Sbjct: 112 DNIGSQY---LLNWCVQIAKGMNYL--EDRRLVHRDLAARNVLVK 151

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  105 bits (263), Expect = 5e-25
 Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 16/139 (11%)

Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           LG G +G VY+G W              + VA+K L  ++M+  EE+  E   +  + HP
Sbjct: 228 LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHP 276

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           NLV+LLG C  +    ++ E+M  G+L ++L  R  + Q +S  + L +A   +  + +L
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYL 334

Query: 216 HTSEKKVIYRDFKASNILL 234
              +K  I+R+  A N L+
Sbjct: 335 --EKKNFIHRNLAARNCLV 351

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  102 bits (256), Expect = 6e-25
 Identities = 41/148 (27%), Positives = 70/148 (47%), Gaps = 17/148 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSH 154
           LGEG FG V +G          + G  + VA+K +  ++   +  EE+ SE   +   SH
Sbjct: 42  LGEGEFGSVMEG------NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH 95

Query: 155 PNLVKLLGYCWEDK-----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR--LKIAIG 207
           PN+++LLG C E       + +++  +M+ G L  +L        P    ++  LK  + 
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLD 235
            A G+ +L  S +  ++RD  A N +L 
Sbjct: 156 IALGMEYL--SNRNFLHRDLAARNCMLR 181

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  102 bits (255), Expect = 7e-25
 Identities = 44/142 (30%), Positives = 69/142 (48%), Gaps = 13/142 (9%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHP 155
           LGEG FG+V           P     G  VA+K L PES      + + E+  L  L H 
Sbjct: 29  LGEGHFGKVELC-----RYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83

Query: 156 NLVKLLGYCWEDKE--LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
           N+VK  G C ED    + L+ E++  GSL+ +L +    I       +LK A+   +G+ 
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ---QLKYAVQICKGMD 140

Query: 214 FLHTSEKKVIYRDFKASNILLD 235
           +L    ++ ++RD  A N+L++
Sbjct: 141 YL--GSRQYVHRDLAARNVLVE 160

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  102 bits (255), Expect = 2e-24
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 18/153 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL-SH 154
           LGEG FG+V         +   K    + VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 89  LGEGCFGQVVMAEAVG--IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------L 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R P     S+DI             +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                 ARG+ +L  + +K I+RD  A N+L+ 
Sbjct: 207 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVT 237

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  100 bits (252), Expect = 2e-24
 Identities = 47/154 (30%), Positives = 71/154 (46%), Gaps = 15/154 (9%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
           K++     LGEGGF  V         L       G   A+K++     Q  EE Q E + 
Sbjct: 29  KHYLFIQKLGEGGFSYVD--------LVEGLHD-GHFYALKRILCHEQQDREEAQREADM 79

Query: 149 LGRLSHPNLVKLLGYCWEDK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
               +HPN+++L+ YC  ++    E  L+  + +RG+L N + R       L+ D  L +
Sbjct: 80  HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL 139

Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            +G  RGL  +H   K   +RD K +NILL   G
Sbjct: 140 LLGICRGLEAIH--AKGYAHRDLKPTNILLGDEG 171

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  101 bits (253), Expect = 2e-24
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 18/153 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL-SH 154
           LGEG FG+V         +   K    + VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 43  LGEGAFGQVVMAEAVG--IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------L 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R P     S+DI             +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                 ARG+ +L  + +K I+RD  A N+L+ 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVT 191

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 99.2 bits (248), Expect = 4e-24
 Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 18/140 (12%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           +G+G FG V  G                 VA+K +  ++    + + +E + + +L H N
Sbjct: 29  IGKGEFGDVMLGDYRGNK-----------VAVKCIKNDATA--QAFLAEASVMTQLRHSN 75

Query: 157 LVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           LV+LLG   E+K  L +V EYM +GSL ++L  R+     L  D  LK ++     + +L
Sbjct: 76  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYL 133

Query: 216 HTSEKKVIYRDFKASNILLD 235
                  ++RD  A N+L+ 
Sbjct: 134 --EGNNFVHRDLAARNVLVS 151

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 99.2 bits (248), Expect = 6e-24
 Identities = 44/151 (29%), Positives = 66/151 (43%), Gaps = 19/151 (12%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHP 155
           LGE  FG+VYKG +               VAIK L  ++     EE++ E     RL HP
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQ----AVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------LK 203
           N+V LLG   +D+ L +++ Y   G L   L  R+P     S D              + 
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           +    A G+ +L  S   V+++D    N+L+
Sbjct: 133 LVAQIAAGMEYL--SSHHVVHKDLATRNVLV 161

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 99.6 bits (249), Expect = 8e-24
 Identities = 45/162 (27%), Positives = 68/162 (41%), Gaps = 23/162 (14%)

Query: 91  FKPDSL-----LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQS 144
           F  ++L     LG G FG+V +          +       VA+K L   +     E   S
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVL----KVAVKMLKSTAHADEKEALMS 98

Query: 145 EVNFLGRL-SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQ--------- 194
           E+  +  L  H N+V LLG C     +L++ EY   G L N L R++  ++         
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158

Query: 195 -PLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
              S    L  +   A+G+ FL  + K  I+RD  A N+LL 
Sbjct: 159 STASTRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLT 198

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  101 bits (253), Expect = 9e-24
 Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 18/140 (12%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           +G+G FG V  G                 VA+K +  ++    + + +E + + +L H N
Sbjct: 201 IGKGEFGDVMLGDYRGNK-----------VAVKCIKNDATA--QAFLAEASVMTQLRHSN 247

Query: 157 LVKLLGYCWEDKELL-LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           LV+LLG   E+K  L +V EYM +GSL ++L  R+     L  D  LK ++     + +L
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYL 305

Query: 216 HTSEKKVIYRDFKASNILLD 235
                  ++RD  A N+L+ 
Sbjct: 306 --EGNNFVHRDLAARNVLVS 323

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 99.3 bits (248), Expect = 1e-23
 Identities = 40/165 (24%), Positives = 73/165 (44%), Gaps = 16/165 (9%)

Query: 72  ETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL 131
           E P+  +   L      K      +LG G FG VYKG        P    + + VAIK+L
Sbjct: 2   EAPNQALLRILKETEFKK----IKVLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKEL 52

Query: 132 NPESMQG-FEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRN 190
              +     +E   E   +  + +P++ +LLG C     + L+ + M  G L +++    
Sbjct: 53  REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK 111

Query: 191 PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
            +I        L   +  A+G+ +L   ++++++RD  A N+L+ 
Sbjct: 112 DNIGSQY---LLNWCVQIAKGMNYL--EDRRLVHRDLAARNVLVK 151

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 99.3 bits (248), Expect = 1e-23
 Identities = 47/154 (30%), Positives = 72/154 (46%), Gaps = 23/154 (14%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL-S 153
           ++GEG FG+V K  +        K GL M  AIK++   + +    ++  E+  L +L  
Sbjct: 32  VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84

Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------ 201
           HPN++ LLG C     L L  EY   G+L + L +        ++ I             
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           L  A   ARG+ +L  S+K+ I+RD  A NIL+ 
Sbjct: 145 LHFAADVARGMDYL--SQKQFIHRDLAARNILVG 176

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 97.6 bits (244), Expect = 1e-23
 Identities = 42/139 (30%), Positives = 61/139 (43%), Gaps = 16/139 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V  G    +            VA+K +   SM   +E+  E   + +LSHP 
Sbjct: 16  LGSGQFGVVKLGKWKGQYD----------VAVKMIKEGSMSE-DEFFQEAQTMMKLSHPK 64

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LVK  G C ++  + +V EY+  G L N+L         L     L++      G+ FL 
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFL- 120

Query: 217 TSEKKVIYRDFKASNILLD 235
               + I+RD  A N L+D
Sbjct: 121 -ESHQFIHRDLAARNCLVD 138

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 98.1 bits (245), Expect = 2e-23
 Identities = 46/160 (28%), Positives = 72/160 (45%), Gaps = 27/160 (16%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
           LGEG FG+V K            T     VA+K L   +      +  SE N L +++HP
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYT----TVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR--------------------NPSIQP 195
           +++KL G C +D  LLL+ EY + GSL   L                       +P  + 
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 196 LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           L+    +  A   ++G+ +L  +E K+++RD  A NIL+ 
Sbjct: 147 LTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVA 184

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 99.4 bits (248), Expect = 2e-23
 Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 18/153 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL-SH 154
           LGEG FG+V         L   K      VA+K L  ++ +    +  SE+  +  +  H
Sbjct: 77  LGEGAFGQVVLAEAIG--LDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------L 202
            N++ LLG C +D  L ++ EY  +G+L  +L  R P     S++              +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
             A   ARG+ +L  + KK I+RD  A N+L+ 
Sbjct: 195 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVT 225

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 98.2 bits (245), Expect = 2e-23
 Identities = 34/149 (22%), Positives = 62/149 (41%), Gaps = 18/149 (12%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSH 154
           LG+G FG V +           + G  + VA+K L  + +     EE+  E   +    H
Sbjct: 31  LGKGEFGSVREA------QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84

Query: 155 PNLVKLLGYCWED------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR--LKIAI 206
           P++ KL+G              +++  +M+ G L   L        P +  ++  ++  +
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144

Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLD 235
             A G+ +L  S +  I+RD  A N +L 
Sbjct: 145 DIACGMEYL--SSRNFIHRDLAARNCMLA 171

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 26/166 (15%)

Query: 83  DLKSATKNFKPD---------SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP 133
           +L  A ++              ++G G FG VY G            G  +  A+K LN 
Sbjct: 10  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNR 63

Query: 134 E-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHL--FRR 189
              +    ++ +E   +   SHPN++ LLG C   +   L+V  YM+ G L N +     
Sbjct: 64  ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 123

Query: 190 NPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           NP+++ L     +   +  A+G+ +L  + KK ++RD  A N +LD
Sbjct: 124 NPTVKDL-----IGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLD 162

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 97.3 bits (243), Expect = 3e-23
 Identities = 41/164 (25%), Positives = 65/164 (39%), Gaps = 16/164 (9%)

Query: 72  ETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL 131
             P      +   +   K+      LG G FG V  G    +            VAIK +
Sbjct: 7   NAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD----------VAIKMI 56

Query: 132 NPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP 191
              SM   +E+  E   +  LSH  LV+L G C + + + ++ EYM  G L N+L     
Sbjct: 57  KEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH 115

Query: 192 SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
             Q       L++       + +L    K+ ++RD  A N L++
Sbjct: 116 RFQT---QQLLEMCKDVCEAMEYL--ESKQFLHRDLAARNCLVN 154

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 95.7 bits (239), Expect = 7e-23
 Identities = 43/139 (30%), Positives = 67/139 (48%), Gaps = 16/139 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           +G G FG V+ G+  +K            VAIK +   +M   E++  E   + +LSHP 
Sbjct: 16  IGSGQFGLVHLGYWLNKDK----------VAIKTIREGAMSE-EDFIEEAEVMMKLSHPK 64

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV+L G C E   + LV E+M+ G L ++L R        + +  L + +    G+ +L 
Sbjct: 65  LVQLYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRG--LFAAETLLGMCLDVCEGMAYL- 120

Query: 217 TSEKKVIYRDFKASNILLD 235
             E  VI+RD  A N L+ 
Sbjct: 121 -EEACVIHRDLAARNCLVG 138

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 96.6 bits (241), Expect = 8e-23
 Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 17/158 (10%)

Query: 84  LKSATKNFKPDSL-----LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-Q 137
           +K   + FK   L     LG G FG V+KG        P    + + V IK +  +S  Q
Sbjct: 3   MKVLARIFKETELRKLKVLGSGVFGTVHKG-----VWIPEGESIKIPVCIKVIEDKSGRQ 57

Query: 138 GFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLS 197
            F+     +  +G L H ++V+LLG C     L LV +Y+  GSL +H+ +   ++ P  
Sbjct: 58  SFQAVTDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQL 116

Query: 198 WDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
               L   +  A+G+ +L   E  +++R+  A N+LL 
Sbjct: 117 ---LLNWGVQIAKGMYYL--EEHGMVHRNLAARNVLLK 149

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 96.2 bits (240), Expect = 9e-23
 Identities = 42/154 (27%), Positives = 76/154 (49%), Gaps = 20/154 (12%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
            + ++    LG+G FG+VYK   + +T        G + A K +  +S +  E++  E+ 
Sbjct: 18  NEVWEIVGELGDGAFGKVYKA-KNKET--------GALAAAKVIETKSEEELEDYIVEIE 68

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI- 206
            L    HP +VKLLG  + D +L ++ E+   G+++  +   +   + L+     +I + 
Sbjct: 69  ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD---RGLTEP---QIQVV 122

Query: 207 --GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                  L FLH   K++I+RD KA N+L+   G
Sbjct: 123 CRQMLEALNFLH--SKRIIHRDLKAGNVLMTLEG 154

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 96.6 bits (241), Expect = 9e-23
 Identities = 41/140 (29%), Positives = 68/140 (48%), Gaps = 11/140 (7%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHP 155
           +G G FG VYKG      L  S     + VAIK L      +   ++  E   +G+ SH 
Sbjct: 52  IGAGEFGEVYKG-----MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           N+++L G   + K ++++ EYM+ G+L+  L R        S    + +  G A G+ +L
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFL-REKDG--EFSVLQLVGMLRGIAAGMKYL 163

Query: 216 HTSEKKVIYRDFKASNILLD 235
             +    ++RD  A NIL++
Sbjct: 164 --ANMNYVHRDLAARNILVN 181

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 57/210 (27%), Positives = 85/210 (40%), Gaps = 27/210 (12%)

Query: 46  SAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRV 105
            +     +   SE  ++   PN      P L     L L+    N +    +GEG FGRV
Sbjct: 4   ESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRV 63

Query: 106 YKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYC 164
           ++            T    +VA+K L  E+      ++Q E   +    +PN+VKLLG C
Sbjct: 64  FQARAPGLLPYEPFT----MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119

Query: 165 WEDKELLLVYEYMQRGSLENHLFRRNP--------------------SIQPLSWDIRLKI 204
              K + L++EYM  G L   L   +P                       PLS   +L I
Sbjct: 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCI 179

Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           A   A G+ +L  SE+K ++RD    N L+
Sbjct: 180 ARQVAAGMAYL--SERKFVHRDLATRNCLV 207

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 96.7 bits (241), Expect = 1e-22
 Identities = 43/143 (30%), Positives = 68/143 (47%), Gaps = 17/143 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
           +G G FG VY G            G  +  A+K LN    +    ++ +E   +   SHP
Sbjct: 97  IGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 150

Query: 156 NLVKLLGYCWEDKE-LLLVYEYMQRGSLENHL--FRRNPSIQPLSWDIRLKIAIGAARGL 212
           N++ LLG C   +   L+V  YM+ G L N +     NP+++ L     +   +  A+G+
Sbjct: 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 205

Query: 213 GFLHTSEKKVIYRDFKASNILLD 235
            FL  + KK ++RD  A N +LD
Sbjct: 206 KFL--ASKKFVHRDLAARNCMLD 226

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 95.4 bits (238), Expect = 1e-22
 Identities = 44/139 (31%), Positives = 72/139 (51%), Gaps = 16/139 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V+ G+ +  T           VA+K L   SM   + + +E N + +L H  
Sbjct: 21  LGAGQFGEVWMGYYNGHT----------KVAVKSLKQGSMSP-DAFLAEANLMKQLQHQR 69

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV+L     ++  + ++ EYM+ GSL + L  + PS   L+ +  L +A   A G+ F+ 
Sbjct: 70  LVRLYAVVTQEP-IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFI- 125

Query: 217 TSEKKVIYRDFKASNILLD 235
             E+  I+RD +A+NIL+ 
Sbjct: 126 -EERNYIHRDLRAANILVS 143

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 95.0 bits (237), Expect = 2e-22
 Identities = 36/139 (25%), Positives = 63/139 (45%), Gaps = 13/139 (9%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHP 155
           +GEG FG V++G      +  S     + VAIK     +     E++  E   + +  HP
Sbjct: 23  IGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           ++VKL+G    +  + ++ E    G L + L  R  S+   S    +  A   +  L +L
Sbjct: 77  HIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLAS---LILYAYQLSTALAYL 132

Query: 216 HTSEKKVIYRDFKASNILL 234
               K+ ++RD  A N+L+
Sbjct: 133 --ESKRFVHRDIAARNVLV 149

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 94.6 bits (236), Expect = 2e-22
 Identities = 37/140 (26%), Positives = 67/140 (47%), Gaps = 13/140 (9%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHP 155
           LGEG FG VY+G      +  +  G  + VA+K    +      E++ SE   +  L HP
Sbjct: 20  LGEGFFGEVYEG------VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 73

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           ++VKL+G   E++   ++ E    G L ++L R   S++ L+    +  ++   + + +L
Sbjct: 74  HIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLT---LVLYSLQICKAMAYL 129

Query: 216 HTSEKKVIYRDFKASNILLD 235
                  ++RD    NIL+ 
Sbjct: 130 --ESINCVHRDIAVRNILVA 147

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 95.0 bits (237), Expect = 3e-22
 Identities = 41/154 (26%), Positives = 63/154 (40%), Gaps = 21/154 (13%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL-SH 154
           LG G FG+V +           KT     VA+K L   +         SE+  L  +  H
Sbjct: 35  LGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90

Query: 155 PNLVKLLGYC-WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------ 201
            N+V LLG C      L+++ E+ + G+L  +L  +     P                  
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           +  +   A+G+ FL  + +K I+RD  A NILL 
Sbjct: 151 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLS 182

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 95.9 bits (239), Expect = 3e-22
 Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 12/148 (8%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVN 147
            N   D ++G G FG V  G           +   + VAIK L      +   ++  E +
Sbjct: 45  TNISIDKVVGAGEFGEVCSG------RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
            +G+  HPN+++L G   + K +++V EYM+ GSL++ L + +      +    + +  G
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRG 155

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLD 235
            A G+ +L  S+   ++RD  A NIL++
Sbjct: 156 IASGMKYL--SDMGYVHRDLAARNILIN 181

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 94.6 bits (236), Expect = 3e-22
 Identities = 47/155 (30%), Positives = 65/155 (41%), Gaps = 22/155 (14%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL-SH 154
           LG G FG+V +        + +       VA+K L P +     E   SE+  L  L +H
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAM----TVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI--------------QPLSWDI 200
            N+V LLG C      L++ EY   G L N L R+  S                 L  + 
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
            L  +   A+G+ FL  + K  I+RD  A NILL 
Sbjct: 147 LLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLT 179

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 94.3 bits (235), Expect = 3e-22
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 17/143 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
           +G+G FG VY G          +    +  AIK L+    MQ  E +  E   +  L+HP
Sbjct: 29  IGKGHFGVVYHG------EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82

Query: 156 NLVKLLGYCWEDKE-LLLVYEYMQRGSLENHL--FRRNPSIQPLSWDIRLKIAIGAARGL 212
           N++ L+G     +    ++  YM  G L   +   +RNP+++ L     +   +  ARG+
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-----ISFGLQVARGM 137

Query: 213 GFLHTSEKKVIYRDFKASNILLD 235
            +L  +E+K ++RD  A N +LD
Sbjct: 138 EYL--AEQKFVHRDLAARNCMLD 158

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 94.7 bits (236), Expect = 4e-22
 Identities = 37/140 (26%), Positives = 64/140 (45%), Gaps = 12/140 (8%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHP 155
           +G G  G V  G               + VAIK L      +   ++ SE + +G+  HP
Sbjct: 57  IGSGDSGEVCYG------RLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHP 110

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           N+++L G     +  ++V EYM+ GSL+  L R +      +    + +  G   G+ +L
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHD--GQFTIMQLVGMLRGVGAGMRYL 167

Query: 216 HTSEKKVIYRDFKASNILLD 235
             S+   ++RD  A N+L+D
Sbjct: 168 --SDLGYVHRDLAARNVLVD 185

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 93.5 bits (233), Expect = 7e-22
 Identities = 40/145 (27%), Positives = 71/145 (48%), Gaps = 18/145 (12%)

Query: 94  DSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLG 150
           D  LG G FG V KG +   K +          VA+K L  E+      +E  +E N + 
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKT--------VAVKILKNEANDPALKDELLAEANVMQ 73

Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           +L +P +V+++G C E +  +LV E  + G L  +L ++N  ++  +    +++    + 
Sbjct: 74  QLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKN---IIELVHQVSM 128

Query: 211 GLGFLHTSEKKVIYRDFKASNILLD 235
           G+ +L   E   ++RD  A N+LL 
Sbjct: 129 GMKYL--EESNFVHRDLAARNVLLV 151

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 43/171 (25%), Positives = 66/171 (38%), Gaps = 32/171 (18%)

Query: 91  FKPDSL-----LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQS 144
           F  ++L     LG G FG+V        +           VA+K L  ++     E   S
Sbjct: 42  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSI----QVAVKMLKEKADSSEREALMS 97

Query: 145 EVNFLGRL-SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR-- 201
           E+  + +L SH N+V LLG C     + L++EY   G L N+L  +         +    
Sbjct: 98  ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157

Query: 202 -----------------LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                            L  A   A+G+ FL    K  ++RD  A N+L+ 
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVLVT 206

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 92.8 bits (231), Expect = 1e-21
 Identities = 44/153 (28%), Positives = 67/153 (43%), Gaps = 21/153 (13%)

Query: 91  FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK--KLNPESMQGFEEWQSEVNF 148
            K D  +G G F  VYKG +D +T         + VA    +    +    + ++ E   
Sbjct: 28  LKFDIEIGRGSFKTVYKG-LDTET--------TVEVAWCELQDRKLTKSERQRFKEEAEM 78

Query: 149 LGRLSHPNLVKLLGYCWED-----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
           L  L HPN+V+     WE      K ++LV E M  G+L+ +L R     + +   +   
Sbjct: 79  LKGLQHPNIVRFYD-SWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRS 133

Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
                 +GL FLHT    +I+RD K  NI + G
Sbjct: 134 WCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG 166

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 91.9 bits (229), Expect = 2e-21
 Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 17/142 (11%)

Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRL 152
           LG+G FG V +G W        + +G  + VA+K L P+ +   +  +++  EVN +  L
Sbjct: 26  LGDGSFGVVRRGEW-------DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78

Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
            H NL++L G       + +V E    GSL + L +              + A+  A G+
Sbjct: 79  DHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGM 134

Query: 213 GFLHTSEKKVIYRDFKASNILL 234
           G+L    K+ I+RD  A N+LL
Sbjct: 135 GYL--ESKRFIHRDLAARNLLL 154

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 94.5 bits (235), Expect = 3e-21
 Identities = 37/147 (25%), Positives = 65/147 (44%), Gaps = 13/147 (8%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVN 147
           +  +    +GEG FG V++G      +  S     M VAIK     +     E++  E  
Sbjct: 390 ERIELGRCIGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
            + +  HP++VKL+G    +  + ++ E    G L + L  R  S+   S    +  A  
Sbjct: 444 TMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLAS---LILYAYQ 499

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILL 234
            +  L +L    K+ ++RD  A N+L+
Sbjct: 500 LSTALAYL--ESKRFVHRDIAARNVLV 524

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 92.5 bits (230), Expect = 3e-21
 Identities = 47/203 (23%), Positives = 80/203 (39%), Gaps = 26/203 (12%)

Query: 36  HTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDS 95
           H++   A + S+G ++  +   E    E     + L+  D       + +          
Sbjct: 11  HSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDY------EYREEVHWMTHQP 64

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
            +G G FG V++   D +T        G   A+KK+  E  +       E+     LS P
Sbjct: 65  RVGRGSFGEVHRM-KDKQT--------GFQCAVKKVRLEVFR-----VEELVACAGLSSP 110

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
            +V L G   E   + +  E ++ GSL   + +       L  D  L     A  GL +L
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYL 166

Query: 216 HTSEKKVIYRDFKASNILLDGVG 238
           H   +++++ D KA N+LL   G
Sbjct: 167 H--TRRILHGDVKADNVLLSSDG 187

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 92.7 bits (230), Expect = 4e-21
 Identities = 32/173 (18%), Positives = 61/173 (35%), Gaps = 7/173 (4%)

Query: 63  EASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGL 122
            + PN    +     +    + +  +K      LLGEG F +VY+       L  +K   
Sbjct: 39  SSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYE--ATQGDLNDAKNK- 95

Query: 123 GMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSL 182
                +K   P +   F      +  L        +K           +LV E    G+L
Sbjct: 96  -QKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL 154

Query: 183 ENHL-FRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
            N +   +N   + +   + +  A+     +  +H  + ++I+ D K  N +L
Sbjct: 155 LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH--DCEIIHGDIKPDNFIL 205

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 93.8 bits (233), Expect = 4e-21
 Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 16/139 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V+ G  +  T           VAIK L P +M   E +  E   + +L H  
Sbjct: 275 LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 323

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV+L     E+  + +V EYM +GSL + L  +  + + L     + +A   A G+ ++ 
Sbjct: 324 LVQLYAVVSEEP-IYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYV- 379

Query: 217 TSEKKVIYRDFKASNILLD 235
                 ++RD +A+NIL+ 
Sbjct: 380 -ERMNYVHRDLRAANILVG 397

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 91.7 bits (228), Expect = 5e-21
 Identities = 51/177 (28%), Positives = 73/177 (41%), Gaps = 27/177 (15%)

Query: 72  ETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL 131
               L       L+     F+   L+G G +G+VYKG    KT        G + AIK +
Sbjct: 7   PARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKG-RHVKT--------GQLAAIKVM 57

Query: 132 NPESMQGFEEWQSEVNFLGRLS-HPNLVKLLG------YCWEDKELLLVYEYMQRGSLEN 184
           +       EE + E+N L + S H N+    G          D +L LV E+   GS+ +
Sbjct: 58  DVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 116

Query: 185 HLFRRNPSIQPLSWDIRLKIAI---GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            +  +N     L  +    IA       RGL  LH  + KVI+RD K  N+LL    
Sbjct: 117 LI--KNTKGNTLKEE---WIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENA 166

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 92.8 bits (231), Expect = 5e-21
 Identities = 38/139 (27%), Positives = 65/139 (46%), Gaps = 16/139 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V+    +  T           VA+K + P SM   E + +E N +  L H  
Sbjct: 196 LGAGQFGEVWMATYNKHTK----------VAVKTMKPGSMSV-EAFLAEANVMKTLQHDK 244

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LVKL     ++  + ++ E+M +GSL + L  ++           +  +   A G+ F+ 
Sbjct: 245 LVKLHAVVTKEP-IYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGMAFI- 300

Query: 217 TSEKKVIYRDFKASNILLD 235
             ++  I+RD +A+NIL+ 
Sbjct: 301 -EQRNYIHRDLRAANILVS 318

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 92.9 bits (231), Expect = 6e-21
 Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 16/139 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG+G FG V+ G  +  T           VAIK L P +M   E +  E   + +L H  
Sbjct: 192 LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 240

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
           LV+L     E+  + +V EYM +GSL + L  +  + + L     + +A   A G+ ++ 
Sbjct: 241 LVQLYAVVSEEP-IYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYV- 296

Query: 217 TSEKKVIYRDFKASNILLD 235
                 ++RD +A+NIL+ 
Sbjct: 297 -ERMNYVHRDLRAANILVG 314

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 90.4 bits (225), Expect = 7e-21
 Identities = 43/154 (27%), Positives = 66/154 (42%), Gaps = 22/154 (14%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
            K +     +G+G  G VY   +D  T        G  VAI+++N +     E   +E+ 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTA-MDVAT--------GQEVAIRQMNLQQQPKKELIINEIL 69

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI- 206
            +    +PN+V  L       EL +V EY+  GSL + +       +        +IA  
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEG-------QIAAV 121

Query: 207 --GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                + L FLH    +VI+RD K+ NILL   G
Sbjct: 122 CRECLQALEFLH--SNQVIHRDIKSDNILLGMDG 153

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 90.1 bits (224), Expect = 1e-20
 Identities = 34/140 (24%), Positives = 62/140 (44%), Gaps = 12/140 (8%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
           +LG+G +G VY G  D            + +AIK++     +  +    E+     L H 
Sbjct: 29  VLGKGTYGIVYAG-RDLSN--------QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 79

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           N+V+ LG   E+  + +  E +  GSL   L  +   ++     I          GL +L
Sbjct: 80  NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYL 138

Query: 216 HTSEKKVIYRDFKASNILLD 235
           H  + ++++RD K  N+L++
Sbjct: 139 H--DNQIVHRDIKGDNVLIN 156

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 89.3 bits (222), Expect = 2e-20
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 23/155 (14%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEV 146
            + F     +G+G FG V+KG +D++T          VVAIK ++ E  +   E+ Q E+
Sbjct: 21  EELFTKLEKIGKGSFGEVFKG-IDNRT--------QKVVAIKIIDLEEAEDEIEDIQQEI 71

Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
             L +   P + K  G   +D +L ++ EY+  GS    L    P  +        +IA 
Sbjct: 72  TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDET-------QIAT 123

Query: 207 ---GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                 +GL +LH   +K I+RD KA+N+LL   G
Sbjct: 124 ILREILKGLDYLH--SEKKIHRDIKAANVLLSEHG 156

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 88.8 bits (221), Expect = 3e-20
 Identities = 40/141 (28%), Positives = 62/141 (43%), Gaps = 16/141 (11%)

Query: 97  LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSH 154
           LG G FG V +G +   K            VAIK L   +     EE   E   + +L +
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQID--------VAIKVLKQGTEKADTEEMMREAQIMHQLDN 69

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           P +V+L+G C + + L+LV E    G L   L  +   I   +     ++    + G+ +
Sbjct: 70  PYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSN---VAELLHQVSMGMKY 125

Query: 215 LHTSEKKVIYRDFKASNILLD 235
           L   EK  ++RD  A N+LL 
Sbjct: 126 L--EEKNFVHRDLAARNVLLV 144

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 89.0 bits (221), Expect = 3e-20
 Identities = 36/151 (23%), Positives = 64/151 (42%), Gaps = 16/151 (10%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
                    +GEG  G V     +  +        G  VA+K ++    Q  E   +EV 
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLA-REKHS--------GRQVAVKMMDLRKQQRRELLFNEVV 94

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
            +    H N+V++       +EL ++ E++Q G+L + +     S   L+ +    +   
Sbjct: 95  IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV-----SQVRLNEEQIATVCEA 149

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
             + L +LH   + VI+RD K+ +ILL   G
Sbjct: 150 VLQALAYLHA--QGVIHRDIKSDSILLTLDG 178

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 88.2 bits (219), Expect = 6e-20
 Identities = 48/154 (31%), Positives = 78/154 (50%), Gaps = 22/154 (14%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
            + F     LGEG +G VYK  +  +T        G +VAIK++  E     +E   E++
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKA-IHKET--------GQIVAIKQVPVE--SDLQEIIKEIS 76

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI- 206
            + +   P++VK  G  +++ +L +V EY   GS+ + +  RN   + L+ D   +IA  
Sbjct: 77  IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN---KTLTED---EIATI 130

Query: 207 --GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +GL +LH    + I+RD KA NILL+  G
Sbjct: 131 LQSTLKGLEYLH--FMRKIHRDIKAGNILLNTEG 162

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 87.8 bits (218), Expect = 6e-20
 Identities = 36/154 (23%), Positives = 58/154 (37%), Gaps = 14/154 (9%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--E 145
           T  F     +G G FG V+K  V            G + AIK+         +E  +  E
Sbjct: 10  TTEFHELEKIGSGEFGSVFKC-VKRLD--------GCIYAIKRSKKPLAGSVDEQNALRE 60

Query: 146 VNFLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           V     L  H ++V+      ED  +L+  EY   GSL + +      +          +
Sbjct: 61  VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120

Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
            +   RGL ++H     +++ D K SNI +    
Sbjct: 121 LLQVGRGLRYIH--SMSLVHMDIKPSNIFISRTS 152

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 90.0 bits (223), Expect = 9e-20
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 16/144 (11%)

Query: 94  DSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGR 151
           D  LG G FG V +G +   K            VAIK L   +     EE   E   + +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQID--------VAIKVLKQGTEKADTEEMMREAQIMHQ 392

Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           L +P +V+L+G C + + L+LV E    G L   L  +   I   +     ++    + G
Sbjct: 393 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSN---VAELLHQVSMG 448

Query: 212 LGFLHTSEKKVIYRDFKASNILLD 235
           + +L   EK  ++R+  A N+LL 
Sbjct: 449 MKYL--EEKNFVHRNLAARNVLLV 470

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 87.0 bits (216), Expect = 1e-19
 Identities = 39/155 (25%), Positives = 61/155 (39%), Gaps = 16/155 (10%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVN 147
            +++   ++G G    V                    VAIK++N E  Q   +E   E+ 
Sbjct: 15  DDYELQEVIGSGATAVVQAA-YCAPK--------KEKVAIKRINLEKCQTSMDELLKEIQ 65

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR-LKIAI 206
            + +  HPN+V          EL LV + +  GS+ + +       +  S  +    IA 
Sbjct: 66  AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125

Query: 207 ---GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                  GL +LH  +   I+RD KA NILL   G
Sbjct: 126 ILREVLEGLEYLH--KNGQIHRDVKAGNILLGEDG 158

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 87.0 bits (216), Expect = 1e-19
 Identities = 37/155 (23%), Positives = 66/155 (42%), Gaps = 18/155 (11%)

Query: 89  KNFKPDSLLGEGGFGRVYKG--WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ--- 143
            NF+ +  +G G F  VY+    +D           G+ VA+KK+    +   +      
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLD-----------GVPVALKKVQIFDLMDAKARADCI 80

Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            E++ L +L+HPN++K      ED EL +V E    G L   +       + +      K
Sbjct: 81  KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK 140

Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
             +     L  +H   ++V++RD K +N+ +   G
Sbjct: 141 YFVQLCSALEHMH--SRRVMHRDIKPANVFITATG 173

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 87.8 bits (218), Expect = 1e-19
 Identities = 38/152 (25%), Positives = 63/152 (41%), Gaps = 15/152 (9%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEV 146
           + +     +GEG FG+     V            G    IK++N   M  +  EE + EV
Sbjct: 24  EKYVRLQKIGEGSFGKAIL--VKSTED-------GRQYVIKEINISRMSSKEREESRREV 74

Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
             L  + HPN+V+      E+  L +V +Y + G L   +  +         D  L   +
Sbjct: 75  AVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG--VLFQEDQILDWFV 132

Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                L  +H  ++K+++RD K+ NI L   G
Sbjct: 133 QICLALKHVH--DRKILHRDIKSQNIFLTKDG 162

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 58/193 (30%), Positives = 80/193 (41%), Gaps = 25/193 (12%)

Query: 53  SQAISEAGVEEASPNGQILET-PDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVD 111
           ++ +   G  +  P G    +  D  V          K F     +G G FG VY    D
Sbjct: 17  TENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFA-RD 75

Query: 112 DKTLAPSKTGLGMVVAIKKLNPESMQGFEEW---QSEVNFLGRLSHPNLVKLLGYCWEDK 168
            +           VVAIKK++    Q  E+W     EV FL +L HPN ++  G    + 
Sbjct: 76  VRN--------SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 127

Query: 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI---GAARGLGFLHTSEKKVIYR 225
              LV EY   GS  + L      +Q       ++IA    GA +GL +LH     +I+R
Sbjct: 128 TAWLVMEYCL-GSASDLLEVHKKPLQ------EVEIAAVTHGALQGLAYLH--SHNMIHR 178

Query: 226 DFKASNILLDGVG 238
           D KA NILL   G
Sbjct: 179 DVKAGNILLSEPG 191

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 85.8 bits (213), Expect = 3e-19
 Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 35/164 (21%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
            +FK   L+G GGFG+V+K     +         G    IK++   + +     + EV  
Sbjct: 11  MDFKEIELIGSGGFGQVFK--AKHRI-------DGKTYVIKRVKYNNEKA----EREVKA 57

Query: 149 LGRLSHPNLVKLLGYCWEDKE-----------------LLLVYEYMQRGSLENHLFRRNP 191
           L +L H N+V   G CW+  +                 L +  E+  +G+LE  + +R  
Sbjct: 58  LAKLDHVNIVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116

Query: 192 SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
             + L   + L++     +G+ ++H   KK+I RD K SNI L 
Sbjct: 117 --EKLDKVLALELFEQITKGVDYIH--SKKLINRDLKPSNIFLV 156

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 85.5 bits (212), Expect = 4e-19
 Identities = 40/161 (24%), Positives = 70/161 (43%), Gaps = 27/161 (16%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVN 147
            +F+P   LG GGFG V++    +K             AIK++   + +   E+   EV 
Sbjct: 5   TDFEPIQCLGRGGFGVVFE--AKNKV-------DDCNYAIKRIRLPNRELAREKVMREVK 55

Query: 148 FLGRLSHPNLVKLLGYCWEDKE-------------LLLVYEYMQRGSLENHLFRRNPSIQ 194
            L +L HP +V+     W +K              L +  +  ++ +L++ +  R  +I+
Sbjct: 56  ALAKLEHPGIVRYFN-AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC-TIE 113

Query: 195 PLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                + L I +  A  + FLH   K +++RD K SNI   
Sbjct: 114 ERERSVCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFFT 152

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 85.4 bits (212), Expect = 6e-19
 Identities = 43/207 (20%), Positives = 74/207 (35%), Gaps = 25/207 (12%)

Query: 36  HTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSAT-KNFKPD 94
           H    S+      ++ + Q++ +      S  G+  ET     +     +S   ++F+  
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRL 62

Query: 95  SLLGEGGFGRVYKG--WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--EVNFLG 150
           S LG G +G V+K     D           G + A+K+         +  +   EV    
Sbjct: 63  SRLGHGSYGEVFKVRSKED-----------GRLYAVKRSMSPFRGPKDRARKLAEVGSHE 111

Query: 151 RL-SHPNLVKLLGYCWEDKELL-LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           ++  HP  V+L    WE+  +L L  E     SL+ H          L            
Sbjct: 112 KVGQHPCCVRLEQ-AWEEGGILYLQTELCG-PSLQQHCEAWG---ASLPEAQVWGYLRDT 166

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLD 235
              L  LH   + +++ D K +NI L 
Sbjct: 167 LLALAHLH--SQGLVHLDVKPANIFLG 191

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 84.2 bits (209), Expect = 9e-19
 Identities = 41/148 (27%), Positives = 62/148 (41%), Gaps = 18/148 (12%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF---EEWQSEVNFLGRL 152
            LG+G FG VY        LA  K     ++A+K L    ++      + + EV     L
Sbjct: 16  PLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66

Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
            HPN+++L GY  +   + L+ EY   G++   L +                    A  L
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANAL 122

Query: 213 GFLHTSEKKVIYRDFKASNILLDGVGFL 240
            + H   K+VI+RD K  N+LL   G L
Sbjct: 123 SYCH--SKRVIHRDIKPENLLLGSAGEL 148

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 85.7 bits (212), Expect = 1e-18
 Identities = 32/146 (21%), Positives = 56/146 (38%), Gaps = 21/146 (14%)

Query: 98  GEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFEEWQSEVNFLGRLSHP 155
           G      V        T        G  V ++++N E+         Q E++     +HP
Sbjct: 36  GFEDLMTVNLA-RYKPT--------GEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI---GAARGL 212
           N+V        D EL +V  +M  GS ++ +      +  ++      IA    G  + L
Sbjct: 87  NIVPYRATFIADNELWVVTSFMAYGSAKDLI--CTHFMDGMNELA---IAYILQGVLKAL 141

Query: 213 GFLHTSEKKVIYRDFKASNILLDGVG 238
            ++H      ++R  KAS+IL+   G
Sbjct: 142 DYIH--HMGYVHRSVKASHILISVDG 165

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 84.3 bits (209), Expect = 1e-18
 Identities = 38/163 (23%), Positives = 66/163 (40%), Gaps = 32/163 (19%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
             +F+  ++LG+G FG+V K    +              AIKK+     +      SEV 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVK--ARNALD-------SRYYAIKKIRHTEEK-LSTILSEVM 54

Query: 148 FLGRLSHPNLVKLLGYCWEDKE--------------LLLVYEYMQRGSLENHLFRRNPSI 193
            L  L+H  +V+     W ++               L +  EY + G+L + +   N + 
Sbjct: 55  LLASLNHQYVVRYYA-AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ 113

Query: 194 QP-LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           Q    W +  +I       L ++H   + +I+RD K  NI +D
Sbjct: 114 QRDEYWRLFRQIL----EALSYIH--SQGIIHRDLKPMNIFID 150

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 42/153 (27%), Positives = 64/153 (41%), Gaps = 19/153 (12%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE-WQSEVNF 148
            ++    LG GGFG V + W+   T        G  VAIK+   E      E W  E+  
Sbjct: 15  PWEMKERLGTGGFGYVLR-WIHQDT--------GEQVAIKQCRQELSPKNRERWCLEIQI 65

Query: 149 LGRLSHPNLVKLL------GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL 202
           + +L+HPN+V              +   LL  EY + G L  +L  +  +   L      
Sbjct: 66  MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIR 124

Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
            +    +  L +LH  E ++I+RD K  NI+L 
Sbjct: 125 TLLSDISSALRYLH--ENRIIHRDLKPENIVLQ 155

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 84.9 bits (210), Expect = 4e-18
 Identities = 31/152 (20%), Positives = 56/152 (36%), Gaps = 24/152 (15%)

Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE-WQSEVNFLGRL 152
              +  GG G +Y     D+ +       G  V +K L        +    +E  FL  +
Sbjct: 85  KGCIAHGGLGWIYLAL--DRNVN------GRPVVLKGLVHSGDAEAQAMAMAERQFLAEV 136

Query: 153 SHPNLVKLLGY-----CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
            HP++V++  +        D    +V EY+   SL+    +       L     +   + 
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLE 190

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILL--DGV 237
               L +LH     ++Y D K  NI+L  + +
Sbjct: 191 ILPALSYLH--SIGLVYNDLKPENIMLTEEQL 220

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 82.9 bits (205), Expect = 6e-18
 Identities = 44/151 (29%), Positives = 64/151 (42%), Gaps = 18/151 (11%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-H 154
           +L EGGF  VY+   D  +        G   A+K+L     +       EV F+ +LS H
Sbjct: 35  VLAEGGFAFVYEA-QDVGS--------GREYALKRLLSNEEEKNRAIIQEVCFMKKLSGH 85

Query: 155 PNLVKLLGYCWEDKE-------LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
           PN+V+        KE         L+   + +G L   L +      PLS D  LKI   
Sbjct: 86  PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR-GPLSCDTVLKIFYQ 144

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
             R +  +H  +  +I+RD K  N+LL   G
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQG 175

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 83.0 bits (205), Expect = 7e-18
 Identities = 45/182 (24%), Positives = 78/182 (42%), Gaps = 20/182 (10%)

Query: 63  EASPNGQILETPDLKVFSFLDLKSATKNFKPDSL-----LGEGGFGRVYKGWVDDKTLAP 117
           +     ++ E    ++ +FL  K      K D       LG G  G V+K      +   
Sbjct: 2   KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKV-SHKPS--- 57

Query: 118 SKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEY 176
                G+V+A K ++ E       +   E+  L   + P +V   G  + D E+ +  E+
Sbjct: 58  -----GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112

Query: 177 MQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
           M  GSL+  L +       +   I  K++I   +GL +L   + K+++RD K SNIL++ 
Sbjct: 113 MDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNS 167

Query: 237 VG 238
            G
Sbjct: 168 RG 169

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 82.4 bits (204), Expect = 8e-18
 Identities = 24/154 (15%), Positives = 63/154 (40%), Gaps = 27/154 (17%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----KLNPESMQGFEEWQ 143
           + +     +G GG  +V++  V ++           + AIK     + + +++  +   +
Sbjct: 28  RIYSILKQIGSGGSSKVFQ--VLNEK--------KQIYAIKYVNLEEADNQTLDSY---R 74

Query: 144 SEVNFLGRLSHPNL--VKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR 201
           +E+ +L +L   +   ++L  Y   D+ + +V E      L + L ++    + +    R
Sbjct: 75  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK----KSIDPWER 129

Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                     +  +H  +  +++ D K +N L+ 
Sbjct: 130 KSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV 161

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 82.9 bits (205), Expect = 8e-18
 Identities = 28/207 (13%), Positives = 75/207 (36%), Gaps = 28/207 (13%)

Query: 36  HTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDS 95
           H          +G  + + A  E    ++   G   +       +   +    + +    
Sbjct: 4   HHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSS-ANECISVKGRIYSILK 62

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----KLNPESMQGFEEWQSEVNFLG 150
            +G GG  +V++    ++           + AIK     + + +++  +   ++E+ +L 
Sbjct: 63  QIGSGGSSKVFQVL--NEK--------KQIYAIKYVNLEEADNQTLDSY---RNEIAYLN 109

Query: 151 RLSHPNL--VKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           +L   +   ++L  Y   D+ + +V E      L + L ++    + +    R       
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK----KSIDPWERKSYWKNM 164

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLD 235
              +  +H  +  +++ D K +N L+ 
Sbjct: 165 LEAVHTIH--QHGIVHSDLKPANFLIV 189

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 83.0 bits (205), Expect = 1e-17
 Identities = 36/155 (23%), Positives = 62/155 (40%), Gaps = 17/155 (10%)

Query: 85  KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE-WQ 143
            ++   +    +LG+G    V++     KT        G + AIK  N  S     +   
Sbjct: 5   STSNHLWLLSDILGQGATANVFR-GRHKKT--------GDLFAIKVFNNISFLRPVDVQM 55

Query: 144 SEVNFLGRLSHPNLVKLLGYCWED---KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDI 200
            E   L +L+H N+VKL     E+   +  +L+ E+   GSL   L   + +   L    
Sbjct: 56  REFEVLKKLNHKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESE 113

Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
            L +      G+  L   E  +++R+ K  NI+  
Sbjct: 114 FLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRV 146

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 82.1 bits (203), Expect = 1e-17
 Identities = 23/154 (14%), Positives = 62/154 (40%), Gaps = 27/154 (17%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----KLNPESMQGFEEWQ 143
           + +     +G GG  +V++    ++           + AIK     + + +++  +   +
Sbjct: 9   RIYSILKQIGSGGSSKVFQVL--NEK--------KQIYAIKYVNLEEADNQTLDSY---R 55

Query: 144 SEVNFLGRLSHPNL--VKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR 201
           +E+ +L +L   +   ++L  Y   D+ + +V E      L + L ++    + +    R
Sbjct: 56  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK----KSIDPWER 110

Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                     +  +H  +  +++ D K +N L+ 
Sbjct: 111 KSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV 142

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 81.7 bits (202), Expect = 1e-17
 Identities = 36/154 (23%), Positives = 62/154 (40%), Gaps = 17/154 (11%)

Query: 85  KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE-WQ 143
            ++   +    +LG+G    V++     KT        G + AIK  N  S     +   
Sbjct: 5   STSNHLWLLSDILGQGATANVFR-GRHKKT--------GDLFAIKVFNNISFLRPVDVQM 55

Query: 144 SEVNFLGRLSHPNLVKLLGYCWED---KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDI 200
            E   L +L+H N+VKL     E+   +  +L+ E+   GSL   L   + +   L    
Sbjct: 56  REFEVLKKLNHKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESE 113

Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
            L +      G+  L   E  +++R+ K  NI+ 
Sbjct: 114 FLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMR 145

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 81.1 bits (201), Expect = 1e-17
 Identities = 40/148 (27%), Positives = 63/148 (42%), Gaps = 18/148 (12%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF---EEWQSEVNFLGRL 152
            LG+G FG VY        LA  K     ++A+K L    ++      + + E+     L
Sbjct: 21  PLGKGKFGNVY--------LAREKQN-KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71

Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
            HPN++++  Y  + K + L+ E+  RG L   L +                    A  L
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH----GRFDEQRSATFMEELADAL 127

Query: 213 GFLHTSEKKVIYRDFKASNILLDGVGFL 240
            + H  E+KVI+RD K  N+L+   G L
Sbjct: 128 HYCH--ERKVIHRDIKPENLLMGYKGEL 153

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 27/167 (16%), Positives = 60/167 (35%), Gaps = 33/167 (19%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----- 144
           +++    L +G F ++         L           A+KK     ++   ++       
Sbjct: 32  DYRIIRTLNQGKFNKII--------LCEKD---NKFYALKKYEKSLLEKKRDFTKSNNDK 80

Query: 145 ------------EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS 192
                       E+  +  + +   +   G      E+ ++YEYM+  S+          
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140

Query: 193 IQPLSWDIRLKIAIGAAR----GLGFLHTSEKKVIYRDFKASNILLD 235
            +  +  I +++     +       ++H +EK + +RD K SNIL+D
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIH-NEKNICHRDVKPSNILMD 186

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 34/151 (22%), Positives = 66/151 (43%), Gaps = 12/151 (7%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNF 148
           + K    +G G +G V K  V   +        G ++A+K++      +  ++   +++ 
Sbjct: 23  DLKDLGEIGRGAYGSVNKM-VHKPS--------GQIMAVKRIRSTVDEKEQKQLLMDLDV 73

Query: 149 LGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
           + R S  P +V+  G  + + +  +  E M     + + +  +     +  +I  KI + 
Sbjct: 74  VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
             + L  L     K+I+RD K SNILLD  G
Sbjct: 134 TVKALNHLK-ENLKIIHRDIKPSNILLDRSG 163

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 16/160 (10%)

Query: 84  LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEE 141
           + S  ++++    +G G +GR  K  +  K+        G ++  K+L+  SM     + 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQK--IRRKS-------DGKILVWKELDYGSMTEAEKQM 51

Query: 142 WQSEVNFLGRLSHPNLVKLLG--YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWD 199
             SEVN L  L HPN+V+         +  L +V EY + G L + + +     Q L  +
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111

Query: 200 IRLKIAIGAARGLGFLH---TSEKKVIYRDFKASNILLDG 236
             L++       L   H        V++RD K +N+ LDG
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG 151

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 79.6 bits (197), Expect = 4e-17
 Identities = 37/144 (25%), Positives = 64/144 (44%), Gaps = 13/144 (9%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLS-H 154
           LG G +G V K      +        G ++A+K++      Q  +    +++   R    
Sbjct: 15  LGRGAYGVVEKM-RHVPS--------GQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC 65

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
           P  V   G  + + ++ +  E M   SL+    +     Q +  DI  KIA+   + L  
Sbjct: 66  PFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 215 LHTSEKKVIYRDFKASNILLDGVG 238
           LH S+  VI+RD K SN+L++ +G
Sbjct: 125 LH-SKLSVIHRDVKPSNVLINALG 147

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 79.9 bits (198), Expect = 4e-17
 Identities = 40/156 (25%), Positives = 64/156 (41%), Gaps = 23/156 (14%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----- 144
            ++    +GEG +G V+K   +  T        G +VAIKK         +         
Sbjct: 4   KYEKIGKIGEGSYGVVFKC-RNRDT--------GQIVAIKKFL---ESEDDPVIKKIALR 51

Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E+  L +L HPNLV LL      + L LV+EY    ++ + L R     + +   +   I
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQ---RGVPEHLVKSI 107

Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                + + F H  +   I+RD K  NIL+     +
Sbjct: 108 TWQTLQAVNFCH--KHNCIHRDVKPENILITKHSVI 141

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 79.9 bits (198), Expect = 4e-17
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 23/162 (14%)

Query: 86  SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS- 144
           S++  FK    LG G +  VYKG  +  T        G+ VA+K++  +S +G     S 
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGL-NKTT--------GVYVALKEVKLDSEEGTP---ST 49

Query: 145 ---EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQ---RGSLENHLFRRNPSIQPLSW 198
              E++ +  L H N+V+L      + +L LV+E+M    +  +++      P  + L  
Sbjct: 50  AIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTP--RGLEL 107

Query: 199 DIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           ++         +GL F H  E K+++RD K  N+L++  G L
Sbjct: 108 NLVKYFQWQLLQGLAFCH--ENKILHRDLKPQNLLINKRGQL 147

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 80.0 bits (198), Expect = 6e-17
 Identities = 38/182 (20%), Positives = 69/182 (37%), Gaps = 18/182 (9%)

Query: 57  SEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLA 116
                  A+P       P  ++   L    + + +     LG+GGF + ++   D  T  
Sbjct: 9   KAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEI-SDADT-- 65

Query: 117 PSKTGLGMVVAIKKLNPESMQGF---EEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173
                   V A K +    +      E+   E++    L+H ++V   G+  ++  + +V
Sbjct: 66  ------KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119

Query: 174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL 233
            E  +R SL     RR    + L+             G  +LH    +VI+RD K  N+ 
Sbjct: 120 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLH--RNRVIHRDLKLGNLF 173

Query: 234 LD 235
           L+
Sbjct: 174 LN 175

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 78.0 bits (193), Expect = 1e-16
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 17/150 (11%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFEE-WQSE 145
           ++FK  +LLG+G F  VY+      T        G+ VAIK ++ ++M   G  +  Q+E
Sbjct: 11  EDFKVGNLLGKGSFAGVYRA-ESIHT--------GLEVAIKMIDKKAMYKAGMVQRVQNE 61

Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
           V    +L HP++++L  Y  +   + LV E    G +  +L  R    +P S +      
Sbjct: 62  VKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV---KPFSENEARHFM 118

Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                G+ +LH     +++RD   SN+LL 
Sbjct: 119 HQIITGMLYLH--SHGILHRDLTLSNLLLT 146

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 43/156 (27%), Positives = 67/156 (42%), Gaps = 23/156 (14%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----- 144
            ++   L+GEG +G V K   +  T        G +VAIKK         ++        
Sbjct: 26  KYENLGLVGEGSYGMVMKC-RNKDT--------GRIVAIKKFLESD---DDKMVKKIAMR 73

Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           E+  L +L H NLV LL  C + K   LV+E++   ++ + L         L + +  K 
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFP---NGLDYQVVQKY 129

Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                 G+GF H     +I+RD K  NIL+   G +
Sbjct: 130 LFQIINGIGFCH--SHNIIHRDIKPENILVSQSGVV 163

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 20/164 (12%)

Query: 82  LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE 141
           LD+KS  K ++    LGEG F  VYK   D  T          +VAIKK+        ++
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKAR-DKNT--------NQIVAIKKIKLGHRSEAKD 53

Query: 142 WQS-----EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPL 196
             +     E+  L  LSHPN++ LL        + LV+++M+   LE  +  ++ S+   
Sbjct: 54  GINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLT 110

Query: 197 SWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
              I+    +   +GL +LH  +  +++RD K +N+LLD  G L
Sbjct: 111 PSHIK-AYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVL 151

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 77.6 bits (192), Expect = 3e-16
 Identities = 34/150 (22%), Positives = 61/150 (40%), Gaps = 18/150 (12%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF---EEWQSE 145
           + +     LG+GGF + ++   D  T          V A K +    +      E+   E
Sbjct: 15  RRYVRGRFLGKGGFAKCFEI-SDADT--------KEVFAGKIVPKSLLLKPHQREKMSME 65

Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
           ++    L+H ++V   G+  ++  + +V E  +R SL     RR    + L+        
Sbjct: 66  ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR----KALTEPEARYYL 121

Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                G  +LH    +VI+RD K  N+ L+
Sbjct: 122 RQIVLGCQYLH--RNRVIHRDLKLGNLFLN 149

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 76.9 bits (190), Expect = 5e-16
 Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 30/160 (18%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS---- 144
           + +     LGEG +  VYKG     T          +VA+K++  E  +G          
Sbjct: 2   ETYIKLDKLGEGTYATVYKGK-SKLT--------DNLVALKEIRLEHEEGAP---CTAIR 49

Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQ---RGSLENHLFRRNPS-IQPLSWDI 200
           EV+ L  L H N+V L      +K L LV+EY+    +  L++     N   ++   + +
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQL 109

Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                    RGL + H   +KV++RD K  N+L++  G L
Sbjct: 110 --------LRGLAYCH--RQKVLHRDLKPQNLLINERGEL 139

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 38/171 (22%), Positives = 72/171 (42%), Gaps = 21/171 (12%)

Query: 75  DLKVFSFLDLKSATKNFKPDSL-----LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK 129
             K   +L +       + + L     +G G  G+V+K     KT        G V+A+K
Sbjct: 6   SGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKM-RFRKT--------GHVIAVK 56

Query: 130 KLNPES-MQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLF 187
           ++      +  +    +++ + +    P +V+  G    + ++ +  E M   + +  L 
Sbjct: 57  QMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK--LK 114

Query: 188 RRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
           +R     P+   I  K+ +   + L +L   +  VI+RD K SNILLD  G
Sbjct: 115 KRMQ--GPIPERILGKMTVAIVKALYYLK-EKHGVIHRDVKPSNILLDERG 162

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 28/220 (12%), Positives = 47/220 (21%), Gaps = 49/220 (22%)

Query: 53  SQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDD 112
             A+ EA      P        +  V S   L    +  K    L  G    V+    D 
Sbjct: 33  PAAMVEAVTATVWPQNA-----ETTVDS--LLSQGERKLKLVEPLRVGDRSVVFLV-RDV 84

Query: 113 KTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS---EVNFLGRLSHPNLVKLLGYC----- 164
           +             A+K     +     E +          RL   +  +          
Sbjct: 85  ER--------LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP 136

Query: 165 ---------------------WEDKELLLVYEYMQ--RGSLENHLFRRNPSIQPLSWDIR 201
                                +     LL+          L + L               
Sbjct: 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILAL 196

Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLF 241
             +     R    L    K +++  F   N+ +   G L 
Sbjct: 197 HILTAQLIRLAANLQ--SKGLVHGHFTPDNLFIMPDGRLM 234

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 74.5 bits (184), Expect = 3e-15
 Identities = 39/165 (23%), Positives = 75/165 (45%), Gaps = 32/165 (19%)

Query: 85  KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS 144
           +   + ++    +GEG +G VYK    D          G +VA+K++    +   +E   
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAK--DSQ--------GRIVALKRIR---LDAEDEGIP 63

Query: 145 -----EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQ---RGSLENHLFRRNPS-IQP 195
                E++ L  L HPN+V L+     ++ L LV+E+M+   +  L+ +      S I+ 
Sbjct: 64  STAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKI 123

Query: 196 LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
             + +         RG+   H  + ++++RD K  N+L++  G L
Sbjct: 124 YLYQL--------LRGVAHCH--QHRILHRDLKPQNLLINSDGAL 158

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 73.7 bits (182), Expect = 5e-15
 Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 24/157 (15%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQS--- 144
           + +     +GEG +G VYK    +          G   A+KK+  E    G     S   
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQ--NNY--------GETFALKKIRLEKEDEGIP---STTI 48

Query: 145 -EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            E++ L  L H N+VKL       K L+LV+E++ +  L+  L      ++ +    +  
Sbjct: 49  REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESV--TAK-S 104

Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
             +    G+ + H  +++V++RD K  N+L++  G L
Sbjct: 105 FLLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGEL 139

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 72.2 bits (178), Expect = 2e-14
 Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 22/157 (14%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS---- 144
           +NF+    +GEG +G VYK   +  T        G VVA+KK+    +    E       
Sbjct: 3   ENFQKVEKIGEGTYGVVYKAR-NKLT--------GEVVALKKIR---LDTETEGVPSTAI 50

Query: 145 -EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
            E++ L  L+HPN+VKLL     + +L LV+E++ +  L+  +     ++  +   +   
Sbjct: 51  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKS 107

Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                 +GL F H    +V++RD K  N+L++  G +
Sbjct: 108 YLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAI 142

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 71.4 bits (176), Expect = 3e-14
 Identities = 39/161 (24%), Positives = 73/161 (45%), Gaps = 31/161 (19%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQS--- 144
           + ++    +GEG +G V+K   + +T          +VA+K++  +    G     S   
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAK-NRET--------HEIVALKRVRLDDDDEGVP---SSAL 49

Query: 145 -EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQ---RGSLENHLFRRNPS-IQPLSWD 199
            E+  L  L H N+V+L      DK+L LV+E+     +   ++     +P  ++   + 
Sbjct: 50  REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ 109

Query: 200 IRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           +         +GLGF H   + V++RD K  N+L++  G L
Sbjct: 110 L--------LKGLGFCH--SRNVLHRDLKPQNLLINRNGEL 140

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 70.7 bits (174), Expect = 6e-14
 Identities = 40/148 (27%), Positives = 64/148 (43%), Gaps = 18/148 (12%)

Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEE-WQSEVNFLG 150
              LG GG   VY    D        T L + VAIK +       +   + ++ EV+   
Sbjct: 16  VDKLGGGGMSTVYLA-ED--------TILNIKVAIKAIFIPPREKEETLKRFEREVHNSS 66

Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           +LSH N+V ++    ED    LV EY++  +L  ++        PLS D  +        
Sbjct: 67  QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILD 122

Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGVG 238
           G+   H  + ++++RD K  NIL+D   
Sbjct: 123 GIKHAH--DMRIVHRDIKPQNILIDSNK 148

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 71.4 bits (175), Expect = 8e-14
 Identities = 34/148 (22%), Positives = 60/148 (40%), Gaps = 17/148 (11%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           +G G +G VYK    D              A+K++    +        E+  L  L HPN
Sbjct: 29  VGRGTYGHVYKAKRKD-------GKDDKDYALKQIEGTGIS--MSACREIALLRELKHPN 79

Query: 157 LVKLLGYCWE--DKELLLVYEYMQ---RGSLENHLFR-RNPSIQPLSWDIRLKIAIGAAR 210
           ++ L        D+++ L+++Y +      ++ H     N     L   +   +      
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139

Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGVG 238
           G+ +LH     V++RD K +NIL+ G G
Sbjct: 140 GIHYLH--ANWVLHRDLKPANILVMGEG 165

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 71.4 bits (175), Expect = 9e-14
 Identities = 54/236 (22%), Positives = 90/236 (38%), Gaps = 25/236 (10%)

Query: 14  SSSNNINANASSSSAGAYNKYGHTMEISATSSSAGKSQFSQAISEAGVE-EASPNGQILE 72
             +  + A      A  +  +     ++   + AG   F   +         +P  + L+
Sbjct: 105 QKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLD 164

Query: 73  TPDLKVF---SFLDLKSATKN-FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAI 128
           +     F    +L+ +   ++ F    +LG GGFG V+            K   G + A 
Sbjct: 165 SLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVF--------ACQMK-ATGKLYAC 215

Query: 129 KKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLEN 184
           KKLN +     +G++    E   L ++    +V L  Y +E K  L LV   M  G +  
Sbjct: 216 KKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRY 274

Query: 185 HLFRRNPSIQPLSWD-IRLKIA-IGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
           H++  +               A I    GL  LH  ++ +IYRD K  N+LLD  G
Sbjct: 275 HIYNVDEDNPGFQEPRAIFYTAQI--VSGLEHLH--QRNIIYRDLKPENVLLDDDG 326

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 71.4 bits (175), Expect = 9e-14
 Identities = 42/205 (20%), Positives = 75/205 (36%), Gaps = 31/205 (15%)

Query: 42  ATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGG 101
           A ++    S     +S +  E           P   +            ++   L+G G 
Sbjct: 6   AAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGS 65

Query: 102 FGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS------EVNFLGRLSHP 155
           +G V +   D             VVAIKK+       FE+         E+  L RL+H 
Sbjct: 66  YGHVCEA-YDKLE--------KRVVAIKKILRV----FEDLIDCKRILREIAILNRLNHD 112

Query: 156 NLVKLL-----GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           ++VK+L         +  EL +V E          LFR   +   L+      +      
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADS-DF-KKLFR---TPVYLTELHIKTLLYNLLV 167

Query: 211 GLGFLHTSEKKVIYRDFKASNILLD 235
           G+ ++H++   +++RD K +N L++
Sbjct: 168 GVKYVHSAG--ILHRDLKPANCLVN 190

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 38/157 (24%), Positives = 63/157 (40%), Gaps = 30/157 (19%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQS----EVNFLGR 151
           LGEG +G VYK   D  T           VAIK++  E   +G          EV+ L  
Sbjct: 42  LGEGTYGEVYKAI-DTVT--------NETVAIKRIRLEHEEEGVP---GTAIREVSLLKE 89

Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQ---RGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           L H N+++L      +  L L++EY +   +  ++ +       I+   + +        
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQL-------- 141

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL 245
             G+ F H   ++ ++RD K  N+LL          L
Sbjct: 142 INGVNFCH--SRRCLHRDLKPQNLLLSVSDASETPVL 176

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 49/242 (20%), Positives = 95/242 (39%), Gaps = 30/242 (12%)

Query: 1   MGNCFGSLFVASNSSSNNINANASSSSAGAYNKYGHTMEISATSSSAGKSQFSQAISEAG 60
           MG+         +  + N+   +  +S    ++ GH    +        +  ++ +    
Sbjct: 1   MGHHHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGH----NEAKEVWSNADLTERMPVKS 56

Query: 61  VEEASPNGQILETPDLKVFSFLDLKSATKN----FKPDSLLGEGGFGRVYKGWVDDKTLA 116
              ++    I   P       +  K    N         +LG G FG+V+K   +  T  
Sbjct: 57  KRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC-EETAT-- 113

Query: 117 PSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEY 176
                 G+ +A K +    M+  EE ++E++ + +L H NL++L        +++LV EY
Sbjct: 114 ------GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167

Query: 177 MQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR----GLGFLHTSEKKVIYRDFKASNI 232
           +  G  E  LF R   I   S+++     I   +    G+  +H  +  +++ D K  NI
Sbjct: 168 VDGG--E--LFDR---IIDESYNLTELDTILFMKQICEGIRHMH--QMYILHLDLKPENI 218

Query: 233 LL 234
           L 
Sbjct: 219 LC 220

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 68.0 bits (167), Expect = 5e-13
 Identities = 38/149 (25%), Positives = 56/149 (37%), Gaps = 18/149 (12%)

Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEE-WQSEVNFLG 150
             L+G GG G VY+   D        T    +VA+K ++    S   F    Q E    G
Sbjct: 39  RRLVGRGGMGDVYEA-ED--------TVRERIVALKLMSETLSSDPVFRTRMQREARTAG 89

Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           RL  P++V +  +   D +L +    +    L   L R+     PL+    + I      
Sbjct: 90  RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGS 145

Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGVGF 239
            L   H       +RD K  NIL+    F
Sbjct: 146 ALDAAH--AAGATHRDVKPENILVSADDF 172

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 44/202 (21%), Positives = 83/202 (41%), Gaps = 25/202 (12%)

Query: 42  ATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFS-FLDLKSATKNFKPDSLLGEG 100
            T+S A   +  Q  S  G  + S +    +   +         +    ++    ++G G
Sbjct: 6   RTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNG 65

Query: 101 GFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKL 160
            FG VY+      +        G +VAIKK+    +Q       E+  + +L H N+V+L
Sbjct: 66  SFGVVYQA-KLCDS--------GELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRL 112

Query: 161 LGY------CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI-GAARGLG 213
             +        ++  L LV +Y+   ++       + + Q L   I +K+ +    R L 
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQLFRSLA 170

Query: 214 FLHTSEKKVIYRDFKASNILLD 235
           ++H+    + +RD K  N+LLD
Sbjct: 171 YIHS--FGICHRDIKPQNLLLD 190

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 68.0 bits (167), Expect = 6e-13
 Identities = 43/168 (25%), Positives = 67/168 (39%), Gaps = 53/168 (31%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS-------EVNFL 149
           +G+G FG V+K     KT        G  VA+KK+  E+     E +        E+  L
Sbjct: 25  IGQGTFGEVFKA-RHRKT--------GQKVALKKVLMEN-----EKEGFPITALREIKIL 70

Query: 150 GRLSHPNLVKLLGYCWEDKE--------LLLVYEYMQ---RGSLENHLFRRNPS------ 192
             L H N+V L+  C             + LV+++ +    G L N L +   S      
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 130

Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
              L              GL ++H    K+++RD KA+N+L+   G L
Sbjct: 131 QMLL-------------NGLYYIH--RNKILHRDMKAANVLITRDGVL 163

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 68.2 bits (166), Expect = 7e-13
 Identities = 26/178 (14%), Positives = 54/178 (30%), Gaps = 43/178 (24%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK---KLNPESMQGFEEWQSEVNFLGRL 152
           +LG+       +    D+         G    +              ++ + EV  L  L
Sbjct: 85  VLGQEDPYAYLEAT--DQET-------GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135

Query: 153 S----------------------HPNLVKLLGYCWEDK-----ELLLVYEYMQR--GSLE 183
                                   P   K++    +++         +Y  MQ    +  
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195

Query: 184 NHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLF 241
             L   + + + L    RL++ +   R L  LH     +++   +  +I+LD  G +F
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQRGGVF 251

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 68.3 bits (167), Expect = 8e-13
 Identities = 30/147 (20%), Positives = 58/147 (39%), Gaps = 20/147 (13%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFL 149
           +F P  +LG G  G +    + D             VA+K++ PE     +    EV  L
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFD----------NRDVAVKRILPECFSFAD---REVQLL 71

Query: 150 GRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
                HPN+++      + +   +  E     +L+ ++ +++ +         + +    
Sbjct: 72  RESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA---HLGLEPITLLQQT 127

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLD 235
             GL  LH     +++RD K  NIL+ 
Sbjct: 128 TSGLAHLH--SLNIVHRDLKPHNILIS 152

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 24/177 (13%), Positives = 57/177 (32%), Gaps = 25/177 (14%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGW--VDDKTLA---PSKTGLGMVVAIKKL----------- 131
            +     ++LG+       +       ++     P  T      AIK++           
Sbjct: 72  PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131

Query: 132 ---NPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYC--WEDKELLLVYEYMQ--RGSLEN 184
              N +  +    +    + +       ++++              +Y  MQ    +   
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191

Query: 185 HLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLF 241
            L   + + + L    RL++ +   R L  LH     +++   +  +I+LD  G +F
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQRGGVF 246

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 43/182 (23%), Positives = 71/182 (39%), Gaps = 33/182 (18%)

Query: 71  LETPDLKVFSFLDLKSATKNFKPDSL---------LGEGGFGRVYKGWVDDKTLAPSKTG 121
           L     KVF F DL    ++  P +L         LG G  G V     + KT       
Sbjct: 108 LSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA-FERKT------- 159

Query: 122 LGMVVAIKKLNPESMQGFEEW--------QSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173
               VAI+ ++                  ++E+  L +L+HP ++K+  +  + ++  +V
Sbjct: 160 -CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIV 217

Query: 174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL 233
            E M+ G  E  LF +    + L               + +LH  E  +I+RD K  N+L
Sbjct: 218 LELMEGG--E--LFDKVVGNKRLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVL 271

Query: 234 LD 235
           L 
Sbjct: 272 LS 273

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 29/110 (26%), Positives = 44/110 (40%), Gaps = 7/110 (6%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNF 148
             K    LG G FG+V +           KT     VA+K L   +         SE+  
Sbjct: 23  RLKLGKPLGRGAFGQVIEA----DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 78

Query: 149 LGRL-SHPNLVKLLGYC-WEDKELLLVYEYMQRGSLENHLFRRNPSIQPL 196
           L  +  H N+V LLG C      L+++ E+ + G+L  +L  +     P 
Sbjct: 79  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 38/169 (22%), Positives = 66/169 (39%), Gaps = 28/169 (16%)

Query: 80  SFLDLKSATKNFK----PDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----K 130
             LD+      F+       ++G+G F  V +  ++ +T        G   A+K     K
Sbjct: 11  GILDMADDDVLFEDVYELCEVIGKGPFSVVRRC-INRET--------GQQFAVKIVDVAK 61

Query: 131 LNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRN 190
                    E+ + E +    L HP++V+LL     D  L +V+E+M    L   + +R 
Sbjct: 62  FTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA 121

Query: 191 PSIQPLSWDIRLKIAIGAAR----GLGFLHTSEKKVIYRDFKASNILLD 235
            +    S      +A    R     L + H  +  +I+RD K   +LL 
Sbjct: 122 DAGFVYSE----AVASHYMRQILEALRYCH--DNNIIHRDVKPHCVLLA 164

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 66.1 bits (162), Expect = 2e-12
 Identities = 31/159 (19%), Positives = 58/159 (36%), Gaps = 36/159 (22%)

Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGR-- 151
             +LG GG   V+    D              VA+K L         +   + +F  R  
Sbjct: 17  GEILGFGGMSEVHLA-RD--------LRDHRDVAVKVLRA-------DLARDPSFYLRFR 60

Query: 152 --------LSHPNLVKLLGYCWEDKELL----LVYEYMQRGSLENHLFRRNPSIQPLSWD 199
                   L+HP +V +      +        +V EY+   +L + +        P++  
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPK 116

Query: 200 IRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
             +++   A + L F H  +  +I+RD K +NI++    
Sbjct: 117 RAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATN 153

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 65.5 bits (160), Expect = 3e-12
 Identities = 27/148 (18%), Positives = 53/148 (35%), Gaps = 20/148 (13%)

Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGF-EEWQSEVNFLG 150
               G     + ++  +D        T L   VA+  ++P+ +      +E  S    L 
Sbjct: 36  LIFHGGVPPLQFWQA-LD--------TALDRQVALTFVDPQGVLPDDVLQETLSRTLRLS 86

Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           R+  P + ++L         L+V E+++ GSL+  +   +PS  P+     ++     A 
Sbjct: 87  RIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQ-EVADTSPS--PVG---AIRAMQSLAA 140

Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGVG 238
                H     V       S + +   G
Sbjct: 141 AADAAH--RAGVALSIDHPSRVRVSIDG 166

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 48/173 (27%), Positives = 73/173 (42%), Gaps = 35/173 (20%)

Query: 79  FSFLDLKSATKN-FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--- 134
           + +L+ +  TKN F+   +LG+GGFG V          A      G + A KKL  +   
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIK 223

Query: 135 SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSI 193
             +G     +E   L +++   +V L  Y +E K+ L LV   M  G L+ H++      
Sbjct: 224 KRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMG--- 279

Query: 194 QPLSWDIRLKIAIGAAR--------GLGFLHTSEKKVIYRDFKASNILLDGVG 238
                  +       A         GL  LH   ++++YRD K  NILLD  G
Sbjct: 280 -------QAGFPEARAVFYAAEICCGLEDLH--RERIVYRDLKPENILLDDHG 323

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 49/225 (21%), Positives = 81/225 (36%), Gaps = 40/225 (17%)

Query: 30  AYNKYG--HTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSA 87
           A NK+G     E +A     G  +  +   +   +     G+   + +   + F   K  
Sbjct: 84  AENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQY 143

Query: 88  TK---NFKPDSL---------LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES 135
                  K D +         LG G FG V++   +  T        G   A K +    
Sbjct: 144 YPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV-TERAT--------GNNFAAKFVMTPH 194

Query: 136 MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP 195
               E  + E+  +  L HP LV L     +D E++++YE+M  G  E  LF +      
Sbjct: 195 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG--E--LFEKV----- 245

Query: 196 LSWDIRL--KIAIGAAR----GLGFLHTSEKKVIYRDFKASNILL 234
                ++    A+   R    GL  +H  E   ++ D K  NI+ 
Sbjct: 246 ADEHNKMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMF 288

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 35/155 (22%), Positives = 58/155 (37%), Gaps = 20/155 (12%)

Query: 85  KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS 144
           +S       + +LG G  G V            S  G    VA+K++  +          
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVV--------FQGSFQG--RPVAVKRMLIDFCDIA---LM 57

Query: 145 EVNFLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
           E+  L     HPN+++       D+ L +  E     +L++ +  +N S + L       
Sbjct: 58  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYN 116

Query: 204 IAI---GAARGLGFLHTSEKKVIYRDFKASNILLD 235
                   A G+  LH    K+I+RD K  NIL+ 
Sbjct: 117 PISLLRQIASGVAHLH--SLKIIHRDLKPQNILVS 149

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 65.3 bits (160), Expect = 4e-12
 Identities = 45/177 (25%), Positives = 71/177 (40%), Gaps = 43/177 (24%)

Query: 85  KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS 144
             AT  ++P + +G G +G VYK   D  +        G  VA+K +    +        
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKA-RDPHS--------GHFVALKSVR---VPNGGGGGG 52

Query: 145 --------EVNFLGRLS---HPNLVKLL-----GYCWEDKELLLVYEYMQ---RGSLENH 185
                   EV  L RL    HPN+V+L+          + ++ LV+E++    R  L+  
Sbjct: 53  GLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA 112

Query: 186 LFRRNPS--IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                P+  I+ L             RGL FLH     +++RD K  NIL+   G +
Sbjct: 113 PPPGLPAETIKDLMRQF--------LRGLDFLH--ANCIVHRDLKPENILVTSGGTV 159

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 65.4 bits (160), Expect = 5e-12
 Identities = 42/162 (25%), Positives = 65/162 (40%), Gaps = 26/162 (16%)

Query: 85  KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS 144
           +     F+ + + G+G FG V  G  +  T        GM VAIKK+  +      E Q 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLG-KEKST--------GMSVAIKKVIQDPRFRNRELQ- 68

Query: 145 EVNFLGRLSHPNLVKLLGY-------CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLS 197
            +  L  L HPN+V+L  Y          D  L +V EY+   +L               
Sbjct: 69  IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP 127

Query: 198 WD-IRL---KIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
              I++   ++     R +G LH     V +RD K  N+L++
Sbjct: 128 PILIKVFLFQLI----RSIGCLHLPSVNVCHRDIKPHNVLVN 165

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 64.9 bits (159), Expect = 6e-12
 Identities = 43/156 (27%), Positives = 65/156 (41%), Gaps = 20/156 (12%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SE 145
           ++FK   +LGEG F  V         LA          AIK L    +    +      E
Sbjct: 30  EDFKFGKILGEGSFSTVV--------LARELAT-SREYAIKILEKRHIIKENKVPYVTRE 80

Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
            + + RL HP  VKL     +D++L     Y + G L  ++ +     +  +   R   A
Sbjct: 81  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT---RFYTA 137

Query: 206 -IGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
            I +A  L +LH   K +I+RD K  NILL+    +
Sbjct: 138 EIVSA--LEYLH--GKGIIHRDLKPENILLNEDMHI 169

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 65.0 bits (159), Expect = 6e-12
 Identities = 51/201 (25%), Positives = 81/201 (40%), Gaps = 27/201 (13%)

Query: 44  SSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFG 103
           +++A K    +++ E   +      +  ETP                F     LG G FG
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQ-------FDRIKTLGTGSFG 55

Query: 104 RVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKL 160
           RV         L   K   G   A+K L+ +    ++  E   +E   L  ++ P LVKL
Sbjct: 56  RVM--------LVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA-IGAARGLGFLHTSE 219
                ++  L +V EY+  G + +HL R     +P +   R   A I       +LH   
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA---RFYAAQIVLT--FEYLH--S 159

Query: 220 KKVIYRDFKASNILLDGVGFL 240
             +IYRD K  N+L+D  G++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYI 180

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 65.5 bits (160), Expect = 8e-12
 Identities = 42/178 (23%), Positives = 68/178 (38%), Gaps = 23/178 (12%)

Query: 62  EEASPNGQILETPDLKVFSFLDLKSA--TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSK 119
           E     G +  TP      F+  K    ++ ++    LG G +G V     D  T     
Sbjct: 12  ENLYFQGDLQATPG----MFITSKKGHLSEMYQRVKKLGSGAYGEVLLC-RDKVT----- 61

Query: 120 TGLGMVVAIKKLNPESMQG--FEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYM 177
               +  AIK +   S+      +   EV  L  L HPN++KL  +  + +   LV E  
Sbjct: 62  ---HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY 118

Query: 178 QRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           + G     LF         +      I      G+ +LH  +  +++RD K  N+LL+
Sbjct: 119 KGGE----LFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH--KHNIVHRDLKPENLLLE 170

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 65.1 bits (159), Expect = 9e-12
 Identities = 45/177 (25%), Positives = 75/177 (42%), Gaps = 24/177 (13%)

Query: 64  ASPNGQILETPDLKVFSFLDLKSA--TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTG 121
            S    +  TP      F+   +A  +  +K   +LG+G FG V     D  T       
Sbjct: 3   GSMMDHLHATPG----MFVQHSTAIFSDRYKGQRVLGKGSFGEVILC-KDKIT------- 50

Query: 122 LGMVVAIKKLNPESMQGFEEWQS---EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQ 178
            G   A+K ++   ++   + +S   EV  L +L HPN++KL  +  +     LV E   
Sbjct: 51  -GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 109

Query: 179 RGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
            G     LF    S +  S     +I      G+ ++H  + K+++RD K  N+LL+
Sbjct: 110 GGE----LFDEIISRKRFSEVDAARIIRQVLSGITYMH--KNKIVHRDLKPENLLLE 160

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 55/208 (26%), Positives = 80/208 (38%), Gaps = 23/208 (11%)

Query: 37  TMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSL 96
           T  I   +    K   ++    +G    +   + +E    K    + +      F+   L
Sbjct: 100 TTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMN----EFEYLKL 155

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS---EVNFLGRLS 153
           LG+G FG+V         L   K   G   A+K L  E +   +E      E   L    
Sbjct: 156 LGKGTFGKVI--------LVKEK-ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 206

Query: 154 HPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
           HP L  L  Y ++  + L  V EY   G L  HL R     +  +   R   A      L
Sbjct: 207 HPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA---RFYGA-EIVSAL 261

Query: 213 GFLHTSEKKVIYRDFKASNILLDGVGFL 240
            +LH SEK V+YRD K  N++LD  G +
Sbjct: 262 DYLH-SEKNVVYRDLKLENLMLDKDGHI 288

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 63.0 bits (154), Expect = 2e-11
 Identities = 31/148 (20%), Positives = 59/148 (39%), Gaps = 15/148 (10%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
            + +  ++ +G G +G V    V   T         +  A KK+    ++  + ++ E+ 
Sbjct: 8   NQYYTLENTIGRGSWGEVKIA-VQKGT--------RIRRAAKKIPKYFVEDVDRFKQEIE 58

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
            +  L HPN+++L     ++ ++ LV E    G  E  LF R    +        +I   
Sbjct: 59  IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGG--E--LFERVVHKRVFRESDAARIMKD 114

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLD 235
               + + H  +  V +RD K  N L  
Sbjct: 115 VLSAVAYCH--KLNVAHRDLKPENFLFL 140

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 36/189 (19%), Positives = 71/189 (37%), Gaps = 31/189 (16%)

Query: 57  SEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLA 116
           +     + +P     +   +        +     +    ++G G FG V++  +      
Sbjct: 8   APLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKL------ 61

Query: 117 PSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLL------GYCWEDKEL 170
             ++     VAIKK+  +          E+  +  + HPN+V L       G   ++  L
Sbjct: 62  -VESD---EVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113

Query: 171 LLVYEYMQRGSLENHLFRRNPSIQPLSWD-IRL---KIAIGAARGLGFLHTSEKKVIYRD 226
            LV EY+   ++           Q +    I+L   ++     R L ++H+    + +RD
Sbjct: 114 NLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQL----LRSLAYIHS--IGICHRD 166

Query: 227 FKASNILLD 235
            K  N+LLD
Sbjct: 167 IKPQNLLLD 175

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 41/174 (23%), Positives = 73/174 (41%), Gaps = 39/174 (22%)

Query: 85  KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQ 143
             A + ++  + +GEG +G+V+K               G  VA+K++  ++  +G     
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMP--- 55

Query: 144 S----EVNFLGRLS---HPNLVKLL-----GYCWEDKELLLVYEYMQ---RGSLENH--L 186
                EV  L  L    HPN+V+L           + +L LV+E++       L+     
Sbjct: 56  LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP 115

Query: 187 FRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                +I+ + + +         RGL FLH    +V++RD K  NIL+   G +
Sbjct: 116 GVPTETIKDMMFQL--------LRGLDFLH--SHRVVHRDLKPQNILVTSSGQI 159

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 50/249 (20%), Positives = 79/249 (31%), Gaps = 50/249 (20%)

Query: 16  SNNINANASSSSAGAYNKYGHTMEISATSSSAGKSQFSQAISEAGVEEA------SPNGQ 69
           S  I          A +       I        K Q    + +  +EE           +
Sbjct: 105 SREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQK 164

Query: 70  ILETPDLKVFSFLDLKSATKNFKPDS-----LLGEGGFGRVYKGWVDDKTLAPSKTGLGM 124
            +E+     F          +   +      ++G GGFG VY                G 
Sbjct: 165 FIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVY--------GCRKA-DTGK 215

Query: 125 VVAIKKLNPE---SMQGFEEWQSEVNFLGRLS---HPNLVKLLGYCWEDKE-LLLVYEYM 177
           + A+K L+ +     QG     +E   L  +S    P +V  + Y +   + L  + + M
Sbjct: 216 MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC-MSYAFHTPDKLSFILDLM 274

Query: 178 QRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR--------GLGFLHTSEKKVIYRDFKA 229
             G L  HL +                +    R        GL  +H   + V+YRD K 
Sbjct: 275 NGGDLHYHLSQHG------------VFSEADMRFYAAEIILGLEHMH--NRFVVYRDLKP 320

Query: 230 SNILLDGVG 238
           +NILLD  G
Sbjct: 321 ANILLDEHG 329

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 37/142 (26%), Positives = 61/142 (42%), Gaps = 22/142 (15%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V++  V+  T        G V   K +N          ++E++ + +L HP 
Sbjct: 59  LGSGAFGVVHRC-VEKAT--------GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR----GL 212
           L+ L     +  E++L+ E++  G  E  LF R   I    + +     I   R    GL
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGG--E--LFDR---IAAEDYKMSEAEVINYMRQACEGL 162

Query: 213 GFLHTSEKKVIYRDFKASNILL 234
             +H  E  +++ D K  NI+ 
Sbjct: 163 KHMH--EHSIVHLDIKPENIMC 182

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 62.5 bits (152), Expect = 4e-11
 Identities = 34/189 (17%), Positives = 63/189 (33%), Gaps = 52/189 (27%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----KLNPESMQGFEEW 142
            K +     +G+G +G V    ++++T          + AIK     K+   + +  E  
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVA-IENQT--------RAIRAIKIMNKNKIRQINPKDVERI 75

Query: 143 QSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL 202
           ++EV  + +L HPN+ +L     +++ + LV E    G L + L               +
Sbjct: 76  KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135

Query: 203 KIAIG-----------------------------AAR-------GLGFLHTSEKKVIYRD 226
           K  I                               +         L +LH   + + +RD
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH--NQGICHRD 193

Query: 227 FKASNILLD 235
            K  N L  
Sbjct: 194 IKPENFLFS 202

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 61.9 bits (151), Expect = 5e-11
 Identities = 40/166 (24%), Positives = 65/166 (39%), Gaps = 19/166 (11%)

Query: 72  ETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL 131
            +   +   F    +  + +    +LG+G FG V K   D  T            A+K +
Sbjct: 7   HSSGRENLYFQ--GTFAERYNIVCMLGKGSFGEVLKC-KDRIT--------QQEYAVKVI 55

Query: 132 NPESMQG--FEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR 189
           N  S +         EV  L +L HPN++KL     +     +V E    G  E  LF  
Sbjct: 56  NKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG--E--LFDE 111

Query: 190 NPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
               +  S     +I      G+ ++H  +  +++RD K  NILL+
Sbjct: 112 IIKRKRFSEHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLE 155

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 44/160 (27%), Positives = 67/160 (41%), Gaps = 35/160 (21%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--- 144
           + +F+  SLLGEG +G V        T        G +VAIKK+ P     F++      
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSA-THKPT--------GEIVAIKKIEP-----FDKPLFALR 55

Query: 145 ---EVNFLGRLSHPNLVKLL-----GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPL 196
              E+  L    H N++ +             E+ ++ E MQ   L   +     S Q L
Sbjct: 56  TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI-----STQML 109

Query: 197 SWDIRLK-IAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           S D  ++       R +  LH S   VI+RD K SN+L++
Sbjct: 110 S-DDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLIN 146

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 62.8 bits (153), Expect = 5e-11
 Identities = 38/150 (25%), Positives = 60/150 (40%), Gaps = 17/150 (11%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSE 145
            + +    +LG+G FG V K   D  T            A+K +N  S +         E
Sbjct: 21  AERYNIVCMLGKGSFGEVLKC-KDRIT--------QQEYAVKVINKASAKNKDTSTILRE 71

Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
           V  L +L HPN++KL     +     +V E    G     LF      +  S     +I 
Sbjct: 72  VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARII 127

Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                G+ ++H  +  +++RD K  NILL+
Sbjct: 128 KQVFSGITYMH--KHNIVHRDLKPENILLE 155

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 62.4 bits (152), Expect = 6e-11
 Identities = 43/218 (19%), Positives = 82/218 (37%), Gaps = 52/218 (23%)

Query: 41  SATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEG 100
              S SA     ++ +++A  +           P+ ++  +   K   + + P  ++G G
Sbjct: 46  DDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRG 105

Query: 101 GFGRVYKGWVDDKTLAPSKTGLGMVVAIK-------KLNPESMQGFEE-WQSEVNFLGRL 152
               V +  V   T        G   A+K       +L+PE ++   E  + E + L ++
Sbjct: 106 VSSVVRRC-VHRAT--------GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156

Query: 153 S-HPNLVKLLGYCWEDKELLLVYEYMQRGSL-----------EN---HLFRRNPSIQPLS 197
           + HP+++ L+        + LV++ M++G L           E     + R       L 
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR-----SLLE 211

Query: 198 WDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                         + FLH     +++RD K  NILLD
Sbjct: 212 -------------AVSFLH--ANNIVHRDLKPENILLD 234

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 62.4 bits (152), Expect = 6e-11
 Identities = 47/183 (25%), Positives = 71/183 (38%), Gaps = 31/183 (16%)

Query: 61  VEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKT 120
           ++ A P    L+   L+   F  LK          ++G G F  V         +   K 
Sbjct: 43  LQWAEPIVVRLKEVRLQRDDFEILK----------VIGRGAFSEVA--------VVKMK- 83

Query: 121 GLGMVVAIKKLNPESMQGFEE---WQSEVNFLGRLSHPNLVKLLGYCWEDKELL-LVYEY 176
             G V A+K +N   M    E   ++ E + L       + +L  + ++D+  L LV EY
Sbjct: 84  QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEY 142

Query: 177 MQRGSLENHLFRRNPSIQPLSWDIRLKIA-IGAARGLGFLHTSEKKVIYRDFKASNILLD 235
              G L   L +    I P     R  +A I  A  +  +H      ++RD K  NILLD
Sbjct: 143 YVGGDLLTLLSKFGERI-PAEM-ARFYLAEIVMA--IDSVH--RLGYVHRDIKPDNILLD 196

Query: 236 GVG 238
             G
Sbjct: 197 RCG 199

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 61.9 bits (151), Expect = 6e-11
 Identities = 37/154 (24%), Positives = 67/154 (43%), Gaps = 36/154 (23%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----EVNFLGR 151
           LLGEG +G+V +  +D +T            A+K L  + ++     ++    E+  L R
Sbjct: 12  LLGEGSYGKVKEV-LDSET--------LCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62

Query: 152 LSHPNLVKLLG--YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
           L H N+++L+   Y  E +++ +V EY   G  E  +    P           +  +  A
Sbjct: 63  LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVP---------EKRFPVCQA 111

Query: 210 R--------GLGFLHTSEKKVIYRDFKASNILLD 235
                    GL +LH   + ++++D K  N+LL 
Sbjct: 112 HGYFCQLIDGLEYLH--SQGIVHKDIKPGNLLLT 143

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 61.5 bits (150), Expect = 7e-11
 Identities = 36/173 (20%), Positives = 60/173 (34%), Gaps = 52/173 (30%)

Query: 85  KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW-- 142
           K+    +     LG G  G V     + KT           VAIK ++            
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLA-FERKT--------CKKVAIKIISKRKFAIGSAREA 56

Query: 143 ------QSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYM----------QRGSL-EN- 184
                 ++E+  L +L+HP ++K+  + ++ ++  +V E M              L E  
Sbjct: 57  DPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEAT 115

Query: 185 --HLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
               F      Q L               + +LH  E  +I+RD K  N+LL 
Sbjct: 116 CKLYFY-----QMLL-------------AVQYLH--ENGIIHRDLKPENVLLS 148

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 61.1 bits (149), Expect = 8e-11
 Identities = 36/150 (24%), Positives = 56/150 (37%), Gaps = 32/150 (21%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW-QSEVNFLGRLSH 154
            LGEG +G V    V+  T           VA+K ++ +      E  + E+     L+H
Sbjct: 14  TLGEGAYGEVQLA-VNRVT--------EEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR---- 210
            N+VK  G+  E     L  EY   G L + +               +      A+    
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----------GMPEP--DAQRFFH 112

Query: 211 ----GLGFLHTSEKKVIYRDFKASNILLDG 236
               G+ +LH     + +RD K  N+LLD 
Sbjct: 113 QLMAGVVYLHG--IGITHRDIKPENLLLDE 140

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 39/161 (24%), Positives = 64/161 (39%), Gaps = 21/161 (13%)

Query: 83  DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE- 141
            ++   ++F+   ++G G FG V         +   K     V A+K LN   M    E 
Sbjct: 68  QMRLHREDFEILKVIGRGAFGEVA--------VVKLK-NADKVFAMKILNKWEMLKRAET 118

Query: 142 --WQSEVNFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSW 198
             ++ E + L       +  L  Y ++D   L LV +Y   G L   L  +     P   
Sbjct: 119 ACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL-SKFEDRLPEEM 176

Query: 199 DIRLKIA-IGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
             R  +A +  A  +  +H  +   ++RD K  NIL+D  G
Sbjct: 177 -ARFYLAEMVIA--IDSVH--QLHYVHRDIKPDNILMDMNG 212

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 49/214 (22%), Positives = 85/214 (39%), Gaps = 21/214 (9%)

Query: 32  NKYGHTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNF 91
            +Y +       S    + +     ++ G    +P  +   T      +    +    +F
Sbjct: 284 GEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDF 343

Query: 92  KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS---EVNF 148
               +LG+G FG+V         L+  K G   + A+K L  + +   ++ +    E   
Sbjct: 344 NFLMVLGKGSFGKVM--------LSERK-GTDELYAVKILKKDVVIQDDDVECTMVEKRV 394

Query: 149 LGR-LSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
           L      P L +L   C++  + L  V EY+  G L  H+ +     +P +     +IAI
Sbjct: 395 LALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 453

Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           G    L FL    K +IYRD K  N++LD  G +
Sbjct: 454 G----LFFLQ--SKGIIYRDLKLDNVMLDSEGHI 481

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 37/150 (24%), Positives = 57/150 (38%), Gaps = 32/150 (21%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW-QSEVNFLGRLSH 154
            LGEG +G V    V+  T           VA+K ++ +      E  + E+     L+H
Sbjct: 14  TLGEGAYGEVQLA-VNRVT--------EEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR---- 210
            N+VK  G+  E     L  EY   G L + +             I +      A+    
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD----------IGMPEP--DAQRFFH 112

Query: 211 ----GLGFLHTSEKKVIYRDFKASNILLDG 236
               G+ +LH     + +RD K  N+LLD 
Sbjct: 113 QLMAGVVYLHG--IGITHRDIKPENLLLDE 140

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 60.6 bits (148), Expect = 2e-10
 Identities = 42/149 (28%), Positives = 71/149 (47%), Gaps = 20/149 (13%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRL 152
            LG G FGRV+        L  S+   G   A+K L  E    ++  E    E   L  +
Sbjct: 13  TLGTGSFGRVH--------LIRSRHN-GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63

Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA-IGAARG 211
           +HP ++++ G   + +++ ++ +Y++ G L + L +      P++   +   A +  A  
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA---KFYAAEVCLA-- 118

Query: 212 LGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           L +LH   K +IYRD K  NILLD  G +
Sbjct: 119 LEYLH--SKDIIYRDLKPENILLDKNGHI 145

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 38/148 (25%), Positives = 65/148 (43%), Gaps = 22/148 (14%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRL 152
            +G+G FG+V         +         + A+K +N +             E+  +  L
Sbjct: 22  AIGKGSFGKVC--------IVQKN-DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72

Query: 153 SHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA-IGAAR 210
            HP LV L  Y ++D+E + +V + +  G L  HL +     +     ++L I  +  A 
Sbjct: 73  EHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVKLFICELVMA- 127

Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGVG 238
            L +L    +++I+RD K  NILLD  G
Sbjct: 128 -LDYLQ--NQRIIHRDMKPDNILLDEHG 152

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 35/161 (21%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQS-- 144
             N+    L+G G +G VY    D  T           VAIKK+        FE+     
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLA-YDKNT--------EKNVAIKKVNRM-----FEDLIDCK 70

Query: 145 ----EVNFLGRLSHPNLVKLL-----GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP 195
               E+  L RL    +++L          +  EL +V E      L   LF+   +   
Sbjct: 71  RILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DL-KKLFK---TPIF 125

Query: 196 LSWDIRLK-IAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           L+ +  +K I      G  F+H S   +I+RD K +N LL+
Sbjct: 126 LT-EEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLN 163

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 60.6 bits (148), Expect = 2e-10
 Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 22/155 (14%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGL--GMVVAIKKLNPESMQGFEEWQ--SE 145
            F+   +LG+G FG+V+        L    +G     + A+K L   +++  +  +   E
Sbjct: 25  QFELLKVLGQGSFGKVF--------LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME 76

Query: 146 VNFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
            + L  ++HP +VKL  Y ++ +  L L+ ++++ G L   L +     +      +  +
Sbjct: 77  RDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV---KFYL 132

Query: 205 A-IGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
           A +  A  L  LH     +IYRD K  NILLD  G
Sbjct: 133 AELALA--LDHLH--SLGIIYRDLKPENILLDEEG 163

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 37/141 (26%), Positives = 62/141 (43%), Gaps = 18/141 (12%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-H 154
           +LGEG   RV    ++  T            A+K +  +          EV  L +   H
Sbjct: 20  VLGEGAHARVQTC-INLIT--------SQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-SIQPLSWDIRLKIAIGAARGLG 213
            N+++L+ +  E+    LV+E M+ GS+ +H+ +R   +    S  ++  +    A  L 
Sbjct: 71  RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ-DV----ASALD 125

Query: 214 FLHTSEKKVIYRDFKASNILL 234
           FLH   K + +RD K  NIL 
Sbjct: 126 FLH--NKGIAHRDLKPENILC 144

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 59.9 bits (146), Expect = 2e-10
 Identities = 36/153 (23%), Positives = 58/153 (37%), Gaps = 23/153 (15%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----KLNPESMQGFEEW 142
           + N+     LG+G F  V +  V   T        G+  A K     KL+    Q  E  
Sbjct: 5   SDNYDVKEELGKGAFSVVRRC-VHKTT--------GLEFAAKIINTKKLSARDFQKLE-- 53

Query: 143 QSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL 202
             E     +L HPN+V+L     E+    LV++ +  G  E  LF    + +  S     
Sbjct: 54  -REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG--E--LFEDIVAREFYSEADAS 108

Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                    + + H     +++R+ K  N+LL 
Sbjct: 109 HCIQQILESIAYCH--SNGIVHRNLKPENLLLA 139

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 59.9 bits (146), Expect = 3e-10
 Identities = 48/156 (30%), Positives = 66/156 (42%), Gaps = 22/156 (14%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS---EV 146
           +F    LLG+G FG+V         L   K   G   A+K L  E +   +E      E 
Sbjct: 6   DFDYLKLLGKGTFGKVI--------LVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTES 56

Query: 147 NFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
             L    HP L  L  Y ++  + L  V EY   G L  HL R     +  +   R   A
Sbjct: 57  RVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA---RFYGA 112

Query: 206 -IGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
            I +A  L +LH   + V+YRD K  N++LD  G +
Sbjct: 113 EIVSA--LEYLH--SRDVVYRDIKLENLMLDKDGHI 144

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 59.5 bits (145), Expect = 4e-10
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 26/158 (16%)

Query: 90  NFKPDSLLGEGGFGRVY---KGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEW--- 142
            F+   +LG+GG+G+V+   K    +          G + A+K L     ++  ++    
Sbjct: 18  CFELLRVLGKGGYGKVFQVRKVTGANT---------GKIFAMKVLKKAMIVRNAKDTAHT 68

Query: 143 QSEVNFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR 201
           ++E N L  + HP +V L+ Y ++    L L+ EY+  G L   L R    ++  +    
Sbjct: 69  KAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA---C 124

Query: 202 LKIA-IGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
             +A I  A  LG LH  +K +IYRD K  NI+L+  G
Sbjct: 125 FYLAEISMA--LGHLH--QKGIIYRDLKPENIMLNHQG 158

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 38/191 (19%), Positives = 65/191 (34%), Gaps = 32/191 (16%)

Query: 62  EEASPNGQILETPDLKVFSFLDLKSATKNFKPD----SLLGEGGFGRVYKGWVDDKTLAP 117
              S   + L    + +   + ++               LG G +G V     +      
Sbjct: 5   HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLC-KEKNG--- 60

Query: 118 SKTGLGMVVAIKKLN-------------PESMQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164
                    AIK +                  +  EE  +E++ L  L HPN++KL    
Sbjct: 61  -----HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115

Query: 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIY 224
            + K   LV E+ + G     LF +  +           I      G+ +LH  +  +++
Sbjct: 116 EDKKYFYLVTEFYEGGE----LFEQIINRHKFDECDAANIMKQILSGICYLH--KHNIVH 169

Query: 225 RDFKASNILLD 235
           RD K  NILL+
Sbjct: 170 RDIKPENILLE 180

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 58.8 bits (143), Expect = 4e-10
 Identities = 34/149 (22%), Positives = 59/149 (39%), Gaps = 12/149 (8%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW-QSEV 146
              F     LG G FG V+    +  +        G+   IK +N +  Q   E  ++E+
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLV-EERSS--------GLERVIKTINKDRSQVPMEQIEAEI 71

Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
             L  L HPN++K+     +   + +V E  + G L   +       + LS     ++  
Sbjct: 72  EVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131

Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLD 235
                L + H   + V+++D K  NIL  
Sbjct: 132 QMMNALAYFH--SQHVVHKDLKPENILFQ 158

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 59.6 bits (145), Expect = 5e-10
 Identities = 35/164 (21%), Positives = 61/164 (37%), Gaps = 45/164 (27%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSE 145
           + N+     LG+G F  V +  V   T        G+  A K +N + +    F++ + E
Sbjct: 28  SDNYDVKEELGKGAFSVVRRC-VHKTT--------GLEFAAKIINTKKLSARDFQKLERE 78

Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSL-----------EN---HLFRRNP 191
                +L HPN+V+L     E+    LV++ +  G L           E    H  +   
Sbjct: 79  ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ--- 135

Query: 192 SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
             Q L               + + H     +++R+ K  N+LL 
Sbjct: 136 --QILE-------------SIAYCH--SNGIVHRNLKPENLLLA 162

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 59.6 bits (145), Expect = 5e-10
 Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 33/159 (20%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--- 144
              +   S +GEG +G V     D+           + VAIKK++P     FE       
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSA-YDNLN--------KVRVAIKKISP-----FEHQTYCQR 71

Query: 145 ---EVNFLGRLSHPNLVKLL-----GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPL 196
              E+  L R  H N++ +          + K++ +V + M   +    L +     Q L
Sbjct: 72  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLK----TQHL 125

Query: 197 SWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           S D          RGL ++H++   V++RD K SN+LL+
Sbjct: 126 SNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN 162

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 59.2 bits (144), Expect = 6e-10
 Identities = 53/218 (24%), Positives = 89/218 (40%), Gaps = 32/218 (14%)

Query: 30  AYNKYGHTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATK 89
           A++ + H  E  ++  +AG S       E  +           T   +       K   +
Sbjct: 2   AHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAE-------KVGIE 54

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTG--LGMVVAIKKLNPESMQGFEEW----Q 143
           NF+   +LG G +G+V+        L    +G   G + A+K L   ++    +     +
Sbjct: 55  NFELLKVLGTGAYGKVF--------LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 106

Query: 144 SEVNFLGRLSH-PNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR 201
           +E   L  +   P LV L  Y ++ +  L L+ +Y+  G L  HL +R    +      +
Sbjct: 107 TERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV---Q 162

Query: 202 LKIA-IGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
           + +  I  A  L  LH  +  +IYRD K  NILLD  G
Sbjct: 163 IYVGEIVLA--LEHLH--KLGIIYRDIKLENILLDSNG 196

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 58.4 bits (142), Expect = 7e-10
 Identities = 37/155 (23%), Positives = 61/155 (39%), Gaps = 42/155 (27%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----KLNPESMQGFEEWQSEVNFLG 150
            LG G FG+V  G     T        G  VA+K     K+    +    + + E+  L 
Sbjct: 18  TLGVGTFGKVKIG-EHQLT--------GHKVAVKILNRQKIRSLDVV--GKIKREIQNLK 66

Query: 151 RLSHPNLVKLLGY-CWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
              HP+++KL  Y       +  +V EY+  G L +++ +            R++     
Sbjct: 67  LFRHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHG----------RVEEM--E 112

Query: 209 AR--------GLGFLHTSEKKVIYRDFKASNILLD 235
           AR         + + H     V++RD K  N+LLD
Sbjct: 113 ARRLFQQILSAVDYCH--RHMVVHRDLKPENVLLD 145

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 59.3 bits (144), Expect = 7e-10
 Identities = 41/168 (24%), Positives = 66/168 (39%), Gaps = 37/168 (22%)

Query: 83  DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE- 141
           DL+   ++++   ++G G FG V         L   K+    V A+K L+   M    + 
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQ--------LVRHKST-RKVYAMKLLSKFEMIKRSDS 113

Query: 142 --WQSEVNFLGRLSHPNLVKLLGYCWEDKELL-LVYEYMQRGSLENHLFRRNPSIQPLSW 198
             +  E + +   + P +V+L  Y ++D   L +V EYM  G L N +            
Sbjct: 114 AFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNY--------- 163

Query: 199 DIRLKIAIGAAR--------GLGFLHTSEKKVIYRDFKASNILLDGVG 238
                +    AR         L  +H      I+RD K  N+LLD  G
Sbjct: 164 ----DVPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSG 205

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 58.4 bits (142), Expect = 8e-10
 Identities = 33/161 (20%), Positives = 55/161 (34%), Gaps = 43/161 (26%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
            K F    +LG G F  V+       T        G + A+K +           ++E+ 
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLV-KQRLT--------GKLFALKCIKKSPAFRDSSLENEIA 58

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYM----------QRGSL-EN---HLFRRNPSI 193
            L ++ H N+V L           LV + +          +RG   E     + +     
Sbjct: 59  VLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ----- 113

Query: 194 QPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           Q LS              + +LH  E  +++RD K  N+L 
Sbjct: 114 QVLS-------------AVKYLH--ENGIVHRDLKPENLLY 139

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 58.5 bits (142), Expect = 9e-10
 Identities = 40/145 (27%), Positives = 64/145 (44%), Gaps = 23/145 (15%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----KLNPESMQGFEEWQSEVNFLGR 151
           +G+G F +V        T        G  VAIK     +LNP S+   ++   EV  +  
Sbjct: 23  IGKGNFAKVKLA-RHILT--------GREVAIKIIDKTQLNPTSL---QKLFREVRIMKI 70

Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           L+HPN+VKL      +K L L+ EY   G + ++L         +               
Sbjct: 71  LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSA 126

Query: 212 LGFLHTSEKKVIYRDFKASNILLDG 236
           + + H  +K++++RD KA N+LLD 
Sbjct: 127 VQYCH--QKRIVHRDLKAENLLLDA 149

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 37/153 (24%), Positives = 62/153 (40%), Gaps = 38/153 (24%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----KLNPESMQGFEEWQSEVNFLG 150
            LG G FG+V  G   + T        G  VA+K     K+    +    + + E+  L 
Sbjct: 23  TLGVGTFGKVKVG-KHELT--------GHKVAVKILNRQKIRSLDVV--GKIRREIQNLK 71

Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
              HP+++KL        ++ +V EY+  G L +++ +            RL      +R
Sbjct: 72  LFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG----------RLDEK--ESR 119

Query: 211 --------GLGFLHTSEKKVIYRDFKASNILLD 235
                   G+ + H     V++RD K  N+LLD
Sbjct: 120 RLFQQILSGVDYCH--RHMVVHRDLKPENVLLD 150

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 38/157 (24%), Positives = 61/157 (38%), Gaps = 29/157 (18%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN------PESMQGFEE 141
              +     LG G F  V K   +  T        G+  A K +              EE
Sbjct: 11  EDFYDIGEELGSGQFAIVKKC-REKST--------GLEYAAKFIKKRQSRASRRGVCREE 61

Query: 142 WQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR 201
            + EV+ L ++ HPN++ L        +++L+ E +  G  E  LF      + LS    
Sbjct: 62  IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGG--E--LFDFLAQKESLSE--- 114

Query: 202 LKIAIGAAR----GLGFLHTSEKKVIYRDFKASNILL 234
            + A    +    G+ +LH   KK+ + D K  NI+L
Sbjct: 115 -EEATSFIKQILDGVNYLH--TKKIAHFDLKPENIML 148

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 41/198 (20%), Positives = 71/198 (35%), Gaps = 24/198 (12%)

Query: 48  GKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYK 107
           G S      S   V   S      +    K+    + +     ++   LLG GGFG VY 
Sbjct: 2   GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYS 61

Query: 108 GWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS------EVNFLGRLSH--PNLVK 159
           G +             + VAIK +  + +  + E  +      EV  L ++S     +++
Sbjct: 62  G-IRVSD--------NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112

Query: 160 LLGYCWEDKELLLVYEYMQ-RGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS 218
           LL +       +L+ E  +    L + +  R      L  ++           +   H  
Sbjct: 113 LLDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHN- 167

Query: 219 EKKVIYRDFKASNILLDG 236
              V++RD K  NIL+D 
Sbjct: 168 -CGVLHRDIKDENILIDL 184

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 34/148 (22%), Positives = 58/148 (39%), Gaps = 29/148 (19%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK------KLNPESMQGFEEWQSEVNFLG 150
           LG G F  V K   +  T        G+  A K        +       E+ + EV+ L 
Sbjct: 19  LGSGQFAVVKKC-REKST--------GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
            + HPN++ L        +++L+ E +  G  E  LF      + L+     + A    +
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGG--E--LFDFLAEKESLTE----EEATEFLK 121

Query: 211 ----GLGFLHTSEKKVIYRDFKASNILL 234
               G+ +LH    ++ + D K  NI+L
Sbjct: 122 QILNGVYYLH--SLQIAHFDLKPENIML 147

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 36/170 (21%), Positives = 64/170 (37%), Gaps = 30/170 (17%)

Query: 72  ETPDLKVFSFLDLKSA--TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK 129
                 +   L   S   T  ++    +G G +    +  +   T         M  A+K
Sbjct: 3   TVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRC-IHKAT--------NMEFAVK 53

Query: 130 KLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR 188
            ++       EE    +  L R   HPN++ L     + K + +V E M+ G L + + R
Sbjct: 54  IIDKSKRDPTEE----IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR 109

Query: 189 RNPSIQPLS----WDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           +    +  S      +   I     + + +LH   + V++RD K SNIL 
Sbjct: 110 Q----KFFSEREASAVLFTI----TKTVEYLH--AQGVVHRDLKPSNILY 149

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 56.9 bits (138), Expect = 2e-09
 Identities = 37/157 (23%), Positives = 59/157 (37%), Gaps = 29/157 (18%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK------KLNPESMQGFEE 141
              +     LG G F  V K   +  T        G+  A K                EE
Sbjct: 11  EDFYDIGEELGSGQFAIVKKC-REKST--------GLEYAAKFIKKRQSRASRRGVSREE 61

Query: 142 WQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR 201
            + EV+ L ++ H N++ L        +++L+ E +  G  E  LF      + LS    
Sbjct: 62  IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGG--E--LFDFLAQKESLSE--- 114

Query: 202 LKIAIGAAR----GLGFLHTSEKKVIYRDFKASNILL 234
            + A    +    G+ +LH   KK+ + D K  NI+L
Sbjct: 115 -EEATSFIKQILDGVNYLH--TKKIAHFDLKPENIML 148

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 34/160 (21%), Positives = 60/160 (37%), Gaps = 34/160 (21%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--- 144
            K ++    +G G  G V     D              VAIKKL     + F+       
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAA-YDAVL--------DRNVAIKKL----SRPFQNQTHAKR 107

Query: 145 ---EVNFLGRLSHPNLVKLL------GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP 195
              E+  +  ++H N++ LL          E +++ LV E M   +    + +       
Sbjct: 108 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQ-----ME 160

Query: 196 LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           L  +    +      G+  LH++   +I+RD K SNI++ 
Sbjct: 161 LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK 198

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 56.8 bits (138), Expect = 3e-09
 Identities = 44/150 (29%), Positives = 64/150 (42%), Gaps = 21/150 (14%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW---QSEVNFLGR- 151
           +LG+G FG+V+        LA  K       AIK L  + +   ++      E   L   
Sbjct: 24  MLGKGSFGKVF--------LAEFK-KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 74

Query: 152 LSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
             HP L  +    ++ KE L  V EY+  G L  H+   +      +     +I +    
Sbjct: 75  WEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL---- 129

Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           GL FLH   K ++YRD K  NILLD  G +
Sbjct: 130 GLQFLH--SKGIVYRDLKLDNILLDKDGHI 157

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 56.5 bits (137), Expect = 4e-09
 Identities = 41/158 (25%), Positives = 66/158 (41%), Gaps = 25/158 (15%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK--------KLNPESMQGF 139
            +N++P  +LG G    V +  +   T            A+K          + E +Q  
Sbjct: 16  YENYEPKEILGRGVSSVVRRC-IHKPT--------CKEYAVKIIDVTGGGSFSAEEVQEL 66

Query: 140 EE-WQSEVNFLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLS 197
            E    EV+ L ++S HPN+++L      +    LV++ M++G  E  LF        LS
Sbjct: 67  REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG--E--LFDYLTEKVTLS 122

Query: 198 WDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                KI       +  LH  +  +++RD K  NILLD
Sbjct: 123 EKETRKIMRALLEVICALH--KLNIVHRDLKPENILLD 158

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 56.5 bits (137), Expect = 4e-09
 Identities = 35/159 (22%), Positives = 60/159 (37%), Gaps = 26/159 (16%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN------PESMQGFEEW 142
             ++   LLG+GGFG V+ G               + VAIK +          +      
Sbjct: 31  AEYRLGPLLGKGGFGTVFAG-HRLTD--------RLQVAIKVIPRNRVLGWSPLSDSVTC 81

Query: 143 QSEVNFLGRLS----HPNLVKLLGYCWEDKELLLVYEYMQRGS-LENHLFRRNPSIQPLS 197
             EV  L ++     HP +++LL +    +  +LV E       L +++  +     PL 
Sbjct: 82  PLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK----GPLG 137

Query: 198 WDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
                         +   H+  + V++RD K  NIL+D 
Sbjct: 138 EGPSRCFFGQVVAAIQHCHS--RGVVHRDIKDENILIDL 174

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 56.0 bits (136), Expect = 4e-09
 Identities = 37/148 (25%), Positives = 56/148 (37%), Gaps = 29/148 (19%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK------KLNPESMQGFEEWQSEVNFLG 150
           LG G F  V K      T        G   A K        +       EE + EVN L 
Sbjct: 13  LGSGQFAIVRKC-RQKGT--------GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
            + HPN++ L        +++L+ E +  G  E  LF      + L+       A    +
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGG--E--LFDFLAEKESLTE----DEATQFLK 115

Query: 211 ----GLGFLHTSEKKVIYRDFKASNILL 234
               G+ +LH   K++ + D K  NI+L
Sbjct: 116 QILDGVHYLH--SKRIAHFDLKPENIML 141

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 56.5 bits (137), Expect = 5e-09
 Identities = 33/162 (20%), Positives = 58/162 (35%), Gaps = 43/162 (26%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE--WQSE 145
           T+ ++    LG+G F  V +  V            G   A   +N + +   +    + E
Sbjct: 10  TEEYQLFEELGKGAFSVVRRC-VKVLA--------GQEYAAMIINTKKLSARDHQKLERE 60

Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
                 L HPN+V+L     E+    L+++ +  G  E  LF     I          +A
Sbjct: 61  ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG--E--LFED---I----------VA 103

Query: 206 IG------AAR-------GLGFLHTSEKKVIYRDFKASNILL 234
                   A+         +   H  +  V++R+ K  N+LL
Sbjct: 104 REYYSEADASHCIQQILEAVLHCH--QMGVVHRNLKPENLLL 143

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 55.7 bits (133), Expect = 7e-09
 Identities = 36/254 (14%), Positives = 63/254 (24%), Gaps = 60/254 (23%)

Query: 77  KVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL----- 131
               F      T+  +    +GEG FG V++   D              VAIK +     
Sbjct: 9   GPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIADHTP-----------VAIKIIAIEGP 56

Query: 132 ---NPESMQGFEEWQSEVNFLGRL---------SHPNLVKLLG-YCWEDK---ELLLVYE 175
              N    + FEE   E+     L              + L   +C +      LL  ++
Sbjct: 57  DLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWD 116

Query: 176 YMQ--RGSLENHLFRRNPS-------------------IQPLSWDIRLKIAIGAARGLGF 214
           +    +GS  +                            +  S      I       L  
Sbjct: 117 HYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAV 176

Query: 215 LHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIY 274
                 +  +RD    N+LL            ++         I      + I  Y    
Sbjct: 177 AEA-SLRFEHRDLHWGNVLLKKTSLKK-----LHYTLNGKSSTIPSCGLQVSIIDYTLSR 230

Query: 275 MYIYKCLRYAILYS 288
           +     + +  +  
Sbjct: 231 LERDGIVVFCDVSM 244

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 55.8 bits (135), Expect = 7e-09
 Identities = 35/149 (23%), Positives = 51/149 (34%), Gaps = 32/149 (21%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
            +G G FG       D  T          +VA+K +   +    E  Q E+     L HP
Sbjct: 27  DIGSGNFGVARLM-RDKLT--------KELVAVKYIERGAAID-ENVQREIINHRSLRHP 76

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR----- 210
           N+V+          L ++ EY   G L   +              R       AR     
Sbjct: 77  NIVRFKEVILTPTHLAIIMEYASGGELYERICNAG----------RFSED--EARFFFQQ 124

Query: 211 ---GLGFLHTSEKKVIYRDFKASNILLDG 236
              G+ + H    ++ +RD K  N LLDG
Sbjct: 125 LLSGVSYCH--SMQICHRDLKLENTLLDG 151

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 55.7 bits (135), Expect = 8e-09
 Identities = 51/165 (30%), Positives = 78/165 (47%), Gaps = 28/165 (16%)

Query: 85  KSATKNFKPD-----SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF 139
            S+  + KP       ++G+G FG+V         LA  K    +  A+K L  +++   
Sbjct: 29  PSSNPHAKPSDFHFLKVIGKGSFGKVL--------LARHK-AEEVFYAVKVLQKKAILKK 79

Query: 140 EEW---QSEVNFLGR-LSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQ 194
           +E     SE N L + + HP LV L  + ++  + L  V +Y+  G L  HL R    ++
Sbjct: 80  KEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLE 138

Query: 195 PLSWDIRLKIA-IGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
           P +   R   A I +A  LG+LH     ++YRD K  NILLD  G
Sbjct: 139 PRA---RFYAAEIASA--LGYLH--SLNIVYRDLKPENILLDSQG 176

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 55.4 bits (134), Expect = 9e-09
 Identities = 38/164 (23%), Positives = 65/164 (39%), Gaps = 42/164 (25%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQS-- 144
            K +   + +G G +G V    +D ++        G  VAIKKL  P     F+      
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSA-IDKRS--------GEKVAIKKLSRP-----FQSEIFAK 68

Query: 145 ----EVNFLGRLSHPNLVKLL------GYCWEDKELLLVYEYMQRGSLENHLFRRNPS-- 192
               E+  L  + H N++ LL             +  LV  +MQ   L   +     S  
Sbjct: 69  RAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DL-QKIMGLKFSEE 126

Query: 193 -IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
            IQ L + +         +GL ++H++   V++RD K  N+ ++
Sbjct: 127 KIQYLVYQM--------LKGLKYIHSAG--VVHRDLKPGNLAVN 160

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 55.3 bits (134), Expect = 1e-08
 Identities = 44/151 (29%), Positives = 67/151 (44%), Gaps = 23/151 (15%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW---QSEVNFLGR- 151
           +LG+G FG+V         L+  K G   + A+K L  + +   ++      E   L   
Sbjct: 27  VLGKGSFGKVM--------LSERK-GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 77

Query: 152 LSHPNLVKLLGYCW--EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
              P L +L   C+   D+ L  V EY+  G L  H+ +     +P +     +IAIG  
Sbjct: 78  GKPPFLTQLH-SCFQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG-- 133

Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
             L FL    K +IYRD K  N++LD  G +
Sbjct: 134 --LFFLQ--SKGIIYRDLKLDNVMLDSEGHI 160

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 55.3 bits (134), Expect = 1e-08
 Identities = 23/142 (16%), Positives = 50/142 (35%), Gaps = 23/142 (16%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           LG G FG V++  V+  +              K +  +        + E++ L    H N
Sbjct: 13  LGRGEFGIVHRC-VETSS--------KKTYMAKFVKVKGTD-QVLVKKEISILNIARHRN 62

Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR----GL 212
           ++ L       +EL++++E++    +   +      +         +  +         L
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNE-------REIVSYVHQVCEAL 115

Query: 213 GFLHTSEKKVIYRDFKASNILL 234
            FLH     + + D +  NI+ 
Sbjct: 116 QFLH--SHNIGHFDIRPENIIY 135

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 36/171 (21%), Positives = 61/171 (35%), Gaps = 52/171 (30%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----KLNPESM---QGFE 140
           + +   S LG G FG V+   VD +            V +K     K+  +         
Sbjct: 24  QKYSTMSPLGSGAFGFVWTA-VDKEK--------NKEVVVKFIKKEKVLEDCWIEDPKLG 74

Query: 141 EWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEY-----------MQRGSLE----NH 185
           +   E+  L R+ H N++K+L          LV E             +   L+    ++
Sbjct: 75  KVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134

Query: 186 LFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
           +FR     Q +S              +G+L    K +I+RD K  NI++  
Sbjct: 135 IFR-----QLVS-------------AVGYLRL--KDIIHRDIKDENIVIAE 165

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 54.6 bits (132), Expect = 1e-08
 Identities = 39/168 (23%), Positives = 66/168 (39%), Gaps = 43/168 (25%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--- 144
              +     LG GG G V+   VD+             VAIKK+         + QS   
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSA-VDNDC--------DKRVAIKKIV------LTDPQSVKH 54

Query: 145 ---EVNFLGRLSHPNLVKLL--------------GYCWEDKELLLVYEYMQRGSLENHLF 187
              E+  + RL H N+VK+               G   E   + +V EYM+  +   ++ 
Sbjct: 55  ALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME--TDLANVL 112

Query: 188 RRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
            +     PL  +          RGL ++H++   V++RD K +N+ ++
Sbjct: 113 EQ----GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFIN 154

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 37/175 (21%), Positives = 55/175 (31%), Gaps = 54/175 (30%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-----PESMQGFEEW 142
              +     +  G +G V      D          G+ VAIK++        ++    + 
Sbjct: 21  QSPYTVQRFISSGSYGAVCA--GVDSE--------GIPVAIKRVFNTVSDGRTVNILSDS 70

Query: 143 QS------EVNFLGRLSHPNLVKLL-----GYCWEDKELLLVYEYM----------QRGS 181
                   E+  L    HPN++ L             +L LV E M          QR  
Sbjct: 71  FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV 130

Query: 182 LEN-HLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           +   H       IQ   + I          GL  LH +   V++RD    NILL 
Sbjct: 131 ISPQH-------IQYFMYHI--------LLGLHVLHEAG--VVHRDLHPGNILLA 168

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 37/187 (19%), Positives = 68/187 (36%), Gaps = 56/187 (29%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
           +K +     LG G FG V +   D ++        G   A+KK+  +          E++
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEV-FDIES--------GKRFALKKVLQDPRYKNR----ELD 52

Query: 148 FLGRLSHPNLVKLLGY--------------------------------------CWEDKE 169
            +  L H N++KL+ Y                                        ++K 
Sbjct: 53  IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY 112

Query: 170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI-GAARGLGFLHTSEKKVIYRDFK 228
           L ++ EY+   +L   L     S + +     + I I    R +GF+H+    + +RD K
Sbjct: 113 LNVIMEYVP-DTLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHS--LGICHRDIK 168

Query: 229 ASNILLD 235
             N+L++
Sbjct: 169 PQNLLVN 175

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 53.4 bits (129), Expect = 3e-08
 Identities = 32/158 (20%), Positives = 63/158 (39%), Gaps = 38/158 (24%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
             +++    LG G +  V++   +              V +K L P   +   + + E+ 
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAI-NITN--------NEKVVVKILKPVKKK---KIKREIK 82

Query: 148 FLGRLS-HPNLVKLLGYCW--EDKELLLVYEYMQRGSLENHLFRRNPSIQPLS-WDIR-- 201
            L  L   PN++ L         +   LV+E+     + N  F++    Q L+ +DIR  
Sbjct: 83  ILENLRGGPNIITLADIVKDPVSRTPALVFEH-----VNNTDFKQ--LYQTLTDYDIRFY 135

Query: 202 ----LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
               L       + L + H+    +++RD K  N+++D
Sbjct: 136 MYEIL-------KALDYCHS--MGIMHRDVKPHNVMID 164

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 53.8 bits (130), Expect = 3e-08
 Identities = 46/152 (30%), Positives = 70/152 (46%), Gaps = 25/152 (16%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW---QSEVNFLGR- 151
           +LG+G FG+V         LA  K   G + A+K L  + +   ++     +E   L   
Sbjct: 30  VLGKGSFGKVM--------LARVK-ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80

Query: 152 LSHPNLVKLLGYCW--EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA-IGA 208
            +HP L +L   C+   D+ L  V E++  G L  H+ +     +  +   R   A I +
Sbjct: 81  RNHPFLTQLF-CCFQTPDR-LFFVMEFVNGGDLMFHIQKSRRFDEARA---RFYAAEIIS 135

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           A  L FLH  +K +IYRD K  N+LLD  G  
Sbjct: 136 A--LMFLH--DKGIIYRDLKLDNVLLDHEGHC 163

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 42/151 (27%), Positives = 69/151 (45%), Gaps = 23/151 (15%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW---QSEVNFLGR- 151
           ++G G + +V         L   K     + A++ +  E +   E+    Q+E +   + 
Sbjct: 59  VIGRGSYAKVL--------LVRLK-KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA 109

Query: 152 LSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA-IGAA 209
            +HP LV L   C++ +  L  V EY+  G L  H+ R+    +  +   R   A I  A
Sbjct: 110 SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA---RFYSAEISLA 165

Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
             L +LH  E+ +IYRD K  N+LLD  G +
Sbjct: 166 --LNYLH--ERGIIYRDLKLDNVLLDSEGHI 192

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 53.3 bits (128), Expect = 4e-08
 Identities = 27/161 (16%), Positives = 56/161 (34%), Gaps = 11/161 (6%)

Query: 80  SFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF 139
             L  +   +  K  + L   G  R +  W++       +    + +  +  +       
Sbjct: 44  RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPS 103

Query: 140 EEWQS--EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP-- 195
                  ++  +   S  N V  L        L +  +  ++ +L++ + RR        
Sbjct: 104 PMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163

Query: 196 -LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
            +   I ++IA      + FLH   K +++RD K SNI   
Sbjct: 164 GVCLHIFIQIA----EAVEFLH--SKGLMHRDLKPSNIFFT 198

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 46.4 bits (110), Expect = 6e-06
 Identities = 28/119 (23%), Positives = 44/119 (36%), Gaps = 11/119 (9%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVN 147
            +F+P   +G GGFG V++    +K             AIK++  P      E+   EV 
Sbjct: 6   TDFEPIQCMGRGGFGVVFE--AKNKV-------DDCNYAIKRIRLPNRELAREKVMREVK 56

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
            L +L HP +V+     W +       E M    L++       S         +KI  
Sbjct: 57  ALAKLEHPGIVRYFN-AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR 114

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 53.4 bits (129), Expect = 4e-08
 Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 23/151 (15%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW---QSEVNFLGR- 151
           ++G G + +V         L   K     + A+K +  E +   E+    Q+E +   + 
Sbjct: 16  VIGRGSYAKVL--------LVRLK-KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 66

Query: 152 LSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA-IGAA 209
            +HP LV L   C++ +  L  V EY+  G L  H+ R+    +  +   R   A I  A
Sbjct: 67  SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA---RFYSAEISLA 122

Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
             L +LH  E+ +IYRD K  N+LLD  G +
Sbjct: 123 --LNYLH--ERGIIYRDLKLDNVLLDSEGHI 149

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 53.4 bits (129), Expect = 4e-08
 Identities = 32/139 (23%), Positives = 54/139 (38%), Gaps = 19/139 (13%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HP 155
           LGEG F    K  V  K+            A+K ++       ++   E+  L     HP
Sbjct: 19  LGEGSFSICRKC-VHKKS--------NQAFAVKIISKRMEANTQK---EITALKLCEGHP 66

Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
           N+VKL     +     LV E +  G L   + ++    +  +  I  K+       +  +
Sbjct: 67  NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL----VSAVSHM 122

Query: 216 HTSEKKVIYRDFKASNILL 234
           H  +  V++RD K  N+L 
Sbjct: 123 H--DVGVVHRDLKPENLLF 139

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 37/153 (24%), Positives = 61/153 (39%), Gaps = 39/153 (25%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----KLNPESMQGFEEWQSEVNFLG 150
            LGEG FG+V       KT           VA+K      L    M      + E+++L 
Sbjct: 16  TLGEGSFGKVKLA-THYKT--------QQKVALKFISRQLLKKSDMH--MRVEREISYLK 64

Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
            L HP+++KL        ++++V EY   G L +++  +           R+       R
Sbjct: 65  LLRHPHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKK----------RMTED--EGR 111

Query: 211 --------GLGFLHTSEKKVIYRDFKASNILLD 235
                    + + H    K+++RD K  N+LLD
Sbjct: 112 RFFQQIICAIEYCHR--HKIVHRDLKPENLLLD 142

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 53.2 bits (128), Expect = 5e-08
 Identities = 41/159 (25%), Positives = 75/159 (47%), Gaps = 34/159 (21%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQS-- 144
            + ++    LG+G +G V+K  +D +T        G VVA+KK+ +      F+      
Sbjct: 8   LRKYELVKKLGKGAYGIVWKS-IDRRT--------GEVVAVKKIFDA-----FQNSTDAQ 53

Query: 145 ----EVNFLGRLS-HPNLVKLLG--YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLS 197
               E+  L  LS H N+V LL       D+++ LV++YM+  +  + + R       L 
Sbjct: 54  RTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME--TDLHAVIRA----NILE 107

Query: 198 WDIRLK-IAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
             +  + +     + + +LH+    +++RD K SNILL+
Sbjct: 108 -PVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLN 143

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 53.0 bits (128), Expect = 6e-08
 Identities = 29/151 (19%), Positives = 49/151 (32%), Gaps = 34/151 (22%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----KLNPESMQGFEEWQSEVNFLGR 151
           LG G F  V +  +   T        G   A K     +   +      E   E+  L  
Sbjct: 37  LGRGKFAVVRQC-ISKST--------GQEYAAKFLKKRRRGQDCR---AEILHEIAVLEL 84

Query: 152 LSH-PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL--KIAIGA 208
               P ++ L        E++L+ EY   G + +                 +     I  
Sbjct: 85  AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE--------MVSENDVIRL 136

Query: 209 AR----GLGFLHTSEKKVIYRDFKASNILLD 235
            +    G+ +LH  +  +++ D K  NILL 
Sbjct: 137 IKQILEGVYYLH--QNNIVHLDLKPQNILLS 165

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 52.7 bits (127), Expect = 7e-08
 Identities = 47/219 (21%), Positives = 79/219 (36%), Gaps = 54/219 (24%)

Query: 31  YNKYGHTMEISATSSSAGKSQFS--QAISEAGVEEASPNGQILETPDLKVFSFLDLKSAT 88
           ++ + H+  +   + +      S   A +  G     P+  I  +    +         +
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDAL---------S 52

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
             F+ +S LG G    VY+      T            A+K L     +  +  ++E+  
Sbjct: 53  DFFEVESELGRGATSIVYRC-KQKGT--------QKPYALKVLKKTVDK--KIVRTEIGV 101

Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG- 207
           L RLSHPN++KL        E+ LV E +  G     LF R   I          +  G 
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGE----LFDR---I----------VEKGY 144

Query: 208 -----AAR-------GLGFLHTSEKKVIYRDFKASNILL 234
                AA         + +LH  E  +++RD K  N+L 
Sbjct: 145 YSERDAADAVKQILEAVAYLH--ENGIVHRDLKPENLLY 181

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 52.3 bits (126), Expect = 9e-08
 Identities = 36/161 (22%), Positives = 61/161 (37%), Gaps = 35/161 (21%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQS-- 144
              ++    +G G +G V    VD +T        G  VAIKKL  P     F+      
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSA-VDGRT--------GAKVAIKKLYRP-----FQSELFAK 69

Query: 145 ----EVNFLGRLSHPNLVKLL------GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQ 194
               E+  L  + H N++ LL          +  +  LV  +M    L   +       +
Sbjct: 70  RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM-----KHE 123

Query: 195 PLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
            L  D    +     +GL ++H +   +I+RD K  N+ ++
Sbjct: 124 KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN 162

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 37/163 (22%), Positives = 61/163 (37%), Gaps = 27/163 (16%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
           + +K  S       G +Y+      TL           ++ KL+ +  + F    +E NF
Sbjct: 42  RQWKLKSFQTRDNQGILYEA-APTSTLTCDSGPQKQKFSL-KLDAKDGRLF----NEQNF 95

Query: 149 LGRLSHPNLV---------------KLLGY-CWEDKELLLVYEYMQRGSLENHLFRRNPS 192
             R + P  V                 +G+   +DK   LV   + R SL+      +P 
Sbjct: 96  FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQ-SALDVSPK 153

Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
              LS    L++A      L FLH  E + ++ +  A NI +D
Sbjct: 154 -HVLSERSVLQVACRLLDALEFLH--ENEYVHGNVTAENIFVD 193

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 51.5 bits (124), Expect = 1e-07
 Identities = 38/173 (21%), Positives = 68/173 (39%), Gaps = 48/173 (27%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----------- 144
            +G+G +G V     ++              A+K L+ + +     +             
Sbjct: 20  EIGKGSYGVVKLA-YNEND--------NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70

Query: 145 ---------------EVNFLGRLSHPNLVKLLGYC-WED---KELLLVYEYMQRGSLENH 185
                          E+  L +L HPN+VKL      +D     L +V+E + +G +   
Sbjct: 71  GGCIQPRGPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPV--- 125

Query: 186 LFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
                P+++PLS D          +G+ +LH   +K+I+RD K SN+L+   G
Sbjct: 126 -MEV-PTLKPLSEDQARFYFQDLIKGIEYLH--YQKIIHRDIKPSNLLVGEDG 174

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 35/161 (21%), Positives = 62/161 (38%), Gaps = 36/161 (22%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--- 144
            K ++    +G G  G V     D              VAIKKL     + F+       
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAA-YDAIL--------ERNVAIKKL----SRPFQNQTHAKR 70

Query: 145 ---EVNFLGRLSHPNLVKLL------GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP 195
              E+  +  ++H N++ LL          E +++ +V E M   +L   + +       
Sbjct: 71  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANL-CQVIQ-----ME 123

Query: 196 LSWDIRLK-IAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           L    R+  +      G+  LH++   +I+RD K SNI++ 
Sbjct: 124 LD-HERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK 161

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 40/160 (25%), Positives = 69/160 (43%), Gaps = 33/160 (20%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--- 144
            + ++  S +G G +G V   + D KT        G+ VA+KKL     + F+       
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAF-DTKT--------GLRVAVKKL----SRPFQSIIHAKR 74

Query: 145 ---EVNFLGRLSHPNLVKLL------GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP 195
              E+  L  + H N++ LL          E  ++ LV   M    L N +       Q 
Sbjct: 75  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV-----KCQK 128

Query: 196 LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
           L+ D    +     RGL ++H+++  +I+RD K SN+ ++
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN 166

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 41/221 (18%), Positives = 77/221 (34%), Gaps = 48/221 (21%)

Query: 32  NKYGHTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNF 91
           N  G +  +   + +      + A+     +   P  Q      +K    +   +   ++
Sbjct: 4   NSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDY 63

Query: 92  KPDS-LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLG 150
           K  S +LG G  G+V +   + +T            A+K      +Q   + + EV    
Sbjct: 64  KVTSQVLGLGINGKVLQI-FNKRT--------QEKFALK-----MLQDCPKARREVELHW 109

Query: 151 RLS-HPNLVKLLGYC----WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
           R S  P++V+++          K LL+V E +  G     LF R          I+ +  
Sbjct: 110 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE----LFSR----------IQDRGD 155

Query: 206 IG-----AAR-------GLGFLHTSEKKVIYRDFKASNILL 234
                  A+         + +LH     + +RD K  N+L 
Sbjct: 156 QAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLY 194

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 40/187 (21%), Positives = 67/187 (35%), Gaps = 52/187 (27%)

Query: 65  SPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGM 124
           S    + + P+ K ++  D    +K      +LG G  G+V +     +T        G 
Sbjct: 10  SGLEVLFQGPEPKKYAVTDDYQLSKQ-----VLGLGVNGKVLEC-FHRRT--------GQ 55

Query: 125 VVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYC----WEDKELLLVYEYMQR 179
             A+K L           + EV+   + S  P++V +L          + LL++ E M+ 
Sbjct: 56  KCALKLLYDSPKA-----RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110

Query: 180 GSLENHLFRRNPSIQPLSWDIRLKIAIG-----AAR-------GLGFLHTSEKKVIYRDF 227
           G L    F R          I+ +         AA         + FLH     + +RD 
Sbjct: 111 GEL----FSR----------IQERGDQAFTEREAAEIMRDIGTAIQFLH--SHNIAHRDV 154

Query: 228 KASNILL 234
           K  N+L 
Sbjct: 155 KPENLLY 161

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 38/202 (18%), Positives = 73/202 (36%), Gaps = 35/202 (17%)

Query: 53  SQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDD 112
           S  +  A     S   + L      V   +   +A   +K    +G+GGFG +Y   ++ 
Sbjct: 1   SMRVKAAQAGRQSSAKRHLAEQ-FAVGEIITDMAAAA-WKVGLPIGQGGFGCIYLADMNS 58

Query: 113 KTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLV-------------- 158
                   G      +K    ++   F    +E+ F  R + P  +              
Sbjct: 59  SE----SVGSDAPCVVKVEPSDNGPLF----TELKFYQRAAKPEQIQKWIRTRKLKYLGV 110

Query: 159 -KLLGYCWEDKELL----LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
            K  G    DK       ++ +      L+  ++  N   +  S    L++++     L 
Sbjct: 111 PKYWGSGLHDKNGKSYRFMIMDRFGS-DLQ-KIYEANA--KRFSRKTVLQLSLRILDILE 166

Query: 214 FLHTSEKKVIYRDFKASNILLD 235
           ++H  E + ++ D KASN+LL+
Sbjct: 167 YIH--EHEYVHGDIKASNLLLN 186

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 46.5 bits (111), Expect = 6e-06
 Identities = 34/155 (21%), Positives = 56/155 (36%), Gaps = 47/155 (30%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HP 155
           LG G  G+V +   + +T            A+K L         + + EV    R S  P
Sbjct: 26  LGLGINGKVLQI-FNKRT--------QEKFALKMLQDC-----PKARREVELHWRASQCP 71

Query: 156 NLVKLLGYC----WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG---- 207
           ++V+++          K LL+V E +  G  E  LF R          I+ +        
Sbjct: 72  HIVRIVDVYENLYAGRKCLLIVMECLDGG--E--LFSR----------IQDRGDQAFTER 117

Query: 208 -AAR-------GLGFLHTSEKKVIYRDFKASNILL 234
            A+         + +LH     + +RD K  N+L 
Sbjct: 118 EASEIMKSIGEAIQYLH--SINIAHRDVKPENLLY 150

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 35/148 (23%), Positives = 56/148 (37%), Gaps = 22/148 (14%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK--KLNPESMQGFEEWQSEVN 147
            F+    +G G FG +Y G  + +T           VAIK   +  +  Q   E +    
Sbjct: 8   KFRLGRKIGSGSFGEIYLG-TNIQT--------NEEVAIKLENVKTKHPQLLYESK---- 54

Query: 148 FLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
               L     +  +  +  E    +LV + +   SLE  LF      + LS    L +A 
Sbjct: 55  IYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCS--RKLSLKTVLMLAD 110

Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILL 234
                + F+H   K  ++RD K  N L+
Sbjct: 111 QMINRVEFVH--SKSFLHRDIKPDNFLM 136

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 37/159 (23%), Positives = 59/159 (37%), Gaps = 21/159 (13%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK--KLNPESMQGFEEWQSEVN 147
           NF+    +G G FG +  G  +  T           VAIK   +   + Q   E++    
Sbjct: 10  NFRVGKKIGCGNFGELRLG-KNLYT--------NEYVAIKLEPMKSRAPQLHLEYRFYKQ 60

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
                    + ++  +    K   +V E +   SLE  LF      +  S    L IAI 
Sbjct: 61  LGS---GDGIPQVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCD--RTFSLKTVLMIAIQ 113

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL 246
               + ++H   K +IYRD K  N L+ G        ++
Sbjct: 114 LISRMEYVH--SKNLIYRDVKPENFLI-GRPGNKTQQVI 149

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 43.5 bits (103), Expect = 6e-05
 Identities = 38/181 (20%), Positives = 70/181 (38%), Gaps = 23/181 (12%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK--KLNPESMQGFEEWQSEVN 147
           ++K    +GEG FG +++G  +              VAIK      ++ Q  +E+++   
Sbjct: 11  HYKVGRRIGEGSFGVIFEG-TNLLN--------NQQVAIKFEPRRSDAPQLRDEYRTYKL 61

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
             G      +  +  +  E    +LV + +   SLE  L       +  S       A  
Sbjct: 62  LAGC---TGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCG--RKFSVKTVAMAAKQ 114

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFK--RHYIYIYIHTYII 265
               +  +H  EK ++YRD K  N L+ G     +++++  V F   + Y       +I 
Sbjct: 115 MLARVQSIH--EKSLVYRDIKPDNFLI-GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 171

Query: 266 Y 266
           Y
Sbjct: 172 Y 172

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.5 bits (99), Expect = 2e-04
 Identities = 39/253 (15%), Positives = 82/253 (32%), Gaps = 73/253 (28%)

Query: 73  TPD--LKVFS-FL-----DLKSATKNFKPD--SLLGE---GGFGRVYKGWVDDKTLAPSK 119
           TPD    +   +L     DL        P   S++ E    G    +  W   K +   K
Sbjct: 299 TPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLAT-WDNW---KHVNCDK 354

Query: 120 TGLGMVVAIKKLNPESMQG-FEE---WQSEVNFLGRLSHPNLVKLLGYCWEDKE----LL 171
               +  ++  L P   +  F+    +    +       P    LL   W D      ++
Sbjct: 355 LTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHI------P--TILLSLIWFDVIKSDVMV 406

Query: 172 LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVI--YRDFKA 229
           +V +  +   +E        SI  +  ++++K+    A     LH   + ++  Y   K 
Sbjct: 407 VVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYA-----LH---RSIVDHYNIPKT 458

Query: 230 SNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSV 289
                      FDS           Y+  Y +++I +       ++   K + +    + 
Sbjct: 459 -----------FDSD-----DLIPPYLDQYFYSHIGH-------HL---KNIEHPERMT- 491

Query: 290 LLPRIY---AWIK 299
           L   ++    +++
Sbjct: 492 LFRMVFLDFRFLE 504

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 33/148 (22%), Positives = 53/148 (35%), Gaps = 22/148 (14%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK--KLNPESMQGFEEWQSEVN 147
            ++    +G G FG +Y G  D           G  VAIK   +  +  Q   E +    
Sbjct: 10  RYRLGRKIGSGSFGDIYLG-TDIAA--------GEEVAIKLECVKTKHPQLHIESK---- 56

Query: 148 FLGRLSH-PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
               +     +  +     E    ++V E +   SLE  LF      +  S    L +A 
Sbjct: 57  IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCS--RKFSLKTVLLLAD 112

Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILL 234
                + ++H   K  I+RD K  N L+
Sbjct: 113 QMISRIEYIH--SKNFIHRDVKPDNFLM 138

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 40.1 bits (94), Expect = 7e-04
 Identities = 42/150 (28%), Positives = 64/150 (42%), Gaps = 27/150 (18%)

Query: 95  SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVNFLGRLS 153
           SL+G+G FG+V K + D              VAIK + N ++     + Q EV  L  ++
Sbjct: 60  SLIGKGSFGQVVKAY-DRVE--------QEWVAIKIIKNKKAF--LNQAQIEVRLLELMN 108

Query: 154 HP------NLVKLLGYCWEDKELLLVYEYMQRGSLENHLF---RRNPSIQPLSWDIRLKI 204
                    +V L  +      L LV+E      L  +L+   R   + + +S ++  K 
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNT-NFRGVSLNLTRKF 162

Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL 234
           A      L FL T E  +I+ D K  NILL
Sbjct: 163 AQQMCTALLFLATPELSIIHCDLKPENILL 192

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 40.1 bits (94), Expect = 8e-04
 Identities = 31/189 (16%), Positives = 66/189 (34%), Gaps = 36/189 (19%)

Query: 95  SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVNFLGRLS 153
             LG G F  V+    D              VA+K +   +     E  + E+  L R++
Sbjct: 25  RKLGWGHFSTVWLAK-DMVN--------NTHVAMKIVRGDKVY--TEAAEDEIKLLQRVN 73

Query: 154 -----------HPNLVKLLGY----CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSW 198
                        +++KLL +          +++V+E +   +L   + ++    + +  
Sbjct: 74  DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALI-KKYEH-RGIPL 130

Query: 199 DIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYF-----KR 253
               +I+     GL ++H     +I+ D K  N+L++ V    +   +            
Sbjct: 131 IYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189

Query: 254 HYIYIYIHT 262
            +    I T
Sbjct: 190 EHYTNSIQT 198

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	376
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.98
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.98
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.98
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.98
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.98
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.98
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.97
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.97
3uqc_A	286	Probable conserved transmembrane protein; structur	99.97
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.97
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.97
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.52
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.36
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.25
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.95
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.89
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.81
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.69
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.67
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.57
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.38
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.3
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.22
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.86
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.86
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.81
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.56
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.55
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.53
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.38
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.26
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.23
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.05
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.99
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.74
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.15
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.91
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.35
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	89.23
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	88.56
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	88.05
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	87.49
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	85.46
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	84.99
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	82.98

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.2e-50  Score=377.37  Aligned_cols=198  Identities=21%  Similarity=0.225  Sum_probs=173.4

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .+.|++.+.||+|+||+||+|.+         +.+++.||||+++.......+.+.+|+.+|+.++|||||+++++|.++
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~---------~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  143 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATV---------RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG  143 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             hHhcEEeEEeecCcCeEEEEEEE---------CCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            45699999999999999999954         447999999999765555556788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +.+|||||||+||+|.+++.+.     .+++..+..++.||+.||+|||  .++||||||||+||||+.+|.+||+|||+
T Consensus       144 ~~~~ivmEy~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DFGl  216 (346)
T 4fih_A          144 DELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGF  216 (346)
T ss_dssp             TEEEEEECCCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEECCCCCEEEecCcC
Confidence            9999999999999999999653     4899999999999999999999  59999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      |+.+.......   .+.    +|||.||               |||++.+..| +.++||||+|++++|+++...+.
T Consensus       217 a~~~~~~~~~~---~~~----~GTp~Ym---------------APEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF  270 (346)
T 4fih_A          217 CAQVSKEVPRR---KSL----VGTPYWM---------------APELISRLPY-GPEVDIWSLGIMVIEMVDGEPPY  270 (346)
T ss_dssp             CEECCSSSCCB---CCC----CSCGGGC---------------CHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ceecCCCCCcc---ccc----ccCcCcC---------------CHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCC
Confidence            99875543221   222    8999999               9999887765 88999999999999999766554

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.9e-50  Score=383.43  Aligned_cols=199  Identities=21%  Similarity=0.230  Sum_probs=174.7

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..+.|++.+.||+|+||.||+|.+         +.+++.||||+++.......+.+.+|+.+|+.++|||||+++++|.+
T Consensus       149 p~~~y~~~~~iG~G~fG~V~~a~~---------~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  219 (423)
T 4fie_A          149 PRSYLDNFIKIGEGSTGIVCIATV---------RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV  219 (423)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hhHhcEeeeEeccCcCcEEEEEEE---------CCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE
Confidence            346799999999999999999954         44799999999987655555678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++.+|||||||+||+|.+++...     .+++..+..++.||+.||+|||  .++||||||||+||||+.+|.+||+|||
T Consensus       220 ~~~~~iVmEy~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH--~~~IiHRDiKp~NILl~~~g~vKl~DFG  292 (423)
T 4fie_A          220 GDELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFG  292 (423)
T ss_dssp             TTEEEEEEECCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSTTTEEECTTCCEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHH--HCCeecccCCHHHEEEcCCCCEEEecCc
Confidence            99999999999999999999653     4899999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      +|+.+......   ..+.    +|||.||               |||++.+..| +.++||||+|++++||++...+.
T Consensus       293 la~~~~~~~~~---~~~~----~GTp~Ym---------------APEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF  347 (423)
T 4fie_A          293 FCAQVSKEVPR---RKSL----VGTPYWM---------------APELISRLPY-GPEVDIWSLGIMVIEMVDGEPPY  347 (423)
T ss_dssp             TCEECCSSCCC---BCCC----EECTTTC---------------CHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cceECCCCCcc---cccc----ccCcCcC---------------CHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCC
Confidence            99987554322   1222    8999999               9999887765 88999999999999999766554

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1e-49  Score=367.57  Aligned_cols=200  Identities=20%  Similarity=0.179  Sum_probs=174.1

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ++|++++.||+|+||+||+|+         ++.+++.||||++++..   ....+.+.+|+++|+.++|||||+++++|+
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~---------~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  102 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLAR---------ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ  102 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEE---------ECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            569999999999999999994         44579999999997542   233577899999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +++.+|||||||+||+|.+++.+.    ..+++..+..++.||+.||+|||  .++||||||||+|||++.+|.+||+||
T Consensus       103 ~~~~~yivmEy~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH--~~~IiHRDlKPeNILl~~~g~vKl~DF  176 (311)
T 4aw0_A          103 DDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQITDF  176 (311)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHeEEcCCCCEEEEEc
Confidence            999999999999999999999876    45999999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      |+|+.+....... ...+.    +|||.||               |||++.+..| +.++|+||+|++++++++-..+.
T Consensus       177 Gla~~~~~~~~~~-~~~~~----~GTp~Ym---------------APEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF  234 (311)
T 4aw0_A          177 GTAKVLSPESKQA-RANSF----VGTAQYV---------------SPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPF  234 (311)
T ss_dssp             TTCEECCTTTTCC-CBCCC----CSCGGGC---------------CHHHHHHSCB-CHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCceecCCCCCcc-cccCc----ccCcccC---------------CHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCC
Confidence            9999875433221 11223    8999999               9999988765 88999999999999999765554

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.7e-49  Score=371.99  Aligned_cols=201  Identities=22%  Similarity=0.241  Sum_probs=168.6

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      .++|++++.||+|+||+||+|++         +.+++.||||+++...  ....+.+.+|+.+|++|+|||||++++++.
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~   93 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKS---------TEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE   93 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEE---------TTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEE---------CCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE
Confidence            36899999999999999999954         4469999999997653  345678899999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +++.+|||||||+||+|.++|...+.  ..+++..++.++.||+.||.|||  +++||||||||+||||+.+|.+||+||
T Consensus        94 ~~~~~yiVmEy~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DF  169 (350)
T 4b9d_A           94 ENGSLYIVMDYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVH--DRKILHRDIKSQNIFLTKDGTVQLGDF  169 (350)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHH--HTTCEETTCCGGGEEECTTCCEEECST
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHHHEEECCCCCEEEccc
Confidence            99999999999999999999976532  45799999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      |+|+........   ..+.    +|||.||               |||++.+..| +.++||||+|+|++|+++...+.
T Consensus       170 Gla~~~~~~~~~---~~~~----~GT~~Ym---------------APE~l~~~~y-~~~~DiwSlGvilyemltG~~PF  225 (350)
T 4b9d_A          170 GIARVLNSTVEL---ARAC----IGTPYYL---------------SPEICENKPY-NNKSDIWALGCVLYELCTLKHAF  225 (350)
T ss_dssp             TEESCCCHHHHH---HHHH----HSCCTTC---------------CHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccceeecCCccc---cccc----CCCcccc---------------CHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCC
Confidence            999987553221   1122    7999999               9999988765 78999999999999999765554

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.7e-48  Score=356.64  Aligned_cols=206  Identities=24%  Similarity=0.323  Sum_probs=173.5

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|.+.+.||+|+||+||+|++...    ....++..||||+++.......+.|.+|+++|++++|||||++++++.++
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~   87 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   87 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSC----C----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCc----ccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            45788999999999999999987542    22345889999999987777778899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcC---------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          168 KELLLVYEYMQRGSLENHLFRRN---------PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      +.+|||||||++|+|.++|.+..         .....+++..++.++.||+.||.|||  .++||||||||+||||+.++
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA--SQHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCccCHhhEEECCCC
Confidence            99999999999999999997642         12356999999999999999999999  59999999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .+||+|||+|+............ ..    .||+.||               |||++.+.. ++.++||||||++++|++
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~-~~----~gt~~ym---------------APE~~~~~~-~~~k~DVwS~Gvvl~Ell  224 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGG-HT----MLPIRWM---------------PPESIMYRK-FTTESDVWSLGVVLWEIF  224 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETT-TE----EECGGGC---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecC-ce----ecChhhc---------------CHHHHcCCC-CCchhhHHHHHHHHHHHH
Confidence            99999999999775554432222 22    7899999               999888765 589999999999999998


Q ss_pred             cc
Q 017177          319 SF  320 (376)
Q Consensus       319 ~~  320 (376)
                      ++
T Consensus       225 t~  226 (299)
T 4asz_A          225 TY  226 (299)
T ss_dssp             TT
T ss_pred             cC
Confidence            74

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.9e-48  Score=352.98  Aligned_cols=198  Identities=21%  Similarity=0.241  Sum_probs=161.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      .++|++.+.||+|+||+||+|         .++.+++.||||++++...   ...+.+.+|+.+|+.++|||||++++++
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~   82 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLA---------YHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI   82 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEE---------ECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEE---------EECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence            468999999999999999999         4445799999999976532   3346789999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .+++.+||||||| +|+|.+++.++    ..+++..+..++.||+.||+|||  +++|+||||||+|||++.+|.+||+|
T Consensus        83 ~~~~~~~ivmEy~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH--~~~IiHRDiKP~NILl~~~~~vkl~D  155 (275)
T 3hyh_A           83 KSKDEIIMVIEYA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCH--RHKIVHRDLKPENLLLDEHLNVKIAD  155 (275)
T ss_dssp             ECSSEEEEEEECC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCTTTEEECTTCCEEECC
T ss_pred             EECCEEEEEEeCC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCChHHeEECCCCCEEEee
Confidence            9999999999999 67999999876    45999999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ||+|+........    .+.    +|||.||               |||++.+..|.+.++||||+|++++++++-..+.
T Consensus       156 FGla~~~~~~~~~----~~~----~GT~~Y~---------------APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF  212 (275)
T 3hyh_A          156 FGLSNIMTDGNFL----KTS----CGSPNYA---------------APEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF  212 (275)
T ss_dssp             SSCC-----------------------CTTS---------------CHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cCCCeecCCCCcc----CCe----eECcccC---------------ChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCC
Confidence            9999876543322    122    8999999               9999999988889999999999999999765554

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.4e-47  Score=356.62  Aligned_cols=205  Identities=25%  Similarity=0.355  Sum_probs=166.6

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      ++|.+.+.||+|+||+||+|++++.    .+..+++.||||+++.......+.|.+|+++|++++|||||++++++.+++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR  116 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSS----CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCc----ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            4678889999999999999987642    233458899999999877777789999999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC
Q 017177          169 ELLLVYEYMQRGSLENHLFRRNP-----------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV  237 (376)
Q Consensus       169 ~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~  237 (376)
                      .+|||||||++|+|.+++++...           ...++++..++.++.||+.||.|||  .++||||||||+||||+.+
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA--GLHFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETT
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh--cCCeecccccHhhEEECCC
Confidence            99999999999999999976532           1246899999999999999999999  5999999999999999999


Q ss_pred             CcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhh
Q 017177          238 GFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCV  317 (376)
Q Consensus       238 g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~  317 (376)
                      +.+||+|||+++..............     .||+.||               |||++.+.. ++.++||||||++++|+
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~-----~gt~~ym---------------APE~~~~~~-~~~~sDvwS~Gvvl~El  253 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRT-----MLPIRWM---------------PPESILYRK-FTTESDVWSFGVVLWEI  253 (329)
T ss_dssp             TEEEECCCC----------------C-----CCCGGGC---------------CHHHHTTCC-CCHHHHHHHHHHHHHHH
T ss_pred             CcEEEcccccceeccCCCcceecCcc-----ccccccc---------------ChhhhcCCC-CCccccccchHHHHHHH
Confidence            99999999999976554333222222     7899999               999888766 48999999999999999


Q ss_pred             ccc
Q 017177          318 FSF  320 (376)
Q Consensus       318 ~~~  320 (376)
                      +++
T Consensus       254 lt~  256 (329)
T 4aoj_A          254 FTY  256 (329)
T ss_dssp             HTT
T ss_pred             HcC
Confidence            874

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.2e-47  Score=357.76  Aligned_cols=196  Identities=21%  Similarity=0.182  Sum_probs=165.6

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .+.|++.+.||+|+||+||+|++         +.+++.||||+++.+..     ..+|+.+|+.++|||||++++++.++
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~---------~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~  122 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKD---------KQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREG  122 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEET
T ss_pred             hhheEeCcEeccCCCeEEEEEEE---------CCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            45688899999999999999954         44799999999976532     24699999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC-cEEEccee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG-FLFDSHLL  246 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g-~~kl~Dfg  246 (376)
                      +.+|||||||+||+|.+++++.    ..+++..+..++.||+.||+|||  .++||||||||+||||+.+| .+||+|||
T Consensus       123 ~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~~vKl~DFG  196 (336)
T 4g3f_A          123 PWVNIFMELLEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFG  196 (336)
T ss_dssp             TEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCCGGGEEECTTSCCEEECCCT
T ss_pred             CEEEEEEeccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCceecccCHHHEEEeCCCCEEEEeeCC
Confidence            9999999999999999999876    45999999999999999999999  69999999999999999998 59999999


Q ss_pred             eeeeeccceeeE--EEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          247 IYVYFKRHYIYI--YIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       247 ~a~~~~~~~~~~--~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      +|+.+.......  ....+.    +|||.||               |||++.+..| +.++||||+|++++|+++-..+
T Consensus       197 la~~~~~~~~~~~~~~~~~~----~GT~~Ym---------------APE~~~~~~y-~~~~DiwSlGvilyemltG~~P  255 (336)
T 4g3f_A          197 HALCLQPDGLGKSLLTGDYI----PGTETHM---------------APEVVMGKPC-DAKVDIWSSCCMMLHMLNGCHP  255 (336)
T ss_dssp             TCEEC------------CCC----CCCGGGC---------------CHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCeEccCCCcccceecCCcc----ccCcccc---------------CHHHHCCCCC-CcHHHHHHHHHHHHHHHHCcCC
Confidence            999876543221  112222    7999999               9999988764 7899999999999999965444

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.8e-48  Score=357.77  Aligned_cols=201  Identities=22%  Similarity=0.207  Sum_probs=165.3

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ++|++++.||+|+||+||+|+...      ...+++.||||++++...  ....++.+|+.+|++++|||||++++++.+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~------~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~   97 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKIS------GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT   97 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECS------STTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEcc------CCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            579999999999999999997542      233588999999976432  223467889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++.+|||||||+||+|.+++.+.    ..+++..+..++.||+.||+|||  +++||||||||+|||++.+|.+||+|||
T Consensus        98 ~~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DFG  171 (304)
T 3ubd_A           98 EGKLYLILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFG  171 (304)
T ss_dssp             TTEEEEEECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECTTSCEEEESSE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHHHeEEcCCCCEEecccc
Confidence            99999999999999999999876    45999999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      +|+........   ..+.    +|||.||               |||++.+..| +.++||||+|++++|+++-..+.
T Consensus       172 la~~~~~~~~~---~~~~----~GT~~Ym---------------APE~~~~~~y-~~~~DiwSlGvilyemltG~~PF  226 (304)
T 3ubd_A          172 LSKESIDHEKK---AYSF----CGTVEYM---------------APEVVNRRGH-TQSADWWSFGVLMFEMLTGTLPF  226 (304)
T ss_dssp             EEEC-----CC---CCSC----CCCGGGC---------------CHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cceeccCCCcc---cccc----ccCcccC---------------CHHHhccCCC-CCCCcccchHHHHHHHHhCCCCC
Confidence            99875443222   1222    8999999               9999987764 78999999999999999765554

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.1e-47  Score=346.64  Aligned_cols=193  Identities=25%  Similarity=0.323  Sum_probs=163.7

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe--
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE--  166 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--  166 (376)
                      |++.+.||+|+||+||+|.+.         .++..||+|++...  .....+.+.+|+.+|++++|||||+++++|.+  
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~   98 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDT---------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   98 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEEC---------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence            467788999999999999544         46899999998754  33456789999999999999999999999875  


Q ss_pred             --CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--cEecCCCCCCEEEcC-CCcEE
Q 017177          167 --DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK--VIYRDFKASNILLDG-VGFLF  241 (376)
Q Consensus       167 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~--iiHrDlKp~NILl~~-~g~~k  241 (376)
                        ++.+|||||||+||+|.+++.+.    ..+++..+..++.||+.||+|||+  ++  ||||||||+||||+. +|.+|
T Consensus        99 ~~~~~~~lvmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~--~~~~IiHRDlKp~NILl~~~~g~vK  172 (290)
T 3fpq_A           99 KGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTGSVK  172 (290)
T ss_dssp             TTEEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHT--SSSCCCCCCCCGGGEEESSTTSCEE
T ss_pred             CCCcEEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCCCEEecccChhheeEECCCCCEE
Confidence              34689999999999999999876    458999999999999999999995  66  999999999999974 79999


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |+|||+|+.......     .+.    +|||.||               |||++.+  .++.++||||+|++++|+++-.
T Consensus       173 l~DFGla~~~~~~~~-----~~~----~GTp~Ym---------------APE~~~~--~y~~~~DiwSlGvilyelltg~  226 (290)
T 3fpq_A          173 IGDLGLATLKRASFA-----KAV----IGTPEFM---------------APEMYEE--KYDESVDVYAFGMCMLEMATSE  226 (290)
T ss_dssp             ECCTTGGGGCCTTSB-----EES----CSSCCCC---------------CGGGGGT--CCCTHHHHHHHHHHHHHHHHSS
T ss_pred             EEeCcCCEeCCCCcc-----CCc----ccCcccc---------------CHHHcCC--CCCcHHHHHHHHHHHHHHHHCC
Confidence            999999986543321     122    7899999               8998865  3689999999999999999766


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      .+.
T Consensus       227 ~Pf  229 (290)
T 3fpq_A          227 YPY  229 (290)
T ss_dssp             CTT
T ss_pred             CCC
Confidence            554

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.5e-46  Score=344.50  Aligned_cols=201  Identities=22%  Similarity=0.286  Sum_probs=164.8

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ...+++++.+.||+|+||+||+|.++            ..||||+++..  .....+.|.+|+.+|++++|||||+++++
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~------------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~  100 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWH------------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY  100 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESS------------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEEC------------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            34567899999999999999999643            24899998754  33456789999999999999999999998


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +. ++.+|||||||++|+|.++|....   ..+++..+..++.||+.||.|||  .++||||||||+||||++++.+||+
T Consensus       101 ~~-~~~~~iVmEy~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH--~~~IiHRDlKp~NILl~~~~~~Ki~  174 (307)
T 3omv_A          101 MT-KDNLAIVTQWCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLH--AKNIIHRDMKSNNIFLHEGLTVKIG  174 (307)
T ss_dssp             EC-SSSCEEEEECCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCCSSSEEEETTEEEEEC
T ss_pred             EE-CCeEEEEEEcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCccCCccCHHHEEECCCCcEEEe
Confidence            75 467899999999999999997653   46999999999999999999999  4899999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh--hhccccccccceeeeehhhcccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI--KYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~--~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |||+|+........... .+.    +|||.||               |||++.+.  ..++.++||||||+|++|+++-.
T Consensus       175 DFGla~~~~~~~~~~~~-~~~----~GT~~ym---------------APE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~  234 (307)
T 3omv_A          175 DFGLATVKSRWSGSQQV-EQP----TGSVLWM---------------APEVIRMQDNNPFSFQSDVYSYGIVLYELMTGE  234 (307)
T ss_dssp             CCSSCBC-------------C----CCCTTSC---------------CHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             eccCceecccCCcceee-ccc----ccCCCcc---------------CHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCC
Confidence            99999876543322111 222    8999999               99998764  34688999999999999999765


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      .+.
T Consensus       235 ~Pf  237 (307)
T 3omv_A          235 LPY  237 (307)
T ss_dssp             CTT
T ss_pred             CCC
Confidence            544

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.3e-46  Score=348.46  Aligned_cols=205  Identities=26%  Similarity=0.345  Sum_probs=168.8

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++++.+.||+|+||+||+|.+...    .+..+++.||||+++.... ...+.|.+|+.++++++|||||++++++.++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~----~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGP----APGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD  101 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCC----ccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence            4567889999999999999987532    2233578999999976533 3457899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPS------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD  235 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~  235 (376)
                      +.++||||||++|+|.++|..+...            ...+++..++.++.||+.||.|||+  ++||||||||+||||+
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS--HHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCccccceEEC
Confidence            9999999999999999999754321            2458999999999999999999994  9999999999999999


Q ss_pred             CCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeeh
Q 017177          236 GVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFS  315 (376)
Q Consensus       236 ~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~  315 (376)
                      +++.+||+|||+++........... ++.    .||+.||               |||++.+.. ++.++||||||+|++
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~-~~~----~gt~~ym---------------APE~l~~~~-~s~ksDVwSfGvvl~  238 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLL-GNS----LLPIRWM---------------APEAIMYGK-FSIDSDIWSYGVVLW  238 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSS-SSS----CBCGGGC---------------CHHHHHHCC-CCHHHHHHHHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEe-ccc----ccCCccc---------------CHHHHhCCC-CCccchhhhHHHHHH
Confidence            9999999999999976554333212 222    7889999               999888765 589999999999999


Q ss_pred             hhccc
Q 017177          316 CVFSF  320 (376)
Q Consensus       316 ~~~~~  320 (376)
                      |++++
T Consensus       239 El~t~  243 (308)
T 4gt4_A          239 EVFSY  243 (308)
T ss_dssp             HHHTT
T ss_pred             HHHhC
Confidence            99874

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.4e-46  Score=344.60  Aligned_cols=203  Identities=21%  Similarity=0.247  Sum_probs=157.5

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ++|++++.||+|+||+||+|++         +.+++.||||+++... ....+.+.+|+.+|++++|||||+++++|.+.
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~   75 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKN---------KVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEK   75 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEE---------TTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred             hhCEEeeEEecCCCeEEEEEEE---------CCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEec
Confidence            4689999999999999999954         4468999999987543 33457789999999999999999999998764


Q ss_pred             C------------eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc
Q 017177          168 K------------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD  235 (376)
Q Consensus       168 ~------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~  235 (376)
                      +            .+|||||||++|+|.+++..... ....++..++.++.||+.||+|||  .++||||||||+||||+
T Consensus        76 ~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH--~~~IiHRDlKp~NILl~  152 (299)
T 4g31_A           76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFFT  152 (299)
T ss_dssp             C----------CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEC
T ss_pred             CccccccccCCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHH--HCcCccccCcHHHeEEC
Confidence            4            37999999999999999976532 233566778999999999999999  49999999999999999


Q ss_pred             CCCcEEEcceeeeeeeccceeeEEEe-----eeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccce
Q 017177          236 GVGFLFDSHLLIYVYFKRHYIYIYIH-----TYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSF  310 (376)
Q Consensus       236 ~~g~~kl~Dfg~a~~~~~~~~~~~~~-----~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~  310 (376)
                      .+|.+||+|||+|+.+..........     .......+|||.||               |||++.+..| +.++||||+
T Consensus       153 ~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Ym---------------APE~~~~~~y-~~~~DiwSl  216 (299)
T 4g31_A          153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYM---------------SPEQIHGNSY-SHKVDIFSL  216 (299)
T ss_dssp             TTCCEEECCCCCC--------------------------CCCTTS---------------CHHHHTTCCC-CTHHHHHHH
T ss_pred             CCCcEEEccCccceecCCCccccccccccccccccCCcccCcccc---------------CHHHHcCCCC-CCHHHHHHH
Confidence            99999999999999876543321110     01112237999999               9999988664 889999999


Q ss_pred             eeeehhhcc
Q 017177          311 AFVFSCVFS  319 (376)
Q Consensus       311 g~v~~~~~~  319 (376)
                      |+|++|+++
T Consensus       217 Gvilyell~  225 (299)
T 4g31_A          217 GLILFELLY  225 (299)
T ss_dssp             HHHHHHHHS
T ss_pred             HHHHHHHcc
Confidence            999999985

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.8e-45  Score=341.99  Aligned_cols=211  Identities=24%  Similarity=0.274  Sum_probs=174.6

Q ss_pred             hhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCC-CCcceE
Q 017177           83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSH-PNLVKL  160 (376)
Q Consensus        83 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h-~nIv~l  160 (376)
                      ++....++|++++.||+|+||+||+|.+...    .+..+++.||||.++.... ...+.+.+|+.+|.+++| ||||++
T Consensus        58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEETS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccEecHHHeEEeeEEecCCCeEEEEEEEcCC----CcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            3445667899999999999999999987642    2334567899999987543 445789999999999975 999999


Q ss_pred             EeEEEeC-CeEEEEEeccCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCC
Q 017177          161 LGYCWED-KELLLVYEYMQRGSLENHLFRRNP------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDF  227 (376)
Q Consensus       161 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDl  227 (376)
                      +++|..+ +.+|||||||++|+|.++|+....            ....+++..++.++.||+.||.|||+  ++||||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~--~~iiHRDL  211 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDL  211 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh--CCeecCcc
Confidence            9998764 568999999999999999976421            12458999999999999999999994  99999999


Q ss_pred             CCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccc
Q 017177          228 KASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYS  307 (376)
Q Consensus       228 Kp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv  307 (376)
                      ||+|||+++++.+||+|||+|+........... ++.    .||+.||               |||++.+.. ++.++||
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~-~~~----~gt~~ym---------------APE~l~~~~-y~~ksDV  270 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRK-GDA----RLPLKWM---------------APETIFDRV-YTIQSDV  270 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEE-TTE----EECGGGC---------------CHHHHHHCC-CCHHHHH
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceee-ccc----ccccccc---------------CHHHHhcCC-CCCcccE
Confidence            999999999999999999999977554332222 222    7899999               999888765 5899999


Q ss_pred             cceeeeehhhccc
Q 017177          308 NSFAFVFSCVFSF  320 (376)
Q Consensus       308 ~s~g~v~~~~~~~  320 (376)
                      ||||++++|++++
T Consensus       271 wS~Gv~l~El~t~  283 (353)
T 4ase_A          271 WSFGVLLWEIFSL  283 (353)
T ss_dssp             HHHHHHHHHHTTT
T ss_pred             eehHHHHHHHHhC
Confidence            9999999999874

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.6e-45  Score=348.44  Aligned_cols=202  Identities=20%  Similarity=0.220  Sum_probs=169.6

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      .++|++++.||+|+||+||+|++         +.+++.||||+++...  ....+.+.+|+.+|+.++|||||++++++.
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~---------~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  123 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARR---------RLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILR  123 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             CCCeEEEEEEecccCeEEEEEEE---------CCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeee
Confidence            46799999999999999999954         4479999999997653  344567889999999999999999999876


Q ss_pred             e------CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc
Q 017177          166 E------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF  239 (376)
Q Consensus       166 ~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~  239 (376)
                      .      .+.+|||||||+ |+|.+++.+.    ..+++..+..++.||+.||.|||  .++||||||||+|||++.+|.
T Consensus       124 ~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH--~~~iiHRDlKP~NIl~~~~~~  196 (398)
T 4b99_A          124 PTVPYGEFKSVYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMH--SAQVIHRDLKPSNLLVNENCE  196 (398)
T ss_dssp             CSSCTTTCCCEEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTCC
T ss_pred             cccccccCCEEEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCcCcCCCcCccccccCCCCC
Confidence            4      357999999996 6899999765    56999999999999999999999  599999999999999999999


Q ss_pred             EEEcceeeeeeeccceee-EEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          240 LFDSHLLIYVYFKRHYIY-IYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~-~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      +||+|||+|+.+...... .....+.    +||+.||               |||++.+..+++.++||||+|+|++|++
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~~----~GT~~Y~---------------APEv~~~~~~~~~~~DiWSlG~il~ell  257 (398)
T 4b99_A          197 LKIGDFGMARGLCTSPAEHQYFMTEY----VATRWYR---------------APELMLSLHEYTQAIDLWSVGCIFGEML  257 (398)
T ss_dssp             EEECCCTTCBCC-------CCCCCSS----CCCCTTC---------------CHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             EEEeecceeeecccCccccccccccc----eeChHhc---------------CHHHhcCCCCCCChhheehhHHHHHHHH
Confidence            999999999876543221 1112222    8999999               9999999888899999999999999999


Q ss_pred             cccccc
Q 017177          319 SFYRTT  324 (376)
Q Consensus       319 ~~y~~~  324 (376)
                      +-..+.
T Consensus       258 ~G~~pF  263 (398)
T 4b99_A          258 ARRQLF  263 (398)
T ss_dssp             HTSCSS
T ss_pred             HCCCCC
Confidence            655443

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.2e-44  Score=333.61  Aligned_cols=196  Identities=23%  Similarity=0.254  Sum_probs=158.4

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      ++|.+.+.||+|+||+||+|.+.           |+.||||+++...... ..+..|+..+..++|||||++++++.+++
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-----------g~~VAvK~l~~~~~~~-~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~   70 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDN   70 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-----------TEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-----------CEEEEEEEECccchhh-HHHHHHHHHHhcCCCCCCCcEEEEEEecC
Confidence            45788899999999999999764           7789999997654322 22345666777899999999999998654


Q ss_pred             ----eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCcEecCCCCCCEEEcCCC
Q 017177          169 ----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS------EKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       169 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~------~~~iiHrDlKp~NILl~~~g  238 (376)
                          .+|||||||++|+|.++|++.     .+++..+..++.|++.||.|||++      ..+||||||||+||||+.++
T Consensus        71 ~~~~~~~lV~Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~  145 (303)
T 3hmm_A           71 GTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  145 (303)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             CCceEEEEEecCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC
Confidence                589999999999999999754     489999999999999999999952      23999999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeE-EEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh-----hhccccccccceee
Q 017177          239 FLFDSHLLIYVYFKRHYIYI-YIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI-----KYLTLLKYSNSFAF  312 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~-~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~-----~~~~~~~dv~s~g~  312 (376)
                      .+||+|||+++......... ....+    .+||+.||               |||++.+.     ..++.++||||||+
T Consensus       146 ~~Ki~DFGla~~~~~~~~~~~~~~~~----~~GT~~ym---------------APE~l~~~~~~~~~~~~~k~DVwS~Gv  206 (303)
T 3hmm_A          146 TCCIADLGLAVRHDSATDTIDIAPNH----RVGTKRYM---------------APEVLDDSINMKHFESFKRADIYAMGL  206 (303)
T ss_dssp             CEEECCCTTCEEEETTTTEESCC---------CCGGGC---------------CHHHHTTCSCTTCHHHHHHHHHHHHHH
T ss_pred             CEEEEeCCCCccccCCCCceeeeccc----cccccccc---------------CHHHhcccccccCCccChhHhhhhHHH
Confidence            99999999999875543321 11112    27999999               99998764     24678999999999


Q ss_pred             eehhhccc
Q 017177          313 VFSCVFSF  320 (376)
Q Consensus       313 v~~~~~~~  320 (376)
                      |++|+++.
T Consensus       207 vl~El~tg  214 (303)
T 3hmm_A          207 VFWEIARR  214 (303)
T ss_dssp             HHHHHHHT
T ss_pred             HHHHHHHC
Confidence            99999853

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2e-43  Score=334.51  Aligned_cols=205  Identities=18%  Similarity=0.137  Sum_probs=168.7

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcC-CCCCcceEEeE
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGY  163 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~  163 (376)
                      ....++|++.+.||+|+||+||+|+.+      .+..+++.||+|.+.....  ..++.+|+++|+.+ +||||++++++
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~------~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~   88 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQ------LQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYC   88 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEE------BTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEE
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEc------ccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEE
Confidence            345578999999999999999999754      2234588999999876543  35678999999998 59999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC-CcEEE
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV-GFLFD  242 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~-g~~kl  242 (376)
                      |.+++++|||||||+||+|.+++.       .+++..+..++.||+.||+|||  .++||||||||+|||++.+ |.+||
T Consensus        89 ~~~~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH--~~gIiHRDiKPeNiLl~~~~~~~kl  159 (361)
T 4f9c_A           89 FRKNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIH--QFGIVHRDVKPSNFLYNRRLKKYAL  159 (361)
T ss_dssp             EEETTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTTTEEEE
T ss_pred             EEECCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCcCCHHHeEEeCCCCeEEE
Confidence            999999999999999999999983       3899999999999999999999  5999999999999999877 89999


Q ss_pred             cceeeeeeeccceee---------------------EEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhc
Q 017177          243 SHLLIYVYFKRHYIY---------------------IYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYL  301 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~---------------------~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~  301 (376)
                      +|||+|+........                     ...........+|||.||               |||++.+..++
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~---------------APE~l~~~~~y  224 (361)
T 4f9c_A          160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFR---------------APEVLTKCPNQ  224 (361)
T ss_dssp             CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGC---------------CHHHHTTCSCC
T ss_pred             CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCcccc---------------CHHHHcCCCCC
Confidence            999999876432110                     000001112237999999               99999988878


Q ss_pred             cccccccceeeeehhhcccc
Q 017177          302 TLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       302 ~~~~dv~s~g~v~~~~~~~y  321 (376)
                      +.++|+||+|+|++|+++-.
T Consensus       225 ~~~~DiWSlG~il~ell~G~  244 (361)
T 4f9c_A          225 TTAIDMWSAGVIFLSLLSGR  244 (361)
T ss_dssp             CTHHHHHHHHHHHHHHHHTC
T ss_pred             CCccchhhhHHHHHHHHHCC
Confidence            99999999999999999643

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.1e-43  Score=351.83  Aligned_cols=199  Identities=23%  Similarity=0.247  Sum_probs=169.3

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHH---HHHHHHHhcCCCCCcceE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEW---QSEVNFLGRLSHPNLVKL  160 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~---~~E~~il~~l~h~nIv~l  160 (376)
                      ..++|+++++||+|+||+||+|+         ++.+++.||||++++...   .....+   .+++.+++.++|||||++
T Consensus       187 slddf~i~k~LG~G~fG~V~la~---------~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l  257 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCR---------KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM  257 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCE
T ss_pred             chHHeEEEEEEecccCeEEEEEE---------ECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEE
Confidence            35689999999999999999994         445799999999975321   111223   345677788899999999


Q ss_pred             EeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcE
Q 017177          161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL  240 (376)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~  240 (376)
                      +++|.+++.+|||||||+||+|.++|.+.    ..+++..+..++.||+.||.|||  .++||||||||+||||+.+|++
T Consensus       258 ~~~f~~~~~lylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH--~~gIiHRDLKPeNILld~~G~v  331 (689)
T 3v5w_A          258 SYAFHTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHV  331 (689)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECTTSCE
T ss_pred             EEEEEECCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCchHHeEEeCCCCE
Confidence            99999999999999999999999999876    45999999999999999999999  6999999999999999999999


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ||+|||+|+.+.....     .+    .+|||.||               |||++.....++.++|+||+|++++||++.
T Consensus       332 KL~DFGlA~~~~~~~~-----~t----~~GTp~Ym---------------APEvl~~~~~y~~~vDiWSLGvilYEmLtG  387 (689)
T 3v5w_A          332 RISDLGLACDFSKKKP-----HA----SVGTHGYM---------------APEVLQKGVAYDSSADWFSLGCMLFKLLRG  387 (689)
T ss_dssp             EECCCTTCEECSSCCC-----CS----CCSCGGGC---------------CHHHHSTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             EecccceeeecCCCCC-----CC----ccCCcCcc---------------CHHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            9999999997755322     12    28999999               999997665678999999999999999966


Q ss_pred             cccc
Q 017177          321 YRTT  324 (376)
Q Consensus       321 y~~~  324 (376)
                      +.+.
T Consensus       388 ~~PF  391 (689)
T 3v5w_A          388 HSPF  391 (689)
T ss_dssp             SCTT
T ss_pred             CCCC
Confidence            5554

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.6e-42  Score=347.11  Aligned_cols=199  Identities=19%  Similarity=0.202  Sum_probs=175.4

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|++++.||+|+||.||+|.         ++.+++.||+|++........+.+.+|+.+|+.++|||||+++++|.++
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~---------~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  226 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVT---------ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD  226 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred             ccccEEEEEEeeccCeEEEEEE---------ECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            4689999999999999999994         4447999999999887776778889999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC--CcEEEcce
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV--GFLFDSHL  245 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~--g~~kl~Df  245 (376)
                      +.+|||||||+||+|.++|.+..   ..+++..+..++.||+.||.|||  .++|+||||||+|||++.+  |.+||+||
T Consensus       227 ~~~~iv~E~~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH--~~~iiHRDlKp~Nill~~~~~~~vKl~DF  301 (573)
T 3uto_A          227 NEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDF  301 (573)
T ss_dssp             SEEEEEEECCCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred             CEEEEEEeecCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCChhhccccCCCCCCEEEeec
Confidence            99999999999999999996542   46899999999999999999999  5999999999999999854  89999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      |+++.+.......        ..+|||.||               |||++.+..| +.++||||+|+++++|++-..+.
T Consensus       302 G~a~~~~~~~~~~--------~~~GT~~y~---------------APEv~~~~~y-~~~~DiWSlGvilyeml~G~~Pf  356 (573)
T 3uto_A          302 GLTAHLDPKQSVK--------VTTGTAEFA---------------APEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPF  356 (573)
T ss_dssp             SSCEECCTTSEEE--------EECSSGGGC---------------CHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSS
T ss_pred             cceeEccCCCcee--------eeEECcccc---------------CHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCC
Confidence            9999886654332        127899999               8999988765 88999999999999999766554

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.2e-38  Score=294.60  Aligned_cols=200  Identities=21%  Similarity=0.224  Sum_probs=172.6

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ...++|++.+.||+|+||.||+|.         +..+++.||+|++........+.+.+|+.+++.++||||+++++++.
T Consensus        17 ~~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   87 (297)
T 3fxz_A           17 DPKKKYTRFEKIGQGASGTVYTAM---------DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL   87 (297)
T ss_dssp             CGGGTBCCCEEEEEETTEEEEEEE---------BTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ChhhceeeeeeeccCCCeEEEEEE---------ECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEE
Confidence            345689999999999999999994         34468999999987665555677889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      .++..|+||||+++|+|.+++.+.     .+++..+..++.|++.||.|||  .++|+||||||+|||++.+|.+||+||
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~Dlkp~Nil~~~~~~~kl~Df  160 (297)
T 3fxz_A           88 VGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDF  160 (297)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred             ECCEEEEEEECCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCHHHEEECCCCCEEEeeC
Confidence            999999999999999999999764     3899999999999999999999  589999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      |++..........   .+.    .||+.|+               |||++.+.. ++.++||||+|++++++++...+.
T Consensus       161 g~~~~~~~~~~~~---~~~----~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf  216 (297)
T 3fxz_A          161 GFCAQITPEQSKR---STM----VGTPYWM---------------APEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPY  216 (297)
T ss_dssp             TTCEECCSTTCCB---CCC----CSCGGGC---------------CHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCceecCCccccc---CCc----cCCcCcc---------------ChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCC
Confidence            9998775543321   111    7888888               899887765 488999999999999999765544

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=7.1e-39  Score=303.13  Aligned_cols=200  Identities=23%  Similarity=0.234  Sum_probs=166.7

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcC-CCCCcceEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLLG  162 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~l~~  162 (376)
                      ..++|++.+.||+|+||.||+|+..         .+++.||+|++++..   ....+.+.+|..+++.+ +||||+++++
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~   91 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVK---------ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFC   91 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEc---------CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEE
Confidence            3578999999999999999999544         468999999997642   23446778999999998 5999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                      ++.+.+.+|+||||++||+|.+++.+.    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.+|.+||
T Consensus        92 ~~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NILl~~~g~ikL  165 (353)
T 3txo_A           92 CFQTPDRLFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLH--DKGIIYRDLKLDNVLLDHEGHCKL  165 (353)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred             EEEeCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCCcccCCCHHHEEECCCCCEEE
Confidence            999999999999999999999999876    45899999999999999999999  599999999999999999999999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      +|||+++........       ....+||+.|+               |||++.+.. ++.++|+||+|++++++++-..
T Consensus       166 ~DFG~a~~~~~~~~~-------~~~~~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~ell~G~~  222 (353)
T 3txo_A          166 ADFGMCKEGICNGVT-------TATFCGTPDYI---------------APEILQEML-YGPAVDWWAMGVLLYEMLCGHA  222 (353)
T ss_dssp             CCCTTCBCSCC----------------CCGGGC---------------CHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSC
T ss_pred             ccccceeecccCCcc-------ccccCCCcCeE---------------ChhhcCCCC-cCCccCCCcchHHHHHHHhCCC
Confidence            999999864332221       11227899999               899887765 4889999999999999996544


Q ss_pred             cc
Q 017177          323 TT  324 (376)
Q Consensus       323 ~~  324 (376)
                      +.
T Consensus       223 Pf  224 (353)
T 3txo_A          223 PF  224 (353)
T ss_dssp             SS
T ss_pred             CC
Confidence            43

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.7e-39  Score=302.13  Aligned_cols=200  Identities=22%  Similarity=0.212  Sum_probs=174.1

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|.+         ..+++.||||++...  .....+.+.+|+.+++.++||||+++++++
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~   83 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARH---------ILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI   83 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEE---------CCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            456899999999999999999954         346899999998754  334557788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      ...+.+|+||||+++|+|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~NIll~~~~~~kl~D  157 (328)
T 3fe3_A           84 ETEKTLYLIMEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCH--QKRIVHRDLKAENLLLDADMNIKIAD  157 (328)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECS
T ss_pred             EECCEEEEEEECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCEeccCCCHHHEEEcCCCCEEEee
Confidence            9999999999999999999999876    45899999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ||++.........    .+.    +||+.|+               |||++.+..+.+.++||||+|++++++++...+.
T Consensus       158 FG~a~~~~~~~~~----~~~----~gt~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  214 (328)
T 3fe3_A          158 FGFSNEFTVGGKL----DAF----CGAPPYA---------------APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF  214 (328)
T ss_dssp             TTCCGGGSSSCGG----GTT----SSSGGGC---------------CHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccCceecCCCCcc----ccc----cCCccee---------------CcccccCCCcCCchhhhhhhHHHHHHHHhCCCCC
Confidence            9999876543322    111    6888888               8999999888789999999999999999755544

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.8e-39  Score=312.11  Aligned_cols=207  Identities=18%  Similarity=0.124  Sum_probs=173.5

Q ss_pred             hhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcce
Q 017177           83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVK  159 (376)
Q Consensus        83 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~  159 (376)
                      +.....++|++.++||+|+||+||+|+..         .+++.||+|++++...   .....+.+|+.++..++||||++
T Consensus        68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~---------~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~  138 (437)
T 4aw2_A           68 QMRLHREDFEILKVIGRGAFGEVAVVKLK---------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT  138 (437)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCC
T ss_pred             cccCChhheEEEEEEEeCCCEEEEEEEEc---------CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            44455678999999999999999999554         3588999999875321   11234788999999999999999


Q ss_pred             EEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc
Q 017177          160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF  239 (376)
Q Consensus       160 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~  239 (376)
                      +++++.+++.+|+|||||++|+|.+++.+..   ..+++..+..++.||+.||.|||  .++|+||||||+|||++.+|.
T Consensus       139 l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH--~~giiHrDLKp~NILl~~~g~  213 (437)
T 4aw2_A          139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVH--QLHYVHRDIKPDNILMDMNGH  213 (437)
T ss_dssp             EEEEEECSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSC
T ss_pred             EEEEEeeCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecccCHHHeeEcCCCC
Confidence            9999999999999999999999999997642   45899999999999999999999  599999999999999999999


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh----hhhccccccccceeeeeh
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW----IKYLTLLKYSNSFAFVFS  315 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~----~~~~~~~~dv~s~g~v~~  315 (376)
                      +||+|||+++.........  ..+    .+||+.||               |||++..    ...++.++||||+|++++
T Consensus       214 vkL~DFGla~~~~~~~~~~--~~~----~~GT~~Y~---------------APE~l~~~~~~~~~~~~~~DvwSlGvil~  272 (437)
T 4aw2_A          214 IRLADFGSCLKLMEDGTVQ--SSV----AVGTPDYI---------------SPEILQAMEGGKGRYGPECDWWSLGVCMY  272 (437)
T ss_dssp             EEECCCTTCEECCTTSCEE--CCS----CCSCGGGC---------------CHHHHHHHHTSCCEECTHHHHHHHHHHHH
T ss_pred             EEEcchhhhhhcccCCCcc--ccc----ccCCcCee---------------ChHHHhhcccCCCCCCCcCeeHHHHHHHH
Confidence            9999999998765543321  111    27899999               8998873    456789999999999999


Q ss_pred             hhccccccc
Q 017177          316 CVFSFYRTT  324 (376)
Q Consensus       316 ~~~~~y~~~  324 (376)
                      |+++...+.
T Consensus       273 elltG~~Pf  281 (437)
T 4aw2_A          273 EMLYGETPF  281 (437)
T ss_dssp             HHHHSSCTT
T ss_pred             HHHhCCCCC
Confidence            999655543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7e-39  Score=301.28  Aligned_cols=198  Identities=22%  Similarity=0.190  Sum_probs=168.6

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      .++|++.+.||+|+||+||+|+.         +.+++.||+|++++..   ......+.+|+.+++.++||||+++++++
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~   74 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVRE---------KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF   74 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEE---------CCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE
Confidence            45799999999999999999954         3468999999997542   23456788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .+.+.+|+||||++||+|.+++.+.    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.+|.+||+|
T Consensus        75 ~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~vkL~D  148 (337)
T 1o6l_A           75 QTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITD  148 (337)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCcCCHHHEEECCCCCEEEee
Confidence            9999999999999999999999876    45899999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ||+++........   ..+.    +||+.|+               |||++.+.. ++.++|+||+|++++++++...+
T Consensus       149 FG~a~~~~~~~~~---~~~~----~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~ell~g~~P  204 (337)
T 1o6l_A          149 FGLCKEGISDGAT---MKTF----CGTPEYL---------------APEVLEDND-YGRAVDWWGLGVVMYEMMCGRLP  204 (337)
T ss_dssp             CTTCBCSCCTTCC---BCCC----EECGGGC---------------CGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             ccchhhcccCCCc---cccc----ccChhhC---------------ChhhhcCCC-CCchhhcccchhHHHHHhcCCCC
Confidence            9999864332221   1112    7899999               899877654 58899999999999999964433

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.5e-39  Score=308.89  Aligned_cols=205  Identities=20%  Similarity=0.180  Sum_probs=172.5

Q ss_pred             hhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcce
Q 017177           83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVK  159 (376)
Q Consensus        83 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~  159 (376)
                      +.....++|++.+.||+|+||.||+|+..         .+++.||+|++++...   ...+.+.+|+.+++.++||||++
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~---------~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~  133 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHK---------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ  133 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCC
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEEC---------CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCe
Confidence            34445678999999999999999999544         4689999999865321   12235778999999999999999


Q ss_pred             EEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc
Q 017177          160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF  239 (376)
Q Consensus       160 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~  239 (376)
                      +++++.+++.+|+|||||+||+|.+++.+.     .+++..+..++.||+.||.|||  .++|+||||||+|||++.+|.
T Consensus       134 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH--~~givHrDLKp~NILl~~~g~  206 (410)
T 3v8s_A          134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGH  206 (410)
T ss_dssp             EEEEEECSSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSC
T ss_pred             EEEEEEECCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeeECCCCC
Confidence            999999999999999999999999999653     3899999999999999999999  599999999999999999999


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhh---hccccccccceeeeehh
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIK---YLTLLKYSNSFAFVFSC  316 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~---~~~~~~dv~s~g~v~~~  316 (376)
                      +||+|||+++........  ...+.    +||+.|+               |||++.+..   +++.++||||+|+++++
T Consensus       207 ikL~DFG~a~~~~~~~~~--~~~~~----~gt~~Y~---------------APE~l~~~~~~~~~~~~~DiwSlGvilye  265 (410)
T 3v8s_A          207 LKLADFGTCMKMNKEGMV--RCDTA----VGTPDYI---------------SPEVLKSQGGDGYYGRECDWWSVGVFLYE  265 (410)
T ss_dssp             EEECCCTTCEECCTTSEE--ECCSC----CSCGGGC---------------CHHHHHTTTTTCEEETHHHHHHHHHHHHH
T ss_pred             EEEeccceeEeeccCCcc--cccCC----cCCcccc---------------CHHHhhccCCCcCCCCcceEecchHHHHH
Confidence            999999999877654332  11122    8999999               899988654   36889999999999999


Q ss_pred             hccccccc
Q 017177          317 VFSFYRTT  324 (376)
Q Consensus       317 ~~~~y~~~  324 (376)
                      +++...+.
T Consensus       266 ll~G~~Pf  273 (410)
T 3v8s_A          266 MLVGDTPF  273 (410)
T ss_dssp             HHHSSCTT
T ss_pred             HHhCCCCC
Confidence            99655544

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.6e-39  Score=308.23  Aligned_cols=207  Identities=17%  Similarity=0.133  Sum_probs=173.9

Q ss_pred             hhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcce
Q 017177           83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVK  159 (376)
Q Consensus        83 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~  159 (376)
                      +.....++|++.+.||+|+||+||+|+..         .+++.||+|++++...   ...+.+.+|..++..++||||++
T Consensus        55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~---------~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~  125 (412)
T 2vd5_A           55 EVRLQRDDFEILKVIGRGAFSEVAVVKMK---------QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ  125 (412)
T ss_dssp             HHSCCGGGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCC
T ss_pred             hccCChhhEEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeee
Confidence            34455678999999999999999999544         4689999999975322   22345788999999999999999


Q ss_pred             EEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc
Q 017177          160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF  239 (376)
Q Consensus       160 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~  239 (376)
                      +++++.+++.+|+||||++||+|.+++.+..   ..+++..+..++.||+.||.|||  .++|+||||||+|||++.+|.
T Consensus       126 l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH--~~giiHrDLKp~NILld~~g~  200 (412)
T 2vd5_A          126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVH--RLGYVHRDIKPDNILLDRCGH  200 (412)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSC
T ss_pred             EEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccCHHHeeecCCCC
Confidence            9999999999999999999999999998752   35899999999999999999999  599999999999999999999


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh------hhhccccccccceeee
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW------IKYLTLLKYSNSFAFV  313 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~------~~~~~~~~dv~s~g~v  313 (376)
                      +||+|||+++.........  ..    ..+||+.|+               |||++..      ...++.++|+||+|++
T Consensus       201 vkL~DFGla~~~~~~~~~~--~~----~~~Gt~~Y~---------------APE~l~~~~~~~~~~~~~~~~DiwSlGvi  259 (412)
T 2vd5_A          201 IRLADFGSCLKLRADGTVR--SL----VAVGTPDYL---------------SPEILQAVGGGPGTGSYGPECDWWALGVF  259 (412)
T ss_dssp             EEECCCTTCEECCTTSCEE--CS----SCCSCGGGC---------------CHHHHHHHHTCTTCSEECTHHHHHHHHHH
T ss_pred             EEEeechhheeccCCCccc--cc----eeccccCcC---------------CHHHHhhcccCcCCCCCChHHhhhHHhHH
Confidence            9999999998875543321  11    127899999               8998875      2456899999999999


Q ss_pred             ehhhccccccc
Q 017177          314 FSCVFSFYRTT  324 (376)
Q Consensus       314 ~~~~~~~y~~~  324 (376)
                      ++|+++...+.
T Consensus       260 lyelltG~~Pf  270 (412)
T 2vd5_A          260 AYEMFYGQTPF  270 (412)
T ss_dssp             HHHHHHSSCTT
T ss_pred             HHHHHhCCCCC
Confidence            99999655443

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.3e-38  Score=297.83  Aligned_cols=202  Identities=20%  Similarity=0.184  Sum_probs=170.3

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~   75 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNR---------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR   75 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEEC---------CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            3578999999999999999999544         3588999999875533 23356789999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +++..|+||||+++|+|.+++...    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.++.+||+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~kl~Df  149 (323)
T 3tki_A           76 EGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDF  149 (323)
T ss_dssp             CSSEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCeEEEEEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccccchHHEEEeCCCCEEEEEe
Confidence            999999999999999999998654    45899999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |++..+.......... ..    .||+.|+               |||++.+..+.+.++||||+|++++++++...+
T Consensus       150 g~a~~~~~~~~~~~~~-~~----~gt~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  207 (323)
T 3tki_A          150 GLATVFRYNNRERLLN-KM----CGTLPYV---------------APELLKRREFHAEPVDVWSCGIVLTAMLAGELP  207 (323)
T ss_dssp             TTCEECEETTEECCBC-SC----CSCGGGS---------------CHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             eccceeccCCcccccC-CC----ccCcCcc---------------CcHHhccCCCCCCcccHHHHHHHHHHHHhCCCC
Confidence            9998765433221111 12    7889998               899998888778899999999999999965444

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.5e-38  Score=303.06  Aligned_cols=208  Identities=23%  Similarity=0.310  Sum_probs=170.4

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcC-CCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|.+....  .....++..||+|+++... ....+.+.+|+.+++.+ +||||+++++++
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCS--TTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEeccc--CcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            3567999999999999999999764311  0123357789999998763 34567889999999999 799999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCE
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNP------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI  232 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NI  232 (376)
                      .+++.+|+||||+++|+|.+++.....            ....+++..++.++.||+.||.|||  .++|+||||||+||
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NI  234 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--SQKCIHRDLAARNV  234 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGE
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCeeccccchhhE
Confidence            999999999999999999999987532            1235789999999999999999999  59999999999999


Q ss_pred             EEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceee
Q 017177          233 LLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAF  312 (376)
Q Consensus       233 Ll~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~  312 (376)
                      |++.+|.+||+|||+++..............     .||+.|+               |||++.+.. ++.++||||+|+
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~-----~~t~~y~---------------aPE~~~~~~-~~~~~DvwslG~  293 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNG-----RLPVKWM---------------APEALFDRV-YTHQSDVWSFGV  293 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTT-----TSCGGGC---------------CHHHHHTCC-CCHHHHHHHHHH
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCC-----CcccceE---------------CHhHhcCCC-CCcHHHHHHHHH
Confidence            9999999999999999976543321111111     5567777               899887654 588999999999


Q ss_pred             eehhhcc
Q 017177          313 VFSCVFS  319 (376)
Q Consensus       313 v~~~~~~  319 (376)
                      +++|+++
T Consensus       294 il~ellt  300 (370)
T 2psq_A          294 LMWEIFT  300 (370)
T ss_dssp             HHHHHHT
T ss_pred             HHHHHHc
Confidence            9999987

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.3e-38  Score=298.68  Aligned_cols=201  Identities=23%  Similarity=0.244  Sum_probs=169.4

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcC-CCCCcceEE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLL  161 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~l~  161 (376)
                      ...++|++.+.||+|+||.||+|+..         .+++.||+|+++...   ....+.+.+|..++..+ +||||++++
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~   84 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFK---------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF   84 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEE
Confidence            45678999999999999999999554         468999999997542   13346678899999987 799999999


Q ss_pred             eEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEE
Q 017177          162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLF  241 (376)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~k  241 (376)
                      +++.+.+.+|+||||++||+|.+++.+.    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.+|.+|
T Consensus        85 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~vk  158 (345)
T 1xjd_A           85 CTFQTKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIK  158 (345)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEE
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCChhhEEECCCCCEE
Confidence            9999999999999999999999999876    45899999999999999999999  59999999999999999999999


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |+|||+++........   ..+.    +||+.|+               |||++.+.. ++.++|+||+|++++++++..
T Consensus       159 L~DFG~a~~~~~~~~~---~~~~----~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~ell~g~  215 (345)
T 1xjd_A          159 IADFGMCKENMLGDAK---TNTF----CGTPDYI---------------APEILLGQK-YNHSVDWWSFGVLLYEMLIGQ  215 (345)
T ss_dssp             ECCCTTCBCCCCTTCC---BCCC----CSCGGGC---------------CHHHHTTCC-BCTHHHHHHHHHHHHHHHHSS
T ss_pred             EeEChhhhhcccCCCc---ccCC----CCCcccC---------------ChhhhcCCC-CCChhhhHHHHHHHHHHhcCC
Confidence            9999999865332211   1112    7889999               899888765 588999999999999999655


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      .+.
T Consensus       216 ~Pf  218 (345)
T 1xjd_A          216 SPF  218 (345)
T ss_dssp             CSS
T ss_pred             CCC
Confidence            443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.8e-38  Score=292.04  Aligned_cols=210  Identities=37%  Similarity=0.545  Sum_probs=177.3

Q ss_pred             ChhhhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcce
Q 017177           80 SFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVK  159 (376)
Q Consensus        80 ~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~  159 (376)
                      ++.++....++|++.+.||+|+||.||+|...          +++.||+|++........+.+.+|+.+++.++||||++
T Consensus        30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   99 (321)
T 2qkw_B           30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR----------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVS   99 (321)
T ss_dssp             CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT----------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCC
T ss_pred             cHHHHHHHHhccCccceeecCCCeeEEEEEEC----------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEee
Confidence            33455567789999999999999999999643          37889999998776666788999999999999999999


Q ss_pred             EEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc
Q 017177          160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF  239 (376)
Q Consensus       160 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~  239 (376)
                      +++++.+.+..++||||+++|+|.+++.........+++..+..++.|++.||.|||  .++|+||||||+|||++.++.
T Consensus       100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~  177 (321)
T 2qkw_B          100 LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFV  177 (321)
T ss_dssp             EEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCSTTEEECTTCC
T ss_pred             EEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc--CCCeecCCCCHHHEEECCCCC
Confidence            999999999999999999999999999765443456899999999999999999999  599999999999999999999


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +||+|||+++........... ..    ..||+.|+               |||++.+.. .+.++||||+|++++++++
T Consensus       178 ~kl~Dfg~~~~~~~~~~~~~~-~~----~~gt~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~ell~  236 (321)
T 2qkw_B          178 PKITDFGISKKGTELDQTHLS-TV----VKGTLGYI---------------DPEYFIKGR-LTEKSDVYSFGVVLFEVLC  236 (321)
T ss_dssp             EEECCCTTCEECSSSSCCCCB-CC----CEEETTTC---------------CHHHHHHCB-CCTHHHHHHHHHHHHHHHH
T ss_pred             EEEeecccccccccccccccc-cc----cCCCcccc---------------CHHHhcCCC-CCcccchHhHHHHHHHHHh
Confidence            999999999875443222111 11    16888888               899887654 5889999999999999986


Q ss_pred             ccc
Q 017177          320 FYR  322 (376)
Q Consensus       320 ~y~  322 (376)
                      ...
T Consensus       237 g~~  239 (321)
T 2qkw_B          237 ARS  239 (321)
T ss_dssp             CCT
T ss_pred             CCC
Confidence            543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-38  Score=293.65  Aligned_cols=196  Identities=23%  Similarity=0.302  Sum_probs=169.5

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      .++|++.+.||+|+||.||+|+..         .+++.||+|++++...   ...+.+.+|+.+++.++||||+++++++
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~   75 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSR---------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF   75 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE
Confidence            467999999999999999999544         4689999999875422   3356778999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .+.+.+|+||||+++|+|.+++.+.    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.+|.+||+|
T Consensus        76 ~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~D  149 (318)
T 1fot_A           76 QDAQQIFMIMDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITD  149 (318)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTSCEEECC
T ss_pred             EeCCEEEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChheEEEcCCCCEEEee
Confidence            9999999999999999999999875    45899999999999999999999  69999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ||+++.......      +    .+||+.|+               |||++.+.. ++.++|+||+|++++++++...+.
T Consensus       150 fg~a~~~~~~~~------~----~~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf  203 (318)
T 1fot_A          150 FGFAKYVPDVTY------T----LCGTPDYI---------------APEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPF  203 (318)
T ss_dssp             CSSCEECSSCBC------C----CCSCTTTC---------------CHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             cCcceecCCccc------c----ccCCcccc---------------CHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCC
Confidence            999987654211      1    27889999               899887765 588999999999999999655443

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-37  Score=289.12  Aligned_cols=199  Identities=14%  Similarity=0.094  Sum_probs=171.4

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|.+.... .....+.+|+.+++.++||||+++++++.+
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   72 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVET---------SSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFES   72 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEEC---------CCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEec
Confidence            4578999999999999999999544         468999999998654 344678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC--CCcEEEcc
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG--VGFLFDSH  244 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~--~g~~kl~D  244 (376)
                      .+.+++|||||++|+|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.  ++.+||+|
T Consensus        73 ~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH--~~givH~Dlkp~NIl~~~~~~~~~kl~D  147 (321)
T 1tki_A           73 MEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIE  147 (321)
T ss_dssp             TTEEEEEECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECC
T ss_pred             CCEEEEEEEeCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCCCcCCCCHHHEEEccCCCCCEEEEE
Confidence            999999999999999999996542   45899999999999999999999  599999999999999987  78999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ||++...........        ..|||.|+               |||++.+. ..+.++|+||+|++++++++...+.
T Consensus       148 fg~a~~~~~~~~~~~--------~~gt~~y~---------------aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf  203 (321)
T 1tki_A          148 FGQARQLKPGDNFRL--------LFTAPEYY---------------APEVHQHD-VVSTATDMWSLGTLVYVLLSGINPF  203 (321)
T ss_dssp             CTTCEECCTTCEEEE--------EESCGGGS---------------CHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCCCeECCCCCcccc--------ccCChhhc---------------CcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            999998765443321        27888888               89988765 4588999999999999999665543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2e-38  Score=302.07  Aligned_cols=199  Identities=23%  Similarity=0.255  Sum_probs=159.7

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHH-HhcCCCCCcceEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNF-LGRLSHPNLVKLLG  162 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~i-l~~l~h~nIv~l~~  162 (376)
                      ..++|++.+.||+|+||+||+|+..         .+++.||+|++++...   .....+.+|..+ ++.++||||+++++
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~  106 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHK---------AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHF  106 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEET---------TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEc---------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEE
Confidence            3467999999999999999999544         4688999999976432   233456677776 57789999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                      ++.+.+.+|+||||++||+|.+++.+.    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.+|.+||
T Consensus       107 ~~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~ikL  180 (373)
T 2r5t_A          107 SFQTADKLYFVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLH--SLNIVYRDLKPENILLDSQGHIVL  180 (373)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred             EEEeCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEECCCCCEEE
Confidence            999999999999999999999999876    45899999999999999999999  599999999999999999999999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      +|||+++........   ..+.    +||+.|+               |||++.+.. ++.++|+||+|++++|+++...
T Consensus       181 ~DFG~a~~~~~~~~~---~~~~----~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~ell~G~~  237 (373)
T 2r5t_A          181 TDFGLCKENIEHNST---TSTF----CGTPEYL---------------APEVLHKQP-YDRTVDWWCLGAVLYEMLYGLP  237 (373)
T ss_dssp             CCCCBCGGGBCCCCC---CCSB----SCCCCCC---------------CHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSC
T ss_pred             eeCccccccccCCCc---cccc----cCCcccc---------------CHHHhCCCC-CCchhhhHHHHHHHHHHHcCCC
Confidence            999999864332211   1112    7888888               899888765 5889999999999999996544


Q ss_pred             c
Q 017177          323 T  323 (376)
Q Consensus       323 ~  323 (376)
                      +
T Consensus       238 P  238 (373)
T 2r5t_A          238 P  238 (373)
T ss_dssp             T
T ss_pred             C
Confidence            4

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4e-38  Score=297.91  Aligned_cols=200  Identities=23%  Similarity=0.214  Sum_probs=169.5

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcC-CCCCcceEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLLG  162 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~l~~  162 (376)
                      ..++|++.+.||+|+||.||+|+..         .+++.||+|++++..   ....+.+.+|..++..+ +||||+++++
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~   88 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERK---------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS   88 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEET---------TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEE
Confidence            4578999999999999999999544         468899999997642   13356778999999998 6999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                      ++.+.+.+|+||||++||+|.+++.+.    ..+++..++.++.||+.||.|||  .++|+||||||+|||++.+|.+||
T Consensus        89 ~~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~vkL  162 (353)
T 2i0e_A           89 CFQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKI  162 (353)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred             EEEcCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCEEeccCCHHHEEEcCCCcEEE
Confidence            999999999999999999999999876    45899999999999999999999  599999999999999999999999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      +|||+++........   ..+.    +||+.|+               |||++.+.. ++.++|+||+|++++++++...
T Consensus       163 ~DFG~a~~~~~~~~~---~~~~----~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~ell~G~~  219 (353)
T 2i0e_A          163 ADFGMCKENIWDGVT---TKTF----CGTPDYI---------------APEIIAYQP-YGKSVDWWAFGVLLYEMLAGQA  219 (353)
T ss_dssp             CCCTTCBCCCCTTCC---BCCC----CSCGGGC---------------CHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSC
T ss_pred             EeCCcccccccCCcc---cccc----cCCcccc---------------ChhhhcCCC-cCCcccccchHHHHHHHHcCCC
Confidence            999999864332211   1111    7889999               899887765 4889999999999999996554


Q ss_pred             cc
Q 017177          323 TT  324 (376)
Q Consensus       323 ~~  324 (376)
                      +.
T Consensus       220 Pf  221 (353)
T 2i0e_A          220 PF  221 (353)
T ss_dssp             SS
T ss_pred             CC
Confidence            43

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.6e-37  Score=286.47  Aligned_cols=201  Identities=22%  Similarity=0.224  Sum_probs=166.9

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC---ChhhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ..++|++.+.||+|+||.||+|...         .++..||+|.+...   .....+.+.+|+.+++.++||||++++++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~   79 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDT---------ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDV   79 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEET---------TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEEC---------CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEe
Confidence            4568999999999999999999543         35889999998543   23445788999999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +.+++..|+||||+++++|.+++...    ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+
T Consensus        80 ~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~Dlkp~Nil~~~~~~~kl~  153 (294)
T 4eqm_A           80 DEEDDCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAH--DMRIVHRDIKPQNILIDSNKTLKIF  153 (294)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred             eeeCCeEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEE
Confidence            99999999999999999999999876    45899999999999999999999  5999999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||++..........  ...    ..||+.|+               +||++.+.. .+.++|+||+|++++++++...+
T Consensus       154 Dfg~~~~~~~~~~~~--~~~----~~gt~~y~---------------aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~p  211 (294)
T 4eqm_A          154 DFGIAKALSETSLTQ--TNH----VLGTVQYF---------------SPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPP  211 (294)
T ss_dssp             CCSSSTTC-------------------CCSSC---------------CHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             eCCCccccccccccc--cCc----cccCcccc---------------CHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCC
Confidence            999998765433221  111    16888888               899887755 48889999999999999975554


Q ss_pred             c
Q 017177          324 T  324 (376)
Q Consensus       324 ~  324 (376)
                      .
T Consensus       212 f  212 (294)
T 4eqm_A          212 F  212 (294)
T ss_dssp             S
T ss_pred             C
Confidence            4

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.8e-38  Score=294.51  Aligned_cols=198  Identities=21%  Similarity=0.242  Sum_probs=168.9

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC---ChhhHHHHHHHHHHHhcC-CCCCcceEEeE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRL-SHPNLVKLLGY  163 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~nIv~l~~~  163 (376)
                      .++|++.+.||+|+||.||+|+..         .+++.||+|++++.   .....+.+.+|..+++.+ +||||++++++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~   78 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLK---------KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC   78 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEE
Confidence            457999999999999999999544         46899999999764   234456788999999988 79999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +.+.+.+|+||||+++|+|.+++.+.    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.+|.+||+
T Consensus        79 ~~~~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~  152 (345)
T 3a8x_A           79 FQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLT  152 (345)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEECCCCCEEEE
Confidence            99999999999999999999999876    45899999999999999999999  5999999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||+++........   ..+.    +||+.|+               |||++.+.. ++.++|+||+|++++++++...+
T Consensus       153 DFG~a~~~~~~~~~---~~~~----~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~ell~g~~p  209 (345)
T 3a8x_A          153 DYGMCKEGLRPGDT---TSTF----CGTPNYI---------------APEILRGED-YGFSVDWWALGVLMFEMMAGRSP  209 (345)
T ss_dssp             CGGGCBCSCCTTCC---BCCC----CSCGGGC---------------CHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             eccccccccCCCCc---cccc----CCCcccc---------------CccccCCCC-CChHHhHHHHHHHHHHHHhCCCC
Confidence            99999864332211   1111    7889999               899888765 48899999999999999965444

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.7e-37  Score=288.54  Aligned_cols=202  Identities=23%  Similarity=0.305  Sum_probs=161.7

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ...++|++.+.||+|+||.||+|...           +..||+|++....  ....+.+.+|+.++++++||||++++++
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~  102 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEWH-----------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA  102 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEEC-----------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            34567999999999999999999653           6779999987654  3445678999999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--cEecCCCCCCEEEcCCCcEE
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK--VIYRDFKASNILLDGVGFLF  241 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~--iiHrDlKp~NILl~~~g~~k  241 (376)
                      +.+.+..++||||+++|+|.+++.+... ...+++..++.++.|++.||.|||  .++  |+||||||+|||++.++.+|
T Consensus       103 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~~~ivH~Dikp~NIll~~~~~~k  179 (309)
T 3p86_A          103 VTQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLH--NRNPPIVHRNLKSPNLLVDKKYTVK  179 (309)
T ss_dssp             ECSTTCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHH--TSSSCCCCTTCCGGGEEECTTCCEE
T ss_pred             EEECCceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHH--cCCCCEECCCCChhhEEEeCCCcEE
Confidence            9999999999999999999999976421 123899999999999999999999  578  99999999999999999999


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |+|||+++.........   .    ...||+.|+               |||++.+.. .+.++||||+|++++++++..
T Consensus       180 L~Dfg~a~~~~~~~~~~---~----~~~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~elltg~  236 (309)
T 3p86_A          180 VCDFGLSRLKASTFLSS---K----SAAGTPEWM---------------APEVLRDEP-SNEKSDVYSFGVILWELATLQ  236 (309)
T ss_dssp             ECCCC------------------------CCTTS---------------CHHHHTTCC-CCTTHHHHHHHHHHHHHHHCC
T ss_pred             ECCCCCCcccccccccc---c----cCCCCcccc---------------ChhhhcCCC-CCchhhHHHHHHHHHHHHhCC
Confidence            99999998654432211   1    127888888               899887765 488999999999999999765


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      .+.
T Consensus       237 ~Pf  239 (309)
T 3p86_A          237 QPW  239 (309)
T ss_dssp             CTT
T ss_pred             CCC
Confidence            443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8.4e-38  Score=295.48  Aligned_cols=196  Identities=23%  Similarity=0.216  Sum_probs=170.2

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      .++|++.+.||+|+||.||+|...         .+++.||+|+++....   ...+.+.+|+.+++.++||||+++++++
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  110 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHK---------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF  110 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEEC---------CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            457999999999999999999544         3688999999865422   3356788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .+++.+|+||||+++|+|.+++.+.    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.+|.+||+|
T Consensus       111 ~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~D  184 (350)
T 1rdq_E          111 KDNSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTD  184 (350)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCccceEEECCCCCEEEcc
Confidence            9999999999999999999999876    45899999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ||+++.......      +    .+||+.|+               |||++.+.. ++.++|+||+|++++++++...+.
T Consensus       185 Fg~a~~~~~~~~------~----~~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf  238 (350)
T 1rdq_E          185 FGFAKRVKGRTW------T----LCGTPEAL---------------APEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF  238 (350)
T ss_dssp             CTTCEECSSCBC------C----CEECGGGC---------------CHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccceeccCCcc------c----ccCCcccc---------------CHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCC
Confidence            999997654321      1    27889999               899888765 588999999999999999655443

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.9e-38  Score=302.84  Aligned_cols=198  Identities=20%  Similarity=0.244  Sum_probs=167.6

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcC-CCCCcceEEeE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRL-SHPNLVKLLGY  163 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~h~nIv~l~~~  163 (376)
                      .++|+++++||+|+||+||+|+..         .+++.||+|++++...   ...+.+.+|..++..+ +||||++++++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~---------~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~  121 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLK---------KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC  121 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence            467999999999999999999554         4688999999976422   2334678899999887 79999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +.+++.+|+||||+++|+|..++.+.    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.+|.+||+
T Consensus       122 ~~~~~~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH--~~givHrDLKp~NILl~~~g~ikL~  195 (396)
T 4dc2_A          122 FQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLT  195 (396)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCEEeccCCHHHEEECCCCCEEEe
Confidence            99999999999999999999999876    45899999999999999999999  5999999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||+++........   ..+.    +||+.|+               |||++.+.. ++.++|+||+|++++++++-..+
T Consensus       196 DFGla~~~~~~~~~---~~~~----~gt~~Y~---------------aPE~l~~~~-~~~~~DiwslGvllyell~G~~P  252 (396)
T 4dc2_A          196 DYGMCKEGLRPGDT---TSTF----CGTPNYI---------------APEILRGED-YGFSVDWWALGVLMFEMMAGRSP  252 (396)
T ss_dssp             CCTTCBCCCCTTCC---BCCC----CBCGGGC---------------CHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ecceeeecccCCCc---cccc----cCCcccC---------------CchhhcCCC-CChHHHHHHHHHHHHHHHhCCCC
Confidence            99999863322221   1112    7899999               899988765 48899999999999999965444

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.1e-37  Score=287.60  Aligned_cols=203  Identities=21%  Similarity=0.294  Sum_probs=170.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|++.+.||+|+||.||+|.+.         .+++.||+|++........+.+.+|+.+++.++||||+++++++.++
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~---------~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   79 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHR---------ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD   79 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEET---------TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred             hhHeeccceecCCCCEEEEEEEEC---------CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC
Confidence            457999999999999999999554         35889999999877767778899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++||||+++|+|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  154 (310)
T 3s95_A           80 KRLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLH--SMNIIHRDLNSHNCLVRENKNVVVADFGL  154 (310)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSTTSEEECTTSCEEECCCTT
T ss_pred             CeeEEEEEecCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCcCeEEECCCCCEEEeeccc
Confidence            99999999999999999998752   45899999999999999999999  59999999999999999999999999999


Q ss_pred             eeeeccceeeEEE-------eeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          248 YVYFKRHYIYIYI-------HTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       248 a~~~~~~~~~~~~-------~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ++...........       .....+...||+.|+               |||++.+.. .+.++||||+|++++++++.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~---------------aPE~~~~~~-~~~~~Di~slG~~l~el~~g  218 (310)
T 3s95_A          155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM---------------APEMINGRS-YDEKVDVFSFGIVLCEIIGR  218 (310)
T ss_dssp             CEECC--------------------CCCCSCGGGC---------------CHHHHTTCC-CCTHHHHHHHHHHHHHHHHT
T ss_pred             ceecccccccccccccccccccccccccCCCccee---------------CHHHhcCCC-CCcHHHHHHHHHHHHHHhcC
Confidence            9987554332110       011112237888898               899887754 58899999999999999843

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3e-37  Score=288.80  Aligned_cols=201  Identities=22%  Similarity=0.294  Sum_probs=166.2

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-ChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|.+...      ...+..||||+++.. .....+.+.+|+.+++.++||||+++++++.+
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  121 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVP------GQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR  121 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCT------TSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecC------CCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            46799999999999999999976531      123567999999875 33455788999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++..|+||||+++|+|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  196 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLS--DLGYVHRDLAARNVLVDSNLVCKVSDFG  196 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred             CCccEEEeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCcceEEECCCCCEEECCCC
Confidence            899999999999999999996542   45899999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +++..............    ..+|+.|+               +||++.+.. .+.++||||+|++++++++
T Consensus       197 ~a~~~~~~~~~~~~~~~----~~~t~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~ell~  249 (325)
T 3kul_A          197 LSRVLEDDPDAAYTTTG----GKIPIRWT---------------APEAIAFRT-FSSASDVWSFGVVMWEVLA  249 (325)
T ss_dssp             SCEECC----CCEECC-------CCGGGS---------------CHHHHHHCE-ECHHHHHHHHHHHHHHHHT
T ss_pred             cccccccCccceeeccC----CCCccccc---------------CHhHhcCCC-CCcHHHHHHHHHHHHHHHc
Confidence            99987654332111111    15667788               899887654 5889999999999999886

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3e-37  Score=288.46  Aligned_cols=215  Identities=35%  Similarity=0.500  Sum_probs=179.9

Q ss_pred             ccccChhhhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh-hHHHHHHHHHHHhcCCC
Q 017177           76 LKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSH  154 (376)
Q Consensus        76 ~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h  154 (376)
                      ...++..++....++|++.+.||+|+||.||+|...          ++..||+|++...... ....+.+|+.+++.++|
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h   86 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----------DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVH   86 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS----------SSCCEEEEECCC-----CCCHHHHHHHGGGTCCC
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEec----------CCCEEEEEEeccccCchHHHHHHHHHHHHHhccC
Confidence            345677788888999999999999999999999432          3788999999875432 22368899999999999


Q ss_pred             CCcceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC---CcEecCCCCCC
Q 017177          155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEK---KVIYRDFKASN  231 (376)
Q Consensus       155 ~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~---~iiHrDlKp~N  231 (376)
                      |||+++++++..++..++||||+++|+|.+++.........+++..+..++.|++.||.|||+  +   +|+||||||+|
T Consensus        87 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~ivH~Dlkp~N  164 (326)
T 3uim_A           87 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD--HCDPKIIHRDVKAAN  164 (326)
T ss_dssp             TTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH--SSSSCEECCCCSGGG
T ss_pred             CCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeEeCCCchhh
Confidence            999999999999999999999999999999998765555669999999999999999999995  6   99999999999


Q ss_pred             EEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcccccccccee
Q 017177          232 ILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFA  311 (376)
Q Consensus       232 ILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g  311 (376)
                      ||++.++.+||+|||++...........  ..    ..||+.|+               +||++.+.. .+.++||||+|
T Consensus       165 il~~~~~~~kl~Dfg~~~~~~~~~~~~~--~~----~~gt~~y~---------------aPE~~~~~~-~~~~~Di~slG  222 (326)
T 3uim_A          165 ILLDEEFEAVVGDFGLAKLMDYKDTHVT--TA----VRGTIGHI---------------APEYLSTGK-SSEKTDVFGYG  222 (326)
T ss_dssp             EEECTTCCEEECCCSSCEECCSSSSCEE--CC----CCSCGGGC---------------CHHHHHHSE-ECHHHHHHHHH
T ss_pred             EEECCCCCEEeccCccccccCccccccc--cc----ccCCcCcc---------------CHHHhccCC-CCccccchhHH
Confidence            9999999999999999997754433211  11    16888888               899887655 58899999999


Q ss_pred             eeehhhccccccc
Q 017177          312 FVFSCVFSFYRTT  324 (376)
Q Consensus       312 ~v~~~~~~~y~~~  324 (376)
                      ++++++++...+.
T Consensus       223 ~il~~l~~g~~pf  235 (326)
T 3uim_A          223 VMLLELITGQRAF  235 (326)
T ss_dssp             HHHHHHHHCCCSB
T ss_pred             HHHHHHHhCCCcc
Confidence            9999999765543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.6e-37  Score=293.86  Aligned_cols=203  Identities=17%  Similarity=0.166  Sum_probs=169.4

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-----hhHHHHHHHHHHHhcCCCCCcceEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-----QGFEEWQSEVNFLGRLSHPNLVKLLG  162 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~h~nIv~l~~  162 (376)
                      .++|++.+.||+|+||.||+|...         .+++.||||+++....     ...+.+.+|+.+++.++||||+++++
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~   93 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINR---------ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE   93 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            456999999999999999999544         3689999999864321     23567899999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc---
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF---  239 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~---  239 (376)
                      ++.+++.+|+|||||++|+|.+.+.+.......+++..+..++.||+.||.|||  .++|+||||||+|||++.++.   
T Consensus        94 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivHrDlkp~NIl~~~~~~~~~  171 (351)
T 3c0i_A           94 TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH--DNNIIHRDVKPHCVLLASKENSAP  171 (351)
T ss_dssp             EEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECSSSTTCC
T ss_pred             EEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCChHHeEEecCCCCCc
Confidence            999999999999999999999888765333345899999999999999999999  599999999999999986654   


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +||+|||++..........   .+.    .||+.|+               |||++.+.. ++.++||||+|++++++++
T Consensus       172 vkl~Dfg~a~~~~~~~~~~---~~~----~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~~ll~  228 (351)
T 3c0i_A          172 VKLGGFGVAIQLGESGLVA---GGR----VGTPHFM---------------APEVVKREP-YGKPVDVWGCGVILFILLS  228 (351)
T ss_dssp             EEECCCTTCEECCTTSCBC---CCC----CSCGGGC---------------CHHHHTTCC-BCTHHHHHHHHHHHHHHHH
T ss_pred             EEEecCcceeEecCCCeee---cCC----cCCcCcc---------------CHHHHcCCC-CCchHhhHHHHHHHHHHHH
Confidence            9999999999876543221   111    7889998               899887765 4889999999999999996


Q ss_pred             ccccc
Q 017177          320 FYRTT  324 (376)
Q Consensus       320 ~y~~~  324 (376)
                      ...+.
T Consensus       229 g~~pf  233 (351)
T 3c0i_A          229 GCLPF  233 (351)
T ss_dssp             SSCSS
T ss_pred             CCCCC
Confidence            55443

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.5e-38  Score=306.82  Aligned_cols=201  Identities=18%  Similarity=0.170  Sum_probs=155.2

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      .++|++.+.||+|+||.||+|.+.         .+++.||||++...  .....+++.+|+.+|+.++||||+++++++.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  122 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDK---------LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI  122 (458)
T ss_dssp             CTTEEECCC-------CEEEEEEC---------C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEEC---------CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence            468999999999999999999544         46899999998764  3345578899999999999999999999985


Q ss_pred             eC-----CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcE
Q 017177          166 ED-----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL  240 (376)
Q Consensus       166 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~  240 (376)
                      ..     ..+|+||||+ +++|.+++...    ..+++..+..++.||+.||.|||  ..+|+||||||+||||+.++.+
T Consensus       123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH--~~~iiHrDlKp~NILl~~~~~~  195 (458)
T 3rp9_A          123 PKDVEKFDELYVVLEIA-DSDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVH--SAGILHRDLKPANCLVNQDCSV  195 (458)
T ss_dssp             CSCTTTCCCEEEEECCC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTCCE
T ss_pred             cCCcccCceEEEEEecc-ccchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHH--hCCcCCCCCChhhEEECCCCCE
Confidence            43     5699999998 56999999765    45899999999999999999999  5899999999999999999999


Q ss_pred             EEcceeeeeeeccceeeE--------------------EEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhh
Q 017177          241 FDSHLLIYVYFKRHYIYI--------------------YIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKY  300 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~--------------------~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~  300 (376)
                      ||+|||+++.........                    ..........+||+.|+               |||++.....
T Consensus       196 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~---------------aPE~~~~~~~  260 (458)
T 3rp9_A          196 KVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYR---------------APELILLQEN  260 (458)
T ss_dssp             EECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTC---------------CHHHHTTCCC
T ss_pred             eecccccchhccCccccccccccCccccccccccccccccccccccCCccccccc---------------ChHHhhCCCC
Confidence            999999998764321100                    00000112237889999               9998876667


Q ss_pred             ccccccccceeeeehhhcc
Q 017177          301 LTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       301 ~~~~~dv~s~g~v~~~~~~  319 (376)
                      ++.++||||+|++++|+++
T Consensus       261 ~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          261 YTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             CCTHHHHHHHHHHHHHHHT
T ss_pred             CCcHhHHHHHHHHHHHHHH
Confidence            7999999999999999986

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.8e-37  Score=294.25  Aligned_cols=199  Identities=21%  Similarity=0.225  Sum_probs=170.8

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh------hHHHHHHHHHHHhcCCCCCcceE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ------GFEEWQSEVNFLGRLSHPNLVKL  160 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~h~nIv~l  160 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|+++.....      ..+.+.+|+.+++.++||||+++
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~---------~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l   80 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREK---------STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL   80 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEEC---------CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcE
Confidence            4567999999999999999999543         46899999998764321      34678999999999999999999


Q ss_pred             EeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC--
Q 017177          161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG--  238 (376)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g--  238 (376)
                      ++++.+.+.+|+||||++||+|.+++...    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.++  
T Consensus        81 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDlkp~NIll~~~~~~  154 (361)
T 2yab_A           81 HDVYENRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIP  154 (361)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCTTSS
T ss_pred             EEEEEeCCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEeCCCCC
Confidence            99999999999999999999999999764    45899999999999999999999  59999999999999998877  


Q ss_pred             --cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehh
Q 017177          239 --FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSC  316 (376)
Q Consensus       239 --~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~  316 (376)
                        .+||+|||++..........    +.    .||+.|+               |||++.+.. ++.++|+||+|+++++
T Consensus       155 ~~~vkl~DFG~a~~~~~~~~~~----~~----~gt~~y~---------------aPE~~~~~~-~~~~~DiwslGvil~~  210 (361)
T 2yab_A          155 IPHIKLIDFGLAHEIEDGVEFK----NI----FGTPEFV---------------APEIVNYEP-LGLEADMWSIGVITYI  210 (361)
T ss_dssp             SCCEEECCCSSCEECCTTCCCC----CC----CSCGGGC---------------CHHHHTTCC-CCTHHHHHHHHHHHHH
T ss_pred             ccCEEEEecCCceEcCCCCccc----cC----CCCccEE---------------CchHHcCCC-CCccccHHHHHHHHHH
Confidence              79999999999876543221    11    7888898               899887654 5889999999999999


Q ss_pred             hccccccc
Q 017177          317 VFSFYRTT  324 (376)
Q Consensus       317 ~~~~y~~~  324 (376)
                      +++.+.+.
T Consensus       211 ll~g~~Pf  218 (361)
T 2yab_A          211 LLSGASPF  218 (361)
T ss_dssp             HHHSCCSS
T ss_pred             HHhCCCCC
Confidence            99765554

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.5e-37  Score=281.90  Aligned_cols=195  Identities=23%  Similarity=0.286  Sum_probs=166.1

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ++|++.+.||+|+||.||+|...         .+++.||+|++.....  ...+.+.+|+.+++.++||||+++++++.+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   72 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNR---------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS   72 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEEC---------CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence            57999999999999999999554         3688999999875432  334678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++..++||||+++ +|.+.+....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.+|.+||+|||
T Consensus        73 ~~~~~lv~e~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH--~~~ivH~dikp~Nil~~~~~~~kl~Dfg  146 (292)
T 3o0g_A           73 DKKLTLVFEFCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFG  146 (292)
T ss_dssp             TTEEEEEEECCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEecCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence            9999999999976 6666665542   55899999999999999999999  5899999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      +++.........  ..     ..||+.|+               |||++.+...++.++|+||+|++++++++.
T Consensus       147 ~~~~~~~~~~~~--~~-----~~~t~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~~l~~~  198 (292)
T 3o0g_A          147 LARAFGIPVRCY--SA-----EVVTLWYR---------------PPDVLFGAKLYSTSIDMWSAGCIFAELANA  198 (292)
T ss_dssp             TCEECCSCCSCC--CS-----CCSCGGGC---------------CHHHHTTCSCCCTHHHHHHHHHHHHHHTTT
T ss_pred             cceecCCccccc--cC-----CccccCCc---------------ChHHHcCCCCcCchHHHHHHHHHHHHHHHc
Confidence            998765432221  11     16788888               899998877789999999999999999854

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.6e-37  Score=289.52  Aligned_cols=201  Identities=23%  Similarity=0.261  Sum_probs=160.2

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC----hhhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES----MQGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      .++|++.+.||+|+||.||+|+...      ...+++.||+|+++...    ......+.+|+.+++.++||||++++++
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   89 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVT------GANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA   89 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECS------STTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEE
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEec------cCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence            4679999999999999999997641      22358899999998653    2234567889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +..++.+|+||||+++|+|.+++.+.    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.+|.+||+
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~Dlkp~Nill~~~~~~kl~  163 (327)
T 3a62_A           90 FQTGGKLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLH--QKGIIYRDLKPENIMLNHQGHVKLT  163 (327)
T ss_dssp             EECSSCEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCTTTEEECTTSCEEEC
T ss_pred             EEcCCEEEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH--hCCEEcccCCHHHeEECCCCcEEEE
Confidence            99999999999999999999999876    45899999999999999999999  5899999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||+++........   ..+    ..||+.|+               |||++.+.. .+.++|+||+|++++++++...+
T Consensus       164 Dfg~~~~~~~~~~~---~~~----~~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~el~~g~~p  220 (327)
T 3a62_A          164 DFGLCKESIHDGTV---THT----FCGTIEYM---------------APEILMRSG-HNRAVDWWSLGALMYDMLTGAPP  220 (327)
T ss_dssp             CCSCC-------------CT----TSSCCTTS---------------CHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             eCCcccccccCCcc---ccc----cCCCcCcc---------------CHhhCcCCC-CCCcccchhHHHHHHHHHHCCCC
Confidence            99999864332221   111    16888888               899887654 48899999999999999965444

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-37  Score=291.28  Aligned_cols=210  Identities=26%  Similarity=0.338  Sum_probs=172.9

Q ss_pred             hhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEE
Q 017177           83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLL  161 (376)
Q Consensus        83 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~  161 (376)
                      ......++|++.+.||+|+||.||+|.....    ....++..||+|+++.... ...+.+.+|+.+++.++||||++++
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~  116 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLL  116 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETS----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCc----CCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            3445567899999999999999999977531    1123468999999987543 4457789999999999999999999


Q ss_pred             eEEEeCCeEEEEEeccCCCCHHHHHhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 017177          162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPS--------------------IQPLSWDIRLKIAIGAARGLGFLHTSEKK  221 (376)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~~~~~~~~~~i~~qi~~~L~yLHs~~~~  221 (376)
                      +++.+++..++||||+++|+|.+++......                    ...+++..++.++.||+.||.|||  .++
T Consensus       117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--~~~  194 (343)
T 1luf_A          117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERK  194 (343)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH--HTT
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH--hCC
Confidence            9999999999999999999999999874321                    156899999999999999999999  599


Q ss_pred             cEecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhc
Q 017177          222 VIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYL  301 (376)
Q Consensus       222 iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~  301 (376)
                      |+||||||+|||++.++.+||+|||+++..............     .||+.|+               +||++.+.. .
T Consensus       195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~-----~~t~~y~---------------aPE~~~~~~-~  253 (343)
T 1luf_A          195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGND-----AIPIRWM---------------PPESIFYNR-Y  253 (343)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----C-----CBCGGGC---------------CHHHHHHCC-C
T ss_pred             eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCC-----cccceec---------------ChhhhccCC-c
Confidence            999999999999999999999999999876544322111111     6778888               899887655 5


Q ss_pred             cccccccceeeeehhhcc
Q 017177          302 TLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       302 ~~~~dv~s~g~v~~~~~~  319 (376)
                      +.++|+||+|++++++++
T Consensus       254 ~~~~Di~slG~il~el~t  271 (343)
T 1luf_A          254 TTESDVWAYGVVLWEIFS  271 (343)
T ss_dssp             CHHHHHHHHHHHHHHHHT
T ss_pred             CcccccHHHHHHHHHHHh
Confidence            889999999999999987

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.5e-37  Score=288.85  Aligned_cols=202  Identities=18%  Similarity=0.171  Sum_probs=161.7

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ..++|++.+.||+|+||.||+|.+.         .+++.||+|+++....   .....+.+|+.+++.++||||++++++
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   80 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDL---------RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDT   80 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEEC---------CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEe
Confidence            4578999999999999999999543         3588999999987532   334678899999999999999999999


Q ss_pred             EEeCC----eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc
Q 017177          164 CWEDK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF  239 (376)
Q Consensus       164 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~  239 (376)
                      +....    ..|+||||+++++|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.
T Consensus        81 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~  154 (311)
T 3ork_A           81 GEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNA  154 (311)
T ss_dssp             EEEEETTEEEEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEETTSC
T ss_pred             eeccCCCCcccEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCCCcCCCCHHHEEEcCCCC
Confidence            87654    359999999999999999876    45899999999999999999999  599999999999999999999


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +||+|||++...............    ..||+.|+               |||++.+.. .+.++||||+|++++++++
T Consensus       155 ~kl~Dfg~a~~~~~~~~~~~~~~~----~~gt~~y~---------------aPE~~~~~~-~~~~~Di~slG~~l~~ll~  214 (311)
T 3ork_A          155 VKVMDFGIARAIADSGNSVTQTAA----VIGTAQYL---------------SPEQARGDS-VDARSDVYSLGCVLYEVLT  214 (311)
T ss_dssp             EEECCCSCC----------------------CCTTC---------------CHHHHHTCC-CCHHHHHHHHHHHHHHHHH
T ss_pred             EEEeeccCcccccccccccccccc----cCcCcccC---------------CHHHhcCCC-CCchHhHHHHHHHHHHHHh
Confidence            999999999877554332111111    27889999               899887764 5789999999999999997


Q ss_pred             cccc
Q 017177          320 FYRT  323 (376)
Q Consensus       320 ~y~~  323 (376)
                      ...+
T Consensus       215 g~~p  218 (311)
T 3ork_A          215 GEPP  218 (311)
T ss_dssp             SSCS
T ss_pred             CCCC
Confidence            5444

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=9.8e-38  Score=296.67  Aligned_cols=208  Identities=16%  Similarity=0.107  Sum_probs=168.3

Q ss_pred             hhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC---CCCcceE
Q 017177           84 LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS---HPNLVKL  160 (376)
Q Consensus        84 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~l  160 (376)
                      .....++|.+.+.||+|+||.||+|.+...    .+..+++.||+|+++....   ..+.+|+.+++.++   |+||+++
T Consensus        60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~  132 (365)
T 3e7e_A           60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDL----NDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKF  132 (365)
T ss_dssp             EECSSSEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred             EEECCEEEEEEEEeeccCCEEEEEEEecCC----cccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhh
Confidence            344567899999999999999999964321    2334688999999987643   45667777777776   9999999


Q ss_pred             EeEEEeCCeEEEEEeccCCCCHHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC---
Q 017177          161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNP-SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG---  236 (376)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~---  236 (376)
                      ++++..++..|+|||||++|+|.+++..... ....+++..++.++.||+.||.|||  .++|+||||||+|||++.   
T Consensus       133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH--~~~ivHrDiKp~NIll~~~~~  210 (365)
T 3e7e_A          133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH--DCEIIHGDIKPDNFILGNGFL  210 (365)
T ss_dssp             EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECGGGT
T ss_pred             heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh--hCCeecCCCCHHHEEeccccc
Confidence            9999999999999999999999999975322 2356999999999999999999999  699999999999999998   


Q ss_pred             --------CCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcccccccc
Q 017177          237 --------VGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSN  308 (376)
Q Consensus       237 --------~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~  308 (376)
                              ++.+||+|||+++............. .    +||+.||               |||++.+.. ++.++|||
T Consensus       211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~-~----~gt~~y~---------------aPE~~~~~~-~~~~~Diw  269 (365)
T 3e7e_A          211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA-K----CETSGFQ---------------CVEMLSNKP-WNYQIDYF  269 (365)
T ss_dssp             CC------CTTEEECCCTTCEEGGGSCTTEEECC-S----SCTTSCC---------------CHHHHTTCC-BSTHHHHH
T ss_pred             CccccccccCCEEEeeCchhhhhhccCCCceeee-e----cCCCCCC---------------ChHHhcCCC-CCccccHH
Confidence                    89999999999987653322211111 1    7889998               899888866 68999999


Q ss_pred             ceeeeehhhcccc
Q 017177          309 SFAFVFSCVFSFY  321 (376)
Q Consensus       309 s~g~v~~~~~~~y  321 (376)
                      |+|++++++++..
T Consensus       270 slG~il~elltg~  282 (365)
T 3e7e_A          270 GVAATVYCMLFGT  282 (365)
T ss_dssp             HHHHHHHHHHHSS
T ss_pred             HHHHHHHHHHhCC
Confidence            9999999998554

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.8e-37  Score=298.94  Aligned_cols=200  Identities=16%  Similarity=0.136  Sum_probs=169.2

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|..         +.+++.||+|++.....  ...+.+.+|+.+++.++||||+++++++
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~---------~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~   79 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVK---------VLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI   79 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEE---------TTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEE---------CCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence            456799999999999999999954         44689999999876543  3456788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc---CCCcEE
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD---GVGFLF  241 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~---~~g~~k  241 (376)
                      .+++..|+|||||++|+|.+.+...    ..+++..+..++.||+.||.|||  .++|+||||||+|||++   .++.+|
T Consensus        80 ~~~~~~~lv~E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH--~~givHrDlKp~NIll~~~~~~~~vk  153 (444)
T 3soa_A           80 SEEGHHYLIFDLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCH--QMGVVHRNLKPENLLLASKLKGAAVK  153 (444)
T ss_dssp             ECSSEEEEEECCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSSTTEEESBSSTTCCEE
T ss_pred             EECCEEEEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEeccCCCCcEE
Confidence            9999999999999999999999876    45899999999999999999999  59999999999999998   468899


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |+|||++..........  .+ .    .||+.|+               |||++.+.. ++.++||||+|++++++++.+
T Consensus       154 L~DFG~a~~~~~~~~~~--~~-~----~gt~~Y~---------------APE~l~~~~-~~~~~DIwSlGvilyell~G~  210 (444)
T 3soa_A          154 LADFGLAIEVEGEQQAW--FG-F----AGTPGYL---------------SPEVLRKDP-YGKPVDLWACGVILYILLVGY  210 (444)
T ss_dssp             ECCCSSCBCCCTTCCBC--CC-S----CSCGGGC---------------CHHHHTTCC-BCTHHHHHHHHHHHHHHHHSS
T ss_pred             EccCceeEEecCCCcee--ec-c----cCCcccC---------------CHHHhcCCC-CCCccccHHHHHHHHHHHhCC
Confidence            99999998776543221  11 1    7889999               899887654 588999999999999999766


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      .+.
T Consensus       211 ~Pf  213 (444)
T 3soa_A          211 PPF  213 (444)
T ss_dssp             CSC
T ss_pred             CCC
Confidence            554

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.8e-37  Score=285.93  Aligned_cols=195  Identities=20%  Similarity=0.189  Sum_probs=167.7

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeE
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKEL  170 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~  170 (376)
                      |...+.||+|+||.||+|...         .+++.||||++........+.+.+|+.+++.++||||+++++++...+..
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~---------~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREK---------HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL  117 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             hhccEEeccCCCeEEEEEEEC---------CCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence            667789999999999999554         35889999999876656667889999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       171 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      ++||||+++++|.+++.+     ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||++..
T Consensus       118 ~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  190 (321)
T 2c30_A          118 WVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLH--AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQ  190 (321)
T ss_dssp             EEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCcEEEeeeeeeee
Confidence            999999999999999864     34899999999999999999999  59999999999999999999999999999987


Q ss_pred             eccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          251 FKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ........   ...    .||+.|+               |||++.+. ..+.++||||+|++++++++...+.
T Consensus       191 ~~~~~~~~---~~~----~gt~~y~---------------aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf  241 (321)
T 2c30_A          191 ISKDVPKR---KSL----VGTPYWM---------------APEVISRS-LYATEVDIWSLGIMVIEMVDGEPPY  241 (321)
T ss_dssp             CCSSSCCB---CCC----CSCGGGC---------------CHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cccCcccc---ccc----cCCcccc---------------CHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            75532221   111    7888888               89988765 4588999999999999999655443

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2e-37  Score=285.63  Aligned_cols=205  Identities=23%  Similarity=0.361  Sum_probs=167.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|++.+.||+|+||.||+|++..     .+..+++.||+|++........+.+.+|+.+++.++||||+++++++...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECT-----TCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEec-----ccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            4679999999999999999997643     24446899999999987777778899999999999999999999998653


Q ss_pred             --CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          168 --KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       168 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                        ..+++||||+++|+|.+++....   ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+||
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~kl~Df  158 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDF  158 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHhhEEEcCCCeEEEccC
Confidence              56899999999999999997652   45899999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      |++................    .+|+.|+               |||++.+.. .+.++||||+|++++++++...
T Consensus       159 g~~~~~~~~~~~~~~~~~~----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~  215 (295)
T 3ugc_A          159 GLTKVLPQDKEFFKVKEPG----ESPIFWY---------------APESLTESK-FSVASDVWSFGVVLYELFTYIE  215 (295)
T ss_dssp             CSCC-------------CT----TCGGGGC---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTC
T ss_pred             cccccccCCcceeeeccCC----CCcccee---------------CcHHhcCCC-CChHHHHHHHHHHHHHHHhccc
Confidence            9999775543321111111    4556677               899887765 5889999999999999997543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-36  Score=290.56  Aligned_cols=200  Identities=18%  Similarity=0.179  Sum_probs=172.0

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|++..........+.+|+.+++.++||||+++++++.+
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~  119 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEK---------ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED  119 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC
T ss_pred             cccceEEEEEEecCCCEEEEEEEEC---------CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe
Confidence            3467999999999999999999544         3688999999987766666788999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC--CCcEEEcc
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG--VGFLFDSH  244 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~--~g~~kl~D  244 (376)
                      .+.+++||||+++|+|.+++...   ...+++..+..++.||+.||.|||  .++|+||||||+|||++.  ++.+||+|
T Consensus       120 ~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDlkp~NIll~~~~~~~vkL~D  194 (387)
T 1kob_A          120 KYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIID  194 (387)
T ss_dssp             SSEEEEEEECCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTCCCEEECC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccchHHeEEecCCCCceEEEe
Confidence            99999999999999999998654   245899999999999999999999  599999999999999974  57899999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ||+++..........        ..||+.|+               |||++.+.. .+.++||||+|++++++++...+.
T Consensus       195 FG~a~~~~~~~~~~~--------~~gt~~y~---------------aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf  250 (387)
T 1kob_A          195 FGLATKLNPDEIVKV--------TTATAEFA---------------APEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPF  250 (387)
T ss_dssp             CTTCEECCTTSCEEE--------ECSSGGGC---------------CHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred             cccceecCCCcceee--------eccCCCcc---------------CchhccCCC-CCCcccEeeHhHHHHHHHhCCCCC
Confidence            999998765433221        16788888               899887654 578999999999999999765544

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=286.72  Aligned_cols=199  Identities=21%  Similarity=0.277  Sum_probs=162.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--------------------------hhHHH
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--------------------------QGFEE  141 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~  141 (376)
                      .++|++.+.||+|+||.||+|...         .+++.||+|++.....                          ...+.
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNE---------NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ   82 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEET---------TTTEEEEEEEEECC-------------------------------CH
T ss_pred             ecceEEEeEEeecCCEEEEEEEEC---------CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHH
Confidence            468999999999999999999544         3688999999865431                          11356


Q ss_pred             HHHHHHHHhcCCCCCcceEEeEEEe--CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 017177          142 WQSEVNFLGRLSHPNLVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSE  219 (376)
Q Consensus       142 ~~~E~~il~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~  219 (376)
                      +.+|+.+++.++||||+++++++.+  .+.+|+||||+++++|.+++..     ..+++..+..++.|++.||.|||  .
T Consensus        83 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH--~  155 (298)
T 2zv2_A           83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLH--Y  155 (298)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHH--H
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH--H
Confidence            8899999999999999999999987  5689999999999999876532     45899999999999999999999  5


Q ss_pred             CCcEecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhh
Q 017177          220 KKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIK  299 (376)
Q Consensus       220 ~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~  299 (376)
                      ++|+||||||+|||++.+|.+||+|||+++.........  ..     ..||+.|+               |||++.+..
T Consensus       156 ~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~-----~~gt~~y~---------------aPE~~~~~~  213 (298)
T 2zv2_A          156 QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL--SN-----TVGTPAFM---------------APESLSETR  213 (298)
T ss_dssp             TTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEE--CC-----CCSCGGGC---------------CGGGCCTTC
T ss_pred             CCeeccCCCHHHEEECCCCCEEEecCCCccccccccccc--cC-----CcCCcccc---------------ChhhhccCC
Confidence            899999999999999999999999999999876543221  11     17888888               899877654


Q ss_pred             h--ccccccccceeeeehhhccccccc
Q 017177          300 Y--LTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       300 ~--~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      .  .+.++|+||+|++++++++...+.
T Consensus       214 ~~~~~~~~Di~slG~~l~~l~~g~~pf  240 (298)
T 2zv2_A          214 KIFSGKALDVWAMGVTLYCFVFGQCPF  240 (298)
T ss_dssp             CCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence            2  477899999999999998655443

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.3e-37  Score=303.64  Aligned_cols=200  Identities=24%  Similarity=0.209  Sum_probs=159.4

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC---ChhhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||||+++..   .......+.+|+.+++.++||||++++++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~  216 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEK---------ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS  216 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEc---------CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEE
Confidence            3467999999999999999999543         46899999998753   22334567889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +.+.+.+|+||||+++|+|.+++.+.    ..+++..+..++.||+.||.|||+ .++|+||||||+|||++.+|.+||+
T Consensus       217 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~-~~giiHrDlkp~NIll~~~~~~kl~  291 (446)
T 4ejn_A          217 FQTHDRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKIT  291 (446)
T ss_dssp             EEETTEEEEEECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCCCGGGEEECSSSCEEEC
T ss_pred             EeeCCEEEEEEeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhh-cCCEEECCCCHHHEEECCCCCEEEc
Confidence            99999999999999999999999776    458999999999999999999993 3899999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||+++........   ..+.    +||+.|+               |||++.+.. ++.++||||+|++++++++-..+
T Consensus       292 DFG~a~~~~~~~~~---~~~~----~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~ell~g~~P  348 (446)
T 4ejn_A          292 DFGLCKEGIKDGAT---MKTF----CGTPEYL---------------APEVLEDND-YGRAVDWWGLGVVMYEMMCGRLP  348 (446)
T ss_dssp             CCCCCCTTCC--------CCS----SSCGGGC---------------CHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCCceeccCCCcc---cccc----cCCcccc---------------CHhhcCCCC-CCCccchhhhHHHHHHHhhCCCC
Confidence            99999864332221   1112    7889999               899887665 58899999999999999864433

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.2e-37  Score=291.38  Aligned_cols=198  Identities=19%  Similarity=0.147  Sum_probs=162.6

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|++...... .+.+.+|+.+++.++||||+++++++.+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~   87 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDK---------LTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILT   87 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEET---------TTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEEC---------CCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEee
Confidence            3568999999999999999999544         46899999999765432 2567899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc--EEEcc
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF--LFDSH  244 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~--~kl~D  244 (376)
                      ++..++||||+++|+|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.  +||+|
T Consensus        88 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH--~~~ivH~Dlkp~Nill~~~~~~~~kl~D  161 (361)
T 3uc3_A           88 PTHLAIIMEYASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICD  161 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTCCSCCCCGGGEEECSSSSCCEEECC
T ss_pred             CCEEEEEEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEcCCCCceEEEee
Confidence            99999999999999999999776    45899999999999999999999  599999999999999987765  99999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ||+++.........        ...||+.|+               |||++.+..+.+.++||||+|++++++++...+
T Consensus       162 fg~a~~~~~~~~~~--------~~~gt~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~ell~g~~P  217 (361)
T 3uc3_A          162 FGYSKSSVLHSQPK--------STVGTPAYI---------------APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP  217 (361)
T ss_dssp             CCCC-----------------------CTTS---------------CHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCccccccccCCCC--------CCcCCCCcC---------------ChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCC
Confidence            99998543322221        117888888               899998888777779999999999999865444

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=7.8e-37  Score=290.25  Aligned_cols=199  Identities=17%  Similarity=0.211  Sum_probs=169.5

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|++....  ....+.+.+|+.+++.++||||+++++++
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~   97 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHK---------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI   97 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEEC---------CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            3467999999999999999999544         368899999997653  34557788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC---CcEE
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV---GFLF  241 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~---g~~k  241 (376)
                      .+++..|+||||+++|+|.+++...    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.+   +.+|
T Consensus        98 ~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~Dlkp~NIll~~~~~~~~~k  171 (362)
T 2bdw_A           98 QEESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVK  171 (362)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEESCSSTTCCEE
T ss_pred             EeCCEEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCchHHEEEecCCCCCCEE
Confidence            9999999999999999999999765    45899999999999999999999  5899999999999999765   4599


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |+|||++..........    ..    .||+.|+               |||++.+.. ++.++||||+|++++++++.+
T Consensus       172 l~DfG~a~~~~~~~~~~----~~----~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~~ll~g~  227 (362)
T 2bdw_A          172 LADFGLAIEVNDSEAWH----GF----AGTPGYL---------------SPEVLKKDP-YSKPVDIWACGVILYILLVGY  227 (362)
T ss_dssp             ECCCTTCBCCTTCCSCC----CS----CSCTTTC---------------CHHHHTTCC-CCTHHHHHHHHHHHHHHHHSS
T ss_pred             EeecCcceEecCCcccc----cC----CCCcccc---------------CHHHHccCC-CCchhhHHHHHHHHHHHHHCC
Confidence            99999998776543221    11    7888888               899887654 578999999999999999765


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      .+.
T Consensus       228 ~Pf  230 (362)
T 2bdw_A          228 PPF  230 (362)
T ss_dssp             CSS
T ss_pred             CCC
Confidence            554

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.8e-37  Score=290.27  Aligned_cols=211  Identities=24%  Similarity=0.267  Sum_probs=172.7

Q ss_pred             hhhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcC-CCCCcce
Q 017177           82 LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVK  159 (376)
Q Consensus        82 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~  159 (376)
                      .......++|++.+.||+|+||.||+|.+.+.    .+..+++.||||+++... ....+.+.+|+.+++++ +||||++
T Consensus        15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccccccccceeeceeecCCCCceEEEEEeccc----cccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            34455678899999999999999999976431    244568999999998753 34456789999999999 6999999


Q ss_pred             EEeEEEeCC-eEEEEEeccCCCCHHHHHhhcCCC----------------------------------------------
Q 017177          160 LLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPS----------------------------------------------  192 (376)
Q Consensus       160 l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------  192 (376)
                      +++++.+.+ .+++||||+++|+|.+++......                                              
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999998765 499999999999999999765321                                              


Q ss_pred             ----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeecccee
Q 017177          193 ----------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYI  256 (376)
Q Consensus       193 ----------------~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~  256 (376)
                                      ...+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||++........
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                            122889999999999999999999  58999999999999999999999999999987644333


Q ss_pred             eEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          257 YIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       257 ~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      .... +..    .||+.|+               |||++.+.. ++.++||||+|++++++++
T Consensus       249 ~~~~-~~~----~~t~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~ellt  290 (359)
T 3vhe_A          249 YVRK-GDA----RLPLKWM---------------APETIFDRV-YTIQSDVWSFGVLLWEIFS  290 (359)
T ss_dssp             CEEC---C----EECGGGC---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHTT
T ss_pred             chhc-ccc----CCCceeE---------------ChhhhcCCC-CCchhhhhhHHHHHHHHHh
Confidence            2112 112    7788888               899887654 5789999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8.1e-37  Score=285.47  Aligned_cols=197  Identities=23%  Similarity=0.241  Sum_probs=165.0

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ...++|++.+.||+|+||.||+|.+.           ++.||||++..... ......+|+.+++.++||||+++++++.
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~   88 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEK   88 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET-----------TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             cchhhchhhheecccCceEEEEEEEC-----------CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceec
Confidence            34568999999999999999999654           67899999976543 2345567999999999999999999998


Q ss_pred             eCC----eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC----------CcEecCCCCCC
Q 017177          166 EDK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEK----------KVIYRDFKASN  231 (376)
Q Consensus       166 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~----------~iiHrDlKp~N  231 (376)
                      ...    .+++||||+++|+|.+++...     .+++..+..++.|++.||.|||  ..          +|+||||||+|
T Consensus        89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH--~~~~~l~~~~~~~ivH~Dlkp~N  161 (322)
T 3soc_A           89 RGTSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLH--EDIPGLKDGHKPAISHRDIKSKN  161 (322)
T ss_dssp             EECSSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHT--CCEEEETTEEECEEECSCCSGGG
T ss_pred             cCCCCCceEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH--hhccccccccCCCEEeCCCChHh
Confidence            754    479999999999999999764     3899999999999999999999  57          99999999999


Q ss_pred             EEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh----hhccccccc
Q 017177          232 ILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI----KYLTLLKYS  307 (376)
Q Consensus       232 ILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~----~~~~~~~dv  307 (376)
                      ||++.++.+||+|||+++..............     .||+.|+               |||++.+.    ...+.++||
T Consensus       162 ill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~-----~gt~~y~---------------aPE~~~~~~~~~~~~~~~~Di  221 (322)
T 3soc_A          162 VLLKNNLTACIADFGLALKFEAGKSAGDTHGQ-----VGTRRYM---------------APEVLEGAINFQRDAFLRIDM  221 (322)
T ss_dssp             EEECTTCCEEECCCTTCEEECTTSCCCCCTTC-----CCCGGGC---------------CHHHHTTCCCCCHHHHHHHHH
T ss_pred             EEECCCCeEEEccCCcccccccccCccccccC-----ccCcccc---------------CHhhcccccccCcCCCccchh
Confidence            99999999999999999887654332111111     7888888               89988873    456788999


Q ss_pred             cceeeeehhhcccc
Q 017177          308 NSFAFVFSCVFSFY  321 (376)
Q Consensus       308 ~s~g~v~~~~~~~y  321 (376)
                      ||+|++++++++..
T Consensus       222 wslG~il~el~tg~  235 (322)
T 3soc_A          222 YAMGLVLWELASRC  235 (322)
T ss_dssp             HHHHHHHHHHHTTB
T ss_pred             HHHHHHHHHHHhCC
Confidence            99999999999753

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=9.6e-37  Score=290.75  Aligned_cols=193  Identities=19%  Similarity=0.255  Sum_probs=161.2

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEEE
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lv  173 (376)
                      .+.||+|+||.||+|...         .+++.||+|+++.......+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~---------~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  164 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEET---------ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV  164 (373)
T ss_dssp             EEECC-----CEEEEEET---------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ceEEecCcCEEEEEEEEc---------CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            578999999999999544         36889999999887766778899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE--cCCCcEEEcceeeeeee
Q 017177          174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL--DGVGFLFDSHLLIYVYF  251 (376)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl--~~~g~~kl~Dfg~a~~~  251 (376)
                      |||+++|+|.+++....   ..+++..+..++.||+.||.|||  ..+|+||||||+|||+  +.++.+||+|||+++..
T Consensus       165 ~E~~~~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~  239 (373)
T 2x4f_A          165 MEYVDGGELFDRIIDES---YNLTELDTILFMKQICEGIRHMH--QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY  239 (373)
T ss_dssp             EECCTTCEEHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred             EeCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence            99999999999886542   45899999999999999999999  5999999999999999  56789999999999987


Q ss_pred             ccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          252 KRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       252 ~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      .........        .||+.|+               |||++.+. ..+.++||||+|++++++++...+.
T Consensus       240 ~~~~~~~~~--------~gt~~y~---------------aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf  288 (373)
T 2x4f_A          240 KPREKLKVN--------FGTPEFL---------------APEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPF  288 (373)
T ss_dssp             CTTCBCCCC--------CSSCTTC---------------CHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCccccccc--------cCCCcEe---------------ChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCC
Confidence            654433111        6888888               89987654 4588999999999999999765544

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=9.4e-37  Score=285.15  Aligned_cols=209  Identities=21%  Similarity=0.250  Sum_probs=166.2

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|...         .+++.||||+++.... ...+.+.+|+.++++++||||+++++++.+
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   75 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNK---------VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLE   75 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEET---------TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEE
T ss_pred             hhcCceeeEecCCCCeEEEEEEEc---------CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            457999999999999999999554         3588999999875433 345788999999999999999999999866


Q ss_pred             CC---------------------------------------------------------eEEEEEeccCCCCHHHHHhhc
Q 017177          167 DK---------------------------------------------------------ELLLVYEYMQRGSLENHLFRR  189 (376)
Q Consensus       167 ~~---------------------------------------------------------~~~lv~e~~~~g~L~~~l~~~  189 (376)
                      .+                                                         ..++|||||++|+|.+++.+.
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~  155 (332)
T 3qd2_B           76 TPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR  155 (332)
T ss_dssp             CCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC
T ss_pred             eccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc
Confidence            43                                                         389999999999999999875


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEee-----eE
Q 017177          190 NPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHT-----YI  264 (376)
Q Consensus       190 ~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~-----~~  264 (376)
                      .. ....++..++.++.||+.||.|||  +++|+||||||+|||++.++.+||+|||+++.............     ..
T Consensus       156 ~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~  232 (332)
T 3qd2_B          156 CS-LEDREHGVCLHIFIQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT  232 (332)
T ss_dssp             CS-GGGSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------C
T ss_pred             cC-ccchhhHHHHHHHHHHHHHHHHHH--hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccc
Confidence            43 234567788999999999999999  59999999999999999999999999999998766432211100     00


Q ss_pred             EEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          265 IYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       265 ~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      .....||+.|+               |||++.+.. .+.++||||+|++++++++-+...
T Consensus       233 ~~~~~gt~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~el~~~~~~~  276 (332)
T 3qd2_B          233 HTGQVGTKLYM---------------SPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQ  276 (332)
T ss_dssp             CCSCC-CGGGS---------------CHHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred             ccccCCCcCcc---------------ChHHhcCCC-CcchhhHHHHHHHHHHHHHcCCCh
Confidence            01126888888               899887764 588999999999999999765543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.7e-37  Score=294.44  Aligned_cols=208  Identities=18%  Similarity=0.153  Sum_probs=171.7

Q ss_pred             cCCCCccceEeec--CcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           88 TKNFKPDSLLGEG--GFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        88 ~~~y~~~~~lG~G--~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      .++|++.+.||+|  +||.||+|...         .+++.||||+++...  ....+.+.+|+.+++.++||||++++++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~   94 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYK---------PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT   94 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEc---------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence            4679999999999  99999999554         368999999997643  3445678899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +.+++.+|+|||||++|+|.+++.....  ..+++..+..++.||+.||.|||  .++|+||||||+|||++.+|.+||+
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~NIll~~~~~~kl~  170 (389)
T 3gni_B           95 FIADNELWVVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLS  170 (389)
T ss_dssp             EEETTEEEEEEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEEC
T ss_pred             EEECCEEEEEEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEc
Confidence            9999999999999999999999977532  45899999999999999999999  5999999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh-hhccccccccceeeeehhhccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI-KYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~-~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      |||.+.....................||+.|+               |||++.+. ..++.++||||+|++++++++...
T Consensus       171 dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~---------------aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~  235 (389)
T 3gni_B          171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL---------------SPEVLQQNLQGYDAKSDIYSVGITACELANGHV  235 (389)
T ss_dssp             CGGGCEECEETTEECSCBCCCCTTCTTTGGGS---------------CHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ccccceeecccccccccccccccccccccccc---------------CHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCC
Confidence            99998866443322111111111126777787               89988874 456889999999999999986544


Q ss_pred             c
Q 017177          323 T  323 (376)
Q Consensus       323 ~  323 (376)
                      +
T Consensus       236 p  236 (389)
T 3gni_B          236 P  236 (389)
T ss_dssp             T
T ss_pred             C
Confidence            3

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=8.3e-37  Score=284.05  Aligned_cols=197  Identities=22%  Similarity=0.277  Sum_probs=166.1

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|...          +++.||+|++.....  ...+.+.+|+.+++.++||||+++++++
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   88 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDS----------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI   88 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEET----------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEEC----------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            4578999999999999999999654          278899999976532  2346788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .+++..++||||+++ +|.+++....   ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~D  162 (311)
T 3niz_A           89 HSERCLTLVFEFMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCH--QHRILHRDLKPQNLLINSDGALKLAD  162 (311)
T ss_dssp             CCSSCEEEEEECCSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred             ccCCEEEEEEcCCCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCchHhEEECCCCCEEEcc
Confidence            999999999999975 8888887653   45899999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      ||+++..........  .     ..||+.|+               |||++.+...++.++||||+|++++++++..
T Consensus       163 fg~a~~~~~~~~~~~--~-----~~~t~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  217 (311)
T 3niz_A          163 FGLARAFGIPVRSYT--H-----EVVTLWYR---------------APDVLMGSKKYSTSVDIWSIGCIFAEMITGK  217 (311)
T ss_dssp             CTTCEETTSCCC-----C-----CCCCCTTC---------------CHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CcCceecCCCccccc--C-----CcccCCcC---------------CHHHhcCCCCCCchHHhHHHHHHHHHHHhCC
Confidence            999997654322211  1     16788888               8999988777899999999999999998644

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.4e-36  Score=289.73  Aligned_cols=201  Identities=24%  Similarity=0.335  Sum_probs=156.7

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-ChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|+...      ....+..||||.++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  117 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKL------PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK  117 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBC------TTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEec------CCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence            4579999999999999999996542      1124778999999865 33455788999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      .+..++||||+++|+|.+++.+..   ..+++..+..++.||+.||.|||  +++|+||||||+|||++.++.+||+|||
T Consensus       118 ~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  192 (373)
T 2qol_A          118 SKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFG  192 (373)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             CCceEEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCcceEEEcCCCCEEECcCc
Confidence            999999999999999999997652   45899999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +++..............    ..+|+.|+               |||++.+.. ++.++||||+|++++|+++
T Consensus       193 ~a~~~~~~~~~~~~~~~----~~~~~~y~---------------aPE~~~~~~-~~~~~Dv~SlG~il~ellt  245 (373)
T 2qol_A          193 LGRVLEDDPEAAYTTRG----GKIPIRWT---------------SPEAIAYRK-FTSASDVWSYGIVLWEVMS  245 (373)
T ss_dssp             -------------------------CTTS---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             cccccccCCccceeccC----CCcCCCcc---------------ChhhhccCC-cCchhcHHHHHHHHHHHHh
Confidence            99977554322111110    14466777               899887654 5889999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=6.5e-37  Score=292.39  Aligned_cols=199  Identities=22%  Similarity=0.269  Sum_probs=167.3

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ...++|++.+.||+|+||.||+|.+..         ++..||||.++.... ...+.+.+|+.+++.++||||+++++++
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  181 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRA---------DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC  181 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEec---------CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            345679999999999999999996543         588999999986532 3345788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      ..++..|+||||+++|+|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|
T Consensus       182 ~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nil~~~~~~~kl~D  256 (377)
T 3cbl_A          182 TQKQPIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLE--SKCCIHRDLAARNCLVTEKNVLKISD  256 (377)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             ecCCCcEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCcCCcccCHHHEEEcCCCcEEECc
Confidence            99899999999999999999997652   45899999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ||+++......... ..+..    .+++.|+               |||++.+.. ++.++||||+|++++|+++
T Consensus       257 fG~s~~~~~~~~~~-~~~~~----~~~~~y~---------------aPE~~~~~~-~~~~~DvwslG~il~el~t  310 (377)
T 3cbl_A          257 FGMSREEADGVYAA-SGGLR----QVPVKWT---------------APEALNYGR-YSSESDVWSFGILLWETFS  310 (377)
T ss_dssp             GGGCEECTTSEEEC-CSSCC----EEEGGGS---------------CHHHHHHCE-EEHHHHHHHHHHHHHHHHT
T ss_pred             CCCceecCCCceee-cCCCC----CCCcCcC---------------CHhHhccCC-CCchhhHHHHHHHHHHHHh
Confidence            99998765432221 11111    4566777               899887654 5889999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=7.9e-37  Score=283.77  Aligned_cols=208  Identities=25%  Similarity=0.265  Sum_probs=172.1

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ....++|++.+.||+|+||.||+|.....    ....++..||+|+++... ....+.+.+|+.+++.++||||++++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   94 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHL----KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGA   94 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETG----GGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEecc----CcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence            34467899999999999999999976431    223357899999998653 3456788999999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcE
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNP--------------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVI  223 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~ii  223 (376)
                      +.+.+..++||||+++|+|.+++.....                    ....+++..+..++.||+.||.|||  .++|+
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~iv  172 (314)
T 2ivs_A           95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA--EMKLV  172 (314)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH--HCCCc
Confidence            9999999999999999999999987532                    1234889999999999999999999  59999


Q ss_pred             ecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccc
Q 017177          224 YRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTL  303 (376)
Q Consensus       224 HrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~  303 (376)
                      ||||||+|||++.++.+||+|||++...............     .+|+.|+               +||++.+.. .+.
T Consensus       173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~-----~~~~~y~---------------aPE~~~~~~-~~~  231 (314)
T 2ivs_A          173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQG-----RIPVKWM---------------AIESLFDHI-YTT  231 (314)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCC-----CSCGGGC---------------CHHHHHHCE-ECH
T ss_pred             ccccchheEEEcCCCCEEEccccccccccccccceeccCC-----CCccccc---------------ChhhhcCCC-cCc
Confidence            9999999999999999999999999987654433211111     5677788               899887654 588


Q ss_pred             cccccceeeeehhhcc
Q 017177          304 LKYSNSFAFVFSCVFS  319 (376)
Q Consensus       304 ~~dv~s~g~v~~~~~~  319 (376)
                      ++|+||+|++++++++
T Consensus       232 ~~Di~slG~il~el~t  247 (314)
T 2ivs_A          232 QSDVWSFGVLLWEIVT  247 (314)
T ss_dssp             HHHHHHHHHHHHHHHT
T ss_pred             hhhHHHHHHHHHHHHh
Confidence            9999999999999987

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.7e-36  Score=286.43  Aligned_cols=194  Identities=26%  Similarity=0.293  Sum_probs=165.7

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      +.|++.+.||+|+||.||+|...         .+++.||||++....   ....+.+.+|+.+++.++||||+++++++.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  124 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDV---------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL  124 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEc---------cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            45889999999999999999543         358899999987543   233467889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +++..++||||+. |+|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.+|.+||+||
T Consensus       125 ~~~~~~lv~e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~Df  198 (348)
T 1u5q_A          125 REHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDF  198 (348)
T ss_dssp             ETTEEEEEEECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEEETTTEEEECCC
T ss_pred             ECCeEEEEEecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEEEeec
Confidence            9999999999997 58888886542   46899999999999999999999  589999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh--hhhccccccccceeeeehhhcccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW--IKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~--~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |++.........           .||+.|+               |||++.+  ...++.++||||+|++++++++...+
T Consensus       199 G~a~~~~~~~~~-----------~gt~~y~---------------aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p  252 (348)
T 1u5q_A          199 GSASIMAPANSF-----------VGTPYWM---------------APEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  252 (348)
T ss_dssp             TTCBSSSSBCCC-----------CSCGGGC---------------CHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             cCceecCCCCcc-----------cCCccee---------------CHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            999876543221           7888888               8998864  35568899999999999999965544

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.3e-37  Score=300.73  Aligned_cols=199  Identities=20%  Similarity=0.211  Sum_probs=172.7

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ..++|.+.+.||+|+||.||+|...         .+++.||||++.....   ...+.+.+|+.+++.++||||++++++
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~---------~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~   84 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHE---------LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV   84 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEET---------TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            4568999999999999999999544         4689999999975422   234678899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +.+.+.+|+||||+++|+|.+++.+.    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.++.+||+
T Consensus        85 ~~~~~~~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDLkp~NIll~~~~~vkL~  158 (476)
T 2y94_A           85 ISTPSDIFMVMEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCH--RHMVVHRDLKPENVLLDAHMNAKIA  158 (476)
T ss_dssp             EECSSEEEEEEECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEECCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCCCcccccHHHEEEecCCCeEEE
Confidence            99999999999999999999999754    45899999999999999999999  6999999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||++.........    .+.    +||+.|+               |||++.+..+.+.++||||+|++++++++...+
T Consensus       159 DFG~a~~~~~~~~~----~~~----~gt~~y~---------------aPE~~~~~~~~~~~~DiwSlGvil~elltG~~P  215 (476)
T 2y94_A          159 DFGLSNMMSDGEFL----RTS----CGSPNYA---------------APEVISGRLYAGPEVDIWSSGVILYALLCGTLP  215 (476)
T ss_dssp             CCSSCEECCTTCCB----CCC----CSCSTTC---------------CHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred             eccchhhccccccc----ccc----CCCcCeE---------------ChhhccCCCCCCCcceehhhHHHHHHHhhCCCC
Confidence            99999987654322    111    7888888               899999888878999999999999999965443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.7e-36  Score=277.47  Aligned_cols=201  Identities=18%  Similarity=0.163  Sum_probs=169.6

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcC-CCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRL-SHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l-~h~nIv~l~~~  163 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|+++...  ......+.+|+..+..+ +||||++++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~   79 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKR---------LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSA   79 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEc---------CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence            3467999999999999999999554         358899999987642  23456788999999999 79999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC------
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV------  237 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~------  237 (376)
                      +.+++..++||||+++++|.+++.........+++..+..++.||+.||.|||  .++|+||||||+|||++.+      
T Consensus        80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dikp~NIl~~~~~~~~~~  157 (289)
T 1x8b_A           80 WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH--SMSLVHMDIKPSNIFISRTSIPNAA  157 (289)
T ss_dssp             EEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEC--------
T ss_pred             eecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH--hCCEeecCCCHHHEEEcCCCCCccc
Confidence            99999999999999999999999765322345899999999999999999999  5999999999999999844      


Q ss_pred             -------------CcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcccc
Q 017177          238 -------------GFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLL  304 (376)
Q Consensus       238 -------------g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~  304 (376)
                                   ..+||+|||++.........           .||+.|+               +||++.+....+.+
T Consensus       158 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~-----------~gt~~y~---------------aPE~~~~~~~~~~~  211 (289)
T 1x8b_A          158 SEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE-----------EGDSRFL---------------ANEVLQENYTHLPK  211 (289)
T ss_dssp             ------------CCCEEECCCTTCEETTCSCCC-----------CCCGGGC---------------CHHHHTTCCTTHHH
T ss_pred             ccccccccccCCceEEEEcccccccccCCcccc-----------CCCcccc---------------ChhHhcCCCCCCch
Confidence                         47999999999987654322           5778888               89998877677889


Q ss_pred             ccccceeeeehhhccccccc
Q 017177          305 KYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       305 ~dv~s~g~v~~~~~~~y~~~  324 (376)
                      +||||+|++++++++.....
T Consensus       212 ~Di~slG~il~~l~~~~~~~  231 (289)
T 1x8b_A          212 ADIFALALTVVCAAGAEPLP  231 (289)
T ss_dssp             HHHHHHHHHHHHHTTCCCCC
T ss_pred             hhHHHHHHHHHHHhcCCCCC
Confidence            99999999999998765443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=297.29  Aligned_cols=198  Identities=21%  Similarity=0.261  Sum_probs=169.7

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      .++|++.+.||+|+||.||+|...         .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~---------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~   84 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKN---------DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF   84 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            467999999999999999999544         468999999987542   23356788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .+.+.+|+||||+.||+|.+++...    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.+|.+||+|
T Consensus        85 ~~~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~vkL~D  158 (384)
T 4fr4_A           85 QDEEDMFMVVDLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQ--NQRIIHRDMKPDNILLDEHGHVHITD  158 (384)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred             EeCCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCcHHHeEECCCCCEEEec
Confidence            9999999999999999999999765    45899999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh--hhccccccccceeeeehhhccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI--KYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~--~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      ||++.........    .+.    +||+.|+               |||++.+.  ..++.++|+||+|++++++++...
T Consensus       159 FG~a~~~~~~~~~----~~~----~gt~~Y~---------------aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~  215 (384)
T 4fr4_A          159 FNIAAMLPRETQI----TTM----AGTKPYM---------------APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR  215 (384)
T ss_dssp             CTTCEECCTTCCB----CCC----CSCGGGC---------------CGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred             cceeeeccCCCce----ecc----CCCcccc---------------CCeeeccCCCCCCCccceeechHHHHHHHHhCCC
Confidence            9999977544322    112    7888898               89988653  346889999999999999996544


Q ss_pred             c
Q 017177          323 T  323 (376)
Q Consensus       323 ~  323 (376)
                      +
T Consensus       216 P  216 (384)
T 4fr4_A          216 P  216 (384)
T ss_dssp             S
T ss_pred             C
Confidence            4

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.8e-36  Score=277.78  Aligned_cols=205  Identities=24%  Similarity=0.351  Sum_probs=169.4

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|.+..     .+..+++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDP-----EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE   94 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECT-----TSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEcc-----ccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence            3568999999999999999997643     3445689999999986532 345778999999999999999999999987


Q ss_pred             C--CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          167 D--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       167 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .  ..+++||||+++|+|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|
T Consensus        95 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~D  169 (302)
T 4e5w_A           95 DGGNGIKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLG--SRQYVHRDLAARNVLVESEHQVKIGD  169 (302)
T ss_dssp             ---CCEEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECC
T ss_pred             CCCceEEEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhh--cCCcccCCCchheEEEcCCCCEEECc
Confidence            6  66899999999999999996653   45899999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      ||++................    .||+.|+               +||++.+.. .+.++|+||+|++++++++...
T Consensus       170 fg~~~~~~~~~~~~~~~~~~----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~  227 (302)
T 4e5w_A          170 FGLTKAIETDKEYYTVKDDR----DSPVFWY---------------APECLMQSK-FYIASDVWSFGVTLHELLTYCD  227 (302)
T ss_dssp             CTTCEECCTTCCEEECCCCT----TCCGGGC---------------CHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTC
T ss_pred             ccccccccCCCcceeccCCC----CCCcccc---------------CCeeecCCC-CCcchhHHHHHHHHHHHHHccC
Confidence            99999876654432222222    6777787               899887665 4788999999999999997543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=5.6e-37  Score=304.29  Aligned_cols=203  Identities=23%  Similarity=0.279  Sum_probs=172.9

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      .++|++.++||+|+||.||+|+..         .+++.||+|++.+...   ...+.+.+|+.+++.++||||+++++++
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~---------~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~  254 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMK---------ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF  254 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEC---------CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            467899999999999999999544         4689999999975422   2346788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .+.+.+|+||||++||+|.+++.........+++..+..++.||+.||.|||  .++|+||||||+|||++.+|.+||+|
T Consensus       255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH--~~gIvHrDLKP~NILl~~~g~vkL~D  332 (543)
T 3c4z_A          255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISD  332 (543)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEECC
T ss_pred             eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH--HcCCcccCCChHHEEEeCCCCEEEee
Confidence            9999999999999999999999765433456999999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ||+++.........   .+    .+||+.|+               |||++.+.. ++.++|+||+|++++++++...+.
T Consensus       333 FGla~~~~~~~~~~---~~----~~GT~~Y~---------------APE~l~~~~-~~~~~DiwSlGvilyelltG~~PF  389 (543)
T 3c4z_A          333 LGLAVELKAGQTKT---KG----YAGTPGFM---------------APELLLGEE-YDFSVDYFALGVTLYEMIAARGPF  389 (543)
T ss_dssp             CTTCEECCTTCCCB---CC----CCSCTTTS---------------CHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cceeeeccCCCccc---cc----ccCCcccc---------------ChhhhcCCC-CChHHhcCcchHHHHHHHhCCCCC
Confidence            99999875543221   11    17889999               899988754 588999999999999999655443

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=7.2e-37  Score=285.18  Aligned_cols=202  Identities=22%  Similarity=0.300  Sum_probs=155.8

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|.         ++.+++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   74 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGL---------NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT   74 (317)
T ss_dssp             ---------------CEEEEEE---------CSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC
T ss_pred             ccceeEeeEECCCCCEEEEEEE---------ECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE
Confidence            4679999999999999999994         444689999999876532 234678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNP--SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      ++..++||||++ |+|.+++.....  ....+++..+..++.||+.||.|||  +++|+||||||+|||++.+|.+||+|
T Consensus        75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl~D  151 (317)
T 2pmi_A           75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGD  151 (317)
T ss_dssp             TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred             CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCChHHeEEcCCCCEEECc
Confidence            999999999998 599999875421  1235899999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ||+++........  . ...    .||+.|+               |||++.+...++.++||||+|++++++++...+
T Consensus       152 fg~~~~~~~~~~~--~-~~~----~~t~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p  208 (317)
T 2pmi_A          152 FGLARAFGIPVNT--F-SSE----VVTLWYR---------------APDVLMGSRTYSTSIDIWSCGCILAEMITGKPL  208 (317)
T ss_dssp             CSSCEETTSCCCC--C-CCC----CSCCTTC---------------CHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CccceecCCCccc--C-CCC----ccccccc---------------CchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            9999876543221  1 111    6788888               899988776778999999999999999965444

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=8.1e-37  Score=280.50  Aligned_cols=199  Identities=24%  Similarity=0.223  Sum_probs=168.6

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|++.+.||+|+||.||+|.......  .....+..||+|++........+.+.+|+.+++.++||||+++++++.++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGD--YGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECG--GGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccc--cccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            4679999999999999999997653110  00011357999999877666678899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc--------
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF--------  239 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~--------  239 (376)
                      +..++||||+++|+|.+++.+..   ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.        
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~~~~  159 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLE--ENTLIHGNVCAKNILLIREEDRKTGNPPF  159 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred             CCCEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHh--hCCeECCCcCcceEEEecCCcccccccce
Confidence            99999999999999999997652   34899999999999999999999  599999999999999998887        


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +||+|||++.........           .||+.|+               |||++.+....+.++||||+|++++++++
T Consensus       160 ~kl~Dfg~~~~~~~~~~~-----------~~~~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~el~~  213 (289)
T 4fvq_A          160 IKLSDPGISITVLPKDIL-----------QERIPWV---------------PPECIENPKNLNLATDKWSFGTTLWEICS  213 (289)
T ss_dssp             EEECCCCSCTTTSCHHHH-----------HHTTTTS---------------CHHHHHCGGGCCHHHHHHHHHHHHHHHHT
T ss_pred             eeeccCcccccccCcccc-----------CCcCccc---------------CHHHhCCCCCCCchhHHHHHHHHHHHHHc
Confidence            999999999765443221           5667777               89999886778999999999999999986

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.2e-36  Score=281.31  Aligned_cols=207  Identities=21%  Similarity=0.192  Sum_probs=164.8

Q ss_pred             hcCCCCcc-ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcC-CCCCcceEEeEE
Q 017177           87 ATKNFKPD-SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~  164 (376)
                      ..+.|++. +.||+|+||.||+|.         +..+++.||||++........+.+.+|+.++.++ +||||+++++++
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~   80 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCI---------NLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF   80 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEE---------CSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceeEEecCceecCCceEEEEEEE---------EcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            34678885 789999999999994         3446889999999776555567889999999995 699999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc---EE
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF---LF  241 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~---~k  241 (376)
                      .+++.+|+||||+++|+|.+++...    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.++.   +|
T Consensus        81 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~~~k  154 (316)
T 2ac3_A           81 EEEDRFYLVFEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLH--NKGIAHRDLKPENILCEHPNQVSPVK  154 (316)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEESCSSSSCSEE
T ss_pred             eeCCEEEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCHHHEEEccCCCcCceE
Confidence            9999999999999999999999876    45899999999999999999999  589999999999999988776   99


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh----hhhccccccccceeeeehhh
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW----IKYLTLLKYSNSFAFVFSCV  317 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~----~~~~~~~~dv~s~g~v~~~~  317 (376)
                      |+|||++.....................||+.|+               |||++.+    ....+.++||||+|++++++
T Consensus       155 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~---------------aPE~~~~~~~~~~~~~~~~DiwslG~il~~l  219 (316)
T 2ac3_A          155 ICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM---------------APEVVEAFSEEASIYDKRCDLWSLGVILYIL  219 (316)
T ss_dssp             ECCTTCCC-------------------CCSGGGC---------------CHHHHHHTSHHHHHHTTTHHHHHHHHHHHHH
T ss_pred             EEEccCccccccCCccccccccccccccCCcCcc---------------ChHHhhcccccccCCCcccccHhHHHHHHHH
Confidence            9999999876543221111111112226888898               8998875    24568899999999999999


Q ss_pred             cccccc
Q 017177          318 FSFYRT  323 (376)
Q Consensus       318 ~~~y~~  323 (376)
                      ++...+
T Consensus       220 ~~g~~p  225 (316)
T 2ac3_A          220 LSGYPP  225 (316)
T ss_dssp             HHSSCS
T ss_pred             HHCCCC
Confidence            975444

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=285.13  Aligned_cols=199  Identities=19%  Similarity=0.204  Sum_probs=169.3

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh------hhHHHHHHHHHHHhcCCCCCcceE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM------QGFEEWQSEVNFLGRLSHPNLVKL  160 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~h~nIv~l  160 (376)
                      ..++|++.+.||+|+||.||+|...         .++..||+|+++....      ...+.+.+|+.+++.++||||+++
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~   79 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREK---------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL   79 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEET---------TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccceEeceEEeeCCCeEEEEEEEC---------CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcE
Confidence            3456999999999999999999544         4689999999875432      135778999999999999999999


Q ss_pred             EeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC--
Q 017177          161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG--  238 (376)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g--  238 (376)
                      ++++.+++..++||||+++|+|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++  
T Consensus        80 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~NIll~~~~~~  153 (326)
T 2y0a_A           80 HEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVP  153 (326)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESCSSSS
T ss_pred             EEEEEeCCEEEEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHH--HCCeEcCCCCHHHEEEecCCCC
Confidence            99999999999999999999999999764    45899999999999999999999  59999999999999999887  


Q ss_pred             --cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehh
Q 017177          239 --FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSC  316 (376)
Q Consensus       239 --~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~  316 (376)
                        .+||+|||+++.........    ..    .||+.|+               |||++.+.. ++.++||||+|+++++
T Consensus       154 ~~~~kl~Dfg~a~~~~~~~~~~----~~----~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~~  209 (326)
T 2y0a_A          154 KPRIKIIDFGLAHKIDFGNEFK----NI----FGTPEFV---------------APEIVNYEP-LGLEADMWSIGVITYI  209 (326)
T ss_dssp             SCCEEECCCTTCEECCTTSCCC----CC----CSCTTTC---------------CHHHHTTCC-CCTHHHHHHHHHHHHH
T ss_pred             CCCEEEEECCCCeECCCCCccc----cc----cCCcCcC---------------CceeecCCC-CCcHHHHHHHHHHHHH
Confidence              79999999999875433221    11    6888888               899887654 5889999999999999


Q ss_pred             hccccccc
Q 017177          317 VFSFYRTT  324 (376)
Q Consensus       317 ~~~~y~~~  324 (376)
                      +++...+.
T Consensus       210 ll~g~~pf  217 (326)
T 2y0a_A          210 LLSGASPF  217 (326)
T ss_dssp             HHHSCCSS
T ss_pred             HHHCcCCC
Confidence            99655543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.8e-36  Score=273.95  Aligned_cols=195  Identities=26%  Similarity=0.333  Sum_probs=168.0

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..++|++.+.||+|+||.||+|....          +..||+|+++.... ..+.+.+|+.+++.++||||+++++++.+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   74 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKG----------QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSK   74 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheeeeeeeccCCCceEEEEEecC----------ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            45679999999999999999996653          66799999986543 33678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++..++||||+++++|.+++....   ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~l~Dfg  149 (268)
T 3sxs_A           75 EYPIYIVTEYISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLE--SHQFIHRDLAARNCLVDRDLCVKVSDFG  149 (268)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHH--HTTEEESSCSGGGEEECTTCCEEECCTT
T ss_pred             CCceEEEEEccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCcCcceEEECCCCCEEEccCc
Confidence            999999999999999999997752   45899999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ++........... .++     .+|+.|+               +||++.+.. .+.++|+||+|++++++++
T Consensus       150 ~~~~~~~~~~~~~-~~~-----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~l~~  200 (268)
T 3sxs_A          150 MTRYVLDDQYVSS-VGT-----KFPVKWS---------------APEVFHYFK-YSSKSDVWAFGILMWEVFS  200 (268)
T ss_dssp             CEEECCTTCEEEC-CSC-----CCCGGGC---------------CHHHHHHSE-EETTHHHHHHHHHHHHHHT
T ss_pred             cceecchhhhhcc-cCC-----CcCcccC---------------CHHHHhccC-CchhhhhHHHHHHHHHHHc
Confidence            9998766544322 222     5667788               899887655 5889999999999999987

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.8e-36  Score=282.83  Aligned_cols=208  Identities=19%  Similarity=0.266  Sum_probs=153.0

Q ss_pred             hhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceE
Q 017177           83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKL  160 (376)
Q Consensus        83 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l  160 (376)
                      +.....++|++.+.||+|+||.||+|.+...      ......||+|+++..  .....+.+.+|+.+++.++||||+++
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   90 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQE------DGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL   90 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEccc------CCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehh
Confidence            3344567899999999999999999965431      111247999999865  33456788999999999999999999


Q ss_pred             EeEEEeCCeE------EEEEeccCCCCHHHHHhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCE
Q 017177          161 LGYCWEDKEL------LLVYEYMQRGSLENHLFRRNP--SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI  232 (376)
Q Consensus       161 ~~~~~~~~~~------~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NI  232 (376)
                      ++++......      ++||||+++|+|.+++.....  ....+++..+..++.|++.||.|||  .++|+||||||+||
T Consensus        91 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH--~~~ivH~Dikp~NI  168 (323)
T 3qup_A           91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS--SRNFIHRDLAARNC  168 (323)
T ss_dssp             CEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGE
T ss_pred             hceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH--cCCcccCCCCcceE
Confidence            9999877654      999999999999999975431  1235899999999999999999999  58999999999999


Q ss_pred             EEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceee
Q 017177          233 LLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAF  312 (376)
Q Consensus       233 Ll~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~  312 (376)
                      |++.++.+||+|||+++..............     .+|+.|+               +||++.+.. .+.++||||+|+
T Consensus       169 li~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~-----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~  227 (323)
T 3qup_A          169 MLAEDMTVCVADFGLSRKIYSGDYYRQGCAS-----KLPVKWL---------------ALESLADNL-YTVHSDVWAFGV  227 (323)
T ss_dssp             EECTTSCEEECCCCC----------------------CCGGGC---------------CHHHHHHCC-CCHHHHHHHHHH
T ss_pred             EEcCCCCEEEeeccccccccccccccccccc-----cCccccc---------------CchhhcCCC-CCCccchhhHHH
Confidence            9999999999999999877554332222222     5667788               899877654 588999999999


Q ss_pred             eehhhcc
Q 017177          313 VFSCVFS  319 (376)
Q Consensus       313 v~~~~~~  319 (376)
                      +++++++
T Consensus       228 il~ell~  234 (323)
T 3qup_A          228 TMWEIMT  234 (323)
T ss_dssp             HHHHHHT
T ss_pred             HHHHHHh
Confidence            9999876

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.3e-37  Score=291.42  Aligned_cols=205  Identities=25%  Similarity=0.280  Sum_probs=167.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-ChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|.+...    .+..+++.||||+++.. .......+.+|+.+++.++||||+++++++.+
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGM----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccC----CCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            46799999999999999999986532    13345889999999765 33445678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC---cE
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNP---SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG---FL  240 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g---~~  240 (376)
                      .+..++||||+++|+|.+++.....   ....+++..++.++.||+.||.|||  .++|+||||||+|||++.+|   .+
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChhhEEEecCCCCceE
Confidence            9999999999999999999987642   1245899999999999999999999  59999999999999999555   59


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ||+|||+++........... ++.    .||+.|+               |||++.+.. ++.++||||+|++++++++
T Consensus       224 kL~DFG~a~~~~~~~~~~~~-~~~----~~t~~y~---------------aPE~~~~~~-~~~~~DvwslG~il~ellt  281 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKG-GCA----MLPVKWM---------------PPEAFMEGI-FTSKTDTWSFGVLLWEIFS  281 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTC-CGG----GSCGGGC---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             EECCCccccccccccccccC-CCc----CCcccEE---------------CHHHhcCCC-CCcHHHHHHHHHHHHHHHh
Confidence            99999999865433221111 111    6778888               899887654 5889999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=6.5e-36  Score=279.74  Aligned_cols=206  Identities=22%  Similarity=0.290  Sum_probs=174.3

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe-
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE-  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-  166 (376)
                      .++|++.+.||+|+||.||+|++..     .+..+++.||+|++........+.+.+|+.+++.++||||+++++++.. 
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   96 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDP-----LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP   96 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECT-----TSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEecc-----CCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence            4579999999999999999997543     3445689999999998877777889999999999999999999999874 


Q ss_pred             -CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          167 -DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       167 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                       ....++||||+++++|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dikp~NIl~~~~~~~kl~Df  171 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLG--SRRCVHRDLAARNILVESEAHVKIADF  171 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCG
T ss_pred             CCceEEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCChhhEEECCCCCEEEccc
Confidence             467999999999999999997752   35899999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |++................    .||+.|+               +||++.+.. .+.++||||+|++++++++...+
T Consensus       172 g~~~~~~~~~~~~~~~~~~----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p  229 (327)
T 3lxl_A          172 GLAKLLPLDKDYYVVREPG----QSPIFWY---------------APESLSDNI-FSRQSDVWSFGVVLYELFTYCDK  229 (327)
T ss_dssp             GGCEECCTTCSEEECSSCC----CSCGGGS---------------CHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCG
T ss_pred             ccceecccCCccceeeccC----Ccccccc---------------CHHHhccCC-CChHHhHHHHHHHHHHHHhCCCC
Confidence            9999876544332222222    6777788               899887654 58899999999999999975443

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-36  Score=289.08  Aligned_cols=209  Identities=24%  Similarity=0.295  Sum_probs=171.2

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcC-CCCCcceEEeE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGY  163 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~l~~~  163 (376)
                      ...++|++.+.||+|+||.||+|......  ......+..||+|+++... ....+.+.+|+++++.+ +||||++++++
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  143 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLD--KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA  143 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSS--TTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEcccc--ccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence            34568999999999999999999764311  0122346789999998753 34457889999999999 89999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCC
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPS------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASN  231 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~N  231 (376)
                      +.+++..++||||+++|+|.+++......            ...+++..++.++.||+.||.|||  +.+|+||||||+|
T Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~N  221 (382)
T 3tt0_A          144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARN  221 (382)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGG
T ss_pred             eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCcce
Confidence            99999999999999999999999875421            245899999999999999999999  5899999999999


Q ss_pred             EEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcccccccccee
Q 017177          232 ILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFA  311 (376)
Q Consensus       232 ILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g  311 (376)
                      ||++.++.+||+|||+++..............     .||+.|+               |||++.+.. .+.++||||+|
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~-----~~t~~y~---------------aPE~~~~~~-~~~~~DiwslG  280 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNG-----RLPVKWM---------------APEALFDRI-YTHQSDVWSFG  280 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTC-----CCGGGGS---------------CHHHHHSCC-CCHHHHHHHHH
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCC-----CCCccee---------------CHHHhcCCC-CCchhHHHHHH
Confidence            99999999999999999876543321111111     5677787               899887654 58899999999


Q ss_pred             eeehhhcc
Q 017177          312 FVFSCVFS  319 (376)
Q Consensus       312 ~v~~~~~~  319 (376)
                      ++++++++
T Consensus       281 ~il~ellt  288 (382)
T 3tt0_A          281 VLLWEIFT  288 (382)
T ss_dssp             HHHHHHHT
T ss_pred             HHHHHHHh
Confidence            99999987

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.3e-36  Score=279.35  Aligned_cols=197  Identities=23%  Similarity=0.264  Sum_probs=165.3

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh--hHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ++|++.+.||+|+||.||+|...          +++.||+|++......  ..+.+.+|+.+++.++||||+++++++.+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT   71 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcC----------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence            57999999999999999999653          3788999999765432  23678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++..++||||+++ +|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.+|.+||+|||
T Consensus        72 ~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  145 (288)
T 1ob3_A           72 KKRLVLVFEHLDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFG  145 (288)
T ss_dssp             SSCEEEEEECCSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECCTT
T ss_pred             CCeEEEEEEecCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEEeECc
Confidence            9999999999976 9999887642   45899999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ++.........  ...     ..||+.|+               |||++.+....+.++|+||+|++++++++...+
T Consensus       146 ~~~~~~~~~~~--~~~-----~~~t~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  200 (288)
T 1ob3_A          146 LARAFGIPVRK--YTH-----EIVTLWYR---------------APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL  200 (288)
T ss_dssp             HHHHHCC----------------CCCTTC---------------CHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccCccccc--ccc-----cccccccc---------------CchheeCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            99876433221  111     16788888               899988777779999999999999999965443

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.4e-36  Score=295.12  Aligned_cols=202  Identities=20%  Similarity=0.219  Sum_probs=165.5

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||||++...  .....+++.+|+.+|+.++||||+++++++
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~   94 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDK---------NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLI   94 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEET---------TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEEC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEEC---------CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEE
Confidence            4678999999999999999999544         46899999999764  334457889999999999999999999998


Q ss_pred             EeC-----CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc
Q 017177          165 WED-----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF  239 (376)
Q Consensus       165 ~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~  239 (376)
                      ...     +.+|+||||++ |+|.+++...    ..+++..+..++.||+.||.|||+  .+|+||||||+|||++.++.
T Consensus        95 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~--~givHrDlkp~NILl~~~~~  167 (432)
T 3n9x_A           95 IPDDLLKFDELYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHE--SGIIHRDLKPANCLLNQDCS  167 (432)
T ss_dssp             CCSCTTTCCCEEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCC
T ss_pred             ecCCCCcCCeEEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHeEECCCCC
Confidence            776     57999999996 5999999765    458999999999999999999994  89999999999999999999


Q ss_pred             EEEcceeeeeeeccceeeEEE---------------eeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcccc
Q 017177          240 LFDSHLLIYVYFKRHYIYIYI---------------HTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLL  304 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~---------------~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~  304 (376)
                      +||+|||+++...........               ........+||+.|+               |||++.....++.+
T Consensus       168 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~---------------APE~~~~~~~~~~~  232 (432)
T 3n9x_A          168 VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYR---------------APELILLQENYTKS  232 (432)
T ss_dssp             EEECCCTTCEEC-------------------------------CCCCCTTC---------------CHHHHTTCSCCCTH
T ss_pred             EEEccCCCcccccccccccccccccccccccccccchhccccCCCCCcccc---------------CHHHHhcCCCCCcc
Confidence            999999999987554321100               001112337889998               99988777778999


Q ss_pred             ccccceeeeehhhcc
Q 017177          305 KYSNSFAFVFSCVFS  319 (376)
Q Consensus       305 ~dv~s~g~v~~~~~~  319 (376)
                      +||||+|++++|+++
T Consensus       233 ~DiwSlG~il~ell~  247 (432)
T 3n9x_A          233 IDIWSTGCIFAELLN  247 (432)
T ss_dssp             HHHHHHHHHHHHHHT
T ss_pred             cccchHHHHHHHHHh
Confidence            999999999999985

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-36  Score=303.07  Aligned_cols=201  Identities=24%  Similarity=0.268  Sum_probs=171.2

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|++.....   .....+.+|+.+|+.++||||++++++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~---------~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~  252 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA  252 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEE
Confidence            4567999999999999999999544         3689999999865421   234567899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +.+.+.+|+||||++||+|.+++....  ...+++..+..++.||+.||.|||  .++|+||||||+|||++.+|.+||+
T Consensus       253 ~~~~~~l~lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH--~~gIvHrDLKPeNILld~~g~vKL~  328 (576)
T 2acx_A          253 YETKDALCLVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLH--RERIVYRDLKPENILLDDHGHIRIS  328 (576)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             EeeCCEEEEEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH--HCCEeccCCchheEEEeCCCCeEEE
Confidence            999999999999999999999997653  245899999999999999999999  5899999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||+++.........   +     .+||+.|+               |||++.+.. ++.++||||+|++++++++...+
T Consensus       329 DFGla~~~~~~~~~~---~-----~~GT~~Y~---------------APEvl~~~~-~~~~~DiwSLGvilyeLltG~~P  384 (576)
T 2acx_A          329 DLGLAVHVPEGQTIK---G-----RVGTVGYM---------------APEVVKNER-YTFSPDWWALGCLLYEMIAGQSP  384 (576)
T ss_dssp             CCTTCEECCTTCCEE---C-----CCSCGGGC---------------CHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCS
T ss_pred             ecccceecccCcccc---c-----cCCCcccc---------------CHHHHcCCC-CCccchHHHHHHHHHHHHhCCCC
Confidence            999998875543221   1     17889999               899888755 58899999999999999965444


Q ss_pred             c
Q 017177          324 T  324 (376)
Q Consensus       324 ~  324 (376)
                      .
T Consensus       385 F  385 (576)
T 2acx_A          385 F  385 (576)
T ss_dssp             S
T ss_pred             C
Confidence            3

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.7e-36  Score=285.15  Aligned_cols=196  Identities=21%  Similarity=0.194  Sum_probs=153.3

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|+++...  ..+.+.+|+.++++++||||+++++++.+
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~  119 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQK---------GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET  119 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEEC---------CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec
Confidence            4567999999999999999999554         358899999997653  33567889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC---CCcEEEc
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG---VGFLFDS  243 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~---~g~~kl~  243 (376)
                      ++..++||||+++|+|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.   ++.+||+
T Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dikp~NIll~~~~~~~~~kl~  193 (349)
T 2w4o_A          120 PTEISLVLELVTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIA  193 (349)
T ss_dssp             SSEEEEEECCCCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEESSSSTTCCEEEC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCcccEEEecCCCCCCEEEc
Confidence            99999999999999999999765    45899999999999999999999  589999999999999975   8999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||+++.........    +    ..||+.|+               |||++.+.. ++.++||||+|++++++++...+
T Consensus       194 Dfg~a~~~~~~~~~~----~----~~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~ell~g~~p  249 (349)
T 2w4o_A          194 DFGLSKIVEHQVLMK----T----VCGTPGYC---------------APEILRGCA-YGPEVDMWSVGIITYILLCGFEP  249 (349)
T ss_dssp             CCC------------------------CGGGS---------------CHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             cCccccccCcccccc----c----ccCCCCcc---------------CHHHhcCCC-CCcccchHHHHHHHHHHHhCCCC
Confidence            999998765432221    1    26888888               899887754 58899999999999999865444

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-36  Score=284.33  Aligned_cols=208  Identities=26%  Similarity=0.330  Sum_probs=169.4

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcC-CCCCcceEEe
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLG  162 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~l~~  162 (376)
                      ....++|++.+.||+|+||.||+|.+...    .+..++..||+|++.... ....+.+.+|+.+++.+ +||||+++++
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  116 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGI----SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG  116 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESC----SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeecc----ccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            34457899999999999999999976431    223457889999998653 23346788999999999 7999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcCCC-------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcE
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRNPS-------------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVI  223 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~~~~i~~qi~~~L~yLHs~~~~ii  223 (376)
                      ++...+..++||||+++|+|.+++......                   ...+++..+..++.||+.||.|||  .++|+
T Consensus       117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~iv  194 (344)
T 1rjb_A          117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCV  194 (344)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            999999999999999999999999765321                   123789999999999999999999  59999


Q ss_pred             ecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccc
Q 017177          224 YRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTL  303 (376)
Q Consensus       224 HrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~  303 (376)
                      ||||||+|||++.++.+||+|||++............ +..    .||+.|+               |||++.+.. .+.
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~-~~~----~~t~~y~---------------aPE~~~~~~-~~~  253 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVR-GNA----RLPVKWM---------------APESLFEGI-YTI  253 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEE-TTE----EECGGGC---------------CHHHHHHCC-CCH
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCccceec-cCc----cCccCcc---------------CHHHhccCC-CCh
Confidence            9999999999999999999999999877554332222 222    6788888               899887654 588


Q ss_pred             cccccceeeeehhhcc
Q 017177          304 LKYSNSFAFVFSCVFS  319 (376)
Q Consensus       304 ~~dv~s~g~v~~~~~~  319 (376)
                      ++||||+|++++++++
T Consensus       254 ~~Di~slG~il~el~t  269 (344)
T 1rjb_A          254 KSDVWSYGILLWEIFS  269 (344)
T ss_dssp             HHHHHHHHHHHHHHTT
T ss_pred             hHhHHHHHHHHHHHHc
Confidence            9999999999999987

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.8e-37  Score=291.49  Aligned_cols=198  Identities=19%  Similarity=0.192  Sum_probs=169.6

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ..++|++.+.||+|+||.||+|.+.         .+++.||+|++.....   .....+.+|+.+++.++||||++++++
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~   77 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHY---------KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV   77 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            3568999999999999999999543         4689999999865321   123578899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +.+++..++||||+ +|+|.+++...    ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+
T Consensus        78 ~~~~~~~~lv~E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~kl~  150 (336)
T 3h4j_B           78 ITTPTDIVMVIEYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCH--RHKIVHRDLKPENLLLDDNLNVKIA  150 (336)
T ss_dssp             EECSSEEEEEECCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH--HHTCCCCCCSTTTEEECTTCCEEEC
T ss_pred             EEeCCEEEEEEECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCchhhEEEcCCCCEEEE
Confidence            99999999999999 67999998776    45899999999999999999999  5899999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||++..........    +.    +||+.|+               |||++.+..+.+.++||||+|++++++++...+
T Consensus       151 DFG~s~~~~~~~~~~----~~----~gt~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~P  207 (336)
T 3h4j_B          151 DFGLSNIMTDGNFLK----TS----CGSPNYA---------------APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP  207 (336)
T ss_dssp             CSSCTBTTTTSBTTC----CC----TTSTTTS---------------CGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             EeccceeccCCcccc----cc----cCCcCcC---------------CHHHHcCCCCCCCccchhHHHHHHHHHHhCCCC
Confidence            999998765543221    11    6888888               899988888878999999999999999865433

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.6e-36  Score=276.29  Aligned_cols=199  Identities=20%  Similarity=0.274  Sum_probs=154.8

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ..++|++.+.||+|+||.||+|.+...      ...+..||+|.++... ....+.+.+|+.+++.++||||+++++++ 
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-   85 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSP------ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-   85 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecC------CCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-
Confidence            456799999999999999999976531      1236789999988653 34457789999999999999999999987 


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      .++..|+||||+++|+|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Df  160 (281)
T 1mp8_A           86 TENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDF  160 (281)
T ss_dssp             CSSSCEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECC-
T ss_pred             ccCccEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeecccccHHHEEECCCCCEEECcc
Confidence            4567899999999999999997652   45899999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      |+++............+      .+|+.|+               |||++.+.. .+.++|+||+|++++++++
T Consensus       161 g~~~~~~~~~~~~~~~~------~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~~l~ell~  212 (281)
T 1mp8_A          161 GLSRYMEDSTYYKASKG------KLPIKWM---------------APESINFRR-FTSASDVWMFGVCMWEILM  212 (281)
T ss_dssp             ------------------------CCGGGC---------------CHHHHHHCC-CSHHHHHHHHHHHHHHHHT
T ss_pred             ccccccCcccccccccC------CCccccc---------------ChhhcccCC-CCCccCchHHHHHHHHHHh
Confidence            99998755433211111      5667788               899887654 5789999999999999874

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.5e-36  Score=309.80  Aligned_cols=200  Identities=23%  Similarity=0.214  Sum_probs=169.5

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcC-CCCCcceEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLLG  162 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~l~~  162 (376)
                      ..++|+++++||+|+||.||+|...         .+++.||||++++..   ....+.+.+|..++..+ +||||+++++
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~---------~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~  409 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERK---------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS  409 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEES---------SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEEC---------CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence            4568999999999999999999544         468899999987542   23346778899999998 5999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                      ++.+.+.+||||||+++|+|.+++.+.    ..+++..++.++.||+.||.|||  .++||||||||+||||+.+|.+||
T Consensus       410 ~~~~~~~~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~gIiHrDLKp~NILl~~~g~ikL  483 (674)
T 3pfq_A          410 CFQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKI  483 (674)
T ss_dssp             ECBCSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTSEECCCCCSTTEEECSSSCEEE
T ss_pred             EEEeCCEEEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeccCChhhEEEcCCCcEEE
Confidence            999999999999999999999999876    45899999999999999999999  599999999999999999999999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      +|||+++........   ..+.    +||+.||               |||++.+.. ++.++|+||+|++++|+++-..
T Consensus       484 ~DFGla~~~~~~~~~---~~~~----~GT~~Y~---------------APE~l~~~~-~~~~~DvwSlGvilyelltG~~  540 (674)
T 3pfq_A          484 ADFGMCKENIWDGVT---TKTF----CGTPDYI---------------APEIIAYQP-YGKSVDWWAFGVLLYEMLAGQA  540 (674)
T ss_dssp             CCCTTCEECCCTTCC---BCCC----CSCSSSC---------------CHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSC
T ss_pred             eecceeeccccCCcc---cccc----cCCCccc---------------CHhhhcCCC-CCccceEechHHHHHHHHcCCC
Confidence            999999864332221   1122    7889999               899887765 4899999999999999996554


Q ss_pred             cc
Q 017177          323 TT  324 (376)
Q Consensus       323 ~~  324 (376)
                      +.
T Consensus       541 Pf  542 (674)
T 3pfq_A          541 PF  542 (674)
T ss_dssp             SS
T ss_pred             CC
Confidence            44

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.7e-36  Score=284.21  Aligned_cols=199  Identities=22%  Similarity=0.263  Sum_probs=160.9

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh--hHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|+++.....  ..+.+.+|+.+++.++||||+++++++
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  102 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDT---------VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI  102 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEEC---------CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEE
Confidence            3467999999999999999999544         46899999999765432  245677999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc-----CCCc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD-----GVGF  239 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~-----~~g~  239 (376)
                      .+++.+++||||+++ +|.+++...    ..+++..+..++.||+.||.|||  .++|+||||||+|||++     .++.
T Consensus       103 ~~~~~~~lv~e~~~~-~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~  175 (329)
T 3gbz_A          103 HHNHRLHLIFEYAEN-DLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCH--SRRCLHRDLKPQNLLLSVSDASETPV  175 (329)
T ss_dssp             EETTEEEEEEECCSE-EHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEC-----CCE
T ss_pred             ecCCEEEEEEecCCC-CHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCEECCCCCHHHEEEecCCCCccce
Confidence            999999999999975 999999776    45899999999999999999999  58999999999999994     4556


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +||+|||+++........  ...     ..||+.|+               |||++.+...++.++||||+|++++++++
T Consensus       176 ~kl~Dfg~a~~~~~~~~~--~~~-----~~~t~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~ell~  233 (329)
T 3gbz_A          176 LKIGDFGLARAFGIPIRQ--FTH-----EIITLWYR---------------PPEILLGSRHYSTSVDIWSIACIWAEMLM  233 (329)
T ss_dssp             EEECCTTHHHHHC------------------CCTTC---------------CHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred             EEECcCCCccccCCcccc--cCC-----CcCCcccc---------------CHHHhcCCCCCCcHHHHHHHHHHHHHHHH
Confidence            999999999876543222  111     16788888               89999887778999999999999999986


Q ss_pred             cccc
Q 017177          320 FYRT  323 (376)
Q Consensus       320 ~y~~  323 (376)
                      -..+
T Consensus       234 g~~p  237 (329)
T 3gbz_A          234 KTPL  237 (329)
T ss_dssp             SSCS
T ss_pred             CCCC
Confidence            4433

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.7e-36  Score=281.81  Aligned_cols=200  Identities=18%  Similarity=0.153  Sum_probs=169.9

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC---ChhhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|++...   .....+.+.+|+.+++.++||||++++++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~  109 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDA---------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF  109 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            3567999999999999999999554         35889999998654   23455778899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +.+.+..|+||||+++++|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+
T Consensus       110 ~~~~~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIl~~~~~~~kl~  183 (335)
T 2owb_A          110 FEDNDFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIG  183 (335)
T ss_dssp             EECSSEEEEEECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEEC
T ss_pred             EecCCeEEEEEecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH--HCCCEecCCCchhEEEcCCCCEEEe
Confidence            99999999999999999999998776    45899999999999999999999  5899999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||++..........   ..    ..||+.|+               +||++.+.. .+.++|+||+|++++++++...+
T Consensus       184 Dfg~~~~~~~~~~~~---~~----~~gt~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p  240 (335)
T 2owb_A          184 DFGLATKVEYDGERK---KV----LCGTPNYI---------------APEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPP  240 (335)
T ss_dssp             CCTTCEECCSTTCCB---CC----CCSCCSSC---------------CHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             eccCceecccCcccc---cc----cCCCcccc---------------CHHHhccCC-CCchhhHHHHHHHHHHHHHCcCC
Confidence            999998775432211   11    16778888               799887654 58899999999999999965444


Q ss_pred             c
Q 017177          324 T  324 (376)
Q Consensus       324 ~  324 (376)
                      .
T Consensus       241 f  241 (335)
T 2owb_A          241 F  241 (335)
T ss_dssp             T
T ss_pred             C
Confidence            3

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.1e-36  Score=275.06  Aligned_cols=195  Identities=25%  Similarity=0.367  Sum_probs=165.6

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..++|++.+.||+|+||.||+|.+..          +..||+|++..... ..+.+.+|+.++++++||||+++++++.+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   76 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE   76 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ChhhceeeheecCCCccEEEEEEecC----------CCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34679999999999999999997653          66799999987543 23678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++..++||||+++++|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg  151 (269)
T 4hcu_A           77 QAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFG  151 (269)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECGGGCEEECCTT
T ss_pred             CCceEEEEEeCCCCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHH--hCCeecCCcchheEEEcCCCCEEecccc
Confidence            999999999999999999997653   45899999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ++.......... ..+.     .||+.|+               +||++.+.. .+.++|+||+|++++++++
T Consensus       152 ~~~~~~~~~~~~-~~~~-----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~~l~~ll~  202 (269)
T 4hcu_A          152 MTRFVLDDQYTS-STGT-----KFPVKWA---------------SPEVFSFSR-YSSKSDVWSFGVLMWEVFS  202 (269)
T ss_dssp             GGGGBCCHHHHS-TTST-----TCCGGGC---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             cccccccccccc-ccCc-----ccccccC---------------CHHHhcCCC-CCchhhhHHHHHHHHHHhc
Confidence            998765432221 1111     5566777               899887655 5889999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-36  Score=281.13  Aligned_cols=197  Identities=20%  Similarity=0.114  Sum_probs=161.5

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcC-CCCCcceEEeEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l-~h~nIv~l~~~~  164 (376)
                      .++|++.+.||+|+||.||+|...         .+++.||||++....  .........|+..+..+ +||||+++++++
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~  126 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSK---------EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW  126 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEET---------TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEEC---------CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence            357999999999999999999654         358899999986542  23344555666666665 799999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .+++.+++||||+ +++|.+++....   ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|
T Consensus       127 ~~~~~~~lv~e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~kl~D  200 (311)
T 3p1a_A          127 EEGGILYLQTELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLH--SQGLVHLDVKPANIFLGPRGRCKLGD  200 (311)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECGGGCEEECC
T ss_pred             EeCCEEEEEEecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEECCCCCEEEcc
Confidence            9999999999999 669999987763   45899999999999999999999  58999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ||++..........        ...||+.|+               |||++.+  ..+.++||||+|++++++++-..+.
T Consensus       201 FG~a~~~~~~~~~~--------~~~gt~~y~---------------aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~  255 (311)
T 3p1a_A          201 FGLLVELGTAGAGE--------VQEGDPRYM---------------APELLQG--SYGTAADVFSLGLTILEVACNMELP  255 (311)
T ss_dssp             CTTCEECC--------------CCCCCGGGC---------------CGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCC
T ss_pred             ceeeeecccCCCCc--------ccCCCcccc---------------CHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99998765433221        116788888               8998776  4688999999999999998765544

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.8e-36  Score=282.43  Aligned_cols=200  Identities=20%  Similarity=0.268  Sum_probs=160.4

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|.+...     .......||+|.+.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   88 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC---------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCC-----CceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence            45699999999999999999976541     11224467999986543 2445788999999999999999999999987


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      +. .++|+||+.+|+|.+++.+..   ..+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||
T Consensus        89 ~~-~~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~Dikp~NIll~~~~~~kl~Dfg  162 (327)
T 3poz_A           89 ST-VQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFG  162 (327)
T ss_dssp             SS-EEEEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred             CC-eEEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCChheEEECCCCCEEEccCc
Confidence            54 789999999999999998753   56899999999999999999999  5899999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +++............+.     .||+.|+               |||++.+.. ++.++||||+|++++++++
T Consensus       163 ~a~~~~~~~~~~~~~~~-----~~t~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~ellt  214 (327)
T 3poz_A          163 LAKLLGAEEKEYHAEGG-----KVPIKWM---------------ALESILHRI-YTHQSDVWSYGVTVWELMT  214 (327)
T ss_dssp             HHHHHTTTCC------------CCCGGGS---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             ceeEccCCcccccccCC-----Ccccccc---------------ChHHhccCC-CCchhhhhhhHHHHHHHHh
Confidence            99987654433222222     5677888               899887654 5889999999999999887

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.9e-35  Score=275.57  Aligned_cols=201  Identities=26%  Similarity=0.345  Sum_probs=167.6

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC--
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED--  167 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--  167 (376)
                      |++++.||+|+||.||++.+..     .+..+++.||||+++... ....+.+.+|+.+++.++||||+++++++.+.  
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDP-----TNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECS-----CC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             HhhhheecCCCCeEEEEEEEcc-----CCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            4999999999999999987654     445578999999998764 34457789999999999999999999999884  


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      ..+++||||+++|+|.+++.+.     .+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+|||+
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH--~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLH--AQHYIHRDLAARNVLLDNDRLVKIGDFGL  180 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             ceEEEEEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCchheEEEcCCCCEEECCccc
Confidence            6799999999999999999654     3899999999999999999999  59999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      +................    .||+.|+               +||++.+.. .+.++||||+|++++++++...+
T Consensus       181 a~~~~~~~~~~~~~~~~----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p  236 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDG----DSPVFWY---------------APECLKEYK-FYYASDVWSFGVTLYELLTHCDS  236 (318)
T ss_dssp             CEECCTTCSEEEC---C----CCCGGGC---------------CHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCG
T ss_pred             cccccccccccccccCC----CCCceee---------------ChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCc
Confidence            99876654332222222    6777788               899887655 57899999999999999975433

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.7e-36  Score=277.87  Aligned_cols=197  Identities=22%  Similarity=0.237  Sum_probs=164.4

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      .++|++.+.||+|+||.||+|...         .+++.||+|++.....  ...+.+.+|+.+++.++||||+++++++.
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   72 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNR---------DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR   72 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeC---------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee
Confidence            367999999999999999999554         3588999999866533  23467789999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +.+..++||||+++++|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+||
T Consensus        73 ~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Df  146 (311)
T 4agu_A           73 RKRRLHLVFEYCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCH--KHNCIHRDVKPENILITKHSVIKLCDF  146 (311)
T ss_dssp             ETTEEEEEEECCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             cCCeEEEEEEeCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCChhhEEEcCCCCEEEeeC
Confidence            999999999999999999888654    45899999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |++...........  .     ..||+.|+               +||++.+....+.++|+||+|++++++++..
T Consensus       147 g~~~~~~~~~~~~~--~-----~~~~~~y~---------------aPE~~~~~~~~~~~~Di~slG~il~~l~~g~  200 (311)
T 4agu_A          147 GFARLLTGPSDYYD--D-----EVATRWYR---------------SPELLVGDTQYGPPVDVWAIGCVFAELLSGV  200 (311)
T ss_dssp             TTCEECC-------------------GGGC---------------CHHHHHTCSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCchhccCcccccC--C-----CcCCcccc---------------ChHHHhcCCCCCcchhhHHHHHHHHHHHhCC
Confidence            99987754332211  1     16778888               8999988777899999999999999998643

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.9e-36  Score=277.72  Aligned_cols=208  Identities=27%  Similarity=0.305  Sum_probs=172.7

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcC-CCCCcceEEe
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRL-SHPNLVKLLG  162 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~l~~  162 (376)
                      ....++|++.+.||+|+||.||+|.+...    .+..+++.||+|+++.... ...+.+.+|+.+++.+ +||||+++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   94 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG   94 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeec----cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence            34456899999999999999999975321    2334588999999986543 4457889999999999 8999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCC
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRNPS--------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFK  228 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlK  228 (376)
                      ++.+++..++||||+++|+|.+++......              ...+++..+..++.|++.||.|||  .++|+|||||
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlk  172 (313)
T 1t46_A           95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLA  172 (313)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCS
T ss_pred             EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCc
Confidence            999999999999999999999999865321              124899999999999999999999  5999999999


Q ss_pred             CCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcccccccc
Q 017177          229 ASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSN  308 (376)
Q Consensus       229 p~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~  308 (376)
                      |+|||++.++.+||+|||++.............. .    .||+.|+               +||++.+.. .+.++|||
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~-~----~~~~~y~---------------aPE~~~~~~-~~~~~Di~  231 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGN-A----RLPVKWM---------------APESIFNCV-YTFESDVW  231 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSS-S----EECGGGC---------------CHHHHHHCC-CCHHHHHH
T ss_pred             cceEEEcCCCCEEEccccccccccccccceeccC-C----CCcceee---------------ChHHhcCCC-CChHHHHH
Confidence            9999999999999999999998765443222222 1    6778888               899877654 68899999


Q ss_pred             ceeeeehhhcc
Q 017177          309 SFAFVFSCVFS  319 (376)
Q Consensus       309 s~g~v~~~~~~  319 (376)
                      |+|++++++++
T Consensus       232 slG~il~ellt  242 (313)
T 1t46_A          232 SYGIFLWELFS  242 (313)
T ss_dssp             HHHHHHHHHHT
T ss_pred             HHHHHHHHHHh
Confidence            99999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3e-36  Score=284.04  Aligned_cols=196  Identities=18%  Similarity=0.221  Sum_probs=163.4

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcC-CCCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~  165 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|+++....    ...+|++++.++ +||||+++++++.
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~   86 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHK---------ATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYD   86 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEE
Confidence            3567999999999999999999544         4689999999976543    235688888888 6999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC----CcEE
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV----GFLF  241 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~----g~~k  241 (376)
                      +++.+|+|||||++|+|.+++.+.    ..+++..+..++.||+.||.|||  .++|+||||||+|||+.++    +.+|
T Consensus        87 ~~~~~~lv~E~~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH--~~givHrDlkp~NIl~~~~~~~~~~~k  160 (342)
T 2qr7_A           87 DGKYVYVVTELMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLH--AQGVVHRDLKPSNILYVDESGNPESIR  160 (342)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESSSSCSGGGEE
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcEeccCCHHHEEEecCCCCcCeEE
Confidence            999999999999999999999765    45899999999999999999999  5999999999999998433    3599


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |+|||+++.........   .+.    +||+.|+               |||++.+.. ++.++|+||+|++++++++.+
T Consensus       161 l~Dfg~a~~~~~~~~~~---~~~----~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~ell~g~  217 (342)
T 2qr7_A          161 ICDFGFAKQLRAENGLL---MTP----CYTANFV---------------APEVLERQG-YDAACDIWSLGVLLYTMLTGY  217 (342)
T ss_dssp             ECCCTTCEECBCTTCCB---CCS----SCCSSCC---------------CHHHHHHHH-HHHHHHHHHHHHHHHHHHHSS
T ss_pred             EEECCCcccCcCCCCce---ecc----CCCcccc---------------CHHHhcCCC-CCCccCeeeHhHHHHHHhcCC
Confidence            99999999765443221   111    7788888               899887765 478999999999999999765


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      .+.
T Consensus       218 ~Pf  220 (342)
T 2qr7_A          218 TPF  220 (342)
T ss_dssp             CSS
T ss_pred             CCC
Confidence            543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.3e-36  Score=275.95  Aligned_cols=198  Identities=17%  Similarity=0.237  Sum_probs=171.1

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..++|++.+.||+|+||.||+|...         .++..||+|++........+.+.+|+.+++.++||||+++++++.+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   77 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQK---------GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED   77 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeC---------CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3457999999999999999999554         3588899999977655566788999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE---cCCCcEEEc
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL---DGVGFLFDS  243 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl---~~~g~~kl~  243 (376)
                      .+..++||||+++++|.+++...    ..+++..+..++.|++.||.|||  +++|+||||||+|||+   +.++.+||+
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~~~~l~  151 (277)
T 3f3z_A           78 NTDIYLVMELCTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCH--KLNVAHRDLKPENFLFLTDSPDSPLKLI  151 (277)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             CCeEEEEEeccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCCHHHEEEecCCCCCcEEEE
Confidence            99999999999999999999776    45899999999999999999999  5999999999999999   788999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||++............        .||+.|+               +||++.+.  .+.++|+||+|++++++++...+
T Consensus       152 Dfg~~~~~~~~~~~~~~--------~~t~~y~---------------aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p  206 (277)
T 3f3z_A          152 DFGLAARFKPGKMMRTK--------VGTPYYV---------------SPQVLEGL--YGPECDEWSAGVMMYVLLCGYPP  206 (277)
T ss_dssp             CCTTCEECCTTSCBCCC--------CSCTTTC---------------CHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             ecccceeccCccchhcc--------CCCCCcc---------------ChHHhccc--CCchhhehhHHHHHHHHHHCCCC
Confidence            99999877654332111        6778888               89988654  78999999999999999975544


Q ss_pred             c
Q 017177          324 T  324 (376)
Q Consensus       324 ~  324 (376)
                      .
T Consensus       207 ~  207 (277)
T 3f3z_A          207 F  207 (277)
T ss_dssp             S
T ss_pred             C
Confidence            3

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2e-36  Score=291.13  Aligned_cols=195  Identities=20%  Similarity=0.207  Sum_probs=154.2

Q ss_pred             hcCCCCcc-ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhc-CCCCCcceEEeEE
Q 017177           87 ATKNFKPD-SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGR-LSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~-l~h~nIv~l~~~~  164 (376)
                      ..++|.+. ++||+|+||.||+|...         .+++.||||+++..     ..+.+|+.++.+ .+||||+++++++
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~---------~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~  124 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNK---------RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY  124 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEEC---------CCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEE
Confidence            34567776 78999999999999543         46899999999643     356778888754 4799999999998


Q ss_pred             Ee----CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC---C
Q 017177          165 WE----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG---V  237 (376)
Q Consensus       165 ~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~---~  237 (376)
                      ..    .+.+|+|||||++|+|.+++....  ...+++..+..++.||+.||.|||  .++|+||||||+|||++.   +
T Consensus       125 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~  200 (400)
T 1nxk_A          125 ENLYAGRKCLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPN  200 (400)
T ss_dssp             EEEETTEEEEEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSTT
T ss_pred             eecccCCcEEEEEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCcCcceEEEecCCCC
Confidence            76    567999999999999999997653  245899999999999999999999  599999999999999987   7


Q ss_pred             CcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhh
Q 017177          238 GFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCV  317 (376)
Q Consensus       238 g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~  317 (376)
                      +.+||+|||+++.........    +    .+||+.|+               |||++.+.. ++.++||||+|++++++
T Consensus       201 ~~~kl~DFG~a~~~~~~~~~~----~----~~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~el  256 (400)
T 1nxk_A          201 AILKLTDFGFAKETTSHNSLT----T----PCYTPYYV---------------APEVLGPEK-YDKSCDMWSLGVIMYIL  256 (400)
T ss_dssp             CCEEECCCTTCEECC-------------------CTTC---------------CGGGSCCCC-SSSHHHHHHHHHHHHHH
T ss_pred             ccEEEEecccccccCCCCccc----c----CCCCCCcc---------------CHhhcCCCC-CCCcccHHHHHHHHHHH
Confidence            899999999998765433221    1    27788888               899776544 57899999999999999


Q ss_pred             cccccc
Q 017177          318 FSFYRT  323 (376)
Q Consensus       318 ~~~y~~  323 (376)
                      ++...+
T Consensus       257 l~g~~p  262 (400)
T 1nxk_A          257 LCGYPP  262 (400)
T ss_dssp             HHSSCS
T ss_pred             HhCCCC
Confidence            865433

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.5e-36  Score=287.56  Aligned_cols=206  Identities=22%  Similarity=0.236  Sum_probs=159.9

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCC-CCCcceEEe
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLS-HPNLVKLLG  162 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~-h~nIv~l~~  162 (376)
                      ...++|++.+.||+|+||.||+|.+.         .+++.||||++...  ......++.+|+.+++.+. ||||+++++
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~   76 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDR---------RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN   76 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEET---------TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEEC---------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeee
Confidence            34678999999999999999999544         46899999998654  3345567889999999998 999999999


Q ss_pred             EEEeCC--eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcE
Q 017177          163 YCWEDK--ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL  240 (376)
Q Consensus       163 ~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~  240 (376)
                      ++..++  .+|+|||||+ ++|.+++...     .+++..+..++.||+.||+|||  ..+|+||||||+|||++.++.+
T Consensus        77 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~  148 (388)
T 3oz6_A           77 VLRADNDRDVYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLH--SGGLLHRDMKPSNILLNAECHV  148 (388)
T ss_dssp             EEECTTSSCEEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCE
T ss_pred             EEecCCCCEEEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHeEEcCCCCE
Confidence            998654  6999999997 5899988653     4889999999999999999999  4999999999999999999999


Q ss_pred             EEcceeeeeeeccceeeE--------------EEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcccccc
Q 017177          241 FDSHLLIYVYFKRHYIYI--------------YIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKY  306 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~--------------~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~d  306 (376)
                      ||+|||+++.+.......              ..........+||+.|+               |||++.+...++.++|
T Consensus       149 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~---------------aPE~~~~~~~~~~~~D  213 (388)
T 3oz6_A          149 KVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYR---------------APEILLGSTKYTKGID  213 (388)
T ss_dssp             EECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGC---------------CHHHHTTCCCCCTHHH
T ss_pred             EecCCcccccccccccccccccccccccccccccccccccCCcccCCcC---------------CHHHhcCCCCCCChhh
Confidence            999999998764311100              00011112237889998               9999988777899999


Q ss_pred             ccceeeeehhhcccccc
Q 017177          307 SNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       307 v~s~g~v~~~~~~~y~~  323 (376)
                      |||+|++++++++...+
T Consensus       214 iwSlG~il~ell~g~~p  230 (388)
T 3oz6_A          214 MWSLGCILGEILCGKPI  230 (388)
T ss_dssp             HHHHHHHHHHHHHSSCS
T ss_pred             HHHHHHHHHHHHhCCCC
Confidence            99999999999965443

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1e-35  Score=279.36  Aligned_cols=209  Identities=22%  Similarity=0.308  Sum_probs=169.9

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcC-CCCCcceEEeE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGY  163 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~l~~~  163 (376)
                      ...++|++.+.||+|+||.||+|.+....  .....++..||+|+++... ....+.+.+|+.+++.+ +||||++++++
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  109 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  109 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCS--TTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEecccc--ccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence            34578999999999999999999875311  0122457889999998653 34567889999999999 79999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCC
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPS------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASN  231 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~N  231 (376)
                      +.+++..++||||+++|+|.+++......            ...+++..++.++.||+.||.|||  .++|+||||||+|
T Consensus       110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~N  187 (334)
T 2pvf_A          110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--SQKCIHRDLAARN  187 (334)
T ss_dssp             ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGG
T ss_pred             EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCccce
Confidence            99999999999999999999999865321            134889999999999999999999  5999999999999


Q ss_pred             EEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcccccccccee
Q 017177          232 ILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFA  311 (376)
Q Consensus       232 ILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g  311 (376)
                      ||++.++.+||+|||+++..............     .+|+.|+               |||++.+.. .+.++||||+|
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~-----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG  246 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNG-----RLPVKWM---------------APEALFDRV-YTHQSDVWSFG  246 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCC-----CCCGGGC---------------CHHHHHHCE-ECHHHHHHHHH
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCC-----Cccccee---------------ChHHhcCCC-cChHHHHHHHH
Confidence            99999999999999999987654432212111     5667787               899887654 58899999999


Q ss_pred             eeehhhcc
Q 017177          312 FVFSCVFS  319 (376)
Q Consensus       312 ~v~~~~~~  319 (376)
                      ++++++++
T Consensus       247 ~il~ellt  254 (334)
T 2pvf_A          247 VLMWEIFT  254 (334)
T ss_dssp             HHHHHHHT
T ss_pred             HHHHHHHh
Confidence            99999987

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.6e-36  Score=277.72  Aligned_cols=196  Identities=23%  Similarity=0.311  Sum_probs=163.6

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ...++|++.+.||+|+||.||+|.+..          +..||+|+++..... .+.+.+|+.+++.++||||+++++++.
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~   89 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCT   89 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEETT----------TEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEcC----------CCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEe
Confidence            345679999999999999999996653          677999999876433 367889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +++..++||||+++++|.+++....   ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+||
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nili~~~~~~kl~Df  164 (283)
T 3gen_A           90 KQRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDF  164 (283)
T ss_dssp             SSSSEEEEECCCTTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCSGGGEEECTTSCEEECST
T ss_pred             cCCCeEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCccceEEEcCCCCEEEccc
Confidence            9999999999999999999997642   45899999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      |++.......... ..+.     .+|+.|+               +||++.+.. .+.++|+||+|++++++++
T Consensus       165 g~~~~~~~~~~~~-~~~~-----~~~~~y~---------------aPE~~~~~~-~~~~~Dv~slG~~l~~l~t  216 (283)
T 3gen_A          165 GLSRYVLDDEYTS-SVGS-----KFPVRWS---------------PPEVLMYSK-FSSKSDIWAFGVLMWEIYS  216 (283)
T ss_dssp             TGGGGBCCHHHHS-TTST-----TSCGGGC---------------CHHHHHHCC-CSHHHHHHHHHHHHHHHHT
T ss_pred             ccccccccccccc-ccCC-----ccCcccC---------------CHHHhccCC-CCchhhHHHHHHHHHHHHh
Confidence            9998765432221 1111     4566777               899887665 5889999999999999986

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.2e-36  Score=281.07  Aligned_cols=200  Identities=17%  Similarity=0.184  Sum_probs=161.8

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCC--CCcceEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSH--PNLVKLLG  162 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h--~nIv~l~~  162 (376)
                      ..++|++.+.||+|+||.||+|...          +++.||||++...  .....+.+.+|+.+++.++|  |||+++++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~   76 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD   76 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECT----------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeC----------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEee
Confidence            3567999999999999999999543          3788999998754  33445788999999999986  99999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                      ++.+++.+|+||| +.+++|.+++...    ..+++..+..++.||+.||.|||  .++|+||||||+|||++ ++.+||
T Consensus        77 ~~~~~~~~~lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH--~~~iiHrDikp~NIll~-~~~~kl  148 (343)
T 3dbq_A           77 YEITDQYIYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV-DGMLKL  148 (343)
T ss_dssp             EEECSSEEEEEEC-CCSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEE-TTEEEE
T ss_pred             eEeeCCEEEEEEe-CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCcceEEEE-CCcEEE
Confidence            9999999999999 5578999999875    45899999999999999999999  58999999999999997 688999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh----------hhhccccccccceee
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW----------IKYLTLLKYSNSFAF  312 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~----------~~~~~~~~dv~s~g~  312 (376)
                      +|||+++........... .+    ..||+.|+               |||++.+          ...++.++||||+|+
T Consensus       149 ~DFG~a~~~~~~~~~~~~-~~----~~gt~~y~---------------aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~  208 (343)
T 3dbq_A          149 IDFGIANQMQPDTTSVVK-DS----QVGTVNYM---------------PPEAIKDMSSSRENGKSKSKISPKSDVWSLGC  208 (343)
T ss_dssp             CCCSSSCCC-----------------CCCCSSC---------------CHHHHHHCC-----------CCHHHHHHHHHH
T ss_pred             eecccccccCcccccccC-CC----CcCCcCcC---------------CHHHHhhccccccccccccCCCchhhHHHHHH
Confidence            999999877543322111 11    27888998               8998865          255688999999999


Q ss_pred             eehhhccccccc
Q 017177          313 VFSCVFSFYRTT  324 (376)
Q Consensus       313 v~~~~~~~y~~~  324 (376)
                      +++++++...+.
T Consensus       209 il~ell~g~~pf  220 (343)
T 3dbq_A          209 ILYYMTYGKTPF  220 (343)
T ss_dssp             HHHHHHHSSCTT
T ss_pred             HHHHHHhCCCcc
Confidence            999998655443

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-36  Score=280.64  Aligned_cols=202  Identities=21%  Similarity=0.231  Sum_probs=169.2

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||||+++.... ...+.+.+|+.+++.++||||+++++++.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   77 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHK---------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEE   77 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEEC---------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEee
Confidence            3467999999999999999999554         3588999999986432 34567789999999999999999999998


Q ss_pred             eCC--eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE----cCCCc
Q 017177          166 EDK--ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL----DGVGF  239 (376)
Q Consensus       166 ~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl----~~~g~  239 (376)
                      ..+  ..++||||+++++|.+++..... ...+++..+..++.|++.||.|||  .++|+||||||+|||+    +.++.
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~  154 (319)
T 4euu_A           78 ETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSV  154 (319)
T ss_dssp             CTTTCCEEEEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEECTTSCEE
T ss_pred             cCCCceEEEEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEEeccCCCCce
Confidence            765  78999999999999999976532 234899999999999999999999  5999999999999999    78888


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh-------hhhccccccccceee
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW-------IKYLTLLKYSNSFAF  312 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~-------~~~~~~~~dv~s~g~  312 (376)
                      +||+|||+++...........        .||+.|+               |||++..       ....+.++||||+|+
T Consensus       155 ~kL~Dfg~a~~~~~~~~~~~~--------~gt~~y~---------------aPE~~~~~~~~~~~~~~~~~~~DiwslG~  211 (319)
T 4euu_A          155 YKLTDFGAARELEDDEQFVSL--------YGTEEYL---------------HPDMYERAVLRKDHQKKYGATVDLWSIGV  211 (319)
T ss_dssp             EEECCCTTCEECCTTCCBCCC--------CSCGGGC---------------CHHHHHHHTSCCCCCCCBCTTHHHHHHHH
T ss_pred             EEEccCCCceecCCCCceeec--------ccCCCcc---------------CHHHhhhccccccccCCCCcHHHHHHHHH
Confidence            999999999987654433111        6788888               8998874       356788999999999


Q ss_pred             eehhhcccccc
Q 017177          313 VFSCVFSFYRT  323 (376)
Q Consensus       313 v~~~~~~~y~~  323 (376)
                      +++++++...+
T Consensus       212 il~el~~g~~p  222 (319)
T 4euu_A          212 TFYHAATGSLP  222 (319)
T ss_dssp             HHHHHHHSSCS
T ss_pred             HHHHHHhCCCC
Confidence            99999965443

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.6e-36  Score=276.10  Aligned_cols=202  Identities=20%  Similarity=0.237  Sum_probs=164.9

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ..++|.+.+.||+|+||.||+|...         .++..+|+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   90 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEER---------SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE   90 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEc---------cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee
Confidence            3457999999999999999999544         358899999987653 234578889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE---cCCCcEEE
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL---DGVGFLFD  242 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl---~~~g~~kl  242 (376)
                      +.+..++||||+++|+|.+++.........+++..+..++.|++.||.|||  .++|+||||||+|||+   +.++.+||
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~dikp~NIl~~~~~~~~~~kl  168 (285)
T 3is5_A           91 DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH--SQHVVHKDLKPENILFQDTSPHSPIKI  168 (285)
T ss_dssp             CSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEESSSSTTCCEEE
T ss_pred             cCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCEEECCCCHHHEEEecCCCCCCEEE
Confidence            999999999999999999998654322356899999999999999999999  5999999999999999   45688999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      +|||++...........        ..||+.|+               +||++.+  ..+.++|+||+|++++++++...
T Consensus       169 ~Dfg~a~~~~~~~~~~~--------~~~t~~y~---------------aPE~~~~--~~~~~~Di~slG~il~~ll~g~~  223 (285)
T 3is5_A          169 IDFGLAELFKSDEHSTN--------AAGTALYM---------------APEVFKR--DVTFKCDIWSAGVVMYFLLTGCL  223 (285)
T ss_dssp             CCCCCCCC------------------CTTGGGC---------------CHHHHTT--CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             EeeecceecCCcccCcC--------cccccCcC---------------ChHHhcc--CCCcccCeehHHHHHHHHHhCCC
Confidence            99999987655332211        16778888               8998763  46889999999999999997544


Q ss_pred             cc
Q 017177          323 TT  324 (376)
Q Consensus       323 ~~  324 (376)
                      +.
T Consensus       224 pf  225 (285)
T 3is5_A          224 PF  225 (285)
T ss_dssp             SS
T ss_pred             CC
Confidence            43

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.5e-35  Score=284.19  Aligned_cols=199  Identities=17%  Similarity=0.191  Sum_probs=161.7

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCC--CCCcceEEeE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLS--HPNLVKLLGY  163 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~--h~nIv~l~~~  163 (376)
                      .++|++.+.||+|+||.||+|...          .++.||||++...  .....+.+.+|+.+++.++  ||||++++++
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~----------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~  124 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY  124 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcC----------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEE
Confidence            346999999999999999999543          2788999998654  3345678899999999997  5999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +..++.+|+||| +.+++|.+++.+.    ..+++..+..++.||+.||.|||  .++|+||||||+|||++ ++.+||+
T Consensus       125 ~~~~~~~~lv~E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH--~~~ivHrDlkp~NIll~-~~~~kl~  196 (390)
T 2zmd_A          125 EITDQYIYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV-DGMLKLI  196 (390)
T ss_dssp             EECSSEEEEEEE-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHH--TTTCCCCCCCGGGEEES-SSCEEEC
T ss_pred             EecCCEEEEEEe-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHEEEE-CCeEEEE
Confidence            999999999999 5688999999876    45889999999999999999999  69999999999999995 6899999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh----------hhccccccccceeee
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI----------KYLTLLKYSNSFAFV  313 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~----------~~~~~~~dv~s~g~v  313 (376)
                      |||+++.+......... .+.    +||+.|+               |||++.+.          ..++.++||||+|++
T Consensus       197 DFG~a~~~~~~~~~~~~-~~~----~gt~~y~---------------aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvi  256 (390)
T 2zmd_A          197 DFGIANQMQPDTTSVVK-DSQ----VGAVNYM---------------PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI  256 (390)
T ss_dssp             CCSSSCCC----------CCS----CCCGGGC---------------CHHHHHCC------------CCHHHHHHHHHHH
T ss_pred             ecCccccccCCCccccC-CCC----CcCCCcc---------------ChHHhhhccccccccccccCCCChhhHHHHHHH
Confidence            99999977543322111 111    7899999               89988752          357889999999999


Q ss_pred             ehhhccccccc
Q 017177          314 FSCVFSFYRTT  324 (376)
Q Consensus       314 ~~~~~~~y~~~  324 (376)
                      ++++++...+.
T Consensus       257 l~ell~G~~Pf  267 (390)
T 2zmd_A          257 LYYMTYGKTPF  267 (390)
T ss_dssp             HHHHHHSSCTT
T ss_pred             HHHHHHCCCcc
Confidence            99998655443

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-35  Score=300.41  Aligned_cols=199  Identities=22%  Similarity=0.288  Sum_probs=159.4

Q ss_pred             cCCCCccc-eEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           88 TKNFKPDS-LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      .+++.+.+ .||+|+||.||+|.+...       ..+..||||+++... ....+.+.+|+.+|+.++||||+++++++.
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  406 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ  406 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECS-------SCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecC-------CCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEec
Confidence            34455555 799999999999976531       136789999998753 345678999999999999999999999987


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      . +.+++||||+++|+|.+++...   ...+++..+..++.||+.||.|||  .++|+||||||+|||++.++.+||+||
T Consensus       407 ~-~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH--~~~iiHrDlkp~NILl~~~~~vkL~DF  480 (613)
T 2ozo_A          407 A-EALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLE--EKNFVHRNLAARNVLLVNRHYAKISDF  480 (613)
T ss_dssp             S-SSEEEEEECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred             c-CCeEEEEEeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHH--HCCEEcCcCCHHHEEEcCCCcEEEeec
Confidence            6 5699999999999999999654   256899999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      |+++.............    ...+|+.|+               |||++.+.. ++.++||||||++++|+++
T Consensus       481 Gla~~~~~~~~~~~~~~----~~~~~~~y~---------------APE~~~~~~-~~~~sDvwSlGv~l~ellt  534 (613)
T 2ozo_A          481 GLSKALGADDSYYTARS----AGKWPLKWY---------------APECINFRK-FSSRSDVWSYGVTMWEALS  534 (613)
T ss_dssp             STTTTCC------------------CCTTS---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             cCcccccCCCceeeecc----CCCCcccee---------------CHhhhcCCC-CCcHHHHHHHHHHHHHHHH
Confidence            99987654332211111    114567787               899887654 5889999999999999987

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-35  Score=277.96  Aligned_cols=206  Identities=25%  Similarity=0.270  Sum_probs=163.9

Q ss_pred             hhhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcC-CCCCcceE
Q 017177           82 LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKL  160 (376)
Q Consensus        82 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l  160 (376)
                      .++....++|++.+.||+|+||.||+|...         .+++.||+|++..... ..+.+.+|+.+++++ +||||+++
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~   86 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHV---------KTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATY   86 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCE
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEEC---------CCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeee
Confidence            344456788999999999999999999554         3588999999876532 336788999999999 69999999


Q ss_pred             EeEEEe------CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE
Q 017177          161 LGYCWE------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL  234 (376)
Q Consensus       161 ~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl  234 (376)
                      ++++..      .+..++||||+++|+|.+++....  ...+++..+..++.||+.||.|||  .++|+||||||+|||+
T Consensus        87 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~NIl~  162 (326)
T 2x7f_A           87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLL  162 (326)
T ss_dssp             EEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEE
T ss_pred             eeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCcHHHEEE
Confidence            999987      467999999999999999997653  245899999999999999999999  5899999999999999


Q ss_pred             cCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh----hhhccccccccce
Q 017177          235 DGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW----IKYLTLLKYSNSF  310 (376)
Q Consensus       235 ~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~----~~~~~~~~dv~s~  310 (376)
                      +.++.+||+|||++..........       ....||+.|+               +||++.+    ....+.++||||+
T Consensus       163 ~~~~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~y~---------------aPE~~~~~~~~~~~~~~~~Di~sl  220 (326)
T 2x7f_A          163 TENAEVKLVDFGVSAQLDRTVGRR-------NTFIGTPYWM---------------APEVIACDENPDATYDFKSDLWSL  220 (326)
T ss_dssp             CTTCCEEECCCTTTC--------------------CCGGGC---------------CHHHHC--------CCTTHHHHHH
T ss_pred             cCCCCEEEeeCcCceecCcCcccc-------ccccCCcccc---------------ChhhhccccccCcCCCccchHHHH
Confidence            999999999999998765432211       1126788888               8998763    3456789999999


Q ss_pred             eeeehhhcccccc
Q 017177          311 AFVFSCVFSFYRT  323 (376)
Q Consensus       311 g~v~~~~~~~y~~  323 (376)
                      |++++++++...+
T Consensus       221 G~il~~l~~g~~p  233 (326)
T 2x7f_A          221 GITAIEMAEGAPP  233 (326)
T ss_dssp             HHHHHHHHHSSCT
T ss_pred             HHHHHHHHhCCCC
Confidence            9999999965444

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2e-35  Score=272.49  Aligned_cols=205  Identities=20%  Similarity=0.227  Sum_probs=162.9

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe-
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE-  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-  166 (376)
                      .++|++.+.||+|+||.||+|...         .+++.||+|++... ....+.+.+|+.+++.++||||+++++++.+ 
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   74 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNA---------LDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLER   74 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred             cccchhhheeccCCcEEEEEEEEc---------CCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhh
Confidence            457999999999999999999543         35889999999643 3445778899999999999999999998865 


Q ss_pred             ------------CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE
Q 017177          167 ------------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL  234 (376)
Q Consensus       167 ------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl  234 (376)
                                  .+..|+||||+++|+|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||+
T Consensus        75 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dlkp~Nil~  149 (303)
T 1zy4_A           75 RNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIH--SQGIIHRDLKPMNIFI  149 (303)
T ss_dssp             CCCCC------CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEE
T ss_pred             cchhhhhcccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHH--hCCeecccCCHHhEEE
Confidence                        356899999999999999997642   45788999999999999999999  5899999999999999


Q ss_pred             cCCCcEEEcceeeeeeeccceeeEE-------EeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccc
Q 017177          235 DGVGFLFDSHLLIYVYFKRHYIYIY-------IHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYS  307 (376)
Q Consensus       235 ~~~g~~kl~Dfg~a~~~~~~~~~~~-------~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv  307 (376)
                      +.++.+||+|||++...........       ..........||+.|+               +||++.+....+.++|+
T Consensus       150 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~---------------aPE~~~~~~~~~~~~Di  214 (303)
T 1zy4_A          150 DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYV---------------ATEVLDGTGHYNEKIDM  214 (303)
T ss_dssp             CTTSCEEECCCCCCSCTTC-------------------------CTTS---------------CHHHHTSCSCCCTHHHH
T ss_pred             cCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCccccc---------------CcccccCCCCCcchhhH
Confidence            9999999999999987654321100       0000111226778888               89998877677899999


Q ss_pred             cceeeeehhhccccc
Q 017177          308 NSFAFVFSCVFSFYR  322 (376)
Q Consensus       308 ~s~g~v~~~~~~~y~  322 (376)
                      ||+|++++++++-+.
T Consensus       215 ~slG~il~~l~~p~~  229 (303)
T 1zy4_A          215 YSLGIIFFEMIYPFS  229 (303)
T ss_dssp             HHHHHHHHHHHSCCS
T ss_pred             HHHHHHHHHHHhccC
Confidence            999999999986443

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.7e-36  Score=283.18  Aligned_cols=211  Identities=18%  Similarity=0.150  Sum_probs=168.4

Q ss_pred             hhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-----ChhhHHHHHHHHHHHhcCCCCCcc
Q 017177           84 LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-----SMQGFEEWQSEVNFLGRLSHPNLV  158 (376)
Q Consensus        84 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~h~nIv  158 (376)
                      +....++|++.+.||+|+||.||+|...         .++..||+|++...     .....+.+.+|+.+++.++||||+
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv   91 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIEN---------QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA   91 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBC
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEEC---------CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcc
Confidence            4456678999999999999999999544         35889999998653     224457889999999999999999


Q ss_pred             eEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCC------------------------------------CCCCCHHHHH
Q 017177          159 KLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS------------------------------------IQPLSWDIRL  202 (376)
Q Consensus       159 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------~~~~~~~~~~  202 (376)
                      ++++++.+.+..++||||+++|+|.+++......                                    ...+++..+.
T Consensus        92 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (345)
T 3hko_A           92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLIS  171 (345)
T ss_dssp             CEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHH
T ss_pred             eeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHH
Confidence            9999999999999999999999999998531100                                    1124677888


Q ss_pred             HHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC--cEEEcceeeeeeeccceeeE-EEeeeEEEEEeeeeehhhhhc
Q 017177          203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG--FLFDSHLLIYVYFKRHYIYI-YIHTYIIYIYIYVYIYMYIYK  279 (376)
Q Consensus       203 ~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g--~~kl~Dfg~a~~~~~~~~~~-~~~~~~~y~~~gt~~y~~~~~  279 (376)
                      .++.||+.||.|||  .++|+||||||+|||++.++  .+||+|||++..+....... .....    ..||+.|+    
T Consensus       172 ~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~----~~gt~~y~----  241 (345)
T 3hko_A          172 NIMRQIFSALHYLH--NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT----KAGTPYFV----  241 (345)
T ss_dssp             HHHHHHHHHHHHHH--HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC------------CCCGGGC----
T ss_pred             HHHHHHHHHHHHHH--HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccc----cCCCcccc----
Confidence            99999999999999  58999999999999998776  89999999999765432211 11111    27888888    


Q ss_pred             chhhHHHHHHHHHHHHhhh-hhccccccccceeeeehhhccccccc
Q 017177          280 CLRYAILYSVLLPRIYAWI-KYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       280 ~~e~~d~~s~~apEi~~~~-~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                                 |||++.+. ..++.++||||+|++++++++...+.
T Consensus       242 -----------aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf  276 (345)
T 3hko_A          242 -----------APEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF  276 (345)
T ss_dssp             -----------CHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             -----------CchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence                       89988753 55688999999999999999765553

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-36  Score=288.39  Aligned_cols=203  Identities=23%  Similarity=0.222  Sum_probs=167.1

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh----hhHHHHHHHHHHHhcC-CCCCcceEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM----QGFEEWQSEVNFLGRL-SHPNLVKLLG  162 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l-~h~nIv~l~~  162 (376)
                      .++|++.+.||+|+||.||+|+...      ...+++.||||+++....    ...+.+.+|+.+++.+ +||||+++++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  126 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKIS------GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY  126 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECS------STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcc------cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEE
Confidence            4579999999999999999997642      123588999999875421    2235567899999999 5999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                      ++...+.+++||||+++|+|.+++...    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.++.+||
T Consensus       127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kl  200 (355)
T 1vzo_A          127 AFQTETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVL  200 (355)
T ss_dssp             EEEETTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred             EEeeCceEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCcEEE
Confidence            999999999999999999999999876    45899999999999999999999  589999999999999999999999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh-hhccccccccceeeeehhhcccc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI-KYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~-~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      +|||+++.........  ....    .||+.|+               +||++.+. ...+.++||||+|++++++++..
T Consensus       201 ~DfG~a~~~~~~~~~~--~~~~----~gt~~y~---------------aPE~~~~~~~~~~~~~DvwslG~il~ell~g~  259 (355)
T 1vzo_A          201 TDFGLSKEFVADETER--AYDF----CGTIEYM---------------APDIVRGGDSGHDKAVDWWSLGVLMYELLTGA  259 (355)
T ss_dssp             SCSSEEEECCGGGGGG--GCGG----GSCCTTC---------------CHHHHTTCC---CTHHHHHHHHHHHHHHHHSS
T ss_pred             eeCCCCeecccCCCCc--ccCc----ccCcCcc---------------ChhhhcCCCCCCCchhhHHHHHHHHHHHHHCC
Confidence            9999998764432211  1111    6788888               89988864 45688999999999999999654


Q ss_pred             cc
Q 017177          322 RT  323 (376)
Q Consensus       322 ~~  323 (376)
                      .+
T Consensus       260 ~p  261 (355)
T 1vzo_A          260 SP  261 (355)
T ss_dssp             CT
T ss_pred             CC
Confidence            43

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1e-36  Score=286.51  Aligned_cols=200  Identities=20%  Similarity=0.205  Sum_probs=170.9

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--------hhHHHHHHHHHHHhcCCCCCc
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--------QGFEEWQSEVNFLGRLSHPNL  157 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~h~nI  157 (376)
                      ...++|++.+.||+|+||.||+|...         .+++.||||+++....        ...+.+.+|+.+++.++||||
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~I   91 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDK---------EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI   91 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEET---------TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTB
T ss_pred             ccccceEEEeEEEecCCEEEEEEEEC---------CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCE
Confidence            34568999999999999999999543         3689999999876531        123456789999999999999


Q ss_pred             ceEEeEEEeCCeEEEEEeccCCC-CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC
Q 017177          158 VKLLGYCWEDKELLLVYEYMQRG-SLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG  236 (376)
Q Consensus       158 v~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~  236 (376)
                      +++++++.+.+..++||||+.+| +|.+++...    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.
T Consensus        92 v~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~  165 (335)
T 3dls_A           92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLR--LKDIIHRDIKDENIVIAE  165 (335)
T ss_dssp             CCEEEEEECSSEEEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECT
T ss_pred             eeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeEEeccCHHHEEEcC
Confidence            99999999999999999999776 999999765    45899999999999999999999  589999999999999999


Q ss_pred             CCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehh
Q 017177          237 VGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSC  316 (376)
Q Consensus       237 ~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~  316 (376)
                      ++.+||+|||++...........        ..||+.|+               |||++.+..+.+.++||||+|+++++
T Consensus       166 ~~~~kL~Dfg~a~~~~~~~~~~~--------~~gt~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~e  222 (335)
T 3dls_A          166 DFTIKLIDFGSAAYLERGKLFYT--------FCGTIEYC---------------APEVLMGNPYRGPELEMWSLGVTLYT  222 (335)
T ss_dssp             TSCEEECCCTTCEECCTTCCBCE--------ECSCGGGC---------------CHHHHTTCCBCSHHHHHHHHHHHHHH
T ss_pred             CCcEEEeecccceECCCCCceec--------cCCCcccc---------------ChhhhcCCCCCCCcccchhHHHHHHH
Confidence            99999999999998765433211        26888888               89999888877899999999999999


Q ss_pred             hcccccc
Q 017177          317 VFSFYRT  323 (376)
Q Consensus       317 ~~~~y~~  323 (376)
                      +++-..+
T Consensus       223 l~~g~~p  229 (335)
T 3dls_A          223 LVFEENP  229 (335)
T ss_dssp             HHHSSCS
T ss_pred             HHhCCCc
Confidence            9855444

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.2e-35  Score=276.98  Aligned_cols=209  Identities=22%  Similarity=0.246  Sum_probs=171.0

Q ss_pred             hhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEe
Q 017177           84 LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLG  162 (376)
Q Consensus        84 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~  162 (376)
                      .....++|++.+.||+|+||.||+|.+...    ....++..||+|.+..... .....+.+|+.+++.++||||+++++
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCc----cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            344567899999999999999999975421    1112478899999986533 44567889999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcC------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRN------PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG  236 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~  236 (376)
                      ++.+.+..++||||+++|+|.+++....      .....+++..+..++.|++.||.|||  .++|+||||||+|||++.
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~NIli~~  173 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAE  173 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCSGGGEEECT
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCCccCCCccceEEEcC
Confidence            9999999999999999999999997532      11245789999999999999999999  589999999999999999


Q ss_pred             CCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehh
Q 017177          237 VGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSC  316 (376)
Q Consensus       237 ~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~  316 (376)
                      ++.+||+|||++............ +..    .||+.|+               +||++.+.. .+.++|+||+|+++++
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~-~~~----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~e  232 (322)
T 1p4o_A          174 DFTVKIGDFGMTRDIYETDYYRKG-GKG----LLPVRWM---------------SPESLKDGV-FTTYSDVWSFGVVLWE  232 (322)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGG-GSS----EECGGGC---------------CHHHHHHCC-CCHHHHHHHHHHHHHH
T ss_pred             CCeEEECcCccccccccccccccc-cCC----CCCCCcc---------------ChhhhccCC-CCchhhHHHHHHHHHH
Confidence            999999999999876554332211 111    6678888               899877654 5889999999999999


Q ss_pred             hcc
Q 017177          317 VFS  319 (376)
Q Consensus       317 ~~~  319 (376)
                      +++
T Consensus       233 l~~  235 (322)
T 1p4o_A          233 IAT  235 (322)
T ss_dssp             HHH
T ss_pred             HHh
Confidence            987

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3e-36  Score=274.70  Aligned_cols=201  Identities=20%  Similarity=0.191  Sum_probs=170.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|...         .+++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   76 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNR---------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE   76 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEEC---------CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc
Confidence            457999999999999999999554         358899999986543 2345778899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++..++||||+++++|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+||+++.++.+||+|||
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~dfg  150 (276)
T 2yex_A           77 GNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFG  150 (276)
T ss_dssp             TTEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCEEEEEEEecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCChHHEEEccCCCEEEeeCC
Confidence            99999999999999999988654    45899999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ++............ ...    .||+.|+               +||++.+..+.+.++|+||+|++++++++...+
T Consensus       151 ~~~~~~~~~~~~~~-~~~----~~~~~y~---------------aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p  207 (276)
T 2yex_A          151 LATVFRYNNRERLL-NKM----CGTLPYV---------------APELLKRREFHAEPVDVWSCGIVLTAMLAGELP  207 (276)
T ss_dssp             TCEECEETTEECCB-CCC----CSCGGGC---------------CGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCC
T ss_pred             CccccCCCcchhcc-cCC----ccccCcc---------------ChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCC
Confidence            99876543322111 111    6788888               899888777678899999999999999965444

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.6e-35  Score=268.84  Aligned_cols=199  Identities=18%  Similarity=0.213  Sum_probs=169.7

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|++...  .....+.+.+|+.+++.++||||+++++++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   74 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHK---------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI   74 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEc---------CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence            4578999999999999999999554         35889999998654  334457788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc---EE
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF---LF  241 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~---~k  241 (376)
                      ..++..++||||+++++|.+.+...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.   +|
T Consensus        75 ~~~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~~~k  148 (284)
T 3kk8_A           75 QEESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVK  148 (284)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESSSSTTCCEE
T ss_pred             EcCCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcCcCCCCHHHEEEecCCCCCcEE
Confidence            9999999999999999999998776    45899999999999999999999  599999999999999976655   99


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |+|||++............        .||+.|+               +||++.+.. .+.++||||+|++++++++..
T Consensus       149 l~Dfg~~~~~~~~~~~~~~--------~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~  204 (284)
T 3kk8_A          149 LADFGLAIEVNDSEAWHGF--------AGTPGYL---------------SPEVLKKDP-YSKPVDIWACGVILYILLVGY  204 (284)
T ss_dssp             ECCCTTCEECCSSCBCCCS--------CSCGGGC---------------CHHHHTTCC-BCTHHHHHHHHHHHHHHHHSS
T ss_pred             EeeceeeEEcccCccccCC--------CCCcCCc---------------CchhhcCCC-CCcccchHHHHHHHHHHHHCC
Confidence            9999999877654332111        6778888               899887654 588999999999999999765


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      .+.
T Consensus       205 ~pf  207 (284)
T 3kk8_A          205 PPF  207 (284)
T ss_dssp             CSS
T ss_pred             CCC
Confidence            543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-35  Score=280.15  Aligned_cols=200  Identities=24%  Similarity=0.295  Sum_probs=160.8

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhh-----HHHHHHHHHHHhcCCCCCcce
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-----FEEWQSEVNFLGRLSHPNLVK  159 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~il~~l~h~nIv~  159 (376)
                      ....++|++.+.||+|+||.||+|..         ..+++.||+|++.......     .+.+.+|+.+++.++||||++
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   76 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARD---------KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG   76 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEEC---------SSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEE---------CCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCe
Confidence            34567899999999999999999954         3468899999997643211     246789999999999999999


Q ss_pred             EEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc
Q 017177          160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF  239 (376)
Q Consensus       160 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~  239 (376)
                      +++++.+.+..++||||+++ +|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.+|.
T Consensus        77 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~  150 (346)
T 1ua2_A           77 LLDAFGHKSNISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGV  150 (346)
T ss_dssp             EEEEECCTTCCEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCC
T ss_pred             EEEEEeeCCceEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHH--HCCEECCCCCHHHEEEcCCCC
Confidence            99999999999999999976 8988886542   45888999999999999999999  599999999999999999999


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +||+|||+++.........   ...    .||+.|+               |||++.+...++.++|+||+|++++++++
T Consensus       151 ~kl~Dfg~a~~~~~~~~~~---~~~----~~t~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~ell~  208 (346)
T 1ua2_A          151 LKLADFGLAKSFGSPNRAY---THQ----VVTRWYR---------------APELLFGARMYGVGVDMWAVGCILAELLL  208 (346)
T ss_dssp             EEECCCGGGSTTTSCCCCC---CCS----CCCCTTC---------------CHHHHTTCSCCCHHHHHHHHHHHHHHHHH
T ss_pred             EEEEecccceeccCCcccC---Ccc----ccccccc---------------CchHhhCCCCCCchhhhHhHHHHHHHHHH
Confidence            9999999998765433221   111    6788888               89998877777899999999999999986


Q ss_pred             cc
Q 017177          320 FY  321 (376)
Q Consensus       320 ~y  321 (376)
                      ..
T Consensus       209 g~  210 (346)
T 1ua2_A          209 RV  210 (346)
T ss_dssp             SS
T ss_pred             CC
Confidence            43

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-35  Score=276.06  Aligned_cols=203  Identities=23%  Similarity=0.314  Sum_probs=160.7

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ..++|++.+.||+|+||.||+|.....     ....+..||+|.++... ......+.+|+.+++.++||||+++++++.
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  116 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTS-----SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS  116 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecC-----CCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence            456788999999999999999976541     12235679999998653 344567889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      ..+..++||||+++|+|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+||
T Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Df  191 (333)
T 1mqb_A          117 KYKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDF  191 (333)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             cCCCcEEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChheEEECCCCcEEECCC
Confidence            9999999999999999999997652   45899999999999999999999  589999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      |+++..............    ..+|+.|+               +||++.+.. .+.++||||+|++++++++
T Consensus       192 g~~~~~~~~~~~~~~~~~----~~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~ellt  245 (333)
T 1mqb_A          192 GLSRVLEDDPEATYTTSG----GKIPIRWT---------------APEAISYRK-FTSASDVWSFGIVMWEVMT  245 (333)
T ss_dssp             CC---------------------CCCGGGS---------------CHHHHHSCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             CcchhhccccccccccCC----CCcccccc---------------CchhcccCC-CCchhhhHHHHHHHHHHHc
Confidence            999987554322111111    14567777               899887654 5789999999999999876

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.9e-35  Score=273.30  Aligned_cols=201  Identities=20%  Similarity=0.179  Sum_probs=160.1

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|++.....   ...+.+.+|+.+++.++||||++++++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~  102 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDT---------VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDF  102 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEc---------CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEE
Confidence            4578999999999999999999544         3588999999976532   234678899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +..++..|+||||+++++|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+
T Consensus       103 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~NIl~~~~~~~kl~  176 (309)
T 2h34_A          103 GEIDGQLYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAH--AAGATHRDVKPENILVSADDFAYLV  176 (309)
T ss_dssp             EEETTEEEEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             EeeCCeEEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCcCCcCCCChHHEEEcCCCCEEEe
Confidence            99999999999999999999999876    45899999999999999999999  5999999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||++..........  ...    ..||+.|+               +||++.+. ..+.++|+||+|++++++++...+
T Consensus       177 Dfg~~~~~~~~~~~~--~~~----~~~~~~y~---------------aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  234 (309)
T 2h34_A          177 DFGIASATTDEKLTQ--LGN----TVGTLYYM---------------APERFSES-HATYRADIYALTCVLYECLTGSPP  234 (309)
T ss_dssp             SCCC----------------------CCGGGC---------------CGGGTCC-----CCCHHHHHHHHHHHHHHSSCS
T ss_pred             cCccCcccccccccc--ccc----cCCCcCcc---------------CHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCC
Confidence            999998765433221  111    16788888               79977654 457899999999999999965544


Q ss_pred             c
Q 017177          324 T  324 (376)
Q Consensus       324 ~  324 (376)
                      .
T Consensus       235 f  235 (309)
T 2h34_A          235 Y  235 (309)
T ss_dssp             S
T ss_pred             C
Confidence            3

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.1e-36  Score=280.94  Aligned_cols=198  Identities=23%  Similarity=0.234  Sum_probs=161.0

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhh-HHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ++|++.+.||+|+||.||+|...         .+++.||+|++....... ...+.+|+.+++.++||||+++++++.++
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   72 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSK---------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE   72 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred             CceEEEEEEcCCCCEEEEEEEEC---------CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence            57999999999999999999554         358899999997654322 12445799999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++||||++ |+|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.+|.+||+|||+
T Consensus        73 ~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  146 (324)
T 3mtl_A           73 KSLTLVFEYLD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGL  146 (324)
T ss_dssp             SCEEEEEECCS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH--HTTEEESSCCGGGEEECTTCCEEECSSSE
T ss_pred             CEEEEEecccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCcCHHHEEECCCCCEEEccCcc
Confidence            99999999997 49999987653   45899999999999999999999  59999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      +.........  ...     ..||+.|+               |||++.+...++.++||||+|++++++++...+
T Consensus       147 a~~~~~~~~~--~~~-----~~~t~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  200 (324)
T 3mtl_A          147 ARAKSIPTKT--YDN-----EVVTLWYR---------------PPDILLGSTDYSTQIDMWGVGCIFYEMATGRPL  200 (324)
T ss_dssp             EECC-------------------CGGGC---------------CHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccCCccc--ccc-----ccCccccc---------------ChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            9865443222  111     16788888               899988877789999999999999999965443

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=9.2e-36  Score=279.21  Aligned_cols=209  Identities=25%  Similarity=0.279  Sum_probs=171.2

Q ss_pred             hhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcC-CCCCcceEE
Q 017177           84 LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLL  161 (376)
Q Consensus        84 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~l~  161 (376)
                      .....++|++.+.||+|+||.||+|.....    ........||+|.+.... ....+.+.+|+.+++.+ +||||++++
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~  116 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGL----GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL  116 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTC----SSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCC----CcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            344567899999999999999999976542    112235689999998654 34457788999999999 799999999


Q ss_pred             eEEEeCCeEEEEEeccCCCCHHHHHhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCC
Q 017177          162 GYCWEDKELLLVYEYMQRGSLENHLFRRNP----------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASN  231 (376)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~N  231 (376)
                      +++.+++..++||||+++|+|.+++.....          ....+++..+..++.|++.||.|||  .++|+||||||+|
T Consensus       117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~N  194 (333)
T 2i1m_A          117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA--SKNCIHRDVAARN  194 (333)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGG
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh--cCCcccCCcccce
Confidence            999999999999999999999999975421          1245799999999999999999999  5899999999999


Q ss_pred             EEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcccccccccee
Q 017177          232 ILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFA  311 (376)
Q Consensus       232 ILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g  311 (376)
                      ||++.++.+||+|||++............ +..    .||+.|+               |||++.+.. .+.++||||+|
T Consensus       195 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~-~~~----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG  253 (333)
T 2i1m_A          195 VLLTNGHVAKIGDFGLARDIMNDSNYIVK-GNA----RLPVKWM---------------APESIFDCV-YTVQSDVWSYG  253 (333)
T ss_dssp             CEEEGGGEEEBCCCGGGCCGGGCTTSEEC-SSC----EECGGGS---------------CHHHHHHCC-CCHHHHHHHHH
T ss_pred             EEECCCCeEEECccccccccccccceeec-CCC----CCCcccc---------------CHHHhccCC-CChHHHHHHHH
Confidence            99999999999999999876544332212 222    6778888               899887654 58899999999


Q ss_pred             eeehhhcc
Q 017177          312 FVFSCVFS  319 (376)
Q Consensus       312 ~v~~~~~~  319 (376)
                      ++++++++
T Consensus       254 ~il~el~t  261 (333)
T 2i1m_A          254 ILLWEIFS  261 (333)
T ss_dssp             HHHHHHTT
T ss_pred             HHHHHHHc
Confidence            99999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.9e-35  Score=270.98  Aligned_cols=200  Identities=18%  Similarity=0.153  Sum_probs=169.6

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC---ChhhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|++...   .....+.+.+|+.+++.++||||++++++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   83 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDA---------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF   83 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEEC---------CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeee
Confidence            3467999999999999999999554         35889999998654   23445778899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +.+++..++||||+++++|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~  157 (294)
T 2rku_A           84 FEDNDFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIG  157 (294)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             eccCCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEcCCCCEEEE
Confidence            99999999999999999999998776    45899999999999999999999  5899999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||++..........   ..    ..||+.|+               +||++.+.. .+.++|+||+|++++++++...+
T Consensus       158 dfg~~~~~~~~~~~~---~~----~~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p  214 (294)
T 2rku_A          158 DFGLATKVEYDGERK---KV----LCGTPNYI---------------APEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPP  214 (294)
T ss_dssp             CCTTCEECCSTTCCB---CC----CCSCCSSC---------------CHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             eccCceecccCcccc---cc----ccCCCCcC---------------CcchhccCC-CCchhhHHHHHHHHHHHHhCCCC
Confidence            999998765432221   11    16778888               899887654 58899999999999999975544


Q ss_pred             c
Q 017177          324 T  324 (376)
Q Consensus       324 ~  324 (376)
                      .
T Consensus       215 ~  215 (294)
T 2rku_A          215 F  215 (294)
T ss_dssp             T
T ss_pred             C
Confidence            3

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=9.9e-36  Score=274.95  Aligned_cols=202  Identities=22%  Similarity=0.301  Sum_probs=165.6

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..++|++.+.||+|+||.||+|...         .++..||+|++........+.+.+|+.+++.++||||+++++++..
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNK---------ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH   87 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEET---------TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CccceeecceeccCCCeEEEEEEEc---------CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee
Confidence            4568999999999999999999554         3588999999987766667889999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++..++||||+++++|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||
T Consensus        88 ~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  162 (302)
T 2j7t_A           88 DGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLH--SKRIIHRDLKAGNVLMTLEGDIRLADFG  162 (302)
T ss_dssp             C-CEEEEEECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEECTTSCEEECCCH
T ss_pred             CCeEEEEEEeCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHHHEEECCCCCEEEEECC
Confidence            999999999999999999987652   45899999999999999999999  5899999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHh----hhhhccccccccceeeeehhhccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYA----WIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~----~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      ++..........   .    ...||+.|+               +||++.    .....+.++|+||+|++++++++...
T Consensus       163 ~~~~~~~~~~~~---~----~~~~~~~y~---------------aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~  220 (302)
T 2j7t_A          163 VSAKNLKTLQKR---D----SFIGTPYWM---------------APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP  220 (302)
T ss_dssp             HHHHHHHHHHC------------CCGGGC---------------CHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCcccccccccc---c----cccCChhhc---------------CCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCC
Confidence            986543321111   1    116788888               799875    23456789999999999999986544


Q ss_pred             cc
Q 017177          323 TT  324 (376)
Q Consensus       323 ~~  324 (376)
                      +.
T Consensus       221 p~  222 (302)
T 2j7t_A          221 PH  222 (302)
T ss_dssp             TT
T ss_pred             CC
Confidence            43

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.9e-36  Score=283.79  Aligned_cols=204  Identities=20%  Similarity=0.135  Sum_probs=166.9

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcC-CCCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~  165 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||||++......  +.+.+|+.+++.+ +||||+++++++.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~h~~i~~~~~~~~   75 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNL---------YTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFGP   75 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEET---------TTTEEEEEEEEETTCSS--CCHHHHHHHHHHHCSCTTSCCEEEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEEC---------CCCcEEEEEEeccccch--HHHHHHHHHHHHhhCCCCCCEEEEEEe
Confidence            3468999999999999999999543         36899999998755322  4578899999999 7999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc-----E
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF-----L  240 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~-----~  240 (376)
                      ..+..++||||+ +++|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.     +
T Consensus        76 ~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH--~~~iiHrDlkp~Nill~~~~~~~~~~~  149 (330)
T 2izr_A           76 CGKYNAMVLELL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVH--SKNLIYRDVKPENFLIGRPGNKTQQVI  149 (330)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECCGGGTCTTSE
T ss_pred             cCCccEEEEEeC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeeeccCCCCCCceE
Confidence            999999999999 899999998652   46899999999999999999999  589999999999999998887     9


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ||+|||+++.+..................||+.|+               |||++.+.. .+.++||||+|++++++++.
T Consensus       150 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~ell~g  213 (330)
T 2izr_A          150 HIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM---------------SINTHLGKE-QSRRDDLEALGHMFMYFLRG  213 (330)
T ss_dssp             EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTC---------------CHHHHTTCC-CCHHHHHHHHHHHHHHHHHS
T ss_pred             EEEEcccceeeecCCCCccccccccCCcCCCcccc---------------ChHHHcCCC-CCchhHHHHHHHHHHHHhcC
Confidence            99999999986554321110000001127889999               899888765 48899999999999999865


Q ss_pred             ccc
Q 017177          321 YRT  323 (376)
Q Consensus       321 y~~  323 (376)
                      ..+
T Consensus       214 ~~P  216 (330)
T 2izr_A          214 SLP  216 (330)
T ss_dssp             SCT
T ss_pred             CCC
Confidence            433

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.3e-36  Score=297.44  Aligned_cols=198  Identities=23%  Similarity=0.350  Sum_probs=168.4

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ....+|++.+.||+|+||.||+|.+..         ++..||||.++.... ..+.+.+|+.+|++++||||+++++++.
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~  286 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCT  286 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGG---------GTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcC---------CCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            345678899999999999999996543         578999999986543 4578899999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +.+.+|+||||+++|+|.+++.....  ..+++..++.++.||+.||.|||  .++|+||||||+|||++.++.+||+||
T Consensus       287 ~~~~~~lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~kl~DF  362 (495)
T 1opk_A          287 REPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE--KKNFIHRNLAARNCLVGENHLVKVADF  362 (495)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECGGGCEEECCT
T ss_pred             cCCcEEEEEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChhhEEECCCCcEEEeec
Confidence            99999999999999999999986532  45899999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      |+++......... ..+.     .+|+.|+               |||++.+.. ++.++||||||++++|+++
T Consensus       363 G~a~~~~~~~~~~-~~~~-----~~~~~y~---------------aPE~~~~~~-~~~~sDvwSlG~~l~el~t  414 (495)
T 1opk_A          363 GLSRLMTGDTYTA-HAGA-----KFPIKWT---------------APESLAYNK-FSIKSDVWAFGVLLWEIAT  414 (495)
T ss_dssp             TCEECCTTCCEEC-CTTC-----CCCGGGC---------------CHHHHHHCE-ECHHHHHHHHHHHHHHHHT
T ss_pred             ccceeccCCceee-cCCC-----cCCccee---------------CHhHHhcCC-CCcHHhHHhHHHHHHHHHh
Confidence            9999875433221 1122     4566777               899887654 5889999999999999987

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-35  Score=277.13  Aligned_cols=200  Identities=20%  Similarity=0.268  Sum_probs=158.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|.+...     .......||+|.+.... ....+.+.+|+.+++.++||||+++++++..
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   88 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCT-----TCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCC-----CceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence            46799999999999999999976542     12223457888886543 3445788999999999999999999999987


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      +. .++|+||+.+|+|.+++....   ..+++..++.++.|++.||.|||  .++|+||||||+|||++.++.+||+|||
T Consensus        89 ~~-~~~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kL~DfG  162 (327)
T 3lzb_A           89 ST-VQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFG  162 (327)
T ss_dssp             SS-EEEEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred             CC-ceEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHh--hCCCcCCCCCHHHEEEcCCCCEEEccCc
Confidence            55 889999999999999998753   45899999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +++............+.     .||+.|+               +||++.+.. ++.++||||+|++++++++
T Consensus       163 ~a~~~~~~~~~~~~~~~-----~~t~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~ell~  214 (327)
T 3lzb_A          163 LAKLLGAEEKEYHAEGG-----KVPIKWM---------------ALESILHRI-YTHQSDVWSYGVTVWELMT  214 (327)
T ss_dssp             C---------------------CCCGGGS---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             ceeEccCccccccccCC-----Ccccccc---------------CHHHHcCCC-CChHHHHHHHHHHHHHHHH
Confidence            99987554333222222     5677788               899887654 5789999999999999887

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.5e-35  Score=272.89  Aligned_cols=208  Identities=22%  Similarity=0.301  Sum_probs=159.0

Q ss_pred             hhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceE
Q 017177           83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKL  160 (376)
Q Consensus        83 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l  160 (376)
                      +.....++|.+.+.||+|+||.||+|....      +..++..||+|.++..  .....+.+.+|+.+++.++||||+++
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~  101 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQ------EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL  101 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEEC------TTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEec------cCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeee
Confidence            334456789999999999999999997653      2234778999999765  33445778999999999999999999


Q ss_pred             EeEEEeCC-----eEEEEEeccCCCCHHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEE
Q 017177          161 LGYCWEDK-----ELLLVYEYMQRGSLENHLFRRN--PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL  233 (376)
Q Consensus       161 ~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NIL  233 (376)
                      ++++.+.+     ..++||||+++|+|.+++....  .....+++..++.++.|++.||.|||  .++|+||||||+|||
T Consensus       102 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dikp~NIl  179 (313)
T 3brb_A          102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS--NRNFLHRDLAARNCM  179 (313)
T ss_dssp             CEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH--TTTCCCCCCSGGGEE
T ss_pred             eEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEE
Confidence            99998754     3599999999999999985432  22356899999999999999999999  699999999999999


Q ss_pred             EcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeee
Q 017177          234 LDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFV  313 (376)
Q Consensus       234 l~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v  313 (376)
                      ++.++.+||+|||++...........     .....+++.|+               +||++.+.. .+.++|+||+|++
T Consensus       180 i~~~~~~kl~Dfg~~~~~~~~~~~~~-----~~~~~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~i  238 (313)
T 3brb_A          180 LRDDMTVCVADFGLSKKIYSGDYYRQ-----GRIAKMPVKWI---------------AIESLADRV-YTSKSDVWAFGVT  238 (313)
T ss_dssp             ECTTSCEEECSCSCC---------------------CCGGGS---------------CHHHHHSSC-CCHHHHHHHHHHH
T ss_pred             EcCCCcEEEeecCcceecccccccCc-----ccccCCCcccc---------------CchhhcCCC-ccchhhhHHHHHH
Confidence            99999999999999987654332211     11225677787               899877654 5789999999999


Q ss_pred             ehhhcc
Q 017177          314 FSCVFS  319 (376)
Q Consensus       314 ~~~~~~  319 (376)
                      ++++++
T Consensus       239 l~el~~  244 (313)
T 3brb_A          239 MWEIAT  244 (313)
T ss_dssp             HHHHHT
T ss_pred             HHHHHh
Confidence            999987

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2e-35  Score=279.92  Aligned_cols=204  Identities=20%  Similarity=0.153  Sum_probs=171.4

Q ss_pred             cChhhhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-----
Q 017177           79 FSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-----  153 (376)
Q Consensus        79 ~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----  153 (376)
                      +.+.+.....++|++.+.||+|+||.||+|...         .+++.||||+++... ...+.+.+|+.+++.+.     
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~   94 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHI---------DNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDIN   94 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTT
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEEC---------CCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCC
Confidence            444455566789999999999999999999554         358899999997533 33466778999999996     


Q ss_pred             CCCcceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEE
Q 017177          154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL  233 (376)
Q Consensus       154 h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NIL  233 (376)
                      ||||+++++++...+..++||||+ +++|.+++.+...  ..+++..+..++.||+.||.|||  .++|+||||||+|||
T Consensus        95 h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIl  169 (360)
T 3llt_A           95 NNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLR--KMSLTHTDLKPENIL  169 (360)
T ss_dssp             GGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEE
T ss_pred             CCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCcccEE
Confidence            999999999999999999999999 8899999987642  45899999999999999999999  599999999999999


Q ss_pred             EcC-------------------------CCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHH
Q 017177          234 LDG-------------------------VGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYS  288 (376)
Q Consensus       234 l~~-------------------------~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s  288 (376)
                      ++.                         ++.+||+|||++........      +.    .||+.|+             
T Consensus       170 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~------~~----~gt~~y~-------------  226 (360)
T 3llt_A          170 LDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHG------SI----INTRQYR-------------  226 (360)
T ss_dssp             ESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCC------SC----CSCGGGC-------------
T ss_pred             EccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCCc------Cc----cCccccc-------------
Confidence            975                         78999999999987544221      11    7788888             


Q ss_pred             HHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          289 VLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       289 ~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                        |||++.+.. ++.++||||+|++++++++...+
T Consensus       227 --aPE~~~~~~-~~~~~DiwslG~il~ell~g~~p  258 (360)
T 3llt_A          227 --APEVILNLG-WDVSSDMWSFGCVLAELYTGSLL  258 (360)
T ss_dssp             --CHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             --CcHHHcCCC-CCCccchHHHHHHHHHHHHCCCC
Confidence              899888765 58899999999999999865433

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.2e-35  Score=269.89  Aligned_cols=196  Identities=22%  Similarity=0.279  Sum_probs=159.6

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhc--CCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGR--LSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|.+.           ++.||||++....   ...+.+|.+++..  ++||||+++++++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~   71 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSWQ-----------GENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASD   71 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEET-----------TEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEEC-----------CEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEee
Confidence            4568999999999999999999653           7789999987543   3455667777666  7899999999987


Q ss_pred             EeC----CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCcEecCCCCCCEEE
Q 017177          165 WED----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS------EKKVIYRDFKASNILL  234 (376)
Q Consensus       165 ~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~------~~~iiHrDlKp~NILl  234 (376)
                      ...    ..+++||||+++|+|.+++..     ..+++..+..++.|++.||.|||+.      .++|+||||||+|||+
T Consensus        72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill  146 (301)
T 3q4u_A           72 MTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV  146 (301)
T ss_dssp             EEEETTEEEEEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE
T ss_pred             ccccCCCceeEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE
Confidence            553    458999999999999999954     3589999999999999999999921      3899999999999999


Q ss_pred             cCCCcEEEcceeeeeeeccceeeEEE-eeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhh-----hcccccccc
Q 017177          235 DGVGFLFDSHLLIYVYFKRHYIYIYI-HTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIK-----YLTLLKYSN  308 (376)
Q Consensus       235 ~~~g~~kl~Dfg~a~~~~~~~~~~~~-~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~-----~~~~~~dv~  308 (376)
                      +.++.+||+|||+++........... ....    .||+.|+               |||++.+..     ..+.++|||
T Consensus       147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~----~gt~~y~---------------aPE~~~~~~~~~~~~~~~~~Dvw  207 (301)
T 3q4u_A          147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPR----VGTKRYM---------------APEVLDETIQVDCFDSYKRVDIW  207 (301)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEECCCCCC----CCCGGGC---------------CHHHHTTCCCTTCHHHHHHHHHH
T ss_pred             cCCCCEEEeeCCCeeeccccccccccccccc----cccccee---------------ChhhhcCcCCCCcccCCchhhHH
Confidence            99999999999999877554332111 1111    7888888               899888763     345789999


Q ss_pred             ceeeeehhhccc
Q 017177          309 SFAFVFSCVFSF  320 (376)
Q Consensus       309 s~g~v~~~~~~~  320 (376)
                      |+|++++++++.
T Consensus       208 slG~il~el~tg  219 (301)
T 3q4u_A          208 AFGLVLWEVARR  219 (301)
T ss_dssp             HHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhh
Confidence            999999999865

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.6e-36  Score=275.29  Aligned_cols=199  Identities=23%  Similarity=0.345  Sum_probs=170.4

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ....++|++.+.||+|+||.||+|.+..         ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~   78 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC   78 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGG---------GTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccceeEEeecCCCCceeEEEeEecC---------CCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3456789999999999999999996543         58899999998654 3457788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .+++..++||||+++++|.+++.....  ..+++..+..++.|++.||.|||  +.+|+||||||+|||++.++.+||+|
T Consensus        79 ~~~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~l~D  154 (288)
T 3kfa_A           79 TREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD  154 (288)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHH--HHTCCCSCCSGGGEEECGGGCEEECC
T ss_pred             ccCCCEEEEEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHH--HCCccCCCCCcceEEEcCCCCEEEcc
Confidence            999999999999999999999977532  55899999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ||++.......... ..+.     .+|+.|+               +||++.+.. .+.++|+||+|++++++++
T Consensus       155 fg~~~~~~~~~~~~-~~~~-----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~ll~  207 (288)
T 3kfa_A          155 FGLSRLMTGDTYTA-HAGA-----KFPIKWT---------------APESLAYNK-FSIKSDVWAFGVLLWEIAT  207 (288)
T ss_dssp             CCGGGTSCSSSSEE-ETTE-----EECGGGC---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             CccceeccCCcccc-ccCC-----ccccCcC---------------ChhhhccCC-CCchhhHHHHHHHHHHHHh
Confidence            99998776543322 1122     6677888               899887664 5889999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.7e-35  Score=275.52  Aligned_cols=206  Identities=24%  Similarity=0.355  Sum_probs=171.2

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|++.+.||+|+||.||+|.+..     .+..+++.||+|++........+.+.+|+.+++.++||||+++++++...
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECT-----TSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             HHHceeeeeeccCCCeEEEEEEecc-----ccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            4568999999999999999997543     23446899999999887666678899999999999999999999998665


Q ss_pred             C--eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          168 K--ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       168 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +  .+++||||+++++|.+++....   ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+||
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dikp~NIli~~~~~~kL~Df  189 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDF  189 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH--hCCEeccCCCcceEEEcCCCcEEEecC
Confidence            4  6899999999999999997753   45899999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |++................    .+|+.|+               |||++.+.. .+.++||||+|++++++++...+
T Consensus       190 g~~~~~~~~~~~~~~~~~~----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~  247 (326)
T 2w1i_A          190 GLTKVLPQDKEYYKVKEPG----ESPIFWY---------------APESLTESK-FSVASDVWSFGVVLYELFTYIEK  247 (326)
T ss_dssp             TTCEECCSSCSEEECSSCC----SCCGGGC---------------CHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCG
T ss_pred             cchhhccccccccccccCC----CCceeEE---------------CchhhcCCC-CCchhhHHHHHHHHHHHHhcCCC
Confidence            9999876543322111111    4566677               799887654 58899999999999999986444

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.2e-35  Score=288.28  Aligned_cols=191  Identities=26%  Similarity=0.315  Sum_probs=161.9

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ...++|++.+.||+|+||.||+|.+.           +..||||+++...  ..+.+.+|+.+|++++||||+++++++.
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~  256 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV  256 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec-----------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEE
Confidence            34567899999999999999999654           5689999998654  3467899999999999999999999987


Q ss_pred             eCC-eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          166 EDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       166 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      ..+ .+|+||||+++|+|.+++.....  ..+++..+..++.||+.||.|||  .++|+||||||+|||++.++.+||+|
T Consensus       257 ~~~~~~~iv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~D  332 (450)
T 1k9a_A          257 EEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSD  332 (450)
T ss_dssp             CTTSCEEEEEECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTSCEEECC
T ss_pred             cCCCceEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHhhEEECCCCCEEEee
Confidence            765 79999999999999999987632  34789999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ||+++........    +      .+++.|+               |||++.+.. ++.++||||+|++++|+++
T Consensus       333 fG~a~~~~~~~~~----~------~~~~~y~---------------aPE~~~~~~-~~~~sDvwslG~~l~el~t  381 (450)
T 1k9a_A          333 FGLTKEASSTQDT----G------KLPVKWT---------------APEALREKK-FSTKSDVWSFGILLWEIYS  381 (450)
T ss_dssp             CTTCEECC----------------CCCTTTS---------------CHHHHHSSC-CCHHHHHHHHHHHHHHHHT
T ss_pred             CCCcccccccccC----C------CCCccee---------------CHHHhcCCC-CCcHHHHHHHHHHHHHHHh
Confidence            9999854332111    1      4566777               899887654 5889999999999999987

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.9e-36  Score=293.16  Aligned_cols=196  Identities=19%  Similarity=0.185  Sum_probs=159.7

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++++.||+|+||.||+|..         ..+++.||||++...  .....+++.+|+.+++.++||||+++++++
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  130 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYD---------AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF  130 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEE---------TTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEE---------CCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            457899999999999999999954         346899999999764  334457788999999999999999999999


Q ss_pred             EeC------CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          165 WED------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       165 ~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      ...      ..+|+||||+++ +|.+.+..      .+++..+..++.||+.||+|||  ..+|+||||||+|||++.+|
T Consensus       131 ~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH--~~~iiHrDlkp~NIll~~~~  201 (464)
T 3ttj_A          131 TPQKTLEEFQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDC  201 (464)
T ss_dssp             CSCCSTTTCCEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTS
T ss_pred             ccCCccccCCeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChHhEEEeCCC
Confidence            654      357999999976 57777743      3899999999999999999999  58999999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .+||+|||+++..........        .+||+.|+               |||++.+.. ++.++||||+|+++++++
T Consensus       202 ~~kl~DFG~a~~~~~~~~~~~--------~~gt~~y~---------------aPE~~~~~~-~~~~~DiwSlG~il~ell  257 (464)
T 3ttj_A          202 TLKILDFGLARTAGTSFMMTP--------YVVTRYYR---------------APEVILGMG-YKENVDIWSVGCIMGEMV  257 (464)
T ss_dssp             CEEECCCCCC-----CCCC------------CCCTTC---------------CHHHHTTCC-CCTTHHHHHHHHHHHHHH
T ss_pred             CEEEEEEEeeeecCCCcccCC--------Cccccccc---------------CHHHHcCCC-CCHHHHHHHHHHHHHHHH
Confidence            999999999987654322211        27888888               899998865 578999999999999999


Q ss_pred             cccccc
Q 017177          319 SFYRTT  324 (376)
Q Consensus       319 ~~y~~~  324 (376)
                      +...+.
T Consensus       258 ~g~~pF  263 (464)
T 3ttj_A          258 RHKILF  263 (464)
T ss_dssp             HSSCSS
T ss_pred             hCCCCC
Confidence            654443

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.9e-35  Score=270.98  Aligned_cols=202  Identities=21%  Similarity=0.267  Sum_probs=158.8

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC---ChhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      .++|++.+.||+|+||.||+|...         .+++.||+|+++..   .....+.+.+|+.+++.++||||+++++++
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~  101 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACL---------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF  101 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEET---------TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEc---------CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            457999999999999999999554         35889999999763   234457788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      ..++..++||||+++++|.+++.........+++..+..++.|++.||.|||  ..+|+||||||+|||++.+|.+||+|
T Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dl~p~NIl~~~~~~~kl~D  179 (310)
T 2wqm_A          102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGD  179 (310)
T ss_dssp             EETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECC
T ss_pred             EcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCcHHHEEEcCCCCEEEEe
Confidence            9999999999999999999999764322356899999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ||++..........       ....||+.|+               +||++.+.. .+.++||||+|++++++++...+
T Consensus       180 fg~~~~~~~~~~~~-------~~~~~~~~y~---------------aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p  235 (310)
T 2wqm_A          180 LGLGRFFSSKTTAA-------HSLVGTPYYM---------------SPERIHENG-YNFKSDIWSLGCLLYEMAALQSP  235 (310)
T ss_dssp             C-------------------------CCSSC---------------CHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             ccceeeecCCCccc-------cccCCCeeEe---------------ChHHhCCCC-CCchhhHHHHHHHHHHHHhCCCC
Confidence            99998765432211       1116778888               899887654 57899999999999999965443

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.1e-35  Score=278.13  Aligned_cols=190  Identities=19%  Similarity=0.151  Sum_probs=146.4

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEEeEEEeCCeEEE
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLL  172 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~l  172 (376)
                      .+.||+|+||.||+|...         .+++.||||++...   ....+.+|+.+++.+. ||||+++++++.+++..|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l   83 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHK---------KSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL   83 (325)
T ss_dssp             SCCSEEETTEEEEEEEET---------TTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCccccCCCeEEEEEEEC---------CCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence            378999999999999554         36889999999653   3356778999999998 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC---cEEEcceeeee
Q 017177          173 VYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG---FLFDSHLLIYV  249 (376)
Q Consensus       173 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g---~~kl~Dfg~a~  249 (376)
                      ||||+++|+|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++   .+||+|||+++
T Consensus        84 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           84 VMELLNGGELFERIKKK----KHFSETEASYIMRKLVSAVSHMH--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             EECCCCSCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             EEEccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            99999999999999875    45899999999999999999999  59999999999999998766   89999999998


Q ss_pred             eeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          250 YFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      .........   .+    ..||+.|+               |||++.+.. ++.++||||+|++++++++...+.
T Consensus       158 ~~~~~~~~~---~~----~~~t~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf  209 (325)
T 3kn6_A          158 LKPPDNQPL---KT----PCFTLHYA---------------APELLNQNG-YDESCDLWSLGVILYTMLSGQVPF  209 (325)
T ss_dssp             ECCC--------------------------------------------CC-CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ecCCCCCcc---cc----cCCCcCcc---------------CHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCC
Confidence            765432221   11    16677777               899887655 578999999999999999754443

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.3e-36  Score=287.31  Aligned_cols=202  Identities=20%  Similarity=0.218  Sum_probs=165.8

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      .++|++.+.||+|+||.||+|...         .+++.||+|++.....  .....+.+|+.+++.++||||+++++++.
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   86 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHR---------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR   86 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEET---------TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccceeEEEEEecCCCcEEEEEEEC---------CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheee
Confidence            467999999999999999999554         3688999999876533  22356789999999999999999999998


Q ss_pred             e--------CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC
Q 017177          166 E--------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV  237 (376)
Q Consensus       166 ~--------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~  237 (376)
                      .        .+.+|+||||+++ +|.+.+....   ..+++..+..++.|++.||.|||  +++|+||||||+|||++.+
T Consensus        87 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIl~~~~  160 (351)
T 3mi9_A           87 TKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRD  160 (351)
T ss_dssp             EC--------CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTT
T ss_pred             ccccccccCCceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCHHHEEEcCC
Confidence            7        3468999999975 7888776542   45899999999999999999999  5999999999999999999


Q ss_pred             CcEEEcceeeeeeeccceeeE-EEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehh
Q 017177          238 GFLFDSHLLIYVYFKRHYIYI-YIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSC  316 (376)
Q Consensus       238 g~~kl~Dfg~a~~~~~~~~~~-~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~  316 (376)
                      +.+||+|||+++......... ......    .||+.|+               |||++.+...++.++||||+|+++++
T Consensus       161 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~----~gt~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~e  221 (351)
T 3mi9_A          161 GVLKLADFGLARAFSLAKNSQPNRYTNR----VVTLWYR---------------PPELLLGERDYGPPIDLWGAGCIMAE  221 (351)
T ss_dssp             SCEEECCCTTCEECCCCSSSSCCCCCSS----CSCGGGC---------------CHHHHTTCCSCCTHHHHHHHHHHHHH
T ss_pred             CCEEEccchhcccccccccccccccCCc----ccccCcc---------------CchhhcCCCCCCcHhHHHHHHHHHHH
Confidence            999999999998765322110 011111    6788888               89999887778999999999999999


Q ss_pred             hcccccc
Q 017177          317 VFSFYRT  323 (376)
Q Consensus       317 ~~~~y~~  323 (376)
                      +++...+
T Consensus       222 ll~g~~p  228 (351)
T 3mi9_A          222 MWTRSPI  228 (351)
T ss_dssp             HHHSSCS
T ss_pred             HHhCCCC
Confidence            9864433

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.9e-36  Score=286.36  Aligned_cols=201  Identities=21%  Similarity=0.232  Sum_probs=168.1

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|.+.         .+++.||||++..... ...+.+.+|+.+++.++||||+++++++..
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   78 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHK---------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE   78 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCceEEEEEEEcCCCeEEEEEEEC---------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence            467999999999999999999554         3588999999986432 335677899999999999999999999987


Q ss_pred             CC--eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE----cCCCcE
Q 017177          167 DK--ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL----DGVGFL  240 (376)
Q Consensus       167 ~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl----~~~g~~  240 (376)
                      .+  ..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||  .++|+||||||+|||+    +.++.+
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~  155 (396)
T 4eut_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVY  155 (396)
T ss_dssp             TTTCCEEEEECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEECTTSCEEE
T ss_pred             CCCCeeEEEEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHH--HCCEEECCcCHHHEEEeecCCCceeE
Confidence            65  78999999999999999976532 233899999999999999999999  5999999999999999    778889


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh-------hhccccccccceeee
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI-------KYLTLLKYSNSFAFV  313 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~-------~~~~~~~dv~s~g~v  313 (376)
                      ||+|||+++...........        .||+.|+               |||++.+.       ..++.++|+||+|++
T Consensus       156 kL~DFG~a~~~~~~~~~~~~--------~gt~~y~---------------aPE~~~~~~~~~~~~~~~~~~~DiwSlG~i  212 (396)
T 4eut_A          156 KLTDFGAARELEDDEQFVSL--------YGTEEYL---------------HPDMYERAVLRKDHQKKYGATVDLWSIGVT  212 (396)
T ss_dssp             EECCGGGCEECCCGGGSSCS--------SSCCTTC---------------CHHHHHHHCC--CHHHHHHHHHHHHHHHHH
T ss_pred             EEecCCCceEccCCCccccc--------cCCcccc---------------CHHHhhccccccccccCCCcHHHHHHHHHH
Confidence            99999999987654332111        6778888               79988762       566889999999999


Q ss_pred             ehhhcccccc
Q 017177          314 FSCVFSFYRT  323 (376)
Q Consensus       314 ~~~~~~~y~~  323 (376)
                      ++++++...+
T Consensus       213 l~el~tg~~P  222 (396)
T 4eut_A          213 FYHAATGSLP  222 (396)
T ss_dssp             HHHHHHSSCS
T ss_pred             HHHHHHCCCC
Confidence            9999965433

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.4e-35  Score=270.81  Aligned_cols=200  Identities=24%  Similarity=0.289  Sum_probs=151.9

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|++.....   ...+.+.+|+.+++.++||||++++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   79 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESI---------HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY   79 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEc---------cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEE
Confidence            3467999999999999999999543         3588999999865422   224678899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +.+.+..++||||+++++|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+
T Consensus        80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nili~~~~~~kl~  154 (278)
T 3cok_A           80 FEDSNYVYLVLEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLH--SHGILHRDLTLSNLLLTRNMNIKIA  154 (278)
T ss_dssp             EECSSEEEEEEECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHH--HTTEECSSCCGGGEEECTTCCEEEC
T ss_pred             EccCCeEEEEEecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEEE
Confidence            999999999999999999999997642   45899999999999999999999  5899999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||++..........       +...||+.|+               +||++.+.. .+.++|+||+|++++++++...+
T Consensus       155 dfg~~~~~~~~~~~~-------~~~~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p  211 (278)
T 3cok_A          155 DFGLATQLKMPHEKH-------YTLCGTPNYI---------------SPEIATRSA-HGLESDVWSLGCMFYTLLIGRPP  211 (278)
T ss_dssp             CCTTCEECC---------------------------------------------------CTHHHHHHHHHHHHHHSSCS
T ss_pred             eecceeeccCCCCcc-------eeccCCCCcC---------------CcchhcCCC-CCchhhHHHHHHHHHHHHhCCCC
Confidence            999998765432221       1126777777               799877654 58899999999999999865444

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=9.7e-36  Score=273.28  Aligned_cols=202  Identities=22%  Similarity=0.199  Sum_probs=153.0

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hh-HHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QG-FEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~-~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|+++.... .. .+.+.++...++.++||||+++++++
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~   75 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHV---------PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGAL   75 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEec---------CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeee
Confidence            3567999999999999999999543         3589999999986532 22 23444555568888999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CcEecCCCCCCEEEcCCCcEEEc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEK-KVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~-~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      .+++..++||||+++ +|.+++.........+++..+..++.|++.||.|||+  + +|+||||||+|||++.++.+||+
T Consensus        76 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~  152 (290)
T 3fme_A           76 FREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMC  152 (290)
T ss_dssp             ECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--HSCCCCCCCSGGGCEECTTCCEEBC
T ss_pred             eccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEe
Confidence            999999999999975 8888876532223569999999999999999999994  6 99999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHH---hhhhhccccccccceeeeehhhccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIY---AWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~---~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      |||++............        .||+.|+               +||++   ......+.++|+||+|++++++++.
T Consensus       153 Dfg~~~~~~~~~~~~~~--------~~t~~y~---------------aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g  209 (290)
T 3fme_A          153 DFGISGYLVDDVAKDID--------AGCKPYM---------------APERINPELNQKGYSVKSDIWSLGITMIELAIL  209 (290)
T ss_dssp             CC-----------------------CCCCCCS---------------CHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHT
T ss_pred             ecCCccccccccccccc--------CCCcccc---------------ChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHC
Confidence            99999876554332212        5777787               79987   3445678899999999999999865


Q ss_pred             ccc
Q 017177          321 YRT  323 (376)
Q Consensus       321 y~~  323 (376)
                      ..+
T Consensus       210 ~~p  212 (290)
T 3fme_A          210 RFP  212 (290)
T ss_dssp             SCS
T ss_pred             CCC
Confidence            544

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3e-35  Score=268.85  Aligned_cols=198  Identities=22%  Similarity=0.243  Sum_probs=165.7

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ..++|++.+.||+|+||.||+|...         .++..||+|++.....   .....+.+|+.+++.++||||++++++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   77 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREK---------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY   77 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEc---------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhhe
Confidence            3467999999999999999999554         3588999999865422   224578899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +.+.+..++||||+++|+|.+++...    ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.+|.++|+
T Consensus        78 ~~~~~~~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH--~~~i~H~dlkp~Nili~~~~~~~l~  151 (279)
T 3fdn_A           78 FHDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIA  151 (279)
T ss_dssp             EECSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--TTTCEECCCCGGGEEECTTSCEEEC
T ss_pred             EecCCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCEecccCChHhEEEcCCCCEEEE
Confidence            99999999999999999999999876    45899999999999999999999  6999999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||++.........         ...||+.|+               +||++.+.. .+.++||||+|++++++++...+
T Consensus       152 Dfg~~~~~~~~~~~---------~~~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p  206 (279)
T 3fdn_A          152 DFGWSVHAPSSRRT---------DLCGTLDYL---------------PPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPP  206 (279)
T ss_dssp             SCCEESCC-----------------CCCCTTC---------------CHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCT
T ss_pred             eccccccCCccccc---------ccCCCCCcc---------------CHhHhccCC-CCccchhHhHHHHHHHHHHCCCC
Confidence            99998654432211         116788888               899887654 57899999999999999865444


Q ss_pred             c
Q 017177          324 T  324 (376)
Q Consensus       324 ~  324 (376)
                      .
T Consensus       207 ~  207 (279)
T 3fdn_A          207 F  207 (279)
T ss_dssp             T
T ss_pred             C
Confidence            3

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.2e-35  Score=266.88  Aligned_cols=195  Identities=22%  Similarity=0.227  Sum_probs=163.8

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      .++|++.+.||+|+||.||+|.+.           +..||+|+++...  ....+.+.+|+.+++.++||||+++++++.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   77 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-----------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ   77 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-----------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence            467999999999999999999654           6779999998653  344567899999999999999999999998


Q ss_pred             eC--CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--cEecCCCCCCEEEcCCCcEE
Q 017177          166 ED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK--VIYRDFKASNILLDGVGFLF  241 (376)
Q Consensus       166 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~--iiHrDlKp~NILl~~~g~~k  241 (376)
                      +.  +..++||||+++|+|.+++....  ...+++..+..++.|++.||.|||  .++  |+||||||+|||++.+|.++
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH--~~~~~i~H~dikp~Nil~~~~~~~~  153 (271)
T 3kmu_A           78 SPPAPHPTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLH--TLEPLIPRHALNSRSVMIDEDMTAR  153 (271)
T ss_dssp             TTTSSSCEEEEECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHT--TSSSCCTTCCCSGGGEEECTTSCEE
T ss_pred             cCCCCCeEeeecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHh--cCCCceecCCCccceEEEcCCccee
Confidence            87  77999999999999999997653  235899999999999999999999  477  99999999999999999999


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcc--ccccccceeeeehhhcc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLT--LLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~--~~~dv~s~g~v~~~~~~  319 (376)
                      +.|||++.......       .     .||+.|+               |||++.+..+..  .++||||+|++++++++
T Consensus       154 l~~~~~~~~~~~~~-------~-----~~t~~y~---------------aPE~~~~~~~~~~~~~~Di~slG~il~el~~  206 (271)
T 3kmu_A          154 ISMADVKFSFQSPG-------R-----MYAPAWV---------------APEALQKKPEDTNRRSADMWSFAVLLWELVT  206 (271)
T ss_dssp             EEGGGSCCTTSCTT-------C-----BSCGGGS---------------CHHHHHSCGGGSCHHHHHHHHHHHHHHHHHH
T ss_pred             EEeccceeeecccC-------c-----cCCcccc---------------ChhhhccCCCCCCCchhhHHHHHHHHHHHHh
Confidence            98888766533211       1     6778888               899988764433  37999999999999996


Q ss_pred             ccccc
Q 017177          320 FYRTT  324 (376)
Q Consensus       320 ~y~~~  324 (376)
                      ...+.
T Consensus       207 g~~p~  211 (271)
T 3kmu_A          207 REVPF  211 (271)
T ss_dssp             CSCTT
T ss_pred             CCCCc
Confidence            54443

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.5e-35  Score=266.31  Aligned_cols=194  Identities=26%  Similarity=0.381  Sum_probs=154.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh----hhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM----QGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      .++|++.+.||+|+||.||+|.+.           +..||+|+++....    ...+.+.+|+.+++.++||||++++++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   74 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-----------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV   74 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-----------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-----------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            467999999999999999999653           67899999876532    234678899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC---cEecCCCCCCEEEcC----
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK---VIYRDFKASNILLDG----  236 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~---iiHrDlKp~NILl~~----  236 (376)
                      +.+++..++||||+++++|.+++..     ..+++..+..++.|++.||.|||+  ++   |+||||||+|||++.    
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~--~~~~~i~H~dikp~Nil~~~~~~~  147 (271)
T 3dtc_A           75 CLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHD--EAIVPIIHRDLKSSNILILQKVEN  147 (271)
T ss_dssp             ECCC--CEEEEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHH--SSSSCCCCSCCSGGGEEESSCCSS
T ss_pred             EecCCceEEEEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh--CCCCceeecCCchHHEEEeccccc
Confidence            9999999999999999999999853     358999999999999999999995  66   999999999999986    


Q ss_pred             ----CCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceee
Q 017177          237 ----VGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAF  312 (376)
Q Consensus       237 ----~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~  312 (376)
                          ++.+||+|||++.........         ...||+.|+               +||++.+.. .+.++|+||+|+
T Consensus       148 ~~~~~~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~  202 (271)
T 3dtc_A          148 GDLSNKILKITDFGLAREWHRTTKM---------SAAGAYAWM---------------APEVIRASM-FSKGSDVWSYGV  202 (271)
T ss_dssp             SCCSSCCEEECCCCC----------------------CCGGGS---------------CHHHHHHCC-CSHHHHHHHHHH
T ss_pred             ccccCcceEEccCCccccccccccc---------CCCCcccee---------------CHHHhccCC-CCchhhHHHHHH
Confidence                788999999999876543221         116788888               899887654 588999999999


Q ss_pred             eehhhccccccc
Q 017177          313 VFSCVFSFYRTT  324 (376)
Q Consensus       313 v~~~~~~~y~~~  324 (376)
                      +++++++...+.
T Consensus       203 ~l~~l~~g~~p~  214 (271)
T 3dtc_A          203 LLWELLTGEVPF  214 (271)
T ss_dssp             HHHHHHHCCCTT
T ss_pred             HHHHHHhCCCCC
Confidence            999999765544

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.1e-35  Score=270.43  Aligned_cols=211  Identities=36%  Similarity=0.520  Sum_probs=172.8

Q ss_pred             cccChhhhhhhcCCCCcc------ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC----hhhHHHHHHHH
Q 017177           77 KVFSFLDLKSATKNFKPD------SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES----MQGFEEWQSEV  146 (376)
Q Consensus        77 ~~~~~~~~~~~~~~y~~~------~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~  146 (376)
                      ..+.+.++....++|...      +.||+|+||.||+|...           +..||+|++....    ....+.+.+|+
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~E~   81 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-----------NTTVAVKKLAAMVDITTEELKQQFDQEI   81 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-----------SCEEEEEEECCCTTSCTTTHHHHHHHHH
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-----------CceEEEEEEecccCcchHHHHHHHHHHH
Confidence            345566666666666554      89999999999999542           6789999987532    23457788999


Q ss_pred             HHHhcCCCCCcceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecC
Q 017177          147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRD  226 (376)
Q Consensus       147 ~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrD  226 (376)
                      .+++.++||||+++++++.+.+..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||  .++|+|||
T Consensus        82 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~d  158 (307)
T 2nru_A           82 KVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLH--ENHHIHRD  158 (307)
T ss_dssp             HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSC
T ss_pred             HHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHh--cCCeecCC
Confidence            999999999999999999999999999999999999999975432 245899999999999999999999  59999999


Q ss_pred             CCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcccccc
Q 017177          227 FKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKY  306 (376)
Q Consensus       227 lKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~d  306 (376)
                      |||+|||++.++.+||+|||++.............. .    .||+.|+               +||++.+.  .+.++|
T Consensus       159 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~-~----~g~~~y~---------------aPE~~~~~--~~~~~D  216 (307)
T 2nru_A          159 IKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR-I----VGTTAYM---------------APEALRGE--ITPKSD  216 (307)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSS-C----CSCGGGC---------------CHHHHTTE--ECTHHH
T ss_pred             CCHHHEEEcCCCcEEEeecccccccccccccccccc-c----CCCcCcC---------------ChHHhcCC--CCccch
Confidence            999999999999999999999987655332211111 1    6888888               89987753  688999


Q ss_pred             ccceeeeehhhcccccc
Q 017177          307 SNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       307 v~s~g~v~~~~~~~y~~  323 (376)
                      +||+|++++++++...+
T Consensus       217 v~slG~il~~l~~g~~p  233 (307)
T 2nru_A          217 IYSFGVVLLEIITGLPA  233 (307)
T ss_dssp             HHHHHHHHHHHHHCCCS
T ss_pred             hHHHHHHHHHHHHCCCC
Confidence            99999999999975443

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.6e-35  Score=297.73  Aligned_cols=191  Identities=24%  Similarity=0.320  Sum_probs=155.9

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLL  172 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l  172 (376)
                      +.||+|+||.||+|.+..       +.+++.||||+++....  ...+.+.+|+.+|+.++||||+++++++.. +..++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l  446 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQM-------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML  446 (635)
T ss_dssp             EEEEECSSEEEEEEEEEC-------SSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             CEeccCCCEEEEEEEEcC-------CCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence            479999999999996643       22478899999986532  345789999999999999999999999864 56899


Q ss_pred             EEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeec
Q 017177          173 VYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFK  252 (376)
Q Consensus       173 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~  252 (376)
                      ||||+++|+|.+++...    ..+++..+..++.||+.||.|||  .++|+||||||+||||+.++.+||+|||+++.+.
T Consensus       447 v~E~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH--~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~  520 (635)
T 4fl3_A          447 VMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  520 (635)
T ss_dssp             EEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred             EEEccCCCCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHH--HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence            99999999999999765    45899999999999999999999  5999999999999999999999999999999775


Q ss_pred             cceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          253 RHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       253 ~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ...........    ..||+.|+               |||++.+.. ++.++||||+|++++|+++
T Consensus       521 ~~~~~~~~~~~----~~~t~~y~---------------APE~~~~~~-~~~~sDvwSlGv~l~ellt  567 (635)
T 4fl3_A          521 ADENYYKAQTH----GKWPVKWY---------------APECINYYK-FSSKSDVWSFGVLMWEAFS  567 (635)
T ss_dssp             C-----------------CGGGS---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             cCccccccccC----CCCceeee---------------ChhhhcCCC-CCcHHHHHHHHHHHHHHHh
Confidence            54332111111    15677788               899887654 5889999999999999987

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.1e-35  Score=292.45  Aligned_cols=198  Identities=21%  Similarity=0.272  Sum_probs=166.5

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-------------hhHHHHHHHHHHHhcCC
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-------------QGFEEWQSEVNFLGRLS  153 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~il~~l~  153 (376)
                      ..++|++++.||+|+||.||+|...         .++..||+|++.....             ...+.+.+|+.+++.++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  104 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEK---------NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD  104 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEET---------TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC
T ss_pred             cccceEEEeEecccCCeEEEEEEEC---------CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC
Confidence            4578999999999999999999544         3688999999875431             23467889999999999


Q ss_pred             CCCcceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEE
Q 017177          154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL  233 (376)
Q Consensus       154 h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NIL  233 (376)
                      ||||+++++++.+++.+|+|||||++|+|.+++...    ..+++..+..++.||+.||.|||  .++|+||||||+|||
T Consensus       105 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil  178 (504)
T 3q5i_A          105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLH--KHNIVHRDIKPENIL  178 (504)
T ss_dssp             CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEE
T ss_pred             CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCcHHHEE
Confidence            999999999999999999999999999999999776    45899999999999999999999  599999999999999


Q ss_pred             EcCCC---cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccce
Q 017177          234 LDGVG---FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSF  310 (376)
Q Consensus       234 l~~~g---~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~  310 (376)
                      ++.++   .+||+|||++...........    .    .||+.|+               |||++.+  .++.++||||+
T Consensus       179 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~----~----~gt~~y~---------------aPE~~~~--~~~~~~Diwsl  233 (504)
T 3q5i_A          179 LENKNSLLNIKIVDFGLSSFFSKDYKLRD----R----LGTAYYI---------------APEVLKK--KYNEKCDVWSC  233 (504)
T ss_dssp             ESSTTCCSSEEECCCTTCEECCTTSCBCC----C----CSCTTTC---------------CHHHHTT--CBCTHHHHHHH
T ss_pred             EecCCCCccEEEEECCCCEEcCCCCcccc----c----cCCcCCC---------------CHHHhcc--CCCchHHHHHH
Confidence            98776   699999999998765433211    1    6888888               8998764  46889999999


Q ss_pred             eeeehhhccccccc
Q 017177          311 AFVFSCVFSFYRTT  324 (376)
Q Consensus       311 g~v~~~~~~~y~~~  324 (376)
                      |++++++++.+.+.
T Consensus       234 G~il~~ll~g~~pf  247 (504)
T 3q5i_A          234 GVIMYILLCGYPPF  247 (504)
T ss_dssp             HHHHHHHHHSSCSS
T ss_pred             HHHHHHHHhCCCCC
Confidence            99999999765554

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.9e-36  Score=285.05  Aligned_cols=199  Identities=21%  Similarity=0.212  Sum_probs=162.3

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ...++|++.+.||+|+||.||+|...         .+++.||+|++.....    ...+|+.+++.++||||+++++++.
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~---------~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~   70 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDI---------ESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFY   70 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEET---------TTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccceEEEEEEEEeccCEEEEEEEEC---------CCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheee
Confidence            34678999999999999999999543         3689999999875532    2246999999999999999999985


Q ss_pred             eC--------------------------------------CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 017177          166 ED--------------------------------------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG  207 (376)
Q Consensus       166 ~~--------------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~q  207 (376)
                      ..                                      ..+++||||+++ +|.+.+.........+++..+..++.|
T Consensus        71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~q  149 (383)
T 3eb0_A           71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQ  149 (383)
T ss_dssp             EC-------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHH
T ss_pred             ecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHH
Confidence            43                                      348999999974 888887653223466999999999999


Q ss_pred             HHHHHHHhhcCCCCcEecCCCCCCEEEc-CCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHH
Q 017177          208 AARGLGFLHTSEKKVIYRDFKASNILLD-GVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAIL  286 (376)
Q Consensus       208 i~~~L~yLHs~~~~iiHrDlKp~NILl~-~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~  286 (376)
                      |+.||.|||  .++|+||||||+|||++ .++.+||+|||+++...........        .||+.|+           
T Consensus       150 i~~aL~~LH--~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~--------~~t~~y~-----------  208 (383)
T 3eb0_A          150 LFRAVGFIH--SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAY--------ICSRFYR-----------  208 (383)
T ss_dssp             HHHHHHHHH--TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCC--------CCCSSCC-----------
T ss_pred             HHHHHHHHH--HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCc--------ccCCCcc-----------
Confidence            999999999  69999999999999998 6899999999999977554433111        6677787           


Q ss_pred             HHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          287 YSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       287 ~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                          |||++.+...++.++||||+|++++++++...+
T Consensus       209 ----aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  241 (383)
T 3eb0_A          209 ----APELMLGATEYTPSIDLWSIGCVFGELILGKPL  241 (383)
T ss_dssp             ----CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ----CHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCC
Confidence                799998877789999999999999999965443

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.2e-35  Score=277.38  Aligned_cols=199  Identities=21%  Similarity=0.213  Sum_probs=169.3

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh------hHHHHHHHHHHHhcCCCCCcceE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ------GFEEWQSEVNFLGRLSHPNLVKL  160 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~h~nIv~l  160 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|+++.....      ..+.+.+|+.+++.++||||+++
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   80 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREK---------STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL   80 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEEC---------CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceE
Confidence            3457999999999999999999544         36889999998754321      35778999999999999999999


Q ss_pred             EeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC--
Q 017177          161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG--  238 (376)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g--  238 (376)
                      ++++.+.+..++||||+++++|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++  
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH--~~~ivH~dikp~NIl~~~~~~~  154 (321)
T 2a2a_A           81 HDVYENRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIP  154 (321)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCTTSS
T ss_pred             EEEEecCCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCChHHEEEecCCCC
Confidence            99999999999999999999999999764    45899999999999999999999  58999999999999999888  


Q ss_pred             --cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehh
Q 017177          239 --FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSC  316 (376)
Q Consensus       239 --~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~  316 (376)
                        .+||+|||++............        .||+.|+               +||++.+.. .+.++|+||+|+++++
T Consensus       155 ~~~~kl~Dfg~~~~~~~~~~~~~~--------~gt~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~  210 (321)
T 2a2a_A          155 IPHIKLIDFGLAHEIEDGVEFKNI--------FGTPEFV---------------APEIVNYEP-LGLEADMWSIGVITYI  210 (321)
T ss_dssp             SCCEEECCCTTCEECCTTCCCCCC--------CSCGGGC---------------CHHHHTTCC-CCTHHHHHHHHHHHHH
T ss_pred             cCCEEEccCccceecCcccccccc--------CCCCCcc---------------CcccccCCC-CCCccccHHHHHHHHH
Confidence              7999999999887654332111        6788888               899887654 5889999999999999


Q ss_pred             hccccccc
Q 017177          317 VFSFYRTT  324 (376)
Q Consensus       317 ~~~~y~~~  324 (376)
                      +++...+.
T Consensus       211 l~~g~~pf  218 (321)
T 2a2a_A          211 LLSGASPF  218 (321)
T ss_dssp             HHHSCCSS
T ss_pred             HHHCCCCC
Confidence            99654443

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.5e-35  Score=269.42  Aligned_cols=199  Identities=24%  Similarity=0.324  Sum_probs=163.3

Q ss_pred             hcCCCCccc-eEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDS-LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ..++|++.+ .||+|+||.||+|.+..       ..++..||+|+++....  ...+.+.+|+.+++.++||||++++++
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   86 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQM-------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI   86 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEEC-------SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cchhhhhccCccccccCeeeEeeeecC-------CCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            345788888 99999999999996542       22478899999986532  335778999999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      + ..+..++||||+++++|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+
T Consensus        87 ~-~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dikp~Nil~~~~~~~kl~  159 (291)
T 1xbb_A           87 C-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKIS  159 (291)
T ss_dssp             E-ESSSEEEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEEC
T ss_pred             E-CCCCcEEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHH--hCCeEcCCCCcceEEEeCCCcEEEc
Confidence            8 567799999999999999999875    45899999999999999999999  5899999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      |||++...............    ..+|+.|+               +||++.+.. .+.++|+||+|++++++++
T Consensus       160 Dfg~~~~~~~~~~~~~~~~~----~~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~l~~  215 (291)
T 1xbb_A          160 DFGLSKALRADENYYKAQTH----GKWPVKWY---------------APECINYYK-FSSKSDVWSFGVLMWEAFS  215 (291)
T ss_dssp             CCTTCEECCTTCSEEEC--------CCCGGGC---------------CHHHHHHCE-EEHHHHHHHHHHHHHHHHT
T ss_pred             cCCcceeeccCCCccccccc----CCCCceee---------------ChHHhccCC-CChhhhHHHHHHHHHHHHh
Confidence            99999987654433211111    14567777               899887654 5789999999999999987

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.2e-35  Score=291.63  Aligned_cols=198  Identities=20%  Similarity=0.245  Sum_probs=164.4

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++++.||+|+||.||+|...         .++..||+|++....  ......+.+|+.+++.++||||+++++++
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  105 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDK---------VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF  105 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEET---------TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEEC---------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            3456999999999999999999544         468899999987653  22346788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC---CCcEE
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG---VGFLF  241 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~---~g~~k  241 (376)
                      .+.+.+|+|||||++|+|.+.+...    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.   ++.+|
T Consensus       106 ~~~~~~~lv~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~k  179 (494)
T 3lij_A          106 EDKRNYYLVMECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLH--KHNIVHRDLKPENLLLESKEKDALIK  179 (494)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSTTCCEE
T ss_pred             EeCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCChhhEEEeCCCCCCcEE
Confidence            9999999999999999999999776    45899999999999999999999  599999999999999976   45599


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |+|||++...........    .    .||+.|+               |||++.+  .++.++||||+|++++++++.+
T Consensus       180 l~DfG~a~~~~~~~~~~~----~----~gt~~y~---------------aPE~l~~--~~~~~~DiwslG~il~~ll~g~  234 (494)
T 3lij_A          180 IVDFGLSAVFENQKKMKE----R----LGTAYYI---------------APEVLRK--KYDEKCDVWSIGVILFILLAGY  234 (494)
T ss_dssp             ECCCTTCEECBTTBCBCC----C----CSCTTTC---------------CHHHHTT--CBCTHHHHHHHHHHHHHHHHSS
T ss_pred             EEECCCCeECCCCccccc----c----CCCcCee---------------CHHHHcc--cCCCchhHHHHHHHHHHHHhCC
Confidence            999999988765433211    1    6888888               8998764  4688999999999999999766


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      .+.
T Consensus       235 ~pf  237 (494)
T 3lij_A          235 PPF  237 (494)
T ss_dssp             CSS
T ss_pred             CCC
Confidence            554

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.9e-35  Score=274.68  Aligned_cols=210  Identities=24%  Similarity=0.273  Sum_probs=171.2

Q ss_pred             hhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcC-CCCCcceE
Q 017177           83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRL-SHPNLVKL  160 (376)
Q Consensus        83 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~l  160 (376)
                      ......++|++.+.||+|+||.||+|.+...    .+..+++.||+|+++.... ...+.+.+|+.+++.+ +||||+++
T Consensus        21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ceecchhheeeeeEEcCCCceeEEEEEEecC----CccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            3444567899999999999999999975431    2344688999999987543 3456788999999999 59999999


Q ss_pred             EeEEEeCC-eEEEEEeccCCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCC
Q 017177          161 LGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPS------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDF  227 (376)
Q Consensus       161 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDl  227 (376)
                      ++++...+ .+++||||+++|+|.+++......            ...+++..+..++.|++.||.|||  .++|+||||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~di  174 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDL  174 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH--HTTCCCSCC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH--hCCcccccC
Confidence            99987754 599999999999999999765321            123789999999999999999999  589999999


Q ss_pred             CCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccc
Q 017177          228 KASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYS  307 (376)
Q Consensus       228 Kp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv  307 (376)
                      ||+|||++.++.+||+|||+++........... +..    .||+.|+               |||++.+.. .+.++|+
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~-~~~----~~t~~y~---------------aPE~~~~~~-~~~~~Di  233 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRK-GDA----RLPLKWM---------------APETIFDRV-YTIQSDV  233 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEE-TTE----EECGGGC---------------CHHHHHHCC-CCHHHHH
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceec-cCC----Ccceeec---------------Cchhhcccc-ccchhHH
Confidence            999999999999999999999876543322112 112    6788888               899887654 5789999


Q ss_pred             cceeeeehhhcc
Q 017177          308 NSFAFVFSCVFS  319 (376)
Q Consensus       308 ~s~g~v~~~~~~  319 (376)
                      ||+|++++++++
T Consensus       234 ~slG~il~~l~t  245 (316)
T 2xir_A          234 WSFGVLLWEIFS  245 (316)
T ss_dssp             HHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHh
Confidence            999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-35  Score=269.25  Aligned_cols=199  Identities=23%  Similarity=0.291  Sum_probs=164.3

Q ss_pred             cCCCCccc-eEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           88 TKNFKPDS-LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      .++|.+.+ .||+|+||.||+|.+..       ...+..||+|+++... ....+.+.+|+.+++.++||||+++++++ 
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-   79 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-   79 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred             HHHhhhhhccccccCceeEEEeEecc-------CCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-
Confidence            45677766 99999999999997542       1247889999998753 34567889999999999999999999998 


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      ..+..++||||+++++|.+++...   ...+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+||
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~kl~Df  154 (287)
T 1u59_A           80 QAEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDF  154 (287)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEEETTEEEECCC
T ss_pred             cCCCcEEEEEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHH--HCCEeeCCCchheEEEcCCCCEEECcc
Confidence            556799999999999999999654   255899999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      |++................    .||+.|+               +||++.+.. .+.++|+||+|++++++++
T Consensus       155 g~~~~~~~~~~~~~~~~~~----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~ellt  208 (287)
T 1u59_A          155 GLSKALGADDSYYTARSAG----KWPLKWY---------------APECINFRK-FSSRSDVWSYGVTMWEALS  208 (287)
T ss_dssp             TTCEECTTCSCEECCCCSS----CCCGGGC---------------CHHHHHHCE-ECHHHHHHHHHHHHHHHHT
T ss_pred             cceeeeccCcceeeccccc----ccccccc---------------CHHHhccCC-CCchhhHHHHHHHHHHHHc
Confidence            9999875543322111111    5677788               899887654 5889999999999999987

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1e-35  Score=282.72  Aligned_cols=212  Identities=14%  Similarity=0.087  Sum_probs=166.5

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhH-----------HHHHHHHHHHhcCCCC
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-----------EEWQSEVNFLGRLSHP  155 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~il~~l~h~  155 (376)
                      ..++|++.+.||+|+||.||+|.+...    .....++.||||++........           ..+.+|+..++.++||
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~  108 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSS----ESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYL  108 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCS----SCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCc----cccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCC
Confidence            356899999999999999999977642    2233468899999876643211           1334567778888999


Q ss_pred             CcceEEeEEEeC----CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCC
Q 017177          156 NLVKLLGYCWED----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASN  231 (376)
Q Consensus       156 nIv~l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~N  231 (376)
                      ||+++++++...    ...||||||+ +++|.+++....   ..+++..++.++.||+.||.|||  .++|+||||||+|
T Consensus       109 ~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH--~~~iiHrDlkp~N  182 (364)
T 3op5_A          109 GVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIH--EHEYVHGDIKASN  182 (364)
T ss_dssp             CSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGG
T ss_pred             CCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeEEecCCHHH
Confidence            999999998764    4589999999 999999997752   46899999999999999999999  5899999999999


Q ss_pred             EEEc--CCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccc
Q 017177          232 ILLD--GVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNS  309 (376)
Q Consensus       232 ILl~--~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s  309 (376)
                      ||++  .++.+||+|||+++.+..................||+.||               |||++.+.. ++.++||||
T Consensus       183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~---------------aPE~~~~~~-~~~~~Di~s  246 (364)
T 3op5_A          183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT---------------SIDAHNGVA-PSRRGDLEI  246 (364)
T ss_dssp             EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTC---------------CHHHHTTCC-CCHHHHHHH
T ss_pred             EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCcc---------------CHHHhCCCC-CCchhhHHH
Confidence            9999  8899999999999887654332111111111125889999               899888765 589999999


Q ss_pred             eeeeehhhccccccc
Q 017177          310 FAFVFSCVFSFYRTT  324 (376)
Q Consensus       310 ~g~v~~~~~~~y~~~  324 (376)
                      +|++++++++...+.
T Consensus       247 lG~~l~el~~g~~Pf  261 (364)
T 3op5_A          247 LGYCMIQWLTGHLPW  261 (364)
T ss_dssp             HHHHHHHHHHSCCTT
T ss_pred             HHHHHHHHHhCCCCc
Confidence            999999999654443

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.1e-34  Score=266.59  Aligned_cols=200  Identities=24%  Similarity=0.317  Sum_probs=154.3

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ...++|++.+.||+|+||.||+|...            ..||+|+++...  ....+.+.+|+.+++.++||||++++++
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWH------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY   88 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESS------------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEc------------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee
Confidence            34578999999999999999999543            249999987653  3455788999999999999999999995


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      . ..+..++||||+++++|.+++....   ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+
T Consensus        89 ~-~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH--~~~i~H~Dlkp~Nil~~~~~~~kl~  162 (289)
T 3og7_A           89 S-TAPQLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLH--AKSIIHRDLKSNNIFLHEDNTVKIG  162 (289)
T ss_dssp             E-CSSSCEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETTTEEEEC
T ss_pred             c-cCCccEEEEEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH--hCCcccccCccceEEECCCCCEEEc
Confidence            4 5667899999999999999996542   56899999999999999999999  5999999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh--hhhccccccccceeeeehhhcccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW--IKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~--~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |||++............. .    ..||+.|+               +||++..  ....+.++||||+|++++++++-.
T Consensus       163 Dfg~~~~~~~~~~~~~~~-~----~~gt~~y~---------------aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~  222 (289)
T 3og7_A          163 DFGLATEKSRWSGSHQFE-Q----LSGSILWM---------------APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ  222 (289)
T ss_dssp             CCC-----------------------CCCTTC---------------CHHHHC----CCSCHHHHHHHHHHHHHHHHHSS
T ss_pred             cceecccccccccccccc-c----cCCCcccc---------------CchhhcccCCCCCCcccchHHHHHHHHHHHHCC
Confidence            999998665422221111 1    16788888               8998863  344577999999999999999654


Q ss_pred             cc
Q 017177          322 RT  323 (376)
Q Consensus       322 ~~  323 (376)
                      .+
T Consensus       223 ~p  224 (289)
T 3og7_A          223 LP  224 (289)
T ss_dssp             CT
T ss_pred             CC
Confidence            33

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.9e-35  Score=267.60  Aligned_cols=196  Identities=23%  Similarity=0.294  Sum_probs=163.9

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      .+.|++.+.||+|+||.||+|...         .++..||+|.+...  .....+.+.+|+.+++.++||||+++++++.
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   95 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDT---------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWE   95 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEec---------CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec
Confidence            445888999999999999999554         35889999998754  3345678899999999999999999999987


Q ss_pred             e----CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--cEecCCCCCCEEEc-CCC
Q 017177          166 E----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK--VIYRDFKASNILLD-GVG  238 (376)
Q Consensus       166 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~--iiHrDlKp~NILl~-~~g  238 (376)
                      .    ...+++||||+++|+|.+++...    ..+++..+..++.|++.||.|||  ..+  |+||||||+|||++ .++
T Consensus        96 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~~~i~H~dikp~Nil~~~~~~  169 (290)
T 1t4h_A           96 STVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLH--TRTPPIIHRDLKCDNIFITGPTG  169 (290)
T ss_dssp             EESSSCEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--TSSSCCCCSCCCGGGEEESSTTS
T ss_pred             cccCCCceEEEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHH--cCCCCEEECCCCHHHEEEECCCC
Confidence            5    35689999999999999999876    45899999999999999999999  477  99999999999997 789


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .+||+|||++......... ..        .||+.|+               +||++.+  ..+.++|+||+|+++++++
T Consensus       170 ~~kl~Dfg~~~~~~~~~~~-~~--------~~t~~y~---------------aPE~~~~--~~~~~~Di~slG~~l~~l~  223 (290)
T 1t4h_A          170 SVKIGDLGLATLKRASFAK-AV--------IGTPEFM---------------APEMYEE--KYDESVDVYAFGMCMLEMA  223 (290)
T ss_dssp             CEEECCTTGGGGCCTTSBE-ES--------CSSCCCC---------------CGGGGGT--CCCTHHHHHHHHHHHHHHH
T ss_pred             CEEEeeCCCcccccccccc-cc--------cCCcCcC---------------CHHHHhc--cCCCcchHHHHHHHHHHHH
Confidence            9999999999765443222 11        5777887               7997764  3688999999999999999


Q ss_pred             cccccc
Q 017177          319 SFYRTT  324 (376)
Q Consensus       319 ~~y~~~  324 (376)
                      +...+.
T Consensus       224 ~g~~pf  229 (290)
T 1t4h_A          224 TSEYPY  229 (290)
T ss_dssp             HSSCTT
T ss_pred             hCCCCC
Confidence            765444

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.5e-35  Score=271.55  Aligned_cols=204  Identities=18%  Similarity=0.121  Sum_probs=166.8

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcC-CCCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~  165 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|++.....  .+.+.+|+.+++.+ +|+||+++++++.
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~   76 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNL---------LNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQ   76 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEET---------TTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEEC---------CCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecC
Confidence            4567999999999999999999543         3588999999865432  24577899999999 6999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc-----E
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF-----L  240 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~-----~  240 (376)
                      +....++||||+ +++|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.     +
T Consensus        77 ~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~NIl~~~~~~~~~~~~  150 (298)
T 1csn_A           77 EGLHNVLVIDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMI  150 (298)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECCSSSTTTTCE
T ss_pred             CCceeEEEEEec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEeccCCCCCCCeE
Confidence            999999999999 899999997652   45899999999999999999999  699999999999999987776     9


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ||+|||+++....................||+.|+               |||++.+.. .+.++||||+|++++++++.
T Consensus       151 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~el~~g  214 (298)
T 1csn_A          151 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM---------------SINTHLGRE-QSRRDDLEALGHVFMYFLRG  214 (298)
T ss_dssp             EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTC---------------CHHHHTTCC-CCHHHHHHHHHHHHHHHHHS
T ss_pred             EEEECccccccccccccccccccCccCCCCCcccC---------------CchhhcCCC-CChHHHHHHHHHHHHHHHcC
Confidence            99999999987654321111000011127888888               899887765 58899999999999999964


Q ss_pred             ccc
Q 017177          321 YRT  323 (376)
Q Consensus       321 y~~  323 (376)
                      ..+
T Consensus       215 ~~p  217 (298)
T 1csn_A          215 SLP  217 (298)
T ss_dssp             SCT
T ss_pred             CCC
Confidence            433

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.4e-35  Score=268.86  Aligned_cols=199  Identities=19%  Similarity=0.184  Sum_probs=164.0

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|++.....   ...+.+.+|+.+++.++||||++++++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   79 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQ---------LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV   79 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEEC---------CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence            4578999999999999999999554         3588999999865422   234678899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +..++..++||||+++++|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+
T Consensus        80 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~  153 (276)
T 2h6d_A           80 ISTPTDFFMVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCH--RHMVVHRDLKPENVLLDAHMNAKIA  153 (276)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH--HHCSSCCCCCGGGEEECTTSCEEEC
T ss_pred             EecCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCChhhEEECCCCCEEEe
Confidence            99999999999999999999999876    45899999999999999999999  5999999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||++............        .||+.|+               +||++.+..+.+.++|+||+|++++++++...+
T Consensus       154 dfg~~~~~~~~~~~~~~--------~~~~~y~---------------aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  210 (276)
T 2h6d_A          154 DFGLSNMMSDGEFLRTS--------CGSPNYA---------------APEVISGRLYAGPEVDIWSCGVILYALLCGTLP  210 (276)
T ss_dssp             CCCGGGCCCC---------------------C---------------CTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ecccccccCCCcceecc--------cCCcccc---------------CHHHHcCCCCCCccchHHHHHHHHHHHHhCCCC
Confidence            99999876554322111        5667777               799888777668899999999999999965444

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.6e-35  Score=289.57  Aligned_cols=198  Identities=21%  Similarity=0.304  Sum_probs=165.3

Q ss_pred             hhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           84 LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        84 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      .....++|++.+.||+|+||.||+|.+..          +..||||+++... ...+.+.+|+.+|+.++||||++++++
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~  251 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV  251 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETT----------TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECC----------ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence            34456789999999999999999997653          6779999998754 345789999999999999999999998


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +. .+.+|+||||+++|+|.+++.....  ..+++..+..++.||+.||.|||  .++|+||||||+|||++.++.+||+
T Consensus       252 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~  326 (454)
T 1qcf_A          252 VT-KEPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIA  326 (454)
T ss_dssp             EC-SSSCEEEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCSGGGEEECTTCCEEEC
T ss_pred             Ee-CCccEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCHHHEEECCCCcEEEe
Confidence            86 6679999999999999999975421  34788999999999999999999  5899999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      |||+++......... ..+.     .+|+.|+               |||++.+.. ++.++||||+|++++|+++
T Consensus       327 DFG~a~~~~~~~~~~-~~~~-----~~~~~y~---------------aPE~~~~~~-~~~~~DvwslG~~l~el~t  380 (454)
T 1qcf_A          327 DFGLARVIEDNEYTA-REGA-----KFPIKWT---------------APEAINFGS-FTIKSDVWSFGILLMEIVT  380 (454)
T ss_dssp             STTGGGGBCCHHHHT-TCSS-----SSCGGGS---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             eCCCceEcCCCceec-cCCC-----ccccccc---------------CHHHhccCC-CCcHHHHHhHHHHHHHHHh
Confidence            999998765432211 1111     4556677               899887654 5889999999999999997

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.2e-34  Score=267.17  Aligned_cols=200  Identities=21%  Similarity=0.176  Sum_probs=169.0

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---------hhhHHHHHHHHHHHhcCC-CC
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---------MQGFEEWQSEVNFLGRLS-HP  155 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~il~~l~-h~  155 (376)
                      ...++|++.+.||+|+||.||+|...         .+++.||+|+++...         ....+.+.+|+.+++++. ||
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~   84 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHK---------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP   84 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCT
T ss_pred             chhhccceeeeecCCCceEEEEEEEc---------CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            34678999999999999999999554         368999999987543         122456789999999996 99


Q ss_pred             CcceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc
Q 017177          156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD  235 (376)
Q Consensus       156 nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~  235 (376)
                      ||+++++++..++..++||||+++++|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++
T Consensus        85 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~  158 (298)
T 1phk_A           85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLD  158 (298)
T ss_dssp             TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEC
T ss_pred             CEeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEEc
Confidence            9999999999999999999999999999999875    45899999999999999999999  59999999999999999


Q ss_pred             CCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh-----hhhccccccccce
Q 017177          236 GVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW-----IKYLTLLKYSNSF  310 (376)
Q Consensus       236 ~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~-----~~~~~~~~dv~s~  310 (376)
                      .+|.+||+|||++............        .||+.|+               +||++.+     ....+.++|+||+
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~--------~~~~~y~---------------aPE~~~~~~~~~~~~~~~~~Di~sl  215 (298)
T 1phk_A          159 DDMNIKLTDFGFSCQLDPGEKLREV--------CGTPSYL---------------APEIIECSMNDNHPGYGKEVDMWST  215 (298)
T ss_dssp             TTCCEEECCCTTCEECCTTCCBCCC--------CSCGGGC---------------CHHHHHHHHCTTSCCBCTHHHHHHH
T ss_pred             CCCcEEEecccchhhcCCCcccccc--------cCCcccc---------------CHHHhccccccccccCCcccccHhH
Confidence            9999999999999877654332111        6778888               7998764     3346789999999


Q ss_pred             eeeehhhcccccc
Q 017177          311 AFVFSCVFSFYRT  323 (376)
Q Consensus       311 g~v~~~~~~~y~~  323 (376)
                      |++++++++...+
T Consensus       216 G~~l~~l~~g~~p  228 (298)
T 1phk_A          216 GVIMYTLLAGSPP  228 (298)
T ss_dssp             HHHHHHHHHSSCS
T ss_pred             HHHHHHHHHCCCC
Confidence            9999999975444

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.3e-34  Score=266.52  Aligned_cols=202  Identities=20%  Similarity=0.167  Sum_probs=165.7

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|....+||+|+||.||+|...         .++..||+|.+........+.+.+|+.+++.++||||+++++++...
T Consensus        21 ~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   91 (295)
T 2clq_A           21 YDENGDRVVLGKGTYGIVYAGRDL---------SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN   91 (295)
T ss_dssp             BCTTSSBCEEEECSSSEEEEEEET---------TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             ccCCCCcEEEeecCcEEEEEEEEC---------CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC
Confidence            345666679999999999999544         35889999999876655567889999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC-CCcEEEccee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-VGFLFDSHLL  246 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~-~g~~kl~Dfg  246 (376)
                      +..++||||+++++|.+++..... ...+++..+..++.|++.||.|||  .++|+||||||+|||++. ++.+||+|||
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg  168 (295)
T 2clq_A           92 GFIKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLH--DNQIVHRDIKGDNVLINTYSGVLKISDFG  168 (295)
T ss_dssp             TEEEEEEECCSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTCCEEECCTT
T ss_pred             CcEEEEEEeCCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHH--hCCEEccCCChhhEEEECCCCCEEEeecc
Confidence            999999999999999999976532 245678999999999999999999  599999999999999987 8999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh-hhccccccccceeeeehhhcccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI-KYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~-~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ++..........   .+    ..||+.|+               +||++.+. ...+.++|+||+|++++++++...+
T Consensus       169 ~~~~~~~~~~~~---~~----~~~~~~y~---------------aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  224 (295)
T 2clq_A          169 TSKRLAGINPCT---ET----FTGTLQYM---------------APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP  224 (295)
T ss_dssp             TCEESCC--------CC----CCCCGGGC---------------CHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCT
T ss_pred             cccccCCCCCcc---cc----cCCCcccc---------------ChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            998765432211   11    16788888               89988765 3468899999999999999965443

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1e-35  Score=293.25  Aligned_cols=198  Identities=22%  Similarity=0.243  Sum_probs=169.1

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||||++....   ....+.+.+|+.+++.++||||++++++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~   94 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDK---------ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF   94 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEEC---------CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            3457999999999999999999544         468999999986542   2345788999999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE---cCCCcE
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL---DGVGFL  240 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl---~~~g~~  240 (376)
                      +.+.+.+|+|||||.+|+|.+++...    ..+++..+..++.||+.||.|||  .++|+||||||+|||+   +.++.+
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~  168 (484)
T 3nyv_A           95 FEDKGYFYLVGEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANI  168 (484)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSSSTTCCE
T ss_pred             EEeCCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEEecCCCCCcE
Confidence            99999999999999999999999765    45899999999999999999999  5899999999999999   567899


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ||+|||+++........    .+.    .||+.|+               |||++.+  .++.++||||+|++++++++-
T Consensus       169 kl~Dfg~a~~~~~~~~~----~~~----~gt~~y~---------------aPE~~~~--~~~~~~DiwslG~il~~ll~g  223 (484)
T 3nyv_A          169 RIIDFGLSTHFEASKKM----KDK----IGTAYYI---------------APEVLHG--TYDEKCDVWSTGVILYILLSG  223 (484)
T ss_dssp             EECCTTHHHHBCCCCSH----HHH----TTGGGTC---------------CHHHHHT--CCCTHHHHHHHHHHHHHHHHS
T ss_pred             EEEeeeeeEEccccccc----ccC----CCCcccc---------------CceeecC--CCCCcceeHHHHHHHHHHHHC
Confidence            99999999876544322    111    6788888               8998876  468899999999999999976


Q ss_pred             cccc
Q 017177          321 YRTT  324 (376)
Q Consensus       321 y~~~  324 (376)
                      +.+.
T Consensus       224 ~~pf  227 (484)
T 3nyv_A          224 CPPF  227 (484)
T ss_dssp             SCSS
T ss_pred             CCCC
Confidence            5554

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=7.7e-36  Score=294.29  Aligned_cols=198  Identities=21%  Similarity=0.241  Sum_probs=166.8

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||||++....  ......+.+|+.+++.++||||+++++++
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~   90 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDR---------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL   90 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEET---------TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEEC---------CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE
Confidence            4567999999999999999999544         468899999986432  23356788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc---CCCcEE
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD---GVGFLF  241 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~---~~g~~k  241 (376)
                      .+.+.+|+|||||++|+|.+.+...    ..+++..+..++.||+.||.|||  .++|+||||||+|||++   .++.+|
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~k  164 (486)
T 3mwu_A           91 EDSSSFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIK  164 (486)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEESSSSTTCCEE
T ss_pred             EcCCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCchHHEEEecCCCCCCEE
Confidence            9999999999999999999999776    45899999999999999999999  59999999999999995   456799


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |+|||+++.........    .    .+||+.|+               |||++.+.  ++.++||||+|++++++++..
T Consensus       165 l~Dfg~a~~~~~~~~~~----~----~~gt~~y~---------------aPE~~~~~--~~~~~DiwslG~il~~ll~g~  219 (486)
T 3mwu_A          165 IIDFGLSTCFQQNTKMK----D----RIGTAYYI---------------APEVLRGT--YDEKCDVWSAGVILYILLSGT  219 (486)
T ss_dssp             ECSCSCTTTBCCC--------C----CTTGGGGC---------------CGGGGGSC--CCHHHHHHHHHHHHHHHHHSS
T ss_pred             EEECCcCeECCCCCccC----C----CcCCCCCC---------------CHHHhCCC--CCchhhHHHHHHHHHHHHhCC
Confidence            99999998765433221    1    17888888               89987753  688999999999999999655


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      .+.
T Consensus       220 ~pf  222 (486)
T 3mwu_A          220 PPF  222 (486)
T ss_dssp             CSS
T ss_pred             CCC
Confidence            554

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.4e-35  Score=286.25  Aligned_cols=197  Identities=22%  Similarity=0.318  Sum_probs=160.1

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ....++|++.+.||+|+||.||+|.+..          +..||||+++.... ..+.+.+|+.+|++++||||+++++++
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~  248 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVV  248 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccChhHceeeeeecCCCCeEEEEEEECC----------CceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3455679999999999999999997653          46799999987543 346789999999999999999999988


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .+ +..++||||+++|+|.+++.....  ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|
T Consensus       249 ~~-~~~~iv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~D  323 (452)
T 1fmk_A          249 SE-EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVAD  323 (452)
T ss_dssp             CS-SSCEEEECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred             cC-CceEEEehhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChhhEEECCCCCEEECC
Confidence            65 679999999999999999975421  34899999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ||+++......... ..+.     .+|+.|+               |||++.+.. ++.++||||+|++++|+++
T Consensus       324 fG~a~~~~~~~~~~-~~~~-----~~~~~y~---------------aPE~~~~~~-~~~~sDvwslG~~l~el~t  376 (452)
T 1fmk_A          324 FGLARLIEDNEYTA-RQGA-----KFPIKWT---------------APEAALYGR-FTIKSDVWSFGILLTELTT  376 (452)
T ss_dssp             CCTTC--------------------CCGGGS---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             CccceecCCCceec-ccCC-----ccccccc---------------CHhHHhcCC-CCccccHHhHHHHHHHHHh
Confidence            99998765432221 1111     5567777               899887654 5889999999999999987

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.7e-35  Score=269.41  Aligned_cols=199  Identities=23%  Similarity=0.321  Sum_probs=163.0

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-ChhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ..++|++.+.||+|+||.||+|.+..      ...++..||+|.+... .....+.+.+|+.+++.++||||+++++++.
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTN------HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEC------TTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcC------CCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            45679999999999999999997653      2234667999999876 3345678899999999999999999999876


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      + +..|+||||+++++|.+++.+..   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+||
T Consensus        84 ~-~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Df  157 (281)
T 3cc6_A           84 E-EPTWIIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLE--SINCVHRDIAVRNILVASPECVKLGDF  157 (281)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEEEETTEEEECCC
T ss_pred             C-CCCEEEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCccceEEECCCCcEEeCcc
Confidence            4 55799999999999999997753   45899999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      |++.............      ..+|+.|+               +||++.+.. .+.++|+||+|++++++++
T Consensus       158 g~~~~~~~~~~~~~~~------~~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~llt  209 (281)
T 3cc6_A          158 GLSRYIEDEDYYKASV------TRLPIKWM---------------SPESINFRR-FTTASDVWMFAVCMWEILS  209 (281)
T ss_dssp             CGGGCC---------C------CCCCGGGC---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             CCCccccccccccccc------CCCCccee---------------CchhhccCC-CCchhccHHHHHHHHHHHh
Confidence            9998765543221111      15667777               899887654 5789999999999999987

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.5e-35  Score=273.58  Aligned_cols=210  Identities=20%  Similarity=0.209  Sum_probs=153.3

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ...++|++.+.||+|+||.||+|...         .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   82 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCA---------PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF   82 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC-------------CEEEEECCC----------------CCCCCCCTTBCCEEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEEC---------CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence            34678999999999999999999543         3588999999876532 3346788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcC----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcE
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRN----PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL  240 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~  240 (376)
                      ..++..++||||+++++|.+++....    .....+++..+..++.|++.||.|||  .++|+||||||+|||++.+|.+
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~  160 (303)
T 2vwi_A           83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--KNGQIHRDVKAGNILLGEDGSV  160 (303)
T ss_dssp             ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEECTTCCE
T ss_pred             eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCCCCChhhEEEcCCCCE
Confidence            99999999999999999999987421    11345899999999999999999999  5899999999999999999999


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ||+|||++...........  ........||+.|+               +||++.+....+.++|+||+|++++++++.
T Consensus       161 kl~dfg~~~~~~~~~~~~~--~~~~~~~~~~~~y~---------------aPE~~~~~~~~~~~~Di~slG~il~~l~~g  223 (303)
T 2vwi_A          161 QIADFGVSAFLATGGDITR--NKVRKTFVGTPCWM---------------APEVMEQVRGYDFKADIWSFGITAIELATG  223 (303)
T ss_dssp             EECCCHHHHHCC-----------------CCCTTC---------------CHHHHHHHHCCCTHHHHHHHHHHHHHHHHS
T ss_pred             EEEeccchheeccCCCccc--hhhhcccCCCcccc---------------CHHHhccccCCCchhhHHHHHHHHHHHHhC
Confidence            9999999987654322110  01111226888888               899887766678999999999999999965


Q ss_pred             ccc
Q 017177          321 YRT  323 (376)
Q Consensus       321 y~~  323 (376)
                      ..+
T Consensus       224 ~~p  226 (303)
T 2vwi_A          224 AAP  226 (303)
T ss_dssp             SCT
T ss_pred             CCC
Confidence            443

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.6e-35  Score=276.23  Aligned_cols=198  Identities=23%  Similarity=0.266  Sum_probs=163.5

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      .++|++.+.||+|+||.||+|...         .+++.||+|++.....  ...+.+.+|+.+++.++||||+++++++.
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   94 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNK---------DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK   94 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEET---------TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEEC---------CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee
Confidence            457999999999999999999554         3588999999865432  33456789999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +.+..++||||+++++|.+++...    ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~Df  168 (331)
T 4aaa_A           95 KKKRWYLVFEFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCH--SHNIIHRDIKPENILVSQSGVVKLCDF  168 (331)
T ss_dssp             ETTEEEEEEECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             cCCEEEEEEecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH--HCCEEccCcChheEEEcCCCcEEEEeC
Confidence            999999999999998888876554    45899999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      |++...........  .     ..||+.|+               +||++.+....+.++||||+|++++++++...
T Consensus       169 g~~~~~~~~~~~~~--~-----~~~t~~y~---------------aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~  223 (331)
T 4aaa_A          169 GFARTLAAPGEVYD--D-----EVATRWYR---------------APELLVGDVKYGKAVDVWAIGCLVTEMFMGEP  223 (331)
T ss_dssp             TTC-------------------CCCCCTTC---------------CHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCceeecCCccccC--C-----CcCCcccc---------------CcccccCCCCcchHHHHHHHHHHHHHHHhCCC
Confidence            99987654322211  1     16788888               89998887677899999999999999986543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4e-35  Score=270.47  Aligned_cols=202  Identities=23%  Similarity=0.297  Sum_probs=163.3

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEE-
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW-  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~-  165 (376)
                      ..+|++.+.||+|+||.||+|....      .......+|+|.+.... ....+.+.+|+.++++++||||+++++++. 
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   97 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLD------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR   97 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred             ceehhhcceeeecCCceEEEEEEec------CCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence            4568999999999999999997653      12235578999988643 345578899999999999999999999864 


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      .++..++||||+++|+|.+++....   ..+++..+..++.|++.||.|||  +++|+||||||+|||++.++.+||+||
T Consensus        98 ~~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Df  172 (298)
T 3f66_A           98 SEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLA--SKKFVHRDLAARNCMLDEKFTVKVADF  172 (298)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCchheEEECCCCCEEECcc
Confidence            4567899999999999999997642   45789999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      |+++............   .....||+.|+               +||++.+.. .+.++|+||+|++++++++
T Consensus       173 g~a~~~~~~~~~~~~~---~~~~~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~l~~  227 (298)
T 3f66_A          173 GLARDMYDKEYYSVHN---KTGAKLPVKWM---------------ALESLQTQK-FTTKSDVWSFGVLLWELMT  227 (298)
T ss_dssp             GGGCCCSCGGGCBC--------CCBCGGGS---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             cccccccccchhcccc---ccCCCCCcccc---------------ChHHhcCCC-CChHHHHHHHHHHHHHHHh
Confidence            9998775543221110   01116778888               899887654 5789999999999999886

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-34  Score=268.31  Aligned_cols=196  Identities=23%  Similarity=0.286  Sum_probs=157.0

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcC--CCCCcceEEe
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL--SHPNLVKLLG  162 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l--~h~nIv~l~~  162 (376)
                      ....++|++.+.||+|+||.||+|.+.           ++.||||++....   ...+.+|.+++..+  +||||+++++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~   98 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-----------GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA   98 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-----------CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEE
Confidence            345568999999999999999999653           7789999986443   23445566666655  8999999999


Q ss_pred             EEEeC----CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--------CcEecCCCCC
Q 017177          163 YCWED----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEK--------KVIYRDFKAS  230 (376)
Q Consensus       163 ~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~--------~iiHrDlKp~  230 (376)
                      ++...    ..+++||||+++|+|.+++...     .+++..+..++.|++.||.|||+  .        +|+||||||+
T Consensus        99 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~--~~~~~~~~~~ivH~Dikp~  171 (337)
T 3mdy_A           99 ADIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHT--EIFSTQGKPAIAHRDLKSK  171 (337)
T ss_dssp             EEEESCGGGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHS--CBCSTTCBCCEECSCCCGG
T ss_pred             EEccCCCCCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHH--hhhhhccCCCEEecccchH
Confidence            99887    7899999999999999999653     48999999999999999999994  6        9999999999


Q ss_pred             CEEEcCCCcEEEcceeeeeeeccceeeEE-EeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccc-----c
Q 017177          231 NILLDGVGFLFDSHLLIYVYFKRHYIYIY-IHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTL-----L  304 (376)
Q Consensus       231 NILl~~~g~~kl~Dfg~a~~~~~~~~~~~-~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~-----~  304 (376)
                      |||++.++.+||+|||+++.......... ...+.    .||+.|+               |||++.+..+...     +
T Consensus       172 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~----~gt~~y~---------------aPE~~~~~~~~~~~~~~~~  232 (337)
T 3mdy_A          172 NILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR----VGTKRYM---------------PPEVLDESLNRNHFQSYIM  232 (337)
T ss_dssp             GEEECTTSCEEECCCTTCEECC---------CCSS----CSCGGGC---------------CHHHHTTCCCTTCTHHHHH
T ss_pred             HEEECCCCCEEEEeCCCceeeccccccccCCCCCC----ccCccee---------------ChhhcccccCCccccCccc
Confidence            99999999999999999987655433211 11122    7888888               8998876644332     4


Q ss_pred             ccccceeeeehhhccc
Q 017177          305 KYSNSFAFVFSCVFSF  320 (376)
Q Consensus       305 ~dv~s~g~v~~~~~~~  320 (376)
                      +||||+|++++++++.
T Consensus       233 ~DiwslG~il~el~tg  248 (337)
T 3mdy_A          233 ADMYSFGLILWEVARR  248 (337)
T ss_dssp             HHHHHHHHHHHHHHTT
T ss_pred             cchHHHHHHHHHHHhc
Confidence            8999999999999765

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.1e-34  Score=265.82  Aligned_cols=198  Identities=21%  Similarity=0.230  Sum_probs=168.2

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ..++|++.+.||+|+||.||+|...         .++..||+|++.....   ...+.+.+|+.+++.++||||++++++
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   82 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREK---------QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNY   82 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhhhceeeheecCCCCeEEEEEEEc---------CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEE
Confidence            3467999999999999999999554         3588999999865321   224678899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +.+.+..++||||+++|+|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.+|.+||+
T Consensus        83 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~  156 (284)
T 2vgo_A           83 FHDRKRIYLMLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCH--ERKVIHRDIKPENLLMGYKGELKIA  156 (284)
T ss_dssp             EECSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECTTCCEEEC
T ss_pred             EEcCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEEcCCCCEEEe
Confidence            99999999999999999999999876    35899999999999999999999  6999999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||++.........     ..    .||+.|+               +||++.+.. .+.++|+||+|++++++++...+
T Consensus       157 Dfg~~~~~~~~~~~-----~~----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p  211 (284)
T 2vgo_A          157 DFGWSVHAPSLRRR-----TM----CGTLDYL---------------PPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPP  211 (284)
T ss_dssp             CCTTCEECSSSCBC-----CC----CSCGGGC---------------CHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCT
T ss_pred             cccccccCcccccc-----cc----cCCCCcC---------------CHHHhccCC-CCcccchhhHHHHHHHHHHCCCC
Confidence            99999766543221     11    6788888               899887654 58899999999999999865444


Q ss_pred             c
Q 017177          324 T  324 (376)
Q Consensus       324 ~  324 (376)
                      .
T Consensus       212 f  212 (284)
T 2vgo_A          212 F  212 (284)
T ss_dssp             T
T ss_pred             C
Confidence            3

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.9e-35  Score=270.85  Aligned_cols=200  Identities=25%  Similarity=0.332  Sum_probs=161.2

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-----hhHHHHHHHHHHHhcCC---CCCcc
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-----QGFEEWQSEVNFLGRLS---HPNLV  158 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~---h~nIv  158 (376)
                      ..++|++.+.||+|+||.||+|.         +..+++.||+|++.....     .....+.+|+.+++.++   ||||+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv   77 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKAR---------DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVV   77 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEE---------CTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBC
T ss_pred             cccceEEEEEEecCCCeEEEEEE---------ECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeE
Confidence            35789999999999999999994         444689999999864321     11245667877777765   99999


Q ss_pred             eEEeEEEeCC-----eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEE
Q 017177          159 KLLGYCWEDK-----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL  233 (376)
Q Consensus       159 ~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NIL  233 (376)
                      ++++++....     .+++||||+. |+|.+++.....  ..+++..+..++.|++.||.|||  .++|+||||||+|||
T Consensus        78 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~Nil  152 (308)
T 3g33_A           78 RLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENIL  152 (308)
T ss_dssp             CEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCTTTEE
T ss_pred             EeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEE
Confidence            9999998765     5899999997 599999976532  34899999999999999999999  599999999999999


Q ss_pred             EcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeee
Q 017177          234 LDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFV  313 (376)
Q Consensus       234 l~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v  313 (376)
                      ++.++.+||+|||+++.........    ..    .||+.|+               |||++.+.. ++.++||||+|++
T Consensus       153 ~~~~~~~kl~Dfg~a~~~~~~~~~~----~~----~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~i  208 (308)
T 3g33_A          153 VTSGGTVKLADFGLARIYSYQMALT----PV----VVTLWYR---------------APEVLLQST-YATPVDMWSVGCI  208 (308)
T ss_dssp             ECTTSCEEECSCSCTTTSTTCCCSG----GG----GCCCSSC---------------CHHHHHTSC-CCSTHHHHHHHHH
T ss_pred             EcCCCCEEEeeCccccccCCCcccC----Cc----ccccccc---------------CchHHcCCC-CCchHHHHHHHHH
Confidence            9999999999999998765433321    11    6778888               899887765 5889999999999


Q ss_pred             ehhhccccccc
Q 017177          314 FSCVFSFYRTT  324 (376)
Q Consensus       314 ~~~~~~~y~~~  324 (376)
                      ++++++...+.
T Consensus       209 l~~l~~g~~pf  219 (308)
T 3g33_A          209 FAEMFRRKPLF  219 (308)
T ss_dssp             HHHTTTSSCSC
T ss_pred             HHHHHhCCCCC
Confidence            99999655443

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-35  Score=280.45  Aligned_cols=196  Identities=20%  Similarity=0.190  Sum_probs=160.6

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||||++...  .....+++.+|+.+++.++||||+++++++
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~   93 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDG---------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVF   93 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEET---------TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred             ecceEEEeEEeeecCCeEEEEEEEC---------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeE
Confidence            4578999999999999999999543         36899999999654  333456788999999999999999999999


Q ss_pred             EeCC------eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          165 WEDK------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       165 ~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      ...+      .+|+||||+ +++|.+++...     .+++..+..++.||+.||.|||  .++|+||||||+|||++.+|
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~  165 (367)
T 1cm8_A           94 TPDETLDDFTDFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDC  165 (367)
T ss_dssp             CSCSSTTTCCCCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTC
T ss_pred             ecCCccccCceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH--HCCccccCcCHHHEEEcCCC
Confidence            7653      469999999 78999998753     4899999999999999999999  59999999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .+||+|||+++.......     +     .+||+.|+               |||++.+...++.++|+||+|+++++++
T Consensus       166 ~~kl~Dfg~a~~~~~~~~-----~-----~~~t~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~ell  220 (367)
T 1cm8_A          166 ELKILDFGLARQADSEMT-----G-----YVVTRWYR---------------APEVILNWMRYTQTVDIWSVGCIMAEMI  220 (367)
T ss_dssp             CEEECCCTTCEECCSSCC-----S-----SCSCGGGC---------------CTHHHHTTTCCCTTHHHHHHHHHHHHHH
T ss_pred             CEEEEeeecccccccccC-----c-----CcCCCCcC---------------CHHHHhCCCCCChhhhHHHHHHHHHHHH
Confidence            999999999997654211     1     16788888               8999888667899999999999999999


Q ss_pred             cccccc
Q 017177          319 SFYRTT  324 (376)
Q Consensus       319 ~~y~~~  324 (376)
                      +...+.
T Consensus       221 ~g~~pf  226 (367)
T 1cm8_A          221 TGKTLF  226 (367)
T ss_dssp             HSSCSS
T ss_pred             hCCCCC
Confidence            654443

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8.5e-35  Score=276.52  Aligned_cols=204  Identities=19%  Similarity=0.194  Sum_probs=171.6

Q ss_pred             hhhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--------hhHHHHHHHHHHHhcC-
Q 017177           82 LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--------QGFEEWQSEVNFLGRL-  152 (376)
Q Consensus        82 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l-  152 (376)
                      .......++|++.+.||+|+||.||+|...         .+++.||||+++....        ...+.+.+|+.+++.+ 
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~---------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  157 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHR---------ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA  157 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEEC---------CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhc
Confidence            334455678999999999999999999654         3588999999865431        1235678999999999 


Q ss_pred             CCCCcceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCE
Q 017177          153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI  232 (376)
Q Consensus       153 ~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NI  232 (376)
                      +||||+++++++...+..|+||||+++++|.+++...    ..+++..+..++.||+.||.|||  ..+|+||||||+||
T Consensus       158 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH--~~gi~H~Dlkp~NI  231 (365)
T 2y7j_A          158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLH--ANNIVHRDLKPENI  231 (365)
T ss_dssp             TCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGE
T ss_pred             CCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHE
Confidence            6999999999999999999999999999999999865    45899999999999999999999  58999999999999


Q ss_pred             EEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh-----hhccccccc
Q 017177          233 LLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI-----KYLTLLKYS  307 (376)
Q Consensus       233 Ll~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~-----~~~~~~~dv  307 (376)
                      |++.+|.+||+|||++...........    .    .||+.|+               |||++.+.     ..++.++||
T Consensus       232 l~~~~~~ikl~DfG~~~~~~~~~~~~~----~----~gt~~y~---------------aPE~~~~~~~~~~~~~~~~~Di  288 (365)
T 2y7j_A          232 LLDDNMQIRLSDFGFSCHLEPGEKLRE----L----CGTPGYL---------------APEILKCSMDETHPGYGKEVDL  288 (365)
T ss_dssp             EECTTCCEEECCCTTCEECCTTCCBCC----C----CSCGGGC---------------CHHHHHHTTCTTSCCBCTTHHH
T ss_pred             EECCCCCEEEEecCcccccCCCccccc----C----CCCCCcc---------------ChhhccccccccCcCCCchhhH
Confidence            999999999999999988765433211    1    7888888               89988753     246789999


Q ss_pred             cceeeeehhhcccccc
Q 017177          308 NSFAFVFSCVFSFYRT  323 (376)
Q Consensus       308 ~s~g~v~~~~~~~y~~  323 (376)
                      ||+|++++++++...+
T Consensus       289 ~slG~il~ell~g~~p  304 (365)
T 2y7j_A          289 WACGVILFTLLAGSPP  304 (365)
T ss_dssp             HHHHHHHHHHHHSSCS
T ss_pred             HhHHHHHHHHHHCCCC
Confidence            9999999999965444

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6e-35  Score=268.15  Aligned_cols=200  Identities=23%  Similarity=0.330  Sum_probs=156.4

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      .++|++.+.||+|+||.||+|.+...      ...+..||+|+++...   ....+.+.+|+.+++.++||||+++++++
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   90 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAP------SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV   90 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECT------TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccC------CCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence            45799999999999999999976431      1124579999987652   23457889999999999999999999998


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      ..+. .++||||+++++|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|
T Consensus        91 ~~~~-~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nili~~~~~~kl~D  164 (291)
T 1u46_A           91 LTPP-MKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGD  164 (291)
T ss_dssp             CSSS-CEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTEEEECC
T ss_pred             ccCC-ceeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHH--hCCcccCCCchheEEEcCCCCEEEcc
Confidence            7655 899999999999999997652   45899999999999999999999  58999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ||++...............    ..+|+.|+               +||++.+.. .+.++|+||+|++++++++
T Consensus       165 fg~~~~~~~~~~~~~~~~~----~~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~l~~  219 (291)
T 1u46_A          165 FGLMRALPQNDDHYVMQEH----RKVPFAWC---------------APESLKTRT-FSHASDTWMFGVTLWEMFT  219 (291)
T ss_dssp             CTTCEECCC-CCEEEC---------CCGGGC---------------CHHHHHHCE-EEHHHHHHHHHHHHHHHHT
T ss_pred             ccccccccccccchhhhcc----CCCCceee---------------CchhhcCCC-CCchhhHHHHHHHHHHHHh
Confidence            9999987654332212111    25677777               899887654 5889999999999999987

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-35  Score=287.95  Aligned_cols=196  Identities=22%  Similarity=0.211  Sum_probs=159.2

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC-
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED-  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~-  167 (376)
                      .+|++.+.||+|+||.||+|.+.         .+++.||||++.....    ...+|+.+|+.++||||+++++++... 
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~---------~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~  120 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLC---------DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSG  120 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEEC---------CCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccC
Confidence            46899999999999999999654         3588999999865432    234699999999999999999988542 


Q ss_pred             -----CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC-CcEE
Q 017177          168 -----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV-GFLF  241 (376)
Q Consensus       168 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~-g~~k  241 (376)
                           ..+++||||+++ +|.+++.........+++..+..++.||+.||.|||  .++|+||||||+||||+.+ +.+|
T Consensus       121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NILl~~~~~~~k  197 (420)
T 1j1b_A          121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLK  197 (420)
T ss_dssp             TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCSGGGEEEETTTTEEE
T ss_pred             CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChhhEEEeCCCCeEE
Confidence                 237799999976 777776543222356899999999999999999999  6999999999999999965 6789


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |+|||+++.........    +    .+||+.|+               |||++.+...++.++||||+|++++|+++..
T Consensus       198 l~DFG~a~~~~~~~~~~----~----~~~t~~y~---------------aPE~~~~~~~~~~~~DiwSlG~il~ell~G~  254 (420)
T 1j1b_A          198 LCDFGSAKQLVRGEPNV----S----YICSRYYR---------------APELIFGATDYTSSIDVWSAGCVLAELLLGQ  254 (420)
T ss_dssp             ECCCTTCEECCTTCCCC----S----CCSCTTSC---------------CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             eccchhhhhcccCCCce----e----eeeCCCcC---------------CHHHHcCCCCCCchhhhHHHHHHHHHHHhCC
Confidence            99999999765433221    1    16788888               8999888767799999999999999999654


Q ss_pred             cc
Q 017177          322 RT  323 (376)
Q Consensus       322 ~~  323 (376)
                      .+
T Consensus       255 ~p  256 (420)
T 1j1b_A          255 PI  256 (420)
T ss_dssp             CS
T ss_pred             CC
Confidence            44

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=7.6e-35  Score=272.68  Aligned_cols=206  Identities=17%  Similarity=0.174  Sum_probs=168.4

Q ss_pred             hhhhhhcCCCCcc-ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCC-CCCc
Q 017177           82 LDLKSATKNFKPD-SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLS-HPNL  157 (376)
Q Consensus        82 ~~~~~~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~-h~nI  157 (376)
                      .......++|.+. +.||+|+||.||+|...         .+++.||+|++.....  .....+.+|+.+++.+. ||||
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i   91 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISK---------STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV   91 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTB
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEEC---------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCE
Confidence            3445556678887 89999999999999544         3588999999876432  33577889999999996 7999


Q ss_pred             ceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC-
Q 017177          158 VKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-  236 (376)
Q Consensus       158 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~-  236 (376)
                      +++++++.+.+..++||||+++|+|.+++....  ...+++..+..++.|++.||.|||  .++|+||||||+|||++. 
T Consensus        92 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH--~~givH~Dikp~NIl~~~~  167 (327)
T 3lm5_A           92 INLHEVYENTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLH--QNNIVHLDLKPQNILLSSI  167 (327)
T ss_dssp             CCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESCB
T ss_pred             EEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH--HCCeecCcCChHHEEEecC
Confidence            999999999999999999999999999986542  256899999999999999999999  599999999999999987 


Q ss_pred             --CCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeee
Q 017177          237 --VGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVF  314 (376)
Q Consensus       237 --~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~  314 (376)
                        ++.+||+|||+++..........        ..||+.|+               +||++.+.. .+.++|+||+|+++
T Consensus       168 ~~~~~~kL~Dfg~a~~~~~~~~~~~--------~~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il  223 (327)
T 3lm5_A          168 YPLGDIKIVDFGMSRKIGHACELRE--------IMGTPEYL---------------APEILNYDP-ITTATDMWNIGIIA  223 (327)
T ss_dssp             TTBCCEEECCGGGCEEC-----------------CCCGGGC---------------CHHHHTTCC-CCTHHHHHHHHHHH
T ss_pred             CCCCcEEEeeCccccccCCcccccc--------ccCCcCcc---------------CCeeecCCC-CCchhhHHHHHHHH
Confidence              78999999999997754432211        16888888               899887654 57899999999999


Q ss_pred             hhhccccccc
Q 017177          315 SCVFSFYRTT  324 (376)
Q Consensus       315 ~~~~~~y~~~  324 (376)
                      +++++...+.
T Consensus       224 ~~ll~g~~pf  233 (327)
T 3lm5_A          224 YMLLTHTSPF  233 (327)
T ss_dssp             HHHHHSSCSS
T ss_pred             HHHHhCCCCC
Confidence            9999765544

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.9e-35  Score=276.49  Aligned_cols=200  Identities=23%  Similarity=0.298  Sum_probs=161.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|.+...     .......||+|.+.... ......+.+|+.+++.++||||+++++++. 
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-   85 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPE-----GESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-   85 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCT-----TCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCC-----CceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence            46799999999999999999976541     12224458899886543 223356678999999999999999999885 


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++..++||||+++|+|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||
T Consensus        86 ~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~kl~Dfg  160 (325)
T 3kex_A           86 GSSLQLVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLE--EHGMVHRNLAARNVLLKSPSQVQVADFG  160 (325)
T ss_dssp             BSSEEEEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHH--HTTCCCSCCSSTTEEESSSSCEEECSCS
T ss_pred             CCccEEEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHH--hCCCCCCccchheEEECCCCeEEECCCC
Confidence            566999999999999999997642   45888999999999999999999  5899999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +++.............     ..||+.|+               +||++.+.. .+.++||||+|++++++++
T Consensus       161 ~a~~~~~~~~~~~~~~-----~~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~~l~el~~  212 (325)
T 3kex_A          161 VADLLPPDDKQLLYSE-----AKTPIKWM---------------ALESIHFGK-YTHQSDVWSYGVTVWELMT  212 (325)
T ss_dssp             GGGGSCCCTTCCC----------CCTTTS---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             cccccCcccccccccC-----CCCccccc---------------ChHHhccCC-CChhhHhHHhHHHHHHHHh
Confidence            9997654332211111     16667788               899887655 5889999999999999887

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=7e-35  Score=266.75  Aligned_cols=197  Identities=22%  Similarity=0.243  Sum_probs=165.3

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh------hhHHHHHHHHHHHhcCCCCCcceEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM------QGFEEWQSEVNFLGRLSHPNLVKLLG  162 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~h~nIv~l~~  162 (376)
                      ++|++.+.||+|+||.||+|...         .+++.||+|+++....      ...+.+.+|+.+++.++||||+++++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   75 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQK---------GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHD   75 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEc---------CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhh
Confidence            46899999999999999999554         3588999999865422      13578899999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC----
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG----  238 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g----  238 (376)
                      ++.+++..++||||+++++|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+||+++.++    
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~~  149 (283)
T 3bhy_A           76 IFENKTDVVLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLH--SKRIAHFDLKPENIMLLDKNVPNP  149 (283)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSSSSC
T ss_pred             eecCCCeEEEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCChHHEEEecCCCCCC
Confidence            999999999999999999999999765    45899999999999999999999  59999999999999998877    


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .+||+|||++...........        ..||+.|+               +||++.+.. .+.++|+||+|+++++++
T Consensus       150 ~~kl~dfg~~~~~~~~~~~~~--------~~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~l~  205 (283)
T 3bhy_A          150 RIKLIDFGIAHKIEAGNEFKN--------IFGTPEFV---------------APEIVNYEP-LGLEADMWSIGVITYILL  205 (283)
T ss_dssp             CEEECCCTTCEECC----------------CCCGGGC---------------CHHHHTTCC-CCTHHHHHHHHHHHHHHH
T ss_pred             ceEEEecccceeccCCCcccc--------cCCCcCcc---------------CcceecCCC-CCcchhhhhHHHHHHHHH
Confidence            899999999987654332211        16778888               899887654 588999999999999999


Q ss_pred             cccccc
Q 017177          319 SFYRTT  324 (376)
Q Consensus       319 ~~y~~~  324 (376)
                      +...+.
T Consensus       206 ~g~~p~  211 (283)
T 3bhy_A          206 SGASPF  211 (283)
T ss_dssp             HSSCTT
T ss_pred             HCCCCC
Confidence            754443

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-34  Score=267.92  Aligned_cols=203  Identities=20%  Similarity=0.200  Sum_probs=164.7

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh----hhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM----QGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      .++|++.+.||+|+||.||+|..         ..+++.||+|+++....    ...+.+.+|+.+++.++||||++++++
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   74 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLD---------SETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV   74 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEB---------TTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ccceeEeeEEecCCCeEEEEEEE---------CCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence            46899999999999999999954         34688999999976432    335678899999999999999999999


Q ss_pred             EEe--CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEE
Q 017177          164 CWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLF  241 (376)
Q Consensus       164 ~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~k  241 (376)
                      +..  .+..++||||++++ |.+++....  ...+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+|
T Consensus        75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH--~~~i~H~dlkp~NIl~~~~~~~k  149 (305)
T 2wtk_C           75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLH--SQGIVHKDIKPGNLLLTTGGTLK  149 (305)
T ss_dssp             EECC---CEEEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEE
T ss_pred             EEcCCCCeEEEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCcccEEEcCCCcEE
Confidence            853  45799999999876 777776643  256899999999999999999999  58999999999999999999999


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh-hhccccccccceeeeehhhccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI-KYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~-~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      |+|||++..............     ..||+.|+               +||++.+. .+.+.++|+||+|++++++++.
T Consensus       150 l~dfg~~~~~~~~~~~~~~~~-----~~~~~~y~---------------aPE~~~~~~~~~~~~~Di~slG~il~~l~~g  209 (305)
T 2wtk_C          150 ISALGVAEALHPFAADDTCRT-----SQGSPAFQ---------------PPEIANGLDTFSGFKVDIWSAGVTLYNITTG  209 (305)
T ss_dssp             ECCCTTCEECCTTCSSCEECC-----CCSCGGGC---------------CHHHHTCCSCEESHHHHHHHHHHHHHHHHHS
T ss_pred             eeccccccccCcccccccccc-----CCCCCCCc---------------ChhhccCcccCCcchhhHHHHHHHHHHHHhC
Confidence            999999987754322211111     16888888               89988764 3457799999999999999965


Q ss_pred             cccc
Q 017177          321 YRTT  324 (376)
Q Consensus       321 y~~~  324 (376)
                      ..+.
T Consensus       210 ~~p~  213 (305)
T 2wtk_C          210 LYPF  213 (305)
T ss_dssp             SCSC
T ss_pred             CCCC
Confidence            5443

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.7e-35  Score=265.49  Aligned_cols=194  Identities=25%  Similarity=0.358  Sum_probs=164.6

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|++.+.||+|+||.||+|....          +..||+|++..... ..+.+.+|+.+++.++||||+++++++.++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   75 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ   75 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             hhheeeeeEecCCCceeEEEEEecC----------CCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            4679999999999999999997643          67899999987643 236788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++||||+++++|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+||+++.++.+||+|||+
T Consensus        76 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nili~~~~~~kl~dfg~  150 (267)
T 3t9t_A           76 APICLVTEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGM  150 (267)
T ss_dssp             SSCEEEECCCTTCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECGGGCEEECCTTG
T ss_pred             CCeEEEEeCCCCCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCchheEEECCCCCEEEccccc
Confidence            99999999999999999997652   45899999999999999999999  59999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +.......... ..+.     .||+.|+               +||++.+.. .+.++|+||+|++++++++
T Consensus       151 ~~~~~~~~~~~-~~~~-----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~l~~  200 (267)
T 3t9t_A          151 TRFVLDDQYTS-STGT-----KFPVKWA---------------SPEVFSFSR-YSSKSDVWSFGVLMWEVFS  200 (267)
T ss_dssp             GGGBCCHHHHS-TTST-----TCCGGGC---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             ccccccccccc-cccc-----ccccccc---------------ChhhhcCCC-ccchhchhhhHHHHHHHhc
Confidence            98764432111 1111     4566677               899887654 5789999999999999987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5e-36  Score=286.17  Aligned_cols=199  Identities=14%  Similarity=0.122  Sum_probs=156.5

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC---ChhhHHHHHHHHH---HHhcCCCCCcceE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVN---FLGRLSHPNLVKL  160 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~---il~~l~h~nIv~l  160 (376)
                      ..++|++.+.||+|+||.||+|..         ..+++.||||++...   .....+.+.+|+.   +++.++||||+++
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~  141 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATD---------QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV  141 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC----------CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHH
T ss_pred             CCceEEEcceeecCCCEEEEEEEE---------CCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHH
Confidence            346799999999999999999954         335889999998743   3345578889994   5555579999999


Q ss_pred             E-------eEEEeCC-----------------eEEEEEeccCCCCHHHHHhhcCCC---CCCCCHHHHHHHHHHHHHHHH
Q 017177          161 L-------GYCWEDK-----------------ELLLVYEYMQRGSLENHLFRRNPS---IQPLSWDIRLKIAIGAARGLG  213 (376)
Q Consensus       161 ~-------~~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~  213 (376)
                      +       +++.+++                 ..|+||||+ +|+|.+++......   ...+++..+..++.||+.||.
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~  220 (377)
T 3byv_A          142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLA  220 (377)
T ss_dssp             HHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHH
T ss_pred             HhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHH
Confidence            8       6666553                 289999999 67999999864210   112335788889999999999


Q ss_pred             HhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHH
Q 017177          214 FLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPR  293 (376)
Q Consensus       214 yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apE  293 (376)
                      |||  .++|+||||||+|||++.+|.+||+|||+++.......      +.    .| +.|+               |||
T Consensus       221 ~LH--~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~------~~----~g-~~y~---------------aPE  272 (377)
T 3byv_A          221 SLH--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV------SS----VS-RGFE---------------PPE  272 (377)
T ss_dssp             HHH--HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTCEEE------CC----CC-TTCC---------------CHH
T ss_pred             HHH--hCCeecCCCCHHHEEEcCCCCEEEEechhheecCCccc------CC----CC-cCcc---------------Chh
Confidence            999  58999999999999999999999999999986433111      11    56 7777               799


Q ss_pred             HHhhh----------hhccccccccceeeeehhhcccccc
Q 017177          294 IYAWI----------KYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       294 i~~~~----------~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ++.+.          ..++.++||||+|++++++++...+
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~P  312 (377)
T 3byv_A          273 LEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP  312 (377)
T ss_dssp             HHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCC
T ss_pred             hhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCC
Confidence            88877          3568999999999999999865444

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.7e-34  Score=293.76  Aligned_cols=202  Identities=20%  Similarity=0.265  Sum_probs=164.6

Q ss_pred             hhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEe
Q 017177           84 LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLG  162 (376)
Q Consensus        84 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~  162 (376)
                      .....++|++.+.||+|+||.||+|.+...      ...+..||+|.++... ....+.+.+|+.+++.++||||+++++
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~  458 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSP------ENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG  458 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCS------SSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecC------CCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            334456799999999999999999977531      1236789999987653 344578899999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                      ++. ++..|+||||+++|+|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.+|.+||
T Consensus       459 ~~~-~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDikp~NILl~~~~~vkL  532 (656)
T 2j0j_A          459 VIT-ENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKL  532 (656)
T ss_dssp             EEC-SSSCEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEE
T ss_pred             EEe-cCceEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--hCCccccccchHhEEEeCCCCEEE
Confidence            884 567999999999999999997652   45899999999999999999999  589999999999999999999999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +|||+++............+      .+|+.||               |||++.+.. ++.++||||+|++++++++
T Consensus       533 ~DFG~a~~~~~~~~~~~~~~------~~t~~y~---------------aPE~~~~~~-~~~~~DiwSlG~il~ellt  587 (656)
T 2j0j_A          533 GDFGLSRYMEDSTYYKASKG------KLPIKWM---------------APESINFRR-FTSASDVWMFGVCMWEILM  587 (656)
T ss_dssp             CCCCCCCSCCC----------------CCGGGC---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             EecCCCeecCCCcceeccCC------CCCccee---------------CHHHhcCCC-CCchhhHHHHHHHHHHHHH
Confidence            99999997755433211111      5677888               899887654 5889999999999999875

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.5e-35  Score=277.64  Aligned_cols=201  Identities=23%  Similarity=0.199  Sum_probs=168.2

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ..++|++.+.||+|+||.||+|...         .++..||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   95 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDN---------LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIR   95 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEEC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEEC---------CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEe
Confidence            3568999999999999999999544         358899999998643 334477889999999999999999999987


Q ss_pred             eC-----CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcE
Q 017177          166 ED-----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL  240 (376)
Q Consensus       166 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~  240 (376)
                      ..     ...|+||||+. |+|.+++...     .+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+
T Consensus        96 ~~~~~~~~~~~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~  167 (364)
T 3qyz_A           96 APTIEQMKDVYIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDL  167 (364)
T ss_dssp             CSSTTTCCCEEEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCE
T ss_pred             cCCccccceEEEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCChHhEEECCCCCE
Confidence            65     36899999997 4999988653     4899999999999999999999  5999999999999999999999


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ||+|||++................    .||+.|+               |||++.+....+.++||||+|++++++++.
T Consensus       168 kl~Dfg~a~~~~~~~~~~~~~~~~----~gt~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~ell~g  228 (364)
T 3qyz_A          168 KICDFGLARVADPDHDHTGFLTEY----VATRWYR---------------APEIMLNSKGYTKSIDIWSVGCILAEMLSN  228 (364)
T ss_dssp             EECCCTTCEECCGGGCBCCTTCCC----CSCGGGC---------------CHHHHHTBCSCSTHHHHHHHHHHHHHHHHS
T ss_pred             EEEeCcceEecCCCCCcccccccc----ccccCCC---------------CCHHhcCCCCCCcchhHHHHHHHHHHHHHC
Confidence            999999999876543321111222    7888888               899887777779999999999999999865


Q ss_pred             ccc
Q 017177          321 YRT  323 (376)
Q Consensus       321 y~~  323 (376)
                      ..+
T Consensus       229 ~~p  231 (364)
T 3qyz_A          229 RPI  231 (364)
T ss_dssp             SCS
T ss_pred             CCC
Confidence            433

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.7e-34  Score=266.99  Aligned_cols=197  Identities=25%  Similarity=0.291  Sum_probs=168.2

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .+.|++.+.||+|+||.||+|...         .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   91 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDN---------RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK   91 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEEC---------CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence            456999999999999999999543         358899999987653 3446788999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++..++||||+++++|.+++..     ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.+|.+||+|||
T Consensus        92 ~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~Dfg  164 (303)
T 3a7i_A           92 DTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFG  164 (303)
T ss_dssp             TTEEEEEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCChheEEECCCCCEEEeecc
Confidence            9999999999999999999854     34899999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ++..........   ..    ..||+.|+               +||++.+.. .+.++|+||+|++++++++...+
T Consensus       165 ~~~~~~~~~~~~---~~----~~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p  218 (303)
T 3a7i_A          165 VAGQLTDTQIKR---NT----FVGTPFWM---------------APEVIKQSA-YDSKADIWSLGITAIELARGEPP  218 (303)
T ss_dssp             TCEECBTTBCCB---CC----CCSCGGGC---------------CHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             cceecCcccccc---Cc----cCCCcCcc---------------CHHHHhcCC-CCchhhhHHHHHHHHHHccCCCC
Confidence            998876543221   11    16788888               899887654 57899999999999999965444

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2e-35  Score=269.88  Aligned_cols=203  Identities=21%  Similarity=0.267  Sum_probs=165.4

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      .++|++.+.||+|+||.||+|...         .+++.||+|.+....  ....+.+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   75 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRK---------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII   75 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEEC---------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence            467999999999999999999554         358899999997643  344577889999999999999999999886


Q ss_pred             e--CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-----cEecCCCCCCEEEcCCC
Q 017177          166 E--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK-----VIYRDFKASNILLDGVG  238 (376)
Q Consensus       166 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~-----iiHrDlKp~NILl~~~g  238 (376)
                      +  .+..++||||+++++|.+++.........+++..+..++.|++.||.|||+  .+     |+||||||+|||++.++
T Consensus        76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~~~ivH~dl~p~NIl~~~~~  153 (279)
T 2w5a_A           76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR--RSDGGHTVLHRDLKPANVFLDGKQ  153 (279)
T ss_dssp             EGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--HC------CCCCCSGGGEEECSSS
T ss_pred             cCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc--ccCCCCeeEEeccchhhEEEcCCC
Confidence            4  568999999999999999997654334558999999999999999999995  77     99999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .+||+|||++..........   ...    .||+.|+               +||++.+.. .+.++|+||+|+++++++
T Consensus       154 ~~kl~dfg~~~~~~~~~~~~---~~~----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~l~  210 (279)
T 2w5a_A          154 NVKLGDFGLARILNHDTSFA---KTF----VGTPYYM---------------SPEQMNRMS-YNEKSDIWSLGCLLYELC  210 (279)
T ss_dssp             CEEECCCCHHHHC---CHHH---HHH----HSCCTTC---------------CHHHHHCC--CCHHHHHHHHHHHHHHHH
T ss_pred             CEEEecCchheeeccccccc---ccc----CCCcccc---------------ChHHhccCC-CCchhhHHHHHHHHHHHH
Confidence            99999999998764422110   011    5677777               899887654 578999999999999999


Q ss_pred             cccccc
Q 017177          319 SFYRTT  324 (376)
Q Consensus       319 ~~y~~~  324 (376)
                      +...+.
T Consensus       211 ~g~~p~  216 (279)
T 2w5a_A          211 ALMPPF  216 (279)
T ss_dssp             HSSCSS
T ss_pred             HCCCCC
Confidence            765443

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-34  Score=268.70  Aligned_cols=198  Identities=26%  Similarity=0.323  Sum_probs=163.3

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|.+....  ..+.+.+|+.+++.++||||+++++++..
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   95 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHK---------ETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK   95 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEET---------TTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEEC---------CCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence            4568999999999999999999554         358899999997653  33678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      .+..++||||+++++|.+++....   ..+++..+..++.|++.||.|||  ..+|+||||||+|||++.+|.+||+|||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~dfg  170 (314)
T 3com_A           96 NTDLWIVMEYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLH--FMRKIHRDIKAGNILLNTEGHAKLADFG  170 (314)
T ss_dssp             TTEEEEEEECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             CCEEEEEeecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCCcCCCcCHHHEEECCCCCEEEeecc
Confidence            999999999999999999997542   46899999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ++..........   ..    ..||+.|+               +||++.+.. .+.++|+||+|++++++++...+
T Consensus       171 ~~~~~~~~~~~~---~~----~~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p  224 (314)
T 3com_A          171 VAGQLTDTMAKR---NT----VIGTPFWM---------------APEVIQEIG-YNCVADIWSLGITAIEMAEGKPP  224 (314)
T ss_dssp             TCEECBTTBSCB---CC----CCSCGGGC---------------CHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCT
T ss_pred             cchhhhhhcccc---Cc----cCCCCCcc---------------ChhhcCCCC-CCccccHHHHHHHHHHHHhCCCC
Confidence            998775543221   11    16778888               899887654 57899999999999999965444

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=6.5e-35  Score=272.91  Aligned_cols=197  Identities=25%  Similarity=0.324  Sum_probs=160.1

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcE--EEEEEcCCCC-hhhHHHHHHHHHHHhcC-CCCCcceEEeE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMV--VAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGY  163 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~--vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~l~~~  163 (376)
                      .++|++.+.||+|+||.||+|....         ++..  +|+|.++... ....+.+.+|+.+++++ +||||++++++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   94 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGA   94 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEcc---------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhcee
Confidence            3579999999999999999996543         3554  5999887542 23446788999999999 79999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCC
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRN------------PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASN  231 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~N  231 (376)
                      +.+.+..|+||||+++|+|.+++....            .....+++..++.++.||+.||.|||  .++|+||||||+|
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~N  172 (327)
T 1fvr_A           95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARN  172 (327)
T ss_dssp             EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGG
T ss_pred             eeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCccce
Confidence            999999999999999999999997653            12246899999999999999999999  5999999999999


Q ss_pred             EEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcccccccccee
Q 017177          232 ILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFA  311 (376)
Q Consensus       232 ILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g  311 (376)
                      ||++.++.+||+|||+++........        ....+|+.|+               +||++.+.. .+.++|+||+|
T Consensus       173 Il~~~~~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG  228 (327)
T 1fvr_A          173 ILVGENYVAKIADFGLSRGQEVYVKK--------TMGRLPVRWM---------------AIESLNYSV-YTTNSDVWSYG  228 (327)
T ss_dssp             EEECGGGCEEECCTTCEESSCEECCC------------CCTTTC---------------CHHHHHHCE-ECHHHHHHHHH
T ss_pred             EEEcCCCeEEEcccCcCccccccccc--------cCCCCCcccc---------------Chhhhcccc-CCchhcchHHH
Confidence            99999999999999999853322111        1115567777               799876654 58899999999


Q ss_pred             eeehhhcc
Q 017177          312 FVFSCVFS  319 (376)
Q Consensus       312 ~v~~~~~~  319 (376)
                      ++++++++
T Consensus       229 ~il~ellt  236 (327)
T 1fvr_A          229 VLLWEIVS  236 (327)
T ss_dssp             HHHHHHHT
T ss_pred             HHHHHHHc
Confidence            99999987

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.1e-35  Score=265.90  Aligned_cols=196  Identities=23%  Similarity=0.347  Sum_probs=163.7

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ...++|++.+.||+|+||.||+|....          +..||+|.+..... ..+.+.+|+.+++.++||||+++++++.
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~   78 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYNG----------HTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT   78 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEcC----------CcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc
Confidence            345689999999999999999997553          66899999976542 3467889999999999999999999876


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                       .+..++||||+++++|.+++.....  ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+||
T Consensus        79 -~~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Df  153 (279)
T 1qpc_A           79 -QEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADF  153 (279)
T ss_dssp             -SSSCEEEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             -CCCcEEEEecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHhhEEEcCCCCEEECCC
Confidence             4568999999999999999965421  25899999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      |++.......... ..+.     .+|+.|+               +||++.+.. .+.++|+||+|++++++++
T Consensus       154 g~~~~~~~~~~~~-~~~~-----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~el~~  205 (279)
T 1qpc_A          154 GLARLIEDNEYTA-REGA-----KFPIKWT---------------APEAINYGT-FTIKSDVWSFGILLTEIVT  205 (279)
T ss_dssp             TTCEECSSSCEEC-CTTC-----CCCTTTS---------------CHHHHHHCE-ECHHHHHHHHHHHHHHHHT
T ss_pred             cccccccCccccc-ccCC-----CCccCcc---------------ChhhhccCC-CCchhhhHHHHHHHHHHHh
Confidence            9999876543321 1111     5566777               899887554 5889999999999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-35  Score=280.06  Aligned_cols=200  Identities=23%  Similarity=0.293  Sum_probs=153.7

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe-C
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE-D  167 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-~  167 (376)
                      .|++.+.||+|+||.||+|.....      ...+..||+|.++... ....+.+.+|+.++++++||||+++++++.. +
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  163 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDN------DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE  163 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEET------TTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS
T ss_pred             eeecCcEeeeCCCeEEEEEEEECC------CCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            477889999999999999976421      1124578999987643 3456789999999999999999999998754 4


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++||||+++|+|.+++....   ..+++..+..++.||+.||.|||  .++|+||||||+|||++.++.+||+|||+
T Consensus       164 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~kL~DFG~  238 (373)
T 3c1x_A          164 GSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGL  238 (373)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             CCeEEEEECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHH--HCCEecCccchheEEECCCCCEEEeeccc
Confidence            67899999999999999997642   45789999999999999999999  59999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ++.............   ....+|+.|+               |||++.+.. ++.++||||+|++++++++
T Consensus       239 a~~~~~~~~~~~~~~---~~~~~~~~y~---------------aPE~~~~~~-~~~~~DvwSlG~il~ellt  291 (373)
T 3c1x_A          239 ARDMYDKEFDSVHNK---TGAKLPVKWM---------------ALESLQTQK-FTTKSDVWSFGVLLWELMT  291 (373)
T ss_dssp             ----------------------CCGGGS---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             ccccccccccccccc---CCCCCccccc---------------ChHHhcCCC-CCcHHHHHHHHHHHHHHHh
Confidence            987654332211110   1115677788               899887654 5889999999999999886

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.7e-35  Score=269.95  Aligned_cols=198  Identities=17%  Similarity=0.181  Sum_probs=164.2

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|+++.......+.+.+|+.+++.++||||+++++++.+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQR---------LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES   77 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEEC---------CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc
Confidence            3457999999999999999999544         3588999999987654445678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE---cCCCcEEEc
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL---DGVGFLFDS  243 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl---~~~g~~kl~  243 (376)
                      .+..++||||+++++|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+|||+   +.++.+||+
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dikp~NIl~~~~~~~~~~kl~  151 (304)
T 2jam_A           78 TTHYYLVMQLVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLH--ENGIVHRDLKPENLLYLTPEENSKIMIT  151 (304)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCSCCGGGCEESSSSTTCCEEBC
T ss_pred             CCEEEEEEEcCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEecCCCCCCEEEc
Confidence            99999999999999999999776    45899999999999999999999  5999999999999999   788999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |||++.........     ..    .||+.|+               |||++.+. ..+.++|+||+|++++++++...+
T Consensus       152 Dfg~~~~~~~~~~~-----~~----~~~~~y~---------------aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  206 (304)
T 2jam_A          152 DFGLSKMEQNGIMS-----TA----CGTPGYV---------------APEVLAQK-PYSKAVDCWSIGVITYILLCGYPP  206 (304)
T ss_dssp             SCSTTCCCCCBTTH-----HH----HSCCCBC---------------CTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             cCCcceecCCCccc-----cc----cCCCCcc---------------ChHHhccC-CCCchhhHHHHHHHHHHHHHCCCC
Confidence            99999765432111     11    5677777               79977654 457899999999999999965544


Q ss_pred             c
Q 017177          324 T  324 (376)
Q Consensus       324 ~  324 (376)
                      .
T Consensus       207 f  207 (304)
T 2jam_A          207 F  207 (304)
T ss_dssp             T
T ss_pred             C
Confidence            3

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.3e-35  Score=277.13  Aligned_cols=197  Identities=23%  Similarity=0.247  Sum_probs=168.1

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|...         .++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  102 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHK---------PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS  102 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEEC---------CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence            457999999999999999999554         358899999998663 3445778999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++..++||||+++++|.+++.+.    ..+++..+..++.|++.||.|||+ .++|+||||||+|||++.++.+||+|||
T Consensus       103 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  177 (360)
T 3eqc_A          103 DGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFG  177 (360)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             CCEEEEEEECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH-hCCEEcCCccHHHEEECCCCCEEEEECC
Confidence            99999999999999999999876    458999999999999999999994 2489999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ++.........         ...||+.|+               +||++.+.. .+.++||||+|++++++++...+
T Consensus       178 ~~~~~~~~~~~---------~~~gt~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p  229 (360)
T 3eqc_A          178 VSGQLIDSMAN---------SFVGTRSYM---------------SPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYP  229 (360)
T ss_dssp             CCHHHHHHC-------------CCCCTTC---------------CHHHHTTCC-CSHHHHHHHHHHHHHHHHHTSCC
T ss_pred             CCccccccccc---------CCCCCCCeE---------------CHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCC
Confidence            99765433211         116788888               899887754 58899999999999999865444

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=7.4e-35  Score=266.45  Aligned_cols=197  Identities=24%  Similarity=0.311  Sum_probs=165.5

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|.++...    +.+.+|+.+++.++||||+++++++..
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~   75 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHR---------IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDG   75 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEET---------TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hccccceeeeeccCCceEEEEEEEc---------CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEec
Confidence            4467999999999999999999654         358899999997654    345689999999999999999998864


Q ss_pred             ----------------CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCC
Q 017177          167 ----------------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKAS  230 (376)
Q Consensus       167 ----------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~  230 (376)
                                      ...+++||||+++|+|.+++.....  ..+++..+..++.|++.||.|||  .++|+||||||+
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~  151 (284)
T 2a19_B           76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIH--SKKLINRDLKPS  151 (284)
T ss_dssp             EEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGG
T ss_pred             cccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCHH
Confidence                            3458999999999999999976532  45899999999999999999999  589999999999


Q ss_pred             CEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccce
Q 017177          231 NILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSF  310 (376)
Q Consensus       231 NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~  310 (376)
                      |||++.++.+||+|||++...........        ..||+.|+               +||++.+.. .+.++|+||+
T Consensus       152 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~--------~~~~~~y~---------------aPE~~~~~~-~~~~~Di~sl  207 (284)
T 2a19_B          152 NIFLVDTKQVKIGDFGLVTSLKNDGKRTR--------SKGTLRYM---------------SPEQISSQD-YGKEVDLYAL  207 (284)
T ss_dssp             GEEEEETTEEEECCCTTCEESSCCSCCCC--------CCSCCTTS---------------CHHHHHCSC-CCTHHHHHHH
T ss_pred             HEEEcCCCCEEECcchhheeccccccccc--------cCCccccc---------------ChhhhccCC-CcchhhhHHH
Confidence            99999999999999999988765432211        16778888               899887654 5889999999


Q ss_pred             eeeehhhccccccc
Q 017177          311 AFVFSCVFSFYRTT  324 (376)
Q Consensus       311 g~v~~~~~~~y~~~  324 (376)
                      |++++++++...+.
T Consensus       208 G~il~~l~~~~~~~  221 (284)
T 2a19_B          208 GLILAELLHVCDTA  221 (284)
T ss_dssp             HHHHHHHHSCCSSH
T ss_pred             HHHHHHHHhcCCcc
Confidence            99999999765443

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.3e-34  Score=275.89  Aligned_cols=196  Identities=19%  Similarity=0.170  Sum_probs=156.5

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||||++...  .....+.+.+|+.+++.++||||+++++++
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~   93 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDA---------ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF   93 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhheeEeeeeEecCCEEEEEEEEC---------CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEee
Confidence            3578999999999999999999543         36889999998754  334456788999999999999999999999


Q ss_pred             EeCC------eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          165 WEDK------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       165 ~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      ...+      ..|+||||+++ +|.+.+..      .+++..+..++.||+.||.|||  .++|+||||||+|||++.+|
T Consensus        94 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~NIl~~~~~  164 (371)
T 2xrw_A           94 TPQKSLEEFQDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDC  164 (371)
T ss_dssp             CSCCSTTTCCEEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTS
T ss_pred             ccccccccccceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHH--HCCeecccCCHHHEEEcCCC
Confidence            7665      78999999975 78888853      3889999999999999999999  59999999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .+||+|||+++.........    .    ..||+.|+               |||++.+.. ++.++||||+|+++++++
T Consensus       165 ~~kl~Dfg~a~~~~~~~~~~----~----~~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~el~  220 (371)
T 2xrw_A          165 TLKILDFGLARTAGTSFMMT----P----YVVTRYYR---------------APEVILGMG-YKENVDIWSVGCIMGEMI  220 (371)
T ss_dssp             CEEECCCCC------------------------CTTC---------------CHHHHTTCC-CCTTHHHHHHHHHHHHHH
T ss_pred             CEEEEEeecccccccccccC----C----ceecCCcc---------------CHHHhcCCC-CCchHhHHHHHHHHHHHH
Confidence            99999999998765432221    1    27788888               899888754 578999999999999999


Q ss_pred             cccccc
Q 017177          319 SFYRTT  324 (376)
Q Consensus       319 ~~y~~~  324 (376)
                      +...+.
T Consensus       221 ~g~~pf  226 (371)
T 2xrw_A          221 KGGVLF  226 (371)
T ss_dssp             HSSCSS
T ss_pred             hCCCCC
Confidence            664443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7.4e-35  Score=272.55  Aligned_cols=205  Identities=25%  Similarity=0.267  Sum_probs=161.4

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-ChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|.+...    .+..++..||+|.+... .......+.+|+.+++.++||||+++++++.+
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGM----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCC----CCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            46799999999999999999975431    13346889999999754 33445678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC---CCcE
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPS---IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG---VGFL  240 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~---~g~~  240 (376)
                      .+..|+||||+++|+|.+++......   ...+++..++.++.|++.||.|||  .++|+||||||+|||++.   ++.+
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH--~~~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh--hCCeecCcCCHhHEEEecCCCcceE
Confidence            99999999999999999999875421   134889999999999999999999  599999999999999984   4469


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ||+|||++............ +..    .||+.|+               +||++.+.. .+.++||||+|++++++++
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~-~~~----~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~ellt  240 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKG-GCA----MLPVKWM---------------PPEAFMEGI-FTSKTDTWSFGVLLWEIFS  240 (327)
T ss_dssp             EECCCHHHHHHHC------C-CGG----GSCGGGC---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             EECccccccccccccccccC-CCc----CCCccee---------------CHhHhcCCC-CCchhhHHHHHHHHHHHHc
Confidence            99999999866443322111 111    5677788               899887654 5889999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.5e-35  Score=286.79  Aligned_cols=200  Identities=18%  Similarity=0.223  Sum_probs=157.6

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--------hhHHHHHHHHHHHhcCCCCC
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--------QGFEEWQSEVNFLGRLSHPN  156 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~h~n  156 (376)
                      ....++|.+.+.||+|+||.||+|...         .+++.||+|++.....        .....+.+|+.+|++++|||
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  201 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFER---------KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC  201 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTT
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEEC---------CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCC
Confidence            345678999999999999999999554         3688999999865321        11235789999999999999


Q ss_pred             cceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC
Q 017177          157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG  236 (376)
Q Consensus       157 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~  236 (376)
                      |+++++++. .+..|+||||+++|+|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.
T Consensus       202 iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH--~~~ivHrDlkp~NIll~~  274 (419)
T 3i6u_A          202 IIKIKNFFD-AEDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSS  274 (419)
T ss_dssp             BCCCCEEEE-SSEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESS
T ss_pred             EeeEEEEEe-cCceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEec
Confidence            999999875 55689999999999999988654    45899999999999999999999  589999999999999965


Q ss_pred             CC---cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh--hhhcccccccccee
Q 017177          237 VG---FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW--IKYLTLLKYSNSFA  311 (376)
Q Consensus       237 ~g---~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~--~~~~~~~~dv~s~g  311 (376)
                      ++   .+||+|||+++.........    +    ..||+.|+               |||++.+  ...++.++|+||+|
T Consensus       275 ~~~~~~~kl~DFG~a~~~~~~~~~~----~----~~gt~~y~---------------aPE~~~~~~~~~~~~~~DiwslG  331 (419)
T 3i6u_A          275 QEEDCLIKITDFGHSKILGETSLMR----T----LCGTPTYL---------------APEVLVSVGTAGYNRAVDCWSLG  331 (419)
T ss_dssp             SSSSCCEEECCSSTTTSCC-------------------CTTC---------------CTTTTC----CTTHHHHHHHHHH
T ss_pred             CCCcceEEEeecccceecCCCcccc----c----cCCCCCcc---------------CceeeecCCCCCCCchhhhHhHH
Confidence            44   59999999998765433221    1    27888888               7997753  34567899999999


Q ss_pred             eeehhhcccccc
Q 017177          312 FVFSCVFSFYRT  323 (376)
Q Consensus       312 ~v~~~~~~~y~~  323 (376)
                      ++++++++-+.+
T Consensus       332 ~il~~lltg~~p  343 (419)
T 3i6u_A          332 VILFICLSGYPP  343 (419)
T ss_dssp             HHHHHHHHSSCS
T ss_pred             HHHHHHHHCCCC
Confidence            999999865444

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=8.5e-35  Score=272.18  Aligned_cols=191  Identities=15%  Similarity=0.167  Sum_probs=164.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|...         .+++.||+|+++...   .+.+.+|+.+++.++ ||||+++++++.+
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~  102 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINI---------TNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKD  102 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             CCceEEEEEecccCCeEEEEEEEC---------CCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence            467999999999999999999543         358899999998644   356789999999998 9999999999988


Q ss_pred             --CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC-cEEEc
Q 017177          167 --DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG-FLFDS  243 (376)
Q Consensus       167 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g-~~kl~  243 (376)
                        ....++||||+++++|.+++.       .+++..+..++.|++.||.|||  .++|+||||||+|||++.++ .+||+
T Consensus       103 ~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~~kl~  173 (330)
T 3nsz_A          103 PVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLI  173 (330)
T ss_dssp             TTTCCEEEEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             CCCCceEEEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEEcCCCCEEEEE
Confidence              567999999999999999883       3789999999999999999999  59999999999999999777 89999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      |||+++...........        .||+.|+               +||++.+....+.++||||+|++++++++...
T Consensus       174 Dfg~a~~~~~~~~~~~~--------~~~~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~  229 (330)
T 3nsz_A          174 DWGLAEFYHPGQEYNVR--------VASRYFK---------------GPELLVDYQMYDYSLDMWSLGCMLASMIFRKE  229 (330)
T ss_dssp             CCTTCEECCTTCCCCSC--------CSCGGGC---------------CHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             eCCCceEcCCCCccccc--------ccccccc---------------ChhhhcCCCcCCchhhHHHHHHHHHHHHhCCC
Confidence            99999877554332111        6777787               89998887778999999999999999985443

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.3e-35  Score=278.90  Aligned_cols=187  Identities=18%  Similarity=0.152  Sum_probs=150.8

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--------hhhHHHHHHHHHHHhcCC------
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--------MQGFEEWQSEVNFLGRLS------  153 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~il~~l~------  153 (376)
                      .++|++.+.||+|+||.||+|++           +++.||||+++...        ....+.+.+|+.+++.++      
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-----------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~   87 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV   87 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-----------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCS
T ss_pred             cccchheeeecccCceEEEEEEe-----------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccc
Confidence            45799999999999999999965           27889999997642        123467889999998886      


Q ss_pred             ---CCCcceEEeEEE-----------------e-------------CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHH
Q 017177          154 ---HPNLVKLLGYCW-----------------E-------------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDI  200 (376)
Q Consensus       154 ---h~nIv~l~~~~~-----------------~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~  200 (376)
                         ||||+++.+++.                 +             .+.+|+|||||++|++.+.+.+     ..+++..
T Consensus        88 ~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~  162 (336)
T 2vuw_A           88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLAT  162 (336)
T ss_dssp             SSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHH
T ss_pred             cccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHH
Confidence               777777666543                 2             6789999999999977666643     3479999


Q ss_pred             HHHHHHHHHHHHHHhh-cCCCCcEecCCCCCCEEEcCCC--------------------cEEEcceeeeeeeccceeeEE
Q 017177          201 RLKIAIGAARGLGFLH-TSEKKVIYRDFKASNILLDGVG--------------------FLFDSHLLIYVYFKRHYIYIY  259 (376)
Q Consensus       201 ~~~i~~qi~~~L~yLH-s~~~~iiHrDlKp~NILl~~~g--------------------~~kl~Dfg~a~~~~~~~~~~~  259 (376)
                      ++.++.||+.||.||| +  ++|+||||||+|||++.+|                    .+||+|||+++.....     
T Consensus       163 ~~~i~~qi~~aL~~lH~~--~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----  235 (336)
T 2vuw_A          163 AKSILHQLTASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----  235 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHH--HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----
T ss_pred             HHHHHHHHHHHHHHHHHh--CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----
Confidence            9999999999999999 6  8999999999999999887                    8999999999976542     


Q ss_pred             EeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeee-ehhhcccc
Q 017177          260 IHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFV-FSCVFSFY  321 (376)
Q Consensus       260 ~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v-~~~~~~~y  321 (376)
                         +    .+||+.||               |||++.+..  +.++||||++.+ ..++...+
T Consensus       236 ---~----~~gt~~y~---------------aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~  274 (336)
T 2vuw_A          236 ---I----VVFCDVSM---------------DEDLFTGDG--DYQFDIYRLMKKENNNRWGEY  274 (336)
T ss_dssp             ---E----EECCCCTT---------------CSGGGCCCS--SHHHHHHHHHHHHHTTCTTSC
T ss_pred             ---c----EEEeeccc---------------ChhhhcCCC--ccceehhhhhCCCCccccccc
Confidence               1    17889999               899888765  789999998655 44444333

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.2e-34  Score=265.78  Aligned_cols=195  Identities=25%  Similarity=0.429  Sum_probs=161.1

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhh-------HHHHHHHHHHHhcCCCCCcceE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-------FEEWQSEVNFLGRLSHPNLVKL  160 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~il~~l~h~nIv~l  160 (376)
                      .++|++.+.||+|+||.||+|.+.         .+++.||+|++.......       .+.+.+|+.+++.++||||+++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   88 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLV---------KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL   88 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEET---------TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCE
T ss_pred             hccceehhccccCCceeEEEEEEc---------CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhh
Confidence            467999999999999999999654         358899999987643211       1678899999999999999999


Q ss_pred             EeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--cEecCCCCCCEEEcCCC
Q 017177          161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK--VIYRDFKASNILLDGVG  238 (376)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~--iiHrDlKp~NILl~~~g  238 (376)
                      ++++.+..  ++||||+++|+|.+++.+..   ..+++..+..++.|++.||.|||  .++  |+||||||+|||++.++
T Consensus        89 ~~~~~~~~--~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH--~~~~~ivH~dikp~Nil~~~~~  161 (287)
T 4f0f_A           89 YGLMHNPP--RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQ--NQNPPIVHRDLRSPNIFLQSLD  161 (287)
T ss_dssp             EEEETTTT--EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHH--TSSSCCBCSCCSGGGEEESCCC
T ss_pred             heeecCCC--eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHH--hCCCCeecCCCCcceEEEeccC
Confidence            99986554  79999999999999886652   46899999999999999999999  578  99999999999998877


Q ss_pred             c-----EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh-hhhccccccccceee
Q 017177          239 F-----LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW-IKYLTLLKYSNSFAF  312 (376)
Q Consensus       239 ~-----~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~-~~~~~~~~dv~s~g~  312 (376)
                      .     +||+|||+++.......     .     ..||+.|+               +||++.+ ....+.++|+||+|+
T Consensus       162 ~~~~~~~kl~Dfg~~~~~~~~~~-----~-----~~g~~~y~---------------aPE~~~~~~~~~~~~~Di~slG~  216 (287)
T 4f0f_A          162 ENAPVCAKVADFGLSQQSVHSVS-----G-----LLGNFQWM---------------APETIGAEEESYTEKADTYSFAM  216 (287)
T ss_dssp             TTCSCCEEECCCTTCBCCSSCEE-----C-----CCCCCTTS---------------CGGGSSCSSCEECHHHHHHHHHH
T ss_pred             CCCceeEEeCCCCcccccccccc-----c-----cCCCcccc---------------CchhhccCCCCcCchhhHHHHHH
Confidence            6     99999999986544211     1     16788888               8997743 344578999999999


Q ss_pred             eehhhcccccc
Q 017177          313 VFSCVFSFYRT  323 (376)
Q Consensus       313 v~~~~~~~y~~  323 (376)
                      +++++++...+
T Consensus       217 ~l~~l~~g~~p  227 (287)
T 4f0f_A          217 ILYTILTGEGP  227 (287)
T ss_dssp             HHHHHHHSSCT
T ss_pred             HHHHHHcCCCC
Confidence            99999965443

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=6.6e-35  Score=277.43  Aligned_cols=196  Identities=21%  Similarity=0.218  Sum_probs=150.4

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||||++...  .....+.+.+|+.+++.++||||+++++++
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~   97 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDT---------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   97 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEET---------TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             CCCceEEeeEEeecCCeEEEEEEEC---------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            4578999999999999999999543         46899999999764  334457788999999999999999999998


Q ss_pred             EeC------CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          165 WED------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       165 ~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      ...      ...|+|||++ +++|.+++..     ..+++..+..++.||+.||.|||  ..+|+||||||+|||++.++
T Consensus        98 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~  169 (367)
T 2fst_X           98 TPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDC  169 (367)
T ss_dssp             CSCSSGGGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTC
T ss_pred             ecCCccccCCeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHhhEEECCCC
Confidence            754      5689999999 6799988854     34899999999999999999999  59999999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .+||+|||+++.......          ...||+.|+               |||++.+...++.++||||+|+++++++
T Consensus       170 ~~kL~DFG~a~~~~~~~~----------~~~~t~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~ell  224 (367)
T 2fst_X          170 ELKILDFGLARHTADEMT----------GYVATRWYR---------------APEIMLNWMHYNQTVDIWSVGCIMAELL  224 (367)
T ss_dssp             CEEECC-------------------------CCCTTC---------------CHHHHTTCCSCCTTHHHHHHHHHHHHHH
T ss_pred             CEEEeeccccccccccCC----------CcCcCcCcc---------------ChHHHcCCcCCCchhhHHHHHHHHHHHH
Confidence            999999999987543211          127888888               8999888677789999999999999999


Q ss_pred             cccccc
Q 017177          319 SFYRTT  324 (376)
Q Consensus       319 ~~y~~~  324 (376)
                      +...+.
T Consensus       225 ~g~~pf  230 (367)
T 2fst_X          225 TGRTLF  230 (367)
T ss_dssp             HSSCSC
T ss_pred             hCCCCC
Confidence            754443

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.2e-35  Score=280.81  Aligned_cols=204  Identities=19%  Similarity=0.243  Sum_probs=151.9

Q ss_pred             CCCCc-cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe-
Q 017177           89 KNFKP-DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE-  166 (376)
Q Consensus        89 ~~y~~-~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-  166 (376)
                      +.|++ +++||+|+||.||+|...+       ..+++.||+|++......  ..+.+|+.+|+.++||||+++++++.. 
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~-------~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~   90 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKD-------GKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSH   90 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESS-------SSCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEcc-------CCCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence            34655 5689999999999997542       124788999999865432  467899999999999999999999965 


Q ss_pred             -CCeEEEEEeccCCCCHHHHHhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE----cC
Q 017177          167 -DKELLLVYEYMQRGSLENHLFRRN-----PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL----DG  236 (376)
Q Consensus       167 -~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl----~~  236 (376)
                       +..+|+||||+++ +|.+++....     .....+++..++.++.||+.||.|||  .++|+||||||+||||    +.
T Consensus        91 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivH~Dlkp~NIll~~~~~~  167 (405)
T 3rgf_A           91 ADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPE  167 (405)
T ss_dssp             TTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECCSSTT
T ss_pred             CCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCEeCCCcCHHHeEEecCCCC
Confidence             6789999999965 8888876321     11234899999999999999999999  5999999999999999    77


Q ss_pred             CCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehh
Q 017177          237 VGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSC  316 (376)
Q Consensus       237 ~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~  316 (376)
                      ++.+||+|||+++.............+    .+||+.|+               |||++.+...++.++||||+|+++++
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~----~~gt~~y~---------------aPE~~~~~~~~~~~~DiwSlG~il~e  228 (405)
T 3rgf_A          168 RGRVKIADMGFARLFNSPLKPLADLDP----VVVTFWYR---------------APELLLGARHYTKAIDIWAIGCIFAE  228 (405)
T ss_dssp             TTCEEECCTTCCC--------------------CCCTTC---------------CHHHHTTCCSCCHHHHHHHHHHHHHH
T ss_pred             CCcEEEEECCCceecCCCCcccccCCC----ceecCccc---------------CchhhcCCCcccchhhhHHHHHHHHH
Confidence            899999999999987543222111122    27888898               89999887778999999999999999


Q ss_pred             hcccccc
Q 017177          317 VFSFYRT  323 (376)
Q Consensus       317 ~~~~y~~  323 (376)
                      +++...+
T Consensus       229 ll~g~~p  235 (405)
T 3rgf_A          229 LLTSEPI  235 (405)
T ss_dssp             HHHSSCT
T ss_pred             HHhCCCC
Confidence            9965443

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-34  Score=267.39  Aligned_cols=199  Identities=22%  Similarity=0.261  Sum_probs=162.6

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      .|++.+.||+|+||.||+|.+...      ...+..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   95 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQ------AQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE   95 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECS------SSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred             EEccCceeccCCCceEEEEEEecC------CCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence            466779999999999999976431      22355799999986533 45678899999999999999999999998766


Q ss_pred             eE-EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          169 EL-LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       169 ~~-~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      .. ++||||+.+|+|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+|||+
T Consensus        96 ~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dikp~Nili~~~~~~kl~Dfg~  170 (298)
T 3pls_A           96 GLPHVLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLA--EQKFVHRDLAARNCMLDESFTVKVADFGL  170 (298)
T ss_dssp             SCCEEEECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred             CCcEEEEecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCCCcEEeCcCCC
Confidence            54 99999999999999997642   55889999999999999999999  58999999999999999999999999999


Q ss_pred             eeeeccceeeE-EEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          248 YVYFKRHYIYI-YIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       248 a~~~~~~~~~~-~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      ++......... .....    ..+|+.|+               +||++.+.. .+.++|+||+|++++++++
T Consensus       171 ~~~~~~~~~~~~~~~~~----~~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~l~~  223 (298)
T 3pls_A          171 ARDILDREYYSVQQHRH----ARLPVKWT---------------ALESLQTYR-FTTKSDVWSFGVLLWELLT  223 (298)
T ss_dssp             SCTTTTGGGGCSCCSSC----TTCGGGGS---------------CHHHHTTCC-CCHHHHHHHHHHHHHHHHH
T ss_pred             cccccCCcccccccCcC----CCCCcccc---------------ChhhhccCC-CChhhchhhHHHHHHHHhh
Confidence            98664432211 01111    15667777               899887654 5789999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-34  Score=267.89  Aligned_cols=194  Identities=27%  Similarity=0.374  Sum_probs=155.4

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|++.+.||+|+||.||+|.+.           ++.||+|.+....  ..+.+.+|+.++++++||||+++++++.  
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~--   71 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-----------AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL--   71 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT--
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-----------CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc--
Confidence            356899999999999999999654           5679999997543  3467899999999999999999999876  


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCcEecCCCCCCEEEcCCCc-EEEcce
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSE-KKVIYRDFKASNILLDGVGF-LFDSHL  245 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~-~~iiHrDlKp~NILl~~~g~-~kl~Df  245 (376)
                      +..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.. ++|+||||||+|||++.++. +||+||
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Df  150 (307)
T 2eva_A           72 NPVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF  150 (307)
T ss_dssp             TTTEEEEECCTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCC
T ss_pred             CCcEEEEEcCCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccc
Confidence            458999999999999999976532 234788999999999999999999411 78999999999999998887 799999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |++.........          ..||+.|+               |||++.+.. .+.++||||+|++++++++...+
T Consensus       151 g~~~~~~~~~~~----------~~gt~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p  202 (307)
T 2eva_A          151 GTACDIQTHMTN----------NKGSAAWM---------------APEVFEGSN-YSEKCDVFSWGIILWEVITRRKP  202 (307)
T ss_dssp             CC----------------------CCTTSS---------------CHHHHTCCC-CCTHHHHHHHHHHHHHHHHTCCT
T ss_pred             cccccccccccc----------CCCCCceE---------------ChhhhCCCC-CCcHHHHHHHHHHHHHHHHCCCC
Confidence            999865432111          16788888               899887654 58899999999999999965444

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.5e-35  Score=271.47  Aligned_cols=211  Identities=25%  Similarity=0.213  Sum_probs=166.2

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|++........+.+.+|+.+++.++||||+++++++..
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   97 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGL---------HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLR   97 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEET---------TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEec---------CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence            3467999999999999999999543         3588999999877666667889999999999999999999999873


Q ss_pred             ----CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          167 ----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       167 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                          ....++||||+++|+|.+++.........+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||
T Consensus        98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~dlkp~NIl~~~~~~~kl  175 (317)
T 2buj_A           98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--AKGYAHRDLKPTNILLGDEGQPVL  175 (317)
T ss_dssp             EETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEE
T ss_pred             ccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEcCCCCEEE
Confidence                34789999999999999999874333467899999999999999999999  589999999999999999999999


Q ss_pred             cceeeeeeeccceeeEEEeee--EEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhh--hccccccccceeeeehhhc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTY--IIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIK--YLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~--~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~--~~~~~~dv~s~g~v~~~~~  318 (376)
                      +|||++...............  ......||+.|+               +||++.+..  ..+.++||||+|+++++++
T Consensus       176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~---------------aPE~~~~~~~~~~~~~~Di~slG~il~el~  240 (317)
T 2buj_A          176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR---------------APELFSVQSHCVIDERTDVWSLGCVLYAMM  240 (317)
T ss_dssp             CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGC---------------CGGGSSCCSEEEECTHHHHHHHHHHHHHHH
T ss_pred             EecCcchhcccccccccccccccccccccCCcccC---------------CHhHhccCCCcCCCchhhHHHHHHHHHHHH
Confidence            999998865432110000000  000003456666               899876543  3578999999999999999


Q ss_pred             ccccc
Q 017177          319 SFYRT  323 (376)
Q Consensus       319 ~~y~~  323 (376)
                      +...+
T Consensus       241 ~g~~p  245 (317)
T 2buj_A          241 FGEGP  245 (317)
T ss_dssp             HSSCT
T ss_pred             hCCCC
Confidence            66544

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=6.9e-35  Score=290.56  Aligned_cols=196  Identities=22%  Similarity=0.318  Sum_probs=163.0

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ...++|++.+.||+|+||.||+|.+..          +..||||+++.... ..+.+.+|+.+|+.++||||+++++++.
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~  332 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS  332 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT----------TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECC----------CceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            445678889999999999999997653          46799999987543 3467899999999999999999999886


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      + +.+||||||+++|+|.+++.....  ..+++..++.++.||+.||.|||  .++|+||||||+|||++.++.+||+||
T Consensus       333 ~-~~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~kl~DF  407 (535)
T 2h8h_A          333 E-EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADF  407 (535)
T ss_dssp             S-SSCEEEECCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCT
T ss_pred             e-ccceEeeehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHhhEEEcCCCcEEEccc
Confidence            5 679999999999999999975421  34889999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      |+++......... ..+.     .+++.|+               |||++.+.. ++.++||||||++++|+++
T Consensus       408 G~a~~~~~~~~~~-~~~~-----~~~~~y~---------------aPE~~~~~~-~~~~sDvwSlGv~l~el~t  459 (535)
T 2h8h_A          408 GLARLIEDNEYTA-RQGA-----KFPIKWT---------------APEAALYGR-FTIKSDVWSFGILLTELTT  459 (535)
T ss_dssp             TSTTTCCCHHHHT-TCST-----TSCGGGS---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHTT
T ss_pred             ccceecCCCceec-ccCC-----cCccccc---------------CHHHhccCC-CCchhhHHHHHHHHHHHHh
Confidence            9998765432110 1111     4456676               899887654 5889999999999999987

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.9e-35  Score=270.02  Aligned_cols=201  Identities=23%  Similarity=0.227  Sum_probs=159.4

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEE-
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW-  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~-  165 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|++........+.+.+|+.+++.++||||+++++++. 
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   79 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDN---------DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGP   79 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEET---------TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECT
T ss_pred             cCCceeEEEEeccCCCeEEEEEEEC---------CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccc
Confidence            4578999999999999999999554         358899999998777677788999999999999999999999873 


Q ss_pred             -------------eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCE
Q 017177          166 -------------EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI  232 (376)
Q Consensus       166 -------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NI  232 (376)
                                   +.+..++||||++ |+|.+++..     ..+++..+..++.|++.||.|||  .++|+||||||+||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Ni  151 (320)
T 2i6l_A           80 SGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIH--SANVLHRDLKPANL  151 (320)
T ss_dssp             TSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGE
T ss_pred             cccccccccccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHE
Confidence                         3467999999997 599999854     34889999999999999999999  59999999999999


Q ss_pred             EEc-CCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcccccccccee
Q 017177          233 LLD-GVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFA  311 (376)
Q Consensus       233 Ll~-~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g  311 (376)
                      |++ .++.+||+|||+++...............    .||+.|+               +||++.+....+.++|+||+|
T Consensus       152 l~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~----~~~~~y~---------------aPE~~~~~~~~~~~~Di~slG  212 (320)
T 2i6l_A          152 FINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG----LVTKWYR---------------SPRLLLSPNNYTKAIDMWAAG  212 (320)
T ss_dssp             EEETTTTEEEECCCTTCBCC--------CCCGG----GSCCTTC---------------CHHHHHCTTCCCHHHHHHHHH
T ss_pred             EEcCCCCeEEEccCccccccCCCcccccccccc----ccccccc---------------CcHHhcCcccCCchhhhHhHH
Confidence            997 56799999999998765432221111111    5577777               899887766778999999999


Q ss_pred             eeehhhcccccc
Q 017177          312 FVFSCVFSFYRT  323 (376)
Q Consensus       312 ~v~~~~~~~y~~  323 (376)
                      ++++++++...+
T Consensus       213 ~il~el~~g~~p  224 (320)
T 2i6l_A          213 CIFAEMLTGKTL  224 (320)
T ss_dssp             HHHHHHHHSSCS
T ss_pred             HHHHHHHhCCCC
Confidence            999999965433

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.5e-34  Score=274.11  Aligned_cols=205  Identities=21%  Similarity=0.198  Sum_probs=162.6

Q ss_pred             hhhhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-----------hhHHHHHHHHHHH
Q 017177           81 FLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-----------QGFEEWQSEVNFL  149 (376)
Q Consensus        81 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~il  149 (376)
                      ..++....++|++.+.||+|+||.||+|...          .+..||||++.....           ...+.+.+|+.++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   83 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS----------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL   83 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECT----------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHH
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECC----------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHH
Confidence            4456777899999999999999999999543          288999999865321           1236789999999


Q ss_pred             hcCCCCCcceEEeEEEeC-----CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEe
Q 017177          150 GRLSHPNLVKLLGYCWED-----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIY  224 (376)
Q Consensus       150 ~~l~h~nIv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiH  224 (376)
                      +.++||||+++++++...     ..+|+||||++ |+|.+++...   ...+++..+..++.||+.||.|||  .++|+|
T Consensus        84 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH  157 (362)
T 3pg1_A           84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLH--EAGVVH  157 (362)
T ss_dssp             HHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHH--HTTCCC
T ss_pred             HhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH--HCcCEe
Confidence            999999999999998543     36899999997 5888888754   246899999999999999999999  589999


Q ss_pred             cCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcccc
Q 017177          225 RDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLL  304 (376)
Q Consensus       225 rDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~  304 (376)
                      |||||+|||++.++.+||+|||++...........        ..||+.|+               |||++.+....+.+
T Consensus       158 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~--------~~~t~~y~---------------aPE~~~~~~~~~~~  214 (362)
T 3pg1_A          158 RDLHPGNILLADNNDITICDFNLAREDTADANKTH--------YVTHRWYR---------------APELVMQFKGFTKL  214 (362)
T ss_dssp             CCCCGGGEEECTTCCEEECCTTC-----------------------CGGGC---------------CHHHHTTCTTCCTH
T ss_pred             cCCChHHEEEcCCCCEEEEecCcccccccccccce--------ecccceec---------------CcHHhcCCCCCCcH
Confidence            99999999999999999999999986544332211        26778888               89998886778999


Q ss_pred             ccccceeeeehhhccccccc
Q 017177          305 KYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       305 ~dv~s~g~v~~~~~~~y~~~  324 (376)
                      +||||+|++++++++...+.
T Consensus       215 ~DiwslG~il~~l~~g~~pf  234 (362)
T 3pg1_A          215 VDMWSAGCVMAEMFNRKALF  234 (362)
T ss_dssp             HHHHHHHHHHHHHHHSSCSC
T ss_pred             hHHHhHHHHHHHHHhCCCCC
Confidence            99999999999998654443

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.7e-35  Score=279.08  Aligned_cols=208  Identities=13%  Similarity=0.030  Sum_probs=160.6

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhh-----------HHHHHHHHHHHhcCCCCC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-----------FEEWQSEVNFLGRLSHPN  156 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~il~~l~h~n  156 (376)
                      .++|++.+.||+|+||.||+|.....      ..++..+|+|++.......           ...+.+|+.+++.++|||
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n  109 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNK------PEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG  109 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSS------CGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCC------CCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence            46799999999999999999976531      1247789999987653211           124668899999999999


Q ss_pred             cceEEeEEEe----CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCE
Q 017177          157 LVKLLGYCWE----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI  232 (376)
Q Consensus       157 Iv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NI  232 (376)
                      |+++++++..    ....|+||||+ +++|.+++...    ..+++..++.++.||+.||.|||  .++|+||||||+||
T Consensus       110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NI  182 (345)
T 2v62_A          110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIH--ENEYVHGDIKAANL  182 (345)
T ss_dssp             CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGE
T ss_pred             cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCcCHHHE
Confidence            9999999988    67899999999 99999999765    36899999999999999999999  58999999999999


Q ss_pred             EEcCCC--cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccce
Q 017177          233 LLDGVG--FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSF  310 (376)
Q Consensus       233 Ll~~~g--~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~  310 (376)
                      |++.++  .+||+|||+++.+..................||+.|+               |||++.+. .++.++||||+
T Consensus       183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~---------------aPE~~~~~-~~~~~~Di~sl  246 (345)
T 2v62_A          183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFT---------------SLDAHKGV-ALSRRSDVEIL  246 (345)
T ss_dssp             EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTC---------------CHHHHHTC-CCCHHHHHHHH
T ss_pred             EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCcccc---------------CHHHhcCC-CCCchhhHHHH
Confidence            999887  9999999999887544322111111111126888888               89988775 45899999999


Q ss_pred             eeeehhhccccccc
Q 017177          311 AFVFSCVFSFYRTT  324 (376)
Q Consensus       311 g~v~~~~~~~y~~~  324 (376)
                      |++++++++...+.
T Consensus       247 G~il~ell~g~~pf  260 (345)
T 2v62_A          247 GYCMLRWLCGKLPW  260 (345)
T ss_dssp             HHHHHHHHHSSCTT
T ss_pred             HHHHHHHHhCCCCc
Confidence            99999999654443

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.2e-34  Score=268.92  Aligned_cols=198  Identities=23%  Similarity=0.306  Sum_probs=154.7

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHH--HhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF--LGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~i--l~~l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|...           ++.||||++.....   ..+..|.++  +..++||||+++++.+
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~   76 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSLD-----------ERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGD   76 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEEC-----------CeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecc
Confidence            3578999999999999999999553           77899999975432   333444444  5558899999999865


Q ss_pred             Ee-----CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC---------CcEecCCCCC
Q 017177          165 WE-----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEK---------KVIYRDFKAS  230 (376)
Q Consensus       165 ~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~---------~iiHrDlKp~  230 (376)
                      ..     ...+++||||+++|+|.+++...     ..++..+..++.||+.||.|||  ..         +|+||||||+
T Consensus        77 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH--~~~~~~~~~~~~ivH~Dikp~  149 (336)
T 3g2f_A           77 ERVTADGRMEYLLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLH--TELPRGDHYKPAISHRDLNSR  149 (336)
T ss_dssp             EEECTTSCEEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHH--CCBCCGGGCBCCEECSSCSGG
T ss_pred             cccccCCCceEEEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHH--hhhccccccccceeecccccc
Confidence            43     23579999999999999999764     2588999999999999999999  47         9999999999


Q ss_pred             CEEEcCCCcEEEcceeeeeeeccceeeEE-EeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh------hhccc
Q 017177          231 NILLDGVGFLFDSHLLIYVYFKRHYIYIY-IHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI------KYLTL  303 (376)
Q Consensus       231 NILl~~~g~~kl~Dfg~a~~~~~~~~~~~-~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~------~~~~~  303 (376)
                      |||++.++.+||+|||+++.......... ..........||+.|+               |||++.+.      ...+.
T Consensus       150 Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~---------------aPE~~~~~~~~~~~~~~~~  214 (336)
T 3g2f_A          150 NVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYM---------------APEVLEGAVNLRDXESALK  214 (336)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGC---------------CHHHHTTCCCGGGHHHHHH
T ss_pred             eEEEcCCCcEEEeeccceeecccccccCccccccccccCCCcccee---------------CchhhcCCccccccccccc
Confidence            99999999999999999998754322110 0000111126888888               89988862      45678


Q ss_pred             cccccceeeeehhhccc
Q 017177          304 LKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       304 ~~dv~s~g~v~~~~~~~  320 (376)
                      ++||||+|++++++++.
T Consensus       215 ~~DiwslG~il~ell~g  231 (336)
T 3g2f_A          215 QVDMYALGLIYWEIFMR  231 (336)
T ss_dssp             HHHHHHHHHHHHHHHTT
T ss_pred             ccchHHHHHHHHHHHhc
Confidence            99999999999999854

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.7e-34  Score=270.41  Aligned_cols=209  Identities=24%  Similarity=0.254  Sum_probs=154.6

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~  165 (376)
                      ...+|++.+.||+|+||.||+|.+.         .+++.||+|++........+.+.+|+.+++++. ||||+++++++.
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~   96 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDV---------GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS   96 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEET---------TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             cCceEEEEEEEccCCceEEEEEEEC---------CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence            3457999999999999999999554         358899999987766666678899999999996 999999999985


Q ss_pred             e--------CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--cEecCCCCCCEEEc
Q 017177          166 E--------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK--VIYRDFKASNILLD  235 (376)
Q Consensus       166 ~--------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~--iiHrDlKp~NILl~  235 (376)
                      .        ...+++||||+. |+|.+++..... ...+++..+..++.||+.||.|||  ..+  |+||||||+|||++
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH--~~~~~ivH~Dikp~NIl~~  172 (337)
T 3ll6_A           97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMH--RQKPPIIHRDLKVENLLLS  172 (337)
T ss_dssp             ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHH--TSSSCCBCCCCCGGGCEEC
T ss_pred             ccccccccCCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH--hCCCCEEEccCCcccEEEC
Confidence            3        345899999996 699998875322 245899999999999999999999  577  99999999999999


Q ss_pred             CCCcEEEcceeeeeeeccceeeEEEee-----eEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHh--hhhhcccccccc
Q 017177          236 GVGFLFDSHLLIYVYFKRHYIYIYIHT-----YIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYA--WIKYLTLLKYSN  308 (376)
Q Consensus       236 ~~g~~kl~Dfg~a~~~~~~~~~~~~~~-----~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~--~~~~~~~~~dv~  308 (376)
                      .++.+||+|||++..............     .......||+.|+               +||++.  .....+.++|||
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~---------------aPE~~~~~~~~~~~~~~Dv~  237 (337)
T 3ll6_A          173 NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYR---------------TPEIIDLYSNFPIGEKQDIW  237 (337)
T ss_dssp             TTSCEEBCCCTTCBCCSSCC----------------------------------------------CCTTSCSSHHHHHH
T ss_pred             CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcC---------------ChhhhhccccCCCChHHhHH
Confidence            999999999999998765433211100     0001125677777               899874  334567899999


Q ss_pred             ceeeeehhhcccccc
Q 017177          309 SFAFVFSCVFSFYRT  323 (376)
Q Consensus       309 s~g~v~~~~~~~y~~  323 (376)
                      |+|++++++++...+
T Consensus       238 slG~il~el~~g~~p  252 (337)
T 3ll6_A          238 ALGCILYLLCFRQHP  252 (337)
T ss_dssp             HHHHHHHHHHHSSCC
T ss_pred             HHHHHHHHHHhCCCC
Confidence            999999999865444

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5e-34  Score=276.90  Aligned_cols=197  Identities=20%  Similarity=0.249  Sum_probs=165.7

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcC------CCCCcceE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL------SHPNLVKL  160 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l------~h~nIv~l  160 (376)
                      ...+|++.+.||+|+||.||+|...         .+++.||||+++... ...+.+.+|+.+++.+      +|+||+++
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~---------~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~  164 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDH---------KVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHM  164 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEET---------TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEEC---------CCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence            4567999999999999999999544         368899999998653 3345677888888877      57799999


Q ss_pred             EeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc-
Q 017177          161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF-  239 (376)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~-  239 (376)
                      ++++...+.+++||||+. ++|.+++.....  ..+++..+..++.||+.||.|||  .++|+||||||+|||++.++. 
T Consensus       165 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlKp~NILl~~~~~~  239 (429)
T 3kvw_A          165 LENFTFRNHICMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALH--KNRIIHCDLKPENILLKQQGRS  239 (429)
T ss_dssp             EEEEEETTEEEEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHH--HHTEECSCCSGGGEEESSTTSC
T ss_pred             EeecccCCeEEEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEEccCCCc
Confidence            999999999999999996 599999987642  45899999999999999999999  589999999999999999987 


Q ss_pred             -EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          240 -LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       240 -~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                       +||+|||++........      +    .+||+.|+               |||++.+.. ++.++||||+|+++++++
T Consensus       240 ~vkL~DFG~a~~~~~~~~------~----~~gt~~y~---------------aPE~~~~~~-~~~~~DiwSlG~il~ell  293 (429)
T 3kvw_A          240 GIKVIDFGSSCYEHQRVY------T----YIQSRFYR---------------APEVILGAR-YGMPIDMWSLGCILAELL  293 (429)
T ss_dssp             CEEECCCTTCEETTCCCC------S----SCSCGGGC---------------CHHHHHTBC-CCTHHHHHHHHHHHHHHH
T ss_pred             ceEEeecccceecCCccc------c----cCCCCCcc---------------ChHHHhCCC-CCchHHHHhHHHHHHHHH
Confidence             99999999976543211      1    17888888               899888766 488999999999999999


Q ss_pred             cccccc
Q 017177          319 SFYRTT  324 (376)
Q Consensus       319 ~~y~~~  324 (376)
                      +.+.+.
T Consensus       294 tG~~pf  299 (429)
T 3kvw_A          294 TGYPLL  299 (429)
T ss_dssp             HSSCSS
T ss_pred             hCCCCC
Confidence            765443

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=7e-35  Score=272.12  Aligned_cols=198  Identities=18%  Similarity=0.213  Sum_probs=160.7

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--------hhHHHHHHHHHHHhcCCCCCcc
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--------QGFEEWQSEVNFLGRLSHPNLV  158 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~h~nIv  158 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||||++.....        .....+.+|+.+++.++||||+
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~   78 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFER---------KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII   78 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBC
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEc---------CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCc
Confidence            3467999999999999999999554         3588999999876432        1234578999999999999999


Q ss_pred             eEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          159 KLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       159 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      ++++++..++ .|+||||+++++|.+++...    ..+++..+..++.||+.||.|||  .++|+||||||+|||++.++
T Consensus        79 ~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~~  151 (322)
T 2ycf_A           79 KIKNFFDAED-YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQE  151 (322)
T ss_dssp             CEEEEEESSS-EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSS
T ss_pred             eEeeEEcCCc-eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEecCC
Confidence            9999987655 89999999999999998754    45899999999999999999999  59999999999999998766


Q ss_pred             c---EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh--hhhccccccccceeee
Q 017177          239 F---LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW--IKYLTLLKYSNSFAFV  313 (376)
Q Consensus       239 ~---~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~--~~~~~~~~dv~s~g~v  313 (376)
                      .   +||+|||++..........    +.    .||+.|+               +||++.+  ....+.++|+||+|++
T Consensus       152 ~~~~~kl~Dfg~~~~~~~~~~~~----~~----~gt~~y~---------------aPE~~~~~~~~~~~~~~Di~slG~i  208 (322)
T 2ycf_A          152 EDCLIKITDFGHSKILGETSLMR----TL----CGTPTYL---------------APEVLVSVGTAGYNRAVDCWSLGVI  208 (322)
T ss_dssp             SSCCEEECCCTTCEECCCCHHHH----HH----HSCCTTC---------------CHHHHHHTTTTTCTTHHHHHHHHHH
T ss_pred             CCCeEEEccCccceecccccccc----cc----cCCcCcc---------------CchhhccCCCCCCCchhhHHHHHHH
Confidence            4   9999999998765432211    11    5677777               7998753  4556889999999999


Q ss_pred             ehhhcccccc
Q 017177          314 FSCVFSFYRT  323 (376)
Q Consensus       314 ~~~~~~~y~~  323 (376)
                      ++++++...+
T Consensus       209 l~~l~~g~~p  218 (322)
T 2ycf_A          209 LFICLSGYPP  218 (322)
T ss_dssp             HHHHHHSSCS
T ss_pred             HHHHHhCCCC
Confidence            9999865443

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.1e-34  Score=264.99  Aligned_cols=201  Identities=17%  Similarity=0.148  Sum_probs=157.6

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEE-E
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYC-W  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~-~  165 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|++......  ..+.+|+.+++.++|++++..+..+ .
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~   75 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDI---------AAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGA   75 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEET---------TTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEc---------CCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecC
Confidence            4578999999999999999999543         35889999986654322  3577899999999987766666554 6


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE---cCCCcEEE
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL---DGVGFLFD  242 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl---~~~g~~kl  242 (376)
                      ..+..++||||+ +++|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||+   +.++.+||
T Consensus        76 ~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIl~~~~~~~~~~kL  149 (296)
T 4hgt_A           76 EGDYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYI  149 (296)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECCGGGTTCEEE
T ss_pred             CCCceEEEEEcc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeeeeccCCCCeEEE
Confidence            678899999999 889999997542   45899999999999999999999  5999999999999999   78999999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      +|||+++....................||+.|+               +||++.+.. .+.++||||+|++++++++.
T Consensus       150 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~l~~g  211 (296)
T 4hgt_A          150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYA---------------SINTHLGIE-QSRRDDLESLGYVLMYFNLG  211 (296)
T ss_dssp             CCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGC---------------CHHHHTTCC-CCHHHHHHHHHHHHHHHHHS
T ss_pred             ecCccceeccCcccCccCCCCcccccCCCcccc---------------chHHhcCCC-CCchhHHHHHHHHHHHHhcC
Confidence            999999987654321100000011127888888               899887765 58899999999999999854

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.7e-34  Score=263.71  Aligned_cols=190  Identities=25%  Similarity=0.308  Sum_probs=154.1

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..++|++.+.||+|+||.||+|...           +..||+|+++...  ..+.+.+|+.+++.++||||+++++++.+
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE   85 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc-----------CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence            3567999999999999999999653           6789999998654  34678899999999999999999998765


Q ss_pred             C-CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          167 D-KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       167 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      . +..++||||+++++|.+++.+...  ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~Df  161 (278)
T 1byg_A           86 EKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDF  161 (278)
T ss_dssp             C--CCEEEECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             CCCceEEEEecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCcceEEEeCCCcEEEeec
Confidence            4 479999999999999999976521  23788999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      |++.........          ..+++.|+               +||++.+.. .+.++|+||+|++++++++
T Consensus       162 g~~~~~~~~~~~----------~~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~l~t  209 (278)
T 1byg_A          162 GLTKEASSTQDT----------GKLPVKWT---------------APEALREKK-FSTKSDVWSFGILLWEIYS  209 (278)
T ss_dssp             CC----------------------CCTTTS---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             cccccccccccC----------CCcccccc---------------CHHHhCCCC-CCchhcHHHHHHHHHHHHh
Confidence            999865432211          15567777               799877654 5789999999999999987

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.4e-34  Score=277.84  Aligned_cols=197  Identities=21%  Similarity=0.202  Sum_probs=157.5

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      ..+|++.+.||+|+||.||+|....          +..+|+|++.....    ...+|+.+++.++||||+++++++...
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~----------~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~  104 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVE----------SDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSN  104 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECC----------CCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEec
Confidence            3469999999999999999996653          33488887754432    123699999999999999999998654


Q ss_pred             C------eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc-CCCcE
Q 017177          168 K------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD-GVGFL  240 (376)
Q Consensus       168 ~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~-~~g~~  240 (376)
                      +      .+++||||+++ ++.+.+.........+++..+..++.||+.||.|||  .++|+||||||+|||++ .++.+
T Consensus       105 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~~  181 (394)
T 4e7w_A          105 GDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH--SIGICHRDIKPQNLLLDPPSGVL  181 (394)
T ss_dssp             SSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTTTEE
T ss_pred             CCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCCHHHEEEcCCCCcE
Confidence            3      38899999977 555444432222356899999999999999999999  59999999999999999 79999


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ||+|||+++..........        ..||+.|+               |||++.+...++.++||||+|++++++++.
T Consensus       182 kL~DFG~a~~~~~~~~~~~--------~~~t~~y~---------------aPE~~~~~~~~~~~~DiwSlG~il~ell~g  238 (394)
T 4e7w_A          182 KLIDFGSAKILIAGEPNVS--------YICSRYYR---------------APELIFGATNYTTNIDIWSTGCVMAELMQG  238 (394)
T ss_dssp             EECCCTTCEECCTTCCCCS--------SCSCGGGC---------------CHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred             EEeeCCCcccccCCCCCcc--------cccCcCcc---------------CHHHHcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            9999999998754433211        16788888               899998877789999999999999999965


Q ss_pred             cccc
Q 017177          321 YRTT  324 (376)
Q Consensus       321 y~~~  324 (376)
                      ..+.
T Consensus       239 ~~pf  242 (394)
T 4e7w_A          239 QPLF  242 (394)
T ss_dssp             SCSS
T ss_pred             CCCC
Confidence            4443

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-34  Score=266.26  Aligned_cols=201  Identities=20%  Similarity=0.228  Sum_probs=160.9

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh------hHHHHHHHHHHHhcC----CC
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ------GFEEWQSEVNFLGRL----SH  154 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l----~h  154 (376)
                      ....++|++.+.||+|+||.||+|..         ..+++.||+|+++.....      ....+.+|+.+++++    +|
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h   97 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHR---------LTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH   97 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEEC---------TTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCC
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEE---------ccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCC
Confidence            34567899999999999999999944         346889999999765331      223455799999998    89


Q ss_pred             CCcceEEeEEEeCCeEEEEEec-cCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEE
Q 017177          155 PNLVKLLGYCWEDKELLLVYEY-MQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL  233 (376)
Q Consensus       155 ~nIv~l~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NIL  233 (376)
                      |||+++++++...+..++|||+ +.+++|.+++.+.    ..+++..+..++.|++.||.|||  .++|+||||||+|||
T Consensus        98 ~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil  171 (312)
T 2iwi_A           98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCH--SRGVVHRDIKDENIL  171 (312)
T ss_dssp             SSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH--HHTEECCCCSGGGEE
T ss_pred             CCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChhhEE
Confidence            9999999999999999999999 7899999999876    45899999999999999999999  589999999999999


Q ss_pred             Ec-CCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceee
Q 017177          234 LD-GVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAF  312 (376)
Q Consensus       234 l~-~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~  312 (376)
                      ++ .++.+||+|||++.........     ..    .||+.|+               +||++.+..+.+.++|+||+|+
T Consensus       172 ~~~~~~~~kl~dfg~~~~~~~~~~~-----~~----~~~~~y~---------------aPE~~~~~~~~~~~~Di~slG~  227 (312)
T 2iwi_A          172 IDLRRGCAKLIDFGSGALLHDEPYT-----DF----DGTRVYS---------------PPEWISRHQYHALPATVWSLGI  227 (312)
T ss_dssp             EETTTTEEEECCCSSCEECCSSCBC-----CC----CSCTTTS---------------CHHHHHHSCBCHHHHHHHHHHH
T ss_pred             EeCCCCeEEEEEcchhhhcccCccc-----cc----CCccccc---------------CceeeecCCCCCccchHHHHHH
Confidence            99 8899999999999887653221     11    5778888               8998888777777999999999


Q ss_pred             eehhhccccccc
Q 017177          313 VFSCVFSFYRTT  324 (376)
Q Consensus       313 v~~~~~~~y~~~  324 (376)
                      +++++++...+.
T Consensus       228 il~~l~~g~~pf  239 (312)
T 2iwi_A          228 LLYDMVCGDIPF  239 (312)
T ss_dssp             HHHHHHHSSCSC
T ss_pred             HHHHHHHCCCCC
Confidence            999999765543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.5e-33  Score=261.66  Aligned_cols=198  Identities=24%  Similarity=0.294  Sum_probs=163.9

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhc--CCCCCcceEEe
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGR--LSHPNLVKLLG  162 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~h~nIv~l~~  162 (376)
                      ....++|++.+.||+|+||.||+|...           ++.||||++....   ...+.+|++++..  ++||||+++++
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~  103 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIA  103 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEE
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEEc-----------CccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEe
Confidence            345578999999999999999999653           7789999997543   3567788888887  68999999999


Q ss_pred             EEEeCC----eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCcEecCCCCCCE
Q 017177          163 YCWEDK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS------EKKVIYRDFKASNI  232 (376)
Q Consensus       163 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~------~~~iiHrDlKp~NI  232 (376)
                      ++...+    ..++||||+++|+|.+++.+.     .+++..+..++.|++.||.|||+.      ..+|+||||||+||
T Consensus       104 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NI  178 (342)
T 1b6c_B          104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI  178 (342)
T ss_dssp             EEECCCSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGE
T ss_pred             eecccCCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHE
Confidence            998876    799999999999999999653     489999999999999999999931      38999999999999


Q ss_pred             EEcCCCcEEEcceeeeeeeccceeeEE-EeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhh-----hcccccc
Q 017177          233 LLDGVGFLFDSHLLIYVYFKRHYIYIY-IHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIK-----YLTLLKY  306 (376)
Q Consensus       233 Ll~~~g~~kl~Dfg~a~~~~~~~~~~~-~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~-----~~~~~~d  306 (376)
                      |++.++.+||+|||++........... .....    .||+.|+               |||++.+..     ..+.++|
T Consensus       179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~----~gt~~y~---------------aPE~~~~~~~~~~~~~~~~~D  239 (342)
T 1b6c_B          179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR----VGTKRYM---------------APEVLDDSINMKHFESFKRAD  239 (342)
T ss_dssp             EECTTSCEEECCCTTCEEEETTTTEEEECCCSC----CCCGGGC---------------CHHHHTSCCCTTCHHHHHHHH
T ss_pred             EECCCCCEEEEECCCceeccccccccccccccC----CcCcccC---------------CHhhhcccccccccccCCccc
Confidence            999999999999999988765433211 11222    6888888               899887652     2347899


Q ss_pred             ccceeeeehhhccc
Q 017177          307 SNSFAFVFSCVFSF  320 (376)
Q Consensus       307 v~s~g~v~~~~~~~  320 (376)
                      |||+|++++++++.
T Consensus       240 i~slG~il~el~tg  253 (342)
T 1b6c_B          240 IYAMGLVFWEIARR  253 (342)
T ss_dssp             HHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHhc
Confidence            99999999999864

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.8e-34  Score=273.14  Aligned_cols=206  Identities=22%  Similarity=0.191  Sum_probs=155.9

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ....++|++.+.||+|+||.||+|...         .+++.||||++..... ......+|+..++.++||||+++++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~   88 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKEK---------STGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYF   88 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEET---------TTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhh
Confidence            445678999999999999999999554         3588999998865432 224556788888999999999999998


Q ss_pred             EeCCe-------EEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC-
Q 017177          165 WEDKE-------LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-  236 (376)
Q Consensus       165 ~~~~~-------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~-  236 (376)
                      ...+.       +++||||+++ +|.+.+.........+++..+..++.|++.||.|||.+.++|+||||||+|||++. 
T Consensus        89 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~  167 (360)
T 3e3p_A           89 YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA  167 (360)
T ss_dssp             EEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETT
T ss_pred             hccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCC
Confidence            76433       8999999976 66655544222235689999999999999999999955599999999999999996 


Q ss_pred             CCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehh
Q 017177          237 VGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSC  316 (376)
Q Consensus       237 ~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~  316 (376)
                      ++.+||+|||+++...........        .||+.|+               |||++.+....+.++||||+|+++++
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~~~~~~--------~gt~~y~---------------aPE~~~~~~~~~~~~Di~slG~il~e  224 (360)
T 3e3p_A          168 DGTLKLCDFGSAKKLSPSEPNVAY--------ICSRYYR---------------APELIFGNQHYTTAVDIWSVGCIFAE  224 (360)
T ss_dssp             TTEEEECCCTTCBCCCTTSCCCST--------TSCGGGC---------------CHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred             CCcEEEeeCCCceecCCCCCcccc--------cCCccee---------------CHHHHcCCCCCCcHHHHHHHHHHHHH
Confidence            899999999999977654332111        6778888               89998887778999999999999999


Q ss_pred             hccccccc
Q 017177          317 VFSFYRTT  324 (376)
Q Consensus       317 ~~~~y~~~  324 (376)
                      +++...+.
T Consensus       225 ll~g~~pf  232 (360)
T 3e3p_A          225 MMLGEPIF  232 (360)
T ss_dssp             HHHSSCSS
T ss_pred             HHhCCCCc
Confidence            99655443

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=8e-34  Score=263.80  Aligned_cols=205  Identities=17%  Similarity=0.201  Sum_probs=163.3

Q ss_pred             hhhhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCC--CCC
Q 017177           81 FLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLS--HPN  156 (376)
Q Consensus        81 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~--h~n  156 (376)
                      +..+....++|++.+.||+|+||.||+|...          +++.||+|++...  .....+.+.+|+.++++++  |||
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~   89 (313)
T 3cek_A           20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK   89 (313)
T ss_dssp             CCEEEETTEEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTT
T ss_pred             eeeeeeccceEEEEEEecCCCCEEEEEEEcC----------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCc
Confidence            3344455678999999999999999999543          2788999998654  3345678899999999997  599


Q ss_pred             cceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC
Q 017177          157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG  236 (376)
Q Consensus       157 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~  236 (376)
                      |+++++++..++..++||| +.+++|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++ 
T Consensus        90 iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIl~~-  161 (313)
T 3cek_A           90 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV-  161 (313)
T ss_dssp             BCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEE-
T ss_pred             eEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcccEEEE-
Confidence            9999999999999999999 5578999999875    45899999999999999999999  58999999999999997 


Q ss_pred             CCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh----------hhcccccc
Q 017177          237 VGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI----------KYLTLLKY  306 (376)
Q Consensus       237 ~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~----------~~~~~~~d  306 (376)
                      ++.+||+|||++............ .    ...||+.|+               |||++.+.          ...+.++|
T Consensus       162 ~~~~kL~Dfg~~~~~~~~~~~~~~-~----~~~gt~~y~---------------aPE~~~~~~~~~~~~~~~~~~~~~~D  221 (313)
T 3cek_A          162 DGMLKLIDFGIANQMQPDTTSVVK-D----SQVGTVNYM---------------PPEAIKDMSSSRENGKSKSKISPKSD  221 (313)
T ss_dssp             TTEEEECCCSSSCC-------------------CCGGGC---------------CHHHHTTCC----------CCCHHHH
T ss_pred             CCeEEEeeccccccccCccccccc-c----CCCCCCCcC---------------CHHHHhhcccccccccccccCCchHH
Confidence            489999999999876543322111 1    126888888               89988752          45678999


Q ss_pred             ccceeeeehhhcccccc
Q 017177          307 SNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       307 v~s~g~v~~~~~~~y~~  323 (376)
                      |||+|++++++++...+
T Consensus       222 i~slG~il~el~~g~~p  238 (313)
T 3cek_A          222 VWSLGCILYYMTYGKTP  238 (313)
T ss_dssp             HHHHHHHHHHHHHSSCT
T ss_pred             HHHHHHHHHHHHhCCCc
Confidence            99999999999865444

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.4e-34  Score=269.20  Aligned_cols=205  Identities=22%  Similarity=0.209  Sum_probs=165.2

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   79 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHK---------PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQR   79 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEEC---------CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeec
Confidence            4578999999999999999999554         358899999997543 334567889999999999999999999876


Q ss_pred             eC-----CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcE
Q 017177          166 ED-----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL  240 (376)
Q Consensus       166 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~  240 (376)
                      .+     ...++||||+. |+|.+++...     .+++..+..++.|++.||.|||  .++|+||||||+|||++.++.+
T Consensus        80 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~Dlkp~Nil~~~~~~~  151 (353)
T 2b9h_A           80 PDSFENFNEVYIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLH--GSNVIHRDLKPSNLLINSNCDL  151 (353)
T ss_dssp             CSCSTTCCCEEEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCE
T ss_pred             ccccCccceEEEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEEcCCCcE
Confidence            54     67999999997 5999988653     4899999999999999999999  5999999999999999999999


Q ss_pred             EEcceeeeeeeccceeeEEEe-e--eEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhh
Q 017177          241 FDSHLLIYVYFKRHYIYIYIH-T--YIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCV  317 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~-~--~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~  317 (376)
                      ||+|||++............. +  .......||+.|+               |||++.+....+.++|+||+|++++++
T Consensus       152 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~---------------aPE~~~~~~~~~~~~Di~slG~il~~l  216 (353)
T 2b9h_A          152 KVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR---------------APEVMLTSAKYSRAMDVWSCGCILAEL  216 (353)
T ss_dssp             EECCCTTCEECC----------------CCCCCCGGGC---------------CHHHHHSCCCCCHHHHHHHHHHHHHHH
T ss_pred             EEEecccccccccccccccCccccccchhhcccccccc---------------CCeeeccCCCccchhhHHHHHHHHHHH
Confidence            999999999875433221100 0  0011126788888               899887767778999999999999999


Q ss_pred             cccccc
Q 017177          318 FSFYRT  323 (376)
Q Consensus       318 ~~~y~~  323 (376)
                      ++...+
T Consensus       217 ~~g~~p  222 (353)
T 2b9h_A          217 FLRRPI  222 (353)
T ss_dssp             HHSSCS
T ss_pred             HhCCCC
Confidence            865444

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.9e-34  Score=262.16  Aligned_cols=203  Identities=17%  Similarity=0.140  Sum_probs=162.1

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEE-E
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYC-W  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~-~  165 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||+|++......  +.+.+|+.+++.++|++++..+..+ .
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~   75 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDI---------AAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGA   75 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEET---------TTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEc---------CCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccC
Confidence            3578999999999999999999543         35899999998765432  4578899999999987766655554 6


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE---cCCCcEEE
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL---DGVGFLFD  242 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl---~~~g~~kl  242 (376)
                      ..+..++||||+ +++|.+++....   ..+++..+..++.|++.||.|||  +++|+||||||+|||+   +.++.+||
T Consensus        76 ~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~~~~~~~kl  149 (296)
T 3uzp_A           76 EGDYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYI  149 (296)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECCGGGTTCEEE
T ss_pred             CCCceEEEEEec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHeEEecCCCCCeEEE
Confidence            678899999999 889999997542   45899999999999999999999  5999999999999999   58899999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      +|||++.....................||+.|+               +||++.+.. .+.++||||+|++++++++...
T Consensus       150 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~  213 (296)
T 3uzp_A          150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYA---------------SINTHLGIE-QSRRDDLESLGYVLMYFNLGSL  213 (296)
T ss_dssp             CCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTC---------------CHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSC
T ss_pred             eeCCCcccccccccccccccccccccccccccC---------------ChhhhcCCC-CCcchhhHHHHHHHHHHHhCCC
Confidence            999999987654331100000011127888888               899887765 5889999999999999986433

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.1e-35  Score=275.57  Aligned_cols=210  Identities=16%  Similarity=0.057  Sum_probs=161.9

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcce--------
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVK--------  159 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~--------  159 (376)
                      .++|++.+.||+|+||.||+|....... ......++.||+|++...     +.+.+|+.+++.++||||++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~-~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLT-CDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCcc-ccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            4689999999999999999997653100 000013788999998754     35678999999999999988        


Q ss_pred             -------EEeEEEe-CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCC
Q 017177          160 -------LLGYCWE-DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASN  231 (376)
Q Consensus       160 -------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~N  231 (376)
                             +++++.. ++..|+||||+ +++|.+++....  ...+++..+..++.||+.||.|||  .++|+||||||+|
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dikp~N  189 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLH--ENEYVHGNVTAEN  189 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCCGGG
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCHHH
Confidence                   6777766 67899999999 999999998642  245899999999999999999999  5899999999999


Q ss_pred             EEEcCCC--cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccc
Q 017177          232 ILLDGVG--FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNS  309 (376)
Q Consensus       232 ILl~~~g--~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s  309 (376)
                      ||++.++  .+||+|||+++.+..................||+.|+               +||++.+.. .+.++||||
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~---------------aPE~~~~~~-~~~~~Di~s  253 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI---------------SMDLHKGCG-PSRRSDLQS  253 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTC---------------CHHHHTTCC-CCHHHHHHH
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCcccc---------------CHHHHccCC-CCchhhHHH
Confidence            9999998  8999999999877654322110000001116788888               899887754 588999999


Q ss_pred             eeeeehhhccccccc
Q 017177          310 FAFVFSCVFSFYRTT  324 (376)
Q Consensus       310 ~g~v~~~~~~~y~~~  324 (376)
                      +|++++++++...+.
T Consensus       254 lG~il~el~~g~~pf  268 (352)
T 2jii_A          254 LGYCMLKWLYGFLPW  268 (352)
T ss_dssp             HHHHHHHHHHSCCTT
T ss_pred             HHHHHHHHHhCCCCc
Confidence            999999998654443

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.2e-34  Score=271.36  Aligned_cols=200  Identities=18%  Similarity=0.226  Sum_probs=167.4

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh-----------------hHHHHHHHHHHH
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-----------------GFEEWQSEVNFL  149 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~il  149 (376)
                      ..++|++.+.||+|+||.||+|..           +++.||+|.+......                 ..+.+.+|+.++
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   97 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK-----------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII   97 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE-----------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHH
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc-----------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHH
Confidence            457899999999999999999965           3889999998653221                 127789999999


Q ss_pred             hcCCCCCcceEEeEEEeCCeEEEEEeccCCCCHHHH------HhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcE
Q 017177          150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENH------LFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVI  223 (376)
Q Consensus       150 ~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~ii  223 (376)
                      +.++||||+++++++.+.+..++||||+++|+|.++      +....  ...+++..+..++.|++.||.|||+ +++|+
T Consensus        98 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~  174 (348)
T 2pml_X           98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHN-EKNIC  174 (348)
T ss_dssp             TTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHH-TSCEE
T ss_pred             HhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhc-cCCEe
Confidence            999999999999999999999999999999999998      54321  3568999999999999999999993 39999


Q ss_pred             ecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcc-
Q 017177          224 YRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLT-  302 (376)
Q Consensus       224 HrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~-  302 (376)
                      ||||||+|||++.++.+||+|||++.........    . .    .||+.|+               +||++.+....+ 
T Consensus       175 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~----~-~----~~~~~y~---------------aPE~~~~~~~~~~  230 (348)
T 2pml_X          175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK----G-S----RGTYEFM---------------PPEFFSNESSYNG  230 (348)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCTTCEECBTTEEC----S-S----CSCGGGC---------------CGGGGSSCCCEEH
T ss_pred             ecCCChHhEEEcCCCcEEEecccccccccccccc----C-C----CCCcCcc---------------CchhhcCCCCCCc
Confidence            9999999999999999999999999987554111    1 1    6778888               899888773344 


Q ss_pred             ccccccceeeeehhhccccccc
Q 017177          303 LLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       303 ~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      .++|+||+|++++++++...+.
T Consensus       231 ~~~Di~slG~il~~l~~g~~pf  252 (348)
T 2pml_X          231 AKVDIWSLGICLYVMFYNVVPF  252 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSS
T ss_pred             chhhHHHHHHHHHHHHhCCCCC
Confidence            4999999999999999765444

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.8e-34  Score=272.63  Aligned_cols=195  Identities=19%  Similarity=0.179  Sum_probs=161.7

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|.+.+.||+|+||.||+|...         .+++.||+|++....  ....+.+.+|+.+++.++||||+++++++
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  110 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDK---------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVF  110 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             ccccEEEEeEEecCCCeEEEEEEEC---------CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhhe
Confidence            4578999999999999999999544         468999999997643  23357788999999999999999999999


Q ss_pred             EeCCeE------EEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          165 WEDKEL------LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       165 ~~~~~~------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      ...+..      |+||||+. ++|.+++.      ..+++..+..++.|++.||.|||  .++|+||||||+|||++.++
T Consensus       111 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIll~~~~  181 (371)
T 4exu_A          111 TPASSLRNFYDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIH--SAGVVHRDLKPGNLAVNEDC  181 (371)
T ss_dssp             CSCSSSTTCCCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTC
T ss_pred             eccCCcccceeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCcCHHHeEECCCC
Confidence            877654      99999997 58888773      33899999999999999999999  58999999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .+||+|||+++.......     +     ..||+.|+               |||++.+....+.++||||+|+++++++
T Consensus       182 ~~kL~Dfg~a~~~~~~~~-----~-----~~~t~~y~---------------aPE~~~~~~~~~~~~DiwslG~il~el~  236 (371)
T 4exu_A          182 ELKILDFGLARHADAEMT-----G-----YVVTRWYR---------------APEVILSWMHYNQTVDIWSVGCIMAEML  236 (371)
T ss_dssp             CEEECSTTCC-------------C-----TTCCCTTS---------------CHHHHSCCSCCCTTHHHHHHHHHHHHHH
T ss_pred             CEEEEecCcccccccCcC-----C-----cccCcccc---------------CHHHhcCCCCCCcHHhHHHHHHHHHHHH
Confidence            999999999986543211     1     16788888               8999888667799999999999999999


Q ss_pred             cccccc
Q 017177          319 SFYRTT  324 (376)
Q Consensus       319 ~~y~~~  324 (376)
                      +...+.
T Consensus       237 ~g~~pf  242 (371)
T 4exu_A          237 TGKTLF  242 (371)
T ss_dssp             HSSCSC
T ss_pred             hCCCCC
Confidence            654443

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.8e-34  Score=262.70  Aligned_cols=199  Identities=21%  Similarity=0.248  Sum_probs=166.3

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEe
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLG  162 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~  162 (376)
                      ....++|++.+.||+|+||.||+|...         .+++.||+|++....  ....+.+.+|+.++++++||||+++++
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   88 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDR---------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE   88 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEc---------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEE
Confidence            345568999999999999999999554         358899999986542  234578889999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC---Cc
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV---GF  239 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~---g~  239 (376)
                      ++.+.+..++||||+++++|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++.+   +.
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dl~p~NIlv~~~~~~~~  162 (287)
T 2wei_A           89 ILEDSSSFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCD  162 (287)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSSTTCC
T ss_pred             EEeCCCeEEEEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCChhhEEEecCCCccc
Confidence            999999999999999999999998766    35899999999999999999999  5899999999999999754   46


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +||+|||++............        .||+.|+               +||++.+.  .+.++|+||+|++++++++
T Consensus       163 ~kL~Dfg~~~~~~~~~~~~~~--------~~~~~y~---------------aPE~~~~~--~~~~~Di~slG~~l~~l~~  217 (287)
T 2wei_A          163 IKIIDFGLSTCFQQNTKMKDR--------IGTAYYI---------------APEVLRGT--YDEKCDVWSAGVILYILLS  217 (287)
T ss_dssp             EEECSTTGGGTBCCCSSCSCH--------HHHHTTC---------------CHHHHTTC--CCTHHHHHHHHHHHHHHHH
T ss_pred             EEEeccCcceeecCCCccccc--------cCccccc---------------ChHHhcCC--CCCchhhHhHHHHHHHHHh
Confidence            999999999876543222111        4666677               89988764  6889999999999999996


Q ss_pred             cccc
Q 017177          320 FYRT  323 (376)
Q Consensus       320 ~y~~  323 (376)
                      ...+
T Consensus       218 g~~p  221 (287)
T 2wei_A          218 GTPP  221 (287)
T ss_dssp             SSCS
T ss_pred             CCCC
Confidence            5444

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=8.6e-35  Score=270.76  Aligned_cols=206  Identities=18%  Similarity=0.236  Sum_probs=160.8

Q ss_pred             hhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceE
Q 017177           83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKL  160 (376)
Q Consensus        83 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l  160 (376)
                      +.....++|++.+.||+|+||.||+|....            .+|+|+++....  ...+.+.+|+.+++.++||||+++
T Consensus        27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~------------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~   94 (319)
T 2y4i_B           27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG------------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF   94 (319)
T ss_dssp             GSSSCCSCEECCCBCCCSSSSEEEEEEESS------------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCC
T ss_pred             cccCCHHHeEEeeEeccCCceEEEEEEEcC------------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEE
Confidence            334456789999999999999999996542            389999876432  223567789999999999999999


Q ss_pred             EeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcE
Q 017177          161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL  240 (376)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~  240 (376)
                      ++++.+++..++||||+++++|.+++....   ..+++..+..++.|++.||.|||  .++|+||||||+|||++ ++.+
T Consensus        95 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dlkp~NIl~~-~~~~  168 (319)
T 2y4i_B           95 MGACMSPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NGKV  168 (319)
T ss_dssp             CEEEECSSCEEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHH--HTTCCCCCCCSTTEEEC---CC
T ss_pred             EEEEecCCceEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCChhhEEEe-CCCE
Confidence            999999999999999999999999997642   45889999999999999999999  58999999999999998 7899


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh--------hhhccccccccceee
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW--------IKYLTLLKYSNSFAF  312 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~--------~~~~~~~~dv~s~g~  312 (376)
                      ||+|||++..........  .........||+.|+               +||++.+        ...++.++||||+|+
T Consensus       169 ~l~Dfg~~~~~~~~~~~~--~~~~~~~~~g~~~y~---------------aPE~~~~~~~~~~~~~~~~~~~~Di~slG~  231 (319)
T 2y4i_B          169 VITDFGLFSISGVLQAGR--REDKLRIQNGWLCHL---------------APEIIRQLSPDTEEDKLPFSKHSDVFALGT  231 (319)
T ss_dssp             EECCCSCCC------------CCSCBCCSGGGGTS---------------CHHHHSCBSCC--CCCSCCCHHHHHHHHHH
T ss_pred             EEeecCCccccccccccc--cccccccCCCccccc---------------ChHHhhhccccccccccCCCchhhHHHHHH
Confidence            999999987654322110  001111125778888               8998875        234678999999999


Q ss_pred             eehhhcccccc
Q 017177          313 VFSCVFSFYRT  323 (376)
Q Consensus       313 v~~~~~~~y~~  323 (376)
                      +++++++...+
T Consensus       232 il~el~~g~~p  242 (319)
T 2y4i_B          232 IWYELHAREWP  242 (319)
T ss_dssp             HHHHHHHSSCS
T ss_pred             HHHHHHhCCCC
Confidence            99999865444

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2e-33  Score=268.66  Aligned_cols=201  Identities=24%  Similarity=0.220  Sum_probs=166.6

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CC-----Ccc
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HP-----NLV  158 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~-----nIv  158 (376)
                      ....++|++.+.||+|+||.||+|...         .+++.||||+++... .....+.+|+.+++.++ |+     +|+
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv  119 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDR---------VEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIV  119 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEET---------TTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBC
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEc---------CCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEE
Confidence            345678999999999999999999544         358899999998543 33466778999988886 55     499


Q ss_pred             eEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc--C
Q 017177          159 KLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD--G  236 (376)
Q Consensus       159 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~--~  236 (376)
                      ++++++...+..++||||++ |+|.+++.....  ..+++..+..++.|++.||.|||+++.+|+||||||+|||++  .
T Consensus       120 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~  196 (382)
T 2vx3_A          120 HLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPK  196 (382)
T ss_dssp             CEEEEEEETTEEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTT
T ss_pred             EeeeeeccCCceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCC
Confidence            99999999999999999996 599999987532  458999999999999999999997568999999999999994  5


Q ss_pred             CCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehh
Q 017177          237 VGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSC  316 (376)
Q Consensus       237 ~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~  316 (376)
                      ++.+||+|||+++.......      +    ..||+.|+               |||++.+.. ++.++||||+|+++++
T Consensus       197 ~~~~kL~DFG~a~~~~~~~~------~----~~~t~~y~---------------aPE~~~~~~-~~~~~DiwSlG~il~e  250 (382)
T 2vx3_A          197 RSAIKIVDFGSSCQLGQRIY------Q----YIQSRFYR---------------SPEVLLGMP-YDLAIDMWSLGCILVE  250 (382)
T ss_dssp             SCCEEECCCTTCEETTCCCC------S----SCSCGGGC---------------CHHHHTTCC-CCTHHHHHHHHHHHHH
T ss_pred             CCcEEEEeccCceecccccc------c----ccCCcccc---------------ChHHHcCCC-CCcHHHHHHHHHHHHH
Confidence            78899999999987654211      1    17788888               899888765 5889999999999999


Q ss_pred             hccccccc
Q 017177          317 VFSFYRTT  324 (376)
Q Consensus       317 ~~~~y~~~  324 (376)
                      +++...+.
T Consensus       251 lltg~~pf  258 (382)
T 2vx3_A          251 MHTGEPLF  258 (382)
T ss_dssp             HHHSSCSS
T ss_pred             HHhCCCCC
Confidence            99654443

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6.8e-34  Score=272.38  Aligned_cols=196  Identities=21%  Similarity=0.175  Sum_probs=162.3

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC--------CCCcc
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS--------HPNLV  158 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~--------h~nIv  158 (376)
                      ..++|++.+.||+|+||.||+|+..         .+++.||||+++... ...+.+.+|+.+++.++        |+||+
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv  104 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDI---------QGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVV  104 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEec---------CCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence            3578999999999999999999544         358899999997543 34567889999999985        78899


Q ss_pred             eEEeEEE----eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CcEecCCCCCCEE
Q 017177          159 KLLGYCW----EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEK-KVIYRDFKASNIL  233 (376)
Q Consensus       159 ~l~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~-~iiHrDlKp~NIL  233 (376)
                      ++++++.    ....+++||||+ +++|.+.+.+..  ...+++..++.++.||+.||.|||+  + +|+||||||+|||
T Consensus       105 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~--~~givHrDikp~NIl  179 (397)
T 1wak_A          105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHT--KCRIIHTDIKPENIL  179 (397)
T ss_dssp             CEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECCCCSGGGEE
T ss_pred             eeecceeecCCCCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHee
Confidence            9999987    456799999999 567777776543  2458999999999999999999994  6 9999999999999


Q ss_pred             EcCCC-------------------------------------------------cEEEcceeeeeeeccceeeEEEeeeE
Q 017177          234 LDGVG-------------------------------------------------FLFDSHLLIYVYFKRHYIYIYIHTYI  264 (376)
Q Consensus       234 l~~~g-------------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~  264 (376)
                      ++.++                                                 .+||+|||++.........      .
T Consensus       180 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~------~  253 (397)
T 1wak_A          180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE------D  253 (397)
T ss_dssp             ECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCS------C
T ss_pred             EeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCcc------C
Confidence            99776                                                 7999999999876543211      1


Q ss_pred             EEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          265 IYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       265 ~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                          .||+.|+               |||++.+.. ++.++||||+|++++++++...+
T Consensus       254 ----~gt~~y~---------------aPE~~~~~~-~~~~~DiwslG~il~elltg~~p  292 (397)
T 1wak_A          254 ----IQTRQYR---------------SLEVLIGSG-YNTPADIWSTACMAFELATGDYL  292 (397)
T ss_dssp             ----CSCGGGC---------------CHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ----CCCCccc---------------CChhhcCCC-CCcHHHHHHHHHHHHHHhhCCCC
Confidence                6788888               899888765 57899999999999999965443

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.8e-34  Score=273.45  Aligned_cols=196  Identities=12%  Similarity=0.005  Sum_probs=145.1

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcC--CCCCcceEE-
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRL--SHPNLVKLL-  161 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l--~h~nIv~l~-  161 (376)
                      ..+|++.+.||+|+||.||+|.+.         .+++.||+|++.....   ...+.+.+|+.+++.+  +||||++++ 
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~  131 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDV---------ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRR  131 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------
T ss_pred             ceeeeeeeeccCCCCEEEEEEEEC---------CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhce
Confidence            345899999999999999999554         3588999999987643   3345677885544444  699988755 


Q ss_pred             ------eEEEeC-----------------CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHH------HHHHHHHHHHH
Q 017177          162 ------GYCWED-----------------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------LKIAIGAARGL  212 (376)
Q Consensus       162 ------~~~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~------~~i~~qi~~~L  212 (376)
                            +++..+                 ..+|+||||++ |+|.+++....   ..+++..+      ..++.||+.||
T Consensus       132 ~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL  207 (371)
T 3q60_A          132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLA  207 (371)
T ss_dssp             CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHH
Confidence                  444433                 33899999998 79999998652   22344444      67779999999


Q ss_pred             HHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHH
Q 017177          213 GFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLP  292 (376)
Q Consensus       213 ~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~ap  292 (376)
                      .|||  .++|+||||||+|||++.+|.+||+|||+++.......     ..     .+|+.|+               ||
T Consensus       208 ~~LH--~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-----~~-----~~t~~y~---------------aP  260 (371)
T 3q60_A          208 ANLQ--SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-----AS-----SVPVTYA---------------PR  260 (371)
T ss_dssp             HHHH--HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-----GG-----GSCGGGC---------------CH
T ss_pred             HHHH--HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCcc-----Cc-----cCCcCCc---------------Ch
Confidence            9999  59999999999999999999999999999997653221     11     5668888               89


Q ss_pred             HHHhh-hhhccccccccceeeeehhhcccccc
Q 017177          293 RIYAW-IKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       293 Ei~~~-~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |++.+ ...++.++||||+|++++++++...+
T Consensus       261 E~~~~~~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          261 EFLNASTATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             HHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             hhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence            98875 24568999999999999999865444

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.5e-34  Score=265.52  Aligned_cols=201  Identities=20%  Similarity=0.230  Sum_probs=169.0

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChh------hHHHHHHHHHHHhcCC--CCC
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ------GFEEWQSEVNFLGRLS--HPN  156 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~--h~n  156 (376)
                      ....++|++.+.||+|+||.||+|...         .+++.||||+++.....      ..+.+.+|+.++++++  |+|
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~  109 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRV---------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG  109 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEET---------TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCS
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEEC---------CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCC
Confidence            345678999999999999999999543         35899999998654221      2245668999999996  599


Q ss_pred             cceEEeEEEeCCeEEEEEeccCC-CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc
Q 017177          157 LVKLLGYCWEDKELLLVYEYMQR-GSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD  235 (376)
Q Consensus       157 Iv~l~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~  235 (376)
                      |+++++++..++..++|||++.+ ++|.+++...    ..+++..+..++.|++.||.|||  .++|+||||||+|||++
T Consensus       110 i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~  183 (320)
T 3a99_A          110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILID  183 (320)
T ss_dssp             BCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEE
T ss_pred             ceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcEeCCCCHHHEEEe
Confidence            99999999999999999999976 8999999876    45899999999999999999999  59999999999999999


Q ss_pred             -CCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeee
Q 017177          236 -GVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVF  314 (376)
Q Consensus       236 -~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~  314 (376)
                       .++.+||+|||++.........     ..    .||+.|+               |||++.+..+.+.++|+||+|+++
T Consensus       184 ~~~~~~kL~Dfg~~~~~~~~~~~-----~~----~gt~~y~---------------aPE~~~~~~~~~~~~Di~slG~il  239 (320)
T 3a99_A          184 LNRGELKLIDFGSGALLKDTVYT-----DF----DGTRVYS---------------PPEWIRYHRYHGRSAAVWSLGILL  239 (320)
T ss_dssp             TTTTEEEECCCTTCEECCSSCBC-----CC----CSCGGGS---------------CHHHHHHSCBCHHHHHHHHHHHHH
T ss_pred             CCCCCEEEeeCcccccccccccc-----CC----CCCccCC---------------ChHHhccCCCCCccchHHhHHHHH
Confidence             7899999999999877643221     11    6788888               899998887778899999999999


Q ss_pred             hhhccccccc
Q 017177          315 SCVFSFYRTT  324 (376)
Q Consensus       315 ~~~~~~y~~~  324 (376)
                      +++++...+.
T Consensus       240 ~el~~g~~pf  249 (320)
T 3a99_A          240 YDMVCGDIPF  249 (320)
T ss_dssp             HHHHHSSCSC
T ss_pred             HHHHHCCCCC
Confidence            9999765443

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.1e-33  Score=261.88  Aligned_cols=198  Identities=20%  Similarity=0.211  Sum_probs=165.4

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCC------CcceE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP------NLVKL  160 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~------nIv~l  160 (376)
                      ..++|++.+.||+|+||.||+|....        .+++.||+|+++... ...+.+.+|+.+++.++|+      +|+++
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~   82 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHK--------AGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQM   82 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecC--------CCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence            45689999999999999999996532        248899999997643 3456788999999988755      49999


Q ss_pred             EeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC----
Q 017177          161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG----  236 (376)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~----  236 (376)
                      ++++...+..++||||+ +++|.+++.....  ..+++..+..++.|++.||.|||  .++|+||||||+|||++.    
T Consensus        83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~  157 (339)
T 1z57_A           83 LEWFEHHGHICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLH--SNKLTHTDLKPENILFVQSDYT  157 (339)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESCCCEE
T ss_pred             ecccccCCcEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHHHEEEeccccc
Confidence            99999999999999999 8899999977632  45889999999999999999999  599999999999999987    


Q ss_pred             ---------------CCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhc
Q 017177          237 ---------------VGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYL  301 (376)
Q Consensus       237 ---------------~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~  301 (376)
                                     ++.+||+|||+++.......      +.    .||+.|+               |||++.+.. .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~------~~----~gt~~y~---------------aPE~~~~~~-~  211 (339)
T 1z57_A          158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHS------TL----VSTRHYR---------------APEVILALG-W  211 (339)
T ss_dssp             EEEC----CEEEEESCCCEEECCCSSCEETTSCCC------SS----CSCGGGC---------------CHHHHTTSC-C
T ss_pred             cccCCccccccccccCCCceEeeCcccccCccccc------cc----cCCcccc---------------ChHHhhCCC-C
Confidence                           67899999999987544321      11    6788888               899887765 5


Q ss_pred             cccccccceeeeehhhccccccc
Q 017177          302 TLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       302 ~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      +.++|+||+|++++++++...+.
T Consensus       212 ~~~~Di~slG~il~el~~g~~pf  234 (339)
T 1z57_A          212 SQPCDVWSIGCILIEYYLGFTVF  234 (339)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CcchhhHHHHHHHHHHHhCCCCC
Confidence            88999999999999998654443

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.3e-33  Score=262.31  Aligned_cols=202  Identities=18%  Similarity=0.184  Sum_probs=147.0

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHH-HHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVN-FLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~-il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||||+++... ......+.+|+. +++.++||||+++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~   90 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHK---------PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGAL   90 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEET---------TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEc---------CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEE
Confidence            4578999999999999999999554         358899999997653 233445566666 77778999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CcEecCCCCCCEEEcCCCcEEE
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRN-PSIQPLSWDIRLKIAIGAARGLGFLHTSEK-KVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~-~iiHrDlKp~NILl~~~g~~kl  242 (376)
                      .+++..++||||+++ +|.+++.... .....+++..+..++.|++.||.|||+  . +|+||||||+|||++.++.+||
T Consensus        91 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~ivH~dlkp~NIll~~~~~~kl  167 (327)
T 3aln_A           91 FREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKL  167 (327)
T ss_dssp             ECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH--HHSCCCSCCCGGGEEEETTTEEEE
T ss_pred             EeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc--cCCEeECCCCHHHEEEcCCCCEEE
Confidence            999999999999975 8888776311 112568999999999999999999994  7 9999999999999999999999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHh---hhhhccccccccceeeeehhhcc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYA---WIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~---~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +|||+++...........        .||+.|+               +||++.   .....+.++|+||+|++++++++
T Consensus       168 ~Dfg~~~~~~~~~~~~~~--------~gt~~y~---------------aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~  224 (327)
T 3aln_A          168 CDFGISGQLVDSIAKTRD--------AGCRPYM---------------APERIDPSASRQGYDVRSDVWSLGITLYELAT  224 (327)
T ss_dssp             CCCSSSCC-----------------------------------------------------CCSHHHHHHHHHHHHHHHH
T ss_pred             ccCCCceecccccccccC--------CCCcccc---------------CceeeccccCcCCCCchhhHHHHHHHHHHHHH
Confidence            999999876543322111        5666676               799874   23446889999999999999997


Q ss_pred             cccc
Q 017177          320 FYRT  323 (376)
Q Consensus       320 ~y~~  323 (376)
                      ...+
T Consensus       225 g~~p  228 (327)
T 3aln_A          225 GRFP  228 (327)
T ss_dssp             SCCC
T ss_pred             CCCC
Confidence            5444

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=9.7e-34  Score=267.82  Aligned_cols=194  Identities=19%  Similarity=0.179  Sum_probs=161.2

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|.+.+.||+|+||.||+|...         .+++.||||++....  ....+.+.+|+.+++.++||||+++++++
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   92 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDK---------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVF   92 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             cCceEEEeeeEecCCCeEEEEEEEC---------CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheE
Confidence            3568999999999999999999544         368999999997643  23456788999999999999999999999


Q ss_pred             EeCCe------EEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          165 WEDKE------LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       165 ~~~~~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      ...+.      .|+||||++ ++|.+++.      ..+++..+..++.||+.||.|||  .++|+||||||+|||++.+|
T Consensus        93 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH--~~~ivH~dlkp~NIl~~~~~  163 (353)
T 3coi_A           93 TPASSLRNFYDFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIH--SAGVVHRDLKPGNLAVNEDC  163 (353)
T ss_dssp             CSCSSGGGCCCCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECTTC
T ss_pred             ecccccccceeEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEeECCCC
Confidence            87654      599999997 58887763      23899999999999999999999  59999999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .+||+|||+++.......     +     ..||+.|+               +||++.+....+.++|+||+|+++++++
T Consensus       164 ~~kl~Dfg~~~~~~~~~~-----~-----~~~t~~y~---------------aPE~~~~~~~~~~~~Di~slG~il~el~  218 (353)
T 3coi_A          164 ELKILDFGLARHADAEMT-----G-----YVVTRWYR---------------APEVILSWMHYNQTVDIWSVGCIMAEML  218 (353)
T ss_dssp             CEEECSTTCTTC------------------CCSBCCS---------------CHHHHSCCSCCCTTHHHHHHHHHHHHHH
T ss_pred             cEEEeecccccCCCCCcc-----c-----cccCcCcC---------------CHHHHhCcCCCCchhhHHHHHHHHHHHH
Confidence            999999999986543211     1     16778888               8998887667789999999999999999


Q ss_pred             ccccc
Q 017177          319 SFYRT  323 (376)
Q Consensus       319 ~~y~~  323 (376)
                      +...+
T Consensus       219 ~g~~p  223 (353)
T 3coi_A          219 TGKTL  223 (353)
T ss_dssp             HSSCS
T ss_pred             hCCCC
Confidence            65444

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.7e-33  Score=276.37  Aligned_cols=202  Identities=18%  Similarity=0.144  Sum_probs=163.2

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCC-CCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH-PNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~l~~~~~  165 (376)
                      ..++|++.+.||+|+||.||+|.+.         .+++.||||++......  ..+.+|+.+++.++| ++|..+..++.
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~---------~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~   73 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNI---------QTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGV   73 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEET---------TTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEEC---------CCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence            3578999999999999999999543         35889999987654332  346789999999985 66667777778


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE---cCCCcEEE
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL---DGVGFLFD  242 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl---~~~g~~kl  242 (376)
                      ..+..+|||||+ +++|.+++....   ..+++..++.++.||+.||.|||  .++|+||||||+||||   +.++.+||
T Consensus        74 ~~~~~~lvme~~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH--~~gIvHrDIKP~NILl~~~~~~~~vkL  147 (483)
T 3sv0_A           74 EGDYNVLVMDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYI  147 (483)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECCGGGTTCEEE
T ss_pred             eCCEEEEEEECC-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccCcceEEEecCCCCCeEEE
Confidence            888999999999 889999997642   45899999999999999999999  5999999999999999   68899999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      +|||+++.+..................||+.|+               +||++.+.. ++.++||||||+|++++++..
T Consensus       148 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~---------------aPE~~~~~~-~s~~sDvwSlGvil~elltG~  210 (483)
T 3sv0_A          148 IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA---------------SVNTHLGIE-QSRRDDLESLGYVLMYFLRGS  210 (483)
T ss_dssp             CCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTC---------------CHHHHTTCC-CCHHHHHHHHHHHHHHHHHSS
T ss_pred             EeCCcceeccCCccccccccccccccCCCcccc---------------CHHHhcCCC-CChHHHHHHHHHHHHHHHhCC
Confidence            999999987654322111000001127888888               899887765 588999999999999998643

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.98  E-value=1.7e-33  Score=288.46  Aligned_cols=191  Identities=18%  Similarity=0.219  Sum_probs=159.0

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ..++|++.+.||+|+||.||+|.+...        +++.||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  149 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNV--------NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVE  149 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGG--------TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCC--------CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEe
Confidence            347899999999999999999965421        37889999987543 344567889999999999999999999998


Q ss_pred             eCCe-----EEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcE
Q 017177          166 EDKE-----LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL  240 (376)
Q Consensus       166 ~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~  240 (376)
                      ..+.     .||||||++|++|.+++..      .+++..++.++.||+.||.|||  .++|+||||||+|||++.+ .+
T Consensus       150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH--~~giiHrDlkp~NIll~~~-~~  220 (681)
T 2pzi_A          150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLH--SIGLVYNDLKPENIMLTEE-QL  220 (681)
T ss_dssp             EECTTSCEEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECSS-CE
T ss_pred             ecCCCCCceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH--HCCCeecccChHHeEEeCC-cE
Confidence            7655     7999999999999887743      4899999999999999999999  5999999999999999875 89


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ||+|||+++......       +.    .||+.|+               +||++.+..  +.++||||+|++++++++-
T Consensus       221 kl~DFG~a~~~~~~~-------~~----~gt~~y~---------------aPE~~~~~~--~~~sDi~slG~~l~~l~~g  272 (681)
T 2pzi_A          221 KLIDLGAVSRINSFG-------YL----YGTPGFQ---------------APEIVRTGP--TVATDIYTVGRTLAALTLD  272 (681)
T ss_dssp             EECCCTTCEETTCCS-------CC----CCCTTTS---------------CTTHHHHCS--CHHHHHHHHHHHHHHHHSC
T ss_pred             EEEecccchhcccCC-------cc----CCCcccc---------------CHHHHcCCC--CCceehhhhHHHHHHHHhC
Confidence            999999998765531       11    7889999               899876543  7899999999999998854


Q ss_pred             cc
Q 017177          321 YR  322 (376)
Q Consensus       321 y~  322 (376)
                      +.
T Consensus       273 ~~  274 (681)
T 2pzi_A          273 LP  274 (681)
T ss_dssp             CC
T ss_pred             CC
Confidence            43

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.98  E-value=7.3e-33  Score=260.25  Aligned_cols=196  Identities=19%  Similarity=0.209  Sum_probs=141.9

Q ss_pred             hcCCCCccc-eEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           87 ATKNFKPDS-LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ..++|++.+ +||+|+||.||+|...         .+++.||+|++.....    ...+....++.++||||+++++++.
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~   92 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHR---------RTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYE   92 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEEC---------CCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHh
Confidence            356788854 6999999999999554         3688999999875421    1122233456678999999999987


Q ss_pred             e----CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC---CC
Q 017177          166 E----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG---VG  238 (376)
Q Consensus       166 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~---~g  238 (376)
                      .    ...+++||||+++|+|.+++.+...  ..+++..+..++.|++.||.|||  .++|+||||||+|||++.   ++
T Consensus        93 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH--~~~ivH~dlkp~NIll~~~~~~~  168 (336)
T 3fhr_A           93 NMHHGKRCLLIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLH--SHNIAHRDVKPENLLYTSKEKDA  168 (336)
T ss_dssp             EEETTEEEEEEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSTTC
T ss_pred             hccCCCceEEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEEecCCCc
Confidence            6    4458999999999999999986532  46899999999999999999999  589999999999999976   45


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .+||+|||++.........     +    ..||+.|+               +||++.+.. ++.++||||+|+++++++
T Consensus       169 ~~kl~Dfg~~~~~~~~~~~-----~----~~~t~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~l~  223 (336)
T 3fhr_A          169 VLKLTDFGFAKETTQNALQ-----T----PCYTPYYV---------------APEVLGPEK-YDKSCDMWSLGVIMYILL  223 (336)
T ss_dssp             CEEECCCTTCEEC----------------------------------------------CH-HHHHHHHHHHHHHHHHHH
T ss_pred             eEEEeccccceeccccccc-----c----CCCCcCcc---------------ChhhhCCCC-CCchhhHHHHHHHHHHHH
Confidence            6999999999866532211     1    15677777               799876554 478999999999999998


Q ss_pred             cccccc
Q 017177          319 SFYRTT  324 (376)
Q Consensus       319 ~~y~~~  324 (376)
                      +...+.
T Consensus       224 ~g~~pf  229 (336)
T 3fhr_A          224 CGFPPF  229 (336)
T ss_dssp             HSSCCC
T ss_pred             HCCCCC
Confidence            655443

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.98  E-value=4.9e-33  Score=270.37  Aligned_cols=197  Identities=20%  Similarity=0.147  Sum_probs=148.6

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcC-CCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~  167 (376)
                      +.|...+.||+|+||+||.+...          +++.||||++....   .+.+.+|+.+++.+ +||||+++++++.++
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~----------~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   81 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSF----------QGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTD   81 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEES----------SSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred             heeeccCeEeeCCCeEEEEEEEE----------CCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence            44566789999999999865322          38899999986532   35678899999987 799999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCC---CCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC-------
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV-------  237 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~---~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~-------  237 (376)
                      +.+|+|||||. |+|.+++.........   ..+..+..++.||+.||.|||  .++|+||||||+|||++.+       
T Consensus        82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~~~~~~  158 (434)
T 2rio_A           82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQ  158 (434)
T ss_dssp             SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEECCHHHHSCC
T ss_pred             CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEecCccccccc
Confidence            99999999996 5999999765321111   123345789999999999999  5899999999999999754       


Q ss_pred             ------CcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh------hhhccccc
Q 017177          238 ------GFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW------IKYLTLLK  305 (376)
Q Consensus       238 ------g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~------~~~~~~~~  305 (376)
                            +.+||+|||+++...........   ......||+.|+               |||++.+      ....+.++
T Consensus       159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~---~~~~~~gt~~y~---------------aPE~~~~~~~~~~~~~~~~~~  220 (434)
T 2rio_A          159 QTGAENLRILISDFGLCKKLDSGQSSFRT---NLNNPSGTSGWR---------------APELLEESNNLQTKRRLTRSI  220 (434)
T ss_dssp             TTCCCSCEEEECCCTTCEECCC-----------------CCTTS---------------CHHHHSCCCTTSCCCCCCTHH
T ss_pred             ccCCCceEEEEcccccceecCCCCcccee---eecCCCCCCCcc---------------CHHHhccccccccccCcchhh
Confidence                  48999999999987654321100   011127889999               8998876      25578999


Q ss_pred             cccceeeeehhhcc
Q 017177          306 YSNSFAFVFSCVFS  319 (376)
Q Consensus       306 dv~s~g~v~~~~~~  319 (376)
                      ||||+|++++++++
T Consensus       221 DiwSlG~il~ellt  234 (434)
T 2rio_A          221 DIFSMGCVFYYILS  234 (434)
T ss_dssp             HHHHHHHHHHHHHT
T ss_pred             hhHhHHHHHHHHHh
Confidence            99999999999987

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.98  E-value=5.5e-33  Score=269.67  Aligned_cols=193  Identities=19%  Similarity=0.152  Sum_probs=148.7

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcC-CCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~  167 (376)
                      .+|.+.++||+|+||.|+.....          +++.||||++......   .+.+|+.+++.+ +||||+++++++.+.
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~----------~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~   90 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMF----------DNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDR   90 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEES----------SSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred             EEEecCCeeecCcCEEEEEEEEe----------CCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence            46889999999999996643222          3788999999765432   346799999999 699999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC---C--CcEEE
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG---V--GFLFD  242 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~---~--g~~kl  242 (376)
                      +..|+|||||. |+|.+++....   ....+..+..++.||+.||.|||  .++|+||||||+|||++.   +  ..+||
T Consensus        91 ~~~~lv~E~~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlKp~NIll~~~~~~~~~~~kL  164 (432)
T 3p23_A           91 QFQYIAIELCA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLH--SLNIVHRDLKPHNILISMPNAHGKIKAMI  164 (432)
T ss_dssp             TEEEEEEECCS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHH--HTTCCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred             CEEEEEEECCC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHH--HCcCEeCCCCHHHEEEecCCCCCceeEEE
Confidence            99999999996 59999997653   23444556789999999999999  589999999999999943   2  35889


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh--hhhccccccccceeeeehhhcc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW--IKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~--~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +|||+++.............+    ..||+.|+               |||++.+  ....+.++||||+|++++++++
T Consensus       165 ~DFG~a~~~~~~~~~~~~~~~----~~gt~~y~---------------APE~l~~~~~~~~t~~~DiwSlG~il~ellt  224 (432)
T 3p23_A          165 SDFGLCKKLAVGRHSFSRRSG----VPGTEGWI---------------APEMLSEDCKENPTYTVDIFSAGCVFYYVIS  224 (432)
T ss_dssp             CCTTEEECC----------------CCSCTTSC---------------CGGGTSCC---CCCTHHHHHHHHHHHHHHHT
T ss_pred             ecccceeeccCCCcceeeccc----cCCCcCcc---------------ChhhhhcccccCCCcHHHHHHHHHHHHHHHc
Confidence            999999987544322111111    27889999               8998764  3445778999999999999987

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.98  E-value=1.3e-32  Score=259.45  Aligned_cols=198  Identities=18%  Similarity=0.169  Sum_probs=163.7

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCC------cceE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN------LVKL  160 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n------Iv~l  160 (376)
                      ..++|++.+.||+|+||.||+|.....        .+..||+|+++... ...+.+.+|+.+++.++|++      ++.+
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~   87 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLM   87 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCC--------CceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence            457899999999999999999965431        13789999997543 34467788999999997665      9999


Q ss_pred             EeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE------
Q 017177          161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL------  234 (376)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl------  234 (376)
                      ++++...+..++||||+ +++|.+++.....  ..+++..+..++.||+.||.|||  .++|+||||||+|||+      
T Consensus        88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH--~~~ivH~Dlkp~NIll~~~~~~  162 (355)
T 2eu9_A           88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLH--ENQLTHTDLKPENILFVNSEFE  162 (355)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEESCCCEE
T ss_pred             eeeeeeCCeEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEeccccc
Confidence            99999999999999999 6678887766532  45899999999999999999999  6999999999999999      


Q ss_pred             -------------cCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhc
Q 017177          235 -------------DGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYL  301 (376)
Q Consensus       235 -------------~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~  301 (376)
                                   +.++.+||+|||+++.......      +.    .||+.|+               |||++.+.. +
T Consensus       163 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~------~~----~gt~~y~---------------aPE~~~~~~-~  216 (355)
T 2eu9_A          163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHT------TI----VATRHYR---------------PPEVILELG-W  216 (355)
T ss_dssp             EEECCC-CCCEEEESCCCEEECCCTTCEETTSCCC------SS----CSCGGGC---------------CHHHHTTCC-C
T ss_pred             ccccccccccccccCCCcEEEeecCcccccccccc------CC----cCCCccc---------------CCeeeecCC-C
Confidence                         6788999999999987544321      11    6788888               899887665 5


Q ss_pred             cccccccceeeeehhhccccccc
Q 017177          302 TLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       302 ~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      +.++|+||+|++++++++...+.
T Consensus       217 ~~~~Di~slG~il~el~~g~~pf  239 (355)
T 2eu9_A          217 AQPCDVWSIGCILFEYYRGFTLF  239 (355)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCccchHHHHHHHHHHHhCCCCC
Confidence            88999999999999999665544

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=2.2e-33  Score=280.83  Aligned_cols=172  Identities=14%  Similarity=0.067  Sum_probs=126.4

Q ss_pred             ccCCCCcEEEEEEcCCCC----------hhhHHHHHHHHHHHhcC-CCCCcceEEeEEEeCCeEEEEEeccCCCCHHHHH
Q 017177          118 SKTGLGMVVAIKKLNPES----------MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL  186 (376)
Q Consensus       118 ~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l  186 (376)
                      ++...|..+++|++....          ....++|.+|+++|+++ .|+||+++++++++++.+||||||++|++|.++|
T Consensus       254 rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i  333 (569)
T 4azs_A          254 RRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDML  333 (569)
T ss_dssp             EEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHH
T ss_pred             ccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHH
Confidence            444468889999986542          12346789999999999 5999999999999999999999999999999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEE
Q 017177          187 FRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIY  266 (376)
Q Consensus       187 ~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y  266 (376)
                      .+.    .++++.   .|+.||+.||+|+|  ++|||||||||+||||+.+|.+||+|||+|+........   .++.  
T Consensus       334 ~~~----~~l~~~---~I~~QIl~AL~ylH--~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~---~~t~--  399 (569)
T 4azs_A          334 AAG----EEIDRE---KILGSLLRSLAALE--KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW---PTNL--  399 (569)
T ss_dssp             HTT----CCCCHH---HHHHHHHHHHHHHH--HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC---SHHH--
T ss_pred             HhC----CCCCHH---HHHHHHHHHHHHHH--HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc---ccCc--
Confidence            876    346654   58899999999999  599999999999999999999999999999876543221   1222  


Q ss_pred             EEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          267 IYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       267 ~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                        +|||.||               |||++.+.  ....+|+|++|++.+++...+.
T Consensus       400 --vGTp~Ym---------------APE~l~g~--~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          400 --VQSFFVF---------------VNELFAEN--KSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             --HHHHHHH---------------HHHHC-------------------CCCCTTHH
T ss_pred             --eechhhc---------------cHHHhCCC--CCCcccccccccchhhhccccc
Confidence              7888888               99998875  3567899999999888765443

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.98  E-value=3.3e-33  Score=260.86  Aligned_cols=201  Identities=23%  Similarity=0.310  Sum_probs=162.0

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcC---CCCCcceEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRL---SHPNLVKLL  161 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l---~h~nIv~l~  161 (376)
                      ..++|++.+.||+|+||.||+|....        .+++.||+|+++....  .....+.+|+.+++.+   +||||++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~   80 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF   80 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred             chhceeeeeeecccccEEEEEEEecC--------CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence            45689999999999999999996532        2478899999864321  1123456777777766   899999999


Q ss_pred             eEEE-----eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC
Q 017177          162 GYCW-----EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG  236 (376)
Q Consensus       162 ~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~  236 (376)
                      +++.     .....++||||++ |+|.+++.....  ..+++..+..++.|++.||.|||  .++|+||||||+|||++.
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~gi~H~dlkp~Nili~~  155 (326)
T 1blx_A           81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTS  155 (326)
T ss_dssp             EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECT
T ss_pred             eeeeecccCCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCHHHeEEcC
Confidence            9987     4567999999997 599999977532  45899999999999999999999  599999999999999999


Q ss_pred             CCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehh
Q 017177          237 VGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSC  316 (376)
Q Consensus       237 ~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~  316 (376)
                      +|.+||+|||++............        .||+.|+               +||++.+.. .+.++||||+|+++++
T Consensus       156 ~~~~kl~Dfg~~~~~~~~~~~~~~--------~~~~~y~---------------aPE~~~~~~-~~~~~Di~slG~il~~  211 (326)
T 1blx_A          156 SGQIKLADFGLARIYSFQMALTSV--------VVTLWYR---------------APEVLLQSS-YATPVDLWSVGCIFAE  211 (326)
T ss_dssp             TCCEEECSCCSCCCCCGGGGGCCC--------CCCCTTC---------------CHHHHTTCC-CCTHHHHHHHHHHHHH
T ss_pred             CCCEEEecCcccccccCCCCcccc--------cccccee---------------CHHHHhcCC-CCcchhHHHHHHHHHH
Confidence            999999999999876543322111        6778888               799887654 5889999999999999


Q ss_pred             hccccccc
Q 017177          317 VFSFYRTT  324 (376)
Q Consensus       317 ~~~~y~~~  324 (376)
                      +++...+.
T Consensus       212 l~~g~~pf  219 (326)
T 1blx_A          212 MFRRKPLF  219 (326)
T ss_dssp             HHHSSCSC
T ss_pred             HHcCCCCC
Confidence            98654443

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.97  E-value=1.5e-32  Score=255.39  Aligned_cols=200  Identities=20%  Similarity=0.164  Sum_probs=145.9

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hh-HHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QG-FEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~-~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++.+.||+|+||.||+|...         .+++.||||++..... .. .+.+.++..+++.++||||+++++++
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~   93 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFR---------KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTF   93 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEET---------TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEe---------cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEE
Confidence            3467999999999999999999654         3588999999976533 22 23444555678888999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .+++..++||||+ ++.+..+.....   ..+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|
T Consensus        94 ~~~~~~~lv~e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~~~kl~d  168 (318)
T 2dyl_A           94 ITNTDVFIAMELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGQIKLCD  168 (318)
T ss_dssp             ECSSEEEEEECCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEECTTSCEEECC
T ss_pred             ecCCcEEEEEecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEECCCCCEEEEE
Confidence            9999999999999 556666655432   458999999999999999999994 13999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHh----hhhhccccccccceeeeehhhccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYA----WIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~----~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ||++...........        ..||+.|+               +||++.    .....+.++||||+|++++++++.
T Consensus       169 fg~~~~~~~~~~~~~--------~~~~~~y~---------------aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g  225 (318)
T 2dyl_A          169 FGISGRLVDDKAKDR--------SAGCAAYM---------------APERIDPPDPTKPDYDIRADVWSLGISLVELATG  225 (318)
T ss_dssp             CTTC----------------------CCTTC---------------CHHHHC--------CCTHHHHHHHHHHHHHHHHS
T ss_pred             CCCchhccCCccccc--------cCCCcccc---------------ChhhcccccccccCCccccchhhHHHHHHHHHhC
Confidence            999987654332211        16778888               799885    234567899999999999999965


Q ss_pred             ccc
Q 017177          321 YRT  323 (376)
Q Consensus       321 y~~  323 (376)
                      ..+
T Consensus       226 ~~p  228 (318)
T 2dyl_A          226 QFP  228 (318)
T ss_dssp             SCT
T ss_pred             CCC
Confidence            433

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.97  E-value=7e-33  Score=263.40  Aligned_cols=195  Identities=18%  Similarity=0.161  Sum_probs=162.3

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-----------CCC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-----------HPN  156 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----------h~n  156 (376)
                      .++|++.+.||+|+||.||+|...         .+++.||||++.... ...+.+.+|+.++++++           |||
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~   87 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDM---------VNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANH   87 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred             CCeEEEEEeeeecCCeEEEEEEec---------CCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccch
Confidence            468999999999999999999543         358899999998543 33467788999999886           899


Q ss_pred             cceEEeEEEeCC----eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CcEecCCCCCC
Q 017177          157 LVKLLGYCWEDK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEK-KVIYRDFKASN  231 (376)
Q Consensus       157 Iv~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~-~iiHrDlKp~N  231 (376)
                      |+++++++...+    .+++|||++ +++|.+++.....  ..+++..+..++.||+.||.|||+  + +|+||||||+|
T Consensus        88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~--~~~ivH~Dikp~N  162 (373)
T 1q8y_A           88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPEN  162 (373)
T ss_dssp             BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGG
T ss_pred             HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChHH
Confidence            999999988654    799999999 8899999987532  458999999999999999999994  6 99999999999


Q ss_pred             EEEc------CCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccc
Q 017177          232 ILLD------GVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLK  305 (376)
Q Consensus       232 ILl~------~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~  305 (376)
                      ||++      ..+.+||+|||++.........      .    .||+.|+               |||++.+.. ++.++
T Consensus       163 Ill~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~------~----~~t~~y~---------------aPE~~~~~~-~~~~~  216 (373)
T 1q8y_A          163 VLMEIVDSPENLIQIKIADLGNACWYDEHYTN------S----IQTREYR---------------SPEVLLGAP-WGCGA  216 (373)
T ss_dssp             EEEEEEETTTTEEEEEECCCTTCEETTBCCCS------C----CSCGGGC---------------CHHHHHTCC-CCTHH
T ss_pred             eEEeccCCCcCcceEEEcccccccccCCCCCC------C----CCCcccc---------------CcHHHhCCC-CCchH
Confidence            9994      3448999999999876543211      1    6788888               899888765 58899


Q ss_pred             cccceeeeehhhcccccc
Q 017177          306 YSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       306 dv~s~g~v~~~~~~~y~~  323 (376)
                      ||||+|++++++++...+
T Consensus       217 Di~slG~il~el~~g~~p  234 (373)
T 1q8y_A          217 DIWSTACLIFELITGDFL  234 (373)
T ss_dssp             HHHHHHHHHHHHHHSSCC
T ss_pred             hHHHHHHHHHHHHhCCCC
Confidence            999999999999975443

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.97  E-value=8.6e-32  Score=247.27  Aligned_cols=168  Identities=15%  Similarity=0.050  Sum_probs=141.5

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ..++|++.+.||+|+||.||+|++.         .+++.||+|++.....   ...+.+.+|+.+++.++||||++++++
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~   99 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDT---------ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDV   99 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEET---------TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEec---------CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEE
Confidence            3467999999999999999999554         3588999999987532   345788999999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +.+++..|+||||++|++|.+++.+.      .....+..++.|++.||.|||  .++|+||||||+|||++.+|.+||+
T Consensus       100 ~~~~~~~~lv~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH--~~givH~Dikp~NIll~~~g~~kl~  171 (286)
T 3uqc_A          100 VHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAH--RAGVALSIDHPSRVRVSIDGDVVLA  171 (286)
T ss_dssp             EEETTEEEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEEETTSCEEEC
T ss_pred             EEECCcEEEEEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHH--HCCCccCCCCcccEEEcCCCCEEEE
Confidence            99999999999999999999999532      355678899999999999999  5999999999999999999999998


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHH--HHHHHHHhhhhh
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYS--VLLPRIYAWIKY  300 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s--~~apEi~~~~~~  300 (376)
                      ++|...                             ....++|+|+  +++.|++.|...
T Consensus       172 ~~~~~~-----------------------------~~~~~~Di~slG~il~elltg~~P  201 (286)
T 3uqc_A          172 YPATMP-----------------------------DANPQDDIRGIGASLYALLVNRWP  201 (286)
T ss_dssp             SCCCCT-----------------------------TCCHHHHHHHHHHHHHHHHHSEEC
T ss_pred             eccccC-----------------------------CCCchhHHHHHHHHHHHHHHCCCC
Confidence            554221                             1466778875  777887777654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.97  E-value=3.7e-31  Score=244.35  Aligned_cols=148  Identities=21%  Similarity=0.246  Sum_probs=127.2

Q ss_pred             hcCCCCcc-ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHH-hcCCCCCcceEEeEE
Q 017177           87 ATKNFKPD-SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFL-GRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il-~~l~h~nIv~l~~~~  164 (376)
                      ..++|.+. +.||+|+||.||+|...         .+++.||+|+++..     ..+.+|+.++ +.++||||+++++++
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~   80 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNK---------RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY   80 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEc---------CCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhh
Confidence            44567777 78999999999999544         35889999998643     4567788888 555799999999999


Q ss_pred             Ee----CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC---C
Q 017177          165 WE----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG---V  237 (376)
Q Consensus       165 ~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~---~  237 (376)
                      ..    ...+++||||+++|+|.+++.....  ..+++..+..++.|++.||.|||  .++|+||||||+|||++.   +
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~  156 (299)
T 3m2w_A           81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPN  156 (299)
T ss_dssp             EEEETTEEEEEEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSSTT
T ss_pred             hhhcCCCceEEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEecCCCC
Confidence            87    6779999999999999999987532  46899999999999999999999  599999999999999988   7


Q ss_pred             CcEEEcceeeeeeec
Q 017177          238 GFLFDSHLLIYVYFK  252 (376)
Q Consensus       238 g~~kl~Dfg~a~~~~  252 (376)
                      +.+||+|||++....
T Consensus       157 ~~~kl~Dfg~a~~~~  171 (299)
T 3m2w_A          157 AILKLTDFGFAKETT  171 (299)
T ss_dssp             CCEEECCCTTCEECT
T ss_pred             CcEEEeccccccccc
Confidence            899999999997543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.97  E-value=7.8e-33  Score=278.46  Aligned_cols=202  Identities=24%  Similarity=0.266  Sum_probs=165.9

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-ChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|         .+..+++.||||+++.. .....+.+.+|+.+++.++||||+++++++..
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla---------~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~   83 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRW---------IHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDG   83 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCC---------CCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTT
T ss_pred             CCCeEEEEEEeeCCCeEEEEE---------EECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecc
Confidence            468999999999999999998         44456889999998765 34456788999999999999999999998755


Q ss_pred             ------CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc-
Q 017177          167 ------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF-  239 (376)
Q Consensus       167 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~-  239 (376)
                            .+..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||  ..+|+||||||+|||++.++. 
T Consensus        84 ~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLH--s~gIVHrDLKP~NILl~~~g~~  160 (676)
T 3qa8_A           84 LQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLH--ENRIIHRDLKPENIVLQPGPQR  160 (676)
T ss_dssp             TCCCCTTSSCCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHH--HTTBCCCCCCSTTEEEECCSSS
T ss_pred             cccccCCCeEEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHeEeecCCCc
Confidence                  6678999999999999999976532 235888999999999999999999  599999999999999997765 


Q ss_pred             --EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhh
Q 017177          240 --LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCV  317 (376)
Q Consensus       240 --~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~  317 (376)
                        +||+|||++...........        ..||+.|+               +||++.+.. .+.++|+||+|++++++
T Consensus       161 ~~vKL~DFG~a~~~~~~~~~~~--------~~gt~~Y~---------------APE~l~~~~-~s~ksDIwSLGviLyeL  216 (676)
T 3qa8_A          161 LIHKIIDLGYAKELDQGELCTE--------FVGTLQYL---------------APELLEQKK-YTVTVDYWSFGTLAFEC  216 (676)
T ss_dssp             CEEEECSCCCCCBTTSCCCCCC--------CCSCCTTC---------------SSCSSCCSC-CSTTHHHHHHHHHHHHH
T ss_pred             eeEEEccccccccccccccccc--------ccCCcccC---------------ChHHhccCC-CCchhHHHHHHHHHHHH
Confidence              99999999998755433211        16778888               799776554 58899999999999999


Q ss_pred             ccccccch
Q 017177          318 FSFYRTTM  325 (376)
Q Consensus       318 ~~~y~~~~  325 (376)
                      ++...+..
T Consensus       217 ltG~~Pf~  224 (676)
T 3qa8_A          217 ITGFRPFL  224 (676)
T ss_dssp             HSSCSSCC
T ss_pred             HHCCCCCC
Confidence            97766653

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.96  E-value=4.4e-31  Score=255.00  Aligned_cols=199  Identities=14%  Similarity=0.100  Sum_probs=147.3

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCC-CCcce---
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSH-PNLVK---  159 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h-~nIv~---  159 (376)
                      ..+.|+..+.||+|+||.||+|.+.         .+++.||||++.....   ...+.+.+|+.+++.++| +|+..   
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~---------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~  146 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQ---------ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV  146 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHH
T ss_pred             CceeEEEecccccCCCEEEEEEEec---------CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHH
Confidence            3445788899999999999999544         3688999999985432   235778999999999987 32211   


Q ss_pred             ------------------EEeEEEe-----CCeEEEEEeccCCCCHHHHHhhc---CCCCCCCCHHHHHHHHHHHHHHHH
Q 017177          160 ------------------LLGYCWE-----DKELLLVYEYMQRGSLENHLFRR---NPSIQPLSWDIRLKIAIGAARGLG  213 (376)
Q Consensus       160 ------------------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~i~~qi~~~L~  213 (376)
                                        +..++..     ....+++|+++ +++|.+++...   ......+++..++.++.||+.||.
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  225 (413)
T 3dzo_A          147 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLA  225 (413)
T ss_dssp             HTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHH
T ss_pred             hcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHH
Confidence                              1111111     12467888876 67999988521   112345778899999999999999


Q ss_pred             HhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHH
Q 017177          214 FLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPR  293 (376)
Q Consensus       214 yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apE  293 (376)
                      |||  .++|+||||||+||||+.+|.+||+|||+++.....      ..+.    +| +.|+               |||
T Consensus       226 ~LH--~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~----~g-~~y~---------------aPE  277 (413)
T 3dzo_A          226 SLH--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSP----IG-RGFA---------------PPE  277 (413)
T ss_dssp             HHH--HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE------ECCC----CC-TTTC---------------CHH
T ss_pred             HHH--hCCcccCCcccceEEEecCCeEEEEeccceeecCCc------cccC----CC-Ccee---------------Cch
Confidence            999  599999999999999999999999999999875443      1111    66 7788               899


Q ss_pred             HHh---------hhhhccccccccceeeeehhhcccccc
Q 017177          294 IYA---------WIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       294 i~~---------~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ++.         ....++.++||||+|++++++++...+
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~P  316 (413)
T 3dzo_A          278 TTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP  316 (413)
T ss_dssp             HHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCC
T ss_pred             hhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCC
Confidence            884         333467899999999999999865433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=1.6e-28  Score=244.32  Aligned_cols=175  Identities=14%  Similarity=0.092  Sum_probs=128.6

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--------hhHHHHHHHHHHHhcCCCCCcceEEe
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--------QGFEEWQSEVNFLGRLSHPNLVKLLG  162 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~h~nIv~l~~  162 (376)
                      +...+.||+|+||.||+|...           +..+++|+......        ...+++.+|++++++++||||+++..
T Consensus       338 ~~~~~~LG~G~fg~Vy~~~~~-----------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~  406 (540)
T 3en9_A          338 KIPEHLIGKGAEADIKRDSYL-----------DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYI  406 (540)
T ss_dssp             ----------CCEEEEEEECS-----------SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCE
T ss_pred             CCCCCEEeeCCCEEEEEEEEC-----------CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEE
Confidence            345679999999999999433           66788888654321        11356889999999999999996666


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                      ++...+..||||||+++++|.+++.+            +..++.|++.||.|||  +++|+||||||+|||++.  .+||
T Consensus       407 ~~~~~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH--~~gIiHrDiKp~NILl~~--~~kL  470 (540)
T 3en9_A          407 FDVDLDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLH--KNDVIHNDLTTSNFIFDK--DLYI  470 (540)
T ss_dssp             EEEETTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHH--HTTEECTTCCTTSEEESS--SEEE
T ss_pred             EEEeCCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHH--HCcCccCCCCHHHEEECC--eEEE
Confidence            66677888999999999999999854            4589999999999999  599999999999999998  9999


Q ss_pred             cceeeeeeeccceeeEE----EeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh-hhcccccccccee
Q 017177          243 SHLLIYVYFKRHYIYIY----IHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI-KYLTLLKYSNSFA  311 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~----~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~-~~~~~~~dv~s~g  311 (376)
                      +|||+++..........    ...+.    .||+.||               +||++.+. ..+....|+|+..
T Consensus       471 ~DFGla~~~~~~~~~~~~~~~~~~~~----~GT~~y~---------------APEv~~~~~~~Y~~~~d~ws~v  525 (540)
T 3en9_A          471 IDFGLGKISNLDEDKAVDLIVFKKAV----LSTHHEK---------------FDEIWERFLEGYKSVYDRWEII  525 (540)
T ss_dssp             CCCTTCEECCCHHHHHHHHHHHHHHH----HHHCGGG---------------HHHHHHHHHHHHHHHCTTHHHH
T ss_pred             EECccCEECCCccccccchhhhhhhh----cCCCCcC---------------CHHHHHHHHHHHHHHHhHHHHH
Confidence            99999998765422110    01122    7888888               89998873 2335666777543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=1.2e-24  Score=199.21  Aligned_cols=136  Identities=12%  Similarity=0.039  Sum_probs=109.4

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh------------------hhHHHHHHHHHHH
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM------------------QGFEEWQSEVNFL  149 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~il  149 (376)
                      ...|.+.+.||+|+||.||+|.+.          +++.||+|.++....                  .....+.+|+.++
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~~----------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l  158 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYSE----------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRAL  158 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEET----------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHH
T ss_pred             CeEEEecCEeccCCCceEEEEEeC----------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHH
Confidence            445667799999999999999662          488999999975422                  1345688999999


Q ss_pred             hcCCCCCcceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCC
Q 017177          150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKA  229 (376)
Q Consensus       150 ~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp  229 (376)
                      +.++  | +++.+++.. +..|+||||++||+|.+ +..          .....++.|++.||.|||  +++|+||||||
T Consensus       159 ~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH--~~giiHrDlkp  221 (282)
T 1zar_A          159 QKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFY--HRGIVHGDLSQ  221 (282)
T ss_dssp             HHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHH--HTTEECSCCST
T ss_pred             Hhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHH--HCCCEeCCCCH
Confidence            9999  4 566665433 55799999999999988 421          123469999999999999  59999999999


Q ss_pred             CCEEEcCCCcEEEcceeeeeee
Q 017177          230 SNILLDGVGFLFDSHLLIYVYF  251 (376)
Q Consensus       230 ~NILl~~~g~~kl~Dfg~a~~~  251 (376)
                      +|||++ +|.+||+|||+++..
T Consensus       222 ~NILl~-~~~vkl~DFG~a~~~  242 (282)
T 1zar_A          222 YNVLVS-EEGIWIIDFPQSVEV  242 (282)
T ss_dssp             TSEEEE-TTEEEECCCTTCEET
T ss_pred             HHEEEE-CCcEEEEECCCCeEC
Confidence            999999 999999999999743

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=1.8e-22  Score=182.26  Aligned_cols=138  Identities=15%  Similarity=0.053  Sum_probs=105.9

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcE--EEEEEcCCCChh------------------------hHHHHHH
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMV--VAIKKLNPESMQ------------------------GFEEWQS  144 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~  144 (376)
                      |++.+.||+|+||.||+|...         .+|+.  ||||+++.....                        ....+.+
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~---------~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  119 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGV---------FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK  119 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEE---------ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEc---------CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence            678899999999999999652         13778  999987653211                        1135788


Q ss_pred             HHHHHhcCCCCCc--ceEEeEEEeCCeEEEEEeccCC-C----CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh-
Q 017177          145 EVNFLGRLSHPNL--VKLLGYCWEDKELLLVYEYMQR-G----SLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH-  216 (376)
Q Consensus       145 E~~il~~l~h~nI--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH-  216 (376)
                      |+.+|..+.|++|  +.+++.    +..+|||||+.+ |    +|.++...       .++..+..++.|++.||.||| 
T Consensus       120 E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~  188 (258)
T 1zth_A          120 EFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQ  188 (258)
T ss_dssp             HHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHH
Confidence            9999999988764  444432    357899999942 3    67766532       234457789999999999999 


Q ss_pred             cCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeec
Q 017177          217 TSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFK  252 (376)
Q Consensus       217 s~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~  252 (376)
                      +  .+|+||||||+|||++.  .++|+|||++....
T Consensus       189 ~--~givHrDlkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          189 E--AELVHADLSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             T--SCEECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred             H--CCEEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence            6  89999999999999998  99999999998653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=4.7e-20  Score=173.83  Aligned_cols=139  Identities=12%  Similarity=0.007  Sum_probs=99.5

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--------------hhHH--------HHHHHHH
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--------------QGFE--------EWQSEVN  147 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~  147 (376)
                      -|.+...||.|+||.||+|...          +|+.||||+++....              ....        ...+|..
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~----------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~  165 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE----------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA  165 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT----------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred             EEEecCEeeeCCceEEEEEECC----------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence            4899999999999999999643          388999998764210              0011        1235677


Q ss_pred             HHhcCCCCCcceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCC
Q 017177          148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDF  227 (376)
Q Consensus       148 il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDl  227 (376)
                      .|.++.+.++.-..-+...  ..+|||||++|++|.++..        .  .....++.|++.+|.+||  +.+||||||
T Consensus       166 nL~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH--~~gIVHrDL  231 (397)
T 4gyi_A          166 FMKALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLA--KHGLIHGDF  231 (397)
T ss_dssp             HHHHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHH--HTTEECSCC
T ss_pred             HHHHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHH--HCCCcCCCC
Confidence            7777754444322211122  2379999999988865431        1  234568899999999999  589999999


Q ss_pred             CCCCEEEcCCC----------cEEEcceeeeeeec
Q 017177          228 KASNILLDGVG----------FLFDSHLLIYVYFK  252 (376)
Q Consensus       228 Kp~NILl~~~g----------~~kl~Dfg~a~~~~  252 (376)
                      ||.|||++++|          .+.|+||+-+....
T Consensus       232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             STTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence            99999998877          38999999887643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.52  E-value=1.8e-14  Score=129.80  Aligned_cols=146  Identities=14%  Similarity=-0.038  Sum_probs=113.0

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEEeE
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGY  163 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~  163 (376)
                      ......|++...++.|+.+.||++...           +..+++|............+.+|+.+++.+. +..+++++++
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-----------~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~   78 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-----------NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHF   78 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-----------SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-----------CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence            344567888888999999999998422           5679999987532122245788999999996 7788899999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------------------------
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS-------------------------  218 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~-------------------------  218 (376)
                      +.+.+..|+||||++|.+|.+.+..         ......++.+++++|..||+.                         
T Consensus        79 ~~~~~~~~lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (263)
T 3tm0_A           79 ERHDGWSNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNND  149 (263)
T ss_dssp             EEETTEEEEEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTT
T ss_pred             EecCCceEEEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcc
Confidence            9998999999999999998876311         112346778899999999951                         


Q ss_pred             --------------------------------CCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          219 --------------------------------EKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       219 --------------------------------~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                                                      ...++|+|++|.|||+++++.+.++||+.+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          150 LADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                            04489999999999998766667999998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.36  E-value=1.5e-12  Score=116.44  Aligned_cols=138  Identities=16%  Similarity=-0.017  Sum_probs=98.5

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCC--cceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN--LVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--Iv~l~~~~~  165 (376)
                      ..++.+..+.+.|..+.||++...          ++..+++|......   ...+.+|+.+++.+.+.+  +.+++++..
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~~----------~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~   85 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVT   85 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEECT----------TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEE
T ss_pred             cCCCceEecccCCCCceEEEEecC----------CCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEecc
Confidence            344555444345666999998432          25679999976542   245678999999986434  567888888


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--------------------------
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSE--------------------------  219 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~--------------------------  219 (376)
                      .++..++||||++|.+|.  ...       ..   ...++.+++..|..||+..                          
T Consensus        86 ~~~~~~~v~e~i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (264)
T 1nd4_A           86 EAGRDWLLLGEVPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLV  153 (264)
T ss_dssp             CSSCEEEEEECCSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCC
T ss_pred             CCCCCEEEEEecCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCc
Confidence            888899999999998873  211       11   1256677777788888411                          


Q ss_pred             ------------------------------CCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          220 ------------------------------KKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       220 ------------------------------~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                                                    ..++|+|++|.|||+++++.+.++||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          154 DQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                          1299999999999998776677999999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.25  E-value=9.1e-12  Score=117.30  Aligned_cols=141  Identities=13%  Similarity=0.164  Sum_probs=104.9

Q ss_pred             ccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcC--CCCh-hhHHHHHHHHHHHhcCC--CCCcceEEeEEEeC
Q 017177           93 PDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN--PESM-QGFEEWQSEVNFLGRLS--HPNLVKLLGYCWED  167 (376)
Q Consensus        93 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~il~~l~--h~nIv~l~~~~~~~  167 (376)
                      ..+.|+.|.++.||++...           +..+++|+..  .... .....+.+|+.+++.+.  +..+++++.++.+.
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-----------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~  110 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-----------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE  110 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-----------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred             eEEEcCCcccceEEEEEEC-----------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence            4567899999999998533           4568888876  3321 22356778999999997  55688899888766


Q ss_pred             ---CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcC--------------------------
Q 017177          168 ---KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS--------------------------  218 (376)
Q Consensus       168 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~--------------------------  218 (376)
                         +..|+||||++|..+.+..      ...++......++.++++.|..||..                          
T Consensus       111 ~~~g~~~~vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (359)
T 3dxp_A          111 SVIGRAFYIMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTK  184 (359)
T ss_dssp             TTTSSCEEEEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHH
T ss_pred             CccCCeEEEEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHH
Confidence               4589999999997774321      13367788888999999999999961                          


Q ss_pred             ------------------------------CCCcEecCCCCCCEEEcCCCc--EEEcceeeeee
Q 017177          219 ------------------------------EKKVIYRDFKASNILLDGVGF--LFDSHLLIYVY  250 (376)
Q Consensus       219 ------------------------------~~~iiHrDlKp~NILl~~~g~--~kl~Dfg~a~~  250 (376)
                                                    ...++|+|++|.|||++.++.  +.++||+.+..
T Consensus       185 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          185 QYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                          146899999999999987753  68999998875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.89  E-value=3.4e-09  Score=97.25  Aligned_cols=136  Identities=19%  Similarity=0.093  Sum_probs=97.8

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCC--cceEEeEEEeCC--
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPN--LVKLLGYCWEDK--  168 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~n--Iv~l~~~~~~~~--  168 (376)
                      .+.++.|....||++              +..+++|+....  .....+.+|+.+++.+. +..  +.+++......+  
T Consensus        25 i~~~~~G~~n~v~~v--------------~~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~   88 (304)
T 3sg8_A           25 IEISGEGNDCIAYEI--------------NRDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY   88 (304)
T ss_dssp             CCEEEECSSEEEEES--------------TTSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred             eEecCCCCcceEEEE--------------CCEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence            456999999999986              345889986533  33467889999998884 333  445554433332  


Q ss_pred             -eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----------------------------
Q 017177          169 -ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS-----------------------------  218 (376)
Q Consensus       169 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~-----------------------------  218 (376)
                       ..|+|||+++|.+|.+....      .++..+...++.+++..|..||+.                             
T Consensus        89 ~~~~~vm~~i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (304)
T 3sg8_A           89 QMSFAGFTKIKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLS  162 (304)
T ss_dssp             SCSCEEEECCCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHT
T ss_pred             CcceEEEcccCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhc
Confidence             35899999999888654322      256667777777777777777741                             


Q ss_pred             ---------------------------CCCcEecCCCCCCEEEcC--CCcEEEcceeeeeee
Q 017177          219 ---------------------------EKKVIYRDFKASNILLDG--VGFLFDSHLLIYVYF  251 (376)
Q Consensus       219 ---------------------------~~~iiHrDlKp~NILl~~--~g~~kl~Dfg~a~~~  251 (376)
                                                 ...++|+|++|.||++++  .+.+.++||+.+...
T Consensus       163 ~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          163 RELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             TTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             ccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                                       134799999999999998  456789999998754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.81  E-value=3.6e-08  Score=90.55  Aligned_cols=135  Identities=18%  Similarity=0.046  Sum_probs=92.3

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCC---CcceEEeEEE-eCCe
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP---NLVKLLGYCW-EDKE  169 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~---nIv~l~~~~~-~~~~  169 (376)
                      .+.++.|....||+.              +..+++|+..  .......+.+|..+|+.+.+.   .+.+++.+.. ..+.
T Consensus        24 v~~l~~G~~n~v~~v--------------g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~   87 (306)
T 3tdw_A           24 VESLGEGFRNYAILV--------------NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN   87 (306)
T ss_dssp             EEEEEECSSEEEEEE--------------TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred             eeecCCCcceeEEEE--------------CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence            467888999999987              4558888853  223446788999999999742   3567777664 3456


Q ss_pred             EEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhc--------------------------------
Q 017177          170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHT--------------------------------  217 (376)
Q Consensus       170 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs--------------------------------  217 (376)
                      .++|||+++|.++.+....      .++......++.++...|..||+                                
T Consensus        88 ~~~v~e~i~G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~  161 (306)
T 3tdw_A           88 PFVGYRKVQGQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVF  161 (306)
T ss_dssp             EEEEEECCCSEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTG
T ss_pred             eEEEEeccCCeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcc
Confidence            8899999999887653211      12333344444444444444442                                


Q ss_pred             --------------------------CCCCcEecCCCCCCEEEcC---CCc-EEEcceeeeee
Q 017177          218 --------------------------SEKKVIYRDFKASNILLDG---VGF-LFDSHLLIYVY  250 (376)
Q Consensus       218 --------------------------~~~~iiHrDlKp~NILl~~---~g~-~kl~Dfg~a~~  250 (376)
                                                ....++|+|++|.|||++.   ++. +.++||+.+..
T Consensus       162 ~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          162 PLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             cccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                      1235699999999999987   455 48999998874

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.67  E-value=1.3e-07  Score=84.90  Aligned_cols=135  Identities=16%  Similarity=0.035  Sum_probs=94.9

Q ss_pred             eEeecCcE-EEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEEeEEEeCCeEEEE
Q 017177           96 LLGEGGFG-RVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        96 ~lG~G~fg-~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lv  173 (376)
                      .+..|..| .||+.....         .+..+++|.-...   ....+.+|..+|+.+. +--+.+++.++.+++..|+|
T Consensus        31 ~~~~G~S~~~v~rl~~~~---------~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv   98 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKP---------NAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL   98 (272)
T ss_dssp             EEECSSSSCEEEEEECCT---------TCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             EccCCCcCCeEEEEEecC---------CCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence            44556555 688764322         3567889986543   3356778999999886 54578899999999999999


Q ss_pred             EeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 017177          174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS-----------------------------------  218 (376)
Q Consensus       174 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~-----------------------------------  218 (376)
                      ||+++|.++.+.....        ......+..++...|.-||..                                   
T Consensus        99 me~l~G~~~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (272)
T 4gkh_A           99 TTAIPGKTAFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDE  170 (272)
T ss_dssp             EECCCSEEHHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGG
T ss_pred             EEeeCCccccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccc
Confidence            9999998887765321        111233455555556656531                                   


Q ss_pred             ---------------------CCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          219 ---------------------EKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       219 ---------------------~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                                           ...++|+|+.+.|||+++++.+-++||+.+..
T Consensus       171 ~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          171 RNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             GTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                 01378999999999999887778999998874

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.38  E-value=3.3e-07  Score=85.76  Aligned_cols=87  Identities=3%  Similarity=-0.073  Sum_probs=54.7

Q ss_pred             cceE-eecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCC-C--CCcceEEeEEEe
Q 017177           94 DSLL-GEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLS-H--PNLVKLLGYCWE  166 (376)
Q Consensus        94 ~~~l-G~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~-h--~nIv~l~~~~~~  166 (376)
                      .+.| +.|....+|+.......   .....+..+++|......   ......+.+|+.+++.+. +  -.+.+++.+..+
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~---~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQ---DGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEE---TTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             EEECCCCCccceEEEEEEeccc---CCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            3567 78888999987532000   000014578888865432   101135677888888885 3  357788887655


Q ss_pred             C---CeEEEEEeccCCCCHH
Q 017177          167 D---KELLLVYEYMQRGSLE  183 (376)
Q Consensus       167 ~---~~~~lv~e~~~~g~L~  183 (376)
                      .   +..|+||||++|..+.
T Consensus       102 ~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          102 GDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             STTTSSCEEEEECCCCBCCC
T ss_pred             CCccCCceEEEEecCCCChh
Confidence            4   3578999999886643

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.30  E-value=8.5e-06  Score=75.32  Aligned_cols=32  Identities=16%  Similarity=0.205  Sum_probs=28.8

Q ss_pred             CCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          219 EKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       219 ~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      ...++|+|+++.|||++.++.+.++||+.+..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            57899999999999998888999999998764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.22  E-value=3.8e-06  Score=79.78  Aligned_cols=76  Identities=16%  Similarity=0.188  Sum_probs=49.6

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-------hhHHHHHHHHHHHhcCCC--C-CcceEEeE
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-------QGFEEWQSEVNFLGRLSH--P-NLVKLLGY  163 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~il~~l~h--~-nIv~l~~~  163 (376)
                      .+.||.|.++.||++....         .++.+++|.......       ....++..|.++++.+..  + .+.+++.+
T Consensus        35 ~~~lg~G~~n~vyrv~~~~---------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~  105 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS  105 (397)
T ss_dssp             EEECCSSSSEEEEEEEC-------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred             EEECCCCceEEEEEEEECC---------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence            4679999999999985432         256799998654211       123456779999988742  3 34456643


Q ss_pred             EEeCCeEEEEEeccCCC
Q 017177          164 CWEDKELLLVYEYMQRG  180 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g  180 (376)
                        +.+..++|||++++.
T Consensus       106 --d~~~~~lvmE~l~g~  120 (397)
T 2olc_A          106 --DTEMAVTVMEDLSHL  120 (397)
T ss_dssp             --ETTTTEEEECCCTTS
T ss_pred             --cCCccEEEEEeCCCc
Confidence              455678999999764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.86  E-value=4.4e-05  Score=73.03  Aligned_cols=31  Identities=10%  Similarity=0.118  Sum_probs=28.1

Q ss_pred             CCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          219 EKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       219 ~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      ...++|+|++|.|||++.++ ++++||+.+..
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            58899999999999999877 99999998875

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.86  E-value=0.00012  Score=66.22  Aligned_cols=77  Identities=16%  Similarity=0.178  Sum_probs=54.8

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-C--CCcceEEeEEEeC
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-H--PNLVKLLGYCWED  167 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h--~nIv~l~~~~~~~  167 (376)
                      ..-.+.+|.|..+.||+....+          |+.|.+|+...........+.+|+..|+.|. .  -.+++++++  + 
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~D----------G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~-   83 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELAD----------GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D-   83 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT----------SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E-
T ss_pred             eEEEEecCCCCCeEEEEEEECC----------CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c-
Confidence            3445789999999999987654          7889999876554333356778999999885 2  234555553  2 


Q ss_pred             CeEEEEEeccCCCC
Q 017177          168 KELLLVYEYMQRGS  181 (376)
Q Consensus       168 ~~~~lv~e~~~~g~  181 (376)
                       .-++||||++++.
T Consensus        84 -~~~lv~e~l~~~~   96 (288)
T 3f7w_A           84 -DRTLAMEWVDERP   96 (288)
T ss_dssp             -TTEEEEECCCCCC
T ss_pred             -CceEEEEeecccC
Confidence             2478999998764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.81  E-value=5.7e-05  Score=69.19  Aligned_cols=76  Identities=14%  Similarity=0.094  Sum_probs=59.2

Q ss_pred             ccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC---CCCcceEEeEEEeCCe
Q 017177           93 PDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS---HPNLVKLLGYCWEDKE  169 (376)
Q Consensus        93 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~l~~~~~~~~~  169 (376)
                      -.+.|+.|....+|+....           +..+++|.....   ....+.+|...|+.|.   ...+++++.+....+.
T Consensus        40 ~~~~l~gG~~n~~y~v~~~-----------~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~  105 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLINDE-----------VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGH  105 (312)
T ss_dssp             EEEEECCSSSSEEEEEESS-----------SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSE
T ss_pred             eeEEeCCccceeeeEEEEC-----------CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCc
Confidence            3467899999999997432           567888986543   2456788999998885   3678889998888889


Q ss_pred             EEEEEeccCCCCH
Q 017177          170 LLLVYEYMQRGSL  182 (376)
Q Consensus       170 ~~lv~e~~~~g~L  182 (376)
                      .++||||++|..+
T Consensus       106 ~~lvme~l~G~~~  118 (312)
T 3jr1_A          106 SFLLLEALNKSKN  118 (312)
T ss_dssp             EEEEEECCCCCCC
T ss_pred             eEEEEEeccCCCC
Confidence            9999999998754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.56  E-value=0.00027  Score=64.16  Aligned_cols=137  Identities=11%  Similarity=0.016  Sum_probs=75.0

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCc-ceEEeEEEeCCeEEE
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNL-VKLLGYCWEDKELLL  172 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nI-v~l~~~~~~~~~~~l  172 (376)
                      .+.|+.|....+|++  .             .+++|+........ ....+|+.+++.+...++ .+++..  +++.-++
T Consensus        23 i~~l~gG~tN~~~~~--~-------------~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~   84 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA--G-------------DLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVM   84 (301)
T ss_dssp             CEEEESCSSEEEEEE--T-------------TEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCE
T ss_pred             eeEcCCcccccccee--e-------------eEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEE
Confidence            678999999999987  1             27888876542211 122468888887752222 455543  3444578


Q ss_pred             EEecc-CCCCHHH---------------HHhhcCCCCCC----CCH-HH---------------------HHHHHHHHHH
Q 017177          173 VYEYM-QRGSLEN---------------HLFRRNPSIQP----LSW-DI---------------------RLKIAIGAAR  210 (376)
Q Consensus       173 v~e~~-~~g~L~~---------------~l~~~~~~~~~----~~~-~~---------------------~~~i~~qi~~  210 (376)
                      ++||+ +|.++..               .|.+-+.....    ... ..                     ....+..+..
T Consensus        85 v~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  164 (301)
T 3dxq_A           85 VTRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRS  164 (301)
T ss_dssp             EEECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHH
T ss_pred             EEeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHH
Confidence            99999 6544421               11111100000    111 11                     1111111111


Q ss_pred             HHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          211 GLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       211 ~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      .+.- +.....++|+|+.|.||| ..++.+.++||..+..
T Consensus       165 ~l~~-~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          165 ALAA-HPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             HHHS-SCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHh-cCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            1111 111356899999999999 5667789999988874

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.55  E-value=0.00091  Score=61.09  Aligned_cols=143  Identities=10%  Similarity=0.023  Sum_probs=76.7

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-C-CCcceEEeE------EEe
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-H-PNLVKLLGY------CWE  166 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h-~nIv~l~~~------~~~  166 (376)
                      +.|+.|....+|++...+          + .+++|.......  ...+..|+.+++.|. + -.+.+++..      ...
T Consensus        28 ~~i~~G~~n~~~~v~~~~----------g-~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~   94 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTK----------D-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL   94 (322)
T ss_dssp             EEECC---EEEEEEEESS----------C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred             eccCCCcccceEEEEeCC----------c-cEEEEEeCCCCC--HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence            456778888999985432          3 588998876311  134456777777764 2 113343321      223


Q ss_pred             CCeEEEEEeccCCCCHHH-----------H---HhhcC-CCCCC----CC---HHHHHH------------HHHHHHHHH
Q 017177          167 DKELLLVYEYMQRGSLEN-----------H---LFRRN-PSIQP----LS---WDIRLK------------IAIGAARGL  212 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~-----------~---l~~~~-~~~~~----~~---~~~~~~------------i~~qi~~~L  212 (376)
                      .+..+++|+|++|..+..           .   ++... .....    ..   +.....            +...+...+
T Consensus        95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~  174 (322)
T 2ppq_A           95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI  174 (322)
T ss_dssp             TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred             CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence            467899999998854311           1   11110 00000    11   111000            000123334


Q ss_pred             HHhhc-----CCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          213 GFLHT-----SEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       213 ~yLHs-----~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      .+++.     ....++|+|+.+.|||++.++.+.++||+.+..
T Consensus       175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            44431     135799999999999999876668999988764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.53  E-value=0.00019  Score=66.17  Aligned_cols=33  Identities=18%  Similarity=-0.001  Sum_probs=28.5

Q ss_pred             CCCcEecCCCCCCEEEcCC----CcEEEcceeeeeee
Q 017177          219 EKKVIYRDFKASNILLDGV----GFLFDSHLLIYVYF  251 (376)
Q Consensus       219 ~~~iiHrDlKp~NILl~~~----g~~kl~Dfg~a~~~  251 (376)
                      ...++|+|+.+.|||++.+    +.+.++||+.+...
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            4689999999999999874    67999999988753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.38  E-value=0.0011  Score=60.84  Aligned_cols=142  Identities=15%  Similarity=0.007  Sum_probs=79.3

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-C-CCcceEEeE-----EEeC
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-H-PNLVKLLGY-----CWED  167 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h-~nIv~l~~~-----~~~~  167 (376)
                      ..|+ |....||++...          .|..+++|....... ....+..|..+++.+. + -.+++++..     ....
T Consensus        32 ~~l~-g~~n~~y~v~~~----------~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~   99 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE----------DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQ   99 (328)
T ss_dssp             EEEC-CSSSEEEEECCT----------TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEET
T ss_pred             Eeec-CcccceEEEEcC----------CCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEEC
Confidence            4566 777889987332          255799999874321 2345667888888775 2 224444442     2235


Q ss_pred             CeEEEEEeccCCCCHH-----H------HH---hhc---CCC--CCCCCHHHH----------------------HHHHH
Q 017177          168 KELLLVYEYMQRGSLE-----N------HL---FRR---NPS--IQPLSWDIR----------------------LKIAI  206 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~-----~------~l---~~~---~~~--~~~~~~~~~----------------------~~i~~  206 (376)
                      +..+++||+++|..+.     .      .+   +..   ...  ...++....                      ...+.
T Consensus       100 g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  179 (328)
T 1zyl_A          100 GFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATD  179 (328)
T ss_dssp             TEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHH
T ss_pred             CEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHH
Confidence            6678999999874321     1      11   110   000  011121110                      11122


Q ss_pred             HHHHHHHHhhc--CCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          207 GAARGLGFLHT--SEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       207 qi~~~L~yLHs--~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      +++..+.-+-.  ....++|+|+++.|||++ + .+.++||+.+..
T Consensus       180 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          180 ELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            22222222110  145689999999999999 4 889999988764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.26  E-value=0.00058  Score=64.18  Aligned_cols=150  Identities=15%  Similarity=0.077  Sum_probs=83.6

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEEeEEEeCCeEEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLLV  173 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lv  173 (376)
                      +.|..|-...+|++...+...  .....+..+++|+.... ......+.+|..+++.|. +.-..++++.+.  +  .+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v  128 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLP--SVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRL  128 (379)
T ss_dssp             EEC-----CCEEEEECCTTSC--CCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEE
T ss_pred             EEcCCcccccEEEEEeCCCcc--ccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccE
Confidence            567678888899986532100  01112567899986432 123455668999998886 333466766553  2  399


Q ss_pred             EeccCCCCHH--------------HHHhhcCCC----CCCC--CHHHHHHHHHHHHH-------------------HHHH
Q 017177          174 YEYMQRGSLE--------------NHLFRRNPS----IQPL--SWDIRLKIAIGAAR-------------------GLGF  214 (376)
Q Consensus       174 ~e~~~~g~L~--------------~~l~~~~~~----~~~~--~~~~~~~i~~qi~~-------------------~L~y  214 (376)
                      |||++|.+|.              +.|.+-+..    ....  -+..+.++..++..                   .+..
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            9999875442              111111110    1111  13444445443321                   1222


Q ss_pred             hh----c--CCCCcEecCCCCCCEEEcCC----CcEEEcceeeeeee
Q 017177          215 LH----T--SEKKVIYRDFKASNILLDGV----GFLFDSHLLIYVYF  251 (376)
Q Consensus       215 LH----s--~~~~iiHrDlKp~NILl~~~----g~~kl~Dfg~a~~~  251 (376)
                      |.    .  ....++|+|+.+.|||++.+    +.+.++||..+...
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~  255 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN  255 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence            22    1  14578999999999999876    78999999888754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.23  E-value=0.00083  Score=64.33  Aligned_cols=80  Identities=14%  Similarity=-0.026  Sum_probs=49.9

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEEeEEEeCCeEEE
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLL  172 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~l  172 (376)
                      .+.|+.|....||++...+...  .....+..+++|+......  ...+.+|..+++.+. +.-.+++++.+.  +  .+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~--~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~  149 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR  149 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred             EEEeCCCcccceEEEEeCCCcc--ccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CE
Confidence            4568888889999986543110  0011256789998854211  134557999999886 333466776543  2  38


Q ss_pred             EEeccCCCC
Q 017177          173 VYEYMQRGS  181 (376)
Q Consensus       173 v~e~~~~g~  181 (376)
                      |+||++|.+
T Consensus       150 v~e~l~G~~  158 (429)
T 1nw1_A          150 LEEYIPSRP  158 (429)
T ss_dssp             EECCCCEEE
T ss_pred             EEEEeCCcc
Confidence            999998643

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.05  E-value=0.0034  Score=60.52  Aligned_cols=75  Identities=15%  Similarity=0.068  Sum_probs=46.6

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCc-ceEEeEEEeCCeEEE
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNL-VKLLGYCWEDKELLL  172 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nI-v~l~~~~~~~~~~~l  172 (376)
                      .+.|+.|-...+|++...+         .+..+++|+......... ...+|..+++.|...++ +++++.+  .+  .+
T Consensus       113 i~~lsgG~tN~~y~v~~~~---------~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~  178 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMS---------KQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFF--TN--GR  178 (458)
T ss_dssp             EEEECC--CEEEEEEEETT---------TTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEE--TT--EE
T ss_pred             EEEcCCCeEeEEEEEEECC---------CCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEe--CC--eE
Confidence            3568888889999986542         136788988754321111 12579999999874444 5677766  22  35


Q ss_pred             EEeccCCCCH
Q 017177          173 VYEYMQRGSL  182 (376)
Q Consensus       173 v~e~~~~g~L  182 (376)
                      ||||++|.+|
T Consensus       179 v~e~I~G~~l  188 (458)
T 2qg7_A          179 IEEFMDGYAL  188 (458)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEeeCCccC
Confidence            9999987443

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.99  E-value=0.0012  Score=61.78  Aligned_cols=81  Identities=11%  Similarity=0.066  Sum_probs=44.2

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCC-cceEEeEEEeCCeEEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN-LVKLLGYCWEDKELLLV  173 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n-Iv~l~~~~~~~~~~~lv  173 (376)
                      +.|+.|....+|++...+.... .....+..+++|+....... ......|..+++.+...+ +.++++.+  +  -++|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~-~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETAN-NYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHT-TCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcc-cccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            5677788889999865320000 00011357888887654221 112356888888886223 45676544  2  3789


Q ss_pred             EeccCCCC
Q 017177          174 YEYMQRGS  181 (376)
Q Consensus       174 ~e~~~~g~  181 (376)
                      |||++|.+
T Consensus       113 ~e~i~G~~  120 (369)
T 3c5i_A          113 EEWLYGDP  120 (369)
T ss_dssp             EECCCSEE
T ss_pred             EEEecCCc
Confidence            99998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.74  E-value=0.0018  Score=59.82  Aligned_cols=33  Identities=12%  Similarity=0.043  Sum_probs=28.8

Q ss_pred             CCCcEecCCCCCCEEEcCCCcEEEcceeeeeee
Q 017177          219 EKKVIYRDFKASNILLDGVGFLFDSHLLIYVYF  251 (376)
Q Consensus       219 ~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~  251 (376)
                      ...++|+|+.+.||+++.++.+.++||..+...
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            357999999999999998888999999877754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.91  E-value=0.017  Score=54.95  Aligned_cols=82  Identities=9%  Similarity=-0.013  Sum_probs=48.6

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEEeEEEeCCeEEE
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLL  172 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~l  172 (376)
                      .+.|..|-...+|++.......  .....+..+++++........ -...+|..+++.+. +.-..++++.+  .  -++
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~  147 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESM--SLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF--P--EGR  147 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-------CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred             EEEcCCCcccceEEEEeCCCcc--cccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCE
Confidence            3567778888999987652110  000115678998865543211 12356888888885 33345666533  2  278


Q ss_pred             EEeccCCCCH
Q 017177          173 VYEYMQRGSL  182 (376)
Q Consensus       173 v~e~~~~g~L  182 (376)
                      ||||++|.+|
T Consensus       148 I~efI~G~~l  157 (424)
T 3mes_A          148 IEEFIDGEPL  157 (424)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEeCCccC
Confidence            9999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.35  E-value=0.19  Score=47.31  Aligned_cols=31  Identities=23%  Similarity=0.122  Sum_probs=25.9

Q ss_pred             CcEecCCCCCCEEE------cCCCcEEEcceeeeeee
Q 017177          221 KVIYRDFKASNILL------DGVGFLFDSHLLIYVYF  251 (376)
Q Consensus       221 ~iiHrDlKp~NILl------~~~g~~kl~Dfg~a~~~  251 (376)
                      .++|+|+.+.|||+      ++++.+.++||-.|...
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            45799999999999      45677999999888754

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=89.23  E-value=0.15  Score=47.09  Aligned_cols=81  Identities=10%  Similarity=-0.032  Sum_probs=51.8

Q ss_pred             HHHHHHhhcC--CCCcE-ecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHH
Q 017177          209 ARGLGFLHTS--EKKVI-YRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAI  285 (376)
Q Consensus       209 ~~~L~yLHs~--~~~ii-HrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d  285 (376)
                      +.....+|.-  ..||+ ..|   .++-|.+-|..+...-.-.     ........||+.|+|   |+......++.++|
T Consensus       201 LH~~~iiHRDLK~~NILl~~~---~~vKi~DFGlar~~~~~~~-----~~~~~~~~gt~~ymA---PE~l~~~~y~~ksD  269 (353)
T 4ase_A          201 LASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMA---PETIFDRVYTIQSD  269 (353)
T ss_dssp             HHHTTCCCSCCSGGGEEECGG---GCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCC---HHHHHHCCCCHHHH
T ss_pred             HhhCCeecCccCccceeeCCC---CCEEECcchhhhhcccCCC-----ceeeccccccccccC---HHHHhcCCCCCccc
Confidence            4445678841  12333 222   3566777777664422211     111123568888999   99999999999999


Q ss_pred             HHH--HHHHHHHh-hhhh
Q 017177          286 LYS--VLLPRIYA-WIKY  300 (376)
Q Consensus       286 ~~s--~~apEi~~-~~~~  300 (376)
                      +||  +++.|+++ |...
T Consensus       270 VwS~Gv~l~El~t~G~~P  287 (353)
T 4ase_A          270 VWSFGVLLWEIFSLGASP  287 (353)
T ss_dssp             HHHHHHHHHHHTTTSCCS
T ss_pred             EeehHHHHHHHHhCCCCC
Confidence            997  99999997 5543

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=88.56  E-value=1.6  Score=37.21  Aligned_cols=86  Identities=10%  Similarity=-0.013  Sum_probs=61.9

Q ss_pred             CCCCcceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHH-HhhcCCCCcEecCCCCCC
Q 017177          153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG-FLHTSEKKVIYRDFKASN  231 (376)
Q Consensus       153 ~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~-yLHs~~~~iiHrDlKp~N  231 (376)
                      .||++  -..+-.+++.+.+.++.-+++.=...++       .++....++++.+|+.... ++    ..-+|-=|.|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~----~~r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHS----ARRLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCC----SSSEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhh----hCceeEEEeCce
Confidence            47877  3444466777888777654443333342       2678888999988887665 44    446788899999


Q ss_pred             EEEcCCCcEEEcceeeeeee
Q 017177          232 ILLDGVGFLFDSHLLIYVYF  251 (376)
Q Consensus       232 ILl~~~g~~kl~Dfg~a~~~  251 (376)
                      |+++.++.+++.-.|+-..+
T Consensus       115 L~f~~~~~p~i~hRGi~~~l  134 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKESL  134 (219)
T ss_dssp             EEECTTCCEEESCCEETTTB
T ss_pred             EEEeCCCcEEEEEcCCcccC
Confidence            99999999999998876543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=88.05  E-value=0.22  Score=45.65  Aligned_cols=65  Identities=9%  Similarity=-0.088  Sum_probs=45.3

Q ss_pred             CEEEcCCCcEEEcce-eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHH--HHHHHHHhhhhhc
Q 017177          231 NILLDGVGFLFDSHL-LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYS--VLLPRIYAWIKYL  301 (376)
Q Consensus       231 NILl~~~g~~kl~Df-g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s--~~apEi~~~~~~~  301 (376)
                      .|-|.+-|..+..+- +.....   ......+||+.|+|   |+......+..++|+||  +++.|++.|...+
T Consensus       189 ~vKl~DFGla~~~~~~~~~~~~---~~~~~~~GT~~YmA---PE~~~~~~y~~~~DiwSlGvilyemltG~~Pf  256 (336)
T 4g3f_A          189 RAALCDFGHALCLQPDGLGKSL---LTGDYIPGTETHMA---PEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW  256 (336)
T ss_dssp             CEEECCCTTCEEC---------------CCCCCCGGGCC---HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             EEEEeeCCCCeEccCCCcccce---ecCCccccCccccC---HHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCC
Confidence            477888888776532 222221   12234679999999   99998888999999997  9999999988654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=87.49  E-value=0.3  Score=44.12  Aligned_cols=82  Identities=6%  Similarity=-0.000  Sum_probs=49.0

Q ss_pred             HHHHHhhcC--CCCcE-ecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhh---hcchhh
Q 017177          210 RGLGFLHTS--EKKVI-YRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYI---YKCLRY  283 (376)
Q Consensus       210 ~~L~yLHs~--~~~ii-HrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~---~~~~e~  283 (376)
                      ..-..+|.-  ..||+ ..|   .++-|.+-|..++.+-...     ........||+.|+|   |+....   ..++.+
T Consensus       149 H~~~IiHRDlKp~NILl~~~---~~~Ki~DFGla~~~~~~~~-----~~~~~~~~GT~~ymA---PE~l~~~~~~~y~~k  217 (307)
T 3omv_A          149 HAKNIIHRDMKSNNIFLHEG---LTVKIGDFGLATVKSRWSG-----SQQVEQPTGSVLWMA---PEVIRMQDNNPFSFQ  217 (307)
T ss_dssp             HHTTCBCSCCCSSSEEEETT---EEEEECCCSSCBC-----------------CCCCTTSCC---HHHHHCCSSCCCCHH
T ss_pred             HHCCccCCccCHHHEEECCC---CcEEEeeccCceecccCCc-----ceeecccccCCCccC---HHHhhccCCCCCCcH
Confidence            345567841  12443 332   3466778887665432211     122234679999999   998853   357889


Q ss_pred             HHHHH--HHHHHHHhhhhhcc
Q 017177          284 AILYS--VLLPRIYAWIKYLT  302 (376)
Q Consensus       284 ~d~~s--~~apEi~~~~~~~~  302 (376)
                      +|+||  +++.|+++|...+.
T Consensus       218 sDVwS~Gvvl~Elltg~~Pf~  238 (307)
T 3omv_A          218 SDVYSYGIVLYELMTGELPYS  238 (307)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTT
T ss_pred             HHhHhHHHHHHHHHHCCCCCC
Confidence            99997  99999999876543

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=85.46  E-value=1.7  Score=36.84  Aligned_cols=86  Identities=6%  Similarity=0.069  Sum_probs=62.4

Q ss_pred             CCCCcceEEeEEEeCCeEEEEEeccCCC-CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCC
Q 017177          153 SHPNLVKLLGYCWEDKELLLVYEYMQRG-SLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASN  231 (376)
Q Consensus       153 ~h~nIv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~N  231 (376)
                      .||+.+.. .+-.+.+.+.+.++.-+.+ ++.. +       ...+....++++.+|+....+++    .-+|-=|.|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~~----~r~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVNR----TRYTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGGG----SSEECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHhc----CceEEEEecce
Confidence            47888866 4556667777776654422 3332 3       23678888999999888775555    35788899999


Q ss_pred             EEEcCCCcEEEcceeeeeee
Q 017177          232 ILLDGVGFLFDSHLLIYVYF  251 (376)
Q Consensus       232 ILl~~~g~~kl~Dfg~a~~~  251 (376)
                      |+++.++.+++.--|+-..+
T Consensus       110 L~f~~~~~p~i~~RGik~~l  129 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNVV  129 (215)
T ss_dssp             EEECTTSCEEESCCEETTTB
T ss_pred             EEEcCCCCEEEEEccCccCC
Confidence            99999999999988875543

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=84.99  E-value=0.081  Score=50.92  Aligned_cols=62  Identities=10%  Similarity=0.081  Sum_probs=17.9

Q ss_pred             CccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEE------EEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           92 KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAI------KKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        92 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vav------K~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      .+.+.||   ||.||++.+...         ..+||+      |..+....  .....+.+|..+++.++|||+++.+++
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~---------~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f  212 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKK---------HMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNF  212 (463)
T ss_dssp             CSTTTSS---BCCC------------------CCBGGGC-----------------------------------CBCCCE
T ss_pred             cccccCC---chhhhccccccc---------CCchhhhhccCccccccccccccccccccccccccccccccccCCCcce
Confidence            4556776   999999976531         345777      66554322  233567889999999999999999887


Q ss_pred             EE
Q 017177          164 CW  165 (376)
Q Consensus       164 ~~  165 (376)
                      ..
T Consensus       213 ~~  214 (463)
T 3cxl_A          213 KV  214 (463)
T ss_dssp             EE
T ss_pred             EE
Confidence            64

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=82.98  E-value=0.21  Score=45.15  Aligned_cols=81  Identities=14%  Similarity=0.135  Sum_probs=52.2

Q ss_pred             HHHHHHhhcC--CCCc-EecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHH
Q 017177          209 ARGLGFLHTS--EKKV-IYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAI  285 (376)
Q Consensus       209 ~~~L~yLHs~--~~~i-iHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d  285 (376)
                      +.....+|..  ..|| +..|   .++-|.+-|..+...-+-...     ......||+.|+|   |++.....++.++|
T Consensus       161 LH~~~iiHRDLK~~NILl~~~---~~~Ki~DFGlar~~~~~~~~~-----~~~~~~gt~~ymA---PE~l~~~~~s~ksD  229 (308)
T 4gt4_A          161 LSSHHVVHKDLATRNVLVYDK---LNVKISDLGLFREVYAADYYK-----LLGNSLLPIRWMA---PEAIMYGKFSIDSD  229 (308)
T ss_dssp             HHHTTCCCSCCSGGGEEECGG---GCEEECCSCCBCGGGGGGCBC-----SSSSSCBCGGGCC---HHHHHHCCCCHHHH
T ss_pred             HHhCCCCCCCccccceEECCC---CCEEECCcccceeccCCCcee-----EecccccCCcccC---HHHHhCCCCCccch
Confidence            3445668841  1233 3333   357788888766543221111     1112457888999   99999999999999


Q ss_pred             HHH--HHHHHHHh-hhhh
Q 017177          286 LYS--VLLPRIYA-WIKY  300 (376)
Q Consensus       286 ~~s--~~apEi~~-~~~~  300 (376)
                      +||  +++.|+++ |...
T Consensus       230 VwSfGvvl~El~t~g~~P  247 (308)
T 4gt4_A          230 IWSYGVVLWEVFSYGLQP  247 (308)
T ss_dssp             HHHHHHHHHHHHTTTCCT
T ss_pred             hhhHHHHHHHHHhCCCCC
Confidence            997  99999997 5543

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	376
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-36
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-35
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-35
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-35
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-35
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-35
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-34
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-34
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-34
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-34
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-34
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-33
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-33
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-33
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-32
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-32
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-32
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-32
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	8e-32
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-31
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-31
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-31
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-30
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-30
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-30
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-30
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-29
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-29
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-29
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-29
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-29
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-29
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-28
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	7e-28
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-27
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-27
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-26
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-26
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-26
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-26
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-25
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-25
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-25
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-25
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-24
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-24
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-24
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-23
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-23
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-23
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-23
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-22
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-22
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-21
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-21
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-21
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-20
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-20
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-20
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-19
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-17
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-14
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-10

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 2e-36
 Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 17/158 (10%)

Query: 82  LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-E 140
           ++LK    +F+  S LG G  G V+K               G+V+A K ++ E       
Sbjct: 1   MELK--DDDFEKISELGAGNGGVVFKVS---------HKPSGLVMARKLIHLEIKPAIRN 49

Query: 141 EWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDI 200
           +   E+  L   + P +V   G  + D E+ +  E+M  GSL+  L +       +   I
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQI 105

Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
             K++I   +GL +L   + K+++RD K SNIL++  G
Sbjct: 106 LGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRG 142

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 1e-35
 Identities = 56/225 (24%), Positives = 83/225 (36%), Gaps = 24/225 (10%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVNF 148
                  LG G FG+V +           K+   M VA+K L P +     E   SE+  
Sbjct: 24  RLSFGKTLGAGAFGKVVEA----TAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79

Query: 149 LGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI-------------- 193
           L  L  H N+V LLG C      L++ EY   G L N L R+  S               
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 194 QPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL--DGVGFLFDSHLLIYVYF 251
             L  +  L  +   A+G+ FL    K  I+RD  A NILL    +  + D  L   +  
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 252 KRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYA 296
             +Y+        +       I+  +Y        Y + L  +++
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 2e-35
 Identities = 40/157 (25%), Positives = 73/157 (46%), Gaps = 20/157 (12%)

Query: 85  KSATKNFKPD------SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG 138
           +  T++  P+        LG+G FG+VYK                ++ A K ++ +S + 
Sbjct: 2   EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQ---------NKETSVLAAAKVIDTKSEEE 52

Query: 139 FEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSW 198
            E++  E++ L    HPN+VKLL   + +  L ++ E+   G+++  +       +PL+ 
Sbjct: 53  LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE---RPLTE 109

Query: 199 DIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                +       L +LH  + K+I+RD KA NIL  
Sbjct: 110 SQIQVVCKQTLDALNYLH--DNKIIHRDLKAGNILFT 144

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 6e-35
 Identities = 44/151 (29%), Positives = 70/151 (46%), Gaps = 18/151 (11%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
           K  K    +G+G FG V  G              G  VA+K +  ++    + + +E + 
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDATA--QAFLAEASV 53

Query: 149 LGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
           + +L H NLV+LLG   E+K  L +V EYM +GSL ++L  R  S   L  D  LK ++ 
Sbjct: 54  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLD 111

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
               + +L       ++RD  A N+L+    
Sbjct: 112 VCEAMEYLE--GNNFVHRDLAARNVLVSEDN 140

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  128 bits (322), Expect = 6e-35
 Identities = 41/167 (24%), Positives = 77/167 (46%), Gaps = 21/167 (12%)

Query: 79  FSFLDLKSATKNF---------KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK 129
           F+F D   A + F         K + ++G G FG V  G +             + VAIK
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFVAIK 60

Query: 130 KLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR 188
            L    + +   ++ SE + +G+  HPN++ L G   +   ++++ E+M+ GSL++ L +
Sbjct: 61  TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120

Query: 189 RNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
            +      +    + +  G A G+ +L       ++RD  A NIL++
Sbjct: 121 NDG---QFTVIQLVGMLRGIAAGMKYLAD--MNYVHRDLAARNILVN 162

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 7e-35
 Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 16/150 (10%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
           +  K    LG G FG V+ G+ +              VA+K L   SM   + + +E N 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNG----------HTKVAVKSLKQGSMSP-DAFLAEANL 61

Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           + +L H  LV+L       + + ++ EYM+ GSL + L   +     L+ +  L +A   
Sbjct: 62  MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQI 118

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
           A G+ F+   E+  I+RD +A+NIL+    
Sbjct: 119 AEGMAFIE--ERNYIHRDLRAANILVSDTL 146

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  125 bits (316), Expect = 2e-34
 Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 14/147 (9%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
            +      LG G +G VY+G               + VA+K L  ++M+  EE+  E   
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDTMEV-EEFLKEAAV 66

Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           +  + HPNLV+LLG C  +    ++ E+M  G+L ++L   N   Q +S  + L +A   
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQI 124

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLD 235
           +  + +L   +K  I+RD  A N L+ 
Sbjct: 125 SSAMEYLE--KKNFIHRDLAARNCLVG 149

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 4e-34
 Identities = 50/179 (27%), Positives = 78/179 (43%), Gaps = 29/179 (16%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVNF 148
           N +   +LG G FG+V            SKTG+ + VA+K L  ++     E   SE+  
Sbjct: 38  NLEFGKVLGSGAFGKVMNA----TAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 93

Query: 149 LGRL-SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP---------------- 191
           + +L SH N+V LLG C     + L++EY   G L N+L  +                  
Sbjct: 94  MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 192 ---SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD--GVGFLFDSHL 245
               +  L+++  L  A   A+G+ FL    K  ++RD  A N+L+    V  + D  L
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDFGL 210

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 6e-34
 Identities = 39/153 (25%), Positives = 64/153 (41%), Gaps = 14/153 (9%)

Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVNFLGRL 152
           D  LG G FG V +G               + VAIK L   + +   EE   E   + +L
Sbjct: 14  DIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 66

Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
            +P +V+L+G C + + L+LV E    G L   L  +    + +      ++    + G+
Sbjct: 67  DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGM 122

Query: 213 GFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL 245
            +L    K  ++RD  A N+LL    +   S  
Sbjct: 123 KYLEE--KNFVHRDLAARNVLLVNRHYAKISDF 153

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  125 bits (315), Expect = 6e-34
 Identities = 49/154 (31%), Positives = 66/154 (42%), Gaps = 18/154 (11%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---S 144
            K F     +G G FG VY                  VVAIKK++    Q  E+WQ    
Sbjct: 14  EKLFSDLREIGHGSFGAVYFAR---------DVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64

Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           EV FL +L HPN ++  G    +    LV EY    + +     +    +PL       +
Sbjct: 65  EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAV 120

Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
             GA +GL +LH     +I+RD KA NILL   G
Sbjct: 121 THGALQGLAYLH--SHNMIHRDVKAGNILLSEPG 152

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 9e-34
 Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 20/148 (13%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVN 147
                  +G G FG VYKG                 VA+K LN  +   Q  + +++EV 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD------------VAVKMLNVTAPTPQQLQAFKNEVG 56

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
            L +  H N++  +GY    + L +V ++ +  SL +HL               + IA  
Sbjct: 57  VLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQ 112

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLD 235
            A+G+ +LH   K +I+RD K++NI L 
Sbjct: 113 TAQGMDYLHA--KSIIHRDLKSNNIFLH 138

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 2e-33
 Identities = 39/148 (26%), Positives = 61/148 (41%), Gaps = 16/148 (10%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
           K+      LG G FG V  G                 VAIK +   SM   +E+  E   
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSMSE-DEFIEEAKV 52

Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           +  LSH  LV+L G C + + + ++ EYM  G L N+L               L++    
Sbjct: 53  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDV 109

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDG 236
              + +L +  K+ ++RD  A N L++ 
Sbjct: 110 CEAMEYLES--KQFLHRDLAARNCLVND 135

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 5e-33
 Identities = 40/162 (24%), Positives = 69/162 (42%), Gaps = 16/162 (9%)

Query: 86  SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQ 143
           S  ++++    +G G +GR  K           +   G ++  K+L+  SM     +   
Sbjct: 1   SRAEDYEVLYTIGTGSYGRCQKIR---------RKSDGKILVWKELDYGSMTEAEKQMLV 51

Query: 144 SEVNFLGRLSHPNLVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR 201
           SEVN L  L HPN+V+      +  +  L +V EY + G L + + +     Q L  +  
Sbjct: 52  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 111

Query: 202 LKIAIGAARGLGFLH---TSEKKVIYRDFKASNILLDGVGFL 240
           L++       L   H        V++RD K +N+ LDG   +
Sbjct: 112 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 153

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 7e-33
 Identities = 46/196 (23%), Positives = 77/196 (39%), Gaps = 22/196 (11%)

Query: 69  QILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAI 128
           +ILE    K+ S + +    K +     +G+G  G VY                G  VAI
Sbjct: 4   EILE----KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAM---------DVATGQEVAI 50

Query: 129 KKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR 188
           +++N +     E   +E+  +    +PN+V  L       EL +V EY+  GSL + +  
Sbjct: 51  RQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE 110

Query: 189 RNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL--FDSHLL 246
                  +       +     + L FLH    +VI+RD K+ NILL   G +   D    
Sbjct: 111 T-----CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163

Query: 247 IYVYFKRHYIYIYIHT 262
             +  ++      + T
Sbjct: 164 AQITPEQSKRSTMVGT 179

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  123 bits (309), Expect = 1e-32
 Identities = 34/146 (23%), Positives = 59/146 (40%), Gaps = 14/146 (9%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFL 149
           ++     LG G FG V++           +   G   A K +        E  + E+  +
Sbjct: 27  HYDIHEELGTGAFGVVHRVT---------ERATGNNFAAKFVMTPHESDKETVRKEIQTM 77

Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
             L HP LV L     +D E++++YE+M  G L   +   +     +S D  ++      
Sbjct: 78  SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVC 134

Query: 210 RGLGFLHTSEKKVIYRDFKASNILLD 235
           +GL  +H  E   ++ D K  NI+  
Sbjct: 135 KGLCHMH--ENNYVHLDLKPENIMFT 158

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 1e-32
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 15/153 (9%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSE 145
           K+ +    LG+G FG V +G  D      + +G  + VA+K L P+ +   +  +++  E
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWD------APSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61

Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
           VN +  L H NL++L G       + +V E    GSL + L +              + A
Sbjct: 62  VNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYA 117

Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
           +  A G+G+L    K+ I+RD  A N+LL    
Sbjct: 118 VQVAEGMGYLE--SKRFIHRDLAARNLLLATRD 148

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  120 bits (301), Expect = 4e-32
 Identities = 51/177 (28%), Positives = 77/177 (43%), Gaps = 27/177 (15%)

Query: 80  SFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF 139
             L L+    N +    +GEG FGRV++       L P +     +VA+K L  E+    
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQAR--APGLLPYEPF--TMVAVKMLKEEASADM 59

Query: 140 E-EWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI----- 193
           + ++Q E   +    +PN+VKLLG C   K + L++EYM  G L   L   +P       
Sbjct: 60  QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119

Query: 194 ---------------QPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                           PLS   +L IA   A G+ +L   E+K ++RD    N L+ 
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVG 174

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 6e-32
 Identities = 52/172 (30%), Positives = 77/172 (44%), Gaps = 27/172 (15%)

Query: 78  VFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SM 136
           ++  LD      + K   ++GEG FG+V K  +        K GL M  AIK++    S 
Sbjct: 3   IYPVLDWN----DIKFQDVIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASK 51

Query: 137 QGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR------ 189
               ++  E+  L +L  HPN++ LLG C     L L  EY   G+L + L +       
Sbjct: 52  DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 111

Query: 190 ------NPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                 N +   LS    L  A   ARG+ +L   +K+ I+RD  A NIL+ 
Sbjct: 112 PAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVG 161

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  120 bits (303), Expect = 8e-32
 Identities = 31/146 (21%), Positives = 60/146 (41%), Gaps = 14/146 (9%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFL 149
            +     LG G FG V++           +   G V   K +N          ++E++ +
Sbjct: 30  YYDILEELGSGAFGVVHRCV---------EKATGRVFVAKFINTPYPLDKYTVKNEISIM 80

Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
            +L HP L+ L     +  E++L+ E++  G L + +   +     +S    +     A 
Sbjct: 81  NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQAC 137

Query: 210 RGLGFLHTSEKKVIYRDFKASNILLD 235
            GL  +H  E  +++ D K  NI+ +
Sbjct: 138 EGLKHMH--EHSIVHLDIKPENIMCE 161

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 2e-31
 Identities = 41/147 (27%), Positives = 67/147 (45%), Gaps = 16/147 (10%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
                   +G G FG V+ G+  +             VAIK +   +M   E++  E   
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAMSE-EDFIEEAEV 53

Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           + +LSHP LV+L G C E   + LV+E+M+ G L ++L  +       + +  L + +  
Sbjct: 54  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDV 110

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLD 235
             G+ +L   E  VI+RD  A N L+ 
Sbjct: 111 CEGMAYLE--EACVIHRDLAARNCLVG 135

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 2e-31
 Identities = 42/154 (27%), Positives = 64/154 (41%), Gaps = 19/154 (12%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEV 146
           +  K D  +G G F  VYKG           T   + VA  +L    +     + ++ E 
Sbjct: 9   RFLKFDIEIGRGSFKTVYKGL---------DTETTVEVAWCELQDRKLTKSERQRFKEEA 59

Query: 147 NFLGRLSHPNLVKLLGYCWE----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL 202
             L  L HPN+V+            K ++LV E M  G+L+ +L R     + +   +  
Sbjct: 60  EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLR 115

Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
                  +GL FLHT    +I+RD K  NI + G
Sbjct: 116 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG 149

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 2e-31
 Identities = 40/180 (22%), Positives = 75/180 (41%), Gaps = 16/180 (8%)

Query: 94  DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSEVNFLGR 151
           D  LG G FG V KG+   K        +   VA+K L  E+      +E  +E N + +
Sbjct: 12  DKELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQ 64

Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
           L +P +V+++G C  +   +LV E  + G L  +L +     + +     +++    + G
Sbjct: 65  LDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMG 119

Query: 212 LGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYV 271
           + +L       ++RD  A N+LL    +   S   +    +    Y    T+  +   + 
Sbjct: 120 MKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 1e-30
 Identities = 37/166 (22%), Positives = 66/166 (39%), Gaps = 13/166 (7%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVNF 148
             +    +GEG FG V++G         S     + VAIK     +     E++  E   
Sbjct: 8   RIELGRCIGEGQFGDVHQGIY------MSPENPALAVAIKTCKNCTSDSVREKFLQEALT 61

Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           + +  HP++VKL+G   E+  + ++ E    G L + L  R      L     +  A   
Sbjct: 62  MRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQL 117

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRH 254
           +  L +L    K+ ++RD  A N+L+     +      +  Y +  
Sbjct: 118 STALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (290), Expect = 1e-30
 Identities = 36/177 (20%), Positives = 63/177 (35%), Gaps = 16/177 (9%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVN 147
           +++     LGEG +G V                    VA+K ++ +      E  + E+ 
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAV---------NRVTEEAVAVKIVDMKRAVDCPENIKKEIC 55

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
               L+H N+VK  G+  E     L  EY   G L + +         +      +    
Sbjct: 56  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQ 111

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYI 264
              G+ +LH     + +RD K  N+LLD    L  S   +   F+ +     ++   
Sbjct: 112 LMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 166

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 6e-30
 Identities = 39/147 (26%), Positives = 69/147 (46%), Gaps = 11/147 (7%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVNF 148
                 ++G G FG VYKG +       S     + VAIK L     +    ++  E   
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKT-----SSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62

Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           +G+ SH N+++L G   + K ++++ EYM+ G+L+  L  ++      S    + +  G 
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGI 119

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLD 235
           A G+ +L       ++RD  A NIL++
Sbjct: 120 AAGMKYLA--NMNYVHRDLAARNILVN 144

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 6e-30
 Identities = 38/152 (25%), Positives = 69/152 (45%), Gaps = 27/152 (17%)

Query: 97  LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
           +G+G FG V++G              G  VA+K  +    + +   ++E+     L H N
Sbjct: 11  IGKGRFGEVWRGKWR-----------GEEVAVKIFSSREERSWFR-EAEIYQTVMLRHEN 58

Query: 157 LVKLLGYCWED----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
           ++  +    +D     +L LV +Y + GSL ++L R       ++ +  +K+A+  A GL
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGL 113

Query: 213 GFLHT------SEKKVIYRDFKASNILLDGVG 238
             LH        +  + +RD K+ NIL+   G
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (282), Expect = 1e-29
 Identities = 38/153 (24%), Positives = 63/153 (41%), Gaps = 18/153 (11%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSE 145
           ++F+    LG+G FG VY            +     ++A+K L    +       + + E
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAR---------EKQSKFILALKVLFKAQLEKAGVEHQLRRE 56

Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
           V     L HPN+++L GY  +   + L+ EY   G++   L + +               
Sbjct: 57  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYI 112

Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
              A  L + H   K+VI+RD K  N+LL   G
Sbjct: 113 TELANALSYCH--SKRVIHRDIKPENLLLGSAG 143

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 1e-29
 Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 13/155 (8%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVN 147
           +       LG+G FG VY+G    K +   +      VAIK +N   SM+   E+ +E +
Sbjct: 20  EKITMSRELGQGSFGMVYEGV--AKGVVKDEPE--TRVAIKTVNEAASMRERIEFLNEAS 75

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR------NPSIQPLSWDIR 201
            +   +  ++V+LLG   + +  L++ E M RG L+++L         NP + P S    
Sbjct: 76  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135

Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
           +++A   A G+ +L+    K ++RD  A N ++  
Sbjct: 136 IQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAE 168

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  114 bits (287), Expect = 2e-29
 Identities = 40/181 (22%), Positives = 71/181 (39%), Gaps = 21/181 (11%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG------FEEWQ 143
           +F    ++G GGFG VY            K   G + A+K L+ + ++           +
Sbjct: 5   DFSVHRIIGRGGFGEVYGCR---------KADTGKMYAMKCLDKKRIKMKQGETLALNER 55

Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
             ++ +     P +V +        +L  + + M  G L  HL +     +        +
Sbjct: 56  IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE 115

Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTY 263
           I      GL  +H   + V+YRD K +NILLD  G +  S L +   F +   +  + T+
Sbjct: 116 I----ILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 169

Query: 264 I 264
            
Sbjct: 170 G 170

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 2e-29
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 15/157 (9%)

Query: 82  LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-E 140
           +   S   +F  + ++G G FG VY G + D        G  +  A+K LN  +  G   
Sbjct: 22  IGPSSLIVHF--NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVS 73

Query: 141 EWQSEVNFLGRLSHPNLVKLLGYCWE-DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWD 199
           ++ +E   +   SHPN++ LLG C   +   L+V  YM+ G L N +          +  
Sbjct: 74  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVK 130

Query: 200 IRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
             +   +  A+G+ FL +  KK ++RD  A N +LD 
Sbjct: 131 DLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDE 165

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (282), Expect = 2e-29
 Identities = 47/208 (22%), Positives = 77/208 (37%), Gaps = 21/208 (10%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNF 148
                  LGEG FG+V         L   K      VA+K L  ++ +    +  SE+  
Sbjct: 14  RLVLGKPLGEGAFGQVVLAE--AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71

Query: 149 LGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI------------QP 195
           +  +  H N++ LLG C +D  L ++ EY  +G+L  +L  R P              + 
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 196 LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHY 255
           LS    +  A   ARG+ +L    KK I+RD  A N+L+          +  +   +  +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDN---VMKIADFGLARDIH 186

Query: 256 IYIYIHTYIIYIYIYVYIYMYIYKCLRY 283
              Y            ++         Y
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIY 214

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 4e-29
 Identities = 38/159 (23%), Positives = 57/159 (35%), Gaps = 18/159 (11%)

Query: 85  KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEE 141
           K   ++FK   +LGEG F  V             +       AIK L    +        
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLAR---------ELATSREYAIKILEKRHIIKENKVPY 54

Query: 142 WQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR 201
              E + + RL HP  VKL     +D++L     Y + G L  ++ +             
Sbjct: 55  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCT 110

Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
                     L +LH   K +I+RD K  NILL+    +
Sbjct: 111 RFYTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHI 147

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (277), Expect = 1e-28
 Identities = 40/150 (26%), Positives = 68/150 (45%), Gaps = 16/150 (10%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
           ++ + +  LG+G FG V+ G  +              VAIK L P +M   E +  E   
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTMSP-EAFLQEAQV 65

Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
           + +L H  LV+L     E+  + +V EYM +GSL + L       + L     + +A   
Sbjct: 66  MKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQI 122

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
           A G+ ++       ++RD +A+NIL+    
Sbjct: 123 ASGMAYVER--MNYVHRDLRAANILVGENL 150

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 7e-28
 Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 12/147 (8%)

Query: 91  FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFL 149
           FK   +LG G FG VYKG        P    + + VAIK+L    S +  +E   E   +
Sbjct: 11  FKKIKVLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65

Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
             + +P++ +LLG C     + L+ + M  G L +++         +     L   +  A
Sbjct: 66  ASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIA 121

Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDG 236
           +G+ +L    +++++RD  A N+L+  
Sbjct: 122 KGMNYLED--RRLVHRDLAARNVLVKT 146

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  107 bits (269), Expect = 1e-27
 Identities = 33/191 (17%), Positives = 69/191 (36%), Gaps = 22/191 (11%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG---FEEWQS 144
           +  ++   +LG GG   V+               L   VA+K L  +  +    +  ++ 
Sbjct: 6   SDRYELGEILGFGGMSEVHLAR---------DLRLHRDVAVKVLRADLARDPSFYLRFRR 56

Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKE----LLLVYEYMQRGSLENHLFRRNPSIQPLSWDI 200
           E      L+HP +V +      +        +V EY+   +L + +        P++   
Sbjct: 57  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKR 112

Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYI 260
            +++   A + L F H  +  +I+RD K +NI++     +      I          +  
Sbjct: 113 AIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 170

Query: 261 HTYIIYIYIYV 271
              +I    Y+
Sbjct: 171 TAAVIGTAQYL 181

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 2e-27
 Identities = 42/189 (22%), Positives = 71/189 (37%), Gaps = 17/189 (8%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEV 146
              +   S +GEG +G V   +              + VAIKK++P   Q + +    E+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAY---------DNVNKVRVAIKKISPFEHQTYCQRTLREI 57

Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
             L R  H N++ +           +   Y+    +   L++   + Q LS D       
Sbjct: 58  KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLY 116

Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIY 266
              RGL ++H     V++RD K SN+LL+    L     +      R     + HT  + 
Sbjct: 117 QILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLK----ICDFGLARVADPDHDHTGFLT 170

Query: 267 IYIYVYIYM 275
            Y+    Y 
Sbjct: 171 EYVATRWYR 179

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  105 bits (262), Expect = 1e-26
 Identities = 38/161 (23%), Positives = 65/161 (40%), Gaps = 25/161 (15%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF---------E 140
           N++P  +LG G    V +                   A+K ++      F         E
Sbjct: 4   NYEPKEILGRGVSSVVRRCI---------HKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 54

Query: 141 EWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWD 199
               EV+ L ++S HPN+++L      +    LV++ M++G L ++L  +      LS  
Sbjct: 55  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEK 110

Query: 200 IRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
              KI       +  LH  +  +++RD K  NILLD    +
Sbjct: 111 ETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNI 149

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 2e-26
 Identities = 28/208 (13%), Positives = 66/208 (31%), Gaps = 25/208 (12%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFL 149
            +     LG G FG V++           +T        K +  +        + E++ L
Sbjct: 6   KYMIAEDLGRGEFGIVHRCV---------ETSSKKTYMAKFVKVKGTDQ-VLVKKEISIL 55

Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
               H N++ L       +EL++++E++    +   +         L+    +       
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVC 112

Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGVGF----LFDSHLLIYVYFKRHYIYIYIHTYII 265
             L FLH     + + D +  NI+          + +      +    ++  ++      
Sbjct: 113 EALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYY 170

Query: 266 YIYIYVYIY------MYIYKCLRYAILY 287
              ++ +        M+    L Y +L 
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLS 198

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  104 bits (260), Expect = 4e-26
 Identities = 29/149 (19%), Positives = 59/149 (39%), Gaps = 16/149 (10%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE-WQSEV 146
              +    +LG G F  V                   +VAIK +  ++++G E   ++E+
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAE---------DKRTQKLVAIKCIAKKALEGKEGSMENEI 58

Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
             L ++ HPN+V L         L L+ + +  G L + +  +       +     ++  
Sbjct: 59  AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIF 114

Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLD 235
                + +LH  +  +++RD K  N+L  
Sbjct: 115 QVLDAVKYLH--DLGIVHRDLKPENLLYY 141

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 7e-26
 Identities = 44/201 (21%), Positives = 75/201 (37%), Gaps = 21/201 (10%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNF 148
             K    LG G FG+V +           KT     VA+K L   +         SE+  
Sbjct: 14  RLKLGKPLGRGAFGQVIEA----DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69

Query: 149 LGRLSH-PNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQP----------- 195
           L  + H  N+V LLG C +    L+++ E+ + G+L  +L  +     P           
Sbjct: 70  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 196 -LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRH 254
            L+ +  +  +   A+G+ FL    +K I+RD  A NILL     +      +     + 
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187

Query: 255 YIYIYIHTYIIYIYIYVYIYM 275
             Y+      + +       +
Sbjct: 188 PDYVRKGDARLPLKWMAPETI 208

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 1e-25
 Identities = 47/210 (22%), Positives = 69/210 (32%), Gaps = 24/210 (11%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEV 146
           +F    +LG+G FG+V+                    AIK L  + +      E    E 
Sbjct: 3   DFILHKMLGKGSFGKVFLAE---------FKKTNQFFAIKALKKDVVLMDDDVECTMVEK 53

Query: 147 NFLGR-LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
             L     HP L  +       + L  V EY+  G L  H+                  A
Sbjct: 54  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYA 109

Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLD--GVGFLFDSHLLIYVYFKRHYIYIYIHTY 263
                GL FLH   K ++YRD K  NILLD  G   + D  +             +  T 
Sbjct: 110 AEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTP 167

Query: 264 IIYIYIYVYIYMYIYKCLRYA---ILYSVL 290
                  +    Y +    ++   +LY +L
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEML 197

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  102 bits (256), Expect = 1e-25
 Identities = 44/190 (23%), Positives = 72/190 (37%), Gaps = 19/190 (10%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSE 145
           ++F+    LG G FGRV+                G   A+K L  E +   +  E    E
Sbjct: 4   QDFQILRTLGTGSFGRVHLIR---------SRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54

Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
              L  ++HP ++++ G   + +++ ++ +Y++       LF      Q     +    A
Sbjct: 55  RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYA 110

Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFK-RHYIYIYIHTYI 264
                 L +LH   K +IYRD K  NILLD  G +  +      Y     Y       YI
Sbjct: 111 AEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYI 168

Query: 265 IYIYIYVYIY 274
               +    Y
Sbjct: 169 APEVVSTKPY 178

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 2e-25
 Identities = 45/289 (15%), Positives = 87/289 (30%), Gaps = 27/289 (9%)

Query: 85  KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS 144
           +    ++    ++G G FG VY+               G +VAIKK+  +          
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAK---------LCDSGELVAIKKVLQDK----RFKNR 62

Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKE------LLLVYEYMQRGSLENHLFRRNPSIQPLSW 198
           E+  + +L H N+V+L  + +   E      L LV +Y+                Q L  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPV 121

Query: 199 DIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF---LFDSHLLIYVYFKRHY 255
                      R L ++H     + +RD K  N+LLD       L D      +      
Sbjct: 122 IYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179

Query: 256 IYIYIHTYIIYIYIYVYIYMYIYKCLRYA--ILYSVLLPRIYAWIKYLTLLKYSNSFAFV 313
           +      Y     +      Y      ++   + + LL     +     + +       +
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239

Query: 314 FSCVFSFYRTTMLKYQILAWQSWGPLVESHMLQPGLWAHMVMQLQNMLQ 362
            +      R     Y    +        + + +P      +     +L+
Sbjct: 240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLE 288

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 7e-25
 Identities = 35/178 (19%), Positives = 62/178 (34%), Gaps = 23/178 (12%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-H 154
           +LG G  G+V + +                 A+K L         + + EV    R S  
Sbjct: 19  VLGLGINGKVLQIF---------NKRTQEKFALKMLQDC-----PKARREVELHWRASQC 64

Query: 155 PNLVKLLGYC----WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
           P++V+++          K LL+V E +  G L + +  R    Q  +     +I      
Sbjct: 65  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGE 122

Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIY 268
            + +LH     + +RD K  N+L           L  + + K    +  + T     Y
Sbjct: 123 AIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 178

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.8 bits (245), Expect = 3e-24
 Identities = 46/210 (21%), Positives = 85/210 (40%), Gaps = 26/210 (12%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVN 147
           NF+    +GEG +G VYK               G VVA+KK+  ++           E++
Sbjct: 3   NFQKVEKIGEGTYGVVYKAR---------NKLTGEVVALKKIRLDTETEGVPSTAIREIS 53

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
            L  L+HPN+VKLL     + +L LV+E++ +   +   F    ++  +   +       
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQ 110

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLD----------GVGFLFDSHLLIYVYFKRHYIY 257
             +GL F H    +V++RD K  N+L++          G+   F   +  Y +      Y
Sbjct: 111 LLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 168

Query: 258 IYIHTYIIYIYIYVYIYMYIYKCLRYAILY 287
                 +   Y    + ++   C+   ++ 
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 99.9 bits (248), Expect = 3e-24
 Identities = 40/155 (25%), Positives = 62/155 (40%), Gaps = 18/155 (11%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEV 146
            F     LG G FGRV                 G   A+K L+ + +   ++ +   +E 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVK---------HKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92

Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
             L  ++ P LVKL     ++  L +V EY+  G + +HL R        S       A 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAA 148

Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLF 241
                  +LH     +IYRD K  N+L+D  G++ 
Sbjct: 149 QIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQ 181

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.0 bits (243), Expect = 6e-24
 Identities = 39/150 (26%), Positives = 61/150 (40%), Gaps = 20/150 (13%)

Query: 96  LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE-----WQSEVNFLG 150
            LGEG F  VYK                 +VAIKK+        ++        E+  L 
Sbjct: 5   FLGEGQFATVYKAR---------DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55

Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
            LSHPN++ LL        + LV+++M+                 L+        +   +
Sbjct: 56  ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQ 111

Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGVGFL 240
           GL +LH  +  +++RD K +N+LLD  G L
Sbjct: 112 GLEYLH--QHWILHRDLKPNNLLLDENGVL 139

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.7 bits (240), Expect = 1e-23
 Identities = 33/153 (21%), Positives = 56/153 (36%), Gaps = 22/153 (14%)

Query: 91  FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE------WQS 144
           ++   LLG GGFG VY G          +    + VAIK +  + +  + E         
Sbjct: 6   YQVGPLLGSGGFGSVYSGI---------RVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56

Query: 145 EVNFLGRLS--HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL 202
           EV  L ++S     +++LL +       +L+ E  +                 L  ++  
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER---GALQEELAR 113

Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
                    +   H     V++RD K  NIL+D
Sbjct: 114 SFFWQVLEAVRHCH--NCGVLHRDIKDENILID 144

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.8 bits (240), Expect = 2e-23
 Identities = 32/163 (19%), Positives = 61/163 (37%), Gaps = 21/163 (12%)

Query: 91  FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF------EEWQS 144
           +     LG G F  V K           +   G+  A K +     +        E+ + 
Sbjct: 12  YDTGEELGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62

Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
           EV+ L  + HPN++ L        +++L+ E +  G L + L  +    + L+ +   + 
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEF 118

Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI 247
                 G+ +LH    ++ + D K  NI+L           +I
Sbjct: 119 LKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKII 159

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 95.3 bits (236), Expect = 4e-23
 Identities = 40/210 (19%), Positives = 75/210 (35%), Gaps = 28/210 (13%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVN 147
            +     +GEG +G VYK    +          G   A+KK+  E            E++
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQ--NNY--------GETFALKKIRLEKEDEGIPSTTIREIS 52

Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
            L  L H N+VKL       K L+LV+E++ +   +            L         + 
Sbjct: 53  ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQ 108

Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLD----------GVGFLFDSHLLIYVYFKRHYIY 257
              G+ + H  +++V++RD K  N+L++          G+   F   +  Y +      Y
Sbjct: 109 LLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWY 166

Query: 258 IYIHTYIIYIYIYVYIYMYIYKCLRYAILY 287
                 +        I ++   C+   ++ 
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.3 bits (236), Expect = 7e-23
 Identities = 40/162 (24%), Positives = 68/162 (41%), Gaps = 23/162 (14%)

Query: 87  ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQS 144
           A + ++  + +GEG +G+V+K               G  VA+K++  ++ +         
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKAR--------DLKNGGRFVALKRVRVQTGEEGMPLSTIR 56

Query: 145 EVNFLGRLS---HPNLVKLLGYCWEDKE-----LLLVYEYMQRGSLENHLFRRNPSIQPL 196
           EV  L  L    HPN+V+L   C   +      L LV+E++ +           P    +
Sbjct: 57  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP---GV 113

Query: 197 SWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
             +    +     RGL FLH    +V++RD K  NIL+   G
Sbjct: 114 PTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSG 153

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.8 bits (235), Expect = 1e-22
 Identities = 44/197 (22%), Positives = 63/197 (31%), Gaps = 20/197 (10%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSE 145
            +F    LLG+G FG+V             +   G   A+K L  E +          +E
Sbjct: 5   NDFDYLKLLGKGTFGKVILVR---------EKATGRYYAMKILRKEVIIAKDEVAHTVTE 55

Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
              L    HP L  L         L  V EY   G L  HL R     +  + +      
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYG 111

Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF--LFDSHLLIYVYFKRHYIYIYIHTY 263
                 L +LH   + V+YRD K  N++LD  G   + D  L          +  +  T 
Sbjct: 112 AEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 169

Query: 264 IIYIYIYVYIYMYIYKC 280
                  +    Y    
Sbjct: 170 EYLAPEVLEDNDYGRAV 186

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.3 bits (231), Expect = 6e-22
 Identities = 32/152 (21%), Positives = 56/152 (36%), Gaps = 13/152 (8%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEV 146
             ++    +G G +G V    VD +T        G  VAIKKL          +    E+
Sbjct: 18  AVYRDLQPVGSGAYGAVCSA-VDGRT--------GAKVAIKKLYRPFQSELFAKRAYREL 68

Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
             L  + H N++ LL     D+ L    ++            +    + L  D    +  
Sbjct: 69  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVY 128

Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
              +GL ++H     +I+RD K  N+ ++   
Sbjct: 129 QMLKGLRYIH--AAGIIHRDLKPGNLAVNEDC 158

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 91.8 bits (227), Expect = 1e-21
 Identities = 32/178 (17%), Positives = 61/178 (34%), Gaps = 19/178 (10%)

Query: 91  FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLG 150
           ++    +G G FG +Y G              G  VAIK    ++     +   E     
Sbjct: 9   YRLGRKIGSGSFGDIYLGT---------DIAAGEEVAIKLECVKTKH--PQLHIESKIYK 57

Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
            +     +  + +C  + +  ++   +   SLE+     +   +  S    L +A     
Sbjct: 58  MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVLLLADQMIS 114

Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIY 268
            + ++H   K  I+RD K  N L+         +L+  + F     Y    T+    Y
Sbjct: 115 RIEYIH--SKNFIHRDVKPDNFLMGLGKK---GNLVYIIDFGLAKKYRDARTHQHIPY 167

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.2 bits (228), Expect = 1e-21
 Identities = 45/202 (22%), Positives = 74/202 (36%), Gaps = 17/202 (8%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM----QGFEEWQS 144
           +NF+   +LG G +G+V+           S    G + A+K L   ++    +  E  ++
Sbjct: 24  ENFELLKVLGTGAYGKVFLVR------KISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 77

Query: 145 EVNFLGRLSH-PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
           E   L  +   P LV L      + +L L+ +Y+  G L  HL +R    +  +      
Sbjct: 78  ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR----ERFTEHEVQI 133

Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTY 263
                   L  LH  +  +IYRD K  NILLD  G +  +   +   F            
Sbjct: 134 YVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 191

Query: 264 IIYIYIYVYIYMYIYKCLRYAI 285
               Y+   I          A+
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAV 213

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 90.3 bits (223), Expect = 6e-21
 Identities = 26/152 (17%), Positives = 53/152 (34%), Gaps = 24/152 (15%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFL 149
           +++    LG G +  V++                  V +K L P      ++ + E+  L
Sbjct: 36  DYQLVRKLGRGKYSEVFEAI---------NITNNEKVVVKILKPVKK---KKIKREIKIL 83

Query: 150 GRLS-HPNLVKLLGYCWEDKE--LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
             L   PN++ L     +       LV+E++     +          Q L+         
Sbjct: 84  ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL-------YQTLTDYDIRFYMY 136

Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
              + L + H     +++RD K  N+++D   
Sbjct: 137 EILKALDYCH--SMGIMHRDVKPHNVMIDHEH 166

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 88.3 bits (218), Expect = 2e-20
 Identities = 30/159 (18%), Positives = 55/159 (34%), Gaps = 16/159 (10%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
            ++K    +GEG FG +++G                 VAIK     S     + + E   
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGT---------NLLNNQQVAIKFEPRRSDA--PQLRDEYRT 53

Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
              L+    +  + Y  ++    ++   +   SLE+ L          S       A   
Sbjct: 54  YKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQM 110

Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI 247
              +  +H  EK ++YRD K  N L+        + + +
Sbjct: 111 LARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYV 147

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.9 bits (214), Expect = 6e-20
 Identities = 39/197 (19%), Positives = 71/197 (36%), Gaps = 20/197 (10%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEV 146
           + ++    +GEG +G V+K                 +VA+K++  +            E+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAK---------NRETHEIVALKRVRLDDDDEGVPSSALREI 52

Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
             L  L H N+V+L      DK+L LV+E+  +   +               +I      
Sbjct: 53  CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD----PEIVKSFLF 108

Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILL--DGVGFLFDSHLLIYVYFKRHYIYIYIHTYI 264
              +GLGF H+  + V++RD K  N+L+  +G   L +  L              + T  
Sbjct: 109 QLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLW 166

Query: 265 IYI-YIYVYIYMYIYKC 280
                +     +Y    
Sbjct: 167 YRPPDVLFGAKLYSTSI 183

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.3 bits (215), Expect = 8e-20
 Identities = 39/208 (18%), Positives = 73/208 (35%), Gaps = 16/208 (7%)

Query: 88  TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSE 145
            + ++  S +G G +G V   +          T  G+ VA+KKL+    S+   +    E
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRE 67

Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
           +  L  + H N++ LL      + L    +      L           Q L+ D    + 
Sbjct: 68  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 127

Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYII 265
               RGL ++H     +I+RD K SN+ ++    L      +  +            +  
Sbjct: 128 YQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYR 185

Query: 266 YIYIYVYIYMYIYKCLRYA---ILYSVL 290
              I +    Y      ++   I+  +L
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELL 213

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.7 bits (211), Expect = 2e-19
 Identities = 33/159 (20%), Positives = 62/159 (38%), Gaps = 25/159 (15%)

Query: 90  NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSEVN 147
            ++  + +G+G FG V+K               G  VA+KK+  E+ +         E+ 
Sbjct: 11  KYEKLAKIGQGTFGEVFKAR---------HRKTGQKVALKKVLMENEKEGFPITALREIK 61

Query: 148 FLGRLSHPNLVKLLGYCWEDKE--------LLLVYEYMQRGSLENHLFRRNPSIQPLSWD 199
            L  L H N+V L+  C             + LV+++ +                  +  
Sbjct: 62  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLS 117

Query: 200 IRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
              ++      GL ++H    K+++RD KA+N+L+   G
Sbjct: 118 EIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDG 154

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.8 bits (193), Expect = 7e-17
 Identities = 32/158 (20%), Positives = 55/158 (34%), Gaps = 26/158 (16%)

Query: 89  KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEV 146
           K ++    +G G  G V   +            L   VAIKKL+         +    E+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67

Query: 147 NFLGRLSHPNLVKLLGYCW------EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDI 200
             +  ++H N++ LL          E +++ LV E M     +               + 
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHER 120

Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG 238
              +      G+  LH     +I+RD K SNI++    
Sbjct: 121 MSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDC 156

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 70.8 bits (172), Expect = 3e-14
 Identities = 32/193 (16%), Positives = 62/193 (32%), Gaps = 23/193 (11%)

Query: 91  FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLG 150
           +     LG G F  V+                   VA+K +  + +   E  + E+  L 
Sbjct: 15  YILVRKLGWGHFSTVWLAK---------DMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQ 64

Query: 151 RLSHPNL-----------VKLLGYCWEDKELLLVYEYMQRGSLENHL-FRRNPSIQPLSW 198
           R++  +            +KLL +        +    +     EN L   +    + +  
Sbjct: 65  RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL 124

Query: 199 DIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYI 258
               +I+     GL ++H     +I+ D K  N+L++ V    +   +          Y 
Sbjct: 125 IYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 183

Query: 259 YIHTYIIYIYIYV 271
             +T  I    Y 
Sbjct: 184 EHYTNSIQTREYR 196

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 57.9 bits (139), Expect = 2e-10
 Identities = 20/144 (13%), Positives = 41/144 (28%), Gaps = 9/144 (6%)

Query: 95  SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH 154
            L+GEG    V+  + +       K       + KK+  +   G   +        R   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
             L KL G           Y +     L   +  +      +       +       +  
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118

Query: 215 LHTSEKKVIYRDFKASNILLDGVG 238
            +   + +++ D    N+L+   G
Sbjct: 119 FY--HRGIVHGDLSQYNVLVSEEG 140

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	376
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.97
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.83
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.19
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.02
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.04
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.84
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.46
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	87.01
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	83.83
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	83.5
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	80.03

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=353.83  Aligned_cols=201  Identities=20%  Similarity=0.188  Sum_probs=171.9

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++++.||+|+||+||+|.+         +.+++.||||+++.... ...+.+.+|+.+|++++||||+++++++.+
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~   74 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVN---------RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE   74 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEE---------CCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence            46799999999999999999954         44689999999876543 334678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++.+|||||||++|+|.+++.+.    ..+++..+..++.||+.||+|||  +++|+||||||+|||++.+|.+||+|||
T Consensus        75 ~~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH--~~~IiHrDiKp~NILl~~~~~~KL~DFG  148 (271)
T d1nvra_          75 GNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFG  148 (271)
T ss_dssp             TTEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             CceeEEEEeccCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH--HcCCccCcccHHHEEECCCCCEEEccch
Confidence            99999999999999999999654    56999999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      +|+........... .+.    +|||.||               |||++.+..+.+.++||||+|++++++++...+
T Consensus       149 ~a~~~~~~~~~~~~-~~~----~GT~~Y~---------------APE~~~~~~~~~~~~DiwSlGvilyeml~G~~p  205 (271)
T d1nvra_         149 LATVFRYNNRERLL-NKM----CGTLPYV---------------APELLKRREFHAEPVDVWSCGIVLTAMLAGELP  205 (271)
T ss_dssp             TCEECEETTEECCB-CCC----CSCGGGS---------------CTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             hheeeccCCccccc-cce----eeCcCcc---------------CHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCC
Confidence            99987554332211 222    8999999               999999888888999999999999999964433

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-47  Score=345.47  Aligned_cols=198  Identities=22%  Similarity=0.238  Sum_probs=172.8

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|++.+.||+|+||+||+|.         ++.+++.||||+++.......+.+.+|+.+|+.++||||+++++++.++
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~---------~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   89 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAM---------DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG   89 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEE---------BTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             ccccEEEEEEecCcCcEEEEEE---------ECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC
Confidence            4579999999999999999994         4456899999999766555567889999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +.+|||||||+||+|.+++.+.     .+++..+..++.||+.||.|||  +++|+||||||+|||++.+|.+||+|||+
T Consensus        90 ~~~~ivmEy~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH--~~~iiHrDiKp~NILl~~~~~vkl~DFG~  162 (293)
T d1yhwa1          90 DELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGF  162 (293)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             CEEEEEEEecCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHH--HCCCcccCCcHHHeEECCCCcEeeccchh
Confidence            9999999999999999988653     4899999999999999999999  59999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ++.+.......   .+.    +||+.||               |||++.+..+ +.++||||+|++++++++...+.
T Consensus       163 a~~~~~~~~~~---~~~----~gt~~Y~---------------aPE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf  216 (293)
T d1yhwa1         163 CAQITPEQSKR---STM----VGTPYWM---------------APEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPY  216 (293)
T ss_dssp             CEECCSTTCCB---CCC----CSCGGGC---------------CHHHHSSSCB-CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             heeeccccccc---ccc----ccCCCcc---------------ChhhhcCCCC-CchhceehHhHHHHHHhhCCCCC
Confidence            99875543221   111    7899999               8999988654 78999999999999999765543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-46  Score=337.34  Aligned_cols=198  Identities=22%  Similarity=0.239  Sum_probs=172.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      .++|++++.||+|+||+||+|+..         .+++.||+|++.+...   ...+.+.+|+.+++.++||||+++++++
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~   75 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREK---------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF   75 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEEC---------CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence            357999999999999999999544         4689999999875322   2346788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .+++.+|+|||||++|+|.+++.+.    ..+++..+..++.||+.||+|||  +++|+||||||+|||++.+|.+||+|
T Consensus        76 ~~~~~~~ivmEy~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH--~~~ivHrDiKp~Nill~~~~~~kl~D  149 (263)
T d2j4za1          76 HDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIAD  149 (263)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECC
T ss_pred             EECCEEEEEEeecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeeeeccccceecCCCCEeecc
Confidence            9999999999999999999999876    45899999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ||+++........     +    ..||+.||               |||++.+..+ +.++||||+|++++++++...+.
T Consensus       150 FG~a~~~~~~~~~-----~----~~Gt~~Y~---------------APE~~~~~~~-~~~~DiwSlGvilyell~G~~Pf  204 (263)
T d2j4za1         150 FGWSVHAPSSRRT-----T----LCGTLDYL---------------PPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPF  204 (263)
T ss_dssp             CCSCSCCCCCCCE-----E----TTEEGGGC---------------CHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             cceeeecCCCccc-----c----cCCCCccc---------------CHHHHcCCCC-CchhhhhhHhHHHHHHhcCCCCC
Confidence            9999876543221     1    27899999               8999988654 88999999999999999766555


Q ss_pred             h
Q 017177          325 M  325 (376)
Q Consensus       325 ~  325 (376)
                      .
T Consensus       205 ~  205 (263)
T d2j4za1         205 E  205 (263)
T ss_dssp             C
T ss_pred             C
Confidence            3

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=342.78  Aligned_cols=201  Identities=19%  Similarity=0.181  Sum_probs=170.2

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      .++|++++.||+|+||+||+|..         +.+++.||||+++...   ....+.+.+|+.+|++++||||+++++++
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~   77 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARE---------LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF   77 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE
Confidence            35799999999999999999954         4468999999987532   23346789999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .+++.+|+|||||+||+|.+++...    ..+++..+..++.|++.||+|||  +++||||||||+|||++++|.+||+|
T Consensus        78 ~~~~~~~ivmEy~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH--~~~iiHrDiKp~NIll~~~~~vkl~D  151 (288)
T d1uu3a_          78 QDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQITD  151 (288)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECC
T ss_pred             EECCEEEEEEEccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhc--cccEEcCcCCccccccCCCceEEecc
Confidence            9999999999999999999998876    45999999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ||+|+.+......... .+    .+||+.||               |||++.+..+ +.++||||+|++++++++...+.
T Consensus       152 FG~a~~~~~~~~~~~~-~~----~~GT~~Y~---------------APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf  210 (288)
T d1uu3a_         152 FGTAKVLSPESKQARA-NS----FVGTAQYV---------------SPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPF  210 (288)
T ss_dssp             CTTCEECC---------------CCCCGGGC---------------CHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccceecccCCccccc-cc----ccCCcccc---------------CceeeccCCC-CcccceehhhHHHHHHhhCCCCC
Confidence            9999987544332211 11    27999999               9999887764 78999999999999999765554

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=340.84  Aligned_cols=204  Identities=21%  Similarity=0.266  Sum_probs=160.3

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ++|++.+.||+|+||+||+|+.         +.+++.||+|+++...  ....+.+.+|+.+|++++||||+++++++.+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   74 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRR---------KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID   74 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred             hhCEEeEEEecCCCeEEEEEEE---------CCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence            5799999999999999999954         4468999999997653  3445678899999999999999999999865


Q ss_pred             --CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcC---CCCcEecCCCCCCEEEcCCCcEE
Q 017177          167 --DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS---EKKVIYRDFKASNILLDGVGFLF  241 (376)
Q Consensus       167 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~---~~~iiHrDlKp~NILl~~~g~~k  241 (376)
                        ++.+|||||||++|+|.+++.+.......+++..++.++.||+.||+|||+.   ..+||||||||+|||++.+|.+|
T Consensus        75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk  154 (269)
T d2java1          75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK  154 (269)
T ss_dssp             ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred             CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence              4568999999999999999975433345699999999999999999999951   12499999999999999999999


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |+|||+++.........   .+    ..|||.||               |||++.+.. ++.++||||+|++++|+++..
T Consensus       155 l~DFG~a~~~~~~~~~~---~~----~~gt~~Y~---------------APE~l~~~~-~~~~~DIwSlGvilyel~tg~  211 (269)
T d2java1         155 LGDFGLARILNHDTSFA---KA----FVGTPYYM---------------SPEQMNRMS-YNEKSDIWSLGCLLYELCALM  211 (269)
T ss_dssp             ECCHHHHHHC------------------CCCSCC---------------CHHHHTTCC-CCHHHHHHHHHHHHHHHHHSS
T ss_pred             EeeccceeecccCCCcc---cc----CCCCcccC---------------CHHHHcCCC-CChHHHHHhhCHHHHHHhhCC
Confidence            99999999875533221   11    27889999               899887765 478999999999999999765


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      .+.
T Consensus       212 ~Pf  214 (269)
T d2java1         212 PPF  214 (269)
T ss_dssp             CSC
T ss_pred             CCC
Confidence            554

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=344.18  Aligned_cols=201  Identities=22%  Similarity=0.311  Sum_probs=172.8

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .+.|++++.||+|+||.||+|++.         .+++.||||+++.......+.+.+|+.+|++++|||||++++++.++
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~---------~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~   81 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNK---------ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE   81 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEEC---------CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            346899999999999999999544         46899999999877666677889999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +.+|+|||||++|+|.+++.+..   ..+++..+..++.||+.||.|||  +++|+||||||+|||++.+|.+||+|||+
T Consensus        82 ~~~~lvmEy~~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH--~~~ivHrDiKp~NIll~~~~~~Kl~DFG~  156 (288)
T d2jfla1          82 NNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFGV  156 (288)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CeEEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCEEEeecChhheeECCCCCEEEEechh
Confidence            99999999999999999987652   45899999999999999999999  59999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhh----hhhccccccccceeeeehhhcccccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAW----IKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~----~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |+.........   .+.    .||+.||               |||++.+    ...++.++||||+|++++++++...+
T Consensus       157 a~~~~~~~~~~---~~~----~Gt~~y~---------------APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~P  214 (288)
T d2jfla1         157 SAKNTRTIQRR---DSF----IGTPYWM---------------APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP  214 (288)
T ss_dssp             CEECHHHHHHH---TCC----CSCCTTC---------------CHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCT
T ss_pred             hhccCCCcccc---ccc----ccccccC---------------CHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCC
Confidence            98765432211   112    7889999               8998853    23457899999999999999976544


Q ss_pred             c
Q 017177          324 T  324 (376)
Q Consensus       324 ~  324 (376)
                      .
T Consensus       215 f  215 (288)
T d2jfla1         215 H  215 (288)
T ss_dssp             T
T ss_pred             C
Confidence            3

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.2e-46  Score=341.95  Aligned_cols=195  Identities=25%  Similarity=0.286  Sum_probs=168.9

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      +.|+.++.||+|+||+||+|+.         +.+++.||||+++....   ...+.+.+|+.+|++++|||||++++++.
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   85 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARD---------VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL   85 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEE---------TTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEE---------CCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence            3489999999999999999954         44689999999876532   33467889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +++.+|+|||||++|+|..++...    ..+++..+..++.||+.||.|||  .++||||||||+|||++.+|.+||+||
T Consensus        86 ~~~~~~iv~E~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH--~~~iiHrDiKp~NILl~~~~~~Kl~DF  159 (309)
T d1u5ra_          86 REHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDF  159 (309)
T ss_dssp             ETTEEEEEEECCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEEETTTEEEECCC
T ss_pred             ECCEEEEEEEecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH--hCCEeccCCCcceEEECCCCCEEEeec
Confidence            999999999999999987766554    45899999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh--hhccccccccceeeeehhhcccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI--KYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~--~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      |+++........           .|||.||               |||++.+.  ..++.++||||+|++++|+++...+
T Consensus       160 G~a~~~~~~~~~-----------~GT~~Y~---------------APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~P  213 (309)
T d1u5ra_         160 GSASIMAPANSF-----------VGTPYWM---------------APEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  213 (309)
T ss_dssp             TTCBSSSSBCCC-----------CSCGGGC---------------CHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             ccccccCCCCcc-----------ccCcccc---------------CHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCC
Confidence            999876543222           7899999               99998764  4568899999999999999976555


Q ss_pred             c
Q 017177          324 T  324 (376)
Q Consensus       324 ~  324 (376)
                      .
T Consensus       214 f  214 (309)
T d1u5ra_         214 L  214 (309)
T ss_dssp             T
T ss_pred             C
Confidence            4

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.7e-46  Score=340.71  Aligned_cols=200  Identities=23%  Similarity=0.358  Sum_probs=172.2

Q ss_pred             hhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        85 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ....++|++.+.||+|+||+||+|.+.         .+++.||||+++.... ..+.+.+|+.+|++++|||||++++++
T Consensus        13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~---------~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~   82 (287)
T d1opja_          13 EMERTDITMKHKLGGGQYGEVYEGVWK---------KYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVC   82 (287)
T ss_dssp             BCCGGGEEEEEETTTTTTSSEEEEEEG---------GGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             EecHHHeEEeeEEeeCCCeEEEEEEEC---------CCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccE
Confidence            344567999999999999999999654         3588999999986543 457889999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .+++.+|+|||||++|+|.+++.+...  ..+++..++.++.||+.||+|||  +++|+||||||+||||+.+|.+||+|
T Consensus        83 ~~~~~~~iv~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH--~~~iiHrDlKp~NILl~~~~~~Kl~D  158 (287)
T d1opja_          83 TREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVAD  158 (287)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred             eeCCeeEEEeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHH--HCCcccCccccCeEEECCCCcEEEcc
Confidence            999999999999999999999976532  56899999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ||+++......... ..++     .||+.||               |||++.+.. ++.++||||+|++++|+++.
T Consensus       159 FG~a~~~~~~~~~~-~~~~-----~g~~~y~---------------aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~  212 (287)
T d1opja_         159 FGLSRLMTGDTYTA-HAGA-----KFPIKWT---------------APESLAYNK-FSIKSDVWAFGVLLWEIATY  212 (287)
T ss_dssp             CCCTTTCCSSSSEE-ETTE-----EECGGGC---------------CHHHHHHCC-CSHHHHHHHHHHHHHHHHTT
T ss_pred             ccceeecCCCCcee-eccc-----ccccccc---------------ChHHHcCCC-CCchhhhhhHHHHHHHHHhC
Confidence            99999776543332 2222     6788888               899888765 48899999999999999864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-45  Score=340.00  Aligned_cols=200  Identities=17%  Similarity=0.181  Sum_probs=157.0

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      +..+.|++.+.||+|+||+||+|+.         +.+++.||||++..... .....+.+|+.+|+.++||||+++++++
T Consensus         6 di~d~Y~~~~~lG~G~fg~Vy~~~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~   76 (307)
T d1a06a_           6 DIRDIYDFRDVLGTGAFSEVILAED---------KRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY   76 (307)
T ss_dssp             CGGGTEEEEEESBSGGGGGEEEEEE---------TTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCccceEEEEEEeeccCeEEEEEEE---------CCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            3456799999999999999999954         34689999999976543 2335678999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc---CCCcEE
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD---GVGFLF  241 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~---~~g~~k  241 (376)
                      .+++.+|||||||+||+|.+++.+.    ..+++..+..++.||+.||.|||  +++|+||||||+|||+.   ++|.+|
T Consensus        77 ~~~~~~~lvmE~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH--~~~iiHrDiKp~Nil~~~~~~~~~vk  150 (307)
T d1a06a_          77 ESGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIM  150 (307)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSSSTTCCEE
T ss_pred             EECCEEEEEEeccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhh--hceeeeEEecccceeecccCCCceEE
Confidence            9999999999999999999999765    45999999999999999999999  59999999999999994   578999


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |+|||+++........    .+    .+||+.||               |||++.+.. ++.++||||+|++++++++..
T Consensus       151 l~DFG~a~~~~~~~~~----~~----~~GT~~y~---------------APE~~~~~~-~~~~~DiwSlGvilyell~g~  206 (307)
T d1a06a_         151 ISDFGLSKMEDPGSVL----ST----ACGTPGYV---------------APEVLAQKP-YSKAVDCWSIGVIAYILLCGY  206 (307)
T ss_dssp             ECCC--------------------------CTTS---------------CHHHHTTCC-CCTHHHHHHHHHHHHHHHHSS
T ss_pred             EeccceeEEccCCCee----ee----eeeCcccc---------------CcHHHcCCC-CCcHHHhhhhhHHHHHHHhCC
Confidence            9999999876543322    11    27899999               899988765 488999999999999999776


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      .+.
T Consensus       207 ~Pf  209 (307)
T d1a06a_         207 PPF  209 (307)
T ss_dssp             CSC
T ss_pred             CCC
Confidence            655

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-46  Score=345.93  Aligned_cols=197  Identities=23%  Similarity=0.246  Sum_probs=170.9

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++++.||+|+||+||+|++         +.+++.||+|+++... ....+.+.+|+.+|+.++|||||+++++|.+
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~   75 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSH---------KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS   75 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEE---------TTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC
T ss_pred             ccCCEEEEEEecCCCeEEEEEEE---------CCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            46799999999999999999954         3468999999997653 2335678999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++++|+|||||+||+|.+++.+.    ..+++..+..++.|++.||.|||+ .++|+||||||+||||+.+|.+||+|||
T Consensus        76 ~~~~~iVmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~-~~~IiHRDiKP~NILl~~~~~vkl~DFG  150 (322)
T d1s9ja_          76 DGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFG  150 (322)
T ss_dssp             SSEEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             CCEEEEEEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHH-hCCEEccccCHHHeeECCCCCEEEeeCC
Confidence            99999999999999999999876    458999999999999999999995 3589999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      +|+........     +    .+||+.||               |||++.+.. ++.++||||+|+|++|+++...+
T Consensus       151 la~~~~~~~~~-----~----~~GT~~Y~---------------APEvl~~~~-y~~~~DiWSlGvil~ell~G~~P  202 (322)
T d1s9ja_         151 VSGQLIDSMAN-----S----FVGTRSYM---------------SPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYP  202 (322)
T ss_dssp             CCHHHHHHTC------------CCSSCCC---------------CHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCC
T ss_pred             CccccCCCccc-----c----ccCCcccc---------------CchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCC
Confidence            99976543221     1    27889999               899998865 58899999999999999975444

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-45  Score=343.40  Aligned_cols=199  Identities=22%  Similarity=0.217  Sum_probs=172.5

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      .++|++++.||+|+||.||+|+         ++.+++.||||++++..   ....+.+.+|+.+|+.++||||+++++++
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~---------~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~   74 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVR---------EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF   74 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEE---------ECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee
Confidence            4679999999999999999994         44479999999997542   23457788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .+++.+|+|||||+||+|.+++.+.    ..+++..++.++.||+.||+|||  .++||||||||+|||++.+|.+||+|
T Consensus        75 ~~~~~~~iv~ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH--~~~iiHRDlKP~NILl~~~g~vkl~D  148 (337)
T d1o6la_          75 QTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITD  148 (337)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred             ccccccccceeccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhh--hcCccccccCHHHeEecCCCCEEEee
Confidence            9999999999999999999999876    45899999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ||+|+.........   .+    .+|||.||               |||++.+..| +.++|+||+|++++|+++-..+.
T Consensus       149 FG~a~~~~~~~~~~---~~----~~GT~~Y~---------------aPE~~~~~~y-~~~~DiwSlGvilyeml~G~~pf  205 (337)
T d1o6la_         149 FGLCKEGISDGATM---KT----FCGTPEYL---------------APEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPF  205 (337)
T ss_dssp             CTTCBCSCCTTCCB---CC----CEECGGGC---------------CGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccccccccCCccc---cc----ceeCHHHh---------------hhhhccCCCC-ChhhcccchhhHHHHHHHCCCCC
Confidence            99999765433221   11    28999999               8998888776 88999999999999999654443

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2e-44  Score=337.66  Aligned_cols=199  Identities=19%  Similarity=0.191  Sum_probs=174.3

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|++++.||+|+||.||+|+.         +.+++.||||++........+.+.+|+.+|++++|||||++++++.++
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~---------~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   95 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTE---------RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD   95 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEE---------TTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET
T ss_pred             ccCeEEEEEEecCcCeEEEEEEE---------CCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            45899999999999999999954         446899999999887777778899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc--CCCcEEEcce
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD--GVGFLFDSHL  245 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~--~~g~~kl~Df  245 (376)
                      +.+|||||||+||+|.+++.+..   ..+++..+..++.||+.||.|||  +++||||||||+|||++  .+|.+||+||
T Consensus        96 ~~~~ivmE~~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH--~~~iiHrDiKp~NIll~~~~~~~vkL~DF  170 (350)
T d1koaa2          96 NEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDF  170 (350)
T ss_dssp             TEEEEEECCCCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTSCCEEECCC
T ss_pred             CEEEEEEEcCCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH--hcCCeeeeechhHeeeccCCCCeEEEeec
Confidence            99999999999999999996542   45999999999999999999999  59999999999999995  4688999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      |+++.+........        ..||+.||               |||++.+..+ +.++||||+|++++++++...+.
T Consensus       171 G~a~~~~~~~~~~~--------~~gT~~Y~---------------aPEv~~~~~~-~~~~DiwSlGvilyell~G~~Pf  225 (350)
T d1koaa2         171 GLTAHLDPKQSVKV--------TTGTAEFA---------------APEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPF  225 (350)
T ss_dssp             TTCEECCTTSCEEE--------ECSCTTTC---------------CHHHHHTCCB-CHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             chheecccccccce--------ecCccccc---------------CHHHHcCCCC-ChhHhhhhhhHHHHHHHhCCCCC
Confidence            99998766544321        27888998               8999888665 78999999999999999765554

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-44  Score=327.06  Aligned_cols=200  Identities=23%  Similarity=0.291  Sum_probs=163.7

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGY  163 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~  163 (376)
                      ...++|++.+.||+|+||+||+|+.+            ..||||+++..  .....+.+.+|+.+|++++|||||+++++
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~------------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~   72 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY   72 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS------------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC------------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEE
Confidence            34578999999999999999999543            24999999764  33456789999999999999999999997


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEc
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDS  243 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~  243 (376)
                      +. .+.+++|||||++|+|.+++....   ..+++..++.++.||+.||+|||+  ++||||||||+||||+.++.+||+
T Consensus        73 ~~-~~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~--~~ivHrDlKp~NiLl~~~~~~Kl~  146 (276)
T d1uwha_          73 ST-APQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIG  146 (276)
T ss_dssp             EC-SSSCEEEEECCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTSSEEEC
T ss_pred             Ee-ccEEEEEEecCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhc--CCEeccccCHHHEEEcCCCCEEEc
Confidence            64 567899999999999999997653   458999999999999999999994  899999999999999999999999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhh--hccccccccceeeeehhhcccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIK--YLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~--~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |||+|+........... .+.    .||+.||               |||++.+..  .++.++||||||++++|+++..
T Consensus       147 DFGla~~~~~~~~~~~~-~~~----~gt~~y~---------------APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~  206 (276)
T d1uwha_         147 DFGLATVKSRWSGSHQF-EQL----SGSILWM---------------APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ  206 (276)
T ss_dssp             CCCCSCC-------------C----CCCGGGC---------------CHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             cccceeeccccCCcccc-ccc----ccCcccC---------------CHHHHhcccCCCCCchhhhhhhHHHHHHHHHCC
Confidence            99999876543332111 222    7899999               999987643  4688999999999999999755


Q ss_pred             cc
Q 017177          322 RT  323 (376)
Q Consensus       322 ~~  323 (376)
                      .+
T Consensus       207 ~P  208 (276)
T d1uwha_         207 LP  208 (276)
T ss_dssp             CT
T ss_pred             CC
Confidence            44

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=327.04  Aligned_cols=193  Identities=24%  Similarity=0.305  Sum_probs=162.8

Q ss_pred             CCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe--
Q 017177           91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE--  166 (376)
Q Consensus        91 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--  166 (376)
                      |++.+.||+|+||+||+|.+.         .+++.||+|++...  .....+.+.+|+++|++++|||||++++++.+  
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~---------~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   81 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDT---------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   81 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred             EEeeeEEecCcCcEEEEEEEC---------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence            467788999999999999544         46889999998754  33455788999999999999999999999875  


Q ss_pred             --CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--cEecCCCCCCEEEc-CCCcEE
Q 017177          167 --DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK--VIYRDFKASNILLD-GVGFLF  241 (376)
Q Consensus       167 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~--iiHrDlKp~NILl~-~~g~~k  241 (376)
                        +..+|+|||||++|+|.+++.+.    ..+++..+..++.||+.||+|||+  ++  |+||||||+|||++ +++.+|
T Consensus        82 ~~~~~~~ivmE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~--~~~~IiHrDiKp~NILl~~~~~~~K  155 (270)
T d1t4ha_          82 KGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTGSVK  155 (270)
T ss_dssp             SSCEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHT--SSSCCCCSCCCGGGEEESSTTSCEE
T ss_pred             ccCCEEEEEEeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHH--CCCCEEeCCcChhhceeeCCCCCEE
Confidence              35689999999999999999876    458999999999999999999994  66  99999999999996 579999


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |+|||+++........     +.    +|||.||               |||++.+.  ++.++||||+|++++++++..
T Consensus       156 l~DFGla~~~~~~~~~-----~~----~GT~~Y~---------------aPE~~~~~--~~~~~DIwSlGvilyel~~g~  209 (270)
T d1t4ha_         156 IGDLGLATLKRASFAK-----AV----IGTPEFM---------------APEMYEEK--YDESVDVYAFGMCMLEMATSE  209 (270)
T ss_dssp             ECCTTGGGGCCTTSBE-----ES----CSSCCCC---------------CGGGGGTC--CCTHHHHHHHHHHHHHHHHSS
T ss_pred             EeecCcceeccCCccC-----Cc----ccCcccc---------------CHHHhCCC--CCCcCchhhHHHHHHHHHHCC
Confidence            9999999865443221     11    7889999               89987653  689999999999999999765


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      .+.
T Consensus       210 ~Pf  212 (270)
T d1t4ha_         210 YPY  212 (270)
T ss_dssp             CTT
T ss_pred             CCC
Confidence            443

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.5e-44  Score=337.30  Aligned_cols=199  Identities=18%  Similarity=0.179  Sum_probs=174.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|++++.||+|+||.||+|..         +.+++.||||+++.......+.+.+|+.+|++++|||||+++++|.++
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~---------~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   98 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVE---------KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK   98 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred             ccceEEEEEEecCCCeEEEEEEE---------CCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            45799999999999999999954         446899999999887766667888999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc--CCCcEEEcce
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD--GVGFLFDSHL  245 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~--~~g~~kl~Df  245 (376)
                      +.+|||||||+||+|.+++...   ...+++..++.++.||+.||.|||  +++||||||||+||||+  .+|.+||+||
T Consensus        99 ~~~~ivmE~~~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH--~~~iiHRDiKp~NILl~~~~~~~vkL~DF  173 (352)
T d1koba_          99 YEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDF  173 (352)
T ss_dssp             SEEEEEEECCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTCCCEEECCC
T ss_pred             CEEEEEEEcCCCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccccccccccccCCCeEEEeec
Confidence            9999999999999999988654   246999999999999999999999  59999999999999997  6789999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      |+|+..........        ..||+.||               |||++.+.. ++.++||||+|++++++++...+.
T Consensus       174 Gla~~~~~~~~~~~--------~~gt~~y~---------------aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf  228 (352)
T d1koba_         174 GLATKLNPDEIVKV--------TTATAEFA---------------APEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPF  228 (352)
T ss_dssp             TTCEECCTTSCEEE--------ECSSGGGC---------------CHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred             ccceecCCCCceee--------ccCccccc---------------CHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCC
Confidence            99998766443322        27788888               899888765 488999999999999999766554

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-45  Score=328.69  Aligned_cols=195  Identities=25%  Similarity=0.360  Sum_probs=159.5

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|++.+.||+|+||.||+|.+.+          +..||||+++.... ..+++.+|+.++++++||||+++++++.++
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~----------~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~   72 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ   72 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETT----------TEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECC----------CCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccC
Confidence            4579999999999999999997653          66799999986543 346789999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +..++|||||++|+|.+++....   ..+++..+..++.||+.||.|||  +++|+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~lv~E~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH--~~~iiHrDlKp~Nill~~~~~~Kl~DFGl  147 (263)
T d1sm2a_          73 APICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGM  147 (263)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCTTCSGGGEEECGGGCEEECSCC-
T ss_pred             CceEEEEEecCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhh--ccceeecccchhheeecCCCCeEecccch
Confidence            99999999999999999987652   55889999999999999999999  59999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ++........... +     ..||+.||               |||++.+.. ++.++||||||++++|+++.
T Consensus       148 a~~~~~~~~~~~~-~-----~~gt~~y~---------------aPE~l~~~~-~~~k~DVwS~Gvil~el~t~  198 (263)
T d1sm2a_         148 TRFVLDDQYTSST-G-----TKFPVKWA---------------SPEVFSFSR-YSSKSDVWSFGVLMWEVFSE  198 (263)
T ss_dssp             -----------------------CTTSC---------------CHHHHTTCC-CCHHHHHHHHHHHHHHHHTT
T ss_pred             heeccCCCceeec-c-----eecCcccC---------------ChHHhcCCC-CCchhhhcchHHHHHHHHHC
Confidence            9877554332111 1     17888888               899988776 58899999999999999864

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-44  Score=331.63  Aligned_cols=204  Identities=22%  Similarity=0.312  Sum_probs=158.2

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-ChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .++|++.++||+|+||+||+|.+...      ......||||.+... .....+.|.+|+.+|++++|||||++++++.+
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~   98 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLP------GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK   98 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCC------CCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            35688899999999999999976531      112347899998765 33456789999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++.+|+|||||++|+|.+++....   ..+++..++.++.||+.||.|||  .++|+||||||+||||+.++.+||+|||
T Consensus        99 ~~~~~iv~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH--~~~iiHrDlKp~NILl~~~~~~Kl~DFG  173 (299)
T d1jpaa_          99 STPVMIITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFG  173 (299)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             CCEEEEEEEecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHh--hCCCccCccccceEEECCCCcEEECCcc
Confidence            999999999999999999887653   45899999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      +++............++.+  ..||+.||               |||++.+.. ++.++||||||++++|++++
T Consensus       174 la~~~~~~~~~~~~~~~~~--~~~t~~y~---------------aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~  229 (299)
T d1jpaa_         174 LSRFLEDDTSDPTYTSALG--GKIPIRWT---------------APEAIQYRK-FTSASDVWSYGIVMWEVMSY  229 (299)
T ss_dssp             ------------------------CGGGS---------------CHHHHHSCC-CCHHHHHHHHHHHHHHHHTT
T ss_pred             cceEccCCCCcceeeeccc--ccCCcccc---------------CHHHHhcCC-CCcccccccchHHHHHHHhC
Confidence            9998765443322222211  16788899               899887654 58899999999999999864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-44  Score=334.52  Aligned_cols=195  Identities=24%  Similarity=0.321  Sum_probs=170.8

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ++|++++.||+|+||+||+|+.         +.+++.||||++++..   ....+.+.+|+.+|+.++||||+++++++.
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~---------~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~   74 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRS---------RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ   74 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEE---------CCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe
Confidence            5699999999999999999954         4468999999987542   233577889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +++.+|+|||||+||+|..++...    ..+++..+..++.||+.||.|||  .++||||||||+||||+.+|.+||+||
T Consensus        75 ~~~~~~ivmE~~~gg~l~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH--~~~iiHrDiKp~NILl~~~g~vkL~DF  148 (316)
T d1fota_          75 DAQQIFMIMDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDF  148 (316)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             eCCeeeeEeeecCCcccccccccc----ccccccHHHHHHHHHHHhhhhhc--cCcEEccccCchheeEcCCCCEEEecC
Confidence            999999999999999999998776    45889999999999999999999  699999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      |+|+.......      +    .+|||.||               |||++.+..| +.++||||+|++++++++...+.
T Consensus       149 G~a~~~~~~~~------~----~~Gt~~Y~---------------APE~l~~~~y-~~~~DiwSlGvilyemltG~~Pf  201 (316)
T d1fota_         149 GFAKYVPDVTY------T----LCGTPDYI---------------APEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPF  201 (316)
T ss_dssp             SSCEECSSCBC------C----CCSCTTTC---------------CHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccceEeccccc------c----ccCccccc---------------CHHHHcCCCC-CchhhccccchhHHHHHhCCCCC
Confidence            99998754322      1    27899999               8999887764 78999999999999999766554

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=328.34  Aligned_cols=196  Identities=23%  Similarity=0.350  Sum_probs=166.5

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..++|++.+.||+|+||.||+|.+++          +..||||+++.... ..+.+.+|+.++++++|||||++++++. 
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~----------~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~-   78 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNG----------HTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-   78 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECC----------CCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeec-
Confidence            45679999999999999999997653          67899999986543 3467899999999999999999999775 


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++.+|+|||||++|+|.+++.....  ..+++..++.++.||+.||.|||  .++|+||||||+||||+.++.+||+|||
T Consensus        79 ~~~~~iv~Ey~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH--~~~ivHrDiKp~NIll~~~~~~Kl~DFG  154 (272)
T d1qpca_          79 QEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFG  154 (272)
T ss_dssp             SSSCEEEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             cCCeEEEEEeCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCccchhheeeecccceeecccc
Confidence            4668999999999999998865432  35899999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      +|+.......... .+.     .||+.||               |||++.+.. ++.++||||||++++|+++.
T Consensus       155 la~~~~~~~~~~~-~~~-----~gt~~y~---------------APE~~~~~~-~~~~sDvwS~Gvvl~ellt~  206 (272)
T d1qpca_         155 LARLIEDNEYTAR-EGA-----KFPIKWT---------------APEAINYGT-FTIKSDVWSFGILLTEIVTH  206 (272)
T ss_dssp             TCEECSSSCEECC-TTC-----CCCTTTS---------------CHHHHHHCE-ECHHHHHHHHHHHHHHHHTT
T ss_pred             ceEEccCCccccc-ccc-----CCccccc---------------ChHHHhCCC-CCchhhhhhhHHHHHHHHhC
Confidence            9998765443311 122     7888888               899887655 58899999999999999874

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-44  Score=325.24  Aligned_cols=203  Identities=23%  Similarity=0.323  Sum_probs=161.8

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      .+.|++.++||+|+||.||+|.++..     .......||||+++... ......+.+|+.++++++|||||++++++.+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~-----~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~   80 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTS-----SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK   80 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCC-----CCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence            35688899999999999999987642     11224679999997653 3445678999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      .+..++|||||.+|++.+++....   ..+++..+..++.||+.||.|||  +++|+||||||+||||+.++.+||+|||
T Consensus        81 ~~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH--~~~iiHrDlKp~NILl~~~~~~Kl~DFG  155 (283)
T d1mqba_          81 YKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFG  155 (283)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             CCceEEEEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhcc--ccccccCccccceEEECCCCeEEEcccc
Confidence            999999999999999999887653   56899999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      +++...............    .||+.||               |||++.+.. ++.++||||||++++|+++.
T Consensus       156 la~~~~~~~~~~~~~~~~----~gt~~Y~---------------APE~l~~~~-~~~~sDI~S~Gvil~el~t~  209 (283)
T d1mqba_         156 LSRVLEDDPEATYTTSGG----KIPIRWT---------------APEAISYRK-FTSASDVWSFGIVMWEVMTY  209 (283)
T ss_dssp             C---------------------CCCGGGS---------------CHHHHHSCC-CCHHHHHHHHHHHHHHHHTT
T ss_pred             hhhcccCCCccceEeccC----CCCcccc---------------CHHHHccCC-CCCcccccccHHHHHHHHhC
Confidence            999875543322111111    6788899               899887765 57899999999999999863

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.1e-44  Score=335.11  Aligned_cols=195  Identities=24%  Similarity=0.239  Sum_probs=171.4

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ++|++++.||+|+||.||+|++         +.+++.||||++++..   ....+.+.+|+.+|+.++||||+++++++.
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~---------~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~  111 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKH---------KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK  111 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEE---------CCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence            5799999999999999999954         4468999999987532   233567889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      +.+.+++||||+.+|+|.+++.+.    ..+++..+..++.||+.||.|||  +++||||||||+|||++.+|.+||+||
T Consensus       112 ~~~~~~~v~e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH--~~~iiHRDIKP~NILl~~~g~ikL~DF  185 (350)
T d1rdqe_         112 DNSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDF  185 (350)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             cccccccccccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCcCCHHHcccCCCCCEEeeec
Confidence            999999999999999999999876    45899999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      |+|+.......      +.    .||+.||               |||++.+..+ +.++||||+|++++++++...+.
T Consensus       186 G~a~~~~~~~~------~~----~Gt~~Y~---------------APE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf  238 (350)
T d1rdqe_         186 GFAKRVKGRTW------TL----CGTPEAL---------------APEIILSKGY-NKAVDWWALGVLIYEMAAGYPPF  238 (350)
T ss_dssp             TTCEECSSCBC------CC----EECGGGC---------------CHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             eeeeecccccc------cc----cCccccC---------------CHHHHcCCCC-CccccccchhHHHHHHHhCCCCC
Confidence            99998754321      12    7899999               9999988664 78999999999999999765554

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-44  Score=331.43  Aligned_cols=207  Identities=26%  Similarity=0.335  Sum_probs=169.3

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcC-CCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRL-SHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~l~~~~  164 (376)
                      ..++|++.++||+|+||+||+|++...    .+......||+|.+..... .....+.+|+.+|.++ +|||||++++++
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~  110 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGI----SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC  110 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESC----SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCC----CcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence            456799999999999999999987542    2223356799999876532 3346788999999998 799999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCC-------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEec
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPS-------------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYR  225 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHr  225 (376)
                      .+++.+|+|||||++|+|.++|+.....                   ...+++..++.++.||+.||.|||  .++||||
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH--~~~IiHR  188 (325)
T d1rjba_         111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHR  188 (325)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH--HTTEEET
T ss_pred             eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeec
Confidence            9999999999999999999999765321                   235889999999999999999999  5999999


Q ss_pred             CCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccc
Q 017177          226 DFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLK  305 (376)
Q Consensus       226 DlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~  305 (376)
                      ||||+|||++.++.+||+|||+|+........... ++.    .||+.||               |||++.+.. ++.++
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~-~~~----~gt~~y~---------------aPE~l~~~~-~~~~~  247 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVR-GNA----RLPVKWM---------------APESLFEGI-YTIKS  247 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEE-TTE----EECGGGC---------------CHHHHHHCC-CCHHH
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeee-ccc----cCCCccC---------------ChHHHcCCC-CCcce
Confidence            99999999999999999999999877654433222 222    7899999               999887665 58899


Q ss_pred             cccceeeeehhhccc
Q 017177          306 YSNSFAFVFSCVFSF  320 (376)
Q Consensus       306 dv~s~g~v~~~~~~~  320 (376)
                      ||||+|++++|++++
T Consensus       248 DiwS~Gvil~emlt~  262 (325)
T d1rjba_         248 DVWSYGILLWEIFSL  262 (325)
T ss_dssp             HHHHHHHHHHHHTTT
T ss_pred             eccchhHHHHHHHhC
Confidence            999999999999864

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-43  Score=320.47  Aligned_cols=192  Identities=23%  Similarity=0.326  Sum_probs=159.6

Q ss_pred             ceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEEeCCeEEE
Q 017177           95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLL  172 (376)
Q Consensus        95 ~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l  172 (376)
                      +.||+|+||+||+|.++.       ..+++.||||+++....  ...+.+.+|+.+|++++|||||++++++.+ +..+|
T Consensus        13 k~iG~G~fG~Vy~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l   84 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQM-------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML   84 (277)
T ss_dssp             EEEEECSSEEEEEEEEEC-------SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred             CCcccCCCeEEEEEEEcc-------CCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence            479999999999997643       22478899999976432  345689999999999999999999999865 45789


Q ss_pred             EEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeeec
Q 017177          173 VYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYFK  252 (376)
Q Consensus       173 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~  252 (376)
                      |||||++|+|.+++.+.    ..+++..++.++.||+.||.|||  +++||||||||+|||++.+|.+|++|||+++...
T Consensus        85 vmE~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH--~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~  158 (277)
T d1xbba_          85 VMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  158 (277)
T ss_dssp             EEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEcCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHH--hCCcccCCCcchhhcccccCcccccchhhhhhcc
Confidence            99999999999999875    45899999999999999999999  5999999999999999999999999999999876


Q ss_pred             cceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          253 RHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       253 ~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ............    .||+.||               |||++.+.. ++.++||||||++++|+++.
T Consensus       159 ~~~~~~~~~~~~----~gt~~y~---------------APE~l~~~~-~~~~sDiwS~Gv~l~ellt~  206 (277)
T d1xbba_         159 ADENYYKAQTHG----KWPVKWY---------------APECINYYK-FSSKSDVWSFGVLMWEAFSY  206 (277)
T ss_dssp             TTCSEEEC--------CCCGGGC---------------CHHHHHHCE-EEHHHHHHHHHHHHHHHHTT
T ss_pred             cccccccccccc----CCCceec---------------CchhhcCCC-CCchhhhccchhhhhHHhhC
Confidence            554432222222    7889999               899887655 58899999999999998864

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4e-43  Score=319.24  Aligned_cols=202  Identities=18%  Similarity=0.194  Sum_probs=164.3

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      .++|++.+.||+|+||.||+|.+         +.+++.||||+++....   ...+.+.+|+.+++.++||||+++++++
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~   76 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARD---------LRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG   76 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCccccee
Confidence            46799999999999999999954         44689999999976532   3356789999999999999999999998


Q ss_pred             EeCC----eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcE
Q 017177          165 WEDK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFL  240 (376)
Q Consensus       165 ~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~  240 (376)
                      ...+    .+|||||||+||+|.+++...    ..+++..++.++.||+.||.|||  +++|+||||||+|||++.++..
T Consensus        77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH--~~~iiHrDiKP~NIll~~~~~~  150 (277)
T d1o6ya_          77 EAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAV  150 (277)
T ss_dssp             EEECSSSEEEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTSCE
T ss_pred             eeccCCCceEEEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHH--hCCccCccccCcccccCccccc
Confidence            7654    389999999999999998776    45899999999999999999999  5999999999999999999999


Q ss_pred             EEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          241 FDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       241 kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      +++|||.+..............+.    +||+.||               |||++.+.. ++.++||||+|++++++++.
T Consensus       151 ~l~d~~~~~~~~~~~~~~~~~~~~----~Gt~~Y~---------------aPE~~~~~~-~~~~~DiwSlGvilyelltG  210 (277)
T d1o6ya_         151 KVMDFGIARAIADSGNSVTQTAAV----IGTAQYL---------------SPEQARGDS-VDARSDVYSLGCVLYEVLTG  210 (277)
T ss_dssp             EECCCTTCEECC--------------------TTC---------------CHHHHTTCC-CCHHHHHHHHHHHHHHHHHS
T ss_pred             eeehhhhhhhhccccccccccccc----cCccccc---------------CHHHHcCCC-CCcceecccchHHHHHHHhC
Confidence            999999998765544332222222    8999999               999988765 47889999999999999977


Q ss_pred             cccc
Q 017177          321 YRTT  324 (376)
Q Consensus       321 y~~~  324 (376)
                      ..+.
T Consensus       211 ~~Pf  214 (277)
T d1o6ya_         211 EPPF  214 (277)
T ss_dssp             SCSC
T ss_pred             CCCC
Confidence            6554

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=324.86  Aligned_cols=199  Identities=19%  Similarity=0.204  Sum_probs=171.1

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh------hhHHHHHHHHHHHhcCCCCCcceE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM------QGFEEWQSEVNFLGRLSHPNLVKL  160 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~h~nIv~l  160 (376)
                      ..++|++++.||+|+||+||+|+.         +.+++.||||++++...      ...+.+.+|+.+|++++|||||++
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~---------~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~   78 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCRE---------KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL   78 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEE---------CCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcE
Confidence            346799999999999999999954         34689999999864321      235788999999999999999999


Q ss_pred             EeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC--
Q 017177          161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG--  238 (376)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g--  238 (376)
                      ++++.+++.+|||||||++|+|.+++.+.    ..+++..++.++.|++.||+|||  +++|+||||||+|||++.+|  
T Consensus        79 ~~~~~~~~~~~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH--~~~ivHrDiKp~Nill~~~~~~  152 (293)
T d1jksa_          79 HEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVP  152 (293)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCSSSS
T ss_pred             EEEEEECCEEEEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhh--hcceeecccccceEEEecCCCc
Confidence            99999999999999999999999999876    45999999999999999999999  59999999999999998776  


Q ss_pred             --cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehh
Q 017177          239 --FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSC  316 (376)
Q Consensus       239 --~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~  316 (376)
                        .+|++|||++..........    +.    .||+.||               |||++.+.. ++.++||||+|+++++
T Consensus       153 ~~~vkl~DfG~a~~~~~~~~~~----~~----~~t~~y~---------------APE~~~~~~-~~~~~DiwSlGvilye  208 (293)
T d1jksa_         153 KPRIKIIDFGLAHKIDFGNEFK----NI----FGTPEFV---------------APEIVNYEP-LGLEADMWSIGVITYI  208 (293)
T ss_dssp             SCCEEECCCTTCEECTTSCBCS----CC----CCCGGGC---------------CHHHHTTCC-BCTHHHHHHHHHHHHH
T ss_pred             ccceEecchhhhhhcCCCcccc----cc----CCCCccc---------------CHHHHcCCC-CCCcccchhhhHHHHH
Confidence              49999999999876543331    11    7788888               899888754 5899999999999999


Q ss_pred             hccccccc
Q 017177          317 VFSFYRTT  324 (376)
Q Consensus       317 ~~~~y~~~  324 (376)
                      +++...+.
T Consensus       209 ll~g~~Pf  216 (293)
T d1jksa_         209 LLSGASPF  216 (293)
T ss_dssp             HHHSSCSS
T ss_pred             HHcCCCCC
Confidence            99765554

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-43  Score=324.85  Aligned_cols=199  Identities=15%  Similarity=0.096  Sum_probs=170.8

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..++|++++.||+|+||+||+|.+         +.+++.||||+++..... ...+.+|+.+|+.++||||++++++|.+
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~---------~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~   72 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVE---------TSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFES   72 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEE---------CCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            457899999999999999999954         446899999999876543 3567899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC--CcEEEcc
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV--GFLFDSH  244 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~--g~~kl~D  244 (376)
                      ++.+|||||||+||+|.+++.+..   ..+++.++..++.||+.||+|||  +++|+||||||+|||++.+  +.+||+|
T Consensus        73 ~~~~~lvmE~~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH--~~~iiHrDlKp~NIll~~~~~~~ikl~D  147 (321)
T d1tkia_          73 MEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIE  147 (321)
T ss_dssp             TTEEEEEECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECC
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HcCCCcccccccceeecCCCceEEEEcc
Confidence            999999999999999999997652   46899999999999999999999  5999999999999999854  5899999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ||+++..........        ..|||.|+               +||++.+.. ++.++||||+|++++++++...+.
T Consensus       148 FG~~~~~~~~~~~~~--------~~~t~~y~---------------ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf  203 (321)
T d1tkia_         148 FGQARQLKPGDNFRL--------LFTAPEYY---------------APEVHQHDV-VSTATDMWSLGTLVYVLLSGINPF  203 (321)
T ss_dssp             CTTCEECCTTCEEEE--------EESCGGGS---------------CHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cchhhccccCCcccc--------cccccccc---------------cchhccCCC-CCchhhcccHHHHHHHHHhCCCCC
Confidence            999998765443321        27788888               899777665 578999999999999999765543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=323.01  Aligned_cols=200  Identities=23%  Similarity=0.310  Sum_probs=166.5

Q ss_pred             cCCCCccce-EeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           88 TKNFKPDSL-LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~-lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      .++|.+.+. ||+|+||.||+|.++..       ..+..||||+++... ....+++.+|+.+|++++|||||++++++.
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~-------~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~   79 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ   79 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecC-------CCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec
Confidence            346777774 99999999999976531       236689999998653 345678999999999999999999999986


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                      + +.+|||||||++|+|.+++...+   ..+++..+..++.||+.||+|||  .++|+||||||+|||++.++.+||+||
T Consensus        80 ~-~~~~lvmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH--~~~iiHrDlKp~Nill~~~~~~Kl~DF  153 (285)
T d1u59a_          80 A-EALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDF  153 (285)
T ss_dssp             S-SSEEEEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEEETTEEEECCC
T ss_pred             c-CeEEEEEEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCcCchhheeeccCCceeeccc
Confidence            5 56899999999999999986542   56899999999999999999999  499999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      |+++.............+.    .||+.||               |||++.+.. ++.++||||||++++|++++
T Consensus       154 Gla~~~~~~~~~~~~~~~~----~gt~~y~---------------aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~  208 (285)
T d1u59a_         154 GLSKALGADDSYYTARSAG----KWPLKWY---------------APECINFRK-FSSRSDVWSYGVTMWEALSY  208 (285)
T ss_dssp             TTCEECTTCSCEECCCCSS----CCCGGGC---------------CHHHHHHCE-ECHHHHHHHHHHHHHHHHTT
T ss_pred             hhhhccccccccccccccc----ccCcccc---------------ChHHHhCCC-CCccchhhcchHHHHHHHhC
Confidence            9999886654432222222    6888898               899887664 58899999999999998764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.9e-43  Score=332.88  Aligned_cols=198  Identities=23%  Similarity=0.240  Sum_probs=167.7

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---hhHHHH---HHHHHHHhcCCCCCcceEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEW---QSEVNFLGRLSHPNLVKLL  161 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~---~~E~~il~~l~h~nIv~l~  161 (376)
                      .++|++.++||+|+||.||+|+.         +.+++.||||++.+...   .....+   .+|+.+++.++|||||+++
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~---------~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~   73 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRK---------ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS   73 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEE---------CCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEE
Confidence            46899999999999999999954         44689999999864322   111223   3457778888999999999


Q ss_pred             eEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEE
Q 017177          162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLF  241 (376)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~k  241 (376)
                      +++.+++.+|+|||||+||+|.+++.+.    ..+++..+..++.||+.||.|||  .++||||||||+|||++.+|.+|
T Consensus        74 ~~~~~~~~~~ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH--~~~iiHrDlKP~NILl~~~g~iK  147 (364)
T d1omwa3          74 YAFHTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVR  147 (364)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECSSSCEE
T ss_pred             EEEEECCEEEEEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHH--HCCccceeeccceeEEcCCCcEE
Confidence            9999999999999999999999999876    45899999999999999999999  59999999999999999999999


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      |+|||+|+.+......    .     ..||+.||               |||++.....++.++||||+|++++++++..
T Consensus       148 l~DFGla~~~~~~~~~----~-----~~GT~~y~---------------APE~~~~~~~~~~~~DiwSlGvilyemltG~  203 (364)
T d1omwa3         148 ISDLGLACDFSKKKPH----A-----SVGTHGYM---------------APEVLQKGVAYDSSADWFSLGCMLFKLLRGH  203 (364)
T ss_dssp             ECCCTTCEECSSSCCC----S-----CCSCGGGC---------------CHHHHSTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             EeeeceeeecCCCccc----c-----cccccccc---------------hhHHhhcCCCCCcccchhHHHHHHHHHHhCC
Confidence            9999999977654221    1     17899999               8999876666789999999999999999665


Q ss_pred             ccc
Q 017177          322 RTT  324 (376)
Q Consensus       322 ~~~  324 (376)
                      .+.
T Consensus       204 ~Pf  206 (364)
T d1omwa3         204 SPF  206 (364)
T ss_dssp             CSS
T ss_pred             CCC
Confidence            543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.5e-43  Score=319.04  Aligned_cols=201  Identities=20%  Similarity=0.166  Sum_probs=171.5

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh---------hhHHHHHHHHHHHhcCC-CCCc
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---------QGFEEWQSEVNFLGRLS-HPNL  157 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~il~~l~-h~nI  157 (376)
                      .++|++.+.||+|+||+||+|+.         +.+++.||||+++....         ...+.+.+|+.++++++ ||||
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~---------~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI   72 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIH---------KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI   72 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred             cccCEEceEEecCcCeEEEEEEE---------CCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCe
Confidence            46899999999999999999954         34689999999876432         12346889999999997 9999


Q ss_pred             ceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC
Q 017177          158 VKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV  237 (376)
Q Consensus       158 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~  237 (376)
                      +++++++.+++.+|||||||++|+|.+++..+    ..+++..++.++.||+.||+|||  +++|+||||||+|||++.+
T Consensus        73 v~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nill~~~  146 (277)
T d1phka_          73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDD  146 (277)
T ss_dssp             CCEEEEEECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTT
T ss_pred             EEEEeecccCcceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HcCCcccccccceEEEcCC
Confidence            99999999999999999999999999999876    45999999999999999999999  5999999999999999999


Q ss_pred             CcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhh-----hhccccccccceee
Q 017177          238 GFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWI-----KYLTLLKYSNSFAF  312 (376)
Q Consensus       238 g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~-----~~~~~~~dv~s~g~  312 (376)
                      +.+||+|||+++..........    .    .||+.|+               +||++.+.     ..++.++||||+|+
T Consensus       147 ~~~kl~DFG~a~~~~~~~~~~~----~----~gt~~y~---------------~PE~~~~~~~~~~~~~~~~~DiwslGv  203 (277)
T d1phka_         147 MNIKLTDFGFSCQLDPGEKLRE----V----CGTPSYL---------------APEIIECSMNDNHPGYGKEVDMWSTGV  203 (277)
T ss_dssp             CCEEECCCTTCEECCTTCCBCC----C----CSCGGGC---------------CHHHHHHHHCTTSCCBCTHHHHHHHHH
T ss_pred             CCeEEccchheeEccCCCceee----e----eccCCCC---------------CHHHhhccccccCCCCCchheEcccch
Confidence            9999999999998765433311    1    7888888               78877754     33578899999999


Q ss_pred             eehhhccccccchh
Q 017177          313 VFSCVFSFYRTTML  326 (376)
Q Consensus       313 v~~~~~~~y~~~~~  326 (376)
                      |++++++...+...
T Consensus       204 ilyeml~g~~Pf~~  217 (277)
T d1phka_         204 IMYTLLAGSPPFWH  217 (277)
T ss_dssp             HHHHHHHSSCSSCC
T ss_pred             hhhhhccCCCCCCC
Confidence            99999976655533

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-43  Score=326.52  Aligned_cols=198  Identities=24%  Similarity=0.268  Sum_probs=169.0

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHh-cCCCCCcceEEeEE
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLG-RLSHPNLVKLLGYC  164 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~-~l~h~nIv~l~~~~  164 (376)
                      ++|++++.||+|+||+||+|..         +.+++.||||++++..   ....+.+.+|..++. .++||||+++++++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~---------~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~   72 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEF---------KKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF   72 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEE---------TTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEE---------CCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence            5799999999999999999954         4469999999997532   233456677777765 68999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .+++.+|||||||++|+|.+++...    ..+++..+..++.||+.||+|||  .++|+||||||+|||++.+|.+||+|
T Consensus        73 ~~~~~~yivmEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH--~~~iiHrDikp~NiL~~~~~~~kl~D  146 (320)
T d1xjda_          73 QTKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIAD  146 (320)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred             ccCCceeEEEeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCcccceeecCCCceeccc
Confidence            9999999999999999999999876    45899999999999999999999  58999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      ||+++.........   ...    .||+.||               |||++.+..+ +.++||||+|++++++++...+.
T Consensus       147 FG~a~~~~~~~~~~---~~~----~gt~~y~---------------aPE~~~~~~~-~~~~DiwSlGvilyemltG~~PF  203 (320)
T d1xjda_         147 FGMCKENMLGDAKT---NTF----CGTPDYI---------------APEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPF  203 (320)
T ss_dssp             CTTCBCCCCTTCCB---CCC----CSCGGGC---------------CHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cchhhhcccccccc---ccc----CCCCCcC---------------CHHHHcCCCC-CchhhhhhhhHHHHHHHhCCCCC
Confidence            99998765433321   111    7889999               8999988765 78999999999999999765554

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-43  Score=315.09  Aligned_cols=195  Identities=24%  Similarity=0.329  Sum_probs=169.3

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|++++.||+|+||+||+|++++          ++.||||+++.... ..+.+.+|+.++++++||||+++++++.++
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~----------~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~   71 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ   71 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETT----------TEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCS
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECC----------CCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeC
Confidence            4689999999999999999997653          77899999987544 346789999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +.+++||||+++|+|.+++....   ..+++..+..++.|+++||.|||  +++|+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~iv~Ey~~~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH--~~~iiH~dlk~~Nill~~~~~~kl~DfG~  146 (258)
T d1k2pa_          72 RPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGL  146 (258)
T ss_dssp             SSEEEEEECCTTEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHH--HTTBCCSCCSGGGEEECTTCCEEECCCSS
T ss_pred             CceEEEEEccCCCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHh--hcCcccccccceeEEEcCCCcEEECcchh
Confidence            99999999999999999976653   45889999999999999999999  59999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ++........... +.     .||+.||               |||++.+.. ++.++||||||++++|++++
T Consensus       147 a~~~~~~~~~~~~-~~-----~~t~~y~---------------aPE~~~~~~-~~~ksDiwS~G~~l~el~t~  197 (258)
T d1k2pa_         147 SRYVLDDEYTSSV-GS-----KFPVRWS---------------PPEVLMYSK-FSSKSDIWAFGVLMWEIYSL  197 (258)
T ss_dssp             CCBCSSSSCCCCC-CS-----CCCGGGC---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHTT
T ss_pred             heeccCCCceeec-cc-----CCCCCcC---------------CcHHhcCCC-CCcceeecccchhhHhHHhc
Confidence            9877654333211 11     7888888               899888766 47899999999999999864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-43  Score=319.91  Aligned_cols=195  Identities=22%  Similarity=0.308  Sum_probs=160.1

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .++|++.+.||+|+||+||+|++++          +..||||+++.... ..+.|.+|+.++++++|||||++++++. +
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~----------~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~   83 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-E   83 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECC----------CCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEe-c
Confidence            4679999999999999999997654          45799999976543 3477999999999999999999999985 5


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +.+|+|||||++|+|..++.....  ..+++..++.++.||+.||+|||  .++|+||||||+||||+.++.+||+|||+
T Consensus        84 ~~~~lv~Ey~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH--~~~ivH~DlKp~NIll~~~~~~kl~DfGl  159 (285)
T d1fmka3          84 EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGL  159 (285)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred             CCeEEEEEecCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHh--hhheecccccceEEEECCCCcEEEcccch
Confidence            668999999999999998876432  45899999999999999999999  59999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ++...........  ..    .||+.|+               |||.+.... ++.++||||||++++|+++.
T Consensus       160 a~~~~~~~~~~~~--~~----~gt~~y~---------------aPE~~~~~~-~~~ksDI~S~Giil~el~t~  210 (285)
T d1fmka3         160 ARLIEDNEYTARQ--GA----KFPIKWT---------------APEAALYGR-FTIKSDVWSFGILLTELTTK  210 (285)
T ss_dssp             TC--------------------CCGGGS---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHTT
T ss_pred             hhhccCCCceeec--cc----ccccccc---------------ChHHHhCCC-CCcHHhhhcchHHHHHHHhC
Confidence            9876544332111  11    7889999               899887655 58899999999999999864

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.9e-43  Score=320.66  Aligned_cols=211  Identities=26%  Similarity=0.351  Sum_probs=174.0

Q ss_pred             hhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEE
Q 017177           83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLL  161 (376)
Q Consensus        83 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~  161 (376)
                      ++....++|++.+.||+|+||+||+|++.+.    .+..++..||||+++.... ...+++.+|+.+|+.++||||++++
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~   82 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLL   82 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETS----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCC----ccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccce
Confidence            3444567899999999999999999987542    2333578899999987543 3456799999999999999999999


Q ss_pred             eEEEeCCeEEEEEeccCCCCHHHHHhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 017177          162 GYCWEDKELLLVYEYMQRGSLENHLFRRNP--------------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKK  221 (376)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~  221 (376)
                      +++.+.+..+++|||+++|+|.+++.....                    ....+++..++.++.|++.||+|||  .++
T Consensus        83 ~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH--~~~  160 (301)
T d1lufa_          83 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERK  160 (301)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH--HTT
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc--cCC
Confidence            999999999999999999999999975421                    1234889999999999999999999  599


Q ss_pred             cEecCCCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhc
Q 017177          222 VIYRDFKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYL  301 (376)
Q Consensus       222 iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~  301 (376)
                      ||||||||+|||++.++.+||+|||+++......... ..++.    .||+.||               |||++.+.. +
T Consensus       161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~-~~~~~----~~~~~y~---------------aPE~~~~~~-~  219 (301)
T d1lufa_         161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK-ADGND----AIPIRWM---------------PPESIFYNR-Y  219 (301)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC-----C----CBCGGGC---------------CHHHHHHCC-C
T ss_pred             eEeeEEcccceEECCCCcEEEccchhheeccCCcccc-ccCCC----CcCcCcC---------------CHHHHccCC-C
Confidence            9999999999999999999999999998765543332 12222    7888888               899888765 5


Q ss_pred             cccccccceeeeehhhccc
Q 017177          302 TLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       302 ~~~~dv~s~g~v~~~~~~~  320 (376)
                      +.++||||||+|++|+++.
T Consensus       220 t~ksDVwS~Gvvl~ell~~  238 (301)
T d1lufa_         220 TTESDVWAYGVVLWEIFSY  238 (301)
T ss_dssp             CHHHHHHHHHHHHHHHHTT
T ss_pred             ChhhhhccchhhHHHHHcc
Confidence            7899999999999998754

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-43  Score=316.23  Aligned_cols=199  Identities=20%  Similarity=0.266  Sum_probs=156.2

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      ..++|++.+.||+|+||.||+|.+..      ....+..||||.++.... ...+.+.+|+.+|++++||||+++++++.
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~------~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~   78 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMS------PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT   78 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECC------C--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEec------CCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            34679999999999999999997653      122356799999976543 44577899999999999999999999985


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcce
Q 017177          166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHL  245 (376)
Q Consensus       166 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Df  245 (376)
                       ++.+|+|||||++|+|.+++....   ..+++..++.++.||+.||.|||  +++|+||||||+|||++.++.+||+||
T Consensus        79 -~~~~~iv~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH--~~~iiHrDlKp~NIll~~~~~~Kl~Df  152 (273)
T d1mp8a_          79 -ENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDF  152 (273)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECC-
T ss_pred             -cCeEEEEEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhc--ccCeeccccchhheeecCCCcEEEccc
Confidence             567999999999999999886653   56899999999999999999999  599999999999999999999999999


Q ss_pred             eeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          246 LIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       246 g~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      |+++............      ..||+.||               |||++.+.. ++.++||||+|++++|+++
T Consensus       153 G~a~~~~~~~~~~~~~------~~gt~~y~---------------apE~l~~~~-~~~~~DiwSlGvil~e~lt  204 (273)
T d1mp8a_         153 GLSRYMEDSTYYKASK------GKLPIKWM---------------APESINFRR-FTSASDVWMFGVCMWEILM  204 (273)
T ss_dssp             ------------------------CCGGGC---------------CHHHHHHCC-CSHHHHHHHHHHHHHHHHT
T ss_pred             hhheeccCCcceeccc------eecCcccc---------------hhhHhccCC-CCCccccccchHHHHHHHh
Confidence            9999875543321111      27888898               899887665 5789999999999999875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-43  Score=321.00  Aligned_cols=192  Identities=22%  Similarity=0.244  Sum_probs=159.7

Q ss_pred             ccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhh-----HHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           93 PDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-----FEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        93 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .+++||+|+||+||+|+         ++.+++.||||+++......     .+.+.+|+.+|+.++|||||++++++.++
T Consensus         2 ~l~~lG~G~fg~Vy~~~---------~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~   72 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKAR---------DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK   72 (299)
T ss_dssp             EEEEEEEETTEEEEEEE---------CSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             cceEeccCcCeEEEEEE---------ECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC
Confidence            45789999999999994         44468999999997653321     24688999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                      +.+|||||||.++++..+....    ..+++..+..++.||+.||+|||  .++|+||||||+|||++.+|.+||+|||+
T Consensus        73 ~~~~ivmE~~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH--~~~iiHrDiKp~NIli~~~~~~KL~DFG~  146 (299)
T d1ua2a_          73 SNISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGL  146 (299)
T ss_dssp             TCCEEEEECCSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred             CceeehhhhhcchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhh--ccceecccCCcceEEecCCCccccccCcc
Confidence            9999999999887766555433    55889999999999999999999  59999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFY  321 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y  321 (376)
                      ++..........  ..     +||+.||               |||++.+...++.++||||+|++++|+++-.
T Consensus       147 a~~~~~~~~~~~--~~-----~gt~~y~---------------aPE~~~~~~~~~~~~DiwSlGvil~el~~g~  198 (299)
T d1ua2a_         147 AKSFGSPNRAYT--HQ-----VVTRWYR---------------APELLFGARMYGVGVDMWAVGCILAELLLRV  198 (299)
T ss_dssp             GSTTTSCCCCCC--CS-----CCCCTTC---------------CHHHHTTCSCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccccCCCccccc--ce-----ecChhhc---------------cHHHHccCCCCChhhhhhhcchHHHHHHhCc
Confidence            987655433211  11     7889999               8999888777899999999999999999643

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-42  Score=317.86  Aligned_cols=200  Identities=20%  Similarity=0.280  Sum_probs=162.7

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED  167 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~  167 (376)
                      .+|+++++||+|+||+||+|.+...     .......||+|.++... ....+.+.+|+.++++++|||||++++++.++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC---------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCC-----CCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            4699999999999999999976541     11224579999987543 34567899999999999999999999999764


Q ss_pred             CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceee
Q 017177          168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLI  247 (376)
Q Consensus       168 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~  247 (376)
                       ..+++||++.+|+|.+++....   ..+++..++.++.||+.||.|||  .++||||||||+|||++.++.+||+|||+
T Consensus        84 -~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH--~~~iiHrDlKp~NIll~~~~~~kl~DFGl  157 (317)
T d1xkka_          84 -TVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGL  157 (317)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEEECCCSH
T ss_pred             -CeeEEEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHH--HcCcccCcchhhcceeCCCCCeEeecccc
Confidence             5778899999999999887653   56899999999999999999999  58999999999999999999999999999


Q ss_pred             eeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          248 YVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       248 a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ++............+.     .||+.||               |||++.+.. ++.++||||||++++|++++
T Consensus       158 a~~~~~~~~~~~~~~~-----~gt~~y~---------------APE~l~~~~-~~~~sDvwS~Gvil~el~t~  209 (317)
T d1xkka_         158 AKLLGAEEKEYHAEGG-----KVPIKWM---------------ALESILHRI-YTHQSDVWSYGVTVWELMTF  209 (317)
T ss_dssp             HHHTTTTCC-------------CCTTTS---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHTT
T ss_pred             ceeccccccccccccc-----ccCcccc---------------ChHHHhcCC-CChhhhhhhHHHHHHHHHHC
Confidence            9987654443222222     6889999               899888765 58999999999999999864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-42  Score=317.71  Aligned_cols=200  Identities=25%  Similarity=0.343  Sum_probs=167.0

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ++|++++.||+|+||+||+|.+         ..+++.||||+++....  ...+.+.+|+.+|++++||||+++++++.+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~   72 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARN---------KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT   72 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEE---------TTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEE---------CCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence            5799999999999999999954         34689999999976533  234678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++.+|+||||+.+ ++.+++....  ...+++..+..++.||+.||+|||  +++||||||||+|||++.++.+|++|||
T Consensus        73 ~~~~~iv~e~~~~-~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH--~~~IiHrDiKpeNIl~~~~~~~kl~DFG  147 (298)
T d1gz8a_          73 ENKLYLVFEFLHQ-DLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFG  147 (298)
T ss_dssp             TTEEEEEEECCSE-EHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred             ccceeEEEeecCC-chhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhh--cCCEEccccCchheeecccCcceeccCC
Confidence            9999999999976 5555554432  256899999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRTT  324 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~~  324 (376)
                      +++.........  ..     ..||+.|+               +||++....+.+.++|+||+|++++++++-..+.
T Consensus       148 ~a~~~~~~~~~~--~~-----~~gt~~y~---------------apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf  203 (298)
T d1gz8a_         148 LARAFGVPVRTY--TH-----EVVTLWYR---------------APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF  203 (298)
T ss_dssp             HHHHHCCCSBCT--TC-----CBCCCTTC---------------CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cceeccCCcccc--ee-----ecccceee---------------ehhhhccccCCCccccccccchhhhHHhhCCCCC
Confidence            998765433221  11     17888888               8999988888899999999999999999765553

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-42  Score=310.13  Aligned_cols=201  Identities=23%  Similarity=0.333  Sum_probs=158.6

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      .++|++.+.||+|+||.||+|++...      ......||||+++...   ....+++.+|+.+|++++||||+++++++
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~------~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~   80 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAP------SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV   80 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECT------TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECC------CCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            35699999999999999999976532      2235579999987652   23457889999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcc
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSH  244 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~D  244 (376)
                      .+ +..++|||||++|++.+++..+.   ..+++..++.++.||+.||.|||  .++|+||||||+|||++.++.+|++|
T Consensus        81 ~~-~~~~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH--~~~iiHrDikp~NIll~~~~~vkl~D  154 (273)
T d1u46a_          81 LT-PPMKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGD  154 (273)
T ss_dssp             CS-SSCEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTEEEECC
T ss_pred             ee-cchheeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhh--hCCEeeeeecHHHhccccccceeecc
Confidence            65 56889999999999999887653   45899999999999999999999  59999999999999999999999999


Q ss_pred             eeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          245 LLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       245 fg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ||+++...............    .||+.||               |||++.+. .++.++||||||++++|++++
T Consensus       155 fGl~~~~~~~~~~~~~~~~~----~~~~~~~---------------aPE~~~~~-~~~~~~Di~S~Gvil~emlt~  210 (273)
T d1u46a_         155 FGLMRALPQNDDHYVMQEHR----KVPFAWC---------------APESLKTR-TFSHASDTWMFGVTLWEMFTY  210 (273)
T ss_dssp             CTTCEECCC-CCEEEC---------CCGGGC---------------CHHHHHHC-EEEHHHHHHHHHHHHHHHHTT
T ss_pred             chhhhhcccCCCcceecCcc----ccCcccC---------------CHHHHhCC-CCCcchhhhhhHHHHHHHHhC
Confidence            99999876654433222222    6677788               89988764 568999999999999999875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-41  Score=313.03  Aligned_cols=209  Identities=24%  Similarity=0.266  Sum_probs=161.3

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCC-CCCcceEEeE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLS-HPNLVKLLGY  163 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~nIv~l~~~  163 (376)
                      ...++|++.+.||+|+||.||+|.+...    .+..+++.||||+++... ....+.+.+|..++.++. |+||+.++++
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEEST----TSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCC----CcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            3457899999999999999999987542    344467899999998653 344567788888888874 8999999998


Q ss_pred             EEeC-CeEEEEEeccCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCC
Q 017177          164 CWED-KELLLVYEYMQRGSLENHLFRRNP------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKAS  230 (376)
Q Consensus       164 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~  230 (376)
                      +..+ +.+++|||||++|+|.+++.....            ....+++..++.++.||+.||.|||  .++||||||||+
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH--~~~ivHrDlKp~  163 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAAR  163 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGG
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH--hCCCcCCcCCcc
Confidence            8765 468999999999999999975421            1245899999999999999999999  599999999999


Q ss_pred             CEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccce
Q 017177          231 NILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSF  310 (376)
Q Consensus       231 NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~  310 (376)
                      ||||+.++.+||+|||+|+........... ++.    .||+.||               |||++.+.. ++.++||||+
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~-~~~----~gt~~y~---------------APE~l~~~~-~~~~sDiwS~  222 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRK-GDA----RLPLKWM---------------APETIFDRV-YTIQSDVWSF  222 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCT-TSC----CCGGGGC---------------CHHHHHHCC-CCHHHHHHHH
T ss_pred             ceeECCCCcEEEccCcchhhcccccccccc-Cce----eeCcccc---------------chhHhhcCC-CCcccceeeh
Confidence            999999999999999999876543322111 222    7889999               899888755 5899999999


Q ss_pred             eeeehhhcccc
Q 017177          311 AFVFSCVFSFY  321 (376)
Q Consensus       311 g~v~~~~~~~y  321 (376)
                      |++++|+++..
T Consensus       223 Gvil~ellt~~  233 (299)
T d1ywna1         223 GVLLWEIFSLG  233 (299)
T ss_dssp             HHHHHHHHTTS
T ss_pred             HHHHHHHHhCC
Confidence            99999998643

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-42  Score=309.87  Aligned_cols=198  Identities=21%  Similarity=0.229  Sum_probs=167.6

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh------hhHHHHHHHHHHHhcCC--CCCcce
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM------QGFEEWQSEVNFLGRLS--HPNLVK  159 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~--h~nIv~  159 (376)
                      .++|++.+.||+|+||.||+|+.         +.+++.||||+++....      ....++.+|+.+|++++  ||||++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~   73 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIR---------VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR   73 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccE
Confidence            35799999999999999999954         44689999999865321      11234668999999997  899999


Q ss_pred             EEeEEEeCCeEEEEEeccCC-CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC-C
Q 017177          160 LLGYCWEDKELLLVYEYMQR-GSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-V  237 (376)
Q Consensus       160 l~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~-~  237 (376)
                      +++++.+++..|+||||+.+ +++.+++.+.    ..+++..+..++.||+.||+|||  +++|+||||||+|||++. +
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH--~~~iiHrDiKp~NIll~~~~  147 (273)
T d1xwsa_          74 LLDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNR  147 (273)
T ss_dssp             EEEEEECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTT
T ss_pred             EEEEEeeCCeEEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH--HCCCccccCcccceEEecCC
Confidence            99999999999999999976 6888888766    45899999999999999999999  599999999999999985 4


Q ss_pred             CcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhh
Q 017177          238 GFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCV  317 (376)
Q Consensus       238 g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~  317 (376)
                      +.+||+|||+++........     +.    .||+.||               |||++.+..+.+.++||||+|++++++
T Consensus       148 ~~vkl~DFG~a~~~~~~~~~-----~~----~GT~~y~---------------aPE~~~~~~~~~~~~DiwSlGvilyel  203 (273)
T d1xwsa_         148 GELKLIDFGSGALLKDTVYT-----DF----DGTRVYS---------------PPEWIRYHRYHGRSAAVWSLGILLYDM  203 (273)
T ss_dssp             TEEEECCCTTCEECCSSCBC-----CC----CSCGGGS---------------CHHHHHHSCBCHHHHHHHHHHHHHHHH
T ss_pred             CeEEECccccceeccccccc-----cc----ccCCCcC---------------CHHHHcCCCCCCcccccccceeeehhH
Confidence            79999999999876543221     22    7889999               899999888888999999999999999


Q ss_pred             ccccccc
Q 017177          318 FSFYRTT  324 (376)
Q Consensus       318 ~~~y~~~  324 (376)
                      ++...+.
T Consensus       204 l~g~~Pf  210 (273)
T d1xwsa_         204 VCGDIPF  210 (273)
T ss_dssp             HHSSCSC
T ss_pred             hhCCCCC
Confidence            9765554

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-42  Score=318.13  Aligned_cols=196  Identities=20%  Similarity=0.207  Sum_probs=162.6

Q ss_pred             hcCCCCccc-eEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcC-CCCCcceEEeEE
Q 017177           87 ATKNFKPDS-LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~  164 (376)
                      ..++|++.. +||+|+||.||+|++         +.+++.||||+++..     ..+.+|+.++.++ +||||++++++|
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~---------~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~   74 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFN---------KRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY   74 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEE---------CCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence            346788764 699999999999954         346899999998643     4567899987655 799999999998


Q ss_pred             Ee----CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC---C
Q 017177          165 WE----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG---V  237 (376)
Q Consensus       165 ~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~---~  237 (376)
                      .+    +..+|||||||+||+|.+++.++.  ...+++..+..++.||+.||.|||  .++|+||||||+|||++.   +
T Consensus        75 ~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH--~~~iiHRDiKp~NIll~~~~~~  150 (335)
T d2ozaa1          75 ENLYAGRKCLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPN  150 (335)
T ss_dssp             EEEETTEEEEEEEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCSSTT
T ss_pred             eecccCCCEEEEEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHH--HcCCcccccccccccccccccc
Confidence            76    356999999999999999997653  256999999999999999999999  599999999999999975   5


Q ss_pred             CcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhh
Q 017177          238 GFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCV  317 (376)
Q Consensus       238 g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~  317 (376)
                      +.+||+|||+++.........    +    ..|||.||               |||++.+.. ++.++||||+|++++++
T Consensus       151 ~~~Kl~DFG~a~~~~~~~~~~----~----~~gt~~y~---------------aPE~~~~~~-y~~~~DiwSlGvily~l  206 (335)
T d2ozaa1         151 AILKLTDFGFAKETTSHNSLT----T----PCYTPYYV---------------APEVLGPEK-YDKSCDMWSLGVIMYIL  206 (335)
T ss_dssp             CCEEECCCTTCEECCCCCCCC----C----CSCCCSSC---------------CCCCCCGGG-GSHHHHHHHHHHHHHHH
T ss_pred             ccccccccceeeeccCCCccc----c----ccCCcccC---------------CcHHHcCCC-CCHHHHHHhhchhHHHH
Confidence            679999999999876543331    1    17889998               899887765 47899999999999999


Q ss_pred             ccccccc
Q 017177          318 FSFYRTT  324 (376)
Q Consensus       318 ~~~y~~~  324 (376)
                      ++...+.
T Consensus       207 ltg~~Pf  213 (335)
T d2ozaa1         207 LCGYPPF  213 (335)
T ss_dssp             TTSSCSC
T ss_pred             hhCCCCC
Confidence            9765543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-41  Score=310.36  Aligned_cols=210  Identities=23%  Similarity=0.257  Sum_probs=172.9

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ...++|++.+.||+|+||.||+|.++..    .+...+..||||+++... ......+.+|+.++++++||||+++++++
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~   92 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   92 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCc----ccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            3457899999999999999999976531    111236789999998653 34456789999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCCHHHHHhhcC------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          165 WEDKELLLVYEYMQRGSLENHLFRRN------PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       165 ~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      ..++..++|||||++|+|.+++....      .....+++..+..++.|+++||.|||  .++|+||||||+|||++.++
T Consensus        93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH--~~~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCSGGGEEECTTC
T ss_pred             ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh--hCCeeeceEcCCceeecCCc
Confidence            99999999999999999999986432      22245789999999999999999999  58999999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      ++||+|||+++............. .    .||+.||               +||.+.+.. .+.++||||||++++|++
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~-~----~~t~~y~---------------aPe~l~~~~-~~~~~Dv~S~G~il~El~  229 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGK-G----LLPVRWM---------------SPESLKDGV-FTTYSDVWSFGVVLWEIA  229 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGS-S----EECGGGC---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHH
T ss_pred             eEEEeecccceeccCCcceeeccc-e----ecccccC---------------CHHHHccCC-CCcccccccHHHHHHHHH
Confidence            999999999997765544322222 2    7889999               899887765 478899999999999998


Q ss_pred             cccc
Q 017177          319 SFYR  322 (376)
Q Consensus       319 ~~y~  322 (376)
                      +..+
T Consensus       230 t~~~  233 (308)
T d1p4oa_         230 TLAE  233 (308)
T ss_dssp             HTSC
T ss_pred             hCCC
Confidence            6543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-41  Score=305.75  Aligned_cols=190  Identities=26%  Similarity=0.313  Sum_probs=155.1

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe-
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE-  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-  166 (376)
                      .++|++.+.||+|+||.||+|.+.           +..||||+++...  ..+.+.+|++++++++||||+++++++.+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-----------~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~   72 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE   72 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-----------CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence            456889999999999999999764           6679999997654  34678999999999999999999999865 


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++.+|+||||+++|+|.+++....  ...+++..++.++.||+.||.|||  .++|+||||||+|||++.+|.+|++|||
T Consensus        73 ~~~~~lv~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH--~~~ivH~dlkp~Nil~~~~~~~kl~dfg  148 (262)
T d1byga_          73 KGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFG  148 (262)
T ss_dssp             --CCEEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred             CCcEEEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccc--cCceeccccchHhheecCCCCEeecccc
Confidence            456899999999999999997642  134899999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      +++........      .    .+|+.||               |||++.+.. ++.++||||||++++|+++.
T Consensus       149 ~s~~~~~~~~~------~----~~~~~y~---------------aPE~l~~~~-~t~~sDIwSfG~il~el~t~  196 (262)
T d1byga_         149 LTKEASSTQDT------G----KLPVKWT---------------APEALREKK-FSTKSDVWSFGILLWEIYSF  196 (262)
T ss_dssp             C----------------------CCTTTS---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHTT
T ss_pred             cceecCCCCcc------c----cccccCC---------------ChHHHhCCC-CChHHHHHhHHHHHHHHHHC
Confidence            99865432211      1    5677787               899887654 58999999999999999864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-40  Score=307.06  Aligned_cols=207  Identities=27%  Similarity=0.303  Sum_probs=173.7

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcC-CCCCcceEEeE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRL-SHPNLVKLLGY  163 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~l~~~  163 (376)
                      ...++|++.+.||+|+||.||+|.+...    .+..+++.||||+++.... .....+.+|+.+++++ +|||||+++++
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~   95 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEecc----ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            3457899999999999999999987532    2334688999999987543 4456788999999999 59999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCC
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNP--------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKA  229 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp  229 (376)
                      +.+++..++|||||++|+|.+++.+...              ....+++..+..++.||+.||+|||  .++||||||||
T Consensus        96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH--~~~ivHrDLKp  173 (311)
T d1t46a_          96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAA  173 (311)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSG
T ss_pred             EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccccc
Confidence            9999999999999999999999976532              1235899999999999999999999  59999999999


Q ss_pred             CCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccc
Q 017177          230 SNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNS  309 (376)
Q Consensus       230 ~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s  309 (376)
                      +|||++.++.+|++|||+++............. .    .||+.|+               |||++.+. ..+.++||||
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~-~----~gt~~y~---------------aPE~~~~~-~~~~~~DIwS  232 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGN-A----RLPVKWM---------------APESIFNC-VYTFESDVWS  232 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSS-S----EECGGGC---------------CHHHHHHC-CCCHHHHHHH
T ss_pred             ccccccccCcccccccchheeccCCCcceEeee-c----ccChHHc---------------CHHHhcCC-CCCCcccccc
Confidence            999999999999999999998765443322222 2    8899999               89987654 4689999999


Q ss_pred             eeeeehhhcc
Q 017177          310 FAFVFSCVFS  319 (376)
Q Consensus       310 ~g~v~~~~~~  319 (376)
                      ||++++|+++
T Consensus       233 ~G~~l~ellt  242 (311)
T d1t46a_         233 YGIFLWELFS  242 (311)
T ss_dssp             HHHHHHHHHT
T ss_pred             hHHHHHHHHh
Confidence            9999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.3e-40  Score=304.00  Aligned_cols=197  Identities=22%  Similarity=0.234  Sum_probs=166.3

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ++|++++.||+|+||+||+|++.          +++.||||+++....  ...+.+.+|+.+|++++||||+++++++.+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~   71 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT   71 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeC----------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence            57999999999999999999654          378999999977543  224788999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ++..+++||++.++.+..+....    ..+++..+..++.||+.||+|||  +.+||||||||+|||++.+|.+|++|||
T Consensus        72 ~~~~~i~~e~~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH--~~~IvHrDiKp~NIll~~~~~~kl~DfG  145 (286)
T d1ob3a_          72 KKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFG  145 (286)
T ss_dssp             SSCEEEEEECCSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECCTT
T ss_pred             CCceeEEEEeehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhc--cCcEEecCCCCceeeEcCCCCEEecccc
Confidence            99999999999876666655443    56999999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYRT  323 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~~  323 (376)
                      ++...........  ..     .||+.|+               +||++.+..+.+.++|+||+|++++|+++..-+
T Consensus       146 ~a~~~~~~~~~~~--~~-----~~~~~y~---------------~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~p  200 (286)
T d1ob3a_         146 LARAFGIPVRKYT--HE-----IVTLWYR---------------APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL  200 (286)
T ss_dssp             HHHHHCC----------------CCCTTC---------------CHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cceecccCccccc--ee-----cccchhh---------------hHHHHhCCCCCCcceeehhcCcHHHHHHHCCCC
Confidence            9987655433211  11     6788888               899999888889999999999999999965433

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-41  Score=309.56  Aligned_cols=201  Identities=26%  Similarity=0.331  Sum_probs=163.3

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-ChhhHHHHHHHHHHHhcC-CCCCcceEEeEEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWE  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~  166 (376)
                      ++|++.++||+|+||.||+|.+...       +....||||.++.. .....+.+.+|+++|+++ +||||+++++++.+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~   82 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKD-------GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   82 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEET-------TEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCC-------CeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence            5789999999999999999976531       11235788887644 334456789999999999 69999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEE
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRN------------PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL  234 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl  234 (376)
                      ++.+|+||||+++|+|.++|.+..            .....+++..+..++.||+.||.|||  +++|+||||||+|||+
T Consensus        83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH--~~~iiHrDlkp~NIL~  160 (309)
T d1fvra_          83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILV  160 (309)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEE
T ss_pred             CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh--cCCccccccccceEEE
Confidence            999999999999999999997541            22356899999999999999999999  5999999999999999


Q ss_pred             cCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeee
Q 017177          235 DGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVF  314 (376)
Q Consensus       235 ~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~  314 (376)
                      +.++.+||+|||+++..........        ..||+.|+               +||++.+.. ++.++||||||+++
T Consensus       161 ~~~~~~kl~DfG~a~~~~~~~~~~~--------~~gt~~y~---------------aPE~l~~~~-~~~~sDvwSfGvil  216 (309)
T d1fvra_         161 GENYVAKIADFGLSRGQEVYVKKTM--------GRLPVRWM---------------AIESLNYSV-YTTNSDVWSYGVLL  216 (309)
T ss_dssp             CGGGCEEECCTTCEESSCEECCC------------CCTTTC---------------CHHHHHHCE-ECHHHHHHHHHHHH
T ss_pred             cCCCceEEccccccccccccccccc--------eecCCccc---------------chHHhccCC-CCccceeehhHHHH
Confidence            9999999999999986544332211        16778888               899887765 58899999999999


Q ss_pred             hhhccccc
Q 017177          315 SCVFSFYR  322 (376)
Q Consensus       315 ~~~~~~y~  322 (376)
                      +|+++...
T Consensus       217 ~ell~~~~  224 (309)
T d1fvra_         217 WEIVSLGG  224 (309)
T ss_dssp             HHHHTTSC
T ss_pred             HHHHhcCC
Confidence            99885433

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-41  Score=307.51  Aligned_cols=210  Identities=24%  Similarity=0.298  Sum_probs=167.5

Q ss_pred             hhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHhcC-CCCCcceEEeE
Q 017177           86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRL-SHPNLVKLLGY  163 (376)
Q Consensus        86 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~l~~~  163 (376)
                      ...++|++++.||+|+||.||+|+.....  ......+..||||+++.... .....+.+|...+.++ +|||||+++++
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~--~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLD--KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCC--cccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            34578999999999999999999765421  01123356899999987643 4457788999999988 69999999999


Q ss_pred             EEeCCeEEEEEeccCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCC
Q 017177          164 CWEDKELLLVYEYMQRGSLENHLFRRNP------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASN  231 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~N  231 (376)
                      +.+++.+++|||||++|+|.+++..+..            ....+++..++.++.||+.||+|||  +++||||||||+|
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH--~~~ivHrDiKp~N  165 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARN  165 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGG
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh--hCCEEeeeecccc
Confidence            9999999999999999999999976532            1245899999999999999999999  5999999999999


Q ss_pred             EEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhcccccccccee
Q 017177          232 ILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFA  311 (376)
Q Consensus       232 ILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g  311 (376)
                      ||++.++.+||+|||+++.............     ..||+.||               |||++.+.. ++.++||||||
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~-----~~~~~~y~---------------aPE~l~~~~-y~~k~DiwS~G  224 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTN-----GRLPVKWM---------------APEALFDRI-YTHQSDVWSFG  224 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTT-----SCCGGGGS---------------CHHHHHHCC-CCHHHHHHHHH
T ss_pred             eeecCCCCeEeccchhhcccccccccccccc-----CCCChhhh---------------hhhHhcCCC-CCchhhhHHhH
Confidence            9999999999999999998766443321111     17888888               899887755 58899999999


Q ss_pred             eeehhhccc
Q 017177          312 FVFSCVFSF  320 (376)
Q Consensus       312 ~v~~~~~~~  320 (376)
                      +|++|++++
T Consensus       225 vvl~ell~~  233 (299)
T d1fgka_         225 VLLWEIFTL  233 (299)
T ss_dssp             HHHHHHHTT
T ss_pred             HHHHHhccC
Confidence            999999864

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-40  Score=304.23  Aligned_cols=196  Identities=23%  Similarity=0.252  Sum_probs=157.8

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeCC
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK  168 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~  168 (376)
                      ++|.+.+.||+|+||.||+|+++           ++.||||+++...... .....|+..+..++||||+++++++.+++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-----------g~~vAvK~~~~~~~~~-~~~e~ei~~~~~~~HpnIv~~~~~~~~~~   70 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDN   70 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-----------CEEEEEEEECccchhH-HHHHHHHHHHhhCCCCcCcceEEEEEeCC
Confidence            45788899999999999999753           7789999997543221 22234555666789999999999997654


Q ss_pred             ----eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCcEecCCCCCCEEEcCCC
Q 017177          169 ----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS------EKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       169 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~------~~~iiHrDlKp~NILl~~~g  238 (376)
                          .+|+|||||++|+|.+++++.     .+++..+..++.|++.||.|||+.      +++||||||||+||||+.+|
T Consensus        71 ~~~~~~~lv~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~  145 (303)
T d1vjya_          71 GTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  145 (303)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred             CcceEEEEEEecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC
Confidence                589999999999999999764     489999999999999999999952      36999999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeEE-EeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhh-----hccccccccceee
Q 017177          239 FLFDSHLLIYVYFKRHYIYIY-IHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIK-----YLTLLKYSNSFAF  312 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~-~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~-----~~~~~~dv~s~g~  312 (376)
                      .+||+|||+++.......... ....    ..||+.||               |||++.+..     .++.++||||||+
T Consensus       146 ~~Kl~DFGl~~~~~~~~~~~~~~~~~----~~gt~~y~---------------aPE~~~~~~~~~~~~~~~k~Di~S~Gv  206 (303)
T d1vjya_         146 TCCIADLGLAVRHDSATDTIDIAPNH----RVGTKRYM---------------APEVLDDSINMKHFESFKRADIYAMGL  206 (303)
T ss_dssp             CEEECCCTTCEEEETTTTEECC--------CCSCGGGC---------------CHHHHTTCSCTTCHHHHHHHHHHHHHH
T ss_pred             CeEEEecCccccccCCCcceeccccc----eecccCcC---------------ChhhccccccccCCCcCcchhhhhhHH
Confidence            999999999998765433211 1122    27899999               899887642     3578899999999


Q ss_pred             eehhhccc
Q 017177          313 VFSCVFSF  320 (376)
Q Consensus       313 v~~~~~~~  320 (376)
                      +++|+++.
T Consensus       207 vl~el~tg  214 (303)
T d1vjya_         207 VFWEIARR  214 (303)
T ss_dssp             HHHHHHHT
T ss_pred             HHHHHhhC
Confidence            99999854

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-39  Score=300.42  Aligned_cols=197  Identities=23%  Similarity=0.300  Sum_probs=161.3

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-ChhhHHHHHHHHHHHhcCCCCCcceEEeEEEe-CCeEE
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE-DKELL  171 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-~~~~~  171 (376)
                      .++||+|+||+||+|.+...      ..+...||||+++.. .....+++.+|+++|++++||||+++++++.+ ++..+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~------~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~  105 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDN------DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  105 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred             ceEEeecCCeEEEEEEEECC------CCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence            57899999999999987542      122457999999754 44566889999999999999999999999876 46899


Q ss_pred             EEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEcceeeeeee
Q 017177          172 LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLLIYVYF  251 (376)
Q Consensus       172 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~~  251 (376)
                      +|||||++|+|.+++....   ..+++..++.++.|++.||.|||  ..+|+||||||+||||++++.+||+|||+++..
T Consensus       106 lv~E~~~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH--~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~  180 (311)
T d1r0pa_         106 VVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  180 (311)
T ss_dssp             EEEECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred             EEEEEeecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhc--ccCcccCCccHHhEeECCCCCEEEecccchhhc
Confidence            9999999999999987653   45788899999999999999999  599999999999999999999999999999977


Q ss_pred             ccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          252 KRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       252 ~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      ...........+   ...||+.|+               +||.+.... .+.++||||||++++|+++.
T Consensus       181 ~~~~~~~~~~~~---~~~gt~~y~---------------aPE~~~~~~-~~~ksDI~SfGivl~El~t~  230 (311)
T d1r0pa_         181 YDKEFDSVHNKT---GAKLPVKWM---------------ALESLQTQK-FTTKSDVWSFGVLLWELMTR  230 (311)
T ss_dssp             TTTTCCCTTCTT---CSSCCGGGS---------------CHHHHHHCC-CCHHHHHHHHHHHHHHHHTT
T ss_pred             cccccccceecc---ccccccccc---------------ChHHHhcCC-CCChhHhhhhHHHHHHHHHC
Confidence            554332111100   016788888               899777654 58999999999999999864

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-40  Score=306.56  Aligned_cols=203  Identities=18%  Similarity=0.182  Sum_probs=162.2

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      .++|++++.||+|+||+||+|++.         .+++.||||++.....  ...+++.+|+.+|++++||||+++++++.
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~   79 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHR---------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR   79 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cCCEEEEEEEecCcCeEEEEEEEC---------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeee
Confidence            468999999999999999999544         4689999999865422  33467889999999999999999999886


Q ss_pred             e--------CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCC
Q 017177          166 E--------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGV  237 (376)
Q Consensus       166 ~--------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~  237 (376)
                      .        ++.+|+||||++++.+.......    ..+++..++.++.||+.||.|||  +++|+||||||+|||++.+
T Consensus        80 ~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH--~~~ivHrDlKp~NILl~~~  153 (318)
T d3blha1          80 TKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRD  153 (318)
T ss_dssp             C----------CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTT
T ss_pred             cccccccccCceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhc--cCCEEecCcCchheeecCC
Confidence            5        34689999999876655443322    56899999999999999999999  5999999999999999999


Q ss_pred             CcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhh
Q 017177          238 GFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCV  317 (376)
Q Consensus       238 g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~  317 (376)
                      +.+|++|||+++.........   ....+..+||+.|+               |||++.+...++.++||||+|++++|+
T Consensus       154 ~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~gT~~Y~---------------aPE~~~~~~~~~~k~DiwSlGvil~el  215 (318)
T d3blha1         154 GVLKLADFGLARAFSLAKNSQ---PNRYTNRVVTLWYR---------------PPELLLGERDYGPPIDLWGAGCIMAEM  215 (318)
T ss_dssp             SCEEECCCTTCEECCC--------CCCCCSCCSCGGGC---------------CHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             CcEEeeecceeeecccccccc---cccccceecCHHHh---------------hHHHHcCCCCCCcHHHcccCCceeeeH
Confidence            999999999998765433221   11112227899999               899998887789999999999999999


Q ss_pred             cccccc
Q 017177          318 FSFYRT  323 (376)
Q Consensus       318 ~~~y~~  323 (376)
                      ++...+
T Consensus       216 ~~g~~p  221 (318)
T d3blha1         216 WTRSPI  221 (318)
T ss_dssp             HHSSCS
T ss_pred             hhCCCC
Confidence            865444

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-39  Score=298.33  Aligned_cols=197  Identities=22%  Similarity=0.259  Sum_probs=169.2

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ++|++++.||+|+||+||+|++.         .+++.||||+++...  ......+.+|+.+|+.++||||+++++++.+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   72 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNR---------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS   72 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CCCEeeeEEecCcCeEEEEEEEC---------CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence            57999999999999999999543         468999999986543  3446788999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEEccee
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFDSHLL  246 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl~Dfg  246 (376)
                      ....++|||++.+++|..++...    ..+++..+..++.|++.||+|||  +++|+||||||+|||++.++.+|++|||
T Consensus        73 ~~~~~iv~~~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH--~~~IvHrDiKP~NIli~~~~~~kl~DFG  146 (292)
T d1unla_          73 DKKLTLVFEFCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFG  146 (292)
T ss_dssp             SSEEEEEEECCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             ccceeEEeeeccccccccccccc----cccchhHHHHHHHHHHHHHHHhh--cCCEeeecccCcccccccCCceeeeecc
Confidence            99999999999998888877654    55899999999999999999999  5999999999999999999999999999


Q ss_pred             eeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          247 IYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       247 ~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      .++............       .+++.|+               +||++.+..+.+.++||||+|++++|+++...
T Consensus       147 ~a~~~~~~~~~~~~~-------~~~~~~~---------------~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~  200 (292)
T d1unla_         147 LARAFGIPVRCYSAE-------VVTLWYR---------------PPDVLFGAKLYSTSIDMWSAGCIFAELANAGR  200 (292)
T ss_dssp             TCEECCSCCSCCCSC-------CSCGGGC---------------CHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSC
T ss_pred             hhhcccCCCccceee-------ccccchh---------------hhhHhccCCCCCchhhccccchHHHHHhhCCC
Confidence            999876543321111       4556666               79998888888999999999999999986443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-40  Score=308.13  Aligned_cols=194  Identities=22%  Similarity=0.195  Sum_probs=158.7

Q ss_pred             CCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCcceEEeEEEeC--
Q 017177           90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED--  167 (376)
Q Consensus        90 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--  167 (376)
                      +|+.+++||+|+||+||+|++.         .+++.||||++.....    ...+|+.+|++++||||++++++|...  
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~---------~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~   87 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLC---------DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGE   87 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred             CcEeeeEEeeCcCeEEEEEEEC---------CCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence            5888999999999999999544         4689999999976542    234799999999999999999998643  


Q ss_pred             ----CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC-cEEE
Q 017177          168 ----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG-FLFD  242 (376)
Q Consensus       168 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g-~~kl  242 (376)
                          .++|||||||+++ +.+.+.........+++..++.++.||+.||+|||  .++|+||||||+|||++.++ .+||
T Consensus        88 ~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH--~~~IiHrDiKp~NILl~~~~~~~kl  164 (350)
T d1q5ka_          88 KKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKL  164 (350)
T ss_dssp             CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTTCCEEE
T ss_pred             cCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH--hcCCcccCCCcceEEEecCCCceeE
Confidence                3589999999765 44444332222356999999999999999999999  59999999999999999776 8999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccccc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSFYR  322 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~y~  322 (376)
                      +|||+++..........    .    +||+.|+               |||++.+...++.++||||+|++++|+++...
T Consensus       165 ~DFG~a~~~~~~~~~~~----~----~gt~~y~---------------aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~  221 (350)
T d1q5ka_         165 CDFGSAKQLVRGEPNVS----Y----ICSRYYR---------------APELIFGATDYTSSIDVWSAGCVLAELLLGQP  221 (350)
T ss_dssp             CCCTTCEECCTTSCCCS----C----CSCTTSC---------------CHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSC
T ss_pred             ecccchhhccCCccccc----c----ccccccc---------------ChHHhhcccCCCcceeecccceEEEehhhCCC
Confidence            99999998765433311    1    7788888               89988888788999999999999999996543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-40  Score=308.41  Aligned_cols=197  Identities=23%  Similarity=0.207  Sum_probs=161.4

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHhcCCCCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~  166 (376)
                      ..+|++++.||+|+||+||+|..         +.+++.||||+++... ....+.+.+|+.+|+.++||||+++++++..
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~   77 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYD---------NVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA   77 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEE---------TTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEE---------CCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEee
Confidence            45799999999999999999954         3468999999997653 3445788899999999999999999999876


Q ss_pred             CC-----eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEE
Q 017177          167 DK-----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLF  241 (376)
Q Consensus       167 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~k  241 (376)
                      +.     .+|++ +++.+|+|.+++...     .+++..++.++.|++.||+|||  +++||||||||+|||++.+|.+|
T Consensus        78 ~~~~~~~~~~l~-~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH--~~~iiHRDIKp~NILl~~~~~~k  149 (345)
T d1pmea_          78 PTIEQMKDVYLV-THLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLK  149 (345)
T ss_dssp             SSTTTCCCEEEE-EECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEE
T ss_pred             ccccccceEEEE-EeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCcceEEECCCCCEE
Confidence            53     34555 556689999999653     4899999999999999999999  59999999999999999999999


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      |+|||++..............+    .+||+.|+               |||++.....++.++|+||+|++++++++-
T Consensus       150 l~DfG~a~~~~~~~~~~~~~~~----~~gt~~y~---------------aPE~l~~~~~~~~~~DiwSlG~il~eml~g  209 (345)
T d1pmea_         150 ICDFGLARVADPDHDHTGFLTE----YVATRWYR---------------APEIMLNSKGYTKSIDIWSVGCILAEMLSN  209 (345)
T ss_dssp             ECCCTTCEECCGGGCBCCTTCC----CCSCGGGC---------------CGGGTTTBCSCSTHHHHHHHHHHHHHHHHS
T ss_pred             EcccCceeeccCCCccceeecc----ccccceec---------------hHHHhhcCCCCCchhhhhccCceehHHhhC
Confidence            9999999977554332212222    27899999               899887777778999999999999999854

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-40  Score=303.24  Aligned_cols=200  Identities=24%  Similarity=0.234  Sum_probs=167.3

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh----hhHHHHHHHHHHHhcCCC-CCcceEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM----QGFEEWQSEVNFLGRLSH-PNLVKLLG  162 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~h-~nIv~l~~  162 (376)
                      .++|++++.||+|+||+||+|...      ..+.+++.||||+++....    ...+.+.+|+.++++++| |||+++++
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~------~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~   96 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKI------SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY   96 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEEC------SSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred             hhceEEEEEEecCCCeEEEEEEEC------ccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeee
Confidence            367999999999999999999654      2234689999999875421    234567889999999976 89999999


Q ss_pred             EEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCcEEE
Q 017177          163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGFLFD  242 (376)
Q Consensus       163 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~~kl  242 (376)
                      ++.+...++++|||+.+|+|.+++...    ..+++..+..++.||+.||.|||  +++|+||||||+|||++.+|.+||
T Consensus        97 ~~~~~~~~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH--~~~ivHrDiKp~Nill~~~~~vkL  170 (322)
T d1vzoa_          97 AFQTETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVL  170 (322)
T ss_dssp             EEEETTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred             eeccCCceeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhh--cCCEEeccCCccceeecCCCCEEE
Confidence            999999999999999999999999877    44789999999999999999999  599999999999999999999999


Q ss_pred             cceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhh-hccccccccceeeeehhhccc
Q 017177          243 SHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIK-YLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       243 ~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~-~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      +|||+++.+.......  ..+.    .||+.|+               +||++.+.. +.+.++||||+|++++++++.
T Consensus       171 ~DFG~a~~~~~~~~~~--~~~~----~g~~~~~---------------~pe~~~~~~~~~~~ksDIWSlG~iLyelltG  228 (322)
T d1vzoa_         171 TDFGLSKEFVADETER--AYDF----CGTIEYM---------------APDIVRGGDSGHDKAVDWWSLGVLMYELLTG  228 (322)
T ss_dssp             SCSSEEEECCGGGGGG--GCGG----GSCCTTC---------------CHHHHTTCC---CTHHHHHHHHHHHHHHHHS
T ss_pred             eeccchhhhccccccc--cccc----ccccccc---------------hhHHhhcCCcCCCchhhhHHHHHHHHHHHhC
Confidence            9999998775433321  1112    6778888               899887654 567899999999999999964

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-39  Score=305.30  Aligned_cols=195  Identities=20%  Similarity=0.190  Sum_probs=161.4

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++++.||+|+||+||+|.+         +.+++.||||+++..  .....+.+.+|+.+|+.++|||||+++++|
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~   86 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVD---------GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVF   86 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEE---------TTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEE---------CCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEe
Confidence            457899999999999999999954         346899999999764  334456788999999999999999999999


Q ss_pred             EeCC------eEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC
Q 017177          165 WEDK------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG  238 (376)
Q Consensus       165 ~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g  238 (376)
                      ...+      .+|+||||| +.+|..+++.     ..+++..++.++.||+.||.|||  +++|+||||||+|||++.++
T Consensus        87 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH--~~~IiHrDiKp~NIL~~~~~  158 (346)
T d1cm8a_          87 TPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDC  158 (346)
T ss_dssp             CSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTC
T ss_pred             ccCccccccceEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHH--hCCCcccccCcchhhccccc
Confidence            7654      579999999 5678877654     34899999999999999999999  59999999999999999999


Q ss_pred             cEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhc
Q 017177          239 FLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVF  318 (376)
Q Consensus       239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~  318 (376)
                      .+|++|||+++........          ..||+.|+               |||++.+..+.+.++||||+|+++++++
T Consensus       159 ~~kl~Dfg~a~~~~~~~~~----------~~~t~~y~---------------aPE~~~~~~~~~~~~DiwSlGvil~ell  213 (346)
T d1cm8a_         159 ELKILDFGLARQADSEMTG----------YVVTRWYR---------------APEVILNWMRYTQTVDIWSVGCIMAEMI  213 (346)
T ss_dssp             CEEECCCTTCEECCSSCCS----------SCSCGGGC---------------CTHHHHTTTCCCTTHHHHHHHHHHHHHH
T ss_pred             ccccccccceeccCCcccc----------cccccccc---------------CHHHHcCCCCCCccchhhcchHHHHHHH
Confidence            9999999999977553221          17888888               8999988888899999999999999998


Q ss_pred             ccccc
Q 017177          319 SFYRT  323 (376)
Q Consensus       319 ~~y~~  323 (376)
                      +...+
T Consensus       214 ~g~~p  218 (346)
T d1cm8a_         214 TGKTL  218 (346)
T ss_dssp             HSSCS
T ss_pred             HCcCC
Confidence            65433

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.8e-39  Score=300.76  Aligned_cols=189  Identities=16%  Similarity=0.184  Sum_probs=162.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~  166 (376)
                      .++|++++.||+|+||+||+|+.         +.+++.||||+++...   .+++.+|+.+|+.++ ||||++++++|..
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~---------~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~  101 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAIN---------ITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKD  101 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             CcCeEEEEEEecCcCeEEEEEEE---------CCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEe
Confidence            35799999999999999999954         4468999999998654   356789999999996 9999999999985


Q ss_pred             C--CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCC-cEEEc
Q 017177          167 D--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVG-FLFDS  243 (376)
Q Consensus       167 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g-~~kl~  243 (376)
                      .  ..+++|||||.+++|..+.       ..+++..++.++.||+.||.|||  .++|+||||||+|||++.++ .+||+
T Consensus       102 ~~~~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH--~~gIvHrDiKp~NILi~~~~~~vkl~  172 (328)
T d3bqca1         102 PVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLI  172 (328)
T ss_dssp             TTTCSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             cCCCceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHh--hcccccccccccceEEcCCCCeeeec
Confidence            4  5699999999999987654       34899999999999999999999  59999999999999998765 69999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      |||+++.........    +.    +||+.|+               |||++.+...++.++|+||+|++++++++.
T Consensus       173 DFG~a~~~~~~~~~~----~~----~~t~~y~---------------aPE~~~~~~~~~~~~DiwslG~~l~e~~~g  226 (328)
T d3bqca1         173 DWGLAEFYHPGQEYN----VR----VASRYFK---------------GPELLVDYQMYDYSLDMWSLGCMLASMIFR  226 (328)
T ss_dssp             CGGGCEECCTTCCCC----SC----CSCGGGC---------------CHHHHTTCCCCCTHHHHHHHHHHHHHHHHT
T ss_pred             ccccceeccCCCccc----cc----ccCcccc---------------CcccccCCCCCCcccchhhhhhhhHHhccC
Confidence            999999876543331    11    6788888               899998888789999999999999998854

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-39  Score=296.74  Aligned_cols=201  Identities=22%  Similarity=0.276  Sum_probs=160.0

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHhcC---CCCCcceEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRL---SHPNLVKLL  161 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l---~h~nIv~l~  161 (376)
                      ..++|++++.||+|+||+||+|++..        ..++.||||+++....  .....+.+|+.+|+.|   +||||++++
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~--------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~   76 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF   76 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEEC--------CCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceee
Confidence            34689999999999999999996532        1267899999865322  1223456788777766   799999999


Q ss_pred             eEEEe-----CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC
Q 017177          162 GYCWE-----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG  236 (376)
Q Consensus       162 ~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~  236 (376)
                      ++|..     ...++++|||++++.+.......   ...+++..++.++.|++.||+|||  +++|+||||||+|||++.
T Consensus        77 ~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH--~~~ivHrDiKp~NILi~~  151 (305)
T d1blxa_          77 DVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTS  151 (305)
T ss_dssp             EEEEEEECSSEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECT
T ss_pred             eeecccccccCceEEEEEEeccCCchhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHH--hCCEEecCCCccEEEEcC
Confidence            99864     24689999999887665444333   256899999999999999999999  599999999999999999


Q ss_pred             CCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehh
Q 017177          237 VGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSC  316 (376)
Q Consensus       237 ~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~  316 (376)
                      +|.+||+|||+++.........    +.    .||+.||               |||++.+.. ++.++||||+|++++|
T Consensus       152 ~~~~kl~dfg~~~~~~~~~~~~----~~----~gT~~Y~---------------APE~~~~~~-y~~~~DiwSlG~il~e  207 (305)
T d1blxa_         152 SGQIKLADFGLARIYSFQMALT----SV----VVTLWYR---------------APEVLLQSS-YATPVDLWSVGCIFAE  207 (305)
T ss_dssp             TCCEEECSCCSCCCCCGGGGGC----CC----CCCCTTC---------------CHHHHTTCC-CCTHHHHHHHHHHHHH
T ss_pred             CCCeeecchhhhhhhcccccCC----Cc----ccChhhc---------------CcchhcCCC-CChhehhhchHHHHHH
Confidence            9999999999998765443321    11    7889998               899888765 4889999999999999


Q ss_pred             hccccccc
Q 017177          317 VFSFYRTT  324 (376)
Q Consensus       317 ~~~~y~~~  324 (376)
                      +++...+.
T Consensus       208 ll~g~~pf  215 (305)
T d1blxa_         208 MFRRKPLF  215 (305)
T ss_dssp             HHHSSCSC
T ss_pred             HHHCCCCC
Confidence            99765443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.8e-39  Score=293.83  Aligned_cols=200  Identities=19%  Similarity=0.141  Sum_probs=164.1

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~  166 (376)
                      .++|++++.||+|+||+||+|++.         .+++.||||++.....  ...+.+|+++++.++ |+||+.+++++..
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~---------~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~   72 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNL---------LNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE   72 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEET---------TTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence            468999999999999999999543         4689999999865432  235678999999998 5999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcC-----CCcEE
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-----VGFLF  241 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~-----~g~~k  241 (376)
                      +...++||||+ +++|.+++....   ..+++..+..++.|++.||.|||  +++|+||||||+|||++.     ++.+|
T Consensus        73 ~~~~~~vme~~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH--~~giiHrDiKp~Nili~~~~~~~~~~vk  146 (293)
T d1csna_          73 GLHNVLVIDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIY  146 (293)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred             CCccEEEEEec-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHH--HCCceeccCCccceeecCcccccCCceE
Confidence            99999999999 679999987653   45899999999999999999999  699999999999999964     67899


Q ss_pred             EcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          242 DSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       242 l~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      |+|||+|+.+..................|||.||               |||++.+.. ++.++|+||+|++++++++-
T Consensus       147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~---------------aPE~~~~~~-~~~~~DiwSlG~~l~elltg  209 (293)
T d1csna_         147 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM---------------SINTHLGRE-QSRRDDLEALGHVFMYFLRG  209 (293)
T ss_dssp             ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTC---------------CHHHHTTCC-CCHHHHHHHHHHHHHHHHHS
T ss_pred             EcccceeEEcccCccccceeecccCceEEchhhc---------------CHHHhcCCC-CChHHHHHHhhHHHHHHHhC
Confidence            9999999987553221111111111127999999               999988765 58899999999999999853

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-38  Score=297.39  Aligned_cols=194  Identities=20%  Similarity=0.176  Sum_probs=161.1

Q ss_pred             hcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEE
Q 017177           87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYC  164 (376)
Q Consensus        87 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~  164 (376)
                      ..++|++++.||+|+||+||+|++         +.+++.||||+++...  ....+++.+|+.+|+.++||||+++++++
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~   86 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFD---------TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   86 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEE---------TTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEE---------CCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            357899999999999999999954         4469999999998653  34456788999999999999999999998


Q ss_pred             EeC-----CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc
Q 017177          165 WED-----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF  239 (376)
Q Consensus       165 ~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~  239 (376)
                      ...     ...+++|+++.+|+|.+++..     ..+++..++.++.||+.||+|||  +++|+||||||+|||++.+|.
T Consensus        87 ~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH--~~giiHrDiKp~NILi~~~~~  159 (348)
T d2gfsa1          87 TPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCE  159 (348)
T ss_dssp             CSCSSTTTCCCCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCC
T ss_pred             eeccccccCceEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHH--hCCCcccccCCcccccccccc
Confidence            643     334666677789999999854     34899999999999999999999  599999999999999999999


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +|++|||++.........      .    .||+.|+               |||++.+..+.+.++|+||+|++++++++
T Consensus       160 ~kl~dfg~a~~~~~~~~~------~----~g~~~y~---------------apE~~~~~~~~~~~~DiwSlGv~l~~ll~  214 (348)
T d2gfsa1         160 LKILDFGLARHTDDEMTG------Y----VATRWYR---------------APEIMLNWMHYNQTVDIWSVGCIMAELLT  214 (348)
T ss_dssp             EEECCC----CCTGGGSS------S----CHHHHTS---------------CHHHHTTCSCCCTTHHHHHHHHHHHHHHH
T ss_pred             ccccccchhcccCccccc------c----ccccccc---------------CchhhcCCccCCcccchhhhhHHHHHHHh
Confidence            999999999876553321      1    6778888               89998888888999999999999999986


Q ss_pred             cc
Q 017177          320 FY  321 (376)
Q Consensus       320 ~y  321 (376)
                      ..
T Consensus       215 g~  216 (348)
T d2gfsa1         215 GR  216 (348)
T ss_dssp             SS
T ss_pred             CC
Confidence            53

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6e-38  Score=288.00  Aligned_cols=200  Identities=17%  Similarity=0.116  Sum_probs=158.0

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCC-cceEEeEEEe
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN-LVKLLGYCWE  166 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n-Iv~l~~~~~~  166 (376)
                      .++|++.+.||+|+||.||+|++.         .+++.||||++......  ..+.+|+++++.++|+| |+.+..++.+
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~---------~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~   74 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDI---------AAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAE   74 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEEC---------CCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEec
Confidence            357999999999999999999544         36889999998765332  45778999999998665 5555666778


Q ss_pred             CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc---CCCcEEEc
Q 017177          167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD---GVGFLFDS  243 (376)
Q Consensus       167 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~---~~g~~kl~  243 (376)
                      ++..++||||+ +++|.+.+....   ..+++..+..++.|++.||+|||  .++||||||||+|||++   .+..+|++
T Consensus        75 ~~~~~ivme~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~iiHrDiKp~NIl~~~~~~~~~vkl~  148 (299)
T d1ckia_          75 GDYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYII  148 (299)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred             CCEEEEEEEEc-CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHhhccccccCCCceeeee
Confidence            88999999999 557777665542   56899999999999999999999  59999999999999985   45579999


Q ss_pred             ceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhccc
Q 017177          244 HLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFSF  320 (376)
Q Consensus       244 Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~~  320 (376)
                      |||+|+.+..................||+.||               |||++.+.. ++.++||||+|++++|+++.
T Consensus       149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~---------------aPE~~~~~~-~~~~~DiwSlG~~l~el~tg  209 (299)
T d1ckia_         149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYA---------------SINTHLGIE-QSRRDDLESLGYVLMYFNLG  209 (299)
T ss_dssp             CCSSCEECBCTTTCCBCCCCBCCSCCCCSSSC---------------CHHHHTTBC-CCHHHHHHHHHHHHHHHHHS
T ss_pred             ccCcceeccccccccceeccccCCcCCCcccc---------------CHHHHhCCC-CCChhhEEecCHHHHHHHhC
Confidence            99999987654322111000011127999999               899888766 58899999999999999963

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-37  Score=289.01  Aligned_cols=194  Identities=20%  Similarity=0.181  Sum_probs=152.7

Q ss_pred             cCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHhcCCCCCcceEEeEEE
Q 017177           88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW  165 (376)
Q Consensus        88 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~  165 (376)
                      .++|+++++||+|+||+||+|++         +.+++.||||++....  .....++.+|+.+++.++||||++++++|.
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d---------~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~   86 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYD---------AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT   86 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEE---------TTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEE---------CCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Confidence            46899999999999999999954         4469999999997543  344567889999999999999999999996


Q ss_pred             eC------CeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEcCCCc
Q 017177          166 ED------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGVGF  239 (376)
Q Consensus       166 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~~~g~  239 (376)
                      ..      ..+|+|||||.+ ++.+.+.      ..+++..++.++.||+.||.|||  .++|+||||||+|||++.++.
T Consensus        87 ~~~~~~~~~~~~iv~Ey~~~-~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH--~~giiHrDlKP~Nil~~~~~~  157 (355)
T d2b1pa1          87 PQKTLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCT  157 (355)
T ss_dssp             SCCSTTTCCEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCC
T ss_pred             cccccccCceeEEEEeccch-HHHHhhh------cCCCHHHHHHHHHHHHHHHHHhh--hcccccccCCccccccccccc
Confidence            43      679999999976 4555553      34899999999999999999999  599999999999999999999


Q ss_pred             EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccceeeeehhhcc
Q 017177          240 LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNSFAFVFSCVFS  319 (376)
Q Consensus       240 ~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s~g~v~~~~~~  319 (376)
                      +|++|||+++..........        ..||+.|+               |||++.+. ..+.++|+||+|++++++++
T Consensus       158 ~kl~df~~~~~~~~~~~~~~--------~~~t~~y~---------------aPE~l~~~-~~~~~~DiwSlG~~l~ell~  213 (355)
T d2b1pa1         158 LKILDFGLARTAGTSFMMTP--------YVVTRYYR---------------APEVILGM-GYKENVDIWSVGCIMGEMVR  213 (355)
T ss_dssp             EEECCCCC-----------------------CCTTC---------------CHHHHTTC-CCCTTHHHHHHHHHHHHHHH
T ss_pred             eeeechhhhhcccccccccc--------cccccccc---------------ChhhhcCC-CCCCCcccccccchHHHHhh
Confidence            99999999987655433322        26788888               89998876 45889999999999999996


Q ss_pred             cccc
Q 017177          320 FYRT  323 (376)
Q Consensus       320 ~y~~  323 (376)
                      ..-+
T Consensus       214 g~~p  217 (355)
T d2b1pa1         214 HKIL  217 (355)
T ss_dssp             SSCS
T ss_pred             CCCC
Confidence            5544

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=2.6e-32  Score=256.67  Aligned_cols=194  Identities=19%  Similarity=0.164  Sum_probs=153.0

Q ss_pred             CCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-----------CCCc
Q 017177           89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-----------HPNL  157 (376)
Q Consensus        89 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----------h~nI  157 (376)
                      .+|+++++||+|+||+||+|+.         +.+++.||||+++.... ..+.+.+|+.+++.++           |+||
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~---------~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i   82 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKD---------MVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHI   82 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             CcEEEEEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence            3599999999999999999954         44699999999987543 3356778999888875           5789


Q ss_pred             ceEEeEEEe--CCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEEEc
Q 017177          158 VKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD  235 (376)
Q Consensus       158 v~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NILl~  235 (376)
                      +++++++..  ....+++|+++..+.......... ....+++..+..++.||+.||.|||+ ..+|+||||||+||||+
T Consensus        83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~-~~~IvHrDlKp~NIll~  160 (362)
T d1q8ya_          83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLME  160 (362)
T ss_dssp             CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEE
T ss_pred             EEEEEEeeeccccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhh-hcCcccccCChhHeeee
Confidence            999988754  456777777776554333332222 13568999999999999999999995 58999999999999998


Q ss_pred             CCCc------EEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHHHHHHHHHhhhhhccccccccc
Q 017177          236 GVGF------LFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYSVLLPRIYAWIKYLTLLKYSNS  309 (376)
Q Consensus       236 ~~g~------~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s~~apEi~~~~~~~~~~~dv~s  309 (376)
                      .++.      ++++|||.+.........          .+||+.|+               |||++.+..+ +.++|+||
T Consensus       161 ~~~~~~~~~~~kl~dfg~s~~~~~~~~~----------~~gt~~y~---------------aPE~~~~~~~-~~~~DiwS  214 (362)
T d1q8ya_         161 IVDSPENLIQIKIADLGNACWYDEHYTN----------SIQTREYR---------------SPEVLLGAPW-GCGADIWS  214 (362)
T ss_dssp             EEETTTTEEEEEECCCTTCEETTBCCCS----------CCSCGGGC---------------CHHHHHTCCC-CTHHHHHH
T ss_pred             ccCcccccceeeEeeccccccccccccc----------cccccccc---------------ChhhccccCC-Cccccccc
Confidence            6654      999999999866543221          17888888               8998887765 78999999


Q ss_pred             eeeeehhhccc
Q 017177          310 FAFVFSCVFSF  320 (376)
Q Consensus       310 ~g~v~~~~~~~  320 (376)
                      +|++++++++.
T Consensus       215 lG~il~el~~g  225 (362)
T d1q8ya_         215 TACLIFELITG  225 (362)
T ss_dssp             HHHHHHHHHHS
T ss_pred             hHHHHHHHHHC
Confidence            99999998864

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=1.1e-24  Score=185.78  Aligned_cols=133  Identities=13%  Similarity=0.111  Sum_probs=103.7

Q ss_pred             CccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCCh------------------hhHHHHHHHHHHHhcCC
Q 017177           92 KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM------------------QGFEEWQSEVNFLGRLS  153 (376)
Q Consensus        92 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~il~~l~  153 (376)
                      .+++.||+|+||.||+|...          +++.||||+++....                  .......+|...+.++.
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~----------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~   72 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE----------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ   72 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET----------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhCCEeeeCcceEEEEEECC----------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc
Confidence            46789999999999999654          378999998764211                  01123457899999999


Q ss_pred             CCCcceEEeEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEecCCCCCCEE
Q 017177          154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL  233 (376)
Q Consensus       154 h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~~~~iiHrDlKp~NIL  233 (376)
                      |++++..+++.    ..+++|||++++.+.+           ++...+..++.|++.+|.|||  .++|+||||||+|||
T Consensus        73 ~~~v~~~~~~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH--~~giiHrDiKP~NIL  135 (191)
T d1zara2          73 GLAVPKVYAWE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFY--HRGIVHGDLSQYNVL  135 (191)
T ss_dssp             TSSSCCEEEEE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHH--HTTEECSCCSTTSEE
T ss_pred             CCCcceEEEec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHh--hCCEEEccCChhhee
Confidence            99999988653    2379999998865432           233445678999999999999  599999999999999


Q ss_pred             EcCCCcEEEcceeeeeeec
Q 017177          234 LDGVGFLFDSHLLIYVYFK  252 (376)
Q Consensus       234 l~~~g~~kl~Dfg~a~~~~  252 (376)
                      +++++ ++++|||+|....
T Consensus       136 v~~~~-~~liDFG~a~~~~  153 (191)
T d1zara2         136 VSEEG-IWIIDFPQSVEVG  153 (191)
T ss_dssp             EETTE-EEECCCTTCEETT
T ss_pred             eeCCC-EEEEECCCcccCC
Confidence            99655 8899999998654

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.83  E-value=3.9e-09  Score=92.35  Aligned_cols=148  Identities=16%  Similarity=-0.008  Sum_probs=99.9

Q ss_pred             hhhhhcCCCCccceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEE
Q 017177           83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLL  161 (376)
Q Consensus        83 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~  161 (376)
                      +++.....|++.+..+-++.+.||+....           +..+.+|............+.+|...+..+. +--+.+++
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-----------~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl   76 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-----------NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVL   76 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEECS-----------SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEeC-----------CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEE
Confidence            44455567777666555556789987432           5567888876554333345677888888775 55578888


Q ss_pred             eEEEeCCeEEEEEeccCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----------------------
Q 017177          162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS-----------------------  218 (376)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~yLHs~-----------------------  218 (376)
                      .+..+++..++||++++|.++.+.....      ..   ...++.++.+.+..||+.                       
T Consensus        77 ~~~~~~~~~~lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~  147 (263)
T d1j7la_          77 HFERHDGWSNLLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLN  147 (263)
T ss_dssp             EEEEETTEEEEEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHH
T ss_pred             EEEecCCceEEEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHH
Confidence            8888889999999999998776544211      11   122333444444444420                       


Q ss_pred             ----------------------------------CCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          219 ----------------------------------EKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       219 ----------------------------------~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                                                        ...++|+|+.|.|||+++++.+-++||+.+..
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         148 NDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                              12378999999999999877677999998874

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.19  E-value=1.6e-06  Score=74.79  Aligned_cols=74  Identities=18%  Similarity=0.075  Sum_probs=51.3

Q ss_pred             eEeecCc-EEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC--CCCcceEEeEEEeCCeEEE
Q 017177           96 LLGEGGF-GRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS--HPNLVKLLGYCWEDKELLL  172 (376)
Q Consensus        96 ~lG~G~f-g~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~--h~nIv~l~~~~~~~~~~~l  172 (376)
                      .+..|.. +.||+....+          +..+++|........   .+..|...++.+.  .-.+.+++.+..+++..++
T Consensus        17 ~~~~G~s~~~v~r~~~~~----------~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~   83 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQG----------RPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL   83 (255)
T ss_dssp             ECSCTTSSCEEEEEECTT----------SCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred             EcCCcccCCeEEEEEeCC----------CCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEE
Confidence            3444543 6789875432          556888987655432   3566888777764  3446778888888888999


Q ss_pred             EEeccCCCCH
Q 017177          173 VYEYMQRGSL  182 (376)
Q Consensus       173 v~e~~~~g~L  182 (376)
                      ||++++|.++
T Consensus        84 v~~~i~G~~~   93 (255)
T d1nd4a_          84 LLGEVPGQDL   93 (255)
T ss_dssp             EEECCSSEET
T ss_pred             EEEeeecccc
Confidence            9999987654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.02  E-value=8.1e-06  Score=75.18  Aligned_cols=77  Identities=16%  Similarity=0.150  Sum_probs=49.1

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCC-------ChhhHHHHHHHHHHHhcCC-C--CCcceEEeE
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-------SMQGFEEWQSEVNFLGRLS-H--PNLVKLLGY  163 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~il~~l~-h--~nIv~l~~~  163 (376)
                      .+.||.|....||++....         .++.+++|.-...       ......+...|.+.|+.+. +  ..+++++.+
T Consensus        31 ~~eig~G~~N~vfrV~~~~---------~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~  101 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS  101 (392)
T ss_dssp             EEECCSSSSEEEEEEEC-------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred             EEEeCCCceEeEEEEEeCC---------CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE
Confidence            3578999999999985432         3678999965431       1112345567888887764 2  345666643


Q ss_pred             EEeCCeEEEEEeccCCCC
Q 017177          164 CWEDKELLLVYEYMQRGS  181 (376)
Q Consensus       164 ~~~~~~~~lv~e~~~~g~  181 (376)
                        +++..++|||++++..
T Consensus       102 --d~~~~~lvmE~L~~~~  117 (392)
T d2pula1         102 --DTEMAVTVMEDLSHLK  117 (392)
T ss_dssp             --ETTTTEEEECCCTTSE
T ss_pred             --cCCCCEEEEeccCCcc
Confidence              5566789999997643

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.04  E-value=0.0011  Score=60.44  Aligned_cols=81  Identities=15%  Similarity=-0.009  Sum_probs=51.9

Q ss_pred             cceEeecCcEEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCC-CCCcceEEeEEEeCCeEEE
Q 017177           94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLL  172 (376)
Q Consensus        94 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~l  172 (376)
                      ++.|+.|-.-.+|++...+.....  +.....|.+++..... . .....+|..+++.+. +.-..++++++.  +  ++
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~--~~~~~~vllRi~g~~~-~-~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~  118 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPI--RNEPNKVLLRVYFNPE-T-ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR  118 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCS--SSCCSEEEEEEECSCC-C-HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred             EEEcCCccccceEEEEeCCCCccc--cCCCCcEEEEecCCcc-h-hhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ce
Confidence            357888888999999776532111  1124567777765322 2 234467999999886 544567777663  2  68


Q ss_pred             EEeccCCCCH
Q 017177          173 VYEYMQRGSL  182 (376)
Q Consensus       173 v~e~~~~g~L  182 (376)
                      |+||++|.+|
T Consensus       119 I~efi~g~~l  128 (395)
T d1nw1a_         119 LEEYIPSRPL  128 (395)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeccccC
Confidence            8999987433

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.84  E-value=0.0017  Score=57.35  Aligned_cols=135  Identities=15%  Similarity=0.022  Sum_probs=74.8

Q ss_pred             EEEEEEEEcCCCCCcccCCCCcEEEEEEcCCCChhhHHHHHHHHHHHhcCCCCCc--ceEE-----eEEEeCCeEEEEEe
Q 017177          103 GRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNL--VKLL-----GYCWEDKELLLVYE  175 (376)
Q Consensus       103 g~V~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nI--v~l~-----~~~~~~~~~~lv~e  175 (376)
                      -.||++...          +|..|++|+.+.... ..+.+..|...+..|...+|  +...     ..+...+..+.+++
T Consensus        36 N~vy~v~~~----------dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~  104 (325)
T d1zyla1          36 NRVYQFQDE----------DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP  104 (325)
T ss_dssp             SEEEEECCT----------TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred             ceeEEEEcC----------CCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEe
Confidence            589998544          377899999876532 33566778888887752222  1111     12345677899999


Q ss_pred             ccCCCCH-----HHH------Hh---h----cC-CCCCC-------------------CC---HHHHHHHHHHHHHHHHH
Q 017177          176 YMQRGSL-----ENH------LF---R----RN-PSIQP-------------------LS---WDIRLKIAIGAARGLGF  214 (376)
Q Consensus       176 ~~~~g~L-----~~~------l~---~----~~-~~~~~-------------------~~---~~~~~~i~~qi~~~L~y  214 (376)
                      +++|..+     ..+      +.   .    .. .....                   ++   .......+.++...+.-
T Consensus       105 ~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~  184 (325)
T d1zyla1         105 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA  184 (325)
T ss_dssp             CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred             ecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence            9976322     111      10   0    00 00001                   11   11122233333333322


Q ss_pred             hh-c-CCCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          215 LH-T-SEKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       215 LH-s-~~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      +- . ...++||+|+.|.|||+++ | ..++||+.+..
T Consensus       185 ~~~~~~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~  220 (325)
T d1zyla1         185 HWREDFTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN  220 (325)
T ss_dssp             HCCSCSCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred             hccccCCceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence            21 1 1357899999999999974 4 35789998874

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.46  E-value=0.004  Score=54.44  Aligned_cols=32  Identities=16%  Similarity=0.052  Sum_probs=28.7

Q ss_pred             CCCcEecCCCCCCEEEcCCCcEEEcceeeeee
Q 017177          219 EKKVIYRDFKASNILLDGVGFLFDSHLLIYVY  250 (376)
Q Consensus       219 ~~~iiHrDlKp~NILl~~~g~~kl~Dfg~a~~  250 (376)
                      ..++||+|+.++||+++.++..-+.||+.+..
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccccCCcchhhhhcccccceeEeccccccc
Confidence            46899999999999999988888999998874

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=87.01  E-value=0.11  Score=44.27  Aligned_cols=104  Identities=11%  Similarity=-0.091  Sum_probs=54.9

Q ss_pred             CEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHH--HHHHHHHhhhhhcccccccc
Q 017177          231 NILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYS--VLLPRIYAWIKYLTLLKYSN  308 (376)
Q Consensus       231 NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s--~~apEi~~~~~~~~~~~dv~  308 (376)
                      ++-|.+-|..+..+-+....    .......||..|+|   |++......+.++|+||  +++.|++.+.......   .
T Consensus       148 ~~Kl~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~A---PE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~---~  217 (283)
T d1mqba_         148 VCKVSDFGLSRVLEDDPEAT----YTTSGGKIPIRWTA---PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE---L  217 (283)
T ss_dssp             CEEECCCCC---------------------CCCGGGSC---HHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT---C
T ss_pred             eEEEcccchhhcccCCCccc----eEeccCCCCccccC---HHHHccCCCCCcccccccHHHHHHHHhCCCCcccc---C
Confidence            67788888777654322211    12223457888999   99999999999999997  9999999865432221   1


Q ss_pred             ceeeeehhhccccccc-----hhhHHHHHHHhhCCCccCcc
Q 017177          309 SFAFVFSCVFSFYRTT-----MLKYQILAWQSWGPLVESHM  344 (376)
Q Consensus       309 s~g~v~~~~~~~y~~~-----~~~~~~~~~~~~~~~~~~~~  344 (376)
                      +...++..+...+++.     ...+.......|..+...+.
T Consensus       218 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  258 (283)
T d1mqba_         218 SNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRP  258 (283)
T ss_dssp             CHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSC
T ss_pred             CHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCc
Confidence            1222233333222222     23345555666766554443

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=83.83  E-value=0.16  Score=43.83  Aligned_cols=127  Identities=11%  Similarity=0.017  Sum_probs=71.9

Q ss_pred             CCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHH--HHHHHHHhhhhhcccccc
Q 017177          229 ASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYS--VLLPRIYAWIKYLTLLKY  306 (376)
Q Consensus       229 p~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s--~~apEi~~~~~~~~~~~d  306 (376)
                      ..++-|.+-|..+............   .....++..|++   |+++....+..++|+||  +++.|++.+........ 
T Consensus       166 ~~~~kL~DFG~~~~~~~~~~~~~~~---~~~~~gt~~y~a---PE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~-  238 (311)
T d1r0pa_         166 KFTVKVADFGLARDMYDKEFDSVHN---KTGAKLPVKWMA---LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-  238 (311)
T ss_dssp             TCCEEECSSGGGCCTTTTTCCCTTC---TTCSSCCGGGSC---HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---
T ss_pred             CCCEEEecccchhhcccccccccee---cccccccccccC---hHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC-
Confidence            3567777777666544332221111   112346777888   99999999999999997  99999998765432221 


Q ss_pred             ccceeeeehhhccccccc-----hhhHHHHHHHhhCCCccCcccCCChhHHHHHHHHHHhhheeeecCC
Q 017177          307 SNSFAFVFSCVFSFYRTT-----MLKYQILAWQSWGPLVESHMLQPGLWAHMVMQLQNMLQQVIFISSP  370 (376)
Q Consensus       307 v~s~g~v~~~~~~~y~~~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  370 (376)
                        +...+...+....++.     ...+.....+.|...+..+.    -..+.+..++++++.  |+++.
T Consensus       239 --~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RP----s~~ei~~~L~~i~~~--~~~~~  299 (311)
T d1r0pa_         239 --NTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRP----SFSELVSRISAIFST--FIGEH  299 (311)
T ss_dssp             ------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC----CHHHHHHHHHHHHHT--CCSCC
T ss_pred             --CHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCc----CHHHHHHHHHHHHHh--hhhhh
Confidence              2222333322222222     34566666777777765553    234555666666655  44444

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=83.50  E-value=0.16  Score=43.24  Aligned_cols=90  Identities=7%  Similarity=-0.156  Sum_probs=60.3

Q ss_pred             HHHHHHHhhcC--CCCcEec-C--CCCCCEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchh
Q 017177          208 AARGLGFLHTS--EKKVIYR-D--FKASNILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLR  282 (376)
Q Consensus       208 i~~~L~yLHs~--~~~iiHr-D--lKp~NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e  282 (376)
                      -+.....+|.-  ..+|+-. +  -...++.+.+-|..+...-................||..|++   |+........+
T Consensus       116 ~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~a---PE~~~~~~~~~  192 (293)
T d1csna_         116 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS---INTHLGREQSR  192 (293)
T ss_dssp             HHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCC---HHHHTTCCCCH
T ss_pred             HHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcC---HHHhcCCCCCh
Confidence            34445677841  1244432 2  234568888888887765443333222223334678999999   99998888999


Q ss_pred             hHHHHH--HHHHHHHhhhhh
Q 017177          283 YAILYS--VLLPRIYAWIKY  300 (376)
Q Consensus       283 ~~d~~s--~~apEi~~~~~~  300 (376)
                      ++|+||  +++.|++.|...
T Consensus       193 ~~DiwSlG~~l~elltg~~P  212 (293)
T d1csna_         193 RDDLEALGHVFMYFLRGSLP  212 (293)
T ss_dssp             HHHHHHHHHHHHHHHHSSCT
T ss_pred             HHHHHHhhHHHHHHHhCCCc
Confidence            999997  999999998754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=80.03  E-value=0.3  Score=41.72  Aligned_cols=64  Identities=6%  Similarity=-0.210  Sum_probs=34.6

Q ss_pred             CEEEcCCCcEEEcceeeeeeeccceeeEEEeeeEEEEEeeeeehhhhhcchhhHHHHH--HHHHHHHh-hhh
Q 017177          231 NILLDGVGFLFDSHLLIYVYFKRHYIYIYIHTYIIYIYIYVYIYMYIYKCLRYAILYS--VLLPRIYA-WIK  299 (376)
Q Consensus       231 NILl~~~g~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~~~gt~~y~~~~~~~e~~d~~s--~~apEi~~-~~~  299 (376)
                      ++-|.+-|..+...-......  ........++..|++   |+.........++|+||  +++.|+++ |..
T Consensus       166 ~~Kl~DFGla~~~~~~~~~~~--~~~~~~~~~t~~y~a---PE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~  232 (299)
T d1jpaa_         166 VCKVSDFGLSRFLEDDTSDPT--YTSALGGKIPIRWTA---PEAIQYRKFTSASDVWSYGIVMWEVMSYGER  232 (299)
T ss_dssp             CEEECCC-------------------------CGGGSC---HHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cEEECCcccceEccCCCCcce--eeecccccCCccccC---HHHHhcCCCCcccccccchHHHHHHHhCCCC
Confidence            577887887665432211111  111112346777888   99998889999999997  99999997 554